PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Katikireddi, SV; Hilton, S; Bonell, C; Bond, L				Katikireddi, Srinivasa Vittal; Hilton, Shona; Bonell, Chris; Bond, Lyndal			Understanding the Development of Minimum Unit Pricing of Alcohol in Scotland: A Qualitative Study of the Policy Process	PLOS ONE			English	Article							PUBLIC-HEALTH; KNOWLEDGE TRANSFER; DRINKING; IDEAS; INEQUALITIES; DEVOLUTION; DRINKERS; BRITAIN; ENGLAND; WORLD	Background: Minimum unit pricing of alcohol is a novel public health policy with the potential to improve population health and reduce health inequalities. Theories of the policy process may help to understand the development of policy innovation and in turn identify lessons for future public health research and practice. This study aims to explain minimum unit pricing's development by taking a 'multiple-lenses' approach to understanding the policy process. In particular, we apply three perspectives of the policy process (Kingdon's multiple streams, Punctuated-Equilibrium Theory, Multi-Level Governance) to understand how and why minimum unit pricing has developed in Scotland and describe implications for efforts to develop evidence-informed policymaking. Methods: Semi-structured interviews were conducted with policy actors (politicians, civil servants, academics, advocates, industry representatives) involved in the development of MUP (n = 36). Interviewees were asked about the policy process and the role of evidence in policy development. Data from two other sources (a review of policy documents and an analysis of evidence submission documents to the Scottish Parliament) were used for triangulation. Findings: The three perspectives provide complementary understandings of the policy process. Evidence has played an important role in presenting the policy issue of alcohol as a problem requiring action. Scotland-specific data and a change in the policy 'image' to a population-based problem contributed to making alcohol-related harms a priority for action. The limited powers of Scottish Government help explain the type of price intervention pursued while distinct aspects of the Scottish political climate favoured the pursuit of price-based interventions. Conclusions: Evidence has played a crucial but complex role in the development of an innovative policy. Utilising different political science theories helps explain different aspects of the policy process, with Multi-Level Governance particularly useful for highlighting important lessons for the future of public health policy.	[Katikireddi, Srinivasa Vittal; Hilton, Shona; Bond, Lyndal] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Katikireddi, Srinivasa Vittal] NHS Lothian, Dept Publ Hlth & Policy, Edinburgh, Midlothian, Scotland; [Bonell, Chris] Univ Oxford, Dept Social Policy & Intervent, Oxford, England; [Bond, Lyndal] Ctr Excellence Intervent & Prevent Sci, Melbourne, Vic, Australia	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of Oxford	Katikireddi, SV (corresponding author), Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland.	srinivasa.katikireddi@glasgow.ac.uk		BOND, LYNDAL/0000-0003-1693-5508; Katikireddi, Srinivasa/0000-0001-6593-9092; Hilton, Shona/0000-0003-0633-8152	Chief Scientist Office at the Scottish Health Directorates as part of the Evaluating Social Interventions programme at the MRC/CSO Social and Public Health Sciences Unit [25605200 68093]; Medical Research Council as part of the Understandings and Uses of Public Health Research programme [25605200 68096]; MRC [MC_UU_12017/6, MC_U130085862, MC_UU_12017/4] Funding Source: UKRI; Medical Research Council [MC_U130085862, MC_UU_12017/4, MC_UU_12017/6] Funding Source: researchfish; Chief Scientist Office [SPHSU1] Funding Source: researchfish	Chief Scientist Office at the Scottish Health Directorates as part of the Evaluating Social Interventions programme at the MRC/CSO Social and Public Health Sciences Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council as part of the Understandings and Uses of Public Health Research programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	This study received no specific funding. At the time of the research SVK and LB were funded by the Chief Scientist Office at the Scottish Health Directorates as part of the Evaluating Social Interventions programme at the MRC/CSO Social and Public Health Sciences Unit (25605200 68093). SH is funded by the Medical Research Council as part of the Understandings and Uses of Public Health Research programme (25605200 68096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Academy of Medical Sciences (AMS), 2004, CALL TIM NAT DRINK M; B, 2011, BBC NEWS; Babor T.F., 2010, ALCHOL NO ORDINARY C, V2nd, DOI DOI 10.1093/ACPROF:OSO/9780199551149.003.002; Baggott R, 2011, PUBLIC HLTH POLICY P, V2nd; Bambra C, 2010, J PUBLIC HEALTH-UK, V32, P496, DOI 10.1093/pubmed/fdq028; Banche I., 2004, PUBLIC POLICY ADMIN, V19, P31, DOI [DOI 10.1177/095207670401900103, 10.1177/095207670401900103]; Baumgartner F. R., 1993, AGENDAS INSTABILITY; Baumgartner FR, 2006, J EUR PUBLIC POLICY, V13, P959, DOI 10.1080/13501760600923805; BBC News, 2013, BBC NEWS; Beeston C, 2011, MONITORING EVALUATIN; Bennetts R., 2008, IAS BRIEFING PAPER U; Berridge V., 2005, TEMPERANCE ITS HIST; Black H, 2011, ADDICTION, V106, P729, DOI 10.1111/j.1360-0443.2010.03225.x; Black J, 2008, REGUL GOV, V2, P137, DOI 10.1111/j.1748-5991.2008.00034.x; Bloor M, 2013, SCI PUBLIC POLICY; Blyth M, 2001, WORLD POLIT, V54, P1, DOI 10.1353/wp.2001.0020; Booth A., 2008, INDEPENDENT REV EFFE; Brennan A., 2008, INDEPENDENT REV EFFE; Cabinet Office, 2003, GREEN BOOK APPR EV C; Cabinet Office, 1999, PROF POL 21 CENT REP; Cairney P., 2007, BRIT POLIT, V2, P45, DOI DOI 10.1057/PALGRAVE.BP.4200061; Cairney P., 2011, ALL POINTS N SCOTTIS; Cairney P, 2008, BRIT POLIT, V3, P350, DOI 10.1057/bp.2008.15; Cairney Paul., 2007, BRIT J POLIT INT REL, V9, P73, DOI DOI 10.1111/J.1467-856X.2007.00259.X; CAPLAN N, 1979, AM BEHAV SCI, V22, P459, DOI 10.1177/000276427902200308; Chief Medical Officer, 2008, HLTH SCOTL 2007 ANN; Davies H, 2008, J HEALTH SERV RES PO, V13, P188, DOI 10.1258/jhsrp.2008.008055; Exworthy M, 2002, POLICY POLIT, V30, P79, DOI 10.1332/0305573022501584; Gillan E, 2007, ALCOHOL PRICE POLICY; Gillan E, 2008, INFLUENCING FAMILY P; Glaser B. G., 2009, DISCOVERY GROUNDED T; Greer SL, 2009, STATE NATIONS 2008 3, P167; Hajer M, 2003, POLICY SCI, V36, P175, DOI 10.1023/A:1024834510939; Health and Sport Committee, 2010, 5 HLTH SPORT COMM SC; Hexagon Research and Consulting, 2009, AN RESP CONS SCOTT G; Hill M., 2013, PUBLIC POLICY PROCES, Vsixth; Hilton S, 2014, SOC SCI MED, V102, P157, DOI 10.1016/j.socscimed.2013.11.041; HM Government, 2012, GOV ALC STRAT; Hogwood B., 1984, POLICY ANAL REAL WOR; Holden C., 2012, PUBLIC POLICY ADMIN, V28, P253, DOI DOI 10.1177/0952076712452290; Holloway SL, 2008, T I BRIT GEOGR, V33, P532, DOI 10.1111/j.1475-5661.2008.00322.x; Hooghe L, 2003, AM POLIT SCI REV, V97, P233; House of Commons Health Committee, 2009, 1 HOUS COMM HLTH COM, V1; Innvaer Simon, 2002, J Health Serv Res Policy, V7, P239, DOI 10.1258/135581902320432778; ISD, 2009, ALC STAT SCOTL 2009; Katikireddi S. V., 2013, RELATIONSHIP EVIDENC; Katikireddi SV, 2014, EUR J PUBLIC HEALTH, V24, P490, DOI 10.1093/eurpub/ckt206; Katikireddi SV, 2012, EUR J PUBLIC HEALTH, V22, P457, DOI 10.1093/eurpub/cks091; Katikireddi SV, 2014, STUDYING PUBLIC POLICY: AN INTERNATIONAL APPROACH, P240; Katikireddi SV, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7310; Katikireddi SV, 2014, MILBANK Q IN PRESS; Keating M, 2009, CAMB J REG ECON SOC, V2, P51, DOI 10.1093/cjres/rsn024; Kingdon J.W., 2010, AGENDAS ALTERNATIVES; Kouri D., 2009, EVID POLICY, V5, P71; Latour B., 1988, SCI ACTION FOLLOW SC; Lavis JN, 2003, MILBANK Q, V81, P221, DOI 10.1111/1468-0009.t01-1-00052; Lavis JN, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000141; Leon DA, 2006, LANCET, V367, P52, DOI 10.1016/S0140-6736(06)67924-5; Lomas J, 2007, BRIT MED J, V334, P129, DOI 10.1136/bmj.39038.593380.AE; LUDBROOK A, 2001, EFFECTIVE COST EFFEC; Ludbrook A, 2008, MINIMUM PRICING ALCO; Marsh D, 2009, POLICY STUD-UK, V30, P269, DOI 10.1080/01442870902863851; Mason J., 2002, QUALITATIVE RES; Mitton C, 2007, MILBANK Q, V85, P729, DOI 10.1111/j.1468-0009.2007.00506.x; Moore SC, 2010, ALCOHOL ALCOHOLISM, V45, P403, DOI 10.1093/alcalc/agq048; NHS Health Scotland, 2012, ALC TOOLS BACKGR; NHS Health Scotland, 2008, ALC LOG MOD 1 STRAT; O'Donnell BA, 2006, INT J DRUG POLICY, V17, P367, DOI 10.1016/j.drugpo.2006.01.006; Ogilvie D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-116; Osborne T, 2004, ECON SOC, V33, P430, DOI 10.1080/0308514042000285224; Pollack MA, 2005, ANNU REV POLIT SCI, V8, P357, DOI 10.1146/annurev.polisci.8.082103.104858; Purshouse R, 2009, MODEL BASED APPRAISA; Purshouse RC, 2010, LANCET, V375, P1355, DOI 10.1016/S0140-6736(10)60058-X; Read B, 2008, ALC026 U SHEFF; Record C, 2009, CLIN MED, V9, P421, DOI 10.7861/clinmedicine.9-5-421; Rice P, 2012, BRIT J PSYCHIAT, V201, P169, DOI 10.1192/bjp.bp.111.105601; ROBINSON M, 2010, MONITORING EVALUATIN; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Sabatier PA, 2007, THEORIES POLICY PROC; Sanderson I, 2009, POLIT STUD-LONDON, V57, P699, DOI 10.1111/j.1467-9248.2009.00791.x; Scotch Whisky Association, 2012, SCOTCH WHISK IND CHA; Scottish Executive, 2002, PLAN ACT ALC PROBL; Scottish Government, 2008, CHANG SCOTL REL ALC; Scottish National Party, 2007, MAN 2007; Scottish National Party, 2011, MAN 2011 REEL SCOTT; SHAAP, 2012, SCOTT HLTH ACT ALC P; Smith K., 2008, HLTH INEQUALITIES SC; Smith KE, 2007, SOC SCI MED, V64, P1438, DOI 10.1016/j.socscimed.2006.11.008; Smith KE, 2013, J EPIDEMIOL COMMUN H, V67, P198, DOI 10.1136/jech-2012-200990; Stockwell T, 2006, ALCOHOL PRICING PUBL; Stockwell T, 2012, AM J PUBLIC HLTH, V102, P10; Stockwell T, 2012, ADDICTION, V107, P912, DOI 10.1111/j.1360-0443.2011.03763.x; The Scottish Government, 2009, CHANG SCOTL REL ALC; True JL, 2007, THEORIES POLICY PROC, P144; Wagenaar AC, 2009, ADDICTION, V104, P179, DOI 10.1111/j.1360-0443.2008.02438.x; WEISS CH, 1979, PUBLIC ADMIN REV, V39, P426, DOI 10.2307/3109916; Wells S, 2009, ADDICTION, V104, P4, DOI 10.1111/j.1360-0443.2008.02393.x; Wood K, 2014, ADDICTION, V109, P578, DOI 10.1111/add.12427; Yin RK, 2014, CASE STUDY RES DESIG, P133	99	47	47	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e91185	10.1371/journal.pone.0091185	http://dx.doi.org/10.1371/journal.pone.0091185			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SR	24670519	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000333677000017
J	Wen, P; Ji, BZ; Sillam-Dusses, D				Wen, Ping; Ji, Bao-Zhong; Sillam-Dusses, David			Trail Communication Regulated by Two Trail Pheromone Components in the Fungus-Growing Termite Odontotermes formosanus (Shiraki)	PLOS ONE			English	Article							SUBTERRANEAN TERMITE; NASUTITERMES-COSTALIS; TRINERVITERMES-TRINERVOIDES; RETICULITERMES-SANTONENSIS; HARVESTER TERMITE; VIBRATION SIGNALS; FEYTAUD ISOPTERA; SEX-PHEROMONES; RHINOTERMITIDAE; ORIENTATION	The eusocial termites are well accomplished in chemical communication, but how they achieve the communication using trace amount of no more than two pheromone components is mostly unknown. In this study, the foraging process and trail pheromones of the fungus-growing termite Odontotermes formosanus (Shiraki) were systematically studied and monitored in real-time using a combination of techniques, including video analysis, solid-phase microextraction, gas chromatography coupled with either mass spectrometry or an electroantennographic detector, and bioassays. The trail pheromone components in foraging workers were (3Z)-dodec-3-en-1-ol and (3Z,6Z)-dodeca-3,6-dien-1-ol secreted by their sternal glands. Interestingly, ratio of the two components changed according to the behaviors that the termites were displaying. This situation only occurs in termites whereas ratios of pheromone components are fixed and species-specific for other insect cuticular glands. Moreover, in bioassays, the active thresholds of the two components ranged from 1 fg/cm to 10 pg/cm according to the behavioral contexts or the pheromonal exposure of tested workers. The two components did not act in synergy. (3Z)-Dodec-3-en-1-ol induced orientation behavior of termites that explore their environment, whereas (3Z,6Z)dodeca-3,6-dien-1-ol had both an orientation effect and a recruitment effect when food was discovered. The trail pheromone of O. formosanus was regulated both quantitatively by the increasing number of workers involved in the early phases of foraging process, and qualitatively by the change in ratio of the two pheromone components on sternal glandular cuticle in the food-collecting workers. In bioassays, the responses of workers to the pheromone were also affected by the variation in pheromone concentration and component ratio in the microenvironment. Thus, this termite could exchange more information with nestmates using the traces of the two trail pheromone components that can be easily regulated within a limited microenvironment formed by the tunnels or chambers.	[Wen, Ping; Ji, Bao-Zhong] Nanjing Forestry Univ, Coll Forest Resources & Environm, Nanjing, Jiangsu, Peoples R China; [Sillam-Dusses, David] IRD, UMR BIOEMCO IBIOS 211, Bondy, France; [Sillam-Dusses, David] Univ Paris 13, Sorbonne Paris Cite, LEEC, EA4443, F-93430 Villetaneuse, France; [Wen, Ping] Jiangsu Agrochem Lab, Changzhou, Peoples R China; [Wen, Ping] Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Nanjing Forestry University; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paris 13; Zhejiang University	Ji, BZ (corresponding author), Nanjing Forestry Univ, Coll Forest Resources & Environm, Nanjing, Jiangsu, Peoples R China.	jbz9885@njfu.edu.cn	Wen, Ping/V-6685-2019; Sillam-Dussès, David/AAI-5942-2021	Wen, Ping/0000-0002-6759-7097; Sillam-Dusses, David/0000-0001-5027-8703	Specialized Research Fund for the Doctoral Program of Higher Education [20123204110001]; Natural Science Foundation of Jiangsu Province, China [BK2012816]; Natural Science Foundation for Young Scientists of Jiangsu Province, China [BK20130257]; Priority Academic Program Development of Jiangsu Higher Education Institutions [PAPD 164010641]; Funding Project of Nanjing Municipal Construction Bureau; Management Office of Dr. Sun Yat-Sen's Mausoleum [200409]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Natural Science Foundation for Young Scientists of Jiangsu Province, China; Priority Academic Program Development of Jiangsu Higher Education Institutions; Funding Project of Nanjing Municipal Construction Bureau; Management Office of Dr. Sun Yat-Sen's Mausoleum	This work was supported by the Specialized Research Fund for the Doctoral Program of Higher Education (grant 20123204110001) in China, the Natural Science Foundation of Jiangsu Province, China (grant BK2012816), the Natural Science Foundation for Young Scientists of Jiangsu Province, China (grant BK20130257), the Priority Academic Program Development of Jiangsu Higher Education Institutions (grant PAPD 164010641), and the Funding Project of Nanjing Municipal Construction Bureau & the Management Office of Dr. Sun Yat-Sen's Mausoleum (grant 200409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T., 1987, P125; Adam RA, 2008, AFR ENTOMOL, V16, P153, DOI 10.4001/1021-3589-16.2.153; Affolter J, 2000, INSECT SOC, V47, P256, DOI 10.1007/PL00001712; Arab Alberto, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/806782; Bordereau C, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P279, DOI 10.1007/978-90-481-3977-4_11; Bordereau C, 2010, BIOL J LINN SOC, V100, P519, DOI 10.1111/j.1095-8312.2010.01446.x; Casarin FE, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.0201; Cheng ML, 2007, SOCIOBIOLOGY, V50, P45; CORK A, 1992, J CHEM ECOL, V18, P403, DOI 10.1007/BF00994240; Deng Xiao-Jun, 2002, Acta Entomologica Sinica, V45, P739; DU TY, 1982, ACTA ENTOMOL SINICA, V25, P172; DUNKELBLUM E, 1980, PHYTOPARASITICA, V8, P209, DOI 10.1007/BF03158319; Evans TA, 2007, INSECT SOC, V54, P374, DOI 10.1007/s00040-007-0958-1; Evans TA, 2005, P NATL ACAD SCI USA, V102, P3732, DOI 10.1073/pnas.0408649102; Gessner S, 2001, INSECT SOC, V48, P238, DOI 10.1007/PL00001772; GRACE JK, 1988, J CHEM ECOL, V14, P653, DOI 10.1007/BF01013913; GRACE JK, 1989, SOCIOBIOLOGY, V16, P175; HALL P, 1985, J CHEM ECOL, V11, P1503, DOI 10.1007/BF01012196; HOLLDOBLER B, 1995, P NATL ACAD SCI USA, V92, P19, DOI 10.1073/pnas.92.1.19; Hu J, 2006, SOCIOBIOLOGY, V48, P661; Hu J, 2012, COMP BIOCHEM PHYS A, V161, P201, DOI 10.1016/j.cbpa.2011.10.028; Huang QY, 2006, STUDY FORAGING BEHAV; Inta R, 2009, J ECON ENTOMOL, V102, P121, DOI 10.1603/029.102.0117; KLUN JA, 1975, ENVIRON ENTOMOL, V4, P891, DOI 10.1093/ee/4.6.891; Lee SH, 2007, BIOSYSTEMS, V90, P802, DOI 10.1016/j.biosystems.2007.04.004; LEUTHOLD RH, 1976, BEHAV ECOL SOCIOBIOL, V1, P127, DOI 10.1007/BF00299194; LEUTHOLD RH, 1974, INSECT SOC, V21, P335, DOI 10.1007/BF02331563; Miura T, 1998, INSECT SOC, V45, P17, DOI 10.1007/s000400050065; Miura T, 1998, J INSECT BEHAV, V11, P179, DOI 10.1023/A:1021039722402; Peppuy A, 2001, INSECT SOC, V48, P245, DOI 10.1007/PL00001773; Reinhard J, 1997, INSECT SOC, V44, P147, DOI 10.1007/s000400050037; Reinhard J, 2001, J INSECT BEHAV, V14, P157, DOI 10.1023/A:1007881510237; Roonwal ML, 1975, J APPL ENTOMOL, V78, P424; RUNCIE CD, 1987, J CHEM ECOL, V13, P1967, DOI 10.1007/BF01014679; Saran RK, 2007, J CHEM ECOL, V33, P369, DOI 10.1007/s10886-006-9229-2; Sillam-Dusses D, 2005, CHEMOECOLOGY, V15, P1, DOI 10.1007/s00049-005-0285-9; Sillam-Dusses D, 2011, J CHEM ECOL, V37, P179, DOI 10.1007/s10886-011-9910-y; Sillam-Dusses D, 2010, BIOL J LINN SOC, V99, P20, DOI 10.1111/j.1095-8312.2009.01348.x; TRANIELLO JFA, 1985, J CHEM ECOL, V11, P319, DOI 10.1007/BF01411418; TRANIELLO JFA, 1982, NATURWISSENSCHAFTEN, V69, P343, DOI 10.1007/BF00480461; TRANIELLO JFA, 1981, P NATL ACAD SCI-BIOL, V78, P1976, DOI 10.1073/pnas.78.3.1976; TSCHINKE.WR, 1973, J INSECT PHYSIOL, V19, P707, DOI 10.1016/0022-1910(73)90079-6; Tschinkel WR, 2010, J INSECT SCI, V10; Wang J, 1999, BAI YI KE JI, V16, P26; Wen P, 2012, J CHEM ECOL, V38, P566, DOI 10.1007/s10886-012-0111-0	45	15	17	50	1662	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e90906	10.1371/journal.pone.0090906	http://dx.doi.org/10.1371/journal.pone.0090906			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670407	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000013
J	Chen, HT; Tsou, HK; Chen, JC; Shih, JMK; Chen, YJ; Tang, CH				Chen, Hsien-Te; Tsou, Hsi-Kai; Chen, Jui-Chieh; Shih, James Meng-Kun; Chen, Yen-Jen; Tang, Chih-Hsin			Adiponectin Enhances Intercellular Adhesion Molecule-1 Expression and Promotes Monocyte Adhesion in Human Synovial Fibroblasts	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CARTILAGE HOMEOSTASIS; RHEUMATOID-ARTHRITIS; KNEE OSTEOARTHRITIS; SIGNALING PATHWAY; GLOBULAR FRAGMENT; FLUID; ICAM-1; CELLS; INFLAMMATION	Adiponectin is a protein hormone secreted predominantly by differentiated adipocytes and is involved in energy homeostasis. Adiponectin expression is significantly high in the synovial fluid of patients with osteoarthritis (OA). Intercellular adhesion molecule-1 (ICAM-1) is an important adhesion molecule that mediates monocyte adhesion and infiltration during OA pathogenesis. Adiponectin-induced expression of ICAM-1 in human OA synovial fibroblasts (OASFs) was examined by using qPCR, flow cytometry and western blotting. The intracellular signaling pathways were investigated by pretreated with inhibitors or transfection with siRNA. The monocyte THP-1 cell line was used for an adhesion assay with OASFs. Stimulation of OASFs with adiponectin induced ICAM-1 expression. Pretreatment with AMP-activated protein kinase (AMPK) inhibitors (AraA and compound C) or transfection with siRNA against AMPK alpha 1 and two AMPK upstream activator-liver kinase B1 (LKB1) and calmodulin-dependent protein kinase II (CaMKII) diminished the adiponectin-induced ICAM-1 expression. Stimulation of OASFs with adiponectin increased phosphorylation of LKB1, CaMKII, AMPK, and c-Jun, resulting in c-Jun binding to AP-1 element of ICAM-1 promoter. In addition, adiponectin-induced activation of the LKB1/CaMKII, AMPK, and AP-1 pathway increased the adhesion of monocytes to the OASF monolayer. Our results suggest that adiponectin increases ICAM-1 expression in human OASFs via the LKB1/CaMKII, AMPK, c-Jun, and AP-1 signaling pathway. Adiponectin-induced ICAM-1 expression promoted the adhesion of monocytes to human OASFs. These findings may provide a better understanding of the pathogenesis of OA and can utilize this knowledge to design a new therapeutic strategy.	[Chen, Hsien-Te] China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan; [Chen, Hsien-Te; Chen, Yen-Jen] China Med Univ Hosp, Dept Orthopaed Surg, Taichung, Taiwan; [Tsou, Hsi-Kai] Taichung Vet Gen Hosp, Dept Neurosurg, Taichung, Taiwan; [Tsou, Hsi-Kai] Jen Teh Jr Coll Med Nursing & Management, Dept Early Childhood Care & Educ, Miaoli, Taiwan; [Shih, James Meng-Kun] Lin Sen Hosp, Dept Orthopaed Surg, Taichung, Taiwan; [Chen, Yen-Jen; Tang, Chih-Hsin] China Med Univ, Sch Med, Taichung, Taiwan; [Chen, Jui-Chieh; Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Tang, Chih-Hsin] Asia Univ, Dept Biotechnol, Coll Hlth Sci, Taichung, Taiwan; [Chen, Jui-Chieh] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan, Miaoli County, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; National Health Research Institutes - Taiwan	Tang, CH (corresponding author), China Med Univ, Sch Med, Taichung, Taiwan.	chtang@mail.cmu.edu.tw	é, çå/HCH-5712-2022; Tang, Chih Hsin/O-5212-2015	Tang, Chih Hsin/0000-0002-7113-8352	National Science Council of Taiwan [NSC100-2320-B-039-028-MY3]; China Medical University Hospital [DMR-102-055]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); China Medical University Hospital	This work was supported by grants from the National Science Council of Taiwan (NSC100-2320-B-039-028-MY3) and China Medical University Hospital (DMR-102-055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulos IE, 2006, J PATHOL, V208, P35, DOI 10.1002/path.1891; Benito MJ, 2005, ANN RHEUM DIS, V64, P1263, DOI 10.1136/ard.2004.025270; Berner HS, 2004, BONE, V35, P842, DOI 10.1016/j.bone.2004.06.008; Blasioli DJ, 2014, BIOMATERIALS, V35, P1185, DOI 10.1016/j.biomaterials.2013.10.050; Bondeson J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2099; Chedid P, 2012, AM J PATHOL, V180, P682, DOI 10.1016/j.ajpath.2011.10.013; Chen TH, 2006, BBA-MOL BASIS DIS, V1762, P711, DOI 10.1016/j.bbadis.2006.06.008; Conde J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052533; de Lange-Brokaar BJE, 2012, OSTEOARTHR CARTILAGE, V20, P1484, DOI 10.1016/j.joca.2012.08.027; Ding C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063878; Dozio E, 2011, ADV CLIN CHEM, V55, P61, DOI 10.1016/B978-0-12-387042-1.00004-6; Ehling A, 2006, J IMMUNOL, V176, P4468, DOI 10.4049/jimmunol.176.7.4468; Filkova M, 2009, ANN RHEUM DIS, V68, P295, DOI 10.1136/ard.2008.095737; Gomez R, 2011, ANN RHEUM DIS, V70, P2052, DOI 10.1136/ard.2010.145672; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Honsawek S, 2010, ARCH MED RES, V41, P593, DOI 10.1016/j.arcmed.2010.11.007; Hu PF, 2011, MOL BIOL REP, V38, P873, DOI 10.1007/s11033-010-0179-y; Huang CY, 2012, BIOMEDICINE-TAIWAN, V2, P129, DOI 10.1016/j.biomed.2012.11.002; Huang CY, 2010, J CELL PHYSIOL, V224, P475, DOI 10.1002/jcp.22145; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kang EH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3218; Karatay S, 2004, ANN CLIN LAB SCI, V34, P330; Koller M, 1999, ANN RHEUM DIS, V58, P709, DOI 10.1136/ard.58.11.709; Koskinen A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3512; Kusunoki N, 2010, ARTHRITIS RHEUM-US, V62, P1641, DOI 10.1002/art.27450; Lago R, 2008, OSTEOARTHR CARTILAGE, V16, P1101, DOI 10.1016/j.joca.2007.12.008; Laurberg TB, 2009, J RHEUMATOL, V36, P1885, DOI 10.3899/jrheum.080907; Lavigne P, 2005, EXPERT OPIN BIOL TH, V5, P313, DOI 10.1517/14712598.5.3.313; Lavigne P, 2004, BONE, V35, P463, DOI 10.1016/j.bone.2003.12.030; Lee SW, 2008, SCAND J RHEUMATOL, V37, P260, DOI 10.1080/03009740801910346; Liu QQ, 2010, FASEB J, V24, P4229, DOI 10.1096/fj.10-159723; Long EO, 2011, J IMMUNOL, V186, P5021, DOI 10.4049/jimmunol.1100646; Pottie P, 2006, ANN RHEUM DIS, V65, P1403, DOI 10.1136/ard.2006.061994; Priya T, 2013, BIOMEDICINE-TAIWAN, V3, P167, DOI 10.1016/j.biomed.2013.05.002; Roebuck KA, 1999, J LEUKOCYTE BIOL, V66, P876, DOI 10.1002/jlb.66.6.876; Scanzello CR, 2012, BONE, V51, P249, DOI 10.1016/j.bone.2012.02.012; Schaffler A, 2003, JAMA-J AM MED ASSOC, V290, P1709, DOI 10.1001/jama.290.13.1709-c; Schellerer VS, 2014, ONCOL REP, V31, P255, DOI 10.3892/or.2013.2860; Shen PC, 2013, HUM GENE THER, V24, P871, DOI 10.1089/hum.2012.189; Tang CH, 2007, J IMMUNOL, V179, P5483, DOI 10.4049/jimmunol.179.8.5483; Tang CH, 2010, ARTHRITIS RHEUM-US, V62, P3615, DOI 10.1002/art.27755; Tang CH, 2009, PROSTATE, V69, P1781, DOI 10.1002/pros.21029; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Tong KM, 2011, J CELL BIOCHEM, V112, P1431, DOI 10.1002/jcb.23059; Toussirot E, 2007, CURR MED CHEM, V14, P1095, DOI 10.2174/092986707780362826; VANDE SA, 1996, J MOL MED, V74, P13, DOI DOI 10.1007/BF00202069; Waki H, 2005, ENDOCRINOLOGY, V146, P790, DOI 10.1210/en.2004-1096; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yu HS, 2013, INT J MOL SCI, V14, P13329, DOI 10.3390/ijms140713329; Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357; Zimmerman T, 2008, CURR PHARM DESIGN, V14, P2128, DOI 10.2174/138161208785740225	53	12	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92741	10.1371/journal.pone.0092741	http://dx.doi.org/10.1371/journal.pone.0092741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667577	Green Submitted, Green Published, gold			2022-12-27	WOS:000333675600069
J	Chiaradia, A; Forero, MG; McInnes, JC; Ramirez, F				Chiaradia, Andre; Forero, Manuela G.; McInnes, Julie C.; Ramirez, Francisco			Searching for the True Diet of Marine Predators: Incorporating Bayesian Priors into Stable Isotope Mixing Models	PLOS ONE			English	Article							PENGUINS EUDYPTULA-MINOR; AVIAN BLOOD; FOOD; SEABIRDS; DNA; SEGREGATION; UNCERTAINTY; MANAGEMENT; FISHERIES; VICTORIA	Reconstructing the diet of top marine predators is of great significance in several key areas of applied ecology, requiring accurate estimation of their true diet. However, from conventional stomach content analysis to recent stable isotope and DNA analyses, no one method is bias or error free. Here, we evaluated the accuracy of recent methods to estimate the actual proportion of a controlled diet fed to a top-predator seabird, the Little penguin (Eudyptula minor). We combined published DNA data of penguins scats with blood plasma delta N-15 and delta C-13 values to reconstruct the diet of individual penguins fed experimentally. Mismatch between controlled (true) ingested diet and dietary estimates obtained through the separately use of stable isotope and DNA data suggested some degree of differences in prey assimilation (stable isotope) and digestion rates (DNA analysis). In contrast, combined posterior isotope mixing model with DNA Bayesian priors provided the closest match to the true diet. We provided the first evidence suggesting that the combined use of these complementary techniques may provide better estimates of the actual diet of top marine predators-a powerful tool in applied ecology in the search for the true consumed diet.	[Chiaradia, Andre; McInnes, Julie C.] Phillip Isl Nat Pk, Dept Res, Cowes, Vic, Australia; [Forero, Manuela G.; Ramirez, Francisco] Estn Biol Donana, Appl Marine Ecol Grp, Dept Conservat Biol, E-41013 Seville, Andalucia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Chiaradia, A (corresponding author), Phillip Isl Nat Pk, Dept Res, Cowes, Vic, Australia.	achiaradia@penguins.org.au	Chiaradia, Andre/AFK-6634-2022; Chiaradia, Andre/AAG-4928-2022; Ramírez, Francisco/I-3553-2014	Chiaradia, Andre/0000-0002-6178-4211; Chiaradia, Andre/0000-0002-6178-4211; Ramírez, Francisco/0000-0001-9670-486X; McInnes, Julie/0000-0001-8902-5199	Penguin Foundation; Junta Andalucia, Spain; European Union Research Fund; Ministerio de Educacion y Ciencia de Espana	Penguin Foundation; Junta Andalucia, Spain; European Union Research Fund; Ministerio de Educacion y Ciencia de Espana(Spanish Government)	Several grants received to support this collaborative research: Penguin Foundation, Junta Andalucia, Spain, European Union Research Fund and Ministerio de Educacion y Ciencia de Espana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett RT, 2007, ICES J MAR SCI, V64, P1675, DOI 10.1093/icesjms/fsm152; Bayes T., 1764, PHILOS T ROY SOC LON, V53, P370, DOI [10.1098/rstl.1763.0053, DOI 10.1098/RSTL.1763.0053]; Bearhop S, 2000, AUK, V117, P504, DOI 10.1642/0004-8038(2000)117[0504:IOLAUA]2.0.CO;2; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Bowen WD, 2013, MAR MAMMAL SCI, V29, P719, DOI 10.1111/j.1748-7692.2012.00604.x; Brooke MD, 2004, P ROY SOC B-BIOL SCI, V271, pS246, DOI 10.1098/rsbl.2003.0153; CAIRNS DK, 1992, CONDOR, V94, P811, DOI 10.2307/1369279; Cherel Y, 2005, PHYSIOL BIOCHEM ZOOL, V78, P106, DOI 10.1086/425202; Chiaradia A, 2003, EMU, V103, P43, DOI 10.1071/MU02020; Chiaradia A, 2012, AUSTRAL ECOL, V37, P610, DOI 10.1111/j.1442-9993.2011.02323.x; Chiaradia A, 2010, ICES J MAR SCI, V67, P1710, DOI 10.1093/icesjms/fsq067; CULLEN JM, 1992, EMU, V91, P318, DOI 10.1071/MU9910318; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Deagle BE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000831; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DUFFY D C, 1986, Colonial Waterbirds, V9, P1, DOI 10.2307/1521138; Forero MG, 2005, MAR ECOL PROG SER, V296, P107, DOI 10.3354/meps296107; Forero MG, 2002, MAR ECOL PROG SER, V234, P289, DOI 10.3354/meps234289; Fossi MC, 2012, MAR ENVIRON RES, V77, P156, DOI 10.1016/j.marenvres.2012.03.003; Franco-Trecu V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080019; Fulton EA, 2003, MAR ECOL PROG SER, V253, P1, DOI 10.3354/meps253001; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Furness RW, 2002, ICES J MAR SCI, V59, P261, DOI 10.1006/jmsc.2001.1155; Hardy CM, 2010, MOL ECOL, V19, P197, DOI 10.1111/j.1365-294X.2009.04411.x; HOBSON KA, 1995, CONDOR, V97, P752, DOI 10.2307/1369183; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Iverson SJ, 2007, MAR ECOL PROG SER, V352, P235, DOI 10.3354/meps07073; Jackson AL, 2009, ECOL LETT, V12, pE1, DOI 10.1111/j.1461-0248.2008.01233.x; Kotz S., 2000, DIRICHLET INVERTED D; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; Maloy AP, 2013, MAR BIOL, V160, P479, DOI 10.1007/s00227-012-2105-4; Montevecchi W.A., 1988, BIOL OCEANOGR, V5, P153; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Morissette L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043966; Ogle K, 2013, ECOLOGICAL APPL, DOI [10.1890/12-1970.1, DOI 10.1890/12-1970.1]; Parnell A, 2011, STABLE ISOTOPE ANAL; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; R Core Team, 2020, R LANG ENV STAT COMP; Ramos R, 2009, MAR ECOL PROG SER, V377, P289, DOI 10.3354/meps07792; Ropert-Coudert Y, 2009, P ROY SOC B-BIOL SCI, V276, P4105, DOI 10.1098/rspb.2009.1399; SCHWARCZ HP, 1991, J ARCHAEOL SCI, V18, P261, DOI 10.1016/0305-4403(91)90065-W; Sydeman WJ, 1997, CONDOR, V99, P327, DOI 10.2307/1369938; Thomas AC, 2014, MOL ECOL, V23, P3706, DOI 10.1111/mec.12523; Votier SC, 2003, POLAR BIOL, V26, P20, DOI 10.1007/s00300-002-0446-z; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x	50	41	43	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92665	10.1371/journal.pone.0092665	http://dx.doi.org/10.1371/journal.pone.0092665			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667296	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600062
J	Gordon, O; He, ZH; Gilon, D; Gruener, S; Pietranico-Cole, S; Oppenheim, A; Keshet, E				Gordon, Oren; He, Zhiheng; Gilon, Dan; Gruener, Sabine; Pietranico-Cole, Sherrie; Oppenheim, Amit; Keshet, Eli			A Transgenic Platform for Testing Drugs Intended for Reversal of Cardiac Remodeling Identifies a Novel 11 beta HSD1 Inhibitor Rescuing Hypertrophy Independently of Re-Vascularization	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITION; ACTIVATED RECEPTOR-GAMMA; MYOCARDIAL-INFARCTION; HEART-FAILURE; DEHYDROGENASE TYPE-1; ANGIOGENESIS; DYSFUNCTION; MICE; EXPRESSION; AGONIST	Rationale: Rescuing adverse myocardial remodeling is an unmet clinical goal and, correspondingly, pharmacological means for its intended reversal are urgently needed. Objectives: To harness a newly-developed experimental model recapitulating progressive heart failure development for the discovery of new drugs capable of reversing adverse remodeling. Methods and Results: A VEGF-based conditional transgenic system was employed in which an induced perfusion deficit and a resultant compromised cardiac function lead to progressive remodeling and eventually heart failure. Ability of candidate drugs administered at sequential remodeling stages to reverse hypertrophy, enlarged LV size and improve cardiac function was monitored. Arguing for clinical relevance of the experimental system, clinically-used drugs operating on the Renin-Angiotensin-Aldosterone-System (RAAS), namely, the ACE inhibitor Enalapril and the direct renin inhibitor Aliskerin fully reversed remodeling. Remodeling reversal by these drugs was not accompanied by neovascularization and reached a point-of-no-return. Similarly, the PPAR gamma agonist Pioglitazone was proven capable of reversing all aspects of cardiac remodeling without affecting the vasculature. Extending the arsenal of remodeling-reversing drugs to pathways other than RAAS, a specific inhibitor of 11 beta-hydroxy-steroid dehydrogenase type 1 (11 beta HSD1), a key enzyme required for generating active glucocorticoids, fully rescued myocardial hypertrophy. This was associated with mitigating the hypertrophy-associated gene signature, including reversing the myosin heavy chain isoform switch but in a pattern distinguishable from that associated with neovascularization-induced reversal. Conclusions: A system was developed suitable for identifying novel remodeling-reversing drugs operating in different pathways and for gaining insights into their mechanisms of action, exemplified here by uncoupling their vascular affects.	[Gordon, Oren; He, Zhiheng; Keshet, Eli] Hebrew Univ Jerusalem, Hadassah Univ Hosp, Dept Dev Biol, Jerusalem, Israel; [Gordon, Oren; He, Zhiheng; Keshet, Eli] Hebrew Univ Jerusalem, Dept Canc Res, Hadassah Univ Hosp, Jerusalem, Israel; [Gilon, Dan; Oppenheim, Amit] Hebrew Univ Jerusalem, Dept Cardiol, Hadassah Univ Hosp, Jerusalem, Israel; [Gruener, Sabine; Pietranico-Cole, Sherrie] Hoffmann La Roche Pharmaceut, Dept Metab & Vasc Dis, Basel, Switzerland	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Roche Holding	Keshet, E (corresponding author), Hebrew Univ Jerusalem, Hadassah Univ Hosp, Dept Dev Biol, Jerusalem, Israel.	keshet@cc.huji.ac.il	Gordon, Oren/AAS-1246-2021; Gordon, Oren/GRJ-4372-2022; Keshet, Eli/GQR-0445-2022	Gordon, Oren/0000-0002-3159-8426; 	Israel Science Foundation (ISF); Hoffmann-La Roche Pharmaceuticals	Israel Science Foundation (ISF)(Israel Science Foundation); Hoffmann-La Roche Pharmaceuticals(Hoffmann-La Roche)	This study was supported by Israel Science Foundation (ISF) and partly funded by Hoffmann-La Roche Pharmaceuticals. Sabine Gruener, Sherrie Pietranico-Cole and Jacques Himber of Hoffmann-La Roche pharmaceuticals have contributed to the design and interpretation of some of the experiments detailed in this study, in particular for the novel 11HSD1 inhibitor. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Balakumar Pitchai, 2007, Journal of Pharmacological and Toxicological Methods, V56, P1, DOI 10.1016/j.vascn.2007.01.003; Brooks WW, 2009, COMPARATIVE MED, V59, P339; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Dobaczewski M, 2010, J MOL CELL CARDIOL, V48, P504, DOI 10.1016/j.yjmcc.2009.07.015; Duan SZ, 2005, CIRC RES, V97, P372, DOI 10.1161/01.RES.0000179226.34112.6d; Fedak PWM, 2005, CARDIOVASC PATHOL, V14, P1, DOI 10.1016/j.carpath.2004.12.002; Finck BN, 2007, CARDIOVASC RES, V73, P269, DOI 10.1016/j.cardiores.2006.08.023; Gordon O, 2012, VEGF INDUCED NEOVASC; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; Koitabashi N, 2012, NAT REV CARDIOL, V9, P147, DOI 10.1038/nrcardio.2011.172; Li L, 2011, CARDIOVASC RES, V91, P80, DOI 10.1093/cvr/cvr067; Lister K, 2006, CARDIOVASC RES, V70, P555, DOI 10.1016/j.cardiores.2006.02.010; Lopez-Sendon J, 2004, EUR HEART J, V25, P1454, DOI 10.1016/j.ehj.2004.06.003; Madrazo JA, 2008, J MOL CELL CARDIOL, V44, P968, DOI 10.1016/j.yjmcc.2008.03.021; May D, 2008, P NATL ACAD SCI USA, V105, P282, DOI 10.1073/pnas.0707778105; McSweeney SJ, 2010, CARDIOVASC RES, V88, P159, DOI 10.1093/cvr/cvq149; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; PFEFFER JM, 1995, ANNU REV PHYSIOL, V57, P805, DOI 10.1146/annurev.ph.57.030195.004105; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Shiomi T, 2002, CIRCULATION, V106, P3126, DOI 10.1161/01.CIR.0000039346.31538.2C; Small GR, 2005, P NATL ACAD SCI USA, V102, P12165, DOI 10.1073/pnas.0500641102; Solomon SD, 2011, EUR HEART J, V32, P1227, DOI 10.1093/eurheartj/ehq522; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Tamargo J, 2011, NAT REV DRUG DISCOV, V10, P536, DOI 10.1038/nrd3431; Wamil M, 2007, DRUG DISCOV TODAY, V12, P504, DOI 10.1016/j.drudis.2007.06.001; Westermann D, 2008, HYPERTENSION, V52, P1068, DOI 10.1161/HYPERTENSIONAHA.108.116350; Yazawa H, 2011, J CARD FAIL, V17, P1041, DOI 10.1016/j.cardfail.2011.09.002; Yu ZH, 1996, CIRC RES, V79, P691, DOI 10.1161/01.RES.79.4.691; Zaragoza C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/497841; ZBINDEN G., 1963, REV CANADIENNE BIOL, V22, P257	33	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92869	10.1371/journal.pone.0092869	http://dx.doi.org/10.1371/journal.pone.0092869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667808	Green Submitted, gold, Green Published			2022-12-27	WOS:000333675600094
J	Taboas, M; Acuna, LG; Scaia, MF; Bruque, CD; Buzzalino, N; Stivel, M; Ceballos, NR; Dain, L				Taboas, Melisa; Gomez Acuna, Luciana; Florencia Scaia, Maria; Bruque, Carlos D.; Buzzalino, Noemi; Stivel, Mirta; Ceballos, Nora R.; Dain, Liliana			Functional Studies of p.R132C, p.R149C, p.M283V, p.E431K, and a Novel c.652-2A > G Mutations of the CYP21A2 Gene	PLOS ONE			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; STEROID 21-HYDROXYLASE DEFICIENCY; ENZYME-ACTIVITY; GENOTYPE; PHENOTYPE; IDENTIFICATION; ASSOCIATION; POPULATION; CONVERSION; DISEASE	Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is the most frequent inborn error of metabolism and accounts for 90-95% of CAH cases. In the present work, we analyzed the functional consequence of four novel previously reported point CYP21A2 mutations p.R132C, p.R149C, p.M283V, p.E431K-found in Argentinean 21-hydroxylase deficient patients. In addition, we report an acceptor splice site novel point mutation, c.652-2A>G, found in a classical patient in compound heterozygosity with the rare p.R483Q mutation. We performed bioinformatic and functional assays to evaluate the biological implication of the novel mutation. Our analyses revealed that the residual enzymatic activity of the isolated mutants coding for CYP21A2 aminoacidic substitutions was reduced to a lesser than 50% of the wild type with both progesterone and 17-OH progesterone as substrates. Accordingly, all the variants would predict mild non-classical alleles. In one non-classical patient, the p.E431K mutation was found in cis with the p.D322G one. The highest decrease in enzyme activity was obtained when both mutations were assayed in the same construction, with a residual activity most likely related to the simple virilizing form of the disease. For the c.652-2A>G mutation, bioinformatic tools predicted the putative use of two different cryptic splicing sites. Nevertheless, functional analyses revealed the use of only one cryptic splice acceptor site located within exon 6, leading to the appearance of an mRNA with a 16 nt deletion. A severe allele is strongly suggested due to the presence of a premature stop codon in the protein only 12 nt downstream.	[Taboas, Melisa; Bruque, Carlos D.; Buzzalino, Noemi; Dain, Liliana] ANLIS, Ctr Nacl Genet Med, Buenos Aires, DF, Argentina; [Taboas, Melisa; Bruque, Carlos D.; Dain, Liliana] Consejo Nacl Invest Cient & Tecn IBYME CONICET, Inst Biol & Med Expt, Buenos Aires, DF, Argentina; [Gomez Acuna, Luciana] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Fisiol Biol Mol & Neurociencias IFIBYNE, Buenos Aires, DF, Argentina; [Gomez Acuna, Luciana; Florencia Scaia, Maria; Ceballos, Nora R.] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina; [Florencia Scaia, Maria; Ceballos, Nora R.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Buenos Aires, DF, Argentina; [Stivel, Mirta] Hosp Durand, Div Endocrinol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Dain, L (corresponding author), ANLIS, Ctr Nacl Genet Med, Buenos Aires, DF, Argentina.	ldain@fbmc.fcen.uba.ar	Scaia, Maria Florencia/L-2769-2015	Bruque, Carlos David/0000-0003-0726-5418; Scaia, Maria Florencia/0000-0003-4069-5567; DAIN, Liliana/0000-0002-2155-4999	ANPCYT [PICT 00208]; UBACYT [X059]; FOCANLIS	ANPCYT(ANPCyT); UBACYT; FOCANLIS	This work was supported by: ANPCYT, PICT 00208 (LD, www.foncyt.gov.ar), UBACYT X059 (LD, www.uba.ar) and FOCANLIS 2010 (LD www.anlis.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admoni O, 2006, CLIN ENDOCRINOL, V64, P645, DOI 10.1111/j.1365-2265.2006.02521.x; Bleicken C, 2009, HUM MUTAT, V30, pE443, DOI 10.1002/humu.20926; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chu XJ, 2014, CLIN ENDOCRINOL, V80, P927, DOI 10.1111/cen.12309; Dain LB, 2002, CLIN ENDOCRINOL, V56, P237; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dolzan V, 2005, EUR J ENDOCRINOL, V153, P99, DOI 10.1530/eje.1.01944; Dolzan V, 1999, EUR J ENDOCRINOL, V141, P132, DOI 10.1530/eje.0.1410132; DONOHOUE PA, 1986, J CLIN ENDOCR METAB, V62, P995, DOI 10.1210/jcem-62-5-995; Elisa A, 2002, J CLIN ENDOCR METAB, V87, P4314, DOI 10.1210/jc.2001-011939; Ezquieta B, 2002, ACTA PAEDIATR, V91, P892, DOI 10.1080/080352502760148595; Ghayee HK, 2011, J CLIN ENDOCR METAB, V96, pE243, DOI 10.1210/jc.2010-1222; Gomes LG, 2008, J CLIN ENDOCR METAB, V93, P2913, DOI 10.1210/jc.2008-0304; Haider S, 2013, P NATL ACAD SCI USA, V110, P2605, DOI 10.1073/pnas.1221133110; HIGASHI Y, 1988, AM J HUM GENET, V42, P17; Jaaskelainen J, 1997, J CLIN ENDOCR METAB, V82, P3293, DOI 10.1210/jc.82.10.3293; Krone N, 2000, J CLIN ENDOCR METAB, V85, P1059, DOI 10.1210/jc.85.3.1059; Krone N, 2005, J CLIN ENDOCR METAB, V90, P445, DOI 10.1210/jc.2004-0813; Lajic S, 1996, HUM GENET, V98, P182, DOI 10.1007/s004390050186; Lee HH, 1998, HUM GENET, V103, P304, DOI 10.1007/s004390050821; Lee HH, 2001, J ENDOCRINOL, V171, P397, DOI 10.1677/joe.0.1710397; Menassa R, 2008, J CLIN ENDOCR METAB, V93, P1901, DOI 10.1210/jc.2007-2701; Merke DP, 2005, LANCET, V365, P2125, DOI 10.1016/S0140-6736(05)66736-0; MILLER WL, 1994, J CLIN ENDOCR METAB, V78, P241, DOI 10.1210/jc.78.2.241; Minutolo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015899; Muro AF, 1999, MOL CELL BIOL, V19, P2657; New MI, 2013, P NATL ACAD SCI USA, V110, P2611, DOI 10.1073/pnas.1300057110; NEW MI, 1989, METABOLIC BASIS INHE, P1881; Nikoshkov A, 1997, J CLIN ENDOCR METAB, V82, P194, DOI 10.1210/jc.82.1.194; Nikoshkov A, 1998, J BIOL CHEM, V273, P6163, DOI 10.1074/jbc.273.11.6163; Nimkarn S, 1999, J CLIN ENDOCR METAB, V84, P378, DOI 10.1210/jc.84.1.378; Ono Makoto, 2008, Clin Pediatr Endocrinol, V17, P49, DOI 10.1297/cpe.17.49; Ordonez-Sanchez ML, 1998, HUM GENET, V102, P170, DOI 10.1007/s004390050672; OWERBACH D, 1992, J CLIN ENDOCR METAB, V74, P553, DOI 10.1210/jc.74.3.553; Pang Songya, 1997, Current Opinion in Pediatrics, V9, P419, DOI 10.1097/00008480-199708000-00018; Pasqualini T, 2007, MEDICINA-BUENOS AIRE, V67, P253; Robins T, 2007, J MOL MED, V85, P243, DOI 10.1007/s00109-006-0121-x; Robins T, 2006, MOL ENDOCRINOL, V20, P2946, DOI 10.1210/me.2006-0172; Soardi FC, 2008, J CLIN ENDOCR METAB, V93, P2416, DOI 10.1210/jc.2007-2594; Solari JJF, 2002, J COMP PHYSIOL B, V172, P685, DOI 10.1007/s00360-002-0296-6; Speiser PW, 2010, J CLIN ENDOCR METAB, V95, P4133, DOI 10.1210/jc.2009-2631; SPEISER PW, 1985, AM J HUM GENET, V37, P650; Stikkelbroeck NMML, 2003, J CLIN ENDOCR METAB, V88, P3852, DOI 10.1210/jc.2002-021681; Tardy V, 2010, J CLIN ENDOCR METAB, V95, P1288, DOI 10.1210/jc.2009-1202; Therrell BL, 2001, ENDOCRIN METAB CLIN, V30, P15, DOI 10.1016/S0889-8529(08)70017-3; TUSIELUNA MT, 1990, J BIOL CHEM, V265, P20916; van der Kamp HJ, 2004, EUR J ENDOCRINOL, V151, pU71, DOI 10.1530/eje.0.151U071; WEDELL A, 1993, HUM MOL GENET, V2, P499, DOI 10.1093/hmg/2.5.499; White PC, 2000, ENDOCR REV, V21, P245, DOI 10.1210/er.21.3.245; WHITE PC, 1986, P NATL ACAD SCI USA, V83, P5111, DOI 10.1073/pnas.83.14.5111; WILSON RC, 1995, J CLIN ENDOCR METAB, V80, P2322, DOI 10.1210/jc.80.8.2322	52	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92181	10.1371/journal.pone.0092181	http://dx.doi.org/10.1371/journal.pone.0092181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667412	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600027
J	Vaccaro, A; Despas, F; Delmas, C; Lairez, O; Lambert, E; Lambert, G; Labrunee, M; Guiraud, T; Esler, M; Galinier, M; Senard, JM; Pathak, A				Vaccaro, Angelica; Despas, Fabien; Delmas, Clement; Lairez, Olivier; Lambert, Elisabeth; Lambert, Gavin; Labrunee, Marc; Guiraud, Thibaut; Esler, Murray; Galinier, Michel; Senard, Jean Michel; Pathak, Atul			Direct Evidences for Sympathetic Hyperactivity and Baroreflex Impairment in Tako Tsubo Cardiopathy	PLOS ONE			English	Article							APICAL BALLOONING SYNDROME; LEFT-VENTRICULAR DYSFUNCTION; CHRONIC HEART-FAILURE; TAKOTSUBO CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; CHEMOREFLEX ACTIVATION; CLINICAL-FEATURES; STRESS; CATECHOLAMINES; WOMEN	Background: The exact pathophysiology of Tako-Tsubo cardiomyopathy (TTC) remains unknown but a role for sympathetic hyperactivity has been suggested. Up to now, no direct evidence of sympathetic nerve hyperactivity has been established nor involvement of sympathetic baroreflex identified. The aim of our study was to determine, by direct sympathetic nerve activity (SNS) recording if sympathetic nervous system activity is increased and spontaneous baroreflex control of sympathetic activity reduced in patients with TTC. Methods: We included 13 patients who presented with TTC and compared their SNS activity and spontaneous baroreflex control of sympathetic activity with that of 13 control patients with acutely decompensated chronic heart failure. SNS activity was evaluated by microneurography, a technique assessing muscle sympathetic nerve activity (MSNA). Spontaneous baroreflex control of sympathetic activity was evaluated as the absolute value of the slope of the regression line representing the relationship between spontaneous diastolic blood pressure values and concomitant SNS activity. Control patients were matched for age, sex, left ventricular ejection fraction and creatinine clearance. Results: The mean age of the patients with TTC was 80 years, all patients were women. There were no significant differences between the two groups of patients for blood pressure, heart rate or oxygen saturation level. TTC patients presented a significant increase in sympathetic nerve activity (MSNA median 63.3 bursts/min [interquartile range 61.3 to 66.0] vs median 55.7 bursts/min [interquartile range 51.0 to 61.7]; p = 0.0089) and a decrease in spontaneous baroreflex control of sympathetic activity compared to matched control patients (spontaneous baroreflex control of sympathetic activity median 0.7%burst/mmHg [interquartile range 0.4 to 1.9] vs median 2.4%burst/mmHg [interquartile range 1.8 to 2.9]; p = 0.005). Conclusions: We report for the first time, through direct measurement of sympathetic nerve activity, that patients with TTC exhibit elevated SNS activity associated with a decrease in spontaneous baroreflex control of sympathetic activity. These data may explain the pathophysiology and clinical presentation of patient with TTC.	[Vaccaro, Angelica; Despas, Fabien; Delmas, Clement; Lairez, Olivier; Labrunee, Marc; Guiraud, Thibaut; Galinier, Michel; Senard, Jean Michel; Pathak, Atul] Inst Metab & Cardiovasc Dis, INSERM, UMR 1048, Toulouse, France; [Despas, Fabien; Lairez, Olivier; Labrunee, Marc; Guiraud, Thibaut; Galinier, Michel; Senard, Jean Michel; Pathak, Atul] Univ Toulouse 3, F-31062 Toulouse, France; [Despas, Fabien; Senard, Jean Michel; Pathak, Atul] Univ Hosp Toulouse, Dept Clin Pharmacol, Toulouse, France; [Delmas, Clement; Lairez, Olivier; Labrunee, Marc; Galinier, Michel; Senard, Jean Michel; Pathak, Atul] Univ Hosp Toulouse, Dept Cardiol, Toulouse, France; [Lambert, Elisabeth; Lambert, Gavin; Esler, Murray; Pathak, Atul] Monash Univ, Human Neurotransmitter Lab, Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [Lambert, Elisabeth; Lambert, Gavin; Esler, Murray; Pathak, Atul] Monash Univ, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3004, Australia; [Pathak, Atul] Univ Hosp Toulouse, CIC, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; CHU de Toulouse; Baker Heart and Diabetes Institute; Monash University; Monash University; CHU de Toulouse	Pathak, A (corresponding author), Inst Metab & Cardiovasc Dis, INSERM, UMR 1048, Toulouse, France.	atul.pathak@univ-tlse3.fr	Lambert, Gavin/Q-4869-2017; O, Lairez/B-7152-2016; Lambert, Gavin W/E-7384-2010; Pathak, Atul/ABC-5223-2020	Lambert, Gavin/0000-0003-0315-645X; O, Lairez/0000-0001-8141-6582; Lambert, Gavin W/0000-0003-0315-645X; Pathak, Atul/0000-0001-6151-0096; GALINIER, Michel/0000-0003-1735-3390; Delmas, Clement/0000-0001-9180-9128; Senard, Jean-Michel/0000-0001-7679-1281; Guiraud, Thibaut/0000-0002-9525-5422; Lambert, Elisabeth/0000-0002-2232-9048; LABRUNEE, MARC/0000-0001-7782-5703				Abraham J, 2009, J AM COLL CARDIOL, V53, P1320, DOI 10.1016/j.jacc.2009.02.020; Akashi YJ, 2004, J NUCL MED, V45, P1121; Akashi YJ, 2003, QJM-INT J MED, V96, P563, DOI 10.1093/qjmed/hcg096; Azzarelli S, 2006, AM J CARDIOL, V98, P1273, DOI 10.1016/j.amjcard.2006.05.065; Barton DA, 2007, J HYPERTENS, V25, P2117, DOI 10.1097/HJH.0b013e32829baae7; Berganzo K, 2011, CLIN AUTON RES, V21, P65, DOI 10.1007/s10286-010-0088-0; Bielecka-Dabrowa A, 2010, INT J CARDIOL, V142, P120, DOI 10.1016/j.ijcard.2009.11.040; Brydon L, 2010, J PSYCHOSOM RES, V68, P109, DOI 10.1016/j.jpsychores.2009.06.007; Burgdorf C, 2008, EUR J HEART FAIL, V10, P1015, DOI 10.1016/j.ejheart.2008.07.008; Bybee KA, 2004, AM J CARDIOL, V94, P343, DOI 10.1016/j.amjcard.2004.04.030; Bybee KA, 2004, ANN INTERN MED, V141, P858, DOI 10.7326/0003-4819-141-11-200412070-00010; Chua TP, 1996, HEART, V76, P483, DOI 10.1136/hrt.76.6.483; Despas F, 2012, J HYPERTENS, V30, P753, DOI 10.1097/HJH.0b013e328350136c; Despas F, 2010, J HEART LUNG TRANSPL, V29, P591, DOI 10.1016/j.healun.2009.10.017; Despas F, 2009, J HYPERTENS, V27, P1849, DOI 10.1097/HJH.0b013e32832e8d0f; Eisenhofer G, 2001, PHARMACOL THERAPEUT, V91, P35, DOI 10.1016/S0163-7258(01)00144-9; Elesber AA, 2007, J AM COLL CARDIOL, V50, P448, DOI 10.1016/j.jacc.2007.03.050; Elian D, 2006, CLIN CARDIOL, V29, P9, DOI 10.1002/clc.4960290104; Franchitto N, 2013, INT J CARDIOL; Gianni M, 2006, EUR HEART J, V27, P1523, DOI 10.1093/eurheartj/ehl032; Grassi G, 2008, EUR J HEART FAIL, V10, P1186, DOI 10.1016/j.ejheart.2008.09.013; KINGWELL BA, 1994, CIRCULATION, V90, P234, DOI 10.1161/01.CIR.90.1.234; Kume T, 2008, CIRC J, V72, P106, DOI 10.1253/circj.72.106; Lavi S, 2007, AM J PHYSIOL-REG I, V292, pR788, DOI 10.1152/ajpregu.00352.2006; LEIMBACH WN, 1986, CIRCULATION, V73, P913, DOI 10.1161/01.CIR.73.5.913; Litvinov IV, 2009, CLIN RES CARDIOL, V98, P457, DOI 10.1007/s00392-009-0028-y; Lyon AR, 2008, NAT CLIN PRACT CARD, V5, P22, DOI 10.1038/ncpcardio1066; Macefield VG, 1999, CIRCULATION, V100, P1708, DOI 10.1161/01.CIR.100.16.1708; MADHAVAN M, 2010, HERZ; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Meyer T, 2010, PSYCHOSOM MED, V72, P9, DOI 10.1097/PSY.0b013e3181c64fc0; Nef HM, 2009, EUR HEART J, V30, P2155, DOI 10.1093/eurheartj/ehp240; Nigmatullina RR, 2009, CARDIOLOGY, V113, P277, DOI 10.1159/000205962; Norcliffe-Kaufmann LJ, 2011, CLIN AUTON RES, V21, P1, DOI 10.1007/s10286-010-0113-3; Parodi G, 2007, AM J CARDIOL, V99, P182, DOI 10.1016/j.amjcard.2006.07.080; Pilgrim TM, 2008, INT J CARDIOL, V124, P283, DOI 10.1016/j.ijcard.2007.07.002; Pilliere R, 2006, AM J CARDIOL, V98, P662, DOI 10.1016/j.amjcard.2006.03.048; Sato H., 1990, CLIN ASPECT MYOCARDI, P56; Scheitz JF, 2011, J NEUROL; Schneider B, 2013, INT J CARDIOL, V166, P584, DOI 10.1016/j.ijcard.2011.11.027; Sharkey SW, 2010, J AM COLL CARDIOL, V55, P333, DOI 10.1016/j.jacc.2009.08.057; SPYER KM, 1994, J PHYSIOL-LONDON, V474, P1; Vizzardi E, 2010, INT J CLIN PRACT, V64, P67, DOI 10.1111/j.1742-1241.2008.01833.x; Volz HC, 2009, CAN J CARDIOL, V25, pE261, DOI 10.1016/S0828-282X(09)70517-3; Waldenborg M, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-14; WALLIN BG, 1992, J PHYSIOL-LONDON, V453, P45, DOI 10.1113/jphysiol.1992.sp019217; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046; Yoshimura S, 2008, ANN NEUROL, V64, P547, DOI 10.1002/ana.21459	48	40	40	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93278	10.1371/journal.pone.0093278	http://dx.doi.org/10.1371/journal.pone.0093278			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667435	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600162
J	Gonzalez, BA; Orozco-terWengel, P; von Borries, R; Johnson, WE; Franklin, WL; Marin, JC				Gonzalez, Benito A.; Orozco-terWengel, Pablo; von Borries, Rainer; Johnson, Warren E.; Franklin, William L.; Marin, Juan C.			Maintenance of Genetic Diversity in an Introduced Island Population of Guanacos after Seven Decades and Two Severe Demographic Bottlenecks: Implications for Camelid Conservation	PLOS ONE			English	Article							LAMA-GUANICOE; MICROSATELLITE MARKERS; NUMBER; MANAGEMENT; SOFTWARE; DIFFERENTIATION; ARTIODACTYLA; ARGENTINA; MUTATION; PROGRAM	Fifteen guanacos were introduced to Staats Island in the Falklands/Malvinas archipelago from Patagonia in the 1930s. Twenty five years later, the population was culled from 300 to 10-20 individuals, but quickly rebounded to a population of almost 400 animals that today retain the genetic signature of the founding event and later bottleneck. The goals of this study were to (i) make a genetic assessment of this island population through comparisons with mainland populations and simulations, and (ii) assess the likely source-population of the introduced guanacos. Genetic variation was estimated from 513 bp of mitochondrial DNA sequence and 15 microsatellite loci among 154 guanacos collected from eight localities, including the adjacent mainland and the islands of Tierra del Fuego and Staats Island. Of the 23 haplotypes observed among our samples, the Staats Island population only contained three haplotypes, all of which were shared with the coastal Monte Leon population in southern Patagonia. Mitochondrial DNA and microsatellite variations on Staats Island were comparable to most mainland populations and greater than those observed on Tierra del Fuego. Patterns of genetic structure suggest that the Staats Island guanaco population was founded with animals from southern Patagonia (as opposed to northern Patagonia or Tierra del Fuego), but that effective reductions in population size lasted only a few generations and that surviving animals were a random sample of the pre-bottleneck genetic variation.	[Gonzalez, Benito A.] Univ Chile, Fac Ciencias Forestales & Conservac Nat, Lab Ecol Vida Silvestre, Santiago, Chile; [Orozco-terWengel, Pablo] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [von Borries, Rainer] Univ Chile, Fac Med, Santiago 7, Chile; [Johnson, Warren E.] Smithsonian Inst, Smithsonian Conservat Biol Inst, Front Royal, VA USA; [Franklin, William L.] Iowa State Univ, Dept Nat Resource Ecol & Management, Ames, IA USA; [Marin, Juan C.] Univ Bio Bio, Fac Ciencias, Lab Genom & Biodiversidad, Chillan, Chile	Universidad de Chile; Cardiff University; Universidad de Chile; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Iowa State University; Universidad del Bio-Bio	Marin, JC (corresponding author), Univ Bio Bio, Fac Ciencias, Lab Genom & Biodiversidad, Chillan, Chile.	jcmarin@ubiobio.cl	González, Benito/H-5189-2013; Orozco-terWengel, Pablo Andres/D-1527-2011; González, Benito/I-9570-2014; Johnson, Warren/D-4149-2016	Orozco-terWengel, Pablo Andres/0000-0002-7951-4148; González, Benito/0000-0001-8201-8789; Johnson, Warren/0000-0002-5954-186X; Gonzalez, Benito/0000-0002-0039-5722	Falkland Research Expeditions; Hidden Corners Inc.; Turner Foundation; University of South Florida; Comision Nacional de Investigacion, Ciencia y Tecnologia (CONICYT) [3050046]	Falkland Research Expeditions; Hidden Corners Inc.; Turner Foundation; University of South Florida; Comision Nacional de Investigacion, Ciencia y Tecnologia (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was partially funded by Falkland Research Expeditions, Hidden Corners Inc., Turner Foundation, University of South Florida, and the Comision Nacional de Investigacion, Ciencia y Tecnologia (CONICYT, Post-Doctoral grants No 3050046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi B, 2008, IUCN 2010 IUCN RED L; Baldi Ricardo, 1997, Mastozoologia Neotropical, V4, P5; Barri FR, 2011, ACTA ETHOL, V14, P103, DOI 10.1007/s10211-011-0098-5; Bas M. F., 2000, Ciencia e Investigacion Agraria, V27, P51; Beheregaray LB, 2003, CONSERV GENET, V4, P31, DOI 10.1023/A:1021864214375; BELKHIR K, 2005, GENETIX 4 05 LOGICIE; Bonhomme M, 2008, MOL ECOL, V17, P1009, DOI 10.1111/j.1365-294X.2007.03645.x; Busch JD, 2007, MOL ECOL, V16, P2450, DOI 10.1111/j.1365-294X.2007.03283.x; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Corander J, 2008, COMPUTATION STAT, V23, P111, DOI 10.1007/s00180-007-0072-x; Cornuet JM, 1996, GENETICS, V144, P2001; Cunazza C., 1995, TECNICAS MANEJO GUAN, P27; de la Tour G. D., 1954, Oryx, V2, P273; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; EBENHARD T, 1995, TRENDS ECOL EVOL, V10, P438, DOI 10.1016/S0169-5347(00)89176-4; Estevez J, 2001, INT J OSTEOARCHAEOL, V11, P24, DOI 10.1002/oa.543; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Flores CE, 2012, RANGELAND J, V34, P439, DOI 10.1071/RJ12040; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Franklin W.L., 1983, Special Publication American Society of Mammalogists, P573; Franklin W. L., 1982, MAMMALIAN BIOL S AM, P457; Franklin W.L., 2005, FALKLAND ISLANDS J, V8, P21; Franklin W.L., 2005, INT CAMELID Q, V4, P7; Franklin William, 2011, HDB MAMMALS WORLD HO, V2, P206, DOI DOI 10.1002/ZOO.21021; Franklin WL, 2005, J BIOGEOGR, V32, P661, DOI 10.1111/j.1365-2699.2004.01220.x; Franklin WL, 2004, REPORT GUANACO RES E; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Georoff TA, 2010, J ZOO WILDLIFE MED, V41, P255, DOI 10.1638/2009-0203R.1; Gonzalez BA, 2010, AMBIENTE FORESTAL, V9, P26; Gonzalez BA, 2006, MAMMAL REV, V36, P157, DOI 10.1111/j.1365-2907.2006.00084.x; Goudet J., 2005, FSTAT VERSION 2 9 4; Hampton JO, 2004, J APPL ECOL, V41, P735, DOI 10.1111/j.0021-8901.2004.00936.x; Hare MP, 2002, EVOLUTION, V56, P804; Hartl D., 1989, PRINCIPLES POPULATIO; HEDRICK PW, 1992, ECOL APPL, V2, P30, DOI 10.2307/1941887; IRIARTE JA, 1986, BIOL CONSERV, V38, P243; Jaksic F.M., 2004, HIST NATURAL PARQUE, P93; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; Kuo CH, 2003, MOL ECOL NOTES, V3, P669, DOI 10.1046/j.1471-8286.2003.00532.x; Lang KDM, 1996, ANIM GENET, V27, P293, DOI 10.1111/j.1365-2052.1996.tb00502.x; Le Page SL, 2000, MOL ECOL, V9, P753, DOI 10.1046/j.1365-294x.2000.00922.x; Lichtenstein G, 2013, J LAT AM GEOGR, V12, P187, DOI 10.1353/lag.2013.0002; Manceau V, 1999, ANIM CONSERV, V2, P33, DOI 10.1111/j.1469-1795.1999.tb00046.x; MARES MA, 1984, BIOSCIENCE, V34, P580, DOI 10.2307/1309601; Marin JC, 2007, REV CHIL HIST NAT, V80, P120; Marin JC, 2008, J MAMMAL, V89, P269, DOI 10.1644/06-MAMM-A-385R.1; Marin JC, 2013, MOL ECOL, V22, P463, DOI 10.1111/mec.12111; Marshall TC, 1999, ANIM CONSERV, V2, P269, DOI 10.1111/j.1469-1795.1999.tb00073.x; Massoia E., 1993, MAMIFEROS SILVESTRES; Mate ML, 2005, ANIM GENET, V36, P316, DOI 10.1111/j.1365-2052.2005.01307.x; McCulloch R., 1997, PATAGONIA NATURAL HI, P12; Montes Carolina, 2000, Mastozoologia Neotropical, V7, P23; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; Park SDE, 2001, THESIS U DUBLIN; Penedo MCT, 1998, ANIM GENET, V29, P411; Penedo MCT, 1999, ANIM GENET, V30, P166, DOI 10.1046/j.1365-2052.1999.00382-8.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Raedeke K., 1978, CONAF PUBLICACION TE, V4; RALLS K, 1986, TRENDS ECOL EVOL, V1, P19, DOI 10.1016/0169-5347(86)90062-5; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Saba Sergio L., 1994, Mastozoologia Neotropical, V1, P113; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sarno RJ, 2000, MOL ECOL, V9, P1922, DOI 10.1046/j.1365-294x.2000.01077-3.x; Sarno RJ, 1996, J AM VET MED ASSOC, V208, P408; Sarno RJ, 2001, ANIM CONSERV, V4, P93, DOI 10.1017/S1367943001001123; Sigg DP, 2006, CONSERV GENET, V7, P577, DOI 10.1007/s10592-005-9096-3; Snyder NFR, 1996, CONSERV BIOL, V10, P338, DOI 10.1046/j.1523-1739.1996.10020338.x; Strange IJ, 1992, FIELD GUIDE WILDLIFE; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WHEELER JC, 1995, BIOL J LINN SOC, V54, P271, DOI 10.1016/0024-4066(95)90021-7; Wilson GA, 2005, CONSERV GENET, V6, P905, DOI 10.1007/s10592-005-9077-6; Young JK, 2004, J MAMMAL, V85, P72, DOI 10.1644/1545-1542(2004)085<0072:TFOMGI>2.0.CO;2	78	7	9	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91714	10.1371/journal.pone.0091714	http://dx.doi.org/10.1371/journal.pone.0091714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663026	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000333459900027
J	Hernandez-Rodriguez, Y; Masuo, S; Johnson, D; Orlando, R; Smith, A; Couto-Rodriguez, M; Momany, M				Hernandez-Rodriguez, Yainitza; Masuo, Shunsuke; Johnson, Darryl; Orlando, Ron; Smith, Amy; Couto-Rodriguez, Mara; Momany, Michelle			Distinct Septin Heteropolymers Co-Exist during Multicellular Development in the Filamentous Fungus Aspergillus nidulans	PLOS ONE			English	Article							ROLES; EMERGENCE; CYTOSKELETON; YEAST; ORGANIZATION; COMPONENT; REVEALS; GTPASES; FAMILY; ACTIN	Septins are important components of the cytoskeleton that are highly conserved in eukaryotes and play major roles in cytokinesis, patterning, and many developmental processes. Septins form heteropolymers which assemble into higher-order structures including rings, filaments, and gauzes. In contrast to actin filaments and microtubules, the molecular mechanism by which septins assemble is not well-understood. Here, we report that in the filamentous fungus Aspergillus nidulans, four core septins form heteropolymeric complexes. AspE, a fifth septin lacking in unicellular yeasts, interacts with only one of the core septins, and only during multicellular growth. AspE is required for proper localization of three of the core septins, and requires this same subset of core septins for its own unique cortical localization. The DaspE mutant lacks developmentally-specific septin higher-order structures and shows reduced spore production and slow growth with low temperatures and osmotic stress. Our results show that at least two distinct septin heteropolymer populations co-exist in A. nidulans, and that while AspE is not a subunit of either heteropolymer, it is required for assembly of septin higher-order structures found in multicellular development.	[Hernandez-Rodriguez, Yainitza; Masuo, Shunsuke; Smith, Amy; Couto-Rodriguez, Mara; Momany, Michelle] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Johnson, Darryl; Orlando, Ron] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Momany, M (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	momany@plantbio.uga.edu	Momany, Michelle/L-2327-2016	Masuo, Shunsuke/0000-0002-0454-3315; Couto-Rodriguez, Mara/0000-0002-9799-0068; Momany, Michelle/0000-0001-7110-063X; Hernandez Rodriguez, Yainitza/0000-0001-8219-6235	NSF from the Developmental Systems Cluster [IOS1051730]; Japan Society for the Promotion of Sciences; NIH Integrated Technology Resource for Biomedical Glycomics [P41RR018502]; Institutional Program for Young Researcher Overseas Visits; Direct For Biological Sciences [1051730] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER	NSF from the Developmental Systems Cluster; Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH Integrated Technology Resource for Biomedical Glycomics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Program for Young Researcher Overseas Visits; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NSF Grant IOS1051730 from the Developmental Systems Cluster (to MM), the Institutional Program for Young Researcher Overseas Visits by the Japan Society for the Promotion of Sciences (to SM) and the NIH Integrated Technology Resource for Biomedical Glycomics Grant P41RR018502 (to RO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berepiki A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063843; Bertin A, 2008, P NATL ACAD SCI USA, V105, P8274, DOI 10.1073/pnas.0803330105; Cao LH, 2007, FEBS LETT, V581, P5526, DOI 10.1016/j.febslet.2007.10.032; Frazier JA, 1998, J CELL BIOL, V143, P737, DOI 10.1083/jcb.143.3.737; Garcia G, 2011, J CELL BIOL, V195, P993, DOI 10.1083/jcb.201107123; Gilden J, 2010, CYTOSKELETON, V67, P477, DOI 10.1002/cm.20461; Gilden JK, 2012, J CELL BIOL, V196, P103, DOI 10.1083/jcb.201105127; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; Hall PA, 2012, J PATHOL, V226, P287, DOI 10.1002/path.3024; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Hernandez-Rodriguez Y, 2012, CURR OPIN MICROBIOL; Hernandez-Rodriguez Y, 2012, EUKARYOT CELL, V11, P311, DOI 10.1128/EC.05164-11; Juvvadi PR, 2013, BIOCHEM BIOPH RES CO, V431, P547, DOI 10.1016/j.bbrc.2013.01.020; Juvvadi PR, 2011, BIOCHEM BIOPH RES CO, V405, P238, DOI 10.1016/j.bbrc.2011.01.017; Kim MS, 2012, J BIOL CHEM, V287, P30406, DOI 10.1074/jbc.M112.387464; Kinoshita M, 2003, J BIOCHEM, V134, P491, DOI 10.1093/jb/mvg182; Kremer BE, 2007, CELL, V130, P837, DOI 10.1016/j.cell.2007.06.053; Lindsey R, 2010, EUKARYOT CELL, V9, P155, DOI 10.1128/EC.00269-09; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; McMurray MA, 2011, DEV CELL, V20, P540, DOI 10.1016/j.devcel.2011.02.004; Meseroll RA, 2012, MOL BIOL CELL; Momany M, 2001, GENETICS, V157, P969; Momany M, 2000, MICROBIOL-UK, V146, P3279, DOI 10.1099/00221287-146-12-3279; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Nishihama R, 2011, BIOL CHEM, V392, P681, DOI 10.1515/BC.2011.086; Oh Y, 2011, TRENDS CELL BIOL, V21, P141, DOI 10.1016/j.tcb.2010.11.006; Pan FF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-103; Powell DW, 2004, MOL CELL BIOL, V24, P7249, DOI 10.1128/MCB.24.16.7249-7259.2004; Sellin ME, 2011, MOL BIOL CELL, V22, P3152, DOI 10.1091/mbc.E11-03-0253; Shin KS, 2009, EUKARYOT CELL, V8, P738, DOI 10.1128/EC.00368-08; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Spiliotis ET, 2012, TRAFFIC, V13, P195, DOI 10.1111/j.1600-0854.2011.01268.x; Tooley AJ, 2009, NAT CELL BIOL, V11, P17, DOI 10.1038/ncb1808; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Yamazaki T, 2013, PLANT J, V74, P605, DOI 10.1111/tpj.12147; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n; Zybailov BL, 2007, MOL BIOSYST, V3, P354, DOI 10.1039/b701483j	38	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92819	10.1371/journal.pone.0092819	http://dx.doi.org/10.1371/journal.pone.0092819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664283	Green Submitted, gold, Green Published			2022-12-27	WOS:000333459900119
J	Konishi, J; Asami, T; Hayano, F; Yoshimi, A; Hayasaka, S; Fukushima, H; Whitford, TJ; Inoue, T; Hirayasu, Y				Konishi, Jun; Asami, Takeshi; Hayano, Fumi; Yoshimi, Asuka; Hayasaka, Shunsuke; Fukushima, Hiroshi; Whitford, Thomas J.; Inoue, Tomio; Hirayasu, Yoshio			Multiple White Matter Volume Reductions in Patients with Panic Disorder: Relationships between Orbitofrontal Gyrus Volume and Symptom Severity and Social Dysfunction	PLOS ONE			English	Article							GENERALIZED ANXIETY DISORDER; ANTERIOR CINGULATE CORTEX; QUALITY-OF-LIFE; VOXEL-BASED MORPHOMETRY; NEUROANATOMICAL HYPOTHESIS; 1ST-EPISODE SCHIZOPHRENIA; FUNCTIONAL CONNECTIVITY; PREFRONTAL CORTEX; BRAIN ACTIVATION; AMYGDALA DAMAGE	Numerous brain regions are believed to be involved in the neuropathology of panic disorder (PD) including fronto-limbic regions, thalamus, brain stem, and cerebellum. However, while several previous studies have demonstrated volumetric gray matter reductions in these brain regions, there have been no studies evaluating volumetric white matter changes in the fiber bundles connecting these regions. In addition, although patients with PD typically exhibit social, interpersonal and occupational dysfunction, the neuropathologies underlying these dysfunctions remain unclear. A voxel-based morphometry study was conducted to evaluate differences in regional white matter volume between 40 patients with PD and 40 healthy control subjects (HC). Correlation analyses were performed between the regional white matter volumes and patients' scores on the Panic Disorder Severity Scale (PDSS) and the Global Assessment of Functioning (GAF). Patients with PD demonstrated significant volumetric reductions in widespread white matter regions including fronto-limbic, thalamo-cortical and cerebellar pathways (p<0.05, FDR corrected). Furthermore, there was a significant negative relationship between right orbitofrontal gyrus (OFG) white matter volume and the severity of patients' clinical symptoms, as assessed with the PDSS. A significant positive relationship was also observed between patients' right OFG volumes and their scores on the GAF. Our results suggest that volumetric reductions in widespread white matter regions may play an important role in the pathology of PD. In particular, our results suggest that structural white matter abnormalities in the right OFG may contribute to the social, personal and occupational dysfunction typically experienced by patients with PD.	[Konishi, Jun; Asami, Takeshi; Hayano, Fumi; Yoshimi, Asuka; Hayasaka, Shunsuke; Fukushima, Hiroshi; Hirayasu, Yoshio] Yokohama City Univ, Grad Sch Med, Dept Psychiat, Yokohama, Kanagawa 232, Japan; [Whitford, Thomas J.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Inoue, Tomio] Yokohama City Univ, Grad Sch Med, Dept Radiol, Yokohama, Kanagawa 232, Japan	Yokohama City University; University of New South Wales Sydney; Yokohama City University	Hirayasu, Y (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Psychiat, Yokohama, Kanagawa 232, Japan.	hirayasu@yokohama-cu.ac.jp			Ministry of Health, Labor and Welfare [Kokoro 200400762A, 200500806A, 200632005]; Japan Society for the Promotion of Science of Japan [13 25861023]; Grants-in-Aid for Scientific Research [25861023] Funding Source: KAKEN	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Ministry of Health, Labor and Welfare (Kokoro 200400762A, 200500806A, and 200632005A, B) (Dr. Hirayasu), and from the Grant-in-Aid for Young Scientists (B) of the Japan Society for the Promotion of Science (13 25861023) (Dr. Asami) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Agustin-Pavon C, 2012, BIOL PSYCHIAT, V72, P266, DOI 10.1016/j.biopsych.2012.03.007; Amaral DG, 2002, BIOL PSYCHIAT, V51, P11, DOI 10.1016/S0006-3223(01)01307-5; AmericanPsychiatricAssociation, 2000, DIAGN STAT MAN MENT; Asami T, 2008, PSYCHIAT CLIN NEUROS, V62, P322, DOI 10.1111/j.1440-1819.2008.01800.x; Asami T, 2013, SCHIZOPHR RES, V143, P253, DOI 10.1016/j.schres.2012.11.030; Asami T, 2012, NEUROIMAGE, V59, P986, DOI 10.1016/j.neuroimage.2011.08.066; Asami T, 2009, PSYCHIAT RES-NEUROIM, V173, P128, DOI 10.1016/j.pscychresns.2008.10.004; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Aupperle Robin L, 2010, Dialogues Clin Neurosci, V12, P517; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Boshuisen ML, 2002, BIOL PSYCHIAT, V52, P126, DOI 10.1016/S0006-3223(02)01355-0; Browning M, 2012, NEUROIMAGE, V59, P1942, DOI 10.1016/j.neuroimage.2011.09.007; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bystritsky A, 2001, NEUROREPORT, V12, P3953, DOI 10.1097/00001756-200112210-00020; Comer JS, 2011, J CLIN PSYCHIAT, V72, P43, DOI 10.4088/JCP.09m05094blu; CORYELL W, 1988, PSYCHIAT CLIN N AM, V11, P433; Croxson PL, 2005, J NEUROSCI, V25, P8854, DOI 10.1523/JNEUROSCI.1311-05.2005; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Dresler T, 2013, J NEURAL TRANSM, V120, P3, DOI 10.1007/s00702-012-0811-1; Eguchi M, 2005, J NERV MENT DIS, V193, P686, DOI 10.1097/01.nmd.0000180966.69049.38; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; Fine C, 2001, BRAIN, V124, P287, DOI 10.1093/brain/124.2.287; First M, 1997, STRRUCTURED CLIN INT; Fujiwara A, 2011, PSYCHIAT CLIN NEUROS, V65, P365, DOI 10.1111/j.1440-1819.2011.02219.x; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gorman JM, 2000, AM J PSYCHIAT, V157, P493, DOI 10.1176/appi.ajp.157.4.493; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Gros DF, 2011, GEN HOSP PSYCHIAT, V33, P482, DOI 10.1016/j.genhosppsych.2011.06.005; Hall J, 2010, PSYCHOL MED, V40, P1183, DOI 10.1017/S0033291709991395; Harlow JM, 1848, BOSTON MED SURGICAL, V39, P389, DOI DOI 10.1056/NEJM184812130392001; Hayano F, 2009, PSYCHIAT CLIN NEUROS, V63, P266, DOI 10.1111/j.1440-1819.2009.01960.x; Hindi Attar C, 2012, PLOS ONE, V7; Hollingshead AB, 1965, 2 FACTOR INDEX SOCIA; Holtz K, 2012, NEUROIMAGE, V61, P857, DOI 10.1016/j.neuroimage.2012.03.019; Hoppenbrouwers SS, 2008, BRAIN RES REV, V59, P185, DOI 10.1016/j.brainresrev.2008.07.005; Inagaki A., 2006, JAPANESE J CLIN PSYC, V9, P1443; Johansen-Berg H, 2008, CEREB CORTEX, V18, P1374, DOI 10.1093/cercor/bhm167; Kent JM, 2005, AM J PSYCHIAT, V162, P1379, DOI 10.1176/appi.ajp.162.7.1379; Kluver H, 1939, ARCH NEURO PSYCHIATR, V42, P979; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lai CH, 2012, J AFFECT DISORDERS, V140, P285, DOI 10.1016/j.jad.2012.01.049; Lai CH, 2011, J CLIN PSYCHOPHARM, V31, P287, DOI 10.1097/JCP.0b013e31821a1045; MARKOWITZ JS, 1989, ARCH GEN PSYCHIAT, V46, P984; Maroun M., 2012, NEUROSCIENTIST; Mendlowicz MV, 2000, AM J PSYCHIAT, V157, P669, DOI 10.1176/appi.ajp.157.5.669; Mori S., 2005, MRI ATLAS HUMAN WHIT; Morris JS, 2004, NEUROIMAGE, V22, P372, DOI 10.1016/j.neuroimage.2004.01.012; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; ORMEL J, 1994, JAMA-J AM MED ASSOC, V272, P1741, DOI 10.1001/jama.272.22.1741; Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004; Rangel A, 2010, CURR OPIN NEUROBIOL, V20, P262, DOI 10.1016/j.conb.2010.03.001; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rodriguez BF, 2005, J ANXIETY DISORD, V19, P752, DOI 10.1016/j.janxdis.2004.10.002; Roppongi T, 2010, PSYCHIAT CLIN NEUROS, V64, P318, DOI 10.1111/j.1440-1819.2010.02085.x; Roy AK, 2013, J AM ACAD CHILD PSY, V52, P290, DOI 10.1016/j.jaac.2012.12.010; Sakai Y, 2005, NEUROREPORT, V16, P927, DOI 10.1097/00001756-200506210-00010; Sakai Y, 2006, NEUROIMAGE, V33, P218, DOI 10.1016/j.neuroimage.2006.06.017; Schweizer S, 2013, J NEUROSCI, V33, P5301, DOI 10.1523/JNEUROSCI.2593-12.2013; SHEAR MK, 1994, ARCH GEN PSYCHIAT, V51, P346; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Siegal M, 2002, NAT REV NEUROSCI, V3, P463, DOI 10.1038/nrn844; Somerville LH, 2006, NAT NEUROSCI, V9, P1007, DOI 10.1038/nn1728; Stone VE, 2003, NEUROPSYCHOLOGIA, V41, P209, DOI 10.1016/S0028-3932(02)00151-3; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Takahashi H, 2004, NEUROIMAGE, V23, P967, DOI 10.1016/j.neuroimage.2004.07.054; Tranel Daniel, 2006, Cogn Neuropsychiatry, V11, P219, DOI 10.1080/13546800444000281; Uchida RR, 2008, PSYCHIAT RES-NEUROIM, V163, P21, DOI 10.1016/j.pscychresns.2007.04.015; van den Heuvel OA, 2005, ARCH GEN PSYCHIAT, V62, P922, DOI 10.1001/archpsyc.62.8.922; Weissman MM, 1997, ARCH GEN PSYCHIAT, V54, P305; Whitford TJ, 2005, PSYCHIAT RES-NEUROIM, V139, P229, DOI 10.1016/j.pscychresns.2005.05.010; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Yoo HK, 2005, EUR J NEUROSCI, V22, P2089, DOI 10.1111/j.1460-9568.2005.04394.x; Zald DH, 2012, CEREB CORTEX	80	11	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92862	10.1371/journal.pone.0092862	http://dx.doi.org/10.1371/journal.pone.0092862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663245	Green Submitted, gold, Green Published			2022-12-27	WOS:000333459900125
J	Leibovitch, EC; Brunetto, GS; Caruso, B; Fenton, K; Ohayon, J; Reich, DS; Jacobson, S				Leibovitch, Emily C.; Brunetto, Giovanna S.; Caruso, Breanna; Fenton, Kaylan; Ohayon, Joan; Reich, Daniel S.; Jacobson, Steven			Coinfection of Human Herpesviruses 6A (HHV-6A) and HHV-6B as Demonstrated by Novel Digital Droplet PCR Assay	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; POLYMERASE-CHAIN-REACTION; CENTRAL-NERVOUS-SYSTEM; REAL-TIME PCR; MULTIPLE-SCLEROSIS; PERIPHERAL-BLOOD; HEALTHY-ADULTS; HUMAN-HERPESVIRUS-6 VARIANT; ACTIVE REPLICATION; DNA	The human herpesviruses HHV-6A and HHV-6B have been associated with various neurologic disorders partly due to the detection of elevated viral DNA levels in patients compared to controls. However the reported frequency of these viruses varies widely, likely reflecting differences in PCR methodologies used for detection. Digital droplet PCR (ddPCR) is a third generation PCR technology that enables the absolute quantification of target DNA molecules. Mounting evidence of the biological differences between HHV-6A and HHV-6B has led to their recent reclassification as separate species. As it is now especially relevant to investigate each virus, our objectives were to first design a multiplex HHV-6A and HHV-6B ddPCR assay and then to investigate the incidence of HHV-6A and HHV-6B coinfection in samples from healthy donors and patients with MS, a disease in which HHV-6 is thought to play a role. In our assessment of healthy donors, we observed a heretofore-underappreciated high frequency of coinfection in PBMC and serum, and found that our assay precisely detects both HHV6A and HHV-6B chromosomally integrated virus, which has important implications in clinical settings. Interestingly, upon comparing the saliva from MS patients and healthy donors, we detected a significantly elevated frequency of coinfection in MS saliva; increased detection of HHV-6A in MS patients is consistent with other studies suggesting that this viral species (thought to be more neurotropic than HHV-6B) is more prevalent among MS patients compared to healthy donors. As the biology and disease associations between these two viral species differ, identifying and quantifying both species of HHV-6 may provide clinically relevant information, as well as enhance our understanding of the roles of each in health and disease.	[Leibovitch, Emily C.; Brunetto, Giovanna S.; Caruso, Breanna; Fenton, Kaylan; Ohayon, Joan; Reich, Daniel S.; Jacobson, Steven] NINDS, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA; [Leibovitch, Emily C.] George Washington Univ, Sch Med & Hlth Sci, Inst Biomed Sci, Washington, DC 20052 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); George Washington University	Jacobson, S (corresponding author), NINDS, Neuroimmunol Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	jacobsons@ninds.nih.gov	Reich, Daniel S./E-5701-2010	Reich, Daniel S./0000-0002-2628-4334; Caruso, Breanna/0000-0001-6163-1023; Caruso, Breanna/0000-0002-1519-8131; Manzano, Giovanna/0000-0002-9991-9222	NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002817, ZIANS002204] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the intramural research program of NINDS, and the funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The authors thank Sandy Chiang, John Chuckalovcak and Dr. Bo Song from Bio-Rad laboratories for technical support. No funding was received from Bio-Rad.	Aberle SW, 1996, J CLIN MICROBIOL, V34, P3223, DOI 10.1128/JCM.34.12.3223-3225.1996; Achour A, 2007, J CLIN VIROL, V38, P280, DOI 10.1016/j.jcv.2006.12.019; Ahlqvist J, 2005, J NEUROVIROL, V11, P384, DOI 10.1080/13550280591002379; Ahram M, 2009, ACTA NEUROL SCAND, V120, P430, DOI 10.1111/j.1600-0404.2009.01187.x; Akhyani N, 2000, J INFECT DIS, V182, P1321, DOI 10.1086/315893; Alvarez-Lafuente R, 2010, EUR J NEUROL, V17, P129, DOI 10.1111/j.1468-1331.2009.02758.x; Alvarez-Lafuente R, 2006, J CLIN VIROL, V37, pS24, DOI 10.1016/S1386-6532(06)70007-5; [Anonymous], 2012, VIRUS TAXONOMY; Arbuckle JH, 2010, P NATL ACAD SCI USA, V107, P5563, DOI 10.1073/pnas.0913586107; Ashshi AM, 2003, J INFECTION, V47, P59, DOI 10.1016/S0163-4453(03)00057-4; Bates M, 2009, J MED VIROL, V81, P779, DOI 10.1002/jmv.21455; Berti R, 2002, J NEUROVIROL, V8, P250, DOI 10.1080/13550280290049615-1; Boutolleau D, 2006, J CLIN VIROL, V35, P257, DOI 10.1016/j.jcv.2005.08.002; Carricart SE, 2002, MEDICINA-BUENOS AIRE, V62, P9; Caserta MT, 2004, J PEDIATR-US, V145, P478, DOI 10.1016/j.jpeds.2004.06.016; Cassina G, 2013, J VIROL METHODS, V189, P172, DOI 10.1016/j.jviromet.2013.01.018; CHALLONER PB, 1995, P NATL ACAD SCI USA, V92, P7440, DOI 10.1073/pnas.92.16.7440; CONE RW, 1993, J CLIN MICROBIOL, V31, P1262, DOI 10.1128/JCM.31.5.1262-1267.1993; Csoma E, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-403; CUENDE JI, 1994, J MED VIROL, V43, P115, DOI 10.1002/jmv.1890430203; De Bolle L, 2005, J MED VIROL, V75, P76, DOI 10.1002/jmv.20240; DEWHURST S, 1993, J CLIN MICROBIOL, V31, P416, DOI 10.1128/JCM.31.2.416-418.1993; Dominguez G, 1999, J VIROL, V73, P8040, DOI 10.1128/JVI.73.10.8040-8052.1999; Donati D, 2005, J VIROL, V79, P9439, DOI 10.1128/JVI.79.15.9439-9448.2005; Flamand L, 2008, J CLIN MICROBIOL, V46, P2700, DOI 10.1128/JCM.00370-08; Fotheringham Julie, 2005, Herpes, V12, P4; FOX JD, 1990, LANCET, V336, P590, DOI 10.1016/0140-6736(90)93392-3; Gautheret-Dejean A, 2009, J CLIN VIROL, V46, P33, DOI 10.1016/j.jcv.2009.05.020; Harberts E, 2011, P NATL ACAD SCI USA, V108, P13734, DOI 10.1073/pnas.1105143108; Hayden RT, 2013, J CLIN MICROBIOL, V51, P540, DOI 10.1128/JCM.02620-12; Henrich TJ, 2012, J VIROL METHODS, V186, P68, DOI 10.1016/j.jviromet.2012.08.019; Hidaka Y, 1997, CLIN INFECT DIS, V24, P1022, DOI 10.1093/clinids/24.5.1022; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; HUANG LM, 1992, J MED VIROL, V38, P7, DOI 10.1002/jmv.1890380103; Hudnall SD, 2008, TRANSFUSION, V48, P1180, DOI 10.1111/j.1537-2995.2008.01685.x; JARRETT RF, 1990, J MED VIROL, V32, P73, DOI 10.1002/jmv.1890320113; Jaworska J, 2010, P NATL ACAD SCI USA, V107, P8369, DOI 10.1073/pnas.0909951107; Kelley K, 2013, J CLIN MICROBIOL; Kim JS, 2000, EUR NEUROL, V43, P170, DOI 10.1159/000008158; Lautenschlager I, 2012, TRANSPL INT, V25, P493, DOI 10.1111/j.1432-2277.2012.01443.x; Lee TH, 2001, TRANSFUSION, V41, P276, DOI 10.1046/j.1537-2995.2001.41020276.x; LEVY JA, 1990, LANCET, V335, P1047, DOI 10.1016/0140-6736(90)92628-U; Magalhaes IM, 2010, MEM I OSWALDO CRUZ, V105, P925, DOI 10.1590/S0074-02762010000700015; Morissette G, 2010, J VIROL, V84, P12100, DOI 10.1128/JVI.01169-10; Muta T, 2009, BONE MARROW TRANSPL, V43, P583, DOI 10.1038/bmt.2008.359; Osiowy C, 1998, J CLIN MICROBIOL, V36, P68, DOI 10.1128/JCM.36.1.68-72.1998; Pellett PE, 2012, REV MED VIROL, V22, P144, DOI 10.1002/rmv.715; Pereira CM, 2004, ARCH ORAL BIOL, V49, P1043, DOI 10.1016/j.archoralbio.2004.06.002; Razonable RR, 2002, J INFECT DIS, V185, P110, DOI 10.1086/324772; SANDHOFF T, 1991, MED MICROBIOL IMMUN, V180, P127; Shimazu Y, 2013, TRANSPL INFECT DIS, V15, P195, DOI 10.1111/tid.12049; Soldan SS, 2000, ANN NEUROL, V47, P306, DOI 10.1002/1531-8249(200003)47:3<306::AID-ANA5>3.0.CO;2-A; Soldan SS, 1997, NAT MED, V3, P1394, DOI 10.1038/nm1297-1394; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Theodore WH, 2008, EPILEPSIA, V49, P1828, DOI 10.1111/j.1528-1167.2008.01699.x; Vinnard C, 2009, LIVER TRANSPLANT, V15, P1242, DOI 10.1002/lt.21816; Ward KN, 2005, J CLIN VIROL, V32, P183, DOI 10.1016/j.jcv.2004.11.008; Yao K, 2010, J MED VIROL, V82, P1669, DOI 10.1002/jmv.21861; Yao K, 2009, ANN NEUROL, V65, P257, DOI 10.1002/ana.21611; Yoshikawa T, 2000, J MED VIROL, V62, P52, DOI 10.1002/1096-9071(200009)62:1&lt;52::AID-JMV9&gt;3.0.CO;2-5; Zerr DM, 2005, NEW ENGL J MED, V352, P768, DOI 10.1056/NEJMoa042207	61	43	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92328	10.1371/journal.pone.0092328	http://dx.doi.org/10.1371/journal.pone.0092328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663487	Green Submitted, Green Published, gold			2022-12-27	WOS:000333459900051
J	Yokoyama, S; Takahashi, K; Kawashima, R				Yokoyama, Satoru; Takahashi, Kei; Kawashima, Ryuta			Animacy or Case Marker Order?: Priority Information for Online Sentence Comprehension in a Head-Final Language	PLOS ONE			English	Article							PASSIVE SENTENCES; INCREMENTAL INTERPRETATION; JAPANESE; REANALYSIS; ACTIVATION; FMRI	It is well known that case marker information and animacy information are incrementally used to comprehend sentences in head-final languages. However, it is still unclear how these two kinds of information are processed when they are in competition in a sentence's surface expression. The current study used sentences conveying the potentiality of some event (henceforth, potential sentences) in the Japanese language with theoretically canonical word order (dative-nominative/animate-inanimate order) and with scrambled word order (nominative-dative/inanimate-animate order). In Japanese, nominative-first case order and animate-inanimate animacy order are preferred to their reversed patterns in simplex sentences. Hence, in these potential sentences, case information and animacy information are in competition. The experiment consisted of a self-paced reading task testing two conditions (that is, canonical and scrambled potential sentences). Forty-five native speakers of Japanese participated. In our results, the canonical potential sentences showed a scrambling cost at the second argument position (the nominative argument). This result indicates that the theoretically scrambled case marker order (nominative-dative) is processed as a mentally canonical case marker order, suggesting that case information is used preferentially over animacy information when the two are in competition. The implications of our findings are discussed with regard to incremental simplex sentence comprehension models for head-final languages.	[Yokoyama, Satoru; Takahashi, Kei; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Yokoyama, Satoru] Tohoku Univ, Grad Sch Int Cultural Studies, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University	Yokoyama, S (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	yokoyama@idac.tohoku.ac.jp			JST/RISTEX; JST/CREST;  [23720192]	JST/RISTEX(Japan Science & Technology Agency (JST)); JST/CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); 	This study was supported by JST/RISTEX and JST/CREST to RK, and Grant-in-Aid for Young Scientists (B): 23720192 to SY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann GTM, 1999, COGNITION, V73, P247, DOI 10.1016/S0010-0277(99)00059-1; Aoshima S, 2009, SYNTAX-UK, V12, P93, DOI 10.1111/j.1467-9612.2009.00123.x; Bornkessel I, 2006, PSYCHOL REV, V113, P787, DOI 10.1037/0033-295X.113.4.787; Bornkessel-Schlesewsky I, 2008, BRAIN RES REV, V59, P55, DOI 10.1016/j.brainresrev.2008.05.003; CHUJO K, 1983, JPN J PSYCHOL, V54, P250, DOI 10.4992/jjpsy.54.250; Ferreira F, 2003, COGNITIVE PSYCHOL, V47, P164, DOI 10.1016/S0010-0285(03)00005-7; HERRIOT P, 1969, J VERB LEARN VERB BE, V8, P166, DOI 10.1016/S0022-5371(69)80056-3; Itoh T, 1993, ROLE CASE PARTICLES; JUST MA, 1982, J EXP PSYCHOL GEN, V111, P228, DOI 10.1037/0096-3445.111.2.228; Kamide Y, 1999, LANG COGNITIVE PROC, V14, P631, DOI 10.1080/016909699386211; KEMPER S, 1979, LANG SPEECH, V22, P253, DOI 10.1177/002383097902200306; Kim J, 2009, J NEUROLINGUIST, V22, P151, DOI 10.1016/j.jneuroling.2008.07.005; Koizumi M., 2004, J LINGUIST SOC JPN, V125, P173; Mazuka R., 2002, SENTENCE PROCESSING, P167; Meltzer JA, 2010, CEREB CORTEX, V20, P1853, DOI 10.1093/cercor/bhp249; Miyamoto E. T., 2005, GENGO KENKYU, V128, P113; Miyamoto ET, 2003, LANG SPEECH, V46, P23, DOI 10.1177/00238309030460010301; Miyamoto ET, 2002, J PSYCHOLINGUIST RES, V31, P307, DOI 10.1023/A:1019540324040; Richardson FM, 2010, J COGNITIVE NEUROSCI, V22, P1283, DOI 10.1162/jocn.2009.21277; SADAKANE K, 1995, LINGUISTICS, V33, P5, DOI 10.1515/ling.1995.33.1.5; Schlesewsky M, 2004, LINGUA, V114, P1213, DOI 10.1016/j.lingua.2003.07.006; SLOBIN DI, 1966, J VERB LEARN VERB BE, V5, P219, DOI 10.1016/S0022-5371(66)80023-3; Tamaoka K, 2005, J PSYCHOLINGUIST RES, V34, P281, DOI 10.1007/s10936-005-3641-6; Yokoyama S, 2006, NEUROIMAGE, V30, P570, DOI 10.1016/j.neuroimage.2005.09.066; Yokoyama S, 2012, PARTIAL INCREMENTAL, P159; Yokoyama S, 2007, NEUROPSYCHOLOGIA, V45, P989, DOI 10.1016/j.neuropsychologia.2006.09.003; Yokoyama S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056106; Yokoyama S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040474; Yokoyama S, 2009, J NEUROLINGUIST, V22, P605, DOI 10.1016/j.jneuroling.2009.07.002	29	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93109	10.1371/journal.pone.0093109	http://dx.doi.org/10.1371/journal.pone.0093109			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD7QO	24664132	gold, Green Published, Green Submitted			2022-12-27	WOS:000333459900153
J	Batstone, RT; Laurich, JR; Salvo, F; Dufour, SC				Batstone, Rebecca T.; Laurich, Jason R.; Salvo, Flora; Dufour, Suzanne C.			Divergent Chemosymbiosis-Related Characters in Thyasira cf. gouldi (Bivalvia: Thyasiridae)	PLOS ONE			English	Article							EDULIS SPECIES COMPLEX; MOLECULAR PHYLOGENY; EVOLUTIONARY RELATIONSHIPS; SYMBIOTIC BACTERIA; SOUTHWEST ENGLAND; CLAMS MOLLUSCA; RIBOSOMAL-RNA; COLD SEEP; VESICOMYIDAE; GASTROPODA	Within the marine bivalve family Thyasiridae, some species have bacterial chemosymbionts associated with gill epithelial cells while other species are asymbiotic. Although the abundance of symbionts in a particular thyasirid species may vary, the structure of their gills (i.e., their frontal-abfrontal thickening) does not. We examined gill structure in a species tentatively identified as Thyasira gouldi from a Northwest Atlantic fjord (Bonne Bay, Newfoundland) and found remarkable differences among specimens. Some individuals had thickened gill filaments with abundant symbionts, while others had thin filaments and lacked symbionts. We could differentiate symbiotic and asymbiotic specimens based on the size and outline of their shell as well as 18S rRNA, 28S rRNA and CO1 sequences. The wide morphological, genetic and symbiosis-related disparity described herein suggests that chemosymbiosis may influence host divergence, and that Thyasira gouldi forms a cryptic species complex.	[Batstone, Rebecca T.; Laurich, Jason R.; Salvo, Flora; Dufour, Suzanne C.] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada	Memorial University Newfoundland	Dufour, SC (corresponding author), Mem Univ Newfoundland, Dept Biol, St John, NF, Canada.	sdufour@mun.ca		Salvo, Flora/0000-0002-5275-2170; Batstone, Rebecca/0000-0002-2530-8998	Natural Sciences and Engineering Research Council of Canada; Newfoundland and Labrador Research and Development Corporation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Newfoundland and Labrador Research and Development Corporation	This project was funded by the Natural Sciences and Engineering Research Council of Canada (Discovery Grant: SCD and Undergraduate Student Research Award: JRL), and Newfoundland and Labrador Research and Development Corporation (Ignite R&D Grant: SCD and Ocean Industries Student Research Award: RTB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blacknell W.M., 1974, Thalassia Jugosl, V10, P23; Brissac T, 2011, MAR ECOL-EVOL PERSP, V32, P198, DOI 10.1111/j.1439-0485.2010.00413.x; Cannuel R, 2009, BIOL BULL-US, V217, P173, DOI 10.1086/BBLv217n2p173; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cheesman SE, 2011, P NATL ACAD SCI USA, V108, P4570, DOI 10.1073/pnas.1000072107; Coan EV, 2000, SANTA BARBARA MUSEUM; Conan Gerard Y., 1996, P INT S BIOL MAN EC P INT S BIOL MAN EC, P59; CRAMPTON JS, 1995, LETHAIA, V28, P179, DOI 10.1111/j.1502-3931.1995.tb01611.x; DANDO PR, 1993, MAR ECOL PROG SER, V92, P151, DOI 10.3354/meps092151; DANDO PR, 1986, J MAR BIOL ASSOC UK, V66, P915, DOI 10.1017/S0025315400048529; Dando PR, 2004, MAR ECOL PROG SER, V280, P181, DOI 10.3354/meps280181; Delgado-Gonzalo R, 2012, IEEE T IMAGE PROCESS, V21, P1258, DOI 10.1109/TIP.2011.2169975; Distel DL, 2011, MOL PHYLOGENET EVOL, V61, P245, DOI 10.1016/j.ympev.2011.05.019; DISTEL DL, 1992, J BACTERIOL, V174, P6317, DOI 10.1128/JB.174.19.6317-6320.1992; Dufour SC, 2005, BIOL BULL-US, V208, P200, DOI 10.2307/3593152; Dufour SC, 2003, NATURE, V426, P65, DOI 10.1038/nature02095; Dufour SC, 2006, MAR ECOL PROG SER, V320, P185, DOI 10.3354/meps320185; Duperron S, 2012, BIOGEOSCIENCES DISCU, V9, P16815, DOI DOI 10.5194/BGD-9-16815-2012; Fujiwara Y, 2001, MAR ECOL PROG SER, V214, P151, DOI 10.3354/meps214151; Gardner JPA, 1996, MAR BIOL, V125, P385, DOI 10.1007/BF00346319; GARDNER JPA, 1994, BIOCHEM SYST ECOL, V22, P1, DOI 10.1016/0305-1978(94)90109-0; Goffredi SK, 2002, MAR ECOL PROG SER, V225, P227, DOI 10.3354/meps225227; Goffredi SK, 2003, MAR BIOL, V142, P311, DOI 10.1007/s00227-002-0941-3; Gorley C.K., 2006, GETTING STARTED PRIM; Gould A.A., 1870, REPORT INVERTEBRATA, P524; Gould A.A., 1841, REPORT INVERTEBRATA, DOI [10.5962/bhl.title.17646, DOI 10.5962/BHL.TITLE.17646]; Gros O, 1998, INVERTEBR REPROD DEV, V34, P219, DOI 10.1080/07924259.1998.9652656; Gros O, 1996, APPL ENVIRON MICROB, V62, P2324, DOI 10.1128/AEM.62.7.2324-2330.1996; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Layton K, 2012, THESIS U GUELPH CANA; Le Pennec M, 1988, J SHELLFISH RES, V7, P483; Littlewood DTJ, 2000, MOL PHYLOGENET EVOL, V16, P449, DOI 10.1006/mpev.2000.0802; Mikkelsen PM, 2011, AM MALACOL BULL, V29, P217, DOI 10.4003/006.029.0212; MONTGOMERY MK, 1994, DEVELOPMENT, V120, P1719; Neumann D, 2003, BIOL BULL-US, V205, P73, DOI 10.2307/1543447; Nussbaumer AD, 2006, NATURE, V441, P345, DOI 10.1038/nature04793; Ockelmann K.W, 1958, MEDD GRONL, V122, P1; Oliver PG, 2002, STUDIES MARINE BIODI; PAYNE CM, 1991, PHILOS T ROY SOC B, V334, P481, DOI 10.1098/rstb.1991.0128; SOUTHWARD EC, 1986, J MAR BIOL ASSOC UK, V66, P889, DOI 10.1017/S0025315400048517; Steiner G, 2000, GEOL SOC SPEC PUBL, V177, P11, DOI 10.1144/GSL.SP.2000.177.01.02; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor JD, 2005, SYST BIODIVERS, V3, P281, DOI 10.1017/S1477200005001672; Taylor JD, 2007, J MAR BIOL ASSOC UK, V87, P565, DOI 10.1017/S0025315407054409; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VRIJENHOEK RC, 1994, DEEP-SEA RES PT I, V41, P1171, DOI 10.1016/0967-0637(94)90039-6; Williams ST, 2004, J MOLLUS STUD, V70, P187, DOI 10.1093/mollus/70.2.187; Williams ST, 2003, MOL PHYLOGENET EVOL, V28, P60, DOI 10.1016/S1055-7903(03)00038-1; Winnepenninckx BMH, 1998, J MOL EVOL, V47, P586, DOI 10.1007/PL00006415; Wlodarska-Kowalczuk M, 2007, POLAR RES, V26, P48, DOI 10.1111/j.1751-8369.2007.00003.x	53	18	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92856	10.1371/journal.pone.0092856	http://dx.doi.org/10.1371/journal.pone.0092856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658402	gold, Green Published, Green Submitted			2022-12-27	WOS:000333355300136
J	Colares, VS; Titan, SMDO; Pereira, ADC; Malafronte, P; Cardena, MM; Santos, S; Santos, PC; Fridman, C; Barros, RT; Woronik, V				Colares, Vinicius Sardao; Titan, Silvia Maria de Oliveira; Pereira, Alexandre da Costa; Malafronte, Patricia; Cardena, Mari M.; Santos, Sidney; Santos, Paulo C.; Fridman, Cintia; Barros, Rui Toledo; Woronik, Viktoria			MYH9 and APOL1 Gene Polymorphisms and the Risk of CKD in Patients with Lupus Nephritis from an Admixture Population	PLOS ONE			English	Article							STAGE RENAL-DISEASE; KIDNEY-DISEASE; AFRICAN; ERYTHEMATOSUS; VARIANTS; PREDNISONE; EXPRESSION; ANCESTRY	MYH9 polymorphisms have been described to be associated with the risk of CKD in non-diabetic nephropathy, HIV nephropathy and FSGS. Predominating in black descendants, MHY9 genetic variants could partially explain the excess risk of CKD associated with African ancestry. However, recent data suggests that APOL1 gene co-segregate with MYH9, and could be the gene truly associated with CKD risk. In this study, we evaluated the role of MYH9 and APOL1 gene polymorphisms in the risk of CKD in Brazilian patients with lupus nephritis (LN). A retrospective analysis of 196 LN patients was done. MYH9 rs4821480, rs2032487, rs4821481 and rs3752462, APOL 1rs73885319, rs16996616, rs60910145, rs71785313, and APOL3 rs11089781 gene polymorphisms were determined. Genetic ancestry was ascertained both by autossomal ancestry and mitochondrial haplogroup. Primary outcome was defined as doubling of serum creatinine (DC) or end stage renal disease (ESRD). Sixty-two patients presented the PO. In our population, MYH9 and APOL1 were not in LD. None APOL polymorphism was associated with the PO, whereas rs3752462 MYH9 polymorphism showed a positive association (HR3.72, 95% CI 1.47-9.38, p = 0.005). When we analyzed the MYH9 E1 haplotype, the GCCT carriers (1 or 2 alelles present in 29.7% in the PO group vs. 18.5% in controls) showed a significant association to the risk of PO, even after adjustments for baseline estimated creatinine clearance and autossomal ancestry (HR 2.0, 95% CI 1.2-3.4, p = 0.01). Our results show that in our population MYH9, but not APOL1, gene polymorphisms confer an increased risk of CKD in LN patients, independently of race.	[Colares, Vinicius Sardao; Titan, Silvia Maria de Oliveira; Malafronte, Patricia; Barros, Rui Toledo; Woronik, Viktoria] Univ Sao Paulo, Sch Med, Hosp Clin, Div Nephrol, Sao Paulo, Brazil; [Pereira, Alexandre da Costa; Santos, Paulo C.] Univ Sao Paulo, Sch Med, Heart Inst InCor, Mol Cardiol Lab, Sao Paulo, Brazil; [Cardena, Mari M.; Fridman, Cintia] Univ Sao Paulo, Sch Med, Dept Legal Med Eth & Occupat Hlth, Sao Paulo, Brazil; [Santos, Sidney] Fed Univ Para, Lab Human Genet & Med, BR-66059 Belem, Para, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Para	Woronik, V (corresponding author), Univ Sao Paulo, Sch Med, Hosp Clin, Div Nephrol, Sao Paulo, Brazil.	viktoriaw@usp.br	Fridman, Cintia/G-1837-2012; Fridman, Cintia/E-2657-2013; Woronik, Viktoria/AAY-4763-2020; Pereira, Alexandre/HHN-1038-2022; Santos, Paulo CJL/D-1367-2012	Fridman, Cintia/0000-0003-2430-4888; Woronik, Viktoria/0000-0002-8318-142X	FAPESP	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Financial support: FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon GS, 1999, LUPUS, V8, P197, DOI 10.1191/096120399678847704; AUSTIN HA, 1986, NEW ENGL J MED, V314, P614, DOI 10.1056/NEJM198603063141004; Behar DM, 2006, AM J KIDNEY DIS, V47, P88, DOI 10.1053/j.ajkd.2005.09.023; Behar DM, 2010, HUM MOL GENET, V19, P1816, DOI 10.1093/hmg/ddq040; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Bostrom MA, 2010, CLIN J AM SOC NEPHRO, V5, P1107, DOI 10.2215/CJN.08721209; Buhaescu I, 2007, SEMIN ARTHRITIS RHEU, V36, P224, DOI 10.1016/j.semarthrit.2006.09.002; Cardena MMSG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062005; Chen Z, 2012, J AM SOC NEPHROL, V23, p136A; Churg J., 1995, RENAL DIS CLASSIFICA, V2nd ed; Estrella MM, 2012, J AM SOC NEPHROL, V23, p248A; Franceschini N, 2010, HUM GENET, V127, P295, DOI 10.1007/s00439-009-0769-8; Freedman BI, 2010, AM J NEPHROL, V32, P66, DOI 10.1159/000314688; Freedman BI, 2009, KIDNEY INT, V75, P736, DOI 10.1038/ki.2008.701; Genovese G, 2013, NAT REV NEPHROL, V9, P240, DOI 10.1038/nrneph.2013.34; Genovese G, 2010, KIDNEY INT, V78, P698, DOI 10.1038/ki.2010.251; Hays T, 2012, AIDS, V26, P797, DOI 10.1097/QAD.0b013e328351f6cf; Hoy WE, 2012, J AM SOC NEPHROL, V23, p77A; Johnstone DB, 2011, MOL CELL BIOL, V31, P2162, DOI 10.1128/MCB.05234-11; Kanji Z, 2011, J AM SOC NEPHROL, V22, P2091, DOI 10.1681/ASN.2010121234; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Larsen CP, 2013, J AM SOC NEPHROL, V24, P722, DOI 10.1681/ASN.2012121180; LEVEY AS, 1992, ANN INTERN MED, V116, P114, DOI 10.7326/0003-4819-116-2-114; Lin CP, 2012, GENES IMMUN, V13, P232, DOI 10.1038/gene.2011.82; Matsha TE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052529; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Monajemi H, 2002, GENOMICS, V79, P539, DOI 10.1006/geno.2002.6729; Muller T, 2011, KIDNEY INT, V80, P1055, DOI 10.1038/ki.2011.256; O'Toole JF, 2012, J AM SOC NEPHROL, V23, p323A; Papeta N, 2011, J AM SOC NEPHROL, V22, P1991, DOI 10.1681/ASN.2011040434; Sanchez E, 2012, ARTHRITIS RHEUM-US, V64, P3687, DOI 10.1002/art.34650; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tzur S, 2010, HUM GENET, V128, P345, DOI 10.1007/s00439-010-0861-0; Zhang YF, 2012, BLOOD, V119, P238, DOI 10.1182/blood-2011-06-358853	35	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e87716	10.1371/journal.pone.0087716	http://dx.doi.org/10.1371/journal.pone.0087716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658608	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300002
J	Gonzalez-Feliciano, JA; Hernandez-Perez, M; Estrella, LA; Colon-Lopez, DD; Lopez, A; Martinez, M; Mauras-Rivera, KR; Lasalde, C; Martinez, D; Araujo-Perez, F; Gonzalez, CI				Gonzalez-Feliciano, Jose A.; Hernandez-Perez, Marimar; Estrella, Luis A.; Colon-Lopez, Daisy D.; Lopez, Armando; Martinez, Marina; Mauras-Rivera, Kirla R.; Lasalde, Clarivel; Martinez, Daviana; Araujo-Perez, Felix; Gonzalez, Carlos I.			The Role of HuR in the Post-Transcriptional Regulation of Interleukin-3 in T Cells	PLOS ONE			English	Article							BINDING PROTEIN HUR; MESSENGER-RNA TURNOVER; AU-RICH ELEMENT; STABILIZING FACTOR HUR; ELAV-LIKE PROTEIN; TRANSLATIONAL CONTROL; HNRNP D; IL-3; EXPRESSION; GENE	Human Interleukin-3 (IL-3) is a lymphokine member of a class of transiently expressed mRNAs harboring Adenosine/Uridine-Rich Elements (ARE) in their 3' untranslated regions (3'-UTRs). The regulatory effects of AREs are often mediated by specific ARE-binding proteins (ARE-BPs). In this report, we show that the human IL-3 3'-UTR plays a post-transcriptional regulation role in two human transformed cell lines. More specifically, we demonstrate that the hIL-3 3'-UTR represses the translation of a luciferase reporter both in HeLa and Jurkat T-cells. These results also revealed that the hIL-3 3'-UTR-mediated translational repression is exerted by an 83 nt region comprised mainly by AREs and some non-ARE sequences. Moreover, electrophoretic mobility shift assays (EMSAs) and UV-crosslinking analysis show that this hIL-3 ARE-rich region recruits five specific protein complexes, including the ARE-BPs HuR and TIA-1. HuR binding to this ARE-rich region appears to be spatially modulated during T-cell activation. Together, these results suggest that HuR recognizes the ARE-rich region and plays a role in the IL-3 3'-UTR-mediated post-transcriptional control in T-cells.	[Gonzalez-Feliciano, Jose A.; Estrella, Luis A.; Colon-Lopez, Daisy D.; Lopez, Armando; Mauras-Rivera, Kirla R.; Lasalde, Clarivel; Martinez, Daviana; Araujo-Perez, Felix; Gonzalez, Carlos I.] Univ Puerto Rico Rio Piedras, Coll Nat Sci, Dept Biol, San Juan, PR 00931 USA; [Hernandez-Perez, Marimar; Martinez, Marina; Gonzalez, Carlos I.] Univ Puerto Rico Med Sci, Dept Biochem, San Juan, PR USA; [Gonzalez, Carlos I.] Mol Sci Res Bldg, San Juan, PR USA	University of Puerto Rico; University of Puerto Rico Rio Piedras; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Gonzalez, CI (corresponding author), Univ Puerto Rico Rio Piedras, Coll Nat Sci, Dept Biol, San Juan, PR 00931 USA.	cigonzal@gmail.com	López, Daisy Colón/L-7978-2019; Martínez Filgueira, Marina/GZG-8145-2022; Colón-López, Daisy/E-9715-2019; Gonzalez, Carlos/V-7628-2019	López, Daisy Colón/0000-0002-3920-310X; Colón-López, Daisy/0000-0002-3920-310X; 	National Institutes of Health [GM008102-3052, KO1 HL-04355-05, U54 CA96297, FIPI, PES-UPR, PR-LSAMP, 2R25GM61151]; National Center for Research Resources, a component of the National Institutes of Health [P20 RR 016174]; NATIONAL CANCER INSTITUTE [U54CA096297] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U13RR016174] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL004355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838, R25GM061151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, a component of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health to CIG (GM008102-3052, KO1 HL-04355-05, U54 CA96297, FIPI, PES-UPR), and JGF (PR-LSAMP and RISE Award 2R25GM61151). This publication was made possible by Grant P20 RR 016174 from the National Center for Research Resources, a component of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Atasoy U, 1998, J CELL SCI, V111, P3145; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Benjamin D, 2006, MOL BIOSYST, V2, P561, DOI 10.1039/b609448a; Bergalet J, 2011, MOL CANCER RES, V9, P485, DOI 10.1158/1541-7786.MCR-10-0351; BURGER H, 1990, BLOOD, V76, P2229; Casolaro V, 2008, J ALLERGY CLIN IMMUN, V121, P853, DOI 10.1016/j.jaci.2007.12.1166; Chang N, 2010, MOL CELL BIOL, V30, P3875, DOI 10.1128/MCB.00169-10; Chen XN, 2008, AM J PSYCHIAT, V165, P13, DOI 10.1176/appi.ajp.2007.07121868; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Denkert C, 2004, CLIN CANCER RES, V10, P5580, DOI 10.1158/1078-0432.CCR-04-0070; Dentelli P, 2011, ONCOGENE, V30, P4930, DOI 10.1038/onc.2011.204; Dickson AM, 2012, J BIOL CHEM, V287, P36229, DOI 10.1074/jbc.M112.371203; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Dorsey JF, 2002, LEUKEMIA, V16, P1589, DOI 10.1038/sj.leu.2402678; DORSSERS L, 1987, GENE, V55, P115, DOI 10.1016/0378-1119(87)90254-X; Ernst J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007469; Espel E, 2005, SEMIN CELL DEV BIOL, V16, P59, DOI 10.1016/j.semcdb.2004.11.008; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Giuliani N, 2006, BLOOD, V107, P841, DOI 10.1182/blood-2005-07-2719; GUBA SC, 1989, J CLIN INVEST, V84, P1701, DOI 10.1172/JCI114352; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Kandasamy K, 2005, J BIOL CHEM, V280, P1931, DOI 10.1074/jbc.M405937200; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; Lee JW, 2004, BLOOD, V103, P2308, DOI 10.1182/blood-2003-06-1992; Liao BS, 2007, NAT STRUCT MOL BIOL, V14, P511, DOI 10.1038/nsmb1249; Loflin P, 1999, GENE DEV, V13, P1884, DOI 10.1101/gad.13.14.1884; LOPEZ AF, 1988, BLOOD, V72, P1797; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Ming XF, 2001, MOL CELL BIOL, V21, P5778, DOI 10.1128/MCB.21.17.5778-5789.2001; Morris KR, 2008, J INTERF CYTOK RES, V28, P435, DOI 10.1089/jir.2007.0051; Mou Z, 2012, FEBS LETT; Mukherjee D, 2004, ANAL RNA EXONUCLEOCY, P195; NIEMEYER CM, 1989, BLOOD, V73, P945; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; OTSUKA T, 1988, J IMMUNOL, V140, P2288; Raghavan A, 2001, J BIOL CHEM, V276, P47958, DOI 10.1074/jbc.M109511200; Raineri I, 2004, NUCLEIC ACIDS RES, V32, P1279, DOI 10.1093/nar/gkh282; Rodrigues L, 2006, J CLIN LAB ANAL, V20, P75, DOI 10.1002/jcla.20104; RYAN GR, 1991, BLOOD, V77, P1195; Seko Y, 2004, J BIOL CHEM, V279, P33359, DOI 10.1074/jbc.M312306200; Shyu AB, 2000, CELL, V102, P135, DOI 10.1016/S0092-8674(00)00018-0; STOECKLIN G, 1994, J BIOL CHEM, V269, P28591; Sureban SM, 2007, GASTROENTEROLOGY, V132, P1055, DOI 10.1053/j.gastro.2006.12.031; Vo DT, 2012, MOL CANCER RES, V10, P143, DOI 10.1158/1541-7786.MCR-11-0208; Wang W, 2002, MOL CELL BIOL, V22, P3425, DOI 10.1128/MCB.22.10.3425-3436.2002; Wang XY, 1998, LEUKEMIA, V12, P520, DOI 10.1038/sj.leu.2400975; Xu NH, 2001, MOL CELL BIOL, V21, P6960, DOI 10.1128/MCB.21.20.6960-6971.2001; Yarovinsky TO, 2006, J IMMUNOL, V177, P4426, DOI 10.4049/jimmunol.177.7.4426; YMER S, 1985, NATURE, V317, P255, DOI 10.1038/317255a0; Zeoli A, 2008, BLOOD, V112, P350, DOI 10.1182/blood-2007-12-128215; Zou TT, 2006, J BIOL CHEM, V281, P19387, DOI 10.1074/jbc.M602344200	59	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92457	10.1371/journal.pone.0092457	http://dx.doi.org/10.1371/journal.pone.0092457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658545	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300084
J	Rahman, MA; Sundaram, K; Mitra, S; Gavrilin, MA; Wewers, MD				Rahman, Mohd. Akhlakur; Sundaram, Kruthika; Mitra, Srabani; Gavrilin, Mikhail A.; Wewers, Mark D.			Receptor Interacting Protein-2 Plays a Critical Role in Human Lung Epithelial Cells Survival in Response to Fas-Induced Cell-Death	PLOS ONE			English	Article							CARD15/NOD2 MUTATIONAL ANALYSIS; DOMAIN-CONTAINING PROTEIN; MEDIATED APOPTOSIS; TYROSINE KINASE; IN-VIVO; PHOSPHORYLATION; LIGAND; SUSCEPTIBILITY; INFLAMMASOME; ACTIVATION	Lung epithelial cell death is critical to the lung injury that occurs in the acute respiratory distress syndrome. It is known that FasL plays a prominent role in this lung cell death pathway and may work in part through activation of the receptor interacting protein-2 (RIP2). RIP2 is serine/threonine kinase with a C-terminal caspase activation and recruitment domain (CARD). This CARD contains a highly conserved, predicted tyrosine phosphorylation site. Thus, involvement of tyrosine phosphorylation in the CARD domain of RIP2 may play a critical role in Fas-mediated apoptosis in the human lung immune system. To test this hypothesis, human lung epithelial cells (BEAS-2B) were induced to undergo cell death in response to the Fas agonist antibody CH11 with and without manipulation of endogenous RIP2 concentrations. We show that CH11 increases lung epithelial cell death in a dose-dependent manner as determined by LDH release and nuclear condensation. Fas-induced LDH release was inhibited by RIP2 knock-down. Reduced levels of RIP2 in BEAS-2B cells after treatment with RIP2 siRNA were confirmed by immunoblot. Overexpression of RIP2 in BEAS-2B cells synergized with Fas ligand-induced LDH release in a dose-dependent manner. Finally, mutation of the tyrosine phosphorylation site in CARD of RIP2 protected BEAS-2B cells from Fas ligand induced cell death. Thus RIP2's CARD tyrosine phosphorylation may represent a new therapeutic target to promote the survival of human lung epithelial cells in disorders that lead to acute lung injury and ARDS.	[Rahman, Mohd. Akhlakur; Sundaram, Kruthika; Mitra, Srabani; Gavrilin, Mikhail A.; Wewers, Mark D.] Ohio State Univ, Dept Internal Med, Wexner Med Ctr, Dorothy M Davis Heart & Lung Res Inst,Div Pulm Al, Columbus, OH 43210 USA	Ohio State University	Wewers, MD (corresponding author), Ohio State Univ, Dept Internal Med, Wexner Med Ctr, Dorothy M Davis Heart & Lung Res Inst,Div Pulm Al, Columbus, OH 43210 USA.	wewers.2@osu.edu	Wewers, Mark/AAB-6202-2021; Sundaram, Kruthika/J-4010-2019	Sundaram, Kruthika/0000-0003-0510-424X; Gavrilin, Mikhail/0000-0003-2003-768X	NIH [HL089440, HL076278]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076278, R01HL089440] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by NIH HL089440 and HL076278. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelaziz DHA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00018; Albertine KH, 2002, AM J PATHOL, V161, P1783, DOI 10.1016/S0002-9440(10)64455-0; APPEL RD, 1994, TRENDS BIOCHEM SCI, V19, P258, DOI 10.1016/0968-0004(94)90153-8; Arostegui JI, 2007, ARTHRITIS RHEUM-US, V56, P3805, DOI 10.1002/art.22966; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Coulter KR, 2002, AM J RESP CELL MOL, V26, P58, DOI 10.1165/ajrcmb.26.1.4285; Fahy RJ, 2008, AM J RESP CRIT CARE, V177, P983, DOI 10.1164/rccm.200703-418OC; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Goltsev YV, 1997, J BIOL CHEM, V272, P19641, DOI 10.1074/jbc.272.32.19641; Hall MW, 2007, PEDIATR RES, V62, P597, DOI 10.1203/PDR.0b013e3181559774; Han DKM, 1997, P NATL ACAD SCI USA, V94, P11333, DOI 10.1073/pnas.94.21.11333; Hsu SC, 1999, EUR J IMMUNOL, V29, P2948, DOI 10.1002/(SICI)1521-4141(199909)29:09<2948::AID-IMMU2948>3.0.CO;2-0; Hu SM, 1997, J BIOL CHEM, V272, P17255, DOI 10.1074/jbc.272.28.17255; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; Inohara N, 1997, P NATL ACAD SCI USA, V94, P10717, DOI 10.1073/pnas.94.20.10717; Inohara N, 1998, J BIOL CHEM, V273, P12296, DOI 10.1074/jbc.273.20.12296; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; King K, 2006, HUM MUTAT, V27, P44, DOI 10.1002/humu.20264; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Lai YM, 2007, AM J PHYSIOL-LUNG C, V293, pL393, DOI 10.1152/ajplung.00392.2006; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Matute-Bello G, 1999, J IMMUNOL, V163, P2217; Matute-Bello G, 2001, AM J PATHOL, V158, P153, DOI 10.1016/S0002-9440(10)63953-3; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Shu HB, 1997, IMMUNITY, V6, P751, DOI 10.1016/S1074-7613(00)80450-1; Simon HU, 1998, BLOOD, V92, P547, DOI 10.1182/blood.V92.2.547.414k02_547_557; Srinivasula SM, 1997, J BIOL CHEM, V272, P18542, DOI 10.1074/jbc.272.30.18542; Sugimura M, 2003, CLIN GENET, V63, P160, DOI 10.1046/j.0009-9163.2002.00174.x; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Tigno-Aranjuez JT, 2010, GENE DEV, V24, P2666, DOI 10.1101/gad.1964410; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Zakharova E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009900	38	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92731	10.1371/journal.pone.0092731	http://dx.doi.org/10.1371/journal.pone.0092731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658576	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300124
J	Satake, A; Schmidt, AM; Nomura, S; Kambayashi, T				Satake, Atsushi; Schmidt, Amanda M.; Nomura, Shosaku; Kambayashi, Taku			Inhibition of Calcineurin Abrogates While Inhibition of mTOR Promotes Regulatory T Cell Expansion and Graft-Versus-Host Disease Protection by IL-2 in Allogeneic Bone Marrow Transplantation	PLOS ONE			English	Article							DENDRITIC CELLS; INTERLEUKIN-2; CD4(+); MAINTENANCE; HOMEOSTASIS; TOLERANCE; RAPAMYCIN; MODEL	Regulatory T cells (Treg)s attenuate excessive immune responses, making their expansion beneficial in immune-mediated diseases including allogeneic bone marrow transplantation (BMT)-associated graft-versus-host disease (GVHD). We have recently reported that Treg expansion does not require phospholipase C gamma activation when IL-2 is provided. As such, the combination of IL-2 and a calcineurin inhibitor (Cyclosporine A; CsA) expands Tregs while inhibiting Tconv proliferation and protects against a mouse model of multiple sclerosis. However, CsA inhibits Treg proliferation in the presence of a TCR stimulus, suggesting that CsA may negatively impact Treg proliferation when they receive strong allogeneic MHC-mediated TCR signals. In this study, we show that CsA inhibits Treg proliferation and inducible Treg generation in allogeneic but not in syngeneic BMT when IL-2 is provided. In contrast to CsA, the mTOR inhibitor (Rapamycin) almost completely suppressed IL-2- mediated Treg proliferation. However, CsA and Rapamycin inhibited Treg proliferation to a similar extent when TCR stimulation was provided. Furthermore, Rapamycin promoted Treg expansion and inducible Treg generation in allogeneic BMT recipients treated with IL-2. Consistent with these observations, CsA abrogated while Rapamycin promoted the protective effect of IL-2 on allogeneic BMT-induced GVHD. These results suggest that while CsA permits IL-2-induced Treg proliferation in the syngeneic setting (absence of strong TCR signals), CsA in combination with IL-2 may be detrimental for Treg proliferation in an allogeneic setting. Thus, in allogeneic settings, an mTOR inhibitor such as Rapamycin is a better choice for adjunct therapy with IL-2 in expansion of Tregs and protection against allogeneic BMT-induced GVHD.	[Satake, Atsushi; Schmidt, Amanda M.; Kambayashi, Taku] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Satake, Atsushi; Nomura, Shosaku] Kansai Med Univ, Dept Internal Med 1, Osaka, Japan	University of Pennsylvania; Pennsylvania Medicine; Kansai Medical University	Kambayashi, T (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	taku.kambayashi@uphs.upenn.edu			National Blood Foundation; University of Pennsylvania; National Institutes of Health [R01HL111501, R01HL107589]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111501, R01HL107589] Funding Source: NIH RePORTER	National Blood Foundation; University of Pennsylvania; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Blood Foundation, the University of Pennsylvania internal funds, and the National Institutes of Health (R01HL111501, R01HL107589). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beres AJ, 2012, J IMMUNOL, V189, P464, DOI 10.4049/jimmunol.1200886; Bhandoola A, 2002, IMMUNITY, V17, P425, DOI 10.1016/S1074-7613(02)00417-X; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Joffre O, 2008, NAT MED, V14, P88, DOI 10.1038/nm1688; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Matsuoka K, 2010, J CLIN INVEST, V120, P1479, DOI 10.1172/JCI41072; Robb RJ, 2012, BLOOD, V119, P5898, DOI 10.1182/blood-2011-12-396119; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakoda Y, 2007, BLOOD, V109, P1756, DOI 10.1182/blood-2006-08-042853; Satake A, 2013, J AUTOIMMUN, V44, P13, DOI 10.1016/j.jaut.2013.06.009; Sawamukai N, 2012, BLOOD, V119, P5575, DOI 10.1182/blood-2011-07-367987; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shin HJ, 2011, BLOOD, V118, P2342, DOI 10.1182/blood-2010-10-313684; Swee LK, 2009, BLOOD, V113, P6277, DOI 10.1182/blood-2008-06-161026; Wang Y, 2011, J IMMUNOL, V186, P2809, DOI 10.4049/jimmunol.0903805; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zeiser R, 2008, BLOOD, V111, P453, DOI 10.1182/blood-2007-06-094482; Zeiser R, 2006, BLOOD, V108, P390, DOI 10.1182/blood-2006-01-0329; Zou T, 2011, TRANSFUSION, V51, p160S, DOI 10.1111/j.1537-2995.2011.03379.x; Zou T, 2010, J IMMUNOL, V185, P2790, DOI 10.4049/jimmunol.0903740	27	25	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92888	10.1371/journal.pone.0092888	http://dx.doi.org/10.1371/journal.pone.0092888			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658577	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300140
J	Ze, YG; Sheng, L; Zhao, XY; Hong, J; Ze, X; Yu, XH; Pan, XY; Lin, A; Zhao, Y; Zhang, C; Zhou, QP; Wang, L; Hong, FS				Ze, Yuguan; Sheng, Lei; Zhao, Xiaoyang; Hong, Jie; Ze, Xiao; Yu, Xiaohong; Pan, Xiaoyu; Lin, Anan; Zhao, Yue; Zhang, Chi; Zhou, Qiuping; Wang, Ling; Hong, Fashui			TiO2 Nanoparticles Induced Hippocampal Neuroinflammation in Mice	PLOS ONE			English	Article							TITANIUM-DIOXIDE NANOPARTICLES; NF-KAPPA-B; CENTRAL-NERVOUS-SYSTEM; MOLECULAR-MECHANISM; SIGNALING PATHWAYS; QUANTITATIVE PCR; IMMUNE-RESPONSES; PARTICLES; MEMORY; TRANSLOCATION	Titanium dioxide nanoparticles (TiO2 NPs) have been used in various medical and industrial areas. However, the impacts of these nanoparticles on neuroinflammation in the brain are poorly understood. In this study, mice were exposed to 2.5, 5, or 10 mg/kg body weight TiO2 NPs for 90 consecutive days, and the TLRs/TNF-alpha/NF-kappa B signaling pathway associated with the hippocampal neuroinflammation was investigated. Our findings showed titanium accumulation in the hippocampus, neuroinflammation and impairment of spatial memory in mice following exposure to TiO2 NPs. Furthermore, TiO2 NPs significantly activated the expression of Toll-like receptors (TLR2, TLR4), tumor necrosis factor-alpha, nucleic I kappa B kinase, NF-kappa B-inducible kinase, nucleic factor-kappa B, NF-kappa B2(p52), RelA(p65), and significantly suppressed the expression of I kappa B and interleukin-2. These findings suggest that neuroinflammation may be involved in TiO2 NP-induced alterations of cytokine expression in mouse hippocampus. Therefore, more attention should be focused on the application of TiO2 NPs in the food industry and their long-term exposure effects, especially in the human central nervous system.	[Ze, Yuguan; Sheng, Lei; Zhao, Xiaoyang; Hong, Jie; Ze, Xiao; Yu, Xiaohong; Pan, Xiaoyu; Lin, Anan; Zhao, Yue; Zhang, Chi; Zhou, Qiuping; Wang, Ling; Hong, Fashui] Soochow Univ, Coll Med, Suzhou, Peoples R China; [Hong, Fashui] Soochow Univ, Jiangsu Prov Key Lab Stem Cell Res, Suzhou, Peoples R China; [Hong, Fashui] Minist Sci & Technol & Jiangsu Prov, Cultivat Base State Key Lab Stem Cell & Biomat Bu, Suzhou, Peoples R China	Soochow University - China; Soochow University - China	Hong, FS (corresponding author), Soochow Univ, Coll Med, Suzhou, Peoples R China.	Hongfsh_cn@sina.com	Pan, Xiaoyu/ABE-1764-2021	Pan, Xiaoyu/0000-0002-5184-222X	National Natural Science Foundation of China [81273036, 30901218]; Priority Academic Program Development of Jiangsu Higher Education Institutions, National New Ideas Foundation of Student of China [111028534]; National Bringing New Ideas Foundation of Student of China [57315427, 57315927]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions, National New Ideas Foundation of Student of China; National Bringing New Ideas Foundation of Student of China	This work was supported by the National Natural Science Foundation of China (grant No. 81273036, 30901218), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, National New Ideas Foundation of Student of China (grant No. 111028534), and the National Bringing New Ideas Foundation of Student of China (grant No. 57315427, 57315927). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akwa Y, 2001, P NATL ACAD SCI USA, V98, P14033, DOI 10.1073/pnas.241503698; Bachevalier J, 1999, BIOL PSYCHIAT, V46, P329, DOI 10.1016/S0006-3223(99)00123-7; Block ML, 2004, FASEB J, V18, P1618, DOI 10.1096/fj.04-1945fje; Chen GY, 2012, BIOMATERIALS, V33, P6559, DOI 10.1016/j.biomaterials.2012.05.064; Chen P, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/1/015008; Chen P, 2011, SENSORS-BASEL, V11, P7219, DOI 10.3390/s110707219; Clark RE, 2000, J NEUROSCI, V20, P8853; Cui YL, 2011, J BIOMED MATER RES A, V96A, P221, DOI 10.1002/jbm.a.32976; Dellu F, 2000, NEUROBIOL LEARN MEM, V73, P31, DOI 10.1006/nlme.1999.3919; Duan YM, 2010, BIOMATERIALS, V31, P894, DOI 10.1016/j.biomaterials.2009.10.003; Elder A, 2006, ENVIRON HEALTH PERSP, V114, P1172, DOI 10.1289/ehp.9030; Fan HK, 2004, SHOCK, V22, P57, DOI 10.1097/01.shk.0000129759.58490.d6; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Grandjean-Laquerriere A, 2007, BIOMATERIALS, V28, P400, DOI 10.1016/j.biomaterials.2006.09.015; Hu RP, 2011, J HAZARD MATER, V191, P32, DOI 10.1016/j.jhazmat.2011.04.027; Hu RP, 2010, BIOMATERIALS, V31, P8043, DOI 10.1016/j.biomaterials.2010.07.011; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jones BW, 2001, J LEUKOCYTE BIOL, V69, P1036; Ke LD, 2000, MOL CELL PROBE, V14, P127, DOI 10.1006/mcpr.2000.0288; Kreyling WG, 2002, J TOXICOL ENV HEAL A, V65, P1513, DOI 10.1080/00984100290071649; Lalancette-Hebert M, 2009, BRAIN, V132, P940, DOI 10.1093/brain/awn345; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockman PR, 2004, J DRUG TARGET, V12, P635, DOI 10.1080/10611860400015936; Ma LL, 2010, BIOMATERIALS, V31, P99, DOI 10.1016/j.biomaterials.2009.09.028; Ma LL, 2009, NANOSCALE RES LETT, V4, P1275, DOI 10.1007/s11671-009-9393-8; Mano SS, 2013, INT J MOL SCI, V14, P13154, DOI 10.3390/ijms140713154; MASUR J, 1971, PSYCHOPHARMACOLOGIA, V19, P388, DOI 10.1007/BF00404383; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Oberdorster C, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-8; Oberdorster G, 2004, INHAL TOXICOL, V16, P437, DOI 10.1080/08958370490439597; Peters A, 2006, PART FIBRE TOXICOL, V8, P3; Shin JA, 2010, NEUROSCIENCE, V165, P445, DOI 10.1016/j.neuroscience.2009.10.057; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Tin-Tin-Win-Shwe, 2006, TOXICOL LETT, V163, P153, DOI 10.1016/j.toxlet.2005.10.006; Tin-Tin-Win-Shwe, 2008, TOXICOL APPL PHARM, V226, P192, DOI 10.1016/j.taap.2007.09.009; Vives-Pi M, 2003, CLIN EXP IMMUNOL, V133, P208, DOI 10.1046/j.1365-2249.2003.02211.x; Wang JX, 2008, TOXICOLOGY, V254, P82, DOI 10.1016/j.tox.2008.09.014; Wang JX, 2008, TOXICOL LETT, V183, P72, DOI 10.1016/j.toxlet.2008.10.001; Wu JH, 2009, TOXICOL LETT, V191, P1, DOI 10.1016/j.toxlet.2009.05.020; Yang P, 2002, MATER LETT, V57, P794, DOI 10.1016/S0167-577X(02)00875-3; Ze YG, 2014, J HAZARD MATER, V264, P219, DOI 10.1016/j.jhazmat.2013.10.072; Ze YG, 2014, J BIOMED MATER RES A, V102, P470, DOI 10.1002/jbm.a.34705; Ze YG, 2013, CHEMOSPHERE, V92, P1183, DOI 10.1016/j.chemosphere.2013.01.094	45	80	82	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92230	10.1371/journal.pone.0092230	http://dx.doi.org/10.1371/journal.pone.0092230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658543	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300062
J	Kennedy, J; Flemer, B; Jackson, SA; Morrissey, JP; O'Gara, F; Dobson, ADW				Kennedy, Jonathan; Flemer, Burkhardt; Jackson, Stephen A.; Morrissey, John P.; O'Gara, Ferghal; Dobson, Alan D. W.			Evidence of a Putative Deep Sea Specific Microbiome in Marine Sponges	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; ANTIMICROBIAL ACTIVITIES; PHYLOGENETIC ANALYSIS; SPATIAL-DISTRIBUTION; HALICLONA-SIMULANS; SP-NOV.; DIVERSITY; COMMUNITY; BACTERIA; ARCHAEA	The microbiota of four individual deep water sponges, Lissodendoryx diversichela, Poecillastra compressa, Inflatella pellicula, and Stelletta normani, together with surrounding seawater were analysed by pyrosequencing of a region of the 16S rRNA gene common to Bacteria and Archaea. Due to sampling constraints at depths below 700 m duplicate samples were not collected. The microbial communities of L. diversichela, P. compressa and I. pellicula were typical of low microbial abundance (LMA) sponges while S. normani had a community more typical of high microbial abundance (HMA) sponges. Analysis of the deep sea sponge microbiota revealed that the three LMA-like sponges shared a set of abundant OTUs that were distinct from those associated with sponges from shallow waters. Comparison of the pyrosequencing data with that from shallow water sponges revealed that the microbial communities of all sponges analysed have similar archaeal populations but that the bacterial populations of the deep sea sponges were distinct. Further analysis of the common and abundant OTUs from the three LMA-like sponges placed them within the groups of ammonia oxidising Archaea (Thaumarchaeota) and sulphur oxidising gamma-Proteobacteria (Chromatiales). Reads from these two groups made up over 70% of all 16S rRNA genes detected from the three LMA-like sponge samples, providing evidence of a putative common microbial assemblage associated with deep sea LMA sponges.	[Kennedy, Jonathan; Flemer, Burkhardt; Jackson, Stephen A.; Morrissey, John P.; O'Gara, Ferghal; Dobson, Alan D. W.] Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Ctr Marine Biotechnol, Lee Rd, Cork, Ireland; [Flemer, Burkhardt; Morrissey, John P.; O'Gara, Ferghal; Dobson, Alan D. W.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [O'Gara, Ferghal] Natl Univ Ireland Univ Coll Cork, BIOMERIT Res Ctr, Cork, Ireland; [O'Gara, Ferghal] Curtin Univ, Sch Biomed Sci, Perth, WA 6845, Australia	University College Cork; University College Cork; University College Cork; Curtin University	Dobson, ADW (corresponding author), Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Ctr Marine Biotechnol, Lee Rd, Cork, Ireland.	a.dobson@ucc.ie	Morrissey, John/AAD-2255-2019; Jackson, Stephen/J-4368-2019; Dobson, Alan D W/M-7844-2017	Jackson, Stephen/0000-0001-7869-9032; Dobson, Alan D W/0000-0002-7713-5574; Flemer, Burkhardt/0000-0003-4614-4432; Morrissey, John/0000-0001-7960-2001; O'Gara, Fergal/0000-0002-2659-0673	PharmaSea project; EU Seventh Framework Programme [312184]; Beuafort Marine Research Award; Marine Institute under the Marine Research Sub-Programme of the National Development Plan	PharmaSea project; EU Seventh Framework Programme; Beuafort Marine Research Award; Marine Institute under the Marine Research Sub-Programme of the National Development Plan	This work was supported by the PharmaSea project (www.pharma-sea.eu) funded by the EU Seventh Framework Programme (contract no. 312184) and by the Beuafort Marine Research Award, part of the Sea Change Strategy and the Strategy for Science Technology and Innovation (2006-2012), with the support of The Marine Institute under the Marine Research Sub-Programme of the National Development Plan 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arellano SM, 2013, MICROB ECOL, V65, P450, DOI 10.1007/s00248-012-0130-y; Brady SF, 2007, NAT PROTOC, V2, P1297, DOI 10.1038/nprot.2007.195; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Bruck WM, 2008, ISME J, V2, P335, DOI 10.1038/ismej.2007.91; Bruck WM, 2010, ISME J, V4, P686, DOI 10.1038/ismej.2009.149; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Flemer B, 2012, J APPL MICROBIOL, V112, P289, DOI 10.1111/j.1365-2672.2011.05211.x; Giles EC, 2013, FEMS MICROBIOL ECOL, V83, P232, DOI 10.1111/j.1574-6941.2012.01467.x; Gunasekera SP, 2003, J NAT PROD, V66, P1615, DOI 10.1021/np030292s; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Hentschel U, 2003, MAR MOL BIOTECHNOL, P59; Hentschel U, 2001, FEMS MICROBIOL ECOL, V35, P305, DOI 10.1111/j.1574-6941.2001.tb00816.x; Hickford SJH, 2009, BIOORGAN MED CHEM, V17, P2199, DOI 10.1016/j.bmc.2008.10.093; Jackson SA, 2012, MICROB ECOL, V64, P105, DOI 10.1007/s00248-011-0002-x; Kennedy J, 2008, ENVIRON MICROBIOL, V10, P1888, DOI 10.1111/j.1462-2920.2008.01614.x; Kennedy J, 2009, MAR BIOTECHNOL, V11, P384, DOI 10.1007/s10126-008-9154-1; Kubota N, 2007, MICROBES ENVIRONMENT, V22, P136, DOI 10.1264/jsme2.22.136; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Meyer B, 2008, MICROB ECOL, V56, P306, DOI 10.1007/s00248-007-9348-5; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Moitinho-Silva L, 2014, MOL ECOL, V23, P1348, DOI 10.1111/mec.12365; Muller F, 2010, ENVIRON MICROBIOL, V12, P2371, DOI 10.1111/j.1462-2920.2010.02309.x; Nishijima M, 2010, MAR BIOTECHNOL, V12, P253, DOI 10.1007/s10126-009-9253-7; Pape T, 2006, POLAR BIOL, V29, P662, DOI 10.1007/s00300-005-0103-4; Preston CM, 1996, P NATL ACAD SCI USA, V93, P6241, DOI 10.1073/pnas.93.13.6241; Radax R, 2012, ENVIRON MICROBIOL, V14, P1308, DOI 10.1111/j.1462-2920.2012.02714.x; Radax R, 2012, ENVIRON MICROBIOL, V14, P909, DOI 10.1111/j.1462-2920.2011.02661.x; Raggi L, 2013, ENVIRON MICROBIOL, V15, P1969, DOI 10.1111/1462-2920.12051; Romanenko LA, 2005, INT J SYST EVOL MICR, V55, P919, DOI 10.1099/ijs.0.63176-0; Romanenko LA, 2008, INT J SYST EVOL MICR, V58, P370, DOI 10.1099/ijs.0.65391-0; Schlappy ML, 2010, MAR BIOL, V157, P593, DOI 10.1007/s00227-009-1344-5; Schmitt S, 2012, HYDROBIOLOGIA, V687, P341, DOI 10.1007/s10750-011-0799-9; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Schmitt S, 2011, FEMS MICROBIOL ECOL, V78, P497, DOI 10.1111/j.1574-6941.2011.01179.x; Simister RL, 2012, ENVIRON MICROBIOL, V14, P517, DOI 10.1111/j.1462-2920.2011.02664.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Thiel V, 2007, MICROB ECOL, V54, P101, DOI 10.1007/s00248-006-9177-y; Thiel V, 2007, FEMS MICROBIOL ECOL, V59, P47, DOI 10.1111/j.1574-6941.2006.00217.x; Trindade-Silva AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039905; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Webster NS, 2001, MAR BIOL, V138, P843, DOI 10.1007/s002270000503; Webster NS, 2001, MAR BIOTECHNOL, V3, P600, DOI 10.1007/s10126-001-0065-7; Weisz JB, 2008, OECOLOGIA, V155, P367, DOI 10.1007/s00442-007-0910-0; White JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038204	54	43	43	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e91092	10.1371/journal.pone.0091092	http://dx.doi.org/10.1371/journal.pone.0091092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670421	Green Published, gold			2022-12-27	WOS:000333677000015
J	Sun, WY; Zheng, Y; Lu, ZY; Cui, Y; Tian, Q; Xiao, SX; Liu, F; Liu, JK				Sun, Wenyan; Zheng, Yan; Lu, Zhuoyang; Cui, Yang; Tian, Qiong; Xiao, Shengxiang; Liu, Feng; Liu, Jiankang			Overexpression of S100A7 Protects LPS-Induced Mitochondrial Dysfunction and Stimulates IL-6 and IL-8 in HaCaT Cells	PLOS ONE			English	Article							EF-HAND TYPE; PSORIASIN INTERACTS; HUMAN KERATINOCYTES; OXIDATIVE STRESS; FUNCTIONAL ROLES; EPITHELIAL-CELLS; BREAST-CANCER; EXPRESSION; AUTOPHAGY; CALCIUM	Background: S100A7 (or psoriasin) is distributed in the cytoplasm of keratinocytes of normal human epidermis, and it is overexpressed in many epidermal inflammatory diseases. Lipopolysaccharide (LPS) induces mitochondrial function changes, which play important roles in multiple cellular mechanisms including inflammation. Although S100A7 expression is regulated by various factors in the human epidermis during inflammation, whether S100A7 interacts with mitochondria in keratinocytes is not clear. Objectives: Our study was designed to investigate whether S100A7 could prohibit mitochondrial dysfunction and stimulate cytokines in cultured normal HaCaT cells treated with LPS. Results: We generated HaCaT cells that constitutively express enhanced green fluorescence protein (EGFP)-S100A7 (S100A7-EGFP) or EGFP alone, as a control. Here, we show that S100A7-EGFP HaCaT cells exhibit an increase in mitochondrial DNA (mtDNA) copy number and mitochondrial membrane potential (MMP). qRT-PCR revealed that expression of three main mitochondrial biogenesis-associated genes was significantly increased: PPAR-coactivator-1alpha (PGC-1 alpha), the mitochondrial transcription factor A (Tfam) and nuclear respiratory factor-1 (NRF1). S100A7 overexpression increased mtDNA content and effectively increased intracellular adenosine 5'-triphosphate (ATP) production, while decreasing reactive oxygen species (ROS) generation. S100A7 overexpression also significantly decreased the expression of Mfn2 and increased DRP1 expression compared with control EGFP cells. S100A7 down-regulated the expression of the autophagy-related proteins Beclin-1 and LC3B. S100A7 also increased expression of IL-6 and IL-8 cytokines. Knockdown of S100A7 decreased MMP and disrupted mitochondrial homeostasis. Conclusions: These findings demonstrate that S100A7 stimulates mitochondrial biogenesis and increases mitochondrial function in HaCaT cells treated with LPS; and S100A7 also promotes secretion of IL-6 and IL-8.	[Sun, Wenyan; Lu, Zhuoyang; Cui, Yang; Liu, Jiankang] Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Ctr Mitochondrial Biol & Med, Sch Life Sci & Technol,Minist Educ, Xian 710049, Peoples R China; [Sun, Wenyan; Lu, Zhuoyang; Cui, Yang; Liu, Jiankang] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710049, Peoples R China; [Zheng, Yan; Tian, Qiong; Xiao, Shengxiang] Xi An Jiao Tong Univ, Dept Dermatol, Affiliated Hosp 2, Xian 710049, Peoples R China; [Liu, Feng] Univ Calif Irvine, Sch Med, Dept Med, Irvine, CA 92717 USA; [Liu, Feng] Univ Calif Irvine, Sch Med, Chao Family Comprehens Canc Ctr, Irvine, CA 92717 USA; [Liu, Jiankang] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Southern California	Zheng, Y (corresponding author), Xi An Jiao Tong Univ, Dept Dermatol, Affiliated Hosp 2, Xian 710049, Peoples R China.	zenyan66@126.com	Liu-Smith, Feng/AAX-7508-2020; Liu, Jiankang/A-1610-2011	Liu-Smith, Feng/0000-0003-3963-0651; Zheng, Yan/0000-0002-1380-3211; Sun, Wenyan/0000-0002-3186-5002	National Natural Science Foundation of China [81371732]; Xi'an Jiaotong University [985, 211]; New Century Excellent Talents in University; Fundamental Research Funds for the Central Universities; Changjiang Scholars and Innovative Research Team in University [PCSIRT:1171]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xi'an Jiaotong University(Xi'an Jiaotong University); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China (81371732) and by projects 985 and 211 of Xi'an Jiaotong University, and was partially supported by New Century Excellent Talents in University and the Fundamental Research Funds for the Central Universities and for Changjiang Scholars and Innovative Research Team in University (PCSIRT:1171). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alowami Salem, 2003, BMC Dermatol, V3, P1, DOI 10.1186/1471-5945-3-1; Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397; Bo H, 2010, ANN NY ACAD SCI, V1201, P121, DOI 10.1111/j.1749-6632.2010.05618.x; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Broome AM, 2003, J HISTOCHEM CYTOCHEM, V51, P675, DOI 10.1177/002215540305100513; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Emberley ED, 2003, CANCER RES, V63, P1954; Enerback C, 2002, CANCER RES, V62, P43; Feng ZH, 2011, FREE RADICAL BIO MED, V50, P1437, DOI 10.1016/j.freeradbiomed.2011.03.001; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Hao JJ, 2010, J NUTR BIOCHEM, V21, P634, DOI 10.1016/j.jnutbio.2009.03.012; HOFFMANN HJ, 1994, J INVEST DERMATOL, V103, P370, DOI 10.1111/1523-1747.ep12395202; Hulse KE, 2012, J ALLERGY CLIN IMMUN, V129, pAB68, DOI 10.1016/j.jaci.2011.12.747; Kang Z, 2012, J INVEST DERMATOL, V132, pS25; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lee KC, 2007, J INVEST DERMATOL, V127, P945, DOI 10.1038/sj.jid.5700663; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li XQ, 2005, BIOCHEMISTRY-US, V44, P14688, DOI 10.1021/bi051519g; Liu JK, 2008, NEUROCHEM RES, V33, P194, DOI 10.1007/s11064-007-9403-0; Luo C, 2013, J CELL BIOCHEM, V114, P212, DOI 10.1002/jcb.24356; MADSEN P, 1991, J INVEST DERMATOL, V97, P701, DOI 10.1111/1523-1747.ep12484041; Niyonsaba F, 2008, J DERMATOL SCI, V52, P216, DOI 10.1016/j.jdermsci.2008.07.003; Perrier S, 2009, FEBS LETT, V583, P259, DOI 10.1016/j.febslet.2008.12.030; Ranger JJ, 2009, CANCER RES, V69, P6823, DOI 10.1158/0008-5472.CAN-09-1684; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Ruse M, 2003, J INVEST DERMATOL, V121, P132, DOI 10.1046/j.1523-1747.2003.12309.x; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Smart N, 2006, CARDIOVASC RES, V69, P164, DOI 10.1016/j.cardiores.2005.08.017; Takeichi T, 2010, J INVEST DERMATOL, V130, P2760, DOI 10.1038/jid.2010.203; Tan JQ, 1996, J INVEST DERMATOL, V107, P5, DOI 10.1111/1523-1747.ep12294284; Nguyen TT, 2012, J DERMATOL SCI, V68, P63, DOI 10.1016/j.jdermsci.2012.07.010; Waxman AB, 2009, AM J RESP CELL MOL, V41, P385, DOI 10.1165/rcmb.2008-0302OC; West NR, 2010, ONCOGENE, V29, P2083, DOI 10.1038/onc.2009.488; Wolf R, 2008, J IMMUNOL, V181, P1499, DOI 10.4049/jimmunol.181.2.1499; Zaccagnino P, 2012, INT J BIOCHEM CELL B, V44, P1962, DOI 10.1016/j.biocel.2012.07.024; Zheng Y, 2008, IMMUNOLOGY, V124, P357, DOI 10.1111/j.1365-2567.2007.02782.x	42	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92927	10.1371/journal.pone.0092927	http://dx.doi.org/10.1371/journal.pone.0092927			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671027	Green Published, gold			2022-12-27	WOS:000333677000092
J	Jubair, M; Atanasova, KR; Rahman, M; Klose, KE; Yasmin, M; Yilmaz, O; Morris, JG; Ali, A				Jubair, Mohammad; Atanasova, Kalina R.; Rahman, Mustafizur; Klose, Karl E.; Yasmin, Mahmuda; Yilmaz, Oezlem; Morris, J. Glenn, Jr.; Ali, Afsar			Vibrio cholerae Persisted in Microcosm for 700 Days Inhibits Motility but Promotes Biofilm Formation in Nutrient-Poor Lake Water Microcosms	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; VPS BIOSYNTHESIS GENES; O1 EL-TOR; EXOPOLYSACCHARIDE PRODUCTION; PSEUDOMONAS-AERUGINOSA; COLONY MORPHOLOGY; EXPRESSION; EVOLUTION; RESISTANCE; PHENOTYPE	Toxigenic Vibrio cholerae, ubiquitous in aquatic environments, is responsible for cholera; humans can become infected after consuming food and/or water contaminated with the bacterium. The underlying basis of persistence of V. cholerae in the aquatic environment remains poorly understood despite decades of research. We recently described a "persister" phenotype of V. cholerae that survived in nutrient-poor "filter sterilized" lake water (FSLW) in excess of 700-days. Previous reports suggest that microorganisms can assume a growth advantage in stationary phase (GASP) phenotype in response to long-term survival during stationary phase of growth. Here we report a V. cholerae GASP phenotype (GASP-700D) that appeared to result from 700 day-old persister cells stored in glycerol broth at -80 degrees C. The GASP-700D, compared to its wildtype N16961, was defective in motility, produced increased biofilm that was independent of vps (p<0.005) and resistant to oxidative stress when grown specifically in FSLW (p<0.005). We propose that V. cholerae GASP-700D represents cell populations that may better fit and adapt to stressful survival conditions while serving as a critical link in the cycle of cholera transmission.	[Jubair, Mohammad; Rahman, Mustafizur; Ali, Afsar] Univ Florida, Sch Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL 32611 USA; [Atanasova, Kalina R.; Yilmaz, Oezlem] Univ Florida, Dept Periodontol, Gainesville, FL USA; [Klose, Karl E.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Yasmin, Mahmuda] Univ Dhaka, Dept Microbiol, Dhaka 1000, Bangladesh; [Yilmaz, Oezlem; Morris, J. Glenn, Jr.; Ali, Afsar] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Texas System; University of Texas at San Antonio (UTSA); University of Dhaka; State University System of Florida; University of Florida	Ali, A (corresponding author), Univ Florida, Sch Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL 32611 USA.	aali@epi.ufl.edu	Atanasova, Kalina/V-6497-2018; Yilmaz, Ozlem/ABG-5367-2021	Atanasova, Kalina/0000-0002-2396-6196; Yilmaz, Ozlem/0000-0003-3487-7217	Department of Defense [C0654_12_UN]; National Institute of Health (NIH) [R01 AI097405, R01 AI039129]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039129, R01AI097405] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a Department of Defense grant (C0654_12_UN) awarded to Afsar Ali, and National Institute of Health (NIH) grants R01 AI097405 awarded to J. Glenn Morris Jr. and R01 AI039129 awarded to R. Bradley Sack at Johns Hopkins University. Afsar Ali is the subcontract PI of R01 AI039129 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2005, J CLIN MICROBIOL, V43, P1426, DOI 10.1128/JCM.43.3.1426-1429.2005; Ali A, 2000, INFECT IMMUN, V68, P1967, DOI 10.1128/IAI.68.4.1967-1974.2000; Ali A, 2002, APPL ENVIRON MICROB, V68, P5773, DOI 10.1128/AEM.68.11.5773-5778.2002; Ali A, 2000, INFECT IMMUN, V68, P6857, DOI 10.1128/IAI.68.12.6857-6864.2000; Balaban NQ, 2011, CURR OPIN GENET DEV, V21, P768, DOI 10.1016/j.gde.2011.10.001; Banning N, 2003, MICROBIOL-SGM, V149, P47, DOI 10.1099/mic.0.25938-0; Beyenal H, 2004, J MICROBIOL METH, V59, P395, DOI 10.1016/j.mimet.2004.08.003; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Casper-Lindley C, 2004, J BACTERIOL, V186, P1574, DOI 10.1128/JB.186.5.1574-1578.2004; COLWELL RR, 1985, BIO-TECHNOL, V3, P817, DOI 10.1038/nbt0985-817; Colwell RR, 1994, VIBRIO CHOLERAE CHOL; Correa NE, 2005, J BACTERIOL, V187, P6324, DOI 10.1128/JB.187.18.6324-6332.2005; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; DONNENBERG MS, 1993, J CLIN INVEST, V92, P1412, DOI 10.1172/JCI116717; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Finkel SE, 1999, P NATL ACAD SCI USA, V96, P4023, DOI 10.1073/pnas.96.7.4023; Fong JCN, 2010, MICROBIOL-SGM, V156, P2757, DOI 10.1099/mic.0.040196-0; Harrison JJ, 2005, ENVIRON MICROBIOL, V7, P981, DOI 10.1111/j.1462-2920.2005.00777.x; Jubair M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045187; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Klose KE, 1998, J BACTERIOL, V180, P303, DOI 10.1128/JB.180.2.303-316.1998; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; Moker N, 2010, J BACTERIOL, V192, P1946, DOI 10.1128/JB.01231-09; Morris JG, 2011, EMERG INFECT DIS, V17, P2099, DOI 10.3201/eid1711.111109; Nelson EJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000187; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; Prouty MG, 2001, MOL MICROBIOL, V39, P1595, DOI 10.1046/j.1365-2958.2001.02348.x; Pruzzo C, 2003, ENVIRON MICROBIOL, V5, P850, DOI 10.1046/j.1462-2920.2003.00498.x; Reidl J, 2002, FEMS MICROBIOL REV, V26, P125, DOI 10.1111/j.1574-6976.2002.tb00605.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Wai SN, 1998, APPL ENVIRON MICROB, V64, P3648; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Watnick PI, 1999, MOL MICROBIOL, V34, P586, DOI 10.1046/j.1365-2958.1999.01624.x; Watnick PI, 2001, MOL MICROBIOL, V39, P223, DOI 10.1046/j.1365-2958.2001.02195.x; Yildiz FH, 2004, MOL MICROBIOL, V53, P497, DOI 10.1111/j.1365-2958.2004.04154.x; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028; Yildiz FH, 2001, J BACTERIOL, V183, P1716, DOI 10.1128/JB.183.5.1716-1726.2001; Zinser ER, 2004, RES MICROBIOL, V155, P328, DOI 10.1016/j.resmic.2004.01.014	42	9	9	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92883	10.1371/journal.pone.0092883	http://dx.doi.org/10.1371/journal.pone.0092883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667909	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600098
J	Lacoste, S; Bhatia, R; Bhatia, S; O'Connor, TR				Lacoste, Sandrine; Bhatia, Ravi; Bhatia, Smita; O'Connor, Timothy R.			Granulocytes Affect Double-Strand Break Repair Assays in Primary Human Lymphocytes	PLOS ONE			English	Article							T-CELL FUNCTION; DNA-REPAIR; ADAPTIVE RESPONSE; RADIATION; BLOOD; EXPRESSION; VALIDATION; EFFICIENCY; ELISPOT	Patients who develop therapy-related myelodysplasia/acute myeloid leukemia after autologous-hematopoietic stem cell (aHCT) transplant show lower expression levels of DNA repair genes in their pre-aHCT CD34(+) cells. To investigate whether this leads to functional differences in DNA repair abilities measurable in patients, we adapted two plasmid-based host-cell reactivation assays for use in primary lymphocytes. Prior to applying these assays to patients who underwent aHCT, we wanted first to verify whether sample preparation affected repair measurements, as patient samples were simply depleted of erythrocytes (with hetastarch) prior to freezing, which is not the classical way to prepare lymphocytes prior to DNA repair experiments (with a density gradient). We show here that lymphocytes from healthy donors freshly prepared with hetastarch show systematically a higher level of double-strand break repair as compared to when prepared with a density gradient, but that most of this difference disappears after samples were frozen. Several observations points to granulocytes as the source for this effect of sample preparation on repair: 1) removal of granulocytes makes the effect disappear, 2) DSB repair measurements for the same individual correlate to the percentage of granulocytes in the sample and 3) nucleofection in presence of granulocytes increases the level of reactive oxygen species (ROS) in neighboring lymphocytes in a dose-dependent manner (R 2 of 0.95). These results indicate that co-purified granulocytes, possibly through the release of ROS at time of transfection, can lead to an enhanced repair in lymphocytes that obfuscates any evaluation of inter individual differences in repair as measured by host-cell reactivation. As a result, hetastarch-prepared samples are likely unsuitable for the assessment of DSB repair in primary cells with that type of assay. Granulocyte contamination that exists after a density gradient preparation, although much more limited, could have similar effects, but might be circumvented by freezing cells prior to analysis.	[Lacoste, Sandrine; O'Connor, Timothy R.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Bhatia, Ravi] City Hope Natl Med Ctr, Div Hematol & Hematopoiet Cell Transplantat, Duarte, CA 91010 USA; [Bhatia, Smita] City Hope Natl Med Ctr, Dept Populat Sci, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; City of Hope	Lacoste, S (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA.	slacoste@coh.org		O'Connor, Timothy/0000-0001-5848-3592	NIH SPORE grant [5P50CA107399]; City of Hope Comprehensive Cancer Center Grant [NCI 5P30CA033572-27]; NATIONAL CANCER INSTITUTE [P30CA033572, P50CA107399] Funding Source: NIH RePORTER	NIH SPORE grant; City of Hope Comprehensive Cancer Center Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by the NIH SPORE grant (5P50CA107399, S. Forman, http://www.nih.gov/index.html) and by the City of Hope Comprehensive Cancer Center Grant (NCI 5P30CA033572-27, S. Rosen, http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso G, 2010, J IMMUNOL METHODS, V359, P28, DOI 10.1016/j.jim.2010.05.005; ATHAS WF, 1991, CANCER RES, V51, P5786; Bhatia R, 2005, J CLIN ONCOL, V23, P6699, DOI 10.1200/JCO.2005.10.330; Chakraborty S, 2009, J CLIN ONCOL, V27, P791, DOI 10.1200/JCO.2008.17.1033; Cherng JY, 1999, J CONTROL RELEASE, V60, P343, DOI 10.1016/S0168-3659(99)00089-9; De Rose R, 2005, J IMMUNOL METHODS, V297, P177, DOI 10.1016/j.jim.2004.12.009; Decordier I, 2010, MUTAT RES-REV MUTAT, V705, P107, DOI 10.1016/j.mrrev.2010.05.002; Gafter-Gvili A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068341; Iyama T, 2013, DNA REPAIR, V12, P620, DOI 10.1016/j.dnarep.2013.04.015; Li L, 2011, CANCER CELL, V20, P591, DOI 10.1016/j.ccr.2011.09.011; Manning G, 2013, INT J RADIAT BIOL, V89, P512, DOI 10.3109/09553002.2013.769694; McKenna KC, 2009, J IMMUNOL METHODS, V341, P68, DOI 10.1016/j.jim.2008.10.019; Mendez P, 2011, DNA REPAIR, V10, P603, DOI 10.1016/j.dnarep.2011.04.001; Modi H, 2011, LEUKEMIA, V25, P305, DOI 10.1038/leu.2010.257; NICKOLOFF JA, 1992, ANAL BIOCHEM, V205, P237, DOI 10.1016/0003-2697(92)90429-B; Nose I, 2013, DNA REPAIR, V12, P508, DOI 10.1016/j.dnarep.2013.04.021; Olemukan RE, 2010, CLIN VACCINE IMMUNOL, V17, P910, DOI 10.1128/CVI.00492-09; Saini D, 2012, MOL CELL BIOCHEM, V364, P271, DOI 10.1007/s11010-012-1227-9; Schmielau J, 2001, CANCER RES, V61, P4756; Secretan MB, 2004, MUTAT RES-FUND MOL M, V554, P351, DOI 10.1016/j.mrfmmm.2004.05.016; Singh S, 2009, DOSE-RESPONSE, V7, P193, DOI 10.2203/dose-response.09-001.Singh; WOLFF S, 1988, INT J RADIAT BIOL, V53, P39, DOI 10.1080/09553008814550401; Wolff S, 1998, ENVIRON HEALTH PERSP, V106, P277, DOI 10.2307/3433927; Wolff S, 1996, MUTAT RES-FUND MOL M, V358, P135, DOI 10.1016/S0027-5107(96)00114-5; Yam PY, 2002, MOL THER, V5, P479, DOI 10.1006/mthe.2002.0558	25	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93185	10.1371/journal.pone.0093185	http://dx.doi.org/10.1371/journal.pone.0093185			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667872	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600155
J	Lon, C; Manning, JE; Vanachayangkul, P; So, M; Sea, D; Se, Y; Gosi, P; Lanteri, C; Chaorattanakawee, S; Sriwichai, S; Chann, S; Kuntawunginn, W; Buathong, N; Nou, S; Walsh, DS; Tyner, SD; Juliano, JJ; Lin, J; Spring, M; Bethell, D; Kaewkungwal, J; Tang, D; Chuor, CM; Satharath, P; Saunders, D				Lon, Chanthap; Manning, Jessica E.; Vanachayangkul, Pattaraporn; So, Mary; Sea, Darapiseth; Se, Youry; Gosi, Panita; Lanteri, Charlotte; Chaorattanakawee, Suwanna; Sriwichai, Sabaithip; Chann, Soklyda; Kuntawunginn, Worachet; Buathong, Nillawan; Nou, Samon; Walsh, Douglas S.; Tyner, Stuart D.; Juliano, Jonathan J.; Lin, Jessica; Spring, Michele; Bethell, Delia; Kaewkungwal, Jaranit; Tang, Douglas; Chuor, Char Meng; Satharath, Prom; Saunders, David			Efficacy of Two versus Three-Day Regimens of Dihydroartemisinin-Piperaquine for Uncomplicated Malaria in Military Personnel in Northern Cambodia: An Open-Label Randomized Trial	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; IN-VITRO; SOUTHEAST-ASIA; RESISTANCE; PFMDR1; THAILAND; SAFETY; PHARMACOKINETICS; MUTATIONS; ASSAY	Introduction: Emerging antimalarial drug resistance in mobile populations remains a significant public health concern. We compared two regimens of dihydroartemisinin-piperaquine in military and civilians on the Thai-Cambodian border to evaluate national treatment policy. Methods: Efficacy and safety of two and three-day regimens of dihydroartemisinin-piperaquine were compared as a nested open-label evaluation within a malaria cohort study in 222 otherwise healthy volunteers (18% malaria-infected at baseline). The first 80 volunteers with slide-confirmed Plasmodium falciparum or vivax malaria were randomized 1: 1 to receive either regimen (total dose 360mg dihydroartemisinin and 2880mg piperaquine) and followed weekly for up to 6 months. The primary endpoint was malaria recurrence by day 42. Volunteers with vivax infection received primaquine at study discharge with six months follow-up. Results: Eighty patients (60 vivax, 15 falciparum, and 5 mixed) were randomized to dihydroartemisinin-piperaquine. Intention-to-treat all-species efficacy at Day 42 was 85% for the two-day regimen (95% CI 69-94) and 90% for the three-day regimen (95% CI 75-97). PCR-adjusted falciparum efficacy was 75% in both groups with nearly half (45%) still parasitemic at Day 3. Plasma piperaquine levels were comparable to prior published reports, but on the day of recrudescence were below measurable in vitro piperaquine IC50 levels in all falciparum treatment failures. Conclusions: In the brief period since introduction of dihydroartemisinin-piperaquine, there is early evidence suggesting declining efficacy relative to previous reports. Parasite IC50 levels in excess of plasma piperaquine levels seen only in treatment failures raises concern for clinically significant piperaquine resistance in Cambodia. These findings warrant improved monitoring of clinical outcomes and follow-up, given few available alternative drugs.	[Lon, Chanthap; Manning, Jessica E.; Vanachayangkul, Pattaraporn; Se, Youry; Gosi, Panita; Lanteri, Charlotte; Chaorattanakawee, Suwanna; Sriwichai, Sabaithip; Kuntawunginn, Worachet; Buathong, Nillawan; Walsh, Douglas S.; Tyner, Stuart D.; Spring, Michele; Bethell, Delia; Satharath, Prom] US Army Med Component, Armed Forces Res Inst Med Sci, Dept Immunol & Med, Bangkok, Thailand; [Manning, Jessica E.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Lon, Chanthap; Se, Youry; Chann, Soklyda; Nou, Samon] US Army Med Component, Armed Forces Res Inst Med Sci, Phnom Penh, Cambodia; [So, Mary; Satharath, Prom] Royal Cambodian Armed Forces, Phnom Penh, Cambodia; [Sea, Darapiseth; Chuor, Char Meng] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Juliano, Jonathan J.; Lin, Jessica] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Kaewkungwal, Jaranit] Mahidol Univ, Ctr Excellence Biomed & Publ Hlth Informat BIOPHI, Bangkok 10700, Thailand; [Tang, Douglas] Fast Track Biol, Potomac, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Harvard University; Brigham & Women's Hospital; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); National Center Parasitology, Entomology & Malaria Control; University of North Carolina; University of North Carolina Chapel Hill; Mahidol University	Saunders, D (corresponding author), US Army Med Component, Armed Forces Res Inst Med Sci, Dept Immunol & Med, Bangkok, Thailand.	David.Saunders@afrims.org	Lin, Jessica/I-2705-2019	Kaewkungwal, Jaranit/0000-0001-7916-8460	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI110651] Funding Source: NIH RePORTER; NIAID NIH HHS [K08 AI110651] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abeyasinghe RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043162; Annerberg A, 2011, ANTIMICROB AGENTS CH, V55, P3971, DOI 10.1128/AAC.00279-11; Bethell D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019283; Cambodian National Center for Parasitology Entomology and Malaria Control, 2011, NAT TREATM GUID MAL; EVERETT WD, 1977, AM J TROP MED HYG, V26, P597, DOI 10.4269/ajtmh.1977.26.597; Hao M, 2013, ANTIMICROB AGENTS CH; Janssens B, 2007, TROP MED INT HEALTH, V12, P251, DOI [10.1111/j.1365-3165.2006.01786.x, 10.1111/j.1365-3156.2006.01786.x]; Krudsood Srivicha, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P971; Leang R, 2012, ANTIMICROB AGENTS CH; Lin JT, 2013, AM J TROP MED HYG; Lopes Dinora, 2002, Malar J, V1, P12, DOI 10.1186/1475-2875-1-12; Muangnoicharoen S, 2009, ANTIMICROB AGENTS CH, V53, P1362, DOI 10.1128/AAC.01656-08; Mytton OT, 2007, AM J TROP MED HYG, V77, P447, DOI 10.4269/ajtmh.2007.77.447; Naing C, 2013, T ROY SOC TROP MED H, V107, P65, DOI 10.1093/trstmh/trs019; Noedl H, 2010, CLIN INFECT DIS, V51, pE82, DOI 10.1086/657120; Pickard AL, 2003, ANTIMICROB AGENTS CH, V47, P2418, DOI 10.1128/AAC.47.8.2418-2423.2003; Purfield A, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-9; Rutvisuttinunt W, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-325; Saunders D, 2012, ANTIMICROB AGENTS CH, V56, P5484, DOI 10.1128/AAC.00044-12; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Sutherland CJ, 2007, J ANTIMICROB CHEMOTH, V59, P1197, DOI 10.1093/jac/dkm104; Tarning J, 2008, ANTIMICROB AGENTS CH, V52, P1052, DOI 10.1128/AAC.00955-07; US Department Of Health nd Human Services National Institutes of Health National Cancer Institute, 2010, COMM TERM CRIT ADV E; Vargas-Rodriguez R D, 2012, AM J TROP MED HYG; Veiga MI, 2012, ANTIMICROB AGENTS CH, V56, P3615, DOI 10.1128/AAC.06350-11; Vinayak S, 2010, J INFECT DIS, V201, P1551, DOI 10.1086/651949; Wilson PE, 2005, ACTA TROP, V93, P97, DOI 10.1016/j.actatropica.2004.09.010; Wong RPM, 2011, ANTIMICROB AGENTS CH, V55, P798, DOI 10.1128/AAC.00939-10; Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601; World Health Organization, 2009, METH SURV ANT DRUG E; World Health Organization Global Malaria Programme, UPD ART RES APR 2012; World Health Organization. Global Malaria Programme, 2012, WORLD MAL REP 2012; Worldwide Antimalarial Resistance Network, 2012, CLIN MOD CLIN DURG E; Zwang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006358	34	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93138	10.1371/journal.pone.0093138	http://dx.doi.org/10.1371/journal.pone.0093138			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667662	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600147
J	Mann, BS; Barnieh, L; Tang, KR; Campbell, DJT; Clement, F; Hemmelgarn, B; Tonelli, M; Lorenzetti, D; Manns, BJ				Mann, Bikaramjit S.; Barnieh, Lianne; Tang, Karen; Campbell, David J. T.; Clement, Fiona; Hemmelgarn, Brenda; Tonelli, Marcello; Lorenzetti, Diane; Manns, Braden J.			Association between Drug Insurance Cost Sharing Strategies and Outcomes in Patients with Chronic Diseases: A Systematic Review	PLOS ONE			English	Review							MEDICARE PART D; ACUTE MYOCARDIAL-INFARCTION; SOCIOECONOMIC-STATUS; HEALTH-INSURANCE; STATIN THERAPY; CARE; HYPERTENSION; ADHERENCE; IMPACT; ADULTS	Background: Prescription drugs are used in people with hypertension, diabetes, and cardiovascular disease to manage their illness. Patient cost sharing strategies such as copayments and deductibles are often employed to lower expenditures for prescription drug insurance plans, but the impact on health outcomes in these patients is unclear. Objective: To determine the association between drug insurance and patient cost sharing strategies on medication adherence, clinical and economic outcomes in those with chronic diseases (defined herein as diabetes, hypertension, hypercholesterolemia, coronary artery disease, and cerebrovascular disease). Methods: Studies were included if they examined various cost sharing strategies including copayments, coinsurance, fixed copayments, deductibles and maximum out-of-pocket expenditures. Value-based insurance design and reference based pricing studies were excluded. Two reviewers independently identified original intervention studies (randomized controlled trials, interrupted time series, and controlled before-after designs). MEDLINE, EMBASE, Cochrane Library, CINAHL, and relevant reference lists were searched until March 2013. Two reviewers independently assessed studies for inclusion, quality, and extracted data. Eleven studies, assessing the impact of seven policy changes, were included: 2 separate reports of one randomized controlled trial, 4 interrupted time series, and 5 controlled before-after studies. Findings: Outcomes included medication adherence, clinical events (myocardial infarction, stroke, death), quality of life, healthcare utilization, or cost. The heterogeneity among the studies precluded meta-analysis. Few studies reported the impact of cost sharing strategies on mortality, clinical and economic outcomes. The association between patient copayments and medication adherence varied across studies, ranging from no difference to significantly lower adherence, depending on the amount of the copayment. Conclusion: Lowering cost sharing in patients with chronic diseases may improve adherence, but the impact on clinical and economic outcomes is uncertain.	[Mann, Bikaramjit S.; Barnieh, Lianne; Tang, Karen; Campbell, David J. T.; Hemmelgarn, Brenda; Manns, Braden J.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Barnieh, Lianne; Campbell, David J. T.; Hemmelgarn, Brenda; Tonelli, Marcello; Manns, Braden J.] Interdisciplinary Chron Dis Collaborat Team, Calgary, AB, Canada; [Clement, Fiona; Hemmelgarn, Brenda; Lorenzetti, Diane; Manns, Braden J.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Clement, Fiona; Hemmelgarn, Brenda; Manns, Braden J.] Univ Calgary, Inst Publ Hlth, Calgary, AB, Canada; [Hemmelgarn, Brenda; Manns, Braden J.] Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada; [Tonelli, Marcello] Univ Alberta, Dept Med, Edmonton, AB, Canada	University of Calgary; University of Calgary; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Alberta	Manns, BJ (corresponding author), Univ Calgary, Dept Med, Calgary, AB, Canada.	braden.manns@albertahealthservices.ca	Tonelli, Marcello/B-3028-2009	Tonelli, Marcello/0000-0002-0846-3187; Lorenzetti, Diane L./0000-0001-8423-3458	Alberta Innovates - Health Solutions (AI-HS); Alberta Innovates - Health Solutions Trainee award; Alberta Innovates - Health Solutions; Roy and Vi Baay Chair in Kidney Research; Government of Canada Research Chair; Government of Alberta; University of Calgary; University of Alberta; Alberta Innovates [201400131] Funding Source: researchfish	Alberta Innovates - Health Solutions (AI-HS); Alberta Innovates - Health Solutions Trainee award; Alberta Innovates - Health Solutions; Roy and Vi Baay Chair in Kidney Research; Government of Canada Research Chair; Government of Alberta; University of Calgary; University of Alberta(University of Alberta); Alberta Innovates	Dr. Campbell is supported by an Alberta Innovates - Health Solutions (AI-HS) Clinician Fellowship award. Dr. Barnieh is supported by an Alberta Innovates - Health Solutions Trainee award. Drs. Manns and Hemmelgarn are supported by career salary support awards from Alberta Innovates - Health Solutions. Dr. Hemmelgarn is also supported by the Roy and Vi Baay Chair in Kidney Research. Dr. Tonelli is supported by a Government of Canada Research Chair. Drs. Manns, Hemmelgarn, and Tonelli are also supported by an alternative funding plan from the Government of Alberta and the Universities of Calgary and Alberta. Primary Funding Source: This study was funded by a team grant from Alberta Innovates - Health Solutions to the Interdisciplinary Chronic Disease Collaboration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Austvoll-Dahlgren A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007017; BROOK RH, 1983, NEW ENGL J MED, V309, P1426, DOI 10.1056/NEJM198312083092305; Chobanian AV, 2004, JNC 7 EXPRESS 7 REPO, P1; Clark AM, 2009, NAT REV CARDIOL, V6, P712, DOI 10.1038/nrcardio.2009.163; Doshi JA, 2009, CIRCULATION, V119, P390, DOI 10.1161/CIRCULATIONAHA.108.783944; [EPOC Group CEPaOoC], 2012, EPOC METH; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Fineberg HV, 2012, NEW ENGL J MED, V366, P1020, DOI 10.1056/NEJMsa1114777; Freeman JD, 2008, MED CARE, V46, P1023, DOI 10.1097/MLR.0b013e318185c913; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Gibson TB, 2005, AM J MANAG CARE, V11, P730; Goldman DP, 2007, JAMA-J AM MED ASSOC, V298, P61, DOI 10.1001/jama.298.1.61; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; Grotto I, 2008, CURR OPIN CARDIOL, V23, P335, DOI 10.1097/HCO.0b013e3283021c70; Grundy SM, 2002, 3 REPORT NATL CHOLES, P1; Haas JS, 2005, ANN INTERN MED, V142, P891, DOI 10.7326/0003-4819-142-11-200506070-00006; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hoffman JM, 2012, AM J HEALTH-SYST PH, V69, pe5; HUTTIN C, 1994, HEALTH POLICY, V27, P53, DOI 10.1016/0168-8510(94)90157-0; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Keehan SP, 2012, HEALTH AFFAIR, V31, P1600, DOI 10.1377/hlthaff.2012.0404; KEELER EB, 1985, JAMA-J AM MED ASSOC, V254, P1926; Levin A, 2008, CAN MED ASSOC J, V179, P1154, DOI 10.1503/cmaj.080351; Li PX, 2012, ANN INTERN MED, V156, P776, DOI 10.7326/0003-4819-156-11-201206050-00004; Liu SZ, 2004, HEALTH POLICY, V68, P277, DOI 10.1016/j.healthpol.2003.12.013; Manns BJ, 2012, CAN MED ASSOC J, V184, pE144, DOI 10.1503/cmaj.110755; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Piette JD, 2004, AM J PUBLIC HEALTH, V94, P1782, DOI 10.2105/AJPH.94.10.1782; Pilote L, 2002, CAN MED ASSOC J, V167, P246; Rabi DM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-124; Reeder C E, 1993, Pharmacoeconomics, V4, P92, DOI 10.2165/00019053-199304020-00004; Schneeweiss S, 2007, AM J MANAG CARE, V13, P445; Schneeweiss S, 2007, CIRCULATION, V115, P2128, DOI 10.1161/CIRCULATIONAHA.106.665992; Smith D G, 1992, Pharmacoeconomics, V2, P335, DOI 10.2165/00019053-199202040-00008; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Zhang YT, 2011, HEALTH SERV RES, V46, P185, DOI 10.1111/j.1475-6773.2010.01183.x; Zhang YT, 2010, MED CARE, V48, P409, DOI 10.1097/MLR.0b013e3181d68978; Zhang Y, 2009, NEW ENGL J MED, V361, P52, DOI 10.1056/NEJMsa0807998	39	44	46	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e89168	10.1371/journal.pone.0089168	http://dx.doi.org/10.1371/journal.pone.0089168			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SD	24667163	gold, Green Submitted, Green Published			2022-12-27	WOS:000333675600001
J	Xu, ZW; Zhang, XY; Xie, J; Yuan, GF; Tang, XZ; Sun, XM; Yu, GR				Xu, Zhiwei; Zhang, Xinyu; Xie, Juan; Yuan, Guofu; Tang, Xinzhai; Sun, Xiaomin; Yu, Guirui			Total Nitrogen Concentrations in Surface Water of Typical Agro- and Forest Ecosystems in China, 2004-2009	PLOS ONE			English	Article							TAIHU LAKE REGION; LAND-USE; RIVER-BASIN; NEW-ZEALAND; ACID-RAIN; MANAGEMENT; STREAMS; AGRICULTURE; CATCHMENT; POLLUTION	We assessed the total nitrogen (N) concentrations of 28 still surface water (lake and pond), and 42 flowing surface water (river), monitoring sites under 29 typical terrestrial ecosystems of the Chinese Ecosystem Research Network (CERN) using monitoring data collected between 2004 and 2009. The results showed that the median total N concentrations of still surface water were significantly higher in the agro- (1.5 mg.L-1) and oasis agro- ecosystems (1.8 mg.L-1) than in the forest ecosystems (1.0 mg.L-1). This was also the case for flowing surface water, with total N concentrations of 2.4 mg.L-1, 1.8 mg.L-1 and 0.5 mg.L-1 for the agro-, oasis agro- and forest ecosystems, respectively. In addition, more than 50% of the samples in agro- and oasis agro- ecosystems were seriously polluted (>1.0 mg.L-1) by N. Spatial analysis showed that the total N concentrations in northern and northwestern regions were higher than those in the southern region for both still and flowing surface waters under agro- and oasis agro- ecosystems, with more than 50% of samples exceeding 1.0 mg.L-1 (the Class III limit of the Chinese National Quality Standards for Surface Waters) in surface water in the northern region. Nitrogen pollution in agro- ecosystems is mainly due to fertilizer applications, while the combination of fertilizer and irrigation exacerbates nitrogen pollution in oasis agro- ecosystems.	[Xu, Zhiwei; Zhang, Xinyu; Xie, Juan; Yuan, Guofu; Tang, Xinzhai; Sun, Xiaomin; Yu, Guirui] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Zhang, XY (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China.	zhangxy@igsnrr.ac.cn	于, 贵瑞/C-1768-2014; yuan, guo fu/Q-1554-2016	于, 贵瑞/0000-0002-1859-8966; Tang, Xinzhai/0000-0003-1072-9172; yuan, guo fu/0000-0002-6945-5017; Xie, Juan/0000-0002-4170-9273	Key Direction in Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-EW-310]; National Natural Science Foundation of China [41171153]	Key Direction in Knowledge Innovation Program of the Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the Key Direction in Knowledge Innovation Program of the Chinese Academy of Sciences (KZCX2-EW-310) and the National Natural Science Foundation of China (No. 41171153). The authors declare that no additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Cobelas M, 2008, ENVIRON POLLUT, V156, P261, DOI 10.1016/j.envpol.2008.02.016; [Anonymous], 2001, ACTA ECOL SIN, DOI DOI 10.3321/J.ISSN:1000-0933.2001.12.006; BAO QS, 1996, GEOGRAPHICAL SCI, V16, P66; Barton L, 2006, AGR WATER MANAGE, V80, P160, DOI 10.1016/j.agwat.2005.07.011; Beaudoin N, 2005, AGR ECOSYST ENVIRON, V111, P292, DOI 10.1016/j.agee.2005.06.006; Bergstrom AK, 2006, GLOBAL CHANGE BIOL, V12, P635, DOI 10.1111/j.1365-2486.2006.01129.x; Boers PCM, 1996, WATER SCI TECHNOL, V33, P183, DOI 10.1016/0273-1223(96)00229-6; Boesch DF, 2001, J ENVIRON QUAL, V30, P303, DOI 10.2134/jeq2001.302303x; [蔡龙炎 Cai Longyan], 2010, [地球与环境, Earth and Environment], V38, P235; Cang HJ, 2004, TROPICAL GEOGRAPHY, V24, P332; Chen LD, 2005, J ENVIRON SCI, V17, P224; Davies JM, 2003, J ENVIRON MANAGE, V68, P273, DOI 10.1016/S0301-4797(03)00070-7; Dayyani S, 2012, T ASABE, V55, P389; Dodds WK, 2000, J N AM BENTHOL SOC, V19, P186, DOI 10.2307/1468291; Duggan IC, 2002, NEW ZEAL J MAR FRESH, V36, P831, DOI 10.1080/00288330.2002.9517136; GALLOWAY JN, 1995, GLOBAL BIOGEOCHEM CY, V9, P235, DOI 10.1029/95GB00158; Galloway JN, 2002, AMBIO, V31, P64, DOI 10.1639/0044-7447(2002)031[0064:RNATWY]2.0.CO;2; General Administration of Quality Supervision and Quarantine of China, 2002, 186682002 GB; Gorham E., 1998, ENVIRON SCI POLICY, V1, P153, DOI [DOI 10.1016/S1462-9011(98)00025-2), 10.1016/S1462-9011(98)00025-2, DOI 10.1016/S1462-9011(98)00025-2]; He B, 2009, WATER SCI TECHNOL, V60, P2009, DOI 10.2166/wst.2009.596; He B, 2009, ECOL MODEL, V220, P2325, DOI 10.1016/j.ecolmodel.2009.05.018; [胡玉婷 Hu Yuting], 2011, [土壤, Soils], V43, P19; Huang Z. L, 1994, ACTA PHYTOECOLOGICA, V18, P194; ISERMANN K, 1990, FERT RES, V26, P253, DOI 10.1007/BF01048764; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Kaushal SS, 2011, ENVIRON SCI TECHNOL, V45, P8225, DOI 10.1021/es200779e; Kemp MJ, 2001, BIOGEOCHEMISTRY, V53, P125, DOI 10.1023/A:1010707632340; Kronvang B, 1996, WATER SCI TECHNOL, V33, P81, DOI 10.1016/0273-1223(96)00217-X; Krusche AV, 2003, ENVIRON POLLUT, V121, P389, DOI 10.1016/S0269-7491(02)00235-X; Kvitek T, 2009, PHYS CHEM EARTH, V34, P541, DOI 10.1016/j.pce.2008.07.003; Larned ST, 2004, NEW ZEAL J MAR FRESH, V38, P347, DOI 10.1080/00288330.2004.9517243; Lassaletta L, 2009, SCI TOTAL ENVIRON, V407, P6034, DOI 10.1016/j.scitotenv.2009.08.002; Letcher RA, 2005, ENVIRON MODELL SOFTW, V20, P93, DOI 10.1016/j.envsoft.2004.01.003; Lewis WM, 2011, INLAND WATERS, V1, P1, DOI 10.5268/IW-1.1.384; Li J, 2010, ENVIRON MONIT ASSESS, V169, P335, DOI 10.1007/s10661-009-1174-4; Likens GE, 2006, BIOGEOCHEMISTRY, V78, P1, DOI 10.1007/s10533-005-2024-2; Liu ZD, 2003, J NATURAL RESOURCES, V16, P467; McKee LJ, 2001, MAR FRESHWATER RES, V52, P235, DOI 10.1071/MF99025; [孟令尧 MENG Ling-yao], 2009, [地理与地理信息科学, Geography and Geo-information Science], V25, P95; Mian IA, 2010, SCI TOTAL ENVIRON, V408, P702, DOI 10.1016/j.scitotenv.2009.11.020; Mouri G, 2011, J ENVIRON MANAGE, V92, P1837, DOI 10.1016/j.jenvman.2011.03.005; Mueller-Warrant GW, 2012, J SOIL WATER CONSERV, V67, P183, DOI 10.2489/jswc.67.3.183; National Research Council, 1993, SOIL WAT QUAL AG AGR; Nie SW, 2009, AGR SCI CHINA, V8, P843, DOI 10.1016/S1671-2927(08)60286-2; Novotny V., 2005, P INT WORKSH DO FERT; OECD, 1982, EUTR WAT MON ASS CON, DOI DOI 10.1002/IROH.19840690206; Ometo JPHB, 2000, FRESHWATER BIOL, V44, P327, DOI 10.1046/j.1365-2427.2000.00557.x; Ren YF, 2014, FRONT ENV SCI ENG, V8, P106, DOI 10.1007/s11783-012-0474-z; Roche LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068127; SCHINDLER DW, 1988, SCIENCE, V239, P149, DOI 10.1126/science.239.4836.149; Shepard R, 2000, J SOIL WATER CONSERV, V55, P63; Smil V, 1999, GLOBAL BIOGEOCHEM CY, V13, P647, DOI 10.1029/1999GB900015; STODDARD JL, 1994, ADV CHEM SER, V237, P223; The Central People's Government of the People's Republic of China, 2012, GAZETTE STAT COUNCIL, V11, P51; Tian YH, 2007, PEDOSPHERE, V17, P445, DOI 10.1016/S1002-0160(07)60054-X; U.S. EPA, 2002, NAT REC WAT QUAL CRI; USEPA, 2000, EPA822B00002; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; [王丽香 WANG Li-xiang], 2009, [土壤, Soils], V41, P402; Xie J, 2014, FRONT ENV SCI ENG, V8, P561, DOI 10.1007/s11783-013-0601-5; Xie YX, 2007, PEDOSPHERE, V17, P200, DOI 10.1016/S1002-0160(07)60026-5; Xu Hai, 2008, Shengtaixue Zazhi, V27, P43; Yang A. L., 1999, TECHNIQUES EQUIPMENT, V7, P60; Yuan G. F., 2007, WATER MONITORING PRO; Zhang D, 2009, HYDROLOG SCI J, V54, P316, DOI 10.1623/hysj.54.2.316; Zhang FuSuo, 2008, Acta Pedologica Sinica, V45, P915; Zhang XY, 2013, J ENVIRON SCI-CHINA, V25, P1007, DOI 10.1016/S1001-0742(12)60139-9; [张颖 ZHANG Ying], 2006, [生态学报, Acta Ecologica Sinica], V26, P1633, DOI 10.1016/S1872-2032(06)60026-7; Zhang Z, 2008, SCI TOTAL ENVIRON, V402, P113, DOI 10.1016/j.scitotenv.2008.04.045; Zhao SZ, 2003, NW GEOLOGY, V36, P92; [朱波 ZHU Bo], 2006, [山地学报, Journal of Mountain Science], V24, P601; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067	72	15	18	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92850	10.1371/journal.pone.0092850	http://dx.doi.org/10.1371/journal.pone.0092850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667701	Green Published, gold			2022-12-27	WOS:000333675600091
J	Zhou, JY; Zhao, J; Sun, K; Wang, B; Wang, LJ; Chen, X; Zheng, J; You, QH; Wang, XL; Ding, W; Zhou, JY				Zhou, Jianya; Zhao, Jing; Sun, Ke; Wang, Bo; Wang, Lijun; Chen, Xi; Zheng, Jing; You, Qihan; Wang, Xiaoling; Ding, Wei; Zhou, Jianying			Accurate and Economical Detection of ALK Positive Lung Adenocarcinoma with Semiquantitative Immunohistochemical Screening	PLOS ONE			English	Article							GENE REARRANGEMENT; CANCER PATIENTS; EGFR MUTATIONS; FISH; CRIZOTINIB; IHC; IDENTIFICATION; CARCINOMA; THERAPY; PATIENT	Right detection of anaplastic lymphoma kinase (ALK) gene rearrangement is pivotal to selection of patients with lung adenocarcinoma for ALK-targeted therapy. We explored the potential of combination of immunohistochemistry (IHC) screening and fluorescence in situ hybridization (FISH) as an affordable practice. We analyzed 410 unselected lung adenocarcinomas by ALK IHC (D5F3 clone) and FISH. Some equivocal cases were further analyzed by RT-PCR. The EGFR mutation was detected by pyrosequencing assay. In total 368 cases which got all IHC, FISH, EGFR mutation results were eligible for analysis. Cases were evaluated as IHC score 3+ (n = 26), score 2+ (n = 9), score 1+ (n = 51), and score 0 (n = 282), respectively. 23 of 26 IHC 3+ and 5 of 9 IHC 2+ cases were FISH positive, whereas 3 of 26 IHC 3+, 4 of 9 IHC 2+ and all 333 IHC 1+/0 cases were FISH negative. If considering FISH as the standard, the sensitivity and specificity of ALK IHC 3+/2+ as ALK positive were 100% and 97.9%, respectively. Three IHC 3+ cases reported as FISH "negative" were actually ALK positive confirmed by ALK RT-PCR or re-detected. Based on the final classify, ALK IHC 3+/2+ was 100% sensitive and 98.8% specific. However, FISH was 90.3% sensitive and 100% specific. IHC 2+ was regarded as equivocal and need to be confirmed by FISH or RT-PCR. In the 368 cases, 8.4% cases had ALK positive, 52.2% cases had EGFR mutation, and only one case had a coexisting. Manually semiquantitative ALK IHC (primary antibody D5F3 coupled with secondary DAKO Envision system) used as the initial screening combined with auxiliary FISH confirmation is a reliable, economical approach to identify ALK positive lung adenocarcinoma. The IHC can find some ALK positive cases which would be missed by FISH only.	[Zhou, Jianya; Chen, Xi; Zheng, Jing; Zhou, Jianying] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Resp Dis,Thorac Dis Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Jing; Sun, Ke; Wang, Bo; Wang, Lijun; You, Qihan; Wang, Xiaoling; Ding, Wei] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zhou, JY (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Resp Dis,Thorac Dis Ctr, Hangzhou 310003, Zhejiang, Peoples R China.	zjyhz@zju.edu.cn			National Natural Science Foundation of China [81101768]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation of China (grant number 81101768). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bavieri M, 2013, TUMORI J, V99, pe229, DOI [10.1177/030089161309900519, 10.1700/1377.15321]; Camidge DR, 2012, CANCER-AM CANCER SOC, V118, P4486, DOI 10.1002/cncr.27411; Camidge DR, 2010, CLIN CANCER RES, V16, P5581, DOI 10.1158/1078-0432.CCR-10-0851; Camidge DR, 2013, CANCER; Conklin CMJ, 2013, J THORAC ONCOL, V8, P45, DOI 10.1097/JTO.0b013e318274a83e; Dufort S, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-57; Hofman P, 2012, ANN ONCOL, V23, P1738, DOI 10.1093/annonc/mdr535; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lindeman NI, 2013, J THORAC ONCOL, V8, P823, DOI 10.1097/JTO.0b013e318290868f; Mano H, 2008, CANCER SCI, V99, P2349, DOI 10.1111/j.1349-7006.2008.00972.x; Martelli MP, 2009, AM J PATHOL, V174, P661, DOI 10.2353/ajpath.2009.080755; McLeer-Florin A, 2012, J THORAC ONCOL, V7, P348, DOI 10.1097/JTO.0b013e3182381535; Minca EC, 2013, J MOL DIAGN, V15, P341, DOI 10.1016/j.jmoldx.2013.01.004; Mino-Kenudson M, 2010, CLIN CANCER RES, V16, P1561, DOI 10.1158/1078-0432.CCR-09-2845; Paik JH, 2011, J THORAC ONCOL, V6, P466, DOI 10.1097/JTO.0b013e31820b82e8; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Peled N, 2012, J THORAC ONCOL, V7, pE14, DOI 10.1097/JTO.0b013e3182614ab5; Selinger CI, 2013, MODERN PATHOL, V26; Sholl LM, 2013, J THORAC ONCOL, V8, P322, DOI 10.1097/JTO.0b013e31827db604; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sun JM, 2012, J THORAC ONCOL, V7, pE36, DOI 10.1097/JTO.0b013e318274694e; Ying J, 2013, ANN ONCOL	22	230	239	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92828	10.1371/journal.pone.0092828	http://dx.doi.org/10.1371/journal.pone.0092828			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667320	Green Submitted, gold, Green Published			2022-12-27	WOS:000333675600082
J	Chen, H; Zheng, X; Chen, YG; Li, M; Liu, K; Li, X				Chen, Hong; Zheng, Xiong; Chen, Yinguang; Li, Mu; Liu, Kun; Li, Xiang			Influence of Copper Nanoparticles on the Physical-Chemical Properties of Activated Sludge	PLOS ONE			English	Article							BIOLOGICAL PHOSPHORUS REMOVAL; EXTRACELLULAR POLYMERIC SUBSTANCES; WASTE-WATER; SILVER NANOPARTICLES; TITANIUM-DIOXIDE; SHOCK LOAD; STABILITY; SURFACE; FLOCS; BIOFLOCCULATION	The physical-chemical properties of activated sludge, such as flocculating ability, hydrophobicity, surface charge, settleability, dewaterability and bacteria extracellular polymer substances (EPS), play vital roles in the normal operation of wastewater treatment plants (WWTPs). The nanoparticles released from commercial products will enter WWTPs and can induce potential adverse effects on activated sludge. This paper focused on the effects of copper nanoparticles (CuNPs) on these specific physical-chemical properties of activated sludge. It was found that most of these properties were unaffected by the exposure to lower CuNPs concentration (5 ppm), but different observation were made at higher CuNPs concentrations (30 and 50 ppm). At the higher CuNPs concentrations, the sludge surface charge increased and the hydrophobicity decreased, which were attributed to more Cu2+ ions released from the CuNPs. The carbohydrate content of EPS was enhanced to defense the toxicity of CuNPs. The flocculating ability was found to be deteriorated due to the increased cell surface charge, the decreased hydrophobicity, and the damaged cell membrane. The worsened flocculating ability made the sludge flocs more dispersed, which further increased the toxicity of the CuNPs by increasing the availability of the CuNPs to the bacteria present in the sludge. Further investigation indicated that the phosphorus removal efficiency decreased at higher CuNPs concentrations, which was consistent with the deteriorated physical-chemical properties of activated sludge. It seems that the physical-chemical properties can be used as an indicator for determining CuNPs toxicity to the bacteria in activated sludge. This work is important because bacteria toxicity effects to the activated sludge caused by nanoparticles may lead to the deteriorated treatment efficiency of wastewater treatment, and it is therefore necessary to find an easy way to indicate this toxicity.	[Chen, Hong; Zheng, Xiong; Chen, Yinguang; Li, Mu; Liu, Kun; Li, Xiang] Tongji Univ, Sch Environm Sci & Engn, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China	Tongji University	Chen, YG (corresponding author), Tongji Univ, Sch Environm Sci & Engn, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China.	yinguangchen@tongji.edu.cn	Zheng, Xiong/Q-4336-2016	Zheng, Xiong/0000-0002-5327-1248; li, xiang/0000-0001-7110-8316; li, xiang/0000-0001-7409-8109	National Science Foundation of China;  [51278354]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	This manuscript was financially supported by the National Science Foundation of China. The relevant grant number is 51278354, and the funder's website is http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; Biggs CA, 2000, WATER RES, V34, P2542, DOI 10.1016/S0043-1354(99)00431-5; Brumfiel G, 2006, NATURE, V440, P262, DOI 10.1038/440262a; BRUUS JH, 1992, WATER RES, V26, P1597, DOI 10.1016/0043-1354(92)90159-2; CABANISS SE, 1992, ENVIRON SCI TECHNOL, V26, P1133, DOI 10.1021/es50002a018; Chen H, 2013, RSC ADV, V3, P9835, DOI 10.1039/c3ra40989a; Chen YG, 2012, J HAZARD MATER, V239, P88, DOI 10.1016/j.jhazmat.2012.07.049; Duan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058640; Ganesh R, 2010, ENVIRON SCI TECHNOL, V44, P7808, DOI 10.1021/es101355k; Henze M., 1995, WASTEWATER TREATMENT, DOI 10.1007/978-3-662-04806-1; Hoa PT, 2003, WATER SA, V29, P437; Jin B, 2003, CHEM ENG J, V95, P221, DOI 10.1016/S1385-8947(03)00108-6; Jorand F, 1998, WATER SCI TECHNOL, V37, P307, DOI 10.2166/wst.1998.0652; Joshi PM, 2009, ENVIRON SCI TECHNOL, V43, P5884, DOI 10.1021/es900063b; Kaegi R, 2011, ENVIRON SCI TECHNOL, V45, P3902, DOI 10.1021/es1041892; Keiding K, 2001, WATER SCI TECHNOL, V43, P17, DOI 10.2166/wst.2001.0330; Kim B, 2010, ENVIRON SCI TECHNOL, V44, P7509, DOI 10.1021/es101565j; Li XY, 2007, WATER RES, V41, P1022, DOI 10.1016/j.watres.2006.06.037; Liang ZH, 2010, WATER RES, V44, P5432, DOI 10.1016/j.watres.2010.06.060; Liao BQ, 2001, WATER RES, V35, P339, DOI 10.1016/S0043-1354(00)00277-3; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Madoni P, 1999, WATER RES, V33, P2459, DOI 10.1016/S0043-1354(98)00455-2; Mikkelsen LH, 2002, WATER RES, V36, P2451, DOI 10.1016/S0043-1354(01)00477-8; Mu H, 2012, ENVIRON SCI TECHNOL, V46, P5997, DOI 10.1021/es300616a; Oehmen A, 2007, WATER RES, V41, P2271, DOI 10.1016/j.watres.2007.02.030; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x; Sani RK, 2001, APPL ENVIRON MICROB, V67, P4765, DOI 10.1128/AEM.67.10.4765-4772.2001; Serafim LS, 2004, BIOTECHNOL BIOENG, V87, P145, DOI 10.1002/bit.20085; Sheng GP, 2006, WATER RES, V40, P1233, DOI 10.1016/j.watres.2006.01.023; Shin H.S., 2000, BIOTECHNOL BIOPROCES, V5, P460, DOI DOI 10.1007/BF02931948; The Project on Emerging Nanotechnologies, NAN EN CONS PROD CON; Tong JA, 2007, ENVIRON SCI TECHNOL, V41, P7126, DOI 10.1021/es071002n; URBAIN V, 1993, WATER RES, V27, P829, DOI 10.1016/0043-1354(93)90147-A; Wilen BM, 2003, WATER RES, V37, P2127, DOI 10.1016/S0043-1354(02)00629-2; Wolterbeek HT, 2005, ASSAY DRUG DEV TECHN, V3, P675, DOI 10.1089/adt.2005.3.675; Wu FC, 2001, GEOCHEM J, V35, P333, DOI 10.2343/geochemj.35.333; Xiong Zheng YC, 2011, ENV SCI TECHNOL; Yan Q, 2008, APPL BIOCHEM BIOTECH, V150, P259, DOI 10.1007/s12010-008-8176-5; Yang XN, 2013, WATER RES, V47, P3947, DOI 10.1016/j.watres.2013.01.056; Zheng X, 2012, ENVIRON SCI TECHNOL, V46, P7182, DOI 10.1021/es300777b; Zheng X, 2011, ENVIRON SCI TECHNOL, V45, P7284, DOI 10.1021/es2008598; Zheng XO, 2011, ENVIRON SCI TECHNOL, V45, P2826, DOI 10.1021/es2000744; ZITA A, 1994, APPL ENVIRON MICROB, V60, P3041, DOI 10.1128/AEM.60.9.3041-3048.1994	43	30	30	4	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92871	10.1371/journal.pone.0092871	http://dx.doi.org/10.1371/journal.pone.0092871			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663333	Green Submitted, Green Published, gold			2022-12-27	WOS:000333459900126
J	Mukherjee, A; Larson, EA; Klein, RF; Rotwein, P				Mukherjee, Aditi; Larson, Emily A.; Klein, Robert F.; Rotwein, Peter			Distinct Actions of Akt1 on Skeletal Architecture and Function	PLOS ONE			English	Article							MICE LACKING; OSTEOBLAST DIFFERENTIATION; CELL-SURVIVAL; PHOSPHATIDYLINOSITOL 3-KINASE; GLUCOSE-HOMEOSTASIS; BONE; GROWTH; KINASE; OSTEOCLAST; INSULIN	Skeletal integrity is dependent on the coordinated actions of bone-forming osteoblasts and bone-resorbing osteoclasts, which recognize and respond to multiple environmental inputs. Here we have studied the roles in bone development and growth of Akt1 and Akt2, two closely related signaling proteins, by evaluating mice lacking either of these enzymes. Global deficiency of Akt1 but not Akt2 caused a reduction in whole body and femoral bone mineral density, in femoral cortical thickness and volume, and in trabecular thickness in both males and females when measured at 20-weeks of age, which was reflected in diminished femoral resistance to fracture. Haplo-deficiency of Akt1 in male mice also decreased femoral cortical and trabecular skeletal parameters, and reduced bone strength. Cell-based studies showed that genetic Akt1 deficiency diminished the rate of proliferation of osteoblast progenitors and impaired osteoclast differentiation in primary culture but that loss of Akt2 did not. Our results demonstrate differential effects of Akt1 and Akt2 on skeletal maturation and architecture through actions on both osteoblast and osteoclast precursors.	[Mukherjee, Aditi; Rotwein, Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; [Larson, Emily A.; Klein, Robert F.] Oregon Hlth & Sci Univ, Dept Med, Bone & Mineral Res Unit, Portland, OR 97201 USA; [Klein, Robert F.] Oregon Hlth & Sci Univ, Portland Vet Affairs Med Ctr, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; VA Portland Health Care System	Rotwein, P (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA.	rotweinp@ohsu.edu	Rotwein, Peter/R-5783-2019	Rotwein, Peter/0000-0002-9505-1817	NIH [R01 DK42748]; VA Medical Research Service; OHSU Medical Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042748] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Medical Research Service(US Department of Veterans Affairs); OHSU Medical Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported in part by NIH grant R01 DK42748 (to P. R.), by the VA Medical Research Service (R. F. K.), and by an OHSU Medical Research Foundation new investigator grant (to A. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amer Y, 2000, J BIOL CHEM, V275, P27307; Atanur SS, 2013, CELL, V154, P691, DOI 10.1016/j.cell.2013.06.040; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brandi ML, 2009, RHEUMATOLOGY, V48, pIV3, DOI 10.1093/rheumatology/kep273; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Ferrari S, 2008, BEST PRACT RES CL EN, V22, P723, DOI 10.1016/j.beem.2008.08.007; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Henriksen K, 2011, ENDOCR REV, V32, P31, DOI 10.1210/er.2010-0006; Karaguzel G, 2010, REV ENDOCR METAB DIS, V11, P237, DOI 10.1007/s11154-010-9154-0; Kawamura N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001058; Khosla S, 2007, NEW ENGL J MED, V356, P2293, DOI 10.1056/NEJMcp070341; Klein R. F., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P287; Liu H, 2006, P NATL ACAD SCI USA, V103, P4134, DOI 10.1073/pnas.0511342103; Liu XM, 2007, P NATL ACAD SCI USA, V104, P2259, DOI 10.1073/pnas.0604153104; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Manolagas SC, 2013, NAT REV ENDOCRINOL, V9, P699, DOI 10.1038/nrendo.2013.179; McGonnell Imelda M, 2012, Front Endocrinol (Lausanne), V3, P88, DOI 10.3389/fendo.2012.00088; Mukherjee A, 2008, MOL ENDOCRINOL, V22, P1238, DOI 10.1210/me.2008-0001; Mukherjee A, 2008, MOL ENDOCRINOL, V22, P206, DOI 10.1210/me.2007-0336; Mukherjee A, 2012, J BONE MINER RES, V27, P1345, DOI 10.1002/jbmr.1590; Mukherjee A, 2012, MOL CELL BIOL, V32, P490, DOI 10.1128/MCB.06361-11; Mukherjee A, 2009, J CELL SCI, V122, P716, DOI 10.1242/jcs.042770; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Ohlsson Claes, 2012, Bonekey Rep, V1, P2, DOI 10.1038/bonekey.2012.3; Osyczka AM, 2005, ENDOCRINOLOGY, V146, P3428, DOI 10.1210/en.2005-0303; Oury F, 2012, ANN NY ACAD SCI, V1260, P1, DOI 10.1111/j.1749-6632.2011.06360.x; Patil CK, 2013, CELL, V154, P481, DOI 10.1016/j.cell.2013.07.022; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Somerville JN, 2004, CALCIFIED TISSUE INT, V74, P469, DOI 10.1007/s00223-003-0101-x; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Sugatani T, 2005, J BIOL CHEM, V280, P3583, DOI 10.1074/jbc.M410480200; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; Toker A, 2011, ADV ENZYME REGUL, V52, P78; Tu QS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.152405; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1925, DOI 10.1016/j.bbamcr.2011.08.014; Xiong Q, 2009, GENOMICS, V93, P401, DOI 10.1016/j.ygeno.2008.12.008; Xu XH, 2010, ENDOCR REV, V31, P447, DOI 10.1210/er.2009-0032; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	50	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93040	10.1371/journal.pone.0093040	http://dx.doi.org/10.1371/journal.pone.0093040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663486	gold, Green Published, Green Submitted			2022-12-27	WOS:000333459900147
J	Soong, RS; Song, LW; Trieu, J; Lee, SY; He, LM; Tsai, YC; Wu, TC; Hung, CF				Soong, Ruey-Shyang; Song, Liwen; Trieu, Janson; Lee, Sung Yong; He, Liangmei; Tsai, Ya-Chea; Wu, T. -C.; Hung, Chien-Fu			Direct T Cell Activation via CD40 Ligand Generates High Avidity CD8(+) T Cells Capable of Breaking Immunological Tolerance for the Control of Tumors	PLOS ONE			English	Article							INTRACELLULAR TARGETING STRATEGIES; DENDRITIC CELLS; DNA VACCINES; GENE-EXPRESSION; CANCER; MEMORY; LYMPHOCYTES; INDUCTION; ANTIGEN; IMMUNOTHERAPY	CD40 and CD40 ligand (CD40L) are costimulatory molecules that play a pivotal role in the proinflammatory immune response. Primarily expressed by activated CD4(+) T cells, CD40L binds to CD40 on antigen presenting cells (APCs), thereby inducing APC activation. APCs, in turn, prime cytotoxic T lymphocytes (CTLs). Here, two tumor-associated antigen (TAA) animal models, p53-based and GP100-based, were utilized to examine the ability of CD40-CD40L to improve antigenspecific CTL-mediated antitumor immune responses. Although p53 and GP100 are self-antigens that generate low affinity antigen-specific CD8(+) T cells, studies have shown that their functional avidity can be improved with CD40L-expressing APCs. Therefore, in the current study, we immunized mice with a DNA construct encoding a TAA in conjunction with another construct encoding CD40L via intramuscular injection followed by electroporation. We observed a significant increase in the antigen-specific CTL-mediated immune responses as well as the potent antitumor effects in both models. Antibody depletion experiments demonstrated that CD8(+) T cells play a crucial role in eliciting antitumor effects in vaccinated mice. Furthermore, we showed that in vitro stimulation with irradiated tumor cells expressing both TAA and CD40L improved the functional avidity of antigen-specific CD8(+) T cells. Thus, our data show that vaccination with TAA/CD40L DNA can induce potent antitumor effects against TAA-expressing tumors through the generation of better functioning antigen-specific CD8(+) T cells. Our study serves as an important foundation for future clinical translation.	[Soong, Ruey-Shyang; Song, Liwen; Lee, Sung Yong; He, Liangmei; Tsai, Ya-Chea; Wu, T. -C.; Hung, Chien-Fu] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Wu, T. -C.] Johns Hopkins Med Inst, Dept Obstet & Gynecol, Baltimore, MD 21205 USA; [Wu, T. -C.] Johns Hopkins Med Inst, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Wu, T. -C.; Hung, Chien-Fu] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; [Soong, Ruey-Shyang] Chang Gung Mem Hosp Keelung, Dept Gen Surg, Keelung, Taiwan; [Soong, Ruey-Shyang] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Song, Liwen] Fudan Univ, Sch Pharm, Shanghai 200433, Peoples R China; [Song, Liwen] Shanghai Inst Planned Parenthood Res, Dept Pharmacol & Toxicol, Shanghai, Peoples R China; [Song, Liwen] Tongji Univ, Dept Obstet & Gynecol, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China; [Trieu, Janson] Johns Hopkins Univ, Baltimore, MD USA; [Lee, Sung Yong] Korea Univ, Dept Internal Med, Med Ctr, Seoul, South Korea	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Chang Gung Memorial Hospital; Chang Gung University; Fudan University; Tongji University; Johns Hopkins University; Korea University; Korea University Medicine (KU Medicine)	Wu, TC (corresponding author), Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA.	wutc@jhmi.edu; chung2@jhmi.edu		LEE, SUNG YONG/0000-0002-8693-5792; Song, Liwen/0000-0002-5013-2007	National Institutes of Health/National Cancer Institute Cervical Cancer SPORE [P50CA098252, 2R01CA114425-06]; Chang Gung Memorial Hospital, Keelung, Taiwan [CMRPG2C0371]; NATIONAL CANCER INSTITUTE [P50CA098252, R01CA114425] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute Cervical Cancer SPORE; Chang Gung Memorial Hospital, Keelung, Taiwan(Chang Gung Memorial Hospital); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health/National Cancer Institute Cervical Cancer SPORE P50CA098252 and 2R01CA114425-06 grants and by CMRPG2C0371 from Chang Gung Memorial Hospital, Keelung, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar AN, 1996, EUR J IMMUNOL, V26, P294, DOI 10.1002/eji.1830260204; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Best SR, 2009, VACCINE, V27, P5450, DOI 10.1016/j.vaccine.2009.07.005; Boise LH, 1997, P NATL ACAD SCI USA, V94, P3759, DOI 10.1073/pnas.94.8.3759; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Chang CL, 2007, GENE THER, V14, P1189, DOI 10.1038/sj.gt.3302974; Cheng WF, 2001, J CLIN INVEST, V108, P669, DOI 10.1172/JCI200112346; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Cho HI, 2009, CANCER RES, V69, P9012, DOI 10.1158/0008-5472.CAN-09-2019; Dahl AM, 1996, J IMMUNOL, V157, P239; de Gruijl TD, 2002, J IMMUNOL, V169, P5322, DOI 10.4049/jimmunol.169.9.5322; DeBenedette MA, 2008, J IMMUNOL, V181, P5296, DOI 10.4049/jimmunol.181.8.5296; Disis ML, 2009, LANCET, V373, P673, DOI 10.1016/S0140-6736(09)60404-9; Forero-Torres A, 2013, LEUKEMIA LYMPHOMA, V54, P277, DOI 10.3109/10428194.2012.710328; FOX BA, 1990, J BIOL RESP MODIF, V9, P499; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Hangalapura BN, 2012, J GENE MED, V14, P416, DOI 10.1002/jgm.1648; Hangalapura BN, 2010, J IMMUNOTHER, V33, P706, DOI 10.1097/CJI.0b013e3181eccbd4; Hung CF, 2007, GENE THER, V14, P921, DOI 10.1038/sj.gt.3302913; Ishizaki H, 2010, J IMMUNOTHER, V33, P609, DOI 10.1097/CJI.0b013e3181e032c6; Ji HX, 1999, HUM GENE THER, V10, P2727, DOI 10.1089/10430349950016474; Johnson S, 2009, IMMUNITY, V30, P218, DOI 10.1016/j.immuni.2008.11.015; Jones DS, 2008, J IMMUNOL, V181, P1760, DOI 10.4049/jimmunol.181.3.1760; Kang TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035141; Kato K, 1998, J CLIN INVEST, V101, P1133, DOI 10.1172/JCI1472; Khong A, 2012, INT REV IMMUNOL, V31, P246, DOI 10.3109/08830185.2012.698338; Kim TW, 2005, HUM GENE THER, V16, P26, DOI 10.1089/hum.2005.16.26; Kim TW, 2003, J IMMUNOL, V171, P2970, DOI 10.4049/jimmunol.171.6.2970; Lane DP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001222; Lee CH, 2006, MOL CANCER THER, V5, P2592, DOI 10.1158/1535-7163.MCT-06-0310; Lin KY, 1996, CANCER RES, V56, P21; Loskog Angelica, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P23; Machado-Silva A, 2010, SEMIN CANCER BIOL, V20, P57, DOI 10.1016/j.semcancer.2010.02.005; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Nemunaitis J, 2011, HEAD NECK-J SCI SPEC, V33, P131, DOI 10.1002/hed.21364; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; Pedersen SR, 2013, J IMMUNOL, V191, P3955, DOI 10.4049/jimmunol.1300555; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Rizzuto GA, 2009, J EXP MED, V206, P849, DOI 10.1084/jem.20081382; Sardesai NY, 2011, CURR OPIN IMMUNOL, V23, P421, DOI 10.1016/j.coi.2011.03.008; Seah SGK, 2013, J LEUKOCYTE BIOL, V93, P145, DOI 10.1189/jlb.0612266; Soong RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056912; Suttles J, 2009, SEMIN IMMUNOL, V21, P257, DOI 10.1016/j.smim.2009.05.011; Suzuki I, 1998, J EXP MED, V187, P123, DOI 10.1084/jem.187.1.123; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Vierboom MPM, 2000, CANCER RES, V60, P5508; Yang YP, 2004, NAT IMMUNOL, V5, P508, DOI 10.1038/ni1059	50	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93162	10.1371/journal.pone.0093162	http://dx.doi.org/10.1371/journal.pone.0093162			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664420	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900160
J	Otero-Losada, M; Cao, G; Mc Loughlin, S; Rodriguez-Granillo, G; Ottaviano, G; Milei, J				Otero-Losada, Matilde; Cao, Gabriel; Mc Loughlin, Santiago; Rodriguez-Granillo, Gaston; Ottaviano, Graciela; Milei, Jose			Rate of Atherosclerosis Progression in ApoE(-/-) Mice Long After Discontinuation of Cola Beverage Drinking	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; ENDOTHELIAL DYSFUNCTION; PREVENTION; INFLAMMATION; CHILDHOOD; ADULTHOOD; LIVER	This study was conducted in order to evaluate the effect of cola beverages drinking on atherosclerosisand test the hypothesis whether cola beverages consumption at early life stages might affect the development and progression of atherosclerosis later in life. ApoE(-/-) C57BL/6J mice (8 week-old) were randomized in 3 groups (n = 20 each) according to free accessto water (W), sucrose sweetened carbonated cola drink(C) or aspartame-acesulfame K sweetened carbonated 'light' cola drink (L) for the next 8 weeks. Drinking treatment was ended by switching C and L groups to drinking water. Four mice per group and time were sequentially euthanized: before treatment (8weeks-old), at the end of treatment (16 weeks-old) and after treatment discontinuation (20 weeks-old, 24 weeks-old, 30 week-old mice). Aortic roots and livers were harvested, processed for histology and serial cross-sections were stained. Aortic plaque area was analyzed and plaque/media-ratio was calculated. Early consumption of cola drinks accelerated atherosclerotic plaque progression favoring the interaction between macrophages and myofibroblasts, without the participation of either T lymphocytes or proliferative activity. Plaque/media-ratio varied according to drink treatment (F-2,F-54 = 3.433, p<0.04) and mice age (F-4,F-54 = 5.009, p<0.03) and was higher in C and L groups compared with age-matched W group (p<0.05 at 16 weeks and 20 weeks, p<0.01 at 24 weeks and 30 weeks). Natural evolution of atherosclerosis in ApoE(-/-) mice (W group) evidenced atherosclerosis acceleration in parallel with a rapid increase in liver inflammation around the 20 weeks of age. Cola drinking within the 8-16 weeks of age accelerated atherosclerosis progression in ApoE(-/-) mice favoring aortic plaque enlargement (inward remodeling) over media thinning all over the study time. Data suggest that cola drinking at early life stages may predispose to atherosclerosis progression later in life in ApoE(-/-) mice.	[Otero-Losada, Matilde; Cao, Gabriel; Mc Loughlin, Santiago; Rodriguez-Granillo, Gaston; Ottaviano, Graciela; Milei, Jose] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Inst Invest Cardiol, ININCA,CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Milei, J (corresponding author), Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Inst Invest Cardiol, ININCA,CONICET, Buenos Aires, DF, Argentina.	ininca@fmed.uba.ar	Rodriguez-Granillo, Gaston/ABG-2534-2021; Otero-Losada, Matilde/J-3050-2019; Rodriguez-Granillo, Gaston A/A-6279-2010	Rodriguez-Granillo, Gaston/0000-0003-0820-2611; Otero-Losada, Matilde/0000-0001-6650-1033; MILEI, JOSE/0000-0003-4029-5993	Fundacion Florencio Fiorini; Instituto de Investigaciones Cardiologicas, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Cientificas y Tecnicas (ININCA.UBA.CONICET)	Fundacion Florencio Fiorini; Instituto de Investigaciones Cardiologicas, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Cientificas y Tecnicas (ININCA.UBA.CONICET)	This work was partially supported by an educational grant of the Fundacion Florencio Fiorini and by funds from Instituto de Investigaciones Cardiologicas, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Cientificas y Tecnicas (ININCA.UBA.CONICET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Auclair Sylvain, 2009, Atherosclerosis, V204, pe21, DOI 10.1016/j.atherosclerosis.2008.12.007; Cornier MA, 2011, CIRCULATION, V124, P840, DOI 10.1161/CIRCULATIONAHA.110.968461; d'Uscio LV, 2001, ARTERIOSCL THROM VAS, V21, P1017, DOI 10.1161/01.ATV.21.6.1017; Fenyo IM, 2013, IMMUNOBIOLOGY, V218, P1376, DOI 10.1016/j.imbio.2013.06.005; Gaspari T, 2011, DIAB VASC DIS RES; Green D, 2009, ATHEROSCLEROSIS, V202, P623, DOI 10.1016/j.atherosclerosis.2008.05.039; Iwata H, 2013, CIRCULATION, V127, P1173, DOI 10.1161/CIRCULATIONAHA.113.001461; Kressel G, 2009, ATHEROSCLEROSIS, V202, P263, DOI 10.1016/j.atherosclerosis.2008.04.012; Lennartz MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021803; Li SX, 2003, JAMA-J AM MED ASSOC, V290, P2271, DOI 10.1001/jama.290.17.2271; Maersk M, 2012, AM J CLIN NUTR, V95, P283, DOI 10.3945/ajcn.111.022533; Mahe G, 2011, PUBLIC HEALTH NUTR, V14, P319, DOI 10.1017/S1368980010001862; Meyrelles SS, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-211; Milei J, 2011, WORLD J CARDIOL, V3, P111, DOI 10.4330/wjc.v3.i4.111; Otero-Losada ME, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-57; Otero-Losada ME, 2011, INT J CARDIOL, V146, P106, DOI 10.1016/j.ijcard.2010.09.066; Pham NA, 2007, DIAGN PATHOL, V2, DOI 10.1186/1746-1596-2-8; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Rasanen M, 2002, J AM DIET ASSOC, V102, P518, DOI 10.1016/S0002-8223(02)90118-5; Reddick RL, 1998, ATHEROSCLEROSIS, V140, P297, DOI 10.1016/S0021-9150(98)00133-6; Report of Sir David Weatherall's working group, 2006, US NONH PRIM RES; Sun CX, 2011, CIRCULATION, V124, P48, DOI 10.1161/CIRCULATIONAHA.110.988915; Tesanovic S, 2010, ARTERIOSCL THROM VAS, V30, P1606, DOI 10.1161/ATVBAHA.110.204453; Verhagen SN, 2012, ATHEROSCLEROSIS, V225, P99, DOI 10.1016/j.atherosclerosis.2012.08.031; Watson AMD, 2011, DIABETOLOGIA, V54, P681, DOI 10.1007/s00125-010-2000-9; Xu ZY, 2009, ATHEROSCLEROSIS, V206, P427, DOI 10.1016/j.atherosclerosis.2009.03.023	27	10	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e89838	10.1371/journal.pone.0089838	http://dx.doi.org/10.1371/journal.pone.0089838			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670925	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000004
J	Brenes, R; Gray, MJ; Waltzek, TB; Wilkes, RP; Miller, DL				Brenes, Roberto; Gray, Matthew J.; Waltzek, Thomas B.; Wilkes, Rebecca P.; Miller, Debra L.			Transmission of Ranavirus between Ectothermic Vertebrate Hosts	PLOS ONE			English	Article							TERRAPENE-CAROLINA-CAROLINA; TRACHEMYS-SCRIPTA-ELEGANS; FROGS RANA-SYLVATICA; BOX TURTLES; ENVIRONMENTAL PERSISTENCE; AMPHIBIAN POPULATIONS; INFECTIOUS-DISEASES; LETHAL RANAVIRUS; LIFE-HISTORY; VIRUS 3	Transmission is an essential process that contributes to the survival of pathogens. Ranaviruses are known to infect different classes of lower vertebrates including amphibians, fishes and reptiles. Differences in the likelihood of infection among ectothermic vertebrate hosts could explain the successful yearlong persistence of ranaviruses in aquatic environments. The goal of this study was to determine if transmission of a Frog Virus 3 (FV3)-like ranavirus was possible among three species from different ectothermic vertebrate classes: Cope's gray treefrog (Hyla chrysoscelis) larvae, mosquito fish (Gambusia affinis), and red-eared slider (Trachemys scripta elegans). We housed individuals previously exposed to the FV3-like ranavirus with naive (unexposed) individuals in containers divided by plastic mesh screen to permit water flow between subjects. Our results showed that infected gray treefrog larvae were capable of transmitting ranavirus to naive larval conspecifics and turtles (60% and 30% infection, respectively), but not to fish. Also, infected turtles and fish transmitted ranavirus to 50% and 10% of the naive gray treefrog larvae, respectively. Nearly all infected amphibians experienced mortality, whereas infected turtles and fish did not die. Our results demonstrate that ranavirus can be transmitted through water among ectothermic vertebrate classes, which has not been reported previously. Moreover, fish and reptiles might serve as reservoirs for ranavirus given their ability to live with subclinical infections. Subclinical infections of ranavirus in fish and aquatic turtles could contribute to the pathogen's persistence, especially when highly susceptible hosts like amphibians are absent as a result of seasonal fluctuations in relative abundance.	[Brenes, Roberto] Carroll Univ, Dept Biol, Waukesha, WI 53186 USA; [Gray, Matthew J.; Miller, Debra L.] Univ Tennessee, Ctr Wildlife Hlth, Knoxville, TN USA; [Waltzek, Thomas B.] Univ Florida, Coll Vet Med, Gainesville, FL USA; [Wilkes, Rebecca P.; Miller, Debra L.] Univ Tennessee, Coll Vet Med, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; State University System of Florida; University of Florida; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Brenes, R (corresponding author), Carroll Univ, Dept Biol, Waukesha, WI 53186 USA.	rbrenes@carrollu.edu	Waltzek, Thomas/AHD-3209-2022	Waltzek, Thomas/0000-0001-6383-5978; Miller, Debra/0000-0002-8544-174X	University of Tennessee (UT) Institute of Agriculture through an AgResearch Access and Diversity Fellowship; UT College of Agricultural Sciences and Natural Resources via Hazelwood; UT-ESPN Scholarships; Society of Wetland Scientists, Student Research Award	University of Tennessee (UT) Institute of Agriculture through an AgResearch Access and Diversity Fellowship; UT College of Agricultural Sciences and Natural Resources via Hazelwood; UT-ESPN Scholarships; Society of Wetland Scientists, Student Research Award	Funding for this research was provided by The University of Tennessee (UT) Institute of Agriculture through an AgResearch Access and Diversity Fellowship, UT College of Agricultural Sciences and Natural Resources via Hazelwood and the UT-ESPN Scholarships, and the Society of Wetland Scientists, Student Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allender MC, 2013, J COMP PATHOL, V149, P356, DOI 10.1016/j.jcpa.2013.01.007; Allender M. C., 2009, Journal of Herpetological Medicine and Surgery, V19, P16; Allender MC, 2011, J WILDLIFE DIS, V47, P759, DOI 10.7589/0090-3558-47.3.759; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Ariel E, 1997, DIS AQUAT ORGAN, V29, P1, DOI 10.3354/dao029001; Baer C.K., 2006, GUIDELINES EUTHANASI; Balseiro A, 2010, VET J, V186, P256, DOI 10.1016/j.tvjl.2009.07.038; Bang-Jensen B., 2009, DIS AQUAT ORGAN, V83, P169; Bang-Jensen B., 2011, AQUACULTURE, V313, P24; Bayley AE, 2013, DIS AQUAT ORGAN, V103, P171, DOI 10.3354/dao02574; Breban R, 2013, J MATH BIOL, V66, P535, DOI 10.1007/s00285-012-0520-2; Brenes R, 2014, J AQUATIC A IN PRESS, V26; Brenes RM, 2013, THESIS U TENNESSEE K; Brunner JL, 2007, DIS AQUAT ORGAN, V77, P87, DOI 10.3354/dao01845; Brunner JL, 2005, OECOLOGIA, V144, P399, DOI 10.1007/s00442-005-0093-5; Brunner JL, 2004, ECOLOGY, V85, P560, DOI 10.1890/02-0374; Budy P, 2011, ENVIRON MANAGE, V48, P691, DOI 10.1007/s00267-011-9717-1; Cronin JP, 2010, ECOL LETT, V13, P1221, DOI 10.1111/j.1461-0248.2010.01513.x; Cunningham AA, 2007, EPIDEMIOL INFECT, V135, P1200, DOI 10.1017/S0950268806007679; Cunningham AA, 2007, EPIDEMIOL INFECT, V135, P1213, DOI 10.1017/S0950268807007935; De Voe R, 2004, J ZOO WILDLIFE MED, V35, P534, DOI 10.1638/03-037; Duffus ALJ, 2008, J WILDLIFE DIS, V44, P109, DOI 10.7589/0090-3558-44.1.109; Gobbo F, 2010, DIS AQUAT ORGAN, V90, P167, DOI 10.3354/dao02218; Gray MJ, 2009, DIS AQUAT ORGAN, V87, P243, DOI 10.3354/dao02138; Gray MJ, 2013, WILDL PROFESSIONAL, V6, P51; Greer AL, 2005, DIS AQUAT ORGAN, V67, P9, DOI 10.3354/dao067009; Haislip NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022307; Harp EM, 2006, J WILDLIFE DIS, V42, P307, DOI 10.7589/0090-3558-42.2.307; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Hoverman JT, 2012, ECOHEALTH, V9, P36, DOI 10.1007/s10393-011-0731-9; Hoverman JT, 2011, ECOHEALTH, V8, P301, DOI 10.1007/s10393-011-0717-7; Hoverman JT, 2010, DIS AQUAT ORGAN, V89, P97, DOI 10.3354/dao02200; Hyatt AD, 2002, J WILDLIFE DIS, V38, P239, DOI 10.7589/0090-3558-38.2.239; Iwama George K., 1994, Biochemistry and Molecular Biology of Fishes, V3, P1; Jancovich JK, 2005, MOL ECOL, V14, P213, DOI 10.1111/j.1365-294X.2004.02387.x; Johnson A. J., 2006, Proceedings of the Association of Reptilian and Amphibian Veterinarians, Thirteenth Annual Conference, Baltimore, Maryland, USA, 23-27 April, 2006, P73; Johnson AJ, 2007, VET PATHOL, V44, P285, DOI 10.1354/vp.44-3-285; Johnson AJ, 2008, J WILDLIFE DIS, V44, P851, DOI 10.7589/0090-3558-44.4.851; Marschang RE, 2011, VIRUSES-BASEL, V3, P2087, DOI 10.3390/v3112087; MAY RM, 1979, NATURE, V280, P455, DOI 10.1038/280455a0; MOODY NJG, 1994, DIS AQUAT ORGAN, V18, P95, DOI 10.3354/dao018095; Nazir J, 2012, DIS AQUAT ORGAN, V98, P177, DOI 10.3354/dao02443; Paull SH, 2012, FRONT ECOL ENVIRON, V10, P75, DOI 10.1890/110111; Pearman PB, 2004, J WILDLIFE DIS, V40, P660, DOI 10.7589/0090-3558-40.4.660; Picco AM, 2007, J WILDLIFE DIS, V43, P286, DOI 10.7589/0090-3558-43.2.286; Picco AM, 2010, ECOHEALTH, V7, P252, DOI 10.1007/s10393-010-0310-5; Reeve BC, 2013, ECOHEALTH, V10, P190, DOI 10.1007/s10393-013-0834-6; Relyea RA, 1999, ECOLOGY, V80, P2117, DOI 10.1890/0012-9658(1999)080[2117:QTRBPI]2.0.CO;2; Robert J, 2011, VIROLOGY, V417, P410, DOI 10.1016/j.virol.2011.06.026; SAS Institute Inc, 2012, SAS 9 3; Schock DM, 2008, COPEIA, P133, DOI 10.1643/CP-06-134; Schock DM, 2009, ECOHEALTH, V6, P438, DOI 10.1007/s10393-010-0279-0; Seigel RA, 2013, J TRANSPORTATION RES, V2362; Teacher AGF, 2010, ANIM CONSERV, V13, P514, DOI 10.1111/j.1469-1795.2010.00373.x; Todd-Thompson M, 2010, THESIS U TENNESSEE K; Une Y, 2009, J COMP PATHOL, V141, P310, DOI 10.1016/j.jcpa.2009.08.133; Une Y, 2009, EMERG INFECT DIS, V15, P1146, DOI 10.3201/eid1507.081636; Vignolia L, 2007, ACTA OECOL, V2007, P185; Waltzek TB, DIS AQUATIC IN PRESS; Weng SP, 2002, J FISH DIS, V25, P423, DOI 10.1046/j.1365-2761.2002.00386.x; Werner EE, 2007, OIKOS, V116, P1713, DOI 10.1111/j.2007.0030-1299.16039.x; Whittington RJ, 2010, J FISH DIS, V33, P95, DOI 10.1111/j.1365-2761.2009.01110.x; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009	63	60	66	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92476	10.1371/journal.pone.0092476	http://dx.doi.org/10.1371/journal.pone.0092476			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667325	gold, Green Published			2022-12-27	WOS:000333675600043
J	Chen, WT; Wu, YL; Chen, T; Cheng, CS; Chan, HL; Chou, HC; Chen, YW; Yin, HS				Chen, Wen-Ting; Wu, Yi-Le; Chen, Ting; Cheng, Chao-Sheng; Chan, Hong-Lin; Chou, Hsiu-Chuan; Chen, Yi-Wen; Yin, Hsien-Sheng			Proteomics Analysis of the DF-1 Chicken Fibroblasts Infected with Avian Reovirus Strain S1133	PLOS ONE			English	Article							BURSAL DISEASE VIRUS; VIRAL ARTHRITIS-TENOSYNOVITIS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; APOPTOSIS INDUCTION; NONSTRUCTURAL PROTEIN; SIGNALING PATHWAYS; CULTURED-CELLS; HOST-CELLS; SIGMA-C; ACTIVATION	Background: Avian reovirus (ARV) is a member of the Orthoreovirus genus in the Reoviridae family. It is the etiological agent of several diseases, among which viral arthritis and malabsorption syndrome are the most commercially important, causing considerable economic losses in the poultry industry. Although a small but increasing number of reports have characterized some aspects of ARV infection, global changes in protein expression in ARV-infected host cells have not been examined. The current study used a proteomics approach to obtain a comprehensive view of changes in protein levels in host cells upon infection by ARV. Methodology and Principal Findings: The proteomics profiles of DF-1 chicken fibroblast cells infected with ARV strain S1133 were analyzed by two-dimensional differential-image gel electrophoresis. The majority of protein expression changes (>= 1.5 fold, p<0.05) occurred at 72 h post-infection. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry identified 51 proteins with differential expression levels, including 25 that were upregulated during ARV infection and 26 that were downregulated. These proteins were divided into eight groups according to biological function: signal transduction, stress response, RNA processing, the ubiquitin-proteasome pathway, lipid metabolism, carbohydrate metabolism, energy metabolism, and cytoskeleton organization. They were further examined by immunoblotting to validate the observed alterations in protein expression. Conclusion/Significance: This is the first report of a time-course proteomic analysis of ARV-infected host cells. Notably, all identified proteins involved in signal transduction, RNA processing, and the ubiquitin-proteasome pathway were downregulated in infected cells, whereas proteins involved in DNA synthesis, apoptosis, and energy production pathways were upregulated. In addition, other differentially expressed proteins were linked with the cytoskeleton, metabolism, redox regulation, and stress response. These proteomics data provide valuable information about host cell responses to ARV infection and will facilitate further studies of the molecular mechanisms underlying ARV pathogenesis.	[Chen, Wen-Ting; Wu, Yi-Le; Chen, Ting; Cheng, Chao-Sheng; Chan, Hong-Lin; Chen, Yi-Wen; Yin, Hsien-Sheng] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Chen, Wen-Ting; Wu, Yi-Le; Chen, Ting; Cheng, Chao-Sheng; Chan, Hong-Lin; Chen, Yi-Wen; Yin, Hsien-Sheng] Natl Tsing Hua Univ, Coll Life Sci, Hsinchu, Taiwan; [Chou, Hsiu-Chuan] Natl Hsinchu Univ Educ, Dept Appl Sci, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University	Yin, HS (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan.	hstin@mx.nthu.edu.tw	Chen, Ting/GOE-6981-2022	Chen, Ting/0000-0001-8055-3104	National Science Council, Taiwan (NSC) [NSC-101-2627-B-007-003-]	National Science Council, Taiwan (NSC)(Ministry of Science and Technology, Taiwan)	The authors acknowledge the support of the National Science Council, Taiwan (NSC grant number NSC-101-2627-B-007-003-). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baciu PC, 2000, J CELL SCI, V113, P315; Benavente J, 2006, CURR TOP MICROBIOL, V309, P67; Benavente J, 2007, VIRUS RES, V123, P105, DOI 10.1016/j.virusres.2006.09.005; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bodelon G, 2001, VIROLOGY, V290, P181, DOI 10.1006/viro.2001.1159; Bodelon G, 2002, J BIOL CHEM, V277, P17789, DOI 10.1074/jbc.M202018200; Calvo PG, 2005, J MOL BIOL, V354, P137, DOI 10.1016/j.jmb.2005.09.034; CASELLA JF, 1986, J BIOL CHEM, V261, P915; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Chang LY, 2006, J MED VIROL, V78, P1105, DOI 10.1002/jmv.20669; Chen YW, 2011, FUNCT INTEGR GENOMIC, V11, P225, DOI 10.1007/s10142-011-0210-y; Chen YI, 2008, J VIROL METHODS, V151, P95, DOI 10.1016/j.jviromet.2008.03.016; Chi PI, 2013, J BIOL CHEM, V288, P3571, DOI 10.1074/jbc.M112.390245; Chulu JLC, 2007, BIOCHEM BIOPH RES CO, V356, P529, DOI 10.1016/j.bbrc.2007.02.164; Chulu JLC, 2010, J VIROL, V84, P7683, DOI 10.1128/JVI.02604-09; De BP, 1996, J BIOL CHEM, V271, P24728, DOI 10.1074/jbc.271.40.24728; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fackler OT, 2006, CURR OPIN MICROBIOL, V9, P409, DOI 10.1016/j.mib.2006.06.010; Falke D, 1997, TRENDS MICROBIOL, V5, P306, DOI 10.1016/S0966-842X(97)82226-3; Gachet Y, 1999, J CELL SCI, V112, P1257; Gao G, 2006, CAN J PHYSIOL PHARM, V84, P5, DOI 10.1139/y05-144; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Grande A, 2000, VIROLOGY, V274, P367, DOI 10.1006/viro.2000.0473; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Himly M, 1998, VIROLOGY, V248, P295, DOI 10.1006/viro.1998.9290; Huang WR, 2011, J BIOL CHEM, V286, P30780, DOI 10.1074/jbc.M111.257154; Jamaluddin M, 2010, J VIROL, V84, P9533, DOI 10.1128/JVI.01005-10; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li F, 2001, J BIOL CHEM, V276, P47542, DOI 10.1074/jbc.M108954200; Li ZH, 2012, J VIROL, V86, P1328, DOI 10.1128/JVI.06104-11; Lin PY, 2011, ARCH VIROL, V156, P1917, DOI 10.1007/s00705-011-1063-3; Lin PY, 2010, VIROLOGY, V400, P104, DOI 10.1016/j.virol.2010.01.024; Lin PY, 2009, VIROLOGY, V385, P323, DOI 10.1016/j.virol.2008.12.028; Lin ST, 2013, MOL BIOSYST, V9, P447, DOI 10.1039/c2mb25367d; MORERO RD, 1985, BIOCHEMISTRY-US, V24, P1904, DOI 10.1021/bi00329a015; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; O'Hara D, 2001, J VIROL, V75, P5027, DOI 10.1128/JVI.75.11.5027-5035.2001; Ohman T, 2010, J PROTEOME RES, V9, P1549, DOI 10.1021/pr901040u; Parker JSL, 2002, J VIROL, V76, P4483, DOI 10.1128/JVI.76.9.4483-4496.2002; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; RAU WE, 1980, AVIAN DIS, V24, P648, DOI 10.2307/1589802; Ringrose J, 2008, J VIROL, V82, P4320, DOI 10.1128/JVI.01819-07; Salsman J, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000016; Santamaria E, 2009, MOL CELL PROTEOMICS, V8, P805, DOI 10.1074/mcp.M800202-MCP200; Schultz DE, 1996, J BIOL CHEM, V271, P14134, DOI 10.1074/jbc.271.24.14134; Shih WL, 2004, VIROLOGY, V321, P65, DOI 10.1016/j.virol.2003.12.004; Shmulevitz M, 2000, EMBO J, V19, P902, DOI 10.1093/emboj/19.5.902; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; SORGATO MC, 1993, CRIT REV BIOCHEM MOL, V28, P127; Sun JF, 2008, J PROTEOME RES, V7, P5263, DOI 10.1021/pr800546m; Sun Z, 2010, J CELL PHYSIOL, V223, P798, DOI 10.1002/jcp.22100; Thio CLP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061444; Tonge R, 2001, PROTEOMICS, V1, P377; VANDERHEIDE L, 1977, AVIAN PATHOL, V6, P271, DOI 10.1080/03079457708418237; Walsh B, 2009, REDOX REP, V14, P275, DOI 10.1179/135100009X12525712409652; Wang HC, 2007, DEV COMP IMMUNOL, V31, P672, DOI 10.1016/j.dci.2006.11.001; Wang T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002507; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; WU WY, 1994, J VIROL METHODS, V48, P119, DOI 10.1016/0166-0934(94)90094-9; Wu YP, 2012, PROTEOMICS, V12, P1844, DOI 10.1002/pmic.201100479; Wu YF, 2007, VET IMMUNOL IMMUNOP, V116, P37, DOI 10.1016/j.vetimm.2006.12.010; Yang SH, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-40; Zhang Z, 2008, EMBO J, V27, P852, DOI 10.1038/emboj.2008.25; Zhe JP, 2012, J PROTEOMICS, V75, P1732, DOI 10.1016/j.jprot.2011.12.012; Zheng XJ, 2008, MOL CELL PROTEOMICS, V7, P612, DOI 10.1074/mcp.M700396-MCP200; Zuk D, 1998, EMBO J, V17, P2914, DOI 10.1093/emboj/17.10.2914	67	24	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92154	10.1371/journal.pone.0092154	http://dx.doi.org/10.1371/journal.pone.0092154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667214	Green Submitted, Green Published, gold			2022-12-27	WOS:000333675600022
J	La Scaleia, B; Zago, M; Moscatelli, A; Lacquaniti, F; Viviani, P				La Scaleia, Barbara; Zago, Myrka; Moscatelli, Alessandro; Lacquaniti, Francesco; Viviani, Paolo			Implied Dynamics Biases the Visual Perception of Velocity	PLOS ONE			English	Article							TRAJECTORY FORMS; MOTION; SPEED; DISCRIMINATION; MODEL; LAW; INFORMATION; ACCELERATION; ORIENTATION; ADAPTATION	We expand the anecdotic report by Johansson that back-and-forth linear harmonic motions appear uniform. Six experiments explore the role of shape and spatial orientation of the trajectory of a point-light target in the perceptual judgment of uniform motion. In Experiment 1, the target oscillated back-and-forth along a circular arc around an invisible pivot. The imaginary segment from the pivot to the midpoint of the trajectory could be oriented vertically downward (consistent with an upright pendulum), horizontally leftward, or vertically upward (upside-down). In Experiments 2 to 5, the target moved uni-directionally. The effect of suppressing the alternation of movement directions was tested with curvilinear (Experiment 2 and 3) or rectilinear (Experiment 4 and 5) paths. Experiment 6 replicated the upright condition of Experiment 1, but participants were asked to hold the gaze on a fixation point. When some features of the trajectory evoked the motion of either a simple pendulum or a mass-spring system, observers identified as uniform the kinematic profiles close to harmonic motion. The bias towards harmonic motion was most consistent in the upright orientation of Experiment 1 and 6. The bias disappeared when the stimuli were incompatible with both pendulum and mass-spring models (Experiments 3 to 5). The results are compatible with the hypothesis that the perception of dynamic stimuli is biased by the laws of motion obeyed by natural events, so that only natural motions appear uniform.	[La Scaleia, Barbara; Zago, Myrka; Lacquaniti, Francesco] IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy; [Moscatelli, Alessandro] Univ Bielefeld, Dept Cognit Neurosci, D-33615 Bielefeld, Germany; [Lacquaniti, Francesco] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Lacquaniti, Francesco; Viviani, Paolo] Univ Roma Tor Vergata, Ctr Space Biomed, Rome, Italy	IRCCS Santa Lucia; University of Bielefeld; University of Rome Tor Vergata; University of Rome Tor Vergata	Lacquaniti, F (corresponding author), IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy.	lacquaniti@med.uniroma2.it	Zago, Myrka/B-3669-2012; La Scaleia, Barbara/AAB-2190-2019; Lacquaniti, Francesco/J-9842-2016; La Scaleia, Barbara/A-5981-2015; Moscatelli, Alessandro/L-1391-2018	Zago, Myrka/0000-0001-7100-7582; Lacquaniti, Francesco/0000-0003-0896-7315; La Scaleia, Barbara/0000-0003-2050-2641; Moscatelli, Alessandro/0000-0001-6269-4536	Italian Health Ministry; Italian University Ministry; Italian Space Agency	Italian Health Ministry(Ministry of Health, Italy); Italian University Ministry(Ministry of Education, Universities and Research (MIUR)); Italian Space Agency(Agenzia Spaziale Italiana (ASI))	The work was supported by the Italian Health Ministry, Italian University Ministry (PRIN project), and Italian Space Agency (CRUSOE, COREA and ARIANNA grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Barlow H B, 1959, P S MECH THOUGHT PRO, V2, P537; Bates D, 2011, IME4 LIN MIX EFF MOD; Bex PJ, 1999, J OPT SOC AM A, V16, P2817, DOI 10.1364/JOSAA.16.002817; Bingham G. P., 2008, UNDERSTANDING EVENTS, P255; BINGHAM GP, 1995, J EXP PSYCHOL HUMAN, V21, P1473, DOI 10.1037/0096-1523.21.6.1473; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Bozzi P., 1958, RIV PSICOLOGIA, V52, P281; Brouwer AM, 2002, EXP BRAIN RES, V143, P198, DOI 10.1007/s00221-001-0980-x; Burr D, 2011, VISION RES, V51, P1431, DOI 10.1016/j.visres.2011.02.008; CALDERONE JB, 1989, PERCEPT PSYCHOPHYS, V45, P391, DOI 10.3758/BF03210711; Casella G., 2002, STAT INFERENCE, V2nd; Cohen RL, 1964, PROBLEMS MOTOR PERCE; COLLEWIJN H, 1988, J PHYSIOL-LONDON, V404, P157, DOI 10.1113/jphysiol.1988.sp017284; CUTTING JE, 1982, COGNITION, V12, P25, DOI 10.1016/0010-0277(82)90028-2; DEBRUYN B, 1988, VISION RES, V28, P1323, DOI 10.1016/0042-6989(88)90064-8; deSperati C, 1997, J NEUROSCI, V17, P3932; Eagleman DM, 2001, NAT REV NEUROSCI, V2, P920, DOI 10.1038/35104092; Flash T, 2007, BIOL CYBERN, V96, P577, DOI 10.1007/s00422-007-0145-5; Freeman TCA, 2010, CURR BIOL, V20, P757, DOI 10.1016/j.cub.2010.02.059; Frick A, 2005, SWISS J PSYCHOL, V64, P103, DOI 10.1024/1421-0185.64.2.103; Gibson J.J., 1966, SENSES CONSIDERED PE; GOLDSTEIN J, 1963, J PSYCHOL, V55, P3, DOI 10.1080/00223980.1963.9916594; GOTTSDANKER RM, 1956, PSYCHOL BULL, V53, P477, DOI 10.1037/h0045160; Hammett ST, 2005, P ROY SOC B-BIOL SCI, V272, P2351, DOI 10.1098/rspb.2005.3239; JOHANSSON G, 1975, SCI AM, V232, P76, DOI 10.1038/scientificamerican0675-76; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; JOHANSSON G, 1980, ANNU REV PSYCHOL, V31, P27, DOI 10.1146/annurev.ps.31.020180.000331; Johansson G, 1950, CONFIGURATIONS EVENT, P25; Klemm O, 1907, PSYCHOL STUD, V2, P324; LACQUANITI F, 1983, ACTA PSYCHOL, V54, P115, DOI 10.1016/0001-6918(83)90027-6; Levit-Binnun N, 2006, EXP BRAIN RES, V172, P533, DOI 10.1007/s00221-006-0355-4; Maoz U, 2014, J NEUROPHYSIOL, V111, P336, DOI 10.1152/jn.01071.2012; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; MCKEE SP, 1984, VISION RES, V24, P25, DOI 10.1016/0042-6989(84)90140-8; MCKEE SP, 1986, VISION RES, V26, P609, DOI 10.1016/0042-6989(86)90009-X; Miller WL, 2008, J NEUROPHYSIOL, V99, P1969, DOI 10.1152/jn.00889.2007; Moscatelli A, 2012, J VISION, V12, DOI 10.1167/12.11.26; Moscatelli A, 2011, J VISION, V11, DOI 10.1167/11.4.5; Muchisky MM, 2002, PERCEPT PSYCHOPHYS, V64, P15, DOI 10.3758/BF03194554; ORBAN GA, 1985, J OPT SOC AM A, V2, P1836, DOI 10.1364/JOSAA.2.001836; PIAGET J, 1958, AM J PSYCHOL, V71, P277, DOI 10.2307/1419216; Pittenger J.B., 1990, ECOL PSYCHOL, V2, P55, DOI [10.1207/s15326969eco0201_3, DOI 10.1207/S15326969ECO0201_3, DOI 10.1207/S15326969EC00201_]; PITTENGER JB, 1985, PERCEPTION, V14, P247, DOI 10.1068/p140247; Pollick FE, 1997, VISION RES, V37, P347, DOI 10.1016/S0042-6989(96)00116-2; Radvansky GA, 2011, WIRES COGN SCI, V2, P608, DOI 10.1002/wcs.133; Regan D, 1986, HDB PERCEPTION HUMAN, V1, P19; RUNESON S, 1974, PSYCHOL RES-PSYCH FO, V37, P3, DOI 10.1007/BF00309076; SHEPARD RN, 1984, PSYCHOL REV, V91, P417, DOI 10.1037/0033-295X.91.4.417; Shipley TF, 2003, PSYCHOL SCI, V14, P377, DOI 10.1111/1467-9280.24471; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; SMITH AT, 1994, VISION RES, V34, P253, DOI 10.1016/0042-6989(94)90337-9; Souto D, 2013, J VISION, V13, DOI 10.1167/13.2.9; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; THOMPSON P, 1981, VISION RES, V21, P337, DOI 10.1016/0042-6989(81)90161-9; Traschutz A, 2012, VISION RES, V72, P1, DOI 10.1016/j.visres.2012.08.019; VIVIANI P, 1992, J EXP PSYCHOL HUMAN, V18, P603, DOI 10.1037/0096-1523.18.3.603; Viviani P, 2002, ATTENTION PERFORM, V19, P406; WERKHOVEN P, 1992, VISION RES, V32, P2313, DOI 10.1016/0042-6989(92)90095-Z; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wickelgren EA, 2008, PERCEPT PSYCHOPHYS, V70, P266, DOI 10.3758/PP.70.2.266; Zago M, 2004, J NEUROPHYSIOL, V91, P1620, DOI 10.1152/jn.00862.2003; Zago M, 2011, J VISION, V11, DOI 10.1167/11.10.13	63	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93020	10.1371/journal.pone.0093020	http://dx.doi.org/10.1371/journal.pone.0093020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SD	24667578	gold, Green Submitted, Green Published			2022-12-27	WOS:000333675600128
J	Liu, B; Zhang, YH; Zhang, W				Liu, Bo; Zhang, Yuhong; Zhang, Wei			RNA-Seq-Based Analysis of Cold Shock Response in Thermoanaerobacter tengcongensis, a Bacterium Harboring a Single Cold Shock Protein Encoding Gene	PLOS ONE			English	Article							BACILLUS-SUBTILIS; LOW-TEMPERATURE; ESCHERICHIA-COLI; THERMOPHILIC BACTERIUM; FATTY-ACID; DNA UPTAKE; ADAPTATION; GROWTH; STRESS; IDENTIFICATION	Background: Although cold shock responses and the roles of cold shock proteins in microorganisms containing multiple cold shock protein genes have been well characterized, related studies on bacteria possessing a single cold shock protein gene have not been reported. Thermoanaerobacter tengcongensis MB4, a thermophile harboring only one known cold shock protein gene (TtescpC), can survive from 50 degrees to 80 degrees C, but has poor natural competence under cold shock at 50 degrees C. We therefore examined cold shock responses and their effect on natural competence in this bacterium. Results: The transcriptomes of T. tengcongensis before and after cold shock were analyzed by RNA-seq and over 1200 differentially expressed genes were successfully identified. These genes were involved in a wide range of biological processes, including modulation of DNA replication, recombination, and repair; energy metabolism; production of cold shock protein; synthesis of branched amino acids and branched-chain fatty acids; and sporulation. RNA-seq analysis also suggested that T. tengcongensis initiates cell wall and membrane remodeling processes, flagellar assembly, and sporulation in response to low temperature. Expression profiles of TtecspC and failed attempts to produce a TtecspC knockout strain confirmed the essential role of TteCspC in the cold shock response, and also suggested a role of this protein in survival at optimum growth temperature. Repression of genes encoding ComEA and ComEC and low energy metabolism levels in cold-shocked cells are the likely basis of poor natural competence at low temperature. Conclusion: Our study demonstrated changes in global gene expression under cold shock and identified several candidate genes related to cold shock in T. tengcongensis. At the same time, the relationship between cold shock response and poor natural competence at low temperature was preliminarily elucidated. These findings provide a foundation for future studies on genetic and molecular mechanisms associated with cold shock and acclimation at low temperature.	[Liu, Bo; Zhang, Yuhong; Zhang, Wei] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Zhang, W (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China.	zhangwei02@caas.cn			National Science Foundation for Young Scientists of China [31200072]	National Science Foundation for Young Scientists of China	This work was supported by the National Science Foundation for Young Scientists of China (Grant no. 31200072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Annous BA, 1997, APPL ENVIRON MICROB, V63, P3887, DOI 10.1128/AEM.63.10.3887-3894.1997; Atlung T, 1999, J BACTERIOL, V181, P5557, DOI 10.1128/JB.181.18.5557-5562.1999; Bae WH, 2000, P NATL ACAD SCI USA, V97, P7784, DOI 10.1073/pnas.97.14.7784; Balhesteros H, 2010, ARCH MICROBIOL, V192, P747, DOI 10.1007/s00203-010-0602-8; Bao QY, 2002, GENOME RES, V12, P689, DOI 10.1101/gr.219302; Breaker RR, 2010, MOL CELL, V37, P1, DOI 10.1016/j.molcel.2009.12.032; Bresolin G, 2006, J BACTERIOL, V188, P2945, DOI 10.1128/JB.188.8.2945-2958.2006; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Budde I, 2006, MICROBIOL-SGM, V152, P831, DOI 10.1099/mic.0.28530-0; Carty SM, 1999, J BIOL CHEM, V274, P9677, DOI 10.1074/jbc.274.14.9677; Chanda PK, 2010, J BASIC MICROB, V50, P519, DOI 10.1002/jobm.200900264; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Chen Z, 2013, MOL CELL PROTEOMICS, V12, P2266, DOI 10.1074/mcp.M112.025817; Claverys JP, 2009, FEMS MICROBIOL REV, V33, P643, DOI 10.1111/j.1574-6976.2009.00164.x; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; GOLDSTEIN J, 1990, P NATL ACAD SCI USA, V87, P283, DOI 10.1073/pnas.87.1.283; GRAU R, 1993, MOL MICROBIOL, V8, P535, DOI 10.1111/j.1365-2958.1993.tb01598.x; Graumann P, 1996, J BACTERIOL, V178, P4611, DOI 10.1128/jb.178.15.4611-4619.1996; Graumann Peter L., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P203; Horn G, 2007, CELL MOL LIFE SCI, V64, P1457, DOI 10.1007/s00018-007-6388-4; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; JONES PG, 1987, J BACTERIOL, V169, P2092, DOI 10.1128/jb.169.5.2092-2095.1987; Jung YH, 2010, PROTEIN J, V29, P136, DOI 10.1007/s10930-010-9233-9; Kaan T, 2002, MICROBIOL-SGM, V148, P3441, DOI 10.1099/00221287-148-11-3441; Kamp HD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002153; Klein HL, 2002, MOL CELL, V9, P471, DOI 10.1016/S1097-2765(02)00493-8; Klein W, 1999, J BACTERIOL, V181, P5341, DOI 10.1128/JB.181.17.5341-5349.1999; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laxman S, 2013, CELL, V154, P416, DOI 10.1016/j.cell.2013.06.043; Liu B, 2012, J GENET GENOMICS, V39, P561, DOI 10.1016/j.jgg.2012.07.003; Arvizu-Gomez JL, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-81; Lopez-Garcia P, 2000, BIOESSAYS, V22, P738; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Matityahu I, 2006, AMINO ACIDS, V30, P185, DOI 10.1007/s00726-005-0250-5; Mega R, 2010, BIOCHEM BIOPH RES CO, V399, P336, DOI 10.1016/j.bbrc.2010.07.065; Movahedi S, 2002, J BACTERIOL, V184, P5275, DOI 10.1128/JB.184.19.5275-5281.2002; Phadtare S, 2003, GENES CELLS, V8, P801, DOI 10.1046/j.1365-2443.2003.00675.x; Phadtare S, 2010, RNA BIOL, V7, P788, DOI 10.4161/rna.7.6.13482; Phadtare S, 2009, J MOL MICROB BIOTECH, V17, P110, DOI 10.1159/000226587; Pierce A, 2011, ARCH MICROBIOL, V193, P373, DOI 10.1007/s00203-011-0682-0; Piette F, 2012, EXTREMOPHILES, V16, P681, DOI 10.1007/s00792-012-0456-x; Schaerer K, 2013, FOODBORNE PATHOG DIS, V10, P1023, DOI 10.1089/fpd.2013.1562; Shaw AJ, 2010, APPL ENVIRON MICROB, V76, P4713, DOI 10.1128/AEM.00402-10; SHI WY, 1993, J BACTERIOL, V175, P2236, DOI 10.1128/JB.175.8.2236-2240.1993; Spaniol V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068298; STRAUCH MA, 1989, EMBO J, V8, P1615, DOI 10.1002/j.1460-2075.1989.tb03546.x; Stubs D, 2005, MICROBIOL-SGM, V151, P1895, DOI 10.1099/mic.0.27785-0; Tanaka T, 2012, FEBS J, V279, P1014, DOI 10.1111/j.1742-4658.2012.08492.x; Tribble GD, 2012, MBIO, V3, DOI 10.1128/mBio.00231-11; VANBOGELEN RA, 1990, P NATL ACAD SCI USA, V87, P5589, DOI 10.1073/pnas.87.15.5589; Wang JQ, 2007, PROTEOMICS, V7, P1409, DOI 10.1002/pmic.200500226; Wang JQ, 2004, PROTEOMICS, V4, P136, DOI 10.1002/pmic.200300504; Weber Michael H. W., 2003, Science Progress, V86, P9, DOI 10.3184/003685003783238707; Wiegeshoff F, 2006, J BACTERIOL, V188, P3130, DOI 10.1128/JB.188.8.3130-3133.2006; Xue YF, 2001, INT J SYST EVOL MICR, V51, P1335, DOI 10.1099/00207713-51-4-1335; Yousefi-Nejad M, 2011, J PROTEOMICS, V74, P2100, DOI 10.1016/j.jprot.2011.05.037; Zhong WH, 2011, BEHAV ECOL SOCIOBIOL, V65, P493, DOI 10.1007/s00265-010-1117-7	58	17	19	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93289	10.1371/journal.pone.0093289	http://dx.doi.org/10.1371/journal.pone.0093289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667527	gold, Green Published, Green Submitted			2022-12-27	WOS:000333675600164
J	Trias, M; Arbona, A; Masso, J; Minano, B; Bona, C				Trias, Miquel; Arbona, Antonio; Masso, Joan; Minano, Borja; Bona, Carles			FDA's Nozzle Numerical Simulation Challenge: Non-Newtonian Fluid Effects and Blood Damage	PLOS ONE			English	Article							CAROTID BIFURCATION MODEL; BOUNDARY-CONDITIONS; FLOW; HEMODYNAMICS; PREDICTION; DYNAMICS; ARTERIES; MRI	Data from FDA's nozzle challenge-a study to assess the suitability of simulating fluid flow in an idealized medical device-is used to validate the simulations obtained from a numerical, finite-differences code. Various physiological indicators are computed and compared with experimental data from three different laboratories, getting a very good agreement. Special care is taken with the derivation of blood damage (hemolysis). The paper is focused on the laminar regime, in order to investigate non-Newtonian effects (non-constant fluid viscosity). The code can deal with these effects with just a small extra computational cost, improving Newtonian estimations up to a ten percent. The relevance of non-Newtonian effects for hemolysis parameters is discussed.	[Trias, Miquel; Arbona, Antonio; Masso, Joan; Minano, Borja; Bona, Carles] Univ Balearic Isl, IAC3, Palma De Mallorca, Spain	Universitat de les Illes Balears	Arbona, A (corresponding author), Univ Balearic Isl, IAC3, Palma De Mallorca, Spain.	aarbona@iac3.eu	Bona, Carles/Q-5133-2019; Marti Masso, Jose Felix/D-8619-2013	Bona, Carles/0000-0003-3139-4260; Marti Masso, Jose Felix/0000-0001-8428-4386; Masso, Joan/0000-0001-5816-4874	European Commission [TSI-020400-2010-84]; Ministerio de Educacion y Ciencia [CSD2007-00042, PI12/02565]; Balearic Islands government [53/2011]	European Commission(European CommissionEuropean Commission Joint Research Centre); Ministerio de Educacion y Ciencia(Spanish Government); Balearic Islands government	This research has been partially funded by the European Commission (TSI-020400-2010-84), the Ministerio de Educacion y Ciencia (CSD2007-00042, PI12/02565), and the Balearic Islands government (53/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Feby, 2005, Computer Methods in Biomechanics and Biomedical Engineering, V8, P127, DOI 10.1080/10255840500180799; Arbona A, 2013, COMPUT PHYS COMMUN, V184, P2321, DOI 10.1016/j.cpc.2013.04.012; Arora D, 2004, ARTIF ORGANS, V28, P1002, DOI 10.1111/j.1525-1594.2004.00072.x; Bona C, 2009, J COMPUT PHYS, V228, P2266, DOI 10.1016/j.jcp.2008.12.010; Boyd J, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2772250; Cebral JR, 2005, IEEE T MED IMAGING, V24, P457, DOI 10.1109/TMI.2005.844159; Cole RH, 1948, UNDERWATER EXPLOSION, V41; Faber T. E., 1995, FLUID DYNAMICS PHYS; Ferziger J.H., 2002, COMPUTATIONAL METHOD; Garon A, 2004, ARTIF ORGANS, V28, P1016, DOI 10.1111/j.1525-1594.2004.00026.x; Giersiepen M, 1990, INT J ARTIFICIAL ORG; Gijsen FJH, 1999, J BIOMECH, V32, P601, DOI 10.1016/S0021-9290(99)00015-9; Grigioni M, 2005, BIOMECH MODEL MECHAN, V4, P249, DOI 10.1007/s10237-005-0005-y; Heys Jeffrey J, 2010, Open Biomed Eng J, V4, P123, DOI 10.2174/1874120701004010123; HIRT CW, 1981, J COMPUT PHYS, V39, P201, DOI 10.1016/0021-9991(81)90145-5; ISSA RI, 1986, J COMPUT PHYS, V62, P40, DOI 10.1016/0021-9991(86)90099-9; Johnston BM, 2004, J BIOMECH, V37, P709, DOI 10.1016/j.jbiomech.2003.09.016; Lee S, 2007, J BIOMECHANICAL ENG, P1; LIMA CO, 1983, CIRCULATION, V67, P866, DOI 10.1161/01.CIR.67.4.866; Miller GH, 2002, J COMPUT PHYS, V183, P26, DOI 10.1006/jcph.2002.7158; Monaghan JJ, 2005, REP PROG PHYS, V68, P1703, DOI 10.1088/0034-4885/68/8/R01; Nixon AM, 2010, J NEUROSURG, V112, P1240, DOI 10.3171/2009.10.JNS09759; PATANKAR SV, 1972, INT J HEAT MASS TRAN, V15, P1787, DOI 10.1016/0017-9310(72)90054-3; PERKTOLD K, 1991, J BIOMECH ENG-T ASME, V113, P464, DOI 10.1115/1.2895428; POINSOT TJ, 1992, J COMPUT PHYS, V101, P104, DOI 10.1016/0021-9991(92)90046-2; Razavi A, 2011, J BIOMECH, V44, P2021, DOI 10.1016/j.jbiomech.2011.04.023; SECOMB TW, 1987, MICROVASC RES, V34, P46, DOI 10.1016/0026-2862(87)90078-1; Segalova PA, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005850; SHU CW, 1988, J COMPUT PHYS, V77, P439, DOI 10.1016/0021-9991(88)90177-5; Stalder AF, 2008, MAGN RESON MED, V60, P1218, DOI 10.1002/mrm.21778; Steinman DA, 2002, MAGN RESON MED, V47, P149, DOI 10.1002/mrm.10025; Stewart S., 2012, CARDIOVASCULAR ENG T, V3, P139, DOI [DOI 10.1007/S13239-012-0087-5, 10.1007/s13239-012-0087-5]; SUSSMAN M, 1994, J COMPUT PHYS, V114, P146, DOI 10.1006/jcph.1994.1155; Tritton D. J., 1988, PHYS FLUID DYNAMICS; Wissink AM, 2001, P 2001 ACM IEEE C SU, P6; Yoo CS, 2005, COMBUST THEOR MODEL, V9, P617, DOI 10.1080/13647830500307378	36	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92638	10.1371/journal.pone.0092638	http://dx.doi.org/10.1371/journal.pone.0092638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667931	Green Submitted, Green Published, gold			2022-12-27	WOS:000333675600058
J	Dao, TT; Liebenthal, D; Tran, TK; Vu, BNT; Nguyen, DNT; Tran, HKT; Nguyen, CKT; Vu, HLT; Fox, A; Horby, P; Nguyen, KV; Wertheim, HFL				Trinh Tuyet Dao; Liebenthal, Dror; Toan Khanh Tran; Bich Ngoc Thi Vu; Diep Ngoc Thi Nguyen; Huong Kieu Thi Tran; Chuc Kim Thi Nguyen; Huong Lan Thi Vu; Fox, Annette; Horby, Peter; Kinh Van Nguyen; Wertheim, Heiman F. L.			Klebsiella pneumoniae Oropharyngeal Carriage in Rural and Urban Vietnam and the Effect of Alcohol Consumption	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; GRAM-NEGATIVE BACILLI; INTENSIVE-CARE UNITS; STREPTOCOCCUS-PNEUMONIAE; NEUTROPHIL RECRUITMENT; DRUG-USE; COLONIZATION; ETHANOL; HOST; PREVALENCE	Introduction: Community acquired K. pneumoniae pneumonia is still common in Asia and is reportedly associated with alcohol use. Oropharyngeal carriage of K. pneumoniae could potentially play a role in the pathogenesis of K. pneumoniae pneumonia. However, little is known regarding K. pneumoniae oropharyngeal carriage rates and risk factors. This population-based cross-sectional study explores the association of a variety of demographic and socioeconomic factors, as well as alcohol consumption with oropharyngeal carriage of K. pneumoniae in Vietnam. Methods and Findings: 1029 subjects were selected randomly from age, sex, and urban and rural strata. An additional 613 adult men from a rural environment were recruited and analyzed separately to determine the effects of alcohol consumption. Demographic, socioeconomic, and oropharyngeal carriage data was acquired for each subject. The overall carriage rate of K. pneumoniae was 14.1% (145/1029, 95% CI 12.0%-16.2%). By stepwise logistic regression, K. pneumoniae carriage was found to be independently associated with age (OR 1.03, 95% CI 1.02-1.04), smoking (OR 1.9, 95% CI 1.3-2.9), rural living location (OR 1.6, 95% CI 1.1-2.4), and level of weekly alcohol consumption (OR 1.7, 95% CI 1.04-2.8). Conclusion: Moderate to heavy weekly alcohol consumption, old age, smoking, and living in a rural location are all found to be associated with an increased risk of K. pneumoniae carriage in Vietnamese communities. Whether K. pneumoniae carriage is a risk factor for pneumonia needs to be elucidated.	[Liebenthal, Dror; Bich Ngoc Thi Vu; Diep Ngoc Thi Nguyen; Huong Kieu Thi Tran; Huong Lan Thi Vu; Fox, Annette; Horby, Peter; Wertheim, Heiman F. L.] Univ Oxford, Clin Res Unit, Hanoi, Vietnam; [Fox, Annette; Horby, Peter; Wertheim, Heiman F. L.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Trinh Tuyet Dao; Kinh Van Nguyen] Natl Hosp Trop Dis, Hanoi, Vietnam; [Toan Khanh Tran; Chuc Kim Thi Nguyen] Hanoi Med Univ, Hanoi, Vietnam	University of Oxford; University of Oxford; National Hospital of Tropical Diseases; Hanoi Medical University	Wertheim, HFL (corresponding author), Univ Oxford, Clin Res Unit, Hanoi, Vietnam.	Heiman.wertheim@gmail.com	Tran, Toan K/O-7671-2017; Wertheim, Heiman FL/F-3338-2016	Tran, Toan K/0000-0002-5902-749X; Wertheim, Heiman FL/0000-0002-5003-5565; Horby, Peter/0000-0002-9822-1586; Fox, Annette/0000-0002-0565-7146	Wellcome Trust Major Overseas Program, Vietnam	Wellcome Trust Major Overseas Program, Vietnam	Funding was provided by Wellcome Trust Major Overseas Program, Vietnam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, R LANG ENV STAT COMP; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Farida H, 2013, J CLIN MICROBIOL, V51, P1614, DOI 10.1128/JCM.00589-13; Greenberg SS, 1999, ALCOHOL CLIN EXP RES, V23, P1435, DOI 10.1111/j.1530-0277.1999.tb04664.x; Hoa NQ, 2007, HEALTH POLICY, V82, P320, DOI 10.1016/j.healthpol.2006.10.005; Hoan LT, 2009, PHARMACOEPIDEM DR S, V18, P448, DOI 10.1002/pds.1730; JONG GM, 1995, CHEST, V107, P214, DOI 10.1378/chest.107.1.214; Giang KB, 2013, GLOBAL HEALTH ACTION, V6, P51, DOI 10.3402/gha.v6i0.18937; Kim JK, 2009, EUR J CLIN MICROBIOL, V28, P109, DOI 10.1007/s10096-008-0595-2; Van Nguyen K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1158; Ko WC, 2002, EMERG INFECT DIS, V8, P160, DOI 10.3201/eid0802.010025; Lau HY, 2008, MICROBES INFECT, V10, P1283, DOI 10.1016/j.micinf.2008.07.040; Lima ABM, 2010, BRAZ J MICROBIOL, V41, P24, DOI 10.1590/S1517-83822010000100005; Marra AR, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-24; Nakamura MM, 2010, J CLIN MICROBIOL, V48, P2957, DOI 10.1128/JCM.00547-10; Parm U, 2011, EARLY HUM DEV, V87, P391, DOI 10.1016/j.earlhumdev.2011.02.007; Quinton LJ, 2005, ALCOHOL CLIN EXP RES, V29, P1198, DOI 10.1097/01.ALC.0000171927.66130.AA; Shellito JE, 2001, ALCOHOL CLIN EXP RES, V25, P872, DOI 10.1097/00000374-200106000-00013; Tran TK, 2012, SCAND J PUBLIC HEALT, V40, P765, DOI 10.1177/1403494812464444; Wang S, 2009, CHINESE MED J-PEKING, V122, P315, DOI 10.3760/cma.j.issn.0366-6999.2009.03.015; Yu VL, 2007, EMERG INFECT DIS, V13, P986, DOI 10.3201/eid1307.070187; Zisman DA, 1998, ALCOHOL CLIN EXP RES, V22, P621, DOI 10.1111/j.1530-0277.1998.tb04303.x	23	38	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e91999	10.1371/journal.pone.0091999	http://dx.doi.org/10.1371/journal.pone.0091999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667800	Green Published, gold			2022-12-27	WOS:000333675600017
J	Williams, PS; Hoffman, RL; Clark, BC				Williams, Petra S.; Hoffman, Richard L.; Clark, Brian C.			Cortical and Spinal Mechanisms of Task Failure of Sustained Submaximal Fatiguing Contractions	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; INTERVAL INTRACORTICAL INHIBITION; ELBOW FLEXOR MUSCLES; LOAD TYPE; MOTOR CORTEX; CORTICOCORTICAL INHIBITION; CORTICOMOTOR EXCITABILITY; VISUAL INFORMATION; ENDURANCE TIME; BICEPS-BRACHII	In this and the subsequent companion paper, results are presented that collectively seek to delineate the contribution that supraspinal circuits have in determining the time to task failure (TTF) of sustained submaximal contractions. The purpose of this study was to compare adjustments in supraspinal and spinal excitability taken concurrently throughout the performance of two different fatigue tasks with identical mechanical demands but different TTF (i.e., force-matching and position-matching tasks). On separate visits, ten healthy volunteers performed the force-matching or position-matching task at 15% of maximum strength with the elbow flexors to task failure. Single-pulse transcranial magnetic stimulation (TMS), paired-pulse TMS, paired cortico-cervicomedullary stimulation, and brachial plexus electrical stimulation were delivered in a 6-stimuli sequence at baseline and every 2-3 minutes throughout fatigue-task performance. Contrary to expectations, the force-matching task TTF was 42% shorter (17.567.9 min) than the position-matching task (26.9615.11 min; p < 0.01); however, both tasks caused the same amount of muscle fatigue (p = 0.59). There were no task-specific differences for the total amount or rate of change in the neurophysiologic outcome variables over time (p > 0.05). Therefore, failure occurred after a similar mean decline in motorneuron excitability developed (p < 0.02, ES = 0.35-0.52) coupled with a similar mean increase in measures of corticospinal excitability (p < 0.03, ES = 0.30-0.41). Additionally, the amount of intracortical inhibition decreased (p < 0.03, ES = 0.32) and the amount of intracortical facilitation (p > 0.10) and an index of upstream excitation of the motor cortex remained constant (p > 0.40). Together, these results suggest that as fatigue develops prior to task failure, the increase in corticospinal excitability observed in relationship to the decrease in spinal excitability results from a combination of decreasing intracortical inhibition with constant levels of intracortical facilitation and upstream excitability that together eventually fail to provide the input to the motor cortex necessary for descending drive to overcome the spinal cord resistance, thereby contributing to task failure.	[Williams, Petra S.; Hoffman, Richard L.; Clark, Brian C.] Ohio Univ, OMNI, Athens, OH 45701 USA; [Williams, Petra S.] No Arizona Univ, Dept Phys Therapy & Athlet Training, Flagstaff, AZ 86011 USA; [Clark, Brian C.] Ohio Univ, Dept Biomed Sci, Athens, OH 45701 USA; [Clark, Brian C.] Ohio Univ, Dept Geriatr Med & Gerontol, Athens, OH 45701 USA	University System of Ohio; Ohio University; Northern Arizona University; University System of Ohio; Ohio University; University System of Ohio; Ohio University	Williams, PS (corresponding author), Ohio Univ, OMNI, Athens, OH 45701 USA.	petra.williams@nau.edu			National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development [R15HD065552]; Research and Scholarly Affairs Committee at the Ohio University Heritage College of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD065552] Funding Source: NIH RePORTER	National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Research and Scholarly Affairs Committee at the Ohio University Heritage College of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by grant R15HD065552 from the National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development to B. C. Clark. Additionally, internal support for this work was provided by a grant from the Research and Scholarly Affairs Committee at the Ohio University Heritage College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam A, 2003, J NEUROPHYSIOL, V90, P2919, DOI 10.1152/jn.00179.2003; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Barry BK, 2007, INTEGR COMP BIOL, V47, P465, DOI 10.1093/icb/icm047; Baudry S, 2011, J NEUROPHYSIOL, V106, P265, DOI 10.1152/jn.00954.2010; Baudry S, 2009, J NEUROPHYSIOL, V102, P1725, DOI 10.1152/jn.00382.2009; Benwell NM, 2006, EXP BRAIN RES, V170, P191, DOI 10.1007/s00221-005-0195-7; Bigland-Ritchie B, 1981, Exerc Sport Sci Rev, V9, P75; Bigland-Ritchie B, 1981, Ciba Found Symp, V82, P130; BIGLANDRITCHIE B, 1984, MUSCLE NERVE, V7, P691, DOI 10.1002/mus.880070902; BIGLANDRITCHIE B, 1986, ACTA PHYSIOL SCAND, V128, P137; Bojsen-Moller J, 2011, SCAND J MED SCI SPOR, V21, pE48, DOI 10.1111/j.1600-0838.2010.01148.x; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Chen R, 2004, EXP BRAIN RES, V154, P1, DOI 10.1007/s00221-003-1684-1; Chen R, 1999, EXP BRAIN RES, V128, P539, DOI 10.1007/s002210050878; Damron LA, 2008, J NEUROSCI METH, V173, P121, DOI 10.1016/j.jneumeth.2008.06.001; Dearth DJ, 2010, EUR J APPL PHYSIOL, V108, P1089, DOI 10.1007/s00421-009-1323-z; Di Lazzaro V, 2006, J NEUROPHYSIOL, V96, P1765, DOI 10.1152/jn.00360.2006; Di Lazzaro V, 1998, ELECTROMYOGR MOTOR C, V109, P397, DOI 10.1016/S0924-980X(98)00038-1; Duchateau J, 2002, J PHYSIOL-LONDON, V541, P959, DOI 10.1113/jphysiol.2002.016790; ENOKA RM, 1992, J APPL PHYSIOL, V72, P1631, DOI 10.1152/jappl.1992.72.5.1631; Enoka RM, 2008, J PHYSIOL-LONDON, V586, P11, DOI 10.1113/jphysiol.2007.139477; Enoka RM, 2012, J BIOMECH, V45, P427, DOI 10.1016/j.jbiomech.2011.11.047; Enoka RM, 2011, J ELECTROMYOGR KINES, V21, P208, DOI 10.1016/j.jelekin.2010.10.006; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gandevia SC, 2008, EXP PHYSIOL, V93, P1030, DOI 10.1113/expphysiol.2007.039032; Goss DA, 2012, J VISUALIZED EXPT JO, V20; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Harrison DD, 1999, J MANIP PHYSIOL THER, V22, P594, DOI 10.1016/S0161-4754(99)70020-5; Hong SL, 2008, PERCEPT PSYCHOPHYS, V70, P306, DOI 10.3758/PP.70.2.306; Hong SL, 2008, EXP BRAIN RES, V189, P61, DOI 10.1007/s00221-008-1403-z; Hunter SK, 2008, J APPL PHYSIOL, V105, P463, DOI 10.1152/japplphysiol.90398.2008; Hunter SK, 2003, J APPL PHYSIOL, V94, P108, DOI 10.1152/japplphysiol.00635.2002; Hunter SK, 2004, J APPL PHYSIOL, V96, P195, DOI 10.1152/japplphysiol.00893.2003; Hunter SK, 2003, J APPL PHYSIOL, V94, P2439, DOI 10.1152/japplphysiol.01038.2002; Hunter SK, 2002, J NEUROPHYSIOL, V88, P3087, DOI 10.1152/jn.00232.2002; Hunter SK, 2001, J APPL PHYSIOL, V91, P2686, DOI 10.1152/jappl.2001.91.6.2686; Keenan KG, 2006, J APPL PHYSIOL, V100, P1928, DOI 10.1152/japplphysiol.01282.2005; Klass M, 2008, J NEUROPHYSIOL, V99, P1096, DOI 10.1152/jn.01252.2007; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lauber B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032433; Le Bozec S, 2004, NEUROSCI LETT, V356, P61, DOI 10.1016/j.neulet.2003.09.052; Levenez M, 2008, J NEUROPHYSIOL, V99, P554, DOI 10.1152/jn.00963.2007; Maluf KS, 2005, EXP BRAIN RES, V167, P165, DOI 10.1007/s00221-005-0017-y; Maluf KS, 2005, J APPL PHYSIOL, V99, P389, DOI 10.1152/japplphysiol.00207.2005; Martin PG, 2008, J PHYSIOL-LONDON, V586, P1277, DOI 10.1113/jphysiol.2007.140426; Martin PG, 2009, J NEUROPHYSIOL, V102, P606, DOI 10.1152/jn.91348.2008; Maruyama A, 2006, CLIN NEUROPHYSIOL, V117, P864, DOI 10.1016/j.clinph.2005.12.019; McNeil CJ, 2011, J PHYSIOL-LONDON, V589, P3731, DOI 10.1113/jphysiol.2011.210252; McNeil CJ, 2011, J PHYSIOL-LONDON, V589, P3533, DOI 10.1113/jphysiol.2011.207191; McNeil CJ, 2009, J PHYSIOL-LONDON, V587, P5601, DOI 10.1113/jphysiol.2009.180968; McNeil CJ., 2011, PHYSL NEWS, V82, P29; Mottram CJ, 2006, EXP BRAIN RES, V174, P575, DOI 10.1007/s00221-006-0498-3; Mottram CJ, 2005, J NEUROPHYSIOL, V94, P2878, DOI 10.1152/jn.00390.2005; Mottram CJ, 2005, J NEUROPHYSIOL, V93, P1381, DOI 10.1152/jn.00837.2004; Nakamura H, 1997, J PHYSIOL-LONDON, V498, P817, DOI 10.1113/jphysiol.1997.sp021905; Nordstrom MA, 2007, MUSCLE NERVE, V35, P135, DOI 10.1002/mus.20712; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ortu E, 2008, J PHYSIOL-LONDON, V586, P5147, DOI 10.1113/jphysiol.2008.158956; Petersen NC, 2010, ACTA PHYSIOL, V198, P403, DOI 10.1111/j.1748-1716.2009.02066.x; Place N, 2009, CLIN EXP PHARMACOL P, V36, P334, DOI 10.1111/j.1440-1681.2008.05021.x; Poortvliet PC, 2013, CLIN NEUROPHYSIOL, V124, P732, DOI 10.1016/j.clinph.2012.09.025; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Reis J, 2008, BRAIN STIMUL, V1, P363, DOI 10.1016/j.brs.2008.08.001; RIDDING MC, 1995, J PHYSIOL-LONDON, V487, P541, DOI 10.1113/jphysiol.1995.sp020898; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rothwell JC, 2012, CLIN NEUROL NEUROSUR, V114, P432, DOI 10.1016/j.clineuro.2011.12.053; Rothwell JC, 2009, J PHYSIOL-LONDON, V587, P5517, DOI 10.1113/jphysiol.2009.183475; Rothwell JC, 2009, J PHYSIOL-LONDON, V587, P11, DOI 10.1113/jphysiol.2008.162461; Rothwell J. C, 2008, OXFORD HDB TRANSCRAN, P171; Rudroff T, 2005, MUSCLE NERVE, V31, P78, DOI 10.1002/mus.20241; Rudroff T, 2007, J APPL PHYSIOL, V102, P1000, DOI 10.1152/japplphysiol.00564.2006; Rudroff T, 2007, MUSCLE NERVE, V35, P657, DOI 10.1002/mus.20752; Rudroff T, 2011, J APPL PHYSIOL, V110, P125, DOI 10.1152/japplphysiol.00605.2010; Rudroff T, 2010, EXP BRAIN RES, V203, P307, DOI 10.1007/s00221-010-2233-3; Sacco P, 2000, MUSCLE NERVE, V23, P1840, DOI 10.1002/1097-4598(200012)23:12<1840::AID-MUS7>3.0.CO;2-H; Shemmell J, 2010, CLIN NEUROPHYSIOL, V121, P1680, DOI 10.1016/j.clinph.2010.02.166; Sidhu SK, 2012, J APPL PHYSIOL, V113, P401, DOI 10.1152/japplphysiol.00486.2012; Taylor JL, 2008, J APPL PHYSIOL, V104, P542, DOI 10.1152/japplphysiol.01053.2007; Taylor JL, 2006, J ELECTROMYOGR KINES, V16, P215, DOI 10.1016/j.jelekin.2005.07.001; Taylor JL, 2006, CLIN EXP PHARMACOL P, V33, P400, DOI 10.1111/j.1440-1681.2006.04363.x; Taylor JL, 2004, J APPL PHYSIOL, V96, P1496, DOI 10.1152/japplphysiol.01116.2003; Taylor JL, 1996, J PHYSIOL-LONDON, V490, P519, DOI 10.1113/jphysiol.1996.sp021163; Thomas JS, 2011, J MOTOR BEHAV, V43, P27, DOI 10.1080/00222895.2010.530305; UGAWA Y, 1991, ANN NEUROL, V29, P418, DOI 10.1002/ana.410290413; Vucic S, 2011, CEREB CORTEX, V21, P1639, DOI 10.1093/cercor/bhq235; Yoon T, 2009, J MOTOR BEHAV, V41, P393, DOI 10.3200/35-09-003; Zijdewind I, 2006, EXP BRAIN RES, V175, P526, DOI 10.1007/s00221-006-0570-z	90	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93284	10.1371/journal.pone.0093284	http://dx.doi.org/10.1371/journal.pone.0093284			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667484	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600163
J	Alves, G; Yu, YK				Alves, Gelio; Yu, Yi-Kuo			Accuracy Evaluation of the Unified P-Value from Combining Correlated P-Values	PLOS ONE			English	Article							WEIGHTED Z-TEST; TESTS; COMBINATION; PROBABILITIES; STATISTICS	Meta-analysis methods that combine P-values into a single unified P-value are frequently employed to improve confidence in hypothesis testing. An assumption made by most meta-analysis methods is that the P-values to be combined are independent, which may not always be true. To investigate the accuracy of the unified P-value from combining correlated P-values, we have evaluated a family of statistical methods that combine: independent, weighted independent, correlated, and weighted correlated P-values. Statistical accuracy evaluation by combining simulated correlated P-values showed that correlation among P-values can have a significant effect on the accuracy of the combined P-value obtained. Among the statistical methods evaluated those that weight P-values compute more accurate combined P-values than those that do not. Also, statistical methods that utilize the correlation information have the best performance, producing significantly more accurate combined P-values. In our study we have demonstrated that statistical methods that combine P-values based on the assumption of independence can produce inaccurate P-values when combining correlated P-values, even when the P-values are only weakly correlated. Therefore, to prevent from drawing false conclusions during hypothesis testing, our study advises caution be used when interpreting the P-value obtained from combining P-values of unknown correlation. However, when the correlation information is available, the weighting-capable statistical method, first introduced by Brown and recently modified by Hou, seems to perform the best amongst the methods investigated.	[Alves, Gelio; Yu, Yi-Kuo] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Yu, YK (corresponding author), Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA.	yyu@ncbi.nlm.nih.gov			Intramural Research Program of the National Library of Medicine at the National Institutes of Health/Department of Health and Human Services; National Institutes of Health; NATIONAL LIBRARY OF MEDICINE [ZIALM092404] Funding Source: NIH RePORTER	Intramural Research Program of the National Library of Medicine at the National Institutes of Health/Department of Health and Human Services; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Intramural Research Program of the National Library of Medicine at the National Institutes of Health/Department of Health and Human Services. Funding for Open Access publication charges for this article was provided by the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves G, 2008, J PROTEOME RES, V7, P3102, DOI 10.1021/pr700798h; Alves G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022647; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BHOJ DS, 1992, STAT PROBABIL LETT, V15, P37, DOI 10.1016/0167-7152(92)90282-A; BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826; Chen Z, 2011, J EVOLUTION BIOL, V24, P926, DOI 10.1111/j.1420-9101.2010.02226.x; Chen ZX, 2014, COMPUT STAT DATA AN, V70, P387, DOI 10.1016/j.csda.2013.09.005; Delongchamp R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S11; Demetrescu M, 2006, OXFORD B ECON STAT, V68, P647, DOI 10.1111/j.1468-0084.2006.00181.x; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P360, DOI 10.1002/gepi.10264; Fisher R.A., 1932, STAT METHODS RES WOR, VII; Genovese CR, 2006, BIOMETRIKA, V93, P509, DOI 10.1093/biomet/93.3.509; GOOD IJ, 1955, J ROY STAT SOC B, V17, P264; Hartung J, 1999, BIOMETRICAL J, V41, P849, DOI 10.1002/(SICI)1521-4036(199911)41:7<849::AID-BIMJ849>3.0.CO;2-T; Hedges LV, 2014, STAT METHODS META AN; Hou CD, 2005, STAT PROBABIL LETT, V73, P179, DOI 10.1016/j.spl.2004.11.028; Hu JX, 2010, J AM STAT ASSOC, V105, P1215, DOI 10.1198/jasa.2010.tm09329; Kost JT, 2002, STAT PROBABIL LETT, V60, P183, DOI 10.1016/S0167-7152(02)00310-3; LANCASTER HO, 1961, AUST J STAT, V3, P20, DOI 10.1111/j.1467-842X.1961.tb00058.x; Liechty JC, 2004, BIOMETRIKA, V91, P1, DOI 10.1093/biomet/91.1.1; Liptak T., 1958, MAGYAR TUD AKAD MAT, V3, P171; Loesgen S, 2001, GENET EPIDEMIOL, V21, pS142, DOI 10.1002/gepi.2001.21.s1.s142; Loughin TM, 2004, COMPUT STAT DATA AN, V47, P467, DOI 10.1016/j.csda.2003.11.020; OLKIN I, 1995, J CLIN EPIDEMIOL, V48, P133, DOI 10.1016/0895-4356(94)00136-E; Peng J, 2009, J AM STAT ASSOC, V104, P735, DOI 10.1198/jasa.2009.0126; PEPE MS, 1989, BIOMETRICS, V45, P497, DOI 10.2307/2531492; ROSENTHAL R, 1978, PSYCHOL BULL, V85, P185, DOI 10.1037/0033-2909.85.1.185; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; SCHWEDER T, 1982, BIOMETRIKA, V69, P493; Stouffer S. A., 1949, AM SOLDIER, V1; Vattathil S, 2013, GENOME RES, V23, P152, DOI 10.1101/gr.141374.112; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Won SH, 2009, STAT MED, V28, P1537, DOI 10.1002/sim.3569; Zaykin DV, 2011, J EVOL BIOL; ZELEN M, 1959, ANN MATH STAT, V30, P885, DOI 10.1214/aoms/1177706074	35	21	21	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91225	10.1371/journal.pone.0091225	http://dx.doi.org/10.1371/journal.pone.0091225			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663491	gold, Green Submitted, Green Published			2022-12-27	WOS:000333459900016
J	Bendali, A; Agnes, C; Meffert, S; Forster, V; Bongrain, A; Arnault, JC; Sahel, JA; Offenhausser, A; Bergonzo, P; Picaud, S				Bendali, Amel; Agnes, Charles; Meffert, Simone; Forster, Valerie; Bongrain, Alexandre; Arnault, Jean-Charles; Sahel, Jose-Alain; Offenhaeusser, Andreas; Bergonzo, Philippe; Picaud, Serge			Distinctive Glial and Neuronal Interfacing on Nanocrystalline Diamond	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; FILMS; PROSTHESIS; ELECTRODES; LAMININ; ADSORPTION; STABILITY; SURFACES; SPECTRA; CULTURE	Direct electrode/neuron interfacing is a key challenge to achieve high resolution of neuronal stimulation required for visual prostheses. Neuronal interfacing on biomaterials commonly requires the presence of glial cells and/or protein coating. Nanocrystalline diamond is a highly mechanically stable biomaterial with a remarkably large potential window for the electrical stimulation of tissues. Using adult retinal cell cultures from rats, we found that glial cells and retinal neurons grew equally well on glass and nanocrystalline diamond. The use of a protein coating increased cell survival, particularly for glial cells. However, bipolar neurons appeared to grow even in direct contact with bare diamond. We investigated whether the presence of glial cells contributed to this direct neuron/diamond interface, by using purified adult retinal ganglion cells to seed diamond and glass surfaces with and without protein coatings. Surprisingly, these fully differentiated spiking neurons survived better on nanocrystalline diamond without any protein coating. This greater survival was indicated by larger cell numbers and the presence of longer neurites. When a protein pattern was drawn on diamond, neurons did not grow preferentially on the coated area, by contrast to their behavior on a patterned glass. This study highlights the interesting biocompatibility properties of nanocrystalline diamond, allowing direct neuronal interfacing, whereas a protein coating was required for glial cell growth.	[Bendali, Amel; Forster, Valerie; Sahel, Jose-Alain; Picaud, Serge] INSERM, U968, Inst Vis, Paris, France; [Bendali, Amel; Forster, Valerie; Sahel, Jose-Alain; Picaud, Serge] Sorbonne Univ, Univ Paris 06, UMR S968, Inst Vis, Paris, France; [Bendali, Amel; Forster, Valerie; Sahel, Jose-Alain; Picaud, Serge] CNRS, UMR7210, Inst Vis, Paris, France; [Agnes, Charles; Bongrain, Alexandre; Arnault, Jean-Charles; Bergonzo, Philippe] CEA LIST, Diamond Sensors Lab, Gif Sur Yvette, France; [Meffert, Simone; Offenhaeusser, Andreas] Forschungszentrum Julich, Inst Bio & Nanosyst Bioelect IBN2, D-52425 Julich, Germany; [Sahel, Jose-Alain] Ctr Hosp Natl Ophtalmol Quinze Vingts, Paris, France; [Sahel, Jose-Alain; Picaud, Serge] Fdn Ophtalmol Adolphe de Rothschild, Paris, France; [Sahel, Jose-Alain] UCL, Inst Ophthalmol, London, England; [Sahel, Jose-Alain] French Acad Sci, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Helmholtz Association; Research Center Julich; CHNO des Quinze-Vingts; UDICE-French Research Universities; Sorbonne Universite; University of London; University College London	Picaud, S (corresponding author), INSERM, U968, Inst Vis, Paris, France.	serge.picaud@inserm.fr	Bergonzo, Philippe/A-6567-2015; Bergonzo, P/AFT-4220-2022; Sahel, Jose-Alain/F-3172-2017; Arnault, Jean-Charles/AAN-2948-2021; Picaud, Serge/H-4012-2014; Offenhäusser, Andreas/E-7990-2012	Bergonzo, Philippe/0000-0002-0647-9134; Sahel, Jose-Alain/0000-0002-4831-1153; Picaud, Serge/0000-0002-0548-5145; Offenhäusser, Andreas/0000-0001-6143-2702	INSERM; UPMC (Paris VI); Fondation Ophtalmologique A. de Rothschild (Paris); Agence Nationale pour la Recherche (MEDINAS project) [ANR-07-TECSAN-014]; Fondation Fighting Blindness; Fondation pour la Recherche Medicale; sixth European framework (DREAMS) [FP6-NMP-2006-676033345]; sixth European framework (NEUROCARE) [FP7-NMP-280433]; IMPLANTS project from ITMO-TecSan; Federation des Aveugles de France; IRRP; city of Paris; Regional Council of Ile-de-France	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); UPMC (Paris VI); Fondation Ophtalmologique A. de Rothschild (Paris); Agence Nationale pour la Recherche (MEDINAS project)(French National Research Agency (ANR)); Fondation Fighting Blindness; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); sixth European framework (DREAMS); sixth European framework (NEUROCARE); IMPLANTS project from ITMO-TecSan; Federation des Aveugles de France; IRRP; city of Paris(Region Ile-de-France); Regional Council of Ile-de-France(Region Ile-de-France)	This work was supported by INSERM, UPMC (Paris VI), the Fondation Ophtalmologique A. de Rothschild (Paris), Agence Nationale pour la Recherche (MEDINAS project, ANR-07-TECSAN-014), Fondation Fighting Blindness, Fondation pour la Recherche Medicale, the sixth European framework (DREAMS, project FP6-NMP-2006-676033345; NEUROCARE, project FP7-NMP-280433), IMPLANTS project from ITMO-TecSan, Federation des Aveugles de France, IRRP, the city of Paris, the Regional Council of Ile-de-France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariano P, 2009, BIOSENS BIOELECTRON, V24, P2046, DOI 10.1016/j.bios.2008.10.017; Aumailley M, 2013, CELL ADHES MIGR, V7, P48, DOI 10.4161/cam.22826; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Bates CA, 1997, DEV BIOL, V181, P91, DOI 10.1006/dbio.1996.8438; Briggs D., 1992, HIGH RESOLUTION XPS; Butterwick A, 2009, EXP EYE RES, V88, P22, DOI 10.1016/j.exer.2008.09.018; Chang JC, 2001, BIOSENS BIOELECTRON, V16, P527, DOI 10.1016/S0956-5663(01)00166-X; Chang WC, 2008, LANGMUIR, V24, P13048, DOI 10.1021/la8021479; Chen YC, 2010, BIOMATERIALS, V31, P5575, DOI 10.1016/j.biomaterials.2010.03.061; Chen YC, 2009, BIOMATERIALS, V30, P3428, DOI 10.1016/j.biomaterials.2009.03.058; Djilas M, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046020; Dobelle WH, 2000, ASAIO J, V46, P3, DOI 10.1097/00002480-200001000-00002; Fuchs C, 2005, INVEST OPHTH VIS SCI, V46, P2983, DOI 10.1167/iovs.04-1177; Gao WL, 2010, APPL SURF SCI, V257, P538, DOI 10.1016/j.apsusc.2010.07.029; Ghodbane S, 2010, DIAM RELAT MATER, V19, P630, DOI 10.1016/j.diamond.2010.01.014; GI RS, 1995, JPN J APPL PHYS 1, V34, P5550, DOI 10.1143/JJAP.34.5550; Granger MC, 2000, ANAL CHEM, V72, P3793, DOI 10.1021/ac0000675; Graupner R, 1998, PHYS REV B, V57, P12397, DOI 10.1103/PhysRevB.57.12397; Gupta S, 2008, J APPL PHYS, V104, DOI 10.1063/1.2990058; Hadjinicolaou AE, 2012, BIOMATERIALS, V33, P5812, DOI 10.1016/j.biomaterials.2012.04.063; Humayun MS, 2012, OPHTHALMOLOGY, V119, P779, DOI 10.1016/j.ophtha.2011.09.028; Kiran R, 2012, SENSORS-BASEL, V12, P7669, DOI 10.3390/s120607669; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Lions M, 2009, PHYS STATUS SOLIDI-R, V3, P205, DOI 10.1002/pssr.200903128; Liu BF, 2006, COLLOID SURFACE B, V53, P175, DOI 10.1016/j.colsurfb.2006.08.018; Maynard EM, 2000, J NEUROSCI METH, V97, P93, DOI 10.1016/S0165-0270(00)00159-X; Mehes E, 2005, GLIA, V49, P492, DOI 10.1002/glia.20135; Romano C, 2007, PROG RETIN EYE RES, V26, P379, DOI 10.1016/j.preteyeres.2007.03.001; Rousche PJ, 1998, J NEUROSCI METH, V82, P1, DOI 10.1016/S0165-0270(98)00031-4; Ruiz-Taylor LA, 2001, LANGMUIR, V17, P7313, DOI 10.1021/la010620t; Snidero E, 2003, J APPL PHYS, V93, P2700, DOI 10.1063/1.1539922; Specht CG, 2004, BIOMATERIALS, V25, P4073, DOI 10.1016/j.biomaterials.2003.11.006; Thalhammer A, 2010, BIOMATERIALS, V31, P2097, DOI 10.1016/j.biomaterials.2009.11.109; Vanhove E, 2007, PHYS STATUS SOLIDI A, V204, P2931, DOI 10.1002/pssa.200776340; Vanhove E, 2009, PHYS STATUS SOLIDI A, V206, P2063, DOI 10.1002/pssa.200982235; Wei M, 2009, CHEM COMMUN, P3624, DOI 10.1039/b903284c; Zrenner E, 2011, P ROY SOC B-BIOL SCI, V278, P1489, DOI 10.1098/rspb.2010.1747	37	30	30	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92562	10.1371/journal.pone.0092562	http://dx.doi.org/10.1371/journal.pone.0092562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664111	gold, Green Published, Green Submitted			2022-12-27	WOS:000333459900075
J	Gaignier, F; Schenten, V; Bittencourt, MD; Gauquelin-Koch, G; Frippiat, JP; Legrand-Frossi, C				Gaignier, Fanny; Schenten, Veronique; Bittencourt, Marcelo De Carvalho; Gauquelin-Koch, Guillemette; Frippiat, Jean-Pol; Legrand-Frossi, Christine			Three Weeks of Murine Hindlimb Unloading Induces Shifts from B to T and from Th to Tc Splenic Lymphocytes in Absence of Stress and Differentially Reduces Cell-Specific Mitogenic Responses	PLOS ONE			English	Article							AMPHIBIAN PLEURODELES-WALTL; IMMUNE-SYSTEM; SPACE-FLIGHT; SIMULATED WEIGHTLESSNESS; SPACEFLIGHT CONDITIONS; GENE-EXPRESSION; RODENT MODEL; IMMUNOLOGICAL RESPONSES; APPLIED PHYSIOLOGY; DURATION MISSIONS	Extended space missions are known to induce stress and immune dysregulation. Hindlimb unloading is a ground-based model used to reproduce most spaceflight conditions. The aim of this study was to better characterize the consequences of prolonged exposure to hindlimb unloading on murine splenic lymphocyte sub-populations. To ensure that the observed changes were not due to tail restraint but to the antiorthostatic position, three groups of mice were used: control (C), orthostatic restrained (R) and hindlimb unloaded (HU). After 21 days of exposure, no difference in serum corticosterone levels nor in thymus and spleen weights were observed between HU mice and their counterparts, revealing a low state of stress. Interestingly, flow cytometric analyses showed that B cells were drastically reduced in HU mouse spleens by 59% and, while the T cells number did not change, the Th/Tc ratio was decreased. Finally, the use of a fluorescent dye monitoring lymphoproliferation demonstrated that lymphocyte response to mitogen was reduced in Th and Tc populations and to a greater extent in B cells. Thus, we showed for the first time that, even if restraint has its own effects on the animals and their splenic lymphocytes, the prolonged antiorthostatic position leads, despite the absence of stress, to an inversion of the B/T ratio in the spleen. Furthermore, the lymphoproliferative response was impaired with a strong impact on B cells. Altogether, these results suggest that B cells are more affected by hindlimb unloading than T cells which may explain the high susceptibility to pathogens, such as gram-negative bacteria, described in animal models and astronauts.	[Gaignier, Fanny; Schenten, Veronique; Frippiat, Jean-Pol; Legrand-Frossi, Christine] Lorraine Univ, EA7300, Stress Immun Pathogens Lab, Vandoeuvre Les Nancy, France; [Bittencourt, Marcelo De Carvalho] Lorraine Univ, UMR7039, Res Ctr Automat Control Nancy, Vandoeuvre Les Nancy, France; [Gauquelin-Koch, Guillemette] French Natl Space Agcy, Paris, France	Universite de Lorraine; Universite de Lorraine	Legrand-Frossi, C (corresponding author), Lorraine Univ, EA7300, Stress Immun Pathogens Lab, Vandoeuvre Les Nancy, France.	christine.frossi@univ-lorraine.fr	De Carvalho Bittencourt, Marcelo/E-9316-2012	De Carvalho Bittencourt, Marcelo/0000-0002-2698-2458; Frippiat, Jean-Pol/0000-0002-4027-6269	French National Space Agency (CNES); National Research Agency (ANR); French Ministry of Higher Education and Research; Region Lorraine; Lorraine-University; CNES	French National Space Agency (CNES)(Centre National D'etudes Spatiales); National Research Agency (ANR)(French National Research Agency (ANR)); French Ministry of Higher Education and Research; Region Lorraine(Region Grand-Est); Lorraine-University; CNES(Centre National D'etudes Spatiales)	This work was supported by the French National Space Agency (CNES), the National Research Agency (ANR), the French Ministry of Higher Education and Research, the Region Lorraine and the Lorraine-University. V. S. was supported by a CNES post-doctoral fellowship. F. G. was supported by CNES and the Region Lorraine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviles H, 2005, NEUROIMMUNOMODULAT, V12, P173, DOI 10.1159/000084850; Aviles H, 2004, J APPL PHYSIOL, V97, P1437, DOI 10.1152/japplphysiol.00259.2004; Aviles H, 2003, J APPL PHYSIOL, V95, P73, DOI 10.1152/japplphysiol.00968.2002; Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Bascove M, 2011, FASEB J, V25, P2947, DOI 10.1096/fj.11-185215; Bascove M, 2010, MOL IMMUNOL, V47, P1640, DOI 10.1016/j.molimm.2010.01.005; Bascove M, 2009, FASEB J, V23, P1607, DOI 10.1096/fj.08-121327; Belay T, 2002, J ALLERGY CLIN IMMUN, V110, P262, DOI 10.1067/mai.2002.126459; Boonyaratanakornkit JB, 2005, FASEB J, V19, P2020, DOI 10.1096/fj.05-3778fje; Boxio R, 2005, J APPL PHYSIOL, V98, P905, DOI 10.1152/japplphysiol.00957.2004; CAREN LD, 1980, AVIAT SPACE ENVIR MD, V51, P251; Chang TT, 2012, J LEUKOCYTE BIOL, V92, P1133, DOI 10.1189/jlb.0312157; Chapes SK, 1999, J APPL PHYSIOL, V86, P2065, DOI 10.1152/jappl.1999.86.6.2065; CHAPES SK, 1993, J LEUKOCYTE BIOL, V54, P227, DOI 10.1002/jlb.54.3.227; Chouker A, 2020, STRESS CHALLENGES IM, DOI [10.1007/978-3-030-16996-1_8, DOI 10.1007/978-3-030-16996-1_8]; Cogoli A, 1997, Adv Space Biol Med, V6, P33, DOI 10.1016/S1569-2574(08)60077-5; COGOLI A, 1993, J LEUKOCYTE BIOL, V54, P259, DOI 10.1002/jlb.54.3.259; Crucian BE, 2000, J INTERF CYTOK RES, V20, P547, DOI 10.1089/10799900050044741; Crucian BE, 2008, AVIAT SPACE ENVIR MD, V79, P835, DOI 10.3357/ASEM.2276.2008; DRACOTT BN, 1979, IMMUNOLOGY, V38, P429; DURNOVA GN, 1976, AVIAT SPACE ENVIR MD, V47, P588; Erofeeva LM, 2003, B EXP BIOL MED+, V135, P190, DOI 10.1023/A:1023840419469; Felix K, 2004, MOL CELL BIOCHEM, V266, P79, DOI 10.1023/B:MCBI.0000049136.55611.dd; Frippiat JP, 2013, MOL IMMUNOL, V56, P434, DOI 10.1016/j.molimm.2013.06.011; Gridley DS, 2009, J APPL PHYSIOL, V106, P194, DOI 10.1152/japplphysiol.91126.2008; Gridley DS, 2003, J APPL PHYSIOL, V94, P2095, DOI 10.1152/japplphysiol.01053.2002; Grigorenko D E, 2012, Morfologiia, V142, P67; GROVE DS, 1995, EXP CELL RES, V219, P102, DOI 10.1006/excr.1995.1210; Gueguinou N, 2012, PSYCHONEUROENDOCRINO, V37, P137, DOI 10.1016/j.psyneuen.2011.05.015; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Huin-Schohn C, 2013, FASEB J, V27, P333, DOI 10.1096/fj.12-217547; ILYIN EA, 1980, KOSM BIOL AVIAK MED+, V14, P79; KONSTANTINOVA IV, 1993, J LEUKOCYTE BIOL, V54, P189, DOI 10.1002/jlb.54.3.189; LESNYAK AT, 1993, J LEUKOCYTE BIOL, V54, P214, DOI 10.1002/jlb.54.3.214; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MANDEL AD, 1977, AVIAT SPACE ENVIR MD, V48, P1051; Momken I, 2011, FASEB J, V25, P3646, DOI 10.1096/fj.10-177295; Morey E R, 1979, Physiologist, V22, pS23; Morey-Holton E, 2005, ADV SPACE B, V10, P7, DOI 10.1016/S1569-2574(05)10002-1; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; NASH PV, 1991, EXP CELL RES, V195, P353, DOI 10.1016/0014-4827(91)90384-7; NASH PV, 1992, J APPL PHYSIOL, V73, pS186; O'Donnell PM, 2009, STRESS, V12, P82, DOI 10.1080/10253890802049269; Pecaut MJ, 2004, J APPL PHYSIOL, V97, P29, DOI 10.1152/japplphysiol.01304.2003; Pecaut MJ, 2003, J APPL PHYSIOL, V94, P2085, DOI 10.1152/japplphysiol.01052.2002; Pecaut MJ, 2000, AM J PHYSIOL-REG I, V279, pR2072, DOI 10.1152/ajpregu.2000.279.6.R2072; Rykova M P, 2006, Aviakosm Ekolog Med, V40, P19; Singh KP, 2010, J CELL BIOCHEM, V111, P123, DOI 10.1002/jcb.22674; Sonnenfeld G, 2002, MED SCI SPORT EXER, V34, P2021, DOI 10.1097/00005768-200212000-00024; SONNENFELD G, 1993, J LEUKOCYTE BIOL, V54, P253, DOI 10.1002/jlb.54.3.253; SONNENFELD G, 1992, J APPL PHYSIOL, V73, pS191, DOI 10.1152/jappl.1992.73.2.S191; SONNENFELD G, 1982, J INTERFERON RES, V2, P467, DOI 10.1089/jir.1982.2.467; STEFFEN JM, 1987, AVIAT SPACE ENVIR MD, V58, P996; TAYLOR GR, 1986, AVIAT SPACE ENVIR MD, V57, P213; TAYLOR GR, 1992, J LEUKOCYTE BIOL, V51, P129, DOI 10.1002/jlb.51.2.129; TAYLOR GR, 1993, J LEUKOCYTE BIOL, V54, P202, DOI 10.1002/jlb.54.3.202; Tsvirkun D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039923; VOSS EW, 1984, SCIENCE, V225, P214, DOI 10.1126/science.6729476; Wang KX, 2007, P NATL ACAD SCI USA, V104, P14777, DOI 10.1073/pnas.0703236104; Wei LX, 2003, CELL RES, V13, P465, DOI 10.1038/sj.cr.7290189; WRONSKI TJ, 1987, AVIAT SPACE ENVIR MD, V58, P63; Wronski TJ, 1998, J APPL PHYSIOL, V85, P279, DOI 10.1152/jappl.1998.85.1.279; Yamauchi K, 2002, J APPL PHYSIOL, V93, P161, DOI 10.1152/japplphysiol.01084.2001; Yuwaki Keiichi, 2004, Biol Sci Space, V18, P175; Zhang H, 1999, Space Med Med Eng (Beijing), V12, P423	65	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92664	10.1371/journal.pone.0092664	http://dx.doi.org/10.1371/journal.pone.0092664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664102	gold, Green Submitted, Green Published			2022-12-27	WOS:000333459900093
J	Song, HJ; Baillargeon, R; Fisher, C				Song, Hyun-joo; Baillargeon, Renee; Fisher, Cynthia			The Development of Infants' Use of Novel Verbal Information when Reasoning about Others' Actions	PLOS ONE			English	Article							OBJECT LABELS; GOAL; WORDS; ATTRIBUTION; AGENT; DISAMBIGUATION; DISPOSITION; PERCEPTION; PERFORM; ABILITY	How sophisticated are infants at using novel verbal information when reasoning about which of two objects an agent is likely to select? The present research examined the development of infants' ability to interpret a change from one novel word to another as signaling a possible change in which object the agent would choose next. In three experiments, 7- and 12-month-olds were familiarized to an event in which they heard a novel word ("A dax!") and then saw an agent reach for one of two distinct objects. During test, the infants heard a different novel word ("A pilk!") and then saw the agent grasp the same object or the other object. At 7 months, infants ignored the change in word and expected the agent to continue reaching for the same object. At 12 months, however, infants attended to the change in word: They realized that it signaled a possible change in the agent's upcoming actions, though they were unable to form a specific expectation about what these new actions might be, most likely due to their limited mutual-exclusivity assumption. Control conditions supported these interpretations. Together, these results suggest that by 12 months of age, infants understand not only that words are selected for communicative purposes, but also that a change from one novel word to another may signal a change in an agent's upcoming actions.	[Song, Hyun-joo] Yonsei Univ, Dept Psychol, Seoul 120749, South Korea; [Baillargeon, Renee; Fisher, Cynthia] Univ Illinois, Dept Psychol, Champaign, IL 61820 USA	Yonsei University; University of Illinois System; University of Illinois Urbana-Champaign	Song, HJ (corresponding author), Yonsei Univ, Dept Psychol, Seoul 120749, South Korea.	hsong@yonsei.ac.kr	Song, hyunjoo/GWC-1292-2022		Korea Research Foundation Grant [KRF-2008-332-H00011]; NICHD [HD-021104]; NICHD Grant [HD-054448]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD021104, R01HD054448] Funding Source: NIH RePORTER	Korea Research Foundation Grant(National Research Foundation of Korea); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by Korea Research Foundation Grant KRF-2008-332-H00011 to HS, NICHD Grant HD-021104 to RB, and NICHD Grant HD-054448 to CF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillargeon R., APA HDB PERSONALITY, V1; Bion RAH, 2013, COGNITION, V126, P39, DOI 10.1016/j.cognition.2012.08.008; Biro S, 2011, DEVELOPMENTAL SCI, V14, P1255, DOI 10.1111/j.1467-7687.2011.01042.x; Buresh JS, 2007, COGNITION, V104, P287, DOI 10.1016/j.cognition.2006.07.001; Byers-Heinlein K, 2013, COGNITION, V128, P407, DOI 10.1016/j.cognition.2013.05.010; Byers-Heinlein K, 2009, DEVELOPMENTAL SCI, V12, P815, DOI 10.1111/j.1467-7687.2009.00902.x; Csibra G, 1999, COGNITION, V72, P237, DOI 10.1016/S0010-0277(99)00039-6; Dewar K, 2007, DEV PSYCHOL, V43, P1227, DOI 10.1037/0012-1649.43.5.1227; Diesendruck G, 2001, DEV PSYCHOL, V37, P630, DOI 10.1037//0012-1649.37.5.630; Graham SA, 2006, INFANCY, V9, P341, DOI 10.1207/s15327078in0903_5; Guajardo JJ, 2004, INFANCY, V6, P361, DOI 10.1207/s15327078in0603_3; Halberda J, 2003, COGNITION, V87, pB23, DOI 10.1016/S0010-0277(02)00186-5; Henderson AME, 2012, DEVELOPMENTAL SCI, V15, P641, DOI 10.1111/j.1467-7687.2012.01157.x; Johnson SC, 2007, COGNITIVE DEV, V22, P310, DOI 10.1016/j.cogdev.2007.01.002; Jovanovic B, 2007, PSYCHOLOGIA, V50, P273, DOI 10.2117/psysoc.2007.273; LIITTSCHWAGER JC, 1994, DEV PSYCHOL, V30, P955, DOI 10.1037/0012-1649.30.6.955; Luo Y, 2005, PSYCHOL SCI, V95, P297; Luo YY, 2011, COGNITION, V121, P289, DOI 10.1016/j.cognition.2011.07.011; Martin A, 2012, COGNITION, V123, P50, DOI 10.1016/j.cognition.2011.12.003; Phillips AT, 2002, COGNITION, V85, P53, DOI 10.1016/S0010-0277(02)00073-2; Scofield J, 2007, J CHILD LANG, V34, P875, DOI 10.1017/S0305000907008100; Shimizu YA, 2004, DEVELOPMENTAL SCI, V7, P425, DOI 10.1111/j.1467-7687.2004.00362.x; Sodian B, 2004, J COGN DEV, V5, P289, DOI 10.1207/s15327647jcd0503_1; Song HJ, 2005, COGNITION, V98, pB45, DOI 10.1016/j.cognition.2005.04.004; Song HJ, 2007, ACTA PSYCHOL, V124, P79, DOI 10.1016/j.actpsy.2006.09.008; 김민영, 2008, [THE KOREAN JOURNAL OF DEVELOPMENTAL PSYCHOLOGY, 한국심리학회지: 발달], V21, P41; Spaepen E, 2007, COGNITIVE PSYCHOL, V54, P133, DOI 10.1016/j.cogpsych.2006.06.001; Suanda SH, 2013, CHILD DEV, V84, P143, DOI 10.1111/j.1467-8624.2012.01847.x; Thoermer C., 2001, FIRST LANG, V21, P245, DOI [10.1177/014272370102106303, DOI 10.1177/014272370102106303]; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4; Woodward AL, 2000, PSYCHOL SCI, V11, P73, DOI 10.1111/1467-9280.00218; Woodward AL, 2003, DEVELOPMENTAL SCI, V6, P297, DOI 10.1111/1467-7687.00286; Woodward AL, 2002, COGNITIVE DEV, V17, P1061, DOI 10.1016/S0885-2014(02)00074-6; Woodward AL, 1999, INFANT BEHAV DEV, V22, P145, DOI 10.1016/S0163-6383(99)00007-7; Xu F, 2005, PSYCHOL SCI, V16, P372, DOI 10.1111/j.0956-7976.2005.01543.x	35	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92387	10.1371/journal.pone.0092387	http://dx.doi.org/10.1371/journal.pone.0092387			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD7QO	24664282	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900060
J	Weiner, AKM; Weinkauf, MFG; Kurasawa, A; Darling, KF; Kucera, M; Grimm, GW				Weiner, Agnes K. M.; Weinkauf, Manuel F. G.; Kurasawa, Atsushi; Darling, Kate F.; Kucera, Michal; Grimm, Guido W.			Phylogeography of the Tropical Planktonic Foraminifera Lineage Globigerinella Reveals Isolation Inconsistent with Passive Dispersal by Ocean Currents	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; REPRODUCTIVE ISOLATION; CRYPTIC SPECIATION; MOLECULAR EVIDENCE; DIVERSITY; DIVERSIFICATION; DIFFERENTIATION; AEQUILATERALIS; BIOGEOGRAPHY; PERFORMANCE	Morphologically defined species of marine plankton often harbor a considerable level of cryptic diversity. Since many morphospecies show cosmopolitan distribution, an understanding of biogeographic and evolutionary processes at the level of genetic diversity requires global sampling. We use a database of 387 single-specimen sequences of the SSU rDNA of the planktonic foraminifera Globigerinella as a model to assess the biogeographic and phylogenetic distributions of cryptic diversity in marine microplankton on a global scale. Our data confirm the existence of multiple, well isolated genetic lineages. An analysis of their abundance and distribution indicates that our sampling is likely to approximate the actual total diversity. Unexpectedly, we observe an uneven allocation of cryptic diversity among the phylogenetic lineages. We show that this pattern is neither an artifact of sampling intensity nor a function of lineage age. Instead, we argue that it reflects an ongoing speciation process in one of the three major lineages. Surprisingly, four of the six genetic types in the hyperdiverse lineage are biogeographically restricted to the Indopacific. Their mutual co-occurrence and their hierarchical phylogenetic structure provide no evidence for an origin through sudden habitat fragmentation and their limitation to the Indopacific challenges the view of a global gene flow within the warm-water provinces. This phenomenon shows that passive dispersal is not sufficient to describe the distribution of plankton diversity. Rather, these organisms show differentiated distribution patterns shaped by species interactions and reflecting phylogenetic contingency with unique histories of diversification rates.	[Weiner, Agnes K. M.; Weinkauf, Manuel F. G.; Kucera, Michal] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Kurasawa, Atsushi] Japanese Agcy Marine Earth Sci & Technol, Inst Biogeosci, Yokosuka, Kanagawa, Japan; [Darling, Kate F.] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland; [Darling, Kate F.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Grimm, Guido W.] Swedish Museum Nat Hist, Dept Palaeobiol, S-10405 Stockholm, Sweden	University of Bremen; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Edinburgh; University of Edinburgh; Swedish Museum of Natural History	Weiner, AKM (corresponding author), Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany.	aweiner@marum.de	Weinkauf, Manuel/AAL-5704-2020; Kucera, Michal/ABH-6065-2020; Kucera, Michal/B-9277-2009; Kucera, Michal/AAE-8115-2020	Kucera, Michal/0000-0002-7817-9018; Kucera, Michal/0000-0002-7817-9018; Weinkauf, Manuel F. G./0000-0002-4640-9659; Grimm, Guido/0000-0003-0674-3553; Weiner, Agnes K. M./0000-0002-9917-5235	Deutsche Forschungsgemeinschaf [KU 2259/19]; Natural Environment Research Council of the UK [NER/J/S/2000/00860, NE/ D009707/1]; Swedish Research Council [2008-3726]; Natural Environment Research Council [NER/J/S/2000/00860] Funding Source: researchfish	Deutsche Forschungsgemeinschaf(German Research Foundation (DFG)); Natural Environment Research Council of the UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Deutsche Forschungsgemeinschaft (grant KU 2259/19), the Natural Environment Research Council of the UK (grants NER/J/S/2000/00860 and NE/ D009707/1) and the Swedish Research Council (project no. 2008-3726). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algar AC, 2013, GLOBAL ECOL BIOGEOGR, V22, P391, DOI 10.1111/geb.12003; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Andre A, 2013, PALEOBIOLOGY, V39, P21, DOI 10.1666/0094-8373-39.1.21; Aurahs R, 2009, BIOINFORM BIOL INSIG, V3, P155; Aurahs R, 2009, MOL ECOL, V18, P1692, DOI 10.1111/j.1365-294X.2009.04136.x; Aze T, 2011, BIOL REV, V86, P900, DOI 10.1111/j.1469-185X.2011.00178.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beal LM, 2011, NATURE, V472, P429, DOI 10.1038/nature09983; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; BIJMA J, 1990, J FORAMIN RES, V20, P95, DOI 10.2113/gsjfr.20.2.95; Bijma J, 1998, MAR MICROPALEONTOL, V35, P141, DOI 10.1016/S0377-8398(98)00017-6; Blanco-Bercial L, 2011, J EXP MAR BIOL ECOL, V404, P108, DOI 10.1016/j.jembe.2011.05.011; Darling KF, 2008, MAR MICROPALEONTOL, V67, P216, DOI 10.1016/j.marmicro.2008.01.009; Darling KF, 2007, P NATL ACAD SCI USA, V104, P5002, DOI 10.1073/pnas.0700520104; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; de Vargas C, 2002, MAR MICROPALEONTOL, V45, P101, DOI 10.1016/S0377-8398(02)00037-3; de Vargas C, 1999, P NATL ACAD SCI USA, V96, P2864, DOI 10.1073/pnas.96.6.2864; DMODIFIER LETTER PRIMEOrbigny A.D., 1839, HIST PHYS POLITIQUE, P82; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FABER WW, 1988, J FORAMIN RES, V18, P334, DOI 10.2113/gsjfr.18.4.334; FABER WW, 1989, J FORAMIN RES, V19, P185, DOI 10.2113/gsjfr.19.3.185; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Goker M, 2010, EVOL BIOINFORM, V6, P97; Goetze E, 2011, INTEGR COMP BIOL, V51, P580, DOI 10.1093/icb/icr104; Grimm GW, 2007, MAR MICROPALEONTOL, V62, P75, DOI 10.1016/j.marmicro.2006.07.005; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hemleben C., 1989, MODERN PLANKTONIC FO, DOI [DOI 10.1016/S0016-6995(89)80108-1, DOI 10.1007/978-1-4612-3544-6_2]; Holzmann M, 1996, J FORAMIN RES, V26, P264, DOI 10.2113/gsjfr.26.3.264; Huber BT, 1997, PALEOBIOLOGY, V23, P33, DOI 10.1017/S0094837300016638; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kennett J.P., 1983, NEOGENE PLANKTONIC F; Kucera M, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P409; Lassmann T, 2009, NUCLEIC ACIDS RES, V37, P858, DOI 10.1093/nar/gkn1006; Maddison WP, 2011, MESQUITE MODULAR SYS; McPeek MA, 2007, AM NAT, V169, pE97, DOI 10.1086/512135; Miller M.A., 2010, P GAT COMP ENV WORKS; Morard R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026665; Morard R, 2009, MAR MICROPALEONTOL, V71, P148, DOI 10.1016/j.marmicro.2009.03.001; Morisita M., 1959, MEM FS KYUSHU U    E, V3, P65, DOI DOI 10.18960/SEITAI.11.6_252_4; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Paradis E, 2005, EVOLUTION, V59, P1; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2012, EVOLUTION, V66, P288, DOI 10.1111/j.1558-5646.2011.01429.x; Parket F. L., 1962, Micropaleontology, V8, P219, DOI 10.2307/1484745; Peeters FJC, 2004, NATURE, V430, P661, DOI 10.1038/nature02785; Peijnenburg KTCA, 2013, ECOL EVOL, V3, P2765, DOI 10.1002/ece3.644; Pillet L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032373; QUENOUILLE MH, 1949, J ROY STAT SOC B, V11, P68; Quillevere F, 2013, PALAEOGEOGR IN PRESS, DOI DOI 10.1016/J.PALAE0.2011.1003.1013; R Development Core Team, 2011, R LANG ENV STAT COMP; Rabosky DL, 2007, P ROY SOC B-BIOL SCI, V274, P2915, DOI 10.1098/rspb.2007.0924; Rambaut A, 2009, TREE FIGURE DRAWING; Schlitzer R, 2014, OCEAN DATA VIEW; Seears HA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-54; Sexton PF, 2008, GEOLOGY, V36, P899, DOI 10.1130/G25232A.1; Slapeta J, 2006, MOL BIOL EVOL, V23, P23, DOI 10.1093/molbev/msj001; SMITH EP, 1984, BIOMETRICS, V40, P119, DOI 10.2307/2530750; Stamatakis A., 2006, P IPDPS RHOD GREEC; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Waelbroeck C, 2009, NAT GEOSCI, V2, P127, DOI 10.1038/NGEO411; Weiner A, 2012, MOL ECOL, V21, P4063, DOI 10.1111/j.1365-294X.2012.05686.x; WILLIAMS ERNEST E., 1965, BREVIORA MUS COMP ZOOL HARVARD UNIV, V227, P1; Wuyts J, 2002, NUCLEIC ACIDS RES, V30, P183, DOI 10.1093/nar/30.1.183	65	32	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92148	10.1371/journal.pone.0092148	http://dx.doi.org/10.1371/journal.pone.0092148			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663038	Green Submitted, gold, Green Published			2022-12-27	WOS:000333459900044
J	Huang, KN; Wu, B; Ding, XY; Xu, ZF; Tang, H				Huang, Kenan; Wu, Bin; Ding, Xinyu; Xu, Zhifei; Tang, Hua			Post-Esophagectomy Tube Feeding: A Retrospective Comparison of Jejunostomy and a Novel Gastrostomy Feeding Approach	PLOS ONE			English	Article							ENTERAL NUTRITION; PARENTERAL-NUTRITION; SQUAMOUS-CELL; CANCER; COMPLICATIONS; DISSECTION; BENEFITS; SUPPORT; PATIENT; IMPACT	Background: McKeown-type esophagectomy combined with retrosternal reconstruction is a common surgical treatment for esophageal cancer. Various enteral feeding options are available post-esophagectomy, but no definitive preference exists. Method: "Retrosternal Route Gastrostomy Feeding (RGF)" was developed as an alternative enteral feeding approach that requires few additional surgical interventions. RGF is based on McKeown-type esophagectomy. We retrospectively compared RGF (n = 121) to jejunostomy feeding (JF) (n = 153) in 274 patients at the Department of Cardiothoracic Surgery in Changzheng Hospital (Shanghai, China) between June 2008 and Sept. 2012. Data pertaining to efficacy and procedural complications were compared among patients. Results: RGF had a significantly shorter postoperative hospital stay (11 vs. 15 days, p<0.001) and time to removal of the feeding tube (9 vs. 14 days, p<0.001) compared to JF. Bowel obstruction (0.0% vs. 7.2% p = 0.003), abdominal distension (9.1% vs. 19% p = 0.022), and the occurrence of pneumonia (11.6% vs. 26.1% p = 0.003) were significantly lower in the RGF group. Feeding tube related complications and the associated morbidity rate were reduced in the RGF group. The two groups had similar tolerance to surgery. Conclusion: Our data suggests that RGF is a safe post-esophagectomy enteral feeding alternative to JF.	[Huang, Kenan; Wu, Bin; Ding, Xinyu; Xu, Zhifei; Tang, Hua] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Thorac & Cardiovasc Surg, Shanghai, Peoples R China	Naval Medical University	Xu, ZF (corresponding author), Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Thorac & Cardiovasc Surg, Shanghai, Peoples R China.	doctorxzf@163.com; lordth1982@163.com						Aiko S, 2001, SURG TODAY, V31, P971, DOI 10.1007/s005950170005; Allum WH, 2002, GUT, V50, P1; Altorki N, 2002, ANN SURG, V236, P177, DOI 10.1097/00000658-200208000-00005; ALVERDY J, 1985, ANN SURG, V202, P681, DOI 10.1097/00000658-198512000-00003; BeierHolgersen R, 1996, GUT, V39, P833, DOI 10.1136/gut.39.6.833; BOZZETTI F, 1982, ANN SURG, V196, P170, DOI 10.1097/00000658-198208000-00009; Bozzetti F, 2001, LANCET, V358, P1487, DOI 10.1016/S0140-6736(01)06578-3; Braga M, 2002, ARCH SURG-CHICAGO, V137, P174, DOI 10.1001/archsurg.137.2.174; BURT ME, 1984, SEMIN ONCOL, V11, P127; CHEATHAM ML, 1995, ANN SURG, V221, P469, DOI 10.1097/00000658-199505000-00004; GERNDT SJ, 1994, SURGERY, V115, P164; Gupta V, 2009, WORLD J SURG, V33, P1432, DOI 10.1007/s00268-009-0019-1; JOSHI N, 1992, AM J MED, V93, P135, DOI 10.1016/0002-9343(92)90042-A; Kudsk KA, 2002, AM J SURG, V183, P390, DOI 10.1016/S0002-9610(02)00821-8; Leibovitz A, 2003, J GERONTOL A-BIOL, V58, P52; Lerut T, 2004, ANN SURG, V240, P962, DOI 10.1097/01.sla.0000145925.70409.d7; Li HC, 2012, J SURG ONCOL, V105, P548, DOI 10.1002/jso.22148; Mathus-Vliegen LMH, 1999, GASTROINTEST ENDOSC, V50, P746, DOI 10.1016/S0016-5107(99)70153-7; MAXTON DG, 1989, CLIN SCI, V77, P401, DOI 10.1042/cs0770401; Mochizuki H, 2000, HEPATO-GASTROENTEROL, V47, P1407; MOORE EE, 1986, J TRAUMA, V26, P874, DOI 10.1097/00005373-198610000-00003; Morita M, 2008, SURGERY, V143, P499, DOI 10.1016/j.surg.2007.12.007; MYERS JG, 1995, AM J SURG, V170, P547, DOI 10.1016/S0002-9610(99)80013-0; Nelson R, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004929.pub3; Pennathur A, 2008, ANN THORAC SURG, V85, pS751, DOI 10.1016/j.athoracsur.2007.11.078; Puri V, 2011, ANN THORAC SURG, V92, P499, DOI 10.1016/j.athoracsur.2011.03.082; Swann HM, 1997, J AM VET MED ASSOC, V210, P1764; Urschel JD, 2001, AM J SURG, V182, P470, DOI 10.1016/S0002-9610(01)00763-2; Witzel O., 1891, ZENTRALBLATT CHIRURG, V32, P601	29	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e89190	10.1371/journal.pone.0089190	http://dx.doi.org/10.1371/journal.pone.0089190			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658763	gold, Green Published, Green Submitted			2022-12-27	WOS:000333355300005
J	Sharma, A; Huard, C; Vernochet, C; Ziemek, D; Knowlton, KM; Tyminski, E; Paradis, T; Zhang, Y; Jones, JEC; von Schack, D; Brown, CT; Milos, PM; Coyle, AJ; Tremblay, F; Martinez, RV				Sharma, Ankur; Huard, Christine; Vernochet, Cecile; Ziemek, Daniel; Knowlton, Kelly M.; Tyminski, Edyta; Paradis, Theresa; Zhang, Ying; Jones, Jessica E. C.; von Schack, David; Brown, Christopher T.; Milos, Patrice M.; Coyle, Anthony J.; Tremblay, Frederic; Martinez, Robert V.			Brown Fat Determination and Development from Muscle Precursor Cells by Novel Action of Bone Morphogenetic Protein 6	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; ADIPOSE-TISSUE DEVELOPMENT; ADIPOCYTE DIFFERENTIATION; REGULATED EXPRESSION; INSULIN-RESISTANCE; WHITE ADIPOCYTES; C2C12 CELLS; PPAR-GAMMA; ADIPOGENESIS; MICE	Brown adipose tissue (BAT) plays a pivotal role in promoting energy expenditure by the virtue of uncoupling protein-1 (UCP-1) that differentiates BAT from its energy storing white adipose tissue (WAT) counterpart. The clinical implication of "classical" BAT (originates from Myf5 positive myoblastic lineage) or the "beige" fat (originates through trans-differentiation of WAT) activation in improving metabolic parameters is now becoming apparent. However, the inducers and endogenous molecular determinants that govern the lineage commitment and differentiation of classical BAT remain obscure. We report here that in the absence of any forced gene expression, stimulation with bone morphogenetic protein 6 (BMP6) induces brown fat differentiation from skeletal muscle precursor cells of murine and human origins. Through a comprehensive transcriptional profiling approach, we have discovered that two days of BMP6 stimulation in C2C12 myoblast cells is sufficient to induce genes characteristic of brown preadipocytes. This developmental switch is modulated in part by newly identified regulators, Optineurin (Optn) and Cyclooxygenase-2 (Cox2). Furthermore, pathway analyses using the Causal Reasoning Engine (CRE) identified additional potential causal drivers of this BMP6 induced commitment switch. Subsequent analyses to decipher key pathway that facilitates terminal differentiation of these BMP6 primed cells identified a key role for Insulin Like Growth Factor-1 Receptor (IGF-1R). Collectively these data highlight a therapeutically innovative role for BMP6 by providing a means to enhance the amount of myogenic lineage derived brown fat.	[Sharma, Ankur; Huard, Christine; Knowlton, Kelly M.; Tyminski, Edyta; Milos, Patrice M.; Coyle, Anthony J.; Tremblay, Frederic; Martinez, Robert V.] Pfizer Inc, Ctr Therapeut Innovat, Boston, MA 02115 USA; [Vernochet, Cecile; Jones, Jessica E. C.] Pfizer Inc, CVMED, Cambridge, MA USA; [Ziemek, Daniel] Pfizer Inc, Computat Sci Ctr Emphasis, Cambridge, MA USA; [Paradis, Theresa; Zhang, Ying; von Schack, David] Pfizer Inc, BioTherapeut Clin Res, Cambridge, MA USA; [Brown, Christopher T.] Pfizer Inc, Global BioTherapeut Technol, Cambridge, MA USA	Pfizer; Pfizer; Pfizer; Pfizer; Pfizer	Martinez, RV (corresponding author), Pfizer Inc, Ctr Therapeut Innovat, Boston, MA 02115 USA.	Robert.Martinez@Pfizer.com		Jones, Jessica/0000-0003-2539-5697	Pfizer	Pfizer(Pfizer)	This work was funded, supported and performed using Pfizer resources. The funder did support all authors in the form of salaries, while the research was conducted AND was involved in granting permission and authorizing the publication.	Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P2533, DOI 10.1167/iovs.05-1639; Ahfeldt T, 2012, NAT CELL BIOL, V14, P209, DOI 10.1038/ncb2411; Alexander DL, 1998, J CELL SCI, V111, P3311; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Bell-Parikh LC, 2003, J CLIN INVEST, V112, P945, DOI 10.1172/JCI200318012; Bernot D, 2010, J BIOL CHEM, V285, P6508, DOI 10.1074/jbc.M109.078444; Boucher J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1905; Boucher J, 2010, J BIOL CHEM, V285, P17235, DOI 10.1074/jbc.M110.118620; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Chang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030637; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Cristancho AG, 2011, P NATL ACAD SCI USA, V108, P16271, DOI 10.1073/pnas.1109409108; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Cypess AM, 2013, NAT MED; De Marco N, 2006, J BIOL CHEM, V281, P16147, DOI 10.1074/jbc.M601467200; Entingh-Pearsall A, 2004, J BIOL CHEM, V279, P38016, DOI 10.1074/jbc.M313201200; Fajas L, 2003, J LIPID RES, V44, P1652, DOI 10.1194/jlr.M300248-JLR200; Fournier B, 2012, MOL CELL BIOL, V32, P2871, DOI 10.1128/MCB.06575-11; Fuentealba L, 1999, J BIOL CHEM, V274, P37876, DOI 10.1074/jbc.274.53.37876; FUTAKI N, 1994, PROSTAGLANDINS, V47, P55, DOI 10.1016/0090-6980(94)90074-4; Fux C, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh001; Ghoshal S, 2011, J BIOL CHEM, V286, P889, DOI 10.1074/jbc.M110.139139; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Hsieh PS, 2009, OBESITY, V17, P1150, DOI 10.1038/oby.2008.674; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; John-Aryankalayil M, 2009, MOL CANCER THER, V8, P261, DOI 10.1158/1535-7163.MCT-08-0928; Kachaner D, 2012, CELL CYCLE, V11, P2808, DOI 10.4161/cc.20946; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Kim DH, 2013, J LIPID RES, V54, P786, DOI 10.1194/jlr.M033894; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED; Lindon C, 1998, J CELL BIOL, V140, P111, DOI 10.1083/jcb.140.1.111; Liu P, 2009, GENE, V433, P72, DOI 10.1016/j.gene.2008.12.010; Madsen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011391; Mancini A, 2007, ONCOGENE, V26, P1020, DOI 10.1038/sj.onc.1209853; Maruyama H, 2012, GERIATR GERONTOL INT; Meng QF, 2012, MOL BIOL REP, V39, P5867, DOI 10.1007/s11033-011-1397-7; Nath M, 2011, CELL TISSUE RES, V344, P435, DOI 10.1007/s00441-011-1165-y; Nishio M, 2012, CELL METAB, V16, P394, DOI 10.1016/j.cmet.2012.08.001; Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Petersen RK, 2003, J LIPID RES, V44, P2320, DOI 10.1194/jlr.M300192-JLR200; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; RAJAKUMARI S, 2013, CELL METAB; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sanchez-Gurmaches J, 2012, CELL METAB, V16, P348, DOI 10.1016/j.cmet.2012.08.003; Schulz TJ, 2013, BIOCHEM J, V453, P167, DOI 10.1042/BJ20130457; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Strader AD, 2004, J CLIN INVEST, V114, P1354, DOI 10.1172/JCI200420631; Subbaramaiah K, 2012, CANCER DISCOV, V2, P356, DOI 10.1158/2159-8290.CD-11-0241; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vukicevic S, 2009, CYTOKINE GROWTH F R, V20, P441, DOI 10.1016/j.cytogfr.2009.10.020; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yan HY, 2003, J LIPID RES, V44, P424, DOI 10.1194/jlr.M200357-JLR200; Yin H, 2013, CELL METAB, V17, P210, DOI 10.1016/j.cmet.2013.01.004	69	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92608	10.1371/journal.pone.0092608	http://dx.doi.org/10.1371/journal.pone.0092608			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658703	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300105
J	Subudhi, AW; Bourdillon, N; Bucher, J; Davis, C; Elliott, JE; Eutermoster, M; Evero, O; Fan, JL; Houten, SJV; Julian, CG; Kark, J; Kark, S; Kayser, B; Kern, JP; Kim, SE; Lathan, C; Laurie, SS; Lovering, AT; Paterson, R; Polaner, DM; Ryan, BJ; Spira, JL; Tsao, JW; Wachsmuth, NB; Roach, RC				Subudhi, Andrew W.; Bourdillon, Nicolas; Bucher, Jenna; Davis, Christopher; Elliott, Jonathan E.; Eutermoster, Morgan; Evero, Oghenero; Fan, Jui-Lin; Jameson-Van Houten, Sonja; Julian, Colleen G.; Kark, Jonathan; Kark, Sherri; Kayser, Bengt; Kern, Julia P.; Kim, See Eun; Lathan, Corinna; Laurie, Steven S.; Lovering, Andrew T.; Paterson, Ryan; Polaner, David M.; Ryan, Benjamin J.; Spira, James L.; Tsao, Jack W.; Wachsmuth, Nadine B.; Roach, Robert C.			AltitudeOmics: The Integrative Physiology of Human Acclimatization to Hypobaric Hypoxia and Its Retention upon Reascent	PLOS ONE			English	Article							OPERATION EVEREST-II; PULMONARY GAS-EXCHANGE; ACUTE MOUNTAIN-SICKNESS; PLASMA-VOLUME EXPANSION; COGNITIVE PERFORMANCE; SIMULATED ASCENT; OXYGEN-TRANSPORT; EXERCISE; VO(2MAX); NEOCYTOLYSIS	An understanding of human responses to hypoxia is important for the health of millions of people worldwide who visit, live, or work in the hypoxic environment encountered at high altitudes. In spite of dozens of studies over the last 100 years, the basic mechanisms controlling acclimatization to hypoxia remain largely unknown. The AltitudeOmics project aimed to bridge this gap. Our goals were 1) to describe a phenotype for successful acclimatization and assess its retention and 2) use these findings as a foundation for companion mechanistic studies. Our approach was to characterize acclimatization by measuring changes in arterial oxygenation and hemoglobin concentration [Hb], acute mountain sickness (AMS), cognitive function, and exercise performance in 21 subjects as they acclimatized to 5260 m over 16 days. We then focused on the retention of acclimatization by having subjects reascend to 5260 m after either 7 (n = 14) or 21 (n = 7) days at 1525 m. At 16 days at 5260 m we observed: 1) increases in arterial oxygenation and [Hb] (compared to acute hypoxia: PaO2 rose 964 mmHg to 45 +/- 4 while PaCO2 dropped a further 6 +/- 3 mmHg to 21 +/- 3, and [Hb] rose 1.8 +/- 0.7 g/dL to 16 +/- 2 g/dL; 2) no AMS; 3) improved cognitive function; and 4) improved exercise performance by 8 +/- 8% (all changes p<0.01). Upon reascent, we observed retention of arterial oxygenation but not [Hb], protection from AMS, retention of exercise performance, less retention of cognitive function; and noted that some of these effects lasted for 21 days. Taken together, these findings reveal new information about retention of acclimatization, and can be used as a physiological foundation to explore the molecular mechanisms of acclimatization and its retention.	[Subudhi, Andrew W.; Davis, Christopher; Eutermoster, Morgan; Evero, Oghenero; Jameson-Van Houten, Sonja; Julian, Colleen G.; Kark, Jonathan; Kark, Sherri; Paterson, Ryan; Roach, Robert C.] Univ Colorado, Altitude Res Ctr, Dept Emergency Med, Aurora, CO 80045 USA; [Subudhi, Andrew W.] Univ Colorado, Dept Biol, Colorado Springs, CO 80907 USA; [Bourdillon, Nicolas; Fan, Jui-Lin; Kayser, Bengt] Univ Lausanne, Fac Biol & Med, Inst Sports Sci, Lausanne, Switzerland; [Bourdillon, Nicolas; Fan, Jui-Lin] Univ Lausanne, Fac Biol & Med, Dept Physiol, Lausanne, Switzerland; [Bucher, Jenna; Elliott, Jonathan E.; Kern, Julia P.; Kim, See Eun; Laurie, Steven S.; Lovering, Andrew T.] Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA; [Fan, Jui-Lin] Univ Lausanne, Leman Doctoral Sch Neurosci, Lausanne, Switzerland; [Lathan, Corinna] AnthroTronix Inc, Silver Spring, MD USA; [Polaner, David M.] Univ Colorado, Sch Med, Dept Anesthesiol, Aurora, CO USA; [Polaner, David M.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Polaner, David M.] Childrens Hosp Colorado, Aurora, CO USA; [Ryan, Benjamin J.] Univ Colorado, Dept Integrat Physiol, Boulder, CO USA; [Spira, James L.] Univ Hawaii, US Dept Vet Affairs, Pacific Islands Hlth Care Syst, Natl Ctr PTSD, Honolulu, HI 96822 USA; [Spira, James L.] Univ Hawaii, John A Burns Sch Med, Dept Psychiat, Honolulu, HI 96822 USA; [Tsao, Jack W.] US Navy Bur Med & Surg, Wounded Ill & Injured Directorate M9, Falls Church, VA USA; [Wachsmuth, Nadine B.] Univ Bayreuth, Dept Sports Med Sports Physiol, Bayreuth, Germany	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado at Colorado Springs; University of Lausanne; University of Lausanne; University of Oregon; University of Lausanne; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Boulder; University of Hawaii System; US Department of Veterans Affairs; University of Hawaii System; University of Bayreuth	Roach, RC (corresponding author), Univ Colorado, Altitude Res Ctr, Dept Emergency Med, Anschutz Med Campus, Aurora, CO 80045 USA.	Robert.Roach@ucdenver.edu	Kayser, Bengt/M-8643-2013; Polaner, David M/AAX-2514-2021; Lovering, Andrew/AAV-4419-2021; Roach, Robert/F-4729-2011	Kayser, Bengt/0000-0002-9776-7501; Polaner, David M/0000-0001-8716-6289; Lovering, Andrew/0000-0001-7826-4290; Fan, Jui-Lin/0000-0002-4413-5615; Ryan, Benjamin/0000-0001-5848-6988; Elliott, Jonathan/0000-0002-6992-6851; Wachsmuth, Nadine B./0000-0002-6321-3594; Roach, Robert/0000-0002-7998-8976; Subudhi, Andrew/0000-0001-9719-7660	United States Department of Defense [W81XWH-11-2-0040 TATRC, W81XWH-10-2-0114]; National Institutes of Health (NIH)/National Center for Advancing Translational Sciences Colorado CTSI [UL1 TR000154]; Cardiopulmonary & Respiratory Physiology Laboratory, University of Oregon; Altitude Research Center; Charles S. Houston Endowed Professorship, Department of Emergency Medicine, School of Medicine, University of Colorado Denver; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000154, UL1TR001082] Funding Source: NIH RePORTER	United States Department of Defense(United States Department of Defense); National Institutes of Health (NIH)/National Center for Advancing Translational Sciences Colorado CTSI; Cardiopulmonary & Respiratory Physiology Laboratory, University of Oregon; Altitude Research Center; Charles S. Houston Endowed Professorship, Department of Emergency Medicine, School of Medicine, University of Colorado Denver; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The overall AltitudeOmics study was funded, in part, by grants from the United States Department of Defense (W81XWH-11-2-0040 TATRC to RCR and W81XWH-10-2-0114 to ATL). The project was also supported, in part, by National Institutes of Health (NIH)/National Center for Advancing Translational Sciences Colorado CTSI Grant Number UL1 TR000154. Contents are the author's sole responsibility and do not necessarily represent official NIH views. Major additional support came from the Cardiopulmonary & Respiratory Physiology Laboratory, University of Oregon; the Altitude Research Center and the Charles S. Houston Endowed Professorship, Department of Emergency Medicine, School of Medicine, University of Colorado Denver. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfrey CP, 1997, LANCET, V349, P1389, DOI 10.1016/S0140-6736(96)09208-2; Amann M, 2013, J APPL PHYSIOL, V115, P634, DOI 10.1152/japplphysiol.00606.2013; Barcroft J, 1923, PHILOS T R SOC LON B, V211, P351, DOI 10.1098/rstb.1923.0008; BEBOUT DE, 1989, J APPL PHYSIOL, V67, P2286, DOI 10.1152/jappl.1989.67.6.2286; Beidleman BA, 1997, MED SCI SPORT EXER, V29, P1588, DOI 10.1097/00005768-199712000-00007; Calbet JAL, 2004, AM J PHYSIOL-HEART C, V287, pH1214, DOI 10.1152/ajpheart.00840.2003; Calbet JAL, 2003, J PHYSIOL-LONDON, V551, P379, DOI 10.1113/jphysiol.2003.045112; Calbet JAL, 2003, AM J PHYSIOL-REG I, V284, pR304, DOI 10.1152/ajpregu.00156.2002; Calbet JAL, 2003, AM J PHYSIOL-REG I, V284, pR291, DOI 10.1152/ajpregu.00155.2002; Calbet JAL, 2008, APPL PHYSIOL NUTR ME, V33, P593, DOI 10.1139/H08-010; Cauchy E, 2002, AVIAT SPACE ENVIR MD, V73, P1224; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Dodd JW, 2010, EUR RESPIR J, V35, P913, DOI 10.1183/09031936.00125109; Fan JL, 2013, J APPL PHYSIOL, DOI [10.1152/japplphysiol.00704.2013, DOI 10.1152/JAPPLPHYSI0L.00704.2013)]; Fulco CS, 2005, J APPL PHYSIOL, V99, P867, DOI 10.1152/japplphysiol.00019.2005; Fulco CS, 2002, AVIAT SPACE ENVIR MD, V73, P758; Gerard A B, 2000, High Alt Med Biol, V1, P51, DOI 10.1089/152702900320685; Goodall S, 2014, ACTA PHYSL, DOI [10.1111/apha.12241, DOI 10.1111/APHA.12241)]; GROVES BM, 1987, J APPL PHYSIOL, V63, P521, DOI 10.1152/jappl.1987.63.2.521; HACKETT PH, 1976, LANCET, V2, P1149; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Hill A.V., 1910, J PHYSL, V40, pi, DOI DOI 10.1113/JPHYSIOL.1910.SP191040SUPPLTOC; HORNBEIN TF, 1989, NEW ENGL J MED, V321, P1714, DOI 10.1056/NEJM198912213212505; HORSTMAN D, 1980, J APPL PHYSIOL, V49, P311, DOI 10.1152/jappl.1980.49.2.311; HOUSTON CS, 1987, J APPL PHYSIOL, V63, P877, DOI 10.1152/jappl.1987.63.2.877; Houston CS, 2005, GOING HIGHER OXYGEN; Hultgren H, 1997, HIGH ALTITUDE MED; Janocha AJ, 2011, NEW ENGL J MED, V365, P1942, DOI 10.1056/NEJMc1107887; Julian CG, 2011, J APPL PHYSIOL, V111, P392, DOI 10.1152/japplphysiol.00391.2011; KELMAN GR, 1966, J APPL PHYSIOL, V21, P1375, DOI 10.1152/jappl.1966.21.4.1375; KENNEDY RS, 1989, AVIAT SPACE ENVIR MD, V60, P99; KIDA M, 1993, J APPL PHYSIOL, V74, P1735, DOI 10.1152/jappl.1993.74.4.1735; KNAPIK J, 1989, MIL MED, V154, P326; Lathan C, 2013, MIL MED, V178, P365, DOI 10.7205/MILMED-D-12-00438; Latshang TD, 2011, SCANDINAVIAN J MED S; Leifflen D, 1997, AVIAT SPACE ENVIR MD, V68, P993; Luft U, 1942, LUFTFAHRTMEDIZEN, V7, P205; Lundby C, 2007, SCAND J MED SCI SPOR, V17, P281, DOI 10.1111/j.1600-0838.2006.00530.x; Lundby C, 2006, SCAND J MED SCI SPOR, V16, P35, DOI 10.1111/j.1600-0838.2004.00434.x; Lundby C, 2004, AM J PHYSIOL-REG I, V287, pR1202, DOI 10.1152/ajpregu.00725.2003; LYONS TP, 1995, AVIAT SPACE ENVIR MD, V66, P957; MAHER JT, 1974, J APPL PHYSIOL, V37, P895, DOI 10.1152/jappl.1974.37.6.895; MERINO CF, 1950, BLOOD, V5, P1; Messner R, 1989, CRYSTAL HORIZON EVER; MOORE RJ, 1992, CHANGES SOLDIER NUTR; Muza SR, 1995, ACTA ANDINA, V4, P109; Muza SR, 2010, HIGH ALT MED BIOL, V11, P87, DOI 10.1089/ham.2010.1006; NAKHOSTINE N, 1993, AM J PHYSIOL, V265, pH1289, DOI 10.1152/ajpheart.1993.265.4.H1289; Pavlicek V, 2005, AVIAT SPACE ENVIR MD, V76, P28; REEVES JT, 1987, J APPL PHYSIOL, V63, P531, DOI 10.1152/jappl.1987.63.2.531; REGARD M, 1991, AVIAT SPACE ENVIR MD, V62, P291; REYNAFARJE C, 1959, BLOOD, V14, P433, DOI 10.1182/blood.V14.4.433.433; Rice L, 2005, CELL PHYSIOL BIOCHEM, V15, P245, DOI 10.1159/000087234; Richalet JP, 2012, AM J RESP CRIT CARE, V185, P192, DOI 10.1164/rccm.201108-1396OC; Robach P, 2000, J APPL PHYSIOL, V89, P29; Robach P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002996; SAMPSON JB, 1980, AVIAT SPACE ENVIR MD, V51, P872; Schneider M, 2002, MED SCI SPORT EXER, V34, P1886, DOI 10.1097/00005768-200212000-00005; SCHOENE RB, 1990, MED SCI SPORT EXER, V22, P804, DOI 10.1249/00005768-199012000-00012; Schuler B, 2007, SCAND J MED SCI SPOR, V17, P588, DOI 10.1111/j.1600-0838.2006.00611.x; SEVERINGHAUS JW, 1966, J APPL PHYSIOL, V21, P1108, DOI 10.1152/jappl.1966.21.3.1108; SINGH I, 1969, NEW ENGL J MED, V280, P175, DOI 10.1056/NEJM196901232800402; STAMPER DA, 1970, PERCEPT MOTOR SKILL, V31, P247, DOI 10.2466/pms.1970.31.1.247; Subudhi AW, 2008, AM J PHYSIOL-HEART C, V294, pH164, DOI 10.1152/ajpheart.01104.2007; Subudhi AW, 2011, J APPL PHYSIOL, V110, P1219, DOI 10.1152/japplphysiol.01393.2010; Subudhi AW, 2013, J APPL PHYSIOL, DOI [10.1152/japplphysiol.00880.2013, DOI 10.1152/JAPPLPHYSI0L.00880.2013)]; Subudhi AW, 2013, EXP PHYSIOL, DOI [10.1113/expphysiol.2013.075184, DOI 10.1113/EXPPHYSI0L.2013.075184)]; SUTTON JR, 1988, J APPL PHYSIOL, V64, P1309, DOI 10.1152/jappl.1988.64.4.1309; Thorne DR, 2006, BEHAV RES METHODS, V38, P569, DOI 10.3758/BF03193886; Wagner PD, 2002, J APPL PHYSIOL, V92, P1393, DOI 10.1152/japplphysiol.00093.2001; WAGNER PD, 1987, J APPL PHYSIOL, V63, P2348, DOI 10.1152/jappl.1987.63.6.2348; WOLFEL EE, 1991, J APPL PHYSIOL, V70, P1129, DOI 10.1152/jappl.1991.70.3.1129; Wu TY, 2009, HIGH ALT MED BIOL, V10, P221, DOI 10.1089/ham.2009.1012; Young AJ, 1996, J APPL PHYSIOL, V81, P252, DOI 10.1152/jappl.1996.81.1.252	74	60	64	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92191	10.1371/journal.pone.0092191	http://dx.doi.org/10.1371/journal.pone.0092191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658407	Green Submitted, Green Published, gold			2022-12-27	WOS:000333355300059
J	Postma, DBW; den Otter, AR; Zaal, FTJM				Postma, Dees B. W.; den Otter, A. Rob; Zaal, Frank T. J. M.			Keeping Your Eyes Continuously on the Ball While Running for Catchable and Uncatchable Fly Balls	PLOS ONE			English	Article							ACCELERATION CANCELLATION THEORY; UNIFIED FIELDER THEORY; VIRTUAL-REALITY; INFORMATION; BASEBALL; RUN; TRAJECTORIES; INTERCEPTION; MOVEMENTS; STRATEGY	When faced with a fly ball approaching along the sagittal plane, fielders need information for the control of their running to the interception location. This information could be available in the initial part of the ball trajectory, such that the interception location can be predicted from its initial conditions. Alternatively, such predictive information is not available, and running to the interception location involves continuous visual guidance. The latter type of control would predict that fielders keep looking at the approaching ball for most of its flight, whereas the former type of control would fit with looking at the ball during the early part of the ball's flight; keeping the eyes on the ball during the remainder of its trajectory would not be necessary when the interception location can be inferred from the first part of the ball trajectory. The present contribution studied visual tracking of approaching fly balls. Participants were equipped with a mobile eye tracker. They were confronted with tennis balls approaching from about 20 m, and projected in such a way that some balls were catchable and others were not. In all situations, participants almost exclusively tracked the ball with their gaze until just before the catch or until they indicated that a ball was uncatchable. This continuous tracking of the ball, even when running close to their maximum speeds, suggests that participants employed continuous visual control rather than running to an interception location known from looking at the early part of the ball flight.	[Postma, Dees B. W.; den Otter, A. Rob; Zaal, Frank T. J. M.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Sect F, Groningen, Netherlands	University of Groningen	Zaal, FTJM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Sect F, Groningen, Netherlands.	f.t.j.m.zaal@umcg.nl	Zaal, Frank TJM/A-5578-2008	Zaal, Frank TJM/0000-0003-2697-3612; Postma, Dees/0000-0002-1108-7549				Adair R.K, 2002, PHYS BASEBALL; Arzamarski R, 2007, EXP BRAIN RES, V177, P312, DOI 10.1007/s00221-006-0671-8; Bastin J, 2006, HUM MOVEMENT SCI, V25, P718, DOI 10.1016/j.humov.2006.04.001; Bongers RM, 2008, J EXP PSYCHOL HUMAN, V34, P1515, DOI 10.1037/a0011974; Bootsma RJ, 2009, PERCEPTION, V38, P851; Bootsma RJ, 1997, J EXP PSYCHOL HUMAN, V23, P1282; Bosco G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049381; BRANCAZIO PJ, 1985, AM J PHYS, V53, P849, DOI 10.1119/1.14350; Brouwer AM, 2006, VISION RES, V46, P382, DOI 10.1016/j.visres.2005.09.002; Bruce V., 2003, VISUAL PERCEPTION PH, V4th; CHAPMAN S, 1968, AM J PHYS, V36, P868, DOI 10.1119/1.1974297; CHODOSH LA, 1995, SCIENCE, V268, P1682, DOI 10.1126/science.7792585; Coren S., 2004, SENSATION PERCEPTION, DOI [10.1002/0471264385.wei0105, DOI 10.1002/0471264385.WEI0105]; Fajen BR, 2009, INT J SPORT PSYCHOL, V40, P79; Fink PW, 2009, J VISION, V9, DOI 10.1167/9.13.14; Ledouit S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080827; MCBEATH MK, 1995, SCIENCE, V268, P569, DOI 10.1126/science.7725104; McLeod P, 2006, J EXP PSYCHOL HUMAN, V32, P139, DOI 10.1037/0096-1523.32.1.139; McLeod P, 1996, J EXP PSYCHOL HUMAN, V22, P531; McLeod P, 2003, NATURE, V426, P244, DOI 10.1038/426244a; McLeod P, 2002, J EXP PSYCHOL HUMAN, V28, P1499, DOI 10.1037//0096-1523.28.6.1499; McLeod P, 2001, J EXP PSYCHOL HUMAN, V27, P1347, DOI 10.1037/0096-1523.27.6.1347; McLeod P, 2008, VISION RES, V48, P1479, DOI 10.1016/j.visres.2008.03.016; Michaels Claire F., 1992, Ecological Psychology, V4, P199, DOI 10.1207/s15326969eco0404_1; Montagne G, 1999, EXP BRAIN RES, V129, P87, DOI 10.1007/s002210050939; Oudejans RRD, 1999, J EXP PSYCHOL HUMAN, V25, P531, DOI 10.1037/0096-1523.25.2.531; SAXBERG BVH, 1987, BIOL CYBERN, V56, P177, DOI 10.1007/BF00317992; Shaffer DM, 2008, PERCEPT PSYCHOPHYS, V70, P145, DOI 10.3758/PP.70.1.145; Shaffer DM, 2003, J EXP PSYCHOL HUMAN, V29, P1244, DOI 10.1037/0096-1523.29.6.1244; Shaffer DM, 2002, J EXP PSYCHOL HUMAN, V28, P335, DOI 10.1037//0096-1523.28.2.335; Sugar TG, 2006, PSYCHON B REV, V13, P908, DOI 10.3758/BF03194018; Todd J T, 1981, J Exp Psychol Hum Percept Perform, V7, P975; Zaal FTJM, 2012, ATTEN PERCEPT PSYCHO, V74, P1488, DOI 10.3758/s13414-012-0328-6; Zaal FTJM, 2003, J EXP PSYCHOL HUMAN, V29, P537, DOI 10.1037/0096-1523.29.3.537	34	11	11	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92392	10.1371/journal.pone.0092392	http://dx.doi.org/10.1371/journal.pone.0092392			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SR	24670972	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000043
J	Radford, IJ; Dickman, CR; Start, AN; Palmer, C; Carnes, K; Everitt, C; Fairman, R; Graham, G; Partridge, T; Thomson, A				Radford, Ian J.; Dickman, Christopher R.; Start, Antony N.; Palmer, Carol; Carnes, Karin; Everitt, Corrin; Fairman, Richard; Graham, Gordon; Partridge, Thalie; Thomson, Allan			Mammals of Australia's Tropical Savannas: A Conceptual Model of Assemblage Structure and Regulatory Factors in the Kimberley Region	PLOS ONE			English	Article							KAKADU-NATIONAL-PARK; PSEUDANTECHINUS-MACDONNELLENSIS MARSUPIALIA; DASYURUS-HALLUCATUS MARSUPIALIA; NORTHERN AUSTRALIA; WESTERN-AUSTRALIA; TRANSITION MODELS; ARID AUSTRALIA; MITCHELL PLATEAU; BIODIVERSITY CONSERVATION; POPULATION-DYNAMICS	We construct a state-and-transition model for mammals in tropical savannas in northern Australia to synthesize ecological knowledge and understand mammalian declines. We aimed to validate the existence of alternative mammal assemblage states similar to those in arid Australian grasslands, and to speculate on transition triggers. Based on the arid grassland model, we hypothesized that assemblages are partitioned across rainfall gradients and between substrates. We also predicted that assemblages typical of arid regions in boom periods would be prevalent in savannas with higher and more regular rainfall. Data from eight mammal surveys from the Kimberley region, Western Australia (1994 to 2011) were collated. Survey sites were partitioned across rainfall zones and habitats. Data allowed us to identify three assemblage states: State 0:- low numbers of mammals, State II:- dominated by omnivorous rodents and State III:- dominated by rodents and larger marsupials. Unlike arid grasslands, assemblage dominance by insectivorous dasyurids (State I) did not occur in savannas. Mammal assemblages were partitioned across rainfall zones and between substrates as predicted, but-unlike arid regions-were not related strongly to yearly rainfall. Mammal assemblage composition showed high regional stability, probably related to high annual rainfall and predictable wet season resource pulses. As a consequence, we speculate that perpetually booming assemblages in savannas allow top-down control of the ecosystem, with suppression of introduced cats by the dingo, the region's top predator. Under conditions of low or erratic productivity, imposed increasingly by intense fire regimes and introduced herbivore grazing, dingoes may not limit impacts of cats on native mammals. These interacting factors may explain contemporary declines of savanna mammals as well as historical declines in arid Australia. The cat-ecosystem productivity hypothesis raised here differs from the already-articulated cat-habitat structure hypothesis for mammal declines, and we suggest approaches for explicit testing of transition triggers for competing hypotheses.	[Radford, Ian J.; Carnes, Karin; Everitt, Corrin; Fairman, Richard; Thomson, Allan] Dept Pk & Wildlife, Div Sci & Conservat, Kununurra, WA, Australia; [Dickman, Christopher R.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Start, Antony N.] Dept Pk & Wildlife, Div Sci & Conservat, Woodvale, WA, Australia; [Palmer, Carol] Northern Terr Govt, Dept Land Resource Management, Palmerston, NT, Australia; [Graham, Gordon] Conservat Commiss Western Australia, Crawley, WA, Australia; [Partridge, Thalie] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia	University of Sydney; Northern Territory Government; Macquarie University	Radford, IJ (corresponding author), Dept Pk & Wildlife, Div Sci & Conservat, Kununurra, WA, Australia.	ian.radford@dpaw.wa.gov.au	Dickman, Christopher/Q-4662-2019	Dickman, Christopher/0000-0002-1067-3730	Department of Parks and Wildlife, Western Australia; Department of Environment and Conservation; Department of Conservation and Land Management	Department of Parks and Wildlife, Western Australia; Department of Environment and Conservation; Department of Conservation and Land Management	Funding for research and component surveys was provided by the Department of Parks and Wildlife, Western Australia, and its predecessors (the Department of Environment and Conservation and the Department of Conservation and Land Management). Department of Parks and Wildlife staff designed the studies and collected data. Analyses undertaken and the decision to prepare and publish this manuscript was made by Departmental staff in conjunction with the University of Sydney.	Abbott I, 2002, WILDLIFE RES, V29, P51, DOI 10.1071/WR01011; Andersen AN, 2005, AUSTRAL ECOL, V30, P155, DOI 10.1111/j.1442-9993.2005.01441.x; Ash A. J., 1982, Proceedings of the Australian Society of Animal Production, V14, P377; Ash A. J., 1997, Rangeland Journal, V19, P123, DOI 10.1071/RJ9970123; Bagchi S, 2012, ECOL APPL, V22, P400, DOI 10.1890/11-0704.1; BEGG RJ, 1981, AUST WILDLIFE RES, V8, P515; Beringer J, 2007, GLOBAL CHANGE BIOL, V13, P990, DOI 10.1111/j.1365-2486.2007.01334.x; Bestelmeyer BT, 2011, J APPL ECOL, V48, P746, DOI 10.1111/j.1365-2664.2011.01982.x; Bestelmeyer BT, 2006, J ARID ENVIRON, V65, P296, DOI 10.1016/j.jaridenv.2005.06.028; BRADLEY AJ, 1987, AUST WILDLIFE RES, V14, P397; Braithwaite R. W., 1993, Australian Mammalogy, V16, P93; BRAITHWAITE RW, 1994, WILDLIFE RES, V21, P203, DOI 10.1071/WR9940203; Braithwaite RW, 1996, WILDLIFE RES, V23, P1, DOI 10.1071/WR9960001; Briske DD, 2008, RANGELAND ECOL MANAG, V61, P359, DOI 10.2111/07-051.1; Brook LA, 2012, J APPL ECOL, V49, P1278, DOI 10.1111/j.1365-2664.2012.02207.x; BURBIDGE AA, 1989, BIOL CONSERV, V50, P143, DOI 10.1016/0006-3207(89)90009-8; Burbidge AA, 2002, J BIOGEOGR, V29, P465, DOI 10.1046/j.1365-2699.2002.00699.x; COOK GD, 1994, AUST J ECOL, V19, P359, DOI 10.1111/j.1442-9993.1994.tb00501.x; Corbett LK, 2003, ECOL STU AN, V169, P126; Czembor CA, 2009, FOREST ECOL MANAG, V259, P165, DOI 10.1016/j.foreco.2009.10.002; Dickman CR, 2010, J MAMMAL, V91, P798, DOI 10.1644/09-MAMM-S-205.1; Dickman CR, 1999, WILDLIFE RES, V26, P389, DOI 10.1071/WR97057; Dickman CR, 2001, WILDLIFE RES, V28, P493, DOI 10.1071/WR00023; Dostine PL, 2001, WILDLIFE RES, V28, P445, DOI 10.1071/WR00049; Forbis TA, 2006, ENVIRON MANAGE, V38, P62, DOI 10.1007/s00267-005-0089-2; Franklin DC, 2005, WILDLIFE RES, V32, P399, DOI 10.1071/WR05052; Fuhlendorf SD, 2004, J APPL ECOL, V41, P604, DOI 10.1111/j.0021-8901.2004.00937.x; Gasaway WC, 1992, ECOL MONOGR, V120, P3; Gibson LA, 2012, RECORDS W AUSTR MU S, V81, P15; Gilfillan SL, 2001, WILDLIFE RES, V28, P469, DOI 10.1071/WR99062; Gilfillan SL, 2001, WILDLIFE RES, V28, P481, DOI 10.1071/WR99063; Hobbs R.J., 2009, NEW MODELS ECOSYSTEM; Hopcraft JGC, 2010, TRENDS ECOL EVOL, V25, P119, DOI 10.1016/j.tree.2009.08.001; Johnson C, 2006, AUSTR MAMMAL EXTINCT; KEMPER CM, 1987, J ZOOL, V212, P533, DOI 10.1111/j.1469-7998.1987.tb02923.x; Kennedy M, 2012, AUSTRAL ECOL, V37, P134, DOI 10.1111/j.1442-9993.2011.02256.x; Laundre JW, 2010, CANADIAN J ECOLOGY, V79, P1401; Legge S, 2008, WILDLIFE RES, V35, P33, DOI 10.1071/WR07016; Legge S, 2011, AUSTRAL ECOL, V36, P791, DOI 10.1111/j.1442-9993.2010.02218.x; Letnic M, 2004, J ARID ENVIRON, V59, P85, DOI 10.1016/j.jaridenv.2004.01.014; Letnic M, 2010, BIOL REV, V85, P501, DOI 10.1111/j.1469-185X.2009.00113.x; Letnic M, 2006, BIODIVERS CONSERV, V15, P3847, DOI 10.1007/s10531-005-0601-2; Letnic M, 2012, BIOL REV, V87, P390, DOI 10.1111/j.1469-185X.2011.00203.x; Letnic M, 2011, J MAMMAL, V92, P1210, DOI 10.1644/10-MAMM-S-229.1; Litzow MA, 2007, ECOL LETT, V10, P1124, DOI 10.1111/j.1461-0248.2007.01111.x; Madsen T, 1999, ECOLOGY, V80, P989, DOI 10.1890/0012-9658(1999)080[0989:LHCONS]2.0.CO;2; McKenzie NL, 2007, J BIOGEOGR, V34, P597, DOI 10.1111/j.1365-2699.2006.01639.x; MCKENZIE NL, 1981, J BIOGEOGR, V8, P263, DOI 10.2307/2844762; Moran MD, 2002, OIKOS, V98, P116, DOI 10.1034/j.1600-0706.2002.980112.x; Morton S.R., 1985, Australian Mammalogy, V8, P159; NEWSOME AE, 1989, OECOLOGIA, V78, P458, DOI 10.1007/BF00378734; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Ostfeld RS, 2007, PULSED RESOURCES COM, P30; P Grime J., 2012, EVOLUTIONARY STRATEG, DOI [DOI 10.1002/9781118223246, 10.1002/9781118223246]; Palmer C, 2004, BIODIVERS CONSERV; Pardon LG, 2003, J ANIM ECOL, V72, P106, DOI 10.1046/j.1365-2656.2003.00686.x; Partridge TB, 2010, THESIS MACQUARIE U; Price O, 2005, WILDLIFE RES, V32, P435, DOI 10.1071/WR04033; Radford IJ, 2012, AUSTRAL ECOL, V37, P926, DOI 10.1111/j.1442-9993.2011.02352.x; Radford IJ, 2012, AUSTRAL ECOL, V37, P733, DOI 10.1111/j.1442-9993.2012.02413.x; Radford Ian J., 2010, Conservation Science Western Australia, V7, P469; Richards AE, 2012, AUSTRAL ECOL, V37, P712, DOI 10.1111/j.1442-9993.2012.02395.x; Ripple WJ, 2001, BIOL CONSERV, V102, P227, DOI 10.1016/S0006-3207(01)00107-0; Rumpff L, 2011, BIOL CONSERV, V144, P1224, DOI 10.1016/j.biocon.2010.10.026; Russell-Smith J, 2003, INT J WILDLAND FIRE, V12, P283, DOI 10.1071/WF03015; Russell-Smith J, 2003, ECOL MONOGR, V73, P349, DOI 10.1890/01-4021; Scheffer M, 2008, ECOSYSTEMS, V11, P226, DOI 10.1007/s10021-007-9118-8; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; SCHMITT LH, 1989, J ZOOL, V217, P539, DOI 10.1111/j.1469-7998.1989.tb02510.x; Scott K, 2012, AUSTRAL ECOL, V37, P693, DOI 10.1111/j.1442-9993.2012.02379.x; Standish RJ., 2009, NEW MODELS ECOSYSTEM; Start AN, 2012, AUST MAMMAL, V34, P36, DOI 10.1071/AM10026; Start A. N., 2007, AUST MAMMAL, V29, P1, DOI [10.1071/AM07001, DOI 10.1071/AM07001]; Suding KN, 2009, TRENDS ECOL EVOL, V24, P271, DOI 10.1016/j.tree.2008.11.012; Sutherland EF, 1999, WILDLIFE RES, V26, P405, DOI 10.1071/WR97045; Thackway R., 1995, INTERIM BIOREGIONALI; Tyler I., 2011, GEOLOGY LANDFORMS KI; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; van Nes EH, 2005, ECOLOGY, V86, P1797, DOI 10.1890/04-0550; Walker M, 2001, OIKOS, V93, P177, DOI 10.1034/j.1600-0706.2001.930201.x; Wang YW, 2012, WILDLIFE RES, V39, P611, DOI 10.1071/WR11210; WESTOBY M, 1989, J RANGE MANAGE, V42, P266, DOI 10.2307/3899492; White T. C. R., 1993, INADEQUATE ENV NITRO; Williams RJ, 2003, INT J WILDLAND FIRE, V12, P391, DOI 10.1071/WF03025; Williams RJ, 1999, AUST J ECOL, V24, P50, DOI 10.1046/j.1442-9993.1999.00946.x; Woinarski JCZ, 2011, WILDLIFE RES, V38, P307, DOI 10.1071/WR10184; Woinarski JCZ, 2010, WILDLIFE RES, V37, P116, DOI 10.1071/WR09125; WOINARSKI JCZ, 1992, WILDLIFE RES, V19, P233, DOI 10.1071/WR9920233; Woinarski JCZ, 2004, AUSTRAL ECOL, V29, P156, DOI 10.1111/j.1442-9993.2004.01333.x; Woinarski JCZ, 2001, AUSTRAL ECOL, V26, P360, DOI 10.1046/j.1442-9993.2001.01121.x; Woinarski JCZ, 1992, RES B, V6; Woinarski JCZ, 2011, CONSERV LETT, V4, P192, DOI 10.1111/j.1755-263X.2011.00164.x; Wolff JO, 1997, J ANIM ECOL, V66, P1, DOI 10.2307/5959; Zweig CL, 2009, ECOLOGY, V90, P1900, DOI 10.1890/08-1392.1	95	32	33	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92341	10.1371/journal.pone.0092341	http://dx.doi.org/10.1371/journal.pone.0092341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670997	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677000041
J	van Luijk, J; Bakker, B; Rovers, MM; Ritskes-Hoitinga, M; de Vries, RBM; Leenaars, M				van Luijk, Judith; Bakker, Brenda; Rovers, Maroeska M.; Ritskes-Hoitinga, Merel; de Vries, Rob B. M.; Leenaars, Marlies			Systematic Reviews of Animal Studies; Missing Link in Translational Research?	PLOS ONE			English	Review							SEARCH FILTER; BIAS; METAANALYSES; QUALITY	Background: The methodological quality of animal studies is an important factor hampering the translation of results from animal studies to a clinical setting. Systematic reviews of animal studies may provide a suitable method to assess and thereby improve their methodological quality. Objectives: The aims of this study were: 1) to evaluate the risk of bias assessment in animal-based systematic reviews, and 2) to study the internal validity of the primary animal studies included in these systematic reviews. Data Sources: We systematically searched Pubmed and Embase for SRs of preclinical animal studies published between 2005 and 2012. Results: A total of 91 systematic reviews met our inclusion criteria. The risk of bias was assessed in 48 (52.7%) of these 91 systematic reviews. Thirty-three (36.3%) SRs provided sufficient information to evaluate the internal validity of the included studies. Of the evaluated primary studies, 24.6% was randomized, 14.6% reported blinding of the investigator/caretaker, 23.9% blinded the outcome assessment, and 23.1% reported drop-outs. Conclusions: To improve the translation of animal data to clinical practice, systematic reviews of animal studies are worthwhile, but the internal validity of primary animal studies needs to be improved. Furthermore, risk of bias should be assessed by systematic reviews of animal studies to provide insight into the reliability of the available evidence.	[van Luijk, Judith; Bakker, Brenda; Ritskes-Hoitinga, Merel; de Vries, Rob B. M.; Leenaars, Marlies] Radboud Univ Nijmegen, Med Ctr, SYRCLE Cent Anim Lab, NL-6525 ED Nijmegen, Netherlands; [Rovers, Maroeska M.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, NL-6525 ED Nijmegen, Netherlands; [Rovers, Maroeska M.] Radboud Univ Nijmegen, Med Ctr, Dept Operating Rooms, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	van Luijk, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, SYRCLE Cent Anim Lab, NL-6525 ED Nijmegen, Netherlands.	Judith.vanLuijk@radboudumc.nl	Leenaars, P.P.A.M./L-4478-2015; Ritskes-Hoitinga, J./H-8083-2014; Vries, R.B.M./L-4732-2015; Ritskes-Hoitinga, Merel/GLT-8517-2022; Rovers, Maroeska/F-2969-2014	Leenaars, P.P.A.M./0000-0002-9855-708X; Ritskes-Hoitinga, Merel/0000-0001-5315-284X; Rovers, Maroeska/0000-0002-3095-170X				Baker D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001756; Bebarta V, 2003, ACAD EMERG MED, V10, P684, DOI 10.1197/aemj.10.6.684; de Vries RB, 2013, LAB ANIM; de Vries RBM, 2011, LAB ANIM-UK, V45, P268, DOI 10.1258/la.2011.011056; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Henderson VC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001489; Hooijmans CR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001482; Hooijmans CR, 2010, LAB ANIM-UK, V44, P170, DOI 10.1258/la.2010.009117; Hooijmans CR, 2010, ATLA-ALTERN LAB ANIM, V38, P167, DOI 10.1177/026119291003800208; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Korevaar DA, 2011, LAB ANIM-UK, V45, P225, DOI 10.1258/la.2011.010121; Krauth D, 2013, ENVIRON HEALTH PERSP, V121, P985, DOI 10.1289/ehp.1206389; Macleod MR, 2009, STROKE, V40, pE50, DOI 10.1161/STROKEAHA.108.525386; Mignini Luciano E, 2006, BMC Med Res Methodol, V6, P10, DOI 10.1186/1471-2288-6-10; Peters JL, 2006, J ENVIRON SCI HEAL B, V41, P1245, DOI 10.1080/03601230600857130	16	55	55	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e89981	10.1371/journal.pone.0089981	http://dx.doi.org/10.1371/journal.pone.0089981			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670965	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677000005
J	Amato, SM; Brynildsen, MP				Amato, Stephanie M.; Brynildsen, Mark P.			Nutrient Transitions Are a Source of Persisters in Escherichia coli Biofilms	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA BIOFILMS; GENE-EXPRESSION; RIBOSOMAL-RNA; BACTERIAL PERSISTENCE; MULTIPLE ANTIBIOTICS; MULTIDRUG TOLERANCE; STRINGENT CONTROL; GROWTH; PPGPP; CELLS	Chronic and recurrent infections have been attributed to persisters in biofilms, and despite this importance, the mechanisms of persister formation in biofilms remain unclear. The plethora of biofilm characteristics that could give rise to persisters, including slower growth, quorum signaling, oxidative stress, and nutrient heterogeneity, have complicated efforts to delineate formation pathways that generate persisters during biofilm development. Here we sought to specifically determine whether nutrient transitions, which are a common metabolic stress encountered within surface-attached communities, stimulate persister formation in biofilms and if so, to then identify the pathway. To accomplish this, we established an experimental methodology where nutrient availability to biofilm cells could be controlled exogenously, and then used that method to discover that diauxic carbon source transitions stimulated persister formation in Escherichia coli biofilms. Previously, we found that carbon source transitions stimulate persister formation in planktonic E. coli cultures, through a pathway that involved ppGpp and nucleoid-associated proteins, and therefore, tested the functionality of that pathway in biofilms. Biofilm persister formation was also found to be dependent on ppGpp and nucleoid-associated proteins, but the importance of specific proteins and enzymes between biofilm and planktonic lifestyles was significantly different. Data presented here support the increasingly appreciated role of ppGpp as a central mediator of bacterial persistence and demonstrate that nutrient transitions can be a source of persisters in biofilms.	[Amato, Stephanie M.; Brynildsen, Mark P.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA	Princeton University	Brynildsen, MP (corresponding author), Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA.	mbrynild@princeton.edu			National Science Foundation; Department of the Army [W81XWH-12-2-0138]; Princeton University; National Science Foundation Division of Materials Research through the Princeton University MRSEC [NSF-DMR 0819860]	National Science Foundation(National Science Foundation (NSF)); Department of the Army; Princeton University(Princeton University); National Science Foundation Division of Materials Research through the Princeton University MRSEC	This work was supported by the National Science Foundation (SMA, Graduate Research Fellowship), the Department of the Army (W81XWH-12-2-0138), and with start-up funds from Princeton University. This research was supported by the National Science Foundation Division of Materials Research through the Princeton University MRSEC (NSF-DMR 0819860). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison KR, 2011, CURR OPIN MICROBIOL, V14, P593, DOI 10.1016/j.mib.2011.09.002; Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Amato SM, 2013, MOL CELL, V50, P475, DOI 10.1016/j.molcel.2013.04.002; AN G, 1979, J BACTERIOL, V137, P1100, DOI 10.1128/JB.137.3.1100-1110.1979; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; BACHI B, 1975, BIOCHEM J, V150, P123; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; BARACCHINI E, 1988, J BIOL CHEM, V263, P2597; Bernier SP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003144; Boles BR, 2008, P NATL ACAD SCI USA, V105, P12503, DOI 10.1073/pnas.0801499105; BUJARD H, 1987, METHOD ENZYMOL, V155, P416; Claret L, 1996, J MOL BIOL, V263, P126, DOI 10.1006/jmbi.1996.0564; CLARK B, 1976, J GEN MICROBIOL, V95, P191, DOI 10.1099/00221287-95-2-191; Coenye T, 2010, J MICROBIOL METH, V83, P89, DOI 10.1016/j.mimet.2010.08.018; Dalebroux ZD, 2012, NAT REV MICROBIOL, V10, P203, DOI 10.1038/nrmicro2720; Dame RT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002123; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; DORMAN CJ, 1991, INFECT IMMUN, V59, P745, DOI 10.1128/IAI.59.3.745-749.1991; DORMAN CJ, 1988, J BACTERIOL, V170, P2816, DOI 10.1128/jb.170.6.2816-2826.1988; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; Fasani RA, 2013, P NATL ACAD SCI USA, V110, pE2528, DOI 10.1073/pnas.1301023110; Fauvart M, 2011, J MED MICROBIOL, V60, P699, DOI 10.1099/jmm.0.030932-0; Ferullo DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000300; Ferullo DJ, 2008, PLOS GENET, P1; Harrison JJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-53; Harrison JJ, 2009, ANTIMICROB AGENTS CH, V53, P2253, DOI 10.1128/AAC.00043-09; Kang SH, 2003, J BIOL CHEM, V278, P48779, DOI 10.1074/jbc.M308843200; Kint CI, 2012, TRENDS MICROBIOL, V20, P577, DOI 10.1016/j.tim.2012.08.009; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kolmsee T, 2011, MICROBIOL-SGM, V157, P2871, DOI 10.1099/mic.0.052357-0; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Lee H, 2001, MOL GEN GENET, V264, P931, DOI 10.1007/PL00008701; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Li YF, 2007, ANTIMICROB AGENTS CH, V51, P2092, DOI 10.1128/AAC.00052-07; Ma C, 2010, FEMS MICROBIOL LETT, V303, P33, DOI 10.1111/j.1574-6968.2009.01857.x; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Maxwell A, 1997, TRENDS MICROBIOL, V5, P102, DOI 10.1016/S0966-842X(96)10085-8; Moker N, 2010, J BACTERIOL, V192, P1946, DOI 10.1128/JB.01231-09; Monod J., 1942, ACTUALITES SCI IND; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Narang A, 2007, J THEOR BIOL, V244, P326, DOI 10.1016/j.jtbi.2006.08.007; NINNEMANN O, 1992, EMBO J, V11, P1075, DOI 10.1002/j.1460-2075.1992.tb05146.x; Orman MA, 2013, ANTIMICROB AGENTS CH, V57, P4398, DOI 10.1128/AAC.00372-13; Orman MA, 2013, ANTIMICROB AGENTS CH, V57, P3230, DOI 10.1128/AAC.00243-13; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Potrykus K, 2011, ENVIRON MICROBIOL, V13, P563, DOI 10.1111/j.1462-2920.2010.02357.x; PRUSS BM, 1994, J BACTERIOL, V176, P2143; ROSEMAN S, 1990, J BIOL CHEM, V265, P2993; RYALS J, 1982, J BACTERIOL, V151, P1261, DOI 10.1128/JB.151.3.1261-1268.1982; SAIER MH, 1996, ESCHERICHIA COLI SAL; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; Traxler MF, 2006, P NATL ACAD SCI USA, V103, P2374, DOI 10.1073/pnas.0510995103; Vega NM, 2012, NAT CHEM BIOL, V8, P431, DOI [10.1038/NCHEMBIO.915, 10.1038/nchembio.915]; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; Wexselblatt E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002925; Williamson KS, 2012, J BACTERIOL, V194, P2062, DOI 10.1128/JB.00022-12; Wu Y, 2012, ANTIMICROB AGENTS CH; XIAO H, 1991, J BIOL CHEM, V266, P5980; Zuroff TR, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-185	65	74	75	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93110	10.1371/journal.pone.0093110	http://dx.doi.org/10.1371/journal.pone.0093110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667358	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600142
J	Brandley, MC; Kuriyama, T; Hasegawa, M				Brandley, Matthew C.; Kuriyama, Takeo; Hasegawa, Masami			Snake and Bird Predation Drive the Repeated Convergent Evolution of Correlated Life History Traits and Phenotype in the Izu Island Scincid Lizard (Plestiodon latiscutatus)	PLOS ONE			English	Article							JAPANESE WOOD MOUSE; HAPLOTYPE RECONSTRUCTION; EUMECES-LATISCUTATUS; LIVEBEARING FISH; TIME DEPENDENCY; MIYAKE-JIMA; POPULATIONS; MITOCHONDRIAL; REPTILIA; TAIL	Predation may create strong natural selection pressure on the phenotype and life history characteristics of prey species. The Izu scincid lizards (Plestiodon latiscutatus) that inhabit the four Japanese Izu Islands with only bird predators are drab brown, mature later, lay small clutches of large eggs, and hatch large neonates. In contrast, skinks on seven islands with both snake and bird predators are conspicuously colored, mature early, lay large clutches of small eggs, and hatch small neonates. We test the hypothesis that these suites of traits have evolved independently on each island via natural selection pressures from one of two predator regimes - birds-only and birds + snakes. Using two mtDNA genes and a nuclear locus, we infer a time-calibrated phylogeny of P. latiscutatus that reveals a basal split between Mikura and all islands south, and Miyake, all islands north, and the Izu Peninsula. Populations inhabiting Miyake, Niijima, Shikine, and Toshima are not monophyletic, suggesting either multiple colonizations or an artifact of incomplete lineage sorting (ILS). We therefore developed novel phylogenetic comparative analyses that assume either a multiple colonization or more restrictive single colonization ILS scenario and found 1) statistically significant support for the of different suites of phenotypic and life history characteristics with the presence of bird-only or bird + snake predator assemblages, and 2) strong phylogenetic support for at least two independent derivations of either the "bird-only" or "snakes + birds" phenotypes regardless of colonization scenario. Finally, our time-calibrated phylogeographic analysis supports the conclusion that the ancestor to modern Izu Island P. latiscutatus dispersed from the mainland to the Izu proto-islands between 3-7.6 million years ago (Ma). These lineages remained present in the area during successive formation of the islands, with one lineage re-colonizing the mainland 0.24-0.7 Ma.	[Brandley, Matthew C.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Kuriyama, Takeo; Hasegawa, Masami] Toho Univ, Fac Sci, Funabashi, Chiba 274, Japan	University of Sydney; Toho University	Brandley, MC (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	mbrandley@gmail.com		Kuriyama, Takeo/0000-0002-6919-2966	Ministry of Education, Culture, Sports, Science, and Technology [19570026, 21570024, 24570031]; Sasakawa Scientific Research Grant from The Japan Science Society; Fujiwara Natural History Foundation	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sasakawa Scientific Research Grant from The Japan Science Society; Fujiwara Natural History Foundation	This research was partially supported by Grants-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science, and Technology to M. H. Hasegawa (19570026, 21570024 and 24570031), and the Sasakawa Scientific Research Grant from The Japan Science Society and the Fujiwara Natural History Foundation to T.Kuriyama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alfaro ME, 2009, 9 EXCEPTIONAL RAD PL; Amano K., 1991, Modern Geology, V15, P315; ARNOLD EN, 1984, J NAT HIST, V18, P127, DOI 10.1080/00222938400770131; Brandley MC, 2012, ZOOL J LINN SOC-LOND, V165, P163, DOI 10.1111/j.1096-3642.2011.00801.x; Brandley MC, 2011, SYST BIOL, V60, P3, DOI 10.1093/sysbio/syq045; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Case T., 1983, P159; CASE TJ, 1991, EVOL ECOL, V5, P272, DOI 10.1007/BF02214232; COOPER WE, 1985, Z TIERPSYCHOL, V70, P265; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Galan P, 2003, COPEIA, P657; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; HASEGAWA M, 1990, RES POPUL ECOL, V32, P119, DOI 10.1007/BF02512594; Hasegawa M., 1991, Natural History Research, V1, P53; HASEGAWA M, 1990, Japanese Journal of Herpetology, V13, P65; Hasegawa M, 2003, LIZARD SOCIAL BEHAVIOR, P172; HASEGAWA M, 1994, COPEIA, P732; Hasegawa M., 1989, P414; HASEGAWA M, 1984, HERPETOLOGICA, V40, P194; Hasegawa Masami, 1999, Developments in Animal and Veterinary Sciences, V29, P129; Hasegawa Masami, 2003, Global Environmental Research, V7, P59; Hawlena D, 2006, BEHAV ECOLOGY, V2006; Hawlena D, 2009, BEHAV ECOL SOCIOBIOL, V64, P205, DOI 10.1007/s00265-009-0837-z; Hayashi M, 2004, BIOL J LINN SOC, V81, P417, DOI 10.1111/j.1095-8312.2003.00292.x; Higuchi H., 1973, Tori, V22, P14; Hikida Tsutomu, 1993, Japanese Journal of Herpetology, V15, P1; Hirata D, 2010, J GEOGR-TOKYO, V119, P1125, DOI 10.5026/jgeography.119.1125; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; INOUE K, 1990, AM J BOT, V77, P1440, DOI 10.2307/2444754; Jennions MD, 2002, OECOLOGIA, V132, P44, DOI 10.1007/s00442-002-0942-4; Johnson JB, 2001, OECOLOGIA, V126, P142, DOI 10.1007/s004420000504; Kaneoka I., 1970, GEOCHEM J, V4, P53, DOI [10.2343/geochemj.4.53, DOI 10.2343/GEOCHEMJ.4.53]; Kuriyama T, 2006, ZOOL SCI, V23, P793, DOI 10.2108/zsj.23.793; Kuriyama T, 2011, J BIOGEOGR, V38, P259, DOI 10.1111/j.1365-2699.2010.02403.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leache AD, 2009, SYST BIOL, V58, P547, DOI 10.1093/sysbio/syp057; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Maddison W.P., 1986, MACCLADE VERSION 10; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; McGuire JA, 2007, EVOLUTION, V61, P2879, DOI 10.1111/j.1558-5646.2007.00239.x; Meiri S, 2007, GLOBAL ECOL BIOGEOGR, V16, P702, DOI 10.1111/j.1466-8238.2007.00327.x; Monti DM, 2013, BIOL J LINN SOC, V108, P144, DOI 10.1111/j.1095-8312.2012.02019.x; Motokawa J, 2003, ZOOL SCI, V20, P97, DOI 10.2108/zsj.20.97; Near TJ, 2014, EVOLUTION IN PRESS; Novosolov M, 2013, GLOBAL ECOL BIOGEOGR, V22, P184, DOI 10.1111/j.1466-8238.2012.00791.x; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Oiki S, 2001, ANN BOT-LONDON, V87, P661, DOI 10.1006/anbo.2001.1389; Okamoto T, 2006, ZOOL SCI, V23, P419, DOI 10.2108/zsj.23.419; Ord TJ, 2006, ANIM BEHAV, V71, P1411, DOI 10.1016/j.anbehav.2005.12.003; Orme D, 2012, CAPER COMP ANAL PHYL; Pafilis P, 2011, COPEIA, P545, DOI 10.1643/CE-10-041; Pafilis P, 2009, NATURWISSENSCHAFTEN, V96, P1107, DOI 10.1007/s00114-009-0564-3; Pafilis P, 2009, EVOLUTION, V63, P1262, DOI 10.1111/j.1558-5646.2009.00635.x; Palumbi Stephen R., 1996, P205; Raia P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-289; REZNICK D, 1982, EVOLUTION, V36, P160, DOI 10.1111/j.1558-5646.1982.tb05021.x; Riesch R, 2013, AM NAT, V181, P78, DOI 10.1086/668597; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stuart-Fox D, 2006, BIOL J LINN SOC, V88, P437, DOI 10.1111/j.1095-8312.2006.00631.x; Suzuki H, 2004, GENES GENET SYST, V79, P165, DOI 10.1266/ggs.79.165; Taira A, 1998, ISL ARC, V7, P395, DOI 10.1046/j.1440-1738.1998.00198.x; Takechi R, 2012, ZOOL SCI, V29, P71, DOI 10.2108/zsj.29.71; Tani K, 2011, EARTH PLANET SC LETT, V303, P225, DOI 10.1016/j.epsl.2010.12.052; Tomozawa M, 2008, ZOOL SCI, V25, P273, DOI 10.2108/zsj.25.273; Tsukui M, 2001, J GEOGR, V110, P156, DOI DOI 10.5026/JGE0GRAPHY.110.2_156; Watson CM, 2012, ZOOLOGY, V115, P339, DOI 10.1016/j.zool.2012.04.001	76	15	15	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92233	10.1371/journal.pone.0092233	http://dx.doi.org/10.1371/journal.pone.0092233			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667496	Green Submitted, gold, Green Published			2022-12-27	WOS:000333675600029
J	Emukule, GO; McMorrow, M; Ulloa, C; Khagayi, S; Njuguna, HN; Burton, D; Montgomery, JM; Muthoka, P; Katz, MA; Breiman, RF; Mott, JA				Emukule, Gideon O.; McMorrow, Meredith; Ulloa, Chulie; Khagayi, Sammy; Njuguna, Henry N.; Burton, Deron; Montgomery, Joel M.; Muthoka, Philip; Katz, Mark A.; Breiman, Robert F.; Mott, Joshua A.			Predicting Mortality among Hospitalized Children with Respiratory Illness in Western Kenya, 2009-2012	PLOS ONE			English	Article							INFECTIONS; BURDEN; MANAGEMENT; PNEUMONIA; MALARIA	Background: Pediatric respiratory disease is a major cause of morbidity and mortality in the developing world. We evaluated a modified respiratory index of severity in children (mRISC) scoring system as a standard tool to identify children at greater risk of death from respiratory illness in Kenya. Materials and Methods: We analyzed data from children,5 years old who were hospitalized with respiratory illness at Siaya District Hospital from 2009-2012. We used a multivariable logistic regression model to identify patient characteristics predictive for in-hospital mortality. Model discrimination was evaluated using the concordance statistic. Using bootstrap samples, we re-estimated the coefficients and the optimism of the model. The mRISC score for each child was developed by adding up the points assigned to each factor associated with mortality based on the coefficients in the multivariable model. Results: We analyzed data from 3,581 children hospitalized with respiratory illness; including 218 (6%) who died. Low weight-for-age [adjusted odds ratio (aOR) = 2.1; 95% CI 1.3-3.2], very low weight-for-age (aOR = 3.8; 95% CI 2.7-5.4), caretaker-reported history of unconsciousness (aOR = 2.3; 95% CI 1.6-3.4), inability to drink or breastfeed (aOR = 1.8; 95% CI 1.2-2.8), chest wall in-drawing (aOR = 2.2; 95% CI 1.5-3.1), and being not fully conscious on physical exam (aOR = 8.0; 95% CI 5.1-12.6) were independently associated with mortality. The positive predictive value for mortality increased with increasing mRISC scores. Conclusions: A modified RISC scoring system based on a set of easily measurable clinical features at admission was able to identify children at greater risk of death from respiratory illness in Kenya.	[Emukule, Gideon O.; Khagayi, Sammy; Njuguna, Henry N.; Burton, Deron; Montgomery, Joel M.; Mott, Joshua A.] Kenya Govt Med Res Ctr, Ctr Dis Control & Prevent Kenya, KEMRI, CDC, Nairobi, Kenya; [Emukule, Gideon O.; Khagayi, Sammy; Njuguna, Henry N.; Burton, Deron; Montgomery, Joel M.; Mott, Joshua A.] Kenya Govt Med Res Ctr, Ctr Dis Control & Prevent Kenya, KEMRI, CDC, Kisumu, Kenya; [McMorrow, Meredith] US Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Ulloa, Chulie] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Muthoka, Philip] Minist Publ Hlth & Sanitat, Div Dis Surveillance & Response, Nairobi, Kenya; [Katz, Mark A.] Ctr Dis Control & Prevent, Port Au Prince, Haiti; [Breiman, Robert F.] Emory Univ, Atlanta, GA 30322 USA	Kenya Medical Research Institute; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; Stanford University; Emory University	Emukule, GO (corresponding author), Kenya Govt Med Res Ctr, Ctr Dis Control & Prevent Kenya, KEMRI, CDC, Nairobi, Kenya.	GEmukule@ke.cdc.gov	McMorrow, Meredith/M-1274-2019	McMorrow, Meredith/0000-0001-6363-4033	Core Funding of the Global Disease Detection Division of CDC	Core Funding of the Global Disease Detection Division of CDC	The funding for this project is from Core Funding of the Global Disease Detection Division of CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, CASE STUDY INTEGRATE; Barat L, 1999, AM J TROP MED HYG, V60, P1024, DOI 10.4269/ajtmh.1999.60.1024; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Dalal W, 2012, J ACQUIR IMMUNE DEFI; Feikin DR, 2012, B WORLD HEALTH ORGAN, V90, P256, DOI 10.2471/BLT.11.094326; Graham SM, 2001, INT J TUBERC LUNG D, V5, P12; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Harrell Jr FE, 1996, MULTIVARIABLE PROGNO; Hazir T, 2008, LANCET, V371, P49, DOI 10.1016/S0140-6736(08)60071-9; Jeena P, 2005, INT J TUBERC LUNG D, V9, P708; Kahama-Maro J, 2011, LOW QUALITY ROUTINE; Laxminarayan R., 2006, ACUTE RESP INFECT CH; Madhi SA, 2000, J PEDIATR-US, V137, P78, DOI 10.1067/mpd.2000.105350; Mullei K, 2008, IMPLEMENTING IMCT KE; Nankabirwa J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-66; National AIDS and STI Control Programme (NASCOP), 2009, KEN AIDS IND SURV 20; Odhiambo FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010016; Pattengale N.D., 2009, MANY BOOTSTRAP REPLI; Reed C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027793; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Shah D, 1999, EVALUATION WHO UNICE; Sullivan M., 2004, STAT EVALUATION MED; Thompson MG, 2012, INFLUENZA MALA UNPUB, P2009; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; WHO, 2008, INT MAN CHILDH ILLN; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Wooldridge J.M., 2015, INTRO ECONOMETRICS M; Zar HJ, 2003, PEDIATR PULM, V36, P457, DOI 10.1002/ppul.10345	30	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92968	10.1371/journal.pone.0092968	http://dx.doi.org/10.1371/journal.pone.0092968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667695	gold, Green Published			2022-12-27	WOS:000333675600111
J	Fayzullina, S; Martin, LJ				Fayzullina, Saniya; Martin, Lee J.			Skeletal Muscle DNA Damage Precedes Spinal Motor Neuron DNA Damage in a Mouse Model of Spinal Muscular Atrophy (SMA)	PLOS ONE			English	Article							DISEASE GENE-PRODUCT; CELL-DEATH; NEUROMUSCULAR-JUNCTION; SELECTIVE VULNERABILITY; SATELLITE CELL; PROTEIN; SURVIVAL; COMPLEX; MICE; EXPRESSION	Spinal Muscular Atrophy (SMA) is a hereditary childhood disease that causes paralysis by progressive degeneration of skeletal muscles and spinal motor neurons. SMA is associated with reduced levels of full-length Survival of Motor Neuron (SMN) protein, due to mutations in the Survival of Motor Neuron 1 gene. The mechanisms by which lack of SMN causes SMA pathology are not known, making it very difficult to develop effective therapies. We investigated whether DNA damage is a perinatal pathological event in SMA, and whether DNA damage and cell death first occur in skeletal muscle or spinal cord of SMA mice. We used a mouse model of severe SMA to ascertain the extent of cell death and DNA damage throughout the body of prenatal and newborn mice. SMA mice at birth (postnatal day 0) exhibited internucleosomal fragmentation in genomic DNA from hindlimb skeletal muscle, but not in genomic DNA from spinal cord. SMA mice at postnatal day 5, compared with littermate controls, exhibited increased apoptotic cell death profiles in skeletal muscle, by hematoxylin and eosin, terminal deoxynucleotidyl transferase dUTP nick end labeling, and electron microscopy. SMA mice had no increased cell death, no loss of choline acetyl transferase (ChAT)-positive motor neurons, and no overt pathology in the ventral horn of the spinal cord. At embryonic days 13 and 15.5, SMA mice did not exhibit statistically significant increases in cell death profiles in spinal cord or skeletal muscle. Motor neuron numbers in the ventral horn, as identified by ChAT immunoreactivity, were comparable in SMA mice and control littermates at embryonic day 15.5 and postnatal day 5. These observations demonstrate that in SMA, disease in skeletal muscle emerges before pathology in spinal cord, including loss of motor neurons. Overall, this work identifies DNA damage and cell death in skeletal muscle as therapeutic targets for SMA.	[Fayzullina, Saniya] Johns Hopkins Sch Med, Div Neuropathol, Dept Pathol, Baltimore, MD 21218 USA; Johns Hopkins Sch Med, Pathobiol Grad Program, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Fayzullina, S (corresponding author), Johns Hopkins Sch Med, Div Neuropathol, Dept Pathol, Baltimore, MD 21218 USA.	saniyaf2004@yahoo.com			National Institutes of Health-National Institute of Neurological Disorders and Stroke (NIH-NINDS) [RO1-NS065895]; NIH-NINDS [5-F31-NS076250-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS076250, R01NS065895] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Neurological Disorders and Stroke (NIH-NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health-National Institute of Neurological Disorders and Stroke (NIH-NINDS) grant RO1-NS065895 and NIH-NINDS grant 5-F31-NS076250-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold AS, 2004, LAB INVEST, V84, P1271, DOI 10.1038/labinvest.3700163; Battle DJ, 2006, COLD SPRING HARB SYM, V71, P313, DOI 10.1101/sqb.2006.71.001; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Borisov AB, 2000, ANAT RECORD, V258, P305; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; BURKE SW, 1986, J PEDIATR ORTHOPED, V6, P34, DOI 10.1097/01241398-198601000-00007; Burlet P, 1998, HUM MOL GENET, V7, P1927, DOI 10.1093/hmg/7.12.1927; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; Campbell L, 1997, AM J HUM GENET, V61, P40, DOI 10.1086/513886; Cande C, 2002, BIOCHIMIE, V84, P215, DOI 10.1016/S0300-9084(02)01374-3; CARLSON BM, 1973, AM J ANAT, V137, P119, DOI 10.1002/aja.1001370202; Cifuentes-Diaz C, 2001, J CELL BIOL, V152, P1107, DOI 10.1083/jcb.152.5.1107; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Dachs E, 2011, J NEUROPATH EXP NEUR, V70, P444, DOI 10.1097/NEN.0b013e31821cbd8b; Dale JM, 2011, ACTA NEUROPATHOL, V122, P331, DOI 10.1007/s00401-011-0848-5; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; Didenko V V., 2002, IN SITU DETECTION DN; DUBOWITZ V, 1964, BRAIN, V87, P707, DOI 10.1093/brain/87.4.707; Fan L, 2002, HUM MOL GENET, V11, P1605, DOI 10.1093/hmg/11.14.1605; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; FERRER I, 1994, NEUROSCI LETT, V182, P77, DOI 10.1016/0304-3940(94)90210-0; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Frugier T, 2002, CURR OPIN GENET DEV, V12, P294, DOI 10.1016/S0959-437X(02)00301-5; Frugier T, 2000, HUM MOL GENET, V9, P849, DOI 10.1093/hmg/9.5.849; Garcia-Cabezas MA, 2004, ACTA NEUROPATHOL, V107, P475, DOI 10.1007/s00401-004-0825-3; GARDNERMEDWIN D, 1967, J NEUROL SCI, V5, P121, DOI 10.1016/0022-510X(67)90013-5; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gavrilina TO, 2008, HUM MOL GENET, V17, P1063, DOI 10.1093/hmg/ddm379; Giavazzi A, 2006, J NEUROPATH EXP NEUR, V65, P267, DOI 10.1097/01.jnen.0000205144.54457.a3; Gogliotti RG, 2012, J NEUROSCI, V32, P3818, DOI 10.1523/JNEUROSCI.5775-11.2012; Guettier-Sigrist S, 1998, J NEUROSCI RES, V53, P663, DOI 10.1002/(SICI)1097-4547(19980915)53:6<663::AID-JNR4>3.0.CO;2-3; Guettier-Sigrist S, 2002, MUSCLE NERVE, V25, P700, DOI 10.1002/mus.10081; Hayhurst M, 2012, DEV BIOL, V368, P323, DOI 10.1016/j.ydbio.2012.05.037; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; KATZ B, 1961, PHILOS T ROY SOC B, V243, P221, DOI 10.1098/rstb.1961.0001; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kohn KW, 2005, BIOCHEM BIOPH RES CO, V331, P816, DOI 10.1016/j.bbrc.2005.03.186; KUGELBERG E, 1956, ARCH NEURO PSYCHIATR, V75, P500, DOI 10.1001/archneurpsyc.1956.02330230050005; Labat-Moleur F, 1998, J HISTOCHEM CYTOCHEM, V46, P327, DOI 10.1177/002215549804600306; Lee AJH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046353; Lee YI, 2011, DEV BIOL, V356, P432, DOI 10.1016/j.ydbio.2011.05.667; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Ling KKY, 2012, HUM MOL GENET, V21, P185, DOI 10.1093/hmg/ddr453; Ling KKY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015457; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lutz CM, 2011, J CLIN INVEST, V121, P3029, DOI 10.1172/JCI57291; MacLeod M J, 1999, Eur J Paediatr Neurol, V3, P65, DOI 10.1016/S1090-3798(99)80015-4; Martinez-Hernandez R, 2009, J NEUROPATH EXP NEUR, V68, P474, DOI 10.1097/NEN.0b013e3181a10ea1; Massenet S, 2002, MOL CELL BIOL, V22, P6533, DOI 10.1128/MCB.22.18.6533-6541.2002; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; Mentis GZ, 2011, NEURON, V69, P453, DOI 10.1016/j.neuron.2010.12.032; Meyer K, 2009, HUM MOL GENET, V18, P546, DOI 10.1093/hmg/ddn382; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Mutsaers CA, 2011, HUM MOL GENET, V20, P4334, DOI 10.1093/hmg/ddr360; Nicole S, 2002, MUSCLE NERVE, V26, P4, DOI 10.1002/mus.10110; Ogawa C, 2007, J BIOL CHEM, V282, P11122, DOI 10.1074/jbc.M609297200; Park GH, 2010, J NEUROSCI, V30, P12005, DOI 10.1523/JNEUROSCI.2208-10.2010; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; PERULA EA, 1989, HISTOL HISTOPATHOL, V4, P265; ROBERTS DF, 1970, ARCH DIS CHILD, V45, P33, DOI 10.1136/adc.45.239.33; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Ruggiu M, 2012, MOL CELL BIOL, V32, P126, DOI 10.1128/MCB.06077-11; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Setola V, 2007, P NATL ACAD SCI USA, V104, P1959, DOI 10.1073/pnas.0610660104; Shafey D, 2005, EXP CELL RES, V311, P49, DOI 10.1016/j.yexcr.2005.08.019; Soler-Botija C, 2002, BRAIN, V125, P1624, DOI 10.1093/brain/awf155; Stadelmann C, 2000, CELL TISSUE RES, V301, P19, DOI 10.1007/s004410000203; STUDITSKY AN, 1964, ANN NY ACAD SCI, V120, P789, DOI 10.1111/j.1749-6632.1964.tb34771.x; Takaku M, 2011, BIOCHEMISTRY-US, V50, P6797, DOI 10.1021/bi200828g; Takizawa Y, 2010, NUCLEIC ACIDS RES, V38, P5059, DOI 10.1093/nar/gkq271; THOMAS NH, 1994, NEUROMUSCULAR DISORD, V4, P497, DOI 10.1016/0960-8966(94)90090-6; Velma V, 2010, FEBS LETT, V584, P4735, DOI 10.1016/j.febslet.2010.11.004; Vitte J, 2007, AM J PATHOL, V171, P1269, DOI 10.2353/ajpath.2007.070399; Vitte J, 2009, ADV EXP MED BIOL, V652, P237, DOI 10.1007/978-90-481-2813-6_16; Walker MP, 2008, HUM MOL GENET, V17, P3399, DOI 10.1093/hmg/ddn234; WEBB JN, 1977, J PATHOL, V123, P175, DOI 10.1002/path.1711230307; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006	88	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93329	10.1371/journal.pone.0093329	http://dx.doi.org/10.1371/journal.pone.0093329			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667816	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600172
J	Klinkhammer, BM; Kramann, R; Mallau, M; Makowska, A; van Roeyen, CR; Rong, S; Buecher, EB; Boor, P; Kovacova, K; Zok, S; Denecke, B; Stuettgen, E; Otten, S; Floege, J; Kunter, U				Klinkhammer, Barbara Mara; Kramann, Rafael; Mallau, Monika; Makowska, Anna; van Roeyen, Claudia Renate; Rong, Song; Buecher, Eva Bettina; Boor, Peter; Kovacova, Katarina; Zok, Stephanie; Denecke, Bernd; Stuettgen, Esther; Otten, Simon; Floege, Juergen; Kunter, Uta			Mesenchymal Stem Cells from Rats with Chronic Kidney Disease Exhibit Premature Senescence and Loss of Regenerative Potential	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; CHRONIC-RENAL-FAILURE; ADIPOSE-TISSUE; STROMAL CELLS; EXPRESSION; DIFFERENTIATION; FIBROSIS; GROWTH; PROLIFERATION; CAPACITY	Mesenchymal stem cell (MSC) transplantation has the potential for organ repair. Nevertheless, some factors might lessen the regenerative potential of MSCs, e. g. donor age or systemic disease. It is thus important to carefully assess the patient's suitability for autologous MSC transplantation. Here we investigated the effects of chronic kidney disease (CKD) on MSC function. We isolated bone marrow MSCs from remnant kidney rats (RK) with CKD (CKD-RK-MSC) and found signs of premature senescence: spontaneous adipogenesis, reduced proliferation capacity, active senescence-associated-beta-galactosidase, accumulation of actin and a modulated secretion profile. The functionality of CKD-RK-MSCs in vivo was tested in rats with acute anti-Thy1.1-nephritis, where healthy MSCs have been shown to be beneficial. Rats received healthy MSCs, CKD-RK-MSC or medium by injection into the left renal artery. Kidneys receiving healthy MSCs exhibited accelerated healing of glomerular lesions, whereas CKD-RK-MSC or medium exerted no benefit. The negative influence of advanced CKD/uremia on MSCs was confirmed in a second model of CKD, adenine nephropathy (AD). MSCs from rats with adenine nephropathy (CKD-AD-MSC) also exhibited cellular modifications and functional deficits in vivo. We conclude that CKD leads to a sustained loss of in vitro and in vivo functionality in MSCs, possibly due to premature cellular senescence. Considering autologous MSC therapy in human renal disease, studies identifying uremia-associated mechanisms that account for altered MSC function are urgently needed.	[Klinkhammer, Barbara Mara; Kramann, Rafael; Mallau, Monika; Makowska, Anna; van Roeyen, Claudia Renate; Rong, Song; Buecher, Eva Bettina; Boor, Peter; Kovacova, Katarina; Zok, Stephanie; Stuettgen, Esther; Otten, Simon; Floege, Juergen; Kunter, Uta] RWTH Aachen Univ Hosp, Div Nephrol & Immunol, Aachen, Germany; [Boor, Peter] RWTH Aachen Univ Hosp, Inst Pathol, Aachen, Germany; [Boor, Peter] Comenius Univ, Inst Mol Biomed, Bratislava, Slovakia; [Denecke, Bernd] RWTH Aachen Univ Hosp, Interdisciplinary Ctr Clin Res, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Comenius University Bratislava; RWTH Aachen University; RWTH Aachen University Hospital	Kunter, U (corresponding author), RWTH Aachen Univ Hosp, Div Nephrol & Immunol, Aachen, Germany.	ukunter@ukaachen.de	Boor, Peter/C-7707-2011; Kramann, Rafael/K-7995-2013; Klinkhammer, Barbara Mara/AAB-3524-2019	Boor, Peter/0000-0001-9921-4284; Kramann, Rafael/0000-0003-4048-6351; Klinkhammer, Barbara Mara/0000-0002-1566-7129	European Community [HEALTH-F5-2008-223007 STAR-TREK]; German Research Foundation (Deutsche Forschungsgemeinschaft [SFB TRR57 P19, RO4036/1]; Medical Faculty of the RWTH Aachen (START grant)	European Community(European Commission); German Research Foundation (Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Faculty of the RWTH Aachen (START grant)	European Community's Seventh Framework Programme [FP7/2007-2013] under grant agreement no HEALTH-F5-2008-223007 STAR-TREK; German Research Foundation (Deutsche Forschungsgemeinschaft, SFB TRR57 P19 and RO4036/1); Medical Faculty of the RWTH Aachen (START grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma H, 2011, J SURG RES, V168, pE51, DOI 10.1016/j.jss.2010.06.022; Ball SG, 2012, STEM CELLS; Betjes MGH, 2011, KIDNEY INT, V80, P209, DOI 10.1038/ki.2011.110; Boor P, 2007, J AM SOC NEPHROL, V18, P1508, DOI 10.1681/ASN.2006121343; Boor P, 2011, KIDNEY INT, V80, P1182, DOI 10.1038/ki.2011.254; Breitbach M, 2007, BLOOD, V110, P1362, DOI 10.1182/blood-2006-12-063412; Buemi M, 2010, J NEPHROL, V23, P328; Cavaglieri RC, 2009, TRANSPL P, V41, P947, DOI 10.1016/j.transproceed.2009.01.072; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Choi S, 2009, STEM CELLS DEV, V18, P521, DOI 10.1089/scd.2008.0097; de Groot K, 2005, TRANSPLANTATION, V79, P941, DOI 10.1097/00007890-200504270-00012; de Groot K, 2004, KIDNEY INT, V66, P641, DOI 10.1111/j.1523-1755.2004.00784.x; Di Bonzo LV, 2008, GUT, V57, P223, DOI 10.1136/gut.2006.111617; Drewa T, 2008, TRANSPL P, V40, P1668, DOI 10.1016/j.transproceed.2008.03.141; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Eitner F, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134910; GRAHAM GJ, 1990, NATURE, V344, P442, DOI 10.1038/344442a0; Hanssen L, 2011, J IMMUNOL, V187, P298, DOI 10.4049/jimmunol.1100382; Horn P, 2010, CYTOTHERAPY, V12, P888, DOI 10.3109/14653249.2010.501788; Kanda Y, 2011, LIFE SCI, V89, P250, DOI 10.1016/j.lfs.2011.06.007; Kisseberth WC, 1999, DEV BIOL, V214, P128, DOI 10.1006/dbio.1999.9417; Kramann R, 2011, ARTERIOSCL THROM VAS, V31, pE45, DOI 10.1161/ATVBAHA.111.228601; Krtolica A, 2003, Adv Gerontol, V11, P109; Kunter U, 2007, J AM SOC NEPHROL, V18, P1754, DOI 10.1681/ASN.2007010044; Kunter U, 2006, J AM SOC NEPHROL, V17, P2202, DOI 10.1681/ASN.2005080815; Kunter U, 2011, KIDNEY INT SUPPL, V1, P68, DOI 10.1038/kisup.2011.16; Lange C, 2005, KIDNEY INT, V68, P1613, DOI 10.1111/j.1523-1755.2005.00573.x; Lee SR, REN FAIL, V32, P840; Li B, 2006, KIDNEY INT, V69, P323, DOI 10.1038/sj.ki.5000083; Li ZL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020526; Liu Y, 2003, CARDIOVASC RES, V58, P460, DOI 10.1016/S0008-6363(03)00265-7; Lo LJ, 2009, KIDNEY INT, V76, P893, DOI 10.1038/ki.2009.289; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; Montzka K, 2010, CYTOTHERAPY, V12, P870, DOI 10.3109/14653249.2010.501789; Nakanishi C, 2011, CIRC J, V75, P2260, DOI 10.1253/circj.CJ-11-0246; Neven E, 2011, CIRC RES, V108, P249, DOI 10.1161/CIRCRESAHA.110.225904; Ninichuk V, 2006, KIDNEY INT, V70, P121, DOI 10.1038/sj.ki.5001521; Noh H, 2012, NEPHROL DIAL TRANSPL; Ohnishi S, 2007, FEBS LETT, V581, P3961, DOI 10.1016/j.febslet.2007.07.028; Ostendorf T, 1999, J CLIN INVEST, V104, P913, DOI 10.1172/JCI6740; Ostendorf T, 2003, J AM SOC NEPHROL, V14, P2237, DOI 10.1097/01.ASN.0000083393.00959.02; Roemeling-van Rhijn M, 2012, KIDNEY INT, V82, P748, DOI 10.1038/ki.2012.187; Salazar KD, 2009, AM J PHYSIOL-LUNG C, V297, pL1002, DOI 10.1152/ajplung.90347.2008; Semedo P, 2009, STEM CELLS, V27, P3063, DOI 10.1002/stem.214; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Sugawara J, 2005, J CLIN ENDOCR METAB, V90, P5329, DOI 10.1210/jc.2005-0532; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Urish KL, 2009, MOL BIOL CELL, V20, P509, DOI 10.1091/mbc.E08-03-0274; van Koppen A, CELL TRANSPLANT; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Yang HC, 2011, J AM SOC NEPHROL; Yuen DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009543	52	62	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92115	10.1371/journal.pone.0092115	http://dx.doi.org/10.1371/journal.pone.0092115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667162	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600020
J	Zhang, SJ; Wang, YX; Yuan, J; Jin, JY; Wang, YC; Chang, D; Weng, DH; Greiser, A; Ju, SH				Zhang, Shi-Jun; Wang, Yi-Xiang; Yuan, Jing; Jin, Jiyang; Wang, Yuan-Cheng; Chang, Di; Weng, Dehe; Greiser, Andreas; Ju, Shenghong			Time-Efficient Myocardial Contrast Partition Coefficient Measurement from Early Enhancement with Magnetic Resonance Imaging	PLOS ONE			English	Article							EXTRACELLULAR VOLUME FRACTION; INVERSION-RECOVERY MOLLI; COLD PRESSOR TEST; BLOOD-FLOW; GADOPENTETATE DIMEGLUMINE; INTRAINDIVIDUAL ASSESSMENT; GD-DTPA; T1; FIBROSIS; QUANTIFICATION	Objective: Our purpose was to validate an early enhancement time point for accurately measuring the myocardial contrast partition coefficient (lambda) using dynamic-equilibrium magnetic resonance imaging. Materials and Methods: The pre- and post-contrast longitudinal relaxation rates (reciprocal of T1) of the interventricular septum (R1(m)) and blood pool (R1(b)) were obtained from fifteen healthy volunteers and three diabetic patients with hypertension using two optimized T1 mapping sequences (modified Look-Locker inversion recovery) on a 3-Tesla magnetic resonance scanner. Reference lambda values were calculated as the slope of the regression line of R1(m) versus R1(b) at dynamic equilibrium (multi-point regression method). The simplified pre-/post-enhancement two-acquisition method (two-point method) was used to calculate lambda by relating the change in R1(m) and R1(b) using different protocols according to the acquisition stage of the post-enhancement data point. The agreement with the referential method was tested by calculating Pearson's correlation coefficient and the intra-class correlation coefficient. Results: The lambda values measured by the two-point method increased (from 0.479 +/- 0.041 to 0.534 +/- 0.043) over time from 6 to 45 minutes after contrast and exhibited good correlation with the reference at each time point (r >= 0.875, p<0.05). The intra-class correlation coefficient on absolute agreement with the reference lambda was 0.946, 0.929 and 0.922 at the 6th, 7th and 8th minutes and dropped from 0.878 to 0.403 from the 9th minute on. Conclusions: The time-efficient two-point method at 6-8 minutes after the Gd-DTPA bolus injection exhibited good agreement with the multi-point regression method and can be applied for accurate lambda measurement in normal myocardium.	[Zhang, Shi-Jun; Jin, Jiyang; Wang, Yuan-Cheng; Chang, Di; Ju, Shenghong] Southeast Univ, Jiangsu Key Lab Mol & Funct Imaging, Dept Radiol, Zhongda Hosp,Med Sch, Nanjing, Jiangsu, Peoples R China; [Wang, Yi-Xiang; Yuan, Jing] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China; [Weng, Dehe] Siemens Shenzhen Magnet Resonance, Shenzhen, Peoples R China; [Greiser, Andreas] Siemens AG Healthcare Sect, Erlangen, Bayern, Germany	Southeast University - China; Chinese University of Hong Kong; Prince of Wales Hospital; Siemens AG; Siemens AG	Ju, SH (corresponding author), Southeast Univ, Jiangsu Key Lab Mol & Funct Imaging, Dept Radiol, Zhongda Hosp,Med Sch, Nanjing, Jiangsu, Peoples R China.	jsh0836@hotmail.com	Yuan, Jing/E-4236-2013; Wang, Yi Xiang/I-5952-2016	Yuan, Jing/0000-0001-8112-3608; Wang, Yi Xiang/0000-0001-5697-0717	Major State Basic Research Development Program of China (973 Program) [2013CB733802, 2010CB933903]; National Nature Science Foundation of China (NSFC) [81371538, 81071125, 81071124]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by Major State Basic Research Development Program of China (973 Program, No. 2013CB733802, No. 2010CB933903) and National Nature Science Foundation of China (NSFC, No. 81371538, No. 81071125, No. 81071124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arheden H, 1999, RADIOLOGY, V211, P698, DOI 10.1148/radiology.211.3.r99jn41698; Broberg CS, 2010, CIRC-CARDIOVASC IMAG, V3, P727, DOI 10.1161/CIRCIMAGING.108.842096; Chareonthaitawee P, 2001, CARDIOVASC RES, V50, P151, DOI 10.1016/S0008-6363(01)00202-4; CRAWLEY AP, 1988, MAGN RESON MED, V7, P23, DOI 10.1002/mrm.1910070104; DIESBOURG LD, 1992, MAGNET RESON MED, V23, P239, DOI 10.1002/mrm.1910230205; Efseaff M, 2012, J NUCL CARDIOL, V19, P997, DOI 10.1007/s12350-012-9600-3; Fairbairn TA, 2014, RADIOLOGY, V270, P82, DOI 10.1148/radiol.13122345; Flacke SJ, 2001, RADIOLOGY, V218, P703, DOI 10.1148/radiology.218.3.r01fe18703; Flett AS, 2012, EUR HEART J-CARD IMG, V13, P819, DOI 10.1093/ehjci/jes102; Flett AS, 2010, CIRCULATION, V122, P138, DOI 10.1161/CIRCULATIONAHA.109.930636; Jerosch-Herold M, 2008, AM J PHYSIOL-HEART C, V295, pH1234, DOI 10.1152/ajpheart.00429.2008; Katoh C, 2012, J NUCL CARDIOL, V19, P763, DOI 10.1007/s12350-012-9558-1; Kawel N, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-27; Kawel N, 2012, J MAGN RESON IMAGING, V36, P733, DOI 10.1002/jmri.23651; Kawel N, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-26; Kehr E, 2008, INT J CARDIOVAS IMAG, V24, P61, DOI 10.1007/s10554-007-9223-y; Kellman P, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-56; Kellman P, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-63; Lee JHW, 2011, J HYDRO-ENVIRON RES, V5, P143, DOI 10.1016/j.jher.2011.07.001; Messroghli DR, 2007, J MAGN RESON IMAGING, V26, P1081, DOI 10.1002/jmri.21119; Messroghli DR, 2007, MAGN RESON MED, V58, P34, DOI 10.1002/mrm.21272; Messroghli DR, 2006, RADIOLOGY, V238, P1004, DOI 10.1148/radiol.2382041903; Messroghli DR, 2004, MAGN RESON MED, V52, P141, DOI 10.1002/mrm.20110; Miller CA, 2013, CIRC-CARDIOVASC IMAG, V6, P373, DOI 10.1161/CIRCIMAGING.112.000192; Nacif MS, 2012, RADIOLOGY, V264, P876, DOI 10.1148/radiol.12112458; Puntmann VO, 2013, JACC-CARDIOVASC IMAG, V6, P475, DOI 10.1016/j.jcmg.2012.08.019; Roberts C, 2011, MAGN RESON MED, V65, P108, DOI 10.1002/mrm.22593; Schelbert EB, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-16; Schindler TH, 2007, EUR J NUCL MED MOL I, V34, P1178, DOI 10.1007/s00259-007-0378-5; Sparrow Patrick, 2006, AJR Am J Roentgenol, V187, pW630, DOI 10.2214/AJR.05.1264; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Ugander M, 2012, EUR HEART J, V33, P1268, DOI 10.1093/eurheartj/ehr481; White SK, 2013, JACC-CARDIOVASC IMAG, V6, P955, DOI 10.1016/j.jcmg.2013.01.011	33	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93124	10.1371/journal.pone.0093124	http://dx.doi.org/10.1371/journal.pone.0093124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667489	Green Submitted, gold, Green Published			2022-12-27	WOS:000333675600144
J	Zhang, YL; Ou, P; Lu, XH; Chen, YP; Xu, JM; Dai, RP				Zhang, Yan-Ling; Ou, Peng; Lu, Xiang-Hang; Chen, Yan-Ping; Xu, Jun-Mei; Dai, Ru-Ping			Effect of Intraoperative High-Dose Remifentanil on Postoperative Pain: A Prospective, Double Blind, Randomized Clinical Trial	PLOS ONE			English	Article							OPIOID-INDUCED HYPERALGESIA; ANESTHESIA; TOLERANCE; PROPOFOL	Background: Remifentanil, an ultra-short-acting opioid, is widely used for pain control during surgery. However, regular dose (RD) remifentanil exacerbates postoperative pain in a dose-dependent manner. Recent studies suggest that high-dose (HD) remifentanil offers sustained analgesia in experimental studies. We thus hypothesized that intraoperative administration of high-dose remifentanil may attenuate postoperative pain. Methods: In this prospective, randomized, double blind, controlled clinical study, sixty patients undergoing thyroidectomy (18-60 years-of-age) received an intraoperative infusion of 0.2 (RD group) or 1.2 mu g kg(-1) min(-1) (HD group) remifentanil during thyroidectomy. A visual analogue scale (VAS) was used to measure pain intensity. Mechanical pain threshold on the forearm was assessed using von Frey filaments before surgery (baseline), 2 h postoperatively and 18-24 h postoperatively. The primary outcome was to compare the difference of VAS score at different time points after operation and morphine consumption 24 h postoperatively between RD and HD groups. The second outcome was to compare the difference of mechanical pain thresholds in the forearm postoperatively between RD and the HD groups. Results: VAS scores were lower 30 min postoperatively in the HD group (1.29 +/- 1.67, 95% CI 0.64-1.94) compared with the RD group (2.21 +/- 1.67, 95% CI 1.57-2.84) (t = 3.427, p = 0.0043, RD group vs. HD group). Postoperative morphine consumption was much lower in the HD group compared with the RD group (1.27 +/- 1.88 mg vs. 0.35 +/- 1.25 mg, p = 0.033). In both groups, mechanical pain threshold was decreased 18-24 h postoperatively (2.93 +/- 0.209 Ln(g) vs. 3.454 +/- 2.072 Ln(g), p = 0.032 in RD group; 2.910 +/- 0.196 Ln(g) vs. 3.621 +/- 0.198 Ln(g), p = 0.006 in HD group, 18-24 h postoperatively vs baseline). Conclusions: Intraoperative administration of high-dose remifentanil decreased VAS scores and morphine consumption postoperatively. Thus, modulation of intraoperative opiates may be a simple and effective method of postoperative pain management.	[Zhang, Yan-Ling; Ou, Peng; Lu, Xiang-Hang; Chen, Yan-Ping; Xu, Jun-Mei; Dai, Ru-Ping] Cent S Univ, Xiangya Hosp 2, Dept Anesthesiol, Changsha, Hunan, Peoples R China	Central South University	Dai, RP (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Anesthesiol, Changsha, Hunan, Peoples R China.	xyeyyrupingdai@gmail.com			National Natural Science Foundation of China [NSFC 81070897]; Program for New Century Excellent Talents in University [NCET-12-0543]; Hunan Provincial Natural Science Foundation [13JJ1007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Hunan Provincial Natural Science Foundation(Natural Science Foundation of Hunan Province)	The work is supported by the funding from the National Natural Science Foundation of China (NSFC 81070897), Program for New Century Excellent Talents in University (NCET-12-0543) and Hunan Provincial Natural Science Foundation (13JJ1007) to R. Dai. The development and Reform Foundation of Hunan Province to Y.L. Zhang. The authors declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; Burkle H, 1996, ANESTH ANALG, V83, P646, DOI 10.1097/00000539-199609000-00038; Chang G, 2007, MED CLIN N AM, V91, P199, DOI 10.1016/j.mcna.2006.10.003; Cheng SS, 2008, ANESTH ANALG, V106, P264, DOI 10.1213/01.ane.0000287653.77372.d9; Drdla R, 2009, SCIENCE, V325, P207, DOI 10.1126/science.1171759; Drdla-Schutting R, 2012, SCIENCE, V335, P235, DOI 10.1126/science.1211726; Echevarria G, 2011, BRIT J ANAESTH, V107, P959, DOI 10.1093/bja/aer323; Joly V, 2005, ANESTHESIOLOGY, V103, P147, DOI 10.1097/00000542-200507000-00022; Kim SH, 2013, ANESTHESIOLOGY, V118, P337, DOI 10.1097/ALN.0b013e31827bd108; Manering NA, 2013, BRIT J ANAESTH, V110, P287, DOI 10.1093/bja/aes360; Mills C, 2012, J PAIN, V13, P519, DOI 10.1016/j.jpain.2012.02.009; Pogatzki-Zahn EM, 2007, BEST PRACT RES-CLIN, V21, P3, DOI 10.1016/j.bpa.2006.11.003; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Schmidt S, 2007, CLIN J PAIN, V23, P605, DOI 10.1097/AJP.0b013e318122d1e4; Singler B, 2007, ANESTH ANALG, V104, P1397, DOI 10.1213/01.ane.0000261305.22324.f3; Song JW, 2011, ANESTH ANALG, V113, P390, DOI 10.1213/ANE.0b013e31821d72bc; Zahn PK, 2005, PAIN, V114, P499, DOI 10.1016/j.pain.2005.01.018; Zhao M, 2008, ANESTHESIOLOGY, V109, P308, DOI 10.1097/ALN.0b013e31817f4c5d	18	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e91454	10.1371/journal.pone.0091454	http://dx.doi.org/10.1371/journal.pone.0091454			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667391	Green Submitted, Green Published, gold			2022-12-27	WOS:000333675600008
J	Chung, MC; Dean, S; Marakasova, ES; Nwabueze, AO; van Hoek, ML				Chung, Myung-Chul; Dean, Scott; Marakasova, Ekaterina S.; Nwabueze, Albert O.; van Hoek, Monique L.			Chitinases Are Negative Regulators of Francisella novicida Biofilms	PLOS ONE			English	Article							TULARENSIS SUBSP NOVICIDA; SURFACE-CHARGE; BACTERIAL BIOFILMS; PORE SENSORS; IN-VITRO; VIRULENCE; CELLS; HYDROPHOBICITY; MECHANISMS; ATTACHMENT	Biofilms, multicellular communities of bacteria, may be an environmental survival and transmission mechanism of Francisella tularensis. Chitinases of F. tularensis ssp. novicida (Fn) have been suggested to regulate biofilm formation on chitin surfaces. However, the underlying mechanisms of how chitinases may regulate biofilm formation are not fully determined. We hypothesized that Fn chitinase modulates bacterial surface properties resulting in the alteration of biofilm formation. We analyzed biofilm formation under diverse conditions using chitinase mutants and their counterpart parental strain. Substratum surface charges affected biofilm formation and initial attachments. Biophysical analysis of bacterial surfaces confirmed that the chi mutants had a net negative-charge. Lectin binding assays suggest that chitinase cleavage of its substrates could have exposed the concanavalin A-binding epitope. Fn biofilm was sensitive to chitinase, proteinase and DNase, suggesting that Fn biofilm contains exopolysaccharides, proteins and extracellular DNA. Exogenous chitinase increased the drug susceptibility of Fn biofilms to gentamicin while decreasing the amount of biofilm. In addition, chitinase modulated bacterial adhesion and invasion of A549 and J774A.1 cells as well as intracellular bacterial replication. Our results support a key role of the chitinase(s) in biofilm formation through modulation of the bacterial surface properties. Our findings position chitinase as a potential anti-biofilm enzyme in Francisella species.	[Chung, Myung-Chul] George Mason Univ, Sch Syst Biol, Manassas, VA 20110 USA; George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA	George Mason University; George Mason University	Chung, MC (corresponding author), George Mason Univ, Sch Syst Biol, Manassas, VA 20110 USA.	mchung3@gmu.edu	Marakasova, Ekaterina/K-3470-2014; Dean, Scott/ABB-6978-2020; van Hoek, Monique/E-1629-2011	van Hoek, Monique/0000-0003-1679-4899; Marakasova, Ekaterina/0000-0002-6505-4726	DOD Defense Threat Reduction Agency (DTRA) [421 HDTRA1-12-C0039]	DOD Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	This research was supported by the DOD Defense Threat Reduction Agency (DTRA; grant No. 421 HDTRA1-12-C0039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakane Y, 2010, CELL MOL LIFE SCI, V67, P201, DOI 10.1007/s00018-009-0161-9; BellonFontaine MN, 1996, COLLOID SURFACE B, V7, P47, DOI 10.1016/0927-7765(96)01272-6; Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2; Bryers JD, 2008, BIOTECHNOL BIOENG, V100, P1, DOI 10.1002/bit.21838; Chandler JC, 2011, J BACTERIOL, V193, P3265, DOI 10.1128/JB.00093-11; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dahiya N, 2006, APPL MICROBIOL BIOT, V71, P773, DOI 10.1007/s00253-005-0183-7; Durham-Colleran MW, 2010, MICROB ECOL, V59, P457, DOI 10.1007/s00248-009-9586-9; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Hager AJ, 2006, MOL MICROBIOL, V62, P227, DOI 10.1111/j.1365-2958.2006.05365.x; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Johnsen AR, 2000, APPL ENVIRON MICROB, V66, P3487, DOI 10.1128/AEM.66.8.3487-3491.2000; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; Keyhani NO, 1999, BBA-GEN SUBJECTS, V1473, P108, DOI 10.1016/S0304-4165(99)00172-5; Kozak D, 2012, ACS NANO, V6, P6990, DOI 10.1021/nn3020322; Kraemer PS, 2009, INFECT IMMUN, V77, P232, DOI 10.1128/IAI.00978-08; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Liu JR, 2007, BIOTECHNIQUES, V43, P487, DOI 10.2144/000112574; Mahajan UV, 2011, FEMS MICROBIOL ECOL, V78, P520, DOI 10.1111/j.1574-6941.2011.01182.x; Margolis JJ, 2010, APPL ENVIRON MICROB, V76, P596, DOI 10.1128/AEM.02037-09; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; Melillo A, 2006, FEMS MICROBIOL LETT, V263, P102, DOI 10.1111/j.1574-6968.2006.00413.x; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Orgad O, 2011, BIOFOULING, V27, P787, DOI 10.1080/08927014.2011.603145; Palmer JS, 2010, J IND MICROBIOL BIOT, V37, P1111, DOI 10.1007/s10295-010-0758-x; Pantoom S, 2011, J BIOL CHEM, V286, P24312, DOI 10.1074/jbc.M110.183376; Rahman MM, 2008, WORLD J MICROB BIOT, V24, P1593, DOI 10.1007/s11274-007-9650-x; Reif KE, 2011, INFECT IMMUN, V79, P4941, DOI 10.1128/IAI.05676-11; Skillman LC, 1999, J APPL MICROBIOL, V85, p13S, DOI 10.1111/j.1365-2672.1998.tb05278.x; Sowerby SJ, 2007, SENSOR ACTUAT B-CHEM, V123, P325, DOI 10.1016/j.snb.2006.08.031; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Thethi K, 1997, CELL BIOCHEM FUNCT, V15, P35, DOI 10.1002/(SICI)1099-0844(199703)15:1<35::AID-CBF717>3.0.CO;2-S; Valle J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002843; van Hoek ML, 2013, VIRULENCE, V4, P833, DOI 10.4161/viru.27023; Verhoeven AB, 2010, BIOL BULL-US, V219, P178, DOI 10.1086/BBLv219n2p178; Vogel R, 2012, ANAL CHEM, V84, P3125, DOI 10.1021/ac2030915; Vogel R, 2011, ANAL CHEM, V83, P3499, DOI 10.1021/ac200195n; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Zogaj X, 2012, INFECT IMMUN, V80, P4239, DOI 10.1128/IAI.00702-12	43	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93119	10.1371/journal.pone.0093119	http://dx.doi.org/10.1371/journal.pone.0093119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664176	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900154
J	Khudayberganova, D; Sugiyama, M; Masaki, N; Nishida, N; Mukaide, M; Sekler, D; Latipov, R; Nataliya, K; Dildora, S; Sharapov, S; Usmanova, G; Raxmanov, M; Musabaev, E; Mizokami, M				Khudayberganova, Dinara; Sugiyama, Masaya; Masaki, Naohiko; Nishida, Nao; Mukaide, Motokazu; Sekler, Dildora; Latipov, Renat; Nataliya, Kan; Dildora, Suyarkulova; Sharapov, Said; Usmanova, Guzal; Raxmanov, Mahmarajab; Musabaev, Erkin; Mizokami, Masashi			IL28B Polymorphisms and Clinical Implications for Hepatitis C Virus Infection in Uzbekistan	PLOS ONE			English	Article							PEGYLATED INTERFERON-ALPHA; THERAPY; CLEARANCE; RIBAVIRIN; IFNL4	Aims: Genome-wide association studies highlighted single nucleotide polymorphisms (SNPs) within the IFNL3/IL28B locus predict the treatment outcome for patients with HCV. Furthermore, SNPs in newly discovered IFNL4 are shown to have population-specific correlation with spontaneous clearance of HCV. The aim of this study was to examine the prevalence and clinical significance of the outlined SNPs in a population from Central Asia, a multi-ethnic region with a developing economy and a high prevalence of HCV infection. Methods: One hundred and thirty-five chronic HCV patients from Uzbekistan were enrolled. DNA specimens were extracted from peripheral blood mononuclear cells and the IFNL3 SNPs (rs8099917, rs12979860) were genotyped by the Invader Plus assay, the TaqMan assay, and by direct sequence analysis. The IFL4 region (ss469415590) was sequenced. Results: Of the 135 patients that completed 24 or 48 weeks of treatment with Peg-IFN-alpha plus RBV, 87.4% were of Central Asian (CA) ancestry and 12.6% were of Eastern European (EE) ancestry. A non-virological response was observed in 21.2% of CA and in 35.3% of EE, respectively (p<0.32). The rs12979860 was strongly associated with treatment response (OR, 5.2; 95% CI, 1.9-14.6; p<0.004) in the overall sample; however, SNP rs8099917 was the most predictive of outcome for CA group (OR, 6.9; 95% CI, 2.6-18.0; p<0.002). The allele frequency of IFNL4 SNP, ss469415590, was identical with that of rs12979860 in all samples. Conclusions: SNPs in IFNL3 and IFNL4 can be used to predict HCV treatment outcome in a population of Central Asian ancestry.	[Khudayberganova, Dinara; Sugiyama, Masaya; Masaki, Naohiko; Nishida, Nao; Mukaide, Motokazu; Mizokami, Masashi] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Dept Hepat Dis, Ichikawa, Japan; [Khudayberganova, Dinara; Sekler, Dildora; Latipov, Renat; Nataliya, Kan; Dildora, Suyarkulova; Sharapov, Said; Usmanova, Guzal; Raxmanov, Mahmarajab; Musabaev, Erkin] Minist Publ Hlth, Inst Virol, Tashkent, Uzbekistan	National Center for Global Health & Medicine - Japan	Sugiyama, M (corresponding author), Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Dept Hepat Dis, Ichikawa, Japan.	m.sugiyama@hospk.ncgm.go.jp	Musabaev, Erkin/AAG-3560-2021; Sekler, Dildora/AAY-3683-2020; LATIPOV, RENAT/E-8375-2011	LATIPOV, RENAT/0000-0002-9935-9210; Sekler, Dildora/0000-0001-8380-5952	Japan Society for the Promotion of Science (JSPS) [23390117]; Grants-in-Aid for Scientific Research [24790728] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant-in-Aid for Scientific Research (B) from Japan Society for the Promotion of Science (JSPS) (23390117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beinhardt S, 2013, CLIN INFECT DIS, V56, P118, DOI 10.1093/cid/cis843; Bibert S, 2013, J EXP MED, V210, P1109, DOI 10.1084/jem.20130012; Clark PJ, 2012, J GASTROEN HEPATOL, V27, P212, DOI 10.1111/j.1440-1746.2011.06918.x; Clark PJ, 2011, AM J GASTROENTEROL, V106, P38, DOI 10.1038/ajg.2010.370; Covolo L, 2013, ALIMENT PHARM THER, P1; Fischer J, 2012, HEPATOLOGY, V55, P1700, DOI 10.1002/hep.25582; Franco S, 2013, AIDS, P131; Fujino H, 2013, J GASTROENTEROL; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hayes CN, 2012, NAT REV GASTRO HEPAT, V9, P406, DOI 10.1038/nrgastro.2012.101; Hayes CN, 2011, GUT, V60, P261, DOI 10.1136/gut.2010.223495; Ito K, 2011, J CLIN MICROBIOL, V49, P1853, DOI 10.1128/JCM.02139-10; Kramer B, 2013, AIDS, V6, P27; Kurbanov F, 2003, J MED VIROL, V69, P367, DOI 10.1002/jmv.10298; Kurbanov F, 2008, HEPATOL RES, V38, P457, DOI 10.1111/j.1872-034X.2007.00293.x; Lindh M, 2010, GASTROENTEROLOGY, V139, P1794, DOI 10.1053/j.gastro.2010.08.057; Nozawa Y, 2014, TISSUE ANTIGENS, V83, P45, DOI 10.1111/tan.12264; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Ruzibakiev R, 2001, INTERVIROLOGY, V44, P327, DOI 10.1159/000050066; Stattermayer AF, 2014, ALIMENT PHARM THER, V39, P104, DOI 10.1111/apt.12547; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2010, HEPATOL RES, V40, P449, DOI 10.1111/j.1872-034X.2010.00671.x; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449	26	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93011	10.1371/journal.pone.0093011	http://dx.doi.org/10.1371/journal.pone.0093011			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662995	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900141
J	Krishnan, A; Almen, MS; Fredriksson, R; Schioth, HB				Krishnan, Arunkumar; Almen, Markus Sallman; Fredriksson, Robert; Schioth, Helgi B.			Insights into the Origin of Nematode Chemosensory GPCRs: Putative Orthologs of the Srw Family Are Found across Several Phyla of Protostomes	PLOS ONE			English	Article							RECEPTOR GENE REPERTOIRES; PHEROMONE RECEPTORS; ODORANT RECEPTORS; GENOME REVEALS; EVOLUTION; MAFFT	Nematode chemosensory GPCRs in Caenorhabditis elegans (NemChRs) are classified into 19 gene families, and are initially thought to have split from the ancestral Rhodopsin family of GPCRs. However, earlier studies have shown that among all 19 NemChR gene families, only the srw family has a clear sequence relationship to the ancestral Rhodopsin GPCR family. Yet, the phylogenetic relationships between the srw family of NemChRs and the Rhodopsin subfamilies are not fully understood. Also, a widespread search was not previously performed to check for the presence of putative srw family-like sequences or the other 18 NemChR families in several new protostome species outside the nematode lineage. In this study, we have investigated for the presence of 19 NemChR families across 26 eukaryotic species, covering basal eukaryotic branches and provide the first evidence that the srw family of NemChRs is indeed present across several phyla of protostomes. We could identify 29 putative orthologs of the srw family in insects (15 genes), molluscs (11 genes) and Schistosoma mansoni (3 genes). Furthermore, using HMM-HMM profile based comparisons and phylogenetic analysis we show that among all Rhodopsin subfamilies, the peptide and SOG (somatostatin/opioid/galanin) subfamilies are phylogenetically the closest relatives to the srw family of NemChRs. Taken together, we demonstrate that the srw family split from the large Rhodopsin family, possibly from the peptide and/or SOG subfamilies, well before the split of the nematode lineage, somewhere close to the divergence of the common ancestor of protostomes. Our analysis also suggests that the srsx family of NemChRs shares a clear sequence homology with the Rhodopsin subfamilies, as well as with few of the vertebrate olfactory receptors. Overall, this study provides further insights into the evolutionary events that shaped the GPCR chemosensory system in protostome species.	[Krishnan, Arunkumar; Almen, Markus Sallman; Fredriksson, Robert; Schioth, Helgi B.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Uppsala University	Schioth, HB (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	helgi.schioth@neuro.uu.se	Schioth, Helgi/AAQ-7239-2020	Sallman Almen, Markus/0000-0001-9591-9228; Krishnan, Arunkumar/0000-0002-9677-9092; Fredriksson, Robert/0000-0002-2810-3226	Swedish Research Council; Ahlens Foundation; Tore Nilssons foundation; byggmastare Engquist foundation; Swedish Brain Research Foundation; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF13OC0005723] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ahlens Foundation; Tore Nilssons foundation; byggmastare Engquist foundation; Swedish Brain Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by the Swedish Research Council, the Ahlens Foundation, Tore Nilssons foundation, byggmastare Engquist foundation, the Swedish Brain Research Foundation and the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Churcher AM, 2011, GENOME BIOL EVOL, V3, P36, DOI 10.1093/gbe/evq079; Churcher AM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-242; Cummins SF, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-28; Dong D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-12; Dryer L, 1999, TRENDS PHARMACOL SCI, V20, P413, DOI 10.1016/S0165-6147(99)01381-4; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gaillard I, 2004, CELL MOL LIFE SCI, V61, P456, DOI 10.1007/s00018-003-3273-7; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hashiguchi Y, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-76; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Jekely G, 2013, P NATL ACAD SCI USA, V110, P8702, DOI 10.1073/pnas.1221833110; Johnstone KA, 2009, MOL BIOL EVOL, V26, P1117, DOI 10.1093/molbev/msp027; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Libants S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-180; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Nordstrom KJV, 2011, MOL BIOL EVOL, V28, P2471, DOI 10.1093/molbev/msr061; Pantages E, 2000, NEURON, V28, P835, DOI 10.1016/S0896-6273(00)00157-4; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Raible F, 2006, DEV BIOL, V300, P461, DOI 10.1016/j.ydbio.2006.08.070; Robertson Hugh M, 2006, WormBook, P1; Rouquier S, 2007, MUTAT RES-FUND MOL M, V616, P95, DOI 10.1016/j.mrfmmm.2006.11.012; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Thomas JH, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-42; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	36	15	15	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93048	10.1371/journal.pone.0093048	http://dx.doi.org/10.1371/journal.pone.0093048			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663674	gold, Green Published, Green Submitted			2022-12-27	WOS:000333459900148
J	Muraoka, T; Adachi, K; Chowdhury, R; Kinbara, K				Muraoka, Takahiro; Adachi, Kota; Chowdhury, Rainy; Kinbara, Kazushi			Transetherification on Polyols by Intra- and Intermolecular Nucleophilic Substitutions	PLOS ONE			English	Article							MODULAR SYNTHESIS; POLYMER; PENTAERYTHRITOL; BIOACTIVITY; CHEMISTRY; TRIVALENT; DESIGN; PEG	Transetherification on polyols involving intra-and intermolecular nucleophilic substitutions is reported. Di- or trialkoxide formation of propane-1,3-diol or 2-(hydroxymethyl)propane-1,3-diol derivatives by NaH triggers the reaction via oxetanes formation, where the order to add NaH and a polyol significantly influences the yields of products. It was demonstrated that the protective group on the pentaerythritol skeleton is apparently transferred to the hydrophilic and hydrophobic chain molecules bearing a leaving group in one-step, and a protective group conversion from tosyl to benzyl was successful using a benzyl-appending triol to afford a desired product in 67% yield.	[Muraoka, Takahiro; Adachi, Kota; Chowdhury, Rainy; Kinbara, Kazushi] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 980, Japan; [Muraoka, Takahiro] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	Tohoku University; Japan Science & Technology Agency (JST)	Kinbara, K (corresponding author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 980, Japan.	kinbara@tagen.tohoku.ac.jp	Muraoka, Takahiro/C-6262-2017; Kinbara, Kazushi/E-6347-2017	Muraoka, Takahiro/0000-0001-6744-048X; Kinbara, Kazushi/0000-0002-5945-9612	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [23115003]; Management Expenses Grants for National Universities Corporations; Japan Society for the Promotion of Science (JSPS) [21675003, 24655112]; Hattori Hokokai Foundation; Asahi Group Foundation; Grants-in-Aid for Scientific Research [21675003] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Management Expenses Grants for National Universities Corporations; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hattori Hokokai Foundation; Asahi Group Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), Scientific Research on Innovative Areas "Spying minority in biological phenomena (No.3306)'' (23115003 to KK) and the Management Expenses Grants for National Universities Corporations, by Japan Society for the Promotion of Science (JSPS), Grant-in-Aids for Young Scientists S (21675003 to KK) and Grant-in-Aids for Challenging Exploratory Research (24655112 to TM), by the Hattori Hokokai Foundation (to TM), and by the Asahi Group Foundation (to TM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER RH, 1960, J ORG CHEM, V25, P1496, DOI 10.1021/jo01079a009; BAKER RH, 1948, J AM CHEM SOC, V70, P3857, DOI 10.1021/ja01191a094; Boden N, 1997, TETRAHEDRON, V53, P10939, DOI 10.1016/S0040-4020(97)00698-4; Boekhoven J, 2013, NAT CHEM, V5, P433, DOI 10.1038/nchem.1617; Burns CJ, 1999, SYNTHETIC COMMUN, V29, P2337, DOI 10.1080/00397919908086236; Caras-Quintero D, 2004, CHEM COMMUN, P926, DOI 10.1039/b400965g; Cordonier CEJ, 2005, J ORG CHEM, V70, P3425, DOI 10.1021/jo0500232; Coric I, 2013, ANGEW CHEM INT EDIT, V52, P3490, DOI 10.1002/anie.201209983; Fishman A, 2003, J ORG CHEM, V68, P9843, DOI 10.1021/jo034868u; Garcia-Bernabe A, 2004, CHEM-EUR J, V10, P2822, DOI 10.1002/chem.200305305; Gehin C, 2013, J AM CHEM SOC, V135, P9295, DOI 10.1021/ja404153m; Gouin SG, 2009, CHEMMEDCHEM, V4, P749, DOI 10.1002/cmdc.200900034; Huang Z, 2012, SCIENCE, V337, P1521, DOI 10.1126/science.1224741; Jayakannan M, 2001, MACROMOL RAPID COMM, V22, P1463, DOI 10.1002/1521-3927(20011201)22:18<1463::AID-MARC1463>3.0.CO;2-F; Kihara N, 2009, ORG LETT, V11, P1313, DOI 10.1021/ol900095d; Kondo K, 2013, ANGEW CHEM INT EDIT, V52, P2308, DOI 10.1002/anie.201208643; Kubota Y, 2003, B CHEM SOC JPN, V76, P805, DOI 10.1246/bcsj.76.805; Li L, 2013, ANGEW CHEM INT EDIT, V52, P424, DOI 10.1002/anie.201205940; Li XF, 2012, J ORG CHEM, V77, P8206, DOI 10.1021/jo301573e; Li XF, 2012, MACROMOLECULES, V45, P1447, DOI 10.1021/ma201599p; Liu Y, 2013, J AM CHEM SOC, V135, P4765, DOI 10.1021/ja3122608; Lohmeijer BGG, 2006, ORG LETT, V8, P4683, DOI 10.1021/ol0614166; Muraoka T, 2013, ANGEW CHEM INT EDIT, V52, P2430, DOI 10.1002/anie.201206563; Natarajan A, 2007, CHEM COMMUN, P695, DOI 10.1039/b611636a; NOUGUIER RM, 1985, J ORG CHEM, V50, P3296, DOI 10.1021/jo00218a010; Novakova V, 2011, EUR J ORG CHEM, V2011, P5879, DOI 10.1002/ejoc.201100689; PADIAS AB, 1987, J ORG CHEM, V52, P5305, DOI 10.1021/jo00233a002; Papp I, 2008, CHEM COMMUN, P5851, DOI 10.1039/b813414f; Percec V, 2013, J AM CHEM SOC, V135, P9055, DOI 10.1021/ja403323y; Sarmah MP, 2005, TETRAHEDRON, V61, P4437, DOI 10.1016/j.tet.2005.02.073; Shah STA, 2009, J ORG CHEM, V74, P2179, DOI 10.1021/jo802494t; Stanoeva E, 2004, TETRAHEDRON, V60, P5077, DOI 10.1016/j.tet.2004.04.046; Sun RY, 2013, J AM CHEM SOC, V135, P5990, DOI 10.1021/ja4016952; Sur S, 2012, ACS NANO, V6, P10776, DOI 10.1021/nn304101x; Thompson DS, 2000, MACROMOLECULES, V33, P6412, DOI 10.1021/ma990845z; Touaibia M, 2007, CHEM COMMUN, P380, DOI 10.1039/b612471b; Ueno T, 2010, SOFT MATTER, V6, P6072, DOI 10.1039/c0sm00788a; Wang YM, 2009, BIOMACROMOLECULES, V10, P617, DOI 10.1021/bm801333s; Williamson A., 1850, LONDON EDINBURGH DUB, V37, P350; Wuts PGM, 2007, GREENES PROTECTIVE G, P273; Yao F, 2010, MACROMOLECULES, V43, P9761, DOI 10.1021/ma102039n; Yeh MC, 2013, ANGEW CHEM INT EDIT, V52, P1031, DOI 10.1002/anie.201207708; Zha ZH, 2011, J MED CHEM, V54, P8085, DOI 10.1021/jm2009106; Zhao YJ, 2009, J APPL POLYM SCI, V111, P1638, DOI 10.1002/app.29140	44	1	1	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91912	10.1371/journal.pone.0091912	http://dx.doi.org/10.1371/journal.pone.0091912			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663293	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900031
J	Pan, J; Chen, Y; Mo, C; Wang, D; Chen, J; Mao, X; Guo, S; Zhuang, J; Qiu, S				Pan, Jincheng; Chen, Yu; Mo, Chengqiang; Wang, Daohu; Chen, Junxing; Mao, Xiaopeng; Guo, Shengjie; Zhuang, Jintao; Qiu, Shaopeng			Association of DSC3 mRNA Down-Regulation in Prostate Cancer with Promoter Hypermethylation and Poor Prognosis	PLOS ONE			English	Article							COLORECTAL-CANCER; GENE-EXPRESSION; DNA METHYLATION; DISEASE; TARGET; P53; PATTERNS; FUSION; GENOME	Background: Desmocollin 3 (DSC3), a member of the cadherin gene superfamily, is associated with pathogenesis of some cancers, but its role in prostate cancer (PCa) remains largely unknown. Methods: DSC3 gene expression level in available PCa microarray dataset was examined using the Oncomine database. DSC3 transcript expression in prostate cell line panel and an independent tissue cohort (n = 52) was estimated by quantitative PCR (Q-PCR). Epigenetic status of DSC3 gene promoter in PCa was investigated by uploading three dataset (ENCODE Infinium 450K array data and two methylation sequencing) in UCSC genome browser. While pyrosequencing analysis measured promoter DNA methylation, Q-PCR estimates were obtained for DSC3 transcript re-expression after 5-Aza-deoxycytidine (5-Aza) treatment. Clinical relevance of DSC3 expression was studied by Kaplan-Meier survival analysis. Finally, functional studies monitoring cell proliferation, migration and invasion were performed in prostate cell lines after siRNA mediated DSC3 knockdown or following 5-Aza induced re-expression. EMT markers Vimentin and E-cadherin expression was measured by Western Blot. Results: Microarray data analyses revealed a significant decrease in DSC3 transcript expression in PCa, compared to benign samples. Q-PCR analysis of an independent cohort revealed DSC3 transcript down-regulation, both in PCa cell lines and tumor tissues but not in their benign counterpart. Examination of available NGS and Infinium data identified a role for epigenetic regulation DSC3 mRNA reduction in PCa. Pyrosequencing confirmed the increased DSC3 promoter methylation in cancer cell lines and restoration of transcript expression upon 5-Aza treatment further corroborated this epigenetic silencing mechanism. Importantly Kaplan-Meier analysis of an outcome cohort showed an association between loss of DSC3 expression and significantly increased risk of biochemical recurrence. Functional studies indicate a role for epithelial-mesenchymal transition in DSC3 regulated cell migration/invasion. Conclusion: Taken together, our data suggests that DNA methylation contributes to down-regulation of DSC3 in prostate cancer, and loss of DSC3 predicts poor clinical outcome.	[Pan, Jincheng; Chen, Yu; Mo, Chengqiang; Wang, Daohu; Chen, Junxing; Mao, Xiaopeng; Zhuang, Jintao; Qiu, Shaopeng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Guo, Shengjie] Sun Yat Sen Univ, Ctr Canc, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Qiu, S (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China.	qiushp@hotmail.com	Chen, Yu/Y-3292-2019; Chen, Yi/HIR-2608-2022		China National Natural Science Foundation [81272809]; Science and Technology Planning Project of Guangdong [2011B050400021]; Guangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University [2010A060801016]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong; Guangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University	This work was supported by grants from the China National Natural Science Foundation (81272809); Science and Technology Planning Project of Guangdong (2011B050400021) and Guangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University (2010A060801016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arredouani MS, 2009, CLIN CANCER RES, V15, P5794, DOI 10.1158/1078-0432.CCR-09-0911; Bastian PJ, 2004, EUR UROL, V46, P698, DOI 10.1016/j.eururo.2004.07.022; Borno ST, 2012, CANCER DISCOV, V2, P1024, DOI 10.1158/2159-8290.CD-12-0041; Choudhury AD, 2012, EUR UROL, V62, P577, DOI 10.1016/j.eururo.2012.05.054; Chun MGH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001120; Cui T, 2011, BRIT J CANCER, V104, P1013, DOI 10.1038/bjc.2011.28; Cui TT, 2012, CARCINOGENESIS, V33, P2326, DOI 10.1093/carcin/bgs273; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Han M, 2001, UROL CLIN N AM, V28, P555, DOI 10.1016/S0094-0143(05)70163-4; Huber O, 2003, CELL MOL LIFE SCI, V60, P1872, DOI 10.1007/s00018-003-3050-7; Jeronimo C, 2004, CLIN CANCER RES, V10, P8472, DOI 10.1158/1078-0432.CCR-04-0894; Kacprzyk LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059976; Kim JH, 2011, GENOME RES, V21, P1028, DOI 10.1101/gr.119347.110; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Oshiro MM, 2005, BREAST CANCER RES, V7, pR669, DOI 10.1186/bcr1273; Oshiro MM, 2003, ONCOGENE, V22, P3624, DOI 10.1038/sj.onc.1206545; Pan JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075283; Paulo P, 2012, NEOPLASIA, V14, P600, DOI 10.1593/neo.12600; Salagierski M, 2012, J UROLOGY, V187, P795, DOI 10.1016/j.juro.2011.10.133; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singal R, 2004, ONCOL REP, V12, P631; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001970; Ueno K, 2008, NEOPLASIA, V10, P697, DOI 10.1593/neo.08320; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wang LH, 2007, VIRCHOWS ARCH, V451, P959, DOI 10.1007/s00428-007-0485-5; Woodson K, 2004, PROSTATE, V60, P25, DOI 10.1002/pros.20013; Wu T, 2011, BRIT J CANCER, V105, P65, DOI 10.1038/bjc.2011.143	30	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92815	10.1371/journal.pone.0092815	http://dx.doi.org/10.1371/journal.pone.0092815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664224	Green Submitted, Green Published, gold			2022-12-27	WOS:000333459900117
J	Radhakrishnan, A; Dorronsoro, C; Sawides, L; Marcos, S				Radhakrishnan, Aiswaryah; Dorronsoro, Carlos; Sawides, Lucie; Marcos, Susana			Short-Term Neural Adaptation to Simultaneous Bifocal Images	PLOS ONE			English	Article							VISUAL PERFORMANCE; INTRAOCULAR LENSES; VISION; CONTRAST; COMPENSATION; MECHANISM	Simultaneous vision is an increasingly used solution for the correction of presbyopia (the age-related loss of ability to focus near images). Simultaneous Vision corrections, normally delivered in the form of contact or intraocular lenses, project on the patient's retina a focused image for near vision superimposed with a degraded image for far vision, or a focused image for far vision superimposed with the defocused image of the near scene. It is expected that patients with these corrections are able to adapt to the complex Simultaneous Vision retinal images, although the mechanisms or the extent to which this happens is not known. We studied the neural adaptation to simultaneous vision by studying changes in the Natural Perceived Focus and in the Perceptual Score of image quality in subjects after exposure to Simultaneous Vision. We show that Natural Perceived Focus shifts after a brief period of adaptation to a Simultaneous Vision blur, similar to adaptation to Pure Defocus. This shift strongly correlates with the magnitude and proportion of defocus in the adapting image. The magnitude of defocus affects perceived quality of Simultaneous Vision images, with 0.5 D defocus scored lowest and beyond 1.5 D scored "sharp''. Adaptation to Simultaneous Vision shifts the Perceptual Score of these images towards higher rankings. Larger improvements occurred when testing simultaneous images with the same magnitude of defocus as the adapting images, indicating that wearing a particular bifocal correction improves the perception of images provided by that correction.	[Radhakrishnan, Aiswaryah; Dorronsoro, Carlos; Sawides, Lucie; Marcos, Susana] CSIC, Lab Visual Opt & Biophoton, Inst Opt Daza de Valdes, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Optica (Daza de Valdes)	Radhakrishnan, A (corresponding author), CSIC, Lab Visual Opt & Biophoton, Inst Opt Daza de Valdes, Madrid, Spain.	aishu@io.cfmac.csic.es	Dorronsoro, Carlos/AAC-8003-2019; Dorronsoro, Carlos/A-2297-2011; Sawides, Lucie/O-1431-2016	Dorronsoro, Carlos/0000-0001-5968-1128; Dorronsoro, Carlos/0000-0001-5968-1128; Sawides, Lucie/0000-0002-8918-8753; Radhakrishnan, Aiswaryah/0000-0002-0732-9947	European Research Council under the European Union's Seventh Framework Programme/ERC [294099]; Spanish Government [FIS2011-264605]; European Community through the Marie Curie Initial Training Network OpAL; European Commission under the Seventh Framework Programme [PITN-GA-2010-264605]	European Research Council under the European Union's Seventh Framework Programme/ERC(European Research Council (ERC)); Spanish Government(Spanish GovernmentEuropean Commission); European Community through the Marie Curie Initial Training Network OpAL; European Commission under the Seventh Framework Programme	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement no 294099, Spanish Government grant FIS2011-264605 and 7th Framework Programme of the European Community through the Marie Curie Initial Training Network OpAL (OpAL is an Initial Training Network funded by the European Commission under the Seventh Framework Programme (PITN-GA-2010-264605)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artal P, 2004, J VISION, V4, P281, DOI 10.1167/4.4.4; Bao M, 2012, P NATL ACAD SCI USA, V109, P5898, DOI 10.1073/pnas.1113503109; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Charman WN, 1998, VISION RES, V38, P2841, DOI 10.1016/S0042-6989(97)00447-1; Cillino S, 2008, OPHTHALMOLOGY, V115, P1508, DOI 10.1016/j.ophtha.2008.04.017; Cochener B, 2011, CLIN OPHTHALMOL, V5, P45, DOI 10.2147/OPTH.S14325; de Gracia P, 2013, INVEST OPHTH VIS SCI, V54, P415, DOI 10.1167/iovs.12-11219; Donahue SP, 2009, OPHTHALMOLOGY, P1059; Ehrenstein WH, 1999, MODERN TECHNIQUES NE, P1211, DOI DOI 10.1007/978-3-642-58552-4_43; Gambra E, 2009, J VISION, V9, DOI 10.1167/9.6.4; Kaymak H, 2008, J REFRACT SURG, V24, P287, DOI 10.3928/1081597X-20080301-11; Kim MJ, 2011, J CATARACT REFR SURG, V37, P1305, DOI 10.1016/j.jcrs.2011.03.033; Kohnen T, 2008, J CATARACT REFR SURG, V34, P2005, DOI 10.1016/j.jcrs.2008.10.011; Kwon MY, 2009, J VISION, V9, DOI 10.1167/9.2.20; Lichtinger A, 2012, CURR OPIN OPHTHALMOL, V23, P40, DOI 10.1097/ICU.0b013e32834cd5be; Llorente-Guillemot A, 2012, CLIN EXP OPTOM, V95, P54, DOI 10.1111/j.1444-0938.2011.00666.x; Madrid-Costa D, 2013, OPHTHAL PHYSL OPT, V33, P51, DOI 10.1111/opo.12008; McDonal II J, EUROTIMES, P1; Mon-Williams M, 1998, P ROY SOC B-BIOL SCI, V265, P71, DOI 10.1098/rspb.1998.0266; Neitz J, 2002, NEURON, V35, P783, DOI 10.1016/S0896-6273(02)00818-8; PELI E, 1990, J OPT SOC AM A, V7, P2032, DOI 10.1364/JOSAA.7.002032; Pelli DG, 1995, HDB OPTICS; PESUDOVS K, 1993, OPTOMETRY VISION SCI, V70, P528, DOI 10.1097/00006324-199307000-00002; Phipps Joanna A, 2001, Clin Exp Optom, V84, P264; Poulere E, 2013, OPHTHAL PHYSL OPT, V33, P130, DOI 10.1111/opo.12020; Sawides L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070856; Sawides L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027031; Sawides L, 2011, J VISION, V11, DOI 10.1167/11.7.21; Sawides L, 2010, J VISION, V10, DOI 10.1167/10.12.22; Sawides L, 2010, J VISION, V10, DOI 10.1167/10.5.19; Vinas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046361; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Webster MA, 1997, J OPT SOC AM A, V14, P2355, DOI 10.1364/JOSAA.14.002355; Webster MA, 2002, NAT NEUROSCI, V5, P839, DOI 10.1038/nn906; Webster MA, 2011, J VISION, V11, DOI 10.1167/11.5.3; Werner JS, 2001, HDB OPTICS CLASSICAL, P1323; Yamauchi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068236; Yehezkel O, 2010, VISION RES, V50, P1550, DOI 10.1016/j.visres.2010.05.014	38	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93089	10.1371/journal.pone.0093089	http://dx.doi.org/10.1371/journal.pone.0093089			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664087	Green Submitted, Green Published, gold			2022-12-27	WOS:000333459900151
J	Bonneh, YS; Donner, TH; Cooperman, A; Heeger, DJ; Sagi, D				Bonneh, Yoram S.; Donner, Tobias H.; Cooperman, Alexander; Heeger, David J.; Sagi, Dov			Motion-Induced Blindness and Troxler Fading: Common and Different Mechanisms	PLOS ONE			English	Article							BINOCULAR-RIVALRY; FILLING-IN; ADAPTATION; SCOTOMAS; MOVEMENT; DYNAMICS; STIMULI; REVEALS	Extended stabilization of gaze leads to disappearance of dim visual targets presented peripherally. This phenomenon, known as Troxler fading, is thought to result from neuronal adaptation. Intense targets also disappear intermittently when surrounded by a moving pattern (the "mask''), a phenomenon known as motion-induced blindness (MIB). The similar phenomenology and dynamics of these disappearances may suggest that also MIB is, likewise, solely due to adaptation, which may be amplified by the presence of the mask. Here we directly compared the dependence of both phenomena on target contrast. Observers reported the disappearance and reappearance of a target of varying intensity (contrast levels: 8%-80%). MIB was induced by adding a mask that moved at one of various different speeds. The results revealed a lawful effect of contrast in both MIB and Troxler fading, but with opposite trends. Increasing target contrast increased (doubled) the rate of disappearance events for MIB, but decreased the disappearance rate to half in Troxler fading. The target mean invisible period decreased equally strongly with target contrast in MIB and in Troxler fading. The results suggest that both MIB and Troxler are equally affected by contrast adaptation, but that the rate of MIB is governed by an additional mechanism, possibly involving antagonistic processes between neuronal populations processing target and mask. Our results link MIB to other bi-stable visual phenomena that involve neuronal competition (such as binocular rivalry), which exhibit an analogous dependency on the strength of the competing stimulus components.	[Bonneh, Yoram S.] Univ Haifa, Dept Human Biol, IL-31999 Haifa, Israel; [Bonneh, Yoram S.; Cooperman, Alexander; Sagi, Dov] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Donner, Tobias H.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Donner, Tobias H.] Univ Amsterdam, Ctr Cognit Sci, Amsterdam, Netherlands; [Donner, Tobias H.] Charite, Bernstein Ctr Computat Neurosci, D-13353 Berlin, Germany; [Donner, Tobias H.; Heeger, David J.] NYU, Dept Psychol, New York, NY 10003 USA; [Donner, Tobias H.; Heeger, David J.] NYU, Ctr Neural Sci, New York, NY 10003 USA	University of Haifa; Weizmann Institute of Science; University of Amsterdam; University of Amsterdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; New York University; New York University	Bonneh, YS (corresponding author), Univ Haifa, Dept Human Biol, IL-31999 Haifa, Israel.	yoram.bonneh@gmail.com	Sagi, Dov/A-5454-2008	Sagi, Dov/0000-0002-8446-9230; Bonneh, Yoram/0000-0003-1091-639X; Donner, Tobias H./0000-0002-7559-6019	US-Israel Binational Science Foundation; Weizmann-New York University Demonstration Fund in Neuroscience; German Academy of Science Leopoldina [BMBF-LPD 9901/8-136]; NIH [ROI-EY016752]; NATIONAL EYE INSTITUTE [R01EY016752] Funding Source: NIH RePORTER	US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Weizmann-New York University Demonstration Fund in Neuroscience; German Academy of Science Leopoldina; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by the US-Israel Binational Science Foundation (D. S. and D.J.H.), The Weizmann-New York University Demonstration Fund in Neuroscience (D.J.H. and D. S.), German Academy of Science Leopoldina (BMBF-LPD 9901/8-136, T. H. D.), and NIH (ROI-EY016752, D.J.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Bonneh Y, 2003, J VISION, V3, P221; Bonneh YS, 2010, J VISION, V10, DOI 10.1167/10.14.22; Bonneh YS, 2001, NATURE, V411, P798, DOI 10.1038/35081073; Brascamp JW, 2006, J VISION, V6, P1244, DOI 10.1167/6.11.8; Breitmeyer B.G., 1984, VISUAL MASKING INTEG; BURBECK CA, 1984, J OPT SOC AM A, V1, P216, DOI 10.1364/JOSAA.1.000216; Caetta F, 2009, INTERACTIONS SENSORI; Caetta F, 2007, J VISION, V7, DOI 10.1167/7.7.4; Donner TH, 2008, J NEUROSCI, V28, P10298, DOI 10.1523/JNEUROSCI.2371-08.2008; Donner TH, 2013, J NEUROSCI, V33, P2188, DOI 10.1523/JNEUROSCI.3388-12.2013; Gigante G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000430; Gorea A, 2009, J VISION, V9, DOI 10.1167/9.6.16; Graf EW, 2002, VISION RES, V42, P2731, DOI 10.1016/S0042-6989(02)00390-5; Hofstoetter C, 2004, CONSCIOUS COGN, V13, P691, DOI 10.1016/j.concog.2004.06.007; Hsu LC, 2004, VISION RES, V44, P2857, DOI 10.1016/j.visres.2003.10.029; Hsu LC, 2006, VISION RES, V46, P1973, DOI 10.1016/j.visres.2005.11.004; HUNZELMANN N, 1984, VISION RES, V24, P1765, DOI 10.1016/0042-6989(84)90007-5; Kang MS, 2010, J VISION, V10, DOI 10.1167/10.11.3; Kim CY, 2005, TRENDS COGN SCI, V9, P381, DOI 10.1016/j.tics.2005.06.012; Klink PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003473; Koch C., 2007, QUEST CONSCIOUSNESS; Libedinsky C, 2009, J VISION, V9, DOI 10.1167/9.1.14; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; Martinez-Conde S, 2006, NEURON, V49, P297, DOI 10.1016/j.neuron.2005.11.033; Mitroff SR, 2005, VISION RES, V45, P961, DOI 10.1016/j.visres.2004.09.044; Montaser-Kouhsari L, 2004, PERCEPTION, V33, P249, DOI 10.1068/p5174; New JJ, 2008, PSYCHOL SCI, V19, P653, DOI 10.1111/j.1467-9280.2008.02139.x; Noest AJ, 2007, J VISION, V7, DOI 10.1167/7.8.10; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; Simons D, 2006, J VISION, V6, P1093, DOI 10.1167/6.10.9; Sturzel F, 2001, VISION RES, V41, P2969, DOI 10.1016/S0042-6989(01)00172-9; Troxler D, 1804, OPHTHALMOLOGISCHES B, P51; Wallis TSA, 2009, CURR BIOL, V19, P325, DOI 10.1016/j.cub.2008.12.053; Weil RS, 2011, BRAIN RES REV, V67, P40, DOI 10.1016/j.brainresrev.2010.10.004; Welchman AE, 2001, VISION RES, V41, P2107, DOI 10.1016/S0042-6989(01)00087-6; Wilke M, 2003, NEURON, V39, P1043, DOI 10.1016/j.neuron.2003.08.003	38	19	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92894	10.1371/journal.pone.0092894	http://dx.doi.org/10.1371/journal.pone.0092894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658600	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300141
J	Mishra, GD; Black, S; Stafford, M; Cooper, R; Kuh, D				Mishra, Gita D.; Black, Stephanie; Stafford, Mai; Cooper, Rachel; Kuh, Diana		Natl Survey Hlth Dev	Childhood and Maternal Effects on Physical Health Related Quality of Life Five Decades Later: The British 1946 Birth Cohort	PLOS ONE			English	Article							SURVEY SF-36; PERFORMANCE; DISABILITY; MIDLIFE	Limited research has been done on the relationships between childhood factors and adult physical health related quality of life, with the underlying pathways not fully elucidated. Data from 2292 participants of the British 1946 birth cohort were used to examine the relationship of childhood characteristics and family environment with principal component summary (PCS) scores and the physical functioning (PF) subscale of the SF-36 at age 60-64 years. Impaired physical functioning was defined as the lowest quartile scores in the PF subscale. Childhood factors (father in manual social class versus non-manual (beta = -2.34; 95%CI: -3.39, -1.28) and poor maternal health versus good/excellent maternal health (beta = -6.18; -8.78, -3.57)) were associated with lower PCS scores at 60-64 years. Adult health behaviours (increasing BMI, lifelong smoking, and lower physical activity) at 53 years were identified as strong risk factors for lower PCS scores. After adjusting for these factors and education level (N = 1463), only poor maternal health remained unattenuated (beta = -5.07; -7.62, -2.51). Similarly poor maternal health doubled the risk of reporting impaired PF (Odds ratio = 2.45; 95%CI: 1.39, 4.30); serious illness in childhood (OR = 1.44; 1.01, 2.06) and lower educational level attained were also risk factors for impaired PF (N = 1526). While findings suggest the influence of father's social class on physical health related quality of life are mediated by modifiable adult social factors and health behaviours; health professionals should also be mindful of the inter-generational risk posed by poor maternal health on the physical health related quality of life of her offspring almost five decades later.	[Mishra, Gita D.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Mishra, Gita D.; Black, Stephanie; Stafford, Mai; Cooper, Rachel; Kuh, Diana] UCL, MRC Unit Lifelong Hlth & Ageing, London, England	University of Queensland; University of London; University College London	Mishra, GD (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia.	g.mishra@uq.edu.au	Cooper, Rachel/ABE-3768-2021; Kuh, Diana/L-6019-2014	Cooper, Rachel/0000-0003-3370-5720; Kuh, Diana/0000-0001-7386-2857	Australian Research Council Future Fellowship [FT120100812]; UK Medical Research Council; MRC [MC_UU_12019/4, MC_UU_12019/5, MC_U123092725, MC_UU_12019/1] Funding Source: UKRI; Medical Research Council [MC_UU_12019/1, MC_UU_12019/5, MC_U123092725, MC_UU_12019/4] Funding Source: researchfish	Australian Research Council Future Fellowship(Australian Research Council); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors are grateful to NSHD study members who took part in this latest data collection for their continuing support. GDM is supported by the Australian Research Council Future Fellowship (FT120100812). SB, MS, RC, and DK are supported by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alastalo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069011; Birnie K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015564; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Clennell S, 2008, J EPIDEMIOL COMMUN H, V62, P1051, DOI 10.1136/jech.2007.068312; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; den Ouden MEM, 2011, MATURITAS, V69, P208, DOI 10.1016/j.maturitas.2011.04.008; Hotopf M, 2002, SCAND J PSYCHOL, V43, P139, DOI 10.1111/1467-9450.00279; Jenkinson C, 1999, J PUBLIC HEALTH MED, V21, P372, DOI 10.1093/pubmed/21.4.372; Kuh D, 2012, PUBLIC HEALTH, V126, P193, DOI 10.1016/j.puhe.2012.01.025; Kuh D, 2002, SOC SCI MED, V55, P1957, DOI 10.1016/S0277-9536(01)00324-0; Laaksonen M, 2007, ANN EPIDEMIOL, V17, P431, DOI 10.1016/j.annepidem.2006.11.003; Maggi S, 2010, J PAEDIATR CHILD H, V46, P627, DOI 10.1111/j.1440-1754.2010.01817.x; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Mishra GD, QUAL LIFE R IN PRESS; Power C, 2013, ANNU REV PUBL HEALTH, V34, P7, DOI 10.1146/annurev-publhealth-031912-114423; Singh-Manoux A, 2004, INT J EPIDEMIOL, V33, P1072, DOI 10.1093/ije/dyh224; Stafford M, 2013, EUR J AGEING, V10, P145, DOI 10.1007/s10433-013-0258-8; Strand BH, 2011, EUR J EPIDEMIOL, V26, P475, DOI 10.1007/s10654-011-9562-9; Vermeulen J, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-33; Ware J., 1993, SF 36 HLTH SURVEY MA; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1167, DOI 10.1016/S0895-4356(98)00108-5; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wilkins AJ, 2004, J PAEDIATR CHILD H, V40, P102, DOI 10.1111/j.1440-1754.2004.00309.x	23	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e88524	10.1371/journal.pone.0088524	http://dx.doi.org/10.1371/journal.pone.0088524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SR	24670776	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000333677000001
J	Vandenabeele, SP; Grundy, E; Friswell, MI; Grogan, A; Votier, SC; Wilson, RP				Vandenabeele, Sylvie P.; Grundy, Edward; Friswell, Michael I.; Grogan, Adam; Votier, Stephen C.; Wilson, Rory P.			Excess Baggage for Birds: Inappropriate Placement of Tags on Gannets Changes Flight Patterns	PLOS ONE			English	Article							INTRA-SPECIFIC COMPETITION; FORAGING TRIP DURATION; RADIO TRANSMITTERS; RECORDING DEVICES; FEEDING LOCATIONS; PELAGIC SEABIRD; ADELIE PENGUINS; MORUS-BASSANUS; GPS TRACKING; NORTH-SEA	Devices attached to flying birds can hugely enhance our understanding of their behavioural ecology for periods when they cannot be observed directly. For this, scientists routinely attach units to either birds' backs or their tails. However, inappropriate payload distribution is critical in aircraft and, since birds and planes are subject to the same laws of physics during flight, we considered aircraft aerodynamic constraints to explain flight patterns displayed by northern gannets Sula bassana equipped with (small ca. 14 g) tail- and back-mounted accelerometers and (larger ca. 30 g) tail-mounted GPS units. Tail-mounted GPS-fitted birds showed significantly higher cumulative numbers of flap-glide cycles and a higher pitch angle of the tail than accelerometer-equipped birds, indicating problems with balancing inappropriately placed weights with knock-on consequences relating to energy expenditure. These problems can be addressed by carefully choosing where to place tags on birds according to the mass of the tags and the lifestyle of the subject species.	[Vandenabeele, Sylvie P.; Grundy, Edward; Wilson, Rory P.] Swansea Univ, Biosci Dept, Coll Sci, Swansea, W Glam, Wales; [Friswell, Michael I.] Swansea Univ, Coll Engn, Swansea, W Glam, Wales; [Grogan, Adam] RSPCA Wildlife Dept, Southwater, W Sussex, England; [Votier, Stephen C.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England	Swansea University; Swansea University; University of Exeter	Vandenabeele, SP (corresponding author), Swansea Univ, Biosci Dept, Coll Sci, Singleton Pk, Swansea, W Glam, Wales.	vanden.sylvie@gmail.com	Votier, Stephen C/G-2348-2014; Friswell, Michael I/B-5581-2009	Votier, Stephen C/0000-0002-0976-0167; Friswell, Michael I/0000-0003-4677-7395; Vandenabeele, Sylvie/0000-0003-2963-3410	California Department of Fish and Game's Oil Spill Response Trust Fund (through the Oiled Wildlife Care Network at the Wildlife Health Center, School of Veterinary Medicine, University of California, Davis); Royal Society for Prevention of Cruelty to Animals (RSPCA, Wilberforce Way, Southwater, Horsham, West Sussex, United Kingdom)	California Department of Fish and Game's Oil Spill Response Trust Fund (through the Oiled Wildlife Care Network at the Wildlife Health Center, School of Veterinary Medicine, University of California, Davis); Royal Society for Prevention of Cruelty to Animals (RSPCA, Wilberforce Way, Southwater, Horsham, West Sussex, United Kingdom)	This study would have not been carried out without the financial support from the California Department of Fish and Game's Oil Spill Response Trust Fund (through the Oiled Wildlife Care Network at the Wildlife Health Center, School of Veterinary Medicine, University of California, Davis) and the Royal Society for Prevention of Cruelty to Animals (RSPCA, Wilberforce Way, Southwater, Horsham, West Sussex, RH13 9RS, United Kingdom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2009, NEW ZEAL J ZOOL, V36, P355, DOI 10.1080/03014220909510160; Anderka F.W., 1992, P135; Anderson JD., 2005, ENERGY, V20, P6; Ballard G, 2001, CONDOR, V103, P481, DOI 10.1650/0010-5422(2001)103[0481:EOIAAO]2.0.CO;2; BANNASCH R, 1994, J EXP BIOL, V194, P83; Barron DG, 2010, METHODS ECOL EVOL, V1, P180, DOI 10.1111/j.2041-210X.2010.00013.x; Bowlin MS, 2010, METHODS ECOL EVOL, V1, P398, DOI 10.1111/j.2041-210X.2010.00043.x; Croll DA, 1996, J FIELD ORNITHOL, V67, P1; del Hoyo J, 2013, HDB BIRDS WORLD; Federal Aviation Administration US Department of Transportation, 2007, AIRCR WEIGHT BAL HDB; Garthe S, 2007, MAR BIOL, V151, P687, DOI 10.1007/s00227-006-0523-x; GESSAMAN JA, 1988, CONDOR, V90, P662, DOI 10.2307/1368356; Grecian WJ, 2012, BIOL CONSERV, V156, P43, DOI 10.1016/j.biocon.2011.12.010; Green JA, 2009, J EXP BIOL, V212, P471, DOI 10.1242/jeb.026377; Gremillet D, 2004, MAR ECOL PROG SER, V268, P265, DOI 10.3354/meps268265; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; Hamer KC, 2007, MAR ECOL PROG SER, V338, P295, DOI 10.3354/meps338295; Hamer KC, 2009, J ANIM ECOL, V78, P880, DOI 10.1111/j.1365-2656.2009.01549.x; Hamer KC, 2000, MAR ECOL PROG SER, V200, P257, DOI 10.3354/meps200257; Healy Marg, 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P179; Kenward RE., 2000, MANUAL WILDLIFE RADI; Lewis S, 2001, NATURE, V412, P816, DOI 10.1038/35090566; MILLER GD, 1993, BIOL CONSERV, V63, P223, DOI 10.1016/0006-3207(93)90716-E; MONTEVECCHI WA, 1984, COMP BIOCHEM PHYS A, V78, P15, DOI 10.1016/0300-9629(84)90084-7; Navarro J, 2008, J EXP MAR BIOL ECOL, V358, P14, DOI 10.1016/j.jembe.2008.01.005; NELSON J.B., 1978, SULIDAE GANNETS BOOB; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Powell LA, 1998, J FIELD ORNITHOL, V69, P306; Raymer, 2012, AIAA ED SERIES; Ropert-Coudert Y, 2004, IBIS, V146, P281, DOI 10.1111/j.1474-919x.2003.00250.x; Shepard E., 2008, ENDANGERED SPECIES R, V10; Shepard ELC, 2009, AQUAT BIOL, V4, P235, DOI 10.3354/ab00104; Stauss C, 2012, MAR ECOL PROG SER, V457, P151, DOI 10.3354/meps09734; Stevens B.L., 2015, AIRCRAFT CONTROL SIM; Taylor GK, 2002, J THEOR BIOL, V214, P351, DOI 10.1006/jtbi.2001.2470; Taylor SS, 2001, J AVIAN BIOL, V32, P369, DOI 10.1111/j.0908-8857.2001.320413.x; Vandenabeele SP, 2012, P 11 INT EFF OIL WIL; Vandenabeele SP, 2013, FRONT ECOL ENVIRON, V11, P10, DOI 10.1890/13.WB.002; Vandenabeele SP, 2012, MAR BIOL, V159, P1, DOI 10.1007/s00227-011-1784-6; Votier SC, 2011, MAR BIOL, V158, P355, DOI 10.1007/s00227-010-1563-9; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; WANLESS S, 1989, COLON WATERBIRD, V12, P158, DOI 10.2307/1521336; Watanabe S, 2005, APPL ANIM BEHAV SCI, V94, P117, DOI 10.1016/j.applanim.2005.01.010; WATANUKI Y, 1992, POLAR BIOL, V12, P539; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; WILSON RP, 1989, WILDLIFE SOC B, V17, P77; Wilson RP, 1997, WILDLIFE SOC B, V25, P101	48	47	50	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92657	10.1371/journal.pone.0092657	http://dx.doi.org/10.1371/journal.pone.0092657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671007	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677000061
J	Codeluppi, S; Fernandez-Zafra, T; Sandor, K; Kjell, J; Liu, QS; Abrams, M; Olson, L; Gray, NS; Svensson, CI; Uhlen, P				Codeluppi, Simone; Fernandez-Zafra, Teresa; Sandor, Katalin; Kjell, Jacob; Liu, Qingsong; Abrams, Mathew; Olson, Lars; Gray, Nathanael S.; Svensson, Camilla I.; Uhlen, Per			Interleukin-6 Secretion by Astrocytes Is Dynamically Regulated by PI3K-mTOR-Calcium Signaling	PLOS ONE			English	Article							SPINAL-CORD-INJURY; GENE-EXPRESSION; MESSENGER-RNA; IMMUNE-RESPONSES; SMOOTH-MUSCLE; REGENERATION; RAPAMYCIN; RECEPTOR; RELEASE; PATHWAY	After contusion spinal cord injury (SCI), astrocytes become reactive and form a glial scar. While this reduces spreading of the damage by containing the area of injury, it inhibits regeneration. One strategy to improve the recovery after SCI is therefore to reduce the inhibitory effect of the scar, once the acute phase of the injury has passed. The pleiotropic cytokine interleukin-6 (IL-6) is secreted immediately after injury and regulates scar formation; however, little is known about the role of IL-6 in the sub-acute phases of SCI. Interestingly, IL-6 also promotes axon regeneration, and therefore its induction in reactive astrocytes may improve regeneration after SCI. We found that IL-6 is expressed by astrocytes and neurons one week post-injury and then declines. Using primary cultures of rat astrocytes we delineated the molecular mechanisms that regulate IL-6 expression and secretion. IL-6 expression requires activation of p38 and depends on NF-kappa B transcriptional activity. Activation of these pathways in astrocytes occurs when the PI3K-mTOR-AKT pathway is inhibited. Furthermore, we found that an increase in cytosolic calcium concentration was necessary for IL-6 secretion. To induce IL-6 secretion in astrocytes, we used torin2 and rapamycin to block the PI3K-mTOR pathway and increase cytosolic calcium, respectively. Treating injured animals with torin2 and rapamycin for two weeks, starting two weeks after injury when the scar has been formed, lead to a modest effect on mechanical hypersensitivity, limited to the period of treatment. These data, taken together, suggest that treatment with torin2 and rapamycin induces IL-6 secretion by astrocytes and may contribute to the reduction of mechanical hypersensitivity after SCI.	[Codeluppi, Simone; Fernandez-Zafra, Teresa; Uhlen, Per] Karolinska Inst, Mol Neurobiol Lab, Dept Med Biochem & Biophys, Stockholm, Sweden; [Sandor, Katalin; Svensson, Camilla I.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Kjell, Jacob; Abrams, Mathew; Olson, Lars] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Liu, Qingsong; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Liu, Qingsong; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Codeluppi, S (corresponding author), Karolinska Inst, Mol Neurobiol Lab, Dept Med Biochem & Biophys, Stockholm, Sweden.	simone.codeluppi@ki.se	Kjell, Jacob/HDN-4979-2022; Liu, Qingsong/AFS-0714-2022; 刘, 青松/AEM-1932-2022; codeluppi, simone/I-4143-2012; svensson, camilla/C-9511-2014	Liu, Qingsong/0000-0002-7829-2547; 刘, 青松/0000-0002-7829-2547; codeluppi, simone/0000-0002-7053-0520; Uhlen, Per/0000-0003-1446-1062; svensson, camilla/0000-0001-7980-4631; Kjell, Jacob/0000-0002-8335-0780	Wenner-Gren foundation; Svenska Sallskapet for Medicinsk Forskning; Becas Talentia; Hjarnfonden; Swedish Research Council; Linnaeus Center in Developmental Biology for Regenerative Medicine; Knut and Alice Wallenberg Foundation; Royal Swedish Academy of Sciences; Wings for Life; Vinnova; Karolinska Distinguished Professor Award; Karolinska StratNeuro program	Wenner-Gren foundation; Svenska Sallskapet for Medicinsk Forskning; Becas Talentia; Hjarnfonden; Swedish Research Council(Swedish Research CouncilEuropean Commission); Linnaeus Center in Developmental Biology for Regenerative Medicine; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Royal Swedish Academy of Sciences; Wings for Life; Vinnova(Vinnova); Karolinska Distinguished Professor Award; Karolinska StratNeuro program	This work was supported by: Wenner-Gren foundation (SC, KS), Svenska Sallskapet for Medicinsk Forskning (SC), Becas Talentia (TFZ), Hjarnfonden (SC, PU), Swedish Research Council (CS, PU, LO), Linnaeus Center in Developmental Biology for Regenerative Medicine (PU), the Knut and Alice Wallenberg Foundation Grant to Center of Live Imaging of Cells at Karolinska Institutet (PU), the Royal Swedish Academy of Sciences (PU), Wings for Life (LO, MA), Vinnova (LO), Karolinska Distinguished Professor Award (LO), Karolinska StratNeuro program (LO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; BENVENISTE EN, 1990, J NEUROIMMUNOL, V30, P201, DOI 10.1016/0165-5728(90)90104-U; Blum S, 2001, J BIOL CHEM, V276, P33428, DOI 10.1074/jbc.M105474200; Boyle DL, 2003, ARTHRITIS RES THER, V5, pR352, DOI 10.1186/ar1004; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Cafferty WBJ, 2004, J NEUROSCI, V24, P4432, DOI 10.1523/JNEUROSCI.2245-02.2004; CAMERON AM, 1995, P NATL ACAD SCI USA, V92, P1784, DOI 10.1073/pnas.92.5.1784; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Codeluppi S, 2011, J NEUROSCI METH, V197, P118, DOI 10.1016/j.jneumeth.2011.02.011; Craig R, 2000, J BIOL CHEM, V275, P23814, DOI 10.1074/jbc.M909695199; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Ducreux S, 2004, J BIOL CHEM, V279, P43838, DOI 10.1074/jbc.M403612200; Gratton JP, 2001, J BIOL CHEM, V276, P30359, DOI 10.1074/jbc.M009698200; Guha M, 2002, J BIOL CHEM; Guptarak J, 2013, PAIN; Hirota H, 1996, J EXP MED, V183, P2627, DOI 10.1084/jem.183.6.2627; Jeong HJ, 2002, CELL SIGNAL, V14, P633, DOI 10.1016/S0898-6568(02)00005-0; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Keller Evan T., 1996, Frontiers in Bioscience (online), V1, pD340; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Liu QS, 2011, J MED CHEM, V54, P1473, DOI 10.1021/jm101520v; Ljosa V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000603; Luyendyk JP, 2008, J IMMUNOL, V180, P4218, DOI 10.4049/jimmunol.180.6.4218; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MacMillan D, 2005, J CELL SCI, V118, P5443, DOI 10.1242/jcs.02657; MacMillan D, 2009, BRIT J PHARMACOL, V158, P1112, DOI 10.1111/j.1476-5381.2009.00369.x; Matyash M, 2001, FASEB J; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Okada S, 2009, IEEE INTELEC     OCT, P1; Okada S., 2008, INFLAMM REGEN, V28, P440, DOI [10.2492/inflammregen.28.440, DOI 10.2492/INFLAMMREGEN.28.440]; Onifer SM, 2007, ILAR J, V48, P385, DOI 10.1093/ilar.48.4.385; Parpura V, 2010, NEUROCHEM INT, V57, P451, DOI 10.1016/j.neuint.2010.02.007; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Renault-Mihara F, 2008, INT J BIOCHEM CELL B, V40, P1649, DOI 10.1016/j.biocel.2008.03.009; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schwartz M, 1999, TRENDS NEUROSCI, V22, P295, DOI 10.1016/S0166-2236(99)01405-8; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Snyder SH, 1998, NEURON, V21, P283, DOI 10.1016/S0896-6273(00)80538-3; Stammers AT, 2012, J NEUROSCI RES, V90, P782, DOI 10.1002/jnr.22820; Stanley AC, 2010, PHYSIOLOGY, V25, P218, DOI 10.1152/physiol.00017.2010; Sun J, 2011, J BIOL CHEM, V286, P6791, DOI 10.1074/jbc.M110.172882; Tato I, 2011, J BIOL CHEM, V286, P6128, DOI 10.1074/jbc.M110.166991; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; Weichhart T, 2011, BLOOD, V117, P4273, DOI 10.1182/blood-2010-09-310888; Widenfalk J, 2001, J NEUROSCI, V21, P3457, DOI 10.1523/JNEUROSCI.21-10-03457.2001; Yang P, 2012, EXP NEUROL, V236, P19, DOI 10.1016/j.expneurol.2012.03.019; Zhao W, 2008, J BIOL CHEM, V283, P1778, DOI 10.1074/jbc.M707573200; Zhu XL, 1999, CYTOKINE, V11, P696, DOI 10.1006/cyto.1998.0479	56	27	29	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92649	10.1371/journal.pone.0092649	http://dx.doi.org/10.1371/journal.pone.0092649			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667246	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600061
J	Dalmaso, M; Galfano, G; Coricelli, C; Castelli, L				Dalmaso, Mario; Galfano, Giovanni; Coricelli, Carol; Castelli, Luigi			Temporal Dynamics Underlying the Modulation of Social Status on Social Attention	PLOS ONE			English	Article							DOMINANCE MODULATE; SPATIAL ATTENTION; FACIAL CUES; EYE GAZE; EVOLUTION; RESPONSES; COGNITION; RANK	Fixating someone suddenly moving the eyes is known to trigger a corresponding shift of attention in the observer. This phenomenon, known as gaze-cueing effect, can be modulated as a function of the social status of the individual depicted in the cueing face. Here, in two experiments, we investigated the temporal dynamics underlying this modulation. To this end, a gaze-cueing paradigm was implemented in which centrally-placed faces depicting high-and low-status individuals suddenly shifted the eyes towards a location either spatially congruent or incongruent with that occupied by a subsequent target stimulus. Social status was manipulated by presenting fictive Curriculum Vitae before the experimental phase. In Experiment 1, in which two temporal intervals (50 ms vs. 900 ms) occurred between the direct-gaze face and the averted-gaze face onsets, a stronger gaze-cueing effect in response to high-status faces than low-status faces was observed, irrespective of the time participants were allowed for extracting social information. In Experiment 2, in which two temporal intervals (200 ms vs. 1000 ms) occurred between the averted-gaze face and target onset, a stronger gaze cueing for high-status faces was observed at the shorter interval only. Taken together, these results suggest that information regarding social status is extracted from faces rapidly (Experiment 1), and that the tendency to selectively attend to the locations gazed by high-status individuals may decay with time (Experiment 2).	[Dalmaso, Mario; Galfano, Giovanni; Coricelli, Carol; Castelli, Luigi] Univ Padua, Dipartimento Psicol Sviluppo & Socializzaz, Padua, Italy	University of Padua	Dalmaso, M (corresponding author), Univ Padua, Dipartimento Psicol Sviluppo & Socializzaz, Padua, Italy.	mario.dalmaso@gmail.com	Dalmaso, Mario/F-6507-2011; Galfano, Giovanni/B-7582-2008; GALFANO, GIOVANNI/AAI-6142-2020	Dalmaso, Mario/0000-0003-0199-7861; GALFANO, GIOVANNI/0000-0001-5327-4062; Castelli, Luigi/0000-0002-1472-4507; Coricelli, Carol/0000-0003-1820-0249	Italian Ministry of Education, University and Research (Futuro in Ricerca) [RBFR12F0BD]	Italian Ministry of Education, University and Research (Futuro in Ricerca)(Ministry of Education, Universities and Research (MIUR))	The present research was financially supported by the Italian Ministry of Education, University and Research (Futuro in Ricerca, 2012 Grant RBFR12F0BD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayliss AP, 2005, Q J EXP PSYCHOL-A, V58, P631, DOI 10.1080/02724980443000124; Beasley M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00123; Bowker JC, 2010, J APPL DEV PSYCHOL, V31, P126, DOI 10.1016/j.appdev.2009.10.002; Boyce WT, 2004, ANN NY ACAD SCI, V1036, P47, DOI 10.1196/annals.1330.003; Castelli L, 2004, J PERS SOC PSYCHOL, V86, P373, DOI 10.1037/0022-3514.86.3.373; Chiao JY, 2008, GROUP PROCESS INTERG, V11, P201, DOI 10.1177/1368430207088038; Chiao JY, 2010, CURR OPIN NEUROBIOL, V20, P803, DOI 10.1016/j.conb.2010.08.006; Chiao JY, 2004, COGNITION, V93, pB49, DOI 10.1016/j.cognition.2003.07.008; CLUTTONBROCK TH, 1976, GROWING POINTS ETHOL, P195; Cummins DD, 2000, SYNTHESE, V122, P3, DOI 10.1023/A:1005263825428; Dalmaso M, 2013, NEUROPSYCHOLOGY, V27, P608, DOI 10.1037/a0033518; Dalmaso M, 2012, BIOL LETTERS, V8, P450, DOI 10.1098/rsbl.2011.0881; DAVIS H, 1992, J COMP PSYCHOL, V106, P342, DOI 10.1037/0735-7036.106.4.342; DeWall CN, 2008, EVOL PSYCHOL, V6, P328, DOI 10.1177/147470490800600209; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Dunham Y, 2006, CHILD DEV, V77, P1268, DOI 10.1111/j.1467-8624.2006.00933.x; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; FISKE AP, 1992, PSYCHOL REV, V99, P689, DOI 10.1037/0033-295X.99.4.689; Foulsham T, 2010, COGNITION, V117, P319, DOI 10.1016/j.cognition.2010.09.003; Freeman JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025107; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Frischen A, 2004, J EXP PSYCHOL GEN, V133, P516, DOI 10.1037/0096-3445.133.4.516; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Galfano G, 2012, Q J EXP PSYCHOL, V65, P1895, DOI 10.1080/17470218.2012.663765; Galfano G, 2011, SOC NEUROSCI-UK, V6, P257, DOI 10.1080/17470919.2010.515722; Gould RV, 2002, AM J SOCIOL, V107, P1143, DOI 10.1086/341744; Grosenick L, 2007, NATURE, V445, P429, DOI 10.1038/nature05511; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Hogeveen J, 2013, J EXP PSYCH IN PRESS; Holmes A, 2005, COGNITION EMOTION, V19, P899, DOI 10.1080/02699930441000454; Jones BC, 2011, SWISS J PSYCHOL, V70, P193, DOI 10.1024/1421-0185/a000056; Jones BC, 2010, P ROY SOC B-BIOL SCI, V277, P617, DOI 10.1098/rspb.2009.1575; Kuhn G, 2011, PSYCHON B REV, V18, P89, DOI 10.3758/s13423-010-0033-1; Kuhn G, 2009, ATTEN PERCEPT PSYCHO, V71, P314, DOI 10.3758/APP.71.2.314; Kumaran D, 2012, NEURON, V76, P653, DOI 10.1016/j.neuron.2012.09.035; Lansu TAM, 2013, CHILD DEV IN PRESS; Liuzza MT, 2013, Q J EXP PSYCHOL, V66, P209, DOI 10.1080/17470218.2012.754909; Liuzza MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025117; Ly M, 2011, CURR BIOL, V21, P794, DOI 10.1016/j.cub.2011.03.050; Maestripieri D, 1996, J COMP PSYCHOL, V110, P402, DOI 10.1037/0735-7036.110.4.402; Maner JK, 2008, PERS SOC PSYCHOL B, V34, P488, DOI 10.1177/0146167207311910; Masson MEJ, 2011, BEHAV RES METHODS, V43, P679, DOI 10.3758/s13428-010-0049-5; Muscatell KA, 2012, NEUROIMAGE, V60, P1771, DOI 10.1016/j.neuroimage.2012.01.080; Nummenmaa L, 2009, TRENDS COGN SCI, V13, P135, DOI 10.1016/j.tics.2008.12.006; Ohlsen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059471; Pavan G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025608; Pellegrini AD, 2011, AGGRESSIVE BEHAV, V37, P248, DOI 10.1002/ab.20385; Phillips PJ, 1998, IMAGE VISION COMPUT, V16, P295, DOI 10.1016/S0262-8856(97)00070-X; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Ratcliff NJ, 2012, SOC COGNITION, V30, P631, DOI 10.1521/soco.2012.30.5.631; Ratcliff NJ, 2011, PERS SOC PSYCHOL B, V37, P1003, DOI 10.1177/0146167211407210; Shepherd SV, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00005; Shepherd SV, 2006, CURR BIOL, V16, pR119, DOI 10.1016/j.cub.2006.02.013; Stone A, 2005, COGNITION EMOTION, V19, P537, DOI 10.1080/02699930441000409; Trawalter S, 2008, J EXP SOC PSYCHOL, V44, P1322, DOI 10.1016/j.jesp.2008.03.006; van Ede F, 2012, J NEUROSCI, V32, P10408, DOI 10.1523/JNEUROSCI.1337-12.2012; Wilson E.O., 1975, P1	57	49	49	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93139	10.1371/journal.pone.0093139	http://dx.doi.org/10.1371/journal.pone.0093139			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SD	24667700	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600148
J	Glimaker, M; Johansson, B; Halldorsdottir, H; Wanecek, M; Elmi-Terander, A; Ghatan, PH; Lindquist, L; Bellander, BM				Glimaker, Martin; Johansson, Bibi; Halldorsdottir, Halla; Wanecek, Michael; Elmi-Terander, Adrian; Ghatan, Per Hamid; Lindquist, Lars; Bellander, Bo Michael			Neuro-Intensive Treatment Targeting Intracranial Hypertension Improves Outcome in Severe Bacterial Meningitis: An Intervention-Control Study	PLOS ONE			English	Article							GLASGOW-COMA-SCALE; CEREBRAL HERNIATION; DECOMPRESSIVE CRANIECTOMY; COMPUTED-TOMOGRAPHY; LUMBAR PUNCTURE; ADULTS; PRESSURE; CARE	Objective: To evaluate the efficacy of early intracranial pressure (ICP)-targeted treatment, compared to standard intensive care, in adults with community acquired acute bacterial meningitis (ABM) and severely impaired consciousness. Design: A prospectively designed intervention-control comparison study of adult cases from September 2004 to January 2012. Patients: Included patients were confirmed ABM-cases, aged 16-75 years, with severely impaired mental status on admission. Fifty-two patients, given ICP-targeted treatment at the neuro-intensive care unit, and 53 control cases, treated with conventional intensive care, were included. All the patients received intensive care with mechanical ventilation, sedation, antibiotics and corticosteroids according to current guidelines. Additional ICP-treatment in the intervention group included cerebrospinal fluid drainage using external ventricular catheters (n = 48), osmotherapy (n = 21), hyperventilation (n = 13), external cooling (n = 9), gram-doses of methylprednisolone (n = 3) and deep barbiturate sedation (n = 2) aiming at ICP <20 mmHg and a cerebral perfusion pressure of >50 mmHg. Measurements: The primary endpoint was mortality at two months and secondary endpoint was Glasgow outcome score and hearing ability at follow-up at 2-6 months. Outcomes: The mortality was significantly lower in the intervention group compared to controls, 5/52 (10%) versus 16/53 (30%; relative risk reduction 68%; p<0.05). Furthermore, only 17 patients (32%) in the control group fully recovered compared to 28 (54%) in the intervention group (relative risk reduction 40%; p<0.05). Conclusions: Early neuro-intensive care using ICP-targeted therapy, mainly cerebrospinal fluid drainage, reduces mortality and improves the overall outcome in adult patients with ABM and severely impaired mental status on admission.	[Glimaker, Martin] Karolinska Inst, Dept Med Solna, Infect Dis Unit, Stockholm, Sweden; [Glimaker, Martin; Johansson, Bibi; Lindquist, Lars] Karolinska Univ Hosp, Stockholm, Sweden; [Johansson, Bibi; Lindquist, Lars] Karolinska Inst, Dept Med Huddinge, Infect Dis Unit, Stockholm, Sweden; [Halldorsdottir, Halla; Wanecek, Michael] Karolinska Univ Hosp, Dept Anesthesiol, Stockholm, Sweden; [Elmi-Terander, Adrian; Bellander, Bo Michael] Karolinska Univ Hosp, Sect Neurosurg, Dept Clin Neurosci, Stockholm, Sweden; [Ghatan, Per Hamid] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Glimaker, M (corresponding author), Karolinska Inst, Dept Med Solna, Infect Dis Unit, Stockholm, Sweden.	martin.glimaker@karolinska.se; bo-michael.bellander@karolinska.se	Elmi-Terander, Adrian/AAC-7997-2019; QQ, Simon/D-3888-2014; Viani, Rafael/V-1196-2018; Wanecek, Michael/AAE-7998-2021	Elmi-Terander, Adrian/0000-0002-3776-6136; 				Abulhasan YB, 2013, NEUROCRIT CARE; Ajdukiewicz KMB, 2011, LANCET INFECT DIS, V11, P293, DOI 10.1016/S1473-3099(10)70317-0; Akpede GO, 2000, DEV MED CHILD NEUROL, V42, P462, DOI 10.1017/S0012162200000864; Baussart B, 2006, ACTA ANAESTH SCAND, V50, P762, DOI 10.1111/j.1399-6576.2006.01038.x; Bordes J, 2011, ACTA ANAESTH SCAND, V55, P130, DOI 10.1111/j.1399-6576.2010.02355.x; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; Dzupova O, 2009, SCAND J INFECT DIS, V41, P348, DOI 10.1080/00365540902849391; Edberg M, 2011, ACTA ANAESTH SCAND, V55, P732, DOI 10.1111/j.1399-6576.2011.02460.x; Gardner PA, 2009, J NEUROSURG, V110, P1021, DOI 10.3171/2008.9.JNS17661; Gopal AK, 1999, ARCH INTERN MED, V159, P2681, DOI 10.1001/archinte.159.22.2681; Grande PO, 2012, J NEUROSURG ANESTH, V24, P407, DOI 10.1097/01.ana.0000419730.29492.8b; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P264, DOI 10.1034/j.1399-6576.2002.460307.x; Haring HP, 1998, EUR J NEUROL, V5, P75, DOI 10.1046/j.1468-1331.1998.510075.x; Hasbun R, 2001, NEW ENGL J MED, V345, P1727, DOI 10.1056/NEJMoa010399; HORWITZ SJ, 1980, ANN NEUROL, V7, P524, DOI 10.1002/ana.410070605; JENNETT B, 1975, LANCET, V1, P480; JOHNSTONE AJ, 1993, BRAIN INJURY, V7, P501, DOI 10.3109/02699059309008177; Koster-Rasmussen R, 2008, J INFECTION, V57, P449, DOI 10.1016/j.jinf.2008.09.033; Kramer AH, 2008, CURR TREAT OPTION NE, V10, P201, DOI 10.1007/s11940-008-0022-0; Leib SL, 1999, INFECT DIS CLIN N AM, V13, P527, DOI 10.1016/S0891-5520(05)70093-3; Lepur D, 2007, INFECTION, V35, P225, DOI 10.1007/s15010-007-6202-0; Lindvall P, 2004, CLIN INFECT DIS, V38, P384, DOI 10.1086/380970; Merkelbach S, 1999, INFECTION, V27, P239, DOI 10.1007/s150100050019; MINNS RA, 1989, ARCH DIS CHILD, V64, P814, DOI 10.1136/adc.64.6.814; Perin A, 2008, ACTA NEUROCHIR, V150, P837, DOI 10.1007/s00701-008-1596-8; Proulx N, 2005, QJM-INT J MED, V98, P291, DOI 10.1093/qjmed/hci047; REBAUD P, 1988, INTENS CARE MED, V14, P522, DOI 10.1007/BF00263524; RENNICK G, 1993, BRIT MED J, V306, P953, DOI 10.1136/bmj.306.6883.953; Scheithauer S, 2009, J NEUROL NEUROSUR PS, V80, P1381, DOI 10.1136/jnnp.2008.165357; Scheld WM, 2002, J INFECT DIS, V186, pS225, DOI 10.1086/344939; Schutte CM, 1998, J INFECTION, V37, P112, DOI 10.1016/S0163-4453(98)80163-1; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; van de Beek D, 2012, LANCET, V380, P1693, DOI 10.1016/S0140-6736(12)61186-6; van de Beek D, 2012, LANCET, V380, P1623, DOI 10.1016/S0140-6736(12)61808-X; Weisfelt M, 2008, ANN NEUROL, V63, P90, DOI 10.1002/ana.21216; Weisfelt M, 2006, J AM GERIATR SOC, V54, P1500, DOI 10.1111/j.1532-5415.2006.00878.x; Wijdicks EFM, 2003, NEUROLOGY, V61, P970, DOI 10.1212/01.WNL.0000086804.18169.8D; Winkler F, 2002, J NEUROL, V249, P1292, DOI 10.1007/s00415-002-0844-8	44	52	54	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e91976	10.1371/journal.pone.0091976	http://dx.doi.org/10.1371/journal.pone.0091976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667767	gold, Green Published, Green Submitted			2022-12-27	WOS:000333675600016
J	Lu, YF; Liu, J; Wu, KC; Qu, Q; Fan, F; Klaassen, CD				Lu, Yuan-Fu; Liu, Jie; Wu, Kai Connie; Qu, Qiang; Fan, Fang; Klaassen, Curtis D.			Overexpression of Nrf2 Protects against Microcystin-Induced Hepatotoxicity in Mice	PLOS ONE			English	Article							LIVER-INJURY; BALB/C MICE; LR; GLUTATHIONE; APOPTOSIS; TOXICITY; PATHWAY	Oxidative stress and glutathione (GSH) depletion are implicated in mycocystin hepatotoxicity. To investigate the role of nuclear factor erythroid 2-related factor 2 (Nrf2) in microcystin-induced liver injury, Nrf2-null, wild-type, and Keap1-hepatocyte knockout (Keap1-HKO) mice were treated with microcystin (50 mu g/kg, i.p.). Blood and liver samples were collected 8 h thereafter. Microcystin increased serum alanine aminotransferase and aspartate aminotransferase activities, and caused extensive inflammation and necrosis in Nrf2-null and wild-type mice, but not in Keap1-HKO mice. Oxidative stress and inflammation are implicated in microcystin-induced hepatotoxicity, as evidenced by increased lipid peroxidation and increased expression of pro-inflammatory genes, such as neutrophil-specific chemokines mKC and MIP-2, and pro-inflammatory cytokines IL-1 beta and IL-6. The increased expression of these pro-inflammatory genes was attenuated in Keap1-HKO mice. Nrf2 and Nqo1 mRNA and protein were higher in Keap1-HKO mice at constitutive levels and after microcystin. To further investigate the mechanism of the protection, hepatic GSH and the mRNA of GSH-related enzymes were determined. Microcystin markedly depleted liver GSH by 60-70% in Nrf2 and WT mice but only 35% in Keap1-HKO mice. The mRNAs of GSH conjugation and peroxide reduction enzymes, such as Gst alpha 1, Gst alpha 4, Gst mu, and Gpx2 were higher in livers of Keap1-HKO mice, together with higher expression of the rate-limiting enzyme for GSH synthesis (Gclc). Organic anion transport polypeptides were increased by microcystin with the most increase in Keap1-HKO mice. In conclusion, this study demonstrates that higher basal levels of Nrf2 and GSH-related genes in Keap1-HKO mice prevented microcystin-induced oxidative stress and liver injury.	[Lu, Yuan-Fu; Liu, Jie; Wu, Kai Connie; Qu, Qiang; Fan, Fang; Klaassen, Curtis D.] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; [Lu, Yuan-Fu; Liu, Jie] Zunyi Med Coll, Minist Educ, Key Lab Basic Pharmacol, Zunyi, Peoples R China	University of Kansas; University of Kansas Medical Center; Zunyi Medical University	Klaassen, CD (corresponding author), Univ Kansas, Med Ctr, Kansas City, KS 66103 USA.	curtisklaassenphd@gmail.com	fan, fang/GQY-9173-2022; Fan, Fang/GRO-2696-2022		National Institutes of Health (NIH) [DK-081461, ES-019487]; Chinese National Science Foundation [81160415]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019487] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health (NIH) grants DK-081461 and ES-019487, as well as by a Chinese National Science Foundation Grant 81160415. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischoff K, 2001, VET HUM TOXICOL, V43, P294; Buratti FM, 2011, CHEM RES TOXICOL, V24, P926, DOI 10.1021/tx2000976; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Fischer A, 2010, TOXICOL APPL PHARM, V245, P9, DOI 10.1016/j.taap.2010.02.006; Gan NQ, 2010, CHEM RES TOXICOL, V23, P1477, DOI 10.1021/tx1001628; Gan NQ, 2010, TOXICOL APPL PHARM, V247, P129, DOI 10.1016/j.taap.2010.06.005; Gehringer MM, 2004, INT J BIOCHEM CELL B, V36, P931, DOI 10.1016/j.biocel.2003.10.012; Jayaraj R, 2006, TOXICOLOGY, V220, P136, DOI 10.1016/j.tox.2005.12.007; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Klaassen CD, 2010, TOXICOL APPL PHARM, V244, P57, DOI 10.1016/j.taap.2010.01.013; Komatsu M, 2007, TOXICOL SCI, V97, P407, DOI 10.1093/toxsci/kfm054; KONDO F, 1992, CHEM RES TOXICOL, V5, P591, DOI 10.1021/tx00029a002; Konrad FM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/740987; Lacour Sandrine, 2005, Cancer Biomarkers, V1, P29; Liu J, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/305861; Lu H, 2008, TOXICOL SCI, V103, P35, DOI 10.1093/toxsci/kfn038; Okada K, 2009, BIOCHEM BIOPH RES CO, V389, P431, DOI 10.1016/j.bbrc.2009.08.156; Oudra B, 2009, ENVIRON MONIT ASSESS, V149, P437, DOI 10.1007/s10661-008-0220-y; Sass G, 2012, Z GASTROENTEROL, V50, P34, DOI 10.1055/s-0031-1282046; Sun XY, 2011, TOXICOL APPL PHARM, V255, P9, DOI 10.1016/j.taap.2011.05.011; Svircev Z, 2010, J ENVIRON SCI HEAL C, V28, P39, DOI 10.1080/10590500903585382; Vareli K, 2013, MAR DRUGS, V11, P2751, DOI 10.3390/md11082751; Weng D, 2007, TOXICOLOGY, V232, P15, DOI 10.1016/j.tox.2006.12.010; Wu KC, 2012, TOXICOL APPL PHARM, V263, P14, DOI 10.1016/j.taap.2012.05.017; Wu KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039006; Wu KC, 2011, TOXICOL SCI, V123, P590, DOI 10.1093/toxsci/kfr183	26	20	22	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93013	10.1371/journal.pone.0093013	http://dx.doi.org/10.1371/journal.pone.0093013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667526	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600126
J	Sato, A; Nakashima, H; Nakashima, M; Ikarashi, M; Nishiyama, K; Kinoshita, M; Seki, S				Sato, Atsushi; Nakashima, Hiroyuki; Nakashima, Masahiro; Ikarashi, Masami; Nishiyama, Kiyoshi; Kinoshita, Manabu; Seki, Shuhji			Involvement of the TNF and FasL Produced by CD11b Kupffer Cells/Macrophages in CCl4-Induced Acute Hepatic Injury	PLOS ONE			English	Article							ENCAPSULATED DICHLOROMETHYLENE DIPHOSPHONATE; PHAGOCYTIC B-CELLS; AG+ T-CELLS; MOUSE-LIVER; CARBON-TETRACHLORIDE; ALPHA-GALACTOSYLCERAMIDE; INNATE IMMUNITY; IN-VITRO; MICE; MACROPHAGE	We previously reported that F4/80(+) Kupffer cells are subclassified into CD68(+) Kupffer cells with phagocytic and ROS producing capacity, and CD11b(+) Kupffer cells with cytokine-producing capacity. Carbon tetrachloride (CCl4)-induced hepatic injury is a well-known chemical-induced hepatocyte injury. In the present study, we investigated the immunological role of Kupffer cells/macrophages in CCl4-induced hepatitis in mice. The immunohistochemical analysis of the liver and the flow cytometry of the liver mononuclear cells showed that clodronate liposome (c-lipo) treatment greatly decreased the spindle-shaped F4/80(+) or CD68(+) cells, while the oval-shaped F4/80(+) CD11b(+) cells increased. Notably, severe hepatic injury induced by CCl4 was further aggravated by c-lipo-pretreatment. The population of CD11b(+) Kupffer cells/macrophages dramatically increased 24 hour (h) after CCl4 administration, especially in c-lipo-pretreated mice. The CD11b(+) Kupffer cells expressed intracellular TNF and surface Fas-ligand (FasL). Furthermore, anti-TNF Ab pretreatment (which decreased the FasL expression of CD11b(+) Kupffer cells), anti-FasL Ab pretreatment or gld/gld mice attenuated the liver injury induced by CCl4. CD1d-/- mouse and cell depletion experiments showed that NKT cells and NK cells were not involved in the hepatic injury. The adoptive transfer and cytotoxic assay against primary cultured hepatocytes confirmed the role of CD11b(+) Kupffer cells in CCl4-induced hepatitis. Interestingly, the serum MCP-1 level rapidly increased and peaked at six h after c-lipo pretreatment, suggesting that the MCP-1 produced by c-lipo-phagocytized CD68(+) Kupffer cells may recruit CD11b(+) macrophages from the periphery and bone marrow. The CD11b(+) Kupffer cells producing TNF and FasL thus play a pivotal role in CCl4-induced acute hepatic injury.	[Sato, Atsushi; Nakashima, Hiroyuki; Nakashima, Masahiro; Ikarashi, Masami; Kinoshita, Manabu; Seki, Shuhji] Natl Def Med Coll, Dept Immunol & Microbiol, Tokorozawa, Saitama 359, Japan; [Nishiyama, Kiyoshi] Natl Def Med Coll, Dept Surg 1, Tokorozawa, Saitama 359, Japan	National Defense Medical College - Japan; National Defense Medical College - Japan	Nakashima, H (corresponding author), Natl Def Med Coll, Dept Immunol & Microbiol, Tokorozawa, Saitama 359, Japan.	hiro1618@ndmc.ac.jp			National Defense Medical College; JSPS KAKENHI [25460508]; Takeda Science Foundation	National Defense Medical College; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by a grant from the National Defense Medical College to S. Seki, JSPS KAKENHI Grant Number 25460508, and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; BRATTIN W J, 1985, Journal of Free Radicals in Biology and Medicine, V1, P27, DOI 10.1016/0748-5514(85)90026-1; Cancro MP, 2012, J LEUKOCYTE BIOL, V91, P519, DOI 10.1189/jlb.1111540; CLAWSON GA, 1989, PATHOL IMMUNOPATH R, V8, P104, DOI 10.1159/000157141; Dambach DM, 2002, HEPATOLOGY, V35, P1093, DOI 10.1053/jhep.2002.33162; GALLIGANI L, 1979, TOXICOL APPL PHARM, V48, P131, DOI 10.1016/S0041-008X(79)80015-0; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Ikarashi M, 2013, J LEUKOCYTE BIOL, V94, P1325, DOI 10.1189/jlb.0313144; Inui T, 2005, J HEPATOL, V43, P670, DOI 10.1016/j.jhep.2005.02.027; Inui T, 2002, J IMMUNOL, V169, P6127, DOI 10.4049/jimmunol.169.11.6127; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kawabata T, 2008, HEPATOLOGY, V48, P1586, DOI 10.1002/hep.22489; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Liu C, LAB INVEST, V90, P1805; Liu ZX, 2004, GASTROENTEROLOGY, V127, P1760, DOI 10.1053/j.gastro.2004.08.053; Louis H, 1998, HEPATOLOGY, V28, P1607, DOI 10.1002/hep.510280621; Matsumoto A, 2006, J HEPATOL, V45, P290, DOI 10.1016/j.jhep.2006.02.012; Naito M, 1996, J LEUKOCYTE BIOL, V60, P337, DOI 10.1002/jlb.60.3.337; Nakagawa R, 2001, J IMMUNOL, V166, P6578, DOI 10.4049/jimmunol.166.11.6578; Nakashima H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049339; Nakashima H, 2008, HEPATOLOGY, V48, P1979, DOI 10.1002/hep.22561; Nakashima M, 2012, J LEUKOCYTE BIOL, V91, P537, DOI 10.1189/jlb.0411214; RABINOWITZ SS, 1991, J EXP MED, V174, P827, DOI 10.1084/jem.174.4.827; Ramprasad MP, 1996, P NATL ACAD SCI USA, V93, P14833, DOI 10.1073/pnas.93.25.14833; RECKNAGEL RO, 1989, PHARMACOL THERAPEUT, V43, P139, DOI 10.1016/0163-7258(89)90050-8; SANCHEZMADRID F, 1983, J EXP MED, V158, P586, DOI 10.1084/jem.158.2.586; Seki S, 2000, IMMUNOL REV, V174, P35, DOI 10.1034/j.1600-0528.2002.017404.x; Seki S., 2012, IMMUNOGASTROENTEROLO, V1, P76; Seki S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/868345; Shono S, 2011, SHOCK, V36, P484, DOI 10.1097/SHK.0b013e31822dc6e4; SMITH MJ, 1987, J CELL SCI, V87, P113; TAMAYO RP, 1983, HEPATOLOGY, V3, P112; UNAKAR NJ, 1966, ARCH PATHOL, V82, P170; VANROOIJEN N, 1990, CELL TISSUE RES, V260, P215, DOI 10.1007/BF00318625; Yamamoto T, 1996, AM J PATHOL, V149, P1271; Yang YP, 2003, J HEPATOL, V39, P200, DOI 10.1016/S0168-8278(03)00229-0	37	58	60	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92515	10.1371/journal.pone.0092515	http://dx.doi.org/10.1371/journal.pone.0092515			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667392	Green Submitted, gold, Green Published			2022-12-27	WOS:000333675600045
J	Zhang, HJ; Ding, WX; He, XH; Yu, HY; Fan, JL; Liu, DY				Zhang, Huanjun; Ding, Weixin; He, Xinhua; Yu, Hongyan; Fan, Jianling; Liu, Deyan			Influence of 20-Year Organic and Inorganic Fertilization on Organic Carbon Accumulation and Microbial Community Structure of Aggregates in an Intensively Cultivated Sandy Loam Soil	PLOS ONE			English	Article							PARTICLE-SIZE FRACTIONS; LONG-TERM APPLICATION; FATTY-ACIDS; NO-TILLAGE; MATTER; BIOMASS; MANURE; BACTERIAL; FOREST; SEQUESTRATION	To evaluate the long-term effect of compost (CM) and inorganic fertilizer (NPK) application on microbial community structure and organic carbon (OC) accumulation at aggregate scale, soils from plots amended with CM, NPK and no fertilizer (control) for 20 years (1989-2009) were collected. Soil was separated into large macroaggregate (>2,000 mu m), small macroaggregate (250-2,000 mu m), microaggregate (53-250 mu m), silt (2-53 mu m) and clay fraction (<2 mu m) by wet-sieving, and their OC concentration and phospholipid fatty acids (PLFA) were measured. The 20-year application of compost significantly (P<0.05) increased OC by 123-134% and accelerated the formation of macroaggregates, but decreased soil oxygen diffusion coefficient. NPK mainly increased OC in macroaggregates and displayed weaker influence on aggregation. Bacteria distributed in all aggregates, while fungi and actinobacteria were mainly in macroaggregates and microaggregates. The ratio of monounsaturated to branched (M/B) PLFAs, as an indicator for the ratio of aerobic to anaerobic microorganisms, increased inversely with aggregate size. Both NPK and especially CM significantly (P<0.05) decreased M/B ratios in all aggregates except the silt fraction compared with the control. The increased organic C in aggregates significantly (P<0.05) negatively correlated with M/B ratios under CM and NPK. Our study suggested that more efficient OC accumulations in aggregates under CM-treated than under NPK-treated soil was not only due to a more effective decrease of actinobacteria, but also a decrease of monounsaturated PLFAs and an increase of branched PLFAs. Aggregations under CM appear to alter micro-habitats to those more suitable for anaerobes, which in turn boosts OC accumulation.	[Zhang, Huanjun; Ding, Weixin; Yu, Hongyan; Fan, Jianling; Liu, Deyan] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [He, Xinhua] Forests NSW, NSW Dept Primary Ind, West Pennant Hills, NSW, Australia; [He, Xinhua] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia	Chinese Academy of Sciences; Institute of Soil Science, CAS; NSW Department of Primary Industries; University of Western Australia	Ding, WX (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.	wxding@issas.ac.cn	Deyan, Liu/AAZ-2671-2020; Ding, WeiXin/L-8657-2013; He, Xinhua/B-8047-2015; Fan, Jianling/AAQ-2614-2021; Yu, Houyong/R-1592-2016	He, Xinhua/0000-0002-5570-3454; Fan, Jianling/0000-0003-3048-2621; Yu, Houyong/0000-0002-6543-5924	National Basic Research Program of China [2011CB100503]; Chinese Academy of Sciences [KSCX2-EW-N-08]; National Science Foundation of China [41171190]	National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2011CB100503), the Chinese Academy of Sciences (KSCX2-EW-N-08), and National Science Foundation of China (41171190). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagoz Z, 2009, SOIL TILL RES, V103, P419, DOI 10.1016/j.still.2008.12.006; Anders MM, 2010, SOIL SCI SOC AM J, V74, P1339, DOI 10.2136/sssaj2009.0280; Aoyama M, 1999, CAN J SOIL SCI, V79, P295, DOI 10.4141/S98-049; Bach EM, 2010, SOIL BIOL BIOCHEM, V42, P2182, DOI 10.1016/j.soilbio.2010.08.014; BEGUIN P, 1994, FEMS MICROBIOL REV, V13, P25, DOI 10.1016/0168-6445(94)90099-X; Bhattacharyya R, 2010, NUTR CYCL AGROECOSYS, V86, P1, DOI 10.1007/s10705-009-9270-y; Billings SA, 2008, GLOBAL CHANGE BIOL, V14, P1025, DOI 10.1111/j.1365-2486.2008.01562.x; Blagodatsky S, 2012, SOIL BIOL BIOCHEM, V47, P78, DOI 10.1016/j.soilbio.2011.12.015; Bohme L, 2005, AGR ECOSYST ENVIRON, V109, P141, DOI 10.1016/j.agee.2005.01.017; Bossio DA, 2006, SOIL BIOL BIOCHEM, V38, P1223, DOI 10.1016/j.soilbio.2005.09.027; Bossio DA, 1998, MICROBIAL ECOL, V36, P1, DOI 10.1007/s002489900087; Bossuyt H, 2002, SOIL SCI SOC AM J, V66, P1965, DOI 10.2136/sssaj2002.1965; Brant JB, 2006, SOIL BIOL BIOCHEM, V38, P2219, DOI 10.1016/j.soilbio.2006.01.022; Carter M. R., 1993, SOIL SAMPLING METHOD, P190; Chenu C, 2001, BIOL FERT SOILS, V34, P349, DOI 10.1007/s003740100419; Davis GB, 1998, IAHS-AISH P, P300; Ding HB, 2005, MAR CHEM, V93, P1, DOI 10.1016/j.marchem.2004.04.004; Ding WX, 2007, SOIL BIOL BIOCHEM, V39, P669, DOI 10.1016/j.soilbio.2006.09.024; Dungait JAJ, 2012, GLOBAL CHANGE BIOL, V18, P1781, DOI 10.1111/j.1365-2486.2012.02665.x; ELLIOTT ET, 1986, SOIL SCI SOC AM J, V50, P627, DOI 10.2136/sssaj1986.03615995005000030017x; Feng XJ, 2009, SOIL BIOL BIOCHEM, V41, P804, DOI 10.1016/j.soilbio.2009.01.020; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Hassink J, 1997, PLANT SOIL, V191, P77, DOI 10.1023/A:1004213929699; Helgason BL, 2010, APPL SOIL ECOL, V46, P390, DOI 10.1016/j.apsoil.2010.10.002; Jastrow JD, 1998, SOIL BIOL BIOCHEM, V30, P905, DOI 10.1016/S0038-0717(97)00207-1; Jiang X, 2011, APPL SOIL ECOL, V48, P168, DOI 10.1016/j.apsoil.2011.03.009; John B., 2003, THESIS GEORG AUGUST; Jurgens K, 1999, APPL ENVIRON MICROB, V65, P1241; Kandeler E, 2000, BIOL FERT SOILS, V32, P390, DOI 10.1007/s003740000268; KILLHAM K, 1993, SOIL BIOL BIOCHEM, V25, P57, DOI 10.1016/0038-0717(93)90241-3; Kindler R, 2009, ORG GEOCHEM, V40, P29, DOI 10.1016/j.orggeochem.2008.09.005; Kolbl A, 2004, J PLANT NUTR SOIL SC, V167, P45, DOI 10.1002/jpln.200321185; Kong AYY, 2005, SOIL SCI SOC AM J, V69, P1078, DOI 10.2136/sssaj2004.0215; Kutilek M., 1994, SOIL HYDROLOGY; Ladd JN, 1996, SOIL BIOL BIOCHEM, V28, P893, DOI 10.1016/0038-0717(96)00069-7; Manna MC, 2006, SOIL SCI SOC AM J, V70, P121, DOI 10.2136/sssaj2005.0180; Mikha MM, 2004, SOIL SCI SOC AM J, V68, P809, DOI 10.2136/sssaj2004.0809; Olsson PA, 1999, FEMS MICROBIOL ECOL, V29, P303, DOI 10.1111/j.1574-6941.1999.tb00621.x; Petersen SO, 1997, GEODERMA, V78, P181, DOI 10.1016/S0016-7061(97)00032-3; Ponder F, 2002, APPL SOIL ECOL, V19, P173, DOI 10.1016/S0929-1393(01)00182-2; RAJENDRAN N, 1992, APPL ENVIRON MICROB, V58, P562, DOI 10.1128/AEM.58.2.562-571.1992; Rappoldt C, 1999, GEODERMA, V88, P329, DOI 10.1016/S0016-7061(98)00112-8; Ruamps LS, 2011, SOIL BIOL BIOCHEM, V43, P280, DOI 10.1016/j.soilbio.2010.10.010; Said-Pullicino D, 2007, CHEMOSPHERE, V66, P2166, DOI 10.1016/j.chemosphere.2006.09.010; Sarkar S, 2003, J AGR SCI-CAMBRIDGE, V140, P419, DOI 10.1017/S0021859603003186; Sessitsch A, 2001, APPL ENVIRON MICROB, V67, P4215, DOI 10.1128/AEM.67.9.4215-4224.2001; Simpson AJ, 2007, ENVIRON SCI TECHNOL, V41, P876, DOI 10.1021/es061576c; SINGH S, 1995, SOIL BIOL BIOCHEM, V27, P1027, DOI 10.1016/0038-0717(95)00014-6; Six J, 2000, SOIL BIOL BIOCHEM, V32, P2099, DOI 10.1016/S0038-0717(00)00179-6; Six J, 2000, SOIL SCI SOC AM J, V64, P681, DOI 10.2136/sssaj2000.642681x; Soil Survey Staff, 2010, KEYS SOIL TAX, P106; Spring S, 2000, FEMS MICROBIOL REV, V24, P573, DOI 10.1016/S0168-6445(00)00046-2; Strong DT, 2004, EUR J SOIL SCI, V55, P739, DOI 10.1111/j.1365-2389.2004.00639.x; Su YZ, 2006, NUTR CYCL AGROECOSYS, V75, P285, DOI 10.1007/s10705-006-9034-x; Sundh I, 1997, APPL ENVIRON MICROB, V63, P1476, DOI 10.1128/AEM.63.4.1476-1482.1997; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Verchot LV, 2011, GEODERMA, V161, P182, DOI 10.1016/j.geoderma.2010.12.017; Wixon DL, 2013, SOIL BIOL BIOCHEM, V57, P769, DOI 10.1016/j.soilbio.2012.08.016; Wright AL, 2004, SOIL SCI SOC AM J, V68, P507, DOI 10.2136/sssaj2004.0507; Yu HY, 2012, SOIL TILL RES, V124, P170, DOI 10.1016/j.still.2012.06.011; Yu HY, 2012, BIOL FERT SOILS, V48, P325, DOI 10.1007/s00374-011-0629-2; Zhuang J, 2008, SOIL SCI SOC AM J, V72, P212, DOI 10.2136/sssaj2007.0001S6; Zibilske LM, 2007, SOIL SCI SOC AM J, V71, P133, DOI 10.2136/sssaj2006.0167	63	64	73	7	161	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92733	10.1371/journal.pone.0092733	http://dx.doi.org/10.1371/journal.pone.0092733			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667543	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600068
J	Alvarez, Y; Esteban-Torres, M; Cortes-Cabrera, A; Gago, F; Acebron, I; Benavente, R; Mardo, K; de las Rivas, B; Munoz, R; Mancheno, JM				Alvarez, Yanaisis; Esteban-Torres, Maria; Cortes-Cabrera, Alvaro; Gago, Federico; Acebron, Ivan; Benavente, Rocio; Mardo, Karin; de las Rivas, Blanca; Munoz, Rosario; Mancheno, Jose M.			Esterase LpEst1 from Lactobacillus plantarum: A Novel and Atypical Member of the alpha beta Hydrolase Superfamily of Enzymes	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; CRYSTAL-STRUCTURE; BACTERIAL HOMOLOG; FOLD ENZYMES; CARBOXYLESTERASE; PROTEINS; ACETYLCHOLINESTERASE; PURIFICATION; SUBFAMILY	The genome of the lactic acid bacterium Lactobacillus plantarum WCFS1 reveals the presence of a rich repertoire of esterases and lipases highlighting their important role in cellular metabolism. Among them is the carboxylesterase LpEst1 a bacterial enzyme related to the mammalian hormone-sensitive lipase, which is known to play a central role in energy homeostasis. In this study, the crystal structure of LpEst1 has been determined at 2.05 angstrom resolution; it exhibits an alpha beta-hydrolase fold, consisting of a central beta-sheet surrounded by alpha-helices, endowed with novel topological features. The structure reveals a dimeric assembly not comparable with any other enzyme from the bacterial hormone-sensitive lipase family, probably echoing the specific structural features of the participating subunits. Biophysical studies including analytical gel filtration and ultracentrifugation support the dimeric nature of LpEst1. Structural and mutational analyses of the substrate-binding pocket and active site together with biochemical studies provided insights for understanding the substrate profile of LpEst1 and suggested for the first time the conserved Asp173, which is adjacent to the nucleophile, as a key element in the stabilization of the loop where the oxyanion hole resides.	[Alvarez, Yanaisis; Acebron, Ivan; Benavente, Rocio; Mancheno, Jose M.] CSIC, Dept Crystallog & Struct Biol, Inst Phys Chem Rocasolano, Madrid, Spain; [Alvarez, Yanaisis] CITMA, Ctr Adv Studies Cuba, Havana, Cuba; [Esteban-Torres, Maria; de las Rivas, Blanca; Munoz, Rosario] CSIC, Lab Bacterial Biotechnol, Inst Food Sci & Technol & Nutr ICTAN, Madrid, Spain; [Cortes-Cabrera, Alvaro; Gago, Federico] Univ Alcala, Sch Med & Hlth Sci, Dept Biomed Sci, Madrid, Spain; [Mardo, Karin] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN); Universidad de Alcala; University of Tartu	Mancheno, JM (corresponding author), CSIC, Dept Crystallog & Struct Biol, Inst Phys Chem Rocasolano, Madrid, Spain.	xjosemi@iqfr.csic.es	Esteban-Torres, Maria/AAA-8621-2020; Muñoz, Rosario/H-8597-2012; Ernits, Karin/F-5511-2019; Esteban-Torres, María/AAT-6046-2020; Gago, Federico/H-1004-2015; Gago, Federico/AAS-3992-2020; Ernits, Karin/X-4427-2019; Mancheno, Jose/K-4984-2014; de las Rivas, Blanca/K-3899-2014; Cortes Cabrera, Alvaro/B-3748-2016	Muñoz, Rosario/0000-0003-4170-9713; Ernits, Karin/0000-0003-1072-4945; Esteban-Torres, María/0000-0001-8433-5729; Gago, Federico/0000-0002-3071-4878; Gago, Federico/0000-0002-3071-4878; Ernits, Karin/0000-0003-1072-4945; Mancheno, Jose/0000-0001-6943-3291; de las Rivas, Blanca/0000-0002-8357-5226; Cortes Cabrera, Alvaro/0000-0003-4635-6267; Acebron, Ivan/0000-0003-0397-1550	Ministerio de Economia y Competitividad [BFU2010-17929/BMC]; Factoria de Cristalizacion (Consolider-Ingenio) [AGL2011-22745, FUN-C-FOOD Consolider 25506]	Ministerio de Economia y Competitividad(Spanish Government); Factoria de Cristalizacion (Consolider-Ingenio)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Ministerio de Economia y Competitividad (BFU2010-17929/BMC) and the Factoria de Cristalizacion (Consolider-Ingenio-2007) (to Jose M. Mancheno), and AGL2011-22745 and FUN-C-FOOD Consolider 25506 (to Rosario Munoz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alvarez Y, 2011, ACTA CRYSTALLOGR F, V67, P1436, DOI 10.1107/S1744309111036682; Angkawidjaja C, 2012, FEBS J, V279, P3071, DOI 10.1111/j.1742-4658.2012.08687.x; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Benavente R, 2013, FEBS J, V280, P6658, DOI 10.1111/febs.12569; BRENNER S, 1988, NATURE, V334, P528, DOI 10.1038/334528a0; Byun JS, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-47; Case D.A., 2012, AMBER; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cole JL, 2009, HETEROANALYSIS; Cabrera AC, 2012, J CHEM INF MODEL, V52, P2300, DOI 10.1021/ci300194a; de las Rivas B, 2007, BIOTECHNOL PROGR, V23, P680, DOI 10.1021/bp060318g; De Simone G, 2000, J MOL BIOL, V303, P761, DOI 10.1006/jmbi.2000.4195; De Simone G, 2001, J MOL BIOL, V314, P507, DOI 10.1006/jmbi.2001.5152; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fenster KM, 2003, J DAIRY SCI, V86, P1118, DOI 10.3168/jds.S0022-0302(03)73694-7; Fojan P, 2000, BIOCHIMIE, V82, P1033, DOI 10.1016/S0300-9084(00)01188-3; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Gobbetti M, 1996, J FOOD BIOCHEM, V20, P227, DOI 10.1111/j.1745-4514.1996.tb00553.x; Gobbetti M, 1997, J DAIRY SCI, V80, P3099, DOI 10.3168/jds.S0022-0302(97)76280-5; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Hasan F, 2009, BIOTECHNOL ADV, V27, P782, DOI 10.1016/j.biotechadv.2009.06.001; Heikinheimo P, 1999, STRUCTURE, V7, pR141, DOI 10.1016/S0969-2126(99)80079-3; HEMILA H, 1994, BBA-LIPID LIPID MET, V1210, P249, DOI 10.1016/0005-2760(94)90129-5; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hotelier T, 2004, NUCLEIC ACIDS RES, V32, pD145, DOI 10.1093/nar/gkh141; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klett J, 2012, J CHEM THEORY COMPUT, V8, P3395, DOI 10.1021/ct300497z; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laue TM, 1992, BIOCH POLYM SCI; Liu AMF, 2001, TETRAHEDRON-ASYMMETR, V12, P545, DOI 10.1016/S0957-4166(01)00072-6; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morreale A, 2007, PROTEINS, V67, P606, DOI 10.1002/prot.21269; Nam KH, 2009, BIOCHEM BIOPH RES CO, V379, P553, DOI 10.1016/j.bbrc.2008.12.085; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Ngo TD, 2013, ACTA CRYSTALLOGR D, V69, P1726, DOI 10.1107/S0907444913013425; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Palm GJ, 2011, APPL MICROBIOL BIOT, V91, P1061, DOI 10.1007/s00253-011-3337-9; Powell HR, 2011, ACTA CRYSTALLOGR D, VD69, P1195; Redinbo MR, 2005, DRUG DISCOV TODAY, V10, P313, DOI 10.1016/S1359-6446(05)03383-0; Reis P, 2009, ADV COLLOID INTERFAC, V147-48, P237, DOI 10.1016/j.cis.2008.06.001; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Toone Eric J, 2011, Adv Enzymol Relat Areas Mol Biol, V78, pix; Wei YY, 1999, NAT STRUCT BIOL, V6, P340; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhu XY, 2003, J BIOL CHEM, V278, P2008, DOI 10.1074/jbc.M210103200	57	18	18	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92257	10.1371/journal.pone.0092257	http://dx.doi.org/10.1371/journal.pone.0092257			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663330	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900048
J	Kobayashi, Y; Sanno, Y; Sakai, A; Sawabu, Y; Tsutsumi, M; Goto, M; Kitahata, H; Nakata, S; Kumamoto, J; Denda, M; Nagayama, M				Kobayashi, Yasuaki; Sanno, Yumi; Sakai, Akihiko; Sawabu, Yusuke; Tsutsumi, Moe; Goto, Makiko; Kitahata, Hiroyuki; Nakata, Satoshi; Kumamoto, Junichi; Denda, Mitsuhiro; Nagayama, Masaharu			Mathematical Modeling of Calcium Waves Induced by Mechanical Stimulation in Keratinocytes	PLOS ONE			English	Article							INTRACELLULAR CALCIUM; OSCILLATIONS; PROPAGATION; MUTATIONS; EPIDERMIS; BARRIER; PUMP	Recent studies have shown that the behavior of calcium in the epidermis is closely related to the conditions of the skin, especially the differentiation of the epidermal keratinocytes and the permeability barrier function, and therefore a correct understanding of the calcium dynamics is important in explaining epidermal homeostasis. Here we report on experimental observations of in vitro calcium waves in keratinocytes induced by mechanical stimulation, and present a mathematical model that can describe the experimentally observed wave behavior that includes finite-range wave propagation and a ring-shaped pattern. A mechanism of the ring formation hypothesized by our model may be related to similar calcium propagation patterns observed during the wound healing process in the epidermis. We discuss a possible extension of our model that may serve as a tool for investigating the mechanisms of various skin diseases.	[Kobayashi, Yasuaki; Sawabu, Yusuke; Nagayama, Masaharu] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido, Japan; [Kobayashi, Yasuaki; Kumamoto, Junichi; Denda, Mitsuhiro; Nagayama, Masaharu] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Sanno, Yumi; Sakai, Akihiko] Kanazawa Univ, Grad Sch Sci & Technol, Kanazawa, Ishikawa, Japan; [Tsutsumi, Moe; Goto, Makiko; Kumamoto, Junichi; Denda, Mitsuhiro] Shiseido Co Ltd, Shiseido Res Ctr, Yokohama, Kanagawa, Japan; [Kitahata, Hiroyuki] Chiba Univ, Dept Phys, Grad Sch Sci, Chiba 260, Japan; [Nakata, Satoshi] Hiroshima Univ, Grad Sch Sci, Higashihiroshima 724, Japan	Hokkaido University; Japan Science & Technology Agency (JST); Kanazawa University; Shiseido Company, Limited; Chiba University; Hiroshima University	Nagayama, M (corresponding author), Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido, Japan.	nagayama@es.hokudai.ac.jp	Kitahata, Hiroyuki/E-8635-2015; Nakata, Satoshi/T-4225-2017; Kitahata, Hiroyuki/AGZ-4066-2022; Nagayama, Masaharu/D-6759-2012	Kitahata, Hiroyuki/0000-0003-3453-9883; Nakata, Satoshi/0000-0002-7290-1508; Kitahata, Hiroyuki/0000-0003-3453-9883; Tsutsumi, Moe/0000-0001-9953-7219; Kobayashi, Yasuaki/0000-0003-4966-963X	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [21340023]	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research (B)(21340023) from The Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATRI A, 1993, BIOPHYS J, V65, P1727, DOI 10.1016/S0006-3495(93)81191-3; Burnstock G, 2000, J PHARMACOL EXP THER, V295, P862; Denda M, 2000, BIOCHEM BIOPH RES CO, V272, P134, DOI 10.1006/bbrc.2000.2739; Denda M, 2003, J INVEST DERMATOL, V121, P1557, DOI 10.1111/j.1523-1747.2003.12619.x; Denda M, 2007, SKIN RES TECHNOL, V13, P195, DOI 10.1111/j.1600-0846.2007.00210.x; DUPONT G, 1991, CELL CALCIUM, V12, P73, DOI 10.1016/0143-4160(91)90010-C; Edwards JR, 2010, J THEOR BIOL, V263, P45, DOI 10.1016/j.jtbi.2009.12.002; Elias P.M., 2006, SKIN BARRIER, P1; Elias PM, 2002, J INVEST DERMATOL, V119, P1128, DOI 10.1046/j.1523-1747.2002.19512.x; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Forslind B, 1999, ACTA DERM-VENEREOL, V79, P12; GIRARD S, 1992, BIOPHYS J, V61, P509, DOI 10.1016/S0006-3495(92)81855-6; GOLDBETER A, 1990, P NATL ACAD SCI USA, V87, P1461, DOI 10.1073/pnas.87.4.1461; Goto M, 2010, J CELL PHYSIOL, V224, P229, DOI 10.1002/jcp.22121; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; Keener J., 1998, MATH PHYSL; KEENER JP, 1987, SIAM J APPL MATH, V47, P556, DOI 10.1137/0147038; Koizumi S, 2004, BIOCHEM J, V380, P329, DOI 10.1042/BJ20031089; Li P, 2009, PHYSICA D, V238, P992, DOI 10.1016/j.physd.2008.12.008; Mauro T, 1998, J INVEST DERMATOL, V111, P1198, DOI 10.1046/j.1523-1747.1998.00421.x; MENON GK, 1994, BRIT J DERMATOL, V130, P139, DOI 10.1111/j.1365-2133.1994.tb02892.x; Mese G, 2007, J INVEST DERMATOL, V127, P2516, DOI 10.1038/sj.jid.5700770; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; Sakuntabhai A, 1999, NAT GENET, V21, P271, DOI 10.1038/6784; SNEYD J, 1993, B MATH BIOL, V55, P315; SNEYD J, 1995, AM J PHYSIOL-CELL PH, V268, pC1537, DOI 10.1152/ajpcell.1995.268.6.C1537; Tsutsumi M, 2013, EXP DERMATOL, V22, P367, DOI 10.1111/exd.12136; Tsutsumi M, 2010, SKIN RES TECHNOL, V16, P146, DOI 10.1111/j.1600-0846.2009.00420.x; Tsutsumi M, 2009, CELL TISSUE RES, V338, P99, DOI 10.1007/s00441-009-0848-0; Warren NJ, 2010, EXP PHYSIOL, V95, P232, DOI 10.1113/expphysiol.2009.049585	31	15	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92650	10.1371/journal.pone.0092650	http://dx.doi.org/10.1371/journal.pone.0092650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663805	Green Published, gold			2022-12-27	WOS:000333459900091
J	Lionetti, L; Mollica, MP; Donizzetti, I; Gifuni, G; Sica, R; Pignalosa, A; Cavaliere, G; Gaita, M; De Filippo, C; Zorzano, A; Putti, R				Lionetti, Lilla; Mollica, Maria Pina; Donizzetti, Immacolata; Gifuni, Giorgio; Sica, Raffaella; Pignalosa, Angelica; Cavaliere, Gina; Gaita, Marcello; De Filippo, Chiara; Zorzano, Antonio; Putti, Rosalba			High-Lard and High-Fish-Oil Diets Differ in Their Effects on Function and Dynamic Behaviour of Rat Hepatic Mitochondria (Publication with Expression of Concern. See vol. 17, 2022)	PLOS ONE			English	Article; Publication with Expression of Concern							POLYUNSATURATED FATTY-ACIDS; INSULIN-RESISTANCE; SKELETAL-MUSCLE; FLUORESCENT-PROBE; PROTON LEAK; MEMBRANE; GLUCOSE; LIVER; DYSFUNCTION; CHAIN	Background: Mitochondria are dynamic organelles that frequently undergo fission and fusion processes, and imbalances in these processes may be involved in obesity and insulin resistance. Aims: The present work had the following aims: (a) to evaluate whether the mitochondrial dysfunction present in the hepatic steatosis induced by a high-fat diet is associated with changes in mitochondrial dynamics and morphology; (b) to evaluate whether effects on the above parameters differ between high-lard and high-fish-oil diets, as it has been suggested that fish oil may have anti-obesity and anti-steatotic effects by stimulating fatty acids utilisation. Methods: The development of hepatic steatosis and insulin resistance was monitored in rats fed a high-lard or high-fish-oil diet. Immunohistochemical and electronic microscopic observations were performed on liver sections. In isolated liver mitochondria, assessments of fatty acids oxidation rate, proton conductance and oxidative stress (by measuring H2O2 release and aconitase activity) were performed. Western blot and immunohistochemical analyses were performed to evaluate the presence of proteins involved in mitochondrial dynamics (i.e., fusion and fission processes). To investigate the fusion process, mitofusin 2 and autosomal dominant optic atrophy-1 (OPA1) were analysed. To investigate the fission process, the presence of dynamin-related protein 1 (Drp1) and fission 1 protein (Fis1) was assessed. Results: High-lard feeding elicited greater hepatic lipid accumulation, insulin resistance with associated mitochondrial dysfunction, greater oxidative stress and a shift towards mitochondrial fission processes (versus high-fish-oil feeding, which had an anti-steatotic effect associated with increased mitochondrial fusion processes). Conclusions: Different types of high-fat diets differ in their effect on mitochondrial function and dynamic behaviour, leading to different cellular adaptations to over-feeding.	[Lionetti, Lilla; Mollica, Maria Pina; Donizzetti, Immacolata; Gifuni, Giorgio; Sica, Raffaella; Pignalosa, Angelica; Cavaliere, Gina; Gaita, Marcello; De Filippo, Chiara; Putti, Rosalba] Univ Naples Federico II, Dept Biol, Naples, Italy; [Zorzano, Antonio] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Spain	University of Naples Federico II; University of Barcelona	Putti, R (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	rosalba.putti@unina.it	Lionetti, Lilla/AAM-1756-2021; Zorzano, Antonio/R-5479-2018	Lionetti, Lilla/0000-0002-4059-8030; Mollica, Maria Pina/0000-0003-2726-7779				AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; ALEXSON SEH, 1988, J BIOL CHEM, V263, P13564; Armstrong MB, 2001, AM J PHYSIOL-ENDOC M, V281, pE1197, DOI 10.1152/ajpendo.2001.281.6.E1197; Bach D, 2005, DIABETES, V54, P2685, DOI 10.2337/diabetes.54.9.2685; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Buono S, 2007, COMP BIOCHEM PHYS C, V145, P306, DOI 10.1016/j.cbpc.2006.12.016; Caldwell SH, 2009, HEPATOLOGY, V49, P1888, DOI 10.1002/hep.22851; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Civitarese AE, 2008, ENDOCRINOLOGY, V149, P950, DOI 10.1210/en.2007-1444; COLONNA R, 1973, EUR J BIOCHEM, V34, P577, DOI 10.1111/j.1432-1033.1973.tb02798.x; Cui M, 2010, J BIOL CHEM, V285, P11740, DOI 10.1074/jbc.M109.066662; de Lange P, 2011, DIABETES, V60, P2730, DOI 10.2337/db11-0207; Dobbins RL, 2002, DIABETES, V51, P1825, DOI 10.2337/diabetes.51.6.1825; Estabrook RW, 1967, METHOD ENZYMOL, V10, P4711; Fan YY, 2011, CANCER PREV RES, V4, P1267, DOI 10.1158/1940-6207.CAPR-10-0368; Figueira TR, 2012, METHODS MOL BIOL, V810, P103, DOI 10.1007/978-1-61779-382-0_7; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gao CL, 2010, MOL CELL ENDOCRINOL, V320, P25, DOI 10.1016/j.mce.2010.01.039; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Hausladen A, 1996, METHOD ENZYMOL, V269, P37; Holmstrom MH, 2012, AM J PHYSIOL-ENDOC M, V302, pE731, DOI 10.1152/ajpendo.00159.2011; Holness MJ, 2004, DIABETES, V53, pS166, DOI 10.2337/diabetes.53.2007.S166; Holness MJ, 2003, ENDOCRINOLOGY, V144, P3958, DOI 10.1210/en.2003-0479; Ikemoto S, 1996, METABOLISM, V45, P1539, DOI 10.1016/S0026-0495(96)90185-7; Iossa S, 2001, FEBS LETT, V505, P53, DOI 10.1016/S0014-5793(01)02772-7; Jezek P, 2002, INT J BIOCHEM CELL B, V34, P1190, DOI 10.1016/S1357-2725(02)00061-4; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Johnson-Delaney C, 1996, EXOTIC ANIMAL COMPAN; Kohn D. F., 2002, Laboratory animal medicine, P121; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Lionetti L, 2007, INT J OBESITY, V31, P1596, DOI 10.1038/sj.ijo.0803636; Lionetti L, 2004, CELL MOL LIFE SCI, V61, P1366, DOI 10.1007/s00018-004-4073-4; Liu X, 2011, CELL DEATH DIFFER, V18, P1561, DOI 10.1038/cdd.2011.13; LIVERINI G, 1991, COMP BIOCHEM PHYS B, V98, P583, DOI 10.1016/0305-0491(91)90258-F; Mantena SK, 2009, BIOCHEM J, V417, P183, DOI 10.1042/BJ20080868; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; Mollica MP, 2009, J HEPATOL, V51, P363, DOI 10.1016/j.jhep.2009.03.023; Nakatani T, 2003, J LIPID RES, V44, P369, DOI 10.1194/jlr.M200289-JLR200; NEDERGAARD J, 1983, EUR J BIOCHEM, V133, P185, DOI 10.1111/j.1432-1033.1983.tb07446.x; NISHIHIRA T, 1986, HEPATOLOGY, V6, P220, DOI 10.1002/hep.1840060211; Nunnari J, 2002, METHOD ENZYMOL, V351, P381; Palmer CS, 2011, CELL SIGNAL, V23, P1534, DOI 10.1016/j.cellsig.2011.05.021; Pellegrini L, 2007, CELL DEATH DIFFER, V14, P1275, DOI 10.1038/sj.cdd.4402145; Pessayre D, 2005, J HEPATOL, V42, P928, DOI 10.1016/j.jhep.2005.03.004; Poussin C, 2011, DIABETES, V60, P2216, DOI 10.2337/db11-0338; Putti R, 1996, GEN COMP ENDOCR, V103, P249, DOI 10.1006/gcen.1996.0119; RICHIERI GV, 1993, BIOCHEMISTRY-US, V32, P7574, DOI 10.1021/bi00080a032; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Schonfeld P, 2008, FREE RADICAL BIO MED, V45, P231, DOI 10.1016/j.freeradbiomed.2008.04.029; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Stein DT, 1997, J CLIN INVEST, V100, P398, DOI 10.1172/JCI119546; Stillwell W, 1997, LIPIDS, V32, P497, DOI 10.1007/s11745-997-0064-6; Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138; Xin I, 2011, NUTR METAB CARDIOVAS, V21, pB1; Xin YN, 2008, MED HYPOTHESES, V71, P820, DOI 10.1016/j.mehy.2008.07.008; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zhang Y, 2011, METABOLISM, V60, P767, DOI 10.1016/j.metabol.2010.07.026	61	102	104	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92753	10.1371/journal.pone.0092753	http://dx.doi.org/10.1371/journal.pone.0092753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663492	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900109
J	Liu, R; Liu, X; Zee, PC; Hou, LF; Zheng, Z; Wei, YX; Du, J				Liu, Rong; Liu, Xin; Zee, Phyllis C.; Hou, Lifang; Zheng, Zheng; Wei, Yongxiang; Du, Jie			Association between Sleep Quality and C-Reactive Protein: Results from National Health and Nutrition Examination Survey, 2005-2008	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; RESTLESS LEGS SYNDROME; RISK-FACTOR; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; YOUNG-ADULTS; DURATION; INFLAMMATION; OBESITY; BIOMARKERS	Objective: Our objective was to explore the association between poor sleep quality and hs_CRP in an adult U.S. population. Methods: This study focused on 9,317 participants in the National Health and Nutrition Examination Survey (NHANES) from 2005-2008 who were aged 20-85 years, completed a sleep disorder questionnaire, and had available information on serum hs_CRP. Sleep quality was classified into three categories (good, moderate, poor) based on the responses of participants to the NHANES sleep disorder questionnaire. High CRP was defined as hs-CRP > 1 md/dL. Linear regression model was applied to investigate the association between poor sleep quality and log-transformed hs_CRP. And logistic regression model was fitted to evaluate the association between sleep quality and the risk of high CRP. Results: Females were more likely to report poor sleep quality than males (26% vs. 19%, p<0.0001). Each sleep disorder was significantly associated with increased hs_CRP and correlative to other sleep disorders. In fully-adjusted linear regression model, poor sleep quality was significantly associated with elevated hs_CRP (log transformed) among the overall sample and in females only (beta = 0.10, se = 0.03, p<0.01 and beta = 0.13, se = 0.04, p<0.01, respectively). In fully-adjusted logistics regression model, poor sleep quality was linked with risk of high CRP(OR: 1.42, 95% CI: 1.15-1.76 in overall sample and OR: 1.59, 95%CI: 1.18-2.14 in females, respectively). Conclusion: We found that poor sleep quality was independently associated with elevated hs_CRP in females but not in males in a U.S. adult population.	[Liu, Rong; Du, Jie] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Minist Educ, Beijing An Zhen Hosp,Key Lab Remodeling Related C, Beijing, Peoples R China; [Liu, Rong; Liu, Xin] Northwestern Univ, Feinberg Sch Med, Mary Ann & J Milburn Smith Child Hlth Res Program, Dept Pediat, Chicago, IL 60611 USA; [Liu, Rong; Liu, Xin] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL USA; [Liu, Rong; Liu, Xin] Childrens Hosp Chicago Res Ctr, Chicago, IL USA; [Zee, Phyllis C.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Zee, Phyllis C.] Northwestern Univ, Feinberg Sch Med, Sleep Med Ctr, Chicago, IL 60611 USA; [Hou, Lifang] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Zheng, Zheng] Capital Med Univ, Beijing Xuan Wu Hosp, Beijing Inst Geriatr, Dept Neurobiol, Beijing, Peoples R China; [Wei, Yongxiang] Capital Med Univ, Beijing An Zhen Hosp, Dept Otorhinolaryngol, Beijing, Peoples R China	Capital Medical University; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Capital Medical University; Capital Medical University	Liu, R (corresponding author), Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Minist Educ, Beijing An Zhen Hosp,Key Lab Remodeling Related C, Beijing, Peoples R China.	rongliu606@gmail.com; jdu@bcm.edu	Zee, Phyllis C/GPF-3704-2022		Beijing collaborative innovative research center for cardiovascular diseases [PXM2013_014226_07_000088]	Beijing collaborative innovative research center for cardiovascular diseases	Funding provided by Beijing collaborative innovative research center for cardiovascular diseases (PXM2013_014226_07_000088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agras WS, 2004, J PEDIATR-US, V145, P20, DOI 10.1016/j.jpeds.2004.03.023; Albert MA, 2006, CIRCULATION, V114, pE67, DOI 10.1161/CIRCULATIONAHA.106.613570; APPELS A, 1987, ACTIV NERV SUPER, V29, P147; Bansil P, 2011, J CLIN HYPERTENS, V13, P739, DOI 10.1111/j.1751-7176.2011.00500.x; CDC, 2013, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS), 2013, NHANES AN COURS; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; DINGES DF, 1994, J CLIN INVEST, V93, P1930, DOI 10.1172/JCI117184; Dowd JB, 2011, ANN EPIDEMIOL, V21, P799, DOI 10.1016/j.annepidem.2011.07.004; Ford ES, 2003, CLIN CHEM, V49, P1353, DOI 10.1373/49.8.1353; Gangwisch JE, 2005, SLEEP, V28, P1289, DOI 10.1093/sleep/28.10.1289; Grandner MA, 2013, SLEEP, V36, P769, DOI 10.5665/sleep.2646; Hasler G, 2004, SLEEP, V27, P661, DOI 10.1093/sleep/27.4.661; Ishida K, 2009, CHEST, V136, P125, DOI 10.1378/chest.08-1431; Jackowska M, 2013, PSYCHONEUROENDOCRINO, V38, P1484, DOI 10.1016/j.psyneuen.2012.12.015; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Lagrand WK, 1999, CIRCULATION, V100, P96, DOI 10.1161/01.CIR.100.1.96; Laugsand LE, 2012, PSYCHOSOM MED, V74, P543, DOI 10.1097/PSY.0b013e31825904eb; Li YP, 2012, CIRCULATION, V126, P1689, DOI 10.1161/CIRCULATIONAHA.112.112698; Matthews KA, 2010, SLEEP, V33, P1649, DOI 10.1093/sleep/33.12.1649; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Miller MA, 2009, SLEEP, V32, P857; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Mollicone DJ, 2008, ACTA ASTRONAUT, V63, P833, DOI 10.1016/j.actaastro.2007.12.005; Newman AB, 2000, J AM GERIATR SOC, V48, P115, DOI 10.1111/j.1532-5415.2000.tb03901.x; Pasceri V, 2000, CIRCULATION, V102, P2165; Patel SR, 2006, AM J EPIDEMIOL, V164, P947, DOI 10.1093/aje/kwj280; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Plaisance EP, 2006, SPORTS MED, V36, P443, DOI 10.2165/00007256-200636050-00006; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Ridker PM, 2001, CIRCULATION, V103, P1813, DOI 10.1161/01.CIR.103.13.1813; Rifai N, 1999, CLIN CHEM, V45, P2136; Schwartz SW, 1998, ANN EPIDEMIOL, V8, P384, DOI 10.1016/S1047-2797(97)00238-X; Shearer WT, 2001, J ALLERGY CLIN IMMUN, V107, P165, DOI 10.1067/mai.2001.112270; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Spiegel K, 2008, INT J PEDIATR OBES, V3, P27, DOI 10.1080/17477160802404681; Taheri S, 2007, SLEEP, V30, P991, DOI 10.1093/sleep/30.8.991; Trotti LM, 2012, BRAIN BEHAV IMMUN, V26, P1239, DOI 10.1016/j.bbi.2012.06.003; Vgontzas AN, 1999, J CLIN ENDOCR METAB, V84, P2603, DOI 10.1210/jc.84.8.2603; Vozoris NT, 2012, SLEEP MED, V13, P637, DOI 10.1016/j.sleep.2012.01.004	41	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92607	10.1371/journal.pone.0092607	http://dx.doi.org/10.1371/journal.pone.0092607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663098	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900084
J	Pongsiri, A; Ponlawat, A; Thaisomboonsuk, B; Jarman, RG; Scott, TW; Lambrechts, L				Pongsiri, Arissara; Ponlawat, Alongkot; Thaisomboonsuk, Butsaya; Jarman, Richard G.; Scott, Thomas W.; Lambrechts, Louis			Differential Susceptibility of Two Field Aedes aegypti Populations to a Low Infectious Dose of Dengue Virus	PLOS ONE			English	Article							FRENCH-POLYNESIA; DISEASE SEVERITY; VIREMIA; THAILAND; TRANSMISSION; CHILDREN; VILLAGES; STRAINS; BURDEN	Background: The infectious dose required to infect mosquito vectors when they take a blood meal from a viremic person is a critical parameter underlying the probability of dengue virus (DENV) transmission. Because experimental vector competence studies typically examine the proportion of mosquitoes that become infected at intermediate or high DENV infectious doses in the blood meal, the minimum blood meal titer required to infect mosquitoes is poorly documented. Understanding the factors influencing the lower infectiousness threshold is epidemiologically significant because it determines the transmission potential of humans with a low DENV viremia, possibly including inapparent infections, and during the onset and resolution of the viremic period of acutely infected individuals. Methodology/Principal Findings: We compared the susceptibility of two field-derived Aedes aegypti populations from Kamphaeng Phet, Thailand when they were orally exposed to low titers of six DENV-2 isolates derived from the serum of naturally infected humans living in the same region. The infectious dose, time-point post-blood feeding, viral isolate and mosquito population, were significant predictors of the proportion of mosquitoes that became infected. Importantly, the dose-response profile differed significantly between the two Ae. aegypti populations. Although both mosquito populations had a similar 50% oral infectious dose (OID50), the slope of the dose-response was shallower in one population, resulting in a markedly higher susceptibility at low blood meal titers. Conclusions/Significance: Our results indicate that mosquitoes in nature vary in their infectious dose-response to DENV. Thus, different mosquito populations have a differential ability to acquire DENV infection at low viremia levels. Future studies on human-to-mosquito DENV transmission should not be limited to OID50 values, but rather they should be expanded to account for the shape of the dose-response profile across a range of virus titers.	[Pongsiri, Arissara; Ponlawat, Alongkot] Armed Forces Res Inst Med Sci, Dept Entomol, Bangkok 10400, Thailand; [Thaisomboonsuk, Butsaya; Jarman, Richard G.] Armed Forces Res Inst Med Sci, Dept Virol, Bangkok 10400, Thailand; [Scott, Thomas W.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Scott, Thomas W.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Lambrechts, Louis] Inst Pasteur, CNRS, Dept Genomes & Genet, Insect Virus Interact Grp,Unite Rech Associee 301, Paris, France	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lambrechts, L (corresponding author), Inst Pasteur, CNRS, Dept Genomes & Genet, Insect Virus Interact Grp,Unite Rech Associee 301, Paris, France.	louis.lambrechts@pasteur.fr	Lambrechts, Louis/A-2057-2010	Lambrechts, Louis/0000-0001-5958-2138	United States National Institutes of Health [R01 GM083224]; United States Military Infectious Diseases Research Program; French Agence Nationale de la Recherche [ANR-09-RPDOC-007-01]; French Government's Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases [ANR-10-LABX-62-IBEID]; Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, United States National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083224] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Military Infectious Diseases Research Program; French Agence Nationale de la Recherche(French National Research Agency (ANR)); French Government's Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases(French National Research Agency (ANR)); Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, United States National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was primarily supported by grant R01 GM083224 from the United States National Institutes of Health and by the United States Military Infectious Diseases Research Program. L. L. received funding from the French Agence Nationale de la Recherche (grant ANR-09-RPDOC-007-01) and from the French Government's Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases (grant ANR-10-LABX-62-IBEID). T. W. S. received support from the Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security, and Fogarty International Center, United States National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong PM, 2001, VECTOR-BORNE ZOONOT, V1, P159, DOI 10.1089/153036601316977769; Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bosio CF, 2005, AM J TROP MED HYG, V72, P434, DOI 10.4269/ajtmh.2005.72.434; Choy MM, 2013, AM J TROP MED HYG, V89, P1001, DOI 10.4269/ajtmh.13-0100; Endy TP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000975; Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621; GUBLER DJ, 1981, AM J TROP MED HYG, V30, P1094, DOI 10.4269/ajtmh.1981.30.1094; GUBLER DJ, 1978, AM J TROP MED HYG, V27, P581, DOI 10.4269/ajtmh.1978.27.581; GUBLER DJ, 1981, B WORLD HEALTH ORGAN, V59, P623; GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045, DOI 10.4269/ajtmh.1979.28.1045; Hanley Kathryn A., 2008, BMC Ecology, V8, P1, DOI 10.1186/1472-6785-8-1; Klungthong C, 2007, J CLIN MICROBIOL, V45, P2480, DOI 10.1128/JCM.00305-07; Lambrechts L, 2012, MEM I OSWALDO CRUZ, V107, P1080, DOI 10.1590/S0074-02762012000800022; Lambrechts L, 2012, J VIROL, V86, P1853, DOI 10.1128/JVI.06458-11; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365; Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205; Murgue B, 2000, J MED VIROL, V60, P432, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;432::AID-JMV11&gt;3.0.CO;2-7; Nguyen NM, 2013, P NATL ACAD SCI USA, V110, P9072, DOI 10.1073/pnas.1303395110; Nishiura H, 2007, J INFECT DIS, V195, P1007, DOI 10.1086/511825; Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299; SILER J. F., 1926, PHILIPPINE JOUR SCI, V29, P1; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; SIMMONS JAMES STEVENS, 1931, PHILIPPINE JOUR SCI, V44, P1; Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P292, DOI 10.4269/ajtmh.1999.60.292; Yoon IK, 2012, J INFECT DIS, V206, P389, DOI 10.1093/infdis/jis357	30	19	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92971	10.1371/journal.pone.0092971	http://dx.doi.org/10.1371/journal.pone.0092971			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664142	Green Submitted, Green Published, gold			2022-12-27	WOS:000333459900135
J	Sharma, R; Sahoo, A; Devendran, R; Jain, M				Sharma, Raghvendra; Sahoo, Annapurna; Devendran, Ragunathan; Jain, Mukesh			Over-Expression of a Rice Tau Class Glutathione S-Transferase Gene Improves Tolerance to Salinity and Oxidative Stresses in Arabidopsis	PLOS ONE			English	Article							ABIOTIC STRESS; PROFILING REVEALS; AUXIN; PLANT; OVEREXPRESSION; PEROXIDASE; RESISTANCE; RESPONSES; CATALASE; GROWTH	Glutathione S-transferases (GSTs) are multifunctional proteins encoded by large gene family in plants, which play important role in cellular detoxification of several endobiotic and xenobiotic compounds. Previously, we suggested the diverse roles of rice GST gene family members in plant development and various stress responses based on their differential expression. In this study, we report the functional characterization of a rice tau class GST gene, OsGSTU4. OsGSTU4 fusion protein was found to be localized in nucleus and cytoplasm. The over-expression of OsGSTU4 in E. coli resulted in better growth and higher GST activity under various stress conditions. Further, we raised over-expression transgenic Arabidopsis plants to reveal its in planta function. These transgenic lines showed reduced sensitivity towards plant hormones, auxin and abscisic acid. Various analyses revealed improved tolerance in transgenic Arabidopsis plants towards salinity and oxidative stresses, which may be attributed to the lower accumulation of reactive oxygen species and enhanced GST activity. In addition, microarray analysis revealed up-regulation of several genes involved in stress responses and cellular detoxification processes in the transgenic plants as compared to wild-type. These results suggest that OsGSTU4 can be used as a good candidate for the generation of stress-tolerant crop plants.	[Sharma, Raghvendra; Sahoo, Annapurna; Devendran, Ragunathan; Jain, Mukesh] Natl Inst Plant Genome Res, Funct & Appl Genom Lab, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Jain, M (corresponding author), Natl Inst Plant Genome Res, Funct & Appl Genom Lab, Aruna Asaf Ali Marg, New Delhi, India.	mjain@nipgr.ac.in	Jain, Mukesh/AAP-5816-2021; Devendran, Ragunathan/AAV-6684-2021; Sharma, Raghvendra/M-3400-2013	Jain, Mukesh/0000-0002-7622-1083; Devendran, Ragunathan/0000-0002-0822-1655; Sharma, Raghvendra/0000-0002-7612-6932	Department of Biotechnology, Government of India [BT/BI/12/040/2005, BT/02/IYBA/2010]; NIPGR	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); NIPGR	This work was financially supported by the Department of Biotechnology, Government of India, under Innovative Young Biotechnologists Award scheme (grant numbers BT/BI/12/040/2005 and BT/02/IYBA/2010) and core grant from NIPGR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2002, PLANT SCI, V12, P1939; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Anderson JV, 2004, PHYSIOL PLANTARUM, V120, P421, DOI 10.1111/j.0031-9317.2004.00249.x; Bashandy T, 2010, PLANT CELL, V22, P376, DOI 10.1105/tpc.109.071225; BERHANE K, 1994, P NATL ACAD SCI USA, V91, P1480, DOI 10.1073/pnas.91.4.1480; Bianchi MW, 2002, PHYSIOL PLANTARUM, V116, P96, DOI 10.1034/j.1399-3054.2002.1160112.x; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; Chen IC, 2007, PLANT PHYSIOL, V143, P1189, DOI 10.1104/pp.106.094185; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dixon DP, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews3004; Dixon DP, 2009, J EXP BOT, V60, P1207, DOI 10.1093/jxb/ern365; Dixon DP, 2002, J BIOL CHEM, V277, P30859, DOI 10.1074/jbc.M202919200; Edwards R, 2000, TRENDS PLANT SCI, V5, P193, DOI 10.1016/S1360-1385(00)01601-0; Edwards R, 2005, METHOD ENZYMOL, V401, P169, DOI 10.1016/S0076-6879(05)01011-6; Edwards R., 2000, HERBICIDES THEIR MEC, P33; EZAKI B, 1995, PHYSIOL PLANTARUM, V93, P11, DOI 10.1034/j.1399-3054.1995.930103.x; Ezaki B, 2004, PLANT PHYSIOL, V134, P1672, DOI 10.1104/pp.103.037135; Gazarian IG, 1998, BIOCHEM J, V333, P223, DOI 10.1042/bj3330223; George S, 2010, J PLANT PHYSIOL, V167, P311, DOI 10.1016/j.jplph.2009.09.004; Habig W H, 1981, Methods Enzymol, V77, P398; HARTUNG W, 1988, PLANT PHYSIOL, V86, P908, DOI 10.1104/pp.86.3.908; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Jain M, 2006, FEBS J, V273, P5245, DOI 10.1111/j.1742-4658.2006.05518.x; Jain M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-73; Jain M, 2009, FEBS J, V276, P3148, DOI 10.1111/j.1742-4658.2009.07033.x; Jha B, 2011, MOL BIOL REP, V38, P4823, DOI 10.1007/s11033-010-0625-x; Ji W, 2010, BIOTECHNOL LETT, V32, P1173, DOI 10.1007/s10529-010-0269-x; Iglesias MJ, 2011, PLANT SIGNAL BEHAV, V6, P452, DOI 10.4161/psb.6.3.14676; Kapoor S, 2002, PLANT CELL, V14, P2353, DOI 10.1105/tpc.003061; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Loyall L, 2000, PLANT CELL, V12, P1939, DOI 10.1105/tpc.12.10.1939; McGonigle B, 2000, PLANT PHYSIOL, V124, P1105, DOI 10.1104/pp.124.3.1105; Moons A, 2003, FEBS LETT, V553, P427, DOI 10.1016/S0014-5793(03)01077-9; Pasternak T, 2005, J EXP BOT, V56, P1991, DOI 10.1093/jxb/eri196; Pearson WR, 2005, METHOD ENZYMOL, V401, P186, DOI 10.1016/S0076-6879(05)01012-8; Potters G, 2009, PLANT CELL ENVIRON, V32, P158, DOI 10.1111/j.1365-3040.2008.01908.x; PRICE AH, 1994, PLANT CELL, V6, P1301, DOI 10.1105/tpc.6.9.1301; Qi YC, 2010, RUSS J PLANT PHYSL+, V57, P233, DOI 10.1134/S102144371002010X; Roxas VP, 1997, NAT BIOTECHNOL, V15, P988, DOI 10.1038/nbt1097-988; Sharma R, 2013, PLANTA, V238, P871, DOI 10.1007/s00425-013-1940-y; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Singh VK, 2013, PLANT BIOTECHNOL J, V11, P691, DOI 10.1111/pbi.12059; Song YL, 2009, PLANTA, V229, P577, DOI 10.1007/s00425-008-0853-7; Soranzo N, 2004, MOL GENET GENOMICS, V271, P511, DOI 10.1007/s00438-004-1006-8; TAKAHASHI Y, 1992, P NATL ACAD SCI USA, V89, P56, DOI 10.1073/pnas.89.1.56; Takesawa T, 2002, MOL BREEDING, V9, P93, DOI 10.1023/A:1026718308155; Thom R, 2002, BIOCHEMISTRY-US, V41, P7008, DOI 10.1021/bi015964x; Tsuchiya T, 2004, GENE, V335, P141, DOI 10.1016/j.gene.2004.03.020; Ueki S, 2009, NAT PROTOC, V4, P71, DOI 10.1038/nprot.2008.217; Vollenweider S, 2000, PLANT J, V24, P467, DOI 10.1046/j.1365-313x.2000.00897.x; Wagner U, 2002, PLANT MOL BIOL, V49, P515, DOI 10.1023/A:1015557300450; Willekens H, 1997, EMBO J, V16, P4806, DOI 10.1093/emboj/16.16.4806; Wright STC, 1978, PHYTOHORMONES RELATE, P495; Xu FX, 2002, PLANT PHYSIOL, V130, P362, DOI 10.1104/pp.004796; Yu T, 2003, J PLANT PHYSIOL, V160, P1305, DOI 10.1078/0176-1617-01205; ZEEVAART JAD, 1988, ANNU REV PLANT PHYS, V39, P439, DOI 10.1146/annurev.pp.39.060188.002255; Zhao Feng-Yun, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P231; Zhao FY, 2006, PLANT CELL TISS ORG, V86, P349, DOI 10.1007/s11240-006-9133-z; ZHOU JM, 1993, PLANT MOL BIOL, V22, P517, DOI 10.1007/BF00015980	61	98	103	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92900	10.1371/journal.pone.0092900	http://dx.doi.org/10.1371/journal.pone.0092900			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663444	Green Submitted, Green Published, gold			2022-12-27	WOS:000333459900128
J	Valdez, G; Heyer, MP; Feng, GP; Sanes, JR				Valdez, Gregorio; Heyer, Mary P.; Feng, Guoping; Sanes, Joshua R.			The Role of Muscle microRNAs in Repairing the Neuromuscular Junction	PLOS ONE			English	Article							MOTOR-NEURON DEGENERATION; MESSENGER-RNA LEVELS; RAT NERVOUS-SYSTEM; SKELETAL-MUSCLE; NONCODING RNA; MOUSE; MICE; EXPRESSION; DIFFERENTIATION; MIR-206	microRNAs have been implicated in mediating key aspects of skeletal muscle development and responses to diseases and injury. Recently, we demonstrated that a synaptically enriched microRNA, miR-206, functions to promote maintenance and repair of the neuromuscular junction (NMJ); in mutant mice lacking miR-206, reinnervation is impaired following nerve injury and loss of NMJs is accelerated in a mouse model of amyotrophic lateral sclerosis (ALS). Here, we asked whether other microRNAs play similar roles. One attractive candidate is miR-133b because it is in the same transcript that encodes miR-206. Like miR-206, miR-133b is concentrated near NMJs and induced after denervation. In miR-133b null mice, however, NMJ development is unaltered, reinnervation proceeds normally following nerve injury, and disease progression is unaffected in the SOD1(G93A) mouse model of ALS. To determine if miR-206 compensates for the loss of miR-133b, we generated mice lacking both microRNAs. The phenotype of these double mutants resembled that of miR-206 single mutants. Finally, we used conditional mutants of Dicer, an enzyme required for the maturation of most microRNAs, to generate mice in which microRNAs were depleted from skeletal muscle fibers postnatally, thus circumventing a requirement for microRNAs in embryonic muscle development. Reinnervation of muscle fibers following injury was impaired in these mice, but the defect was similar in magnitude to that observed in miR-206 mutants. Together, these results suggest that miR-206 is the major microRNA that regulates repair of the NMJ following nerve injury.	[Valdez, Gregorio; Sanes, Joshua R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Valdez, Gregorio; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Valdez, Gregorio] Virginia Tech, Virginia Tech Carilion Res Inst, Roanoke, VA USA; [Heyer, Mary P.; Feng, Guoping] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Heyer, Mary P.] Scripps Res Inst Florida, Dept Mol Therapeut, Jupiter, FL USA; [Feng, Guoping] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Harvard University; Harvard University; Virginia Polytechnic Institute & State University; Duke University; Scripps Research Institute; Massachusetts Institute of Technology (MIT)	Valdez, G (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	gvaldez1@vtc.vt.edu	Feng, Guoping/Y-2827-2019		NIH [R01AG032322]; NINDS/NIH; Ruth K. Broad Foundation Fellowship; NINDS NRSA; NIH/NINDS; Poitras Center for Affective Disorders Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032322] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Ruth K. Broad Foundation Fellowship; NINDS NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Poitras Center for Affective Disorders Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant R01AG032322 from the NIH to JRS and GV was supported by a NRSA Postdoctoral Fellowship from NINDS/NIH. MPH was supported by a Ruth K. Broad Foundation Fellowship and a NINDS NRSA. GF was supported by NIH/NINDS and by The Poitras Center for Affective Disorders Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; BaliceGordon RJ, 1997, MUSCLE NERVE, pS83; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; CARDASIS CA, 1987, MUSCLE NERVE, V10, P200, DOI 10.1002/mus.880100303; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chakkalakal JV, 2012, GENESIS, V50, P50, DOI 10.1002/dvg.20794; Chen JF, 2005, NAT GENET; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; FAHIM MA, 1982, J NEUROCYTOL, V11, P641, DOI 10.1007/BF01262429; FAHIM MA, 1983, J NEUROCYTOL, V12, P13, DOI 10.1007/BF01148085; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; GOLDMAN D, 1988, NEURON, V1, P329, DOI 10.1016/0896-6273(88)90081-5; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Gurtan AM, 2013, J MOL BIOL, V425, P3582, DOI 10.1016/j.jmb.2013.03.007; Hasegawa S, 2008, MOL CELL NEUROSCI, V38, P66, DOI 10.1016/j.mcn.2008.01.016; Herault Y, 1998, NAT GENET, V20, P381, DOI 10.1038/3861; Heyer MP, 2012, J NEUROSCI, V32, P10887, DOI 10.1523/JNEUROSCI.1732-12.2012; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McCarthy JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC451, DOI 10.1152/ajpcell.00077.2007; MERLIE JP, 1984, J CELL BIOL, V99, P332, DOI 10.1083/jcb.99.1.332; MOSCOSO LM, 1995, MOL CELL NEUROSCI, V6, P80, DOI 10.1006/mcne.1995.1008; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Punga AR, 2012, CURR OPIN PHARMACOL, V12, P340, DOI 10.1016/j.coph.2012.02.002; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SCHMITT TL, 1991, HISTOCHEMISTRY, V96, P459, DOI 10.1007/BF00267071; SOLBACH S, 1991, ANAT EMBRYOL, V184, P103, DOI 10.1007/BF00942742; Valdez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034640; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; VAUGHAN DW, 1992, J COMP NEUROL, V323, P219, DOI 10.1002/cne.903230207; VELLECA MA, 1994, MOL CELL BIOL, V14, P7095, DOI 10.1128/MCB.14.11.7095; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711	51	48	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93140	10.1371/journal.pone.0093140	http://dx.doi.org/10.1371/journal.pone.0093140			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664281	Green Submitted, Green Published, gold			2022-12-27	WOS:000333459900157
J	Barnwell, E; Padmaraju, V; Baranello, R; Pacheco-Quinto, J; Crosson, C; Ablonczy, Z; Eckman, E; Eckman, CB; Ramakrishnan, V; Greig, NH; Pappolla, MA; Sambamurti, K				Barnwell, Eliza; Padmaraju, Vasudevaraju; Baranello, Robert; Pacheco-Quinto, Javier; Crosson, Craig; Ablonczy, Zsolt; Eckman, Elizabeth; Eckman, Christopher B.; Ramakrishnan, Viswanathan; Greig, Nigel H.; Pappolla, Miguel A.; Sambamurti, Kumar			Evidence of a Novel Mechanism for Partial gamma-Secretase Inhibition Induced Paradoxical Increase in Secreted Amyloid beta Protein	PLOS ONE			English	Article							ENDOTHELIN-CONVERTING ENZYME; CARBOXYL-TERMINAL FRAGMENTS; TRANS-GOLGI NETWORK; ALZHEIMERS-DISEASE; A-BETA; PRECURSOR PROTEIN; CELL-SURFACE; THERAPEUTIC TARGETS; BACE PROMOTER; APP	BACE1 (beta-secretase) and alpha-secretase cleave the Alzheimer's amyloid beta protein (A beta) precursor (APP) to C-terminal fragments of 99 aa (CTF beta) and 83 aa (CTF alpha), respectively, which are further cleaved by gamma-secretase to eventually secrete A beta and A alpha (a.k.a. P3) that terminate predominantly at residues 40 and 42. A number of gamma-secretase inhibitors (GSIs), such as N-[N-(3,5-Difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester (DAPT), have been developed with the goal of reducing A beta to treat Alzheimer's disease (AD). Although most studies show that DAPT inhibits A beta in a dose-dependent manner several studies have also detected a biphasic effect with an unexpected increase at low doses of DAPT in cell cultures, animal models and clinical trials. In this article, we confirm the increase in A beta 40 and A beta 42 in SH-SY5Y human neuroblastoma cells treated with low doses of DAPT and identify one of the mechanisms for this paradox. We studied the pathway by first demonstrating that stimulation of A beta, a product of gamma-secretase, was accompanied by a parallel increase of its substrate CTF beta, thereby demonstrating that the inhibitor was not anomalously stimulating enzyme activity at low levels. Secondly, we have demonstrated that inhibition of an A beta degrading activity, endothelin converting enzyme (ECE), yielded more A beta, but Abolished the DAPT-induced stimulation. Finally, we have demonstrated that A alpha, which is generated in the secretory pathway before endocytosis, is not subject to the DAPT-mediated stimulation. We therefore conclude that impairment of gamma-secretase can paradoxically increase A beta by transiently skirting A beta degradation in the endosome. This study adds to the growing body of literature suggesting that preserving gamma-secretase activity, rather than inhibiting it, is important for prevention of neurodegeneration.	[Barnwell, Eliza; Padmaraju, Vasudevaraju; Baranello, Robert; Sambamurti, Kumar] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Pacheco-Quinto, Javier; Eckman, Elizabeth; Eckman, Christopher B.] MidAtlantic Neonatol Associates & Atlant Hlth Sy, Biomed Res Inst New Jersey, Morristown, NJ USA; [Crosson, Craig; Ablonczy, Zsolt] Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; [Ramakrishnan, Viswanathan] Med Univ S Carolina, Dept Biostat, Charleston, SC 29425 USA; [Greig, Nigel H.] Natl Inst Aging, Intramural Res Program, Translat Gerontol Branch, Drug Design & Dev Sect, Baltimore, MD USA; [Pappolla, Miguel A.] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Texas System; University of Texas Medical Branch Galveston	Sambamurti, K (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA.	sambak@musc.edu	Eckman, Elizabeth/AAL-7316-2021; Padmaraju, Vasudevaraju/ABH-3160-2021; Sambamurti, Kumar/A-1620-2012; Pappolla, Miguel/ABE-4966-2021	Sambamurti, Kumar/0000-0001-9507-9214; PADMARAJU, VASUDEVARAJU/0000-0002-1676-9610; Eckman, Elizabeth/0000-0002-5391-4960	Alzheimer's Association [IIRG 10-173-180]; NIH [AG046200, EY019065, NS073512]; Research to Prevent Blindness; Intramural NIA; NATIONAL EYE INSTITUTE [R01EY019065, R01EY021368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG046200, ZIAAG000311] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Intramural NIA; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Alzheimer's Association IIRG 10-173-180 and NIH AG046200 to KS, EY019065 to ZA, NIH NS073512 to EE, an unrestricted grant of Research to Prevent Blindness to the Department of Ophthalmology at MUSC and Intramural NIA to NHG supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablonczy Z, 2009, J BIOL CHEM, V284, P30177, DOI 10.1074/jbc.M109.032391; Bailey JA, 2011, GENE, V488, P13, DOI 10.1016/j.gene.2011.06.017; Barthet G, 2012, PROG NEUROBIOL, V98, P166, DOI 10.1016/j.pneurobio.2012.05.006; Barthet G, 2011, FASEB J, V25, P2937, DOI 10.1096/fj.11-183806; Brodney MA, 2011, BIOORG MED CHEM LETT, V21, P2637, DOI 10.1016/j.bmcl.2010.12.118; Burton CR, 2008, J BIOL CHEM, V283, P22992, DOI 10.1074/jbc.M804175200; Cai J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021164; Capell A, 2000, NAT CELL BIOL, V2, P205, DOI 10.1038/35008626; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Chen FS, 2002, J BIOL CHEM, V277, P36521, DOI 10.1074/jbc.M205093200; Chen FS, 2000, J BIOL CHEM, V275, P36794, DOI 10.1074/jbc.M006986200; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; Chyung JH, 2003, J BIOL CHEM, V278, P51035, DOI 10.1074/jbc.M304989200; Confaloni A, 2005, MOL BRAIN RES, V136, P12, DOI 10.1016/j.molbrainres.2004.12.022; Cruts M, 2012, HUM MUTAT, V33, P1340, DOI 10.1002/humu.22117; Cummings J, 2010, BIOL PSYCHIAT, V68, P876, DOI 10.1016/j.biopsych.2010.09.020; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Eckman EA, 2003, J BIOL CHEM, V278, P2081, DOI 10.1074/jbc.C200642200; Eckman EA, 2006, J BIOL CHEM, V281, P30471, DOI 10.1074/jbc.M605827200; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Gandhi S, 2004, J MOL NEUROSCI, V24, P137, DOI 10.1385/JMN:24:1:137; Ge YW, 2004, FASEB J, V18, P1037, DOI 10.1096/fj.03-1379fje; Goate A, 2012, J NEUROCHEM, V120, P3, DOI 10.1111/j.1471-4159.2011.07575.x; Golde TE, 2001, TRENDS MOL MED, V7, P264, DOI 10.1016/S1471-4914(01)02064-0; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hardy J, 2005, BIOCHEM SOC T, V33, P578, DOI 10.1042/BST0330578; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He XY, 2002, FEBS LETT, V524, P183, DOI 10.1016/S0014-5793(02)03052-1; Herskowitz JH, 2012, MOL BIOL CELL, V23, P2645, DOI 10.1091/mbc.E12-01-0014; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kelleher RJ, 2010, SCIENCE, V330, P1055, DOI 10.1126/science.1198668; Krafft GA, 2010, NEUROPHARMACOLOGY, V59, P230, DOI 10.1016/j.neuropharm.2010.07.012; Lahiri Debomoy K., 2006, Current Alzheimer Research, V3, P475, DOI 10.2174/156720506779025224; Lane RF, 2013, J NEUROSCI, V33, P7099, DOI 10.1523/JNEUROSCI.5270-12.2013; Lanz TA, 2006, J PHARMACOL EXP THER, V319, P924, DOI 10.1124/jpet.106.110700; Levy N, 2001, ENDOCRINOLOGY, V142, P5254, DOI 10.1210/en.142.12.5254; Maloney B, 2011, GENE, V488, P1, DOI 10.1016/j.gene.2011.06.004; Marlow L, 2003, BIOCHEM BIOPH RES CO, V305, P502, DOI 10.1016/S0006-291X(03)00797-6; Mitsuda N, 2006, LIFE SCI, V78, P2444, DOI 10.1016/j.lfs.2005.10.007; Mori K, 2010, PSYCHOGERIATRICS, V10, P117, DOI 10.1111/j.1479-8301.2010.00330.x; Morihara T, 2000, MOL BRAIN RES, V85, P85, DOI 10.1016/S0169-328X(00)00229-1; Niva C, 2013, EUR J CLIN PHARMACOL, V69, P1247, DOI 10.1007/s00228-012-1459-3; Pacheco-Quinto J, 2013, J BIOL CHEM, V288, P5606, DOI 10.1074/jbc.M112.422964; Pettersson M, 2013, EXPERT OPIN THER PAT, V23, P1349, DOI 10.1517/13543776.2013.821465; Pinnix I, 2001, FASEB J, V15, P1810, DOI 10.1096/fj.00-0891fje; Pinnix I, 2013, AM J GERIAT PSYCHIAT, V21, P474, DOI 10.1016/j.jagp.2013.02.009; Prakasam A, 2010, J ALZHEIMERS DIS, V20, P1243, DOI 10.3233/JAD-2010-100210; Refolo LM, 1999, J NEUROCHEM, V73, P2383, DOI 10.1046/j.1471-4159.1999.0732383.x; REFOLO LM, 1995, J NEUROSCI RES, V40, P694, DOI 10.1002/jnr.490400515; Robakis NK, 2011, NEUROBIOL AGING, V32, P372, DOI 10.1016/j.neurobiolaging.2010.05.022; Robakis NK, 2010, NEURODEGENER DIS, V7, P32, DOI 10.1159/000266476; ROBAKIS NK, 1987, LANCET, V1, P384; Sambamurti K, 1999, J BIOL CHEM, V274, P26810, DOI 10.1074/jbc.274.38.26810; Sambamurti K, 2004, FASEB J, V18, P1034, DOI 10.1096/fj.03-1378fje; SAMBAMURTI K, 1992, J NEUROSCI RES, V33, P319, DOI 10.1002/jnr.490330216; SAMBAMURTI K, 1992, ANN NY ACAD SCI, V674, P118, DOI 10.1111/j.1749-6632.1992.tb27481.x; Sambamurti K, 2011, J NEUROCHEM, V117, P359, DOI 10.1111/j.1471-4159.2011.07213.x; Sambamurti Kumar, 2006, Current Alzheimer Research, V3, P81, DOI 10.2174/156720506775697142; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; Shirotani K, 2007, NEUROBIOL DIS, V27, P102, DOI 10.1016/j.nbd.2007.04.011; Svedruzic ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050759; Udayar V, 2013, CELL REP, V5, P1536, DOI 10.1016/j.celrep.2013.12.005; Vidal R, 2012, FASEB J, V26, P2899, DOI 10.1096/fj.12-205542; Vieira SI, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-40; Walker KR, 2012, J NEUROSCI, V32, P10423, DOI 10.1523/JNEUROSCI.5491-11.2012; Wolfe MS, 2013, BBA-BIOMEMBRANES, V1828, P2886, DOI 10.1016/j.bbamem.2013.04.015; Xia WM, 2012, J ALZHEIMERS DIS, V31, P685, DOI 10.3233/JAD-2012-120751; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Xu XM, 2009, J ALZHEIMERS DIS, V16, P211, DOI 10.3233/JAD-2009-0957; Yanagisawa H, 2000, J CLIN INVEST, V105, P1373, DOI 10.1172/JCI7447; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; Younkin SG, 1998, J PHYSIOLOGY-PARIS, V92, P289, DOI 10.1016/S0928-4257(98)80035-1; Zahs KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00028; Zhou Y, 2008, FASEB J, V22, P47, DOI 10.1096/fj.07-8175com; Zhu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045033	80	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91531	10.1371/journal.pone.0091531	http://dx.doi.org/10.1371/journal.pone.0091531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658363	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300037
J	Bilic, I; Jaskulska, B; Souillard, R; Liebhart, D; Hess, M				Bilic, Ivana; Jaskulska, Barbara; Souillard, Rozenn; Liebhart, Dieter; Hess, Michael			Multi-Locus Typing of Histomonas meleagridis Isolates Demonstrates the Existence of Two Different Genotypes	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; 5.8S RIBOSOMAL-RNA; DIENTAMOEBA-FRAGILIS; UNITED-STATES; TETRATRICHOMONAS-GALLINARUM; MOLECULAR CHARACTERIZATION; TRICHOMONADID PROTOZOA; PARTIAL SEQUENCE; STOOL SPECIMENS; REGIONS	Histomonas meleagridis is the aetiological agent of histomonosis or "blackhead disease". Histomonosis is of special importance today, because there is no effective treatment to prevent its occurrence with considerable losses for the poultry industry. Despite its importance only a few molecular studies have yet been performed to investigate the degree of genetic diversity between different isolates of this parasite. In the present study a collection of well defined samples, previously shown positive for the DNA of H. meleagridis, was used to investigate genetic relatedness of the parasite. Samples originated from 25 turkey flocks collected in France between 2007 and 2010. Additionally, diagnostic samples, collected at our Clinic in Vienna, from different European countries and Azerbaijan, during 2010 to 2013 were included in the analyses. For the analysis three different genetic loci were analyzed: 18S rRNA, alpha-actinin1 and rpb1 genes. To amplify partial sequences of alpha-actinin1 and rpb1 genes, primers specifically targeting H. meleagridis were designed. Following PCR, the sequences of 18S rRNA, alpha-actinin1 and rpb1 loci were analyzed. Phylogenetic analyses demonstrated separation of H. meleagridis isolates in two different clusters. The majority of isolates grouped within the cluster 1 and originated from different European countries. The cluster 2 was rare and predominantly found in samples originating from France. Considering that the genetic variability of clusters can be seen as two distinct genetic types we propose the term genotype instead of cluster.	[Bilic, Ivana; Jaskulska, Barbara; Liebhart, Dieter; Hess, Michael] Univ Vet Med Vienna, Dept Farm Animals & Vet Publ Hlth, Clin Poultry & Fish Med, Vienna, Austria; [Souillard, Rozenn] European Univ Brittany, French Agcy Food Environm & Occupat Hlth Safety A, Unit Epidemiol & Welf poultry, F-22440 Ploufragan, France; [Souillard, Rozenn] Rabbit Ploufragan Plouzane Lab, F-22440 Ploufragan, France	University of Veterinary Medicine Vienna	Bilic, I (corresponding author), Univ Vet Med Vienna, Dept Farm Animals & Vet Publ Hlth, Clin Poultry & Fish Med, Vienna, Austria.	ivana.bilic@vetmeduni.ac.at	Liebhart, Dieter/P-3765-2019	Liebhart, Dieter/0000-0003-2412-1248; Bilic, Ivana/0000-0003-3296-5117; Hess, Michael/0000-0002-6991-0120	French Turkey Producers Association; Bretagne Region; Pays de Loire Region; France Agrimer; Vetmeduni Vienna, Austria; Anses	French Turkey Producers Association; Bretagne Region(Region Bretagne); Pays de Loire Region; France Agrimer; Vetmeduni Vienna, Austria; Anses	The French study was supported financially by the French Turkey Producers Association, Bretagne and Pays de Loire Regions, France Agrimer and Anses. All other additional funds for consumables were obtained from the Vetmeduni Vienna, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bart A, 2008, J CLIN MICROBIOL, V46, P3270, DOI 10.1128/JCM.00680-08; Cepicka I, 2010, PROTIST, V161, P400, DOI 10.1016/j.protis.2009.11.005; Esquenet C, 2003, AVIAN PATHOL, V32, P305, DOI 10.1080/0307945031000097903; Felleisen RSJ, 1997, PARASITOLOGY, V115, P111, DOI 10.1017/S0031182097001212; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Gerbod D, 2001, J EUKARYOT MICROBIOL, V48, P498, DOI 10.1111/j.1550-7408.2001.tb00185.x; Gerhold RW, 2011, J PARASITOL, V97, P354, DOI 10.1645/GE-2618.1; Gerhold RW, 2008, J PARASITOL, V94, P1335, DOI 10.1645/GE-1585.1; Grabensteiner E, 2010, VET PARASITOL, V172, P53, DOI 10.1016/j.vetpar.2010.04.015; Hauck R, 2010, AVIAN DIS, V54, P1021, DOI 10.1637/9261-012910-Reg.1; Hauck R, 2010, J PARASITOL, V96, P396, DOI 10.1645/GE-2267.1; Hauck R, 2009, PARASITOL RES, V104, P1183, DOI 10.1007/s00436-008-1309-5; Hess M, 2006, PARASITOLOGY, V133, P547, DOI 10.1017/S0031182006000758; Kleina P, 2004, INT J PARASITOL, V34, P963, DOI 10.1016/j.ijpara.2004.04.004; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lollis L, 2011, J PARASITOL, V97, P610, DOI 10.1645/GE-2648.1; Malik SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020774; Mantini C, 2009, PARASITOL RES, V106, P163, DOI 10.1007/s00436-009-1643-2; McDougald LR, 2005, AVIAN DIS, V49, P462, DOI 10.1637/7420-081005R.1; Munsch M, 2009, PARASITOL RES, V104, P1137, DOI 10.1007/s00436-008-1299-3; Noda S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029938; Peek R, 2004, J CLIN MICROBIOL, V42, P631, DOI 10.1128/JCM.42.2.631-635.2004; Stark D, 2005, INT J PARASITOL, V35, P57, DOI 10.1016/j.ijpara.2004.09.003; Tyzzer E. E., 1920, Journal of Parasitology Urbana, V6, DOI 10.2307/3271065; van der Heijden HMJF, 2006, AVIAN PATHOL, V35, P330, DOI 10.1080/03079450600815499; Walker RL, 2003, J VET DIAGN INVEST, V15, P14, DOI 10.1177/104063870301500104; Windsor JJ, 2006, J EUKARYOT MICROBIOL, V53, P188, DOI 10.1111/j.1550-7408.2006.00092.x	27	28	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92438	10.1371/journal.pone.0092438	http://dx.doi.org/10.1371/journal.pone.0092438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658534	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300083
J	Hao, LP; Lu, F; Wu, Q; Shao, LM; He, PJ				Hao, Liping; Lu, Fan; Wu, Qing; Shao, Liming; He, Pinjing			High Concentrations of Methyl Fluoride Affect the Bacterial Community in a Thermophilic Methanogenic Sludge	PLOS ONE			English	Article							RICE FIELD SOIL; ISOTOPE FRACTIONATION; ACETOCLASTIC METHANOGENESIS; SP NOV.; ACETATE; INHIBITION; DIVERSITY; QUANTIFICATION; OXIDATION; PATHWAYS	To precisely control the application of methyl fluoride (CH3F) for analysis of methanogenic pathways, the influence of 0-10% CH3F on bacterial and archaeal communities in a thermophilic methanogenic sludge was investigated. The results suggested that CH3F acts specifically on acetoclastic methanogenesis. The inhibitory effect stabilized at an initial concentration of 3-5%, with around 90% of the total methanogenic activity being suppressed, and a characteristic of hydrogenotrophic pathway in isotope fractionation was demonstrated under this condition. However, extended exposure (12 days) to high concentrations of CH3F (>3%) altered the bacterial community structure significantly, resulting in increased diversity and decreased evenness, which can be related to acetate oxidation and CH3F degradation. Bacterial clone library analysis showed that syntrophic acetate oxidizing bacteria Thermacetogenium phaeum were highly enriched under the suppression of 10% CH3F. However, the methanogenic community did not change obviously. Thus, excessive usage of CH3F over the long term can change the composition of the bacterial community. Therefore, data from studies involving the use of CH3F as an acetoclast inhibitor should be interpreted with care. Conversely, CH3F has been suggested as a factor to stimulate the enrichment of syntrophic acetate oxidizing bacteria.	[Hao, Liping; Lu, Fan; Wu, Qing] Tongji Univ, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China; [Lu, Fan; Shao, Liming; He, Pinjing] Tongji Univ, Inst Waste Treatment & Reclamat, Shanghai 200092, Peoples R China; [Shao, Liming; He, Pinjing] Minist Housing & Urban Rural Dev PR China MOHURD, Ctr Technol Res & Training Household Waste Small, Shanghai, Peoples R China	Tongji University; Tongji University	Lu, F (corresponding author), Tongji Univ, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China.	lvfan.rhodea@tongji.edu.cn; solidwaste@tongji.edu.cn	He, Pinjing/O-6215-2019; Lü, Fan/F-4812-2013; Hao, Liping/GLN-4379-2022	Lü, Fan/0000-0002-8496-3941; 	National Basic Research Program of China (973 Program) [2012CB719801]; National Science Foundation of China [51378375, 51178327, 21177096]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was sponsored by National Basic Research Program of China (973 Program, No. 2012CB719801) and National Science Foundation of China (51378375; 51178327; 21177096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balk M, 2002, INT J SYST EVOL MICR, V52, P1361, DOI [10.1099/ijs.0.02165-0, 10.1099/00207713-52-4-1361]; Bodelier PLE, 1999, APPL ENVIRON MICROB, V65, P1826; Chau JF, 2011, ENVIRON FORENSICS, V12, P333, DOI 10.1080/15275922.2011.622348; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Conrad R, 2005, ORG GEOCHEM, V36, P739, DOI 10.1016/j.orggeochem.2004.09.006; Conrad R, 2002, CHEMOSPHERE, V47, P797, DOI 10.1016/S0045-6535(02)00120-0; Conrad R, 1999, FEMS MICROBIOL ECOL, V30, P47, DOI 10.1111/j.1574-6941.1999.tb00634.x; Conrad R, 2010, LIMNOL OCEANOGR, V55, P689, DOI 10.4319/lo.2009.55.2.0689; Daebeler A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053656; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Fotidis IA, 2013, BIORESOURCE TECHNOL, V146, P57, DOI 10.1016/j.biortech.2013.07.041; Frenzel P, 1996, FEMS MICROBIOL ECOL, V21, P25; Hao LP, 2011, CHEMOSPHERE, V84, P1194, DOI 10.1016/j.chemosphere.2011.06.045; Hao LP, 2011, ENVIRON SCI TECHNOL, V45, P508, DOI 10.1021/es102228v; Hao LP, 2013, J ENVIRON SCI, V25, P857, DOI 10.1016/S1001-0742(12)60203-4; Hao LP, 2013, BIORESOURCE TECHNOL, V140, P319, DOI 10.1016/j.biortech.2013.04.113; Hattori S, 2008, MICROBES ENVIRON, V23, P118, DOI 10.1264/jsme2.23.118; Janssen PH, 1997, APPL ENVIRON MICROB, V63, P4552, DOI 10.1128/AEM.63.11.4552-4557.1997; Kamagata Y, 1989, RECENT ADV MICROBIAL, P459; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Liu FH, 2010, ENVIRON MICROBIOL, V12, P2341, DOI 10.1111/j.1462-2920.2010.02289.x; Liu JJ, 2011, APPL MICROBIOL BIOT, V91, P1659, DOI 10.1007/s00253-011-3354-8; OREMLAND RS, 1992, APPL ENVIRON MICROB, V58, P2983, DOI 10.1128/AEM.58.9.2983-2992.1992; Penger J, 2012, APPL ENVIRON MICROB, V78, P7596, DOI 10.1128/AEM.01773-12; Penning H, 2006, APPL ENVIRON MICROB, V72, P178, DOI 10.1128/AEM.72.1.178-184.2006; Penning H, 2007, ORG GEOCHEM, V38, P2058, DOI 10.1016/j.orggeochem.2007.08.004; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Schnurer A, 1996, INT J SYST BACTERIOL, V46, P1145, DOI 10.1099/00207713-46-4-1145; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; TIWARI SC, 1993, BIOL FERT SOILS, V16, P131, DOI 10.1007/BF00369414; Westerholm M., 2012, BIOGAS PRODUCTION SY; Westerholm M, 2011, SYST APPL MICROBIOL, V34, P260, DOI 10.1016/j.syapm.2010.11.018; Westerholm M, 2010, FEMS MICROBIOL LETT, V309, P100, DOI 10.1111/j.1574-6968.2010.02023.x; Wittebolle L, 2008, APPL ENVIRON MICROB, V74, P286, DOI 10.1128/AEM.01006-07; Ye Ningfang, 2007, Chinese Journal of Applied and Environmental Biology, V13, P238; Zhang XL, 2005, J MICROBIOL METH, V60, P1, DOI 10.1016/j.mimet.2004.08.015	36	1	2	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92604	10.1371/journal.pone.0092604	http://dx.doi.org/10.1371/journal.pone.0092604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658656	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300104
J	Evans, CC; LePard, KJ; Kwak, JW; Stancukas, MC; Laskowski, S; Dougherty, J; Moulton, L; Glawe, A; Wang, YW; Leone, V; Antonopoulos, DA; Smith, D; Chang, EB; Ciancio, MJ				Evans, Christian C.; LePard, Kathy J.; Kwak, Jeff W.; Stancukas, Mary C.; Laskowski, Samantha; Dougherty, Joseph; Moulton, Laura; Glawe, Adam; Wang, Yunwei; Leone, Vanessa; Antonopoulos, Dionysios A.; Smith, Dan; Chang, Eugene B.; Ciancio, Mae J.			Exercise Prevents Weight Gain and Alters the Gut Microbiota in a Mouse Model of High Fat Diet-Induced Obesity	PLOS ONE			English	Article							BODY-MASS INDEX; INSULIN-RESISTANCE; PHYSICAL-EXERCISE; LACTOBACILLUS; INFLAMMATION; PREVALENCE; INDUCTION; COMMUNITY; CHILDREN; PROTECTS	Background: Diet-induced obesity (DIO) is a significant health concern which has been linked to structural and functional changes in the gut microbiota. Exercise (Ex) is effective in preventing obesity, but whether Ex alters the gut microbiota during development with high fat (HF) feeding is unknown. Objective: Determine the effects of voluntary Ex on the gastrointestinal microbiota in LF-fed mice and in HF-DIO. Methods: Male C57BL/6 littermates (5 weeks) were distributed equally into 4 groups: low fat (LF) sedentary (Sed) LF/Sed, LF/Ex, HF/Sed and HF/Ex. Mice were individually housed and LF/Ex and HF/Ex cages were equipped with a wheel and odometer to record Ex. Fecal samples were collected at baseline, 6 weeks and 12 weeks and used for bacterial DNA isolation. DNA was subjected both to quantitative PCR using primers specific to the 16S rRNA encoding genes for Bacteroidetes and Firmicutes and to sequencing for lower taxonomic identification using the Illumina MiSeq platform. Data were analyzed using a one or two-way ANOVA or Pearson correlation. Results:HF diet resulted in significantly greater body weight and adiposity as well as decreased glucose tolerance that were prevented by voluntary Ex (p<0.05). Visualization of Unifrac distance data with principal coordinates analysis indicated clustering by both diet and Ex at week 12. Sequencing demonstrated Ex-induced changes in the percentage of major bacterial phyla at 12 weeks. A correlation between total Ex distance and the Delta Ct Bacteroidetes: Delta Ct Firmicutes ratio from qPCR demonstrated a significant inverse correlation (r(2) = 0.35, p = 0.043). Conclusion: Ex induces a unique shift in the gut microbiota that is different from dietary effects. Microbiota changes may play a role in Ex prevention of HF-DIO.	[Evans, Christian C.] Midwestern Univ, Coll Hlth Sci, Dept Phys Therapy, Downers Grove, IL 60515 USA; [LePard, Kathy J.] Midwestern Univ, Coll Osteopath Med, Dept Physiol, Downers Grove, IL 60515 USA; [Kwak, Jeff W.; Stancukas, Mary C.; Dougherty, Joseph; Moulton, Laura; Glawe, Adam; Ciancio, Mae J.] Midwestern Univ, Coll Hlth Sci, Dept Biomed Sci, Downers Grove, IL 60515 USA; [Laskowski, Samantha] Midwestern Univ, Coll Osteopath Med, Downers Grove, IL 60515 USA; [Dougherty, Joseph] Midwestern Univ, Coll Dent Med, Dept Dent Med, Downers Grove, IL 60515 USA; [Wang, Yunwei; Leone, Vanessa; Chang, Eugene B.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Antonopoulos, Dionysios A.; Smith, Dan] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA	Midwestern University; Midwestern University - College of Health Sciences - Illinois; Midwestern University; Midwestern University - Chicago College of Osteopathic Medicine; Midwestern University; Midwestern University - College of Health Sciences - Illinois; Midwestern University; Midwestern University - Chicago College of Osteopathic Medicine; Midwestern University; Midwestern University - College of Dental Medicine - Illinois; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory	Evans, CC (corresponding author), Midwestern Univ, Coll Hlth Sci, Dept Phys Therapy, Downers Grove, IL 60515 USA.	cevans@midwestern.edu	Antonopoulos, Dionysios/ABE-6212-2020	Antonopoulos, Dionysios/0000-0002-2238-5031; Kwak, Jeff/0000-0003-1481-3654	Midwestern University (MJC), Midwestern University College of Health Sciences Research Facilitation grants; Kenneth A. Suarez Summer Research Fellowship; National Institutes of Health (NIH) of the Digestive Disease Research Core Center, University of Chicago [P30 DK 42086]; NIH [DK097268]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK047722, R01DK097268, R01DK047722, P30DK042086] Funding Source: NIH RePORTER	Midwestern University (MJC), Midwestern University College of Health Sciences Research Facilitation grants; Kenneth A. Suarez Summer Research Fellowship; National Institutes of Health (NIH) of the Digestive Disease Research Core Center, University of Chicago; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was through: Midwestern University (MJC), Midwestern University College of Health Sciences Research Facilitation grants (CCE and MJC), a Kenneth A. Suarez Summer Research Fellowship (SL), National Institutes of Health (NIH) grant P30 DK 42086 to the Host-Microbe Core of the Digestive Disease Research Core Center, University of Chicago and NIH grant DK097268 (EBC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2010, BENEF MICROBES, V1, P189, DOI 10.3920/BM2009.0036; Angelakis E, 2012, FUTURE MICROBIOL, V7, P91, DOI [10.2217/FMB.11.142, 10.2217/fmb.11.142]; Angelakis E, 2012, MICROB PATHOGENESIS, V52, P61, DOI 10.1016/j.micpath.2011.10.004; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Atalay M, 2004, J APPL PHYSIOL, V97, P605, DOI 10.1152/japplphysiol.01183.2003; Aube AC, 2006, GUT, V55, P630, DOI 10.1136/gut.2005.067595; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Bernardeau M, 2002, INT J FOOD MICROBIOL, V77, P19, DOI 10.1016/S0168-1605(02)00059-4; Bervoets L, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-10; Bradley RL, 2008, AM J PHYSIOL-ENDOC M, V295, pE586, DOI 10.1152/ajpendo.00309.2007; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2013, BRIEF FUNCT GENOMICS, V12, P381, DOI 10.1093/bfgp/elt014; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Choi JJ, 2013, ENVIRON HEALTH PERSP, V121, P725, DOI 10.1289/ehp.1306534; Colditz GA, 1997, CANCER CAUSE CONTROL, V8, P649, DOI 10.1023/A:1018458700185; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; DAPOIGNY M, 1991, AM J PHYSIOL, V260, pG646, DOI 10.1152/ajpgi.1991.260.4.G646; de Oliveira EP, 2009, CURR OPIN CLIN NUTR, V12, P533, DOI 10.1097/MCO.0b013e32832e6776; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Eeg-Olofsson K, 2009, DIABETOLOGIA, V52, P65, DOI 10.1007/s00125-008-1190-x; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Fraulob JC, 2010, J CLIN BIOCHEM NUTR, V46, P212, DOI 10.3164/jcbn.09-83; Geurts L, 2014, BENEF MICROBES, V5, P3, DOI 10.3920/BM2012.0065; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Haange SB, 2012, J PROTEOME RES, V11, P5406, DOI 10.1021/pr3006364; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Huang EY, 2013, JPEN-PARENTER ENTER, V37, P746, DOI 10.1177/0148607113486931; Huang P, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-59; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Konhilas JP, 2005, AM J PHYSIOL-HEART C, V289, pH455, DOI 10.1152/ajpheart.00085.2005; KONTUREK SJ, 1973, J APPL PHYSIOL, V34, P324, DOI 10.1152/jappl.1973.34.3.324; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Malago JJ, 2002, CELL STRESS CHAPERON, V7, P191, DOI 10.1379/1466-1268(2002)007<0191:THSRAC>2.0.CO;2; Martins C, 2007, J ENDOCRINOL, V193, P251, DOI 10.1677/JOE-06-0030; Matsumoto M, 2008, BIOSCI BIOTECH BIOCH, V72, P572, DOI 10.1271/bbb.70474; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; MILLER MS, 1981, J PHARMACOL METHOD, V6, P211, DOI 10.1016/0160-5402(81)90110-8; Million M, 2012, MICROB PATHOGENESIS, V53, P100, DOI 10.1016/j.micpath.2012.05.007; Mujico JR, 2013, BRIT J NUTR, V110, P711, DOI 10.1017/S0007114512005612; Musch MW, 1996, AM J PHYSIOL-CELL PH, V270, pC429, DOI 10.1152/ajpcell.1996.270.2.C429; Musch MW, 1999, GASTROENTEROLOGY, V117, P115, DOI 10.1016/S0016-5085(99)70557-3; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Naito E, 2011, J APPL MICROBIOL, V110, P650, DOI 10.1111/j.1365-2672.2010.04922.x; Nathan C, 2008, MOL MED, V14, P485, DOI 10.2119/2008-00038.Nathan; Noble EG, 2006, ACTA PHYSIOL, V187, P495, DOI 10.1111/j.1748-1716.2006.01591.x; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Oliveira AG, 2011, DIABETES, V60, P784, DOI 10.2337/db09-1907; Pedersen BK, 2004, P NUTR SOC, V63, P263, DOI 10.1079/PNS2004338; Peters HPF, 2001, GUT, V48, P435, DOI 10.1136/gut.48.3.435; Petersen AMW, 2006, J PHYSIOL PHARMACOL, V57, P43; Rao SSC, 1999, AM J PHYSIOL-GASTR L, V276, pG1221, DOI 10.1152/ajpgi.1999.276.5.G1221; Rastmanesh R, 2011, CHEM-BIOL INTERACT, V189, P1, DOI 10.1016/j.cbi.2010.10.002; Simoes CD, 2013, J NUTR, V143, P417, DOI 10.3945/jn.112.166322; Tehrani AB, 2012, NEUROGASTROENT MOTIL, V24, P305, DOI 10.1111/j.1365-2982.2012.01895.x; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Wright JD, 2007, J AM DIET ASSOC, V107, P822, DOI 10.1016/j.jada.2007.02.017	70	360	386	12	172	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92193	10.1371/journal.pone.0092193	http://dx.doi.org/10.1371/journal.pone.0092193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670791	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677000035
J	Kubena, AA; Houdek, P; Lindova, J; Priplatova, L; Flegr, J				Kubena, Ales Antonin; Houdek, Petr; Lindova, Jitka; Priplatova, Lenka; Flegr, Jaroslav			Justine Effect: Punishment of the Unduly Self-Sacrificing Cooperative Individuals	PLOS ONE			English	Article							PUBLIC-GOOD; ALTRUISTIC PUNISHMENT; BEHAVIORAL-CHANGES; GENDER-DIFFERENCES; GAMES; SANCTIONS; MEMBERS; HUMANS	Background: Allowing players to punish their opponents in Public Goods Game sustains cooperation within a group and thus brings advantage to the cooperative individuals. However, the possibility of punishment of the co-players can result in antisocial punishment, the punishment of those players who contribute the most in the group. To better understand why antisocial punishment exists, it must be determined who are the anti-social punishers and who are their primary targets. Methods: For resolving these questions we increased the number of players in a group from usual four to twelve. Each group played six rounds of the standard Public Goods Game and six rounds of the Public Goods Game with punishment. Each player in each round received 20 CZK ($ 1.25). Players (N=118) were rematched after each round so that they would not take into consideration opponents' past behavior. Results: The amount of the punishment received correlated negatively with the contribution (p= -0.665, p<0.001). However, this correlation was positive for players in the highest contributors-quartile (p =0.254, p<0.001). Therefore, the graph of relation between the contribution given and punishment obtained was U-shaped (R-2=0.678, p<0.001) with the inflection point near the left boarder of the upper quartile. The antisocial punishment was present in all groups, and in eight out of ten groups the Justine Effect (the positive correlation between the contribution to the public pool and the risk of suffering punishment in the subpopulation of altruistic players) emerged. In our sample, 22.5% subjects, all of them Free riders and low contributors, punished the altruistic players. Conclusions: The results of our experimental game-study revealed the existence of the Justine effect - the positive correlation between the contribution to the public pool by a subpopulation of the most altruistic players, and the amount of punishment these players obtained from free-riders.	[Kubena, Ales Antonin; Houdek, Petr; Priplatova, Lenka; Flegr, Jaroslav] Charles Univ Prague, Fac Sci, Dept Philosophy & Hist Sci, Prague, Czech Republic; [Houdek, Petr] JE Purkyne Univ Usti Nad Labem, Fac Social & Econ Studies, Dept Econ, Usti Nad Labem, Czech Republic; [Lindova, Jitka] Charles Univ Prague, Dept Anthropol, Fac Humanities, Prague, Czech Republic	Charles University Prague; University of Jan Evangelista Purkyne; Charles University Prague	Flegr, J (corresponding author), Charles Univ Prague, Fac Sci, Dept Philosophy & Hist Sci, Prague, Czech Republic.	flegr@cesnet.cz	Lindová, Jitka/T-3756-2017; Flegr, Jaroslav/AAG-7568-2021; Houdek, Petr/D-8818-2014; Lindová, Jitka/AAL-6658-2021; Flegr, Jaroslav/A-1564-2008; Kuběna, Aleš Antonín/A-3766-2015	Lindová, Jitka/0000-0001-8846-4552; Flegr, Jaroslav/0000-0002-0822-0126; Houdek, Petr/0000-0001-9755-6635; Lindová, Jitka/0000-0001-8846-4552; Flegr, Jaroslav/0000-0002-0822-0126; Kuběna, Aleš Antonín/0000-0002-9599-8277; Priplatova, Lenka/0000-0002-2860-3853	Grand Agency of the Czech Republic [P303/11/1398]; Charles University of Prague [GAUK 18810, UNCE 204004]	Grand Agency of the Czech Republic; Charles University of Prague	This work work was supported by the Grand Agency of the Czech Republic (Grant No. P303/11/1398) and Charles University of Prague (GAUK 18810, grant UNCE 204004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CM, 2006, GAME ECON BEHAV, V54, P1, DOI 10.1016/j.geb.2004.08.007; Burton-Chellew MN, 2013, P NATL ACAD SCI USA, V110, P216, DOI 10.1073/pnas.1210960110; Chaudhuri A, 2011, EXP ECON, V14, P47, DOI 10.1007/s10683-010-9257-1; Cinyabuguma M, 2006, EXP ECON, V9, P265, DOI 10.1007/s10683-006-9127-z; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Falk A, 2005, ECONOMETRICA, V73, P2017, DOI 10.1111/j.1468-0262.2005.00644.x; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Gintis H, 2003, EVOL HUM BEHAV, V24, P153, DOI 10.1016/S1090-5138(02)00157-5; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Johnson T, 2009, ECON LETT, V102, P192, DOI 10.1016/j.econlet.2009.01.003; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Krupp DB, 2008, EVOL HUM BEHAV, V29, P49, DOI 10.1016/j.evolhumbehav.2007.08.002; Lindova J, 2006, INT J PARASITOL, V36, P1485, DOI 10.1016/j.ijpara.2006.07.008; Lindova J, 2010, FOLIA PARASIT, V57, P136, DOI 10.14411/fp.2010.017; Nikiforakis N, 2008, EXP ECON, V11, P358, DOI 10.1007/s10683-007-9171-3; Nikiforakis N, 2008, J PUBLIC ECON, V92, P91, DOI 10.1016/j.jpubeco.2007.04.008; Novakova J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060966; Parks CD, 2010, J PERS SOC PSYCHOL, V99, P303, DOI 10.1037/a0018403; Rand DG, 2010, J THEOR BIOL, V265, P624, DOI 10.1016/j.jtbi.2010.06.010; Sade, 2005, JUSTINE MISFORTUNES; Shinada M, 2004, EVOL HUM BEHAV, V25, P379, DOI 10.1016/j.evolhumbehav.2004.08.001; Shinada M, 2007, EVOL HUM BEHAV, V28, P330, DOI 10.1016/j.evolhumbehav.2007.04.001	26	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92336	10.1371/journal.pone.0092336	http://dx.doi.org/10.1371/journal.pone.0092336			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SR	24670974	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000039
J	Rodier, M; Prigent-Tessier, A; Bejot, Y; Jacquin, A; Mossiat, C; Marie, C; Garnier, P				Rodier, Marion; Prigent-Tessier, Anne; Bejot, Yannick; Jacquin, Agnes; Mossiat, Claude; Marie, Christine; Garnier, Philippe			Exogenous t-PA Administration Increases Hippocampal! Mature BDNF Levels. Plasmin- or NMDA-Dependent: Mechanism?	PLOS ONE			English	Article							LONG-TERM POTENTIATION; NEUROTROPHIC FACTOR; SYNAPTIC-PLASTICITY; DENDRITIC GROWTH; NEURONAL DEATH; SPATIAL MEMORY; ACTIVATOR; BRAIN; RECEPTORS; TPA	Brain-derived neurotrophic factor (BDNF) through TrkB activation is central for brain functioning. Since the demonstration that plasmin is able to process pro-BDNF to mature BDNF and that these two forms have opposite effects on neuronal survival and plasticity, a particular attention has been paid to the link between tissue plasminogen activator (tPA)/plasmin system and BDNF metabolism. However, t-PA via its action on different N-methyl-D-aspartate (NMDA) receptor subunits is also considered as a neuromodulator of glutamatergic transmission. In this context, the aim of our study was to investigate the effect of recombinant (r)t-PA administration on brain BDNF metabolism in rats. In the hippocampus, we found that rt-PA (10 mg/kg) administration induced a progressive increase in mature BDNF levels associated with TrkB activation. In order to delineate the mechanistic involved, plasmin activity was assessed and its inhibition was attempted using tranexamic acid (30 or 300 mg/kg, i.v.) while NMDA receptors were antagonized with MK801 (0.3 or 3 mg/kg, i.p.) in combination with rt-PA treatment. Our results showed that despite a rise in rt-PA activity, rt-PA administration failed to increase hippocampal plasmin activity suggesting that the plasminogen/plasmin system is not involved whereas MK801 abrogated the augmentation in mature BDNF levels observed after rt-PA administration. All together, our results show that rt-PA administration induces increase in hippocampal mature BDNF expression and suggests that rt-PA contributes to the control of brain BDNF synthesis through a plasmin-independent potentiation of NMDA receptors signaling.	[Rodier, Marion; Prigent-Tessier, Anne; Mossiat, Claude; Marie, Christine; Garnier, Philippe] Unite INSERM U1093 Cognit Act & Plast Sensorimotr, Dijon, France; [Rodier, Marion; Prigent-Tessier, Anne; Mossiat, Claude; Marie, Christine; Garnier, Philippe] Univ Bourgogne, Dijon, France; [Garnier, Philippe] IUT, Dept Genie Biol, Dijon, France; [Rodier, Marion; Bejot, Yannick; Jacquin, Agnes] Univ Hosp, Dept Neurol, Dijon, France; [Bejot, Yannick; Jacquin, Agnes] Ctr Epidemiol Populat, EA4184, Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; Universite de Bourgogne; CHU Dijon Bourgogne; Universite de Bourgogne	Garnier, P (corresponding author), Unite INSERM U1093 Cognit Act & Plast Sensorimotr, Dijon, France.	pgarnier@u-bourgogne.fr	JACQUIN, Agnès/AFN-9891-2022; Béjot, Yannick/D-3942-2019	Béjot, Yannick/0000-0001-7848-7072; Garnier, Philippe/0000-0002-7877-3113; marie, christine/0000-0003-3724-0713; tessier, anne/0000-0001-6655-5074	University of Burgundy; Region of Burgundy; INSERM, France	University of Burgundy; Region of Burgundy(Region Bourgogne-Franche-Comte); INSERM, France(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by grants from the University of Burgundy, the Region of Burgundy and the INSERM, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas M, 2013, PROG NEURO-PSYCHOPH, V46, P181, DOI 10.1016/j.pnpbp.2013.07.008; Anderson CM, 2002, J NEUROSCI, V22, P9203; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; Barker PA, 2009, NAT NEUROSCI, V12, P105, DOI 10.1038/nn0209-105; Baron A, 2010, CELL DEATH DIFFER, V17, P860, DOI 10.1038/cdd.2009.172; Benchenane K, 2005, CIRCULATION, V111, P2241, DOI 10.1161/01.CIR.0000163542.48611.A2; Benchenane K, 2007, J CELL SCI, V120, P578, DOI 10.1242/jcs.03354; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Cowansage Kiriana K, 2010, Curr Mol Pharmacol, V3, P12; Ding Q, 2011, NEUROSCIENCE, V192, P773, DOI 10.1016/j.neuroscience.2011.06.032; Echeverry R, 2010, J CLIN INVEST, V120, P2194, DOI 10.1172/JCI41722; Furtmuller R, 2002, J PHARMACOL EXP THER, V301, P168, DOI 10.1124/jpet.301.1.168; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; Horii-Hayashi N, 2011, NEUROCHEM INT, V58, P1, DOI 10.1016/j.neuint.2010.10.007; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; Kawashita E, 2013, J NEUROCHEM, V126, P58, DOI 10.1111/jnc.12281; Kolarow R, 2007, J NEUROSCI, V27, P10350, DOI 10.1523/JNEUROSCI.0692-07.2007; Kotermanski SE, 2013, PHARMACOL BIOCHEM BE, V109, P67, DOI 10.1016/j.pbb.2013.05.005; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Liot G, 2004, J CEREBR BLOOD F MET, V24, P1153, DOI 10.1097/01.WCB.0000134476.93809.75; Lipsky RH, 2007, ANN NY ACAD SCI, V1122, P130, DOI 10.1196/annals.1403.009; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Madinier A, 2013, NEUROSCIENCE, V231, P169, DOI 10.1016/j.neuroscience.2012.11.054; Martin AM, 2008, J BIOL CHEM, V283, P12004, DOI 10.1074/jbc.M707607200; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; Menoud PA, 1996, J CLIN INVEST, V97, P2478, DOI 10.1172/JCI118694; Nagappan G, 2009, P NATL ACAD SCI USA, V106, P1267, DOI 10.1073/pnas.0807322106; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Obiang P, 2012, J NEUROSCI, V32, P12726, DOI 10.1523/JNEUROSCI.6202-11.2012; Obiang P, 2011, NEUROBIOL LEARN MEM, V96, P121, DOI 10.1016/j.nlm.2011.03.004; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Parcq J, 2012, CELL DEATH DIFFER, V19, P1983, DOI 10.1038/cdd.2012.86; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P443, DOI 10.1073/pnas.0406454102; Quirie A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044218; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Samson AL, 2006, NEURON, V50, P673, DOI 10.1016/j.neuron.2006.04.013; Sartori CR, 2011, NEUROSCIENCE, V180, P9, DOI 10.1016/j.neuroscience.2011.02.055; Segawa M, 2013, INT J NEUROPSYCHOPH, V16, P339, DOI 10.1017/S1461145712000053; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Taniguchi Y, 2011, CELL TISSUE RES, V343, P303, DOI 10.1007/s00441-010-1110-5; Vaynman S, 2003, NEUROSCIENCE, V122, P647, DOI 10.1016/j.neuroscience.2003.08.001; Vivien D, 2000, J CEREBR BLOOD F MET, V20, P755, DOI 10.1097/00004647-200005000-00001; Waterhouse EG, 2009, MOL CELL NEUROSCI, V42, P81, DOI 10.1016/j.mcn.2009.06.009; Yeh CM, 2012, J PHYSIOL-LONDON, V590, P991, DOI 10.1113/jphysiol.2011.222042; Yepes M, 2009, TRENDS NEUROSCI, V32, P48, DOI 10.1016/j.tins.2008.09.006; Zhuo M, 2000, J NEUROSCI, V20, P542, DOI 10.1523/JNEUROSCI.20-02-00542.2000	54	28	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92416	10.1371/journal.pone.0092416	http://dx.doi.org/10.1371/journal.pone.0092416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670989	gold, Green Submitted, Green Published			2022-12-27	WOS:000333677000045
J	Barbosa, ERM; Tomlinson, KW; Carvalheiro, LG; Kirkman, K; de Bie, S; Prins, HHT; van Langevelde, F				Barbosa, Eduardo R. M.; Tomlinson, Kyle W.; Carvalheiro, Luisa G.; Kirkman, Kevin; de Bie, Steven; Prins, Herbert H. T.; van Langevelde, Frank			Short-Term Effect of Nutrient Availability and Rainfall Distribution on Biomass Production and Leaf Nutrient Content of Savanna Tree Species	PLOS ONE			English	Article							SEMIARID SAVANNAS; MINERAL-NUTRITION; NITROGEN; FIRE; PHOSPHORUS; RESPONSES; SEEDLINGS; DYNAMICS; GROWTH; CARBON	Changes in land use may lead to increased soil nutrient levels in many ecosystems (e. g. due to intensification of agricultural fertilizer use). Plant species differ widely in their response to differences in soil nutrients, and for savannas it is uncertain how this nutrient enrichment will affect plant community dynamics. We set up a large controlled short-term experiment in a semi-arid savanna to test how water supply (even water supply vs. natural rainfall) and nutrient availability (no fertilisation vs. fertilisation) affects seedlings' above-ground biomass production and leaf-nutrient concentrations (N, P and K) of broad-leafed and fine-leafed tree species. Contrary to expectations, neither changes in water supply nor changes in soil nutrient level affected biomass production of the studied species. By contrast, leaf-nutrient concentration did change significantly. Under regular water supply, soil nutrient addition increased the leaf phosphorus concentration of both fine-leafed and broad-leafed species. However, under uneven water supply, leaf nitrogen and phosphorus concentration declined with soil nutrient supply, this effect being more accentuated in broad-leafed species. Leaf potassium concentration of broad-leafed species was lower when growing under constant water supply, especially when no NPK fertilizer was applied. We found that changes in environmental factors can affect leaf quality, indicating a potential interactive effect between land-use changes and environmental changes on savanna vegetation: under more uneven rainfall patterns within the growing season, leaf quality of tree seedlings for a number of species can change as a response to changes in nutrient levels, even if overall plant biomass does not change. Such changes might affect herbivore pressure on trees and thus savanna plant community dynamics. Although longer term experiments would be essential to test such potential effects of eutrophication via changes in leaf nutrient concentration, our findings provide important insights that can help guide management plans that aim to preserve savanna biodiversity.	[Barbosa, Eduardo R. M.; Tomlinson, Kyle W.; de Bie, Steven; Prins, Herbert H. T.; van Langevelde, Frank] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands; [Barbosa, Eduardo R. M.] Univ Brasilia, Inst Ciencias Biol, Dept Bot, Lab Termobiol, Brasilia, DF, Brazil; [Tomlinson, Kyle W.] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Community Ecol & Conservat Grp, Beijing 100864, Yunnan, Peoples R China; [Carvalheiro, Luisa G.] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; [Carvalheiro, Luisa G.] Nat Biodivers Ctr, Leiden, Netherlands; [Kirkman, Kevin; Prins, Herbert H. T.] Univ KwaZulu Natal, Sch Life Sci, Scottsville, South Africa	Wageningen University & Research; Universidade de Brasilia; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; University of Leeds; Naturalis Biodiversity Center; University of Kwazulu Natal	Barbosa, ERM (corresponding author), Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands.	eduardormbarbosa@gmail.com	Carvalheiro, Luisa/D-9414-2012; Barbosa, Eduardo R M/D-3082-2014; Kirkman, Kevin/GNM-5334-2022; Kirkman, Kevin P/F-4160-2010	Carvalheiro, Luisa/0000-0001-7655-979X; Kirkman, Kevin/0000-0001-9580-5191; Kirkman, Kevin P/0000-0001-9580-5191; Moribe Barbosa, Eduardo Rogerio/0000-0001-9464-2247; Van Langevelde, Frank/0000-0001-8870-0797; Prins, Herbert/0000-0003-1131-5107	Shell Research Foundation	Shell Research Foundation	Funding and research assistance for this project were provided by Shell Research Foundation (http://www.shellfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2004, AMBIO, V33, P530, DOI 10.1639/0044-7447(2004)033[0530:SFRTEN]2.0.CO;2; Ahrestani FS, 2011, BASIC APPL ECOL, V12, P634, DOI 10.1016/j.baae.2011.08.008; Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P2898, DOI 10.1111/j.1365-2486.2008.01716.x; Barbosa ERM, 2014, OECOLOGIA, V174, P1345, DOI 10.1007/s00442-013-2853-y; Bohrer G, 2001, J VEG SCI, V12, P279, DOI 10.2307/3236612; CHAPIN FS, 1983, ECOLOGY, V64, P376, DOI 10.2307/1937083; CHAPIN FS, 1990, ANNU REV ECOL SYST, V21, P423, DOI 10.1146/annurev.ecolsys.21.1.423; CHAPIN FS, 1986, AM NAT, V127, P48, DOI 10.1086/284466; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; CHAPIN FS, 1993, AM NAT, V142, pS78, DOI 10.1086/285524; Cheng LL, 2000, J EXP BOT, V51, P1687, DOI 10.1093/jexbot/51.351.1687; Christensen N.L., 1981, FOREST SUCCESSION CO, P230, DOI DOI 10.1007/978-1-4612-5950-3; DUTOIT JT, 1990, ECOLOGY, V71, P149; Field C. B., 2012, SPECIAL REPORT WORKI, P1, DOI DOI 10.1017/CBO9781139177245; Fornara DA, 2008, ECOSCIENCE, V15, P129, DOI 10.2980/1195-6860(2008)15[129:ROWSET]2.0.CO;2; Garg BK, 2004, J PLANT NUTR SOIL SC, V167, P503, DOI 10.1002/jpln.200320368; GOWER ST, 1992, ECOL MONOGR, V62, P43, DOI 10.2307/2937170; Grime J. P., 1979, Plant strategies and vegetation processes.; Higgins SI, 2000, J ECOL, V88, P213, DOI 10.1046/j.1365-2745.2000.00435.x; Hu YC, 2005, J PLANT NUTR SOIL SC, V168, P541, DOI 10.1002/jpln.200420516; Johnston P, 2013, AFRICAN AGR CLIMATE; Kambatuku JR, 2013, ECOHYDROLOGY, V6, P464, DOI 10.1002/eco.1273; Kambatuku JR, 2011, J VEG SCI, V22, P225, DOI 10.1111/j.1654-1103.2010.01239.x; Kgope B. S., 2004, South African Journal of Botany, V70, P760, DOI 10.1016/S0254-6299(15)30177-0; Kitajima K., 2000, Seeds: the ecology of regeneration in plant communities, P331, DOI 10.1079/9780851994321.0331; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Kraaij T, 2006, PLANT ECOL, V186, P235, DOI 10.1007/s11258-006-9125-4; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3; Lehmann CER, 2009, NEW PHYTOL, V181, P508, DOI 10.1111/j.1469-8137.2009.02734.x; Marschner H., 1995, MARSCHNERS MINERAL N, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; Miyazaki K, 2012, ATMOS CHEM PHYS, V12, P2263, DOI 10.5194/acp-12-2263-2012; Mucina L., 2006, VEGETATION S AFRICA; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; NOVOZAMSKY I, 1983, COMMUN SOIL SCI PLAN, V14, P239, DOI 10.1080/00103628309367359; Olff H, 2002, NATURE, V415, P901, DOI 10.1038/415901a; Paquin R, 2000, TREE PHYSIOL, V20, P229; Parks SE, 2000, PLANT SOIL, V227, P59, DOI 10.1023/A:1026563926187; Pessarakli M., 2005, HDB PHOTOSYNTHESIS; Polis GA, 1999, OIKOS, V86, P3, DOI 10.2307/3546565; PORTIS AR, 1992, ANNU REV PLANT PHYS, V43, P415, DOI 10.1146/annurev.pp.43.060192.002215; PREGITZER KS, 1990, TREE PHYSIOL, V7, P79, DOI 10.1093/treephys/7.1-2-3-4.79; Prins Herbert H. T., 2008, V23, P129; Prior SA, 1997, TREE PHYSIOL, V17, P397; Rittenhouse LR, 1987, INTEGRATED PEST MANA, P25; Sankaran M, 2004, ECOL LETT, V7, P480, DOI 10.1111/j.1461-0248.2004.00596.x; Sankaran M, 2008, GLOBAL ECOL BIOGEOGR, V17, P236, DOI 10.1111/j.1466-8238.2007.00360.x; Scholes R. J., 1997, P258; Scholes R.J., 1993, AFRICAN SAVANNA SYNT; Scholes RJ, 2003, KRUGER EXPERIENCE EC, P131; Shane MW, 2004, PLANT PHYSIOL, V135, P549, DOI 10.1104/pp.103.035659; Shipley B, 2002, FUNCT ECOL, V16, P326, DOI 10.1046/j.1365-2435.2002.00626.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tefera S, 2011, AFR J AGR RES, V6, P2494; TILMAN D, 1986, ECOLOGY, V67, P555, DOI 10.2307/1938598; TILMAN GD, 1984, ECOLOGY, V65, P1445, DOI 10.2307/1939125; Tomlinson KW, 2013, J ECOL, V101, P430, DOI 10.1111/1365-2745.12056; Treydte AC, 2007, PERSPECT PLANT ECOL, V8, P197, DOI 10.1016/j.ppees.2007.03.001; van der Waal C, 2011, OECOLOGIA, V165, P1095, DOI 10.1007/s00442-010-1899-3; van der Waal C, 2009, J ECOL, V97, P430, DOI 10.1111/j.1365-2745.2009.01498.x; van Langevelde F, 2003, ECOLOGY, V84, P337, DOI 10.1890/0012-9658(2003)084[0337:EOFAHO]2.0.CO;2; Van Langevelde F, 2011, ECOSYST FUNCT SAVANN, P257; Venter F.J., 2003, KRUGER EXPERIENCE EC, P83, DOI DOI 10.2989/10220110409485835; Ward D., 2005, African Journal of Range & Forage Science, V22, P101, DOI 10.2989/10220110509485867; Ward D, 2009, BIO HABIT, P1; Ward D, 2011, PLANT ECOL, V212, P245, DOI 10.1007/s11258-010-9818-6; Wiegand K, 2006, PERSPECT PLANT ECOL, V7, P229, DOI 10.1016/j.ppees.2005.10.001; Wijesinghe DK, 2005, J ECOL, V93, P99, DOI 10.1111/j.0022-0477.2004.00934.x; Xu LK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002281; Zuur Alain F., 2009, P1	69	20	22	4	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92619	10.1371/journal.pone.0092619	http://dx.doi.org/10.1371/journal.pone.0092619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667837	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600055
J	El-Khoury, R; Panayotis, N; Matagne, V; Ghata, A; Villard, L; Roux, JC				El-Khoury, Rita; Panayotis, Nicolas; Matagne, Valerie; Ghata, Adeline; Villard, Laurent; Roux, Jean-Christophe			GABA and Glutamate Pathways Are Spatially and Developmentally Affected in the Brain of Mecp2-Deficient Mice	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; SYNAPTIC CIRCUIT ABNORMALITIES; 2/3 PYRAMIDAL NEURONS; RETT-SYNDROME; MOUSE MODEL; HIPPOCAMPAL SLICES; MECP2-NULL MOUSE; DECARBOXYLASE; RAT; NEUROTRANSMISSION	Proper brain functioning requires a fine-tuning between excitatory and inhibitory neurotransmission, a balance maintained through the regulation and release of glutamate and GABA. Rett syndrome (RTT) is a rare genetic disorder caused by mutations in the methyl-CpG binding protein 2 (MECP2) gene affecting the postnatal brain development. Dysfunctions in the GABAergic and glutamatergic systems have been implicated in the neuropathology of RTT and a disruption of the balance between excitation and inhibition, together with a perturbation of the electrophysiological properties of GABA and glutamate neurons, were reported in the brain of the Mecp2-deficient mouse. However, to date, the extent and the nature of the GABA/glutamate deficit affecting the Mecp2-deficient mouse brain are unclear. In order to better characterize these deficits, we simultaneously analyzed the GABA and glutamate levels in Mecp2-deficient mice at 2 different ages (P35 and P55) and in several brain areas. We used a multilevel approach including the quantification of GABA and glutamate levels, as well as the quantification of the mRNA and protein expression levels of key genes involved in the GABAergic and glutamatergic pathways. Our results show that Mecp2-deficient mice displayed regional- and age-dependent variations in the GABA pathway and, to a lesser extent, in the glutamate pathway. The implication of the GABA pathway in the RTT neuropathology was further confirmed using an in vivo treatment with a GABA reuptake inhibitor that significantly improved the lifespan of Mecp2-deficient mice. Our results confirm that RTT mouse present a deficit in the GABAergic pathway and suggest that GABAergic modulators could be interesting therapeutic agents for this severe neurological disorder.	[El-Khoury, Rita; Panayotis, Nicolas; Matagne, Valerie; Ghata, Adeline; Villard, Laurent; Roux, Jean-Christophe] Aix Marseille Univ, GMGF, Marseille, France; [El-Khoury, Rita; Panayotis, Nicolas; Matagne, Valerie; Ghata, Adeline; Villard, Laurent; Roux, Jean-Christophe] INSERM, UMR S 910, F-13258 Marseille, France; [Panayotis, Nicolas] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Weizmann Institute of Science	Roux, JC (corresponding author), Aix Marseille Univ, GMGF, Marseille, France.	jean-christophe.roux@univ-amu.fr	Roux, Jean-Christophe/S-2563-2016; Panayotis, Nicolas/N-3412-2019; Villard, Laurent/E-3941-2016; Panayotis, Nicolas/E-6734-2015	Roux, Jean-Christophe/0000-0002-9721-8844; Panayotis, Nicolas/0000-0002-6204-6771; Villard, Laurent/0000-0001-6657-5008; Panayotis, Nicolas/0000-0002-6204-6771; EL KHOURY, RITA/0000-0002-5132-5038	Inserm; Aix-Marseille University; region Provence-Alpes-Cote d'Azur; AFSR (Association Francaise du Syndrome de Rett); ANR Rett cure; UE Initial Training Network [238242]; INSERM-Region Provence-Alpes-Cote d'Azur; French Muscular Dystrophy Association (AFM-Telethon)	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Aix-Marseille University; region Provence-Alpes-Cote d'Azur(Region Provence-Alpes-Cote d'Azur); AFSR (Association Francaise du Syndrome de Rett); ANR Rett cure(French National Research Agency (ANR)); UE Initial Training Network; INSERM-Region Provence-Alpes-Cote d'Azur(Institut National de la Sante et de la Recherche Medicale (Inserm)Region Provence-Alpes-Cote d'Azur); French Muscular Dystrophy Association (AFM-Telethon)	This work was funded by Inserm, Aix-Marseille University, the region Provence-Alpes-Cote d'Azur, AFSR (Association Francaise du Syndrome de Rett) and was supported in part by funding from the ANR Rett cure. Rita El-Khoury was supported by the UE Initial Training Network Project no238242 "DISCHROM", Dr Nicolas Panayotis was supported by an INSERM-Region Provence-Alpes-Cote d'Azur PhD fellowship and Valerie Matagne was supported by the French Muscular Dystrophy Association (AFM-Telethon). The different funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala APL, 2010, P NATL ACAD SCI USA, V107, P18208, DOI 10.1073/pnas.1012104107; Akbarian S, 2001, NEUROBIOL DIS, V8, P784, DOI 10.1006/nbdi.2001.0420; Ben-Ari Y, 2012, NEUROSCIENTIST, V18, P467, DOI 10.1177/1073858412438697; Buddhala C, 2009, NEUROCHEM INT, V55, P9, DOI 10.1016/j.neuint.2009.01.020; Calfa G, 2011, J NEUROPHYSIOL, V105, P1768, DOI 10.1152/jn.00800.2010; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; CHANG YC, 1988, J NEUROSCI, V8, P2123; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chatton JY, 2003, P NATL ACAD SCI USA, V100, P12456, DOI 10.1073/pnas.2132096100; COENEN AML, 1995, EPILEPSY RES, V21, P89, DOI 10.1016/0920-1211(95)00015-3; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dani VS, 2009, J NEUROSCI, V29, P11263, DOI 10.1523/JNEUROSCI.1019-09.2009; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Fischer M, 2009, J NEUROPHYSIOL, V101, P1016, DOI 10.1152/jn.91124.2008; Guerrini R, 2012, EPILEPSIA, V53, P2067, DOI 10.1111/j.1528-1167.2012.03656.x; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Ide S, 2005, NEUROSCI LETT, V386, P14, DOI 10.1016/j.neulet.2005.05.056; Jin H, 2003, P NATL ACAD SCI USA, V100, P4293, DOI 10.1073/pnas.0730698100; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kline DD, 2010, J NEUROSCI, V30, P5303, DOI 10.1523/JNEUROSCI.5503-09.2010; Kron M, 2012, J NEUROSCI, V32, P13860, DOI 10.1523/JNEUROSCI.2159-12.2012; Kullmann DM, 2011, CURR OPIN NEUROBIOL, V21, P709, DOI 10.1016/j.conb.2011.05.006; Lang M, 2013, HUM MOL GENET, V22, P358, DOI 10.1093/hmg/dds433; Lee M, 2011, GLIA, V59, P1600, DOI 10.1002/glia.21202; Lerner A, 2012, BRAIN, V135, P1926, DOI 10.1093/brain/aws104; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madsen KK, 2010, PHARMACOL THERAPEUT, V125, P394, DOI 10.1016/j.pharmthera.2009.11.007; Maezawa I, 2010, J NEUROSCI, V30, P5346, DOI 10.1523/JNEUROSCI.5966-09.2010; Mathews GC, 2003, J NEUROSCI, V23, P2040; McDonald LM, 2008, PSYCHOPHARMACOLOGY, V197, P591, DOI 10.1007/s00213-008-1077-z; Medrihan L, 2008, J NEUROPHYSIOL, V99, P112, DOI 10.1152/jn.00826.2007; Mel Bartlett W, 2004, Sci STKE, V2004, pPE44; Minh VCN, 2012, J NEUROSCI, V32, P10021, DOI 10.1523/JNEUROSCI.1316-12.2012; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Nelson ED, 2011, J NEUROPHYSIOL, V106, P193, DOI 10.1152/jn.00751.2010; Obata K, 1999, NEUROSCIENCE, V93, P1475, DOI 10.1016/S0306-4522(99)00274-2; Okabe Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035354; Palkovits N, 1988, MAPS GUIDE MICRODISS; Panayotis N, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-47; Panayotis N, 2011, NEUROBIOL DIS, V41, P385, DOI 10.1016/j.nbd.2010.10.006; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pratte M, 2011, BEHAV BRAIN RES, V216, P313, DOI 10.1016/j.bbr.2010.08.011; Ricceri L, 2008, BEHAV PHARMACOL, V19, P501, DOI 10.1097/FBP.0b013e32830c3645; Ricciardi S, 2011, HUM MOL GENET, V20, P1182, DOI 10.1093/hmg/ddq563; Roux JC, 2003, J NEURAL TRANSM, V110, P51, DOI 10.1007/s00702-002-0767-7; Roux JC, 2012, NEUROBIOL DIS, V45, P786, DOI 10.1016/j.nbd.2011.11.002; Roux JC, 2010, J NEUROSCI RES, V88, P1500, DOI 10.1002/jnr.22312; Roux JC, 2010, BEHAV GENET, V40, P59, DOI 10.1007/s10519-009-9303-y; Roux JC, 2008, NEUROSCI LETT, V447, P82, DOI 10.1016/j.neulet.2008.09.045; Rowley NM, 2012, NEUROCHEM INT, V61, P546, DOI 10.1016/j.neuint.2012.02.013; Samaco RC, 2009, P NATL ACAD SCI USA, V106, P21966, DOI 10.1073/pnas.0912257106; Santos M, 2010, NEUROSCIENCE, V170, P453, DOI 10.1016/j.neuroscience.2010.07.010; Sauvinet V, 2003, ELECTROPHORESIS, V24, P3187, DOI 10.1002/elps.200305565; Schousboe A, 2006, CURR TOP MED CHEM, V6, P929, DOI 10.2174/156802606777323719; SHERIF F, 1991, J NEURAL TRANSM-GEN, V84, P95, DOI 10.1007/BF01249113; Sloviter RS, 1996, J COMP NEUROL, V373, P593; Stanley BG, 2011, PHYSIOL BEHAV, V104, P40, DOI 10.1016/j.physbeh.2011.04.046; Stettner GM, 2007, J PHYSIOL-LONDON, V579, P863, DOI 10.1113/jphysiol.2006.119966; Taneja P, 2009, J NEUROSCI, V29, P12187, DOI 10.1523/JNEUROSCI.3156-09.2009; Thoeringer CK, 2010, J PSYCHOPHARMACOL, V24, P733, DOI 10.1177/0269881109103091; Viemari JC, 2005, J NEUROSCI, V25, P11521, DOI 10.1523/JNEUROSCI.4373-05.2005; Viola A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000157; Wood L, 2010, NEUROBIOL DIS, V38, P281, DOI 10.1016/j.nbd.2010.01.018; Wood L, 2009, J NEUROSCI, V29, P12440, DOI 10.1523/JNEUROSCI.3321-09.2009; Zhang L, 2008, HIPPOCAMPUS, V18, P294, DOI 10.1002/hipo.20389; Zhang ZW, 2010, J NEUROPHYSIOL, V103, P2470, DOI 10.1152/jn.00601.2009	73	40	40	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92169	10.1371/journal.pone.0092169	http://dx.doi.org/10.1371/journal.pone.0092169			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667344	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600025
J	Liu, CH; Xin, N; Zhai, Y; Jiang, LM; Zhai, JM; Zhang, QQ; Qi, J				Liu, Conghui; Xin, Nian; Zhai, Yi; Jiang, Liming; Zhai, Jieming; Zhang, Quanqi; Qi, Jie			Reference Gene Selection for Quantitative Real-Time RT-PCR Normalization in the Half-Smooth Tongue Sole (Cynoglossus semilaevis) at Different Developmental Stages, in Various Tissue Types and on Exposure to Chemicals	PLOS ONE			English	Article							POTENTIAL REFERENCE GENES; EXPRESSION PROFILES; JAPANESE FLOUNDER; KUPFFERS VESICLE; VALIDATION; FISH; SOFTWARE; FEMALE; ASSAYS; L.	Quantitative real time RT-PCR has been described as the most sensitive method for the detection of low abundance mRNA. To date, no reference genes have been screened in the half-smooth tongue sole (Cynoglossus semilaevis). The aim of this study was to select the most stable genes for quantitative real-time RT-PCR. Eight housekeeping genes (18S, TUBA, B2M, ACTB, EF1A, GAPDH, RPL17 and UBCE) were tested at different developmental stages, in different tissues, and following exposure to the drug SB-431542. Using geNorm, BestKeeper and NormFinder software, GAPDH/B2M, GAPDH/18S and UBCE/GAPDH were identified as the most suitable genes from samples taken of different developmental stages while 18S/RPL17 were consistently ranked as the best reference genes for different tissue types. Furthermore, TUBA/B2M, TUBA/UBCE and B2M/TUBA were found to be the most suitable genes in samples treated with the drug, SB-431542 by geNorm, BestKeeper and NormFinder respectively. Across both different developmental stages and tissue types, the combination of 18S and GAPDH was the most stable reference gene analyzed by Ref-Finder. To test and verify the screened reference genes, the expression profiles of LEFTY-normalized to the combination of GAPDH/18S and ACTB were presented. These results will be useful for future gene-expression studies in the half-smooth tongue sole.	[Liu, Conghui; Xin, Nian; Zhai, Yi; Jiang, Liming; Zhang, Quanqi; Qi, Jie] Ocean Univ China, Key Lab Marine Genet & Breeding, Qingdao, Shandong, Peoples R China; [Zhai, Jieming] Laizhou Mingbo Aquat CO Ltd, Laizhou, Shandong, Peoples R China	Ocean University of China	Qi, J (corresponding author), Ocean Univ China, Key Lab Marine Genet & Breeding, Qingdao, Shandong, Peoples R China.	qijie@ouc.edu.cn	Liu, Conghui/AAA-7192-2021	liu, cong hui/0000-0002-8374-2047	National Science Foundation of China [31072204]; National High Technology Research and Development Program of China [2012AA10A401]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This study was financially supported by grants from the National Science Foundation of China (No. 31072204) and the National High Technology Research and Development Program of China (No. 2012AA10A401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamar E, 2010, DEV DYNAM, V239, P2980, DOI 10.1002/dvdy.22431; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Aroua S, 2007, GEN COMP ENDOCR, V153, P333, DOI 10.1016/j.ygcen.2007.02.027; Aursnes Ingrid A., 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-104; Bower NI, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-80; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; Chechi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032265; Chen DL, 2011, J CELL PHYSIOL, V226, P2469, DOI 10.1002/jcp.22725; Concha ML, 2000, NEURON, V28, P399, DOI 10.1016/S0896-6273(00)00120-3; Crisafi F, 2011, RES MICROBIOL, V162, P223, DOI 10.1016/j.resmic.2010.11.004; Evrard E, 2010, BIOMARKERS, V15, P111, DOI 10.3109/13547500903315598; Fernandes JMO, 2008, COMP BIOCHEM PHYS B, V150, P23, DOI 10.1016/j.cbpb.2008.01.003; Francescatto L, 2010, DEVELOPMENT, V137, P2753, DOI 10.1242/dev.049627; Hashimoto H, 2002, MECH DEVELOP, V111, P17, DOI 10.1016/S0925-4773(01)00596-2; Hashimoto H, 2007, ZOOL SCI, V24, P137, DOI 10.2108/zsj.24.137; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ingerslev HC, 2006, MOL IMMUNOL, V43, P1194, DOI 10.1016/j.molimm.2005.07.009; Ji XS, 2011, MAR GENOM, V4, P9, DOI 10.1016/j.margen.2010.11.002; Jorgensen SM, 2006, MAR BIOTECHNOL, V8, P398, DOI 10.1007/s10126-005-5164-4; Kortner TM, 2011, AQUACULTURE, V318, P355, DOI 10.1016/j.aquaculture.2011.05.038; Lin XY, 2009, DEVELOPMENT, V136, P207, DOI 10.1242/dev.029561; Lland H, 2006, MYELOID LEUKENMIA ME; Ma Q, 2012, GENE, V511, P341, DOI 10.1016/j.gene.2012.09.082; Ma Q, 2011, COMP BIOCHEM PHYS B, V160, P208, DOI 10.1016/j.cbpb.2011.08.008; Mazmanian G, 2010, GENESIS, V48, P20, DOI 10.1002/dvg.20578; MINAMI T, 1982, B JPN SOC SCI FISH, V48, P1581; Nagae Masaki, 2007, Environmental Sciences, V14, P255; Okada N, 2001, CELL TISSUE RES, V304, P59, DOI 10.1007/s004410100353; Olsvik Pal A, 2008, BMC Res Notes, V1, P47, DOI 10.1186/1756-0500-1-47; Olsvik Pal A, 2007, BMC Physiol, V7, P12, DOI 10.1186/1472-6793-7-12; Overgard AC, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-36; Pena Andrea A, 2010, BMC Res Notes, V3, P101, DOI 10.1186/1756-0500-3-101; Schneider I, 2010, DEV BIOL, V348, P22, DOI 10.1016/j.ydbio.2010.08.040; Small BC, 2008, COMP BIOCHEM PHYS B, V151, P296, DOI 10.1016/j.cbpb.2008.07.010; Suzuki T, 2000, APPL OPTICS, V39, P2646, DOI 10.1364/AO.39.002646; Suzuki T, 2009, DEV GROWTH DIFFER, V51, P797, DOI 10.1111/j.1440-169X.2009.01139.x; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wei D, 2011, FISH SHELLFISH IMMUN, V30, P720, DOI 10.1016/j.fsi.2010.12.028; Wloga D, 2009, DEV CELL, V16, P867, DOI 10.1016/j.devcel.2009.04.008; Xiao XQ, 2011, FISH SHELLFISH IMMUN, V30, P1072, DOI 10.1016/j.fsi.2011.02.008; Ye X, 2010, BIOTECHNOL LETT, V32, P1031, DOI 10.1007/s10529-010-0258-0; Zheng WJ, 2011, FISH SHELLFISH IMMUN, V30, P638, DOI 10.1016/j.fsi.2010.12.014; Zhong QW, 2008, MAR BIOTECHNOL, V10, P310, DOI 10.1007/s10126-007-9064-7; Zhou Rui-Xue, 2010, Zoological Research, V31, P141, DOI 10.3724/SP.J.1141.2010.02141; Zhou WB, 2010, AM J PHYSIOL-RENAL, V299, pF55, DOI 10.1152/ajprenal.00043.2010	48	31	33	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e91715	10.1371/journal.pone.0091715	http://dx.doi.org/10.1371/journal.pone.0091715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667563	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600012
J	Perlin, MW; Dormer, K; Hornyak, J; Schiermeier-Wood, L; Greenspoon, S				Perlin, Mark W.; Dormer, Kiersten; Hornyak, Jennifer; Schiermeier-Wood, Lisa; Greenspoon, Susan			TrueAllele Casework on Virginia DNA Mixture Evidence: Computer and Manual Interpretation in 72 Reported Criminal Cases	PLOS ONE			English	Article							IDENTIFICATION; VALIDATION	Mixtures are a commonly encountered form of biological evidence that contain DNA from two or more contributors. Laboratory analysis of mixtures produces data signals that usually cannot be separated into distinct contributor genotypes. Computer modeling can resolve the genotypes up to probability, reflecting the uncertainty inherent in the data. Human analysts address the problem by simplifying the quantitative data in a threshold process that discards considerable identification information. Elevated stochastic threshold levels potentially discard more information. This study examines three different mixture interpretation methods. In 72 criminal cases, 111 genotype comparisons were made between 92 mixture items and relevant reference samples. TrueAllele computer modeling was done on all the evidence samples, and documented in DNA match reports that were provided as evidence for each case. Threshold-based Combined Probability of Inclusion (CPI) and stochastically modified CPI (mCPI) analyses were performed as well. TrueAllele's identification information in 101 positive matches was used to assess the reliability of its modeling approach. Comparison was made with 81 CPI and 53 mCPI DNA match statistics that were manually derived from the same data. There were statistically significant differences between the DNA interpretation methods. TrueAllele gave an average match statistic of 113 billion, CPI averaged 6.68 million, and mCPI averaged 140. The computer was highly specific, with a false positive rate under 0.005%. The modeling approach was precise, having a factor of two within-group standard deviation. TrueAllele accuracy was indicated by having uniformly distributed match statistics over the data set. The computer could make genotype comparisons that were impossible or impractical using manual methods. TrueAllele computer interpretation of DNA mixture evidence is sensitive, specific, precise, accurate and more informative than manual interpretation alternatives. It can determine DNA match statistics when threshold-based methods cannot. Improved forensic science computation can affect criminal cases by providing reliable scientific evidence.	[Perlin, Mark W.; Dormer, Kiersten; Hornyak, Jennifer] Cybergenetics, Pittsburgh, PA 15213 USA; [Schiermeier-Wood, Lisa; Greenspoon, Susan] Dept Forens Sci, Richmond, VA USA		Perlin, MW (corresponding author), Cybergenetics, Pittsburgh, PA 15213 USA.	perlin@cybgen.com						Aitken C., 2004, STAT EVALUATION EVID, P26; Aitken CGG, 1998, SCI JUSTICE, V38, P279, DOI 10.1016/S1355-0306(98)72128-8; [Anonymous], 1950, PROBABILITY WEIGHING; BALDING DJ, 1994, FORENSIC SCI INT, V64, P125, DOI 10.1016/0379-0738(94)90222-4; Ballantyne J, 2013, SCI JUSTICE, V53, P103, DOI 10.1016/j.scijus.2012.04.004; Biology Program Manager, 2011, FOR BIOL SECT PROC M, P126; Brenner CH, 2011, AAFS 63 ANN SCI M, P79; Budowle B, 2009, J FORENSIC SCI, V54, P810, DOI 10.1111/j.1556-4029.2009.01046.x; Coble MD, 2011, EXPLORING CAPABILITI; Cowell RG, 2007, FORENSIC SCI INT, V166, P28, DOI 10.1016/j.forsciint.2006.03.021; Curran JM, 2010, J FORENSIC SCI, V55, P1171, DOI 10.1111/j.1556-4029.2010.01446.x; Curran JM, 2008, SCI JUSTICE, V48, P168, DOI 10.1016/j.scijus.2007.09.014; Curran JM, 1999, J FORENSIC SCI, V44, P987; Devlin B, 1993, Stat Methods Med Res, V2, P241, DOI 10.1177/096228029300200304; Dror IE, 2011, SCI JUSTICE, V51, P204, DOI 10.1016/j.scijus.2011.08.004; EDWARDS A, 1991, AM J HUM GENET, V49, P746; Essen-Moller E, 1938, MITT ANTHR GES WIEN, V68; EVETT IW, 1998, INTERPRETING DNA EVI; Flaherty MP, 2011, VIRGINIA REEVALUATES; Gelman Andrew, 1995, BAYESIAN DATA ANAL; Gilks WR, 1996, MARKOV CHAIN MONTE C; Gill P, 2006, FORENSIC SCI INT, V160, P90, DOI 10.1016/j.forsciint.2006.04.009; Gill P, 2009, FORENSIC SCI INT-GEN, V3, P104, DOI 10.1016/j.fsigen.2008.11.009; Greenspoon SA, 2013, PUSHING LIMITS UNPUB; JEFFREYS AJ, 1985, NATURE, V316, P76, DOI 10.1038/316076a0; Kadash K, 2004, J FORENSIC SCI, V49, P660; Kelly H, 2012, FORENSIC SCI INT-GEN, V6, P191, DOI 10.1016/j.fsigen.2011.04.013; Kline MC, 2011, FORENSIC SCI INT G S; Koehler JJ, 2001, LAW HUMAN BEHAV, V25, P493, DOI 10.1023/A:1012892815916; Krenke BE, 2002, J FORENSIC SCI, V47, P773; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Mortera J, 2003, THEOR POPUL BIOL, V63, P191, DOI 10.1016/S0040-5809(03)00006-6; O'Hagan A., 2004, BAYESIAN INFERENCE; Perlin M.W., 2012, FORENSIC MAGAZINE, V9, P32; Perlin MW, 2013, J FORENSIC SCI, V58, P1458, DOI 10.1111/1556-4029.12223; Perlin MW, 2011, J FORENSIC SCI, V56, P1430, DOI 10.1111/j.1556-4029.2011.01859.x; Perlin MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008327; Perlin MW, 2001, J FORENSIC SCI, V46, P1372; Perlin MW, 2003, PROM 14 INT S HUM ID; Perlin MW, 2010, PROM 21 INT S HUM ID; Schweitzer N.J., 2007, JURIMETRICS, V47, P357, DOI DOI 10.2307/29762978; Scientific Working Group on DNA Analysis Methods (SWGDAM), 2000, FORENSIC SCI COMMUNI, P2; Stolovitzky G, 1996, P NATL ACAD SCI USA, V93, P12947, DOI 10.1073/pnas.93.23.12947; SWGDAM, 2010, INT GUID AUT STR TYP; Thomas MC, 2006, ELEMENTS INFORM THEO; Tvedebrink T, 2012, J COMPUT BIOL, V19, P887, DOI 10.1089/cmb.2010.0055; WEBER JL, 1989, AM J HUM GENET, V44, P388; Wecht CH, 2012, FORENSIC SCI	48	13	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92837	10.1371/journal.pone.0092837	http://dx.doi.org/10.1371/journal.pone.0092837			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667531	Green Submitted, gold, Green Published			2022-12-27	WOS:000333675600087
J	Prokop, JW; Schmidt, C; Gasper, D; Duff, RJ; Milsted, A; Ohkubo, T; Ball, HC; Shawkey, MD; Mays, HL; Cogburn, LA; Londraville, RL				Prokop, Jeremy W.; Schmidt, Cameron; Gasper, Donald; Duff, Robert J.; Milsted, Amy; Ohkubo, Takeshi; Ball, Hope C.; Shawkey, Matthew D.; Mays, Herman L., Jr.; Cogburn, Larry A.; Londraville, Richard L.			Discovery of the Elusive Leptin in Birds: Identification of Several 'Missing Links' in the Evolution of Leptin and Its Receptor	PLOS ONE			English	Article							I-TASSER; OB GENE; PROTEIN; EXPRESSION; GENERATION; REVEALS; INSIGHT; CLONING; WEIGHT; GENOME	Leptin is a pleiotropic protein best known for regulation of appetite and fat storage in mammals. While many leptin orthologs have been identified among vertebrates, an authentic leptin in birds has remained elusive and controversial. Here we identify leptin sequence from the Peregrine falcon, Falco peregrinus (pfleptin), and identify sequences from two other birds (mallard and zebra finch), and 'missing' vertebrates (elephant shark, alligator, Indian python, Chinese soft-shelled turtle, and coelacanth). The pattern of genes surrounding leptin (snd1, rbm28) is syntenic between the falcon and mammalian genomes. Phylogenetic analysis of all known leptin protein sequences improves our understanding of leptin's evolution. Structural modeling of leptin orthologs highlights a highly conserved hydrophobic core in the four-helix cytokine packing domain. A docked model of leptin with the leptin receptor for Peregrine falcon reveals several conserved amino acids important for the interaction and possible coevolution of leptin with its receptor. We also show for the first time, an authentic avian leptin sequence that activates the JAK-STAT signaling pathway. These newly identified sequences, structures, and tools for avian leptin and its receptor will allow elucidation of the function of these proteins in feral and domestic birds.	[Prokop, Jeremy W.; Schmidt, Cameron; Gasper, Donald; Duff, Robert J.; Milsted, Amy; Ball, Hope C.; Shawkey, Matthew D.; Londraville, Richard L.] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA; [Prokop, Jeremy W.] Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; [Ohkubo, Takeshi] Ibaraki Univ, Coll Agr, Amimachi, Ibaraki, Japan; [Mays, Herman L., Jr.] Cincinnati Museum Ctr, Geier Collect & Res Ctr, Cincinnati, OH USA; [Cogburn, Larry A.] Univ Delaware, Newark, DE 19716 USA	University System of Ohio; University of Akron; Medical College of Wisconsin; Ibaraki University; University of Delaware	Cogburn, LA (corresponding author), Univ Delaware, Newark, DE 19716 USA.	londraville@uakron.edu	Prokop, Jeremy/AAG-4931-2019	Prokop, Jeremy/0000-0002-1818-9695; Shawkey, Matthew/0000-0002-5131-8209; Mays, Herman/0000-0003-1104-5100; Cogburn, Larry/0000-0003-0977-7580; Londraville, Richard/0000-0002-9438-7976	American Heart Association [11PRE7380033]; Ohio Board of regents; NIH [2R15DK079282-02]; University of Akron; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK079282] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Ohio Board of regents; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Akron; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	JWP was funded by American Heart Association award 11PRE7380033; JWP/CS/HCB by the Ohio Board of regents, and RLL by NIH 2R15DK079282-02. The project was started from funding provided by The University of Akron to JWP/CS/DG/HCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2008, J ENDOCRINOL, V197, P335, DOI 10.1677/JOE-08-0098; Adachi H, 2012, J POULT SCI, V49, P46, DOI 10.2141/jpsa.011085; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Byerly MS, 2009, AM J PHYSIOL-REG I, V296, pR1180, DOI 10.1152/ajpregu.90813.2008; Carpenter B, 2012, STRUCTURE, V20, P487, DOI 10.1016/j.str.2012.01.019; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Copeland DL, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00026; Crespi EJ, 2006, P NATL ACAD SCI USA, V103, P10092, DOI 10.1073/pnas.0507519103; Dagil R, 2012, STRUCTURE, V20, P270, DOI 10.1016/j.str.2011.12.010; Denver RJ, 2011, NEUROENDOCRINOLOGY, V94, P21, DOI 10.1159/000328435; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Doyon C, 2001, GEN COMP ENDOCR, V124, P188, DOI 10.1006/gcen.2001.7701; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Friedman-Einat M, 1999, GEN COMP ENDOCR, V115, P354, DOI 10.1006/gcen.1999.7322; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Haniu M, 1998, J BIOL CHEM, V273, P28691, DOI 10.1074/jbc.273.44.28691; Hen G, 2008, J ENDOCRINOL, V197, P325, DOI 10.1677/JOE-08-0065; Horev G, 2000, MOL CELL ENDOCRINOL, V162, P95, DOI 10.1016/S0303-7207(00)00205-7; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Huising MO, 2006, ENDOCRINOLOGY, V147, P5786, DOI 10.1210/en.2006-0824; Johnson RM, 2000, J EXP ZOOL, V286, P718, DOI 10.1002/(SICI)1097-010X(20000601)286:7&lt;718::AID-JEZ6&gt;3.0.CO;2-I; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Liu Q, 2012, GEN COMP ENDOCR, V178, P562, DOI 10.1016/j.ygcen.2012.07.011; Mancour LV, 2012, MOL CELL, V48, P655, DOI 10.1016/j.molcel.2012.09.003; Mariano G, 2013, PEPTIDES, V48, P59, DOI 10.1016/j.peptides.2013.07.026; Niewiarowski PH, 2000, J EXP BIOL, V203, P295; Ohkubo T, 2007, GEN COMP ENDOCR, V151, P269, DOI 10.1016/j.ygcen.2007.01.021; Ohkubo T, 2008, J POULT SCI, V45, P233, DOI 10.2141/jpsa.45.233; Pitel F, 2000, ANIM GENET, V31, P281, DOI 10.1046/j.1365-2052.2000.00610.x; Pitel F, 2010, GEN COMP ENDOCR, V167, P1, DOI 10.1016/j.ygcen.2009.10.006; Prokop JW, 2012, PEPTIDES, V38, P326, DOI 10.1016/j.peptides.2012.10.002; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Resnyk CW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-557; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sharp PJ, 2008, GEN COMP ENDOCR, V158, P2, DOI 10.1016/j.ygcen.2008.05.018; SOMERO GN, 1995, ANNU REV PHYSIOL, V57, P43, DOI 10.1146/annurev.ph.57.030195.000355; St John JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-415; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Zhan XJ, 2013, NAT GENET, V45, P563, DOI 10.1038/ng.2588; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	43	49	52	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92751	10.1371/journal.pone.0092751	http://dx.doi.org/10.1371/journal.pone.0092751			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663438	Green Submitted, Green Published, gold			2022-12-27	WOS:000333459900108
J	Wang, TN; Huang, MS; Lin, MC; Duh, TH; Lee, CH; Wang, CC; Chen, PH; Chiang, SL; Sheu, CC; Chen, VCH; Wu, CC; Ferri, CP; Stewart, R; Ko, YC				Wang, Tsu-Nai; Huang, Ming-Shyan; Lin, Meng-Chih; Duh, Tsai-Hui; Lee, Chih-Hung; Wang, Chin-Chou; Chen, Ping-Ho; Chiang, Shang-Lun; Sheu, Chau-Chyun; Chen, Vincent Chin-Hung; Wu, Chao-Chien; Ferri, Cleusa P.; Stewart, Robert; Ko, Ying-Chin			Betel Chewing and Arecoline Affects Eotaxin-1, Asthma and Lung Function	PLOS ONE			English	Article							ALLERGIC AIRWAY INFLAMMATION; ORAL-CANCER; ACTIVATOR PROTEIN-1; GUINEA-PIGS; RISK-FACTOR; KAPPA-B; NUT; FIBROBLASTS; EXPRESSION; TAIWAN	Background: Betel nut is commonly used in many countries. Despite evidence suggesting an association with asthma, few studies have investigated the connection between betel nut use and asthma; thus, the underlying mechanism for the association with asthma is also unclear. The aim of this study was to investigate the association between betel chewing and asthma as well as the associations of plasma arecoline (a biomarker for exposure) and eotaxin-1 (a potential mediator) with asthma and lung function. Methods: We recruited 600 hospital-based asthmatic patients and 1200 age- and gender-matched community controls in southern Taiwan. To clarify the mechanism of action for eotaxin-1 in the association between betel chewing and asthma, we also designed an in vitro experiment to study the functional associations between arecoline exposure and eotaxin-1 levels. Results: A significant association was found between asthma and current betel chewing (adjusted odds ratio 2.05, 95% CI = 1.12-3.76), which was independent of potential confounders but was attenuated following adjustment for eotaxin-1. Arecoline and eotaxin-1 levels were positively correlated (Spearman r = 0.303, p = 0.02), while arecoline and arecaidine were negatively correlated with lung function. Functionally, arecoline alone does not induce eotaxin-1 release in vitro from dermal and gingival fibroblasts. However, in the presence of IL-4 and TNF-alpha, arecoline at 100 mg/ml induced more eotaxin-1 release than arecoline at 0 mu g/ml (2700 +/- 98 pg/ml vs 1850 +/- 142 pg/ml, p = 0.01 in dermal fibroblast cells, and 1489 +/- 78 pg/ml vs 1044 +/- 95 pg/ml, p = 0.03 in gingival fibroblast cells, respectively). Conclusion: Betel chewing is associated with asthma in this population, with arecoline induction of eotaxin-1 supported as a plausible causal pathway.	[Wang, Tsu-Nai] Kaohsiung Med Univ, Coll Hlth Sci, Dept Publ Hlth, Kaohsiung, Taiwan; [Wang, Tsu-Nai; Huang, Ming-Shyan; Duh, Tsai-Hui; Chen, Ping-Ho] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung, Taiwan; [Huang, Ming-Shyan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Dept Internal Med,Div Pulm & Crit Care Med & Geri, Kaohsiung, Taiwan; [Lin, Meng-Chih; Wu, Chao-Chien] Chang Gung Univ, Chang Gung Mem Hospital, Coll Med, Med Ctr,Dept Med,Div Pulm & Critical Care Med, Kaohsiung, Taiwan; [Duh, Tsai-Hui] Kaohsiung Med Univ, Dept Med & Appl Chem, Kaohsiung, Taiwan; [Lee, Chih-Hung] Kaohsiung Chang Gung Mem Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Lee, Chih-Hung] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chen, Ping-Ho] Kaohsiung Med Univ, Coll Dent Med, Sch Dent, Kaohsiung, Taiwan; [Chiang, Shang-Lun; Ko, Ying-Chin] China Med Univ Hosp, Environment Omics Dis Res Ctr, Taichung, Taiwan; [Chiang, Shang-Lun; Ko, Ying-Chin] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Sheu, Chau-Chyun] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Fac Med,Dept Internal Med,Div Pulm & Crit Care Me, Kaohsiung, Taiwan; [Chen, Vincent Chin-Hung] Chung Shan Med Univ, Chung Shan Med Univ Hosp, Sch Med, Inst Med,Dept Psychiat, Taichung, Taiwan; [Ferri, Cleusa P.] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil; [Chen, Vincent Chin-Hung; Stewart, Robert] Kings Coll London, Inst Psychiat, London, England	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Universidade Federal de Sao Paulo (UNIFESP); University of London; King's College London	Wu, CC (corresponding author), Chang Gung Univ, Chang Gung Mem Hospital, Coll Med, Med Ctr,Dept Med,Div Pulm & Critical Care Med, Kaohsiung, Taiwan.	my47104710@gmail.com; ycko0406@gmail.com	Sheu, Chau-Chyun/AAC-7244-2020; Ferri, Cleusa Pinheiro/B-2922-2010; Stewart, Robert/B-1667-2010; Lee, Chih-Hung/AAJ-5551-2020	Sheu, Chau-Chyun/0000-0002-7979-3749; Ferri, Cleusa Pinheiro/0000-0002-1815-7685; Stewart, Robert/0000-0002-4435-6397; Lee, Chih-Hung/0000-0001-9804-3874; Wang, Tsu-Nai/0000-0002-0278-289X	National Health Research Institutes [NHRI-CN-PD9611P]; National Science Council, Taiwan [NSC96-2314-B-037-040-MY3, NSC100-2314-B-037-025-MY3]; National Institute for Health Research (NIHR) Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust; King's College London	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Institute for Health Research (NIHR) Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust(National Institute for Health Research (NIHR)); King's College London(General Electric)	This work was supported by grants NHRI-CN-PD9611P from the National Health Research Institutes, NSC96-2314-B-037-040-MY3 and NSC100-2314-B-037-025-MY3 from National Science Council, Taiwan. RS is part-funded by the National Institute for Health Research (NIHR) Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chakraborty P, 2009, INT ARCH ALLERGY IMM, V149, P305, DOI 10.1159/000205576; Chen CL, 2002, J TOXICOL ENV HEAL A, V65, P327, DOI 10.1080/15287390252800909; Chiang SL, 2007, TOXICOL SCI, V100, P66, DOI 10.1093/toxsci/kfm201; GINA, 1995, NAT I HLTH BETH NAT, V95-3659; Gupta PC, 2002, ADDICT BIOL, V7, P77, DOI 10.1080/13556210020091437; Henderson WR, 2002, J IMMUNOL, V169, P5294, DOI 10.4049/jimmunol.169.9.5294; IARC, 1985, IARC MONOGR EVAL CAR, V37, P145; KIYINGI KS, 1991, PAPUA NEW GUINEA MED, V34, P117; KO YC, 1992, J ORAL PATHOL MED, V21, P261, DOI 10.1111/j.1600-0714.1992.tb01007.x; KO YC, 1995, J ORAL PATHOL MED, V24, P450, DOI 10.1111/j.1600-0714.1995.tb01132.x; LADENIUS ARC, 1993, EUR J PHARMACOL, V235, P127; Lamkhioued B, 1997, J IMMUNOL, V159, P4593; Lu HH, 2010, AUTOPHAGY, V6, P725, DOI 10.4161/auto.6.6.12423; Manna SK, 2006, BIOCHEM PHARMACOL, V71, P1602, DOI 10.1016/j.bcp.2006.02.014; Min MG, 2007, J IMMUNOL, V178, P5321, DOI 10.4049/jimmunol.178.8.5321; Miyamasu M, 1999, CYTOKINE, V11, P751, DOI 10.1006/cyto.1999.0487; Moerloose KB, 2005, AM J RESP CRIT CARE, V172, P168, DOI 10.1164/rccm.200409-1174OC; Nelson BS, 1999, ANN EMERG MED, V34, P238, DOI 10.1016/S0196-0644(99)70239-8; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; PICKWELL SM, 1994, WESTERN J MED, V160, P326; ROTHENBERG ME, 1995, P NATL ACAD SCI USA, V92, P8960, DOI 10.1073/pnas.92.19.8960; Sabatini F, 2002, IMMUNOL LETT, V84, P173, DOI 10.1016/S0165-2478(02)00183-9; TAYLOR RFH, 1992, LANCET, V339, P1134, DOI 10.1016/0140-6736(92)90732-I; Teran LM, 1999, AM J RESP CELL MOL, V20, P777, DOI 10.1165/ajrcmb.20.4.3508; TIMBERLAKE CM, 1992, PAPUA NEW GUINEA MED, V35, P186; Trivedy C, 1999, BMJ-BRIT MED J, V318, P1287; VANOOSTERHOUT AJM, 1993, AM REV RESPIR DIS, V147, P548, DOI 10.1164/ajrccm/147.3.548; Vayssier M, 1998, AM J PHYSIOL-LUNG C, V275, pL771, DOI 10.1152/ajplung.1998.275.4.L771; Wang TN, 2010, AM J RESP CRIT CARE, V182, P1369, DOI 10.1164/rccm.200906-0969OC; Warnakulasuriya S, 2002, BMJ-BRIT MED J, V324, P799, DOI 10.1136/bmj.324.7341.799; Wu IC, 2010, J ANAL TOXICOL, V34, P325, DOI 10.1093/jat/34.6.325	31	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91889	10.1371/journal.pone.0091889	http://dx.doi.org/10.1371/journal.pone.0091889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658613	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300043
J	Chen, D; Bao, L; Lu, SQ; Xu, F				Chen, Du; Bao, Long; Lu, Shi-qi; Xu, Feng			Serum Albumin and Prealbumin Predict the Poor Outcome of Traumatic Brain Injury	PLOS ONE			English	Article							GLYCEMIC CONTROL; HYPERGLYCEMIA; RESUSCITATION; PROGNOSIS; CHILDREN	Background: Serum albumin and prealbumin are both negative acute-phase reactants, and usually at low levels in stress. We aim to determine their predictive values for poor outcome of traumatic brain injury (TBI). Methods: A total of 326 patients of TBI were enrolled and followed-up by telephone 6 months after discharge. They were divided into a favorable group (GOS: 3 to 5) and an unfavorable group (GOS: 1 to 2). Serum albumin and prealbumin were measured from vein blood within 24 h after admission. Results: Ninety one (27.9%) patients were with poor outcome (GOS: 1 to 2). The unfavorable group had lower albumin and prealbumin (P, 0.001). Albumin and prealbumin were both positively correlated with GCS (r = 0.489, P < 0.001; r = 0.222, P < 0.001, respectively) and GOS (r = 0.518, P < 0.001; r = 0.314, P < 0.001, respectively). After adjustment for confounding factors, the odds ratios of albumin and prealbumin were 0.866, 95% CI: 0.829 to 0.904 and 0.990, 95% CI: 0.985 to 0.995, respectively. In subgroup of GCS <= 8 (n = 101), the crude and adjusted odds ratios of serum albumin were both statistically significant (P = 0.027, P = 0.033, respectively), while prealbumin were not (P = 0.553, P = 0.576, respectively). The AUC of albumin for predicting poor outcome was 0.762, 95% CI: 0.712 to 0.807, which was significantly higher than that of prealbumin (0.664, 95% CI: 0.610 to 0.715). In analyses of all patients and subgroup of GCS <= 8, the AUCs of serum albumin were both significantly higher than those of prealbumin (P = 0.001, P = 0.045, respectively). Conclusions: Both serum albumin and prealbumin could predict the poor outcome of TBI, but the former is much better, especially, in patients with severe TBI.	[Chen, Du; Bao, Long; Lu, Shi-qi; Xu, Feng] Soochow Univ, Affiliated Hosp 1, Dept Emergency Med, Suzhou, Peoples R China	Soochow University - China	Xu, F (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Emergency Med, Suzhou, Peoples R China.	sdfyycd@foxmail.com	Chen, Du/AAM-8789-2021	Chen, Du/0000-0001-6990-3310				Belayev L, 1999, J NEUROTRAUM, V16, P445, DOI 10.1089/neu.1999.16.445; Bernard F, 2008, J TRAUMA, V64, P872, DOI 10.1097/TA.0b013e31803428cc; Cabassi A, 2013, INT J CARDIOL; Collins N, 2001, Adv Skin Wound Care, V14, P235, DOI 10.1097/00129334-200109000-00009; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Gao C, 2011, CLIN EXP MED, V11, P49, DOI 10.1007/s10238-010-0103-8; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Kawai H, 2012, WORLD J SURG, V36, P2853, DOI 10.1007/s00268-012-1766-y; Kramer AH, 2012, CRIT CARE, V16, DOI 10.1186/cc11812; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Matsushima K, 2012, J CRIT CARE, V27, P125, DOI 10.1016/j.jcrc.2011.08.012; Melo JRT, 2010, ACTA NEUROCHIR, V152, P1559, DOI 10.1007/s00701-010-0680-z; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nelson DW, 2012, J NEUROTRAUM, V29, P2613, DOI 10.1089/neu.2012.2468; ROCCA B, 1987, Annales Francaises d'Anesthesie et de Reanimation, V6, P476, DOI 10.1016/S0750-7658(87)80091-6; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Rossi JL, 2011, J NEUROSCI RES, V89, P852, DOI 10.1002/jnr.22600; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Saadat SMS, 2012, CHILD NERV SYST, V28, P1773, DOI 10.1007/s00381-012-1753-5; Sharma Deepak, 2012, Anesthesiol Clin, V30, P333, DOI 10.1016/j.anclin.2012.04.003; Shutter L, 2012, CRIT CARE MED, V40, P1995, DOI 10.1097/CCM.0b013e3182514c15; Smith RL, 2012, PEDIATR CRIT CARE ME, V13, P85, DOI 10.1097/PCC.0b013e3182192c30; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Wahlstrom MR, 2009, ACTA ANAESTH SCAND, V53, P18, DOI 10.1111/j.1399-6576.2008.01798.x; Yang Tian-jun, 2013, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V25, P301, DOI 10.3760/cma.j.issn.2095-4352.2013.05.016; YURCHENCO PD, 1990, FASEB J, V4, P1577, DOI 10.1096/fasebj.4.6.2180767	28	28	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93167	10.1371/journal.pone.0093167	http://dx.doi.org/10.1371/journal.pone.0093167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671050	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677000123
J	Hiraki, LT; Joshi, AD; Ng, K; Fuchs, CS; Ma, J; Hazra, A; Peters, U; Karlson, EW; Giovannucci, E; Kraft, P; Chan, AT				Hiraki, Linda T.; Joshi, Amit D.; Ng, Kimmie; Fuchs, Charles S.; Ma, Jing; Hazra, Aditi; Peters, Ulrike; Karlson, Elizabeth W.; Giovannucci, Edward; Kraft, Peter; Chan, Andrew T.			Joint Effects of Colorectal Cancer Susceptibility Loci, Circulating 25-Hydroxyvitamin D Risk of Colorectal Cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VITAMIN-D; COLON-CANCER; DISEASE; METAANALYSIS; CALCIUM; SCAN; LOCATIONS; 8Q24	Background: Genome wide association studies (GWAS) have identified several SNPs associated with colorectal cancer (CRC) susceptibility. Vitamin D is also inversely associated with CRC risk. Methods: We examined main and joint effects of previously GWAS identified genetic markers of CRC and plasma 25-hydroxyvitamin D (25(OH)D) on CRC risk in three prospective cohorts: the Nurses' Health Study (NHS), the Health Professionals Follow-up Study (HPFS), and the Physicians' Health Study (PHS). We included 1895 CRC cases and 2806 controls with genomic DNA. We calculated odds ratios and 95% confidence intervals for CRC associated with additive genetic risk scores (GRSs) comprised of all CRC SNPs and subsets of these SNPs based on proximity to regions of increased vitamin D receptor binding to vitamin D response elements (VDREs), based on published ChiP-seq data. Among a subset of subjects with additional prediagnostic 25(OH)D we tested multiplicative interactions between plasma 25(OH)D and GRS's. We used fixed effects models to meta-analyze the three cohorts. Results: The per allele multivariate OR was 1.12 (95% CI, 1.06-1.19) for GRS-proximalVDRE; and 1.10 (95% Cl, 1.06-1.14) for GRS-nonproxVDRE. The lowest quartile of plasma 25(OH)D compared with the highest, had a multivariate OR of 0.63 (95% Cl, 0.48-0.82) for CRC. We did not observe any significant interactions between any GRSs and plasma 25(OH)D. Conclusions: We did not observe evidence for the modification of genetic susceptibility for CRC according to vitamin D status, or evidence that the effect of common CRC risk alleles differed according to their proximity to putative VDR binding sites.	[Hiraki, Linda T.; Joshi, Amit D.; Hazra, Aditi; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Ng, Kimmie; Fuchs, Charles S.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Fuchs, Charles S.; Ma, Jing; Hazra, Aditi; Giovannucci, Edward; Chan, Andrew T.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Fuchs, Charles S.; Ma, Jing; Hazra, Aditi; Karlson, Elizabeth W.; Giovannucci, Edward; Chan, Andrew T.] Harvard Univ, Sch Med, Boston, MA USA; [Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Karlson, Elizabeth W.] Brigham & Womens Hosp, Dept Med, Div Rheumatol, Boston, MA 02115 USA; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Chan, Andrew T.] Massachusetts Gen Hosp, Dept Med, Div Gastroenterol, Boston, MA 02114 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Fred Hutchinson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Chan, AT (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.	ACHAN@partners.org	Chan, Andrew T/P-8293-2014; Hiraki, Linda/AAN-6411-2021	Chan, Andrew T/0000-0001-7284-6767; 	National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services [U01 CA137088, R01 CA059045, RO1 CA137178, K24 DK098311]; Canadian Institute of Health Research (CIHR) Fellowship Award; NIH [5K07CA148894]; NATIONAL CANCER INSTITUTE [R01CA059045, R01CA137178, U01CA137088, K07CA148894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR052403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK098311] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Institute of Health Research (CIHR) Fellowship Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support was provided by National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services (U01 CA137088; R01 CA059045; RO1 CA137178; K24 DK098311). Dr. Hiraki was supported by a Canadian Institute of Health Research (CIHR) Fellowship Award, Dr. Ng was supported by an NIH 5K07CA148894 award. Dr. Chan is a Damon Runyon Clinical Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, NEW ENGL J MED, V321, P129, DOI DOI 10.1056/NEJM198907203210301; BELANGER CF, 1978, AM J NURS, V78, P1039, DOI 10.2307/3462013; BOSTICK RM, 1993, AM J EPIDEMIOL, V137, P1302, DOI 10.1093/oxfordjournals.aje.a116640; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Carlberg C, 2012, ANTICANCER RES, V32, P271; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; Feskanich D, 2004, CANCER EPIDEM BIOMAR, V13, P1502; GARLAND C, 1985, LANCET, V1, P307, DOI 10.1016/S0140-6736(85)91082-7; Gorham ED, 2007, AM J PREV MED, V32, P210, DOI 10.1016/j.amepre.2006.11.004; Haiman CA, 2007, CANCER RES, V67, P1893, DOI 10.1158/0008-5472.CAN-06-4123; Heikkinen S, 2011, NUCLEIC ACIDS RES, V39, P9181, DOI 10.1093/nar/gkr654; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Hutter CM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-670; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Jia WH, 2013, NAT GENET, V45, P191, DOI 10.1038/ng.2505; Kearney J, 1996, AM J EPIDEMIOL, V143, P907, DOI 10.1093/oxfordjournals.aje.a008834; Kocarnik JD, 2010, CANC EPIDEMIOL BIOMA; Lee JE, 2011, CANCER PREV RES, V4, P735, DOI 10.1158/1940-6207.CAPR-10-0289; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Ma YL, 2011, J CLIN ONCOL, V29, P3775, DOI 10.1200/JCO.2011.35.7566; Martinez ME, 1996, JNCI-J NATL CANCER I, V88, P1375, DOI 10.1093/jnci/88.19.1375; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Peters U, 2012, GASTROENTEROLOGY; Peters U, 2011, HUM GENET; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Woolcott CG, 2010, CANCER EPIDEM BIOMAR, V19, P130, DOI 10.1158/1055-9965.EPI-09-0475; Wu K, 2007, J NATL CANCER I, V99, P1120, DOI 10.1093/jnci/djm038; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	38	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92212	10.1371/journal.pone.0092212	http://dx.doi.org/10.1371/journal.pone.0092212			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670869	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000036
J	Varma, S; Pommier, Y; Sunshine, M; Weinstein, JN; Reinhold, WC				Varma, Sudhir; Pommier, Yves; Sunshine, Margot; Weinstein, John N.; Reinhold, William C.			High Resolution Copy Number Variation Data in the NCI-60 Cancer Cell Lines from Whole Genome Microarrays Accessible through CellMiner	PLOS ONE			English	Article							HUMAN BREAST-TUMORS; DRUG-SENSITIVITY; MULTIDRUG-RESISTANCE; EXPRESSION PROFILES; GENE-EXPRESSION; MESSENGER-RNA; ARRAY-CGH; PANEL; MALIGNANCIES; PHARMACOLOGY	Array-based comparative genomic hybridization (aCGH) is a powerful technique for detecting gene copy number variation. It is generally considered to be robust and convenient since it measures DNA rather than RNA. In the current study, we combine copy number estimates from four different platforms Agilent 44 K, NimbleGen 385 K, Affymetrix 500 K and Illumina Human1Mv1_C) to compute a reliable, high-resolution, easy to understand output for the measure of copy number changes in the 60 cancer cells of the NCI-DTP (the NCI-60). We then relate the results to gene expression. We explain how to access that database using our CellMiner web-tool and provide an example of the ease of comparison with transcript expression, whole exome sequencing, rnicroRNA expression and response to 20,000 drugs and other chemical compounds. We then demonstrate how the data can be analyzed integratively with transcript expression data for the whole genome (26,065 genes). Comparison of copy number and expression levels shows an overall medium high correlation (median r=0.247), with significantly higher correlations (median r=0.408) for the known tumor suppressor genes. That observation is consistent with the hypothesis that gene loss IS an important mechanism for tumor suppressor inactivation. An integrated analysis of concurrent DNA copy number and gene expression change is presented. Limiting attention to focal DNA gains or losses we identify and reveal novel candidate tumor suppressors With matching alterations in transcript level.	[Varma, Sudhir; Pommier, Yves; Sunshine, Margot; Reinhold, William C.] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Varma, Sudhir] HiThru Analyt Inc, Laurel, MD USA; [Sunshine, Margot] Syst Res & Applicat Corp, Fairfax, VA USA; [Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat, Houston, TX 77030 USA; [Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Computat Biol, Houston, TX 77030 USA; [Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Pommier, Y (corresponding author), NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	pommier@nih.gov; wcr@mail.nih.gov	Varma, Sudhir/N-8763-2014; Reinhold, William/J-6704-2017	Varma, Sudhir/0000-0002-4096-4782; Reinhold, William/0000-0001-5513-9323; Weinstein, John/0000-0001-9401-6908	Center for Cancer Research, Intramural Program of the National Cancer Institute; NATIONAL CANCER INSTITUTE [P50CA100632, P30CA016672, ZICBC011475] Funding Source: NIH RePORTER	Center for Cancer Research, Intramural Program of the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Center for Cancer Research, Intramural Program of the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Baumbusch LO, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-379; Bussey KJ, 2006, MOL CANCER THER, V5, P853, DOI 10.1158/1535-7163.MCT-05-0155; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chang SS, 2010, ORL-J OTO-RHIN-LARYN, V72, P337, DOI 10.1159/000320597; Costa JL, 2008, SEMIN RADIAT ONCOL, V18, P98, DOI 10.1016/j.semradonc.2007.10.005; Davies JJ, 2005, CHROMOSOME RES, V13, P237, DOI 10.1007/s10577-005-2168-x; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gmeiner WH, 2010, MOL CANCER THER, V9, P3105, DOI 10.1158/1535-7163.MCT-10-0674; Goh XY, 2011, GUT; Gu W, 2008, CANC INFORM, V2008; Holbeck SL, 2010, MOL CANCER THER, V9, P1451, DOI 10.1158/1535-7163.MCT-10-0106; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; JEN J, 1994, CANCER RES, V54, P6353; Kuwano M, 2003, CANCER SCI, V94, P9, DOI 10.1111/j.1349-7006.2003.tb01344.x; Lai LA, 2007, GENE CHROMOSOME CANC, V46, P532, DOI 10.1002/gcc.20435; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; OGAWA S, 1994, BLOOD, V84, P2431, DOI 10.1182/blood.V84.8.2431.bloodjournal8482431; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Platzer P, 2002, CANCER RES, V62, P1134; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Reiman A, 2012, ANTICANCER RES, V32, P4663; Reinhold WC, 2007, MOL CANCER THER, V6, P391, DOI 10.1158/1535-7163.MCT-06-0609; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; Reinhold WC, 2010, CANCER RES, V70, P2191, DOI 10.1158/0008-5472.CAN-09-3528; Roschke AV, 2003, CANCER RES, V63, P8634; Ruan XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031628; Schwab M, 1998, BIOESSAYS, V20, P473, DOI 10.1002/(SICI)1521-1878(199806)20:6<473::AID-BIES5>3.3.CO;2-N; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Vincent LM, 2010, MOL GENET METAB, V101, P62, DOI 10.1016/j.ymgme.2010.05.015; Weaver BAA, 2007, CANCER RES, V67, P10103, DOI 10.1158/0008-5472.CAN-07-2266; Weinstein JN, 2003, CR BIOL, V326, P909, DOI 10.1016/j.crvi.2003.08.005; Weinstein JN, 2002, CURR OPIN PHARMACOL, V2, P361, DOI 10.1016/S1471-4892(02)00185-6; Weinstein JN, 2006, MOL CANCER THER, V5, P2601, DOI 10.1158/1535-7163.MCT-06-0640; Weinstein JN, 2012, NATURE, V483, P544, DOI 10.1038/483544a; Yasui K, 2004, CANCER RES, V64, P1403, DOI 10.1158/0008-5472.CAN-3263-2; Zeeberg BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040062	42	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92047	10.1371/journal.pone.0092047	http://dx.doi.org/10.1371/journal.pone.0092047			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670534	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677000031
J	Golubic, R; May, AM; Borch, KB; Overvad, K; Charles, MA; Diaz, MJT; Amiano, P; Palli, D; Valanou, E; Vigl, M; Franks, PW; Wareham, N; Ekelund, U; Brage, S				Golubic, Rajna; May, Anne M.; Borch, Kristin Benjaminsen; Overvad, Kim; Charles, Marie-Aline; Tormo Diaz, Maria Jose; Amiano, Pilar; Palli, Domenico; Valanou, Elisavet; Vigl, Matthaeus; Franks, Paul W.; Wareham, Nicholas; Ekelund, Ulf; Brage, Soren			Validity of Electronically Administered Recent Physical Activity Questionnaire (RPAQ) in Ten European Countries	PLOS ONE			English	Article							HEART-RATE; ENERGY-EXPENDITURE; RELIABILITY; HEALTH; ACCELEROMETRY; INDIVIDUALS; OBESITY; REPEATABILITY; POPULATIONS; VALIDATION	Objective: To examine the validity of the Recent Physical Activity Questionnaire (RPAQ) which assesses physical activity (PA) in 4 domains (leisure, work, commuting, home) during past month. Methods: 580 men and 1343 women from 10 European countries attended 2 visits at which PA energy expenditure (PAEE), time at moderate-to-vigorous PA (MVPA) and sedentary time were measured using individually-calibrated combined heart-rate and movement sensing. At the second visit, RPAQ was administered electronically. Validity was assessed using agreement analysis. Results: RPAQ significantly underestimated PAEE in women [median(IQR) 34.1 (22.1, 52.2) vs. 40.6 (32.4, 50.9) kJ/kg/day, 95%LoA: -44.4, 63.4 kJ/kg/day) and in men (43.7 (29.0, 69.0) vs. 45.5 (34.1, 57.6) kJ/kg/day, 95%LoA: -47.2, 101.3 kJ/kg/day]. Using individualised definition of 1MET, RPAQ significantly underestimated MVPA in women [median(IQR): 62.1 (29.4, 124.3) vs. 73.6 (47.8, 107.2) min/day, 95%LoA: -130.5, 305.3 min/day] and men [82.7 (38.8, 185.6) vs. 83.3 (55.1, 125.0) min/day, 95%LoA: -136.4, 400.1 min/day]. Correlations (95%CI) between subjective and objective estimates were statistically significant [PAEE: women, rho = 0.20 (0.15-0.26); men, rho = 0.37 (0.30-0.44); MVPA: women, rho = 0.18 (0.13-0.23); men, rho = 0.31 (0.24-0.39)]. When using non-individualised definition of 1MET (3.5 mlO(2)/kg/min), MVPA was substantially overestimated (similar to 30 min/day). Revisiting occupational intensity assumptions in questionnaire estimation algorithms with occupational group-level empirical distributions reduced median PAEE-bias in manual (25.1 kJ/kg/day vs. 29.0 kJ/kg/day, p<0.001) and heavy manual workers (64.1 vs. -4.6 kJ/kg/day, p<0.001) in an independent hold-out sample. Conclusion: Relative validity of RPAQ-derived PAEE and MVPA is comparable to previous studies but underestimation of PAEE is smaller. Electronic RPAQ may be used in large-scale epidemiological studies including surveys, providing information on all domains of PA.	[Golubic, Rajna; Wareham, Nicholas; Ekelund, Ulf; Brage, Soren] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England; [May, Anne M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Borch, Kristin Benjaminsen] Arctic Univ Norway, Univ Tromso, Dept Community Med, Fac Hlth Sci, Tromso, Norway; [Overvad, Kim] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Overvad, Kim] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Tormo Diaz, Maria Jose] INSERM, Ctr Res Epidemiol & Populat Hlth, U1018, Lifelong Epidemiol Obes Diabet & Chron Renal Dis, F-94807 Villejuif, France; [Charles, Marie-Aline] Univ Paris 11, UMRS 1018, F-94807 Villejuif, France; [Tormo Diaz, Maria Jose] Murcia Reg Hlth Author, Dept Epidemiol, Murcia, Spain; [Tormo Diaz, Maria Jose] Murcia Sch Med, Dept Sociosanitary Sci, Murcia, Spain; [Amiano, Pilar] Subdirecc Salud Publ Gipuzkoa, San Sebastian, Spain; [Palli, Domenico] Canc Prevent & Res Inst, Mol & Nutr Epidemiol Unit, ISPO, Florence, Italy; [Valanou, Elisavet] HHF, Athens, Greece; [Vigl, Matthaeus] Deutsch Inst Ernahrungsforsch Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Franks, Paul W.] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Genet & Mol Epidemiol Unit, Malmo, Sweden; [Franks, Paul W.] Umea Univ, Med Sect, Dept Publ Hlth & Clin Med, Genet Epidemiol & Clin Res Grp, Umea, Sweden	University of Cambridge; Utrecht University; Utrecht University Medical Center; UiT The Arctic University of Tromso; Aarhus University; Aalborg University; Aalborg University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Murcia Regional Health Council; University of Murcia; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Lund University; Skane University Hospital; Umea University	Brage, S (corresponding author), Univ Cambridge, MRC Epidemiol Unit, Cambridge, England.	soren.brage@mrc-epid.cam.ac.uk	Charles, Marie Aline/F-8567-2017; Golubic, Rajna/GNH-4374-2022; Ekelund, Ulf/AAE-8471-2019; Charles, Marie Aline/S-1866-2019; Brage, Soren/C-6415-2013; Franks, Paul/AAA-3300-2020; May, Anne M/G-9183-2011	Charles, Marie Aline/0000-0003-4025-4390; Golubic, Rajna/0000-0003-0419-9582; Ekelund, Ulf/0000-0003-2115-9267; Charles, Marie Aline/0000-0003-4025-4390; Brage, Soren/0000-0002-1265-7355; Overvad, Kim/0000-0001-6429-7921; PALLI, Domenico/0000-0002-5558-2437; Valanou, Elissavet Maria/0000-0003-1970-6460; Benjaminsen Borch, Kristin/0000-0002-1741-2322; Franks, Paul/0000-0002-0520-7604; tumino, rosario/0000-0003-2666-414X	European Union (Integrated Project in the Framework Programme 6 of the European Community) [LSHM-CT-2006-037197]; Medical Research Council, UK [MC_UU_12015/3]; Gates Cambridge; St. John's College Cambridge; School of Clinical Medicine, University of Cambridge; Medical Research Council [MC_UU_12015/1, MC_U106179471, MC_U106179473, MC_UU_12015/3] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10135] Funding Source: researchfish; MRC [MC_U106179473, MC_UU_12015/1, MC_UU_12015/3] Funding Source: UKRI	European Union (Integrated Project in the Framework Programme 6 of the European Community); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Gates Cambridge; St. John's College Cambridge; School of Clinical Medicine, University of Cambridge(University of Cambridge); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by funding from the European Union (Integrated Project LSHM-CT-2006-037197 in the Framework Programme 6 of the European Community) and the Medical Research Council, UK (grant code MC_UU_12015/3). RG is financially supported by a scholarship from the Gates Cambridge, Benefactors' Scholarship from St. John's College Cambridge and Raymond and Beverly Sackler Studentship from the School of Clinical Medicine, University of Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003607; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; AINSWORTH BE, 1993, J OCCUP ENVIRON MED, V35, P1017; Barker M, 2011, J HEALTH PSYCHOL, V16, P178, DOI 10.1177/1359105310371397; Bates B, 2010, NATL DIET NUTR SURVE; Bell R, 2013, EUR J OBSTET GYN R B, V170, P90, DOI 10.1016/j.ejogrb.2013.05.018; Besson H, 2010, AM J CLIN NUTR, V91, P106, DOI 10.3945/ajcn.2009.28432; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bonnefoy M, 2001, J AM GERIATR SOC, V49, P28, DOI 10.1046/j.1532-5415.2001.49006.x; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Brage S, 2004, J APPL PHYSIOL, V96, P343, DOI 10.1152/japplphysiol.00703.2003; Brage S, 2007, J APPL PHYSIOL, V103, P682, DOI 10.1152/japplphysiol.00092.2006; Buchowski MS, 2009, J PHYS ACT HEALTH, V6, P252, DOI 10.1123/jpah.6.2.252; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Byrne NM, 2005, J APPL PHYSIOL, V99, P1112, DOI 10.1152/japplphysiol.00023.2004; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Cave Hill Campus Barbados, 2010, ANN REP COUNC 2010 2; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cust AE, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-33; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Mediano MFF, 2013, CLINICS, V68, P1121, DOI 10.6061/clinics/2013(08)10; Ferrari P, 2007, AM J EPIDEMIOL, V166, P832, DOI 10.1093/aje/kwm148; Godino JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075398; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Helmerhorst HJF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-103; Henry CJK, 2005, PUBLIC HEALTH NUTR, V8, P1133, DOI 10.1079/PHN2005801; Howe TE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000333, 10.1002/14651858.CD000333.pub2]; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Johansen NB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1078; KLESGES RC, 1990, MED SCI SPORT EXER, V22, P690, DOI 10.1249/00005768-199010000-00022; Lagerros YT, 2007, EUR J EPIDEMIOL, V22, P353, DOI 10.1007/s10654-007-9154-x; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Leenders NYJM, 2001, MED SCI SPORT EXER, V33, P1233; Matthews C.E., 2002, PHYS ACTIVITY ASSESS, P107; Matton L, 2007, RES Q EXERCISE SPORT, V78, P293; Miles L, 2007, NUTR BULL, V32, P314, DOI 10.1111/j.1467-3010.2007.00668.x; Nanchahal K, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000793; Neilson HK, 2008, AM J CLIN NUTR, V87, P279, DOI 10.1093/ajcn/87.2.279; Ogilvie D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-703; Parkinson KN, 2011, INT J EPIDEMIOL, V40, P308, DOI 10.1093/ije/dyq015; Peters T, 2012, EUR J EPIDEMIOL, V27, P15, DOI 10.1007/s10654-011-9625-y; Peters TM, 2010, AM J PREV MED, V38, P583, DOI 10.1016/j.amepre.2010.02.012; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; RICHARDSON MT, 1994, J CLIN EPIDEMIOL, V47, P271, DOI 10.1016/0895-4356(94)90008-6; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Smith NR, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001840; *SPORTS COUNC HLTH, 1992, ALL DUNB NAT FITN SU; Stegle O, 2008, IEEE T BIO-MED ENG, V55, P2143, DOI 10.1109/TBME.2008.923118; Tremblay MS, APPL PHYSL NUTR META, V35, P725; van Poppel MNM, 2010, SPORTS MED, V40, P565, DOI 10.2165/11531930-000000000-00000; Wareham NJ, 1998, INT J OBESITY, V22, pS30; Wareham NJ, 2002, INT J EPIDEMIOL, V31, P168, DOI 10.1093/ije/31.1.168; Wijndaele K, MED SCI SPORTS EXERC, V42, P1511; Wijndaele K, 2011, INT J EPIDEMIOL, V40, P150, DOI 10.1093/ije/dyq105	58	54	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92829	10.1371/journal.pone.0092829	http://dx.doi.org/10.1371/journal.pone.0092829			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667343	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600083
J	Klein, C; Hain, EG; Braun, J; Riek, K; Mueller, S; Steiner, B; Sack, I				Klein, Charlotte; Hain, Elisabeth G.; Braun, Juergen; Riek, Kerstin; Mueller, Susanne; Steiner, Barbara; Sack, Ingolf			Enhanced Adult Neurogenesis Increases Brain Stiffness: In Vivo Magnetic Resonance Elastography in a Mouse Model of Dopamine Depletion	PLOS ONE			English	Article							PRECURSOR CELL-PROLIFERATION; HIPPOCAMPAL NEUROGENESIS; VISCOELASTIC PROPERTIES; NEURONS; PROJECTIONS; BEHAVIOR; MPTP; RAT	The mechanical network of the brain is a major contributor to neural health and has been recognized by in vivo magnetic resonance elastography (MRE) to be highly responsive to diseases. However, until now only brain softening was observed and no mechanism was known that reverses the common decrement of neural elasticity during aging or disease. We used MRE in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride (MPTP) mouse model for dopaminergic neurodegeneration as observed in Parkinson's disease (PD) to study the mechanical response of the brain on adult hippocampal neurogenesis as a robust correlate of neuronal plasticity in healthy and injured brain. We observed a steep transient rise in elasticity within the hippocampal region of up to over 50% six days after MPTP treatment correlating with increased neuronal density in the dentate gyrus, which could not be detected in healthy controls. Our results provide the first indication that new neurons reactively generated following neurodegeneration substantially contribute to the mechanical scaffold of the brain. Diagnostic neuroimaging may thus target on regions of the brain displaying symptomatically elevated elasticity values for the detection of neuronal plasticity following neurodegeneration.	[Klein, Charlotte; Hain, Elisabeth G.; Steiner, Barbara] Charite, Dept Neurol, D-13353 Berlin, Germany; [Braun, Juergen] Charite, Inst Med Informat, D-13353 Berlin, Germany; [Riek, Kerstin; Sack, Ingolf] Charite, Dept Radiol, D-13353 Berlin, Germany; [Mueller, Susanne] Ctr Stroke Res Berlin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Steiner, B (corresponding author), Charite, Dept Neurol, D-13353 Berlin, Germany.	barbara.steiner@charite.de		Braun, Jurgen/0000-0001-5183-7546; Hain, Elisabeth G./0000-0001-5755-5339; Steiner, Barbara/0000-0003-2106-4532; Mueller, Susanne/0000-0002-5053-2211	German Research Foundation [Sa 901/4]; Else Kroener Fresenius Foundation [P21/10//A141/09]	German Research Foundation(German Research Foundation (DFG)); Else Kroener Fresenius Foundation	The work was supported by the German Research Foundation (Sa 901/4 to IS) and by the Else Kroener Fresenius Foundation (P21/10//A141/09 to BS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni R, 2005, J NEUROSCI, V25, P8217, DOI 10.1523/JNEUROSCI.1859-05.2005; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Baker SA, 2004, EUR J NEUROSCI, V20, P575, DOI 10.1111/j.1460-9568.2004.03486.x; Barnhill E, 2013, PHYSIOL MEAS, V34, P1675, DOI 10.1088/0967-3334/34/12/1675; Borta A, 2007, J NEUROCHEM, V100, P587, DOI 10.1111/j.1471-4159.2006.04241.x; Clayton EH, 2011, PHYS MED BIOL, V56, P2391, DOI 10.1088/0031-9155/56/8/005; Clayton EH, 2012, J R SOC INTERFACE, V9, P2899, DOI 10.1098/rsif.2012.0325; Freimann FB, 2013, NMR BIOMED, V26, P1534, DOI 10.1002/nbm.2987; Freundlieb N, 2006, J NEUROSCI, V26, P2321, DOI 10.1523/JNEUROSCI.4859-05.2006; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Gasbarri A, 1997, PROG NEURO-PSYCHOPH, V21, P1, DOI 10.1016/S0278-5846(96)00157-1; GASBARRI A, 1994, BRAIN RES, V668, P71, DOI 10.1016/0006-8993(94)90512-6; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Guo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071807; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Huehnchen P, 2011, GLIA, V59, P132, DOI 10.1002/glia.21082; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; Johnson CL, 2013, NEUROIMAGE, V79, P145, DOI 10.1016/j.neuroimage.2013.04.089; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kippin TE, 2005, J NEUROSCI, V25, P5815, DOI 10.1523/JNEUROSCI.1120-05.2005; Klaissle P, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-132; KOPIN IJ, 1987, ENVIRON HEALTH PERSP, V75, P45, DOI 10.2307/3430575; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Kurkowska-Jastrzebska I, 1999, EXP NEUROL, V156, P50, DOI 10.1006/exnr.1998.6993; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lesemann A, 2012, BRAIN RES, V1457, P51, DOI 10.1016/j.brainres.2012.03.046; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Lu YB, 2011, FASEB J, V25, P624, DOI 10.1096/fj.10-163790; Murphy MC, 2011, J MAGN RESON IMAGING, V34, P494, DOI 10.1002/jmri.22707; Muthupillai R, 1996, NAT MED, V2, P601, DOI 10.1038/nm0596-601; Papazoglou S, 2008, PHYS MED BIOL, V53, P3147, DOI 10.1088/0031-9155/53/12/005; Park JH, 2010, EXP NEUROL, V222, P267, DOI 10.1016/j.expneurol.2010.01.004; Peng J, 2008, NEUROSCIENCE, V153, P664, DOI 10.1016/j.neuroscience.2008.02.063; Posnansky O, 2012, PHYS MED BIOL, V57, P4023, DOI 10.1088/0031-9155/57/12/4023; Riek K, 2012, NEUROIMAGE-CLIN, V1, P81, DOI 10.1016/j.nicl.2012.09.003; Sack I, 2008, NMR BIOMED, V21, P265, DOI 10.1002/nbm.1189; Sack I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023451; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; SCATTON B, 1980, NEUROSCI LETT, V18, P125, DOI 10.1016/0304-3940(80)90314-6; Schregel K, 2012, P NATL ACAD SCI USA, V109, P6650, DOI 10.1073/pnas.1200151109; Steiner B, 2008, NEUROSCIENCE, V154, P521, DOI 10.1016/j.neuroscience.2008.04.023; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Streitberger KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029888; Streitberger KJ, 2011, NMR BIOMED, V24, P385, DOI 10.1002/nbm.1602; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Tully B, 2011, J FLUID MECH, V667, P188, DOI 10.1017/S0022112010004428; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Weaver JB, 2012, PHYS MED BIOL, V57, P7275, DOI 10.1088/0031-9155/57/22/7275; Wuerfel J, 2010, NEUROIMAGE, V49, P2520, DOI 10.1016/j.neuroimage.2009.06.018; Yang P, 2008, J NEUROSCI, V28, P2231, DOI 10.1523/JNEUROSCI.3574-07.2008	52	45	45	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92582	10.1371/journal.pone.0092582	http://dx.doi.org/10.1371/journal.pone.0092582			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667730	Green Published, gold			2022-12-27	WOS:000333675600051
J	Liu, SH; Li, YJ; Wu, HH; Lee, CC; Lin, CY; Weng, CH; Chen, YC; Chang, MY; Hsu, HH; Fang, JT; Hung, CC; Yang, CW; Tian, YC				Liu, Shou-Hsuan; Li, Yi-Jung; Wu, Hsin-Hsu; Lee, Cheng-Chia; Lin, Chan-Yu; Weng, Cheng-Hao; Chen, Yung-Chang; Chang, Ming-Yang; Hsu, Hsiang-Hao; Fang, Ji-Tseng; Hung, Cheng-Chieh; Yang, Chih-Wei; Tian, Ya-Chung			High-Sensitivity C-Reactive Protein Predicts Mortality and Technique Failure in Peritoneal Dialysis Patients	PLOS ONE			English	Article							RESIDUAL RENAL-FUNCTION; SOLUTE TRANSPORT RATE; SERUM-ALBUMIN; HEMODIALYSIS-PATIENTS; CARDIOVASCULAR-DISEASE; CHRONIC INFLAMMATION; ALL-CAUSE; MEMBRANE-TRANSPORT; SURVIVAL; OUTCOMES	Introduction: An elevated level of serum C-reactive protein (CRP) is widely considered an indicator of an underlying inflammatory disease and a long-term prognostic predictor for dialysis patients. This cross-sectional cohort study was designed to assess the correlation between the level of high-sensitivity CRP (HS-CRP) and the outcome of peritoneal dialysis (PD) patients. Methods: A total of 402 patients were stratified into 3 tertiles (lower, middle, upper) according to serum HS-CRP level and and followed up from October 2009 to September 2011. During follow-up, cardiovascular events, infection episodes, technique failure, and mortality rate were recorded. Results: During the 24-month follow-up, 119 of 402 patients (29.6%) dropped out from PD, including 28 patients (7.0%) who died, 81 patients (20.1%) who switched to hemodialysis, and 10 patients (2.5%) who underwent kidney transplantation. The results of Kaplan-Meier analysis and log-rank test demonstrated a significant difference in the cumulative patient survival rate across the 3 tertiles (the lowest rate in upper tertile). On multivariate Cox regression analysis, only higher HS-CRP level, older age, the presence of diabetes mellitus (DM), lower serum albumin level, and the occurrence of cardiovascular events during follow-up were identified as independent predictors of mortality. Every 1 mg/L increase in HS-CRP level was independently predictive of a 1.4% increase in mortality. Multivariate Cox regression analysis also showed that higher HS-CRP level, the presence of DM, lower hemoglobin level, lower serum albumin level, higher dialysate/plasma creatinine ratio, and the occurrence of infective episodes and cardiovascular events during follow-up were independent predictors of technique failure. Conclusions: The present study shows the importance of HS-CRP in the prediction of 2-year mortality and technique survival in PD patients independent of age, diabetes, hypoalbuminemia, and the occurrence of cardiovascular events.	[Liu, Shou-Hsuan; Li, Yi-Jung; Wu, Hsin-Hsu; Lee, Cheng-Chia; Lin, Chan-Yu; Weng, Cheng-Hao; Chen, Yung-Chang; Chang, Ming-Yang; Hsu, Hsiang-Hao; Fang, Ji-Tseng; Hung, Cheng-Chieh; Yang, Chih-Wei; Tian, Ya-Chung] Chang Gung Univ, Kidney Res Ctr, Dept Nephrol, Lin Kou Chang Gung Mem Hosp, Tao Yuan, Taiwan; [Liu, Shou-Hsuan; Li, Yi-Jung; Wu, Hsin-Hsu; Lee, Cheng-Chia; Lin, Chan-Yu; Weng, Cheng-Hao; Chen, Yung-Chang; Chang, Ming-Yang; Hsu, Hsiang-Hao; Fang, Ji-Tseng; Hung, Cheng-Chieh; Yang, Chih-Wei; Tian, Ya-Chung] Chang Gung Univ, Dept Med, Tao Yuan, Taiwan; [Li, Yi-Jung; Wu, Hsin-Hsu; Weng, Cheng-Hao] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University	Tian, YC (corresponding author), Chang Gung Univ, Kidney Res Ctr, Dept Nephrol, Lin Kou Chang Gung Mem Hosp, Tao Yuan, Taiwan.	dryctian@adm.cgmh.org.tw	Chang, Ming-Yang/AGH-5397-2022	Chang, Ming-Yang/0000-0001-8899-0376; Lee, Cheng-Chia/0000-0002-6973-5908; Wu, Hsin Hsu/0000-0002-0028-7836				Ates K, 2005, PERITON DIALYSIS INT, V25, P256; Avram Morrell M, 2005, Adv Perit Dial, V21, P154; Bargman JM, 2001, J AM SOC NEPHROL, V12, P2158, DOI 10.1681/ASN.V12102158; Brimble KS, 2006, J AM SOC NEPHROL, V17, P2591, DOI 10.1681/ASN.2006030194; Calle MC, 2012, DIABETES METAB; Chen HY, 2010, QJM-INT J MED, V103, P837, DOI 10.1093/qjmed/hcq036; Cho JH, 2010, NEPHROL DIAL TRANSPL, V25, P1964, DOI 10.1093/ndt/gfp767; Choi HY, 2010, NEPHROL DIAL TRANSPL, V25, P1266, DOI 10.1093/ndt/gfp598; Chung SH, 2003, NEPHROL DIAL TRANSPL, V18, P590, DOI 10.1093/ndt/18.3.590; Chung SH, 2001, NEPHROL DIAL TRANSPL, V16, P2240, DOI 10.1093/ndt/16.11.2240; Churchill DN, 1998, J AM SOC NEPHROL, V9, P1285; Corrado E, 2007, G ITAL CARDIOL, V8, P327, DOI 10.1714/681.7922; Don BR, 2000, J NEPHROL, V13, P249; Ducloux D, 2002, KIDNEY INT, V62, P1417, DOI 10.1111/j.1523-1755.2002.kid562.x; Filiopoulos Vasilis, 2009, Inflammation & Allergy Drug Targets, V8, P369; Filiopoulos V, 2009, INT J ARTIF ORGANS, V32, P872, DOI 10.1177/039139880903201206; Fine A, 2002, KIDNEY INT, V61, P615, DOI 10.1046/j.1523-1755.2002.00145.x; Herzig KA, 2001, J AM SOC NEPHROL, V12, P814, DOI 10.1681/ASN.V124814; Honda H, 2006, AM J KIDNEY DIS, V47, P139, DOI 10.1053/j.ajkd.2005.09.014; Johnson David W, 2007, Hemodial Int, V11, P1, DOI 10.1111/j.1542-4758.2007.00146.x; Jones CH, 1997, NEPHROL DIAL TRANSPL, V12, P554, DOI 10.1093/ndt/12.3.554; Kang SH, 2012, RENAL FAILURE, V34, P149, DOI 10.3109/0886022X.2011.646808; Kaul K, 2010, CURR DIABETES REV, V6, P294, DOI 10.2174/157339910793360851; Kavanagh D, 2004, NEPHROL DIAL TRANSPL, V19, P2584, DOI 10.1093/ndt/gfh386; Kaysen GA, 2000, KIDNEY INT, V58, P346, DOI 10.1046/j.1523-1755.2000.00172.x; Kaysen GA, 2009, CLIN J AM SOC NEPHRO, V4, pS56, DOI 10.2215/CJN.03090509; Krediet RT, 2010, NAT REV NEPHROL, V6, P451, DOI 10.1038/nrneph.2010.68; Lacson E, 2004, SEMIN DIALYSIS, V17, P438, DOI 10.1111/j.0894-0959.2004.17604.x; Li PKT, 2005, PERITON DIALYSIS INT, V25, pS80; Liao CT, 2009, NEPHROL DIAL TRANSPL, V24, P2909, DOI 10.1093/ndt/gfp056; Meuwese CL, 2011, NAT REV NEPHROL, V7, P166, DOI 10.1038/nrneph.2011.2; Mujais S, 2006, KIDNEY INT, V70, pS21, DOI 10.1038/sj.ki.5001912; Noh H, 1998, PERITON DIALYSIS INT, V18, P387; Nolan CR, 2005, J AM SOC NEPHROL, V16, pS120, DOI 10.1681/ASN.2005060662; Oh KH, 2008, NEPHROL DIAL TRANSPL, V23, P2356, DOI 10.1093/ndt/gfm921; OWEN WF, 1993, NEW ENGL J MED, V329, P1001, DOI 10.1056/NEJM199309303291404; Panichi V, 2000, BLOOD PURIFICAT, V18, P183, DOI 10.1159/000014417; Pecoits-Filho R, 2004, PERITON DIALYSIS INT, V24, P327; Perez-Flores Isabel, 2007, Adv Perit Dial, V23, P140; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Rumpsfeld M, 2006, J AM SOC NEPHROL, V17, P271, DOI 10.1681/ASN.2005050566; Stenvinkel P, 2005, BLOOD PURIFICAT, V23, P72, DOI 10.1159/000082014; Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x; Torzewski J, 1998, ARTERIOSCL THROM VAS, V18, P1386, DOI 10.1161/01.ATV.18.9.1386; VOLANAKIS JE, 1981, J IMMUNOL, V126, P1820; Wang AYM, 2009, NEPHROL DIAL TRANSPL, V24, P3826, DOI 10.1093/ndt/gfp325; Wang AYM, 2003, J AM SOC NEPHROL, V14, P1871, DOI 10.1097/01.ASN.0000070071.57901.B3; Wang T, 1999, PERITON DIALYSIS INT, V19, P17; Wanner C, 2002, NEPHROL DIAL TRANSPL, V17, P29, DOI 10.1093/ndt/17.suppl_8.29; Wanner C, 2009, SEMIN DIALYSIS, V22, P438, DOI 10.1111/j.1525-139X.2009.00596.x; Westhuyzen J, 2005, ANN CLIN LAB SCI, V35, P46; Windgassen EB, 2011, POSTGRAD MED, V123, P114, DOI 10.3810/pgm.2011.01.2252; Yeun JY, 2000, AM J KIDNEY DIS, V35, P469, DOI 10.1016/S0272-6386(00)70200-9; Yeun JY, 1997, AM J KIDNEY DIS, V30, P923, DOI 10.1016/S0272-6386(97)90105-0; Zalunardo NY, 2007, KIDNEY INT, V71, P687, DOI 10.1038/sj.ki.5002127	55	24	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93063	10.1371/journal.pone.0093063	http://dx.doi.org/10.1371/journal.pone.0093063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667814	gold, Green Published, Green Submitted			2022-12-27	WOS:000333675600134
J	Wadhawan, M; Singh, N; Rathaur, S				Wadhawan, Mohit; Singh, Neetu; Rathaur, Sushma			Inhibition of Cathepsin B by E-64 Induces Oxidative Stress and Apoptosis in Filarial Parasite	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; SETARIA-CERVI; CELL-DEATH; CYSTEINE PROTEASES; STRUCTURAL BASIS; ACID; IDENTIFICATION; PURIFICATION; PHOSPHATASES; OXIDASE	Background: Current available antifilarial drug strategies only eliminate the larval stages of filarial parasites. Therefore, there is an urgent need of drugs which are macrofilaricidals. Identification of molecular targets crucial for survival of parasite is a prerequisite for drug designing. Cathepsin B, a cysteine protease family member is known to play crucial role in the normal growth, digestion of nutrients, exsheathment of the helminth parasites. Therefore, we targeted this enzyme in the filarial parasite using its specific inhibitor, E-64. Methods and Findings: We have exposed the parasites to E-64 and observed their motility and viability at various time intervals. It caused marked decrease in the motility and viability of the parasites ultimately leading to their death after 8 hours. It is well known that E-64 protects the cell from apoptosis, however, it causes apoptotic effect in carcinoma cell lines. To understand the mechanism of action of E-64 on parasite survival, we have measured levels of different apoptotic markers in the treated parasites. E-64 significantly reduced the level of ced-9 and activity of tyrosine phosphatases, cytochrome c oxidase. It also activated ced-3, homolog of mammalian caspase 3 suggesting initiation of an apoptotic like event in the filarial parasites. Different antioxidant enzymes were also evaluated to further explore the mechanism behind the death of the parasites. There was marked decrease in the level of GSH and activity of Glutathione reductase and glutathione-s-transferase leading to increased generation of reactive oxygen species. This led to the induced oxidation of fatty acids and protein which might alter the mitochondrial membrane permeability. Conclusion: This study suggests that inhibition of cathepsin B by E-64 generates oxidative stress followed by mitochondrial mediated apoptotic like event in filarial parasites leading to their death. Hence, suggesting filarial cathepsin B as a potential chemotherapeutic target for lymphatic filariasis.	[Wadhawan, Mohit; Singh, Neetu; Rathaur, Sushma] Banaras Hindu Univ, Fac Sci, Dept Biochem, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Rathaur, S (corresponding author), Banaras Hindu Univ, Fac Sci, Dept Biochem, Varanasi 221005, Uttar Pradesh, India.	surathaur@rediffmail.com	Wadhawan, Mohit/GYJ-2459-2022		Alexander von Humboldt, Germany; Council of Scientific and Industrial research, India	Alexander von Humboldt, Germany; Council of Scientific and Industrial research, India(Council of Scientific & Industrial Research (CSIR) - India)	Authors gratefully acknowledge Alexander von Humboldt, Germany and Council of Scientific and Industrial research, India for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthi SK, 2009, AM J TROP MED HYG, V80, P764, DOI 10.4269/ajtmh.2009.80.764; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Barrett A.J., 1997, PROTEINASES MAMMALIA, P240; Behm CA, 2005, TRENDS PARASITOL, V21, P97, DOI 10.1016/j.pt.2004.12.003; Behm CA, 2000, PARASITOL TODAY, V16, P202, DOI 10.1016/S0169-4758(99)01620-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brindley PJ, 1997, MOL BIOCHEM PARASIT, V89, P1, DOI 10.1016/S0166-6851(97)00098-4; Caffrey CR, 1997, PARASITOL RES, V83, P632, DOI 10.1007/s004360050310; CARLBERG I, 1981, ANAL BIOCHEM, V116, P531, DOI 10.1016/0003-2697(81)90398-5; Castino R, 2002, INT J CANCER, V97, P775, DOI 10.1002/ijc.10139; Chantree P, 2013, EXP PARASITOL, V135, P102, DOI 10.1016/j.exppara.2013.06.010; Choi HS, 2006, J IMMUNOASS IMMUNOCH, V27, P31, DOI 10.1080/15321810500403722; Correnti JA, 2005, MOL BIOCHEM PARASIT, V143, P209, DOI 10.1016/j.molbiopara.2005.06.007; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Ericson NG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002689; Ginger C.D., 1983, WHOOCPOCT831; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hemachand T, 2002, J CELL SCI, V115, P2053; HEYNEMAN RA, 1984, J LEUKOCYTE BIOL, V36, P751, DOI 10.1002/jlb.36.6.751; Horvitz HR, 1999, CANCER RES, V59, p1701S; KATUNUMA N, 1995, METHOD ENZYMOL, V251, P382, DOI 10.1016/0076-6879(95)51142-3; KAUSHAL NA, 1987, IMMUNOL INVEST, V16, P139, DOI 10.3109/08820138709030571; Kim R, 2005, CANCER-AM CANCER SOC, V103, P1551, DOI 10.1002/cncr.20947; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Levinthal DJ, 2005, J BIOL CHEM, V280, P5875, DOI 10.1074/jbc.M410771200; Liu LX, 1996, NEW ENGL J MED, V334, P1178, DOI 10.1056/NEJM199605023341808; Lopez CJ, 2005, NEUROSCI LETT, V386, P78, DOI 10.1016/j.neulet.2005.04.089; Malla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013731; Matsumoto K, 1999, BIOPOLYMERS, V51, P99, DOI 10.1002/(SICI)1097-0282(1999)51:1<99::AID-BIP11>3.0.CO;2-R; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Paradies G, 1998, FEBS LETT, V424, P155, DOI 10.1016/S0014-5793(98)00161-6; Pokharel DR, 2009, PARASITOL RES, V104, P1399, DOI 10.1007/s00436-009-1336-x; Rozman-Pungercar J, 2003, CELL DEATH DIFFER, V10, P881, DOI 10.1038/sj.cdd.4401247; Saini P, 2012, PARASITOL INT, V61, P520, DOI 10.1016/j.parint.2012.04.002; Schroeter H, 2001, BIOCHEM J, V358, P547, DOI 10.1042/0264-6021:3580547; Sener G, 2005, FUND CLIN PHARMACOL, V19, P155, DOI 10.1111/j.1472-8206.2005.00322.x; Singh A, 2005, BIOCHEM BIOPH RES CO, V331, P1069, DOI 10.1016/j.bbrc.2005.03.235; Singh A, 2010, BIOCHIMIE, V92, P894, DOI 10.1016/j.biochi.2010.03.018; TAGA EM, 1982, ARCH BIOCHEM BIOPHYS, V214, P505, DOI 10.1016/0003-9861(82)90054-6; Tort J, 1999, ADV PARASIT, V43, P161, DOI 10.1016/S0065-308X(08)60243-2; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Tsou PS, 2012, ARTHRITIS RHEUM-US, V64, P1978, DOI 10.1002/art.34336; von Haefen C, 2003, ONCOGENE, V22, P2236, DOI 10.1038/sj.onc.1206280; World Health Organization, 2010, WHO GLOB PROGR EL LY; Yadav SS, 2013, PARASITOL INT, V62, P193, DOI 10.1016/j.parint.2012.12.008; Yamamoto A, 2002, BBA-PROTEIN STRUCT M, V1597, P244, DOI 10.1016/S0167-4838(02)00284-4	50	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93161	10.1371/journal.pone.0093161	http://dx.doi.org/10.1371/journal.pone.0093161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667798	Green Submitted, gold, Green Published			2022-12-27	WOS:000333675600151
J	Azad, GK; Singh, V; Tomar, RS				Azad, Gajendra Kumar; Singh, Vikash; Tomar, Raghuvir S.			Assessment of the Biological Pathways Targeted by Isocyanate Using N-Succinimidyl N-Methylcarbamate in Budding Yeast Saccharomyces cerevisiae	PLOS ONE			English	Article							RIBONUCLEOTIDE REDUCTASE INHIBITOR; HUMAN RAD52 PROTEIN; OXIDATIVE STRESS; DNA-DAMAGE; GLUTATHIONE PEROXIDASES; CHROMATIN; ADDUCTS; EBSELEN; BHOPAL; GAS	Isocyanates, a group of low molecular weight aromatic and aliphatic compounds possesses the functional isocyanate group. They are highly toxic in nature hence; we used N-succinimidyl N-methylcarbamate (NSNM), a surrogate chemical containing a functional isocyanate group to understand the mode of action of this class of compounds. We employed budding yeast Saccharomyces cerevisiae as a model organism to study the pathways targeted by NSNM. Our screening with yeast mutants revealed that it affects chromatin, DNA damage response, protein-ubiquitylation and chaperones, oxidative stress, TOR pathway and DNA repair processes. We also show that NSNM acts as an epigenetic modifier as its treatment causes reduction in global histone acetylation and formation of histone adducts. Cells treated with NSNM exhibited increase in mitochondrial membrane potential as well as intracellular ROS levels and the effects were rescued by addition of reduced glutathione to the medium. We also report that deletion of SOD1 and SOD2, the superoxide dismutase in Saccharomyces cerevisiae displayed hypersensitivity to NSNM. Furthermore, NSNM treatment causes rapid depletion of total glutathione and reduced glutathione. We also demonstrated that NSNM induces degradation of Sml1, a ribonucleotide reductase inhibitor involved in regulating dNTPs production. In summary, we define the various biological pathways targeted by isocyanates.	[Azad, Gajendra Kumar; Singh, Vikash; Tomar, Raghuvir S.] Indian Inst Sci Educ & Res, Dept Biol Sci, Lab Chromatin Biol, Bhopal, India	Indian Institute of Science Education & Research (IISER) - Bhopal	Tomar, RS (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Lab Chromatin Biol, Bhopal, India.	rst@iiserb.ac.in	Azad, Gajendra/K-3381-2014; Azad, Gajendra Kumar/AAC-7014-2019; Singh, Vikash/HCI-9902-2022	Azad, Gajendra/0000-0003-0338-3265; Singh, Vikash/0000-0002-5325-1386; Azad, Gajendra Kumar/0000-0001-5478-526X	Council of Scientific and Industrial Research (CSIR); Department of Biotechnology (DBT), Govt. of India; Department of Science & Technology (DST), Govt. of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT), Govt. of India(Department of Biotechnology (DBT) India); Department of Science & Technology (DST), Govt. of India(Department of Science & Technology (India))	Council of Scientific and Industrial Research (CSIR) is acknowledged for fellowship support to GKA. This work was financially supported by the Department of Biotechnology (DBT) and Department of Science & Technology (DST), Govt. of India to RST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreson BL, 2010, NUCLEIC ACIDS RES, V38, P6490, DOI 10.1093/nar/gkq552; Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; Azad GK, 2012, BIOCHEM PHARMACOL, V83, P296, DOI 10.1016/j.bcp.2011.10.011; Azad GK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059003; Azad GK, 2014, FEBS OPEN BIO; Azad GK, 2014, MOL BIOL REP; Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; Balkrishna SJ, 2014, ORG BIOMOL CHEM, V12, P1215, DOI 10.1039/c4ob00027g; Balkrishna SJ, 2010, ORG LETT, V12, P5394, DOI 10.1021/ol102027j; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barzilai A, 2004, DNA REPAIR, V3, P1109, DOI 10.1016/j.dnarep.2004.03.002; Baumann RP, 2005, ONCOL RES, V15, P313, DOI 10.3727/096504005776404553; Beyerbach A, 2006, CHEM RES TOXICOL, V19, P1611, DOI 10.1021/tx0600853; BHARUCHA EP, 1987, INDIAN J MED RES, V86, P59; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; Chen DQ, 2013, J BIOL CHEM, V288, P21678, DOI 10.1074/jbc.M113.476630; DANIEL CS, 1987, INDIAN J MED RES, V86, P83; Devasagayam T P A, 2004, J Assoc Physicians India, V52, P794; Devasagayam TPA, 2009, INDIAN J BIOCHEM BIO, V46, P5; Dutkiewicz R, 2003, J BIOL CHEM, V278, P29719, DOI 10.1074/jbc.M303527200; Edwards TM, 2007, ENVIRON HEALTH PERSP, V115, P1264, DOI 10.1289/ehp.9951; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Fisseler-Eckhoff A, 2011, INT J ENV RES PUB HE, V8, P3672, DOI 10.3390/ijerph8093672; Golla U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064798; Harris Thurl E, 2003, Sci STKE, V2003, pre15; Herrero E, 2008, BBA-GEN SUBJECTS, V1780, P1217, DOI 10.1016/j.bbagen.2007.12.004; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Johnston M, 1996, CURR BIOL, V6, P500, DOI 10.1016/S0960-9822(02)00526-2; KANHERE S, 1987, INDIAN J MED RES, V86, P77; Koharyova M, 2008, GEN PHYSIOL BIOPHYS, V27, P71; Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006; Lushchak V, 2010, BIOCHEMISTRY-MOSCOW+, V75, P281, DOI 10.1134/S0006297910030041; Mandal P, 2012, BIOCHEM BIOPH RES CO, V421, P261, DOI 10.1016/j.bbrc.2012.03.149; MARTINEZ J, 1982, J MED CHEM, V25, P178, DOI 10.1021/jm00344a017; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mishra PK, 2009, GENET MOL RES, V8, P129, DOI 10.4238/vol8-1gmr544; Mishra PK, 2008, J BIOCHEM MOL TOXIC, V22, P429, DOI 10.1002/jbt.20260; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; Parsons CA, 2000, EMBO J, V19, P4175, DOI 10.1093/emboj/19.15.4175; Pidoux A, 2004, METHODS, V33, P252, DOI 10.1016/j.ymeth.2003.11.021; SEGAL A, 1989, CHEM-BIOL INTERACT, V69, P359, DOI 10.1016/0009-2797(89)90122-1; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Singh V, 2014, FEBS LETT; Stasiak AZ, 2000, CURR BIOL, V10, P337, DOI 10.1016/S0960-9822(00)00385-7; TAMURA N, 1992, MUTAT RES, V283, P97, DOI 10.1016/0165-7992(92)90140-D; Tang HMV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000697; Tosatto SCE, 2008, ANTIOXID REDOX SIGN, V10, P1515, DOI 10.1089/ars.2008.2055; Wu B, 2011, CHEM-EUR J, V17, P3562, DOI 10.1002/chem.201100298; Wu CY, 2007, J BIOL CHEM, V282, P2184, DOI 10.1074/jbc.M606639200; Zhao XL, 2001, EMBO J, V20, P3544, DOI 10.1093/emboj/20.13.3544; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299	53	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92993	10.1371/journal.pone.0092993	http://dx.doi.org/10.1371/journal.pone.0092993			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664350	gold, Green Published, Green Submitted			2022-12-27	WOS:000333459900140
J	Holzer, LA; Sevelda, F; Fraberger, G; Bluder, O; Kickinger, W; Holzer, G				Holzer, Lukas A.; Sevelda, Florian; Fraberger, Georg; Bluder, Olivia; Kickinger, Wolfgang; Holzer, Gerold			Body Image and Self-Esteem in Lower-Limb Amputees	PLOS ONE			English	Article							QUALITY-OF-LIFE; RHEUMATOID-ARTHRITIS; AESTHETIC SURGERY; AMPUTATION; PEOPLE; PAIN; ADJUSTMENT; EPIDEMIOLOGY; DISEASE; SCALE	Background: Limb amputation is often an inevitable procedure in the advanced condition of various diseases and poses a dramatic impact on a patient's life. The aim of the present study is to analyze the impact of lower-limb amputations on aesthetic factors such as body image and self-esteem as well as quality of life (QoL). Methods: 298 patients (149 uni- or bilateral lower-limb amputees and 149 controls) were included in this cross-sectional study in three centers. Demographic data was collected and patients received a 118-item questionnaire including the Multidimensional Body-Self Relations Questionnaire (MBSRQ), the Rosenberg Self-esteem (RSE) scale and the SF-36 Health Survey (QoL). ANOVA and student's t-test were used for statistical analysis. Results: Unilateral lower-limb amputees showed a significant lower MBSRQ score of 3.07 +/- 0.54 compared with 3.41 +/- 0.34 in controls (p<0.001) and a lower score in the RSE compared to controls (21.63 +/- 4.72 vs. 21.46 +/- 5.86). However, differences were not statistically significant (p = 0.36). Patients with phantom pain sensation had a significantly reduced RSE (p = 0.01). The SF-36 health survey was significantly lower in patients with lower-limb amputation compared to controls (42.17 +/- 14.47 vs. 64.05 +/- 12.39) (p<0.001). Conclusion: This study showed that lower-limb amputations significantly influence patients' body image and QoL. Self-esteem seems to be an independent aspect, which is not affected by lower-limb amputation. However, self-esteem is influenced significantly by phantom pain sensation.	[Holzer, Lukas A.] Med Univ Graz, Dept Orthopaed Surg, Graz, Austria; [Sevelda, Florian; Fraberger, Georg; Holzer, Gerold] Med Univ Vienna, Dept Orthopaed, Vienna, Austria; [Bluder, Olivia] Kompetenzzentrum Automobil & Ind Elekt KAI GmbH, Villach, Austria; [Kickinger, Wolfgang] Orthopad Rehabil Zentrum SKA Zicksee, St Andra, Austria	Medical University of Graz; Medical University of Vienna; KAI	Holzer, LA (corresponding author), Med Univ Graz, Dept Orthopaed Surg, Graz, Austria.	lukas.holzer@medunigraz.at	Holzer, Lukas/AAJ-4581-2020; Holzer, Gerold/AAD-6905-2021	Pfeiler, Olivia/0000-0002-7644-7656				Adamson Peter A, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P295, DOI 10.1097/00020840-200308000-00014; Alagoz MS, 2003, AESTHET PLAST SURG, V27, P345, DOI 10.1007/s00266-003-3028-8; Atherton R, 2006, DISABIL REHABIL, V28, P1201, DOI 10.1080/09638280600551674; Bode C, 2010, PSYCHOL HEALTH MED, V15, P672, DOI 10.1080/13548506.2010.507774; Breakey JW, 1997, J PROSTHET ORTHOT, V9, P58; Bullinger M, 1998, SF 36 FRAGEBOGEN ZUM; Caraceni A, 2002, J PAIN SYMPTOM MANAG, V23, P239, DOI 10.1016/S0885-3924(01)00409-2; Carr AJ, 1999, OSTEOARTHR CARTILAGE, V7, P230, DOI 10.1053/joca.1998.0154; Carroll P, 1999, J BEHAV MED, V22, P59, DOI 10.1023/A:1018799618864; Cash TF, MBSRQ USERS MANUAL; Ching S, 2003, PLAST RECONSTR SURG, V111, P469, DOI 10.1097/01.PRS.0000036041.67101.48; de Vries HJ, 2012, DISABIL REHABIL, V34, P443, DOI 10.3109/09638288.2011.607551; Ephraim PL, 2003, ARCH PHYS MED REHAB, V84, P747, DOI 10.1016/S0003-9993(03)04932-8; Etcoff N., 1999, SURVIVAL PRETTIEST S; Ferring D, 1996, DIAGNOSTICA, V42, P284; Fisher K, 1998, INT J REHABIL RES, V21, P355, DOI 10.1097/00004356-199812000-00002; FRANK RG, 1984, BRIT J PSYCHIAT, V144, P493, DOI 10.1192/bjp.144.5.493; Gallagher P, 2004, ARCH PHYS MED REHAB, V85, P730, DOI 10.1016/j.apmr.2003.07.009; Gallagher P, 2007, AM J PHYS MED REHAB, V86, P205, DOI 10.1097/PHM.0b013e3180321439; Geertzen JHB, 2009, DISABIL REHABIL, V31, P522, DOI 10.1080/09638280802240589; Hewitt JP., 2009, OXFORD HDB POSITIVE; Holloway I, 2007, DISABIL REHABIL, V29, P1456, DOI 10.1080/09638280601107260; Horgan O, 2004, DISABIL REHABIL, V26, P837, DOI 10.1080/09638280410001708869; KROL B, 1994, SCAND J RHEUMATOL, V23, P8, DOI 10.3109/03009749409102127; Mayer A, 2008, PROSTHET ORTHOT INT, V32, P363, DOI 10.1080/03093640802024971; Muhlan H, MULTIDIMENSIONAL BOD; Murray CD, 2002, DISABIL REHABIL, V24, P925, DOI 10.1080/09638280210150014; Nagyova I, 2005, PATIENT EDUC COUNS, V58, P55, DOI 10.1016/j.pec.2004.06.011; Novotny MP, 1986, J ASS PEDIAT ONCOL N, V2, P8; Olsen J. M., 2008, SOCIAL PSYCHOL ALIVE; PREUPER HRS, 2008, EUR SPINE J, V17, P1448, DOI DOI 10.1007/S00586-008-0772-0; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Senra H, 2012, CLIN REHABIL, V26, P180, DOI 10.1177/0269215511410731; Thompson J. K., 1999, EXACTING BEAUTY THEO, DOI [10.1037/10312-000, DOI 10.1037/10312-000]; Unwin N, 2000, BRIT J SURG, V87, P328, DOI 10.1046/j.1365-2168.2000.01344.x; Wetterhahn KA, 2002, AM J PHYS MED REHAB, V81, P194, DOI 10.1097/00002060-200203000-00007; Whalen GF, 2001, J SURG ONCOL, V77, P270, DOI 10.1002/jso.1107; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005	38	65	67	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92943	10.1371/journal.pone.0092943	http://dx.doi.org/10.1371/journal.pone.0092943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD7QO	24663958	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900132
J	Oran, PE; Trenchevska, O; Nedelkov, D; Borges, CR; Schaab, MR; Rehder, DS; Jarvis, JW; Sherma, ND; Shen, LH; Krastins, B; Lopez, MF; Schwenke, DC; Reaven, PD; Nelson, RW				Oran, Paul E.; Trenchevska, Olgica; Nedelkov, Dobrin; Borges, Chad R.; Schaab, Matthew R.; Rehder, Douglas S.; Jarvis, Jason W.; Sherma, Nisha D.; Shen, Luhui; Krastins, Bryan; Lopez, Mary F.; Schwenke, Dawn C.; Reaven, Peter D.; Nelson, Randall W.			Parallel Workflow for High-Throughput (> 1,000 Samples/Day) Quantitative Analysis of Human Insulin-Like Growth Factor 1 Using Mass Spectrometric Immunoassay	PLOS ONE			English	Article							FACTOR-I; IGF-I; HORMONE; PLASMA; PROTEINS; INSULIN-LIKE-GROWTH-FACTOR-1; POLYMORPHISMS; POPULATION; BIOMARKERS; RECEPTOR	Insulin-like growth factor 1 (IGF1) is an important biomarker for the management of growth hormone disorders. Recently there has been rising interest in deploying mass spectrometric (MS) methods of detection for measuring IGF1. However, widespread clinical adoption of any MS-based IGF1 assay will require increased throughput and speed to justify the costs of analyses, and robust industrial platforms that are reproducible across laboratories. Presented here is an MS-based quantitative IGF1 assay with performance rating of >1,000 samples/day, and a capability of quantifying IGF1 point mutations and posttranslational modifications. The throughput of the IGF1 mass spectrometric immunoassay (MSIA) benefited from a simplified sample preparation step, IGF1 immunocapture in a tip format, and high-throughput MALDI-TOF MS analysis. The Limit of Detection and Limit of Quantification of the resulting assay were 1.5 mu g/L and 5 mu g/L, respectively, with intra-and inter-assay precision CVs of less than 10%, and good linearity and recovery characteristics. The IGF1 MSIA was benchmarked against commercially available IGF1 ELISA via Bland-Altman method comparison test, resulting in a slight positive bias of 16%. The IGF1 MSIA was employed in an optimized parallel workflow utilizing two pipetting robots and MALDI-TOF-MS instruments synced into one-hour phases of sample preparation, extraction and MSIA pipette tip elution, MS data collection, and data processing. Using this workflow, high-throughput IGF1 quantification of 1,054 human samples was achieved in approximately 9 hours. This rate of assaying is a significant improvement over existing MS-based IGF1 assays, and is on par with that of the enzyme-based immunoassays. Furthermore, a mutation was detected in <1% of the samples (SNP: rs17884626, creating an A -> T substitution at position 67 of the IGF1), demonstrating the capability of IGF1 MSIA to detect point mutations and posttranslational modifications.	[Oran, Paul E.; Trenchevska, Olgica; Nedelkov, Dobrin; Borges, Chad R.; Schaab, Matthew R.; Rehder, Douglas S.; Jarvis, Jason W.; Sherma, Nisha D.; Nelson, Randall W.] Arizona State Univ, Biodesign Inst, Mol Biomarkers Lab, Tempe, AZ 85069 USA; [Shen, Luhui] Arizona State Univ, Biodesign Inst, Ctr Innovat Med, Tempe, AZ USA; [Krastins, Bryan; Lopez, Mary F.] Thermo Fisher Sci, Biomarkers Res Initiat Mass Spectrometry Ctr, Cambridge, MA USA; [Schwenke, Dawn C.; Reaven, Peter D.] Phoenix VA Hlth Care Syst, Phoenix, AZ USA; [Schwenke, Dawn C.] Arizona State Univ, Coll Nursing & Hlth Innovat, Phoenix, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Thermo Fisher Scientific; Arizona State University; Arizona State University-Downtown Phoenix	Oran, PE (corresponding author), Arizona State Univ, Biodesign Inst, Mol Biomarkers Lab, Tempe, AZ 85069 USA.	Paul.Oran@asu.edu	Nedelkov, Dobrin/I-3603-2013	Sherma, Nisha/0000-0002-9454-8653; Schwenke, Dawn/0000-0003-0920-8441	NIH [R01DK082542, R24DK090958]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK090958, R01DK082542] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by NIH grants R01DK082542 and R24DK090958. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addona TA, 2011, NAT BIOTECHNOL, V29, P635, DOI 10.1038/nbt.1899; Baserga R, 1999, EXP CELL RES, V253, P1, DOI 10.1006/excr.1999.4667; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Bobin S, 2001, ANALYST, V126, P1996, DOI 10.1039/b105022m; Borges CR, 2010, CLIN CHEM, V56, P202, DOI 10.1373/clinchem.2009.134858; Brabant G, 2003, HORM RES, V60, P53, DOI 10.1159/000071871; Bystrom C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043457; Bystrom CE, 2011, ANAL CHEM, V83, P9005, DOI 10.1021/ac201800g; Clemmons DR, 2001, HORM RES, V55, P73, DOI 10.1159/000063480; D'Aloisio AA, 2009, CANCER EPIDEM BIOMAR, V18, P954, DOI 10.1158/1055-9965.EPI-08-0856; de Kock SS, 2001, RAPID COMMUN MASS SP, V15, P1191, DOI 10.1002/rcm.363; FRANCIS GL, 1992, J MOL ENDOCRINOL, V8, P213, DOI 10.1677/jme.0.0080213; Frystyk J, 2010, GROWTH HORM IGF RES, V20, P8, DOI 10.1016/j.ghir.2009.09.004; Higashi Y, 2010, TRENDS ENDOCRIN MET, V21, P245, DOI 10.1016/j.tem.2009.12.005; HOPPENER JWM, 1985, HUM GENET, V69, P157, DOI 10.1007/BF00293288; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kay RG, 2009, RAPID COMMUN MASS SP, V23, P3173, DOI 10.1002/rcm.4237; Kay R, 2013, CLIN ENDOCRINOL, V78, P424, DOI 10.1111/cen.12085; Kim JW, 2011, ONCOL REP, V25, P167, DOI 10.3892/or_00001057; Krebs A, 2008, CLIN CHEM LAB MED, V46, P1776, DOI 10.1515/CCLM.2008.349; Laron Z, 2001, J CLIN PATHOL-MOL PA, V54, P311; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; Merimee T.J., 1996, GROWTH HORMONE IGF I; Nedelkov D, 2003, FEBS LETT, V536, P130, DOI 10.1016/S0014-5793(03)00042-5; NELSON RW, 1995, ANAL CHEM, V67, P1153, DOI 10.1021/ac00103a003; Nelson RW, 2004, J PROTEOME RES, V3, P851, DOI 10.1021/pr0499388; NILSSON A, 1986, SCIENCE, V233, P571, DOI 10.1126/science.3523759; Oran PE, 2011, PROTEOM CLIN APPL, V5, P454, DOI 10.1002/prca.201000112; PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; Thevis M, 2008, MASS SPECTROM REV, V27, P35, DOI 10.1002/mas.20154; Trenchevska O, 2010, J PROTEOME RES, V9, P5969, DOI 10.1021/pr1007587	32	36	36	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92801	10.1371/journal.pone.0092801	http://dx.doi.org/10.1371/journal.pone.0092801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664114	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900114
J	Fiorillo, A; di Marino, D; Bertuccini, L; Via, A; Pozio, E; Camerini, S; Ilari, A; Lalle, M				Fiorillo, Annarita; di Marino, Daniele; Bertuccini, Lucia; Via, Allegra; Pozio, Edoardo; Camerini, Serena; Ilari, Andrea; Lalle, Marco			The Crystal Structure of Giardia duodenalis 14-3-3 in the Apo Form: When Protein Post-Translational Modifications Make the Difference	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; ALPHA-SYNUCLEIN; BINDING; POLYGLYCINE; ISOFORMS	The 14-3-3s are a family of dimeric evolutionary conserved pSer/pThr binding proteins that play a key role in multiple biological processes by interacting with a plethora of client proteins. Giardia duodenalis is a flagellated protozoan that affects millions of people worldwide causing an acute and chronic diarrheal disease. The single giardial 14-3-3 isoform ( g14-3-3), unique in the 14-3-3 family, needs the constitutive phosphorylation of Thr214 and the polyglycylation of its C-terminus to be fully functional in vivo. Alteration of the phosphorylation and polyglycylation status affects the parasite differentiation into the cyst stage. To further investigate the role of these post-translational modifications, the crystal structure of the g14-3-3 was solved in the unmodified apo form. Oligomers of g14-3-3 were observed due to domain swapping events at the protein C-terminus. The formation of filaments was supported by TEM. Mutational analysis, in combination with native PAGE and chemical cross-linking, proved that polyglycylation prevents oligomerization. In silico phosphorylation and molecular dynamics simulations supported a structural role for the phosphorylation of Thr214 in promoting target binding. Our findings highlight unique structural features of g14-3-3 opening novel perspectives on the evolutionary history of this protein family and envisaging the possibility to develop anti-giardial drugs targeting g14-3-3.	[Fiorillo, Annarita] Univ Rome Sapienza, Dept Biochem Sci A Rossi Fanelli, Rome, Italy; [Fiorillo, Annarita; Ilari, Andrea] CNR, Inst Mol Biol & Pathol, Rome, Italy; [Fiorillo, Annarita; Ilari, Andrea] Univ Rome Sapienza, Inst Pasteur, Cenci Bolognetti Fdn, Dept Biochem Sci A Rossi Fanelli, Rome, Italy; [di Marino, Daniele; Via, Allegra] Univ Rome Sapienza, Dept Phys, Rome, Italy; [Bertuccini, Lucia] Ist Super Sanita, Dept Hlth & Technol, I-00161 Rome, Italy; [Pozio, Edoardo; Lalle, Marco] Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy; [Camerini, Serena] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome; Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Lalle, M (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	marco.lalle@iss.it	Bertuccini, Lucia/AAI-6683-2021; Lalle, Marco/O-2287-2015; Di Marino, Daniele/AAB-9653-2019; Ilari, Andrea/AAC-7670-2022; Di Marino, Daniele/ABB-2333-2020; Via, Allegra/AAY-7435-2020; Camerini, Serena/A-4637-2017; Ilari, Andrea/T-5501-2017; BERTUCCINI, LUCIA/F-2102-2015	Bertuccini, Lucia/0000-0002-4278-2376; Lalle, Marco/0000-0001-5168-2150; Di Marino, Daniele/0000-0001-6961-3129; Ilari, Andrea/0000-0002-7754-399X; Camerini, Serena/0000-0001-6131-4335; Ilari, Andrea/0000-0002-7754-399X; 	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca [RBFR08F41U]; Istituto Superiore di Sanita [1APC/1303/2011]; Fondazione Istituto Italiano di Tecnologia (IIT); King Abdullah University of Science and Technology (KAUST) [KUK-I1-012-43]	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Istituto Superiore di Sanita; Fondazione Istituto Italiano di Tecnologia (IIT); King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology)	This study has been partially supported by the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (FIRB grant RBFR08F41U), Istituto Superiore di Sanita (1APC/1303/2011), Fondazione Istituto Italiano di Tecnologia (IIT), (grant "Tecniche di Bioinformatica strutturale: Modellizzazione di proteine, docking e simulazione di dinamica molecolare), and the King Abdullah University of Science and Technology (KAUST, grant KUK-I1-012-43). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Aitken A, 2011, SEMIN CELL DEV BIOL, V22, P673, DOI 10.1016/j.semcdb.2011.08.003; [Anonymous], [No title captured], DOI DOI 10.1016/B978-0-12-059820-5.50015-X; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brock TG, 2008, NEUROCHEM RES, V33, P801, DOI 10.1007/s11064-007-9498-3; Brokx SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014827; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GARCIA AE, 1992, PHYS REV LETT, V68, P2696, DOI 10.1103/PhysRevLett.68.2696; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Haladova K, 2012, J STRUCT BIOL, V179, P10, DOI 10.1016/j.jsb.2012.04.016; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim TD, 2004, BIOCHEM BIOPH RES CO, V324, P1352, DOI 10.1016/j.bbrc.2004.09.208; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lalle M, 2006, J BIOL CHEM, V281, P5137, DOI 10.1074/jbc.M509673200; Lalle M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078090; Lalle M, 2012, J PROTEOME RES, V11, P2666, DOI 10.1021/pr3000199; Lalle M, 2011, J BIOL CHEM, V286, P4471, DOI 10.1074/jbc.M110.181511; Lalle M, 2010, INT J PARASITOL, V40, P201, DOI 10.1016/j.ijpara.2009.07.010; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; LOTZ B, 1974, J MOL BIOL, V87, P169, DOI 10.1016/0022-2836(74)90141-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Ohnishi S, 2006, J AM CHEM SOC, V128, P16338, DOI 10.1021/ja066008b; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Ottmann C, 2013, BIOORGAN MED CHEM, V21, P4058, DOI 10.1016/j.bmc.2012.11.028; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rosenquist M, 2000, J MOL EVOL, V51, P446, DOI 10.1007/s002390010107; Rousseau F, 2012, ADV EXP MED BIOL, V747, P137, DOI 10.1007/978-1-4614-3229-6_9; Siles-Lucas MD, 2003, TRENDS PARASITOL, V19, P575, DOI 10.1016/j.pt.2003.10.003; Steinacker P, 2011, SEMIN CELL DEV BIOL, V22, P696, DOI 10.1016/j.semcdb.2011.08.005; Thompson RCA, 2012, ADV PARASIT, V78, P57, DOI 10.1016/B978-0-12-394303-3.00003-7; Thompson RCA, 2000, INT J PARASITOL, V30, P1259, DOI 10.1016/S0020-7519(00)00127-2; Tomassi Laura, 2008, BMC Biochemistry, V9, P21, DOI 10.1186/1471-2091-9-21; Veisova D, 2010, BIOCHEMISTRY-US, V49, P3853, DOI 10.1021/bi100273k; VERLET L, 1967, PHYS REV, V159, P98, DOI 10.1103/PhysRev.159.98; Wan WY, 1999, J MOL BIOL, V286, P1651, DOI 10.1006/jmbi.1999.2551; Williams DM, 2011, BIOCHEM J, V437, P493, DOI 10.1042/BJ20102178; Wurtele M, 2003, EMBO J, V22, P987, DOI 10.1093/emboj/cdg104; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103	53	9	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92902	10.1371/journal.pone.0092902	http://dx.doi.org/10.1371/journal.pone.0092902			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658679	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300143
J	Hernaus, D; van Winkel, R; Gronenschild, E; Habets, P; Kenis, G; Marcelis, M; van Os, J; Myin-Germeys, I; Collip, D				Hernaus, Dennis; van Winkel, Ruud; Gronenschild, Ed; Habets, Petra; Kenis, Gunter; Marcelis, Machteld; van Os, Jim; Myin-Germeys, Inez; Collip, Dina		Genetic Risk Outcome Psychosis GRO	Brain-Derived Neurotrophic Factor/FK506-Binding Protein 5 Genotype by Childhood Trauma Interactions Do Not Impact on Hippocampal Volume and Cognitive Performance	PLOS ONE			English	Article							EARLY-LIFE STRESS; FACTOR VAL66MET POLYMORPHISM; BDNF VAL(66)MET; FKBP5; PSYCHOSIS; GENE; ASSOCIATION; EXPOSURE; REACTIVITY; ADVERSITY	In the development of psychotic symptoms, environmental and genetic factors may both play a role. The reported association between childhood trauma and psychotic symptoms could therefore be moderated by single nucleotide polymorphisms (SNPs) associated with the stress response, such as FK506-binding protein 5 (FKBP5) and brain-derived neurotrophic factor (BDNF). Recent studies investigating childhood trauma by SNP interactions have inconsistently found the hippocampus to be a potential target underlying these interactions. Therefore, more detailed modelling of these effects, using appropriate covariates, is required. We examined whether BDNF/FKBP5 and childhood trauma interactions affected two proxies of hippocampal integrity: (i) hippocampal volume and (ii) cognitive performance on a block design (BD) and delayed auditory verbal task (AVLT). We also investigated whether the putative interaction was different for patients with a psychotic disorder (n = 89) compared to their non-psychotic siblings (n = 95), in order to elicit possible group-specific protective/vulnerability effects. SNPs were rs9296158, rs4713916, rs992105, rs3800373 (FKBP5) and rs6265 (BDNF). In the combined sample, no BDNF/FKBP5 by childhood trauma interactions were apparent for either outcome, and BDNF/FKBP5 by childhood trauma interactions were not different for patients and siblings. The omission of drug use and alcohol consumption sometimes yielded false positives, greatly affected explained error and influenced p-values. The consistent absence of any significant BDNF/FKBP5 by childhood trauma interactions on assessments of hippocampal integrity suggests that the effect of these interactions on psychotic symptoms is not mediated by hippocampal integrity. The importance of appropriate statistical designs and inclusion of relevant covariates should be carefully considered.	[Hernaus, Dennis; van Winkel, Ruud; Gronenschild, Ed; Habets, Petra; Kenis, Gunter; Marcelis, Machteld; van Os, Jim; Myin-Germeys, Inez; Collip, Dina] Maastricht Univ, Sch Mental Hlth & NeuroSci MHeNS, EURON, Dept Psychiat & Psychol,South Limburg Mental Hlth, Maastricht, Netherlands; [van Winkel, Ruud] Catholic Univ Louvain, Univ Psychiat Ctr, Kortenberg, Belgium; [van Os, Jim] Kings Coll London, Kings Hlth Partners, Inst Psychiat, Dept Psychosis Studies, London, England	Maastricht University; Universite Catholique Louvain; University of London; King's College London	van Os, J (corresponding author), Maastricht Univ, Sch Mental Hlth & NeuroSci MHeNS, EURON, Dept Psychiat & Psychol,South Limburg Mental Hlth, Maastricht, Netherlands.	j.vanos@maastrichtuniversity.nl	van Os, Jim/V-8884-2019; van Os, Jim/C-2113-2014; Myin-Germeys, Inez/L-5106-2014; Myin Germeys, Inez/HIR-3364-2022; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Habets, Petra/AAZ-1258-2021	van Os, Jim/0000-0002-7245-1586; Myin Germeys, Inez/0000-0002-3731-4930; Habets, Petra/0000-0001-9184-517X; Hernaus, Dennis/0000-0002-8370-5756; Marcelis, Machteld/0000-0003-0045-9244	Geestkracht program of the Netherlands Organization for Scientific Research (NWO) (GROUP); European Community [HEALTH F2-2009-241909]; National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award; Dutch Medical Research Council (VENI and VIDI grant); European Research Council [ERC-2012-StG -309767]; Eli Lilly; BMS; Lundbeck; Organon; Janssen; GlaxoSmithKline; AstraZeneca; Pfizer; Servier; King Baudouin Foundation; Maastricht University	Geestkracht program of the Netherlands Organization for Scientific Research (NWO) (GROUP)(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission); National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award(NARSAD); Dutch Medical Research Council (VENI and VIDI grant); European Research Council(European Research Council (ERC)European Commission); Eli Lilly(Eli Lilly); BMS(Bristol-Myers Squibb); Lundbeck(Lundbeck Corporation); Organon; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); GlaxoSmithKline(GlaxoSmithKline); AstraZeneca(AstraZeneca); Pfizer(Pfizer); Servier(Servier); King Baudouin Foundation; Maastricht University	This work was sponsored by the Geestkracht program of the Netherlands Organization for Scientific Research (NWO) (GROUP) and the European Community's Seventh Framework Programme under grant agreement HEALTH F2-2009-241909 (EU-GEI consortium). Furthermore, it was sponsored by a 2006 National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award and by the Dutch Medical Research Council (VENI and VIDI grant), and a European Research Council consolidator grant (ERC-2012-StG -309767) to I. Myin-Germeys. J. van Os is or has been an unrestricted research grant holder with, or his institution has received financial compensation as an independent symposium speaker from, Eli Lilly, BMS, Lundbeck, Organon, Janssen, GlaxoSmithKline, AstraZeneca, Pfizer, and Servier. M. Marcelis has received financial compensation as an independent symposium speaker from Eli Lilly and Janssen. G. Kenis has received financial compensation as an independent symposium speaker from Eli Lilly, Janssen and Servier. Ruud van Winkel is supported by the King Baudouin Foundation (Fund Dr. Gustave Delport). Dina Collip is supported by a Maastricht University post-doc Kootstra fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera M, 2009, PSYCHOL MED, V39, P1425, DOI 10.1017/S0033291709005248; Alemany S, 2011, BRIT J PSYCHIAT, V199, P38, DOI 10.1192/bjp.bp.110.083808; Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; Appel K, 2011, NEUROPSYCHOPHARMACOL, V36, P1982, DOI 10.1038/npp.2011.81; Baker LM, 2013, BRAIN IMAGING BEHAV, V7, P196, DOI 10.1007/s11682-012-9215-y; Banner H, 2011, EUR J NEUROSCI, V33, P968, DOI 10.1111/j.1460-9568.2010.07550.x; Bernstein DP, 1997, J AM ACAD CHILD PSY, V36, P340, DOI 10.1097/00004583-199703000-00012; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Carballedo A, 2013, AM J MED GENET B, V162B, P183, DOI 10.1002/ajmg.b.32130; Cohen RA, 2006, BIOL PSYCHIAT, V59, P975, DOI 10.1016/j.biopsych.2005.12.016; Collip D, 2013, BRIT J PSYCHIAT, V202, P261, DOI 10.1192/bjp.bp.112.115972; DEBELLIS MD, 1994, J CLIN ENDOCR METAB, V78, P249, DOI 10.1210/jc.78.2.249; den Hollander B, 2012, J NEUROL NEUROSUR PS, V83, P83, DOI 10.1136/jnnp.2010.228387; Fani N, 2013, JAMA PSYCHIAT, V70, P392, DOI 10.1001/2013.jamapsychiatry.210; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Geibprasert S, 2010, EUR RADIOL, V20, P1492, DOI 10.1007/s00330-009-1668-z; Gerritsen L, 2012, MOL PSYCHIATR, V17, P597, DOI 10.1038/mp.2011.51; Goodman J, 2013, J CHILD PSYCHOL PSYC; Gron G, 2000, NAT NEUROSCI, V3, P404, DOI 10.1038/73980; Habets P, 2012, PSYCHOL MED, V42, P1523, DOI 10.1017/S0033291711002728; Heins M, 2011, AM J PSYCHIAT, V168, P1286, DOI 10.1176/appi.ajp.2011.10101531; Hoy K, 2012, SCHIZOPHRENIA BULL, V38, P1162, DOI 10.1093/schbul/sbr085; Kambeitz JP, 2012, NEUROSCI BIOBEHAV R, V36, P2165, DOI 10.1016/j.neubiorev.2012.07.002; Kelleher I, 2013, AM J PSYCHIAT, V170, P734, DOI 10.1176/appi.ajp.2012.12091169; Keller MC, 2014, BIOL PSYCHIAT, V75, P18, DOI 10.1016/j.biopsych.2013.09.006; Klaassens ER, 2009, PROG NEURO-PSYCHOPH, V33, P889, DOI 10.1016/j.pnpbp.2009.04.011; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lorenzetti V, 2010, SUBST USE MISUSE, V45, P1787, DOI 10.3109/10826084.2010.482443; McGrath J, 2010, ARCH GEN PSYCHIAT, V67, P440, DOI 10.1001/archgenpsychiatry.2010.6; Miller S, 2013, J PSYCHIATR RES, V47, P252, DOI 10.1016/j.jpsychires.2012.10.015; Molendijk ML, 2012, AM J MED GENET B, V159B, P731, DOI 10.1002/ajmg.b.32078; Myin-Germeys I, 2007, CLIN PSYCHOL REV, V27, P409, DOI 10.1016/j.cpr.2006.09.005; Rosazza C, 2009, AM J NEURORADIOL, V30, P1134, DOI 10.3174/ajnr.A1518; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1222; Savitz J, 2007, BIOL PSYCHIAT, V62, P391, DOI 10.1016/j.biopsych.2006.10.017; Scharf SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016883; Smith MA, 1995, ANN NY ACAD SCI, V771, P234, DOI 10.1111/j.1749-6632.1995.tb44684.x; Strange BA, 2002, J NEUROSCI, V22, P523, DOI 10.1523/JNEUROSCI.22-02-00523.2002; Teicher MH, 2012, P NATL ACAD SCI USA, V109, pE563, DOI 10.1073/pnas.1115396109; Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764; UNO H, 1990, DEV BRAIN RES, V53, P157, DOI 10.1016/0165-3806(90)90002-G; Van Bokhoven P, 2011, EUR J NEUROSCI, V33, P1833, DOI 10.1111/j.1460-9568.2011.07668.x; van Winkel R, 2013, CAN J PSYCHIAT, V58, P44, DOI 10.1177/070674371305800109; White MG, 2012, GENES BRAIN BEHAV, V11, P869, DOI 10.1111/j.1601-183X.2012.00837.x; WOOLLEY CS, 1990, BRAIN RES, V531, P225, DOI 10.1016/0006-8993(90)90778-A; Yucel M, 2008, ARCH GEN PSYCHIAT, V65, P694, DOI 10.1001/archpsyc.65.6.694	52	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92722	10.1371/journal.pone.0092722	http://dx.doi.org/10.1371/journal.pone.0092722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658422	Green Submitted, gold, Green Published			2022-12-27	WOS:000333355300120
J	Li, ZJ; Xiang, Y; Xiang, LX; Xiao, YN; Li, FJ; Hao, P				Li, Zhongjun; Xiang, Yang; Xiang, Lixin; Xiao, Yanni; Li, Fengjie; Hao, Ping			ALDH Maintains the Stemness of Lung Adenoma Stem Cells by Suppressing the Notch/CDK2/CCNE Pathway	PLOS ONE			English	Article							CANCER-CELLS; CYCLE ARREST; EXPRESSION; CARCINOMA; PROGRESSION; PHENOTYPES; INDUCTION; LEUKEMIA; MARKERS; HEAD	Objective: To evaluate the expression of ALDH1A1 in lung adenoma stem cells (LASCs) and maintenance of their stemness through the Notch pathway. Methods: LASCs (A549s) were isolated from lung adenoma cells (A549) and identified by their coexpression of CD133 and CD326 and their capacity formulti-directional differentiation. Expression of ALDH1A1 in A549 and A549s cells were evaluated by Real-time PCR. Effects of ALDH1A1 upregulation in A549 cells and its downregulation in A549s cells on the clonogenicity and cell cycle were assessed by colony-forming unit assay. Moreover, the effects of ALDH1A1 on the Notch pathway, and thus on the cell cycle, were studied. Results: A549s cells were successfully isolated and identified. ALDH1A1expression was significantly higher in A549s than in A549 cells. Clonogenicity was significantly decreased in A549s cells treated with ALDH1A1 siRNA. Duration of the G1 stage of the cell cycle increased after ALDH1A1 was overexpressed, or decreased with ALDH1A1 siRNA. ALDH1A1, Notch1, -2, and -3, CDK2, and CCNE1 expression levels were higher in A549s cells than in A549 cells. Expression of Notch1, -2, and -3, CDK2, and CCNE1 was significantly decreased by upregulation of ALDH1A1 in A549 cells, but increased by its interruption in A549s cells. When Notch3 or CDK2 expression was downregulated, the expression levels of ALDH1A1, Notch1, -2, and -3, CDK2, and CCNE1 were reduced in all cell types. Conclusion: ALDH1A1 expression improved clonogenicity and inhibited the cell cycle, maintaining the stemness of the A549s cells; this may involve suppression of the Notch/CDK2/Cyclin pathway.	[Hao, Ping] Third Mil Med Univ, Affiliated Hosp 2, Dept Oncol, Chongqing, Peoples R China; [Li, Zhongjun; Xiang, Yang; Xiang, Lixin; Xiao, Yanni; Li, Fengjie] Third Mil Med Univ, Affiliated Hosp 2, Dept Blood Transfus, Chongqing, Peoples R China	Army Medical University; Army Medical University	Hao, P (corresponding author), Third Mil Med Univ, Affiliated Hosp 2, Dept Oncol, Chongqing, Peoples R China.	haoping833@hotmail.com			National Natural Science Foundation of China [81071911]; Natural Science Foundation Project of Chongqing [CSTC2009BB5148]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing(Natural Science Foundation of Chongqing)	This study was supported by the National Natural Science Foundation of China (Grant no. 81071911) and the Natural Science Foundation Project of Chongqing (CSTC2009BB5148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamgeer M, 2013, THORAX, V68, P1095, DOI 10.1136/thoraxjnl-2012-203021; Alamgeer M, 2013, RESPIROLOGY, V18, P757, DOI 10.1111/resp.12094; Alison MR, 2012, CANCER TREAT REV, V38, P589, DOI 10.1016/j.ctrv.2012.03.003; Arafat K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066931; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chen Y, 2011, BIOCHEM BIOPH RES CO, V405, P173, DOI 10.1016/j.bbrc.2011.01.002; Debeb BG, 2012, BREAST CANCER RES TR, V134, P495, DOI 10.1007/s10549-012-2075-8; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Furuichi Y, 2007, CANCER RES, V67, P9852, DOI 10.1158/0008-5472.CAN-07-0105; Geissler C, 2012, IN VIVO, V26, P593; Gomez-Casal R, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-94; Guo DM, 2009, LEUKEMIA RES, V33, P678, DOI 10.1016/j.leukres.2008.10.026; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kuang BH, 2013, BRIT J CANCER, V109, P1252, DOI 10.1038/bjc.2013.439; Li H, 2013, ONCOGENE; Luo YC, 2012, STEM CELLS, V30, P2100, DOI 10.1002/stem.1193; Marei HES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033542; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Park SH, 2012, EXP EYE RES, V101, P16, DOI 10.1016/j.exer.2012.05.009; Qi RZ, 2003, CANCER RES, V63, P8323; Ronchini C, 2001, MOL CELL BIOL, V21, P5925, DOI 10.1128/MCB.21.17.5925-5934.2001; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Steg AD, 2012, CLIN CANCER RES, V18, P869, DOI 10.1158/1078-0432.CCR-11-2188; Sullivan JP, 2010, CANCER RES, V70, P9937, DOI 10.1158/0008-5472.CAN-10-0881; Wang H, 2011, CARCINOGENESIS, V32, P1033, DOI 10.1093/carcin/bgr081; Wang KF, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0574-z; Xia Hui, 2013, Zhongguo Fei Ai Za Zhi, V16, P400, DOI 10.3779/j.issn.1009-3419.2013.08.02; Yatabe Y, 2011, LUNG CANCER, V74, P7, DOI 10.1016/j.lungcan.2011.05.021; Zhang X, 2011, TRANSPL P, V43, P2770, DOI 10.1016/j.transproceed.2011.05.048; Zhang ZC, 2012, ORAL ONCOL, V48, P1, DOI 10.1016/j.oraloncology.2011.10.004	30	20	20	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92669	10.1371/journal.pone.0092669	http://dx.doi.org/10.1371/journal.pone.0092669			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671051	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677000062
J	Liu, F; Qimuge; Hao, JF; Yan, HJ; Bach, T; Fan, LF; Morigen				Liu, Feng; Qimuge; Hao, Jianfeng; Yan, Huijuan; Bach, Trond; Fan, Lifei; Morigen			AspC-Mediated Aspartate Metabolism Coordinates the Escherichia coli Cell Cycle	PLOS ONE			English	Article							DNA-REPLICATION; GROWTH-RATE; SALMONELLA-TYPHIMURIUM; FLOW-CYTOMETRY; CHROMOSOME-REPLICATION; CARBON METABOLISM; ACID BIOSYNTHESIS; MOLECULAR-CLONING; INITIATION MASS; SIZE CONTROL	Background: The fast-growing bacterial cell cycle consists of at least two independent cycles of chromosome replication and cell division. To ensure proper cell cycles and viability, chromosome replication and cell division must be coordinated. It has been suggested that metabolism could affect the Escherichia coli cell cycle, but the idea is still lacking solid evidences. Methodology/Principle Findings: We found that absence of AspC, an aminotransferase that catalyzes synthesis of aspartate, led to generation of small cells with less origins and slow growth. In contrast, excess AspC was found to exert the opposite effect. Further analysis showed that AspC-mediated aspartate metabolism had a specific effect in the cell cycle, as only extra aspartate of the 20 amino acids triggered production of bigger cells with more origins per cell and faster growth. The amount of DnaA protein per cell was found to be changed in response to the availability of AspC. Depletion of (p)ppGpp by Delta re/A Delta spoT led to a slight delay in initiation of replication, but did not change the replication pattern found in the Delta aspC mutant. Conclusion/Significances:The results suggest that AspC-mediated metabolism of aspartate coordinates the E. coli cell cycle through altering the amount of the initiator protein DnaA per cell and the division signal UDP-glucose. Furthermore, AspC sequence conservation suggests similar functions in other organisms.	[Liu, Feng; Qimuge; Hao, Jianfeng; Yan, Huijuan; Fan, Lifei; Morigen] Inner Mongolia Univ, Sch Life Sci, Hohhot, Peoples R China; [Bach, Trond] Univ Oslo, Fac Med, Dept Pharmacol, Oslo, Norway; [Bach, Trond] Oslo Univ Hosp, Oslo, Norway	Inner Mongolia University; University of Oslo; University of Oslo	Fan, LF (corresponding author), Inner Mongolia Univ, Sch Life Sci, Hohhot, Peoples R China.	fanlifei95@gmail.com; morigenm@hotmail.com			National Natural Science Foundation of China "NSFC" [31060015]; Natural Science Foundation of Inner Mongolia [2010Zd14, 20102009]; Program of Higher-level Talents of Inner Mongolia University "SPH-IMU" [Z20090107]	National Natural Science Foundation of China "NSFC"(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Inner Mongolia; Program of Higher-level Talents of Inner Mongolia University "SPH-IMU"	The work was supported by grants from the National Natural Science Foundation of China "NSFC"(Grant no. 31060015 to Morigen), the Natural Science Foundation of Inner Mongolia (Grant no. 2010Zd14 and 20102009 to Morigen), and the Program of Higher-level Talents of Inner Mongolia University "SPH-IMU" (Grant no. Z20090107 to Morigcn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER TA, 1987, J BIOL CHEM, V262, P6877; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; BOYE E, 1991, RES MICROBIOL, V142, P131, DOI 10.1016/0923-2508(91)90020-B; Boye E, 2003, EMBO REP, V4, P757, DOI 10.1038/sj.embor.embor895; BRAMHILL D, 1988, CELL, V54, P915, DOI 10.1016/0092-8674(88)90102-X; BRAUN RE, 1985, CELL, V40, P159, DOI 10.1016/0092-8674(85)90319-8; CHIARAMELLO AE, 1989, J BACTERIOL, V171, P4272, DOI 10.1128/JB.171.8.4272-4280.1989; Chien AC, 2012, CURR BIOL, V22, pR340, DOI 10.1016/j.cub.2012.02.032; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; CRONAN JE, 1982, J BACTERIOL, V149, P916, DOI 10.1128/JB.149.3.916-922.1982; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DONACHIE WD, 1968, NATURE, V219, P1077, DOI 10.1038/2191077a0; FANTES P, 1977, EXP CELL RES, V107, P377, DOI 10.1016/0014-4827(77)90359-7; GLANSDORFF N, 1965, GENETICS, V51, P167; Goh EB, 2005, J BACTERIOL, V187, P4890, DOI 10.1128/JB.187.14.4890-4899.2005; Gon S, 2006, EMBO J, V25, P1137, DOI 10.1038/sj.emboj.7600990; HANAWALT PC, 1961, J MOL BIOL, V3, P156, DOI 10.1016/S0022-2836(61)80042-9; HAYASHI H, 1993, BIOCHEMISTRY-US, V32, P12229, DOI 10.1021/bi00096a036; Hill NS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003663; Hill NS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002549; HIRAGA S, 1975, MOL GEN GENET, V137, P239, DOI 10.1007/BF00333019; Janniere L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000447; Jin DJ, 2012, FEMS MICROBIOL REV, V36, P269, DOI 10.1111/j.1574-6976.2011.00279.x; Jin L, 1999, PROTEINS, V37, P729, DOI 10.1002/(SICI)1097-0134(19991201)37:4<729::AID-PROT21>3.0.CO;2-F; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; LOBNEROLESEN A, 1989, CELL, V57, P881, DOI 10.1016/0092-8674(89)90802-7; LU M, 1994, J BACTERIOL, V176, P5847, DOI 10.1128/JB.176.18.5847-5851.1994; Maciag M, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-19; Maciag-Dorszynska M, 2013, FEBS OPEN BIO, V3, P161, DOI 10.1016/j.fob.2013.03.001; Miller RV., 1992, VIRUS MEDIATED GENE, P51; Morigen, 2003, MOL MICROBIOL, V50, P349, DOI 10.1046/j.1365-2958.2003.03695.x; Morigen, 2005, J BACTERIOL, V187, P3913, DOI 10.1128/JB.187.12.3913-3920.2005; Morigen, 2001, BBA-GENE STRUCT EXPR, V1521, P73; Ote T, 2006, MOL MICROBIOL, V59, P265, DOI 10.1111/j.1365-2958.2005.04932.x; PLAMANN MD, 1983, NUCLEIC ACIDS RES, V11, P2065, DOI 10.1093/nar/11.7.2065; Potrykus K, 2011, ENVIRON MICROBIOL, V13, P563, DOI 10.1111/j.1462-2920.2010.02357.x; RICHAUD C, 1987, J BACTERIOL, V169, P1454, DOI 10.1128/jb.169.4.1454-1459.1987; Ryan VT, 2002, MOL MICROBIOL, V46, P113, DOI 10.1046/j.1365-2958.2002.03129.x; SARGENT MG, 1975, J BACTERIOL, V123, P7, DOI 10.1128/JB.123.1.7-19.1975; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; SKARSTAD K, 1983, J BACTERIOL, V154, P656, DOI 10.1128/JB.154.2.656-662.1983; SKARSTAD K, 1985, J BACTERIOL, V163, P661, DOI 10.1128/JB.163.2.661-668.1985; SKARSTAD K, 1986, EMBO J, V5, P1711, DOI 10.1002/j.1460-2075.1986.tb04415.x; Tedeschi G, 2010, BIOCHIMIE, V92, P1335, DOI 10.1016/j.biochi.2010.06.015; Teplyakov A, 2004, J BACTERIOL, V186, P7134, DOI 10.1128/JB.186.21.7134-7140.2004; Viola RE, 2001, ACCOUNTS CHEM RES, V34, P339, DOI 10.1021/ar000057q; Wang JD, 2009, NAT REV MICROBIOL, V7, P822, DOI 10.1038/nrmicro2202; WASSERMAN SA, 1983, J BACTERIOL, V153, P1439, DOI 10.1128/JB.153.3.1439-1450.1983; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; WECHSLER JA, 1971, MOL GEN GENET, V113, P273, DOI 10.1007/BF00339547; WHALEN WA, 1982, J BACTERIOL, V150, P739, DOI 10.1128/JB.150.2.739-746.1982; White D., 2007, PHYSL BIOCH PROKARYO; WOLD S, 1994, EMBO J, V13, P2097, DOI 10.1002/j.1460-2075.1994.tb06485.x; XIAO H, 1991, J BIOL CHEM, V266, P5980; Yao ZZ, 2012, P NATL ACAD SCI USA, V109, pE2561, DOI 10.1073/pnas.1209742109; Zhang Y, 2008, CELL MOL LIFE SCI, V65, P3699, DOI 10.1007/s00018-008-8295-8; ZYSKIND JW, 1992, CELL, V69, P5, DOI 10.1016/0092-8674(92)90112-P; ZYSKIND JW, 1977, J BACTERIOL, V129, P1476, DOI 10.1128/JB.129.3.1476-1486.1977	58	20	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92229	10.1371/journal.pone.0092229	http://dx.doi.org/10.1371/journal.pone.0092229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670900	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000037
J	Dan, ZW; Liu, P; Huang, WC; Zhou, W; Yao, GX; Hu, J; Zhu, RS; Lu, BR; Zhu, YG				Dan, Zhiwu; Liu, Ping; Huang, Wenchao; Zhou, Wei; Yao, Guoxin; Hu, Jun; Zhu, Renshan; Lu, Baorong; Zhu, Yingguo			Balance between a Higher Degree of Heterosis and Increased Reproductive Isolation: A Strategic Design for Breeding Inter-Subspecific Hybrid Rice	PLOS ONE			English	Article							ORYZA-SATIVA L; MICROSATELLITE MARKERS; SPIKELET FERTILITY; GENETIC DIVERSITY; POLLEN STERILITY; JAPONICA; INDICA; DIFFERENTIATION; L.; IDENTIFICATION	The application of heterosis (hybrid vigor) has brought great success to plant breeding, particularly of hybrid rice, achieving significant yield increases. Attempts to explore the heterosis of inter-subspecific hybrids between indica and japonica rice, which result in even greater yield increases, have greatly increased in the past decades. However, because of the reduced seed setting rate in F-1 hybrids as a result of increased reproductive isolation, the application of inter-subspecific hybrids in rice has slowed. Understanding the balance between heterosis and the reproductive isolation of inter-subspecific hybrids will facilitate the strategic design of inter-subspecific hybrid breeding. In this study, five indica and seven japonica rice varieties were chosen as the parental lines of a complete diallel mating design. Data from six group traits from all of the hybrids and inbred lines were collected. We found that the grain weight per plant, grain number per panicle, tiller per plant, thousand grain weight and plant height, which reflected increased heterosis, were associated with the genetic divergence index (GDI) of the parents. Meanwhile, owing to the reduced seed setting rate, which was also associated with the parents' GDI, the grain production of the hybrids was negatively affected. After analyzing the relationships between the GDI of indica-japonica parents and the grain weight per plant of the F-1 hybrids, an ideal GDI value (0.37) for the two indica-japonica parents that could provide an optimal balance between the inter-subspecific heterosis and reproductive isolation was proposed. Our findings will help in the strategic design of an inter-subspecific hybrid rice breeding program by identifying the ideal indica and japonica parents for a hybrid combination to achieve hybrid rice with an optimal yield. This strategic design of an inter-subspecific hybrid rice breeding program will be time saving and cost effective.	[Dan, Zhiwu; Huang, Wenchao; Zhou, Wei; Yao, Guoxin; Hu, Jun; Zhu, Renshan; Zhu, Yingguo] Wuhan Univ, State Key Lab Hybrid Rice, Coll Life Sci, Wuhan 430072, Peoples R China; [Dan, Zhiwu; Huang, Wenchao; Zhou, Wei; Yao, Guoxin; Hu, Jun; Zhu, Renshan; Zhu, Yingguo] Wuhan Univ, Minist Educ, Engn Res Ctr Plant Biotechnol & Germplasm Utiliza, Wuhan 430072, Peoples R China; [Liu, Ping; Lu, Baorong] Fudan Univ, Inst Biodivers Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China	Wuhan University; Wuhan University; Fudan University	Zhu, YG (corresponding author), Wuhan Univ, State Key Lab Hybrid Rice, Coll Life Sci, Wuhan 430072, Peoples R China.	zhuyg@public.wh.hb.cn	huang, wen/GXW-0661-2022; Lu, Bao-Rong/C-3130-2009; Dan, Zhiwu/AAM-5103-2021; Dan, Zhiwu/AAC-7071-2022	Lu, Bao-Rong/0000-0002-0214-2390; Dan, Zhiwu/0000-0002-3930-9158	National Natural Science Foundation of China [C130401]; National High-Tech Research and Development Project [2011AA10A101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Project(National High Technology Research and Development Program of China)	This work is supported by funds from the National Natural Science Foundation of China (C130401) and the National High-Tech Research and Development Project (2011AA10A101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng SH, 2007, ANN BOT-LONDON, V100, P959, DOI 10.1093/aob/mcm121; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; GLASZMANN JC, 1987, THEOR APPL GENET, V74, P21, DOI 10.1007/BF00290078; He JH, 2011, J EXP BOT, V62, P4433, DOI 10.1093/jxb/err098; Ji Q, 2010, J GENET GENOMICS, V37, P57, DOI 10.1016/S1673-8527(09)60025-4; [姜健 Jiang Jian], 2002, 吉林农业科学, V27, P3; Jiang T, 1999, J AGR BIOTECHNOLOGY, V7, P295; Jiang T, 1999, SCI AGR SINICA, V32, P1; Johns MA, 2007, FUNCT INTEGR GENOMIC, V7, P135, DOI 10.1007/s10142-006-0036-1; Khush G. S., 1995, Geojournal, V35, P329, DOI 10.1007/BF00989140; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Khush GS, 1996, 1996 INCREASING YIEL, P36; Li H, 2012, GUANGDONG AGR SCI, V21; Li RH, 1998, MOL BREEDING, V4, P205, DOI 10.1023/A:1009658310154; Li WT, 2008, THEOR APPL GENET, V116, P915, DOI 10.1007/s00122-008-0723-5; Li YaLi, 2012, Southwest China Journal of Agricultural Sciences, V25, P347; Li ZK, 1997, GENETICS, V145, P1139; Lin S, 1980, HYBRID RICE BREEDING, P35; Long H, 2003, SCI AGR SINICA, V36, P1; Lu BR, 2009, PROG NAT SCI-MATER, V19, P1241, DOI 10.1016/j.pnsc.2009.01.011; Mizuta Y, 2010, P NATL ACAD SCI USA, V107, P20417, DOI 10.1073/pnas.1003124107; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nakamura Y, 2002, STARCH-STARKE, V54, P117, DOI [10.1002/1521-379X(200204)54:3/4<117::AID-STAR117>3.0.CO;2-2, 10.1002/1521-379X(200204)54:3/4&lt;117::AID-STAR117&gt;3.0.CO;2-2]; Ouyang YD, 2010, CURR OPIN PLANT BIOL, V13, P186, DOI 10.1016/j.pbi.2010.01.002; Qi YW, 2009, J GENET GENOMICS, V36, P305, DOI 10.1016/S1673-8527(08)60119-8; Singh SP, 2006, THEOR APPL GENET, V113, P509, DOI 10.1007/s00122-006-0316-0; Song X, 2005, THEOR APPL GENET, V110, P205, DOI 10.1007/s00122-004-1798-2; Sun C, 2000, ACTA AGRON SIN, V26, P641; Sun J, 1999, J TIANJIN AGR COLL, V6, P1; Vanniarajan C, 2012, J GENET, V91, P9, DOI 10.1007/s12041-012-0146-6; Wang MM, 2013, BREEDING SCI, V63, P227, DOI 10.1270/jsbbs.63.227; Xu Hai, 2012, Journal of Shenyang Agricultural University, V43, P704; YANG GP, 1994, MOL GEN GENET, V245, P187, DOI 10.1007/BF00283266; Yang S, 1962, ZUOWUXUEBAO, V1, P97; Yuan L, 1998, CHINA IRRI IMPROVING, P10; Zeng SX, 1980, ACTA AGRON SIN, V6, P193; Zhang H, 2009, PLANT PHYSIOL BIOCH, V47, P195, DOI 10.1016/j.plaphy.2008.11.012; ZHANG QF, 1992, THEOR APPL GENET, V83, P495, DOI 10.1007/BF00226539	38	20	20	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93122	10.1371/journal.pone.0093122	http://dx.doi.org/10.1371/journal.pone.0093122			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667442	gold, Green Submitted, Green Published			2022-12-27	WOS:000333675600143
J	Darkoh, C; Comer, L; Zewdie, G; Harold, S; Snyder, N; DuPont, HL				Darkoh, Charles; Comer, Latoya; Zewdie, Getie; Harold, Stephen; Snyder, Ned; DuPont, Herbert L.			Chemotactic Chemokines Are Important in the Pathogenesis of Irritable Bowel Syndrome	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; RHEUMATOID-ARTHRITIS; EXPRESSION; DISEASE; MCP-1; PREVALENCE; CLONING; IBS; EPIDEMIOLOGY; INFLAMMATION	Irritable bowel syndrome (IBS) is one of the most frequently diagnosed disorders, affecting about 20% of the general population in Western countries. This syndrome poses an enormous socio-economic burden, impairs the quality of life substantially, and increases healthcare costs. IBS can be classified as either idiopathic (ID-IBS) with unknown etiology or post-infectious (PI-IBS), which develops after a bout of acute diarrhea or gastroenteritis. Little is known about the immunopathogenesis of these two forms of IBS. We evaluated various biomarkers in clinical samples of ID-IBS and PI-IBS patients with the goal to test the hypothesis that the immunologic presentations of these forms of IBS are similar, despite their apparent different etiologic origins. Sera and stool samples from PI-IBS, ID-IBS, and healthy volunteers were analyzed for relative amounts of 36 different biomarkers using the Proteome Profiler Human Cytokine Array Panel A Kit and quantitative ELISA. Our results demonstrated significantly high levels of chemotactic chemokines monocytes chemotactic protein-1 (CCL2) [p-value = 0.003], macrophage inflammatory protein-1 beta (CCL4) [p-value = 0.010], and CXCL16 (p-value 0.001) in the sera and stools of both ID-IBS and PI-IBS patients. Furthermore, pro-inflammatory cytokines (IFN-gamma, IL-1 beta, and TNF-alpha) were significantly higher in IBS patients. Anti-inflammatory cytokines (IL-10, IL-4, and IL-13) were variable except IL-10, which was significantly higher in the healthy volunteers than the IBS patients. Remarkably, the amounts and expression pattern of these biomarkers were not significantly different between ID-IBS and PI-IBS. Thus, ID-IBS and PI-IBS present similar immunologic and clinical phenotypes, in spite of their different etiologic origins.	[Darkoh, Charles; Zewdie, Getie; DuPont, Herbert L.] Univ Texas Houston, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Ctr Infect Dis, Houston, TX 77030 USA; [Comer, Latoya; DuPont, Herbert L.] Univ Texas Houston, Sch Med, Houston, TX USA; [Harold, Stephen; Snyder, Ned; DuPont, Herbert L.] Kelsey Res Fdn, Houston, TX USA; [Snyder, Ned; DuPont, Herbert L.] Kelsey Seybold Clin, Houston, TX USA; [DuPont, Herbert L.] St Lukes Med Ctr, Houston, TX USA; [DuPont, Herbert L.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Darkoh, C (corresponding author), Univ Texas Houston, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Ctr Infect Dis, Houston, TX 77030 USA.	Charles.darkoh@uth.tmc.edu	DuPont, Herbert/AAH-6776-2021	Darkoh, Charles/0000-0003-0063-7856	University of Texas School of Public Health; Public Health Service Grant [DK56338]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	University of Texas School of Public Health; Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part, by discretionary funds from The University of Texas School of Public Health and Public Health Service Grant DK56338, which funds the Texas Medical Center Digestive Disease Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbara G, 2004, ALIMENT PHARM THER, V20, P1, DOI 10.1111/j.1365-2036.2004.02036.x; BRIELAND JK, 1992, AM J RESP CELL MOL, V7, P134, DOI 10.1165/ajrcmb/7.2.134; Chang L, 2012, AM J GASTROENTEROL, V107, P262, DOI 10.1038/ajg.2011.423; Chen JL, 2012, BMC GASTROENTEROL, V2012, P1, DOI DOI 10.1186/1471-230X-12-91; Day C, 2009, EXP LUNG RES, V35, P272, DOI 10.1080/01902140802635517; Diegelmann J, 2010, INFLAMM BOWEL DIS, V16, P1871, DOI 10.1002/ibd.21306; Dorn SD, 2009, J CLIN GASTROENTEROL, V43, P214, DOI 10.1097/MCG.0b013e31815bd749; Dunlop SP, 2003, AM J GASTROENTEROL, V98, P1578, DOI 10.1016/S0002-9270(03)000375-7; DuPont HL, 2011, CURR OPIN INFECT DIS, V24, P503, DOI 10.1097/QCO.0b013e32834a962d; DuPont HL, 2010, AM J TROP MED HYG, V82, P301, DOI 10.4269/ajtmh.2010.09-0538; Engel MA, 2010, J GASTROENTEROL, V45, P571, DOI 10.1007/s00535-010-0219-3; FAHEY TJ, 1992, J IMMUNOL, V148, P2764; Faresjo A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-832; Gao JG, 2013, EXP THER MED, V6, P93, DOI 10.3892/etm.2013.1101; Gunn MD, 1997, J IMMUNOL, V158, P376; Haagsma JA, 2010, EPIDEMIOL INFECT, V138, P1650, DOI 10.1017/S0950268810000531; Hasegawa M, 1999, CLIN EXP IMMUNOL, V117, P159; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Ji S, 2005, J GASTROEN HEPATOL, V20, P381, DOI 10.1111/j.1440-1746.2005.03574.x; JIANG YL, 1992, J IMMUNOL, V148, P2423; JONES ML, 1992, J IMMUNOL, V149, P2147; LEONARD EJ, 1990, IMMUNOL TODAY, V11, P97, DOI 10.1016/0167-5699(90)90035-8; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; Marshall JK, 2006, GASTROENTEROLOGY, V131, P445, DOI 10.1053/j.gastro.2006.05.053; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; McKernan DP, 2011, ALIMENT PHARM THER, V33, P1045, DOI 10.1111/j.1365-2036.2011.04624.x; MORITA N, 1995, J GASTROENTEROL, V30, P1; Nanki T, 2005, ARTHRITIS RHEUM, V52, P3004, DOI 10.1002/art.21301; Okhuysen PC, 2004, AM J GASTROENTEROL, V99, P1774, DOI 10.1111/j.1572-0241.2004.30435.x; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Rana S V, 2012, Trop Gastroenterol, V33, P251; Romero-Valdovinos M, 2012, MOL BIOL REP, V39, P8837, DOI 10.1007/s11033-012-1745-2; Ruth JH, 2006, ARTHRITIS RHEUM-US, V54, P765, DOI 10.1002/art.21662; Schmulson M, 2012, AM J GASTROENTEROL, V107, P747, DOI 10.1038/ajg.2011.484; Shimaoka T, 2000, J BIOL CHEM, V275, P40663, DOI 10.1074/jbc.C000761200; STAHL RAK, 1993, KIDNEY INT, V44, P1036, DOI 10.1038/ki.1993.346; Swan C, 2013, GUT, V62, P985, DOI 10.1136/gutjnl-2011-301213; Thabane M, 2009, AM J GASTROENTEROL, V104, P2267, DOI 10.1038/ajg.2009.302; Thompson WG, 2000, ROME 2 FUNCTIONAL GA, V2nd, P351; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Wilbanks A, 2001, J IMMUNOL, V166, P5145, DOI 10.4049/jimmunol.166.8.5145; YOSHIMURA T, 1989, FEBS LETT, V244, P487, DOI 10.1016/0014-5793(89)80590-3	44	40	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93144	10.1371/journal.pone.0093144	http://dx.doi.org/10.1371/journal.pone.0093144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667736	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600149
J	de Oliveira, JMPF; Costa, M; Pedrosa, T; Pinto, P; Remedios, C; Oliveira, H; Pimentel, F; Almeida, L; Santos, C				Ferreira de Oliveira, Jose Miguel P.; Costa, Maria; Pedrosa, Tiago; Pinto, Pedro; Remedios, Catarina; Oliveira, Helena; Pimentel, Francisco; Almeida, Luis; Santos, Conceicao			Sulforaphane Induces Oxidative Stress and Death by p53-Independent Mechanism: Implication of Impaired Glutathione Recycling	PLOS ONE			English	Article							NF-KAPPA-B; CELL-CYCLE ARREST; TRAIL-INDUCED APOPTOSIS; INHIBITS TUMOR-GROWTH; CANCER-CELLS; CHEMOPREVENTIVE AGENTS; ISOTHIOCYANATE SULFORAPHANE; 2-OXOHEXYL ISOTHIOCYANATE; HISTONE DEACETYLASE; OSTEOSARCOMA CELLS	Sulforaphane (SFN) is a naturally-occurring isothiocyanate best known for its role as an indirect antioxidant. Notwithstanding, in different cancer cell lines, SFN may promote the accumulation of reactive oxygen species (ROS) and cause cell death e.g. by apoptosis. Osteosarcoma often becomes chemoresistant, and new molecular targets to prevent drug resistance are needed. Here, we aimed to determine the effect of SFN on ROS levels and to identify key biomarkers leading to ROS unbalance and apoptosis in the p53-null MG-63 osteosarcoma cell line. MG-63 cells were exposed to SFN for up to 48 h. At 10 mu M concentration or higher, SFN decreased cell viability, increased the% early apoptotic cells and increased caspase 3 activity. At these higher doses, SFN increased ROS levels, which correlated with apoptotic endpoints and cell viability decline. In exposed cells, gene expression analysis revealed only partial induction of phase-2 detoxification genes. More importantly, SFN inhibited ROS-scavenging enzymes and impaired glutathione recycling, as evidenced by inhibition of glutathione reductase (GR) activity and combined inhibition of glutathione peroxidase (GPx) gene expression and enzyme activity. In conclusion, SFN induced oxidative stress and apoptosis via a p53-independent mechanism. GPx expression and activity were found associated with ROS accumulation in MG-63 cells and are potential biomarkers for the efficacy of ROS-inducing agents e. g. as co-adjuvant drugs in osteosarcoma.	[Ferreira de Oliveira, Jose Miguel P.; Costa, Maria; Pedrosa, Tiago; Pinto, Pedro; Remedios, Catarina; Oliveira, Helena; Santos, Conceicao] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Ferreira de Oliveira, Jose Miguel P.; Costa, Maria; Pedrosa, Tiago; Pinto, Pedro; Remedios, Catarina; Oliveira, Helena; Santos, Conceicao] Univ Aveiro, Dept Biol, Lab Biotechnol & Cyt, P-3800 Aveiro, Portugal; [Pimentel, Francisco] Lenitudes, Lisbon, Portugal; [Pimentel, Francisco] Univ Fernando Pessoa, Fac Hlth Sci, Oporto, Portugal; [Pimentel, Francisco] Univ Coimbra, Ctr Hlth Studies & Res, Coimbra, Portugal; [Pimentel, Francisco] Univ Beira Interior, Fac Ciencias Saude, Covilha, Portugal; [Almeida, Luis] Luzitin SA, Coimbra, Portugal; [Almeida, Luis] Blueclin Phase I, Oporto, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade Fernando Pessoa; Universidade de Coimbra; Universidade da Beira Interior	de Oliveira, JMPF (corresponding author), Univ Aveiro, CESAM, Campus Univ Santiago, P-3800 Aveiro, Portugal.	oliveira.miguel@ua.pt	Santos, Conceição/ABE-6172-2020; Pimentel, Francisco/M-3619-2013; Ferreira de Oliveira, Jose Miguel P/F-6250-2011; Remédios, Catarina/G-6836-2011; Almeida, Luis/E-3870-2010; Ferreira de Oliveira, José Miguel P./AFM-8368-2022; Santos, Conceição LV/A-8651-2008; de Oliveira, Jose Miguel Ferreira/AAU-8778-2020; santos, conceição/GQQ-7378-2022; Oliveira, Helena/M-5068-2013	Santos, Conceição/0000-0003-4129-6381; Pimentel, Francisco/0000-0001-5993-5132; Ferreira de Oliveira, Jose Miguel P/0000-0002-3883-0806; Remédios, Catarina/0000-0001-9567-2130; Almeida, Luis/0000-0002-4861-8649; Ferreira de Oliveira, José Miguel P./0000-0002-3883-0806; Santos, Conceição LV/0000-0003-4129-6381; de Oliveira, Jose Miguel Ferreira/0000-0002-3883-0806; Oliveira, Helena/0000-0002-4673-0696; Pinto, Pedro/0000-0002-3794-3833; Marques da Costa, Maria Eugenia/0000-0002-1498-603X	Portuguese Foundation for Science and Technology (FCT) [SFRH/BPD/48853/2008, SFRH/BPD/74868/2010]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	This study was supported by the Portuguese Foundation for Science and Technology (FCT, http://www.fct.pt/) through the post-doctoral fellowships of HO (SFRH/BPD/48853/2008) and JMPFO (SFRH/BPD/74868/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljubran AH, 2009, ANN ONCOL, V20, P1136, DOI 10.1093/annonc/mdn731; Barcelo S, 1996, CARCINOGENESIS, V17, P277, DOI 10.1093/carcin/17.2.277; Bielack SS, 2009, J CLIN ONCOL, V27, P557, DOI 10.1200/JCO.2008.16.2305; Dringen R, 2002, METHOD ENZYMOL, V348, P281, DOI 10.1016/S0076-6879(02)48646-6; ervinka M, 2009, FOOD CHEM TOXICOL, V47, P2366; Feridooni T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022801; Ferreira de Oliveira JMP, 2014, SULFORAPHANE INDUCES; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; Gao XQ, 2001, P NATL ACAD SCI USA, V98, P15221, DOI 10.1073/pnas.261572998; Gorlick R, 2010, J BONE MINER RES, V25, P683, DOI 10.1002/jbmr.77; Hayes JD, 2008, EUR J NUTR, V47, P73, DOI 10.1007/s00394-008-2009-8; Higdon JV, 2007, PHARMACOL RES, V55, P224, DOI 10.1016/j.phrs.2007.01.009; Hu R, 2006, CANCER LETT, V243, P170, DOI 10.1016/j.canlet.2005.11.050; Hu Y, 2007, BIOL CHEM, V388, P1069, DOI 10.1515/BC.2007.135; Jakubikova J, 2011, HAEMATOL-HEMATOL J, V96, P1170, DOI 10.3324/haematol.2010.029363; Jeong WS, 2004, PHARM RES-DORDR, V21, P661, DOI 10.1023/B:PHAM.0000022413.43212.cf; Kim H, 2006, CANCER RES, V66, P1740, DOI 10.1158/0008-5472.CAN-05-1568; Kim MR, 2011, MOL MED REP, V4, P929, DOI 10.3892/mmr.2011.520; Kwak MK, 2007, FREE RADICAL BIO MED, V43, P809, DOI 10.1016/j.freeradbiomed.2007.05.029; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Matsui TA, 2007, ONCOL REP, V18, P1263; Matsui T, 2006, CARCINOGENESIS, V27, P1768, DOI 10.1093/carcin/bgl015; Misiewicz I, 2003, ONCOL REP, V10, P2045; Misiewicz I, 2007, PHARMACOL REP, V59, P80; Moon DO, 2009, CANCER LETT, V274, P132, DOI 10.1016/j.canlet.2008.09.013; Mukherjee S, 2010, BRIT J NUTR, V103, P815, DOI 10.1017/S0007114509992492; Myzak MC, 2006, FASEB J, V20, P506, DOI 10.1096/fj.05-4785fje; Myzak MC, 2004, CANCER RES, V64, P5767, DOI 10.1158/0008-5472.CAN-04-1326; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pham NA, 2004, MOL CANCER THER, V3, P1239; Picci P, 2010, ANN ONCOL, V21, P1366, DOI 10.1093/annonc/mdp502; Quick KL, 2000, J NEUROSCI METH, V97, P139, DOI 10.1016/S0165-0270(00)00179-5; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Ritter J, 2010, ANN ONCOL, V21, P320, DOI 10.1093/annonc/mdq276; Rozen S, 2000, Methods Mol Biol, V132, P365; Sestili P, 2010, MUTAT RES-FUND MOL M, V689, P65, DOI 10.1016/j.mrfmmm.2010.05.003; Shankar S, 2008, CLIN CANCER RES, V14, P6855, DOI 10.1158/1078-0432.CCR-08-0903; Shen GX, 2005, ANTIOXID REDOX SIGN, V7, P1648, DOI 10.1089/ars.2005.7.1648; Singh SV, 2005, J BIOL CHEM, V280, P19911, DOI 10.1074/jbc.M412443200; Smith AD, 2002, METHOD ENZYMOL, V347, P113; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tarozzi A, 2009, J NEUROCHEM, V111, P1161, DOI 10.1111/j.1471-4159.2009.06394.x; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Tsang WP, 2003, LIFE SCI, V73, P2047, DOI 10.1016/S0024-3205(03)00566-6; Wachtel M, 2010, CANCER TREAT REV, V36, P318, DOI 10.1016/j.ctrv.2010.02.007; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; Xiao D, 2009, PHARM RES-DORDR, V26, P1729, DOI 10.1007/s11095-009-9883-5; Xu CJ, 2005, ONCOGENE, V24, P4486, DOI 10.1038/sj.onc.1208656; Zanichelli F, 2012, APOPTOSIS, V17, P964, DOI 10.1007/s10495-012-0740-3; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zhu H, 2008, CARDIOVASC TOXICOL, V8, P115, DOI 10.1007/s12012-008-9020-4; Zhu M, 2004, MOL CARCINOGEN, V41, P179, DOI 10.1002/mc.20052	53	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92980	10.1371/journal.pone.0092980	http://dx.doi.org/10.1371/journal.pone.0092980			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667842	gold, Green Published, Green Submitted			2022-12-27	WOS:000333675600117
J	Hirst, JA; Stevens, RJ; Farmer, AJ				Hirst, Jennifer A.; Stevens, Richard J.; Farmer, Andrew J.			Changes in HbA1c Level over a 12-Week Follow-up in Patients with Type 2 Diabetes following a Medication Change	PLOS ONE			English	Article							GLYCEMIC CONTROL; PLASMA-GLUCOSE; GLYCATED HEMOGLOBIN; ASSOCIATION; PREVALENCE; ADHERENCE; KINETICS; HBA(1C); IMPACT	Background: Current guidance about the interval needed before retesting HbA1c when monitoring for glycaemic control is based on expert opinion rather than well-powered studies. The aim of our work was to explore how fast HbA1c changes after a change in glucose-lowering medication. This has implications for whether routine HbA1c testing intervals before 12 weeks could inform diabetes medication adjustments. Methods: This 12-week cohort study recruited patients from 18 general practices in the United Kingdom with non-insulin treated diabetes who were initiating or changing dose of oral glucose-lowering medication. HbA1c was measured at baseline and 2, 4, 8 and 12 weeks after recruitment. HbA1c levels at earlier time intervals were correlated with 12-week HbA1c. A ROC curve analysis was used to identify the 8-week threshold above which medication adjustment may be clinically appropriate. Results: Ninety-three patients were recruited to the study. Seventy-nine patients with no change in medication and full 12week follow-up had the following baseline characteristics: mean +/- standard deviation age of 61.3 +/- 10.8 years, 34% were female and diabetes duration of 6.0 +/- 4.3 years. Mean HbA1c at baseline, 2, 4, 8 and 12 weeks was 8.7 +/- 1.5%, (72.0 +/- 16.8 mmol/mol) 8.6 +/- 1.6% (70.7 +/- 17.0 mmol/mol), 8.4 +/- 1.5% (68.7 +/- 15.9 mmol/mol), 8.2 +/- 1.4% (66.3 +/- 15.8 mmol/mol) and 8.1 +/- 1.4% (64.8 +/- 15.7 mmol/mol) respectively. At the end of the study 61% of patients had sub-optimal glycaemic control (HbA1c > 7.5% or 59 mmol/mol). The 8-week change correlated significantly with the 12-week change in HbA1c and an HbA1c above 8.2% (66 mmol/mol) at 8 weeks correctly classified all 28 patients who had not achieved glycaemic control by 12 weeks. Conclusions/interpretation: This is the first study designed with sufficient power to examine short-term changes in HbA1c. The 12-week change in HbA1c can be predicted 8 weeks after a medication change. Many participants who had not achieved glycaemic control after 12 weeks may have benefitted from an earlier review of their HbA1c and medication.	[Hirst, Jennifer A.] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; Natl Inst Hlth Res Sch Primary Care Res, Oxford, England	University of Oxford	Hirst, JA (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England.	jennifer.hirst@phc.ox.ac.uk		Hirst, Jennifer/0000-0002-8416-2159; Stevens, Richard/0000-0002-9258-4060	UK's National Institute for Health Research (NIHR) School for Primary Care Research (SPCR); National Institute for Health Research (NIHR); NIHR Oxford Biomedical Research Centre; National Institute for Health Research [NF-SI-0512-10077] Funding Source: researchfish	UK's National Institute for Health Research (NIHR) School for Primary Care Research (SPCR); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was funded by the UK's National Institute for Health Research (NIHR) School for Primary Care Research (SPCR). This article/paper/report presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. AF receives support from the NIHR Oxford Biomedical Research Centre and is an NIHR Senior Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akan P, 2007, J EVAL CLIN PRACT, V13, P21, DOI 10.1111/j.1365-2753.2006.00641.x; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Berard LD, 2013, CAN J DIABETES, V37, pS35, DOI 10.1016/j.jcjd.2013.01.017; Bosi E, 2009, DIABETES OBES METAB, V11, P506, DOI 10.1111/j.1463-1326.2009.01040.x; BUNN HF, 1976, J CLIN INVEST, V57, P1652, DOI 10.1172/JCI108436; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Driskell OJ, 2012, CLIN CHEM, V58, P906, DOI 10.1373/clinchem.2011.176487; Kanavos P, 2012, DIABETES EXPENDITURE; Kennedy L, 2006, DIABETES CARE, V29, P1; Kilpatrick ES, 2008, J CLIN PATHOL, V61, P977, DOI 10.1136/jcp.2007.054304; Loh TP, 2011, DIABETES RES CLIN PR, V94, pE40, DOI 10.1016/j.diabres.2011.07.034; Lyon Andrew W, 2009, J Diabetes Sci Technol, V3, P411; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; MORTENSEN HB, 1983, CLIN CHIM ACTA, V134, P317, DOI 10.1016/0009-8981(83)90370-4; Muntner P, 2013, J CLIN HYPERTENS, V15, P112, DOI 10.1111/jch.12037; NGSP, 2014, LIST NGSP CERT METH; NICE, 2008, TYP 2 DIAB NAT CLIN, V66; Osterman-Golkar SM, 2006, J DIABETES COMPLICAT, V20, P285, DOI 10.1016/j.jdiacomp.2005.07.009; Sacks DB, 2011, CLIN CHEM, V57, pE1, DOI 10.1373/clinchem.2010.161596; Salvagno GL, 2007, CLIN CHEM LAB MED, V45, P1065, DOI 10.1515/CCLM.2007.195; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; TAHARA Y, 1993, DIABETES CARE, V16, P1313, DOI 10.2337/diacare.16.9.1313; TAHARA Y, 1995, DIABETES CARE, V18, P440, DOI 10.2337/diacare.18.4.440; Tanis SP, 1996, J MED CHEM, V39, P5053, DOI 10.1021/jm9605694	24	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92458	10.1371/journal.pone.0092458	http://dx.doi.org/10.1371/journal.pone.0092458			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667212	Green Published, gold			2022-12-27	WOS:000333675600041
J	Patel, RB; Mathur, MB; Gould, M; Uyeki, TM; Bhattacharya, J; Xiao, Y; Khazeni, N				Patel, Rita B.; Mathur, Maya B.; Gould, Michael; Uyeki, Timothy M.; Bhattacharya, Jay; Xiao, Yang; Khazeni, Nayer			Demographic and Clinical Predictors of Mortality from Highly Pathogenic Avian Influenza A (H5N1) Virus Infection: CART Analysis of International Cases	PLOS ONE			English	Article							PUBLIC-HEALTH; UNITED-STATES; HOST GENETICS; SUSCEPTIBILITY; SEROEVIDENCE; MORBIDITY; INDONESIA; CHILDREN; DEATHS; ASIA	Background: Human infections with highly pathogenic avian influenza (HPAI) A (H5N1) viruses have occurred in 15 countries, with high mortality to date. Determining risk factors for morbidity and mortality from HPAI H5N1 can inform preventive and therapeutic interventions. Methods: We included all cases of human HPAI H5N1 reported in World Health Organization Global Alert and Response updates and those identified through a systematic search of multiple databases (PubMed, Scopus, and Google Scholar), including articles in all languages. We abstracted predefined clinical and demographic predictors and mortality and used bivariate logistic regression analyses to examine the relationship of each candidate predictor with mortality. We developed and pruned a decision tree using nonparametric Classification and Regression Tree methods to create risk strata for mortality. Findings: We identified 617 human cases of HPAI H5N1 occurring between December 1997 and April 2013. The median age of subjects was 18 years (interquartile range 6-29 years) and 54% were female. HPAI H5N1 case-fatality proportion was 59%. The final decision tree for mortality included age, country, per capita government health expenditure, and delay from symptom onset to hospitalization, with an area under the receiver operator characteristic (ROC) curve of 0.81 (95% CI: 0.76-0.86). Interpretation: A model defined by four clinical and demographic predictors successfully estimated the probability of mortality from HPAI H5N1 illness. These parameters highlight the importance of early diagnosis and treatment and may enable early, targeted pharmaceutical therapy and supportive care for symptomatic patients with HPAI H5N1 virus infection.	[Patel, Rita B.; Mathur, Maya B.; Khazeni, Nayer] Stanford Univ, Med Ctr, Div Pulm & Crit Care Med, Stanford, CA 94305 USA; [Gould, Michael] Kaiser Permanente So Calif, Pasadena, CA 91101 USA; [Uyeki, Timothy M.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Bhattacharya, Jay; Khazeni, Nayer] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Bhattacharya, Jay; Khazeni, Nayer] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; [Xiao, Yang] Univ S Carolina, Dept Languages Literatures & Cultures, Columbia, SC 29208 USA	Stanford University; Kaiser Permanente; Centers for Disease Control & Prevention - USA; Stanford University; Stanford University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Mathur, MB (corresponding author), Stanford Univ, Med Ctr, Div Pulm & Crit Care Med, Stanford, CA 94305 USA.	mmathur@stanford.edu		Xiao-Desai, Yang/0000-0002-3609-2758	Agency for Healthcare Research and Quality [1 K08 HS019816]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS019816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG017253] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Agency for Healthcare Research and Quality (1 K08 HS019816, Dr. Khazeni). See http://www.ahrq.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Adisasmito W, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-571; Adisasmito W, 2010, J INFECT DIS, V202, P1154, DOI 10.1086/656316; [Anonymous], 2013, WHO GLOBAL HLTH OBSE; Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Bird SM, 2008, LANCET, V372, P696, DOI 10.1016/S0140-6736(08)61126-5; Boltz DA, 2008, J INFECT DIS, V197, P1315, DOI 10.1086/586711; Breiman L., 1984, CLASSIFICATION REGRE; Cavailler P, 2010, J CLIN VIROL, V48, P123, DOI 10.1016/j.jcv.2010.02.021; Chan PKS, 2012, J INFECT DIS, V206, P1359, DOI 10.1093/infdis/jis509; Chan PKS, 2002, CLIN INFECT DIS, V34, pS58, DOI 10.1086/338820; Chmielewski R, 2011, ANNU REV FOOD SCI T, V2, P37, DOI 10.1146/annurev-food-022510-133710; Coker R, 2006, LANCET, V368, P886, DOI 10.1016/S0140-6736(06)69209-X; Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; Cox CM, 2011, CLIN INFECT DIS, V52, pS69, DOI 10.1093/cid/ciq011; Cunha BA, 2004, INFECT DIS CLIN N AM, V18, P141, DOI 10.1016/S0891-5520(03)00095-3; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Govorkova EA, 2007, ANTIMICROB AGENTS CH, V51, P1414, DOI 10.1128/AAC.01312-06; Harrell FE, 2001, REGRESSION MODELING; Hastie TJ, 2011, ELEMENTS STAT LEARNI; Horby P, 2010, EPIDEMIOL INFECT, V138, P1550, DOI 10.1017/S0950268810000518; Horby P, 2013, INFLUENZA OTHER RESP, V7, P37, DOI 10.1111/irv.12079; Horby P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033180; Kandeel A, 2010, EMERG INFECT DIS, V16, P1101, DOI 10.3201/eid1607.091695; Kandun IN, 2008, LANCET, V372, P744, DOI 10.1016/S0140-6736(08)61125-3; Kayali G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017730; Liao QH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071765; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Muller R, 2008, CLIN CHIM ACTA, V394, P1, DOI 10.1016/j.cca.2008.04.007; Murakami DR, 2008, 13 INT C INF DIS; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nguyen TL, 2009, CLIN INFECT DIS, V48, P1639, DOI 10.1086/599031; Pongcharoensuk P, 2012, HEALTH POLICY PLANN, V27, P374, DOI 10.1093/heapol/czr056; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Toner ES, 2013, CLIN INFECT DIS, V56, P1206, DOI 10.1093/cid/cit047; Uyeki TM, 2009, CLIN INFECT DIS, V49, P279, DOI 10.1086/600035; Van Kerkhove MD, 2012, SCIENCE, V336, DOI 10.1126/science.1221434; Vong S, 2009, J INFECT DIS, V199, P1744, DOI 10.1086/599208; Wang TT, 2012, SCIENCE, V335, P1463, DOI 10.1126/science.1218888; Western Pacific Regional Office of the World Health Organization, 2013, 22 NEW HUM CAS AV IN; Western Pacific Regional Office of the World Health Organization, 2013, AV INFL H5N1 WEEKL U; WHO/GIP, 2003, CUM NUMB CONF HUM CA; World Health Organization, 2013, WHO H5N1 CLIN CAS SU; World Health Organization, 2013, WHO CAS DEF HUM INF; Yalcin C, 2010, AVIAN DIS, V54, P390, DOI 10.1637/8710-031809-Reg.1; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9	47	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e91630	10.1371/journal.pone.0091630	http://dx.doi.org/10.1371/journal.pone.0091630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667532	Green Submitted, Green Published, gold			2022-12-27	WOS:000333675600011
J	Steenbergh, AK; Bodelier, PLE; Slomp, CP; Laanbroek, HJ				Steenbergh, Anne K.; Bodelier, Paul L. E.; Slomp, Caroline P.; Laanbroek, Hendrikus J.			Effect of Redox Conditions on Bacterial Community Structure in Baltic Sea Sediments with Contrasting Phosphorus Fluxes	PLOS ONE			English	Article							BIOGEOCHEMICAL PROCESSES; FRESH-WATER; MARINE; REGENERATION; POPULATIONS; DIVERSITY	Phosphorus release from sediments can exacerbate the effect of eutrophication in coastal marine ecosystems. The flux of phosphorus from marine sediments to the overlying water is highly dependent on the redox conditions at the sediment-water interface. Bacteria are key players in the biological processes that release or retain phosphorus in marine sediments. To gain more insight in the role of bacteria in phosphorus release from sediments, we assessed the effect of redox conditions on the structure of bacterial communities. To do so, we incubated surface sediments from four sampling sites in the Baltic Sea under oxic and anoxic conditions and analyzed the fingerprints of the bacterial community structures in these incubations and the original sediments. This paper describes the effects of redox conditions, sampling station, and sample type (DNA, RNA, or whole-cell sample) on bacterial community structure in sediments. Redox conditions explained only 5% of the variance in community structure, and bacterial communities from contrasting redox conditions showed considerable overlap. We conclude that benthic bacterial communities cannot be classified as being typical for oxic or anoxic conditions based on community structure fingerprints. Our results suggest that the overall structure of the benthic bacterial community has only a limited impact on benthic phosphate fluxes in the Baltic Sea.	[Steenbergh, Anne K.; Bodelier, Paul L. E.; Laanbroek, Hendrikus J.] Netherlands Inst Ecol NIOO KNAW, Wageningen, Netherlands; [Slomp, Caroline P.] Univ Utrecht, Fac Geosci, Dept Earth Sci Geochem, Utrecht, Netherlands; [Laanbroek, Hendrikus J.] Univ Utrecht, Fac Sci, Inst Environm Biol, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Utrecht University; Utrecht University	Steenbergh, AK (corresponding author), Netherlands Inst Ecol NIOO KNAW, Wageningen, Netherlands.	a.steenbergh@nioo.knaw.nl	Laanbroek, Hendrikus/AAV-9215-2020; Slomp, Caroline P/A-9406-2012; Bodelier, Paul/AAF-8353-2020; Bodelier, Paul L/A-9591-2011; Haygarth, Philip Matthew/F-6790-2014; Laanbroek, Hendrikus J./C-3830-2008; KNAW, NIOO-KNAW/A-4320-2012	Laanbroek, Hendrikus/0000-0003-2400-3399; Slomp, Caroline P/0000-0002-7272-0109; Bodelier, Paul/0000-0002-5757-5572; Bodelier, Paul L/0000-0002-5757-5572; Laanbroek, Hendrikus J./0000-0003-2400-3399; Steenbergh, Anne/0000-0002-0360-5078; KNAW, NIOO-KNAW/0000-0002-3835-159X	Darwin Center for Biogeosciences [142.16.1101]; Baltic Sea foundation; Netherlands Organisation for Scientific Research (Vidi NWO); EU-BONUS project HYPER; European Research Council under the European Community [278364]	Darwin Center for Biogeosciences; Baltic Sea foundation; Netherlands Organisation for Scientific Research (Vidi NWO)(Netherlands Organization for Scientific Research (NWO)); EU-BONUS project HYPER; European Research Council under the European Community(European Research Council (ERC))	This work was funded by grants from the Darwin Center for Biogeosciences (http://www.darwincenter.nl/; grant number 142.16.1101), the Baltic Sea 2020 foundation (http://www.balticsea2020.org/), the Netherlands Organisation for Scientific Research (Vidi NWO to C.P. Slomp; http://www.nwo.nl/), the EU-BONUS project HYPER (http://www.bonusportal.org/) and the European Research Council (http://erc.europa.eu/) under the European Community's Seventh Framework Programme for ERC Starting Grant 278364. This is publication number XXX of the Netherlands Institute of Ecology (NIOO-KNAW), and publication number XXX of the Darwin Center for Biogeosciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algeo TJ, 2007, PALAEOGEOGR PALAEOCL, V256, P130, DOI 10.1016/j.palaeo.2007.02.029; Bodrossy L, 2006, APPL ENVIRON MICROB, V72, P1672, DOI 10.1128/AEM.72.2.1672-1676.2006; Brock J, 2011, ISME J, V5, P497, DOI 10.1038/ismej.2010.135; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Edlund A, 2006, ENVIRON MICROBIOL, V8, P223, DOI 10.1111/j.1462-2920.2005.00887.x; Edlund A, 2008, ENVIRON MICROBIOL, V10, P2051, DOI 10.1111/j.1462-2920.2008.01624.x; Emeis K, 2002, J MARINE SYST, V35, P151, DOI 10.1016/S0924-7963(02)00127-6; Emeis KC, 2000, MAR GEOL, V167, P43, DOI 10.1016/S0025-3227(00)00015-3; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Frossard A, 2012, ISME J, V6, P680, DOI 10.1038/ismej.2011.134; GACHTER R, 1993, HYDROBIOLOGIA, V253, P103, DOI 10.1007/BF00050731; Grote J, 2008, APPL ENVIRON MICROB, V74, P7546, DOI 10.1128/AEM.01186-08; Illian JB, 2009, J MICROBIOL METH, V79, P89, DOI 10.1016/j.mimet.2009.08.010; INGALL E, 1994, GEOCHIM COSMOCHIM AC, V58, P2571, DOI 10.1016/0016-7037(94)90033-7; Jilbert T, 2011, BIOGEOSCIENCES, V8, P1699, DOI 10.5194/bg-8-1699-2011; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Lindahl V, 1996, J MICROBIOL METH, V25, P279, DOI 10.1016/0167-7012(95)00102-6; Llobet-Brossa E, 1998, APPL ENVIRON MICROB, V64, P2691; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Luo HW, 2009, P NATL ACAD SCI USA, V106, P21219, DOI 10.1073/pnas.0907586106; Mermillod-Blondin F, 2011, J N AM BENTHOL SOC, V30, P770, DOI 10.1899/10-121.1; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Oksanen J., 2016, R PACKAG; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; Pett-Ridge J, 2005, APPL ENVIRON MICROB, V71, P6998, DOI 10.1128/AEM.71.11.6998-7007.2005; Ramsay J. O., 2011, FDA FUNCTIONAL DATA; REDFIELD AC, 1958, AM SCI, V46, P205; SANDER BC, 1993, MICROB ECOL, V26, P79, DOI 10.1007/BF00177045; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sinkko H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021555; Soetaert K, 2007, MAR CHEM, V105, P30, DOI 10.1016/j.marchem.2006.12.012; Steenbergh AK, 2013, ENVIRON MICROBIOL, V15, P1572, DOI 10.1111/1462-2920.12042; Steenbergh AK, 2011, LIMNOL OCEANOGR, V56, P2018, DOI 10.4319/lo.2011.56.6.2018; Steenbergh AK, 2010, FEMS MICROBIOL ECOL, V71, P12, DOI 10.1111/j.1574-6941.2009.00782.x; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Sukenik A, 2012, ISME J, V6, P670, DOI 10.1038/ismej.2011.128; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zinger L, 2011, PLOS ONE, V6	40	9	9	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92401	10.1371/journal.pone.0092401	http://dx.doi.org/10.1371/journal.pone.0092401			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667801	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600037
J	Guo, XF; Zhu, XF; Yang, WC; Zhang, SH; Zhen, YS				Guo, Xiao-Fang; Zhu, Xiao-Fei; Yang, Wan-Cai; Zhang, Sheng-Hua; Zhen, Yong-Su			An EGFR/HER2-Bispecific and Enediyne-Energized Fusion Protein Shows High Efficacy against Esophageal Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MOUSE XENOGRAFT MODEL; SQUAMOUS-CELL CARCINOMA; PHASE-I TRIAL; RECOMBINANT IMMUNOTOXIN; EGFR; EXPRESSION; HER2; MALIGNANCIES; TRASTUZUMAB	Esophageal cancer is one of the most common cancers, and the 5-year survival rate is less than 10% due to lack of effective therapeutic agents. This study was to evaluate antitumor activity of Ec-LDP-Hr-AE, a recently developed bispecific enediyne-energized fusion protein targeting both epidermal growth factor receptor (EGFR) and epidermal growth factor receptor 2 (HER2), on esophageal cancer. The fusion protein Ec-LDP-Hr-AE consists of two oligopeptide ligands and an enediyne antibiotic lidamycin (LDM) for receptor binding and cell killing, respectively. The current study demonstrated that Ec-LDP-Hr had high affinity to bind to esophageal squamous cell carcinoma (ESCC) cells, and enediyne-energized fusion protein Ec-LDP-Hr-AE showed potent cytotoxicity to ESCC cells with differential expression of EGFR and HER2. Ec-LDP-Hr-AE could cause significant G2-M arrest in EC9706 and KYSE150 cells, and it also induced apoptosis in ESCC cells in a dosage-dependent manner. Western blot assays showed that Ec-LDP-Hr-AE promoted caspase-3 and caspase-7 activities as well as PARP cleavage. Moreover, Ec-LDP-Hr-AE inhibited cell proliferation via decreasing phosphorylation of EGFR and HER2, and further exerted inhibition of the activation of their downstream signaling molecules. In vivo, at a tolerated dose, Ec-LDP-Hr-AE inhibited tumor growth by 88% when it was administered to nude mice bearing human ESCC cell KYSE150 xenografts. These results indicated that Ec-LDP-Hr-AE exhibited potent anti-caner efficacy on ESCC, suggesting it could be a promising candidate for targeted therapy of esophageal cancer.	[Guo, Xiao-Fang] Xinxiang Med Univ, Dept Microbiol, Xinxiang, Peoples R China; [Zhu, Xiao-Fei] Xinxiang Med Univ, Sch Lab Med, Xinxiang, Peoples R China; [Yang, Wan-Cai] Xinxiang Med Univ, Dept Pathol, Xinxiang, Peoples R China; [Yang, Wan-Cai] Univ Illinois, Dept Pathol, Chicago, IL USA; [Zhang, Sheng-Hua; Zhen, Yong-Su] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China; [Zhang, Sheng-Hua; Zhen, Yong-Su] Perking Union Med Coll, Beijing, Peoples R China	Xinxiang Medical University; Xinxiang Medical University; Xinxiang Medical University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhen, YS (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China.	zhenys@public.bta.net.cn	Yang, Wancai/O-7655-2019; xiaofei, Zhu/AAH-2181-2019	Yang, Wancai/0000-0001-7437-9197; xiaofei, Zhu/0000-0001-6360-140X; Xiao-Fang, Guo/0000-0003-4005-7530	Natural Science Research Project of the Education Department of Henan Province, China [12B350004]; National Natural Science Foundation of China [81202447]; USCACA [USCACA-TIGM-001]	Natural Science Research Project of the Education Department of Henan Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); USCACA	This work is supported in part by the Natural Science Research Project of the Education Department of Henan Province, China (No. 12B350004 to XFG), National Natural Science Foundation of China (No. 81202447 to XFG, http://www.nsfc.gov.cn/Portal0/default152.htm), and a grant from the USCACA (No. USCACA-TIGM-001 to WCY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelstein DJ, 2012, INVEST NEW DRUG, V30, P1684, DOI 10.1007/s10637-011-9736-z; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Campbell NP, 2010, WORLD J GASTROENTERO, V16, P3793, DOI 10.3748/wjg.v16.i30.3793; Crosby T, 2013, LANCET ONCOL, V14, P627, DOI 10.1016/S1470-2045(13)70136-0; Fidias Panos, 2002, Clin Lung Cancer, V3, P219, DOI 10.3816/CLC.2002.n.006; FitzGerald DJ, 2011, CANCER RES, V71, P6300, DOI 10.1158/0008-5472.CAN-11-1374; Forde PM, 2013, J THORAC ONCOL, V8, P673, DOI 10.1097/JTO.0b013e31828b5172; Frankel AE, 2009, LEUKEMIA RES, V33, P1173, DOI 10.1016/j.leukres.2009.03.037; Garland L, 2005, J IMMUNOTHER, V28, P376, DOI 10.1097/01.cji.0000162782.86008.mL; Ge D, 2003, CLIN MED J CHINA, V10, P699; Gibault L, 2005, BRIT J CANCER, V93, P107, DOI 10.1038/sj.bjc.6602625; Guo XF, 2010, CLIN CANCER RES, V16, P2085, DOI 10.1158/1078-0432.CCR-09-2699; Holbro T, 2003, EXP CELL RES, V284, P99, DOI 10.1016/S0014-4827(02)00099-X; Homs MYV, 2009, EXPERT OPIN EMERG DR, V14, P329, DOI 10.1517/14728210902976842; Hong TS, 2013, SEMIN RADIAT ONCOL, V23, P31, DOI 10.1016/j.semradonc.2012.09.004; Ilson DH, 2011, CANCER-AM CANCER SOC, V117, P1409, DOI 10.1002/cncr.25602; ITAKURA Y, 1994, CANCER, V74, P795, DOI 10.1002/1097-0142(19940801)74:3<795::AID-CNCR2820740303>3.0.CO;2-I; Kawaguchi Y, 2007, BRIT J CANCER, V97, P494, DOI 10.1038/sj.bjc.6603885; Kreitman RJ, 2005, J CLIN ONCOL, V23, P6719, DOI 10.1200/JCO.2005.11.437; Neuner Geoffrey, 2009, Gastrointest Cancer Res, V3, P57; Olsen E, 2001, J CLIN ONCOL, V19, P376, DOI 10.1200/JCO.2001.19.2.376; Pastan I, 2007, ANNU REV MED, V58, P221, DOI 10.1146/annurev.med.58.070605.115320; Reddy D, 2011, CURR TREAT OPTION ON, V12, P46, DOI 10.1007/s11864-011-0138-4; Reid A, 2007, EUR J CANCER, V43, P481, DOI 10.1016/j.ejca.2006.11.007; Rusnak DW, 2007, CELL PROLIFERAT, V40, P580, DOI 10.1111/j.1365-2184.2007.00455.x; Safran H, 2007, INT J RADIAT ONCOL, V67, P405, DOI 10.1016/j.ijrobp.2006.08.076; Shah MA, 2004, ANN SURG ONCOL, V11, P641, DOI 10.1245/ASO.2004.04.907; Stish BJ, 2007, CLIN CANCER RES, V13, P6486, DOI 10.1158/1078-0432.CCR-07-0938; Stish BJ, 2007, CLIN CANCER RES, V13, P3058, DOI 10.1158/1078-0432.CCR-06-2454; Todhunter DA, 2004, PROTEIN ENG DES SEL, V17, P157, DOI 10.1093/protein/gzh023; Vallera DA, 2005, CLIN CANCER RES, V11, P3879, DOI 10.1158/1078-0432.CCR-04-2290; Waldron NN, 2013, TARGET ONCOL; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wei QC, 2007, INT J ONCOL, V31, P493; Wiernik A, 2013, CLIN CANCER RES, V19, P3844, DOI 10.1158/1078-0432.CCR-13-0505; Zhang DW, 2008, MOL CANCER THER, V7, P1846, DOI 10.1158/1535-7163.MCT-08-0168	36	11	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92986	10.1371/journal.pone.0092986	http://dx.doi.org/10.1371/journal.pone.0092986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664246	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900138
J	Jeffree, RA; Markich, SJ; Twining, JR				Jeffree, Ross A.; Markich, Scott J.; Twining, John R.			Diminished Metal Accumulation in Riverine Fishes Exposed to Acid Mine Drainage over Five Decades	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; FRESH-WATER; COPPER-METABOLISM; ORGANIC-MATTER; FINNISS RIVER; SPECIATION; POLLUTION; CADMIUM; VARIABILITY; TOLERANCE	Bony bream (Nematalosa erebi) and black catfish (Neosilurus ater) were sampled from the fresh surface waters of the Finniss River in tropical northern Australia, along a metal pollution gradient draining the Rum Jungle copper/uranium mine, a contaminant source for over five decades. Paradoxically, populations of both fish species exposed to the highest concentrations of mine-related metals (cobalt, copper, lead, manganese, nickel, uranium and zinc) in surface water and sediment had the lowest tissue (bone, liver and muscle) concentrations of these metals. The degree of reduction in tissue concentrations of exposed populations was also specific to each metal and inversely related to its degree of environmental increase above background. Several explanations for diminished metal bioaccumulation in fishes from the contaminated region were evaluated. Geochemical speciation modeling of metal bioavailability in surface water showed no differences between the contaminated region and the control sites. Also, the macro-nutrient (calcium, magnesium and sodium) water concentrations, that may competitively inhibit metal uptake, were not elevated with trace metal contamination. Reduced exposure to contaminants due to avoidance behavior was unlikely due to the absence of refugial water bodies with the requisite metal concentrations lower than the control sites and very reduced connectivity at time of sampling. The most plausible interpretation of these results is that populations of both fish species have modified kinetics within their metal bioaccumulation physiology, via adaptation or tolerance responses, to reduce their body burdens of metals. This hypothesis is consistent with (i) reduced tissue concentrations of calcium, magnesium and sodium (macro-nutrients), in exposed populations of both species, (ii) experimental findings for other fish species from the Finniss River and other contaminated regions, and (iii) the number of generations exposed to likely selection pressure over 50 years.	[Jeffree, Ross A.] Univ Technol Sydney, Sch Environm C3, Sydney, NSW 2007, Australia; [Markich, Scott J.] Aquat Solut Int, Collaroy, NSW, Australia; [Twining, John R.] Austral Radioecol, Oyster Bay, NSW, Australia	University of Technology Sydney	Jeffree, RA (corresponding author), Univ Technol Sydney, Sch Environm C3, Sydney, NSW 2007, Australia.	ross.jeffree@uts.edu.au			Australian Nuclear Science and Technology Organisation	Australian Nuclear Science and Technology Organisation	This research was primarily supported by the Australian Nuclear Science and Technology Organisation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemi JA, 2013, AQUAT TOXICOL, V130, P51, DOI 10.1016/j.aquatox.2013.01.001; ALLENGIL SM, 1995, SCI TOTAL ENVIRON, V160-61, P653, DOI 10.1016/0048-9697(95)93634-T; American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; Andres S, 2000, SCI TOTAL ENVIRON, V248, P11, DOI 10.1016/S0048-9697(99)00477-5; ANZECC (Australian and New Zealand Environment and Conservation Council), 2000, GUID FRESH MAR WAT Q; BARKER D, 2009, GUIDE ACCEPTABLE PRO; Bishop KA, 2001, ECOLOGICAL STUDIES F; Bryan SE, 2002, COMP BIOCHEM PHYS C, V133, P37, DOI 10.1016/S1532-0456(02)00083-2; Burger J, 2002, ENVIRON RES, V89, P85, DOI 10.1006/enrs.2002.4330; Chowdhury MJ, 2008, ENVIRON SCI TECHNOL, V42, P1359, DOI 10.1021/es071889n; Edwards CA, 2002, THESIS U TECHNOLOGY; Farkas A., 2000, Lakes and Reservoirs Research and Management, V5, P271, DOI 10.1046/j.1440-1770.2000.00127.x; Gale SA, 2003, AQUAT TOXICOL, V62, P135, DOI 10.1016/S0166-445X(02)00081-4; Gorley C.K., 2006, GETTING STARTED PRIM; Groenenberg JE, 2010, ENVIRON SCI TECHNOL, V44, P1340, DOI 10.1021/es902615w; Gustafsson JP, 2012, VISUAL MINTEQ V3 0 W; HOLM PE, 1995, WATER RES, V29, P803, DOI 10.1016/0043-1354(94)00205-L; Hydrobiology, 2013, HYDROBIOLOGY; JEFFREE RA, 1980, ECOL MONOGR, V50, P457, DOI 10.2307/1942653; Jeffree RA, 2001, ENVIRON SCI TECHNOL, V35, P2932, DOI 10.1021/es001719+; Jeffree RA, 2000, CONTAMINATED SITE RE, P51; Jeffree RA, 1975, RUM JUNGLE ENV STUDI; Kamunde C, 2002, J EXP BIOL, V205, P279; Kamunde CN, 2001, CAN J FISH AQUAT SCI, V58, P293, DOI 10.1139/cjfas-58-2-293; Klerks PL, 2002, ENVIRON POLLUT, V45, P173; Lenoir T, 2010, ENVIRON SCI TECHNOL, V44, P6221, DOI 10.1021/es1015313; Markich SJ, 1998, SCI TOTAL ENVIRON, V217, P201, DOI 10.1016/S0048-9697(98)00188-0; Markich SJ, 2002, ENVIRON SCI TECHNOL, V36, P821, DOI 10.1021/es011066c; Markich SJ, 2012, C112 ASI; Medeiros ES, 2014, ENV BIOL FI IN PRESS, V97; Minghetti M, 2010, AQUAT TOXICOL, V97, P23, DOI 10.1016/j.aquatox.2009.11.017; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Pusey B., 2004, FRESHWATER FISHES NE; Rohlf FJ., 2011, BIOMETRY PRINCIPLES; Ryan B, 2005, 498 IR AUSTR GOV; Sjostedt CS, 2010, ENVIRON SCI TECHNOL, V44, P8587, DOI 10.1021/es102415r; Sternberg D, 2008, MAR FRESHWATER RES, V59, P137, DOI 10.1071/MF07125; Taweel A, 2011, AFR J BIOTECHNOL, V10, P11562; Thompson PA, 2005, ENVIRON MONIT ASSESS, V110, P71, DOI 10.1007/s10661-005-6291-0; Tipping E, 2011, ENVIRON CHEM, V8, P225, DOI 10.1071/EN11016; UNEP, 2010, CLEAR WAT FOC WAT QU; Velcheva Iliana G., 2006, Turkish Journal of Zoology, V30, P1; Vulkan R, 2000, ENVIRON SCI TECHNOL, V34, P5115, DOI 10.1021/es0000910; WEIS JS, 1989, BIOSCIENCE, V39, P89, DOI 10.2307/1310907; Wood C.M., 2012, FISH PHYSL A, V31A; Wood C.M., 2012, FISH PHYSL B, V31B; WRIGHT DA, 1986, J MAR BIOL ASSOC UK, V66, P83, DOI 10.1017/S0025315400039667; Xie LT, 2004, AQUAT TOXICOL, V66, P73, DOI 10.1016/j.aquatox.2003.08.003	48	5	5	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91371	10.1371/journal.pone.0091371	http://dx.doi.org/10.1371/journal.pone.0091371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663964	Green Submitted, Green Published, gold			2022-12-27	WOS:000333459900019
J	Koetschan, C; Kittelmann, S; Lu, JL; Al-Halbouni, D; Jarvis, GN; Muller, T; Wolf, M; Janssen, PH				Koetschan, Christian; Kittelmann, Sandra; Lu, Jingli; Al-Halbouni, Djamila; Jarvis, Graeme N.; Mueller, Tobias; Wolf, Matthias; Janssen, Peter H.			Internal Transcribed Spacer 1 Secondary Structure Analysis Reveals a Common Core throughout the Anaerobic Fungi (Neocallimastigomycota)	PLOS ONE			English	Article							SEQUENCE-STRUCTURE ANALYSIS; RNA SEQUENCE; ITS2; PHYLOGENY; RECONSTRUCTION; CHLOROPHYCEAE; DIVERSITY; TOOL; POPULATIONS; ALIGNMENT	The internal transcribed spacer (ITS) is a popular barcode marker for fungi and in particular the ITS1 has been widely used for the anaerobic fungi (phylum Neocallimastigomycota). A good number of validated reference sequences of isolates as well as a large number of environmental sequences are available in public databases. Its highly variable nature predisposes the ITS1 for low level phylogenetics; however, it complicates the establishment of reproducible alignments and the reconstruction of stable phylogenetic trees at higher taxonomic levels (genus and above). Here, we overcame these problems by proposing a common core secondary structure of the ITS1 of the anaerobic fungi employing a Hidden Markov Model-based ITS1 sequence annotation and a helix-wise folding approach. We integrated the additional structural information into phylogenetic analyses and present for the first time an automated sequence-structure-based taxonomy of the ITS1 of the anaerobic fungi. The methodology developed is transferable to the ITS1 of other fungal groups, and the robust taxonomy will facilitate and improve high-throughput anaerobic fungal community structure analysis of samples from various environments.	[Koetschan, Christian; Kittelmann, Sandra; Lu, Jingli; Janssen, Peter H.] AgResearch Ltd, Grasslands Res Ctr, Palmerston North, New Zealand; [Mueller, Tobias; Wolf, Matthias] Univ Wurzburg, Bioctr, Dept Bioinformat, D-97070 Wurzburg, Germany; [Al-Halbouni, Djamila] ViaLactia Biosci Ltd, Auckland, New Zealand; [Al-Halbouni, Djamila] New Zealand Trade & Enterprise, Wellington, New Zealand	AgResearch - New Zealand; University of Wurzburg	Kittelmann, S (corresponding author), AgResearch Ltd, Grasslands Res Ctr, Palmerston North, New Zealand.	sandra.kittelmann@agresearch.co.nz	Wolf, Matthias/A-5580-2008; Müller, Tobias/A-8952-2008	Wolf, Matthias/0000-0003-2004-1806; Kittelmann, Sandra/0000-0002-6019-9854; Janssen, Peter/0000-0002-1022-3502	Pastoral Greenhouse Gas Research Consortium (PGgRc); New Zealand Ministry for Primary Industries (MPI); Global Research Alliance on Agricultural Greenhouse Gases (GRA)	Pastoral Greenhouse Gas Research Consortium (PGgRc); New Zealand Ministry for Primary Industries (MPI); Global Research Alliance on Agricultural Greenhouse Gases (GRA)	This work was supported by and research was carried out under contract to the Pastoral Greenhouse Gas Research Consortium (PGgRc; www.pggrc.co.nz), and the New Zealand Ministry for Primary Industries (MPI; www.mpi.govt.nz) as part of its support for the Global Research Alliance on Agricultural Greenhouse Gases (GRA; www.globalresearchalliance.org). The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The authors required the funders' approval to publish.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bates ST, 2013, STAND GENOMIC SCI, V8, P118, DOI 10.4056/sigs.3737409; Benson D, 2011, NUCLEIC ACIDS RES, V40, P48; Buchheim MA, 2012, ANN BOT-LONDON, V109, P109, DOI 10.1093/aob/mcr275; Buchheim MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016931; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Coleman AW, 2007, NUCLEIC ACIDS RES, V35, P3322, DOI 10.1093/nar/gkm233; Coleman AW, 1998, PROTIST, V149, P135, DOI 10.1016/S1434-4610(98)70018-5; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; Molina MD, 2011, LICHENOLOGIST, V43, P585, DOI 10.1017/S0024282911000521; Ebersberger I, 2012, MOL BIOL EVOL, V29, P1319, DOI 10.1093/molbev/msr285; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Fliegerova K, 2010, FOLIA MICROBIOL, V55, P319, DOI 10.1007/s12223-010-0049-y; Friedrich J, 2005, BIOINFORMATICS, V21, P2108, DOI 10.1093/bioinformatics/bti289; Gottschling M, 2001, PLANT BIOLOGY, V3, P629, DOI 10.1055/s-2001-19371; Herrera J, 2011, MICROB ECOL, V61, P239, DOI 10.1007/s00248-010-9744-0; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Hibbett DS, 2013, NAT REV MICROBIOL, V11, P129, DOI 10.1038/nrmicro2963; Hoshina R, 2010, MICROBES ENVIRON, V25, P313, DOI 10.1264/jsme2.ME10129; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; Keller A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-4; Kittelmann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036866; Koetschan C, 2012, MOL PHYLOGENET EVOL, V63, P585, DOI 10.1016/j.ympev.2012.01.026; Lamanna AC, 2011, J MOL BIOL, V405, P3, DOI 10.1016/j.jmb.2010.09.064; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letsch HO, 2010, MOL BIOL EVOL, V27, P2507, DOI 10.1093/molbev/msq140; Liggenstoffer AS, 2010, ISME J, V4, P1225, DOI 10.1038/ismej.2010.49; Markert SM, 2012, PLANT BIOLOGY, V14, P987, DOI 10.1111/j.1438-8677.2012.00576.x; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; McNeill J., 2006, V146, P1; Mello A, 2011, MYCOLOGIA, V103, P1184, DOI 10.3852/11-027; Monard C, 2013, FEMS MICROBIOL ECOL, V84, P165, DOI 10.1111/1574-6941.12046; Muller T, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-20; Nicholson MJ, 2010, ANAEROBE, V16, P66, DOI 10.1016/j.anaerobe.2009.05.003; Nilsson RH, 2009, FEMS MICROBIOL LETT, V296, P97, DOI 10.1111/j.1574-6968.2009.01618.x; ORPIN CG, 1975, J GEN MICROBIOL, V91, P249, DOI 10.1099/00221287-91-2-249; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rambaut A., 2009, FIGTREE; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Schultz J, 2005, RNA, V11, P361, DOI 10.1261/rna.7204505; Schultz J, 2009, MOL PHYLOGENET EVOL, V52, P520, DOI 10.1016/j.ympev.2009.01.008; Seibel PN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-498; Seibel Philipp N, 2008, BMC Res Notes, V1, P91, DOI 10.1186/1756-0500-1-91; Shaw AJ, 2010, AM J BOT, V97, P1511, DOI 10.3732/ajb.1000055; Thornhill DJ, 2010, PROTIST, V161, P434, DOI 10.1016/j.protis.2009.11.004; Tuckwell DS, 2005, MICROBIOL-SGM, V151, P1557, DOI 10.1099/mic.0.27689-0; Wolf M, 2005, RNA, V11, P1616, DOI 10.1261/rna.2144205; Wolf M, 2008, BIOINFORMATICS, V24, P2401, DOI 10.1093/bioinformatics/btn453	48	60	64	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91928	10.1371/journal.pone.0091928	http://dx.doi.org/10.1371/journal.pone.0091928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663345	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900032
J	Kuzelova, K; Grebenova, D; Holoubek, A; Roselova, P; Obr, A				Kuzelova, Katerina; Grebenova, Dana; Holoubek, Ales; Roeselova, Pavla; Obr, Adam			Group I PAK Inhibitor IPA-3 Induces Cell Death and Affects Cell Adhesivity to Fibronectin in Human Hematopoietic Cells	PLOS ONE			English	Article							P21-ACTIVATED KINASE; PHOSPHORYLATION; ACTIVATION; OVEREXPRESSION; MODULATION; EXPRESSION; APOPTOSIS; MIGRATION; INVASION; PATHWAY	P21-activated kinases (PAKs) are involved in the regulation of multiple processes including cell proliferation, adhesion and migration. However, the current knowledge about their function is mainly based on results obtained in adherent cell types. We investigated the effect of group I PAK inhibition using the compound IPA-3 in a variety of human leukemic cell lines (JURL-MK1, MOLM-7, K562, CML-T1, HL-60, Karpas-299, Jurkat, HEL) as well as in primary blood cells. IPA-3 induced cell death with EC50 ranging from 5 to more than 20 mu M. Similar range was found for IPA-3-mediated dephosphorylation of a known PAK downstream effector, cofilin. The cell death was associated with caspase-3 activation, PARP cleavage and apoptotic DNA fragmentation. In parallel, 20 mM IPA-3 treatment induced rapid and marked decrease of the cell adhesivity to fibronectin. Per contra, partial reduction of PAK activity using lower dose IPA-3 or siRNA resulted in a slight increase in the cell adhesivity. The changes in the cell adhesivity were also studied using real-time microimpedance measurement and by interference reflection microscopy. Significant differences in the intracellular IPA-3 level among various cell lines were observed indicating that an active mechanism is involved in IPA-3 transport.	[Kuzelova, Katerina; Grebenova, Dana; Holoubek, Ales; Roeselova, Pavla; Obr, Adam] Inst Hematol & Blood Transfus, Dept Cellular Biochem, CR-12820 Prague, Czech Republic	Institute of Hematology Prague	Kuzelova, K (corresponding author), Inst Hematol & Blood Transfus, Dept Cellular Biochem, CR-12820 Prague, Czech Republic.	kuzel@uhkt.cz	Kuzelova, Katerina/ADE-8303-2022	Kuzelova, Katerina/0000-0002-9628-6255; Obr, Adam/0000-0003-0057-076X	Ministry of Health of the Czech Republic (Project for conceptual development of research organization) [00023736]; European Union [ERDF OPPK CZ.2.16/3.1.00/24001, CZ.2.16/3.1.00/28007]	Ministry of Health of the Czech Republic (Project for conceptual development of research organization); European Union(European Commission)	The work was supported by the Ministry of Health of the Czech Republic (Project for conceptual development of research organization No 00023736) and by European Union (grants ERDF OPPK CZ.2.16/3.1.00/24001 and CZ.2.16/3.1.00/28007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai A, 2005, CELL SIGNAL, V17, P497, DOI 10.1016/j.cellsig.2004.09.007; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Barr Valarie A, 2009, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0423s45; Bright MD, 2009, CELL SIGNAL, V21, P1738, DOI 10.1016/j.cellsig.2009.07.005; Coniglio SJ, 2008, MOL CELL BIOL, V28, P4162, DOI 10.1128/MCB.01532-07; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Dorrance AM, 2013, BLOOD, V121, P2474, DOI 10.1182/blood-2012-10-460709; Flaiz C, 2009, EXP NEUROL, V218, P137, DOI 10.1016/j.expneurol.2009.04.019; Grebenova D, 2012, J PROTEOMICS; Hoover WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042601; Kamai T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-164; Kichina JV, 2010, EXPERT OPIN THER TAR, V14, P703, DOI 10.1517/14728222.2010.492779; Kosoff R, 2013, J BIOL CHEM, V288, P974, DOI 10.1074/jbc.M112.422295; Kuzelova K, 2007, CYTOM PART A, V71A, P605, DOI 10.1002/cyto.a.20415; Kuzelova K, 2011, J CELL BIOCHEM, V112, P3334, DOI 10.1002/jcb.23263; Kuzelova K, 2010, J CELL BIOCHEM, V109, P184, DOI 10.1002/jcb.22397; Lee MY, 2011, FERTIL STERIL, V96, P508, DOI 10.1016/j.fertnstert.2011.05.082; Lee N, 1997, P NATL ACAD SCI USA, V94, P13642, DOI 10.1073/pnas.94.25.13642; Li TT, 2011, CARCINOGENESIS, V32, P659, DOI 10.1093/carcin/bgq271; Luo SQ, 2009, J CELL SCI, V122, P875, DOI 10.1242/jcs.050013; Marlin JW, 2011, MAMM GENOME, V22, P306, DOI 10.1007/s00335-011-9326-6; MARTIN P, 1982, SCIENCE, V216, P1233, DOI 10.1126/science.6177045; McCarty SK, 2010, ENDOCR-RELAT CANCER, V17, P989, DOI 10.1677/ERC-10-0168; Mulloy JC, 2010, BLOOD, V115, P936, DOI 10.1182/blood-2009-09-198127; Obr A, 2013, CELL ADHES MIGR, V7, P275, DOI 10.4161/cam.24531; Ong CC, 2013, J NATL CANC I; Ong CC, 2011, P NATL ACAD SCI USA, V108, P7177, DOI 10.1073/pnas.1103350108; Parekh P, 2007, CELL BIOL INT, V31, P35, DOI 10.1016/j.cellbi.2006.09.005; Persico A, 2010, MOL BIOL CELL, V21, P3708, DOI 10.1091/mbc.E10-03-0243; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Sato M, 2013, J GASTROENTEROL HEPA; Singhal R, 2012, ONCOTARGET, V3, P700, DOI 10.18632/oncotarget.587; Siu MKY, 2010, INT J CANCER, V127, P21, DOI 10.1002/ijc.25005; Stockton RA, 2004, J BIOL CHEM, V279, P46621, DOI 10.1074/jbc.M408877200; Tsuji-Takayama K, 1994, Hum Cell, V7, P167; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; Viaud J, 2009, MOL CANCER THER, V8, P2559, DOI 10.1158/1535-7163.MCT-09-0102; Walsh K, 2013, CLIN CANCER RES, V19, P1106, DOI 10.1158/1078-0432.CCR-12-1060; Wang H, 2010, CELL SIGNAL, V22, P1022, DOI 10.1016/j.cellsig.2010.02.005; Wang RA, 2006, ONCOGENE, V25, P2931, DOI 10.1038/sj.onc.1209309; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Wu R, 2010, INT J CANCER, V127, P2230, DOI 10.1002/ijc.25226; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104	44	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92560	10.1371/journal.pone.0092560	http://dx.doi.org/10.1371/journal.pone.0092560			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664099	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900074
J	Nagatomo, Y; Meguro, T; Ito, H; Koide, K; Anzai, T; Fukuda, K; Ogawa, S; Yoshikawa, T				Nagatomo, Yuji; Meguro, Tomomi; Ito, Hiroyuki; Koide, Kimi; Anzai, Toshihisa; Fukuda, Keiichi; Ogawa, Satoshi; Yoshikawa, Tsutomu			Significance of AT(1) Receptor Independent Activation of Mineralocorticoid Receptor in Murine Diabetic Cardiomyopathy	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC DYSFUNCTION; CONVERTING ENZYME-INHIBITION; CONGESTIVE-HEART-FAILURE; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; CARDIAC-FUNCTION; NADPH OXIDASE; DOPPLER-ECHOCARDIOGRAPHY; HYPERTENSIVE-RATS; DEFICIENT MICE	Background: Diabetes mellitus (DM) has deleterious influence on cardiac performance independent of coronary artery disease and hypertension. The objective of the present study was to investigate the role of the renin-angiotensin-aldosterone system, especially angiotensin II type 1a receptor (AT(1a)R) and mineralocorticoid receptor (MR) signaling, in left ventricular (LV) dysfunction induced by diabetes mellitus (DM). Methods and Results: DM was induced by intraperitoneal injection of streptozotocin (200 mg/ kg BW) in wild-type (WT) or AT1aR knockout (KO) male mice, and they were bred during 6 or 12 weeks. Some KO mice were administered the MR antagonist eplerenone (100 mg/ kg body weight). At 6 weeks, LV diastolic function was impaired in WT-DM, but preserved in KO-DM. At that time point MR mRNA expression was upregulated, NADPH oxidase subunit (p47phox) and glutathione peroxidase (GPx1) mRNA expression were upregulated, the staining intensities of LV tissue for 4-hydroxy-2-nonenal was stronger in immunohistochemistry, the number of terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) positive cells was increased, Bcl-2 protein expression was significantly downregulated, and the expression of SERCA2a and phosphorylated phospholamban was depressed in WT-DM, while these changes were not seen in KO-DM. At 12 weeks, however, these changes were also noted in KO-DM. Eplerenone arrested those changes. The plasma aldosterone concentration was elevated in WT-DM but not in KO-DM at 6 weeks. It showed 3.7-fold elevation at 12 weeks even in KO-DM, which suggests "aldosterone breakthrough'' phenomenon. However, the aldosterone content in LV tissue was unchanged in KO-DM. Conclusions: DM induced diastolic dysfunction was observed even in KO at 12 weeks, which was ameliorated by minelarocorticoid receptor antagonist, eplerenone. AT(1)-independent MR activation in the LV might be responsible for the pathogenesis of diabetic cardiomyopathy.	[Nagatomo, Yuji; Ito, Hiroyuki; Koide, Kimi; Anzai, Toshihisa; Fukuda, Keiichi; Ogawa, Satoshi; Yoshikawa, Tsutomu] Keio Univ, Sch Med, Dept Med, Div Cardiol, Tokyo 160, Japan; [Meguro, Tomomi] Int Univ Hlth & Welf, KAKEN Hosp, Dept Cardiol, Ichikawa, Japan	Keio University; International University of Health & Welfare	Meguro, T (corresponding author), Int Univ Hlth & Welf, KAKEN Hosp, Dept Cardiol, Ichikawa, Japan.	tmeguro@iuhw.ac.jp	Fukuda, Keiichi/L-3777-2013; Nagatomo, Yuji/AAQ-1590-2020; Anzai, Toshihisa/J-2179-2015; Nagatomo, Yuji/HDM-4151-2022	Nagatomo, Yuji/0000-0002-3430-4614; Anzai, Toshihisa/0000-0003-3319-4967; 	Japanese Ministry of Education, Culture, Sports, Science and Technology [17790500]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology (No. 17790500; http://www.mext.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shafei AIM, 2002, J PHYSIOL-LONDON, V538, P555, DOI 10.1113/jphysiol.2001.012857; Baba A, 2006, INT J CARDIOL, V112, P15, DOI 10.1016/j.ijcard.2006.05.026; Candido R, 2002, CIRCULATION, V106, P246, DOI 10.1161/01.CIR.0000021122.63813.32; CASTREN M, 1995, J MOL ENDOCRINOL, V14, P285, DOI 10.1677/jme.0.0140285; Choi KM, 2002, AM J PHYSIOL-HEART C, V283, pH1398, DOI 10.1152/ajpheart.00313.2002; Delcayre C, 2002, J MOL CELL CARDIOL, V34, P1577, DOI 10.1006/jmcc.2002.2088; Edelmann F, 2013, JAMA-J AM MED ASSOC, V309, P781, DOI 10.1001/jama.2013.905; Gorcsan J, 1997, CIRCULATION, V95, P2423, DOI 10.1161/01.CIR.95.10.2423; Gottdiener JS, 2000, J AM COLL CARDIOL, V35, P1628, DOI 10.1016/S0735-1097(00)00582-9; Guo ZX, 2007, AM J PHYSIOL-HEART C, V292, pH1728, DOI 10.1152/ajpheart.01328.2005; Hafezi-Moghadam A, 2002, NAT MED, V8, P473, DOI 10.1038/nm0502-473; Heymes C, 2003, J AM COLL CARDIOL, V41, P2164, DOI 10.1016/S0735-1097(03)00471-6; Joffe II, 1999, J AM COLL CARDIOL, V34, P2111, DOI 10.1016/S0735-1097(99)00436-2; Kajstura J, 2001, DIABETES, V50, P1414, DOI 10.2337/diabetes.50.6.1414; Kaneko H, 2011, CIRC J, V75, P2482, DOI 10.1253/circj.CJ-11-0182; Kanki H, 1999, LIFE SCI, V65, P2305, DOI 10.1016/S0024-3205(99)00497-X; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Katada J, 2005, CIRCULATION, V111, P2157, DOI 10.1161/01.CIR.0000163562.82134.8E; Le Menuet D, 2001, J BIOL CHEM, V276, P38911, DOI 10.1074/jbc.M103984200; Mano Y, 2011, CIRC J, V75, P1717, DOI 10.1253/circj.CJ-10-1199; Matsue Y, 2011, CIRC J, V75, P2833, DOI 10.1253/circj.CJ-11-0754; Matsushima S, 2006, AM J PHYSIOL-HEART C, V291, pH2237, DOI 10.1152/ajpheart.00427.2006; Meguro T, 1999, CIRC RES, V84, P735, DOI 10.1161/01.RES.84.6.735; Mizuno Y, 2001, CIRCULATION, V103, P72; Nagata K, 2006, HYPERTENSION, V47, P656, DOI 10.1161/01.HYP.0000203772.78696.67; Naruse M, 2002, HYPERTENSION, V40, P28, DOI 10.1161/01.HYP.0000022606.52221.2F; Noda K, 2012, J CARDIOVASC PHARM, V60, P140, DOI 10.1097/FJC.0b013e318258f8ce; O'Keefe JH, 2008, DIABETES OBES METAB, V10, P492, DOI 10.1111/j.1463-1326.2007.00730.x; Ogawa S, 2006, CLIN EXP PHARMACOL P, V33, P477, DOI 10.1111/j.1440-1681.2006.04390.x; Ouvrard-Pascaud A, 2005, CIRCULATION, V111, P3025, DOI 10.1161/CIRCULATIONAHA.104.503706; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Qin FZ, 2007, FREE RADICAL BIO MED, V43, P271, DOI 10.1016/j.freeradbiomed.2007.04.021; Qin WN, 2003, CIRC RES, V93, P69, DOI 10.1161/01.RES.0000080521.15238.E5; Rossier MF, 2008, HYPERTENSION, V52, P721, DOI 10.1161/HYPERTENSIONAHA.108.114223; Sato A, 2001, J INT MED RES, V29, P13, DOI 10.1177/147323000102900103; Schannwell CM, 2002, CARDIOLOGY, V98, P33, DOI 10.1159/000064682; SECHI LA, 1994, DIABETES, V43, P1180, DOI 10.2337/diabetes.43.10.1180; Solomon SD, 2003, J AM COLL CARDIOL, V42, P1674, DOI 10.1016/j.jacc.2003.08.008; STAESSEN J, 1981, J ENDOCRINOL, V91, P457, DOI 10.1677/joe.0.0910457; SUGAYA T, 1995, J BIOL CHEM, V270, P18719, DOI 10.1074/jbc.270.32.18719; Takeda M, 2007, HYPERTENS RES, V30, P427, DOI 10.1291/hypres.30.427; Trost SU, 2002, DIABETES, V51, P1166, DOI 10.2337/diabetes.51.4.1166; Tsutsui H, 2007, HYPERTENS RES, V30, P439, DOI 10.1291/hypres.30.439; Wang H, 2008, J HYPERTENS, V26, P1453, DOI 10.1097/HJH.0b013e328300a232; Yamashita K, 2008, J CHROMATOGR A, V1200, P114, DOI 10.1016/j.chroma.2008.05.034; Yang GP, 2001, J MOL CELL CARDIOL, V33, P1505, DOI 10.1006/jmcc.2001.1413; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492; Zhang L, 2008, DIABETES, V57, P2158, DOI 10.2337/db08-0140	49	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93145	10.1371/journal.pone.0093145	http://dx.doi.org/10.1371/journal.pone.0093145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664319	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900158
J	Skocaj, M; Resnik, N; Grundner, M; Ota, K; Rojko, N; Hodnik, V; Anderluh, G; Sobota, A; Macek, P; Veranic, P; Sepcic, K				Skocaj, Matej; Resnik, Natasa; Grundner, Maja; Ota, Katja; Rojko, Nejc; Hodnik, Vesna; Anderluh, Gregor; Sobota, Andrzej; Macek, Peter; Veranic, Peter; Sepcic, Kristina			Tracking Cholesterol/Sphingomyelin-Rich Membrane Domains with the Ostreolysin A-mCherry Protein	PLOS ONE			English	Article							MUSHROOM PLEUROTUS-OSTREATUS; PORE-FORMING PROTEIN; LIPID RAFTS; EDIBLE MUSHROOM; CYTOLYTIC PROTEIN; PERFRINGOLYSIN-O; EQUINATOXIN-II; CHOLESTEROL; SPHINGOMYELIN; BINDING	Ostreolysin A (OlyA) is an similar to 15-kDa protein that has been shown to bind selectively to membranes rich in cholesterol and sphingomyelin. In this study, we investigated whether OlyA fluorescently tagged at the C-terminal with mCherry (OlyA-mCherry) labels cholesterol/sphingomyelin domains in artificial membrane systems and in membranes of Madin-Darby canine kidney (MDCK) epithelial cells. OlyA-mCherry showed similar lipid binding characteristics to non-tagged OlyA. OlyA-mCherry also stained cholesterol/sphingomyelin domains in the plasma membranes of both fixed and living MDCK cells, and in the living cells, this staining was abolished by pretreatment with either methyl-beta-cyclodextrin or sphingomyelinase. Double labelling of MDCK cells with OlyA-mCherry and the sphingomyelin-specific markers equinatoxin II-Alexa488 and GST-lysenin, the cholera toxin B subunit as a probe that binds to the ganglioside GM1, or the cholesterol-specific D4 domain of perfringolysin O fused with EGFP, showed different patterns of binding and distribution of OlyA-mCherry in comparison with these other proteins. Furthermore, we show that OlyA-mCherry is internalised in living MDCK cells, and within 90 min it reaches the juxtanuclear region via caveolin-1-positive structures. No binding to membranes could be seen when OlyA-mCherry was expressed in MDCK cells. Altogether, these data clearly indicate that OlyA-mCherry is a promising tool for labelling a distinct pool of cholesterol/sphingomyelin membrane domains in living and fixed cells, and for following these domains when they are apparently internalised by the cell.	[Skocaj, Matej; Ota, Katja; Rojko, Nejc; Hodnik, Vesna; Anderluh, Gregor; Macek, Peter; Sepcic, Kristina] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia; [Resnik, Natasa; Veranic, Peter] Univ Ljubljana, Fac Med, Inst Cell Biol, Ljubljana, Slovenia; [Grundner, Maja] Univ Ljubljana, Fac Med, Inst Biophys, Ljubljana, Slovenia; [Anderluh, Gregor] Natl Inst Chem, Ljubljana, Slovenia; [Sobota, Andrzej] Nencki Inst Expt Biol, Warsaw, Poland	University of Ljubljana; University of Ljubljana; University of Ljubljana; National Institute of Chemistry - Slovenia; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Veranic, P (corresponding author), Univ Ljubljana, Fac Med, Inst Cell Biol, Ljubljana, Slovenia.	peter.veranic@mf.uni-lj.si; kristina.sepcic@bf.uni-lj.si	Maček, Peter/Y-9877-2019; Anderluh, Gregor/C-6905-2014; Sepcic, Kristina/S-5533-2018; skocaj, matej/AAD-2754-2022; Maček, Peter/U-4662-2017; Veranic, Peter/I-6276-2015	Maček, Peter/0000-0001-6470-7759; Anderluh, Gregor/0000-0002-9916-8465; Sepcic, Kristina/0000-0002-4023-5379; Maček, Peter/0000-0001-6470-7759; Veranic, Peter/0000-0003-1999-9988	Slovenian Research Agency [JI-4305, PI-0207]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the Slovenian Research Agency (http://www.arrs.gov.si/en/agencija), grants JI-4305 and PI-0207. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2013, BIOCH BIOPH IN PRESS; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Angus AA, 2008, INFECT IMMUN, V76, P1992, DOI 10.1128/IAI.01221-07; [Anonymous], 1965, REG AN CELL LIN SE S; Bakrac B, 2010, J BIOL CHEM, V285, P22186, DOI 10.1074/jbc.M110.105122; BELMONTE G, 1993, J MEMBRANE BIOL, V131, P11, DOI 10.1007/BF02258530; Berne S, 2005, BIOCHEMISTRY-US, V44, P11137, DOI 10.1021/bi051013y; Berne S, 2002, BBA-GEN SUBJECTS, V1570, P153, DOI 10.1016/S0304-4165(02)00190-3; Berne S, 2009, PROTEIN SCI, V18, P694, DOI 10.1002/pro.85; Besenicar M, 2006, CHEM PHYS LIPIDS, V141, P169, DOI 10.1016/j.chemphyslip.2006.02.010; Bhat HB, 2013, J LIPID RES, V54, P2933, DOI 10.1194/jlr.D041731; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chowdhury HH, 2008, TOXICON, V51, P1345, DOI 10.1016/j.toxicon.2008.03.010; Coskun U, 2011, STRUCTURE, V19, P1543, DOI 10.1016/j.str.2011.10.010; Duggan J, 2008, EUR BIOPHYS J BIOPHY, V37, P1279, DOI 10.1007/s00249-008-0349-1; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Freeman MR, 2004, J CELL BIOCHEM, V91, P54, DOI 10.1002/jcb.10724; Gerl MJ, 2012, J CELL BIOL, V196, P213, DOI 10.1083/jcb.201108175; Hodnik V, 2010, METHODS MOL BIOL, V627, P201, DOI 10.1007/978-1-60761-670-2_13; Ishitsuka R, 2005, J BIOCHEM, V137, P249, DOI 10.1093/jb/mvi041; Ishitsuka R, 2004, BIOPHYS J, V86, P296, DOI 10.1016/S0006-3495(04)74105-3; Ishitsuka R., 2008, PROBES TAGS STUDY BI, P53; Keyel PA, 2011, J CELL SCI, V124, P2414, DOI 10.1242/jcs.076182; Kolanjiappan K, 2003, CLIN BIOCHEM, V36, P61, DOI 10.1016/S0009-9120(02)00421-6; Kulma M, 2010, BBA-BIOMEMBRANES, V1798, P471, DOI 10.1016/j.bbamem.2009.12.004; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; Lencer WI, 2005, BBA-MOL CELL RES, V1746, P314, DOI 10.1016/j.bbamcr.2005.07.007; Lencer WI, 1999, BBA-MOL CELL RES, V1450, P177, DOI 10.1016/S0167-4889(99)00070-1; Li HY, 2003, BLOOD, V101, P3628, DOI 10.1182/blood-2002-07-2283; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; London E, 2002, CURR OPIN STRUC BIOL, V12, P480, DOI 10.1016/S0959-440X(02)00351-2; McConnell HM, 2003, ANNU REV BIOPH BIOM, V32, P469, DOI 10.1146/annurev.biophys.32.110601.141704; Michel V, 2007, BIOL CELL, V99, P129, DOI 10.1042/BC20060051; Mishra R, 2010, P NATL ACAD SCI USA, V107, P17633, DOI 10.1073/pnas.1012424107; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Ohno-Iwashita Y, 2010, SUBCELL BIOCHEM, V51, P597, DOI 10.1007/978-90-481-8622-8_22; Ota K, 2013, BIOCHIMIE, V95, P1855, DOI 10.1016/j.biochi.2013.06.012; Pletnev S, 2010, J AM CHEM SOC, V132, P2243, DOI 10.1021/ja908418r; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Resnik N, 2011, J BIOL CHEM, V286, P1499, DOI 10.1074/jbc.M110.189464; Rojko N, 2013, J BIOL CHEM, V288, P23704, DOI 10.1074/jbc.M113.481572; Schlumberger S, 2014, FEBS LETT, V588, P35, DOI 10.1016/j.febslet.2013.10.038; Sepcic K, 2003, EUR J BIOCHEM, V270, P1199, DOI 10.1046/j.1432-1033.2003.03480.x; Shakor ABA, 2003, FEBS LETT, V542, P1, DOI 10.1016/S0014-5793(03)00330-2; Shibata T, 2010, TOXICON, V56, P1436, DOI 10.1016/j.toxicon.2010.08.010; Shimada Y, 2002, EUR J BIOCHEM, V269, P6195, DOI 10.1046/j.1432-1033.2002.03338.x; Shogomori H, 2001, J BIOL CHEM, V276, P9182, DOI 10.1074/jbc.M009414200; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Skocaj M, 2013, CURR MED CHEM, V20, P491; Tomita T, 2004, J BIOL CHEM, V279, P26975, DOI 10.1074/jbc.M402676200; van Meer G, 2010, FEBS LETT, V584, P1800, DOI 10.1016/j.febslet.2009.10.020; van Zanten TS, 2010, P NATL ACAD SCI USA, V107, P15437, DOI 10.1073/pnas.1003876107; Waheed AA, 2001, P NATL ACAD SCI USA, V98, P4926, DOI 10.1073/pnas.091090798; Waugh MG, 2013, NAT PROTOC, V8, P2429, DOI 10.1038/nprot.2013.148; Yachi R, 2012, GENES CELLS, V17, P720, DOI 10.1111/j.1365-2443.2012.01621.x; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300; Zinchuk V, 2013, NATURE SCI REPORTS, V1356, P1	63	51	51	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92783	10.1371/journal.pone.0092783	http://dx.doi.org/10.1371/journal.pone.0092783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664106	Green Published, gold			2022-12-27	WOS:000333459900113
J	Yang, ZX; Yang, XL; Wu, Y; Wang, JM; Zhang, YH; Xiong, H; Jiang, YW; Qin, J				Yang, Zhixian; Yang, Xiaoling; Wu, Ye; Wang, Jingmin; Zhang, Yuehua; Xiong, Hui; Jiang, Yuwu; Qin, Jiong			Clinical Diagnosis, Treatment, and ALDH7A1 Mutations in Pyridoxine-Dependent Epilepsy in Three Chinese Infants	PLOS ONE			English	Article							TERM-FOLLOW-UP; RESPONSIVE SEIZURES; PIPECOLIC ACID; MRI FINDINGS; ANTIQUITIN; EEG; EPIDEMIOLOGY; DEFICIENCY; PATIENT; MARKER	Pyridoxine-dependent epilepsy (PDE) is a rare autosomal recessive disorder that causes seizures in neonates and infants. Mutations of the ALDH7A1 gene are now recognized as the molecular basis PDE and help to define this disease. Three Chinese children with PDE were clinically analyzed, followed by treatment and examination of the ALDH7A1 mutations. The seizures of the 3 patients were all resistant to multiple anticonvulsants (2 to 7 types). For case 1, onset of seizures was at the age of 2 months. His seizures were well controlled by intravenous pyridoxine for several days at the age of 3 months 20 days and recurred at intervals of 13, 14 and 38 days after pyridoxine withdrawn for 3 times. At the age of 7 months, symptoms of PDE appeared and uninterrupted oral pyridoxine started. For case 2, her seizures occurred at 8 days after birth. After administration of multiple antiepileptic drugs observed ineffective, high-dose pyridoxine continuous therapy was taken at the age of 10 months and the significant treatment effect induced a diagnostic PDE. Seizure onset in case 3 was at the first day of birth. He experienced inadvertently pyridoxine therapy several times (first time at 2 days after birth) and achieved good therapeutic effect, which was confirmed by physicians until 4 months 10 days. The treatment process in our 3 patients suggested that pyridoxine should be early and purposefully used in patients with early onset seizures. ALDH7A1 gene mutation analysis revealed compound heterozygous mutations in each case: heterozygous c.410G>A (p.G137E) and IVS11+1G>A in case 1, heterozygous c.952G>C (p.A318P) and heterozygous c.965C>T (p.A322V) in case 2, and heterozygous c.902A>T (p.N301I) and IVS11+1G>A in case 3. Only p.N301I was reported previously, all other mutations were novel. This is the first time to report cases of Chinese patients diagnosed with PDE by molecular genetic analysis.	[Yang, Zhixian; Yang, Xiaoling; Wu, Ye; Wang, Jingmin; Zhang, Yuehua; Xiong, Hui; Jiang, Yuwu; Qin, Jiong] Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China	Peking University	Yang, ZX (corresponding author), Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China.	zhixian.yang@163.com	jiang, yu/HGU-0029-2022	Zhang, Yuehua/0000-0003-1432-5423				Basura GJ, 2009, EUR J PEDIATR, V168, P697, DOI 10.1007/s00431-008-0823-x; Baxter P, 2001, DEV MED CHILD NEUROL, V43, P416, DOI 10.1017/S0012162201000779; Baxter P, 1999, ARCH DIS CHILD, V81, P431, DOI 10.1136/adc.81.5.431; Baxter P, 2003, BBA-PROTEINS PROTEOM, V1647, P36, DOI 10.1016/S1570-9639(03)00045-1; Been JV, 2005, ARCH DIS CHILD, V90, P1293, DOI 10.1136/adc.2005.075069; Bennett CL, 2009, EPILEPSIA, V50, P1167, DOI 10.1111/j.1528-1167.2008.01816.x; Bok LA, 2010, EPILEPSIA, V51, P2406, DOI 10.1111/j.1528-1167.2010.02747.x; COKER SB, 1992, PEDIATRICS, V90, P221; Cormier-Daire V, 2000, AM J HUM GENET, V67, P991, DOI 10.1086/303087; Ebinger M, 1999, J PEDIATR-US, V134, P795, DOI 10.1016/S0022-3476(99)70307-0; Gospe Sidney M Jr, 2010, Chang Gung Med J, V33, P1; Gospe SM, 1998, NEUROLOGY, V51, P74, DOI 10.1212/WNL.51.1.74; Gospe SM, 2006, CURR OPIN NEUROL, V19, P148, DOI 10.1097/01.wco.0000218230.81301.12; HUNT AD, 1954, PEDIATRICS, V13, P140; Kluger G, 2008, NEUROPEDIATRICS, V39, P276, DOI 10.1055/s-0029-1202833; Kure S, 1998, J HUM GENET, V43, P128, DOI 10.1007/s100380050053; LEE P, 1994, GENOMICS, V21, P371, DOI 10.1006/geno.1994.1279; MIKATI MA, 1991, ELECTROEN CLIN NEURO, V78, P215, DOI 10.1016/0013-4694(91)90035-3; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Millet A, 2011, EUR J PAEDIATR NEURO, V15, P74, DOI 10.1016/j.ejpn.2010.03.011; Mills PB, 2006, NAT MED, V12, P307, DOI 10.1038/nm1366; Mills PB, 2010, BRAIN, V133, P2148, DOI 10.1093/brain/awq143; Naasan G, 2009, EPILEPTIC DISORD, V11, P293, DOI 10.1684/epd.2009.0280; Nam SH, 2012, ANN CLIN LAB SCI, V42, P65; Ohtsuka Y, 1999, DEV MED CHILD NEUROL, V41, P203, DOI 10.1017/S0012162299000390; Plecko B, 2005, NEUROPEDIATRICS, V36, P200, DOI 10.1055/s-2005-865727; Plecko B, 2000, ANN NEUROL, V48, P121, DOI 10.1002/1531-8249(200007)48:1<121::AID-ANA20>3.0.CO;2-V; Plecko B, 2007, HUM MUTAT, V28, P19, DOI 10.1002/humu.20433; Rankin PM, 2007, DEV MED CHILD NEUROL, V49, P300, DOI 10.1111/j.1469-8749.2007.00300.x; Scharer G, 2010, J INHERIT METAB DIS, V33, P571, DOI 10.1007/s10545-010-9187-2; Shih JJ, 1996, NEUROLOGY, V47, P824, DOI 10.1212/WNL.47.3.824; Stockler S, 2011, MOL GENET METAB, V104, P48, DOI 10.1016/j.ymgme.2011.05.014; Ulvi H, 2002, J TROP PEDIATRICS, V48, P303, DOI 10.1093/tropej/48.5.303	33	13	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92803	10.1371/journal.pone.0092803	http://dx.doi.org/10.1371/journal.pone.0092803			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664145	Green Submitted, Green Published, gold			2022-12-27	WOS:000333459900115
J	Nettiksimmons, J; Simonsick, EM; Harris, T; Satterfield, S; Rosano, C; Yaffe, K				Nettiksimmons, Jasmine; Simonsick, Eleanor M.; Harris, Tamara; Satterfield, Suzanne; Rosano, Caterina; Yaffe, Kristine		Hlth ABC Study	The Associations between Serum Brain-Derived Neurotrophic Factor, Potential Confounders, and Cognitive Decline: A Longitudinal Study	PLOS ONE			English	Article							BDNF MESSENGER-RNA; ALZHEIMERS-DISEASE; CARDIORESPIRATORY FITNESS; DECREASED-LEVELS; BLOOD-BRAIN; IMPAIRMENT; DEPRESSION; SURVIVAL; NEURONS; MEN	Brain-derived neurotrophic factor (BDNF) plays a role in the maintenance and function of neurons. Although persons with Alzheimer's disease have lower cortical levels of BDNF, evidence regarding the association between circulating BDNF and cognitive function is conflicting. We sought to determine the correlates of BDNF level and whether BDNF level was prospectively associated with cognitive decline in healthy older adults. We measured serum BDNF near baseline in 912 individuals. Cognitive status was assessed repeatedly with the modified Mini-Mental Status Examination and the Digit Symbol Substitution test over the next 10 years. We evaluated the association between BDNF and cognitive decline with longitudinal models. We also assessed the association between BDNF level and demographics, comorbidities and health behaviors. We found an association between serum BDNF and several characteristics that are also associated with dementia (race and depression), suggesting that future studies should control for these potential confounders. We did not find evidence of a longitudinal association between serum BDNF and subsequent cognitive test trajectories in older adults, although we did identify a potential trend toward a cross-sectional association. Our results suggest that serum BDNF may have limited utility as a biomarker of prospective cognitive decline.	[Nettiksimmons, Jasmine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Simonsick, Eleanor M.] NIA, Clin Res Branch, Baltimore, MD 21224 USA; [Harris, Tamara] NIA, Lab Epidemiol Demog & Biometry, Intramural Res Program, Bethesda, MD 20892 USA; [Satterfield, Suzanne] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA; [Rosano, Caterina] Univ Pittsburgh, Dept Epidemiol, Ctr Aging & Populat Hlth, Pittsburgh, PA 15261 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco Vet Affairs Med Ctr, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco Vet Affairs Med Ctr, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco Vet Affairs Med Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Tennessee System; University of Tennessee Health Science Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Nettiksimmons, J (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	Jasmine.nettiksimmons@ucsf.edu	Simonsick, Eleanor/W-6864-2019	Rosano, Caterina/0000-0002-4271-6010; Rosano, Caterina/0000-0002-0909-1506	NIA [N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106, R01-AG028050]; NINR [R01-NR012459]; Intramural Research Program of the NIH, National Institute of Aging; American Health Assistance Foundation [A201-0029]; National Institute of Aging [K24AG031155]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR012459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG007390, N01AG062106, N01AG062103, N01AG062101, P30AG024827, K24AG031155, R01AG028050] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Intramural Research Program of the NIH, National Institute of Aging; American Health Assistance Foundation(BrightFocus Foundation); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the following: NIA contract numbers: N01-AG-6-2101; N01-AG-6-2103; N01-AG-6-2106; NIA grant numbers: R01-AG028050, NINR grant R01-NR012459. This research was supported in part by the Intramural Research Program of the NIH, National Institute of Aging and by a grant from the American Health Assistance Foundation, grant number A201-0029. Dr. Yaffe is supported in part by a National Institute of Aging Grant (K24AG031155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; Angelucci F, 2010, CURR ALZHEIMER RES, V7, P15, DOI 10.2174/156720510790274473; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Bus BAA, 2011, PSYCHONEUROENDOCRINO, V36, P228, DOI 10.1016/j.psyneuen.2010.07.013; Currie J, 2009, NEUROSCI LETT, V451, P152, DOI 10.1016/j.neulet.2008.12.043; Driscoll I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035217; Fahnestock M, 2011, FUTUR NEUROL, V6, P627, DOI 10.2217/FNL.11.44; Fujimura H, 2002, THROMB HAEMOSTASIS, V87, P728; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Gunstad J, 2008, J GERIATR PSYCH NEUR, V21, P166, DOI 10.1177/0891988708316860; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; Holsinger RMD, 2000, MOL BRAIN RES, V76, P347, DOI 10.1016/S0169-328X(00)00023-1; Jung SH, 2011, EUR J APPL PHYSIOL, V111, P303, DOI 10.1007/s00421-010-1658-5; Klein AB, 2011, INT J NEUROPSYCHOPH, V14, P347, DOI 10.1017/S1461145710000738; Lang UE, 2004, NEUROPSYCHOPHARMACOL, V29, P795, DOI 10.1038/sj.npp.1300382; Laske C, 2006, J NEURAL TRANSM, V113, P1217, DOI 10.1007/s00702-005-0397-y; Laske C, 2007, J PSYCHIATR RES, V41, P387, DOI 10.1016/j.jpsychires.2006.01.014; Laske C, 2011, INT J NEUROPSYCHOPH, V14, P399, DOI 10.1017/S1461145710001008; Leyhe T, 2008, EUR ARCH PSY CLIN N, V258, P124, DOI 10.1007/s00406-007-0764-9; Li G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005424; Minelli A, 2011, EUR ARCH PSY CLIN N, V261, P323, DOI 10.1007/s00406-011-0189-3; Molendijk ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048046; MURPHY PW, 1993, J READING, V37, P124; O'Bryant SE, 2011, DEMENT GERIATR COGN, V31, P31, DOI 10.1159/000321980; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Wechsler D., 1997, WECHSLER ADULT INTEL; Yasutake C, 2006, EUR ARCH PSY CLIN N, V256, P402, DOI [10.1007/s00406-006-0652-8, 10.1007/s00406-006-0702-2]; Yu H, 2008, J CLIN PSYCHIAT, V69, P1104, DOI 10.4088/JCP.v69n0710; Ziegenhorn AA, 2007, NEUROBIOL AGING, V28, P1436, DOI 10.1016/j.neurobiolaging.2006.06.011	35	48	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e91339	10.1371/journal.pone.0091339	http://dx.doi.org/10.1371/journal.pone.0091339			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670553	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000333677000018
J	Zueva, KJ; Lumme, J; Veselov, AE; Kent, MP; Lien, S; Primmer, CR				Zueva, Ksenia J.; Lumme, Jaakko; Veselov, Alexey E.; Kent, Matthew P.; Lien, Sigbjorn; Primmer, Craig R.			Footprints of Directional Selection in Wild Atlantic Salmon Populations: Evidence for Parasite-Driven Evolution?	PLOS ONE			English	Article							INFECTIOUS PANCREATIC NECROSIS; GYRODACTYLUS-SALARIS MALMBERG; HISTOCOMPATIBILITY CLASS-I; GENE ONTOLOGY CATEGORIES; IMMUNE-RELEVANT GENES; FATTY-ACIDS; SALINITY TOLERANCE; NATURAL-SELECTION; PROTEIN-KINASE; LOCAL ADAPTATION	Mechanisms of host-parasite co-adaptation have long been of interest in evolutionary biology; however, determining the genetic basis of parasite resistance has been challenging. Current advances in genome technologies provide new opportunities for obtaining a genome-scale view of the action of parasite-driven natural selection in wild populations and thus facilitate the search for specific genomic regions underlying inter-population differences in pathogen response. European populations of Atlantic salmon (Salmo salar L.) exhibit natural variance in susceptibility levels to the ectoparasite Gyrodactylus salaris Malmberg 1957, ranging from resistance to extreme susceptibility, and are therefore a good model for studying the evolution of virulence and resistance. However, distinguishing the molecular signatures of genetic drift and environment-associated selection in small populations such as land-locked Atlantic salmon populations presents a challenge, specifically in the search for pathogen-driven selection. We used a novel genome-scan analysis approach that enabled us to i) identify signals of selection in salmon populations affected by varying levels of genetic drift and ii) separate potentially selected loci into the categories of pathogen (G. salaris)-driven selection and selection acting upon other environmental characteristics. A total of 4631 single nucleotide polymorphisms (SNPs) were screened in Atlantic salmon from 12 different northern European populations. We identified three genomic regions potentially affected by parasite-driven selection, as well as three regions presumably affected by salinity-driven directional selection. Functional annotation of candidate SNPs is consistent with the role of the detected genomic regions in immune defence and, implicitly, in osmoregulation. These results provide new insights into the genetic basis of pathogen susceptibility in Atlantic salmon and will enable future searches for the specific genes involved.	[Zueva, Ksenia J.; Primmer, Craig R.] Univ Turku, Dept Biol, SF-20500 Turku, Finland; [Lumme, Jaakko] Univ Oulu, Dept Biol, Oulu, Finland; [Veselov, Alexey E.] RAS, Inst Biol, Karelian Res Ctr, Petrozavodsk, Russia; [Kent, Matthew P.; Lien, Sigbjorn] Norwegian Univ Life Sci, Ctr Integrat Genet CIGENE, As, Norway; [Kent, Matthew P.; Lien, Sigbjorn] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway	University of Turku; University of Oulu; Russian Academy of Sciences; Karelian Research Centre of the Russian Academy of Sciences; Institute of Biology of Karelian Research Centre RAS; Norwegian University of Life Sciences; Norwegian University of Life Sciences	Zueva, KJ (corresponding author), Univ Turku, Dept Biol, SF-20500 Turku, Finland.	ksezue@utu.fi	Primmer, Craig R/B-8179-2008	Primmer, Craig R/0000-0002-3687-8435; Zueva, Ksenia/0000-0002-9812-214X	Finnish Academy; NordForsk; Finnish Population Genetics Graduate School	Finnish Academy(Academy of Finland); NordForsk; Finnish Population Genetics Graduate School	This study was supported by grants from the Finnish Academy and NordForsk (to CRP), and by Finnish Population Genetics Graduate School (to KJZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2006, TRENDS ECOL EVOL, V21, P433, DOI 10.1016/j.tree.2006.05.010; Adelman JS, 2013, AM NAT, V181, P674, DOI 10.1086/670024; Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Anderson M, 2002, J NUTR, V132, P3566, DOI 10.1093/jn/132.12.3566; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Armstrong JD, 2003, FISH RES, V62, P143, DOI 10.1016/S0165-7836(02)00160-1; Asp E, 2008, EUKARYOT CELL, V7, P328, DOI 10.1128/EC.00358-07; BAKKE TA, 1990, J FISH BIOL, V37, P577, DOI 10.1111/j.1095-8649.1990.tb05890.x; Bandyopadhyay A, 2002, J BIOL CHEM, V277, P2360, DOI 10.1074/jbc.M107790200; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Bierne N, 2011, MOL ECOL, V20, P2044, DOI 10.1111/j.1365-294X.2011.05080.x; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; BJORCK S, 1995, QUATERN INT, V27, P19, DOI 10.1016/1040-6182(94)00057-C; Bourret V, 2013, MOL ECOL, V22, P532, DOI 10.1111/mec.12003; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Brenna-Hansen S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-432; Buckling A, 2002, NATURE, V420, P496, DOI 10.1038/nature01164; Calder PC, 2001, LIPIDS, V36, P1007, DOI 10.1007/s11745-001-0812-7; Calder PC, 1998, BRAZ J MED BIOL RES, V31, P467, DOI 10.1590/S0100-879X1998000400002; Carballeira NM, 2008, PROG LIPID RES, V47, P50, DOI 10.1016/j.plipres.2007.10.002; Carval D, 2010, EVOLUTION, V64, P2988, DOI 10.1111/j.1558-5646.2010.01035.x; Chang WH, 2004, CELL CALCIUM, V35, P183, DOI 10.1016/j.ceca.2003.10.012; Cunningham R, 2007, J AM SOC NEPHROL, V18, P1419, DOI 10.1681/ASN.2006090980; Cutter AD, 2013, NAT REV GENET, V14, P262, DOI 10.1038/nrg3425; Davidson WS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-403; Dionne M, 2007, EVOLUTION, V61, P2154, DOI 10.1111/j.1558-5646.2007.00178.x; Dionne M, 2009, PHILOS T R SOC B, V364, P1555, DOI 10.1098/rstb.2009.0011; Duffy MA, 2009, J ANIM ECOL, V78, P1106, DOI 10.1111/j.1365-2656.2009.01568.x; Eizaguirre C, 2010, J FISH BIOL, V77, P2023, DOI 10.1111/j.1095-8649.2010.02819.x; ELLIOTT JM, 1991, FRESHWATER BIOL, V25, P61, DOI 10.1111/j.1365-2427.1991.tb00473.x; Elphinstone MS, 2003, MOL ECOL NOTES, V3, P317, DOI 10.1046/j.1471-8286.2003.00397.x; Ewart KV, 2005, DEV COMP IMMUNOL, V29, P333, DOI [10.1016/j.dci.2004.08.084, 10.1016/j.dci.2004.08.004]; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frichot E, 2013, MOL BIOL EVOL, V30, P1687, DOI 10.1093/molbev/mst063; Gilbey J, 2004, ANIM GENET, V35, P98, DOI 10.1111/j.1365-2052.2004.01091.x; Gilbey J, 2006, DIS AQUAT ORGAN, V71, P119, DOI 10.3354/dao071119; GONZALEZCABRERA PJ, 1995, J EXP BIOL, V198, P2279; Grimholt U, 2003, IMMUNOGENETICS, V55, P210, DOI 10.1007/s00251-003-0567-8; Harbige LS, 2003, LIPIDS, V38, P323, DOI 10.1007/s11745-003-1067-z; Harris PD, 2011, PARASITES PATHOGENS; HARTLEY SE, 1984, CHROMOSOMA, V89, P377, DOI 10.1007/BF00331255; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Homer CR, 2012, J BIOL CHEM, V287, P25565, DOI 10.1074/jbc.M111.326835; Houston RD, 2010, HEREDITY, V105, P318, DOI 10.1038/hdy.2009.171; Houston RD, 2008, GENETICS, V178, P1109, DOI 10.1534/genetics.107.082974; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; Imen R, 2013, MAR FRESHW BEHAV PHY, V46, P59, DOI 10.1080/10236244.2013.793470; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; JOHNSEN BO, 1991, AQUACULTURE, V98, P289, DOI 10.1016/0044-8486(91)90393-L; Jolley KA, 2005, MOL BIOL EVOL, V22, P562, DOI 10.1093/molbev/msi041; Jonsson B, 2009, J FISH BIOL, V75, P2381, DOI 10.1111/j.1095-8649.2009.02380.x; Jorgensen HBH, 2005, MOL ECOL, V14, P3219, DOI 10.1111/j.1365-294X.2005.02658.x; Kania PW, 2010, J HELMINTHOL, V84, P166, DOI 10.1017/S0022149X09990460; KAZAKOV RV, 1991, J FISH BIOL, V39, P1, DOI 10.1111/j.1095-8649.1991.tb04335.x; Kheriji S, 2003, AQUACULT INT, V11, P571, DOI 10.1023/B:AQUI.0000013321.93743.6d; Kiiskinen P, 2003, ANN ZOOL FENN, V40, P441; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kjoglum S, 2006, FISH SHELLFISH IMMUN, V21, P431, DOI 10.1016/j.fsi.2006.02.001; Konishi H, 1996, P NATL ACAD SCI USA, V93, P7639, DOI 10.1073/pnas.93.15.7639; Kuusela J, 2009, ANN ZOOL FENN, V46, P21, DOI 10.5735/086.046.0103; Langefors A, 2001, P ROY SOC B-BIOL SCI, V268, P479, DOI 10.1098/rspb.2000.1378; Larsen PF, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-12; Le Bras Y, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-46; Lien S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-615; Lindenstrom T, 2006, J FISH DIS, V29, P123, DOI 10.1111/j.1365-2761.2006.00696.x; Liska AJ, 2004, PLANT PHYSIOL, V136, P2806, DOI 10.1104/pp.104.039438; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054451; Lohm J, 2002, P ROY SOC B-BIOL SCI, V269, P2029, DOI 10.1098/rspb.2002.2114; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Makinen HS, 2008, MOL ECOL, V17, P3565, DOI 10.1111/j.1365-294X.2008.03714.x; Matejusova I, 2006, INT J PARASITOL, V36, P1175, DOI 10.1016/j.ijpara.2006.04.009; Matsumoto M, 2009, PROTEOMICS, V9, P3549, DOI 10.1002/pmic.200900011; Miyamoto S, 2005, J BIOL CHEM, V280, P28251, DOI 10.1074/jbc.M414129200; Moen T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-368; Nakanishi T, 2002, DEV COMP IMMUNOL, V26, P131, DOI 10.1016/S0145-305X(01)00055-6; Nearing J, 2002, P NATL ACAD SCI USA, V99, P9231, DOI 10.1073/pnas.152294399; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Nilsson J, 2001, MOL ECOL, V10, P89, DOI 10.1046/j.1365-294X.2001.01168.x; Norman JD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-420; Norman JD, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-81; Oleksyk TK, 2010, PHILOS T R SOC B, V365, P185, DOI 10.1098/rstb.2009.0219; Oleksyk TK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001712; Olsen JB, 2011, CONSERV GENET, V12, P223, DOI 10.1007/s10592-010-0135-3; Ozerov MY, 2010, CONSERV GENET, V11, P1711, DOI 10.1007/s10592-010-0064-1; Papakostas S, 2012, MOL ECOL, V21, P3516, DOI 10.1111/j.1365-294X.2012.05553.x; Papakostas S, 2010, J PROTEOME RES, V9, P4790, DOI 10.1021/pr100507s; Pavlidis P, 2012, MOL BIOL EVOL, V29, P3237, DOI 10.1093/molbev/mss136; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Piertney SB, 2010, GENETICA, V138, P419, DOI 10.1007/s10709-008-9322-2; Pompeia C, 2000, BRAZ J MED BIOL RES, V33, P1255, DOI 10.1590/S0100-879X2000001100001; Primmer CR, 2013, MOL ECOL, V22, P3216, DOI 10.1111/mec.12309; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Rise ML, 2004, PHYSIOL GENOMICS, V20, P21, DOI 10.1152/physiolgenomics.00036.2004; Roberge C, 2007, MOL IMMUNOL, V44, P1374, DOI 10.1016/j.molimm.2006.05.005; Rokas A, 2009, TRENDS ECOL EVOL, V24, P192, DOI 10.1016/j.tree.2008.11.004; Saarnisto M, 2001, GLOBAL PLANET CHANGE, V31, P387, DOI 10.1016/S0921-8181(01)00131-X; Schlenke TA, 2003, GENETICS, V164, P1471; Schlotterer C, 2003, TRENDS GENET, V19, P32, DOI 10.1016/S0168-9525(02)00012-4; Schmid-Hempel P, 2001, NATURWISSENSCHAFTEN, V88, P147, DOI 10.1007/s001140100222; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; STAURNES M, 1994, COMP BIOCHEM PHYS A, V109, P413, DOI 10.1016/0300-9629(94)90145-7; Sun CM, 2013, NUCLEIC ACIDS RES, V41, P7512, DOI 10.1093/nar/gkt510; Sutton JT, 2011, MOL ECOL, V20, P4408, DOI 10.1111/j.1365-294X.2011.05292.x; Teacher AGF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004616; Tielens AG, 2006, 20 UNUSIAL ASPECTS M; Tonteri A, 2005, ANN ZOOL FENN, V42, P1; Tonteri A, 2010, MOL ECOL, V19, P1273, DOI 10.1111/j.1365-294X.2010.04573.x; Tonteri A, 2009, CAN J FISH AQUAT SCI, V66, P717, DOI 10.1139/F09-010; Tseng YC, 2008, COMP BIOCHEM PHYS C, V148, P419, DOI 10.1016/j.cbpc.2008.04.009; Tsoi SCM, 2004, MAR BIOTECHNOL, V6, P199, DOI 10.1007/s10126-002-0101-2; Van Anholt RD, 2012, FISH PHYSIOL BIOCHEM, V38, P703, DOI 10.1007/s10695-011-9552-6; Vasemagi A, 2005, MOL BIOL EVOL, V22, P1067, DOI 10.1093/molbev/msi093; Vasemagi A, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/628204; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; Wand M.P., 1995, MONOGRAPHS STAT APPL; Weinman EJ, 2006, LONGITUDINAL STUDY U, V21202, P838; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitehead A, 2012, J EXP BIOL, V215, P1293, DOI 10.1242/jeb.062075; Whiteley AR, 2011, MOL ECOL, V20, P4259, DOI 10.1111/j.1365-294X.2011.05272.x; Wikelski M, 2004, ECOL SOC, V9; Wysocki M, 2012, ANIM GENET, V43, P328, DOI 10.1111/j.1365-2052.2011.02251.x; Zhao HX, 2012, BIOL PLANTARUM, V56, P64, DOI 10.1007/s10535-012-0017-2; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14	133	28	29	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e91672	10.1371/journal.pone.0091672	http://dx.doi.org/10.1371/journal.pone.0091672			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670947	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000024
J	Chou, PS; Chang, WC; Chou, WP; Liu, ME; Lai, CL; Liu, CK; Ku, YC; Tsai, SJ; Chou, YH; Chang, WP				Chou, Ping-Song; Chang, Wei-Chiao; Chou, Wei-Po; Liu, Mu-En; Lai, Chiou-Lian; Liu, Ching-Kuan; Ku, Yan-Chiou; Tsai, Shih-Jen; Chou, Yii-Her; Chang, Wei-Pin			Increased Risk of Benign Prostate Hyperplasia in Sleep Apnea Patients: A Nationwide Population-Based Study	PLOS ONE			English	Article							INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; SYSTEMIC INFLAMMATION; INTERMITTENT HYPOXIA; GLUCOSE-INTOLERANCE; PATHOGENESIS; ASSOCIATION; ATHEROSCLEROSIS; METAANALYSIS; HIF-1-ALPHA	Background: Sleep apnea (SA) is a common sleep disorder characterized by chronic intermittent hypoxia (IH). Chronic IH induces systemic inflammatory processes, which can cause tissue damage and contribute to prostatic enlargement. The purpose of this study was to evaluate the association between benign prostate hyperplasia (BPH) and SA in a Taiwanese population. Methods: The study population was identified from Taiwan's National Health Insurance Research Database (NHIRD) and contained 202 SA patients and 1010 control patients. The study cohort consisted of men aged >= 30 years who were newly diagnosed with SA between January 1997 and December 2005. Each patient was monitored for 5 years from the index date for the development of BPH. A Cox regression analysis was used to calculate the hazard ratios (HRs) for BPH in the SA and control patients. Results: During the 5-year follow-up, 18 SA patients (8.9%) and 32 non-SA control patients (3.2%) developed BPH. The adjusted HR for BPH was 2.35-fold higher in the patients with SA than in the control patients (95% confidence interval (CI) 1.28-4.29, P<.01). We further divided the SA patients into 4 age groups. After adjusting for potential confounding factors, the highest adjusted HR for BPH in the SA patients compared with the control patients was 5.59 (95% CI = 2.19-14.31, P<.001) in the patients aged between 51 and 65 years. Conclusion: Our study results indicate that patients with SA are associated with increased longitudinal risk of BPH development, and that the effects of SA on BPH development are age-dependent.	[Chou, Ping-Song; Lai, Chiou-Lian; Liu, Ching-Kuan] Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Chou, Wei-Po] Kaohsiung Med Univ Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Liu, Mu-En] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Lai, Chiou-Lian; Liu, Ching-Kuan] Kaohsiung Med Univ, Coll Med, Fac Med, Dept & Masters Program Neurol, Kaohsiung, Taiwan; [Ku, Yan-Chiou] Kaohsiung Vet Gen Hosp, Dept Nursing, Kaohsiung, Taiwan; [Tsai, Shih-Jen] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Chou, Yii-Her] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Urol, Kaohsiung, Taiwan; [Chou, Yii-Her] Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan; [Chang, Wei-Pin] Yuanpei Univ, Dept Healthcare Management, Hsinchu, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Taipei Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Veterans General Hospital; Taipei Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chou, YH (corresponding author), Kaohsiung Med Univ, Coll Med, Fac Med, Dept Urol, Kaohsiung, Taiwan.	yihech@gap.kmu.edu.tw; wpchang@mail.ypu.edu.tw	Tsai, Shih-Jen/AAK-7944-2020	Tsai, Shih-Jen/0000-0002-9987-022X; Chang, Wei-Chiao/0000-0002-8573-5924; Chou, Ping-Song/0000-0003-3693-3323; Chou, Wei-Po/0000-0001-8525-6010				Arnardottir ES, 2009, SLEEP, V32, P447, DOI 10.1093/sleep/32.4.447; Berger AP, 2006, BJU INT, V98, P1038, DOI 10.1111/j.1464-410X.2006.06400.x; Berger AP, 2005, BJU INT, V96, P1073, DOI 10.1111/j.1464-410X.2005.05777.x; Bostanci Y, 2013, CURR OPIN UROL, V23, P5, DOI 10.1097/MOU.0b013e32835abd4a; Chang WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078655; Devulapally K, 2009, HEART FAIL REV, V14, P155, DOI 10.1007/s10741-008-9101-2; Drager LF, 2011, CHEST, V140, P534, DOI 10.1378/chest.10-2223; Fibbi B, 2010, INT J ANDROL, V33, P475, DOI 10.1111/j.1365-2605.2009.00972.x; Gandaglia G, 2013, BJU INT, V112, P432, DOI 10.1111/bju.12118; Garvey JF, 2009, EUR RESPIR J, V33, P1195, DOI 10.1183/09031936.00111208; Haffner SM, 2000, INT J OBESITY, V24, pS56, DOI 10.1038/sj.ijo.0801279; Hatipoglu U, 2003, RESPIRATION, V70, P665, DOI 10.1159/000075218; Kang SH, 2012, BJU INT, V110, pE851, DOI 10.1111/j.1464-410X.2012.11342.x; Kesarwani P, 2010, INDIAN J CLIN BIOCHE, V25, P342, DOI 10.1007/s12291-010-0072-4; Kim HJ, 2013, BBA-MOL BASIS DIS, V1832, P183, DOI 10.1016/j.bbadis.2012.09.002; Kullisaar T, 2012, PROSTATE, V72, P977, DOI 10.1002/pros.21502; Lee Won, 2008, Expert Rev Respir Med, V2, P349, DOI 10.1586/17476348.2.3.349; Liu ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061771; Loke YK, 2012, CIRC-CARDIOVASC QUAL, V5, P720, DOI 10.1161/CIRCOUTCOMES.111.964783; Macoska JA, 2011, DIFFERENTIATION, V82, P253, DOI 10.1016/j.diff.2011.04.003; Mannarino MR, 2012, EUR J INTERN MED, V23, P586, DOI 10.1016/j.ejim.2012.05.013; McNicholas WT, 2009, PROG CARDIOVASC DIS, V51, P392, DOI 10.1016/j.pcad.2008.10.005; McVary KT, 2006, AM J MANAG CARE, V12, pS122; Pamidi S, 2010, BEST PRACT RES CL EN, V24, P703, DOI 10.1016/j.beem.2010.08.009; Punjabi NM, 2004, AM J EPIDEMIOL, V160, P521, DOI 10.1093/aje/kwh261; Punjabi NM, 2003, RESP PHYSIOL NEUROBI, V136, P167, DOI 10.1016/S1569-9048(03)00079-X; Robert G, 2009, PROSTATE, V69, P1774, DOI 10.1002/pros.21027; Ryan S, 2009, THORAX, V64, P631, DOI 10.1136/thx.2008.105577; Schenk JM, 2010, AM J EPIDEMIOL, V171, P571, DOI 10.1093/aje/kwp406; St Sauver Jennifer L, 2008, Curr Prostate Rep, V6, P67, DOI 10.1007/s11918-008-0011-5; Varvarigou V, 2011, SLEEP, V34, P1461, DOI 10.5665/sleep.1376; Vikram A, 2010, EUR J PHARMACOL, V641, P75, DOI 10.1016/j.ejphar.2010.05.042; Wang ZW, 2011, DIFFERENTIATION, V82, P261, DOI 10.1016/j.diff.2011.04.004; Williams AM, 1999, J ANDROL, V20, P474; Yamamoto H, 2007, HYPERTENS RES, V30, P1065, DOI 10.1291/hypres.30.1065; Yuan G, 2008, J CELL PHYSIOL, V217, P674, DOI 10.1002/jcp.21537	36	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93081	10.1371/journal.pone.0093081	http://dx.doi.org/10.1371/journal.pone.0093081			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667846	Green Submitted, Green Published, gold			2022-12-27	WOS:000333675600136
J	Courtot, M; Brinkman, RR; Ruttenberg, A				Courtot, Melanie; Brinkman, Ryan R.; Ruttenberg, Alan			The Logic of Surveillance Guidelines: An Analysis of Vaccine Adverse Event Reports from an Ontological Perspective	PLOS ONE			English	Article							CLASSIFICATION; ANAPHYLAXIS; RISK	Background: When increased rates of adverse events following immunization are detected, regulatory action can be taken by public health agencies. However to be interpreted reports of adverse events must be encoded in a consistent way. Regulatory agencies rely on guidelines to help determine the diagnosis of the adverse events. Manual application of these guidelines is expensive, time consuming, and open to logical errors. Representing these guidelines in a format amenable to automated processing can make this process more efficient. Methods and Findings: Using the Brighton anaphylaxis case definition, we show that existing clinical guidelines used as standards in pharmacovigilance can be logically encoded using a formal representation such as the Adverse Event Reporting Ontology we developed. We validated the classification of vaccine adverse event reports using the ontology against existing rule-based systems and a manually curated subset of the Vaccine Adverse Event Reporting System. However, we encountered a number of critical issues in the formulation and application of the clinical guidelines. We report these issues and the steps being taken to address them in current surveillance systems, and in the terminological standards in use. Conclusions: By standardizing and improving the reporting process, we were able to automate diagnosis confirmation. By allowing medical experts to prioritize reports such a system can accelerate the identification of adverse reactions to vaccines and the response of regulatory agencies. This approach of combining ontology and semantic technologies can be used to improve other areas of vaccine adverse event reports analysis and should inform both the design of clinical guidelines and how they are used in the future.	[Courtot, Melanie; Brinkman, Ryan R.] BC Canc Agcy, Vancouver, BC, Canada; [Brinkman, Ryan R.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Ruttenberg, Alan] SUNY Buffalo, Sch Dent Med, Buffalo, NY 14260 USA	British Columbia Cancer Agency; University of British Columbia; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Courtot, M (corresponding author), BC Canc Agcy, Vancouver, BC, Canada.	mcourtot@gmail.com	Brinkman, Ryan/B-1108-2008	Brinkman, Ryan/0000-0002-9765-2990; Ruttenberg, Alan/0000-0002-1604-3078; Courtot, Melanie/0000-0002-9551-6370	PHAC/CIHR Influenza Research Network (PCIRN); Michael Smith Foundation for Health Research (MSFHR)	PHAC/CIHR Influenza Research Network (PCIRN); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	MC's work was partially funded by the PHAC/CIHR Influenza Research Network (PCIRN, http://pcirn.ca) and the Michael Smith Foundation for Health Research (MSFHR, http://www.msfhr.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aduna, SES TRIP; Amit S., 2001, IEEE DATA ENG B, V24, P35; [Anonymous], 2013, CNN; Avorn J, 2000, ANN INTERN MED, V133, P128, DOI 10.7326/0003-4819-133-2-200007180-00012; Ball LK, 1998, PEDIATRICS, V101, P453, DOI 10.1542/peds.101.3.453; Banerji A, 2013, DIR DEV, P1; Bonhoeffer J, 2002, VACCINE, V21, P298, DOI 10.1016/S0264-410X(02)00449-8; Botsis T, 2013, DRUG SAFETY, V36, P573, DOI 10.1007/s40264-013-0064-4; Botsis T, 2011, J AM MED INFORM ASSN, V18, P631, DOI 10.1136/amiajnl-2010-000022; Brighton Collaboration, ABC TOOL; CHEN RT, 1994, VACCINE, V12, P542, DOI 10.1016/0264-410X(94)90315-8; Courtot M, 2011, P INT C BIOM ONT ICB; DiMiceli L, 2006, VACCINE, V24, P703, DOI 10.1016/j.vaccine.2005.07.069; Gagnier JJ, 2013, J CLIN EPIDEMIOLOGY; Gatto M, 2013, CLIN RHEUMATOL, P1; Glanz JM, 2009, PEDIATRICS, V123, P1446, DOI 10.1542/peds.2008-2150; Gold MS, 2010, VACCINE, V28, P4487, DOI 10.1016/j.vaccine.2010.04.041; Horridge M., 2006, OWLED, V216; Horridge M, SEMANTIC WEB, V2, P11; Iskander JK, 2004, PEDIATR ANN, V33, P599, DOI 10.3928/0090-4481-20040901-11; Kelso JM, 1999, J ALLERGY CLIN IMMUN, V103, P698, DOI 10.1016/S0091-6749(99)70245-9; Kohl K S, 2005, ADV PATIENT SAFETY R, V2, P87; Lindsey NP, 2008, VACCINE, V26, P6077, DOI 10.1016/j.vaccine.2008.09.009; Minard J, 2013, J ASTHMA, P1; Moro PL, 2013, VACCINE, P2011; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Scheifele David W, 2003, Semin Pediatr Infect Dis, V14, P213, DOI 10.1016/S1045-1870(03)00036-0; Shearer Rob, 2008, OWLED, V432; Sirin E, 2007, J WEB SEMANT, V5, P51, DOI 10.1016/j.websem.2007.03.004; Slade BA, 2009, JAMA-J AM MED ASSOC, V302, P750, DOI 10.1001/jama.2009.1201; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Smith B, 2008, FRONT ARTIF INTEL AP, V183, P21, DOI 10.3233/978-1-58603-923-3-21; WHO Global Advisory Committee on Vaccine Safety, 2013, M HELD 12 13 JUN; Zafrir Y, 2012, LUPUS, V21, P146, DOI 10.1177/0961203311429318	34	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92632	10.1371/journal.pone.0092632	http://dx.doi.org/10.1371/journal.pone.0092632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667848	gold, Green Published			2022-12-27	WOS:000333675600056
J	Deck, C; Kimbrough, EO; Mongrain, S				Deck, Cary; Kimbrough, Erik O.; Mongrain, Steeve			Paying for Express Checkout: Competition and Price Discrimination in Multi-Server Queuing Systems	PLOS ONE			English	Article							CONGESTED MARKETS; SWITCHING COSTS; SERVICE; EQUILIBRIUM; PERFORMANCE; CAPACITY; INDUSTRY; ARRIVAL; QUEUES; TIME	We model competition between two firms selling identical goods to customers who arrive in the market stochastically. Shoppers choose where to purchase based upon both price and the time cost associated with waiting for service. One seller provides two separate queues, each with its own server, while the other seller has a single queue and server. We explore the market impact of the multi-server seller engaging in waiting cost-based-price discrimination by charging a premium for express checkout. Specifically, we analyze this situation computationally and through the use of controlled laboratory experiments. We find that this form of price discrimination is harmful to sellers and beneficial to consumers. When the two-queue seller offers express checkout for impatient customers, the single queue seller focuses on the patient shoppers thereby driving down prices and profits while increasing consumer surplus.	[Deck, Cary] Univ Arkansas, Dept Econ, Fayetteville, AR 72701 USA; [Kimbrough, Erik O.; Mongrain, Steeve] Simon Fraser Univ, Dept Econ, Burnaby, BC V5A 1S6, Canada	University of Arkansas System; University of Arkansas Fayetteville; Simon Fraser University	Kimbrough, EO (corresponding author), Simon Fraser Univ, Dept Econ, Burnaby, BC V5A 1S6, Canada.	ekimbrou@sfu.ca			Center for Retailing Excellence at the Sam M. Walton College of Business	Center for Retailing Excellence at the Sam M. Walton College of Business	Research Support from the Center for Retailing Excellence at the Sam M. Walton College of Business is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acemoglu D, 2007, MATH OPER RES, V32, P1, DOI 10.1287/moor.1060.0231; Allon G, 2007, OPER RES, V55, P37, DOI 10.1287/opre.1060.0337; Aloysius J, 2012, INT J ECON BUS, V19, P25, DOI 10.1080/13571516.2012.642637; ALPERSTEIN H, 1988, MANAGE SCI, V34, P666, DOI 10.1287/mnsc.34.5.666; Armony M, 2003, EUR J OPER RES, V147, P32, DOI 10.1016/S0377-2217(02)00238-2; Bester H, 1996, INT J IND ORGAN, V14, P227, DOI 10.1016/0167-7187(94)00469-2; Blinder A., 1994, MONETARY POLICY, V29, P117; BORENSTEIN S, 1994, J POLIT ECON, V102, P653, DOI 10.1086/261950; Brown-Kruse J, 1994, ECONOMETRICA, P343; Brown-Kruse JL, 2008, HDB EXPT EC RESULTS, V1, P71; Carlsson F, 2006, APPL ECON, V38, P1469, DOI 10.1080/00036840500419608; Chen H, 2003, IIE TRANS, V35, P817, DOI [10.1080/07408170304412, 10.1080/07408170390220575]; Chen Y, 2007, ECON THEOR, V33, P121, DOI 10.1007/s00199-007-0213-z; Chen YX, 2005, MANAGE SCI, V51, P1131, DOI 10.1287/mnsc.1050.0391; Cook JP, 2005, 1240 CALTECH; DANIEL JI, 1995, ECONOMETRICA, V63, P327, DOI 10.2307/2951629; Davis DD., 1993, EXP ECON, DOI [10.1515/9780691233376, DOI 10.1515/9780691233376]; Dube P, 2009, DEC CONTR 2009 HELD, P8588; Dufwenberg M, 2000, INT J IND ORGAN, V18, P7, DOI 10.1016/S0167-7187(99)00031-4; DYER D, 1989, ECON J, V99, P108, DOI 10.2307/2234207; GERSTNER E, 1994, AM ECON REV, V84, P1437; Hampton K, 2012, RAND J ECON, V43, P139, DOI 10.1111/j.1756-2171.2012.00160.x; Huck S, 2004, J ECON BEHAV ORGAN, V53, P435, DOI 10.1016/j.jebo.2002.10.002; Klausz FJ, 1998, P ANN HICSS, P363, DOI 10.1109/HICSS.1998.655056; LEVHARI D, 1978, EUR ECON REV, V11, P17, DOI 10.1016/0014-2921(78)90024-7; LI LD, 1994, MANAGE SCI, V40, P633, DOI 10.1287/mnsc.40.5.633; LUSKI I, 1976, REV ECON STUD, V43, P519, DOI 10.2307/2297230; McKelvey R., 2007, GAMBIT SOFTWARE TOOL; Moorthy K. S., 1984, MARKET SCI, V3, P288, DOI DOI 10.1287/MKSC.3.4.288; NAOR P, 1969, ECONOMETRICA, V37, P15, DOI 10.2307/1909200; Narasimhan C., 1984, MARKET SCI, V3, P128; Pazgal AI, 2008, COMPUT OPER RES, V35, P2537, DOI 10.1016/j.cor.2006.12.027; Rapoport A, 2004, J ECON BEHAV ORGAN, V55, P67, DOI 10.1016/j.jebo.2003.07.003; Rapoport A, 2010, TRANSPORT RES B-METH, V44, P1166, DOI 10.1016/j.trb.2010.01.005; REITMAN D, 1991, J IND ECON, V39, P621, DOI 10.2307/2098666; Rust RT, 2006, MARKET SCI, V25, P560, DOI 10.1287/mksc.1050.0139; Sankaranarayanan K, 2011, THESIS U LUGANO; Savage DA, 2010, EC ANAL POLICY, V40; Seale DA, 2005, EXP ECON, V8, P117, DOI 10.1007/s10683-005-0872-1; Shaffer G, 2000, J ECON MANAGE STRAT, V9, P397, DOI 10.1162/105864000567918; Smith V. L., 1993, NONLINEAR DYNAMICS E; Stole L, 2007, HDB IND ORG, V3, P2221; Van Mieghem JA, 2000, MANAGE SCI, V46, P1249, DOI 10.1287/mnsc.46.9.1249.12238	44	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92070	10.1371/journal.pone.0092070	http://dx.doi.org/10.1371/journal.pone.0092070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SD	24667809	Green Published, gold			2022-12-27	WOS:000333675600018
J	Graumann, K				Graumann, Katja			Evidence for LINC1-SUN Associations at the Plant Nuclear Periphery	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; LINC COMPLEXES; SUN PROTEINS; ENVELOPE; CYTOSKELETON; MORPHOLOGY; BRIDGES; DOMAIN; RANGAP; SHAPE	Sad1/UNC84 (SUN) domain proteins are a highly conserved family of inner nuclear membrane localised proteins in eukaryotes. One of their main functions is as key components of nucleo-cytoskeletal bridging complexes, in which SUN proteins associate with nucleoskeletal elements. In metazoans these are the lamins, which form a supportive structural network termed the lamina. Plants lack sequence homologs of lamins but have a similar nucleoplasmic structural network to support the plant NE. Putative components of this plant lamina-like structure are Little Nuclei (LINC) proteins, which bear structural resemblance to lamins and fulfil similar functions. This work explores the associations between AtLINC1, AtSUN1 and AtSUN2. AtLINC1 is recruited to the NE by SUN proteins and is immobilised therein. This recruitment and the immobile properties are likely due to AtSUN1/2-AtLINC1 protein interactions occurring in planta. In addition, the SUN N-terminus appears to play an important role in mediating these interactions. The associations between AtLINC1 and plant SUN proteins are a first indicator of how the nucleoskeleton may be anchored to the nuclear membrane in plants. Building on the previous characterisation of Klarsicht/Anc1/Syne1 homology (KASH) like proteins in plants, this study advances the identification and characterisation of nucleo-cytoskeletal bridging complexes in plants.	Oxford Brookes Univ, Dept Biol & Med Sci, Oxford OX3 0BP, England	Oxford Brookes University	Graumann, K (corresponding author), Oxford Brookes Univ, Dept Biol & Med Sci, Oxford OX3 0BP, England.	kgraumann@brookes.ac.uk	Graumann, Katja/AAS-9247-2020; Graumann, Katja/N-8838-2016	Graumann, Katja/0000-0002-1529-8255; Graumann, Katja/0000-0002-1529-8255	Leverhulme Trust [F00382/H, ECF-2012-006]	Leverhulme Trust(Leverhulme Trust)	This research was funded by a Leverhulme Trust research grant (F00382/H) and a Leverhulme Trust Early Career Fellowhip (ECF-2012-006), http://www.leverhulme.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ciska M, 2013, J EXP BOT, V64, P1553, DOI 10.1093/jxb/ert020; Dittmer TA, 2007, PLANT CELL, V19, P2793, DOI 10.1105/tpc.107.053231; Fiserova J, 2009, PLANT J, V59, P243, DOI 10.1111/j.1365-313X.2009.03865.x; Graumann K, 2011, BIOCHEM J, V435, P661, DOI 10.1042/BJ20101769; Graumann K, 2013, NUCLEUS-AUSTIN, V4, P3, DOI 10.4161/nucl.23385; Graumann K, 2010, BIOCHEM SOC T, V38, P741, DOI 10.1042/BST0380741; Graumann K, 2010, PLANT J, V61, P134, DOI 10.1111/j.1365-313X.2009.04038.x; Graunnann K, 2007, BIOL CELL, V99, P553, DOI [10.1042/BC20070013, 10.1042/BC20070033]; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Kimura Y, 2010, CHROMOSOMA, V119, P195, DOI 10.1007/s00412-009-0248-y; Masuda K, 1997, EXP CELL RES, V232, P173, DOI 10.1006/excr.1997.3531; Meier I, 2007, J EXP BOT, V58, P27, DOI 10.1093/jxb/erl009; Mejat A, 2010, NUCLEUS-PHILA, V1, P40, DOI 10.4161/nucl.1.1.10530; Murphy SP, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-269; Oda Y, 2011, PLANT J, V66, P629, DOI 10.1111/j.1365-313X.2011.04523.x; Sakamoto Y, 2013, PLANT CELL PHYSIOL, V54, P622, DOI 10.1093/pcp/pct031; Sosa BA, 2012, CELL, V149, P1035, DOI 10.1016/j.cell.2012.03.046; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; Tamura K, 2013, CURR BIOL, V23, P1776, DOI 10.1016/j.cub.2013.07.035; van Damme D, 2004, PLANT J, V40, P386, DOI 10.1111/j.1365-313X.2004.02222.x; Xu XM, 2007, CURR BIOL, V17, P1157, DOI 10.1016/j.cub.2007.05.076; Zhou X, 2012, J CELL BIOL, V196, P203, DOI 10.1083/jcb.201108098	23	49	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93406	10.1371/journal.pone.0093406	http://dx.doi.org/10.1371/journal.pone.0093406			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667841	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600174
J	Karnuth, B; Dedy, N; Spieker, T; Lawlor, ER; Gattenlohner, S; Ranft, A; Dirksen, U; Jurgens, H; Brauninger, A				Karnuth, Bianca; Dedy, Nicolas; Spieker, Tilmann; Lawlor, Elizabeth R.; Gattenloehner, Stefan; Ranft, Andreas; Dirksen, Uta; Juergens, Heribert; Braeuninger, Andreas			Differentially Expressed miRNAs in Ewing Sarcoma Compared to Mesenchymal Stem Cells: Low miR-31 Expression with Effects on Proliferation and Invasion	PLOS ONE			English	Article							GENE; MICRORNA; METASTASIS; SURVIVAL; RISK; TRANSLOCATION; IFOSFAMIDE; CARCINOMAS; ETOPOSIDE; PATHWAYS	Ewing sarcoma, the second most common bone tumor in children and young adults, is an aggressive malignancy with a strong potential to metastasize. Ewing sarcoma is characterised by translocations encoding fusion transcription factors with an EWSR1 transactivation domain fused to an ETS family DNA binding domain. microRNAs are post-transcriptional regulators of gene expression and aberrantly expressed microRNAs have been identified as tumor suppressors or oncogenes in most cancer types. To identify potential oncogenic and tumor suppressor microRNAs in Ewing sarcoma, we determined and compared the expression of 377 microRNAs in 40 Ewing sarcoma biopsies, 6 Ewing sarcoma cell lines and mesenchymal stem cells, the putative cellular origin of Ewing sarcoma, from 6 healthy donors. Of the 35 differentially expressed microRNAs identified (fold change >4 and q<0.05), 19 were higher and 16 lower expressed in Ewing sarcoma. In comparisons between Ewing sarcoma samples with EWS-FLI or EWS-ERG translocations, with differing dissemination characteristics and of primary samples and metastases no significantly differential expressed microRNAs were detected using various stringency criteria. For miR-31, the microRNA with lowest expression in comparison to mesenchymal stem cells, functional analyses were performed to determine its potential as a tumor suppressor in Ewing sarcoma. Two of four miR-31 transfected Ewing sarcoma cell lines showed a significantly reduced proliferation (19% and 33% reduction) due to increased apoptosis in one and increased length of G1-phase in the other cell line. All three tested miR-31 transfected Ewing sarcoma cell lines showed significantly reduced invasiveness (56% to 71% reduction). In summary, we identified 35 microRNAs differentially expressed in Ewing sarcoma and demonstrate that miR-31 affects proliferation and invasion of Ewing sarcoma cell lines in ex vivo assays.	[Karnuth, Bianca; Spieker, Tilmann; Braeuninger, Andreas] Univ Munster, Gerhard Domagk Inst Pathol, Univ Hosp Munster, D-48149 Munster, Germany; [Dedy, Nicolas] Univ Munster, Dept Orthoped & Tumor Orthoped, Univ Hosp Munster, D-48149 Munster, Germany; [Lawlor, Elizabeth R.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Lawlor, Elizabeth R.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Gattenloehner, Stefan; Braeuninger, Andreas] Univ Giessen, Dept Pathol, D-35390 Giessen, Germany; [Ranft, Andreas; Dirksen, Uta; Juergens, Heribert] Univ Munster, Univ Hosp Munster, D-48149 Munster, Germany	University of Munster; University of Munster; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Justus Liebig University Giessen; University of Munster	Brauninger, A (corresponding author), Univ Munster, Gerhard Domagk Inst Pathol, Univ Hosp Munster, D-48149 Munster, Germany.	andreas.braeuninger@patho.med.uni-giessen.de	Dirksen, Uta/AGX-8472-2022; Dedy, Nicolas J./AAC-9163-2019	Dedy, Nicolas J./0000-0002-4654-3014; Ranft, Andreas/0000-0003-4424-7569	Deutsche Krebshilfe [108873, 108128]; Bundesministerium fur Bildung und Forschung [TranSaRNet, 01GM0869]; NIH [1U01 CA114757, 1R01-CA134604]; NATIONAL CANCER INSTITUTE [U01CA114757, R01CA134604] Funding Source: NIH RePORTER	Deutsche Krebshilfe(Deutsche Krebshilfe); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Deutsche Krebshilfe (project reference 108873 and 108128), the Bundesministerium fur Bildung und Forschung (TranSaRNet and 01GM0869) and NIH grants 1U01 CA114757 and 1R01-CA134604. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avigad S, 2004, CANCER-AM CANCER SOC, V100, P1053, DOI 10.1002/cncr.20059; Ban J, 2011, ONCOGENE, V30, P2173, DOI 10.1038/onc.2010.581; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhatnagar N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.85; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Creighton CJ, 2010, CANCER RES, V70, P1906, DOI 10.1158/0008-5472.CAN-09-3875; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; De Vito C, 2012, CANCER CELL, V21, P807, DOI 10.1016/j.ccr.2012.04.023; De Vito C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023592; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; DORFMAN HD, 1995, CANCER, V75, P203, DOI 10.1002/1097-0142(19950101)75:1+<203::AID-CNCR2820751308>3.0.CO;2-V; Esiashvili N, 2008, J PEDIAT HEMATOL ONC, V30, P425, DOI 10.1097/MPH.0b013e31816e22f3; Fletcher CDM, 2002, TUMORS SOFT TISSUE B, P297; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fuse M, 2012, J HUM GENET, V57, P691, DOI 10.1038/jhg.2012.95; Ginsberg JP, 1999, J CLIN ONCOL, V17, P1809, DOI 10.1200/JCO.1999.17.6.1809; Griffiths-Jones S, 2012, MIRBASE MICRORNA DAT; Ivanov SV, 2010, J BIOL CHEM, V285, P22807, DOI 10.1074/jbc.M110.100354; Juergens C, 2006, PEDIATR BLOOD CANCER, V47, P22, DOI 10.1002/pbc.20820; Kauppinen S, 2006, HANDB EXP PHARM, V173, P405; Le Deley MC, 2010, J CLIN ONCOL, V28, P1982, DOI 10.1200/JCO.2009.23.3585; Lopez-Camarillo C, 2012, INT J MOL SCI, V13, P1347, DOI 10.3390/ijms13021347; Martignetti L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041770; McKinsey EL, 2011, ONCOGENE, V30, P4910, DOI 10.1038/onc.2011.197; Mosakhani N, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-24; Nakatani F, 2012, J PATHOL, V226, P796, DOI 10.1002/path.3007; Paulussen M, 2008, J CLIN ONCOL, V26, P4385, DOI 10.1200/JCO.2008.16.5720; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Renne C, 2005, BLOOD, V105, P4051, DOI 10.1182/blood-2004-10-4008; Richter GHS, 2009, P NATL ACAD SCI USA, V106, P5324, DOI 10.1073/pnas.0810759106; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Riggi N, 2010, GENE DEV, V24, P916, DOI 10.1101/gad.1899710; Robin TP, 2012, MOL CANCER RES, V10, P1098, DOI 10.1158/1541-7786.MCR-12-0086; Schleiermacher G, 2003, J CLIN ONCOL, V21, P85, DOI 10.1200/JCO.2003.03.006; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; Stahl M, 2011, PEDIATR BLOOD CANCER, V57, P549, DOI 10.1002/pbc.23040; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Toomey EC, 2010, ONCOGENE, V29, P4504, DOI 10.1038/onc.2010.205; Valastyan S, 2009, GENE DEV, V23, P2592, DOI 10.1101/gad.1832709; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; von Levetzow C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019305; White NMA, 2011, NAT REV CLIN ONCOL, V8, P75, DOI 10.1038/nrclinonc.2010.173; Yamagishi M, 2012, CANCER CELL, V21, P121, DOI 10.1016/j.ccr.2011.12.015	46	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93067	10.1371/journal.pone.0093067	http://dx.doi.org/10.1371/journal.pone.0093067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667836	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600135
J	Quan, QM; Chen, LL; Wang, X; Li, S; Yang, XL; Zhu, YG; Wang, M; Cheng, Z				Quan, Qing-Mei; Chen, Ling-Ling; Wang, Xi; Li, Shan; Yang, Xiao-Ling; Zhu, Yun-Guo; Wang, Mu; Cheng, Zhou			Genetic Diversity and Distribution Patterns of Host Insects of Caterpillar Fungus Ophiocordyceps sinensis in the Qinghai-Tibet Plateau	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; CORDYCEPS-SINENSIS; CHLOROPLAST PHYLOGEOGRAPHY; MOLECULAR PHYLOGEOGRAPHY; QUATERNARY CLIMATE; STATISTICAL TESTS; POPULATION-GROWTH; UPLIFT; CONSEQUENCES; MAXIMUM	The caterpillar fungus Ophiocordyceps sinensis is one of the most valuable medicinal fungi in the world, and it requires host insects in family Hepialidae (Lepidoptera) to complete its life cycle. However, the genetic diversity and phylogeographic structures of the host insects remain to be explored. We analyzed the genetic diversity and temporal and spatial distribution patterns of genetic variation of the host insects throughout the O. sinensis distribution. Abundant haplotype and nucleotide diversity mainly existed in the areas of Nyingchi, ShangriLa, and around the edge of the Qinghai-Tibet Plateau, where are considered as the diversity center or micro-refuges of the host insects of O. sinensis. However, there was little genetic variation among host insects from 72.1% of all populations, indicating that the host species composition might be relatively simple in large-scale O. sinensis populations. All host insects are monophyletic except for those from four O. sinensis populations around Qinghai Lake. Significant phylogeographic structure (N-ST > G(ST), P < 0.05) was revealed for the monophyletic host insects, and the three major phylogenetic groups corresponded with specific geographical areas. The divergence of most host insects was estimated to have occurred at ca. 3.7 Ma, shortly before the rapid uplift of the QTP. The geographical distribution and star-like network of the haplotypes implied that most host insects were derived from the relicts of a once-widespread host that subsequently became fragmented. Neutrality tests, mismatch distribution analysis, and expansion time estimation confirmed that most host insects presented recent demographic expansions that began ca. 0.118 Ma in the late Pleistocene. Therefore, the genetic diversity and distribution of the present-day insects should be attributed to effects of the Qinghai-Tibet Plateau uplift and glacial advance/retreat cycles during the Quaternary ice age. These results provide valuable information to guide the protection and sustainable use of these host insects as well as O. sinensis.	[Quan, Qing-Mei; Chen, Ling-Ling; Wang, Xi; Li, Shan; Yang, Xiao-Ling; Zhu, Yun-Guo; Cheng, Zhou] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Wang, Mu] Agr & Anim Husb Coll Tibet, Sch Plant Sci & Technol, Nyingchi, Tibet, Peoples R China	Tongji University; Tibet Agriculture & Animal Husbandry University	Cheng, Z (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.	chengzhou@tongji.edu.cn	Chen, Ling-Ling/AAY-3547-2021	CHENG, Zhou/0000-0001-5866-748X	National Natural Science Foundation of China [31270068]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (31270068) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Avise John C., 2004, P1; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Buenz EJ, 2005, J ETHNOPHARMACOL, V96, P19, DOI 10.1016/j.jep.2004.09.029; Chen ST, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-58; Chen SY, 2008, BOT J LINN SOC, V157, P125, DOI 10.1111/j.1095-8339.2008.00785.x; Chen WY, 1980, VERTEBRAT PALASIATIC, V1, P52; Chu HF, 2004, FAUNA SINICA, V38, P291; Drummond A. J., 2010, GENEIOUS VERSION 4 8; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Falk DA, 1991, GENETICS CONSERVATIO; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Ge XJ, 2002, CONSERV GENET, V3, P351, DOI 10.1023/A:1020579617678; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huenneke LF, 1991, ECOLOGICAL IMPLICATI, P31; KUTZBACH JE, 1989, J GEOPHYS RES-ATMOS, V94, P18393, DOI 10.1029/JD094iD15p18393; Li J.J., 1998, CHINESE SCI BULL, V43, P1569, DOI DOI 10.1360/CSB1998-43-15-1569; LI SP, 2004, OXIDAT STRESS DIS, P657; Li Yu-Ling, 2007, Chinese Bulletin of Entomology, V44, P285; Liang HH, 2008, J MICROBIOL, V46, P549, DOI 10.1007/s12275-008-0107-1; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu F., 2005, CHONGQING J RES CHIN, V51, P45; Madsen DB, 2008, QUATERNARY RES, V69, P316, DOI 10.1016/j.yqres.2007.10.013; Masters BC, 2011, MOL ECOL RESOUR, V11, P154, DOI 10.1111/j.1755-0998.2010.02896.x; Meng LH, 2007, MOL ECOL, V16, P4128, DOI 10.1111/j.1365-294X.2007.03459.x; Newton AC, 1999, TRENDS ECOL EVOL, V14, P140, DOI 10.1016/S0169-5347(98)01555-9; Nylander J, 2008, MRMODELTEST2 V 2 3 P; PONS O, 1995, THEOR APPL GENET, V90, P462, DOI 10.1007/BF00221991; Pons O, 1996, GENETICS, V144, P1237; Qi W.L., 2007, PRATACULTURE ANIMAL, V7, P33; Qiang XK, 2001, EARTH PLANET SC LETT, V187, P83, DOI 10.1016/S0012-821X(01)00281-3; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Quan QM, 2014, J MICROBIOL, V52, P99, DOI 10.1007/s12275-014-3391-y; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Shi Y, 2002, QUATERN INT, V97-8, P79, DOI 10.1016/S1040-6182(02)00053-8; Shi Y.F., 1999, ACTA GEOGRAPH SIN, V54, P10, DOI DOI 10.1007/S11295-016-0968-0; Shi YF, 1998, UPLIFT ENV CHANGES Q; Shimitsu D, 1978, GREEN; SLATKIN M, 1991, GENETICS, V129, P555; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; Suzuki H, 2003, BIOL J LINN SOC, V80, P469, DOI 10.1046/j.1095-8312.2003.00253.x; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TEMPLETON AR, 1990, ANN MO BOT GARD, V77, P13, DOI 10.2307/2399621; The State Pharmacopoeia Commission of PR China, 2010, PHARM PEOPL REP CHIN, V1, P224; Thomas JA, 2005, PHILOS T R SOC B, V360, P339, DOI 10.1098/rstb.2004.1585; Wang BS, 2011, MOL ECOL, V20, P3796, DOI 10.1111/j.1365-294X.2011.05157.x; Wang CS, 2008, P NATL ACAD SCI USA, V105, P4987, DOI 10.1073/pnas.0703595105; Wang GD, 1995, CORDYCEPS SPECIES EC, P307; Wang XL, 2011, ZOOKEYS, P43, DOI 10.3897/zookeys.127.802; Yang Darong, 1996, Acta Entomologica Sinica, V39, P413; Yang FS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037196; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Yang P, 2005, QINGHAI ENV, V3, P93; Yang SJ, 2009, PROG NAT SCI-MATER, V19, P789, DOI 10.1016/j.pnsc.2008.10.006; Yao YJ, 2004, SCI NEWS, V15, P28; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Yuan B.Y., 1990, QUATERNARY SCI, V3, P233; Yuan Y, 2012, J ANHUI AGR SCI, V40, P9815; Zakharov EV, 2004, SYST BIOL, V53, P193, DOI 10.1080/10635150490423403; Zeng LY, 2010, J SYST EVOL, V48, P257, DOI 10.1111/j.1759-6831.2010.00084.x; Zhan XJ, 2011, MOL ECOL, V20, P3014, DOI 10.1111/j.1365-294X.2011.05144.x; Zhang DF, 2000, ENVIRON GEOL, V39, P1352, DOI 10.1007/s002540000174; Zhang Q, 2005, MOL ECOL, V14, P3513, DOI 10.1111/j.1365-294X.2005.02677.x; Zhang TC, 2011, MOL PHYLOGENET EVOL, V60, P1, DOI 10.1016/j.ympev.2011.04.009; Zheng BX, 2002, QUATERN INT, V97-8, P93, DOI 10.1016/S1040-6182(02)00054-X; Zhou C, 2007, PROG NAT SCI-MATER, V17, P789, DOI 10.1080/10002007088537474; Zhu HY, 2006, CRISIS BREAKTHROUGH, P291; Zhu JS, 1998, J ALTERN COMPLEM MED, V4, P289, DOI 10.1089/acm.1998.4.3-289; Zhuo Z, 1998, EPISODES, V21, P152; Zou ZW, 2010, J HUNAN U SCI TECHNO, V25, P114, DOI DOI 10.3969/J.ISSN.1672-9102.2010.01.025	80	31	31	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92293	10.1371/journal.pone.0092293	http://dx.doi.org/10.1371/journal.pone.0092293			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667533	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600030
J	Sakka, L; Deletage, N; Lalloue, F; Duval, A; Chazal, J; Lemaire, JJ; Meiniel, A; Monnerie, H; Gobron, S				Sakka, Laurent; Deletage, Nathalie; Lalloue, Fabrice; Duval, Amelie; Chazal, Jean; Lemaire, Jean-Jacques; Meiniel, Annie; Monnerie, Hubert; Gobron, Stephane			SCO-Spondin Derived Peptide NX210 Induces Neuroprotection In Vitro and Promotes Fiber Regrowth and Functional Recovery after Spinal Cord Injury	PLOS ONE			English	Article							TYPE-1 REPEAT TSR; SUBCOMMISSURAL ORGAN; NEURITE OUTGROWTH; REISSNERS FIBER; TIRILAZAD MESYLATE; PLACING REACTIONS; CONTUSION MODEL; POTENT ACTIVITY; REGENERATION; COMPLEX	In mammals, the limited regenerating potential of the central nervous system (CNS) in adults contrasts with the plasticity of the embryonic and perinatal periods. SCO (subcommissural organ)-spondin is a protein secreted early by the developing central nervous system, potentially involved in the development of commissural fibers. SCO-spondin stimulates neuronal differentiation and neurite growth in vitro. NX210 oligopeptide was designed from SCO-spondin's specific thrombospondin type 1 repeat (TSR) sequences that support the main neurogenic properties of the molecule. The objective of this work was to assess the neuroprotective and neuroregenerative properties of NX210 in vitro and in vivo for the treatment of spinal cord injury (SCI). In vitro studies were carried out on the B104 neuroblastoma cell line demonstrating neuroprotection by the resistance to oxidative damage using hydrogen peroxide and the measure of cell viability by metabolic activity. In vivo studies were performed in two rat models of SCI: (1) a model of aspiration of dorsal funiculi followed by the insertion of a collagen tube in situ to limit collateral sprouting; white matter regeneration was assessed using neurofilament immunostaining; (2) a rat spinal cord contusion model to assess functional recovery using BBB scale and reflex testing. We demonstrate for the first time that NX210 (a) provides neuroprotection to oxidative stress in the B104 neuroblastoma cells, (b) stimulates axonal regrowth in longitudinally oriented neofibers in the aspiration model of SCI and (c) significantly improves functional recovery in the contusive model of SCI.	[Sakka, Laurent; Chazal, Jean; Lemaire, Jean-Jacques] Univ Auvergne, EA7282, Fac Med, Clermont Ferrand, France; [Deletage, Nathalie; Duval, Amelie; Gobron, Stephane] Neuronax, Biopole Clermont Limagne, St Beauzire, France; [Sakka, Laurent; Chazal, Jean; Lemaire, Jean-Jacques] Ctr Hosp & Univ Clermont Ferrand, Serv Neurochirurg, Clermont Ferrand, France; [Lalloue, Fabrice] Fac Med Limoges, EA3842, F-87025 Limoges, France; [Meiniel, Annie] Univ Auvergne, Lab GReD Inserm CNRS U110, UMR 629, Fac Med, Clermont Ferrand, France; [Monnerie, Hubert] Childrens Hosp Philadelphia, Dept Neurol, Philadelphia, PA 19104 USA	Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Sakka, L (corresponding author), Univ Auvergne, EA7282, Fac Med, Clermont Ferrand, France.	laurent.sakka@udamail.fr	Gobron, Stephane/AAJ-5390-2021	Lalloue, Fabrice/0000-0003-0382-4948; Lemaire, Jean-Jacques/0000-0003-4395-5328; Gobron, Stephane/0000-0002-2318-352X	European Regional Development Fund; Regional Council of Auvergne	European Regional Development Fund(European Commission); Regional Council of Auvergne(Region Auvergne-Rhone-Alpes)	This work was supported by the European Regional Development Fund (http://ec.europa.eu/regional_policy/thefunds/regional/index_fr.cfm) and the Regional Council of Auvergne (http://www.auvergne.fr). The funders (European Regional Development Fund and the Regional Council of Auvergne) had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams JC, 2000, DEV DYNAM, V218, P280; AMASSIAN VE, 1973, J PHYSIOL-LONDON, V230, pP55; Bamdad M, 2004, CELL TISSUE RES, V315, P15, DOI 10.1007/s00441-003-0793-2; Bao F, 2008, EXP NEUROL, V214, P160, DOI 10.1016/j.expneurol.2008.09.006; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Barreiro-Iglesias A, 2009, NEUROSCI LETT, V464, P34, DOI 10.1016/j.neulet.2009.08.019; Barros CS, 2009, DEVELOPMENT, V136, P2717, DOI 10.1242/dev.038679; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bignami G, 1996, ENVIRON HEALTH PERSP, V104, P285, DOI 10.2307/3432648; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; BRADLEY NS, 1983, EXP NEUROL, V82, P73, DOI 10.1016/0014-4886(83)90244-3; Buss A, 2007, BRAIN, V130, P940, DOI 10.1093/brain/awl374; Cao QL, 2005, EXP NEUROL, V191, pS3, DOI 10.1016/j.expneurol.2004.08.026; Chen ZL, 2009, DEV BIOL, V327, P158, DOI 10.1016/j.ydbio.2008.12.006; Chernoff EAG, 1996, INT J DEV BIOL, V40, P823; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; DIDIER R, 1992, DEV NEUROSCI-BASEL, V14, P44, DOI 10.1159/000111646; Dietz V, 2006, LANCET NEUROL, V5, P688, DOI 10.1016/S1474-4422(06)70522-1; DONATELLE JM, 1977, J COMP NEUROL, V175, P207, DOI 10.1002/cne.901750205; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Duchossoy Y, 2001, EXP NEUROL, V167, P329, DOI 10.1006/exnr.2000.7556; Estivill-Torrus G, 2001, MECH DEVELOP, V109, P215, DOI 10.1016/S0925-4773(01)00527-5; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Fehlings MG, 2010, SPINE, V35, pS166, DOI 10.1097/BRS.0b013e3181f386f6; Ferretti P, 2003, DEV DYNAM, V226, P245, DOI 10.1002/dvdy.10226; FORSSBERG H, 1974, ACTA PHYSIOL SCAND, V92, P114, DOI 10.1111/j.1748-1716.1974.tb05727.x; Fouad K, 2000, BEHAV BRAIN RES, V115, P107, DOI 10.1016/S0166-4328(00)00244-8; GALE K, 1985, EXP NEUROL, V88, P123, DOI 10.1016/0014-4886(85)90118-9; Gerlai R, 1999, TRENDS NEUROSCI, V22, P47, DOI 10.1016/S0166-2236(98)01346-0; Gobron S, 2000, GLIA, V32, P177, DOI 10.1002/1098-1136(200011)32:2<177::AID-GLIA70>3.0.CO;2-V; Gu XQ, 1996, BRAIN RES, V735, P50; Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033; Hawthorne AL, 2011, J NEUROSCI, V31, P5605, DOI 10.1523/JNEUROSCI.6663-10.2011; Hilario JD, 2009, DEV BIOL, V326, P190, DOI 10.1016/j.ydbio.2008.11.007; Hill CE, 2001, EXP NEUROL, V171, P153, DOI 10.1006/exnr.2001.7734; HUBER G, 1985, J CELL BIOL, V100, P496, DOI 10.1083/jcb.100.2.496; Hurlbert RJ, 2013, NEUROSURGERY, V72, P93, DOI 10.1227/NEU.0b013e31827765c6; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Lehmann C, 2005, DEV BRAIN RES, V154, P1, DOI 10.1016/j.devbrainres.2004.09.009; Liebscher T, 2005, ANN NEUROL, V58, P706, DOI 10.1002/ana.20627; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Meiniel A, 2003, INT REV CYTOL, V230, P1, DOI 10.1016/S0074-7696(03)30001-4; Meiniel A, 1996, PROG HISTOCHEM CYTOC, V30, P1; Meiniel A, 2001, MICROSC RES TECHNIQ, V52, P484, DOI 10.1002/1097-0029(20010301)52:5<484::AID-JEMT1034>3.0.CO;2-0; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Metz GAS, 2000, J NEUROTRAUM, V17, P1, DOI 10.1089/neu.2000.17.1; Monnerie H, 1997, CELL TISSUE RES, V287, P285, DOI 10.1007/s004410050753; Monnerie H, 1998, CELL TISSUE RES, V293, P407, DOI 10.1007/s004410051132; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Roof RL, 2001, STROKE, V32, P2648, DOI 10.1161/hs1101.097397; Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2; Saunders NR, 1998, J NEUROSCI, V18, P339; Sedy J, 2008, NEUROSCI BIOBEHAV R, V32, P550, DOI 10.1016/j.neubiorev.2007.10.001; Seki T, 2002, NEUROSURGERY, V50, P1075, DOI 10.1097/00006123-200205000-00024; Snow DM, 2003, EXP NEUROL, V182, P310, DOI 10.1016/S0014-4886(03)00034-7; Stanic K, 2010, DEV DYNAM, V239, P2584, DOI 10.1002/dvdy.22387; Toda M, 1999, DEV BRAIN RES, V114, P193, DOI 10.1016/S0165-3806(99)00030-9; TYNDALE RF, 1994, J NEUROSCI, V14, P5417; vonEuler M, 1997, EXP NEUROL, V145, P502, DOI 10.1006/exnr.1997.6481; Yoo S, 2003, J NEUROSCI RES, V74, P541, DOI 10.1002/jnr.10771; Zisman S, 2007, J CELL BIOL, V178, P1237, DOI 10.1083/jcb.200702184	64	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93179	10.1371/journal.pone.0093179	http://dx.doi.org/10.1371/journal.pone.0093179			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667843	Green Submitted, Green Published, gold			2022-12-27	WOS:000333675600154
J	Severino, P; Silva, E; Baggio-Zappia, GL; Brunialti, MKC; Nucci, LA; Rigato, O; da Silva, IDCG; Machado, FR; Salomao, R				Severino, Patricia; Silva, Eliezer; Baggio-Zappia, Giovana Lotici; Colo Brunialti, Milena Karina; Nucci, Laura Alejandra; Rigato, Otelo, Jr.; Cotrim Guerreiro da Silva, Ismael Dale; Machado, Flavia Ribeiro; Salomao, Reinaldo			Patterns of Gene Expression in Peripheral Blood Mononuclear Cells and Outcomes from Patients with Sepsis Secondary to Community Acquired Pneumonia	PLOS ONE			English	Article							HUMAN SEPTIC SHOCK; NITRIC-OXIDE; SYSTEMIC INFLAMMATION; CYTOKINE PRODUCTION; OXIDATIVE STRESS; DOWN-REGULATION; WHOLE-BLOOD; KAPPA-B; NEUTROPHILS; MONOCYTES	Mechanisms governing the inflammatory response during sepsis have been shown to be complex, involving cross-talk between diverse signaling pathways. Current knowledge regarding the mechanisms underlying sepsis provides an incomplete picture of the syndrome, justifying additional efforts to understand this condition. Microarray-based expression profiling is a powerful approach for the investigation of complex clinical conditions such as sepsis. In this study, we investigate whole-genome expression profiles in mononuclear cells from survivors (n = 5) and non-survivors (n = 5) of sepsis. To circumvent the heterogeneity of septic patients, only patients admitted with sepsis caused by community-acquired pneumonia were included. Blood samples were collected at the time of sepsis diagnosis and seven days later to evaluate the role of biological processes or genes possibly involved in patient recovery. Principal Components Analysis (PCA) profiling discriminated between patients with early sepsis and healthy individuals. Genes with differential expression were grouped according to Gene Ontology, and most genes related to immune defense were up-regulated in septic patients. Additionally, PCA in the early stage was able to distinguish survivors from non-survivors. Differences in oxidative phosphorylation seem to be associated with clinical outcome because significant differences in the expression profile of genes related to mitochondrial electron transport chain (ETC) I-V were observed between survivors and non-survivors at the time of patient enrollment. Global gene expression profiles after seven days of sepsis progression seem to reproduce, to a certain extent, patterns collected at the time of diagnosis. Gene expression profiles comparing admission and follow-up samples differed between survivors and non-survivors, with decreased expression of genes related to immune functions in non-survivors. In conclusion, genes related to host defense and inflammatory response ontology were up-regulated during sepsis, consistent with the need for a host response to infection, and the sustainability of their expression in follow-up samples was associated with outcomes.	[Severino, Patricia] Hosp Israelita Albert Einstein, Inst Israelita Ensino & Pesquisa, Ctr Expt Res, Sao Paulo, Brazil; [Silva, Eliezer] Hosp Israelita Albert Einstein, Intens Care Unit, Sao Paulo, Brazil; [Baggio-Zappia, Giovana Lotici; Colo Brunialti, Milena Karina; Nucci, Laura Alejandra; Salomao, Reinaldo] Univ Fed Sao Paulo Unifesp, EPM, Hosp Sao Paulo, Div Infect Dis, Sao Paulo, Brazil; [Rigato, Otelo, Jr.] Hosp Sirio Libanes, Intens Care Unit, Sao Paulo, Brazil; [Cotrim Guerreiro da Silva, Ismael Dale] Univ Fed Sao Paulo Unifesp, EPM, Dept Gynecol, Sao Paulo, Brazil; [Machado, Flavia Ribeiro] Univ Fed Sao Paulo Unifesp, Intens Care Unit, Hosp Sao Paulo, Sao Paulo, Brazil	Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein; Universidade Federal de Sao Paulo (UNIFESP); Hospital Sirio Libanes; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Salomao, R (corresponding author), Univ Fed Sao Paulo Unifesp, EPM, Hosp Sao Paulo, Div Infect Dis, Sao Paulo, Brazil.	rsalomao@unifesp.br	Salomao, Reinaldo/C-6419-2013; Machado, Flavia R/G-4651-2012; Brunialti, Milena K C/C-4905-2012; Severino, Patricia/H-2013-2012	Salomao, Reinaldo/0000-0003-1149-4598; Machado, Flavia R/0000-0002-2356-4867; Brunialti, Milena K C/0000-0003-2874-520X; Severino, Patricia/0000-0002-6682-9343	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP 2006/58744-1]; Albert Einstein Research and Education Institute - Hospital Israelita Albert Einstein	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Albert Einstein Research and Education Institute - Hospital Israelita Albert Einstein	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2006/58744-1) (http://www.fapesp.br/) and the Albert Einstein Research and Education Institute - Hospital Israelita Albert Einstein (http://www.einstein.br/Paginas/home.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves JC, 2010, SHOCK, V34, P15, DOI 10.1097/SHK.0b013e3181e7e61b; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Besecker BY, 2011, AM J CLIN NUTR, V93, P1356, DOI 10.3945/ajcn.110.008417; Blackwell TS, 1997, AM J RESP CELL MOL, V17, P3, DOI 10.1165/ajrcmb.17.1.f132; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bone RC, 1996, CRIT CARE MED, V24, P1125, DOI 10.1097/00003246-199607000-00010; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Brunialti MKC, 2006, SHOCK, V25, P351, DOI 10.1097/01.shk.0000217815.57727.29; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chinnaiyan AM, 2001, AM J PATHOL, V159, P1199, DOI 10.1016/S0002-9440(10)62505-9; Chishti AD, 2004, INTENS CARE MED, V30, P605, DOI 10.1007/s00134-004-2175-y; Cummings CJ, 1999, J IMMUNOL, V162, P2341; del Fresno C, 2009, J IMMUNOL, V182, P6494, DOI 10.4049/jimmunol.0803350; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; ERTEL W, 1995, BLOOD, V85, P1341, DOI 10.1182/blood.V85.5.1341.bloodjournal8551341; Eto A, 2003, BIOCHEM BIOPH RES CO, V301, P495, DOI 10.1016/S0006-291X(02)03082-6; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Galley HF, 2010, CRIT CARE, V14, DOI 10.1186/cc9098; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Huet O, 2007, CRIT CARE MED, V35, P821, DOI 10.1097/01.CCM.0000257464.79067.AF; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kaufmann I, 2006, SHOCK, V26, P254, DOI 10.1097/01.shk.0000223131.64512.7a; Martins PS, 2008, CRIT CARE, V12, DOI 10.1186/cc6801; Martins PS, 2003, SHOCK, V20, P208, DOI 10.1097/01.shk.0000079425.52617.db; MUNOZ C, 1991, J CLIN INVEST, V88, P1747, DOI 10.1172/JCI115493; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Ohya M, 2002, SHOCK, V18, P116, DOI 10.1097/00024382-200208000-00004; Pachot A, 2006, IMMUNOL LETT, V106, P63, DOI 10.1016/j.imlet.2006.04.010; Parnell GP, 2013, SHOCK, V40, P166, DOI 10.1097/SHK.0b013e31829ee604; Prasad AS, 2009, CURR OPIN CLIN NUTR, V12, P646, DOI 10.1097/MCO.0b013e3283312956; Rios-Santos F, 2007, AM J RESP CRIT CARE, V175, P490, DOI 10.1164/rccm.200601-103OC; Russell JA, 2011, CRIT CARE, V15, DOI 10.1186/cc9384; Salomao R, 2009, CRIT CARE MED, V37, P132, DOI 10.1097/CCM.0b013e318192fbaf; Salomao R, 2008, SHOCK, V30, P73, DOI 10.1097/SHK.0b013e318181af2a; Salomao R, 2012, SHOCK, V38, P227, DOI 10.1097/SHK.0b013e318262c4b0; Santos SS, 2012, SHOCK, V38, P18, DOI 10.1097/SHK.0b013e318257114e; Strand OA, 2000, CRIT CARE MED, V28, P2779, DOI 10.1097/00003246-200008000-00017; Szabo C, 1996, P NATL ACAD SCI USA, V93, P1753, DOI 10.1073/pnas.93.5.1753; Talwar S, 2006, PHYSIOL GENOMICS, V25, P203, DOI 10.1152/physiolgenomics.00192.2005; Tang BM, 2010, CRIT CARE, V14, DOI 10.1186/cc9392; Tang BMP, 2008, CRIT CARE MED, V36, P1125, DOI 10.1097/CCM.0b013e3181692c0b; Tang BMP, 2007, AM J RESP CRIT CARE, V176, P676, DOI 10.1164/rccm.200612-1819OC; Tang BMP, 2009, CRIT CARE MED, V37, P882, DOI 10.1097/CCM.0b013e31819b52fd; Villar J, 2007, CRIT CARE MED, V35, P2292, DOI 10.1097/01.CCM.0000284511.73556.59; Wong HR, 2012, CRIT CARE, V16, DOI [10.1186/cc10537, 10.1186/cc10811]; Wong HR, 2009, CRIT CARE MED, V37, P1558, DOI 10.1097/CCM.0b013e31819fcc08; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354	47	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e91886	10.1371/journal.pone.0091886	http://dx.doi.org/10.1371/journal.pone.0091886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667684	Green Submitted, gold, Green Published			2022-12-27	WOS:000333675600014
J	Terao, M; Tani, M; Itoi, S; Yoshimura, T; Hamasaki, T; Murota, H; Katayama, I				Terao, Mika; Tani, Mamori; Itoi, Saori; Yoshimura, Takuji; Hamasaki, Toshimitsu; Murota, Hiroyuki; Katayama, Ichiro			11 beta-Hydroxysteroid Dehydrogenase 1 Specific Inhibitor Increased Dermal Collagen Content and Promotes Fibroblast Proliferation	PLOS ONE			English	Article							GLUCOCORTICOID SYNTHESIS; CARDIAC STEROIDOGENESIS; SKIN COLLAGEN; EXPRESSION; TYPE-1; RECEPTOR; 11-BETA-HSD1; PROGRESSION; METABOLISM; RESPONSES	Glucocorticoids (GCs) are one of the most effective anti-inflammatory drugs for treating acute and chronic inflammatory diseases. However, several studies have shown that GCs alter collagen metabolism in the skin and induce skin atrophy. Cortisol is the endogenous GC that is released in response to various stressors. Over the last decade, extraadrenal cortisol production in various tissues has been reported. Skin also synthesizes cortisol through a de novo pathway and through an activating enzyme. 11 beta-hydroxysteroid dehydrogenase 1 (11 beta-HSD1) is the enzyme that catalyzes the conversion of hormonally inactive cortisone to active cortisol in cells. We previously found that 11 beta-HSD1 negatively regulates proliferation of keratinocytes. To determine the function of 11 beta-HSD1 in dermal fibroblasts and collagen metabolism, the effect of a selective 11 beta-HSD1 inhibitor was studied in mouse tissues and dermal fibroblasts. The expression of 11 beta-HSD1 increased with age in mouse skin. Subcutaneous injection of a selective 11 beta-HSD1 inhibitor increased dermal thickness and collagen content in the mouse skin. In vitro, proliferation of dermal fibroblasts derived from 11 beta-HSD1 null mice (Hsd11b1(-/-) mice) was significantly increased compared with fibroblasts from wild-type mice. However, in vivo, dermal thickness of Hsd11b1(-/-) mice was not altered in 3-month-old and 1-year-old mouse skin compared with wild-type mouse skin. These in vivo findings suggest the presence of compensatory mechanisms in Hsd11b1(-/-) mice. Our findings suggest that 11 beta-HSD1 inhibition may reverse the decreased collagen content observed in intrinsically and extrinsically aged skin and in skin atrophy that is induced by GC treatment.	[Terao, Mika; Tani, Mamori; Itoi, Saori; Murota, Hiroyuki; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Dept Dermatol, Suita, Osaka, Japan; [Yoshimura, Takuji] Osaka Univ, Sch Med, Inst Expt Anim Sci, Lab Reprod Engn, Suita, Osaka 565, Japan; [Hamasaki, Toshimitsu] Osaka Univ, Grad Sch Med, Dept Biomed Stat, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University	Terao, M (corresponding author), Osaka Univ, Grad Sch Med, Dept Dermatol, Suita, Osaka, Japan.	mterao@derma.med.osaka-u.ac.jp	Hamasaki, Toshimitsu/N-3851-2015	Hamasaki, Toshimitsu/0000-0002-4928-1160; Yoshimura, Takuji/0000-0002-7856-0679	Japan Society for the Promotion of Science [24659529, 24689045]; Cosmetology Research Foundation; Grants-in-Aid for Scientific Research [24659529] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Cosmetology Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Exploratory Research (No. 24659529) and Grant-in-Aid for Young Scientists (A) (No. 24689045) and from the Japan Society for the Promotion of Science and The Cosmetology Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averbeck M, 2010, EXP DERMATOL, V19, P757, DOI 10.1111/j.1600-0625.2010.01099.x; Baumann L, 2007, J PATHOL, V211, P241, DOI 10.1002/path.2098; Chebotaev D, 2007, MOL CARCINOGEN, V46, P732, DOI 10.1002/mc.20349; Chebotaev DV, 2007, J INVEST DERMATOL, V127, P2749, DOI 10.1038/sj.jid.5700992; Chung JH, 2000, J INVEST DERMATOL, V115, P177, DOI 10.1046/j.1523-1747.2000.00009.x; Cirillo N, 2011, J CELL BIOCH; Coste A, 2007, P NATL ACAD SCI USA, V104, P13098, DOI 10.1073/pnas.0702440104; Davies E, 2003, CLIN EXP PHARMACOL P, V30, P437, DOI 10.1046/j.1440-1681.2003.03867.x; Ezure T, 2010, EXP DERMATOL, V19, P878, DOI 10.1111/j.1600-0625.2009.00970.x; FENSKE NA, 1986, J AM ACAD DERMATOL, V15, P571, DOI 10.1016/S0190-9622(86)70208-9; Hannen RF, 2011, BIOCHEM BIOPH RES CO, V404, P62, DOI 10.1016/j.bbrc.2010.11.059; Hardy R, 2008, ANN RHEUM DIS, V67, P1204, DOI 10.1136/ard.2008.090662; Hermanowski-Vosatka A, 2005, J EXP MED, V202, P517, DOI 10.1084/jem.20050119; Hostettler N, 2012, ALLERGY, V67, P227, DOI 10.1111/j.1398-9995.2011.02749.x; Ishii T, 2007, FEBS LETT, V581, P349, DOI 10.1016/j.febslet.2006.11.032; Kayes-Wandover KM, 2000, J CLIN ENDOCR METAB, V85, P2519, DOI 10.1210/jc.85.7.2519; Kohl E, 2011, J EUR ACAD DERMATOL, V25, P873, DOI 10.1111/j.1468-3083.2010.03963.x; Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924; LEHMANN P, 1983, J INVEST DERMATOL, V81, P169, DOI 10.1111/1523-1747.ep12543603; Mueller M, 2006, J EXP MED, V203, P2057, DOI 10.1084/jem.20060357; Noti M, 2010, J EXP MED, V207, P1057, DOI 10.1084/jem.20090849; Nuutinen P, 2001, J EUR ACAD DERMATOL, V15, P361, DOI 10.1046/j.1468-3083.2001.00272-4.x; Odermatt A, 2006, MOL CELL ENDOCRINOL, V248, P15, DOI 10.1016/j.mce.2005.11.040; Ohtani T, 2009, J HYPERTENS, V27, P1074, DOI 10.1097/HJH.0b013e328326cb04; Oishi Y, 2002, BRIT J DERMATOL, V147, P859, DOI 10.1046/j.1365-2133.2002.04949.x; Quan TH, 2010, J INVEST DERMATOL, V130, P415, DOI 10.1038/jid.2009.224; SALDANHA C, 1986, CLIN EXP RHEUMATOL, V4, P365; Sandeep TC, 2001, TRENDS ENDOCRIN MET, V12, P446, DOI 10.1016/S1043-2760(01)00499-4; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Seckl JR, 2001, ENDOCRINOLOGY, V142, P1371, DOI 10.1210/en.142.4.1371; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski A, 2004, EUR J BIOCHEM, V271, P4178, DOI 10.1111/j.1432-1033.2004.04356.x; Slominski A, 2006, J INVEST DERMATOL, V126, P1177, DOI 10.1038/sj.jid.5700204; Slominski Andrzej, 2008, Drug Discov Today Dis Mech, V5, P137; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Terao M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025039; Terao M, 2010, EXP DERMATOL, V19, P38, DOI 10.1111/j.1600-0625.2009.00973.x; Tiganescu A, 2013, J CLIN INVEST, V123, P3051, DOI 10.1172/JCI64162; Tiganescu A, 2011, J INVEST DERMATOL, V131, P30, DOI 10.1038/jid.2010.257; Vukelic S, 2011, J BIOL CHEM, V286, P10265, DOI 10.1074/jbc.M110.188268; Young MJ, 2001, J CLIN ENDOCR METAB, V86, P5121, DOI 10.1210/jc.86.11.5121; Zhou JG, 2005, STEROIDS, V70, P407, DOI 10.1016/j.steroids.2005.02.006	42	18	19	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93051	10.1371/journal.pone.0093051	http://dx.doi.org/10.1371/journal.pone.0093051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667799	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600133
J	Xiong, HY; Li, JJ; Liu, PL; Duan, JZ; Zhao, Y; Guo, X; Li, Y; Zhang, HL; Ali, J; Li, ZC				Xiong, Haiyan; Li, Jinjie; Liu, Pengli; Duan, Junzhi; Zhao, Yan; Guo, Xiao; Li, Yang; Zhang, Hongliang; Ali, Jauhar; Li, Zichao			Overexpression of OsMYB48-1, a Novel MYB-Related Transcription Factor, Enhances Drought and Salinity Tolerance in Rice	PLOS ONE			English	Article							RESPONSIVE GENE-EXPRESSION; ABSCISIC-ACID BIOSYNTHESIS; OSMOTIC-STRESS TOLERANCE; FUNCTIONAL-ANALYSIS; WATER-STRESS; GRAIN-YIELD; LEA GENE; COLD; SALT; DEHYDRATION	MYB-type transcription factors (TFs) play essential roles in plant growth, development and respond to environmental stresses. Role of MYB-related TFs of rice in drought stress tolerance is not well documented. Here, we report the isolation and characterization of a novel MYB-related TF, OsMYB48-1, of rice. Expression of OsMYB48-1 was strongly induced by polyethylene glycol (PEG), abscisic acid (ABA), H2O2, and dehydration, while being slightly induced by high salinity and cold treatment. The OsMYB48-1 protein was localized in the nucleus with transactivation activity at the C terminus. Overexpression of OsMYB48-1 in rice significantly improved tolerance to simulated drought and salinity stresses caused by mannitol, PEG, and NaCl, respectively, and drought stress was caused by drying the soil. In contrast to wild type plants, the overexpression lines exhibited reduced rate of water loss, lower malondialdehyde (MDA) content and higher proline content under stress conditions. Moreover, overexpression plants were hypersensitive to ABA at both germination and post-germination stages and accumulated more endogenous ABA under drought stress conditions. Further studies demonstrated that overexpression of OsMYB48-1 could regulate the expression of some ABA biosynthesis genes (OsNCED4, OsNCED5), early signaling genes (OsPP2C68, OSRK1) and late responsive genes (RAB21, OsLEA3, RAB16C and RAB16D) under drought stress conditions. Collectively, these results suggested that OsMYB48-1 functions as a novel MYB-related TF which plays a positive role in drought and salinity tolerance by regulating stress-induced ABA synthesis.	[Xiong, Haiyan; Li, Jinjie; Liu, Pengli; Duan, Junzhi; Zhao, Yan; Guo, Xiao; Li, Yang; Zhang, Hongliang; Li, Zichao] China Agr Univ, Minist Educ, Key Lab Crop Heterosis & Utilizat, Beijing 100094, Peoples R China; [Xiong, Haiyan; Li, Jinjie; Liu, Pengli; Duan, Junzhi; Zhao, Yan; Guo, Xiao; Li, Yang; Zhang, Hongliang; Li, Zichao] China Agr Univ, Beijing Key Lab Crop Genet Improvement, Beijing 100094, Peoples R China; [Ali, Jauhar] Int Rice Res Inst, Manila, Philippines	China Agricultural University; China Agricultural University; CGIAR; International Rice Research Institute (IRRI)	Li, ZC (corresponding author), China Agr Univ, Minist Educ, Key Lab Crop Heterosis & Utilizat, Beijing 100094, Peoples R China.	lizichao@cau.edu.cn	Xiong, Haiyan/AAL-9383-2021; Ali, Jauhar Ali or A. Jauhar/E-4432-2012; Li, Zichao/AAS-8954-2021	Xiong, Haiyan/0000-0003-4145-2719; Ali, Jauhar Ali or A. Jauhar/0000-0002-3177-2607; Li, Zichao/0000-0002-3186-1132	National Natural Science Foundation of China [31061140458]; Ministry of Agriculture of the People's Republic of China [2011ZX08009-003-002]; National Basic Research Program of China [2010CB125904]; Program of the Co-Construction with Beijing Municipal Commission of Education of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of the People's Republic of China(Ministry of Agriculture & Rural Affairs); National Basic Research Program of China(National Basic Research Program of China); Program of the Co-Construction with Beijing Municipal Commission of Education of China	This work was supported by grants from National Natural Science Foundation of China (Grant No. 31061140458. http://www.nsfc.gov.cn/Portal0/default166.htm); Ministry of Agriculture of the People's Republic of China (Grant No. 2011ZX08009-003-002. http://english.agri.gov.cn/np/); National Basic Research Program of China (Grant No. 2010CB125904. http://www.973.gov.cn/English/Index.aspx); the Program of the Co-Construction with Beijing Municipal Commission of Education of China (http://english.bjedu.gov.cn/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Chae MJ, 2007, PLANT MOL BIOL, V63, P151, DOI 10.1007/s11103-006-9079-x; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Chen ZZ, 2005, PLANT J, V43, P273, DOI 10.1111/j.1365-313X.2005.02452.x; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Denekamp M, 2003, PLANT PHYSIOL, V132, P1415, DOI 10.1104/pp.102.019273; Du H, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1, DOI 10.1134/S0006297909010015; Duan JZ, 2012, PLANT SCI, V196, P143, DOI 10.1016/j.plantsci.2012.08.003; El-kereamy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052030; Finkelstein Ruth R., 2002, Plant Cell, V14, pS15; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Ganesan G, 2012, J EXP BOT, V63, P4549, DOI 10.1093/jxb/ers135; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hou X, 2009, P NATL ACAD SCI USA, V106, P6410, DOI 10.1073/pnas.0901940106; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Hwang SG, 2010, PLANT SCI, V178, P12, DOI 10.1016/j.plantsci.2009.09.014; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Jeong JS, 2010, PLANT PHYSIOL, V153, P185, DOI 10.1104/pp.110.154773; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Lu CA, 2002, PLANT CELL, V14, P1963, DOI 10.1105/tpc.001735; Ma QB, 2009, PLANT PHYSIOL, V150, P244, DOI 10.1104/pp.108.133454; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Oh SJ, 2009, PLANT PHYSIOL, V150, P1368, DOI 10.1104/pp.109.137554; Pasquali G, 2008, PLANT CELL REP, V27, P1677, DOI 10.1007/s00299-008-0587-9; RoyChoudhury A, 2007, PLANT CELL REP, V26, P1839, DOI 10.1007/s00299-007-0371-2; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Shin D, 2011, PLANT PHYSIOL, V155, P421, DOI 10.1104/pp.110.163634; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Song SY, 2011, PLANTA, V234, P331, DOI 10.1007/s00425-011-1403-2; Su CF, 2010, PLANT PHYSIOL, V153, P145, DOI 10.1104/pp.110.153015; Tang N, 2012, PLANT PHYSIOL, V158, P1755, DOI 10.1104/pp.111.190389; Vannini C, 2004, PLANT J, V37, P115, DOI 10.1046/j.1365-313X.2003.01938.x; Vannini C, 2007, PLANT SCI, V173, P231, DOI 10.1016/j.plantsci.2007.05.007; Wang HG, 2007, THEOR APPL GENET, V115, P1109, DOI 10.1007/s00122-007-0637-7; Wang HH, 2007, PLANT MOL BIOL, V65, P799, DOI 10.1007/s11103-007-9244-x; Wang M, 2004, PLANT MOL BIOL REP, V22, P409, DOI 10.1007/BF02772683; Wang ZY, 2011, PLANT CELL, V23, P1971, DOI 10.1105/tpc.110.081943; Xiang Y, 2008, PLANT PHYSIOL, V148, P1938, DOI 10.1104/pp.108.128199; Xiao BZ, 2007, THEOR APPL GENET, V115, P35, DOI 10.1007/s00122-007-0538-9; Xue TT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-550; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang A, 2012, J EXP BOT, V63, P2541, DOI 10.1093/jxb/err431; Yang JC, 2001, PLANT PHYSIOL, V127, P315, DOI 10.1104/pp.127.1.315; Yue YS, 2012, J EXP BOT, V63, P3741, DOI 10.1093/jxb/ers069; Zhang LC, 2012, J EXP BOT, V63, P5873, DOI 10.1093/jxb/ers237; Zhu QH, 2004, PLANT PHYSIOL, V135, P1514, DOI 10.1104/pp.104.041459	50	212	236	18	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92913	10.1371/journal.pone.0092913	http://dx.doi.org/10.1371/journal.pone.0092913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667379	gold, Green Submitted, Green Published			2022-12-27	WOS:000333675600104
J	Goyer, K; Bertolo, A; Pepino, M; Magnan, P				Goyer, Katerine; Bertolo, Andrea; Pepino, Marc; Magnan, Pierre			Effects of Lake Warming on Behavioural Thermoregulatory Tactics in a Cold-Water Stenothermic Fish	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; LACUSTRINE BROOK CHARR; ECOLOGICAL DATA; SOCKEYE-SALMON; HABITAT USE; TEMPERATURE PREFERENCE; THERMAL TOLERANCE; NEIGHBOR MATRICES; RAINBOW-TROUT; BROWN TROUT	Despite some evidence of within-population phenotypic variation in fish thermal behaviour, the occurrence of alternative tactics of this behaviour is rarely explicitly considered when studying natural populations. Brook charr provide an example of within-population variability in behavioural thermoregulation as revealed by a recent study on a lacustrine population of this species. The objectives of the present study were (i) to determine the influence of natural variability in the lake's thermal profiles on the expression of thermoregulatory tactics, and (ii) to determine the vertical and horizontal movements of individuals at different periods of the day to better understand the spatio-temporal behaviour associated with each thermoregulatory tactic. During summer 2010, 30 adult brook charr were equipped with thermo-sensitive radio transmitters to monitor their selected temperatures and daily movements. These individuals exhibited the same four behavioural thermoregulatory tactics observed in 2003 and 2005, but the expression of two of these was weaker in 2010. This result was associated with lake warming, which constrained the expression of two thermoregulatory tactics: brook charr significantly decreased their selected temperatures and daily movements when the mean daily epilimnion temperature was above 22.4 degrees C. This study shows for the first time that the expression of behavioural thermoregulatory tactics is related to the lake's thermal regime and that the tactics are plastic through time.	[Goyer, Katerine; Bertolo, Andrea; Pepino, Marc; Magnan, Pierre] Univ Quebec Trois Rivieres, Ctr Rech Interact Bassins Versants Ecosyst Aquat, Trois Rivieres, PQ GA9 5H7, Canada	University of Quebec; University of Quebec Trois Rivieres	Bertolo, A (corresponding author), Univ Quebec Trois Rivieres, Ctr Rech Interact Bassins Versants Ecosyst Aquat, Trois Rivieres, PQ GA9 5H7, Canada.	andrea.bertolo@uqtr.ca	Magnan, Pierre/U-9342-2019	Magnan, Pierre/0000-0003-3122-7163; Bertolo, Andrea/0000-0002-6018-816X	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chair program; NSERC; Fonds de recherche du Quebec - Nature et technologies	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair program(Canada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de recherche du Quebec - Nature et technologies	This research was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canada Research Chair program to P. Magnan. K. Goyer was supported by post-graduate fellowships from NSERC and the Fonds de recherche du Quebec - Nature et technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanara A, 2001, J ANIM ECOL, V70, P980, DOI 10.1046/j.0021-8790.2001.00550.x; Angilletta MJ, 2002, J THERM BIOL, V27, P199, DOI 10.1016/S0306-4565(01)00084-5; Atkinson EJ, 2000, 61 MAYO FDN; Baird OE, 2003, T AM FISH SOC, V132, P1194, DOI 10.1577/T02-127; Belanger G, 2001, J FISH BIOL, V59, P987, DOI 10.1111/j.1095-8649.2001.tb00166.x; Bertolo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018603; Bicego KC, 2007, COMP BIOCHEM PHYS A, V147, P616, DOI 10.1016/j.cbpa.2006.06.032; Biro PA, 1998, T AM FISH SOC, V127, P212, DOI 10.1577/1548-8659(1998)127<0212:SCBTDS>2.0.CO;2; Blanchet FG, 2008, ECOL MODEL, V215, P325, DOI 10.1016/j.ecolmodel.2008.04.001; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Bourke P, 1999, EVOL ECOL, V13, P19, DOI 10.1023/A:1006530029418; Bourke P, 1996, J FISH BIOL, V49, P1174; Bourke P, 1997, J FISH BIOL, V51, P783, DOI 10.1111/j.1095-8649.1997.tb01999.x; Breau C, 2011, J ANIM ECOL, V80, P844, DOI 10.1111/j.1365-2656.2011.01828.x; Breiman L., 1984, CLASSIFICATION REGRE; BRETT JR, 1971, AM ZOOL, V11, P99; Bridger CJ, 2003, REV FISH SCI, V11, P13, DOI 10.1080/16226510390856510; CHERRY DS, 1975, J FISH RES BOARD CAN, V32, P485, DOI 10.1139/f75-059; CRAWSHAW LI, 1977, J FISH RES BOARD CAN, V34, P730, DOI 10.1139/f77-113; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Dynes J, 1999, J FISH BIOL, V54, P955, DOI 10.1111/j.1095-8649.1999.tb00850.x; Fry FEJ, 1947, U TORONTO STUD BIOL, V55; Fry FEJ, 1947, RES LAB, V68, P1; Griffith DA, 2006, ECOLOGY, V87, P2603, DOI 10.1890/0012-9658(2006)87[2603:SMIETF]2.0.CO;2; Hansson LA, 2009, P R SOC B, V276, P331, DOI 10.1098/rspb.2008.1088; Hayes DB, 1998, HEADWATERS: WATER RESOURCES AND SOIL CONSERVATION, P175; Hays GC, 2001, LIMNOL OCEANOGR, V46, P2050, DOI 10.4319/lo.2001.46.8.2050; Hight BV, 2007, J EXP MAR BIOL ECOL, V352, P114, DOI 10.1016/j.jembe.2007.07.021; Hrabik TR, 2006, CAN J FISH AQUAT SCI, V63, P2286, DOI 10.1139/F06-124; JAVAID MY, 1967, J FISH RES BOARD CAN, V24, P1515, DOI 10.1139/f67-125; Keefer ML, 2009, CAN J FISH AQUAT SCI, V66, P1734, DOI 10.1139/F09-131; Kobler A, 2009, OECOLOGIA, V161, P837, DOI 10.1007/s00442-009-1415-9; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 2012, NUMERICAL ECOLOGY; MAGNAN P, 1988, CAN J FISH AQUAT SCI, V45, P999, DOI 10.1139/f88-123; MAGNUSON JJ, 1979, AM ZOOL, V19, P331; Magnuson JJ, 1997, HYDROL PROCESS, V11, P825; MATTHEWS KR, 1994, T AM FISH SOC, V123, P549, DOI 10.1577/1548-8659(1994)123<0549:CWFATH>2.3.CO;2; McDermid JL, 2012, T AM FISH SOC, V141, P1230, DOI 10.1080/00028487.2012.688917; Mehner T, 2011, J ANIM ECOL, V80, P761, DOI 10.1111/j.1365-2656.2011.01823.x; MOYLE PB, 2000, FISHES INTRO ICHTHYO; Music B., 2011, CRCM DIAGNOSTICS FUT; NEVERMAN D, 1994, OECOLOGIA, V98, P247, DOI 10.1007/BF00324211; Podrabsky JE, 2008, J COMP PHYSIOL A, V194, P385, DOI 10.1007/s00359-008-0313-7; Power G, 1980, CHARRS SALMONID FISH, P141; R Development Core Team, 2007, R LANG ENV STAT COMP; Rejwan C, 1999, ECOLOGY, V80, P341, DOI 10.1890/0012-9658(1999)080[0341:TRAOTN]2.0.CO;2; REYNOLDS WW, 1979, HYDROBIOLOGIA, V62, P79, DOI 10.1007/BF00012567; REYNOLDS WW, 1979, AM ZOOL, V19, P193; Richter A, 2005, REV FISH SCI, V13, P23, DOI 10.1080/10641260590885861; Robinson JM, 2010, T AM FISH SOC, V139, P685, DOI 10.1577/T08-185.1; Roscoe DW, 2010, ECOL FRESHW FISH, V19, P51, DOI 10.1111/j.1600-0633.2009.00388.x; Scheuerell MD, 2003, ECOLOGY, V84, P1713, DOI 10.1890/0012-9658(2003)084[1713:DVMBJS]2.0.CO;2; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sims DW, 2005, J ANIM ECOL, V74, P755, DOI 10.1111/j.1365-2656.2005.00971.x; SNUCINS EJ, 1995, T AM FISH SOC, V124, P118, DOI 10.1577/1548-8659(1995)124<0118:CWAWEB>2.3.CO;2; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; van Dijk PLM, 2002, OECOLOGIA, V130, P496, DOI 10.1007/s00442-001-0830-3; Wehrly KE, 2007, T AM FISH SOC, V136, P365, DOI 10.1577/T06-163.1; Wetzel RG, 2001, LIMNOLOGY, Vthird, P331; Wismer D. A., 1987, SPECIAL PUBLICATION, V87; WURTSBAUGH WA, 1975, T AM FISH SOC, V104, P88, DOI 10.1577/1548-8659(1975)104<88:FADOUB>2.0.CO;2	64	28	31	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92514	10.1371/journal.pone.0092514	http://dx.doi.org/10.1371/journal.pone.0092514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663489	Green Submitted, Green Published, gold			2022-12-27	WOS:000333459900069
J	Lee, PH; Lin, HC; Huang, ASE; Wei, SH; Lai, MS; Lin, HH				Lee, Pin-Hui; Lin, Hui-Chen; Huang, Angela Song-En; Wei, Sung-Hsi; Lai, Mei-Shu; Lin, Hsien-Ho			Diabetes and Risk of Tuberculosis Relapse: Nationwide Nested Case-Control Study	PLOS ONE			English	Article							RECURRENT TUBERCULOSIS; PULMONARY TUBERCULOSIS; TREATMENT OUTCOMES; MELLITUS; ASSOCIATION; MANAGEMENT; DIAGNOSIS; IMPACT; MICE	The aim of this study was to investigate the association between diabetes mellitus (DM) and tuberculosis (TB) relapse using the nationwide TB registry in Taiwan. We conducted a case-control study nested within a nationwide cohort of all incident cases of pulmonary TB that were notified during 2006-2007 and had completed anti-TB treatment. The relapse of TB was confirmed by bacteriological or pathological findings. For each relapse case, one control was selected from the study cohort matching by time since treatment completion. DM status was ascertained by medical chart review and cross-matching with the National Health Insurance claims database. A total of 305 cases of relapse were identified after a median follow-up of 3 years (relapse rate: 488 per 100,000 person-year; 95% confidence interval (CI): 434-546). Presence of DM during previous anti-TB treatment was 34.0% and 22.7% in cases and controls, respectively. After adjusting for other potential confounders, DM was associated with increased risk of TB relapse (adjusted odds ratio: 1.96, 95% CI: 1.22-3.15). Only one-third of the DM-TB patients in our study received glycaemic monitoring using HbA1c during anti-TB treatment. Presence of DM was independently associated with risk of TB relapse. TB programs should seriously consider rigorous glucose control in DM-TB patients.	[Lee, Pin-Hui; Lin, Hui-Chen; Huang, Angela Song-En; Wei, Sung-Hsi] Ctr Dis Control, Taipei, Taiwan; [Lee, Pin-Hui; Lai, Mei-Shu; Lin, Hsien-Ho] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Wei, Sung-Hsi] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Wei, Sung-Hsi] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan	Centers For Disease Control - Taiwan; National Taiwan University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lin, HH (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	hsienho@ntu.edu.tw		Lai, Mei-shu/0000-0001-6130-3468; LIN, HSIEN-HO/0000-0002-7481-6016	Centers for Disease Control, Taiwan [DOH100-DC-2043]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002043] Funding Source: NIH RePORTER	Centers for Disease Control, Taiwan; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by the Centers for Disease Control, Taiwan [Grant DOH100-DC-2043]. The sponsors had no role in the study design or the collection, or analysis, or interpretation of data, or the writing of the article, or the decision to submit it for publication.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Bang D, 2010, INT J TUBERC LUNG D, V14, P447; Bloss E, 2012, INT J TUBERC LUNG D, V16, P462, DOI 10.5588/ijtld.11.0121; Chang TJ, 2012, J FORMOS MED ASSOC, V111, P605, DOI 10.1016/j.jfma.2012.09.011; Crofts JP, 2010, THORAX, V65, P310, DOI 10.1136/thx.2009.124677; Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Jimenez-Corona ME, 2013, THORAX, V68, P214, DOI 10.1136/thoraxjnl-2012-201756; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Goldhaber-Fiebert JD, 2011, INT J EPIDEMIOL, V40, P417, DOI 10.1093/ije/dyq238; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Jasmer RM, 2004, AM J RESP CRIT CARE, V170, P1360, DOI 10.1164/rccm.200408-1081OC; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Leung CC, 2008, AM J EPIDEMIOL, V167, P1486, DOI 10.1093/aje/kwn075; Lo HY, 2015, ASIA-PAC J PUBLIC HE, V27, pNP758, DOI 10.1177/1010539511429591; Lo HY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-915; Martens GW, 2007, AM J RESP CELL MOL, V37, P518, DOI 10.1165/rcmb.2006-0478OC; Millet JP, 2009, J EPIDEMIOL COMMUN H, V63, P799, DOI 10.1136/jech.2008.077560; Murray J, 1999, AM J RESP CRIT CARE, V159, P733, DOI 10.1164/ajrccm.159.3.9804147; Panjabi R, 2007, INT J TUBERC LUNG D, V11, P828; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Sacks DB, 2011, DIABETES CARE, V34, P1419, DOI 10.2337/dc11-9997; Selassie AW, 2005, ANN EPIDEMIOL, V15, P519, DOI 10.1016/j.annepidem.2005.03.002; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stalenhoef JE, 2008, EUR J CLIN MICROBIOL, V27, P97, DOI 10.1007/s10096-007-0395-0; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Sullivan T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001269; Taiwan Bureau of National Health Insurance, 2012, NAT HLTH INS TAIW 20; Taiwan Centers for Disease Control, 2006, TREATM GUID TUB; Thomas A, 2005, INT J TUBERC LUNG D, V9, P556; Vallerskog T, 2010, J IMMUNOL, V184, P6275, DOI 10.4049/jimmunol.1000304; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2009, TREATM TUB GUID NAT; World Health Organization International Union against Tuberculosis and Lung Disease, 2011, COLL FRAM CAR CONTR; Yamashiro S, 2005, CLIN EXP IMMUNOL, V139, P57, DOI 10.1111/j.1365-2249.2005.02677.x; Yang ZH, 2004, CLIN INFECT DIS, V38, P199, DOI 10.1086/380644	39	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92623	10.1371/journal.pone.0092623	http://dx.doi.org/10.1371/journal.pone.0092623			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663327	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900086
J	Michaud, A; Lacroix-Pepin, N; Pelletier, M; Veilleux, A; Noel, S; Bouchard, C; Marceau, P; Fortier, MA; Tchernof, A				Michaud, Andreanne; Lacroix-Pepin, Nicolas; Pelletier, Melissa; Veilleux, Alain; Noel, Suzanne; Bouchard, Celine; Marceau, Picard; Fortier, Michel A.; Tchernof, Andre			Prostaglandin (PG) F2 Alpha Synthesis in Human Subcutaneous and Omental Adipose Tissue: Modulation by Inflammatory Cytokines and Role of the Human Aldose Reductase AKR1B1	PLOS ONE			English	Article							ADIPOCYTE DIFFERENTIATION; 3T3-L1 CELLS; F-2 ALPHA; 20-ALPHA-HYDROXYSTEROID DEHYDROGENASE; PREADIPOCYTE DIFFERENTIATION; BOVINE ENDOMETRIUM; PRIMARY CULTURE; DOWN-REGULATION; FAT-CELLS; SYNTHASE	Introduction: PGF(2 alpha) may be involved in the regulation of adipose tissue function. Objectives: 1) To examine PGF(2 alpha) release by primary preadipocytes, mature adipocytes and whole tissue explants from the subcutaneous and omental fat compartments; 2) To assess which PGF synthase is the most relevant in human adipose tissue. Methods: Fat samples were obtained by surgery in women. PGF(2 alpha) release by preadipocytes, adipocytes and explants under stimulation by TNF-alpha, IL-1 beta or both was measured. Messenger RNA expression levels of AKR1B1 and AKR1C3 were measured by RT-PCR in whole adipose tissue and cytokine-treated preadipocytes. The effect of AKR1B1 inhibitor ponalrestat on PGF(2 alpha) synthesis was investigated. Results: PGF(2 alpha) release was significantly induced in response to cytokines compared to control in omental (p = 0.01) and to a lesser extent in subcutaneous preadipocytes (p = 0.02). Messenger RNA of COX-2 was significantly higher in omental compared to subcutaneous preadipocytes in response to combined TNF-alpha and IL-1 beta (p = 0.01). Inflammatory cytokines increased AKR1B1 mRNA expression and protein levels (p <= 0.05), but failed to increase expression levels of AKR1C3 in cultured preadipocytes. Accordingly, ponalrestat blunted PGF(2 alpha) synthesis by preadipocytes in basal and stimulated conditions (p <= 0.05). Women with the highest PGF(2 alpha) release by omental adipocytes had a higher BMI (p = 0.05), waist circumference (p <= 0.05) and HOMAir index (p <= 0.005) as well as higher mRNA expression of AKR1B1 in omental (p < 0.10) and subcutaneous (p <= 0.05) adipose tissue compared to women with low omental adipocytes PGF(2 alpha) release. Positive correlations were observed between mRNA expression of AKR1B1 in both compartments and BMI, waist circumference as well as HOMAir index (p <= 0.05 for all). Conclusion: PGF(2 alpha) release by omental mature adipocytes is increased in abdominally obese women. Moreover, COX-2 expression and PGF(2 alpha) release is particularly responsive to inflammatory stimulation in omental preadipocytes. Yet, blockade of PGF synthase AKR1B1 inhibits most of the PGF(2 alpha) release.	[Michaud, Andreanne; Lacroix-Pepin, Nicolas; Pelletier, Melissa; Fortier, Michel A.; Tchernof, Andre] Univ Laval, Med Ctr, Quebec City, PQ, Canada; [Michaud, Andreanne; Veilleux, Alain; Tchernof, Andre] Univ Laval, Dept Nutr, Quebec City, PQ, Canada; [Noel, Suzanne; Bouchard, Celine] Univ Laval, Med Ctr, Gynecol Unit, Quebec City, PQ, Canada; [Marceau, Picard] Quebec Cardiol & Pulmonol Inst, Dept Surg, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Tchernof, A (corresponding author), Univ Laval, Med Ctr, Quebec City, PQ, Canada.	andre.tchernof@crchul.ulaval.ca	Veilleux, Alain/I-5028-2019	Veilleux, Alain/0000-0003-4078-1908; Michaud, Andreanne/0000-0003-2028-8307; Bouchard, Celine/0000-0003-2258-058X; Tchernof, Andre/0000-0002-2587-1000	Canadian Institutes of Health Research [MOP-64182]; Fonds de recherche du Quebec - Sante	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec)	This study was supported by grant MOP-64182 (A. Tchernof) from the Canadian Institutes of Health Research. Andreanne Michaud was funded by Fonds de recherche du Quebec - Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprikian O, 2007, AM J PHYSIOL-REG I, V293, pR2006, DOI 10.1152/ajpregu.00382.2007; Asselin E, 1996, BIOL REPROD, V54, P371, DOI 10.1095/biolreprod54.2.371; AXELROD L, 1986, DIABETES, V35, P1004, DOI 10.2337/diabetes.35.9.1004; AXELROD L, 1983, PROSTAG OTH LIPID M, V25, P571, DOI 10.1016/0090-6980(83)90029-1; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Blouin K, 2003, J CLIN ENDOCR METAB, V88, P5944, DOI 10.1210/jc.2003-030535; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; Borglum JD, 1999, PROSTAG OTH LIPID M, V57, P305, DOI 10.1016/S0090-6980(98)00082-3; Bresson E, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00098; Bresson E, 2011, J CLIN ENDOCR METAB, V96, P210, DOI 10.1210/jc.2010-1589; Casimir DA, 1996, DIFFERENTIATION, V60, P203, DOI 10.1046/j.1432-0436.1996.6040203.x; Chapdelaine P, 2006, MOL HUM REPROD, V12, P309, DOI 10.1093/molehr/gal034; CHATZIPANTELI K, 1992, DIABETES, V41, P927, DOI 10.2337/diabetes.41.8.927; Chou WL, 2007, J BIOL CHEM, V282, P18162, DOI 10.1074/jbc.M702289200; CURTISPRIOR PB, 1979, EXPERIENTIA, V35, P911, DOI 10.1007/BF01955144; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dufort I, 1999, ENDOCRINOLOGY, V140, P568, DOI 10.1210/en.140.2.568; Fain JN, 2002, PROSTAG LEUKOTR ESS, V67, P467, DOI 10.1054/plef.2002.0430; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Fain JN, 2008, METABOLISM, V57, P1005, DOI 10.1016/j.metabol.2008.02.019; Farb MG, 2013, OBESITY, V10; Frayn KN, 2002, DIABETOLOGIA, V45, P1201, DOI 10.1007/s00125-002-0873-y; Fujimori K, 2007, J BIOL CHEM, V282, P18458, DOI 10.1074/jbc.M701141200; Fujimori K, 2010, J BIOL CHEM, V285, P8880, DOI 10.1074/jbc.M109.077164; Hayaishi O, 1988, Prog Clin Biol Res, V274, P577; Hetu PO, 2007, OBESITY, V15, P60, DOI 10.1038/oby.2007.514; Kabututu Z, 2009, J BIOCHEM, V145, P161, DOI 10.1093/jb/mvn152; Liu L, 2007, J CELL BIOCHEM, V100, P161, DOI 10.1002/jcb.21044; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; Madan AK, 2006, OBES SURG, V16, P1342, DOI 10.1381/096089206778663652; Madore E, 2003, J BIOL CHEM, V278, P11205, DOI 10.1074/jbc.M208318200; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McQuaid SE, 2011, DIABETES, V60, P47, DOI 10.2337/db10-0867; Michaud A, 2012, METABOLISM, V61, P689, DOI 10.1016/j.metabol.2011.10.004; Miller CW, 1996, ENDOCRINOLOGY, V137, P5641, DOI 10.1210/en.137.12.5641; Nagata N, 2011, FEBS J, V278, P1288, DOI 10.1111/j.1742-4658.2011.08049.x; Nishimura K, 2006, BIOSCI BIOTECH BIOCH, V70, P2145, DOI 10.1271/bbb.60106; RICHELSEN B, 1987, BIOCHEM J, V247, P389, DOI 10.1042/bj2470389; RODBELL M, 1964, J BIOL CHEM, V239, P375; Serrero G, 1997, BIOCHEM BIOPH RES CO, V233, P200, DOI 10.1006/bbrc.1997.6433; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; SOCHOR M, 1988, BIOCHEM PHARMACOL, V37, P3349, DOI 10.1016/0006-2952(88)90649-1; Tsuboi H, 2004, BIOCHEM BIOPH RES CO, V322, P1066, DOI 10.1016/j.bbrc.2004.08.018; van Harmelen V, 2004, METABOLISM, V53, P632, DOI 10.1016/j.metabol.2003.11.012; VASSAUX G, 1992, ENDOCRINOLOGY, V131, P2393, DOI 10.1210/en.131.5.2393; WATANABE K, 1985, J BIOL CHEM, V260, P7035; Watanabe K, 2002, PROSTAG OTH LIPID M, V68-9, P401, DOI 10.1016/S0090-6980(02)00044-8; Watanabe K, 2011, J BIOCHEM, V150, P593, DOI 10.1093/jb/mvr116; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Yan HY, 2003, J LIPID RES, V44, P424, DOI 10.1194/jlr.M200357-JLR200; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Zhang Y, 2000, J MOL ENDOCRINOL, V25, P221, DOI 10.1677/jme.0.0250221	54	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e90861	10.1371/journal.pone.0090861	http://dx.doi.org/10.1371/journal.pone.0090861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663124	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900011
J	Muller, M; Demeret, C				Muller, Mandy; Demeret, Caroline			CCHCR1 Interacts Specifically with the E2 Protein of Human Papillomavirus Type 16 on a Surface Overlapping BRD4 Binding	PLOS ONE			English	Article							TRANSACTIVATION DOMAIN; HUMAN KERATINOCYTES; CERVICAL-CANCER; CANDIDATE GENE; PSORS1 LOCUS; EXPRESSION; HCR; PSORIASIS; COMPLEX; CELLS	The Human Papillomavirus E2 proteins are key regulators of the viral life cycle, whose functions are commonly mediated through protein-protein interactions with the host cell proteome. We identified an interaction between E2 and a cellular protein called CCHCR1, which proved highly specific for the HPV16 genotype, the most prevalent in HPV-associated cancers. Further characterization of the interaction revealed that CCHCR1 binds the N-terminal alpha helices of HPV16 E2 N-terminal domain. On this domain, the CCHCR1 binding interface overlaps that of BRD4, a key mediator of E2 transcriptional activity. Consequently a physical competition occurs between the two proteins for the binding to HPV16 E2, and CCHCR1 interferes with BRD4-mediated enhancement of E2-dependent transcription. In addition, we showed that the interaction with CCHCR1 induced a massive redistribution of HPV16 E2, from a predominantly nuclear to a cytoplasmic localization in dot-like structures, where E2 perfectly co-localizes with CCHCR1. Such a cytoplasmic docking likely interferes with the nuclear functions of HPV16 E2. Upon co-expression of BRD4 and CCHCR1, E2 accumulates both in the nucleus and in the cytoplasm, indicating that for HPV16, both sub-cellular localization and transcriptional functions of E2 may depend on the proportion of both factors within the cell. We provided evidence of a strong induction of the keratinocyte differentiation marker K10 by HPV16 E2, and showed that this activation is compromised by the interaction with CCHCR1. The specific interaction described here could thus impact on the pathogenesis of HPV16. We propose that it could underlie some specific traits of HPV16 infection, such as an enhanced propensity to give rise to lesions evolving toward cancer.	[Muller, Mandy; Demeret, Caroline] Inst Pasteur, Unite Genet Papillomavirus & Canc Humain, Paris, France; [Muller, Mandy] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Demeret, C (corresponding author), Inst Pasteur, Unite Genet Mol Virus ARN, Paris, France.	caroline.demeret@pasteur.fr	Muller, Mandy/AAD-1126-2019	Muller, Mandy/0000-0002-0056-3589; Demeret, caroline/0000-0002-1103-6805	Institut Pasteur; M.E.N.R.T fellowship	Institut Pasteur(European Commission); M.E.N.R.T fellowship	This work was supported by funding from the Institut Pasteur. M. M. is a recipient of a M.E.N.R.T fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate EA, 2004, GENE DEV, V18, P1981, DOI 10.1101/gad.1220104; Abbate EA, 2006, MOL CELL, V24, P877, DOI 10.1016/j.molcel.2006.11.002; Antson AA, 2000, NATURE, V403, P805, DOI 10.1038/35001638; Asumalahti K, 2002, HUM MOL GENET, V11, P589, DOI 10.1093/hmg/11.5.589; Asumalahti K, 2000, HUM MOL GENET, V9, P1533, DOI 10.1093/hmg/9.10.1533; Bellanger S, 2001, J VIROL, V75, P7244, DOI 10.1128/JVI.75.16.7244-7251.2001; Blachon S, 2005, J BIOL CHEM, V280, P36088, DOI 10.1074/jbc.M505138200; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Burns JE, 2010, VIROLOGY, V401, P314, DOI 10.1016/j.virol.2010.03.002; Cassonnet P, 2011, NAT METHODS, V8, P990, DOI 10.1038/nmeth.1773; Corbi N, 2005, J CELL SCI, V118, P4253, DOI 10.1242/jcs.02545; D'Abramo C M, 2011, Open Virol J, V5, P80, DOI 10.2174/1874357901105010080; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Helfer CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077994; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Micallef L, 2009, EXP DERMATOL, V18, P143, DOI 10.1111/j.1600-0625.2008.00775.x; Muller Mandy, 2012, Open Virol J, V6, P173, DOI 10.2174/1874357901206010173; Muller M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002761; Olejnik-Schmidt AK, 2008, ARCH VIROL, V153, P983, DOI 10.1007/s00705-008-0061-6; Pacholska-Bogalska J, 2012, INT J MOL MED, V29, P669, DOI 10.3892/ijmm.2012.877; Santin AD, 2005, VIROLOGY, V331, P269, DOI 10.1016/j.virol.2004.09.045; Schweiger MR, 2006, J VIROL, V80, P4276, DOI 10.1128/JVI.80.9.4276-4285.2006; Suomela S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006030; Tervaniemi MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049920; Tiala I, 2008, HUM MOL GENET, V17, P1043, DOI 10.1093/hmg/ddm377; Tiala I, 2007, J MOL MED, V85, P589, DOI 10.1007/s00109-006-0155-0; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Wang Y, 2004, J BIOL CHEM, V279, P6976, DOI 10.1074/jbc.M311376200; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	30	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92581	10.1371/journal.pone.0092581	http://dx.doi.org/10.1371/journal.pone.0092581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664238	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900079
J	Li, JB; Jia, WS; Zhao, QS				Li, Junbo; Jia, Wenshuang; Zhao, Qingshun			Excessive Nitrite Affects Zebrafish Valvulogenesis through Yielding Too Much NO Signaling	PLOS ONE			English	Article							CARDIAC-VALVE FORMATION; OXIDE; HEART; EXPRESSION; PATHWAY; NITRATE	Sodium nitrite, a common food additive, exists widely not only in the environment but also in our body. Excessive nitrite causes toxicological effects on human health; however, whether it affects vertebrate heart valve development remains unknown. In vertebrates, developmental defects of cardiac valves usually lead to congenital heart disease. To understand the toxic effects of nitrite on valvulogenesis, we exposed zebrafish embryos with different concentrations of sodium nitrite. Our results showed that sodium nitrite caused developmental defects of zebrafish heart dose dependently. It affected zebrafish heart development starting from 36 hpf (hour post fertilization) when heart initiates looping process. Comprehensive analysis on the embryos at 24 hpf and 48 hpf showed that excessive nitrite did not affect blood circulation, vascular network, myocardium and endocardium development. But development of endocardial cells in atrioventricular canal (AVC) of the embryos at 48 hpf was disrupted by too much nitrite, leading to defective formation of primitive valve leaflets at 76 hpf. Consistently, excessive nitrite diminished expressions of valve progenitor markers including bmp4, has2, vcana and notch1b at 48 hpf. Furthermore, 39', 59'-cyclic guanosine monophosphate (cGMP), downstream of nitric oxide (NO) signaling, was increased its level significantly in the embryos exposed with excessive nitrite and microinjection of soluble guanylate cyclase inhibitor ODQ (1H-[1,2,4]Oxadiazolo[4,3-a] quinoxalin-1-one), an antagonist of NO signaling, into nitrite-exposed embryos could partly rescue the cardiac valve malformation. Taken together, our results show that excessive nitrite affects early valve leaflet formation by producing too much NO signaling.	[Li, Junbo; Jia, Wenshuang; Zhao, Qingshun] Nanjing Univ, Model Anim Res Ctr, Key Lab Model Anim Dis Study, Minist Educ, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Zhao, QS (corresponding author), Nanjing Univ, Model Anim Res Ctr, Key Lab Model Anim Dis Study, Minist Educ, Nanjing 210008, Jiangsu, Peoples R China.	qingshun@nju.edu.cn			Ministry of Science and Technology of China [2011CB943804]; National Natural Science Foundation of China [31271569]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China [2011CB943804] and the National Natural Science Foundation of China [31271569]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataya B, 2011, TRENDS CARDIOVAS MED, V21, P157, DOI 10.1016/j.tcm.2012.05.002; Auman HJ, 2007, PLOS BIOL, V5, P604, DOI 10.1371/journal.pbio.0050053; Balashova N, 2005, J BIOL CHEM, V280, P2186, DOI 10.1074/jbc.M411545200; Banjo T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2978; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Blue GM, 2012, MED J AUSTRALIA, V197, P155, DOI 10.5694/mja12.10811; BRUNNER F, 1995, FEBS LETT, V376, P262, DOI 10.1016/0014-5793(95)01297-X; Bryan NS, 2008, FREE RADICAL BIO MED, V45, P468, DOI 10.1016/j.freeradbiomed.2008.04.040; Bryan NS, 2005, NAT CHEM BIOL, V1, P290, DOI 10.1038/nchembio734; Bryan NS, 2011, NUTR HEALTH SER, P1, DOI 10.1007/978-1-60761-616-0; Chang ACY, 2011, DEV CELL, V21, P288, DOI 10.1016/j.devcel.2011.06.022; Combs MD, 2009, CIRC RES, V105, P408, DOI 10.1161/CIRCRESAHA.109.201566; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; EFSA, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.689; Fashena D, 1999, J COMP NEUROL, V406, P415, DOI 10.1002/(SICI)1096-9861(19990412)406:3<415::AID-CNE9>3.0.CO;2-2; Feng QP, 2002, CIRCULATION, V106, P873, DOI 10.1161/01.CIR.0000024114.82981.EA; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Gladwin MT, 2004, FREE RADICAL BIO MED, V36, P707, DOI 10.1016/j.freeradbiomed.2003.11.032; Gracia R, 2004, PHARMACOTHERAPY, V24, P1358, DOI 10.1592/phco.24.14.1358.43149; HADDAD EK, 1995, J EXP MED, V182, P1143, DOI 10.1084/jem.182.4.1143; Hunter L, 2011, BRIT J CLIN PHARMACO, V72, P18, DOI 10.1111/j.1365-2125.2011.03950.x; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC MONOGR EVAL CAR, V94, p[v, 1]; Jensen FB, 2003, COMP BIOCHEM PHYS A, V135, P9, DOI 10.1016/S1095-6433(02)00323-9; Jensen FB, 2007, J EXP BIOL, V210, P3387, DOI 10.1242/jeb.008748; Lagendijk AK, 2011, CIRC RES, V109, P649, DOI 10.1161/CIRCRESAHA.111.247635; Liang D, 2008, GENE EXPR PATTERNS, V8, P248, DOI 10.1016/j.gep.2007.12.007; Lundberg JO, 2009, NAT CHEM BIOL, V5, P865, DOI 10.1038/nchembio.260; Madigan M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00174; Marshall HE, 2000, FASEB J, V14, P1889, DOI 10.1096/fj.00.011rev; McKnight GM, 1999, BRIT J NUTR, V81, P349, DOI 10.1017/S000711459900063X; Miquerol L, 1999, DEV BIOL, V212, P307, DOI 10.1006/dbio.1999.9355; Rastaldo R, 2007, LIFE SCI, V81, P779, DOI 10.1016/j.lfs.2007.07.019; Rottbauer W, 2006, CIRC RES, V99, P323, DOI 10.1161/01.RES.0000234807.16034.fe; Scherz PJ, 2008, DEVELOPMENT, V135, P1179, DOI 10.1242/dev.010694; Simmons AE, 2012, ZEBRAFISH, V9, P200, DOI 10.1089/zeb.2012.0746; Staudt D, 2012, ANNU REV GENET, V46, P397, DOI 10.1146/annurev-genet-110711-155646; U.S. EPA, 1991, FED REGISTER, V56, P3526; Vermot J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000246; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; YUTZEY KE, 1994, DEVELOPMENT, V120, P871	42	14	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92728	10.1371/journal.pone.0092728	http://dx.doi.org/10.1371/journal.pone.0092728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658539	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300123
J	Wojciechowski, J; Stolarski, M; Matthews, G				Wojciechowski, Jerzy; Stolarski, Maciej; Matthews, Gerald			Emotional Intelligence and Mismatching Expressive and Verbal Messages: A Contribution to Detection of Deception	PLOS ONE			English	Article							GENDER-DIFFERENCES; FACIAL EXPRESSIONS; LIE DETECTION; SEX-DIFFERENCES; VISUAL-STIMULI; ABILITY; RECOGNITION; ACCURACY; PERSONALITY; PERCEPTION	Processing facial emotion, especially mismatches between facial and verbal messages, is believed to be important in the detection of deception. For example, emotional leakage may accompany lying. Individuals with superior emotion perception abilities may then be more adept in detecting deception by identifying mismatch between facial and verbal messages. Two personal factors that may predict such abilities are female gender and high emotional intelligence (EI). However, evidence on the role of gender and EI in detection of deception is mixed. A key issue is that the facial processing skills required to detect deception may not be the same as those required to identify facial emotion. To test this possibility, we developed a novel facial processing task, the FDT (Face Decoding Test) that requires detection of inconsistencies between facial and verbal cues to emotion. We hypothesized that gender and ability EI would be related to performance when cues were inconsistent. We also hypothesized that gender effects would be mediated by EI, because women tend to score as more emotionally intelligent on ability tests. Data were collected from 210 participants. Analyses of the FDT suggested that EI was correlated with superior face decoding in all conditions. We also confirmed the expected gender difference, the superiority of high EI individuals, and the mediation hypothesis. Also, EI was more strongly associated with facial decoding performance in women than in men, implying there may be gender differences in strategies for processing affective cues. It is concluded that integration of emotional and cognitive cues may be a core attribute of EI that contributes to the detection of deception.	[Wojciechowski, Jerzy; Stolarski, Maciej] Univ Warsaw, Fac Psychol, Warsaw, Poland; [Matthews, Gerald] Univ Cent Florida, Inst Simulat & Training, Orlando, FL 32816 USA	University of Warsaw; State University System of Florida; University of Central Florida	Wojciechowski, J (corresponding author), Univ Warsaw, Fac Psychol, Warsaw, Poland.	jerzy.wojciechowski@psych.uw.edu.pl	Matthews, G/AAM-2968-2020	Matthews, G/0000-0003-4869-338X; Wojciechowski, Jerzy/0000-0001-5188-2590	Polish Ministry of Science and Higher Educations [N N106 352540]	Polish Ministry of Science and Higher Educations(Ministry of Science and Higher Education, Poland)	Primary support for this work was provided by Polish Ministry of Science and Higher Educations N N106 352540 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akehurst L, 1996, APPL COGNITIVE PSYCH, V10, P461, DOI 10.1002/(SICI)1099-0720(199612)10:6<461::AID-ACP413>3.0.CO;2-2; [Anonymous], 2008, NEW HDB METHODS NONV; Baker A, 2013, LEGAL CRIMINOL PSYCH, V18, P300, DOI 10.1111/j.2044-8333.2012.02054.x; Bar-On R., 1997, BARON EMOTIONAL QUOT; Barrett LF, 2011, CURR DIR PSYCHOL SCI, V20, P286, DOI 10.1177/0963721411422522; Bernieri FJ, 2001, LEA SER PER CLIN PSY, P3; Bond CF, 2008, PSYCHOL BULL, V134, P477, DOI 10.1037/0033-2909.134.4.477; Brackett MA, 2006, J PERS SOC PSYCHOL, V91, P780, DOI 10.1037/0022-3514.91.4.780; BRODY LR, 1985, J PERS, V53, P102, DOI 10.1111/j.1467-6494.1985.tb00361.x; Brody LR, 2016, HDB EMOTIONS, P369; Campanella S, 2004, NEUROSCI LETT, V367, P14, DOI 10.1016/j.neulet.2004.05.097; Campbell MA, 2002, CAN J BEHAV SCI, V34, P217, DOI 10.1037/h0087174; Chaplin TM, 2005, EMOTION, V5, P80, DOI 10.1037/1528-3542.5.1.80; Collignon O, 2010, NEUROPSYCHOLOGIA, V48, P220, DOI 10.1016/j.neuropsychologia.2009.09.007; Conte JM, 2005, J ORGAN BEHAV, V26, P433, DOI 10.1002/job.319; COYNE JC, 1976, PSYCHIATRY, V39, P28, DOI 10.1080/00332747.1976.11023874; DePaulo BM, 1996, J PERS SOC PSYCHOL, V70, P979, DOI 10.1037/0022-3514.70.5.979; DePaulo BM, 2003, J SOC ISSUES, V59, P391, DOI 10.1111/1540-4560.00070; DEPAULO BM, 1994, J RES PERS, V28, P142, DOI 10.1006/jrpe.1994.1012; Donges US, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041745; Edelstein RS, 2006, LAW HUMAN BEHAV, V30, P1, DOI 10.1007/s10979-006-9031-2; EKMAN P, 1991, AM PSYCHOL, V46, P913, DOI 10.1037/0003-066X.46.9.913; Ekman P, 2003, ANN NY ACAD SCI, V1000, P205, DOI 10.1196/annals.1280.010; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Ekman P., 1975, UNMASKING FACE; Ekman P., 2003, EMOTIONS REVEALED RE, Vsecond; Elfenbein HA, 2002, EMO SOC BEH, P37; Elfenbein HA, 2010, J RES PERS, V44, P199, DOI 10.1016/j.jrp.2010.01.001; Fellner AN, 2012, J RES PERS, V46, P239, DOI 10.1016/j.jrp.2012.01.004; Hall J. A., 1984, NONVERBAL SEX DIFFER; Hall JA, 2004, EMOTION, V4, P201, DOI 10.1037/1528-3542.4.2.201; HALL JA, 1978, PSYCHOL BULL, V85, P845, DOI 10.1037/0033-2909.85.4.845; Hampson E, 2006, EVOL HUM BEHAV, V27, P401, DOI 10.1016/j.evolhumbehav.2006.05.002; Hoffmann H, 2010, ACTA PSYCHOL, V135, P278, DOI 10.1016/j.actpsy.2010.07.012; HURD K, 1988, J NONVERBAL BEHAV, V12, P217, DOI 10.1007/BF00987489; Jaworowska A., 2005, POPULARNY KWESTIONAR; Johnson AK, 2004, PERS INDIV DIFFER, V37, P1417, DOI 10.1016/j.paid.2004.01.011; Kassin SM, 2012, AM PSYCHOL, V67, P431, DOI 10.1037/a0028212; Kaufmann G, 2003, APPL COGNITIVE PSYCH, V17, P21, DOI 10.1002/acp.842; Klein KJK, 2001, PERS SOC PSYCHOL B, V27, P720, DOI 10.1177/0146167201276007; Lane JD, 1999, J RES PERS, V33, P311, DOI 10.1006/jrpe.1999.2253; Leach AM, 2009, LAW HUMAN BEHAV, V33, P96, DOI 10.1007/s10979-008-9137-9; Lewis M., 1993, LYING DECEPTION EVER, P90; MARGALIT M, 1990, J RES PERS, V24, P510, DOI 10.1016/0092-6566(90)90036-6; Matczak A., 2005, SKALA INTELIGENCJI E; Matsumoto D, 2000, J NONVERBAL BEHAV, V24, P179, DOI 10.1023/A:1006668120583; Matsumoto D, 2011, MOTIV EMOTION, V35, P181, DOI 10.1007/s11031-011-9212-2; Mayer J., 2002, MAYER SALOVEY CARUSO; Mayer J. D., 1997, EMOTIONAL DEV EMOTIO, P3, DOI DOI 10.1177/1066480710387486; Mayer JD, 1999, INTELLIGENCE, V27, P267, DOI 10.1016/S0160-2896(99)00016-1; MAYER JD, 1990, J PERS ASSESS, V54, P772, DOI 10.1207/s15327752jpa5403&4_29; Mayer JD, 2008, AM PSYCHOL, V63, P503, DOI 10.1037/0003-066X.63.6.503; MCCORNACK SA, 1990, J SOC PERS RELAT, V7, P107, DOI 10.1177/0265407590071006; Montagne Barbara, 2005, Cogn Process, V6, P136, DOI 10.1007/s10339-005-0050-6; O'Sullivan M., 2008, DETECTION DECEPTION, P269, DOI DOI 10.1017/CBO9780511490071.012; O'Sullivan M, 2008, PSYCHOL BULL, V134, P493, DOI 10.1037/0033-2909.134.4.493; Peace KA, 2012, LEGAL CRIMINOL PSYCH, V17, P322, DOI 10.1111/j.2044-8333.2011.02013.x; Porter S, 2008, PSYCHOL SCI, V19, P508, DOI 10.1111/j.1467-9280.2008.02116.x; Porter S, 2012, J NONVERBAL BEHAV, V36, P23, DOI 10.1007/s10919-011-0120-7; Porter S, 2011, PERS INDIV DIFFER, V51, P133, DOI 10.1016/j.paid.2011.03.031; Porter S, 2010, J FORENSIC PSYCHI PS, V21, P66, DOI 10.1080/14789940903174246; Rivers S. E., 2007, SCI EMOTIONAL INTELL, P230; Roberts RD, 2006, EMOTION, V6, P663, DOI 10.1037/1528-3542.6.4.663; Saarni C, 1993, LYING DECEPTION EVER, P1; Sacharin V, 2012, COGNITION EMOTION, V26, P1273, DOI 10.1080/02699931.2012.656583; Salguero JM, 2012, PERS INDIV DIFFER, V53, P29, DOI 10.1016/j.paid.2012.02.006; Salovey P., 1990, IMAG COGN PERS, P185, DOI [10.2190/dugg-p24--52wk-6cdg, DOI 10.2190/DUGG-P24E-52WK-6CDG, 10.2190/DUGG-P24E-52WK-6CDG]; Schutte NS, 1998, PERS INDIV DIFFER, V25, P167, DOI 10.1016/S0191-8869(98)00001-4; Smieja M, 2007, STUD PSYCHOL, V45, P80; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Soper D. S., 2013, INTERACTION VERSION; Stolarski M., 2011, STUD PSYCHOL, V49, P65, DOI [DOI 10.2478/V10167-010-0041-9, 10.2478/v10167-010-0041-9.]; Stolarski M, 2011, TIME SOC, V20, P346, DOI 10.1177/0961463X11414296; Terracciano A, 2003, ANN NY ACAD SCI, V1000, P309, DOI 10.1196/annals.1280.032; Thomas G, 2003, J PERS SOC PSYCHOL, V85, P1079, DOI 10.1037/0022-3514.85.6.1079; Trnka R, 2007, PERCEPT MOTOR SKILL, V104, P1217, DOI 10.2466/PMS.104.4.1217-1222; Van Rooy DL, 2005, PERS INDIV DIFFER, V38, P689, DOI 10.1016/j.paid.2004.05.023; Vanger P., 1998, METHODS PSYCHOL RES, V3, P25; Vrij A, 1996, J NONVERBAL BEHAV, V20, P65, DOI 10.1007/BF02248715; Vrij A, 2004, GROUP DECIS NEGOT, V13, P61, DOI 10.1023/B:GRUP.0000011946.74290.bc; Vrij A., 2008, DETECTING LIES DECEI; Vrij A, 2008, LAW HUMAN BEHAV, V32, P253, DOI 10.1007/s10979-007-9103-y; Vrij A, 2006, APPL COGNITIVE PSYCH, V20, P741, DOI 10.1002/acp.1200; Wrase J, 2003, NEUROSCI LETT, V348, P41, DOI 10.1016/S0304-3940(03)00565-2; Zeidner M, 2009, BRADFORD BOOKS, P1	85	26	27	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92570	10.1371/journal.pone.0092570	http://dx.doi.org/10.1371/journal.pone.0092570			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6GL	24658500	Green Published, gold			2022-12-27	WOS:000333355300100
J	Chon, YE; Kim, SU; Park, JY; Kim, DY; Ahn, SH; Han, KH; Chon, CY; Lee, S				Chon, Young Eun; Kim, Seung Up; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub; Chon, Chae Yoon; Lee, Sak			Dynamics of the Liver Stiffness Value Using Transient Elastography during the Perioperative Period in Patients with Valvular Heart Disease	PLOS ONE			English	Article							NATRIURETIC PEPTIDE LEVELS; FAILURE; DIAGNOSIS; CIRRHOSIS; FIBROSIS; ULTRASOUND; SEVERITY; SYMPTOMS; MARKER; IMPACT	Background/Aims: Liver congestion due to heart failure in patients with valvular heart disease (VHD) can result in an overestimate of the liver stiffness (LS) as assessed by transient elastography (TE). This prospective pilot study investigated the dynamics of LS during the perioperative valve operation period. Methods: Thirty-two patients who underwent a valve operation (case) and 12 who underwent a varicose vein operation (control) were prospectively enrolled. LS and cardiologic parameters at three time points [baseline, post-operative day (POD) 7, and POD90] were collected. Results: LS at three time points were consistently higher in the case group than those in the control group, although all participants did not show evidence of underlying chronic liver disease (all P<0.05). In the case group, LS at POD7 increased slightly from the LS at baseline (median 7.9 -> 8.4 kPa, P = 0.816), whereas LS at POD90 decreased significantly from the LS at POD7 (median 8.4 -> 6.0 kPa; P = 0.026). LS was significantly correlated with N-terminal-pro brain natriuretic peptide (NT-proBNP) (rho = 0.412), left ventricular ejection fraction (rho = -0.494), and central venous pressure during the operation (rho = 0.555) at baseline (all P<0.05). LS was significantly correlated with NT-proBNP (rho = 0.526) and right ventricular pressure (rho = 0.572) at POD7, whereas LS was significantly correlated with NT-proBNP (rho = 0.590) at POD90 (all P<0.05). Conclusions: LS can be overestimated in patients with VHD due to hepatic congestion. However, LS can be dynamically reversed during the perioperative period reflecting the restoration of cardiac function after a successful operation.	[Chon, Young Eun; Kim, Seung Up; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub; Chon, Chae Yoon] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Seung Up; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub; Chon, Chae Yoon] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea; [Lee, Sak] Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea; [Chon, Young Eun; Kim, Seung Up; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub; Chon, Chae Yoon] Liver Cirrhosis Clin Res Ctr, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, S (corresponding author), Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea.	SAK911@yuhs.ac	Park, Jun Yong/H-7127-2019	Lee, Sak/0000-0001-6130-2342; Kim, Seung Up/0000-0002-9658-8050; Han, Kwang-Hyub/0000-0003-3960-6539; Ahn, Sang Hoon/0000-0002-3629-4624; Park, Jun Yong/0000-0001-6324-2224				Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007; Bettencourt P, 2004, CIRCULATION, V110, P2168, DOI 10.1161/01.CIR.0000144310.04433.BE; Bioulac-Sage P, 2009, J HEPATOL, V50, P423, DOI 10.1016/j.jhep.2008.11.003; Brookes CIO, 1997, J HEART VALVE DIS, V6, P608; Chon YE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044930; Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x; Colli A, 2010, RADIOLOGY, V257, P872, DOI 10.1148/radiol.10100013; Feringa HHH, 2007, INT J CARDIOVAS IMAG, V23, P159, DOI 10.1007/s10554-006-9138-z; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Ganne-Carrie N, 2006, HEPATOLOGY, V44, P1511, DOI 10.1002/hep.21420; Gardner RS, 2003, EUR HEART J, V24, P1735, DOI 10.1016/j.ehj.2003.07.005; Gottdiener JS, 2004, J AM SOC ECHOCARDIOG, V17, P1086, DOI 10.1016/j.echo.2004.07.013; Hall C, 2004, EUR J HEART FAIL, V6, P257, DOI 10.1016/j.ejheart.2003.12.015; Hopper I, 2012, EUR J HEART FAIL, V14, P621, DOI 10.1093/eurjhf/hfs044; Januzzi JL, 2006, EUR HEART J, V27, P330, DOI 10.1093/eurheartj/ehi631; Kiesewetter CH, 2007, HEART, V93, P579, DOI 10.1136/hrt.2006.094516; Kim SU, 2010, LIVER INT, V30, P268, DOI 10.1111/j.1478-3231.2009.02172.x; Kim SU, 2009, LIVER INT, V29, P810, DOI 10.1111/j.1478-3231.2008.01894.x; Kim SU, 2009, LIVER INT, V29, P760, DOI 10.1111/j.1478-3231.2009.02035.x; Lebray P, 2008, HEPATOLOGY, V48, P2089, DOI 10.1002/hep.22594; Levin ER, 1998, NEW ENGL J MED, V339, P321; Mair J, 2001, CLIN CHEM LAB MED, V39, P571, DOI 10.1515/CCLM.2001.093; Mayer SA, 2004, AM J CARDIOL, V93, P1002, DOI 10.1016/j.amjcard.2004.01.008; Millonig G, 2008, HEPATOLOGY, V48, P1718, DOI 10.1002/hep.22577; Millonig G, 2010, J HEPATOL, V52, P206, DOI 10.1016/j.jhep.2009.11.018; Roulot D, 2008, J HEPATOL, V48, P606, DOI 10.1016/j.jhep.2007.11.020; Sagir A, 2008, HEPATOLOGY, V47, P592, DOI 10.1002/hep.22056; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; SAVERYMUTTU SH, 1986, BRIT MED J, V292, P13, DOI 10.1136/bmj.292.6512.13; Sharma P, 2012, RADIOLOGY, V263, P893, DOI 10.1148/radiol.12111046; Simonovsky V, 1999, BRIT J RADIOL, V72, P29, DOI 10.1259/bjr.72.853.10341686; Sutton TM, 2003, J AM COLL CARDIOL, V41, P2280, DOI 10.1016/S0735-1097(03)00486-8; Woo JJ, 2008, YONSEI MED J, V49, P625, DOI 10.3349/ymj.2008.49.4.625	34	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92795	10.1371/journal.pone.0092795	http://dx.doi.org/10.1371/journal.pone.0092795			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670988	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000076
J	Imahashi, M; Izumi, T; Watanabe, D; Imamura, J; Matsuoka, K; Ode, H; Masaoka, T; Sato, K; Kaneko, N; Ichikawa, S; Koyanagi, Y; Takaori-Kondo, A; Utsumi, M; Yokomaku, Y; Shirasaka, T; Sugiura, W; Iwatani, Y; Naoe, T				Imahashi, Mayumi; Izumi, Taisuke; Watanabe, Dai; Imamura, Junji; Matsuoka, Kazuhiro; Ode, Hirotaka; Masaoka, Takashi; Sato, Kei; Kaneko, Noriyo; Ichikawa, Seiichi; Koyanagi, Yoshio; Takaori-Kondo, Akifumi; Utsumi, Makoto; Yokomaku, Yoshiyuki; Shirasaka, Takuma; Sugiura, Wataru; Iwatani, Yasumasa; Naoe, Tomoki			Lack of Association between Intact/Deletion Polymorphisms of the APOBEC3B Gene and HIV-1 Risk	PLOS ONE			English	Article							POLYPEPTIDE-LIKE 3G; RNA-EDITING ENZYME; VIF; DELETION; EXPRESSION; INFECTION; DNA; SUSCEPTIBILITY; HYPERMUTATION; REPLICATION	Objective: The human APOBEC3 family of proteins potently restricts HIV-1 replication APOBEC3B, one of the family genes, is frequently deleted in human populations. Two previous studies reached inconsistent conclusions regarding the effects of APOBEC3B loss on HIV-1 acquisition and pathogenesis. Therefore, it was necessary to verify the effects of APOBEC3B on HIV-1 infection in vivo. Methods: Intact (I) and deletion (D) polymorphisms of APOBEC3B were analyzed using PCR. The syphilis, HBV and HCV infection rates, as well as CD4(+) T cell counts and viral loads were compared among three APOBEC3B genotype groups (I/I, D/I, and D/D). HIV-1 replication kinetics was assayed in vitro using primary cells derived from PBMCs. Results: A total of 248 HIV-1-infected Japanese men who have sex with men (MSM) patients and 207 uninfected Japanese MSM were enrolled in this study. The genotype analysis revealed no significant differences between the APOBEC3B genotype ratios of the infected and the uninfected cohorts (p = 0.66). In addition, HIV-1 disease progression parameters were not associated with the APOBEC3B genotype. Furthermore, the PBMCs from D/D and I/I subjects exhibited comparable HIV-1 susceptibility. Conclusion: Our analysis of a population-based matched cohort suggests that the antiviral mechanism of APOBEC3B plays only a negligible role in eliminating HIV-1 in vivo.	[Imahashi, Mayumi; Imamura, Junji; Matsuoka, Kazuhiro; Ode, Hirotaka; Masaoka, Takashi; Utsumi, Makoto; Yokomaku, Yoshiyuki; Sugiura, Wataru; Iwatani, Yasumasa; Naoe, Tomoki] Natl Hosp Org Nagoya Med Ctr, Dept Infect Dis & Immunol, Clin Res Ctr, Nagoya, Aichi, Japan; [Imahashi, Mayumi; Naoe, Tomoki] Nagoya Univ, Dept Hematol & Oncol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Izumi, Taisuke; Takaori-Kondo, Akifumi] Kyoto Univ, Dept Hematol & Oncol, Grad Sch Med, Kyoto, Japan; [Izumi, Taisuke] Japanese Fdn AIDS Prevent, Chiyoda Ku, Tokyo, Japan; [Watanabe, Dai; Shirasaka, Takuma] Natl Hosp Org Osaka Med Ctr, Clin Res Ctr, Osaka, Japan; [Sato, Kei; Koyanagi, Yoshio] Kyoto Univ, Inst Virus Res, Ctr Human Retrovirus Res, Kyoto 606, Japan; [Kaneko, Noriyo; Ichikawa, Seiichi] Nagoya City Univ, Grad Sch Nursing, Dept Int Hlth Nursing, Nagoya, Aichi, Japan; [Sugiura, Wataru; Iwatani, Yasumasa] Nagoya Univ, Grad Sch Med, Dept AIDS Res, Nagoya, Aichi 4648601, Japan	Nagoya Medical Center; Nagoya University; Kyoto University; Kyoto University; Nagoya City University; Nagoya University	Iwatani, Y (corresponding author), Natl Hosp Org Nagoya Med Ctr, Dept Infect Dis & Immunol, Clin Res Ctr, Nagoya, Aichi, Japan.	iwataniy@nnh.hosp.go.jp	Naoe, Tomoki/I-1888-2012; Matsuoka, Kazuhiro/N-8419-2015; Izumi, Taisuke/J-5607-2014; Iwatani, Yasumasa/A-8675-2016	Izumi, Taisuke/0000-0002-9694-1459; Iwatani, Yasumasa/0000-0001-9269-4828; Ode, Hirotaka/0000-0001-8624-2382; Izumi, Taisuke/0000-0001-8193-0813	National Hospital Organization Network [NHO H23-AIDS]; Ministry of Health, Labor, and Welfare of Japan [H22-AIDS-004, H24-AIDS-005]	National Hospital Organization Network; Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was partly supported by a grant from the National Hospital Organization Network (grant NHO H23-AIDS) and by grants for HIV/AIDS research from the Ministry of Health, Labor, and Welfare of Japan (grants H22-AIDS-004 and H24-AIDS-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscripts.	Abe H, 2009, HEPATOL RES, V39, P1159, DOI 10.1111/j.1872-034X.2009.00566.x; Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; An P, 2009, J INFECT DIS, V200, P1054, DOI 10.1086/605644; Biasin M, 2007, J INFECT DIS, V195, P960, DOI 10.1086/511988; Bishop KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000231; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2008, RNA, V14, P1228, DOI 10.1261/rna.964708; Bonvin M, 2007, J GEN VIROL, V88, P3270, DOI 10.1099/vir.0.83149-0; Burnett A, 2007, J VIROL, V81, P5000, DOI 10.1128/JVI.02237-06; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Chaipan C, 2013, J VIROL, V87, P444, DOI 10.1128/JVI.00676-12; Do H, 2005, J INFECT DIS, V191, P159, DOI 10.1086/426826; Doehle BP, 2005, VIROLOGY, V339, P281, DOI 10.1016/j.virol.2005.06.005; Goila-Gaur R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-51; Hattori J, 2010, ANTIVIR RES, V88, P72, DOI 10.1016/j.antiviral.2010.07.008; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Itaya S, 2010, J INFECT DIS, V202, P815, DOI 10.1086/655227; Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750; Iwatani Y, 2006, J VIROL, V80, P5992, DOI 10.1128/JVI.02680-05; Jha P, 2012, INFECT GENET EVOL, V12, P142, DOI 10.1016/j.meegid.2011.11.001; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Kitamura S, 2012, NAT STRUCT MOL BIOL, V19, P1005, DOI 10.1038/nsmb.2378; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Kourteva Y, 2012, VIROLOGY, V430, P1, DOI 10.1016/j.virol.2012.03.018; Larue RS, 2009, J VIROL, V83, P494, DOI 10.1128/JVI.01976-08; Li MMH, 2010, J VIROL, V84, P88, DOI 10.1128/JVI.01344-09; Mahieux R, 2005, J GEN VIROL, V86, P2489, DOI 10.1099/vir.0.80973-0; Mulder LCF, 2010, J VIROL, V84, P9613, DOI 10.1128/JVI.02630-09; Ooms M, 2012, J VIROL, V86, P6097, DOI 10.1128/JVI.06570-11; Pak V, 2011, J VIROL, V85, P8538, DOI 10.1128/JVI.02645-10; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Russell RA, 2009, J VIROL, V83, P1992, DOI 10.1128/JVI.01621-08; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shinohara M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00806; Smith JL, 2010, J VIROL, V84, P12599, DOI 10.1128/JVI.01437-10; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Ulenga NK, 2008, J INFECT DIS, V198, P486, DOI 10.1086/590212; Vetter ML, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000292; Wichroski MJ, 2006, PLOS PATHOG, V2, pe41, DOI DOI 10.1371/journal.ppat.0020041; Xuan D, 2013, CARCINOGENESIS; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhen AJ, 2010, J VIROL, V84, P1902, DOI 10.1128/JVI.01509-09	45	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92861	10.1371/journal.pone.0092861	http://dx.doi.org/10.1371/journal.pone.0092861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667791	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600093
J	Peeling, P; Sim, M; Badenhorst, CE; Dawson, B; Govus, AD; Abbiss, CR; Swinkels, DW; Trinder, D				Peeling, Peter; Sim, Marc; Badenhorst, Claire E.; Dawson, Brian; Govus, Andrew D.; Abbiss, Chris R.; Swinkels, Dorine W.; Trinder, Debbie			Iron Status and the Acute Post-Exercise Hepcidin Response in Athletes	PLOS ONE			English	Article							SERUM HEPCIDIN; INFLAMMATION; DEFICIENCY; EXERCISE; PARAMETERS; INTENSITY; CYTOKINES; HEMOLYSIS; MEDIATOR	This study explored the relationship between serum ferritin and hepcidin in athletes. Baseline serum ferritin levels of 54 athletes from the control trial of five investigations conducted in our laboratory were considered; athletes were grouped according to values <30 mu g/L (SF<30), 30-50 mu g/L (SF30-50), 50-100 mu g/L (SF50-100), or >100 mu g/L (SF>100). Data pooling resulted in each athlete completing one of five running sessions: (1) 8x3 min at 85% vVO(2peak); (2) 5x4 min at 90% vVO(2peak); (3) 90 min continuous at 75% vVO(2peak); (4) 40 min continuous at 75% vVO(2peak); (5) 40 min continuous at 65% vVO(2peak). Athletes from each running session were represented amongst all four groups; hence, the mean exercise duration and intensity were not different (p>0.05). Venous blood samples were collected pre-, post-and 3 h post-exercise, and were analysed for serum ferritin, iron, interleukin-6 (IL-6) and hepcidin-25. Baseline and post-exercise serum ferritin levels were different between groups (p<0.05). There were no group differences for pre- or post-exercise serum iron or IL-6 (p>0.05). Post-exercise IL-6 was significantly elevated compared to baseline within each group (p<0.05). Pre- and 3 h post-exercise hepcidin-25 was sequentially greater as the groups baseline serum ferritin levels increased (p<0.05). However, post-exercise hepcidin levels were only significantly elevated in three groups (SF30-50, SF50-100, and SF>100; p<0.05). An athlete's iron stores may dictate the baseline hepcidin levels and the magnitude of post-exercise hepcidin response. Low iron stores suppressed post-exercise hepcidin, seemingly overriding any inflammatory-driven increases.	[Peeling, Peter; Sim, Marc; Badenhorst, Claire E.; Dawson, Brian] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Crawley, WA, Australia; [Govus, Andrew D.; Abbiss, Chris R.] Edith Cowan Univ, Sch Exercise & Hlth Sci, Ctr Exercise & Sports Sci Res, Churchlands, WA 6018, Australia; [Swinkels, Dorine W.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Lab Genet Endocrine & Metab Dis, Nijmegen, Netherlands; [Swinkels, Dorine W.] Hepcidinanal Com, Nijmegen, Netherlands; [Trinder, Debbie] Univ Western Australia, Sch Med & Pharmacol, Fremantle, WA, Australia	University of Western Australia; Edith Cowan University; Radboud University Nijmegen; University of Western Australia	Peeling, P (corresponding author), Univ Western Australia, Sch Sport Sci Exercise & Hlth, Crawley, WA, Australia.	peter.peeling@uwa.edu.au	Swinkels, Dorine W./H-8098-2014; Peeling, Peter/H-5615-2014; Badenhorst, Claire/AAS-7194-2021	Swinkels, Dorine W./0000-0002-1040-9446; Badenhorst, Claire/0000-0002-8434-9730; Govus, Andrew/0000-0001-6224-0454; Abbiss, Chris/0000-0003-3940-5542; Peeling, Peter/0000-0002-3895-0015; Sim, Marc/0000-0001-5166-0605				Auersperger I, 2012, INT J SPORT NUTR EXE, V22, P55, DOI 10.1123/ijsnem.22.1.55; Australasia RCoPo, 2013, IR STUD STAND REP PR; Darshan D, 2010, HAEMATOL-HEMATOL J, V95, P1660, DOI 10.3324/haematol.2010.022426; Galesloot TE, 2011, BLOOD, V117, pE218, DOI 10.1182/blood-2011-02-337907; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Garvican LA, 2014, MED SCI SPORT EXER, V46, P376, DOI 10.1249/MSS.0b013e3182a53594; Jaeggi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057513; Karl JP, 2010, AM J CLIN NUTR, V92, P93, DOI 10.3945/ajcn.2010.29185; Kroot JJC, 2011, CLIN CHEM, V57, P1650, DOI 10.1373/clinchem.2009.140053; Liu QD, 2012, J CLIN INVEST, V122, P4635, DOI 10.1172/JCI63924; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Peeling P, 2008, EUR J APPL PHYSIOL, V103, P381, DOI 10.1007/s00421-008-0726-6; Peeling P, 2010, EUR J APPL PHYSIOL, V110, P877, DOI 10.1007/s00421-010-1594-4; Peeling P, 2009, INT J SPORT NUTR EXE, V19, P583, DOI 10.1123/ijsnem.19.6.583; Peeling P, 2009, MED SCI SPORT EXER, V41, P1138, DOI 10.1249/MSS.0b013e318192ce58; Peeling P, 2009, EUR J APPL PHYSIOL, V106, P51, DOI 10.1007/s00421-009-0988-7; Piperno A, 2011, BLOOD, V117, P2953, DOI 10.1182/blood-2010-08-299859; Robson-Ansley P, 2011, CYTOKINE, V53, P196, DOI 10.1016/j.cyto.2010.10.001; Roecker L, 2005, EUR J APPL PHYSIOL, V95, P569, DOI 10.1007/s00421-005-0055-y; Schaap CCM, 2013, CLIN CHEM, V59, P527, DOI 10.1373/clinchem.2012.194977; Sim M, 2013, INT J SPORT NUTR EXE, V23, P178, DOI 10.1123/ijsnem.23.2.178; Sim M, 2012, EUR J APPL PHYSIOL, V112, P1889, DOI 10.1007/s00421-011-2156-0; Talbot NP, 2012, BLOOD, V119, P857, DOI 10.1182/blood-2011-03-341776; Telford RD, 2003, J APPL PHYSIOL, V94, P38, DOI 10.1152/japplphysiol.00631.2001; van Santen S, 2011, ARTHRITIS RHEUM-US, V63, P3672, DOI 10.1002/art.30623	27	104	107	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93002	10.1371/journal.pone.0093002	http://dx.doi.org/10.1371/journal.pone.0093002			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667393	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600123
J	Prinz, RD; Willis, CM; van Kuppevelt, TH; Kluppel, M				Prinz, Robert D.; Willis, Catherine M.; van Kuppevelt, Toin H.; Klueppel, Michael			Biphasic Role of Chondroitin Sulfate in Cardiac Differentiation of Embryonic Stem Cells through Inhibition of Wnt/beta-Catenin Signaling	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-1; CARDIOMYOCYTE DIFFERENTIATION; BRAIN-DEVELOPMENT; SPINAL-CORD; IN-VITRO; WNT; CANCER; PROTEOGLYCANS; MAINTENANCE; BIGLYCAN	The glycosaminoglycan chondroitin sulfate is a critical component of proteoglycans on the cell surface and in the extracellular matrix. As such, chondroitin sulfate side chains and the sulfation balance of chondroitin play important roles in the control of signaling pathways, and have a functional importance in human disease. In contrast, very little is known about the roles of chondroitin sulfate molecules and sulfation patterns during mammalian development and cell lineage specification. Here, we report a novel biphasic role of chondroitin sulfate in the specification of the cardiac cell lineage during embryonic stem cell differentiation through modulation of Wnt/beta-catenin signaling. Lineage marker analysis demonstrates that enzymatic elimination of endogenous chondroitin sulfates leads to defects specifically in cardiac differentiation. This is accompanied by a reduction in the number of beating cardiac foci. Mechanistically, we show that endogenous chondroitin sulfate controls cardiac differentiation in a temporal biphasic manner through inhibition of the Wnt/beta-catenin pathway, a known regulatory pathway for the cardiac lineage. Treatment with a specific exogenous chondroitin sulfate, CS-E, could mimic these biphasic effects on cardiac differentiation and Wnt/beta-catenin signaling. These results establish chondroitin sulfate and its sulfation balance as important regulators of cardiac cell lineage decisions through control of the Wnt/beta-catenin pathway. Our work suggests that targeting the chondroitin biosynthesis and sulfation machinery is a novel promising avenue in regenerative strategies after heart injury.	[Prinz, Robert D.; Willis, Catherine M.; Klueppel, Michael] Ann & Robert H Lurie Childrens Hosp Chicago Res C, Chicago, IL 60611 USA; [Willis, Catherine M.; Klueppel, Michael] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Klueppel, Michael] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [van Kuppevelt, Toin H.] Radboud Inst Mol Life Sci, Dept Biochem, Nijmegen, Netherlands	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Kluppel, M (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago Res C, Chicago, IL 60611 USA.	m-kluppel@northwestern.edu	van Kuppevelt, A.H.M.S.M./L-4463-2015		Ann and Robert H. Lurie Children's Hospital of Chicago Research Center	Ann and Robert H. Lurie Children's Hospital of Chicago Research Center	The authors wish to acknowledge financial support from the Ann and Robert H. Lurie Children's Hospital of Chicago Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asimakopoulou AP, 2008, IN VIVO, V22, P385; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bartus K, 2012, EXP NEUROL, V235, P5, DOI 10.1016/j.expneurol.2011.08.008; BASHEY RI, 1993, MATRIX, V13, P363, DOI 10.1016/S0934-8832(11)80041-7; Behrens J, 2005, BIOCHEM SOC T, V33, P672, DOI 10.1042/BST0330672; Bradbury EJ, 2011, BRAIN RES BULL, V84, P306, DOI 10.1016/j.brainresbull.2010.06.015; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Chen K, 2008, J CELL BIOCHEM, V104, P119, DOI 10.1002/jcb.21604; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dell'Era P, 2003, CIRC RES, V93, P414, DOI 10.1161/01.RES.0000089460.12061.E1; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Gardner RT, 2013, J NEUROSCI, V33, P7175, DOI 10.1523/JNEUROSCI.5866-12.2013; Gaspar C, 2004, INT J DEV BIOL, V48, P377, DOI 10.1387/ijdb.041807cg; Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531; Habuchi O, 2000, BBA-GEN SUBJECTS, V1474, P115, DOI 10.1016/S0304-4165(00)00016-7; Heegaard AM, 2007, CIRCULATION, V115, P2731, DOI 10.1161/CIRCULATIONAHA.106.653980; Hermanns P, 2008, AM J HUM GENET, V82, P1368, DOI 10.1016/j.ajhg.2008.05.006; Hinek A, 2005, AM J MED GENET A, V133A, P1, DOI 10.1002/ajmg.a.30495; Hirata A, 2013, DEVELOPMENT, V140, P66, DOI 10.1242/dev.084103; Huelsken J, 2009, EUR J IMMUNOL, V39, P3582, DOI 10.1002/eji.200838982; Hwang JY, 2008, AM J PATHOL, V173, P1919, DOI 10.2353/ajpath.2008.070875; Kluppel M, 2012, EUR J HUM GENET, V20, P870, DOI 10.1038/ejhg.2012.12; Kluppel M, 2011, MOL CELL BIOCHEM, V351, P1, DOI 10.1007/s11010-010-0705-1; Kluppel M, 2010, PROG MOL BIOL TRANSL, V93, P113, DOI 10.1016/S1877-1173(10)93006-8; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kluppel M, 2002, MECH DEVELOP, V118, P77, DOI 10.1016/S0925-4773(02)00198-3; Kuhl SJ, 2013, BBA-GEN SUBJECTS, V1830, P2297, DOI 10.1016/j.bbagen.2012.08.010; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Kwon C, 2008, CELL CYCLE, V7, P3815, DOI 10.4161/cc.7.24.7189; Laabs T, 2005, CURR OPIN NEUROBIOL, V15, P116, DOI 10.1016/j.conb.2005.01.014; Lam AP, 2011, CURR OPIN RHEUMATOL, V23, P562, DOI 10.1097/BOR.0b013e32834b3309; Mizumoto S, 2013, GLYCOCONJUGATE J, V30, P619, DOI 10.1007/s10719-012-9463-5; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 2005, SCI STKE; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; Nagy A, 2006, CSH PROTOCOLS, V2006; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Oerlemans MIFJ, 2010, BASIC RES CARDIOL, V105, P631, DOI 10.1007/s00395-010-0100-9; Peal DS, 2009, DEV DYNAM, V238, P3103, DOI 10.1002/dvdy.22154; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Prinz RD, 2011, GENET MOL RES, V10, P3901, DOI 10.4238/2011.December.8.9; Prosperi JR, 2010, CURR DRUG TARGETS, V11, P1074; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; Purushothaman A, 2012, J BIOL CHEM, V287, P2935, DOI 10.1074/jbc.R111.298430; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ronca R, 2009, J CELL MOL MED, V13, P1489, DOI 10.1111/j.1582-4934.2009.00805.x; Sato T, 2011, J BIOL CHEM, V286, P5803, DOI 10.1074/jbc.M110.159244; Smetsers TFCM, 2004, J INVEST DERMATOL, V122, P707, DOI 10.1111/j.0022-202X.2004.22316.x; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; ten Dam GB, 2007, AM J PATHOL, V171, P1324, DOI 10.2353/ajpath.2007.070111; Theocharis AD, 2006, ADV PHARMACOL, V53, P281, DOI 10.1016/S1054-3589(05)53013-8; Theocharis AD, 2000, BBA-MOL BASIS DIS, V1502, P201, DOI 10.1016/S0925-4439(00)00051-X; Theocharis AD, 2002, BIOCHIMIE, V84, P667, DOI 10.1016/S0300-9084(02)01428-1; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; Tuysuz B, 2009, CLIN GENET, V75, P375, DOI 10.1111/j.1399-0004.2009.01167.x; Uchimura K, 2002, J BIOL CHEM, V277, P1443, DOI 10.1074/jbc.M104719200; Uebelhart D, 2008, OSTEOARTHR CARTILAGE, V16, pS19, DOI 10.1016/j.joca.2008.06.006; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; van Es JH, 2005, TRENDS MOL MED, V11, P496, DOI 10.1016/j.molmed.2005.09.008; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649; Westermann D, 2008, CIRCULATION, V117, P1269, DOI 10.1161/CIRCULATIONAHA.107.714147; Willis CM, 2009, GENET MOL RES, V8, P1331, DOI 10.4238/vol8-4gmr673; Willis CM, 2012, J BIOL CHEM, V287, P37042, DOI 10.1074/jbc.M112.391490; Wilson DG, 2012, DEV BIOL, V363, P413, DOI 10.1016/j.ydbio.2012.01.005; Yu PP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059285	67	24	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92381	10.1371/journal.pone.0092381	http://dx.doi.org/10.1371/journal.pone.0092381			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667694	gold, Green Published, Green Submitted			2022-12-27	WOS:000333675600034
J	Steiner, T; Francescut, L; Byrne, S; Hughes, T; Jayanthi, A; Guschina, I; Harwood, J; Cianflone, K; Stover, C; Francis, S				Steiner, Tanja; Francescut, Lorenza; Byrne, Simon; Hughes, Timothy; Jayanthi, Archana; Guschina, Irina; Harwood, John; Cianflone, Katherine; Stover, Cordula; Francis, Sheila			Protective Role for Properdin in Progression of Experimental Murine Atherosclerosis	PLOS ONE			English	Article							ACYLATION-STIMULATING PROTEIN; RECEPTOR-DEFICIENT MICE; MACROPHAGE PLASTICITY; ALTERNATIVE PATHWAY; COMPLEMENT; C3; ACTIVATION; DIET; SUSCEPTIBILITY; POLARIZATION	Genetic, dietary and immune factors contribute to the pathogenesis of atherosclerosis in humans and mice. Complement activation is an integral part of the innate immune defence but also shapes cellular responses and influences directly triglyceride synthesis. Deficiency of Factor B of the alternative pathway (AP) of complement is beneficial in LDLR-/- mice fed a high fat diet. The serum glycoprotein properdin is a key positive regulator of the AP but has not been studied in experimental atherosclerosis. Atherosclerosis was assessed after feeding low fat (LFD) or high fat (HFD) Western type diets to newly generated LDLR-/- Properdin(KO) ((LDLR-/-PKO)) and (LDLR-/-PWT) mice. Lipids, lymphocytes and monocytes were similar among genotypes, genders and diets. Complement C3, but not C3a(desarg), levels were enhanced in LDLR-/- P-KO mice regardless of diet type or gender. Non-esterified fatty acids (NEFA) were decreased in male (LDLR-/-PKO) fed a HFD compared with controls. All mice showed significant atherosclerotic burden in aortae and at aortic roots but male LDLR-/- mice fed a LFD were affected to the greatest extent by the absence of properdin. The protective effect of properdin expression was overwhelmed in both genders of LDLR-/- mice when fed a HFD. We conclude that properdin plays an unexpectedly beneficial role in the development and progression of early atherosclerotic lesions.	[Steiner, Tanja; Francis, Sheila] Univ Sheffield, Sch Med, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Francescut, Lorenza; Byrne, Simon; Stover, Cordula] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Hughes, Timothy; Jayanthi, Archana] Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff CF10 3AX, S Glam, Wales; [Guschina, Irina; Harwood, John] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Cianflone, Katherine] Univ Laval, CRIUCPQ, Quebec City, PQ, Canada	University of Sheffield; University of Leicester; Cardiff University; Cardiff University; Laval University	Francis, S (corresponding author), Univ Sheffield, Sch Med, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England.	s.francis@sheffield.ac.uk	Harwood, John L/A-4308-2010	Harwood, John/0000-0003-2377-2612; Stover, Cordula/0000-0002-0125-4868; Francis, Sheila/0000-0001-6552-0339	British Heart Foundation [PG/09/053/27836]; British Heart Foundation [PG/13/28/29833] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	British Heart Foundation grant PG/09/053/27836 funded this research. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bacci M, 2009, AM J PATHOL, V175, P547, DOI 10.2353/ajpath.2009.081011; Bolego C, 2013, ARTERIOSCL THROM VAS, V33, P1127, DOI 10.1161/ATVBAHA.113.301328; Buono C, 2002, CIRCULATION, V105, P3025, DOI 10.1161/01.CIR.0000019584.04929.83; Camous L, 2011, BLOOD, V117, P1340, DOI 10.1182/blood-2010-05-283564; Cianflone K, 2004, J LIPID RES, V45, P124, DOI 10.1194/jlr.M300214-JLR200; DAVIS AE, 1979, J CLIN INVEST, V64, P721, DOI 10.1172/JCI109515; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; FEARON DT, 1975, J EXP MED, V142, P856, DOI 10.1084/jem.142.4.856; Fisette A, 2013, IMMUNOBIOLOGY, V218, P127, DOI 10.1016/j.imbio.2012.04.001; Francescut L, 2012, J INNATE IMMUN, V4, P260, DOI 10.1159/000332435; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Glenn S, 2014, MED MICROBI IN PRESS; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Joven J, 2007, ATHEROSCLEROSIS, V195, pE85, DOI 10.1016/j.atherosclerosis.2007.06.012; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Lewis RD, 2011, AM J PATHOL, V179, P1601, DOI 10.1016/j.ajpath.2011.06.015; Lutz HU, 2007, MOL IMMUNOL, V44, P3862, DOI 10.1016/j.molimm.2007.06.146; LYNCH DM, 1993, EUR J IMMUNOGENET, V20, P1, DOI 10.1111/j.1744-313X.1993.tb00090.x; Malik TH, 2010, CIRCULATION, V122, P1948, DOI 10.1161/CIRCULATIONAHA.110.981365; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Mogilenko DA, 2012, J BIOL CHEM, V287, P5954, DOI 10.1074/jbc.M111.289322; Paglialunga S, 2008, AM J PHYSIOL-ENDOC M, V294, pE521, DOI 10.1152/ajpendo.00590.2007; Paglialunga Sabina, 2010, BMC Physiology, V10, P4, DOI 10.1186/1472-6793-10-4; Persson L, 2004, ARTERIOSCL THROM VAS, V24, P1062, DOI 10.1161/01.ATV.0000127302.24266.40; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Singh U, 2004, CLIN SCI, V106, P421, DOI 10.1042/CS20030375; Stover CM, 2008, J IMMUNOL, V180, P3313, DOI 10.4049/jimmunol.180.5.3313; Teupser D, 2003, ARTERIOSCL THROM VAS, V23, P1907, DOI 10.1161/01.ATV.0000090126.34881.B1; van Tits LJH, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Yasojima K, 2001, ARTERIOSCL THROM VAS, V21, P1214, DOI 10.1161/hq0701.092160; Yun S, 2008, ARTERIOSCL THROM VAS, V28, P1714, DOI 10.1161/ATVBAHA.108.169912	33	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92404	10.1371/journal.pone.0092404	http://dx.doi.org/10.1371/journal.pone.0092404			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667818	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600038
J	Wu, M; Du, Y; Liu, YW; He, YQ; Yang, CX; Wang, WJ; Gao, F				Wu, Man; Du, Yan; Liu, Yiwen; He, Yiqing; Yang, Cuixia; Wang, Wenjuan; Gao, Feng			Low Molecular Weight Hyaluronan Induces Lymphangiogenesis through LYVE-1-Mediated Signaling Pathways	PLOS ONE			English	Article							ANGIOGENIC OLIGOSACCHARIDES; TUMOR LYMPHANGIOGENESIS; ENDOTHELIAL-CELLS; CANCER METASTASIS; PROSTATE-CANCER; BREAST-CANCER; TISSUE-INJURY; PROMOTES; GROWTH; RECEPTOR	Hyaluronan (HA), a large nonsulfated glycosaminogycan in the extracellular matrix, whose degraded fragments termed as low molecular weight hyaluronan (LMW-HA), has been reported as an important regulator of angiogenesis. However, little is known about the influence of LMW-HA on lymphangiogenesis. In this study, we try to explore the in vitro effects of LMW-HA on lymphangiogenesis and identify the underlying molecular mechanisms. Our results showed that LMW-HA stimulation significantly increased lymphatic endothelial cells (LECs) proliferation, migration and tube formation. Further experiments demonstrated that LMW-HA altered actin cytoskeleton rearrangement and increased the formation of intense stress fibers, lamellipodia and filopodia. Mechanistically, LMW-HA stimulation resulted in rapid tyrosine phosphorylation of protein kinase C alpha/beta II (PKC alpha/beta II) and extracellular-regulated kinase 1/2 (ERK1/2). Lymphalic vessel endotheilial hyaluronan receptor 1 (LYVE-1), a homologue of CD44, is the main cell surface receptor for HA in LECs. Blocking the binding interaction of LMW-HA with LYVE-1 using neutralizing anti-LYVE-1 antibodies significantly inhibited LECs proliferation, migration, tube formation and signal transduction induced by LMW-HA, suggesting that LMW-HA may play a critical role in the processes required for lymphangiogenesis through interactions with its receptor LYVE-1 and triggering intracellular signal cascades.	[Wu, Man; Du, Yan; Liu, Yiwen; He, Yiqing; Yang, Cuixia; Wang, Wenjuan] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Mol Biol, Shanghai 200030, Peoples R China; [Gao, Feng] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Mol Biol & Clin Lab, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Gao, F (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Mol Biol & Clin Lab, Shanghai 200030, Peoples R China.	gao3507@126.com	Wu, Man/AAH-6253-2020; liu, yi/GXE-9662-2022		National Natural Science Foundation of China [81071814, 81172027, 81272479]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors' research was supported by the National Natural Science Foundation of China (No. 81071814, 81172027 and 81272479) http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Chalkiadaki G, 2011, CANCER LETT, V312, P235, DOI 10.1016/j.canlet.2011.08.016; Chang VWH, 2001, GENE, V267, P201, DOI 10.1016/S0378-1119(01)00400-0; Deed R, 1997, INT J CANCER, V71, P251, DOI 10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO;2-J; Du Y, 2011, CLIN INVEST MED, V34, pE45; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Gao F, 2006, J BIOMED MATER RES B, V78B, P385, DOI 10.1002/jbm.b.30499; Guo LX, 2005, ACTA BIOCH BIOPH SIN, V37, P601, DOI 10.1111/j.1745-7270.2005.00083.x; Hayen W, 1999, J CELL SCI, V112, P2241; Hou WH, 2012, FEBS LETT, V586, P1480, DOI 10.1016/j.febslet.2012.04.001; Hou WH, 2011, J CELL SCI, V124, P1231, DOI 10.1242/jcs.078154; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Jackson DG, 2001, TRENDS IMMUNOL, V22, P317, DOI 10.1016/S1471-4906(01)01936-6; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Kouvidi K, 2011, J BIOL CHEM, V286, P38509, DOI 10.1074/jbc.M111.275875; KUMAR S, 1989, INT J CANCER, V44, P445, DOI 10.1002/ijc.2910440311; Kuzmenko ES, 2004, INT J BIOCHEM CELL B, V36, P519, DOI 10.1016/j.biocel.2003.09.010; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; Liu NF, 2001, CANCER RES, V61, P5207; Lokeshwar VB, 2001, J BIOL CHEM, V276, P11922, DOI 10.1074/jbc.M008432200; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Mattila MMT, 2002, INT J CANCER, V98, P946, DOI 10.1002/ijc.10283; Mumprecht V, 2009, J CELL MOL MED, V13, P1405, DOI 10.1111/j.1582-4934.2009.00834.x; Nightingale TD, 2009, J BIOL CHEM, V284, P3935, DOI 10.1074/jbc.M805105200; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; OCONNELL KA, 1990, J IMMUNOL, V144, P521; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Qian Y, 1998, ONCOGENE, V16, P2185, DOI 10.1038/sj.onc.1201753; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; Sathish KG, 2008, THESIS U SO CALIFORN; SHERMAN L, 1994, CURR OPIN CELL BIOL, V6, P726, DOI 10.1016/0955-0674(94)90100-7; Simpson MA, 2002, AM J PATHOL, V161, P849, DOI 10.1016/S0002-9440(10)64245-9; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Slevin M, 2004, INT J CANCER, V109, P793, DOI 10.1002/ijc.20059; Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200; Slevin M, 1998, LAB INVEST, V78, P987; Slomiany MG, 2009, CANCER RES, V69, P4992, DOI 10.1158/0008-5472.CAN-09-0143; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Thorne RF, 2004, J CELL SCI, V117, P373, DOI 10.1242/jcs.00954; Toole BP, 2002, GLYCOBIOLOGY, V12, p37R, DOI 10.1093/glycob/12.3.37R; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; TURLEY EA, 1994, GLIA, V12, P68, DOI 10.1002/glia.440120109; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zhang YY, 2002, CANCER RES, V62, P3962	48	51	53	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92857	10.1371/journal.pone.0092857	http://dx.doi.org/10.1371/journal.pone.0092857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667755	gold, Green Submitted, Green Published			2022-12-27	WOS:000333675600092
J	Clumeck, C; Garcia, SS; Bourguignon, M; Wens, V; Op de Beeck, M; Marty, B; Deconinck, N; Soncarrieu, MV; Goldman, S; Jousmaki, V; Van Bogaert, P; De Tiege, X				Clumeck, Catherine; Garcia, Sarah Suarez; Bourguignon, Mathieu; Wens, Vincent; Op de Beeck, Marc; Marty, Brice; Deconinck, Nicolas; Soncarrieu, Marie-Vincianne; Goldman, Serge; Jousmaki, Veikko; Van Bogaert, Patrick; De Tiege, Xavier			Preserved Coupling between the Reader's Voice and the Listener's Cortical Activity in Autism Spectrum Disorders	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; HIGH-FUNCTIONING AUTISM; SOCIAL-PERCEPTION; SPEECH-PERCEPTION; ASPERGER-SYNDROME; MIRROR NEURONS; CHILDREN; LANGUAGE; NETWORK; MIND	Purpose: Investigating the steadiness of the phase-coupling between the time-course of the reader's voice and brain signals of subjects with autism spectrum disorder (ASD) passively listening to connected speech using magnetoencephalography (MEG). In typically developed subjects, such coupling occurs at the right posterior temporal sulcus (pSTS) for frequencies below 1 Hz, and reflects the neural processing of sentence-level rhythmic prosody at the prelexical level. Methods: Cortical neuromagnetic signals were recorded with MEG (Elekta Oy, Finland) while seven right-handed and native French-speaking ASD subjects (six males, one female, range: 13-20 years) listened to live (Live) or recorded (Recorded) voices continuously reading a text in French for five minutes. Coherence was computed between the reader's voice time-course and ASD subjects' MEG signals. Coherent neural sources were subsequently reconstructed using a beamformer. Key findings: Significant coupling was found at 0.5 Hz in all ASD subjects in Live and in six subjects in Recorded. Coherent sources were located close to the right pSTS in both conditions. No significant difference was found in coherence levels between Live and Recorded, and between ASD subjects and ten typically developed subjects (right-handed, native French-speaking adults, 5 males, 5 females, age range: 21-38 years) included in a previous study. Significance: This study discloses a preserved coupling between the reader's voice and ASD subjects' cortical activity at the right pSTS. These findings support the existence of preserved neural processing of sentence-level rhythmic prosody in ASD. The preservation of early cortical processing of prosodic elements in verbal language might be exploited in therapeutic interventions in ASD.	[Clumeck, Catherine; Garcia, Sarah Suarez; Bourguignon, Mathieu; Wens, Vincent; Op de Beeck, Marc; Marty, Brice; Goldman, Serge; Van Bogaert, Patrick; De Tiege, Xavier] Univ Libre Bruxelles, UNI ULB Neurosci Inst, Lab Cartog Fonct Cerveau, Brussels, Belgium; [Clumeck, Catherine] Univ Libre Bruxelles, UNI ULB Neurosci Inst, Lab Rech Psychiat, Brussels, Belgium; [Deconinck, Nicolas; Soncarrieu, Marie-Vincianne] Hop Univ Enfants Reine Fabiola, Ctr Reference Troubles Envahissants Dev & Trouble, Brussels, Belgium; [Jousmaki, Veikko] Aalto Univ, Brain Res Unit, OV Lounasmaa Lab, Espoo, Finland; [Jousmaki, Veikko] Aalto Univ, MEG Core, Espoo, Finland	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Aalto University; Aalto University	De Tiege, X (corresponding author), Univ Libre Bruxelles, UNI ULB Neurosci Inst, Lab Cartog Fonct Cerveau, Brussels, Belgium.	xdetiege@ulb.ac.be	Jousmäki, Veikko/H-6008-2012; Bourguignon, Mathieu/I-6967-2012	Jousmäki, Veikko/0000-0003-1963-5834; Bourguignon, Mathieu/0000-0003-1694-5087; Marty, Brice/0000-0002-0522-8245; De Tiege, Xavier/0000-0003-0127-089X; Goldman, Serge/0000-0002-9917-8735	Fonds de la Recherche Scientifique (FRS-FNRS, Belgium); FRS-FNRS [J.0021.13]	Fonds de la Recherche Scientifique (FRS-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); FRS-FNRS(Fonds de la Recherche Scientifique - FNRS)	Catherine Clumeck (Research Fellow) and Xavier De Tiege (Postdoctorate Clinical Master Specialist) benefit of a research grant form the Fonds de la Recherche Scientifique (FRS-FNRS, Belgium). This study was supported by a research grant from the FRS-FNRS (research project: J.0021.13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; [Anonymous], TEST LANGAGE ORAL CO; Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; Baron-Cohen S, 2005, ANNU REV NEUROSCI, V28, P109, DOI 10.1146/annurev.neuro.27.070203.144137; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Bertone A, 2005, BRAIN, V128, P2430, DOI 10.1093/brain/awh561; Boddaert N, 2004, NEUROIMAGE, V23, P364, DOI 10.1016/j.neuroimage.2004.06.016; Bonnel A, 2003, J COGNITIVE NEUROSCI, V15, P226, DOI 10.1162/089892903321208169; Bourguignon M, 2013, NEUROIMAGE, V66, P500, DOI 10.1016/j.neuroimage.2012.10.038; Bourguignon M, 2013, HUM BRAIN MAPP, V34, P314, DOI 10.1002/hbm.21442; Bourguignon M, 2012, NEUROIMAGE, V59, P1684, DOI 10.1016/j.neuroimage.2011.09.022; Brandwein AB, 2013, CEREB CORTEX, V23, P1329, DOI [10.1093/cercor/bhs109, 10.1093/cercor/bht213]; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Cohen D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061402; Collignon O, 2013, CORTEX, V49, P1704, DOI 10.1016/j.cortex.2012.06.001; Faes L, 2004, IEEE T BIO-MED ENG, V51, P1156, DOI 10.1109/TBME.2004.827271; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Gepner B, 2009, NEUROSCI BIOBEHAV R, V33, P1227, DOI 10.1016/j.neubiorev.2009.06.006; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; Golan O, 2008, J AUTISM DEV DISORD, V38, P1534, DOI 10.1007/s10803-007-0533-7; Groen WB, 2008, NEUROSCI BIOBEHAV R, V32, P1416, DOI 10.1016/j.neubiorev.2008.05.008; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hadjikhani N, 2006, CEREB CORTEX, V16, P1276, DOI 10.1093/cercor/bh069; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; Henson RN, 2009, NEUROIMAGE, V46, P168, DOI 10.1016/j.neuroimage.2009.01.062; Hesling I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011571; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Jarvinen-Pasley A, 2008, J AUTISM DEV DISORD, V38, P239, DOI 10.1007/s10803-007-0386-0; Kaland N, 2008, J AUTISM DEV DISORD, V38, P1112, DOI 10.1007/s10803-007-0496-8; Kilner JM, 2011, TRENDS COGN SCI, V15, P352, DOI 10.1016/j.tics.2011.06.005; Lim HA, 2011, J MUSIC THER, V48, P532, DOI 10.1093/jmt/48.4.532; Lim HA, 2010, J MUSIC THER, V47, P2, DOI 10.1093/jmt/47.1.2; Litvak V, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/852961; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; MILLER SB, 1979, J CLIN PSYCHIAT, V40, P201; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nishitani N, 2004, ANN NEUROL, V55, P558, DOI 10.1002/ana.20031; O'Connor K, 2012, NEUROSCI BIOBEHAV R, V36, P836, DOI 10.1016/j.neubiorev.2011.11.008; Ohnishi T, 2000, BRAIN, V123, P1838, DOI 10.1093/brain/123.9.1838; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peelle JE, 2013, CEREB CORTEX, V23, P1378, DOI 10.1093/cercor/bhs118; Piitulainen H, 2013, NEUROIMAGE, V72, P83, DOI 10.1016/j.neuroimage.2013.01.029; Poeppel D, 2008, PHILOS T R SOC B, V363, P1071, DOI 10.1098/rstb.2007.2160; Rapin I, 2003, BRAIN DEV-JPN, V25, P166, DOI 10.1016/S0387-7604(02)00191-2; Redcay E, 2008, NEUROSCI BIOBEHAV R, V32, P123, DOI 10.1016/j.neubiorev.2007.06.004; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Rizzolatti G, 2009, NAT CLIN PRACT NEURO, V5, P24, DOI 10.1038/ncpneuro0990; Samson F, 2006, J AUTISM DEV DISORD, V36, P65, DOI 10.1007/s10803-005-0043-4; Schroeder JH, 2010, RES AUTISM SPECT DIS, V4, P555, DOI 10.1016/j.rasd.2010.01.004; Schultz RT, 2005, INT J DEV NEUROSCI, V23, P125, DOI 10.1016/j.ijdevneu.2004.12.012; Taulu S, 2005, IEEE T SIGNAL PROCES, V53, P3359, DOI 10.1109/TSP.2005.853302; von dem Hagen EAH, 2011, CEREB CORTEX, V21, P493, DOI 10.1093/cercor/bhq062; Wang AT, 2007, ARCH GEN PSYCHIAT, V64, P698, DOI 10.1001/archpsyc.64.6.698; Wechsler D, 1974, WECHSLER INTELLIGENC; Wechsler D., 1997, WECHSLER ADULT INTEL; Williams JHG, 2001, NEUROSCI BIOBEHAV R, V25, P287, DOI 10.1016/S0149-7634(01)00014-8; Wilson M, 2005, PSYCHON B REV, V12, P957, DOI 10.3758/BF03206432; Zilbovicius M, 2006, TRENDS NEUROSCI, V29, P359, DOI 10.1016/j.tins.2006.06.004	65	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92329	10.1371/journal.pone.0092329	http://dx.doi.org/10.1371/journal.pone.0092329			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663673	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900052
J	Ding, WG; Xie, Y; Toyoda, F; Matsuura, H				Ding, Wei-Guang; Xie, Yu; Toyoda, Futoshi; Matsuura, Hiroshi			Improved Functional Expression of Human Cardiac Kv1.5 Channels and Trafficking-Defective Mutants by Low Temperature Treatment	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME PATHWAY; TRANSMEMBRANE CONDUCTANCE REGULATOR; ANCHORING PROTEIN SAP97; CELL-SURFACE EXPRESSION; N-LINKED GLYCOSYLATION; RECTIFIER K+ CURRENT; LONG QT SYNDROME; ATRIAL-FIBRILLATION; MOLECULAR-BASIS; POTASSIUM CHANNELS	We herein investigated the effect of low temperature exposure on the expression, degradation, localization and activity of human Kv1.5 (hKv1.5). In hKv1.5-expressing CHO cells, the currents were significantly increased when cultured at a reduced temperature (28 degrees C) compared to those observed at 37 degrees C. Western blot analysis indicated that the protein levels (both immature and mature proteins) of hKv1.5 were significantly elevated under the hypothermic condition. Treatment with a proteasome inhibitor, MG132, significantly increased the immature, but not the mature, hKv1.5 protein at 37 degrees C, however, there were no changes in either the immature or mature hKv1.5 proteins at low temperature following MG132 exposure. These observations suggest that the enhancement of the mature hKv1.5 protein at reduced temperature may not result from the inhibition of proteolysis. Moreover, the hKv1.5 fluorescence signal in the cells increased significantly on the cell surface at 28 degrees C versus those cultured at 37 degrees C. Importantly, the low temperature treatment markedly shifted the subcellular distribution of the mature hKv1.5, which showed considerable overlap with the trans-Golgi component. Experiments using tunicamycin, an inhibitor of N-glycosylation, indicated that the N-glycosylation of hKv1.5 is more effective at 28 degrees C than at 37 degrees C. Finally, the hypothermic treatment also rescued the protein expression and currents of trafficking-defective hKv1.5 mutants. These results indicate that low temperature exposure stabilizes the protein in the cellular organelles or on the plasma membrane, and modulates its maturation and trafficking, thus enhancing the currents of hKv1.5 and its trafficking defect mutants.	[Ding, Wei-Guang; Xie, Yu; Toyoda, Futoshi; Matsuura, Hiroshi] Shiga Univ Med Sci, Dept Physiol, Otsu, Shiga 52021, Japan	Shiga University of Medical Science	Ding, WG (corresponding author), Shiga Univ Med Sci, Dept Physiol, Otsu, Shiga 52021, Japan.	ding@belle.shiga-med.ac.jp			Japan Society for the Promotion of Science [22590206, 22590205]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grant-in-Aid for Scientific Research (Nos. 22590206 to W-G. D. and Nos. 22590205 to H. M.) from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Char J, 2008, AM J PHYSIOL-HEART C, V294, pH1851, DOI 10.1152/ajpheart.01045.2007; Al-Fageeh MB, 2006, BIOTECHNOL BIOENG, V93, P829, DOI 10.1002/bit.20789; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Beers MF, 1996, J BIOL CHEM, V271, P14361, DOI 10.1074/jbc.271.24.14361; Chen MX, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-93; Chen QA, 2010, AM J PHYSIOL-ENDOC M, V299, pE62, DOI 10.1152/ajpendo.00067.2010; Cohen DM, 2006, SEMIN CELL DEV BIOL, V17, P630, DOI 10.1016/j.semcdb.2006.11.007; Decher N, 2004, J BIOL CHEM, V279, P394, DOI 10.1074/jbc.M307411200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Eldstrom J, 2006, FEBS LETT, V580, P6039, DOI 10.1016/j.febslet.2006.09.069; FEDIDA D, 1993, CIRC RES, V73, P210, DOI 10.1161/01.RES.73.1.210; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; Gong YZ, 2008, EUR J PHARMACOL, V600, P18, DOI 10.1016/j.ejphar.2008.10.010; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Kleizen B, 2000, EUR J CELL BIOL, V79, P544, DOI 10.1078/0171-9335-00078; Koshida S, 2009, EUR J PHARMACOL, V604, P93, DOI 10.1016/j.ejphar.2008.12.016; Li GR, 1996, CIRC RES, V78, P689, DOI 10.1161/01.RES.78.4.689; Li HL, 2005, J MOL CELL CARDIOL, V39, P121, DOI 10.1016/j.yjmcc.2005.03.013; MAHONEY WC, 1979, J BIOL CHEM, V254, P6572; McEwen DP, 2007, J BIOL CHEM, V282, P29612, DOI 10.1074/jbc.M704402200; Olson TM, 2006, HUM MOL GENET, V15, P2185, DOI 10.1093/hmg/ddl143; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Ravens U, 2008, EUROPACE, V10, P1133, DOI 10.1093/europace/eun193; Ravens U, 2011, CARDIOVASC RES, V89, P776, DOI 10.1093/cvr/cvq398; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Schumacher SM, 2010, HEART RHYTHM, V7, P1309, DOI 10.1016/j.hrthm.2010.02.017; Schumacher SM, 2009, CIRC RES, V104, P1390, DOI 10.1161/CIRCRESAHA.108.192773; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; Stump GL, 2005, J PHARMACOL EXP THER, V315, P1362, DOI 10.1124/jpet.105.092197; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Ting YK, 2011, BRIT J PHARMACOL, V162, P1832, DOI 10.1111/j.1476-5381.2011.01204.x; van der Heyden MAG, 2008, BRIT J PHARMACOL, V153, P406, DOI 10.1038/sj.bjp.0707618; WANG ZG, 1993, CIRC RES, V73, P1061, DOI 10.1161/01.RES.73.6.1061; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Watanabe I, 2004, J BIOL CHEM, V279, P8879, DOI 10.1074/jbc.M309802200; Watanabe I, 2003, J PHYSIOL-LONDON, V550, P51, DOI 10.1113/jphysiol.2003.040337; Wettwer E, 2004, CIRCULATION, V110, P2299, DOI 10.1161/01.CIR.0000145155.60288.71; Wu J, 2009, BRIT J PHARMACOL, V156, P377, DOI 10.1111/j.1476-5381.2008.00017.x; Yanagawa T, 2007, CANCER RES, V67, P8682, DOI 10.1158/0008-5472.CAN-07-1586; Yang YQ, 2009, J HUM GENET, V54, P277, DOI 10.1038/jhg.2009.26; Yang Z, 2008, CARDIOVASC RES, V78, P449, DOI 10.1093/cvr/cvn038; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123	42	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92923	10.1371/journal.pone.0092923	http://dx.doi.org/10.1371/journal.pone.0092923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663680	gold, Green Published, Green Submitted			2022-12-27	WOS:000333459900130
J	Holder, PW; Armstrong, K; Van Hale, R; Millet, MA; Frew, R; Clough, TJ; Baker, JA				Holder, Peter W.; Armstrong, Karen; Van Hale, Robert; Millet, Marc-Alban; Frew, Russell; Clough, Timothy J.; Baker, Joel A.			Isotopes and Trace Elements as Natal Origin Markers of Helicoverpa armigera - An Experimental Model for Biosecurity Pests	PLOS ONE			English	Article							NEW-ZEALAND; STABLE-ISOTOPES; LEPIDOPTERA-NOCTUIDAE; MONARCH BUTTERFLIES; GEOGRAPHICAL ORIGIN; HUBNER LEPIDOPTERA; HYDROGEN ISOTOPES; MINERAL PROFILES; BIRD FEATHERS; STRONTIUM	Protecting a nation's primary production sector and natural estate is heavily dependent on the ability to determine the risk presented by incursions of exotic insect species. Identifying the geographic origin of such biosecurity breaches can be crucial in determining this risk and directing the appropriate operational responses and eradication campaigns, as well as ascertaining incursion pathways. Reading natural abundance biogeochemical markers using mass spectrometry is a powerful tool for tracing ecological pathways as well as provenance determination of commercial products and items of forensic interest. However, application of these methods to trace insects has been underutilised to date and our understanding in this field is still in a phase of basic development. In addition, biogeochemical markers have never been considered in the atypical situation of a biosecurity incursion, where sample sizes are often small, and of unknown geographic origin and plant host. These constraints effectively confound the interpretation of the one or two isotope geo-location markers systems that are currently used, which are therefore unlikely to achieve the level of provenance resolution required in biosecurity interceptions. Here, a novel approach is taken to evaluate the potential for provenance resolution of insect samples through multiple biogeochemical markers. The international pest, Helicoverpa armigera, has been used as a model species to assess the validity of using naturally occurring delta(2) H, Sr-87/Sr-86, Pb-207/Pb-206 and Pb-208/Pb-206 isotope ratios and trace element concentration signatures from single moth specimens for regional assignment to natal origin. None of the biogeochemical markers selected were individually able to separate moths from the different experimental regions (150-3000 km apart). Conversely, using multivariate analysis, the region of origin was correctly identified for approximately 75% of individual H. armigera samples. The geographic resolution demonstrated with this approach has considerable potential for biosecurity as well as other disciplines including forensics, ecology and pest management.	[Holder, Peter W.; Armstrong, Karen] Lincoln Univ, Bioprotect Res Ctr, Canterbury, New Zealand; [Van Hale, Robert; Frew, Russell] Univ Otago, Dept Chem, Dunedin, New Zealand; [Millet, Marc-Alban; Baker, Joel A.] Victoria Univ Wellington, Sch Geog Environm & Earth Sci, Wellington, New Zealand; [Clough, Timothy J.] Lincoln Univ, Dept Soil & Phys Sci, Canterbury, New Zealand	Lincoln University - New Zealand; University of Otago; Victoria University Wellington; Lincoln University - New Zealand	Holder, PW (corresponding author), Lincoln Univ, Bioprotect Res Ctr, Canterbury, New Zealand.	peter.holder@lincoln.ac.nz	Clough, Timothy/Q-4982-2018; Holder, Peter/C-5224-2014; Frew, Russell/HDN-6138-2022; Frew, Russell/I-5591-2012; Armstrong, Karen/J-3460-2013	Clough, Timothy/0000-0002-5978-5274; Holder, Peter/0000-0003-2942-7289; Frew, Russell/0000-0002-6138-2116; Armstrong, Karen/0000-0003-4973-2651; Millet, Marc-Alban/0000-0003-2710-5374; Baker, Joel/0000-0001-6371-5060	New Zealand Tertiary Education Commission PhD scholarship; National Isotope Map of New Zealand Precipitation Cross Department Research Project grant [10749/2007]	New Zealand Tertiary Education Commission PhD scholarship; National Isotope Map of New Zealand Precipitation Cross Department Research Project grant	This work was funded by a New Zealand Tertiary Education Commission PhD scholarship and a National Isotope Map of New Zealand Precipitation Cross Department Research Project grant (10749/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abney MR, 2008, ENTOMOL EXP APPL, V126, P46, DOI 10.1111/j.1570-7458.2007.00633.x; Adams CJ, 2004, NEW ZEAL J GEOL GEOP, V47, P201, DOI 10.1080/00288306.2004.9515048; Adams CJ, 2004, NEW ZEAL J GEOL GEOP, V47, P173, DOI 10.1080/00288306.2004.9515046; Anderson KA, 2005, J AGR FOOD CHEM, V53, P410, DOI 10.1021/jf048907u; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Baker J, 2004, CHEM GEOL, V211, P275, DOI 10.1016/j.chemgeo.2004.06.030; BARLEY ME, 1987, J VOLCANOL GEOTH RES, V32, P247, DOI 10.1016/0377-0273(87)90047-3; Barr NB, 2009, J ECON ENTOMOL, V102, P401, DOI 10.1603/029.102.0153; Baxter MJ, 2008, ARCHAEOMETRY, V50, P968, DOI 10.1111/j.1475-4754.2008.00427.x; Biosecurity-New-Zealand, 2011, PATHW AN REP 2010 11; Biosecurity-New-Zealand, 2006, PATHW AN REP 2005 06; Blum JD, 2000, BIOGEOCHEMISTRY, V49, P87, DOI 10.1023/A:1006390707989; Blum JD, 2001, OECOLOGIA, V126, P569, DOI 10.1007/s004420000550; BORTOLOTTI GR, 1988, J WILDLIFE MANAGE, V52, P736, DOI 10.2307/3800939; BOWDEN J, 1984, B ENTOMOL RES, V74, P207, DOI 10.1017/S0007485300011354; BOWDEN J, 1979, ECOL ENTOMOL, V4, P199, DOI 10.1111/j.1365-2311.1979.tb00576.x; Bowen GJ, 2010, ANNU REV EARTH PL SC, V38, P161, DOI 10.1146/annurev-earth-040809-152429; Brattstrom O, 2008, ECOGRAPHY, V31, P490, DOI 10.1111/j.0906-7590.2008.05267.x; Brevault T, 2008, B ENTOMOL RES, V98, P565, DOI 10.1017/S0007485308005877; Capo RC, 1998, GEODERMA, V82, P197, DOI 10.1016/S0016-7061(97)00102-X; Chamberlain CP, 1997, OECOLOGIA, V109, P132, DOI 10.1007/s004420050067; COMMON IFB, 1953, AUST J ZOOL, V1, P319, DOI 10.1071/ZO9530319; DEMPSTER JP, 1986, ECOL ENTOMOL, V11, P51, DOI 10.1111/j.1365-2311.1986.tb00279.x; EDWARDS WR, 1984, J WILDLIFE MANAGE, V48, P853, DOI 10.2307/3801432; FAO, 2002, GUID PHYT CERT INT S; Farmer A, 2008, OECOLOGIA, V158, P183, DOI 10.1007/s00442-008-1143-6; Faure G., 2005, ISOTOPES PRINCIPLES, VThird; Feng HQ, 2010, ECOL MODEL, V221, P1819, DOI 10.1016/j.ecolmodel.2010.04.003; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Fitzpatrick BM, 2012, BIOL INVASIONS, V14, P245, DOI 10.1007/s10530-011-0064-1; Font L, 2007, J ANAL ATOM SPECTROM, V22, P513, DOI 10.1039/b616328a; Frei KM, 2011, APPL GEOCHEM, V26, P325, DOI 10.1016/j.apgeochem.2010.12.006; GOEDE AA, 1986, ENVIRON MONIT ASSESS, V7, P249, DOI 10.1007/BF00418017; Goldson SL, 2005, NEW ZEAL J AGR RES, V48, P401, DOI 10.1080/00288233.2005.9513673; Grocke DR, 2011, TOP GEOBIOL, V34, P105, DOI 10.1007/978-90-481-9684-5_5; GULSON BL, 1981, ENVIRON SCI TECHNOL, V15, P691, DOI 10.1021/es00088a008; Hill T, 2011, STAT METHODS APPL; Hobson KA, 2005, DIVERS DISTRIB, V11, P157, DOI 10.1111/j.1366-9516.2005.00149.x; Hobson KA, 2008, TERR ECOL SER, V2, P1; Hobson KA, 1999, OECOLOGIA, V120, P397, DOI 10.1007/s004420050872; Hobson KA, 2012, METHODS ECOL EVOL, V3, P766, DOI 10.1111/j.2041-210X.2012.00202.x; Holder PW, 2013, ARHOPALUS FERUS CERA, DOI DOI 10.6084/M9.FIGSHARE.813315; Holder PW, 2013, THESIS LINCOLN U; Husheer T, 2005, STABLE ISOTOPE INVES; Kaimal B, 2009, J GEOCHEM EXPLOR, V102, P176, DOI 10.1016/j.gexplo.2009.02.008; Kamber BS, 2010, PALAEOGEOGR PALAEOCL, V298, P432, DOI 10.1016/j.palaeo.2010.06.024; Kelly S, 2005, TRENDS FOOD SCI TECH, V16, P555, DOI 10.1016/j.tifs.2005.08.008; Kelly S, 2002, EUR FOOD RES TECHNOL, V214, P72, DOI 10.1007/s002170100400; Lancaster J, 2001, LIMNOL OCEANOGR, V46, P723, DOI 10.4319/lo.2001.46.3.0723; Langin KM, 2007, OECOLOGIA, V152, P449, DOI 10.1007/s00442-007-0669-3; Lavandero B, 2004, INT J PEST MANAGE, V50, P147, DOI 10.1080/09670870410001731853; Longhurst RD, 2004, NEW ZEAL J AGR RES, V47, P23, DOI 10.1080/00288233.2004.9513567; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; McLean J.A., 1979, P369; MCLEAN JA, 1978, ENVIRON ENTOMOL, V7, P93, DOI 10.1093/ee/7.1.93; MERTZ W, 1981, SCIENCE, V213, P1332, DOI 10.1126/science.7022654; Montgomery J, 2007, APPL GEOCHEM, V22, P1502, DOI 10.1016/j.apgeochem.2007.02.009; Norris DR, 2007, CAN J ZOOL, V85, P579, DOI 10.1139/Z07-024; Notten MJM, 2008, APPL GEOCHEM, V23, P1581, DOI 10.1016/j.apgeochem.2008.01.010; Ouin A, 2011, RAPID COMMUN MASS SP, V25, P2793, DOI 10.1002/rcm.5127; Oulhote Y, 2011, TRAC-TREND ANAL CHEM, V30, P302, DOI 10.1016/j.trac.2010.10.015; Pimentel D, 2011, BIOLOGICAL INVASIONS: ECONOMIC AND ENVIRONMENTAL COSTS OF ALIEN PLANT, ANIMAL, AND MICROBE SPECIES, 2ND EDITION, P1, DOI 10.1201/b10938; PIN C, 1992, ANAL CHIM ACTA, V269, P249, DOI 10.1016/0003-2670(92)85409-Y; Pogue MG, 2004, ANN ENTOMOL SOC AM, V97, P1222, DOI 10.1603/0013-8746(2004)097[1222:ANSOHZ]2.0.CO;2; Revel-Rolland M, 2006, EARTH PLANET SC LETT, V249, P1, DOI 10.1016/j.epsl.2006.06.028; Rossmann A, 2001, FOOD REV INT, V17, P347, DOI 10.1081/FRI-100104704; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Sarbas B, 2012, GEOCHEMISTRY ROCKS O; Sauer PE, 2009, RAPID COMMUN MASS SP, V23, P949, DOI 10.1002/rcm.3954; Savin S., 1993, CLIMATE CHANGE CONTI, V78, P367, DOI 10.1029/GM078P0367; Schimmelmann A, 1999, GEOCHIM COSMOCHIM AC, V63, P3751, DOI 10.1016/S0016-7037(99)00221-5; Sellick MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004735; Spence KO, 2005, OECOLOGIA, V146, P89, DOI 10.1007/s00442-005-0170-9; Szep T, 2003, J AVIAN BIOL, V34, P307, DOI 10.1034/j.1600-048X.2003.03026.x; Timm C, 2009, J PETROL, V50, P989, DOI 10.1093/petrology/egp029; Timm NH, 2002, APPL MULTIVARIATE AN, DOI 10.1007/b98963; Torres-Dowdall J, 2010, CONDOR, V112, P490, DOI 10.1525/cond.2010.090166; TURNER RH, 1983, SCAN ELECTRON MICROS, P873; Wassenaar LI, 2006, RAPID COMMUN MASS SP, V20, P2505, DOI 10.1002/rcm.2626; Wassenaar LI, 1998, P NATL ACAD SCI USA, V95, P15436, DOI 10.1073/pnas.95.26.15436; Wassenaar LI, 2010, 7 INT C APPL STABL I; Wunder MB, 2008, ECOL APPL, V18, P549, DOI 10.1890/07-0058.1	82	27	27	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92384	10.1371/journal.pone.0092384	http://dx.doi.org/10.1371/journal.pone.0092384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664236	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000333459900059
J	Kung, E; Coward, WR; Neill, DR; Malak, HA; Muhlemann, K; Kadioglu, A; Hilty, M; Hathaway, LJ				Kueng, Eliane; Coward, William R.; Neill, Daniel R.; Malak, Hesham A.; Muehlemann, Kathrin; Kadioglu, Aras; Hilty, Markus; Hathaway, Lucy J.			The Pneumococcal Polysaccharide Capsule and Pneumolysin Differentially Affect CXCL8 and IL-6 Release from Cells of the Upper and Lower Respiratory Tract	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; EPITHELIAL-CELLS; COLONIZATION; INNATE; GENES	The polysaccharide capsule and pneumolysin toxin are major virulence factors of the human bacterial pathogen Streptococcus pneumoniae. Colonization of the nasopharynx is asymptomatic but invasion of the lungs can result in invasive pneumonia. Here we show that the capsule suppresses the release of the pro-inflammatory cytokines CXCL8 (IL-8) and IL-6 from the human pharyngeal epithelial cell line Detroit 562. Release of both cytokines was much less from human bronchial epithelial cells (iHBEC) but levels were also affected by capsule. Pneumolysin stimulates CXCL8 release from both cell lines. Suppression of CXCL8 homologue (CXCL2/MIP-2) release by the capsule was also observed in vivo during intranasal colonization of mice but was only discernable in the absence of pneumolysin. When pneumococci were administered intranasally to mice in a model of long term, stable nasopharyngeal carriage, encapsulated S. pneumoniae remained in the nasopharynx whereas the nonencapsulated pneumococci disseminated into the lungs. Pneumococcal capsule plays a role not only in protection from phagocytosis but also in modulation of the pro-inflammatory immune response in the respiratory tract.	[Kueng, Eliane; Muehlemann, Kathrin; Hilty, Markus; Hathaway, Lucy J.] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Kueng, Eliane] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Coward, William R.] Nottingham Resp Biomed Res Unit, Nottingham, England; [Neill, Daniel R.; Malak, Hesham A.; Kadioglu, Aras] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Hilty, Markus] Univ Hosp Bern, Dept Infect Dis, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University of Nottingham; University of Liverpool; University of Bern; University Hospital of Bern	Hathaway, LJ (corresponding author), Univ Bern, Inst Infect Dis, Bern, Switzerland.	lucy.hathaway@ifik.unibe.ch	Kummer, Juerg/B-3322-2011; Neill, Daniel/Q-6290-2019; Neill, Daniel/E-1403-2012; Hilty, Markus/H-9560-2019	Neill, Daniel/0000-0002-7911-8153; Neill, Daniel/0000-0002-7911-8153; Hilty, Markus/0000-0002-2418-6474; kadioglu, aras/0000-0003-1137-6321; Hathaway, Lucy Jane/0000-0002-5361-5397	Swiss National Science Foundation [31003A_133157/1]; Wellcome Trust	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a grant from the Swiss National Science Foundation (31003A_133157/1) to KM and currently led by LJH. WRC receives funding from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A.K., 2016, CELL MOL IMMUNOL, V9th; Battig P, 2007, FEMS IMMUNOL MED MIC, V50, P324, DOI 10.1111/j.1574-695X.2007.00246.x; Bootsma HJ, 2007, INFECT IMMUN, V75, P5489, DOI 10.1128/IAI.01823-06; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Brugger SD, 2009, J CLIN MICROBIOL, V47, P1750, DOI 10.1128/JCM.01877-08; Dogan S, 2011, MICROBES INFECT, V13, P65, DOI 10.1016/j.micinf.2010.10.003; Engel H, 2013, ANTIMICROB AGENTS CH, V57, P2801, DOI 10.1128/AAC.00223-13; Gomez MI, 2008, PEDIATR PULM, V43, P11, DOI 10.1002/ppul.20735; Hathaway LJ, 2004, J BACTERIOL, V186, P3721, DOI 10.1128/JB.186.12.3721-3729.2004; Hathaway LJ, 2007, MICROBIOL-SGM, V153, P2465, DOI 10.1099/mic.0.2006/005066-0; Hathaway LJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002574; Isaacman DJ, 2010, INT J INFECT DIS, V14, pE197, DOI 10.1016/j.ijid.2009.05.010; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Kronenberg A, 2006, J CLIN MICROBIOL, V44, P2032, DOI 10.1128/JCM.00275-06; Luer S, 2011, SUPPORT CARE CANCER, V19, P799, DOI 10.1007/s00520-010-0894-x; Marriott HM, 2012, INFECT IMMUN, V80, P1140, DOI 10.1128/IAI.05697-11; Mayer AK, 2007, ARCH IMMUNOL THER EX, V55, P353, DOI 10.1007/s00005-007-0041-7; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; Meier PS, 2003, ANTIMICROB AGENTS CH, V47, P863, DOI 10.1128/AAC.47.3.863-868.2003; Ogunniyi AD, 2002, MICROBIOL-SGM, V148, P2045, DOI 10.1099/00221287-148-7-2045; Paterson GK, 2010, RESPIROLOGY, V15, P1057, DOI 10.1111/j.1440-1843.2010.01814.x; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Rastogi D, 2001, Paediatr Respir Rev, V2, P245, DOI 10.1053/prrv.2001.0147; Ratner AJ, 2005, P NATL ACAD SCI USA, V102, P3429, DOI 10.1073/pnas.0500599102; Richards L, 2010, IMMUNOBIOLOGY, V215, P251, DOI 10.1016/j.imbio.2009.12.004; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; van Cuyck H, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-241; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x; Yoon BN, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/813610; Yuste J, 2005, J IMMUNOL, V175, P1813, DOI 10.4049/jimmunol.175.3.1813	33	15	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92355	10.1371/journal.pone.0092355	http://dx.doi.org/10.1371/journal.pone.0092355			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664110	Green Submitted, Green Published, gold			2022-12-27	WOS:000333459900056
J	Yue, M; Zeng, L; Singh, A; Xu, YJ				Yue, Ming; Zeng, Li; Singh, Amanpreet; Xu, Yongjie			Rad4 Mainly Functions in Chk1-Mediated DNA Damage Checkpoint Pathway as a Scaffold Protein in the Fission Yeast Schizosaccharomyces pombe	PLOS ONE			English	Article							S-PHASE CHECKPOINT; STALLED REPLICATION FORKS; C-TERMINAL TAIL; KINASE CDS1; RAD3-RAD26 COMPLEX; BUDDING YEAST; MEC1 KINASE; ACTIVATION; PHOSPHORYLATION; DPB11	Rad4/Cut5 is a scaffold protein in the Chk1-mediated DNA damage checkpoint in S. pombe. However, whether it contains a robust ATR-activation domain (AAD) required for checkpoint signaling like its orthologs TopBP1 in humans and Dpb11 in budding yeast has been incompletely clear. To identify the putative AAD in Rad4, we carried out an extensive genetic screen looking for novel mutants with an enhanced sensitivity to replication stress or DNA damage in which the function of the AAD can be eliminated by the mutations. Two new mutations near the N-terminus were identified that caused significantly higher sensitivities to DNA damage or chronic replication stress than all previously reported mutants, suggesting that most of the checkpoint function of the protein is eliminated. However, these mutations did not affect the activation of Rad3 (ATR in humans) yet eliminated the scaffolding function of the protein required for the activation of Chk1. Several mutations were also identified in or near the recently reported AAD in the C-terminus of Rad4. However, all mutations in the C-terminus only slightly sensitized the cells to DNA damage. Interestingly, a mutant lacking the whole C-terminus was found resistant to DNA damage and replication stress almost like the wild type cells. Consistent with the resistance, all known Rad3 dependent phosphorylations of checkpoint proteins remained intact in the C-terminal deletion mutant, indicating that unlike that in Dpb11, the C-terminus of Rad4 does not contain a robust AAD. These results, together with those from the biochemical studies, show that Rad4 mainly functions as a scaffold protein in the Chk1, not the Cds1(CHK2 in humans), checkpoint pathway. It plays a minor role or is functionally redundant with an unknown factor in Rad3 activation.	[Yue, Ming; Singh, Amanpreet; Xu, Yongjie] Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Zeng, Li] Zhengzhou Univ, Affiliated Hosp 1, Dept Pediat, Zhengzhou 450052, Peoples R China	University System of Ohio; Wright State University Dayton; Zhengzhou University	Xu, YJ (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA.	yong-jie.xu@wright.edu			Wright State University Boonshoft School of Medicine; Ohio Cancer Research Associates, Inc.	Wright State University Boonshoft School of Medicine; Ohio Cancer Research Associates, Inc.	This work was supported in part by the Emerging Science Seed Grant from Wright State University Boonshoft School of Medicine and a grant from Ohio Cancer Research Associates, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; Bhaumik D, 1998, MOL BIOL CELL, V9, P2107, DOI 10.1091/mbc.9.8.2107; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Callegari AJ, 2007, CELL CYCLE, V6, P660, DOI 10.4161/cc.6.6.3984; Callegari AJ, 2006, P NATL ACAD SCI USA, V103, P15877, DOI 10.1073/pnas.0607343103; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Edwards RJ, 1999, NAT CELL BIOL, V1, P393, DOI 10.1038/15623; Esashi F, 1999, MOL CELL, V4, P167, DOI 10.1016/S1097-2765(00)80364-0; FENECH M, 1991, NUCLEIC ACIDS RES, V19, P6737, DOI 10.1093/nar/19.24.6737; FROMANT M, 1995, ANAL BIOCHEM, V224, P347, DOI 10.1006/abio.1995.1050; Fukuura M, 2011, MOL BIOL CELL, V22, P2620, DOI 10.1091/mbc.E10-12-0995; Furuya K, 2004, GENE DEV, V18, P1154, DOI 10.1101/gad.291104; Furuya K, 2003, J CELL SCI, V116, P3847, DOI 10.1242/jcs.00790; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Harris S, 2003, J CELL SCI, V116, P3519, DOI 10.1242/jcs.00677; Hermand D, 2007, MOL CELL, V26, P553, DOI 10.1016/j.molcel.2007.04.014; Hu JZ, 2012, CELL, V149, P1221, DOI 10.1016/j.cell.2012.04.030; Kai M, 2006, METHOD ENZYMOL, V409, P183, DOI 10.1016/S0076-6879(05)09011-7; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; KELLY TJ, 1993, CELL, V74, P371, DOI 10.1016/0092-8674(93)90427-R; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Kumar S, 2013, GENE DEV, V27, P313, DOI 10.1101/gad.204750.112; Limbo O, 2011, MOL CELL BIOL, V31, P573, DOI 10.1128/MCB.00994-10; Lin SJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002801; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Majka J, 2004, J BIOL CHEM, V279, P20921, DOI 10.1074/jbc.M400898200; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; McGowan CH, 2004, CURR OPIN CELL BIOL, V16, P629, DOI 10.1016/j.ceb.2004.09.005; Mochida S, 2004, EMBO J, V23, P418, DOI 10.1038/sj.emboj.7600018; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Navadgi-Patil VM, 2011, J BIOL CHEM, V286, P40999, DOI 10.1074/jbc.M111.283994; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; NAVAS TA, 1995, CELL, V80, P29, DOI 10.1016/0092-8674(95)90448-4; Ohouo PY, 2013, NATURE, V493, P120, DOI 10.1038/nature11658; Pfander B, 2011, EMBO J, V30, P4897, DOI 10.1038/emboj.2011.345; Qu M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002817; Sabatinos SA, 2012, MOL CELL BIOL, V32, P4986, DOI 10.1128/MCB.01060-12; Saka Y, 1997, GENE DEV, V11, P3387, DOI 10.1101/gad.11.24.3387; SAKA Y, 1993, CELL, V74, P383, DOI 10.1016/0092-8674(93)90428-S; SAMEJIMA I, 1993, J CELL SCI, V105, P135; SCHUPBACH M, 1971, MUTAT RES, V11, P361; Shimada K, 2002, GENE DEV, V16, P3236, DOI 10.1101/gad.239802; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Stracker TH, 2008, MOL CELL, V31, P21, DOI 10.1016/j.molcel.2008.04.028; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tanaka K, 2001, MOL CELL BIOL, V21, P3398, DOI 10.1128/MCB.21.10.3398-3404.2001; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Taricani L, 2006, MOL BIOL CELL, V17, P3456, DOI 10.1091/mbc.E06-01-0056; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Xu YJ, 2006, GENE DEV, V20, P990, DOI 10.1101/gad.1406706; Xu YJ, 2009, J BIOL CHEM, V284, P16016, DOI 10.1074/jbc.M900785200; Yamane K, 1999, ONCOGENE, V18, P5194, DOI 10.1038/sj.onc.1202922; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yue M, 2011, J BIOL CHEM, V286, P22864, DOI 10.1074/jbc.M111.236687; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430; Zou L, 2009, MOL CELL, V36, P734, DOI 10.1016/j.molcel.2009.11.026	66	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92936	10.1371/journal.pone.0092936	http://dx.doi.org/10.1371/journal.pone.0092936			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663817	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900131
J	Oberst, S; Baro, EN; Lai, JCS; Evans, TA				Oberst, Sebastian; Baro, Enrique Nava; Lai, Joseph C. S.; Evans, Theodore A.			Quantifying Ant Activity Using Vibration Measurements	PLOS ONE			English	Article							LEAF-CUTTING ANTS; IRIDOMYRMEX-PURPUREUS; MEAT ANTS; COMMUNICATION; STRIDULATION; RECRUITMENT; HYMENOPTERA; ABUNDANCE	Ant behaviour is of great interest due to their sociality. Ant behaviour is typically observed visually, however there are many circumstances where visual observation is not possible. It may be possible to assess ant behaviour using vibration signals produced by their physical movement. We demonstrate through a series of bioassays with different stimuli that the level of activity of meat ants (Iridomyrmex purpureus) can be quantified using vibrations, corresponding to observations with video. We found that ants exposed to physical shaking produced the highest average vibration amplitudes followed by ants with stones to drag, then ants with neighbours, illuminated ants and ants in darkness. In addition, we devised a novel method based on wavelet decomposition to separate the vibration signal owing to the initial ant behaviour from the substrate response, which will allow signals recorded from different substrates to be compared directly. Our results indicate the potential to use vibration signals to classify some ant behaviours in situations where visual observation could be difficult.	[Oberst, Sebastian; Baro, Enrique Nava; Lai, Joseph C. S.] Univ New S Wales, Sch Engn & Informat Technol, Acoust & Vibrat Unit, Canberra, ACT, Australia; [Baro, Enrique Nava] Univ Malaga, Escuela Tecn Super Ingn Telecomunicac, Dept Ingn Comunicac, E-29071 Malaga, Spain; [Evans, Theodore A.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	University of New South Wales Sydney; Universidad de Malaga; National University of Singapore	Oberst, S (corresponding author), Univ New S Wales, Sch Engn & Informat Technol, Acoust & Vibrat Unit, Canberra, ACT, Australia.	s.oberst@adfa.edu.au	Nava-Baro, Enrique/R-4589-2019; Evans, Theodore A/A-6020-2008; Oberst, Sebastian/AAQ-2854-2020	Nava-Baro, Enrique/0000-0001-7817-6442; Evans, Theodore A/0000-0002-0558-3036; Oberst, Sebastian/0000-0002-1388-2749; Lai, Joseph/0000-0002-8946-9993	Australian Research Council [DP110102564]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council's Discovery Project funding scheme (project number DP110102564, http://www.arc.gov.au/pdf/DP11_fundingrules.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akay A, 2002, J ACOUST SOC AM, V111, P1525, DOI 10.1121/1.1456514; ANDERSEN AN, 1994, OECOLOGIA, V98, P15, DOI 10.1007/BF00326085; BAERENDS GP, 1959, ANNU REV ENTOMOL, V4, P207, DOI 10.1146/annurev.en.04.010159.001231; Balch T., 2001, Proceedings of the Fifth International Conference on Autonomous Agents, P521, DOI 10.1145/375735.376434; Baro EN, 2013, INT 2013 INNSBR AUST, P1; BARONIURBANI C, 1988, INSECT SOC, V35, P241, DOI 10.1007/BF02224057; GREAVES T, 1973, Journal of the Australian Entomological Society, V12, P284; GREENSLADE PJ, 1974, SOIL BIOL BIOCHEM, V6, P7, DOI 10.1016/0038-0717(74)90004-2; GREENSLADE PJM, 1987, AUST J ZOOL, V35, P259, DOI 10.1071/ZO9870259; Hickling R, 2000, J ACOUST SOC AM, V108, P1920, DOI 10.1121/1.1290515; Hogg RV., 1987, ENG STAT; Holldobler B, 1999, J COMP PHYSIOL A, V184, P129, DOI 10.1007/s003590050313; Holldobler B., 1990, pi; HUA Y, 1990, IEEE T ACOUST SPEECH, V38, P814, DOI 10.1109/29.56027; Keller L., 2009, LIVES ANTS; Lach L, 2010, ANT ECOLOGY, P1; Mankin RW, 2006, J ECON ENTOMOL, V99, P244, DOI 10.1603/0022-0493(2006)099[0244:GDOSTA]2.0.CO;2; MARKL H, 1965, SCIENCE, V149, P1392, DOI 10.1126/science.149.3690.1392; Oster G.F., 1978, Monographs in Population Biology, pi; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; ROCES F, 1995, BEHAV ECOL SOCIOBIOL, V37, P297; ROCES F, 1993, NATURWISSENSCHAFTEN, V80, P521, DOI 10.1007/BF01140810; SPANGLER HG, 1967, SCIENCE, V155, P1687, DOI 10.1126/science.155.3770.1687; Spanos A., 1999, PROBABILITY THEORY S; Stephane M., 1999, WAVELET TOUR SIGNAL; TAUTZ J, 1995, SCIENCE, V267, P84, DOI 10.1126/science.267.5194.84; Ward-Fear G, 2010, J APPL ECOL, V47, P273, DOI 10.1111/j.1365-2664.2010.01773.x; Wheeler W. M., 1913, ANTS THEIR STRUCTURE	29	6	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e90902	10.1371/journal.pone.0090902	http://dx.doi.org/10.1371/journal.pone.0090902			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658467	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300022
J	Jones, S; Dodd, A; Gruber, J				Jones, Steven; Dodd, Alyson; Gruber, June			Development and Validation of a New Multidimensional Measure of Inspiration: Associations with Risk for Bipolar Disorder	PLOS ONE			English	Article							NEGATIVE COGNITIVE-STYLE; HYPOMANIC PERSONALITY; BEHAVIORAL ACTIVATION; POSITIVE MOOD; CREATIVITY; MANIA; IMPULSIVITY; UNIPOLAR; EMOTION; APPRAISALS	Background: Individuals at risk for, and diagnosed with, bipolar disorder (BD) appear to have heightened levels of creativity. Although inspiration is creativity, the ways in which individuals appraise and respond emotionally to inspiration in BD remain unexplored. Method: The present study reports on a new measure of inspiration (External and Internal Sources of Inspiration Scale - EISI). The reliability and validity of EISI were explored along with associations between EISI and BD risk. Results: Among a cross-national student sample (N = 708) 5 inspiration factors were derived from EISI (self, other, achievement, prosocial and external inspiration). Reliability, concurrent validity and convergent/divergent validity were good. Total EISI and all subscales were associated with increased positive rumination, and total EISI and the achievement EISI subscale were associated with impulsivity. Total EISI, self and prosocial EISI subscales were independently associated with BD risk and current mania symptoms. Conclusion: This new measure of inspiration is multidimensional, reliable and valid. Findings suggest that self and prosocial focused inspiration are particularly associated with risk for BD after controlling for current manic symptoms. Future studies in clinical populations may illuminate the relationships between inspiration and creativity in BD.	[Jones, Steven; Dodd, Alyson] Univ Lancaster, Fac Hlth & Med, Spectrum Ctr Mental Hlth Res, Lancaster, England; [Gruber, June] Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Lancaster University; Yale University	Jones, S (corresponding author), Univ Lancaster, Fac Hlth & Med, Spectrum Ctr Mental Hlth Res, Lancaster, England.	s.jones7@lancaster.ac.uk		Dodd, Alyson/0000-0002-8872-2272; Jones, Steven/0000-0002-8801-5113	University of Lancaster; University of Yale	University of Lancaster; University of Yale	This research was supported by the internal resources of the Universities of Lancaster and Yale rather than a formal grant. The institutions had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript.	Alloy LB, 2008, BIPOLAR DISORD, V10, P310, DOI 10.1111/j.1399-5618.2007.00547.x; Altman E, 2001, BIOL PSYCHIAT, V50, P468, DOI 10.1016/S0006-3223(01)01065-4; Altman EG, 1997, BIOL PSYCHIAT, V42, P948, DOI 10.1016/S0006-3223(96)00548-3; Curran PJ, 1996, PSYCHOL METHODS, V1, P16, DOI 10.1037//1082-989X.1.1.16; Cyders MA, 2007, PSYCHOL ASSESSMENT, V19, P107, DOI 10.1037/1040-3590.19.1.107; Dempsey RC, 2011, J CLIN PSYCHOL, V67, P673, DOI 10.1002/jclp.20789; Dodd AL, 2011, PSYCHOL ASSESSMENT, V23, P635, DOI 10.1037/a0022972; Dodd AL, 2011, COGNITIVE THER RES, V35, P497, DOI 10.1007/s10608-010-9342-y; ECKBLAD M, 1986, J ABNORM PSYCHOL, V95, P214, DOI 10.1037/0021-843X.95.3.214; Farmer A, 2006, PSYCHOL MED, V36, P1213, DOI 10.1017/S0033291706007835; Feldman GC, 2008, COGNITIVE THER RES, V32, P507, DOI 10.1007/s10608-006-9083-0; Galvez JF, 2011, J AFFECT DISORDERS, V128, P185, DOI 10.1016/j.jad.2010.03.017; Gruber J, 2008, EMOTION, V8, P23, DOI 10.1037/1528-3542.8.1.23; Gruber J, 2010, J COGN PSYCHOTHER, V24, P16, DOI 10.1891/0889-8391.24.1.16; Gruber J, 2011, J ABNORM PSYCHOL, V120, P956, DOI 10.1037/a0023667; Gruber J, 2011, CURR DIR PSYCHOL SCI, V20, P217, DOI 10.1177/0963721411414632; Gruber J, 2011, J AFFECT DISORDERS, V133, P457, DOI 10.1016/j.jad.2011.05.009; Gruber J, 2011, PERSPECT PSYCHOL SCI, V6, P222, DOI 10.1177/1745691611406927; Gruber J, 2009, INT J COGN THER, V2, P176, DOI 10.1521/ijct.2009.2.2.176; Gruber J, 2009, BEHAV RES THER, V47, P697, DOI 10.1016/j.brat.2009.05.005; Jamison K.R., 1993, TOUCHED FIRE MANIC D; JAMISON KR, 1989, PSYCHIATRY, V52, P125, DOI 10.1080/00332747.1989.11024436; Johnson S., 2007, EMOTION PSYCHOPATHOL; Johnson SL, 2012, CLIN PSYCHOL REV, V32, P1, DOI 10.1016/j.cpr.2011.10.001; Johnson SL, 2009, J CLIN PSYCHOL, V65, P891, DOI 10.1002/jclp.20585; Johnson SL, 2005, CLIN PSYCHOL REV, V25, P241, DOI 10.1016/j.cpr.2004.11.002; Johnson SL, 2005, J SOC CLIN PSYCHOL, V24, P894, DOI 10.1521/jscp.2005.24.6.894; Jones SH, 2001, CLIN PSYCHOL REV, V21, P1193, DOI 10.1016/S0272-7358(01)00111-8; Jones S, 2008, PERS INDIV DIFFER, V45, P643, DOI 10.1016/j.paid.2008.07.008; Jones S, 2007, PERS INDIV DIFFER, V43, P1366, DOI 10.1016/j.paid.2007.04.005; Jones S, 2006, J AFFECT DISORDERS, V93, P19, DOI 10.1016/j.jad.2006.01.017; Jones S, 2009, INT J COGN THER, V2, P343, DOI 10.1521/ijct.2009.2.4.343; Kelly RE, 2011, J AFFECT DISORDERS, V134, P438, DOI 10.1016/j.jad.2011.05.042; Kinney D. K., 1990, CREATIVITY RES J, V3, P202, DOI [10.1080/10400419009534353, DOI 10.1080/10400419009534353]; Klein DN, 1996, J AFFECT DISORDERS, V38, P135, DOI 10.1016/0165-0327(96)00005-5; Knowles R, 2007, BIPOLAR DISORD, V9, P490, DOI 10.1111/j.1399-5618.2007.00457.x; Krippner S, 2010, LUMINA, V21, P1; Kwapil TR, 2000, J ABNORM PSYCHOL, V109, P222, DOI 10.1037/0021-843X.109.2.222; Lam DH, 2010, COGNITIVE THERAPY BI; Lobban F, 2012, J AFFECT DISORDERS, V141, P204, DOI 10.1016/j.jad.2012.03.001; Lonnqvist JE, 2009, J ABNORM PSYCHOL, V118, P418, DOI 10.1037/a0015127; LOVEJOY MC, 1995, J ABNORM PSYCHOL, V104, P381, DOI 10.1037/0021-843X.104.2.381; LUDWIG AM, 1992, AM J PSYCHOTHER, V46, P330, DOI 10.1176/appi.psychotherapy.1992.46.3.330; LUDWIG AM, 1994, AM J PSYCHIAT, V151, P1650; M'Bailara K, 2009, BIPOLAR DISORD, V11, P63, DOI 10.1111/j.1399-5618.2008.00656.x; Mansell W, 2006, BEHAV RES THER, V44, P1787, DOI 10.1016/j.brat.2006.01.002; MARTINDALE C, 1978, BIOL PSYCHOL, V6, P157, DOI 10.1016/0301-0511(78)90018-2; Meyer B, 2001, J PSYCHOPATHOL BEHAV, V23, P133, DOI 10.1023/A:1010929402770; Milyavskaya M, 2012, PERS INDIV DIFFER, V52, P56, DOI 10.1016/j.paid.2011.08.031; Murray G, 2010, CLIN PSYCHOL REV, V30, P721, DOI 10.1016/j.cpr.2010.05.006; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; O'Connor BP, 2000, SPSS SAS MATLAB PROG; RICHARDS R, 1988, J ABNORM PSYCHOL, V97, P281, DOI 10.1037/0021-843X.97.3.281; Schuldberg D, 2000, CREATIVITY RES J, V13, P105; Swann AC, 2005, AM J PSYCHIAT, V162, P1680, DOI 10.1176/appi.ajp.162.9.1680; Swann AC, 2004, BIPOLAR DISORD, V6, P204, DOI 10.1111/j.1399-5618.2004.00110.x; Tabachnick B. G., 2001, USING MULTIVARIATE S; Thrash TM, 2004, J PERS SOC PSYCHOL, V87, P957, DOI 10.1037/0022-3514.87.6.957; Thrash TM, 2003, J PERS SOC PSYCHOL, V84, P871, DOI 10.1037/0022-3514.84.4.871; Thrash TM, 2010, J PERS SOC PSYCHOL, V98, P469, DOI 10.1037/a0017907; Victor SE, 2011, BIPOLAR DISORD, V13, P303, DOI 10.1111/j.1399-5618.2011.00919.x; Wills GI, 2003, BRIT J PSYCHIAT, V183, P255, DOI 10.1192/bjp.183.3.255; Wood AM, 2010, CLIN PSYCHOL REV, V30, P819, DOI 10.1016/j.cpr.2010.06.003	63	8	9	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e91669	10.1371/journal.pone.0091669	http://dx.doi.org/10.1371/journal.pone.0091669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SR	24670894	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000023
J	Pinho, GM; da Silva, AG; Hrbek, T; Venticinque, EM; Farias, IP				Pinho, Gabriela M.; da Silva, Anders Goncalves; Hrbek, Tomas; Venticinque, Eduardo M.; Farias, Izeni P.			Kinship and Social Behavior of Lowland Tapirs (Tapirus terrestris) in a Central Amazon Landscape	PLOS ONE			English	Article							HOME-RANGE OVERLAP; GENETIC-STRUCTURE; POPULATION-STRUCTURE; PAIRWISE RELATEDNESS; COMPUTER-PROGRAM; MATING SYSTEM; DISPERSAL; PATTERNS; DNA; PHILOPATRY	We tested the hypothesis that tapirs tolerate individuals adjacent and overlapping home ranges if they are related. We obtained genetic data from fecal samples collected in the Balbina reservoir landscape, central Amazon. Samples were genotyped at 14 microsatellite loci, of which five produced high quality informative genotypes. Based on an analysis of 32 individuals, we inferred a single panmictic population with high levels of heterozygosity. Kinship analysis identified 10 pairs of full siblings or parent-offspring, 10 pairs of half siblings and 25 unrelated pairs. In 10 cases, the related individuals were situated on opposite margins of he reservoir, suggesting that tapirs are capable of crossing the main river, even after damming. The polygamous model was the most likely mating system for Tapirus terrestris. Moran/index of allele sharing between pairs of individuals geographically close km) was similar to that observed between individual pairs at larger distances (>3 km). Confirming this result, the related individuals were not geographically closer than unrelated ones (W=188.5; p=0.339). Thus, we found no evidence of a preference for being close to relatives and observed a tendency for dispersal. The small importance of relatedness in determining spatial distribution of individuals is unusual in mammals, but unheard of. Finally, non-invasive sampling allowed efficient access to the genetic data, despite the warm and humid climate of the Amazon, which accelerates DNA degradation.	[Pinho, Gabriela M.] INPA, Programa Posgrad Ecol, Manaus, Amazonas, Brazil; [Pinho, Gabriela M.; Hrbek, Tomas; Farias, Izeni P.] Univ Fed Amazonas UFAM, Dept Biol, Lab Evolucao & Genet Anim, Manaus, Amazonas, Brazil; [da Silva, Anders Goncalves] CSIRO, Div Marine & Atmospher Res, Hobart, Tas, Australia; [da Silva, Anders Goncalves] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Venticinque, Eduardo M.] Univ Fed Rio Grande Norte UFRN, Ctr Biociencias, Lab Ecol & Conservacao Biodiversidade, Natal, RN, Brazil	Institute Nacional de Pesquisas da Amazonia; Universidade Federal de Amazonas; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Monash University; Universidade Federal do Rio Grande do Norte	Pinho, GM (corresponding author), INPA, Programa Posgrad Ecol, Manaus, Amazonas, Brazil.	gabriela.m.pinho@gmail.com	Pinho, Gabriela Medeiros de/AAH-2816-2020; Hrbek, Tomas/J-6988-2012; Venticinque, Eduardo M/G-8961-2015; Farias, Izeni Pires/J-3069-2014	Pinho, Gabriela Medeiros de/0000-0003-4671-8221; Hrbek, Tomas/0000-0003-3239-7068; Venticinque, Eduardo M/0000-0002-3455-9107; Farias, Izeni Pires/0000-0002-1416-4351; Goncalves da Silva, Anders/0000-0002-2257-8781	National Council for Scientific and Technological Development (CNPq)/ Sistema Nacional de Pesquisa em Biodiversidade/ BioPHAM [563348/2010-0]; Uatuma Biological Reserve; CNPq [307997/2009-0]	National Council for Scientific and Technological Development (CNPq)/ Sistema Nacional de Pesquisa em Biodiversidade/ BioPHAM(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Uatuma Biological Reserve; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The National Council for Scientific and Technological Development (CNPq)/ Sistema Nacional de Pesquisa em Biodiversidade/ BioPHAM (http://www. cnpq.br/) provided funding for data collection and laboratory analysis (IPF Proc 563348/2010-0). The field logistics were supported by the Uatuma Biological Reserve. GMP received reagents and equipment from IDEA WILD (http://www.ideawild.org/) and a Master's fellowship from CNPq. EMV had funding from CNPq (Proc 307997/2009-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barongi R. A., 1993, International Zoo Yearbook, V32, P7; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beja-Pereira A, 2009, MOL ECOL RESOUR, V9, P1279, DOI 10.1111/j.1755-0998.2009.02699.x; Belkhir K, 2002, MOL ECOL NOTES, V2, P611, DOI 10.1046/j.1471-8286.2002.00273.x; Bellemain E, 2005, CONSERV BIOL, V19, P150, DOI 10.1111/j.1523-1739.2005.00549.x; Bjornstad O. N, 2012, NCF SPATIAL NONPARAM; Blouin MS, 2003, TRENDS ECOL EVOL, V18, P503, DOI 10.1016/S0169-5347(03)00225-8; Brinkman TJ, 2010, CONSERV GENET, V11, P1547, DOI 10.1007/s10592-009-9928-7; Broquet T, 2007, CONSERV GENET, V8, P249, DOI 10.1007/s10592-006-9146-5; CAUGHLEY G, 1966, ECOLOGY, V47, P906, DOI 10.2307/1935638; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Crawford AM, 1996, GENOME RES, V6, P876, DOI 10.1101/gr.6.9.876; da Silva AG, 2009, CONSERV GENET RESOUR, V1, P39, DOI 10.1007/s12686-009-9009-8; de Thoisy B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-278; de Thoisy Benoit, 2006, Tapir Conservation, V15, P14; DeWoody JA, 2004, BIOTECHNIQUES, V37, P348, DOI 10.2144/04373BM02; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Earl Cranbrook, 2013, INTEGR ZOOL, V8, P95, DOI 10.1111/j.1749-4877.2012.00319.x; EISENBERG J F, 1973, Biotropica, V5, P150, DOI 10.2307/2989807; Environmental Systems Research Institute (ESRI), 2008, ARCGIS 9 3; Epperson BK, 1996, P NATL ACAD SCI USA, V93, P10528, DOI 10.1073/pnas.93.19.10528; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farrell LE, 2000, MOL ECOL, V9, P1583, DOI 10.1046/j.1365-294x.2000.01037.x; Foerster CR, 2002, BIOTROPICA, V34, P423, DOI 10.1111/j.1744-7429.2002.tb00556.x; Garcia MJ, 2012, INTEGR ZOOL, V7, P346, DOI 10.1111/j.1749-4877.2012.00317.x; Garnier JN, 2001, MOL ECOL, V10, P2031, DOI 10.1046/j.0962-1083.2001.01338.x; GEIST V, 1974, AM ZOOL, V14, P205, DOI 10.1093/icb/14.1.205; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Goncalves da Silva A, 2010, J HERED, V101, P581, DOI 10.1093/jhered/esq055; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hirsch BT, 2013, ANIM BEHAV, V85, P463, DOI 10.1016/j.anbehav.2012.12.011; HOLMES WG, 1983, AM SCI, V71, P46; Holzhauer SIJ, 2006, LANDSCAPE ECOL, V21, P891, DOI 10.1007/s10980-005-0438-9; Instituto Brasileiro do Meio Ambiente e dos Recursos Naturais Renovaveis, 1997, PLAN MAN FAS 1 RES B; JANIS CM, 1988, TRENDS ECOL EVOL, V3, P291, DOI 10.1016/0169-5347(88)90104-8; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Jordan NR, 2007, ANIM BEHAV, V73, P613, DOI 10.1016/j.anbehav.2006.06.010; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kitchen AM, 2005, J ANIM ECOL, V74, P1173, DOI 10.1111/j.1365-2656.2005.01017.x; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Kuhner MK, 2009, TRENDS ECOL EVOL, V24, P86, DOI 10.1016/j.tree.2008.09.007; Longmire JL, 1988, GENOMICS, V2, P14, DOI 10.1016/0888-7543(88)90104-8; Lucchini V, 2002, MOL ECOL, V11, P857, DOI 10.1046/j.1365-294X.2002.01489.x; Lynch M, 1999, GENETICS, V152, P1753; MacFadden BJ, 2006, TRENDS ECOL EVOL, V21, P157, DOI 10.1016/j.tree.2005.12.003; McEachern MB, 2007, BEHAV ECOL SOCIOBIOL, V61, P1459, DOI 10.1007/s00265-007-0378-2; Medici E. P, 2010, ASSESSING VIABILITY; MELNICK DJ, 1992, INT J PRIMATOL, V13, P379, DOI 10.1007/BF02547824; Norton JE, 2004, ANIM CONSERV, V7, P211, DOI 10.1017/S1367943004001295; Noss A.J., 2003, Tapir Conservation, V12, P24; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; POPE TR, 1992, EVOLUTION, V46, P1112, DOI 10.1111/j.1558-5646.1992.tb00623.x; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; RALLS K, 1971, SCIENCE, V171, P443, DOI 10.1126/science.171.3970.443; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Rooney AP, 1999, J MOL EVOL, V49, P682, DOI 10.1007/PL00006589; ROPER TJ, 1993, BEHAVIOUR, V127, P289, DOI 10.1163/156853993X00074; Ross KG, 2001, MOL ECOL, V10, P265, DOI 10.1046/j.1365-294x.2001.01191.x; Rostain RR, 2004, ANIM BEHAV, V68, P703, DOI 10.1016/j.anbehav.2003.10.027; Sanches A, 2009, CONSERV GENET RESOUR, V1, P115, DOI 10.1007/s12686-009-9028-5; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Spong G, 2000, MOL ECOL, V9, P1773, DOI 10.1046/j.1365-294x.2000.01067.x; Storz JF, 1999, J MAMMAL, V80, P553, DOI 10.2307/1383301; Taberlet P, 1999, BIOL J LINN SOC, V68, P41, DOI 10.1111/j.1095-8312.1999.tb01157.x; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Team R. D. C, 2011, R LANG ENV STAT COMP; Temple HJ, 2006, MOL ECOL, V15, P3449, DOI 10.1111/j.1365-294X.2006.03006.x; Tobler MW., 2008, ECOLOGY LOWLAND TAPI; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van de Casteele T, 2001, MOL ECOL, V10, P1539, DOI 10.1046/j.1365-294X.2001.01288.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; WALDMAN B, 1988, ANNU REV ECOL SYST, V19, P543; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; WASER PM, 1983, Q REV BIOL, V58, P355, DOI 10.1086/413385; Wright S., 1969, THEORY GENE FREQUENC, V2, P520; Wronski T, 2006, BEHAV ECOL SOCIOBIOL, V59, P819, DOI 10.1007/s00265-005-0128-2; Wronski T, 2005, J ZOOL, V266, P227, DOI 10.1017/S0952836905006825	83	10	10	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92507	10.1371/journal.pone.0092507	http://dx.doi.org/10.1371/journal.pone.0092507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671057	Green Published, gold			2022-12-27	WOS:000333677000048
J	Wagner, F; Rossi, V; Aubry-Kientz, M; Bonal, D; Dalitz, H; Gliniars, R; Stahl, C; Trabucco, A; Herault, B				Wagner, Fabien; Rossi, Vivien; Aubry-Kientz, Melaine; Bonal, Damien; Dalitz, Helmut; Gliniars, Robert; Stahl, Clement; Trabucco, Antonio; Herault, Bruno			Pan-Tropical Analysis of Climate Effects on Seasonal Tree Growth	PLOS ONE			English	Article							RAIN-FOREST TREE; SEMI-DECIDUOUS FOREST; CARBON DYNAMICS; INTERANNUAL VARIABILITY; EXPERIMENTAL DROUGHT; CAMBIUM ACTIVITY; CENTRAL AMAZON; DRY SEASON; WATER-USE; PHENOLOGY	Climate models predict a range of changes in tropical forest regions, including increased average temperatures, decreased total precipitation, reduced soil moisture and alterations in seasonal climate variations. These changes are directly related to the increase in anthropogenic greenhouse gas concentrations, primarily CO2. Assessing seasonal forest growth responses to climate is of utmost importance because woody tissues, produced by photosynthesis from atmospheric CO2, water and light, constitute the main component of carbon sequestration in the forest ecosystem. In this paper, we combine intra-annual tree growth measurements from published tree growth data and the corresponding monthly climate data for 25 pan-tropical forest sites. This meta-analysis is designed to find the shared climate drivers of tree growth and their relative importance across pan-tropical forests in order to improve carbon uptake models in a global change context. Tree growth reveals significant intra-annual seasonality at seasonally dry sites or in wet tropical forests. Of the overall variation in tree growth, 28.7% was explained by the site effect, i.e. the tree growth average per site. The best predictive model included four climate variables: precipitation, solar radiation (estimated with extrasolar radiation reaching the atmosphere), temperature amplitude and relative soil water content. This model explained more than 50% of the tree growth variations across tropical forests. Precipitation and solar radiation are the main seasonal drivers of tree growth, causing 19.8% and 16.3% of the tree growth variations. Both have a significant positive association with tree growth. These findings suggest that forest productivity due to tropical tree growth will be reduced in the future if climate extremes, such as droughts, become more frequent.	[Wagner, Fabien] Natl Inst Space Res INPE, Remote Sensing Div, Sao Jose Dos Campos, SP, Brazil; [Wagner, Fabien; Stahl, Clement; Herault, Bruno] Cirad, UMR Ecol Forets Guyane 93, Kourou, France; [Rossi, Vivien] Cirad, UR Biens & Serv Ecosyst Forestiers Trop 105, Montpellier, France; [Rossi, Vivien] Univ Yaounde I, UMI Modelisat Math & Informat Syst Complexes 209, Yaounde, Cameroon; [Aubry-Kientz, Melaine] Univ Antilles Guyane, UMR Ecol Forets Guyane 93, Kourou, France; [Bonal, Damien] INRA, UMR EEF 1137, Champenoux, France; [Dalitz, Helmut; Gliniars, Robert] Univ Hohenheim, Inst Bot, Stuttgart, Germany; [Stahl, Clement] CIRAD, UMR Syst Elevage Milieux Mediterraneens & Trop, Kourou, France; [Trabucco, Antonio] Euromediterranean Ctr Climate Change, Sassari, Italy; [Trabucco, Antonio] Katholieke Univ Leuven, Div Forest Nat & Landscape, Leuven, Belgium	Instituto Nacional de Pesquisas Espaciais (INPE); CIRAD; CIRAD; UDICE-French Research Universities; Sorbonne Universite; Cadi Ayyad University of Marrakech; Hanoi University of Science & Technology; Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar; University of Yaounde I; INRAE; Universite de Lorraine; University Hohenheim; CIRAD; Centro Euro-Mediterraneo sui Cambiamenti Climatici (CMCC); KU Leuven	Wagner, F (corresponding author), Natl Inst Space Res INPE, Remote Sensing Div, Sao Jose Dos Campos, SP, Brazil.	wagner.h.fabien@gmail.com	Wagner, Fabien FW/B-8364-2013; Hérault, Bruno/B-2765-2011; Rossi, Vivien/C-9721-2009	Wagner, Fabien FW/0000-0002-9623-1182; Hérault, Bruno/0000-0002-6950-7286; Rossi, Vivien/0000-0001-5458-1523; Trabucco, Antonio/0000-0002-0743-3680	Climfor (Fondation pour la Recherche sur la Biodiversite); Guyasim (European structural fundings, PO-Feder); Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [13/14520-6]; Agence Nationale de la Recherche (CEBA) [ANR-10-LABX-0025]	Climfor (Fondation pour la Recherche sur la Biodiversite); Guyasim (European structural fundings, PO-Feder); Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Agence Nationale de la Recherche (CEBA)(French National Research Agency (ANR))	Funding came from the project Climfor (Fondation pour la Recherche sur la Biodiversite, www.fondationbiodiversite.fr/), from the project Guyasim (European structural fundings, PO-Feder, http://www.europe-guyane.eu/index.php?option = com_content&task= view&id =14&Itemid = 206), and from the Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, processo 13/14520-6, http://www.bv.fapesp.br/pt/bolsas/146751/quantificacao-e-modelagem-da-sazonalidade-da-producao-primaria-liquida-florestal-pantropical-usando-/). This work has also benefited from an "Investissement d'Avenir" grant managed by Agence Nationale de la Recherche (CEBA, ref. ANR-10-LABX-0025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R.G., 1998, FAO IRRIGATION DRAIN, DOI DOI 10.1016/J.EJA.2010.12.001; Allen R.G., 1994, ICID B, V43, P35; Arias PA, 2011, CLIM DYNAM, V37, P1151, DOI 10.1007/s00382-010-0903-2; Baker PJ, 2008, AUST J BOT, V56, P311, DOI 10.1071/BT08040; Baker TR, 2003, PERSPECT PLANT ECOL, V6, P21, DOI 10.1078/1433-8319-00040; Baker TR, 2002, FOREST ECOL MANAG, V171, P261, DOI 10.1016/S0378-1127(01)00787-3; Barnett, 2010, ANAL SEASONAL HLTH D; Bates D., 2013, LME4 LINEAR MIXED EF; Batjes NH, 1997, SOIL USE MANAGE, V13, P9, DOI 10.1111/j.1475-2743.1997.tb00550.x; Batjes NH, 2012, TECHNICAL REPORT; Zanon MLB, 2010, CIENC FLOREST, V20, P467, DOI 10.5902/198050982061; Bonal D, 2008, GLOBAL CHANGE BIOL, V14, P1917, DOI 10.1111/j.1365-2486.2008.01610.x; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Borchert R, 1999, IAWA J, V20, P239, DOI 10.1163/22941932-90000687; Borchert R, 1998, CLIMATIC CHANGE, V39, P381, DOI 10.1023/A:1005383020063; Bradley AV, 2011, GLOBAL CHANGE BIOL, V17, P2245, DOI 10.1111/j.1365-2486.2011.02405.x; Brauning A, 2009, ERDKUNDE, V63, P337, DOI 10.3112/erdkunde.2009.04.04; Brando PM, 2008, PHILOS T R SOC B, V363, P1839, DOI 10.1098/rstb.2007.0031; Brando PM, 2010, P NATL ACAD SCI USA, V107, P14685, DOI 10.1073/pnas.0908741107; Braswell BH, 1997, SCIENCE, V278, P870, DOI 10.1126/science.278.5339.870; Brienen RJW, 2011, TREES-STRUCT FUNCT, V25, P103, DOI 10.1007/s00468-010-0474-1; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cardoso FCG, 2012, PLANT SOIL, V354, P269, DOI 10.1007/s11104-011-1063-9; Chambers JQ, 2004, OECOLOGIA, V141, P596, DOI 10.1007/s00442-004-1676-2; Chave J, 2003, J ECOL, V91, P240, DOI 10.1046/j.1365-2745.2003.00757.x; Clark DA, 2003, P NATL ACAD SCI USA, V100, P5852, DOI 10.1073/pnas.0935903100; Clark DB, 2010, GLOBAL CHANGE BIOL, V16, P747, DOI 10.1111/j.1365-2486.2009.02004.x; Clark DA, 2013, J GEOPHYS RES-BIOGEO, V118, P783, DOI 10.1002/jgrg.20067; Condit R, 2004, J TROP ECOL, V20, P51, DOI 10.1017/S0266467403001081; Couralet C, 2010, BIOTROPICA, V42, P503, DOI 10.1111/j.1744-7429.2009.00613.x; da Silva RP, 2002, FOREST ECOL MANAG, V166, P295, DOI 10.1016/S0378-1127(01)00678-8; DAUBENMIRE R, 1972, J ECOL, V60, P147, DOI 10.2307/2258048; Detienne P, 1988, REV BOIS FORETS TROP; DEVINEAU JL, 1991, REV ECOL-TERRE VIE, V46, P95; Doughty CE, 2008, J GEOPHYS RES-BIOGEO, V113, DOI [10.1029/2007JG000632, 10.1029/2007JG000590]; Doughty CE, 2011, BIOTROPICA, V43, P658, DOI 10.1111/j.1744-7429.2010.00746.x; Ekstrom M, 2007, HYDROL EARTH SYST SC, V11, P1069, DOI 10.5194/hess-11-1069-2007; Enquist BJ, 2001, J TROP ECOL, V17, P41, DOI 10.1017/S0266467401001031; FAO, 2012, TECHNICAL REPORT; Feeley KJ, 2007, P ROY SOC B-BIOL SCI, V274, P2857, DOI 10.1098/rspb.2007.0954; Feng X, 2013, NAT CLIM CHANGE, V3, P811, DOI [10.1038/nclimate1907, 10.1038/NCLIMATE1907]; Field C, 2012, IPCC 2012 MANAGING R, DOI [10.1136/jech-2012-201045, DOI 10.1136/JECH-2012-201045]; Figueira A, 2011, LBA ECO CD 04 DENDRO, DOI [10.3334/ornldaac/989, DOI 10.3334/0RNLDAAC/989]; Franks PJ, 1999, PLANT CELL ENVIRON, V22, P1337, DOI 10.1046/j.1365-3040.1999.00494.x; Gliniars R, 2012, DATA FROM BIOTA E AF; Gliniars R, 2013, TREES-STRUCT FUNCT, V27, P1129, DOI 10.1007/s00468-013-0863-3; Goetz S, 2011, CARBON MANAG, V2, P231, DOI 10.4155/CMT.11.18; Graham EA, 2003, P NATL ACAD SCI USA, V100, P572, DOI 10.1073/pnas.0133045100; Granier A, 1999, ECOL MODEL, V116, P269, DOI 10.1016/S0304-3800(98)00205-1; Grogan J, 2012, BIOTROPICA, V44, P331, DOI 10.1111/j.1744-7429.2011.00825.x; Gurka MJ, 2006, AM STAT, V60, P19, DOI 10.1198/000313006X90396; Harris NL, 2008, ECOL MODEL, V216, P253, DOI 10.1016/j.ecolmodel.2008.04.008; Herault B, 2011, J ECOL, V99, P1431, DOI 10.1111/j.1365-2745.2011.01883.x; Herault B, 2010, J APPL ECOL, V47, P821, DOI 10.1111/j.1365-2664.2010.01826.x; Houghton RA, 2005, GLOBAL CHANGE BIOL, V11, P945, DOI 10.1111/j.1365-2486.2005.00955.x; Huete AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025583; Hutyra LR, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000365; JANZEN D H, 1974, Biotropica, V6, P260, DOI 10.2307/2989669; Krepkowski J, 2011, TREES-STRUCT FUNCT, V25, P59, DOI 10.1007/s00468-010-0460-7; Susan GWL, 2009, J VEG SCI, V20, P323, DOI 10.1111/j.1654-1103.2009.01044.x; Lewis SL, 2009, ANNU REV ECOL EVOL S, V40, P529, DOI 10.1146/annurev.ecolsys.39.110707.173345; LIEBERMAN D, 1982, J ECOL, V70, P791, DOI 10.2307/2260105; Lisi CS, 2008, IAWA J, V29, P189, DOI 10.1163/22941932-90000179; Lloyd J, 2008, PHILOS T R SOC B, V363, P1811, DOI 10.1098/rstb.2007.0032; da Costa ACL, 2010, NEW PHYTOL, V187, P579, DOI 10.1111/j.1469-8137.2010.03309.x; Lopez-Ayala JL, 2006, AGROCIENCIA-MEXICO, V40, P139; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; MARENGO JA, 1992, INT J CLIMATOL, V12, P853, DOI 10.1002/joc.3370120808; Metcalf CJE, 2009, J TROP ECOL, V25, P1, DOI 10.1017/S0266467408005646; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Nath CD, 2006, J BIOSCIENCES, V31, P651, DOI 10.1007/BF02708418; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Nepstad DC, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000360; Ohashi S, 2009, TREES-STRUCT FUNCT, V23, P813, DOI 10.1007/s00468-009-0322-3; Ohashi Y, 2001, HOLZFORSCHUNG, V55, P151, DOI 10.1515/HF.2001.024; Oliveira JM, 2009, TREES-STRUCT FUNCT, V23, P107, DOI 10.1007/s00468-008-0259-y; Orelien JG, 2008, COMPUT STAT DATA AN, V52, P1896, DOI 10.1016/j.csda.2007.06.006; Orlowsky B, 2012, CLIMATIC CHANGE, V110, P669, DOI 10.1007/s10584-011-0122-9; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pelissier R, 2000, J TROP ECOL, V16, P429, DOI 10.1017/S0266467400001498; Pennec A, 2011, REMOTE SENS LETT, V2, P337, DOI 10.1080/01431161.2010.507610; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Poorter L, 2007, ECOLOGY, V88, P1000, DOI 10.1890/06-0984; Reichstein M, 2002, FUNCT ECOL, V16, P27, DOI 10.1046/j.0269-8463.2001.00597.x; Rozendaal DMA, 2011, TREES-STRUCT FUNCT, V25, P3, DOI 10.1007/s00468-010-0480-3; Ruger N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025330; Saatchi SS, 2007, GLOBAL CHANGE BIOL, V13, P816, DOI 10.1111/j.1365-2486.2007.01323.x; Saleska SR, 2003, SCIENCE, V302, P1554, DOI 10.1126/science.1091165; Schenk H, 2009, ISLSCP INITIATIVE 2, DOI [10.3334/ORNLDAAC/929, 10.3334/ORNLDAAC/929., DOI 10.3334/ORNLDAAC/929]; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sheil D, 2003, CAN J FOREST RES, V33, P2027, DOI 10.1139/X03-121; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P19; Sombroek W, 2001, AMBIO, V30, P388, DOI 10.1639/0044-7447(2001)030[0388:SATPOA]2.0.CO;2; Spracklen DV, 2012, NATURE, V489, P282, DOI 10.1038/nature11390; Stahl C, 2010, J TROP ECOL, V26, P393, DOI 10.1017/S0266467410000155; Stark SC, 2012, ECOL LETT, V15, P1406, DOI 10.1111/j.1461-0248.2012.01864.x; Tian HQ, 1998, NATURE, V396, P664, DOI 10.1038/25328; Toledo M, 2011, J ECOL, V99, P254, DOI 10.1111/j.1365-2745.2010.01741.x; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; Vieira S, 2004, OECOLOGIA, V140, P468, DOI 10.1007/s00442-004-1598-z; Vincent G, 2012, DATA IRD WORLD AGROF; Volland-Voigt F, 2011, TREES-STRUCT FUNCT, V25, P39, DOI 10.1007/s00468-010-0461-6; Vonesh EF, 1996, BIOMETRICS, V52, P572, DOI 10.2307/2532896; Wagner F, 2013, BIOGEOSCI DISCUSS, V10, P8247; Wagner F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034074; Wagner F, 2011, AGR FOREST METEOROL, V151, P1202, DOI 10.1016/j.agrformet.2011.04.012; Way DA, 2010, TREE PHYSIOL, V30, P669, DOI 10.1093/treephys/tpq015; Worbes M, 1999, J ECOL, V87, P391, DOI 10.1046/j.1365-2745.1999.00361.x; Wright SJ, 2010, ANN NY ACAD SCI, V1195, P1, DOI [10.1111/j.1749-6632.2009.05400.x, 10.1111/j.1749-6632.2010.05455.x]; Wurth MKR, 2005, OECOLOGIA, V143, P11, DOI 10.1007/s00442-004-1773-2; Xiao XM, 2006, REMOTE SENS ENVIRON, V103, P465, DOI 10.1016/j.rse.2006.04.013; Zorner RJ, 2008, AGR ECOSYST ENVIRON, V126, P67, DOI 10.1016/j.agee.2008.01.014	118	48	50	4	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92337	10.1371/journal.pone.0092337	http://dx.doi.org/10.1371/journal.pone.0092337			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670981	Green Published, gold			2022-12-27	WOS:000333677000040
J	Wickramarathna, LN; Noss, C; Lorke, A				Wickramarathna, Lalith N.; Noss, Christian; Lorke, Andreas			Hydrodynamic Trails Produced by Daphnia: Size and Energetics	PLOS ONE			English	Article							FREELY SWIMMING COPEPOD; STEADY MOTION; FLOW-FIELD; BEHAVIOR; TURBULENCE; EFFICIENCY; ORGANISMS; MODEL; OCEAN	This study focuses on quantifying hydrodynamic trails produced by freely swimming zooplankton. We combined volumetric tracking of swimming trajectories with planar observations of the flow field induced by Daphnia of different size and swimming in different patterns. Spatial extension of the planar flow field along the trajectories was used to interrogate the dimensions (length and volume) and energetics (dissipation rate of kinetic energy and total dissipated power) of the trails. Our findings demonstrate that neither swimming pattern nor size of the organisms affect the trail width or the dissipation rate. However, we found that the trail volume increases with increasing organism size and swimming velocity, more precisely the trail volume is proportional to the third power of Reynolds number. This increase furthermore results in significantly enhanced total dissipated power at higher Reynolds number. The biggest trail volume observed corresponds to about 500 times the body volume of the largest daphnids. Trail-averaged viscous dissipation rate of the swimming daphnids vary in the range of 1.8 x 10(-6) W/kg to 3.4 x 10(-6) W/kg and the observed magnitudes of total dissipated power between 1.3 x 10(-9) W and 1 x 10(-8) W, respectively. Among other zooplankton species, daphnids display the highest total dissipated power in their trails. These findings are discussed in the context of fluid mixing and transport by organisms swimming at intermediate Reynolds numbers.	[Wickramarathna, Lalith N.; Noss, Christian; Lorke, Andreas] Univ Koblenz Landau, Inst Environm Sci, Koblenz Landau, Germany	University of Koblenz & Landau	Wickramarathna, LN (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Koblenz Landau, Germany.	lalith@uni-landau.de	Lorke, Andreas/B-9195-2008	Lorke, Andreas/0000-0001-5533-1817	German Research Foundation [LO 1150/6-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by the German Research Foundation (URL: www.dfg.de) (grant no. LO 1150/6-1). The proposal prepared by CN and AL based on preliminary work conducted, was submitted to and approved by the listed agency. The agency had no direct say in the methods or outcome of the project beyond providing funding for materials, and did not directly contribute to the writing of this manuscript. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, GUID TEST CHEM 202; Ardekani AM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.084502; BAKER MA, 1987, J PHYS OCEANOGR, V17, P1817, DOI 10.1175/1520-0485(1987)017<1817:STITSO>2.0.CO;2; Borazjani I, 2010, J EXP BIOL, V213, P3019, DOI 10.1242/jeb.043588; Dabiri JO, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043556; Dantec Dynamics A/S, 2012, DYNAMICSTUDIO V3 20; Dewar WK, 2006, J MAR RES, V64, P541, DOI 10.1357/002224006778715720; Doostmohammadi A, 2012, P NATL ACAD SCI USA, V109, P3856, DOI 10.1073/pnas.1116210109; Duren LA, 2003, J EXP BIOL, V206, P255; EAMES I, 1994, J FLUID MECH, V275, P201, DOI 10.1017/S0022112094002338; Elsinga GE, 2006, EXP FLUIDS, V41, P933, DOI 10.1007/s00348-006-0212-z; Fields DM, 1997, J PLANKTON RES, V19, P79, DOI 10.1093/plankt/19.1.79; Gries T, 1999, J PLANKTON RES, V21, P509, DOI 10.1093/plankt/21.3.509; Huntley ME, 2004, MAR ECOL PROG SER, V273, P65, DOI 10.3354/meps273065; Jiang HS, 2011, J EXP BIOL, V214, P476, DOI 10.1242/jeb.049288; Jiang HS, 2004, SURV GEOPHYS, V25, P339, DOI 10.1007/s10712-003-1282-6; Jiang HS, 2002, J PLANKTON RES, V24, P191, DOI 10.1093/plankt/24.3.191; Jiang HS, 2002, J PLANKTON RES, V24, P167, DOI 10.1093/plankt/24.3.167; Katija K, 2009, NATURE, V460, P624, DOI 10.1038/nature08207; Kiorboe T, 2007, LIMNOL OCEANOGR, V52, P1511, DOI 10.4319/lo.2007.52.4.1511; Kiorboe T, 2011, BIOL REV, V86, P311, DOI 10.1111/j.1469-185X.2010.00148.x; Kiorboe T, 2010, P ROY SOC B-BIOL SCI, V277, P3229, DOI 10.1098/rspb.2010.0629; KIRK KL, 1985, LIMNOL OCEANOGR, V30, P679, DOI 10.4319/lo.1985.30.3.0679; Kohlhage K, 1994, ZOOL BEITR, V35, P47; Kundu P.K, 2008, FLUID MECH; Kunze E, 2011, J MAR RES, V69, P591, DOI 10.1357/002224011799849435; Lauga E, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/9/096601; LEAL LG, 1980, ANNU REV FLUID MECH, V12, P435, DOI 10.1146/annurev.fl.12.010180.002251; Leshansky AM, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.025301; Lombard F, 2013, LIMNOL OCEANOGR, V58, P185, DOI 10.4319/lo.2013.58.1.0185; Mathews J. H., 2004, NUMERICAL METHODS US; MORRIS MJ, 1985, MAR BIOL, V86, P283, DOI 10.1007/BF00397515; MORRIS MJ, 1990, MAR BIOL, V107, P83, DOI 10.1007/BF01313245; Noss C, 2013, LIMNOL OCEANOGR-METH, V11, P139, DOI 10.4319/lom.2013.11.139; Noss C, 2014, LIMNOL OCEA IN PRESS; Noss C, 2012, WATER QUAL RES J CAN, V47, P276, DOI 10.2166/wqrjc.2012.135; Penalva-Arana DC, 2007, HYDROBIOLOGIA, V594, P153, DOI 10.1007/s10750-007-9080-7; Pijanowska J, 1997, FRESHWATER BIOL, V37, P649, DOI 10.1046/j.1365-2427.1997.00192.x; PRICE HJ, 1989, LIMNOL OCEANOGR, V34, P649, DOI 10.4319/lo.1989.34.4.0649; RANTA E, 1993, ANN ZOOL FENN, V30, P299; Ringelberg J, 1999, BIOL REV, V74, P397, DOI 10.1017/S0006323199005381; Ringelberg Joop, 1997, Advances in Limnology, V49, P71; Schlichting H, 1977, BOUNDARY LAYER THEOR, P234; Seuront Laurent, 2004, P333; Stamhuis EJ, 2002, EXP FLUIDS, V33, P801, DOI [10.1007/s00348-002-0520-x, 10.1007/s00348-002-0520-X]; Strutton PG, 2007, HDB SCALING METHODS, P338; Tennekes H, 1973, 1 COURSE TURBULENCE; TISELIUS P, 1992, LIMNOL OCEANOGR, V37, P1640, DOI 10.4319/lo.1992.37.8.1640; van Gool E, 1997, J PLANKTON RES, V19, P2041, DOI 10.1093/plankt/19.12.2041; Videler JJ, 2002, INTEGR COMP BIOL, V42, P988, DOI 10.1093/icb/42.5.988; Visser AW, 2009, J PLANKTON RES, V31, P121, DOI 10.1093/plankt/fbn109; Visser AW, 2001, MAR ECOL PROG SER, V222, P1, DOI 10.3354/meps222001; Walker JA, 2002, INTEGR COMP BIOL, V42, P232, DOI 10.1093/icb/42.2.232; Woodson CB, 2007, LIMNOL OCEANOGR, V52, P2701, DOI 10.4319/lo.2007.52.6.2701; WU JS, 1993, AIAA J, V31, P1448, DOI 10.2514/3.11794; Yen J, 1996, INVERTEBR BIOL, V115, P191, DOI 10.2307/3226930; Yen J, 2000, BIOL BULL, V198, P213, DOI 10.2307/1542525	58	34	34	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92383	10.1371/journal.pone.0092383	http://dx.doi.org/10.1371/journal.pone.0092383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671019	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000042
J	Cartland, SP; Erlich, JH; Kavurma, MM				Cartland, Sian P.; Erlich, Jonathan H.; Kavurma, Mary M.			TRAIL Deficiency Contributes to Diabetic Nephropathy in Fat-Fed ApoE(-/-) Mice	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; NF-KAPPA-B; CYSTATIN-C; KIDNEY-FUNCTION; RENAL-DISEASE; MARKER; ATHEROSCLEROSIS; INFLAMMATION; EXPRESSION; ACTIVATION	Background: We recently demonstrated that TNF-related apoptosis-inducing ligand (TRAIL) is protective of diet-induced diabetes in mice. While TRAIL has been implicated in chronic kidney disease, its role in vivo in diabetic nephropathy is not clear. The present study investigated the role of TRAIL in the pathogenesis of diabetic nephropathy using TRAIL(-/-)ApoE(-/-) mice. Methods: TRAIL(-/-)ApoE(-/-) and ApoE(-/-) mice were fed a high fat diet for 20 w. Plasma glucose and insulin levels were assessed over 0, 5, 8 and 20 w. At 20 w, markers of kidney function including creatinine, phosphate, calcium and cystatin C were measured. Changes in mRNA expression of MMPs, TIMP-1, IL-1 beta and IL-18 were assessed in the kidney. Functional and histological changes in kidneys were examined. Glucose and insulin tolerance tests were performed. Results: TRAIL(-/-)ApoE(-/-) mice had significantly increased urine protein, urine protein: creatinine ratio, plasma phosphorous, and plasma cystatin C, with accelerated nephropathy. Histologically, increased extracellular matrix, mesangial expansion and mesangial cell proliferation in the glomeruli were observed. Moreover, TRAIL(-/-)ApoE(-/-) kidneys displayed loss of the brush border and disorganisation of tubular epithelium, with increased fibrosis. TRAIL-deficient kidneys also had increased expression of MMPs, TIMP-1, PAI-1, IL-1 beta and IL-18, markers of renal injury and inflammation. Compared with ApoE(-/-) mice, TRAIL(-/-)ApoE(-/-) mice displayed insulin resistance and type-2 diabetic features with reduced renal insulin-receptor expression. Conclusions: Here, we show that TRAIL-deficiency in ApoE(-/-) mice exacerbates nephropathy and insulin resistance. Understanding TRAIL signalling in kidney disease and diabetes, may therefore lead to novel strategies for the treatment of diabetic nephropathy.	[Cartland, Sian P.; Kavurma, Mary M.] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Erlich, Jonathan H.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Cartland, Sian P.; Kavurma, Mary M.] Heart Res Inst, Sydney, NSW, Australia; [Kavurma, Mary M.] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; Heart Research Institute; University of Sydney	Kavurma, MM (corresponding author), Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia.	mary.kavurma@hri.org.au	Erlich, Jonathan/AAJ-6310-2020; Erlich, Jonathan/AAB-7292-2021	Erlich, Jonathan/0000-0002-4447-2179; Cartland, Sian/0000-0003-1723-2679; Kavurma, Mary/0000-0001-7353-0932	Heart Foundation Career Development Fellowship [CR 12S 6833]	Heart Foundation Career Development Fellowship	MMK is supported by a Heart Foundation Career Development Fellowship (CR 12S 6833). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelidis C, 2013, CURR TOP MED CHEM, V13, P164, DOI 10.2174/1568026611313020006; Azahri NSM, 2013, CELL MOL LIFE SCI, V70, P3617, DOI 10.1007/s00018-013-1264-x; Benito-Martin A, 2009, NEFROLOGIA, V29, P13, DOI 10.3265/Nefrologia.2009.29.1.13.1.en.full.pdf; Candido R, 2014, CURR OPIN NEPHROL HY, V23, P69, DOI 10.1097/01.mnh.0000437611.42417.7a; Chan J, 2010, CIRC RES, V106, P1061, DOI 10.1161/CIRCRESAHA.109.206029; Chang YH, 2011, METABOLISM, V60, P1064, DOI 10.1016/j.metabol.2010.11.002; Charlesworth JA, 2005, METABOLISM, V54, P821, DOI 10.1016/j.metabol.2005.01.028; Chasseraud M, 2011, THER APHER DIAL, V15, P140, DOI 10.1111/j.1744-9987.2010.00886.x; Chen Bing, 2008, Zhonghua Yi Xue Za Zhi, V88, P540; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Di Bartolo BA, 2011, DIABETOLOGIA, V54, P3157, DOI 10.1007/s00125-011-2308-0; Di Bartolo BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074211; Di Pietro R, 2004, J CELL PHYSIOL, V201, P331, DOI 10.1002/jcp.20099; Diao ZJ, 2013, CANCER IMMUNOL IMMUN, V62, P653, DOI 10.1007/s00262-012-1370-x; Dorothee G, 2002, J IMMUNOL, V169, P809, DOI 10.4049/jimmunol.169.2.809; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; Fanger NA, 1999, J EXP MED, V190, P1155, DOI 10.1084/jem.190.8.1155; Griffith TS, 1999, J EXP MED, V189, P1343, DOI 10.1084/jem.189.8.1343; Grubb A, 2011, SCAND J CLIN LAB INV, V71, P145, DOI 10.3109/00365513.2010.546879; Jouan-Lanhouet S, 2012, CELL DEATH DIFFER, V19, P2003, DOI 10.1038/cdd.2012.90; Kavurma MM, 2008, ARTERIOSCL THROM VAS, V28, P1694, DOI 10.1161/ATVBAHA.107.155143; Kavurma MM, 2008, BIOCHEM PHARMACOL, V75, P1441, DOI 10.1016/j.bcp.2007.10.020; Krieg A, 2003, BRIT J CANCER, V88, P918, DOI 10.1038/sj.bjc.6600772; Lamhamedi-Cherradi SE, 2003, DIABETES, V52, P2274, DOI 10.2337/diabetes.52.9.2274; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P2596, DOI 10.1093/ndt/gfq042; Lim AKH, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/146154; Lorz C, 2008, J AM SOC NEPHROL, V19, P904, DOI 10.1681/ASN.2007050581; Lv W, 2013, PHARMACOLOGY, V92, P227, DOI 10.1159/000354600; Maisonneuve P, 2000, AM J KIDNEY DIS, V35, P157, DOI 10.1016/S0272-6386(00)70316-7; Malyszko J, 2011, TRANSPL P, V43, P1877, DOI 10.1016/j.transproceed.2011.03.035; Okura T, 2010, CLIN EXP NEPHROL, V14, P584, DOI 10.1007/s10157-010-0334-8; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Sedger LM, 2002, EUR J IMMUNOL, V32, P2246, DOI 10.1002/1521-4141(200208)32:8<2246::AID-IMMU2246>3.0.CO;2-6; Spierings DC, 2004, J HISTOCHEM CYTOCHEM, V52, P821, DOI 10.1369/jhc.3A6112.2004; Takeda K, 2002, J EXP MED, V195, P161, DOI 10.1084/jem.20011171; Van Vliet AI, 2001, J PATHOL, V193, P256; Wang PZ, 2011, LIFE SCI, V89, P839, DOI 10.1016/j.lfs.2011.09.003; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Xie Q, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-108; Yu QL, 2009, AM J PHYSIOL-HEART C, V297, pH76, DOI 10.1152/ajpheart.01285.2008; Yu XQ, 1999, AM J PATHOL, V154, P833, DOI 10.1016/S0002-9440(10)65330-8	43	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92952	10.1371/journal.pone.0092952	http://dx.doi.org/10.1371/journal.pone.0092952			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667560	Green Submitted, gold, Green Published			2022-12-27	WOS:000333675600108
J	Chang, JW; Kang, SU; Shin, YS; Kim, KI; Seo, SJ; Yang, SS; Lee, JS; Moon, E; Lee, K; Kim, CH				Chang, Jae Won; Kang, Sung Un; Shin, Yoo Seob; Kim, Kang Il; Seo, Seong Jin; Yang, Sang Sik; Lee, Jong-Soo; Moon, Eunpyo; Lee, Keunho; Kim, Chul-Ho			Non-Thermal Atmospheric Pressure Plasma Inhibits Thyroid Papillary Cancer Cell Invasion via Cytoskeletal Modulation, Altered MMP-2/-9/uPA Activity	PLOS ONE			English	Article							FOCAL ADHESION KINASE; MATRIX METALLOPROTEINASES; SIGNALING PATHWAYS; CARCINOMA-CELLS; MELANOMA-CELLS; OVARIAN-CANCER; IN-VITRO; FAK; METASTASIS; MIGRATION	Plasma, the fourth state of matter, is defined as a partially or completely ionized gas that includes a mixture of electrons and ions. Advances in plasma physics have made it possible to use non-thermal atmospheric pressure plasma (NTP) in cancer research. However, previous studies have focused mainly on apoptotic cancer cell death mediated by NTP as a potential cancer therapy. In this study, we investigated the effect of NTP on invasion or metastasis, as well as the mechanism by which plasma induces anti-migration and anti-invasion properties in human thyroid papillary cancer cell lines (BHP10-3 and TPC1). Wound healing, pull-down, and Transwell assays demonstrated that NTP reduced cell migration and invasion. In addition, NTP induced morphological changes and cytoskeletal rearrangements, as detected by scanning electron microscopy and immunocytochemistry. We also examined matrix metalloproteinase (MMP)-2/-9 and urokinase-type plasminogen activator (uPA) activity using gelatin zymography, uPA assays and RT-PCR. FAK, Src, and paxillin expression was detected using Western blot analyses and immunocytochemistry. NTP decreased FAK, Src, and paxillin expression as well as MMP/uPA activity. In conclusion, NTP inhibited the invasion and metastasis of BHP10-3 and TPC1 cells by decreasing MMP-2/-9 and uPA activities and rearranging the cytoskeleton, which is regulated by the FAK/Src complex. These findings suggest novel actions for NTP and may aid in the development of new therapeutic strategies for locally invasive and metastatic cancers.	[Chang, Jae Won; Kang, Sung Un; Shin, Yoo Seob; Seo, Seong Jin; Kim, Chul-Ho] Ajou Univ, Sch Med, Dept Otolaryngol, Suwon 441749, South Korea; [Kim, Kang Il; Yang, Sang Sik] Ajou Univ, Dept Elect & Comp Engn, Suwon 441749, South Korea; [Lee, Jong-Soo; Moon, Eunpyo] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Lee, Jong-Soo; Moon, Eunpyo] Ajou Univ, Dept Life Sci, Suwon 441749, South Korea; [Lee, Keunho] Plasma Syst & Mat PSM Amer Inc, Colorado Springs, CO USA	Ajou University; Ajou University; Ajou University; Ajou University	Kim, CH (corresponding author), Ajou Univ, Sch Med, Dept Otolaryngol, Suwon 441749, South Korea.	ostium@ajou.ac.kr	kang, sung un/AAK-8050-2021; Chang, Jae Won/R-3511-2019	Chang, Jae Won/0000-0002-6596-931X	Bio & Medical Technology Development Program of the NRF; Korean government [2012M3A9B2052870]	Bio & Medical Technology Development Program of the NRF; Korean government(Korean Government)	This research was supported by the Bio & Medical Technology Development Program of the NRF funded by the Korean government (2012M3A9B2052870). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007; Burduk PK, 2014, HEAD NECK; Caccia D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-278; Chan KT, 2009, J CELL BIOL, V185, P357, DOI 10.1083/jcb.200809110; Chen BH, 2002, J BIOL CHEM, V277, P33857, DOI 10.1074/jbc.M204429200; Entschladen F, 2004, LANCET ONCOL, V5, P254, DOI 10.1016/S1470-2045(04)01431-7; Gorla L, 2009, MOL CARCINOGEN, V48, P220, DOI 10.1002/mc.20474; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Kim CH, 2010, J BIOTECHNOL, V150, P530, DOI 10.1016/j.jbiotec.2010.10.003; Kim CH, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3449575; Kim YS, 2012, OTOLARYNG HEAD NECK, V147, P15, DOI 10.1177/0194599812439277; Kornberg LJ, 2007, MICROVASC RES, V73, P157, DOI 10.1016/j.mvr.2007.02.005; Kramer A, 2008, GMS KRANKENHHYG INTE, V3; Kwiatkowska A, 2011, BBA-MOL CELL RES, V1813, P655, DOI 10.1016/j.bbamcr.2011.01.020; Lee BS, 2012, CANCER LETT, V322, P45, DOI 10.1016/j.canlet.2012.02.007; Lim YC, 2008, CANCER LETT, V271, P140, DOI 10.1016/j.canlet.2008.05.048; Lu ZJ, 2012, TOXICOL LETT, V209, P211, DOI 10.1016/j.toxlet.2011.12.022; Luo M, 2009, CANCER RES, V69, P466, DOI 10.1158/0008-5472.CAN-08-3078; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Nomura H, 1996, INT J CANCER, V69, P9, DOI 10.1002/(SICI)1097-0215(19960220)69:1<9::AID-IJC3>3.0.CO;2-8; O'Neill CJ, 2013, ANZ J SURG; Ota I, 2013, ONCOL REP, V30, P1593, DOI 10.3892/or.2013.2659; Owens LV, 1996, ANN SURG ONCOL, V3, P100, DOI 10.1007/BF02409059; Panngom K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.168; Rahmani Nasrin, 2013, Med Glas (Zenica), V10, P164; Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396; Sensenig R, 2011, ANN BIOMED ENG, V39, P674, DOI 10.1007/s10439-010-0197-x; Shibata K, 1998, CANCER RES, V58, P900; Shih YW, 2010, CELL BIOCHEM BIOPHYS, V58, P31, DOI 10.1007/s12013-010-9091-2; Siesser PMF, 2006, CLIN CANCER RES, V12, P3233, DOI 10.1158/1078-0432.CCR-06-0456; Tong B, 2013, VASC PHARMACOL, V58, P118, DOI 10.1016/j.vph.2012.09.006; Tuhvatulin AI, 2012, ACTA NATURAE, V4, P82, DOI 10.32607/20758251-2012-4-3-82-87; Turner CE, 2000, J CELL SCI, V113, P4139; van Buul JD, 2007, J CELL BIOL, V178, P1279, DOI 10.1083/jcb.200612053; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; Vandamme M, 2012, INT J CANCER, V130, P2185, DOI 10.1002/ijc.26252; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Watts AE, 2006, AM J VET RES, V67, P2030, DOI 10.2460/ajvr.67.12.2030; WEINER TM, 1993, LANCET, V342, P1024, DOI 10.1016/0140-6736(93)92881-S; Xiao WB, 2013, MOL MED REP, V8, P703, DOI 10.3892/mmr.2013.1555; Yang YN, 2012, OPHTHALMIC RES, V48, P165, DOI 10.1159/000338819; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001; Zippi M, 2012, CLIN TER, V163, pE435; Zucker SN, 2012, CANCER BIOL THER, V13, P1299, DOI 10.4161/cbt.21787	46	53	54	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92198	10.1371/journal.pone.0092198	http://dx.doi.org/10.1371/journal.pone.0092198			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667444	gold, Green Published, Green Submitted			2022-12-27	WOS:000333675600028
J	Jiang, DH; Li, DY; Cao, LJ; Wang, LL; Zhu, SS; Xu, TD; Wang, C; Pan, DF				Jiang, Dehua; Li, Dongye; Cao, Lijuan; Wang, Lele; Zhu, Shasha; Xu, Tongda; Wang, Cheng; Pan, Defeng			Positive Feedback Regulation of Proliferation in Vascular Smooth Muscle Cells Stimulated by Lipopolysaccharide Is Mediated through the TLR 4/Rac1/Akt Pathway	PLOS ONE			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTORS; TOLL-LIKE-RECEPTOR-4 EXPRESSION; PROINFLAMMATORY PHENOTYPE; ATHEROSCLEROTIC LESIONS; CARDIOVASCULAR-DISEASE; ENDOTHELIAL-CELLS; NADPH OXIDASES; GROWTH-FACTOR; ACTIVATION	Toll-like receptor 4 (TLR4) are important in inflammation and regulating vascular smooth muscle cells (VSMCs) proliferation, which are related to atherosclerosis and restenosis. We have investigated the mechanisms involved in Lipopolysaccharide (LPS)-induced proliferation of VSMCs. Stimulation of rat aortic VSMCs with LPS significantly increases the proliferation of VSMCs. This effect is regulated by Rac1 (Ras-related C3 botulinum toxin substrate l), which mediates the activation of phosphatidylinositol 3-kinase/Akt (PI3K/Akt) signaling pathways. Inhibition of Rac1 activity by NSC23766 is associated with inhibition of Akt activity. Treatment with NSC23766 or LY294002 significantly decreases LPS-induced TLR4 protein and mRNA expression. The data show that positive feedback regulation of proliferation in VSMCs is mediated through the TLR4/Rac1/Akt pathway.	[Jiang, Dehua; Li, Dongye; Cao, Lijuan; Wang, Lele; Zhu, Shasha] Xuzhou Med Coll, Inst Cardiovasc Dis Res, Xuzhou, Jiangsu, Peoples R China; [Li, Dongye; Xu, Tongda; Wang, Cheng; Pan, Defeng] Xuzhou Med Coll, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University	Li, DY (corresponding author), Xuzhou Med Coll, Inst Cardiovasc Dis Res, Xuzhou, Jiangsu, Peoples R China.	ldy@xzmc.edu.cn; wangcxz@163.com	jiang, dehua/K-3261-2019; 李, 东野/AAY-6410-2020; 李, 东/GYA-4703-2022	jiang, dehua/0000-0001-8517-1623; Xu, Tongda/0000-0002-5594-3992				Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Chen BC, 2009, MOL IMMUNOL, V46, P1179, DOI 10.1016/j.molimm.2008.11.006; de Graaf R, 2006, MICROBES INFECT, V8, P1859, DOI 10.1016/j.micinf.2006.02.024; Devaraj S, 2011, CYTOKINE, V55, P441, DOI 10.1016/j.cyto.2011.03.023; Diebold I, 2008, THROMB HAEMOSTASIS, V100, P1021, DOI 10.1160/TH08-07-0473; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Frantz S, 2007, NAT CLIN PRACT CARD, V4, P444, DOI 10.1038/ncpcardio0938; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Gosu V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049771; Hattori Y, 2003, EUR J PHARMACOL, V481, P153, DOI 10.1016/j.ejphar.2003.09.034; Hayashi C, 2012, J IMMUNOL, V189, P3681, DOI 10.4049/jimmunol.1201541; He ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035926; Katsargyris A, 2008, EXPERT OPIN THER TAR, V12, P1329, DOI [10.1517/14728222.12.11.1329, 10.1517/14728222.12.11.1329 ]; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kong G, 2001, J KOREAN MED SCI, V16, P712, DOI 10.3346/jkms.2001.16.6.712; Kumerz M, 2011, MOL NUTR FOOD RES, V55, P1230, DOI 10.1002/mnfr.201100309; Lee MY, 2009, ARTERIOSCL THROM VAS, V29, P480, DOI 10.1161/ATVBAHA.108.181925; Li HL, 2007, CELL BIOL INT, V31, P831, DOI 10.1016/j.cellbi.2007.01.034; Li SW, 2009, MOL ENDOCRINOL, V23, P901, DOI 10.1210/me.2008-0368; Li XY, 2010, CYTOKINE, V49, P1, DOI 10.1016/j.cyto.2009.08.010; Li XW, 2003, INFECT IMMUN, V71, P4414, DOI 10.1128/IAI.71.8.4414-4420.2003; Lin FY, 2006, ARTERIOSCL THROM VAS, V26, P2630, DOI 10.1161/01.ATV.0000247259.01257.b3; Lin ML, 2012, MOL CARCINOG; Lu ZY, 2013, J ENDOCRINOL, V216, P61, DOI 10.1530/JOE-12-0338; Maitra U, 2009, J BIOL CHEM, V284, P35403, DOI 10.1074/jbc.M109.059501; Meng D, 2008, CARDIOVASC RES, V80, P299, DOI 10.1093/cvr/cvn173; Miyake H, 2011, CIRC RES, V108, P1170, DOI 10.1161/CIRCRESAHA.110.236174; Miyano K, 2009, BIOCHEM J, V422, P373, DOI 10.1042/BJ20082182; Murga C, 2002, ONCOGENE, V21, P207, DOI 10.1038/sj.onc.1205036; Ohkawara H, 2009, J ATHEROSCLER THROMB, V16, P846; Perez J, 2010, BIOCHEM J, V428, P255, DOI 10.1042/BJ20100090; Pi Y, 2013, LAB INVEST, V93, P880, DOI 10.1038/labinvest.2013.79; Rice JB, 2003, ARTERIOSCL THROM VAS, V23, P1576, DOI 10.1161/01.ATV.0000081741.38087.F9; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Schultz K, 2007, AM J PHYSIOL-HEART C, V292, pH2927, DOI 10.1152/ajpheart.00700.2006; Setacci C, 2012, J CARDIOVASC SURG, V53, P735; Shen YN, 2010, INFECT IMMUN, V78, P2857, DOI 10.1128/IAI.01138-09; Vink A, 2002, CIRCULATION, V106, P1985, DOI 10.1161/01.CIR.0000032146.75113.EE; Weidemann A, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-80; Wu J, 2013, BIOMED PHARMACOTHER, V67, P313, DOI 10.1016/j.biopha.2013.01.011; Yang X, 2005, AM J PHYSIOL-HEART C, V289, pH1069, DOI 10.1152/ajpheart.00143.2005; Yung HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017894; Zhang LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044590; Zhu HQ, 2009, J MOL CELL CARDIOL, V47, P264, DOI 10.1016/j.yjmcc.2009.05.002	47	32	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92398	10.1371/journal.pone.0092398	http://dx.doi.org/10.1371/journal.pone.0092398			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667766	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600036
J	Porcaro, C; Medaglia, MT; Thai, NJ; Seri, S; Rotshtein, P; Tecchio, F				Porcaro, Camillo; Medaglia, Maria Teresa; Thai, Ngoc Jade; Seri, Stefano; Rotshtein, Pia; Tecchio, Franca			Contradictory Reasoning Network: An EEG and fMRI Study	PLOS ONE			English	Article							PREFRONTAL CORTEX; NEURAL BASIS; DISSOCIATION; LANGUAGE; ANATOMY; COMMON; INFERENCE	Contradiction is a cornerstone of human rationality, essential for everyday life and communication. We investigated electroencephalographic (EEG) and functional magnetic resonance imaging (fMRI) in separate recording sessions during contradictory judgments, using a logical structure based on categorical propositions of the Aristotelian Square of Opposition (ASoO). The use of ASoO propositions, while controlling for potential linguistic or semantic confounds, enabled us to observe the spatial temporal unfolding of this contradictory reasoning. The processing started with the inversion of the logical operators corresponding to right middle frontal gyrus (rMFG-BA11) activation, followed by identification of contradictory statement associated with in the right inferior frontal gyrus (rIFG-BA47) activation. Right medial frontal gyrus (rMeFG, BA10) and anterior cingulate cortex (ACC, BA32) contributed to the later stages of process. We observed a correlation between the delayed latency of rBA11 response and the reaction time delay during inductive vs. deductive reasoning. This supports the notion that rBA11 is crucial for manipulating the logical operators. Slower processing time and stronger brain responses for inductive logic suggested that examples are easier to process than general principles and are more likely to simplify communication.	[Porcaro, Camillo; Medaglia, Maria Teresa; Tecchio, Franca] LETS ISTC CNR, Rome, Italy; [Medaglia, Maria Teresa] Roma Tre Univ, Phylosophy Dept, Rome, Italy; [Thai, Ngoc Jade; Seri, Stefano] Aston Univ, Sch Life & Hlth Sci, Aston Brain Ctr, Birmingham B4 7ET, W Midlands, England; [Rotshtein, Pia] Univ Birmingham, Sch Psychol, Behav Brain Sci Ctr, Birmingham B15 2TT, W Midlands, England; [Tecchio, Franca] IRCCS San Raffaele Pisana, Dept Neuroimaging, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); Roma Tre University; Aston University; University of Birmingham; IRCCS San Raffaele Pisana	Porcaro, C (corresponding author), LETS ISTC CNR, Rome, Italy.	camillo.porcaro@istc.cnr.it	Porcaro, Camillo/K-7864-2016; tecchio, franca/AAX-2770-2020	Porcaro, Camillo/0000-0003-4847-163X; tecchio, franca/0000-0002-1325-5059; Thai, Ngoc Jade/0000-0001-6125-7326; Rotshtein, Pia/0000-0002-0301-9511	Lord Dowding Fund for Humane Research; Leverhulme Trust	Lord Dowding Fund for Humane Research; Leverhulme Trust(Leverhulme Trust)	The MRI scan costs of the study were supported by the Lord Dowding Fund for Humane Research. PR was supported by the Leverhulme Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrusci VM, 2013, LOG J IGPL, V21, P1017, DOI 10.1093/jigpal/jzt008; Atkinson RK, 2000, REV EDUC RES, V70, P181, DOI 10.3102/00346543070002181; Barbati G, 2004, CLIN NEUROPHYSIOL, V115, P1220, DOI 10.1016/j.clinph.2003.12.015; Colli G, 2003, ARISTOTLE ORGANON; Colom R, 2013, NEUROIMAGE, V72, P143, DOI 10.1016/j.neuroimage.2013.01.032; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Coricelli G, 2009, P NATL ACAD SCI USA, V106, P9163, DOI 10.1073/pnas.0807721106; Doricchi F, 2005, NAT NEUROSCI, V8, P1663, DOI 10.1038/nn1563; Doya K, 2008, NAT NEUROSCI, V11, P410, DOI 10.1038/nn2077; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Duncan J, 2013, NEURON, V80, P35, DOI 10.1016/j.neuron.2013.09.015; Ebisch SJ, 2012, NEUROIMAGE, V62, P331, DOI 10.1016/j.neuroimage.2012.04.053; Fenker DB, 2010, J COGNITIVE NEUROSCI, V22, P2151, DOI 10.1162/jocn.2009.21387; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Friston K.J., 2003, HUMAN BRAIN FUNCTION, P823; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Goel V, 2004, COGNITION, V93, pB109, DOI 10.1016/j.cognition.2004.03.001; Goel V, 2003, NEUROIMAGE, V20, P2314, DOI 10.1016/j.neuroimage.2003.07.027; Goel V, 2000, NEUROIMAGE, V12, P504, DOI 10.1006/nimg.2000.0636; Goel V, 2007, TRENDS COGN SCI, V11, P435, DOI 10.1016/j.tics.2007.09.003; Johnson-Laird PN, 2010, P NATL ACAD SCI USA, V107, P18243, DOI 10.1073/pnas.1012933107; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; Kiebel S., 2003, HUMAN BRAIN FUNCTION, P725; Kroger JK, 2008, BRAIN RES, V1243, P86, DOI 10.1016/j.brainres.2008.07.128; LEHMANN D, 1984, PROG NEUROBIOL, V23, P227, DOI 10.1016/0301-0082(84)90003-0; Medaglia MT, 2009, HUM BRAIN MAPP, V30, P4187, DOI 10.1002/hbm.20838; Monti MM, 2007, NEUROIMAGE, V37, P1005, DOI 10.1016/j.neuroimage.2007.04.069; Monti MM, 2012, BRAIN RES, V1428, P33, DOI 10.1016/j.brainres.2011.05.061; Monti MM, 2009, P NATL ACAD SCI USA, V106, P12554, DOI 10.1073/pnas.0902422106; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Noveck IA, 2004, CORTEX, V40, P613, DOI 10.1016/S0010-9452(08)70157-6; Ojemann G A, 1982, Hum Neurobiol, V1, P243; Osherson D, 1998, NEUROPSYCHOLOGIA, V36, P369, DOI 10.1016/S0028-3932(97)00099-7; Parsons LM, 2001, CEREB CORTEX, V11, P954, DOI 10.1093/cercor/11.10.954; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Penny W.D., 2004, HUMAN BRAIN FUNCTION, P843; Perfetti B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026249; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; Porcaro C, 2006, BRAIN RES, V1101, P51, DOI 10.1016/j.brainres.2006.04.134; Porcaro C, 2009, HUM BRAIN MAPP, V30, P660, DOI 10.1002/hbm.20533; Prado J, 2011, J COGNITIVE NEUROSCI, V23, P3483, DOI 10.1162/jocn_a_00063; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Qiu J, 2009, BRAIN RES, V1273, P106, DOI 10.1016/j.brainres.2009.03.054; Rossi S, 2001, NAT NEUROSCI, V4, P948, DOI 10.1038/nn0901-948; Shallice T, 2008, CORTEX, V44, P794, DOI 10.1016/j.cortex.2007.04.002; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Swick D, 2002, P NATL ACAD SCI USA, V99, P16354, DOI 10.1073/pnas.252521499; Van Overwalle F, 2011, NEUROIMAGE, V54, P1589, DOI 10.1016/j.neuroimage.2010.09.043; Watanabe M, 1998, REV NEUROSCIENCE, V9, P225; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; [No title captured]	53	9	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92835	10.1371/journal.pone.0092835	http://dx.doi.org/10.1371/journal.pone.0092835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667491	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000333675600086
J	Ayme, L; Baud, S; Dubreucq, B; Joffre, F; Chardot, T				Ayme, Laure; Baud, Sebastien; Dubreucq, Bertrand; Joffre, Florent; Chardot, Thierry			Function and Localization of the Arabidopsis thaliana Diacylglycerol Acyltransferase DGAT2 Expressed in Yeast	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; TRIACYLGLYCEROL SYNTHESIS; LIPID BODIES; HETEROLOGOUS EXPRESSION; KEY ENZYME; IDENTIFICATION; CLONING; FAMILY; PURIFICATION; BIOGENESIS	Diacylglycerol acyltransferases (DGATs) catalyze the final and only committed step of triacylglycerol synthesis. DGAT activity is rate limiting for triacylglycerol accumulation in mammals, plants and microbes. DGATs belong to three different evolutionary classes. In Arabidopsis thaliana, DGAT1, encoded by At2g19450, is the major DGAT enzyme involved in triacylglycerol accumulation in seeds. Until recently, the function of DGAT2 (At3g51520) has remained elusive. Previous attempts to characterize its enzymatic function by heterologous expression in yeast were unsuccessful. In the present report we demonstrate that expression of a codon-optimized version of the DGAT2 gene is able to restore neutral lipid accumulation in the Saccharomyces cerevisiae mutant strain (H1246), which is defective in triacylglycerol biosynthesis. Heterologous expression of codon-optimized DGAT2 and DGAT1 induced the biogenesis of subcellular lipid droplets containing triacylglycerols and squalene. Both DGAT proteins were found to be associated with these lipid droplets. The fatty acid composition was affected by the nature of the acyltransferase expressed. DGAT2 preferentially incorporated C16:1 fatty acids whereas DGAT1 displayed preference for C16: 0, strongly suggesting that these enzymes have contrasting substrate specificities.	[Ayme, Laure; Baud, Sebastien; Dubreucq, Bertrand; Chardot, Thierry] INRA, Inst Jean Pierre Bourgin, UMR1318, Saclay Plant Sci, F-78026 Versailles, France; [Ayme, Laure; Baud, Sebastien; Dubreucq, Bertrand; Chardot, Thierry] AgroParisTech, Inst Jean Pierre Bourgin, Saclay Plant Sci, Versailles, France; [Joffre, Florent] ITERG, Pessac, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Chardot, T (corresponding author), INRA, Inst Jean Pierre Bourgin, UMR1318, Saclay Plant Sci, F-78026 Versailles, France.	thierry.chardot@versailles.inra.fr	Baud, Sébastien/ABI-7606-2020; DUBREUCQ, Bertrand/AAY-9948-2020	Baud, Sébastien/0000-0002-5507-327X; DUBREUCQ, Bertrand/0000-0003-2661-5479; Chardot, Thierry/0000-0001-6689-6151; JOFFRE, Florent/0000-0002-5028-5302	DGA (Direction Generale de l'Armement)/DGAC (Direction Generale de l'Aviation Civile) [2012 93 0805]	DGA (Direction Generale de l'Armement)/DGAC (Direction Generale de l'Aviation Civile)	This work was done in the context of the program CAER supported by DGA (Direction Generale de l'Armement)/DGAC (Direction Generale de l'Aviation Civile) under the convention no 2012 93 0805. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Beopoulos A, 2012, APPL MICROBIOL BIOT, V93, P1523, DOI 10.1007/s00253-011-3506-x; Bouvier-Nave P, 2000, EUR J BIOCHEM, V267, P85, DOI 10.1046/j.1432-1327.2000.00961.x; BROWSE J, 1986, ANAL BIOCHEM, V152, P141, DOI 10.1016/0003-2697(86)90132-6; Burgal J, 2008, PLANT BIOTECHNOL J, V6, P819, DOI 10.1111/j.1467-7652.2008.00361.x; Cahoon EB, 2007, CURR OPIN PLANT BIOL, V10, P236, DOI 10.1016/j.pbi.2007.04.005; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chen HC, 2002, DIABETES, V51, P3189, DOI 10.2337/diabetes.51.11.3189; Chiapello H, 1998, GENE, V209, pGC1, DOI 10.1016/S0378-1119(97)00671-9; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; FOLCH J, 1957, J BIOL CHEM, V226, P497; Froissard Marine, 2006, Biotechnology Journal, V1, P308, DOI 10.1002/biot.200500034; Froissard M, 2009, FEMS YEAST RES, V9, P428, DOI 10.1111/j.1567-1364.2009.00483.x; Graham IA, 2008, ANNU REV PLANT BIOL, V59, P115, DOI 10.1146/annurev.arplant.59.032607.092938; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Jako C, 2001, PLANT PHYSIOL, V126, P861, DOI 10.1104/pp.126.2.861; KATAVIC V, 1995, PLANT PHYSIOL, V108, P399, DOI 10.1104/pp.108.1.399; Kroon JTM, 2006, PHYTOCHEMISTRY, V67, P2541, DOI 10.1016/j.phytochem.2006.09.020; Kwiatkowska M, 2012, FOLIA HISTOCHEM CYTO, V50, P427, DOI [10.5603/19752, 10.5603/FHC.2012.0058]; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; LEHNER R, 1993, J BIOL CHEM, V268, P8781; Liu Q, 2012, PROG LIPID RES, V51, P350, DOI 10.1016/j.plipres.2012.06.001; Hernandez ML, 2012, PLANT PHYSIOL, V160, P215, DOI 10.1104/pp.112.201541; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; McFie PJ, 2010, J BIOL CHEM, V285, P37377, DOI 10.1074/jbc.M110.163691; Miquel M., 1995, SEED DEV GERMINATION, P169; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; POCKLINGTON WD, 1985, PURE APPL CHEM, V57, P1515, DOI 10.1351/pac198557101515; Routaboul JM, 1999, PLANT PHYSIOL BIOCH, V37, P831, DOI 10.1016/S0981-9428(99)00115-1; Saha S, 2006, PLANT PHYSIOL, V141, P1533, DOI 10.1104/pp.106.082198; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Schneiter Roger, 2006, Methods Mol Biol, V313, P75; Schneiter Roger, 2006, Methods Mol Biol, V313, P41; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Spanova M, 2011, EUROPEAN J LIPID SCI, V113, P1299; Spanova M, 2012, BBA-MOL CELL BIOL L, V1821, P647, DOI 10.1016/j.bbalip.2012.01.015; Spanova M, 2010, J BIOL CHEM, V285, P6127, DOI 10.1074/jbc.M109.074229; Stahl U, 2004, PLANT PHYSIOL, V135, P1324, DOI 10.1104/pp.104.044354; Stobart K, 1997, PLANTA, V203, P58, DOI 10.1007/s004250050165; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Turchetto-Zolet AC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-263; Vindigni JD, 2013, BBA-BIOMEMBRANES, V1828, P1881, DOI 10.1016/j.bbamem.2013.04.009; Weselake Randall J., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-24; Weselake RJ, 2009, BIOTECHNOL ADV, V27, P866, DOI 10.1016/j.biotechadv.2009.07.001; Xu JY, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-4; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yu WG, 2000, BLOOD, V95, P1078, DOI 10.1182/blood.V95.3.1078.003k16_1078_1085; Zhang M, 2009, PLANT CELL, V21, P3885, DOI 10.1105/tpc.109.071795; Zhou XR, 2013, FEBS LETT, V587, P2371, DOI 10.1016/j.febslet.2013.06.003; Zou JT, 1999, PLANT J, V19, P645, DOI 10.1046/j.1365-313x.1999.00555.x; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	56	41	44	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92237	10.1371/journal.pone.0092237	http://dx.doi.org/10.1371/journal.pone.0092237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663078	gold, Green Published, Green Submitted			2022-12-27	WOS:000333459900045
J	De Michele, C; Accatino, F				De Michele, Carlo; Accatino, Francesco			Tree Cover Bimodality in Savannas and Forests Emerging from the Switching between Two Fire Dynamics	PLOS ONE			English	Article							ALTERNATIVE STABLE STATES; POSITIVE FEEDBACKS; TROPICAL SAVANNA; AFRICAN SAVANNA; MATRIX MODEL; VEGETATION; ECOLOGY; DETERMINANTS; THRESHOLDS; RESILIENCE	Moist savannas and tropical forests share the same climatic conditions and occur side by side. Experimental evidences show that the tree cover of these ecosystems exhibits a bimodal frequency distribution. This is considered as a proof of savanna-forest bistability, predicted by dynamic vegetation models based on non-linear differential equations. Here, we propose a change of perspective about the bimodality of tree cover distribution. We show, using a simple matrix model of tree dynamics, how the bimodality of tree cover can emerge from the switching between two linear dynamics of trees, one in presence and one in absence of fire, with a feedback between fire and trees. As consequence, we find that the transitions between moist savannas and tropical forests, if sharp, are not necessarily catastrophic.	[De Michele, Carlo; Accatino, Francesco] Politecn Milan, Dept Civil & Environm Engn, I-20133 Milan, Italy	Polytechnic University of Milan	De Michele, C (corresponding author), Politecn Milan, Dept Civil & Environm Engn, I-20133 Milan, Italy.	carlo.demichele@polimi.it	ACCATINO, Francesco/AAQ-8022-2020; De Michele, Carlo/L-7503-2015	De Michele, Carlo/0000-0002-7098-4725	Ministry of Foreign Affairs	Ministry of Foreign Affairs(Ministry of Foreign Affairs and International Cooperation (Italy))	Funded by Ministry of Foreign Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accatino F, 2013, ECOL MODEL, V265, P170, DOI 10.1016/j.ecolmodel.2013.05.022; Accatino F, 2010, J THEOR BIOL, V267, P235, DOI 10.1016/j.jtbi.2010.08.012; Beckage B, 2011, ECOL MODEL, V222, P2227, DOI 10.1016/j.ecolmodel.2011.01.015; Beckage B, 2009, AM NAT, V174, P805, DOI 10.1086/648458; Beisner BE, 2003, FRONT ECOL ENVIRON, V1, P376, DOI 10.2307/3868190; Bestelmeyer BT, 2013, ECOL LETT, V16, P339, DOI 10.1111/ele.12045; Boettiger C, 2013, NATURE, V493, P157, DOI 10.1038/493157a; Bond WJ, 2008, ANNU REV ECOL EVOL S, V39, P641, DOI 10.1146/annurev.ecolsys.39.110707.173411; Buceta J, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.036216; Buckley YM, 2010, ECOL LETT, V13, P1182, DOI 10.1111/j.1461-0248.2010.01506.x; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Conlisk J, 1973, ECONOMICA, V11, P402; Costa O. L. V., 2006, DISCRETE TIME MARKOV; D'Odorico P, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027499; De Michele C, 2011, J THEOR BIOL, V289, P74, DOI 10.1016/j.jtbi.2011.08.014; Dogruel M, 1995, 383 P 1995 IEEE INT, V2, P1324; Favier C, 2012, GLOBAL ECOL BIOGEOGR, V21, P787, DOI 10.1111/j.1466-8238.2011.00725.x; Gavin DG, 2006, ECOLOGY, V87, P1722, DOI 10.1890/0012-9658(2006)87[1722:WCCOSF]2.0.CO;2; Grimm V, 1999, ECOL MODEL, V115, P129, DOI 10.1016/S0304-3800(98)00188-4; GURVITS L, 1995, LINEAR ALGEBRA APPL, V231, P47, DOI 10.1016/0024-3795(94)00010-7; Higgins SI, 2007, ECOLOGY, V88, P1119, DOI 10.1890/06-1664; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Hoffmann WA, 1999, ECOLOGY, V80, P1354, DOI 10.1890/0012-9658(1999)080[1354:FAPDOW]2.0.CO;2; Hoffmann WA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015424; Hoffmann WA, 2003, FUNCT ECOL, V17, P720, DOI 10.1111/j.1365-2435.2003.00796.x; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; Rietkerk M, 1997, OIKOS, V79, P69, DOI 10.2307/3546091; Salguero-Gomez R, 2010, AM NAT, V176, P710, DOI 10.1086/657044; Salguero-Gomez R, 2010, J ECOL, V98, P250, DOI 10.1111/j.1365-2745.2009.01635.x; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Scheffer M., 2020, CRITICAL TRANSITIONS, V16, DOI 10.2307/j.ctv173f1g1; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Schroder A, 2005, OIKOS, V110, P3, DOI 10.1111/j.0030-1299.2005.13962.x; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Staver AC, 2011, ECOLOGY, V92, P1063, DOI 10.1890/i0012-9658-92-5-1063; Staver AC, 2009, ECOL APPL, V19, P1909, DOI 10.1890/08-1907.1; STUARTHILL GC, 1989, J APPL ECOL, V26, P285, DOI 10.2307/2403668; Van Nes EH, 2005, ECOL MODEL, V185, P153, DOI 10.1016/j.ecolmodel.2004.12.001; van Wilgen BW, 2009, S AFR J SCI, V105, P343; Van Wilgen B.W., 2003, KRUGER EXPERIENCE, P149; Ward D., 2005, African Journal of Range & Forage Science, V22, P101, DOI 10.2989/10220110509485867; Whitlock C., 2010, OPEN ECOL J, V3, P6	42	8	8	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91195	10.1371/journal.pone.0091195	http://dx.doi.org/10.1371/journal.pone.0091195			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663432	Green Published, gold			2022-12-27	WOS:000333459900015
J	Mohan-Gibbons, H; Weiss, E; Garrison, L; Allison, M				Mohan-Gibbons, Heather; Weiss, Emily; Garrison, Laurie; Allison, Meg			Evaluation of a Novel Dog Adoption Program in Two US Communities	PLOS ONE			English	Article							SHELTER DOGS	Millions of dogs enter animal welfare organizations every year and only a fraction of them are adopted. Despite the most recent American Pet Products Association (APPA) data that nearly half the US population owns a dog, only 20% acquired their dog from an animal welfare organization. Studies show that people consider adopting from an animal shelter more often than they actually do, which indicates a potential market increase if programs can make shelter dogs more visible to adopters. This research focused on a novel adoption program where shelter dogs were transferred into foster homes who were tasked with finding an adopter. Shelter dogs were placed in the path of potential adopters and bypassed the need for the adopter to go to the shelter. The results show that this novel program was effective in a variety of ways including getting dogs adopted. Although length of stay was significantly longer for dogs in the program, the dogs were in a home environment, not taking up kennel space in the shelter. The program also had a lower rate of returns than dogs adopted at the shelter. The foster program tapped adopters in different geographical segments of the community than the dogs adopted from the shelter. By bringing shelter dogs to where adopters spend their time (ex: restaurants, parks, hair salons), the program potentially captured a segment of the population who might have obtained their dog from other sources besides the shelter (such as breeders or pet stores). This novel approach can be an effective method for adoption, has many benefits for shelters, and can tap into a new adopter market by engaging their community in a new way.	[Mohan-Gibbons, Heather] Amer Soc Prevent Cruelty Anim ASPCA, Shelter Res & Dev, Ojai, CA 93024 USA; [Weiss, Emily] Amer Soc Prevent Cruelty Anim ASPCA, Shelter Res & Dev, Palm City, FL USA; [Garrison, Laurie] Amer Soc Prevent Cruelty Anim ASPCA, Shelter Res & Dev, Little Silver, NJ USA; [Allison, Meg] Amer Soc Prevent Cruelty Anim ASPCA, Shelter Res & Dev, New Orleans, LA USA		Mohan-Gibbons, H (corresponding author), Amer Soc Prevent Cruelty Anim ASPCA, Shelter Res & Dev, Ojai, CA 93024 USA.	heather.mohan-gibbons@aspca.org	Mohan-Gibbons, Heather/AAO-4282-2020					American Humane Association, 2013, KEEP PETS DOGS CATS; [Anonymous], 2010, GUIDELINES STANDARDS; APPA, 2013, AAPA NAT PET OWN SUR; CARTER CN, 1990, J AM VET MED ASSOC, V197, P192; Hays LD, 2004, EFFECTS STANDARDIZED; Hennessy MB, 2006, APPL ANIM BEHAV SCI, V99, P157, DOI 10.1016/j.applanim.2005.09.011; Kass P. H., 2001, Journal of Applied Animal Welfare Science, V4, P237, DOI 10.1207/S15327604JAWS0404_01; Marston LC, 2003, APPL ANIM BEHAV SCI, V83, P227, DOI 10.1016/S0168-1591(03)00135-7; Newbury S, 2013, SHELTER MED VET STAF, P93; Normando S, 2006, ANTHROZOOS, V19, P211, DOI 10.2752/089279306785415556; Rooney N, 2009, J VET BEHAV, V4, P127, DOI 10.1016/j.jveb.2008.10.037; ROWAN AN, 1992, ANTHROZOOS, V5, P140, DOI 10.2752/089279392787011430; Scarlett J., 2013, SHELTER MED VET STAF, V2nd, P13; Scarlett JM, 2008, PREV VET MED, V86, P188, DOI 10.1016/j.prevetmed.2008.02.007; Smith-Blackmore M, 2013, SHELTER MED VET STAF, P495; Thorn Judith M., 2006, Journal of Applied Animal Welfare Science, V9, P25, DOI 10.1207/s15327604jaws0901_3; Zawistowski S, 2004, SHELTER MEDICINE FOR VETERINARIANS AND STAFF, P3; Zawistowski S, 1998, J Appl Anim Welf Sci, V1, P193, DOI 10.1207/s15327604jaws0103_1	18	19	19	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91959	10.1371/journal.pone.0091959	http://dx.doi.org/10.1371/journal.pone.0091959			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663804	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900035
J	Ouyang, B; Sun, XZ; Han, DY; Chen, SF; Yao, B; Gao, Y; Bian, J; Huang, YP; Zhang, YD; Wan, Z; Yang, B; Xiao, HP; Zhou, SY; Liu, GH; Zhang, YY; Deng, CH				Ouyang, Bin; Sun, Xiangzhou; Han, Dayu; Chen, Shenfu; Yao, Bing; Gao, Yong; Bian, Jun; Huang, Yanping; Zhang, Yadong; Wan, Zi; Yang, Bin; Xiao, Haipeng; Zhou Songyang; Liu, Guihua; Zhang, Yuanyuan; Deng, Chunhua			Human Urine-Derived Stem Cells Alone or Genetically-Modified with FGF2 Improve Type 2 Diabetic Erectile Dysfunction in a Rat Model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; ANGIOGENESIS; EXPRESSION; DIFFERENTIATION; TRANSPLANTATION; MEN; RECONSTRUCTION; RECEPTORS; ISCHEMIA	Aim: The aim of this study was to determine the possibility of improving erectile dysfunction using cell therapy with either human urine-derived stem cells (USCs) or USCs genetically-modified with FGF2 in a type 2 diabetic rat model. Methods: Human USCs were collected from 3 healthy donors. USCs were transfected with FGF2 (USCs-FGF2). Sixty-five SD male rats were divided into five groups (G). A control group of normal rats (G1, n = 10), and four other test groups of type 2 diabetic erectile dysfunction rats: PBS as a negative control (G2, n = 10), USCs (G3, n = 15), lentivirus-FGF2 (G4, n = 15), and USCs-FGF2 (G5, n = 15). Diabetes was induced in the rats via a high fat diet for 28 days and a subsequent intraperitoneal injection of streptozotocin (35 mg/kg). Erectile dysfunction was screened with apomorphine (100 mg/kg). Cell injections in the test groups (G2-G5) occurred directly into the corpora cavernosa. The implanted cells were tracked at 7 days (n = 5 animals/G) and 28 days (n = 10 animals/G) post injection. Mean arterial pressure (MAP), intracavernosal pressure (ICP), expression of endothelial markers (CD31, VEGF and eNOS), smooth muscle markers (desmin and smoothelin), histological changes and erectile function were assessed for each group. Results: USCs expressed mesenchymal stem cell markers, and secreted a number of proangiogenic growth factors. USCs expressed endothelial cell markers (CD31 and vWF) after transfection with FGF2. Implanted USCs or USCs-FGF2 displayed a significantly raised ICP and ICP/MAP ratio (p<0.01) 28 days after intracavernous injection. Although few cell were detected within the implanted sites, histological and western blot analysis demonstrated an increased expression of endothelial and smooth muscle markers within the cavernous tissue following USC or USC-FGF2 injection. Conclusions: The paracrine effect of USCs or USCs-FGF2 induced improvement of erectile function in type 2 diabetic rats by recruiting resident cells and increasing the endothelial expression and contents of smooth muscle.	[Ouyang, Bin; Sun, Xiangzhou; Han, Dayu; Chen, Shenfu; Yao, Bing; Zhang, Yadong; Wan, Zi; Deng, Chunhua] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Gao, Yong] Sun Yat Sen Univ, Affiliated Hosp 1, Reprod Med Ctr, Key Lab Reprod Med Guangdong Prov, Guangzhou 510275, Guangdong, Peoples R China; [Bian, Jun] Southern Med Univ, Affiliated Hosp 3, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Huang, Yanping] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Shanghai Inst Androl, Shanghai 200030, Peoples R China; [Yang, Bin] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Urol, Shanghai 200092, Peoples R China; [Yang, Bin; Liu, Guihua; Zhang, Yuanyuan] Wake Forest Univ, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA; [Xiao, Haipeng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou 510275, Guangdong, Peoples R China; [Zhou Songyang] Sun Yat Sen Univ, Sch Life Sci, Minist Educ, Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China; [Zhou Songyang] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Zhou Songyang] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Liu, Guihua] Sun Yat Sen Univ, Affiliated Hosp 6, Ctr Reprod Med, Dept Androl, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Southern Medical University - China; Shanghai Jiao Tong University; Tongji University; Wake Forest University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Baylor College of Medicine; Sun Yat Sen University	Liu, GH (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Ctr Reprod Med, Dept Androl, Guangzhou 510275, Guangdong, Peoples R China.	lgh99707@163.com; yzhang@wakehealth.edu; dch0313@163.com	zhang, yuanyuan/GYA-4428-2022; guihua, liu/B-1060-2012	Huang, Yan-Ping/0000-0002-3301-2847	National Natural Science Foundation of China [81270696, 81302223]; Research Fund for the Doctoral Program of Higher Education of China [20130171120078]; Guangdong natural science fund [S2011010005282]; Guangdong province science & technology project [2011B031800115, 2011B032000003]; Science and Technology Planning Project of Guangzhou [201300000094]; Medical Scientific Research Foundation of Guangdong Province, China [B2013104]; International Program of Project 985, Sun Yat-Sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Guangdong natural science fund; Guangdong province science & technology project; Science and Technology Planning Project of Guangzhou; Medical Scientific Research Foundation of Guangdong Province, China; International Program of Project 985, Sun Yat-Sen University	This work was funded by the grant from the National Natural Science Foundation of China (81270696 and 81302223)(http://www.nsfc.gov.cn/Portal0/default152.htm), Research Fund for the Doctoral Program of Higher Education of China (20130171120078)(http://www.cutech.edu.cn), Guangdong natural science fund (S2011010005282) (http://gdsf.gdstc.gov.cn/), the Guangdong province science & technology project (2011B031800115, 2011B032000003)(http://pro.gdstc.gov.cn/stms/main.jsp), Science and Technology Planning Project of Guangzhou (201300000094) (Http://www.gzsi.gov.cn), Medical Scientific Research Foundation of Guangdong Province, China (B2013104)(http://www.gdwst.gov.cn/), and the International Program of Project 985, Sun Yat-Sen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albersen M, 2011, UROLOGY; Asplin IR, 2001, BLOOD, V97, P3450, DOI 10.1182/blood.V97.11.3450; Bacon CG, 2002, DIABETES CARE, V25, P1458, DOI 10.2337/diacare.25.8.1458; Bahk JY, 2010, EXP CLIN TRANSPLANT, V8, P150; Bahramsoltani M, 2010, CLIN HEMORHEOL MICRO, V46, P189, DOI 10.3233/CH-2010-1345; Bharadwaj S, 2013, STEM CELLS; Bharadwaj S, 2011, TISSUE ENG PT A, V17, P2123, DOI [10.1089/ten.TEA.2010.0637, 10.1089/ten.tea.2010.0637]; Billinton N, 2001, ANAL BIOCHEM, V291, P175, DOI 10.1006/abio.2000.5006; Bodin A, 2010, BIOMATERIALS, V31, P8889, DOI 10.1016/j.biomaterials.2010.07.108; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Fujii T, 2008, ATHEROSCLEROSIS, V200, P51, DOI 10.1016/j.atherosclerosis.2007.12.012; Garcia MM, 2010, J SEX MED, V7, P89, DOI 10.1111/j.1743-6109.2009.01541.x; Giugliano F, 2010, INT J IMPOT RES, V22, P204, DOI 10.1038/ijir.2010.1; Gou X, 2011, ASIAN J ANDROL, V13, P332, DOI 10.1038/aja.2010.116; Green PJ, 1996, BIOESSAYS, V18, P639, DOI 10.1002/bies.950180807; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; HEATON JPW, 1991, J UROLOGY, V145, P1099, DOI 10.1016/S0022-5347(17)38543-9; Huang YP, 2012, INT J IMPOT RES, V24, P247, DOI 10.1038/ijir.2012.26; Jesmin S, 2003, J MOL ENDOCRINOL, V31, P401, DOI 10.1677/jme.0.0310401; Kalter-Leibovici O, 2005, DIABETES CARE, V28, P1739, DOI 10.2337/diacare.28.7.1739; Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559; Li WQ, 2010, CELL TRANSPLANT, V19, P1181, DOI 10.3727/096368910X504469; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Lin CS, 2012, STEM CELLS DEV, V21, P2770, DOI 10.1089/scd.2012.0176; Lin G, 2011, INT J IMPOT RES; Liu GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072790; Liu GH, 2013, BIOMATERIALS, V34, P1311, DOI 10.1016/j.biomaterials.2012.10.038; Liu GH, 2010, J SEX MED, V7, P3868, DOI 10.1111/j.1743-6109.2010.01844.x; Malavige LS, 2009, J SEX MED, V6, P1232, DOI 10.1111/j.1743-6109.2008.01168.x; Masaki I, 2002, CIRC RES, V90, P966, DOI 10.1161/01.RES.0000019540.41697.60; Moreland RB, 2000, INT J IMPOT RES, V12, pS39, DOI 10.1038/sj.ijir.3900576; Ning HX, 2009, J SEX MED, V6, P967, DOI 10.1111/j.1743-6109.2008.01172.x; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Penson DF, 2003, DIABETES CARE, V26, P1093, DOI 10.2337/diacare.26.4.1093; Qiu X, 2011, J ANDROL; Qiu XF, 2011, J SEX MED, V8, P427, DOI 10.1111/j.1743-6109.2010.02118.x; Rinaldi B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069954; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; Shamloul R, 2013, LANCET, V381, P153, DOI 10.1016/S0140-6736(12)60520-0; Sun XZ, 2011, CHINESE MED J-PEKING, V124, P3093, DOI 10.3760/cma.j.issn.0366-6999.2011.19.026; Szebenyi G, 1999, INT REV CYTOL, V185, P45; VLODAVSKY I, 1990, CANCER METAST REV, V9, P203, DOI 10.1007/BF00046361; Wu R.P., 2012, 3 ANN REG MED FDN C; Wu SF, 2011, J UROLOGY, V186, P640, DOI 10.1016/j.juro.2011.03.152; Wu SF, 2011, BIOMATERIALS, V32, P1317, DOI 10.1016/j.biomaterials.2010.10.006; Zhang YY, 2008, J UROLOGY, V180, P2226, DOI 10.1016/j.juro.2008.07.023; Zhu XY, 2009, BIOCHEM BIOPH RES CO, V379, P1084, DOI 10.1016/j.bbrc.2009.01.019	47	83	95	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92825	10.1371/journal.pone.0092825	http://dx.doi.org/10.1371/journal.pone.0092825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663037	Green Submitted, Green Published, gold			2022-12-27	WOS:000333459900122
J	Zhang, Z; Ober, U; Erbe, M; Zhang, H; Gao, N; He, JL; Li, JQ; Simianer, H				Zhang, Zhe; Ober, Ulrike; Erbe, Malena; Zhang, Hao; Gao, Ning; He, Jinlong; Li, Jiaqi; Simianer, Henner			Improving the Accuracy of Whole Genome Prediction for Complex Traits Using the Results of Genome Wide Association Studies	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; GENETIC ARCHITECTURE; LINKAGE DISEQUILIBRIUM; QUANTITATIVE TRAITS; DAIRY-CATTLE; MILK-PRODUCTION; DATABASE TOOL; SELECTION; LOCI; INFORMATION	Utilizing the whole genomic variation of complex traits to predict the yet-to-be observed phenotypes or unobserved genetic values via whole genome prediction (WGP) and to infer the underlying genetic architecture via genome wide association study (GWAS) is an interesting and fast developing area in the context of human disease studies as well as in animal and plant breeding. Though thousands of significant loci for several species were detected via GWAS in the past decade, they were not used directly to improve WGP due to lack of proper models. Here, we propose a generalized way of building trait-specific genomic relationship matrices which can exploit GWAS results in WGP via a best linear unbiased prediction (BLUP) model for which we suggest the name BLUP|GA. Results from two illustrative examples show that using already existing GWAS results from public databases in BLUP|GA improved the accuracy of WGP for two out of the three model traits in a dairy cattle data set, and for nine out of the 11 traits in a rice diversity data set, compared to the reference methods GBLUP and BayesB. While BLUP|GA outperforms BayesB, its required computing time is comparable to GBLUP. Further simulation results suggest that accounting for publicly available GWAS results is potentially more useful for WGP utilizing smaller data sets and/or traits of low heritability, depending on the genetic architecture of the trait under consideration. To our knowledge, this is the first study incorporating public GWAS results formally into the standard GBLUP model and we think that the BLUP|GA approach deserves further investigations in animal breeding, plant breeding as well as human genetics.	[Zhang, Zhe; Zhang, Hao; Gao, Ning; He, Jinlong; Li, Jiaqi] South China Agr Univ, Coll Anim Sci, Natl Engn Res Ctr Breeding Swine Ind, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou, Guangdong, Peoples R China; [Zhang, Zhe; Ober, Ulrike; Erbe, Malena; Simianer, Henner] Univ Gottingen, Dept Anim Sci, Anim Breeding & Genet Grp, D-37073 Gottingen, Germany	South China Agricultural University; University of Gottingen	Li, JQ (corresponding author), South China Agr Univ, Coll Anim Sci, Natl Engn Res Ctr Breeding Swine Ind, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou, Guangdong, Peoples R China.	jqli@scau.edu.cn; hsimian@gwdg.de	Simianer, Henner/A-6574-2015; Zhang, Zhe/AAG-9641-2019	Simianer, Henner/0000-0002-7551-3797; Zhang, Zhe/0000-0001-7338-7718	National Natural Science Foundation of China [31200925, 31371258]; earmarked fund for China Agriculture Research System [CARS-36]; Ph.D. Programs Foundation of Ministry of Education of China [20124404120001]; Guangdong Natural Science Foundation [S2012040007753]; Key Scientific and Technological Projects of Guangzhou [11A62100441]; German Federal Ministry of Education and Research within the AgroClustEr "Synbreed - Synergistic plant and animal breeding" [0315528C]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for China Agriculture Research System; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Key Scientific and Technological Projects of Guangzhou; German Federal Ministry of Education and Research within the AgroClustEr "Synbreed - Synergistic plant and animal breeding"	This work was supported by the National Natural Science Foundation of China (31200925, 31371258), the earmarked fund for China Agriculture Research System (CARS-36), the Ph.D. Programs Foundation (the Doctoral Fund) of Ministry of Education of China (20124404120001), the Guangdong Natural Science Foundation (S2012040007753), the Key Scientific and Technological Projects of Guangzhou (11A62100441). HS, UO and ME acknowledge the funding by the German Federal Ministry of Education and Research within the AgroClustEr "Synbreed - Synergistic plant and animal breeding" (Funding ID: 0315528C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2007, ANIM GENET, V38, P491, DOI 10.1111/j.1365-2052.2007.01642.x; Aguilar I, 2010, J DAIRY SCI, V93, P743, DOI 10.3168/jds.2009-2730; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Browning BL, 2007, GENET EPIDEMIOL, V31, P606; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Daetwyler HD, 2013, GENETICS, V193, P347, DOI 10.1534/genetics.112.147983; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; de los Campos G, 2010, NAT REV GENET, V11, P880, DOI 10.1038/nrg2898; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; Drinkwater NR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002975; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; Flint J, 2012, NAT REV GENET, V13, P807, DOI 10.1038/nrg3335; Forni S, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-1; GELDERMANN H, 1975, THEOR APPL GENET, V46, P319, DOI 10.1007/BF00281673; GEORGES M, 1995, GENETICS, V139, P907; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Gonzalez-Recio O, 2008, GENETICS, V178, P2305, DOI 10.1534/genetics.107.084293; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Henderson C. R, 1984, APPL LINEAR MODELS A; HENDERSON CR, 1959, BIOMETRICS, V15, P192, DOI 10.2307/2527669; Hindorff LA, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hu ZL, 2007, NUCLEIC ACIDS RES, V35, pD604, DOI 10.1093/nar/gkl946; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Ibanez-Escriche N, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-12; Jaiswal P, 2006, RICE GENETICS NEWSLE, V22, P9; Jaiswal P, 2006, NUCLEIC ACIDS RES, V34, pD717, DOI 10.1093/nar/gkj154; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kapell DNRG, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-42; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Knott SA, 1996, THEOR APPL GENET, V93, P71, DOI 10.1007/BF00225729; Lawrence CJ, 2004, NUCLEIC ACIDS RES, V32, pD393, DOI 10.1093/nar/gkh011; Li MLJ, 2012, NUCLEIC ACIDS RES, V40, pD1047, DOI 10.1093/nar/gkr1182; Liu WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028600; LUND MS, 2010, 9 WORLD C GEN APPL L, P880; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Madsen P., 2006, WORLD C GENETICS APP; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Meredith BK, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-21; Meuwissen THE, 2001, GENETICS, V157, P1819; Muir WM, 2007, J ANIM BREED GENET, V124, P342, DOI 10.1111/j.1439-0388.2007.00700.x; Ober U, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002685; Phifer-Rixey M, 2012, MOL BIOL EVOL, V29, P2949, DOI 10.1093/molbev/mss105; Qanbari S, 2010, ANIM GENET, V41, P346, DOI 10.1111/j.1365-2052.2009.02011.x; Riedelsheimer C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-452; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Stranden I, 2009, J DAIRY SCI, V92, P2971, DOI 10.3168/jds.2008-1929; Stranden I, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-25; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Uimari P, 2011, J ANIM SCI, V89, P609, DOI 10.2527/jas.2010-3249; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Wang H, 2012, GENET RES, V94, P73, DOI 10.1017/S0016672312000274; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Welsh CS, 2010, J ANIM SCI, V88, P1610, DOI 10.2527/jas.2009-2537; Wray NR, 2008, CURR OPIN GENET DEV, V18, P257, DOI 10.1016/j.gde.2008.07.006; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhang Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012648; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhao W, 2006, NUCLEIC ACIDS RES, V34, pD752, DOI 10.1093/nar/gkj011; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264	76	125	133	5	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93017	10.1371/journal.pone.0093017	http://dx.doi.org/10.1371/journal.pone.0093017			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663104	gold, Green Published, Green Submitted			2022-12-27	WOS:000333459900143
J	Zurovac, D; Githinji, S; Memusi, D; Kigen, S; Machini, B; Muturi, A; Otieno, G; Snow, RW; Nyandigisi, A				Zurovac, Dejan; Githinji, Sophie; Memusi, Dorothy; Kigen, Samuel; Machini, Beatrice; Muturi, Alex; Otieno, Gabriel; Snow, Robert W.; Nyandigisi, Andrew			Major Improvements in the Quality of Malaria Case-Management under the "Test and Treat" Policy in Kenya	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; LUMEFANTRINE TREATMENT POLICY; ARTEMETHER-LUMEFANTRINE; UNCOMPLICATED MALARIA; CLINICAL-IMPLICATIONS; HEALTH FACILITIES; OLDER CHILDREN; MICROSCOPY; TANZANIA; CHALLENGES	Background: Monitoring implementation of the "test and treat" case-management policy for malaria is an important component of all malaria control programmes in Africa. Unfortunately, routine information systems are commonly deficient to provide necessary information. Using health facility surveys we monitored health systems readiness and malaria case-management practices prior to and following implementation of the 2010 "test and treat" policy in Kenya. Methods/Findings: Between 2010 and 2013 six national, cross-sectional, health facility surveys were undertaken. The number of facilities assessed ranged between 172 and 176, health workers interviewed between 216 and 237 and outpatient consultations for febrile patients evaluated between 1,208 and 2,408 across six surveys. Comparing baseline and the last survey results, all readiness indicators showed significant (p<0.005) improvements: availability of parasitological diagnosis (55.2% to 90.7%); RDT availability (7.5% to 69.8%); total artemether-lumefantrine (AL) stock-out (27.2% to 7.0%); stock-out of one or more AL packs (59.5% to 21.6%); training coverage (0 to 50.2%); guidelines access (0 to 58.1%) and supervision (17.9% to 30.8%). Testing increased by 34.0% (23.9% to 57.9%; p<0.001) while testing and treatment according to test result increased by 34.2% (15.7% to 49.9%; p<0.001). Treatment adherence for test positive patients improved from 83.3% to 90.3% (p = 0.138) and for test negative patients from 47.9% to 83.4% (p<0.001). Significant testing and treatment improvements were observed in children and adults. There was no difference in practices with respect to the type and result of malaria test (RDT vs microscopy). Of eight dosing, dispensing and counseling tasks, improvements were observed for four tasks. Overall AL use for febrile patients decreased from 63.5% to 35.6% (p<0.001). Conclusions: Major improvements in the implementation of "test and treat" policy were observed in Kenya. Some gaps towards universal targets still remained. Other countries facing similar needs and challenges may consider health facility surveys to monitor malaria case-management.	[Zurovac, Dejan; Githinji, Sophie; Otieno, Gabriel; Snow, Robert W.] Univ Oxford Res Programme, Wellcome Trust, Kenya Med Res Inst, Malaria Publ Hlth Dept, Nairobi, Kenya; [Zurovac, Dejan; Snow, Robert W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Zurovac, Dejan] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Memusi, Dorothy; Kigen, Samuel; Machini, Beatrice; Nyandigisi, Andrew] Minist Hlth, Div Malaria Control, Nairobi, Kenya; [Muturi, Alex] Management Sci Hlth, Nairobi, Kenya	Kenya Medical Research Institute; University of Oxford; Boston University	Zurovac, D (corresponding author), Univ Oxford Res Programme, Wellcome Trust, Kenya Med Res Inst, Malaria Publ Hlth Dept, Nairobi, Kenya.	dzurovac@kemri-wellcome.org	Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088	Global Fund [KEN-405-G06-M]; U.S. President's Malaria Initiative/USAID through the Management Sciences for Health; Wellcome Trust-UK; Kenya Medical Research Institute; University of Oxford; Medicines for Malaria Ventures; Wellcome Trust [079080, 092654]	Global Fund; U.S. President's Malaria Initiative/USAID through the Management Sciences for Health(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); Wellcome Trust-UK(Wellcome Trust); Kenya Medical Research Institute; University of Oxford; Medicines for Malaria Ventures; Wellcome Trust(Wellcome Trust)	Funding for the study is provided by The Global Fund to Fight AIDS, Tuberculosis and Malaria (round 4 grant number KEN-405-G06-M) and U.S. President's Malaria Initiative/USAID through the Management Sciences for Health. DZ is grateful for the support from the Wellcome Trust-UK, Kenya Medical Research Institute, University of Oxford and Medicines for Malaria Ventures. RWS is supported by the Wellcome Trust as Principal Research Fellow (#079080). DZ, SG, GO, and RWS acknowledge the support provided by the Wellcome Trust Major Overseas Programme grant (#092654). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgader I, 2012, BMC PUBLIC HEALTH, V12, P11; Amin AA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-72; [Anonymous], 2011, GOOD PRACT SEL PROC; [Anonymous], 2012, T3 TEST TREAT TRACK; [Anonymous], 2012, IND EV PHAS 1 AFF ME; [Anonymous], 2011, UN ACC MAL DIAGN TES; [Anonymous], KEN MAL MON EV PLAN; [Anonymous], NAT MAL STRAT 2009 2; [Anonymous], 2012, NAT GUID DIAGN TREAT; Barat L, 1999, AM J TROP MED HYG, V60, P1024, DOI 10.4269/ajtmh.1999.60.1024; Bastiaens GJH, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-76; Beer N, 2009, TROP MED INT HEALTH, V14, P1; Bisoffi Z, 2009, TROP MED INT HEALTH, V14, P1; Bruxvoort K, 2013, TROP MED INT HEALTH, V18, P1269, DOI 10.1111/tmi.12168; Chandler CIR, 2008, TROP MED INT HEALTH, V13, P1131, DOI 10.1111/j.1365-3156.2008.02118.x; Cibulskis RE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001142; Conteh L, 2007, TROP MED INT HEALTH, V12, P382, DOI 10.1111/j.1365-3156.2006.01806.x; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; Githinji S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054066; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; Kangwana BB, 2009, AM J TROP MED HYG, V80, P737, DOI 10.4269/ajtmh.2009.80.737; Kyabayinze DJ, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-200; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Mace KE, 2011, CLIN INFECT DIS, V53, P772, DOI 10.1093/cid/cir498; Maokola W, 2011, TROP MED INT HEALTH, V16, P721, DOI 10.1111/j.1365-3156.2011.02751.x; Masanja IM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-221; MoPHS, 2010, PART MAN DIAGN MAN P; MOPHS, 2010, NAT GUID DIAGN TREAT; MOPHS, 2012, KEN ANN MAL REP 2011; Msellem MI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000070; Mtove G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-290; Mubi M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-293; Nankabirwa J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-66; Njogu J, 2008, East Afr Med J, V85, P213; NMCP DOPH MOH, 2015, UPD GUID MAL DIAGN T; Nyandigisi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024781; Piola P, 2005, LANCET, V365, P1467, DOI 10.1016/S0140-6736(05)66416-1; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Rowe AK, 2001, AM J PUBLIC HEALTH, V91, P1625, DOI 10.2105/AJPH.91.10.1625; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-275; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-209; Schellenberg JA, 2004, HEALTH POLICY PLANN, V19, P1, DOI 10.1093/heapol/czh001; Sears D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-252; Skarbinski J, 2009, AM J TROP MED HYG, V80, P919; Thiam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018419; Whitty CJM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S7; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2010, GUID TREATM MAL, V2nd; WHO, 2012, DIS SURV MAL CONTR E; Yukich JO, 2012, AM J TROP MED HYG, V87, P437, DOI 10.4269/ajtmh.2012.12-0127; Zurovac D, 2008, TROP MED INT HEALTH, V13, P784, DOI 10.1111/j.1365-3156.2008.02072.x; Zurovac D, 2008, TROP MED INT HEALTH, V13, P99, DOI 10.1111/j.1365-3156.2007.01980.x; Zurovac D, 2006, TROP MED INT HEALTH, V11, P1185, DOI 10.1111/j.1365-3156.2006.01674.x; Zurovac D, 2006, TROP MED INT HEALTH, V11, P432, DOI 10.1111/j.1365-3156.2006.01587.x; Zurovac D, 2005, ANN TROP MED PARASIT, V99, P321, DOI 10.1179/136485905X24247; Zurovac D, 2008, AM J TROP MED HYG, V78, P884, DOI 10.4269/ajtmh.2008.78.884; Zurovac D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-31; Zurovac D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-181	59	41	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92782	10.1371/journal.pone.0092782	http://dx.doi.org/10.1371/journal.pone.0092782			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663961	gold, Green Published, Green Submitted			2022-12-27	WOS:000333459900112
J	Guan, HB; Wu, L; Wu, QJ; Zhu, JJ; Gong, TT				Guan, Hong-Bo; Wu, Lang; Wu, Qi-Jun; Zhu, Jingjing; Gong, Tingting			Parity and Pancreatic Cancer Risk: A Dose-Response Meta-Analysis of Epidemiologic Studies	PLOS ONE			English	Article							REPRODUCTIVE FACTORS; ESTROGEN-RECEPTOR; DIABETES-MELLITUS; LUNG-CANCER; WEIGHT-GAIN; LIFE-STYLE; WOMEN; COHORT; MORTALITY; CHILDBEARING	Background: Previous epidemiologic studies have reported inconsistent results between parity and pancreatic cancer (PC) risk. To our knowledge, a comprehensive and quantitative assessment of this association has not been conducted. Methods: Relevant published studies of parity and PC were identified using MEDLINE (PubMed) and Web of Science databases until November 2013. Two authors (H-BG and LW) independently assessed eligibility and extracted data. Eleven prospective and 11 case-control studies reported relative risk (RR) estimates and 95% confidence intervals (CIs) of PC associated with parity. Fixed-and random-effects models were used to estimate the summary RR depending on the heterogeneity of effects. Results: The summary RR for PC comparing the highest versus lowest parity was 0.86 (95% CI: 0.73-1.02; Q = 50.49, P<0.001, I-2 = 58.4%). Significant inverse associations were also observed in the studies that adjusted for cigarette smoking (RR = 0.81; 95% CI: 0.68-0.98), Type 2 diabetes mellitus (RR = 0.83; 95% CI: 0.75-0.93), and those that included all confounders or important risk factors (RR = 0.85; 95% CI: 0.76-0.96). Additionally, in the dose-response analysis, the summary RR for per one live birth was 0.97 (95% CI: 0.94-1.01; Q = 62.83, P<0.001, I-2 = 69.8%), which also indicated a borderline statistically significant inverse effect of parity on PC risk. No evidence of publication bias and significant heterogeneity between subgroups were detected by meta-regression analyses. Conclusion: In summary, these findings suggest that higher parity is associated with a decreased risk of PC. Future large consortia or pooled studies are warranted to fully adjust for potential confounders to confirm this association.	[Guan, Hong-Bo; Gong, Tingting] China Med Univ, Shengjing Hosp, Dept Obstet & Gynecol, Shenyang, Peoples R China; [Wu, Lang] Mayo Clin, Ctr Clin & Translat Sci, Rochester, MN USA; [Wu, Qi-Jun] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, Dept Epidemiol, Shanghai 200030, Peoples R China; [Wu, Qi-Jun] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogene & Related Genes, Shanghai 200030, Peoples R China; [Zhu, Jingjing] Univ Minnesota, Dept Educ Psychol, Minneapolis, MN 55455 USA	China Medical University; Mayo Clinic; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Minnesota System; University of Minnesota Twin Cities	Guan, HB (corresponding author), China Med Univ, Shengjing Hosp, Dept Obstet & Gynecol, Shenyang, Peoples R China.	hong_bo_guan@163.com	Wu, Lang/M-4053-2017					Anderson KE, 2006, CANC EPIDEMIOLOGY PR, P721; Andren-Sandberg A, 1999, ANN ONCOL, V10, P131, DOI 10.1023/A:1008377928466; Bagnardi V, 2004, AM J EPIDEMIOL, V159, P1077, DOI 10.1093/aje/kwh142; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BENZ C, 1986, CANCER RES, V46, P2276; BOURHIS J, 1987, LANCET, V2, P977; CANTOR KP, 1993, CANCER CAUSE CONTROL, V4, P505, DOI 10.1007/BF00052425; Chang CC, 2010, PANCREAS, V39, P567, DOI 10.1097/MPA.0b013e3181c7341e; Dahabreh IJ, 2012, LUNG CANCER, V76, P150, DOI 10.1016/j.lungcan.2011.10.014; DEMESQUITA HBB, 1992, INT J CANCER, V52, P24, DOI 10.1002/ijc.2910520106; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duell EJ, 2005, AM J EPIDEMIOL, V161, P741, DOI 10.1093/aje/kwi104; Duell EJ, 2013, INT J CANCER, V132, P2164, DOI 10.1002/ijc.27875; Duell EJ, 2009, CANCER CAUSE CONTROL, V20, P1757, DOI 10.1007/s10552-009-9408-x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FERNANDEZ E, 1995, INT J CANCER, V62, P11, DOI 10.1002/ijc.2910620104; GREENLAND S, 1994, AM J EPIDEMIOL, V140, P290, DOI 10.1093/oxfordjournals.aje.a117248; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; GREENWAY B, 1981, BRIT MED J, V283, P751, DOI 10.1136/bmj.283.6294.751; Guan HB, 2013, CANCER EPIDEM BIOMAR, V22, P2345, DOI 10.1158/1055-9965.EPI-13-0759-T; HAINES AP, 1982, J CANCER RES CLIN, V103, P93, DOI 10.1007/BF00410309; Hamling J, 2008, STAT MED, V27, P954, DOI 10.1002/sim.3013; Hanley AJG, 2001, INT J CANCER, V94, P140, DOI 10.1002/ijc.1446; Heuch I, 2008, BRIT J CANCER, V98, P189, DOI 10.1038/sj.bjc.6604095; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holmes MD, 2002, CANCER EPIDEM BIOMAR, V11, P862; Il'yasova D, 2005, CANCER CAUSE CONTROL, V16, P383, DOI 10.1007/s10552-004-5025-x; IQBAL MJ, 1983, CLIN SCI, V65, P71, DOI 10.1042/cs0650071; Jemal A, 2004, CANCER-AM CANCER SOC, V101, P3, DOI 10.1002/cncr.20288; Ji BT, 1996, INT J CANCER, V66, P432; KALAPOTHAKI V, 1993, CANCER CAUSE CONTROL, V4, P375, DOI 10.1007/BF00051341; Karlson BM, 1998, INT J CANCER, V77, P224, DOI 10.1002/(SICI)1097-0215(19980717)77:2<224::AID-IJC10>3.3.CO;2-5; Kreiger N, 2001, ANN EPIDEMIOL, V11, P563, DOI 10.1016/S1047-2797(01)00219-8; KRITZSILVERSTEIN D, 1989, NEW ENGL J MED, V321, P1214, DOI 10.1056/NEJM198911023211802; KVALE G, 1994, INT J EPIDEMIOL, V23, P691, DOI 10.1093/ije/23.4.691; LAVECCHIA C, 1993, INT J CANCER, V53, P215, DOI 10.1002/ijc.2910530207; Lee E, 2013, AM J EPIDEMIOL, V178, P1403, DOI 10.1093/aje/kwt154; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Lin YS, 2006, J GASTROENTEROL, V41, P878, DOI 10.1007/s00535-006-1869-z; LINDBLAD P, 1995, INT J CANCER, V61, P192, DOI 10.1002/ijc.2910610209; Lo AC, 2007, PANCREAS, V35, P120, DOI 10.1097/mpa.0b013e318053e7d3; LONGNECKER DS, 1990, INT J PANCREATOL, V7, P159; Luan NN, 2013, AM J CLIN NUTR, V98, P1020, DOI 10.3945/ajcn.113.062794; Lucenteforte E, 2011, PANCREAS, V40, P460, DOI 10.1097/MPA.0b013e31820bf986; MILLER AB, 1980, J CHRON DIS, V33, P595, DOI 10.1016/0021-9681(80)90002-8; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nicholson WK, 2006, DIABETES CARE, V29, P2349, DOI 10.2337/dc06-0825; Prizment AE, 2007, J PANCREAS, V8, P16; Rosenberg L, 2003, OBES RES, V11, P1526, DOI 10.1038/oby.2003.204; Royston P, 2000, STAT MED, V19, P1831, DOI 10.1002/1097-0258(20000730)19:14<1831::AID-SIM502>3.0.CO;2-1; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Silvera SAN, 2005, PANCREAS, V30, P369, DOI 10.1097/01.mpa.0000160301.59319.ba; Singh S, 1997, BRIT J SURG, V84, P1085, DOI 10.1002/bjs.1800840812; Skinner HG, 2003, CANCER EPIDEM BIOMAR, V12, P433; Stevens RJ, 2009, CANCER EPIDEM BIOMAR, V18, P1457, DOI 10.1158/1055-9965.EPI-08-1134; SUMI C, 1989, CANCER RES, V49, P2332; SUMI C, 1989, CANCER RES, V49, P6687; Teras LR, 2005, CANCER CAUSE CONTROL, V16, P1035, DOI 10.1007/s10552-005-0332-4; Wahi MM, 2009, ANN EPIDEMIOL, V19, P103, DOI 10.1016/j.annepidem.2008.11.003; Wells G.A., NEWCASTLE OTTAWA SCA; WILLIAMSON DF, 1994, INT J OBESITY, V18, P561; Wu QJ, 2013, ANN ONCOL, V24, P1918, DOI 10.1093/annonc/mdt119; Yen SS, 1994, MATERNAL FETAL MED P, P382; Zhang YQ, 2010, CANCER CAUSE CONTROL, V21, P473, DOI 10.1007/s10552-009-9478-9	64	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92738	10.1371/journal.pone.0092738	http://dx.doi.org/10.1371/journal.pone.0092738			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658609	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300125
J	Kwok, H; Briggs, K; Tabard-Cossa, V				Kwok, Harold; Briggs, Kyle; Tabard-Cossa, Vincent			Nanopore Fabrication by Controlled Dielectric Breakdown	PLOS ONE			English	Article							SOLID-STATE NANOPORES; DIOXIDE FILMS; SILICON; MICROSCOPE; MOLECULES; MEMBRANES; CHANNEL; SENSORS; NOISE; MODEL	Nanofabrication techniques for achieving dimensional control at the nanometer scale are generally equipment-intensive and time-consuming. The use of energetic beams of electrons or ions has placed the fabrication of nanopores in thin solid-state membranes within reach of some academic laboratories, yet these tools are not accessible to many researchers and are poorly suited for mass-production. Here we describe a fast and simple approach for fabricating a single nanopore down to 2-nm in size with sub-nm precision, directly in solution, by controlling dielectric breakdown at the nanoscale. The method relies on applying a voltage across an insulating membrane to generate a high electric field, while monitoring the induced leakage current. We show that nanopores fabricated by this method produce clear electrical signals from translocating DNA molecules. Considering the tremendous reduction in complexity and cost, we envision this fabrication strategy would not only benefit researchers from the physical and life sciences interested in gaining reliable access to solid-state nanopores, but may provide a path towards manufacturing of nanopore-based biotechnologies.	[Kwok, Harold; Briggs, Kyle; Tabard-Cossa, Vincent] Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada	University of Ottawa	Tabard-Cossa, V (corresponding author), Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada.	tcossa@uOttawa.ca	Briggs, Kyle/AAE-8202-2020; Tabard-Cossa, Vincent/M-5202-2013	Briggs, Kyle/0000-0002-0183-6585; Tabard-Cossa, Vincent/0000-0003-4375-717X	Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; Ontario Network of Excellence	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Network of Excellence	This work was supported by the Natural Sciences and Engineering Research Council of Canada, the Canada Foundation for Innovation, and Ontario Network of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beamish E, 2013, JOVE-J VIS EXP, DOI 10.3791/51081; Beamish E, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/40/405301; BEZRUKOV SM, 1994, NATURE, V370, P279, DOI 10.1038/370279a0; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Chen P, 2004, NANO LETT, V4, P2293, DOI 10.1021/nl048654j; Dekker C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/nnano.2007.27; DIMARIA DJ, 1993, J APPL PHYS, V73, P3367, DOI 10.1063/1.352936; Fologea D, 2007, ELECTROPHORESIS, V28, P3186, DOI 10.1002/elps.200700047; Frament CM, 2012, J PHYS CHEM C, V116, P23315, DOI 10.1021/jp305381j; Frenkel J, 1938, PHYS REV, V54, P647, DOI 10.1103/PhysRev.54.647; Habermehl S, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3065477; Jain T, 2013, ANAL CHEM, V85, P3871, DOI 10.1021/ac302972c; Jamasb S, 1998, SENSOR ACTUAT B-CHEM, V49, P146, DOI 10.1016/S0925-4005(98)00040-9; Jeong DS, 2005, J APPL PHYS, V98, DOI 10.1063/1.2135895; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Kasianowicz JJ, 2008, ANNU REV ANAL CHEM, V1, P737, DOI 10.1146/annurev.anchem.1.031207.112818; Kimura M, 1996, J APPL PHYS, V80, P6360, DOI 10.1063/1.363655; Kosinska ID, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2212394; Kowalczyk SW, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/31/315101; Kuan AT, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4719679; Lee S, 2010, NAT NANOTECHNOL, V5, P412, DOI [10.1038/nnano.2010.81, 10.1038/NNANO.2010.81]; Letant SE, 2003, NAT MATER, V2, P391, DOI 10.1038/nmat888; Li J, 2001, NATURE, V412, P166, DOI 10.1038/35084037; Li JL, 2003, NAT MATER, V2, P611, DOI 10.1038/nmat965; Liu HT, 2009, J AM CHEM SOC, V131, P17034, DOI 10.1021/ja903333s; Lombardo S, 2005, J APPL PHYS, V98, DOI 10.1063/1.2147714; McPherson JW, 1998, J APPL PHYS, V84, P1513, DOI 10.1063/1.368217; Miles BN, 2013, CHEM SOC REV, V42, P15, DOI 10.1039/c2cs35286a; Oukhaled A, 2012, ACS CHEM BIOL, V7, P1935, DOI 10.1021/cb300449t; Rosenstein JK, 2012, NAT METHODS, V9, P487, DOI [10.1038/NMETH.1932, 10.1038/nmeth.1932]; Russo CJ, 2012, P NATL ACAD SCI USA, V109, P5953, DOI 10.1073/pnas.1119827109; Smeets RMM, 2008, P NATL ACAD SCI USA, V105, P417, DOI 10.1073/pnas.0705349105; Storm AJ, 2005, J APPL PHYS, V98, DOI 10.1063/1.1947391; Storm AJ, 2003, NAT MATER, V2, P537, DOI 10.1038/nmat941; Tabard-Cossa V, 2013, MICRO NANO TECHNOL, P59; Tabard-Cossa V, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/30/305505; THOMPSON GE, 1981, NATURE, V290, P230, DOI 10.1038/290230a0; Tseng AA, 2005, J VAC SCI TECHNOL B, V23, P877, DOI 10.1116/1.1926293; Venkatesan BM, 2011, NAT NANOTECHNOL, V6, P615, DOI [10.1038/NNANO.2011.129, 10.1038/nnano.2011.129]; VODYANOY I, 1992, BIOPHYS J, V62, P10, DOI 10.1016/S0006-3495(92)81762-9; Yang JJ, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/28/285310	41	276	291	10	154	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92880	10.1371/journal.pone.0092880	http://dx.doi.org/10.1371/journal.pone.0092880			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658537	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300139
J	Petchey, OL; Fox, JW; Haddon, L				Petchey, Owen L.; Fox, Jeremy W.; Haddon, Lindsay			Imbalance in Individual Researcher's Peer Review Activities Quantified for Four British Ecological Society Journals, 2003-2010	PLOS ONE			English	Article							TRAGEDY; COMMONS	Researchers contribute to the scientific peer review system by providing reviews, and "withdraw'' from it by submitting manuscripts that are subsequently reviewed. So far as we are aware, there has been no quantification of the balance of individual's contributions and withdrawals. We compared the number of reviews provided by individual researchers (i.e., their contribution) to the number required by their submissions (i.e. their withdrawals) in a large and anonymised database provided by the British Ecological Society. The database covered the Journal of Ecology, Journal of Animal Ecology, Journal of Applied Ecology, and Functional Ecology from 2003-2010. The majority of researchers (64%) did not have balanced contributions and withdrawals. Depending on assumptions, 12% to 44% contributed more than twice as much as required; 20% to 52% contributed less than half as much as required. Balance, or lack thereof, varied little in relation to the number of years a researcher had been active (reviewing or submitting). Researchers who contributed less than required did not lack the opportunity to review. Researchers who submitted more were more likely to accept invitations to review. These finding suggest overall that peer review of the four analysed journals is not in crisis, but only due to the favourable balance of over- and under-contributing researchers. These findings are limited to the four journals analysed, and therefore cannot include researcher's other peer review activities, which if included might change the proportions reported. Relatively low effort was required to assemble, check, and analyse the data. Broader analyses of individual researcher's peer review activities would contribute to greater quality, efficiency, and fairness in the peer review system.	[Petchey, Owen L.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Fox, Jeremy W.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Haddon, Lindsay] British Ecol Soc, London, England	University of Zurich; University of Calgary	Petchey, OL (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	owen.petchey@ieu.uzh.ch	Petchey, Owen/D-8851-2011	Petchey, Owen/0000-0002-7724-1633	Royal Society; University of Zurich	Royal Society(Royal Society of London); University of Zurich	OLP was funded by the Royal Society and University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akst J, 2010, SCIENTIST, V24, P36; Baveye PC, 2010, J SCHOLARLY PUBL, V41, P191; Cintas P, 2010, INCREASING VISIBILIT, P2; Hagen NT, 2013, J INFORMETR, V7, P784, DOI 10.1016/j.joi.2013.06.005; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hardin G, 1998, SCIENCE, V280, P682, DOI 10.1126/science.280.5364.682; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Hochberg ME, 2009, ECOL LETT, V12, P2, DOI 10.1111/j.1461-0248.2008.01276.x; Larsen P, 2000, MAR ECOL PROG SER, V192, P305; Lortie CJ, 2012, IMMEDIATE SCI ECOL, V1, P1; McPeek MA, 2009, AM NAT, V173, pE155, DOI 10.1086/598847; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Riisgard HU, 2003, MAR ECOL PROG SER, V258, P297, DOI 10.3354/meps258297; Siegel D, 2010, SCIENCE, V329, P1466, DOI 10.1126/science.329.5998.1466-a; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Verissimo D, 2013, TRENDS ECOL EVOL, V28, P623, DOI 10.1016/j.tree.2013.07.003; Vines T, 2010, NATURE, V468, P1041, DOI 10.1038/4681041a; Waltman L, 2012, J INFORMETR, V6, P700, DOI 10.1016/j.joi.2012.07.008	18	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92896	10.1371/journal.pone.0092896	http://dx.doi.org/10.1371/journal.pone.0092896			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658631	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300142
J	Wang, L; Huang, W; Du, J; Chen, YW; Yang, JM				Wang, Lei; Huang, Wei; Du, Jing; Chen, Youwei; Yang, Jianmin			Diagnostic Yield of the Light Blue Crest Sign in Gastric Intestinal Metaplasia: A Meta-Analysis	PLOS ONE			English	Article							MAGNIFYING ENDOSCOPY; BARRETTS-ESOPHAGUS; TARGETED BIOPSY; CANCER RISK; BAND; DYSPLASIA; LESIONS; CHROMOENDOSCOPY; CLASSIFICATION; SURVEILLANCE	Background: The diagnostic yield of light blue crest(LBC) sign, which was observed by narrow band imaging with magnification endoscopy(NBI-ME), in detecting gastric intestinal metaplasia(IM) has shown variable results. Objective: We aimed to assess the diagnostic value of LBC under NBI-ME for detecting gastric IM. Methods: We performed a literature search of the Medline/PubMed, Embase, Web of Science, Science Direct and the Cochrane Library Databases; and a meta-analysis of pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and SROC area under the curve, using fixed-and random-effects models, for the accuracy of LBC-based IM diagnosis. Results: We initially included 4 articles, but excluded 1 article to counter significant heterogeneity. When pooled, the remaining 3 articles, which included 247 patients with 721 lesions, showed the following patterns in IM diagnosis: sensitivity: 0.90 (95% confidence interval [CI] 0.86-0.92); specificity: 0.90 (95% CI 0.86-0.93), positive likelihood ratio: 8.98 (95% CI 6.42-12.58), negative likelihood ratio: 0.12 (95% CI 0.09-0.16), and SROC area under the curve: 0.9560. Limitations: As the studies varied by their definitions for positive LBC, endoscopy types, biopsy protocols, race of patient cohort, and physicians' proficiency, some sample sizes were limited so that subgroup analyses could not be performed. Conclusion: We concluded that observing LBC under NBI-ME is an accurate and precise means of diagnosing gastric IM.	[Wang, Lei; Huang, Wei; Du, Jing; Chen, Youwei; Yang, Jianmin] Zhejiang Prov Peoples Hosp, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial People's Hospital	Huang, W (corresponding author), Zhejiang Prov Peoples Hosp, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China.	hw771119@163.com						An JK, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-169; Anagnostopoulos GK, 2007, ALIMENT PHARM THER, V26, P501, DOI 10.1111/j.1365-2036.2007.03374.x; Ang TL, 2012, EUR J GASTROEN HEPAT, V24, P362, DOI 10.1097/MEG.0b013e3283500968; Capelle LG, 2010, DIGEST DIS SCI, V55, P3442, DOI 10.1007/s10620-010-1189-2; Corbo M, 2012, GASTROENTEROLOGY, V142, pS335; CORREA P, 1988, CANCER RES, V48, P3554; de Vries AC, 2008, GASTROENTEROLOGY, V134, P945, DOI 10.1053/j.gastro.2008.01.071; Dinis-Ribeiro M, 2012, ENDOSCOPY, V44, P74, DOI 10.1055/s-0031-1291491; Dinis-Ribeiro M, 2003, GASTROINTEST ENDOSC, V57, P498, DOI 10.1067/mge.2003.145; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Fang JY, 2007, MODERN DIGESTION INT, V12, P55; Gono K, 2004, J BIOMED OPT, V9, P568, DOI 10.1117/1.1695563; Imraporn B, 2008, GASTROINTEST ENDOSC, V67, pAB280, DOI 10.1016/j.gie.2008.03.791; Imraporn B, 2009, GASTROINTEST ENDOSC, V69, pAB182, DOI 10.1016/j.gie.2009.03.369; Kaminishi M., 2002, DIGEST ENDOSC, V14, P138, DOI DOI 10.1046/J.1443-1661.2002.00199.X; Liu BS, 2009, J MED BIOL ENG, V29, P29; Norimura D, 2010, DIGEST ENDOSC, V22, P101, DOI 10.1111/j.1443-1661.2010.00940.x; Olliver JR, 2003, LANCET, V362, P373, DOI 10.1016/S0140-6736(03)14026-3; Pimentel-Nunes P, 2012, ENDOSCOPY, V44, P236, DOI 10.1055/s-0031-1291537; Rerknimitr R, 2011, WORLD J GASTROENTERO, V17, P1336, DOI 10.3748/wjg.v17.i10.1336; Savarino E, 2013, WORLD J GASTROENTERO, V19, P2668, DOI 10.3748/wjg.v19.i17.2668; Song LMWK, 2008, GASTROINTEST ENDOSC, V67, P581, DOI 10.1016/j.gie.2008.01.013; Uedo N, 2006, ENDOSCOPY, V38, P819, DOI 10.1055/s-2006-944632; Wang AY, 2010, GASTROINTEST ENDOSC, V71, pAB362, DOI 10.1016/j.gie.2010.03.984; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Zhou Y, 2012, CHINESE J GASTROENTE, V17, P36; Zullo A, 2012, WORLD J GASTRO ONCOL, V4, P30, DOI 10.4251/wjgo.v4.i3.30	27	14	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92874	10.1371/journal.pone.0092874	http://dx.doi.org/10.1371/journal.pone.0092874			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658503	gold, Green Published, Green Submitted			2022-12-27	WOS:000333355300138
J	Buhnerkempe, MG; Tildesley, MJ; Lindstrom, T; Grear, DA; Portacci, K; Miller, RS; Lombard, JE; Werkman, M; Keeling, MJ; Wennergren, U; Webb, CT				Buhnerkempe, Michael G.; Tildesley, Michael J.; Lindstrom, Tom; Grear, Daniel A.; Portacci, Katie; Miller, Ryan S.; Lombard, Jason E.; Werkman, Marleen; Keeling, Matt J.; Wennergren, Uno; Webb, Colleen T.			The Impact of Movements and Animal Density on Continental Scale Cattle Disease Outbreaks in the United States	PLOS ONE			English	Article							MOUTH-DISEASE; 2001 FOOT; VACCINATION STRATEGIES; LIVESTOCK MOVEMENTS; SIMULATION-MODEL; GREAT-BRITAIN; EPIDEMIC; DYNAMICS; NETWORK; SPREAD	Globalization has increased the potential for the introduction and spread of novel pathogens over large spatial scales necessitating continental-scale disease models to guide emergency preparedness. Livestock disease spread models, such as those for the 2001 foot-and-mouth disease (FMD) epidemic in the United Kingdom, represent some of the best case studies of large-scale disease spread. However, generalization of these models to explore disease outcomes in other systems, such as the United States's cattle industry, has been hampered by differences in system size and complexity and the absence of suitable livestock movement data. Here, a unique database of US cattle shipments allows estimation of synthetic movement networks that inform a near-continental scale disease model of a potential FMD-like (i.e., rapidly spreading) epidemic in US cattle. The largest epidemics may affect over one-third of the US and 120,000 cattle premises, but cattle movement restrictions from infected counties, as opposed to national movement moratoriums, are found to effectively contain outbreaks. Slow detection or weak compliance may necessitate more severe state-level bans for similar control. Such results highlight the role of large-scale disease models in emergency preparedness, particularly for systems lacking comprehensive movement and outbreak data, and the need to rapidly implement multi-scale contingency plans during a potential US outbreak.	[Buhnerkempe, Michael G.; Grear, Daniel A.; Webb, Colleen T.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Tildesley, Michael J.; Werkman, Marleen; Keeling, Matt J.] Univ Warwick, Math Inst, Ctr Complex Sci, Coventry CV4 7AL, W Midlands, England; [Lindstrom, Tom; Wennergren, Uno] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden; [Portacci, Katie; Miller, Ryan S.; Lombard, Jason E.] US Anim & Plant Hlth Inspect Serv, USDA, Ctr Epidemiol, Ft Collins, CO USA; [Portacci, Katie; Miller, Ryan S.; Lombard, Jason E.] US Anim & Plant Hlth Inspect Serv, USDA, Ctr Anim Hlth, Ft Collins, CO USA	Colorado State University; University of Warwick; Linkoping University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Buhnerkempe, MG (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA.	michael.buhnerkempe@gmail.com	Buhnerkempe, Michael G./N-2411-2019; Miller, Ryan/H-9848-2019; Keeling, Matt J/J-9280-2012; Lindström, Tom/AAX-6492-2020	Buhnerkempe, Michael G./0000-0002-5996-8927; Miller, Ryan/0000-0003-3892-0251; Keeling, Matt J/0000-0003-4639-4765; Werkman, Marleen/0000-0002-2252-9357; Tildesley, Michael/0000-0002-6875-7232; Grear, Daniel/0000-0002-5478-1549	Research and Policy for Infectious Disease Dynamics (RAPIDD) Program, Science and Technology Directorate, US Department of Homeland Security, and Fogarty International Center, National Institutes of Health; Foreign Animal Disease Modeling Program, Science and Technology Directorate, US Department of Homeland Security [ST-108-000017]; USDA [11-9208-0269-CA 11-1, 09-9208-0235-CA]	Research and Policy for Infectious Disease Dynamics (RAPIDD) Program, Science and Technology Directorate, US Department of Homeland Security, and Fogarty International Center, National Institutes of Health; Foreign Animal Disease Modeling Program, Science and Technology Directorate, US Department of Homeland Security; USDA(United States Department of Agriculture (USDA))	Funding provided by the Research and Policy for Infectious Disease Dynamics (RAPIDD) Program, Science and Technology Directorate, US Department of Homeland Security, and Fogarty International Center, National Institutes of Health; Foreign Animal Disease Modeling Program, Science and Technology Directorate, US Department of Homeland Security (Grant ST-108-000017); and USDA Cooperative Agreements 11-9208-0269-CA 11-1 and 09-9208-0235-CA. Data included in this analysis were provided by the US Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services. However, the views and conclusions contained in this document are those of the authors and should not be interpreted as necessarily representing the official policies, either expressed or implied, of USDA-APHIS-Veterinary Services or the US Department of Homeland Security. The authors also acknowledge the National Institute for Mathematical and Biological Synthesis for supporting the Modeling Bovine Tuberculosis working group, where the initial ideas for using ICVI data were developed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajardi P, 2012, J R SOC INTERFACE, V9, P2814, DOI 10.1098/rsif.2012.0289; Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019869; Bates TW, 2003, AM J VET RES, V64, P195, DOI 10.2460/ajvr.2003.64.195; Buhnerkempe MG, 2013, PREV VET MED, V112, P318, DOI 10.1016/j.prevetmed.2013.08.002; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; Green DM, 2006, P ROY SOC B-BIOL SCI, V273, P2729, DOI 10.1098/rspb.2006.3648; Harvey N, 2007, PREV VET MED, V82, P176, DOI 10.1016/j.prevetmed.2007.05.019; Kao RR, 2006, P ROY SOC B-BIOL SCI, V273, P1999, DOI 10.1098/rspb.2006.3505; Kao RR, 2007, J R SOC INTERFACE, V4, P907, DOI 10.1098/rsif.2007.1129; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Keeling MJ, 2003, NATURE, V421, P136, DOI 10.1038/nature01343; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129; Lindstrom T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053432; Lindstrom T, 2012, J R SOC INTERFACE, V9, P1287, DOI 10.1098/rsif.2011.0625; National Agricultural Statistics Service, 2007, CENS AGR; National Agricultural Statistics Service US Department of Agriculture, 2012, QUICK STATS; National Research Council, 2012, EV UPD SIT SPEC RISK; National Research Council, 2010, EV SIT SPEC RISK ASS; Ortiz-Pelaez A, 2006, PREV VET MED, V76, P40, DOI 10.1016/j.prevetmed.2006.04.007; Ovaskainen O, 2002, AM NAT, V160, P612, DOI 10.1086/342818; Ovaskainen O, 2001, THEOR POPUL BIOL, V60, P281, DOI 10.1006/tpbi.2001.1548; Portacci K, 2013, JAVMA-J AM VET MED A, V243, P555, DOI 10.2460/javma.243.4.555; R Development Core Team, 2012, R LANG ENV STAT COMP; Robinson SE, 2007, J R SOC INTERFACE, V4, P669, DOI 10.1098/rsif.2007.0214; SATTENSPIEL L, 1995, MATH BIOSCI, V128, P71, DOI 10.1016/0025-5564(94)00068-B; Shields DA, 2003, LDPM10801 USDA ERS; Smith DL, 2002, P NATL ACAD SCI USA, V99, P3668, DOI [10.1073/pnas.042400799, 10.1073/pnas.132272199]; Speck DE, 2008, LLNLTR404724 US DEP; Ster IC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000502; Ster IC, 2009, EPIDEMICS-NETH, V1, P21, DOI 10.1016/j.epidem.2008.09.001; Thompson D, 2002, REV SCI TECH OIE, V21, P675, DOI 10.20506/rst.21.3.1353; Tildesley MJ, 2008, P ROY SOC B-BIOL SCI, V275, P1459, DOI 10.1098/rspb.2008.0006; Tildesley MJ, 2006, NATURE, V440, P83, DOI 10.1038/nature04324; United States Department of Agriculture (USDA), 2008, DAIRY 2007 2; US Department of Agriculture, 2011, 5960411 USDAAPHISVS; Vernon MC, 2012, PREV VET MED, V105, P110, DOI 10.1016/j.prevetmed.2011.12.016; Yang PC, 1999, VET REC, V145, P731, DOI 10.1136/vr.145.25.731	39	51	51	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e91724	10.1371/journal.pone.0091724	http://dx.doi.org/10.1371/journal.pone.0091724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670977	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000026
J	Grossl, T; Hammer, E; Bien-Moller, S; Geisler, A; Pinkert, S; Roger, C; Poller, W; Kurreck, J; Volker, U; Vetter, R; Fechner, H				Groessl, Tobias; Hammer, Elke; Bien-Moeller, Sandra; Geisler, Anja; Pinkert, Sandra; Roeger, Carsten; Poller, Wolfgang; Kurreck, Jens; Voelker, Uwe; Vetter, Roland; Fechner, Henry			A Novel Artificial MicroRNA Expressing AAV Vector for Phospholamban Silencing in Cardiomyocytes Improves Ca2+ Uptake into the Sarcoplasmic Reticulum.	PLOS ONE			English	Article							CARDIAC GENE-TRANSFER; SHORT HAIRPIN RNA; HEART-FAILURE; DILATED CARDIOMYOPATHY; TRANSGENE EXPRESSION; INTERFERON RESPONSE; COXSACKIEVIRUS B3; MAMMALIAN-CELLS; FAILING HEART; KNOCKDOWN	In failing rat hearts, post-transcriptonal inhibition of phospholamban (PLB) expression by AAV9 vector-mediated cardiac delivery of short hairpin RNAs directed against PLB (shPLBr) improves both impaired SERCA2a controlled Ca2+ cycling and contractile dysfunction. Cardiac delivery of shPLB, however, was reported to cause cardiac toxicity in canines. Thus we developed a new AAV vector, scAAV6-amiR155-PLBr, expressing a novel engineered artificial microRNA (amiR155-PLBr) directed against PLB under control of a heart-specific hybrid promoter. Its PLB silencing efficiency and safety were compared with those of an AAV vector expressing shPLBr (scAAV6-shPLBr) from an ubiquitously active U6 promoter. Investigations were carried out in cultured neonatal rat cardiomyocytes (CM) over a period of 14 days. Compared to shPLBr, amiR155-PLBr was expressed at a significantly lower level, resulting in delayed and less pronounced PLB silencing. Despite decreased knockdown efficiency of scAAV6-amiR155-PLBr, a similar increase of the SERCA2a-catalyzed Ca2+ uptake into sarcoplasmic reticulum (SR) vesicles was observed for both the shPLBr and amiR155-PLBr vectors. Proteomic analysis confirmed PLB silencing of both therapeutic vectors and revealed that shPLBr, but not the amiR155-PLBr vector, increased the proinflammatory proteins STAT3, STAT1 and activated STAT1 phosphorylation at the key amino acid residue Tyr701. Quantitative RT-PCR analysis detected alterations in the expression of several cardiac microRNAs after treatment of CM with scAAV6-shPLBr and scAAV6-amiR155-PLBr, as well as after treatment with its related amiR155- and shRNAs-expressing control AAV vectors. The results demonstrate that scAAV6-amiR155-PLBr is capable of enhancing the Ca2+ transport function of the cardiac SR PLB/SERCA2a system as efficiently as scAAV6-shPLBr while offering a superior safety profile.	[Groessl, Tobias; Geisler, Anja; Pinkert, Sandra; Roeger, Carsten; Kurreck, Jens; Fechner, Henry] Tech Univ Berlin, Inst Biotechnol, Dept Appl Biochem, Berlin, Germany; [Hammer, Elke; Voelker, Uwe] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Bien-Moeller, Sandra] Univ Med Greifswald, Ctr Drug Absorpt & Transport, Dept Pharmacol, Greifswald, Germany; [Poller, Wolfgang] Charite, Dept Cardiol & Pneumol, D-13353 Berlin, Germany; [Vetter, Roland] Charite, Inst Clin Pharmacol & Toxicol, Campus Charite Mitte, D-13353 Berlin, Germany	Technical University of Berlin; Greifswald Medical School; Greifswald Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Fechner, H (corresponding author), Tech Univ Berlin, Inst Biotechnol, Dept Appl Biochem, Berlin, Germany.	henry.fechner@tu-berlin.de	Poller, Wolfgang/AAB-2185-2021; Kurreck, Jens/B-7785-2008	Kurreck, Jens/0000-0002-1469-0052; Volker, Uwe/0000-0002-5689-3448; Poller, Wolfgang/0000-0002-2805-6634; Hammer, Elke/0000-0002-1507-0402	Deutsche Forschungsgemeinschaft through SFB Transregio 19	Deutsche Forschungsgemeinschaft through SFB Transregio 19	This work was supported by the Deutsche Forschungsgemeinschaft through SFB Transregio 19 project grants to HF UV and RV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andino LM, 2008, J GENE MED, V10, P132, DOI 10.1002/jgm.1131; Bish LT, 2011, HUM GENE THER, V22, P969, DOI 10.1089/hum.2011.035; Boden D, 2004, NUCLEIC ACIDS RES, V32, P1154, DOI 10.1093/nar/gkh278; Borel Florie, 2011, J RNAi Gene Silencing, V7, P434; Boudreau RL, 2008, RNA, V14, P1834, DOI 10.1261/rna.1062908; Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cernohorsky J, 1998, AM J PHYSIOL-HEART C, V275, pH264, DOI 10.1152/ajpheart.1998.275.1.H264; Cheng YH, 2010, J CARDIOVASC TRANSL, V3, P251, DOI 10.1007/s12265-010-9169-7; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; del Monte F, 2001, CIRCULATION, V104, P1424, DOI 10.1161/hc3601.095574; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dieterle T, 2005, CARDIOVASC RES, V67, P678, DOI 10.1016/j.cardiores.2005.04.029; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fechner H, 2007, GENE THER, V14, P960, DOI 10.1038/sj.gt.3302948; Fechner H, 2007, GENE THER, V14, P211, DOI 10.1038/sj.gt.3302872; Fechner H, 2008, J MOL MED, V86, P987, DOI 10.1007/s00109-008-0363-x; Fechner H, 2011, MOLECULES, V16, P8475, DOI 10.3390/molecules16108475; Geisler A, 2011, GENE THER, V18, P199, DOI 10.1038/gt.2010.141; Giering JC, 2008, MOL THER, V16, P1630, DOI 10.1038/mt.2008.144; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hadri L, 2011, CLIN PHARMACOL THER, V90, P620, DOI 10.1038/clpt.2011.161; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Hammer E, 2011, J PROTEOME RES, V10, P2161, DOI 10.1021/pr1008042; Huang Z, 2012, LIFE SCI, V91, P1207, DOI 10.1016/j.lfs.2012.09.015; Hulot JS, 2012, GENE THER, V19, P596, DOI 10.1038/gt.2012.34; Hutson TH, 2012, J GENE MED, V14, P299, DOI 10.1002/jgm.2626; Iwanaga Y, 2004, J CLIN INVEST, V113, P727, DOI 10.1172/JCI200418716; Kawase Y, 2008, J AM COLL CARDIOL, V51, P1112, DOI 10.1016/j.jacc.2007.12.014; Kawase Y, 2011, J AM COLL CARDIOL, V57, P1169, DOI 10.1016/j.jacc.2010.11.023; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kenworthy R, 2009, NUCLEIC ACIDS RES, V37, P6587, DOI 10.1093/nar/gkp714; Kurreck J, 2009, ANGEW CHEM INT EDIT, V48, P1378, DOI 10.1002/anie.200802092; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lompre AM, 2010, CIRCULATION, V121, P822, DOI 10.1161/CIRCULATIONAHA.109.890954; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Maczuga P, 2012, MOL THER; Maczuga P, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-42; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Muller OJ, 2008, GENE THER, V15, P1558, DOI 10.1038/gt.2008.111; Muller OJ, 2006, CARDIOVASC RES, V70, P70, DOI 10.1016/j.cardiores.2005.12.017; Pinkert S, 2009, CIRCULATION, V120, P2358, DOI 10.1161/CIRCULATIONAHA.108.845339; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Shan ZX, 2009, MOL BIOL REP, V36, P1483, DOI 10.1007/s11033-008-9339-8; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Singh S, 2011, PHARM RES-DORDR, V28, P2996, DOI 10.1007/s11095-011-0608-1; Sipo I, 2007, GENE THER, V14, P1319, DOI 10.1038/sj.gt.3302987; Suckau L, 2009, CIRCULATION, V119, P1241, DOI 10.1161/CIRCULATIONAHA.108.783852; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Varkonyi-Gasic E, 2010, METHODS MOL BIOL, V631, P109, DOI 10.1007/978-1-60761-646-7_10; Vetter R, 1998, MOL CELL BIOCHEM, V188, P177, DOI 10.1023/A:1006850724830; Watanabe A, 2004, J MOL CELL CARDIOL, V37, P691, DOI 10.1016/j.yjmcc.2004.06.009; Xiao SQ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-491; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhang HS, 2012, MOL THER, V20, P1508, DOI 10.1038/mt.2012.80	58	12	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92188	10.1371/journal.pone.0092188	http://dx.doi.org/10.1371/journal.pone.0092188			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670775	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000034
J	Wander, PL; Hochner, H; Sitlani, CM; Enquobahrie, DA; Lumley, T; Lawrence, GM; Burger, A; Savitsky, B; Manor, O; Meiner, V; Hesselson, S; Kwok, PY; Siscovick, DS; Friedlander, Y				Wander, Pandora L.; Hochner, Hagit; Sitlani, Colleen M.; Enquobahrie, Daniel A.; Lumley, Thomas; Lawrence, Gabriela M.; Burger, Ayala; Savitsky, Bella; Manor, Orly; Meiner, Vardiella; Hesselson, Stephanie; Kwok, Pui Y.; Siscovick, David S.; Friedlander, Yechiel			Maternal Genetic Variation Accounts in Part for the Associations of Maternal Size during Pregnancy with Offspring Cardiometabolic Risk in Adulthood	PLOS ONE			English	Article							GESTATIONAL WEIGHT-GAIN; BODY-MASS INDEX; ADIPOSITY; VARIANTS; SEQUENCE; OBESITY; COHORT; BIRTH; DIET	Background: Maternal pre-pregnancy body-mass index (ppBMI) and gestational weight gain (GWG) are associated with cardiometabolic risk (CMR) traits in the offspring. The extent to which maternal genetic variation accounts for these associations is unknown. Methods/Results: In 1249 mother-offspring pairs recruited from the Jerusalem Perinatal Study, we used archival data to characterize ppBMI and GWG and follow-up data from offspring to assess CMR, including body mass index (BMI), waist circumference, glucose, insulin, blood pressure, and lipid levels, at an average age of 32. Maternal genetic risk scores (GRS) were created using a subset of SNPs most predictive of ppBMI, GWG, and each CMR trait, selected among 1384 single-nucleotide polymorphisms (SNPs) characterizing variation in 170 candidate genes potentially related to fetal development and/or metabolic risk. We fit linear regression models to examine the associations of ppBMI and GWG with CMR traits with and without adjustment for GRS. Compared to unadjusted models, the coefficient for the association of a one-standard-deviation (SD) difference in GWG and offspring BMI decreased by 41% (95%CI -81%, -11%) from 0.847 to 0.503 and the coefficient for a 1SD difference in GWG and WC decreased by 63% (95%CI -318%, -11%) from 1.196 to 0.443. For other traits, there were no statistically significant changes in the coefficients for GWG with adjustment for GRS. None of the associations of ppBMI with CMR traits were significantly altered by adjustment for GRS. Conclusions: Maternal genetic variation may account in part for associations of GWG with offspring BMI and WC in young adults.	[Wander, Pandora L.; Enquobahrie, Daniel A.; Siscovick, David S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Wander, Pandora L.; Sitlani, Colleen M.; Siscovick, David S.] Univ Washington, Dept Med, Seattle, WA USA; [Hochner, Hagit; Lawrence, Gabriela M.; Burger, Ayala; Savitsky, Bella; Manor, Orly; Friedlander, Yechiel] Hebrew Univ Jerusalem, Hadassah Med Ctr, Braun Sch Publ Hlth, Jerusalem, Israel; [Sitlani, Colleen M.; Siscovick, David S.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Lumley, Thomas] Univ Auckland, Dept Stat, Auckland 1, New Zealand; [Meiner, Vardiella] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Human Genet, Jerusalem, Israel; [Hesselson, Stephanie; Kwok, Pui Y.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Kwok, Pui Y.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Kwok, Pui Y.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Washington; University of Washington Seattle; University of Auckland; Hebrew University of Jerusalem; Hadassah University Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wander, PL (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	lwander@u.washington.edu		Savitsky, Bella/0000-0001-8917-8419; Wander, Pandora/0000-0003-3671-1464	National Heart, Lung, and Blood Institute [T32-HL07902, R01-HL088884]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007902, R01HL088884] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the T32-HL07902 training grant and R01-HL088884 from the National Heart, Lung, and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branum AM, 2011, AM J EPIDEMIOL, V174, P1159, DOI 10.1093/aje/kwr250; Cohen TR, 2013, J PREGNANCY, V2013, DOI 10.1155/2013/787032; Cox J, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.041; DAVIES AM, 1969, ISRAEL J MED SCI, V5, P1095; Drake AJ, 2012, CLIN ENDOCRINOL, V77, P808, DOI 10.1111/j.1365-2265.2012.04453.x; Drake AJ, 2010, REPRODUCTION, V140, P387, DOI 10.1530/REP-10-0077; Fan L, 2013, INT J OBESITY, V37, P254, DOI 10.1038/ijo.2012.42; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Guenard F, 2013, P NATL ACAD SCI US; HARLAP S, 1977, ISRAEL J MED SCI, V13, P1073; Harlap S, 2007, PAEDIATR PERINAT EP, V21, P256, DOI 10.1111/j.1365-3016.2007.00799.x; Hochner H, 2012, CIRCULATION; Hochner H, 2012, CIRCULATION, V125, P1381, DOI 10.1161/CIRCULATIONAHA.111.070060; Kim SY, 2007, OBESITY, V15, P986, DOI 10.1038/oby.2007.621; Lawlor DA, 2011, AM J CLIN NUTR, V94, P149, DOI 10.3945/ajcn.110.010751; Lawlor DA, 2011, AM J CLIN NUTR, V94, P142, DOI 10.3945/ajcn.110.009324; Lawrence G, 2013, OBESITY SIL IN PRESS; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Ludwig DS, 2010, LANCET, V376, P984, DOI 10.1016/S0140-6736(10)60751-9; Macones G, 2013, WEIGHT GAIN LOSS PRE; May LE, 2012, MED SCI SPORT EXER, V44, P1252, DOI 10.1249/MSS.0b013e318247b324; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; SMITH DE, 1994, JAMA-J AM MED ASSOC, V271, P1747, DOI 10.1001/jama.271.22.1747; Stotland NE, 2006, OBSTET GYNECOL, V108, P635, DOI 10.1097/01.AOG.0000228960.16678.bd; Stuebe AM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.069; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Zaina S, 2010, CURR GENOMICS, V11, P359, DOI 10.2174/138920210791616662	32	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e91835	10.1371/journal.pone.0091835	http://dx.doi.org/10.1371/journal.pone.0091835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670385	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677000027
J	Warrilow, D; Watterson, D; Hall, RA; Davis, SS; Weir, R; Kurucz, N; Whelan, P; Allcock, R; Hall-Mendelin, S; O'Brien, CA; Hobson-Peters, J				Warrilow, David; Watterson, Daniel; Hall, Roy A.; Davis, Steven S.; Weir, Richard; Kurucz, Nina; Whelan, Peter; Allcock, Richard; Hall-Mendelin, Sonja; O'Brien, Caitlin A.; Hobson-Peters, Jody			A New Species of Mesonivirus from the Northern Territory, Australia	PLOS ONE			English	Article							ENCEPHALITIS-VIRUS; RNA	Here we describe Casuarina virus (CASV), a new virus in the family Mesoniviridae. This is the first report of a mesonivirus in Australia, which extends the geographical range of this virus family to 3 continents. The virus was isolated in 2010 from Coquillettidia xanthogaster mosquitoes during surveillance in the suburbs of Darwin, the capital of the Northern Territory. Cryo-electron microscopy of the CASV virions revealed spherical particles of 65 nm in size with large club-shaped projections of approximately 15 nm in length. The new virus was most closely related to Alphamesonivirus 1, the only currently recognized species in the family. In 2013 a further 5 putative new mesonivirus species were described: Hana, Meno, Nse, Moumo and Dak Nong viruses. The evolutionary distance between CASV and two of its closest relatives, Cavally and Hana viruses (Jones-Taylor-Thornton distance of 0.151 and 0.224, respectively), along with its isolation from a different genus of mosquitoes captured on a separate continent indicate that CASV is a new species.	[Warrilow, David; Hall-Mendelin, Sonja] Dept Hlth, Forens Serv, Publ Hlth Virol Lab, Archerfield, Qld, Australia; [Warrilow, David; Hall-Mendelin, Sonja] Dept Hlth, Sci Serv, Publ Hlth Virol Lab, Archerfield, Qld, Australia; [Watterson, Daniel; Hall, Roy A.; O'Brien, Caitlin A.; Hobson-Peters, Jody] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia; [Davis, Steven S.; Weir, Richard] Dept Primary Ind & Fisheries, Berrimah Vet Labs, Darwin, NT, Australia; [Kurucz, Nina; Whelan, Peter] Northern Terr Dept Hlth, Hlth Protect Div, Ctr Dis Control, Darwin, NT, Australia; [Allcock, Richard] Univ Western Australia, Sch Pathol & Lab Med, LotteryWest State Biomed Facil, Perth, WA 6009, Australia; [Allcock, Richard] Royal Perth Hosp, Pathwest Lab Med Western Australia, Dept Clin Immunol, Perth, WA 6001, Australia	University of Queensland; University of Western Australia; Royal Perth Hospital	Warrilow, D (corresponding author), Dept Hlth, Forens Serv, Publ Hlth Virol Lab, Archerfield, Qld, Australia.	David_Warrilow@health.qld.gov.au; j.peters2@uq.edu.au		Watterson, Daniel/0000-0001-5957-2853	Australian Infectious Diseases Research Centre; Australian Research Council [DP120103994]	Australian Infectious Diseases Research Centre; Australian Research Council(Australian Research Council)	This work was partially funded by an Australian Infectious Diseases Research Centre support grant and by the Australian Research Council (DP120103994). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beniac DR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001082; Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856; Briggs JAG, 2004, J VIROL, V78, P2606, DOI 10.1128/JVI.78.5.2606-2608.2004; Clark DC, 2007, J GEN VIROL, V88, P1175, DOI 10.1099/vir.0.82609-0; CONDREAY LD, 1986, J VIROL, V58, P81, DOI 10.1128/JVI.58.1.81-86.1986; Hall-Mendelin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058026; Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534; Hsu S.H., 1971, ARTHROPOD CELL CULTU, P140; Junglen S, 2009, ECOHEALTH, V6, P239, DOI 10.1007/s10393-009-0260-y; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Kuwata R, 2013, ARCH VIROL; Lauber C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003500; Lauber C, 2012, ARCH VIROL, V157, P1623, DOI 10.1007/s00705-012-1295-x; May FJ, 2006, J GEN VIROL, V87, P329, DOI 10.1099/vir.0.81252-0; Neuman BW, 2006, J VIROL, V80, P7918, DOI 10.1128/JVI.00645-06; Thuy NT, 2013, VIROLOGY, V444, P337, DOI 10.1016/j.virol.2013.06.030; Nga PT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002215; REED L. J., 1938, AMER JOUR HYG, V27, P493; Risco C, 1996, J VIROL, V70, P4773, DOI 10.1128/JVI.70.7.4773-4777.1996; Ritchie SA, 1997, AM J TROP MED HYG, V56, P80, DOI 10.4269/ajtmh.1997.56.80; Rohe D.L., 1979, Bulletin of the Society of Vector Ecologists, V4, P24; Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848; Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861; Voronin D, 2010, J APPL MICROBIOL, V108, P2133, DOI 10.1111/j.1365-2672.2009.04621.x; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Whelan P. L., 1993, ARBOVIRUS RES AUST, V6, P270; Zirkel F, 2013, J VIROL, V87, P6346, DOI 10.1128/JVI.00416-13; Zirkel F, 2011, MBIO, V2, DOI 10.1128/mBio.00077-11	28	43	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e91103	10.1371/journal.pone.0091103	http://dx.doi.org/10.1371/journal.pone.0091103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670468	gold, Green Submitted, Green Published			2022-12-27	WOS:000333677000016
J	Hayes, BJ; Riehle, KJ; Shimizu-Albergine, M; Bauer, RL; Hudkins, KL; Johansson, F; Yeh, MM; Mahoney, WM; Yeung, RS; Campbell, JS				Hayes, Brian J.; Riehle, Kimberly J.; Shimizu-Albergine, Masami; Bauer, Renay L.; Hudkins, Kelly L.; Johansson, Fredrik; Yeh, Matthew M.; Mahoney, William M., Jr.; Yeung, Raymond S.; Campbell, Jean S.			Activation of Platelet-Derived Growth Factor Receptor Alpha Contributes to Liver Fibrosis	PLOS ONE			English	Article							RAT HEPATIC LIPOCYTES; PDGFR-ALPHA; HEPATOCELLULAR-CARCINOMA; CARBON-TETRACHLORIDE; IN-VIVO; EXPRESSION; BETA; CIRRHOSIS; CELLS; HEPATOTOXICITY	Chronic liver injury leads to fibrosis, cirrhosis, and loss of liver function. Liver cirrhosis is the 12th leading cause of death in the United States, and it is the primary risk factor for developing liver cancer. Fibrosis and cirrhosis result from activation of hepatic stellate cells (HSCs), which are the primary collagen producing cell type in the liver. Here, we show that platelet-derived growth factor receptor alpha (PDGFR alpha) is expressed by human HSCs, and PDGFR alpha expression is elevated in human liver disease. Using a green fluorescent protein (GFP) reporter mouse strain, we evaluated the role of PDGFR alpha in liver disease in mice and found that mouse HSCs express PDGFR alpha and expression is upregulated during carbon tetrachloride (CCl4) induced liver injury and fibrosis injection. This fibrotic response is reduced in Pdgfr alpha heterozygous mice, consistent with the hypothesis that liver fibrosis requires upregulation and activation of PDGFR alpha. These results indicate that Pdgfr alpha expression is important in the fibrotic response to liver injury in humans and mice, and suggest that blocking PDGFR alpha-specific signaling pathways in HSCs may provide therapeutic benefit for patients with chronic liver disease.	[Hayes, Brian J.; Riehle, Kimberly J.; Shimizu-Albergine, Masami; Bauer, Renay L.; Hudkins, Kelly L.; Johansson, Fredrik; Yeh, Matthew M.; Mahoney, William M., Jr.; Yeung, Raymond S.; Campbell, Jean S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Shimizu-Albergine, Masami] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Riehle, Kimberly J.; Yeung, Raymond S.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Mahoney, William M., Jr.] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Mahoney, William M., Jr.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Campbell, JS (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	campjs@u.washington.edu	Mahoney, William/GQB-0802-2022	Hayes, Brian J/0000-0002-0930-0160; Campbell, Jean/0000-0002-9187-2204	Herbert S. Coe Foundation; American College of Surgeons Louis C. Argenta Fellowship; American Surgical Association Foundation Fellowship; Howard Hughes Medical Institute program in Molecular Medicine;  [R01CA127228];  [T32HL007312]; NATIONAL CANCER INSTITUTE [R01CA127228] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER	Herbert S. Coe Foundation; American College of Surgeons Louis C. Argenta Fellowship; American Surgical Association Foundation Fellowship; Howard Hughes Medical Institute program in Molecular Medicine; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants R01CA127228 (to J.S. Campbell), the Herbert S. Coe Foundation, American College of Surgeons Louis C. Argenta Fellowship, the American Surgical Association Foundation Fellowship (to K.J. Riehle), and the Howard Hughes Medical Institute program in Molecular Medicine and T32HL007312 (to B.J. Hayes). The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2005, J EXP MED, V201, P925, DOI 10.1084/jem.20041393; Andrae J, 2013, MOL CELL BIOL; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; ANTONIADES HN, 1990, J CLIN INVEST, V86, P1055, DOI 10.1172/JCI114808; Argast GM, 2004, J BIOL CHEM, V279, P34530, DOI 10.1074/jbc.M405703200; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; Borkham-Kamphorst E, 2008, LAB INVEST, V88, P1090, DOI 10.1038/labinvest.2008.71; Breitkopf K, 2005, CYTOKINE, V31, P349, DOI 10.1016/j.cyto.2005.06.005; Campbell JS, 2007, DIFFERENTIATION, V75, P843, DOI 10.1111/j.1432-0436.2007.00235.x; Campbell JS, 2006, J IMMUNOL, V176, P2522, DOI 10.4049/jimmunol.176.4.2522; Campbell JS, 2005, P NATL ACAD SCI USA, V102, P3389, DOI 10.1073/pnas.0409722102; Chen HN, 2011, NATURE, V478, P349, DOI 10.1038/nature10502; Chen YT, 2011, KIDNEY INT, V80, P1170, DOI 10.1038/ki.2011.208; Chong JJH, 2013, STEM CELLS DEV, V22, P1932, DOI 10.1089/scd.2012.0542; Crosby JR, 1998, NAT GENET, V18, P385, DOI 10.1038/ng0498-385; Czochra P, 2006, J HEPATOL, V45, P419, DOI 10.1016/j.jhep.2006.04.010; Floege J, 2008, J AM SOC NEPHROL, V19, P12, DOI 10.1681/ASN.2007050532; FRIEDMAN SL, 1989, J CLIN INVEST, V84, P1780, DOI 10.1172/JCI114362; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; Hasinoff BB, 2010, TOXICOL APPL PHARM, V249, P132, DOI 10.1016/j.taap.2010.08.026; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Ikura Y, 1997, J GASTROENTEROL, V32, P496, DOI 10.1007/BF02934089; Iwayama T, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-012-0304-0; Johnson Simon, 2012, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0939s61; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Krampert M, 2008, LAB INVEST, V88, P1204, DOI 10.1038/labinvest.2008.81; McKinnon RD, 2005, J NEUROSCI, V25, P3499, DOI 10.1523/JNEUROSCI.5049-04.2005; Mellgren AM, 2008, CIRC RES, V103, P1393, DOI 10.1161/CIRCRESAHA.108.176768; Olson LE, 2011, DEV CELL, V20, P815, DOI 10.1016/j.devcel.2011.04.019; Olson LE, 2009, DEV CELL, V16, P303, DOI 10.1016/j.devcel.2008.12.003; PIERCE GF, 1995, J CLIN INVEST, V96, P1336, DOI 10.1172/JCI118169; Pinzani M, 1996, AM J PATHOL, V148, P785; ROCKEY DC, 1992, J SUBMICR CYTOL PATH, V24, P193; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Soriano P, 1997, DEVELOPMENT, V124, P2691; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Starr SP, 2011, AM FAM PHYSICIAN, V84, P1353; Tallquist MD, 2003, DEVELOPMENT, V130, P507, DOI 10.1242/dev.00241; Teo YL, 2013, CANCER TREAT REV, V39, P199, DOI 10.1016/j.ctrv.2012.09.004; Thieringer F, 2008, GENE, V423, P23, DOI 10.1016/j.gene.2008.05.022; TIRIBELLI C, 1989, HEPATOLOGY, V10, P998, DOI 10.1002/hep.1840100618; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; WONG L, 1994, J CLIN INVEST, V94, P1563, DOI 10.1172/JCI117497; Wright J. H., 2013, INT J CANC, DOI 10.1002/ijc.28421; YAMAOKA K, 1993, DIGEST DIS SCI, V38, P1473, DOI 10.1007/BF01308606; Yeh MM, 2007, AM J SURG PATHOL, V31, P681, DOI 10.1097/PAS.0b013e31802ff7aa; Zymek P, 2006, J AM COLL CARDIOL, V48, P2315, DOI 10.1016/j.jacc.2006.07.060	52	37	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92925	10.1371/journal.pone.0092925	http://dx.doi.org/10.1371/journal.pone.0092925			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667490	Green Submitted, gold, Green Published			2022-12-27	WOS:000333675600106
J	Meng, F; Zhang, YY; Liu, F; Guo, XQ; Xu, BH				Meng, Fei; Zhang, Yuanying; Liu, Feng; Guo, Xingqi; Xu, Baohua			Characterization and Mutational Analysis of Omega-Class GST (GSTO1) from Apis cerana cerana, a Gene Involved in Response to Oxidative Stress	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; MOLECULAR CHARACTERIZATION; THIOREDOXIN PEROXIDASE; CATALYTIC MECHANISM; HONEY-BEE; IDENTIFICATION; ENZYME; CELLS; EXPRESSION; RADICALS	The Omega-class of GSTs (GSTOs) is a class of cytosolic GSTs that have specific structural and functional characteristics that differ from those of other GST groups. In this study, we demonstrated the involvement of the GSTO1 gene from A. cerana cerana in the oxidative stress response and further investigated the effects of three cysteine residues of GSTO1 protein on this response. Real-time quantitative PCR (qPCR) showed that AccGSTO1 was highly expressed in larvae and foragers, primarily in the midgut, epidermis, and flight muscles. The AccGSTO1 mRNA was significantly induced by cold and heat at 1 h and 3 h. The TBA (2-Thiobarbituric acid) method indicated that cold or heat resulted in MDA accumulation, but silencing of AccGSTO1 by RNAi in honeybees increased the concentration of MDA. RNAi also increased the temperature sensitivity of honeybees and markedly reduced their survival. Disc diffusion assay indicated that overexpression of AccGSTO1 in E. coli caused the resistance to long-term oxidative stress. Furthermore, AccGSTO1 was active in an in vitro DNA protection assay. Mutations in Cys-28, Cys-70, and Cys-124 affected the catalytic activity and antioxidant activity of AccGSTO1. The predicted three-dimensional structure of AccGSTO1 was also influenced by the replacement of these cysteine residues. These findings suggest that AccGSTO1 plays a protective role in the response to oxidative stress.	[Meng, Fei; Zhang, Yuanying; Guo, Xingqi] Shandong Agr Univ, Coll Life Sci, Tai An, Shandong, Peoples R China; [Liu, Feng; Xu, Baohua] Shandong Agr Univ, Coll Anim Sci & Technol, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Xu, BH (corresponding author), Shandong Agr Univ, Coll Anim Sci & Technol, Tai An, Shandong, Peoples R China.	bhxu@sdau.edu.cn			National Natural Science Foundation in China [31172275]; China Agriculture Research System [CARS-45]	National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System	This work was financially supported by the National Natural Science Foundation (No. 31172275) in China and the China Agriculture Research System (No. CARS-45). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball LJ, 2005, ANGEW CHEM INT EDIT, V44, P2852, DOI 10.1002/anie.200400618; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Board PG, 2011, DRUG METAB REV, V43, P226, DOI 10.3109/03602532.2011.561353; Burmeister C, 2008, FASEB J, V22, P343, DOI 10.1096/fj.06-7426com; Caccuri AM, 2002, J BIOL CHEM, V277, P18777, DOI 10.1074/jbc.M201137200; Cavallo D, 2003, TOXICOL IN VITRO, V17, P603, DOI 10.1016/S0887-2333(03)00138-3; Chowdhury UK, 2006, TOXICOL APPL PHARM, V216, P446, DOI 10.1016/j.taap.2006.06.014; CHU FF, 1993, J BIOL CHEM, V268, P2571; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; Corona M, 2006, INSECT MOL BIOL, V15, P687, DOI 10.1111/j.1365-2583.2006.00695.x; Ding YC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-35; Dixon DP, 2002, J BIOL CHEM, V277, P30859, DOI 10.1074/jbc.M202919200; Dugan Laura L, 2005, Sci Aging Knowledge Environ, V2005, ppe20, DOI 10.1126/sageke.2005.26.pe20; Dulhunty A, 2001, J BIOL CHEM, V276, P3319, DOI 10.1074/jbc.M007874200; Elias-Neto M, 2010, INSECT BIOCHEM MOLEC, V40, P241, DOI 10.1016/j.ibmb.2010.02.004; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Flanagan SW, 1998, FEBS LETT, V431, P285, DOI 10.1016/S0014-5793(98)00779-0; Garcera A, 2006, BIOCHEM J, V398, P187, DOI 10.1042/BJ20060034; Gustafsson A, 2001, BIOCHEMISTRY-US, V40, P15835, DOI 10.1021/bi010429i; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Harrison JF, 2002, COMP BIOCHEM PHYS A, V133, P323, DOI 10.1016/S1095-6433(02)00163-0; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Kim J, 2006, BIOCHEM J, V398, P451, DOI 10.1042/BJ20060424; Kleinhenz M, 2003, J EXP BIOL, V206, P4217, DOI 10.1242/jeb.00680; Laliberte RE, 2003, J BIOL CHEM, V278, P16567, DOI 10.1074/jbc.M211596200; Li YJ, 2003, HUM MOL GENET, V12, P3259, DOI 10.1093/hmg/ddg357; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Mahadev K, 2001, J BIOL CHEM, V276, P48662, DOI 10.1074/jbc.M105061200; Mannervik B, 2005, METHOD ENZYMOL, V401, P1, DOI 10.1016/S0076-6879(05)01001-3; Meng F, 2012, NATURWISSENSCHAFTEN, V99, P343, DOI 10.1007/s00114-012-0905-5; Meng F, 2010, ARCH INSECT BIOCHEM, V75, P121, DOI 10.1002/arch.20386; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Scharlaken B, 2008, DEV COMP IMMUNOL, V32, P883, DOI 10.1016/j.dci.2008.01.010; Story MD, 1999, CANCER CHEMOTH PHARM, V44, P362, DOI 10.1007/s002800050990; Suttiprapa S, 2008, MOL BIOCHEM PARASIT, V160, P116, DOI 10.1016/j.molbiopara.2008.04.010; Tanaka-Kagawa T, 2003, BIOCHEM BIOPH RES CO, V301, P516, DOI 10.1016/S0006-291X(02)03066-8; Touyz RM, 2004, HYPERTENSION, V44, P248, DOI 10.1161/01.HYP.0000138070.47616.9d; Tsuda M, 2010, FEBS LETT, V584, P3398, DOI 10.1016/j.febslet.2010.06.034; Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89; Vogt G, 1997, FOLD DES, V2, pS40, DOI 10.1016/S1359-0278(97)00062-X; Walters KB, 2009, J HERED, V100, P742, DOI 10.1093/jhered/esp043; Wan Q, 2009, COMP BIOCHEM PHYS C, V150, P558, DOI 10.1016/j.cbpc.2009.08.003; WELLS WW, 1995, METHOD ENZYMOL, V252, P30; Whitbread AK, 2005, METHOD ENZYMOL, V401, P78, DOI 10.1016/S0076-6879(05)01005-0; Whitbread AK, 2003, PHARMACOGENETICS, V13, P131, DOI 10.1097/00008571-200303000-00003; Winayanuwattikun P, 2005, J BIOL CHEM, V280, P31776, DOI 10.1074/jbc.M502612200; Xun LY, 2010, BIOCHEM J, V428, P419, DOI 10.1042/BJ20091863; Yamamoto K, 2011, INSECT MOL BIOL, V20, P379, DOI 10.1111/j.1365-2583.2011.01073.x; Yan XD, 2007, J PROTEOME RES, V6, P772, DOI 10.1021/pr060402r; Yu F, 2011, INSECT MOL BIOL, V20, P367, DOI 10.1111/j.1365-2583.2011.01071.x; Zhang YY, 2013, CELL STRESS CHAPERON, V18, P503, DOI 10.1007/s12192-013-0406-2	52	25	26	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93100	10.1371/journal.pone.0093100	http://dx.doi.org/10.1371/journal.pone.0093100			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667966	Green Submitted, Green Published, gold			2022-12-27	WOS:000333675600138
J	Momot, D; Zheng, CY; Yin, HG; Elbekai, RH; Vallant, M; Chiorini, JA				Momot, Dariya; Zheng, Changyu; Yin, Hongen; Elbekai, Reem H.; Vallant, Molly; Chiorini, John A.			Toxicity and Biodistribution of the Serotype 2 Recombinant Adeno-Associated Viral Vector, Encoding Aquaporin-1, after Retroductal Delivery to a Single Mouse Parotid Gland	PLOS ONE			English	Article							ADENOVIRAL-MEDIATED TRANSFER; RAT SALIVARY-GLANDS; FLUID SECRETION; CDNA	In preparation for testing the safety of using serotype 2 recombinant adeno-associated vector, encoding Aquaporin-1 to treat radiation-induced salivary gland damage in a phase 1 clinical trial, we conducted a 13 week GLP biodistribution and toxicology study using Balb/c mice. To best assess the safety of rAAV2hAQP1 as well as resemble clinical delivery, vector (10(6), 10(9), 10(10), or 4.4x10(10) vector particles/gland) or saline was delivered to the right parotid gland of mice via retroductal cannulation. Very mild surgically induced inflammation was caused by this procedure, seen in 3.6% of animals for the right parotid gland, and 5.3% for the left parotid gland. Long term distribution of vector appeared to be localized to the site of cannulation as well as the right and left draining submandibular lymph nodes at levels >50 copies/mu g in some animals. As expected, there was a dose-related increase in neutralizing antibodies produced by day 29. Overall, animals appeared to thrive, with no differences in mean body weight, food or water consumption between groups. There were no significant adverse effects due to treatment noted by clinical chemistry and pathology evaluations. Hematology assessment of serum demonstrated very limited changes to the white blood cell, segmented neutrophils, and hematocrit levels and were concluded to not be vector-associated. Indicators for liver, kidney, cardiac functions and general tissue damage showed no changes due to treatment. All of these indicators suggest the treatment is clinically safe.	[Momot, Dariya; Zheng, Changyu; Yin, Hongen; Chiorini, John A.] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA; [Elbekai, Reem H.] BioReliance SAFC, Div Toxicol, Rockville, MD USA; [Vallant, Molly] NIEHS, Natl Toxicol Program, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Chiorini, JA (corresponding author), Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA.	jchiorini@dir.nidcr.nih.gov			NTP/NIEHS (National Toxicology Program, National Institute of Environmental Health Sciences) [NO1-ES-55536]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000695] Funding Source: NIH RePORTER	NTP/NIEHS (National Toxicology Program, National Institute of Environmental Health Sciences); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was conducted at BioReliance, supported by NTP/NIEHS (National Toxicology Program, National Institute of Environmental Health Sciences) contract NO1-ES-55536. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; Baum BJ, 2012, P NATL ACAD SCI USA, V109, P19403, DOI 10.1073/pnas.1210662109; Braam PM, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-3; Delporte C, 1997, P NATL ACAD SCI USA, V94, P3268, DOI 10.1073/pnas.94.7.3268; Gao R, 2011, GENE THER, V18, P38, DOI 10.1038/gt.2010.128; Johnson PA, 1992, J VIROL, V66, P2652; Kagami H, 1998, HUM GENE THER, V9, P305, DOI 10.1089/hum.1998.9.3-305; Katano H, 2006, GENE THER, V13, P594, DOI 10.1038/sj.gt.3302691; LI J, 1994, PFLUG ARCH EUR J PHY, V428, P455, DOI 10.1007/BF00374565; Voutetakis A, 2007, HUM GENE THER, V18, P1109, DOI 10.1089/hum.2007.072; Zheng CY, 2006, HUM GENE THER, V17, P1122, DOI 10.1089/hum.2006.17.1122	11	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92832	10.1371/journal.pone.0092832	http://dx.doi.org/10.1371/journal.pone.0092832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667436	Green Submitted, Green Published, gold			2022-12-27	WOS:000333675600085
J	Skowronski, DM; Janjua, NZ; De Serres, G; Sabaiduc, S; Eshaghi, A; Dickinson, JA; Fonseca, K; Winter, AL; Gubbay, JB; Krajden, M; Petric, M; Charest, H; Bastien, N; Kwindt, TL; Mahmud, SM; Van Caeseele, P; Li, Y				Skowronski, Danuta M.; Janjua, Naveed Z.; De Serres, Gaston; Sabaiduc, Suzana; Eshaghi, Alireza; Dickinson, James A.; Fonseca, Kevin; Winter, Anne-Luise; Gubbay, Jonathan B.; Krajden, Mel; Petric, Martin; Charest, Hugues; Bastien, Nathalie; Kwindt, Trijntje L.; Mahmud, Salaheddin M.; Van Caeseele, Paul; Li, Yan			Low 2012-13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses	PLOS ONE			English	Article							SENTINEL SURVEILLANCE NETWORK; PANDEMIC H1N1 VACCINE; HEMAGGLUTININ; CANADA; EFFICACY; SUBSTITUTIONS; RECEPTOR; BINDING; SYSTEM; ACID	Background: Influenza vaccine effectiveness (VE) is generally interpreted in the context of vaccine match/mismatch to circulating strains with evolutionary drift in the latter invoked to explain reduced protection. During the 2012-13 season, however, detailed genotypic and phenotypic characterization shows that low VE was instead related to mutations in the egg-adapted H3N2 vaccine strain rather than antigenic drift in circulating viruses. Methods/Findings: Component-specific VE against medically-attended, PCR-confirmed influenza was estimated in Canada by test-negative case-control design. Influenza A viruses were characterized genotypically by amino acid (AA) sequencing of established haemagglutinin (HA) antigenic sites and phenotypically through haemagglutination inhibition (HI) assay. H3N2 viruses were characterized in relation to the WHO-recommended, cell-passaged vaccine prototype (A/Victoria/361/2011) as well as the egg-adapted strain as per actually used in vaccine production. Among the total of 1501 participants, influenza virus was detected in 652 (43%). Nearly two-thirds of viruses typed/subtyped were A(H3N2) (394/626; 63%); the remainder were A(H1N1) pdm09 (79/626; 13%), B/Yamagata (98/626; 16%) or B/Victoria (54/626; 9%). Suboptimal VE of 50% (95% CI: 33-63%) overall was driven by predominant H3N2 activity for which VE was 41% (95% CI: 17-59%). All H3N2 field isolates were HI-characterized as well-matched to the WHO-recommended A/Victoria/361/2011 prototype whereas all but one were antigenically distinct from the egg-adapted strain as per actually used in vaccine production. The egg-adapted strain was itself antigenically distinct from the WHO-recommended prototype, and bore three AA mutations at antigenic sites B [H156Q, G186V] and D [S219Y]. Conversely, circulating viruses were identical to the WHO-recommended prototype at these positions with other genetic variation that did not affect antigenicity. VE was 59% (95% CI: 16-80%) against A(H1N1) pdm09, 67% (95% CI: 30-85%) against B/Yamagata (vaccine-lineage) and 75% (95% CI: 29-91%) against B/Victoria (non-vaccinelineage) viruses. Conclusions: These findings underscore the need to monitor vaccine viruses as well as circulating strains to explain vaccine performance. Evolutionary drift in circulating viruses cannot be regulated, but influential mutations introduced as part of egg-based vaccine production may be amenable to improvements.	[Skowronski, Danuta M.; Sabaiduc, Suzana; Krajden, Mel; Petric, Martin] British Columbia Ctr Dis Control, Communicable Dis Prevent & Control Serv, Vancouver, BC, Canada; [Skowronski, Danuta M.; Janjua, Naveed Z.; Kwindt, Trijntje L.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Janjua, Naveed Z.; Krajden, Mel; Petric, Martin] British Columbia Ctr Dis Control, Clin Prevent Serv, Vancouver, BC, Canada; [De Serres, Gaston] Inst Natl Sante Publ Quebec, Dept Biol & Occupat Risks, Quebec City, PQ, Canada; [De Serres, Gaston] Univ Laval, Dept Social & Prevent Med, Quebec City, PQ, Canada; [Eshaghi, Alireza] Publ Hlth Ontario, Dept Mol Res, Toronto, ON, Canada; [Dickinson, James A.] Univ Calgary, Calgary, AB, Canada; [Fonseca, Kevin] Prov Lab Publ Hlth, Dept Virol, Calgary, AB, Canada; [Fonseca, Kevin] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Winter, Anne-Luise] Publ Hlth Ontario, Communicable Dis Prevent & Control, Toronto, ON, Canada; [Gubbay, Jonathan B.] Publ Hlth Ontario, Dept Microbiol, Toronto, ON, Canada; [Gubbay, Jonathan B.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Gubbay, Jonathan B.] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; [Gubbay, Jonathan B.] Hosp Sick Children, Dept Paediat, Toronto, ON M5G 1X8, Canada; [Charest, Hugues] Inst Natl Sante Publ Quebec, Lab Sante Publ Quebec, Ste Anne De Bellevue, PQ, Canada; [Charest, Hugues] Univ Montreal, Fac Med, Dept Microbiol Infectiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Bastien, Nathalie; Li, Yan] Natl Microbiol Lab, Influenza & Resp Virus Sect, Winnipeg, MB, Canada; [Mahmud, Salaheddin M.] Univ Manitoba, Winnipeg, MB, Canada; [Van Caeseele, Paul] Manitoba Hlth, Cadham Prov Lab, Winnipeg, MB, Canada; [Van Caeseele, Paul; Li, Yan] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	University of British Columbia; Institut national de sante publique du Quebec (INSPQ); Laval University; University of Calgary; University of Calgary; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Institut national de sante publique du Quebec (INSPQ); Universite de Montreal; University of Manitoba; University of Manitoba	Skowronski, DM (corresponding author), British Columbia Ctr Dis Control, Communicable Dis Prevent & Control Serv, Vancouver, BC, Canada.	danuta.skowronski@bccdc.ca	Zafar, Naveed/A-2712-2008; Gubbay, Jonathan/Q-8580-2019	Zafar, Naveed/0000-0001-5681-719X; Gubbay, Jonathan/0000-0003-0026-3786; Eshaghi, Alireza/0000-0001-5150-483X; Dickinson, James/0000-0003-3675-6865; Mahmud, Salaheddin/0000-0002-6574-0574	Canadian Institutes of Health Research (CIHR) - Institute of Infection and Immunity [TPA-90193]; Ministries of Health	Canadian Institutes of Health Research (CIHR) - Institute of Infection and Immunity(Canadian Institutes of Health Research (CIHR)); Ministries of Health	Funding was provided by the Canadian Institutes of Health Research (CIHR) - Institute of Infection and Immunity, grant TPA-90193 (http://www.cihr-irsc.gc.ca/), as well as Ministries of Health and Institutes of the investigators. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter adherence to all PLOS policies on sharing data and materials.	[Anonymous], PYMOL MOL GRAPHICS S; BC Centre for Disease Control, 2013, INFL IMM COV BC HLTH; BC Centre for Disease Control, 2013, BRIT COL ANN SUMM RE; Bresee J, 2013, NEW ENGL J MED, V368, P589, DOI 10.1056/NEJMp1300375; Broemeling Anne-Marie, 2008, Healthc Q, V11, P70; Brownlee GG, 2001, PHILOS T ROY SOC B, V356, P1871, DOI 10.1098/rstb.2001.1001; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; Centers for Disease Control and Prevention (CDC), 2013, FLU VIEW; Chen ZY, 2010, VACCINE, V28, P4079, DOI 10.1016/j.vaccine.2010.03.078; De Serres G, 2013, Euro Surveill, V18; European Centre for Disease Prevention and Control (ECDC), 2014, INFL VIR CHAR SUMM E; Gilca V, 2011, VACCINE, V30, P35, DOI 10.1016/j.vaccine.2011.10.062; Gilmour H, 2010, HLTH REPORTS, V21; Irving SA, 2009, VACCINE, V27, P6546, DOI 10.1016/j.vaccine.2009.08.050; Jackson L, 2013, MMWR-MORBID MORTAL W, V62, P119; Janjua NZ, 2012, J INFECT DIS, V205, P1858, DOI 10.1093/infdis/jis283; Jin H, 2005, VIROLOGY, V336, P113, DOI 10.1016/j.virol.2005.03.010; Katz JM, 2011, EXPERT REV ANTI-INFE, V9, P669, DOI [10.1586/ERI.11.51, 10.1586/eri.11.51]; KATZ JM, 1989, J INFECT DIS, V160, P191, DOI 10.1093/infdis/160.2.191; Koel BF, 2013, SCIENCE, V342, P976, DOI 10.1126/science.1244730; National Advisory Committee on Immunization (NACI), 2013, CAN COMMUN DIS REP, V39, P1; National Advisory Committee on Immunization (NACI), 2012, CAN COMMUN DIS REP, V38, P1; National Institute for Biological Standards and Control, 2012, INFL REAG INFL VIR I; Ndifon W, 2009, P NATL ACAD SCI USA, V106, P8701, DOI 10.1073/pnas.0903427106; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Popova L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041895; Public Health Agency of Canada, 2013, FLUWATCH; ROBERTSON JS, 1993, J GEN VIROL, V74, P2047, DOI 10.1099/0022-1317-74-10-2047; ROBERTSON JS, 1993, REV MED VIROL, V3, P97, DOI 10.1002/rmv.1980030206; ROCHA EP, 1993, J GEN VIROL, V74, P2513, DOI 10.1099/0022-1317-74-11-2513; SAUTER NK, 1992, BIOCHEMISTRY-US, V31, P9609, DOI 10.1021/bi00155a013; Skowronski D. M., 2005, Canada Communicable Disease Report, V31, P181; Skowronski DM, 2007, VACCINE, V25, P2842, DOI 10.1016/j.vaccine.2006.10.002; Skowronski DM, 2013, EUROSURVEILLANCE, V18, P7; Skowronski DM, 2014, J INFECT DIS, V210, P126, DOI 10.1093/infdis/jiu048; Skowronski DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038929; Skowronski DM, 2012, CLIN INFECT DIS, V55, P332, DOI 10.1093/cid/cis431; Skowronski DM, 2011, PEDIATR INFECT DIS J, V30, P833, DOI 10.1097/INF.0b013e31822db4dc; Skowronski DM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7297; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Skowronski DM, 2009, J INFECT DIS, V199, P168, DOI 10.1086/595862; Smith DJ, 1999, P NATL ACAD SCI USA, V96, P14001, DOI 10.1073/pnas.96.24.14001; Statistics Canada, TABL 105 0502 HLTH I; Treanor J, 2004, NEW ENGL J MED, V351, P2037, DOI 10.1056/NEJMp048290; Tricco AC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-153; Valenciano M, 2013, EUROSURVEILLANCE, V18, P12; WHO, 2013, WHO REC COMP INFL VI; WHO, 2011, WHO INF MOL DIAGN IN; World Health Organization, INFL UPD; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430	51	288	297	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92153	10.1371/journal.pone.0092153	http://dx.doi.org/10.1371/journal.pone.0092153			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667168	Green Submitted, Green Published, gold			2022-12-27	WOS:000333675600021
J	Zhang, XY; Wang, W; Chen, WL; Zhang, NL; Zeng, H				Zhang, Xinyue; Wang, Wei; Chen, Weile; Zhang, Naili; Zeng, Hui			Comparison of Seasonal Soil Microbial Process in Snow-Covered Temperate Ecosystems of Northern China	PLOS ONE			English	Article							ARCTIC TUNDRA SOILS; FATTY-ACID PROFILES; FOREST SOIL; COMMUNITY COMPOSITION; NITROGEN DYNAMICS; EXTRACTION METHOD; DECIDUOUS FOREST; GLOBAL PATTERNS; CLIMATE-CHANGE; ELEVATED CO2	More than half of the earth's terrestrial surface currently experiences seasonal snow cover and soil frost. Winter compositional and functional investigations in soil microbial community are frequently conducted in alpine tundra and boreal forest ecosystems. However, little information on winter microbial biogeochemistry is known from seasonally snow-covered temperate ecosystems. As decomposer microbes may differ in their ability/strategy to efficiently use soil organic carbon (SOC) within different phases of the year, understanding seasonal microbial process will increase our knowledge of biogeochemical cycling from the aspect of decomposition rates and corresponding nutrient dynamics. In this study, we measured soil microbial biomass, community composition and potential SOC mineralization rates in winter and summer, from six temperate ecosystems in northern China. Our results showed a clear pattern of increased microbial biomass C to nitrogen (N) ratio in most winter soils. Concurrently, a shift in soil microbial community composition occurred with higher fungal to bacterial biomass ratio and gram negative (G-) to gram positive (G+) bacterial biomass ratio in winter than in summer. Furthermore, potential SOC mineralization rate was higher in winter than in summer. Our study demonstrated a distinct transition of microbial community structure and function from winter to summer in temperate snow-covered ecosystems. Microbial N immobilization in winter may not be the major contributor for plant growth in the following spring.	[Zhang, Xinyue; Wang, Wei; Chen, Weile] Peking Univ, Minist Educ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China; [Zhang, Xinyue; Wang, Wei; Chen, Weile] Peking Univ, Minist Educ, Key Lab Earth Surface Proc, Beijing 100871, Peoples R China; [Zhang, Xinyue; Zeng, Hui] Peking Univ, Shenzhen Grad Sch, Sch Urban Planning & Design, Key Lab Cycl Econ, Shenzhen, Peoples R China; [Zhang, Naili] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China	Peking University; Peking University; Peking University; University Town of Shenzhen; Chinese Academy of Sciences; Institute of Botany, CAS	Wang, W (corresponding author), Peking Univ, Minist Educ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China.	wangw@urban.pku.edu.cn	zhang, Naili/D-9986-2017		Projects of National Natural Science Foundation of China [31222011, 31270363]; National Basic Research Program of China [2010CB950604, 2013CB956303]; Foundation for Innovative Research Groups of National Natural Science Foundation of China [31021001]; Construction Projects between Beijing City; University in the Central Authorities	Projects of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Foundation for Innovative Research Groups of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Construction Projects between Beijing City; University in the Central Authorities	This research was funded by grants from Projects of National Natural Science Foundation of China (31222011 and 31270363), National Basic Research Program of China (2010CB950604 and 2013CB956303), the Foundation for Innovative Research Groups of National Natural Science Foundation of China (31021001) and Construction Projects between Beijing City and the University in the Central Authorities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanderud ZT, 2013, SOIL BIOL BIOCHEM, V57, P217, DOI 10.1016/j.soilbio.2012.07.022; Anderson J.P.E., 1982, METHODS SOIL ANAL 2, Vsecond, P831; Baldrian P, 2013, FUNGAL ECOL, V6, P1, DOI 10.1016/j.funeco.2012.10.002; Balser TC, 2009, GLOBAL CHANGE BIOL, V15, P2935, DOI 10.1111/j.1365-2486.2009.01946.x; Bjork RG, 2008, SOIL BIOL BIOCHEM, V40, P266, DOI 10.1016/j.soilbio.2007.07.017; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Bradley RL, 1995, SOIL BIOL BIOCHEM, V27, P1565, DOI 10.1016/0038-0717(95)00089-W; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Brooks PD, 2011, GEOGR COMPASS, V5, DOI 10.1111/j.1749-8198.2011.00420.x; Brooks PD, 1996, BIOGEOCHEMISTRY, V32, P93, DOI 10.1007/BF00000354; Buckeridge KM, 2008, APPL SOIL ECOL, V39, P210, DOI 10.1016/j.apsoil.2007.12.010; Buckeridge KM, 2007, J ECOL, V95, P283, DOI 10.1111/j.1365-2745.2007.01214.x; Cardon ZG, 2001, SOIL BIOL BIOCHEM, V33, P365, DOI 10.1016/S0038-0717(00)00151-6; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; Drotz SH, 2010, P NATL ACAD SCI USA, V107, P21046, DOI 10.1073/pnas.1008885107; Edwards KA, 2006, SOIL BIOL BIOCHEM, V38, P2843, DOI 10.1016/j.soilbio.2006.04.042; Edwards KA, 2013, SOIL BIOL BIOCHEM, V57, P83, DOI 10.1016/j.soilbio.2012.07.018; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; FROSTEGARD A, 1993, SOIL BIOL BIOCHEM, V25, P723, DOI 10.1016/0038-0717(93)90113-P; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Groffman PM, 2006, GLOBAL CHANGE BIOL, V12, P1748, DOI 10.1111/j.1365-2486.2006.01194.x; Grogan P, 2005, GLOBAL CHANGE BIOL, V11, P465, DOI 10.1111/j.1365-2486.2005.00912.x; Gutknecht JLM, 2012, GLOBAL CHANGE BIOL, V18, P2256, DOI 10.1111/j.1365-2486.2012.02686.x; Haei M, 2011, SOIL BIOL BIOCHEM, V43, P2069, DOI 10.1016/j.soilbio.2011.06.005; Hayhoe K, 2007, CLIM DYNAM, V28, P381, DOI 10.1007/s00382-006-0187-8; Henry HAL, 2008, CLIMATIC CHANGE, V87, P421, DOI 10.1007/s10584-007-9322-8; Huntington TG, 2009, CAN J FOREST RES, V39, P199, DOI 10.1139/X08-116; Judd KE, 2007, ECOSYSTEMS, V10, P217, DOI 10.1007/s10021-007-9027-x; Kaiser C, 2011, ECOLOGY, V92, P1036, DOI 10.1890/i0012-9658-92-5-1036; Keiblinger KM, 2010, FEMS MICROBIOL ECOL, V73, P430, DOI 10.1111/j.1574-6941.2010.00912.x; Kramer C, 2006, SOIL BIOL BIOCHEM, V38, P3267, DOI 10.1016/j.soilbio.2006.04.006; Kreyling J, 2010, ECOLOGY, V91, P1939, DOI 10.1890/09-1160.1; Larsen KS, 2007, ARCT ANTARCT ALP RES, V39, P268, DOI 10.1657/1523-0430(2007)39[268:RAMDIT]2.0.CO;2; Larsen KS, 2012, ECOSYSTEMS, V15, P927, DOI 10.1007/s10021-012-9555-x; Lipson DA, 2002, MICROB ECOL, V43, P307, DOI 10.1007/s00248-001-1057-x; Lipson DA, 2004, APPL ENVIRON MICROB, V70, P2867, DOI 10.1128/AEM.70.5.2867-2879.2004; Lipson DA, 2000, SOIL BIOL BIOCHEM, V32, P441, DOI 10.1016/S0038-0717(99)00068-1; Lipson DA, 2009, BIOGEOCHEMISTRY, V95, P23, DOI 10.1007/s10533-008-9252-1; Liptzin D, 2009, SOIL BIOL BIOCHEM, V41, P1696, DOI 10.1016/j.soilbio.2009.05.013; Liu LL, 2009, GLOBAL CHANGE BIOL, V15, P441, DOI 10.1111/j.1365-2486.2008.01747.x; Mariko S, 2000, ECOL RES, V15, P363, DOI 10.1046/j.1440-1703.2000.00357.x; McMahon SK, 2009, ENV MICROBIOL REP, V1, P162, DOI 10.1111/j.1758-2229.2009.00025.x; Mielke P. W., 2001, PERMUTATION METHODS; MIELKE PW, 1984, HDB STAT, V4; Monson RK, 2006, NATURE, V439, P711, DOI 10.1038/nature04555; Neilson CB, 2001, SOIL SCI SOC AM J, V65, P1723, DOI 10.2136/sssaj2001.1723; Pietikainen J, 2005, FEMS MICROBIOL ECOL, V52, P49, DOI 10.1016/j.femsec.2004.10.002; Pokarzhevskii AD, 2003, PEDOBIOLOGIA, V47, P213, DOI 10.1078/0031-4056-00185; Price PB, 2004, P NATL ACAD SCI USA, V101, P4631, DOI 10.1073/pnas.0400522101; Robroek BJM, 2013, PLANT SOIL, V369, P151, DOI 10.1007/s11104-012-1547-2; Romanovsky VE, 2000, PERMAFROST PERIGLAC, V11, P219, DOI 10.1002/1099-1530(200007/09)11:3&lt;219::AID-PPP352&gt;3.0.CO;2-7; ROSS DJ, 1990, SOIL BIOL BIOCHEM, V22, P295, DOI 10.1016/0038-0717(90)90103-7; ROVIRA AD, 1969, BOT REV, V35, P35, DOI 10.1007/BF02859887; RUZICKA J, 1983, ANAL CHEM, V55, P1040; Schadt CW, 2003, SCIENCE, V301, P1359, DOI 10.1126/science.1086940; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; Schimel JP, 2006, ARCT ANTARCT ALP RES, V38, P249, DOI 10.1657/1523-0430(2006)38[249:CPOCIA]2.0.CO;2; Schimel JP, 2005, SOIL BIOL BIOCHEM, V37, P1411, DOI 10.1016/j.soilbio.2004.12.011; Schimel JP, 2004, SOIL BIOL BIOCHEM, V36, P217, DOI 10.1016/j.soilbio.2003.09.008; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; Schindlbacher A, 2011, SOIL BIOL BIOCHEM, V43, P1417, DOI 10.1016/j.soilbio.2011.03.005; Schmidt SK, 2007, ECOLOGY, V88, P1379, DOI 10.1890/06-0164; Schumacher B., 2002, SOILS SEDIMENTS; Sinsabaugh RL, 2002, BIOGEOCHEMISTRY, V60, P1, DOI 10.1023/A:1016541114786; Sinsabaugh RL, 2008, ECOL LETT, V11, P1252, DOI 10.1111/j.1461-0248.2008.01245.x; Strickland MS, 2010, SOIL BIOL BIOCHEM, V42, P1385, DOI 10.1016/j.soilbio.2010.05.007; Turner MM, 2010, OECOLOGIA, V162, P227, DOI 10.1007/s00442-009-1435-5; Uchida M, 2005, AGR FOREST METEOROL, V134, P102, DOI 10.1016/j.agrformet.2005.11.003; Walder F, 2012, PLANT PHYSIOL, V159, P789, DOI 10.1104/pp.112.195727; Waldrop MP, 2000, SOIL BIOL BIOCHEM, V32, P1837, DOI 10.1016/S0038-0717(00)00157-7; Wallenstein MD, 2009, GLOBAL CHANGE BIOL, V15, P1631, DOI 10.1111/j.1365-2486.2008.01819.x; Wallenstein MD, 2007, FEMS MICROBIOL ECOL, V59, P428, DOI 10.1111/j.1574-6941.2006.00260.x; Wang W, 2010, SOIL BIOL BIOCHEM, V42, P1236, DOI 10.1016/j.soilbio.2010.04.013; Wang W, 2010, SOIL BIOL BIOCHEM, V42, P451, DOI 10.1016/j.soilbio.2009.11.028; Weintraub MN, 2005, BIOGEOCHEMISTRY, V73, P359, DOI 10.1007/s10533-004-0363-z; Winkler JP, 1996, SOIL BIOL BIOCHEM, V28, P1067, DOI 10.1016/0038-0717(96)00076-4; Yang YH, 2011, NEW PHYTOL, V190, P977, DOI 10.1111/j.1469-8137.2011.03645.x; Yao HY, 2011, SOIL BIOL BIOCHEM, V43, P1536, DOI 10.1016/j.soilbio.2011.03.031; Zelles L, 1997, CHEMOSPHERE, V35, P275, DOI 10.1016/S0045-6535(97)00155-0; Zhang T, 2004, POLAR GEOGRAPHY, V28, P63; Zhou YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015134; Zogg GP, 1997, SOIL SCI SOC AM J, V61, P475, DOI 10.2136/sssaj1997.03615995006100020015x	85	17	22	5	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92985	10.1371/journal.pone.0092985	http://dx.doi.org/10.1371/journal.pone.0092985			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667929	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600119
J	Shah, VB; Aiken, C				Shah, Vaibhav B.; Aiken, Christopher			Gene Expression Analysis of a Panel of Cell Lines That Differentially Restrict HIV-1 CA Mutants Infection in a Cyclophilin A-Dependent Manner	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; OLD-WORLD MONKEY; CYCLOSPORINE-A; LIFE-CYCLE; TRIM5-ALPHA RESTRICTION; NONDIVIDING CELLS; LENTIVIRAL VECTOR; REPLICATION; GAG; PROTEIN	HIV-1 replication is dependent on binding of the viral capsid to the host protein cyclophilin A (CypA). Interference with cyclophilin A binding, either by mutations in the HIV-1 capsid protein (CA) or by the drug cyclosporine A (CsA), inhibits HIV-1 replication in cell culture. Resistance to CsA is conferred by A92E or G94D substitutions in CA. The mutant viruses are also dependent on CsA for their replication. Interestingly, infection of some cell lines by these mutants is enhanced by CsA, while infection of others is not affected by the drug. The cells are thus termed nonpermissive and permissive, respectively, for infection by CsA-dependent mutants. The mechanistic basis for the cell type dependence is not well understood, but has been hypothesized to result from a dominant-acting host factor that blocks HIV-1 infection by a mechanism that requires CypA binding to the viral capsid. In an effort to identify a CypA-dependent host restriction factor, we adopted a strategy involving comparative gene expression analysis in three permissive and three non-permissive cell types. We ranked the genes based on their relative overexpression in non-permissive cell types compared to the permissive cell types. Based on specific selection criteria, 26 candidate genes were selected and targeted using siRNA in nonpermissive (HeLa) cells. Depletion of none of the selected candidate genes led to the reversal of CsA-dependent phenotype of the A92E mutant. Our data suggest that none of the 26 genes tested is responsible for the dependence of the A92E mutant on CsA. Our study provides gene expression data that may be useful for future efforts to identify the putative CypA-dependent HIV-1 restriction factor and in studies of other cell-specific phenotypes.	[Shah, Vaibhav B.; Aiken, Christopher] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA	Vanderbilt University	Aiken, C (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.	chris.aiken@vanderbilt.edu	Aiken, Christopher/Y-9252-2019		National Institutes of Health [AI073137]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI073137 (CA) (www.niaid.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberham C, 1996, J VIROL, V70, P3536, DOI 10.1128/JVI.70.6.3536-3544.1996; An P, 2007, PLOS PATHOG, V3, P849, DOI 10.1371/journal.ppat.0030088; Berthoux L, 2005, P NATL ACAD SCI USA, V102, P14849, DOI 10.1073/pnas.0505659102; Bleiber G, 2005, J VIROL, V79, P12674, DOI 10.1128/JVI.79.20.12674-12680.2005; Braaten D, 1996, J VIROL, V70, P3551, DOI 10.1128/JVI.70.6.3551-3560.1996; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; De Iaco A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-11; De Iaco A, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-20; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Di Nunzio F, 2013, VIROLOGY, V440, P8, DOI 10.1016/j.virol.2013.02.008; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Gatanaga H, 2006, J BIOL CHEM, V281, P1241, DOI 10.1074/jbc.M505920200; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Gupta P, 2011, J MOL BIOL, V410, P681, DOI 10.1016/j.jmb.2011.03.022; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hatziioannou T, 2005, J VIROL, V79, P176, DOI 10.1128/JVI.79.1.176-183.2005; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; Henning MS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003868; Ikeda Y, 2004, J VIROL, V78, P11816, DOI 10.1128/JVI.78.21.11816-11822.2004; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; Keckesova Z, 2006, J VIROL, V80, P4683, DOI 10.1128/JVI.80.10.4683-4690.2006; Kiernan RE, 1998, J VIROL, V72, P4116, DOI 10.1128/JVI.72.5.4116-4126.1998; Kootstra NA, 2003, P NATL ACAD SCI USA, V100, P1298, DOI 10.1073/pnas.0337541100; LANDAU NR, 1992, J VIROL, V66, P5110, DOI 10.1128/JVI.66.8.5110-5113.1992; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Li Y, 2009, J VIROL, V83, P10951, DOI 10.1128/JVI.00682-09; Liu ZL, 2013, CELL HOST MICROBE, V14, P398, DOI 10.1016/j.chom.2013.08.015; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Misumi S, 2010, J BIOL CHEM, V285, P25185, DOI 10.1074/jbc.M110.114256; POPOVIC M, 1984, LANCET, V2, P1472; Price AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002896; Qi ML, 2008, J VIROL, V82, P12001, DOI 10.1128/JVI.01518-08; Rits MAN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003975; ROSENWIRTH B, 1994, ANTIMICROB AGENTS CH, V38, P1763, DOI 10.1128/AAC.38.8.1763; Sayah DM, 2004, J VIROL, V78, P12066, DOI 10.1128/JVI.78.21.12066-12070.2004; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Shah VB, 2013, J VIROL, V87, P422, DOI 10.1128/JVI.07177-11; Sokolskaja E, 2006, J VIROL, V80, P2855, DOI 10.1128/JVI.80.6.2855-2862.2006; Sokolskaja E, 2004, J VIROL, V78, P12800, DOI 10.1128/JVI.78.23.12800-12808.2004; Song C, 2007, J VIROL, V81, P11946, DOI 10.1128/JVI.00620-07; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2006, VIROLOGY, V351, P112, DOI 10.1016/j.virol.2006.03.015; Takemura T, 2013, J VIROL, V87, P4086, DOI 10.1128/JVI.01319-12; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; Towers G, 2002, J VIROL, V76, P2548, DOI 10.1128/JVI.76.5.2548-2550.2002; Towers GJ, 2003, NAT MED, V9, P1138, DOI 10.1038/nm910; WAINBERG MA, 1988, BLOOD, V72, P1904; Wehrly K, 1997, METHODS, V12, P288, DOI 10.1006/meth.1997.0481; WEISS A, 1984, J IMMUNOL, V133, P123; Yang RF, 2007, J VIROL, V81, P3749, DOI 10.1128/JVI.02634-06; YEE JK, 1994, METHOD CELL BIOL, V43, P99; Yin L, 1998, J VIROL, V72, P6430, DOI 10.1128/JVI.72.8.6430-6436.1998; Ylinen LMJ, 2009, J VIROL, V83, P2044, DOI 10.1128/JVI.01876-08; Zhou LH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002194	61	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92724	10.1371/journal.pone.0092724	http://dx.doi.org/10.1371/journal.pone.0092724			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663101	Green Submitted, Green Published, gold			2022-12-27	WOS:000333459900103
J	Zhang, LJ; Chen, YY; Li, C; Lin, XJ; Cheng, XL; Li, T				Zhang, Lijuan; Chen, Yanyan; Li, Cheng; Lin, Xiaojie; Cheng, Xiaoli; Li, Tang			Protective Effects of Combined Intervention with Adenovirus Vector Mediated IL-10 and IGF-1 Genes on Endogenous Islet beta Cells in Nonobese Diabetes Mice with Onset of Type 1 Diabetes Mellitus	PLOS ONE			English	Article							AUTOIMMUNE-DISEASES; APOPTOSIS; MECHANISMS; EXPRESSION; PREVENTS; THERAPY; VIRUSES; MOUSE	Objective: To investigate the protective effects of combined intervention with adenovirus vector mediated interleukin 10 (IL-10) and insulin-like growth factor 1 (IGF-1) genes on islet beta cells in nonobese diabetes (NOD) mice with type 1 diabetes mellitus (T1D) at early stage. Methods: Twenty-four female NOD mice at onset of diabetes and aged 17-20 weeks old were randomly divided into four groups. Mouse 1, 2 and 3 groups were intraperitoneally injected 0.1 ml of Ad-mIGF-1, Ad-mIL-10, and combined Ad-mIGF-1 and Ad-mIL-10, respectively. Mouse 4 group were used as diabetes control. In addition, six age-and sex-matched nondiabetic NOD mice were intraperitoneally injected 0.1 ml of PBS and assigned 5 group as normal controls. All mice were weekly monitored for body weight, urine glucose and blood glycose, and sacrificed 3 weeks after injection. Their serum levels of IL-10, IGF-1, IFN-gamma, IL-4 and C-peptide were measured and the degree of insulitis and the local expression of IGF-1 and IL-10 gene were observed. Results: 1) IL-10 and IGF-1 levels in serum and pancreas were enhanced in 1, 2, and 3 groups; 2) serum INF-gamma level was decreased while serum IL-10 and IL-4 levels were increased in 1, 2 and 3 groups, and these alterations were more significant in 3 group than 1 and 2 groups (P<0.01); 3) C-peptide level was not enhanced in 1 group, but significantly increased in 2 and 3 groups, and these increases were more significant in the latter (P<0.01); 4) Three weeks later, the body mass of mice in 2 and 3 groups decreased significantly (P<0.05). Conclusion: The administration of adenovirus vector mediated IL-10 and/or IGF-1 gene showed limited immune regulatory and protective effects on islet beta-cells in NOD mice with T1D at early stage, and no significant reduction in insulitis, blood glucose and body weight.	[Zhang, Lijuan; Li, Cheng; Lin, Xiaojie; Li, Tang] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Pediat, Qingdao, Shandong, Peoples R China; [Chen, Yanyan] Peoples Hosp RiZhao, Dept Pediat, Rizhao, Shandong, Peoples R China; [Cheng, Xiaoli] Qingdao Sanat Shandong Prov, Dept Med Ctr, Qingdao, Shandong, Peoples R China	Qingdao University	Li, T (corresponding author), Qingdao Univ, Coll Med, Affiliated Hosp, Dept Pediat, Qingdao, Shandong, Peoples R China.	ljuanzhang1983@126.com	Zhang, Li/GWM-7501-2022		National Natural Science Foundation of China [81170762]; Shandong Province Natural Science Foundation [Y2008C50]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province)	This study is supported by the National Natural Science Foundation of China (81170762) and Shandong Province Natural Science Foundation (Y2008C50). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerblom HK, 2002, AM J MED GENET, V115, P18, DOI 10.1002/ajmg.10340; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Ansaria MJI, 2008, CLIN IMMUNOL, V126, P140, DOI 10.1016/j.clim.2007.07.019; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Atkinson MA, 2001, SEMINAR, P358; Bharhani MS, 2006, AM J PHYSIOL-GASTR L, V291, pG820, DOI 10.1152/ajpgi.00438.2005; Capoluongo E, 2006, EUR CYTOKINE NETW, V17, P167, DOI 10.1684/ecn.2006.0036; Casellas A, 2006, DIABETES, V55, P3246, DOI 10.2337/db06-0328; Chen W, 2004, ENDOCRINOLOGY, V145, P627, DOI 10.1210/en.2003-1274; Chen ZH, 2009, CHINESE MED J-PEKING, V122, P2159, DOI 10.3760/cma.j.issn.0366-6999.2009.18.016; Chen Zhi-hong, 2007, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V21, P188; Chen Zhihong, 2009, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V26, P1067; Denes B, 2010, DIABETES TECHNOL THE, V12, P649, DOI 10.1089/dia.2009.0116; Dunger DB, 2005, ENDOCR DEV, V9, P107, DOI 10.1159/000085761; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Fiorina P, 2008, DIABETES, V57, P3013, DOI 10.2337/db08-0420; Guleria I, 2007, CLIN IMMUNOL, V125, P16, DOI 10.1016/j.clim.2007.05.013; Hu CY, 2013, DIABETES, V62, P2849, DOI 10.2337/db12-1175; Jun HS, 2003, DIABETES-METAB RES, V19, P8, DOI 10.1002/dmrr.337; Jun HS, 2001, DIABETOLOGIA, V44, P271, DOI 10.1007/s001250051614; Kanagawa O, 2002, J IMMUNOL, V168, P6159, DOI 10.4049/jimmunol.168.12.6159; Leger J, 2006, J CLIN ENDOCR METAB, V91, P3947, DOI 10.1210/jc.2006-0711; Lehtihet M, 2008, CLIN SCI, V115, P167, DOI 10.1042/CS20070372; Makino S, 1980, Jikken Dobutsu, V29, P1; Moyer-Mileur LJ, 2008, J BONE MINER RES, V23, P1884, DOI 10.1359/JBMR.080713; Prud'homme GJ, 2000, J GENE MED, V2, P222; Rewers M, 1996, J AUTOIMMUN, V9, P405, DOI 10.1006/jaut.1996.0055; [石昌红 Shi Changhong], 2006, [中国免疫学杂志, Chinese Journal of Immunology], V22, P771; Vergani A, 2010, DIABETES, V59, P2253, DOI 10.2337/db09-1264; Wang H, 2010, INT J IMMUNOLOGY, V37, P315; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; Wong FS, 1999, CURR OPIN IMMUNOL, V11, P643, DOI 10.1016/S0952-7915(99)00031-X; Xie XW, 2010, J PRACTICAL PEDIAT C, V25, P555; Xu Ai-jing, 2010, Zhonghua Yi Xue Za Zhi, V90, P1711; Xu AJ, 2010, MOL CELL BIOCHEM, V344, P163, DOI 10.1007/s11010-010-0539-x; [徐爱晶 Xu Aijing], 2011, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V27, P158; Zhang YC, 2003, DIABETES, V52, P708, DOI 10.2337/diabetes.52.3.708; Zhou JH, 2001, J IMMUNOL, V167, P4436, DOI 10.4049/jimmunol.167.8.4436	39	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92616	10.1371/journal.pone.0092616	http://dx.doi.org/10.1371/journal.pone.0092616			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663217	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900085
J	Diesch, J; Sanij, E; Gilan, O; Love, C; Tran, H; Fleming, NI; Ellul, J; Amalia, M; Haviv, I; Pearson, RB; Tulchinsky, E; Mariadason, JM; Sieber, OM; Hannan, RD; Dhillon, AS				Diesch, Jeannine; Sanij, Elaine; Gilan, Omer; Love, Christopher; Tran, Hoanh; Fleming, Nicholas I.; Ellul, Jason; Amalia, Marcia; Haviv, Izhak; Pearson, Richard B.; Tulchinsky, Eugene; Mariadason, John M.; Sieber, Oliver M.; Hannan, Ross D.; Dhillon, Amardeep S.			Widespread FRA1-Dependent Control of Mesenchymal Transdifferentiation Programs in Colorectal Cancer Cells	PLOS ONE			English	Article							FOS FAMILY-MEMBERS; BETA-CATENIN; DIFFERENTIAL EXPRESSION; TRANSCRIPTION FACTORS; FRA-1; TRANSITION; INVASION; RAS; METASTASIS; PHENOTYPE	Tumor invasion and metastasis involves complex remodeling of gene expression programs governing epithelial homeostasis. Mutational activation of the RAS-ERK is a frequent occurrence in many cancers and has been shown to drive overexpression of the AP-1 family transcription factor FRA1, a potent regulator of migration and invasion in a variety of tumor cell types. However, the nature of FRA1 transcriptional targets and the molecular pathways through which they promote tumor progression remain poorly understood. We found that FRA1 was strongly expressed in tumor cells at the invasive front of human colorectal cancers (CRCs), and that its depletion suppressed mesenchymal-like features in CRC cells in vitro. Genome-wide analysis of FRA1 chromatin occupancy and transcriptional regulation identified epithelial-mesenchymal transition (EMT)-related genes as a major class of direct FRA1 targets in CRC cells. Expression of the promesenchymal subset of these genes predicted adverse outcomes in CRC patients, and involved FRA-1-dependent regulation and cooperation with TGF beta signaling pathway. Our findings reveal an unexpectedly widespread and direct role for FRA1 in control of epithelial-mesenchymal plasticity in CRC cells, and suggest that FRA1 plays an important role in mediating cross talk between oncogenic RAS-ERK and TGF beta signaling networks during tumor progression.	[Diesch, Jeannine; Sanij, Elaine; Gilan, Omer; Ellul, Jason; Amalia, Marcia; Pearson, Richard B.; Hannan, Ross D.; Dhillon, Amardeep S.] Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic, Australia; [Gilan, Omer; Amalia, Marcia; Pearson, Richard B.; Hannan, Ross D.] Univ Melbourne, Dept Biochem & Mol Biol, Inst Bio21, Melbourne, Vic, Australia; [Sanij, Elaine; Pearson, Richard B.; Hannan, Ross D.; Dhillon, Amardeep S.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Sanij, Elaine; Dhillon, Amardeep S.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Love, Christopher; Fleming, Nicholas I.; Sieber, Oliver M.] Walter & Eliza Inst Med Res, Parkville, Vic, Australia; [Tran, Hoanh; Mariadason, John M.] Ludwig Inst Canc Res, Heidelberg, Vic, Australia; [Haviv, Izhak] Bar Ilan Univ, Fac Med, Tel Aviv, Israel; [Tulchinsky, Eugene] Univ Leicester, Sch Canc Studies & Mol Med, Leicester, Leics, England; [Hannan, Ross D.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Hannan, Ross D.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; Walter & Eliza Hall Institute; Ludwig Institute for Cancer Research; Bar Ilan University; University of Leicester; Monash University; University of Queensland	Dhillon, AS (corresponding author), Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic, Australia.	Amardeep.Dhillon@petermac.org	Tulchinsky, Eugene/ABD-7070-2021; Haviv, Izhak/E-3782-2015; Pearson, Richard Bruce/I-1451-2013; Sieber, Oliver/ABA-9211-2021; Diesch, Jeannine/J-8558-2017; Sieber, Oliver/M-9473-2015	Haviv, Izhak/0000-0002-0837-5005; Pearson, Richard Bruce/0000-0001-5919-5090; Sieber, Oliver/0000-0001-9480-0786; Diesch, Jeannine/0000-0002-4667-3468; Sieber, Oliver/0000-0001-9480-0786; Ellul, Jason/0000-0002-6046-5139; Mariadason, John/0000-0001-9123-7684; Sanij, Elaine/0000-0002-2063-7813; Hannan, Ross/0000-0002-2166-4493; Dhillon, Amardeep/0000-0002-6065-663X	National Health and Medical Research Council of Australia [1026228, 1044168]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by project grants 1026228 and 1044168 (to A. S. D.) and Senior Research Fellowships (to R. D. H., R. B. P. and J.M.M.) from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiseshaiah P, 2007, CANCER RES, V67, P6204, DOI 10.1158/0008-5472.CAN-06-4687; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen H, 2002, ONCOGENE, V21, P4843, DOI 10.1038/sj.onc.1205590; Andreolas C, 2008, INT J CANCER, V122, P1745, DOI 10.1002/ijc.23309; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Blahnik KR, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1012; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Brabletz T, 2002, VIRCHOWS ARCH, V441, P1, DOI 10.1007/s00428-002-0642-9; Cejas P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008199; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Debinski W, 2005, MOL CANCER RES, V3, P237; Desmet CJ, 2013, P NATL ACAD SCI USA, V110, P5139, DOI 10.1073/pnas.1222085110; Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002; Eger A, 2004, ONCOGENE, V23, P2672, DOI 10.1038/sj.onc.1207416; Fleming NI, 2013, CANCER RES, V73, P725, DOI 10.1158/0008-5472.CAN-12-2706; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilles C, 2003, CANCER RES, V63, P2658; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hlubek F, 2001, CANCER RES, V61, P8089; Hlubek F, 2004, INT J CANCER, V108, P321, DOI 10.1002/ijc.11522; Hlubek F, 2007, INT J CANCER, V121, P1941, DOI 10.1002/ijc.22916; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hung KE, 2010, P NATL ACAD SCI USA, V107, P1565, DOI 10.1073/pnas.0908682107; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LeGolvan MP, 2010, J SURG ONCOL, V102, P898, DOI 10.1002/jso.21817; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Luo YP, 2010, ONCOGENE, V29, P662, DOI 10.1038/onc.2009.308; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Nash GM, 2010, ANN SURG ONCOL, V17, P572, DOI 10.1245/s10434-009-0605-3; Olson A, 2006, NUCLEIC ACIDS RES, V34, pD153, DOI 10.1093/nar/gkj051; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; Pino MS, 2010, GASTROENTEROLOGY, V138, P1406, DOI 10.1053/j.gastro.2009.12.010; Pollock CB, 2005, CANCER RES, V65, P1244, DOI 10.1158/0008-5472.CAN-04-1911; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; RETTIG WJ, 1986, CANCER RES, V46, P6406; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Sanij E, 2008, J CELL BIOL, V183, P1259, DOI 10.1083/jcb.200805146; Sayan AE, 2012, ONCOGENE, V31, P1493, DOI 10.1038/onc.2011.336; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thompson EW, 2011, NAT MED, V17, P1048, DOI 10.1038/nm.2437; Tice DA, 2002, J BIOL CHEM, V277, P6118, DOI 10.1074/jbc.M111255200; Tkach V, 2003, ONCOGENE, V22, P5045, DOI 10.1038/sj.onc.1206570; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Vial E, 2003, J CELL SCI, V116, P4957, DOI 10.1242/jcs.00812; Watanabe T, 2001, NEW ENGL J MED, V344, P1196, DOI 10.1056/NEJM200104193441603; Young MR, 2006, GENE, V379, P1, DOI 10.1016/j.gene.2006.05.001; Zhang WH, 2005, AM J CLIN PATHOL, V124, P11, DOI 10.1309/T1H2Y2CHWY7PD2BN; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237; Zlobec I, 2010, ONCOTARGET, V1, P651, DOI 10.18632/oncotarget.199	64	59	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e88950	10.1371/journal.pone.0088950	http://dx.doi.org/10.1371/journal.pone.0088950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658684	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300004
J	Le Guillou, S; Marthey, S; Laloe, D; Laubier, J; Mobuchon, L; Leroux, C; Le Provost, F				Le Guillou, Sandrine; Marthey, Sylvain; Laloe, Denis; Laubier, Johann; Mobuchon, Lenha; Leroux, Christine; Le Provost, Fabienne			Characterisation and Comparison of Lactating Mouse and Bovine Mammary Gland miRNomes	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED MICRORNAS; CELL-DIFFERENTIATION; LIPID-METABOLISM; IDENTIFICATION; RNAS; SEQUENCE; REVEALS; TARGETS; MIRNAS; GROWTH	Background: The mammary gland is a dynamic organ that undergoes important physiological changes during reproductive cycles. Until now, data regarding the characterisation of miRNA in the mammary gland have been scarce and mainly focused on their abnormal expression in breast cancer. Our goal was to characterise the microRNA (miRNA) involved in mechanisms regulating the mammary function, with particular focus on the lactation stage. Methodology/principal findings: Using high-throughput sequencing technology, the exhaustive repertoires of miRNA expressed (miRNome) in mouse and bovine mammary glands during established lactation were identified, characterized and compared. Furthermore, in order to obtain more information on miRNA loading in the RNA-induced silencing complex (RISC), the miRNome was compared with that obtained from RNA associated with the AGO2 protein (AGO2-miRNome) in mouse lactating mammary gland. This study enabled the identification of 164 and 167 miRNA in mouse and bovine, respectively. Among the 30 miRNA most highly expressed in each species, 24 were common to both species and six of them were preferentially highly expressed in lactating than non-lactating mammary gland. The potential functional roles of these 24 miRNA were deduced using DIANA-miRPath software, based on miRNA/mRNA interactions. Moreover, seven putative novel miRNA were identified. Using DAVID analysis, it was concluded that the predicted targets of two of these putative novel miRNA are involved in mammary gland morphogenesis. Conclusion/significance: Our study provides an overview of the characteristics of lactating mouse and bovine mammary gland miRNA expression profiles. Moreover, species-conserved miRNA involved in this fundamental biological function were identified. These miRNomes will now be used as references for further studies during which the impact of animal breeding on the miRNA expression will be analysed.	[Le Guillou, Sandrine; Marthey, Sylvain; Laloe, Denis; Laubier, Johann; Mobuchon, Lenha; Le Provost, Fabienne] INRA, UMR1313 Genet Anim & Biol Integrat, Jouy En Josas, France; [Mobuchon, Lenha; Leroux, Christine] INRA, UMR1213 Herbivores, St Genes Champanelle, France; [Mobuchon, Lenha; Leroux, Christine] Clermont Univ, VetAgro Sup, UMR1213 Herbivores, Clermont Ferrand, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; VetAgro Sup	Le Provost, F (corresponding author), INRA, UMR1313 Genet Anim & Biol Integrat, Jouy En Josas, France.	LeProvost@jouy.inra.fr	Laloe, Denis/O-7045-2019	Leroux, Christine/0000-0001-6835-3978; Laloe, Denis/0000-0001-8359-0760	INRA AIP BioRessources	INRA AIP BioRessources	This study was partially supported by the INRA AIP BioRessources funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ambros V, 2011, CURR OPIN GENET DEV, V21, P511, DOI 10.1016/j.gde.2011.04.003; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; Avril-Sassen S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-548; Bao H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-609; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beitzinger M, 2011, METHODS MOL BIOL, V732, P153, DOI 10.1007/978-1-61779-083-6_12; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300; Capuco AV, 2001, J DAIRY SCI, V84, P2177, DOI 10.3168/jds.S0022-0302(01)74664-4; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Chen YH, 2013, UROL ONCOL-SEMIN ORI, V31, P219, DOI 10.1016/j.urolonc.2010.11.007; Dueck A, 2012, NUCLEIC ACIDS RES, V40, P9850, DOI 10.1093/nar/gks705; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Farr VC, 1996, J DAIRY SCI, V79, P543, DOI 10.3168/jds.S0022-0302(96)76398-1; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Galio L, 2013, PHYSIOL GENOMICS, V45, P151, DOI 10.1152/physiolgenomics.00091.2012; Greene SB, 2010, J CELL SCI, V123, P606, DOI 10.1242/jcs.056812; Gu ZL, 2007, FEBS LETT, V581, P981, DOI 10.1016/j.febslet.2007.01.081; Guduric-Fuchs J, 2012, J CELL BIOCHEM, V113, P2098, DOI 10.1002/jcb.24084; Hafner M, 2012, METHODS, V58, P94, DOI 10.1016/j.ymeth.2012.08.006; Hafner M, 2011, RNA, V17, P1697, DOI 10.1261/rna.2799511; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Hou XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052123; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang JM, 2011, INT J BIOL SCI, V7, P1016, DOI 10.7150/ijbs.7.1016; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Inukai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040028; Jayaprakash AD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr693; Ji ZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049463; Ji ZB, 2012, MOL BIOL REP, V39, P9361, DOI 10.1007/s11033-012-1779-5; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Le Guillou S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045727; Le Quesne J, 2010, MOL ONCOL, V4, P230, DOI 10.1016/j.molonc.2010.04.009; Leptidis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057800; Li D, 2011, J BIOL CHEM, V286, P36677, DOI 10.1074/jbc.M111.270561; Li Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-731; Li ZM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041658, 10.1371/journal.pone.0053176]; Lian SZ, 2013, CURR PHARM DESIGN, V19, P6382; Liu JL, 2012, J BIOL CHEM, V287, P13899, DOI 10.1074/jbc.M111.301275; Lynn FC, 2009, TRENDS ENDOCRIN MET, V20, P452, DOI 10.1016/j.tem.2009.05.007; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Matkovich SJ, 2011, CIRC RES, V108, P18, DOI 10.1161/CIRCRESAHA.110.233528; Moore KJ, 2010, TRENDS ENDOCRIN MET, V21, P699, DOI 10.1016/j.tem.2010.08.008; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; Nagaoka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065127; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Podolska A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-459; Rau A, 2013, BIOINFORMATICS, V29, P2146, DOI 10.1093/bioinformatics/btt350; Ribeiro-dos-Santos A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013205; Rowson AR, 2012, SEMIN CELL DEV BIOL, V23, P557, DOI 10.1016/j.semcdb.2012.03.018; Sdassi N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-149; Song Lin, 2006, Birth Defects Research, V78, P140, DOI 10.1002/bdrc.20070; Sun GH, 2011, RNA, V17, P2256, DOI 10.1261/rna.028621.111; Sun KL, 2013, NAT REV GENET, V14, P535, DOI 10.1038/nrg3471; Timoneda O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055402; Ucar A, 2010, NAT GENET, V42, P1101, DOI 10.1038/ng.709; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wang Chunmei, 2007, Journal of Genetics and Genomics, V34, P966, DOI 10.1016/S1673-8527(07)60109-X; Wang M, 2012, J DAIRY SCI, V95, P6529, DOI 10.3168/jds.2012-5748; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wilfred BR, 2007, MOL GENET METAB, V91, P209, DOI 10.1016/j.ymgme.2007.03.011; Zheng H, 2013, CARCINOGENESIS; Zhu Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-718	75	42	42	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91938	10.1371/journal.pone.0091938	http://dx.doi.org/10.1371/journal.pone.0091938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658750	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300045
J	Martin, J; Edwards, HH; Bled, F; Fonnesbeck, CJ; Dupuis, JA; Gardner, B; Koslovsky, SM; Aven, AM; Ward-Geiger, LI; Carmichael, RH; Fagan, DE; Ross, MA; Reinert, TR				Martin, Julien; Edwards, Holly H.; Bled, Florent; Fonnesbeck, Christopher J.; Dupuis, Jerome A.; Gardner, Beth; Koslovsky, Stacie M.; Aven, Allen M.; Ward-Geiger, Leslie I.; Carmichael, Ruth H.; Fagan, Daniel E.; Ross, Monica A.; Reinert, Thomas R.			Estimating Upper Bounds for Occupancy and Number of Manatees in Areas Potentially Affected by Oil from the Deepwater Horizon Oil Spill	PLOS ONE			English	Article							ESTIMATING ABUNDANCE	The explosion of the Deepwater Horizon drilling platform created the largest marine oil spill in U. S. history. As part of the Natural Resource Damage Assessment process, we applied an innovative modeling approach to obtain upper estimates for occupancy and for number of manatees in areas potentially affected by the oil spill. Our data consisted of aerial survey counts in waters of the Florida Panhandle, Alabama and Mississippi. Our method, which uses a Bayesian approach, allows for the propagation of uncertainty associated with estimates from empirical data and from the published literature. We illustrate that it is possible to derive estimates of occupancy rate and upper estimates of the number of manatees present at the time of sampling, even when no manatees were observed in our sampled plots during surveys. We estimated that fewer than 2.4% of potentially affected manatee habitat in our Florida study area may have been occupied by manatees. The upper estimate for the number of manatees present in potentially impacted areas (within our study area) was estimated with our model to be 74 (95%CI 46 to 107). This upper estimate for the number of manatees was conditioned on the upper 95%CI value of the occupancy rate. In other words, based on our estimates, it is highly probable that there were 107 or fewer manatees in our study area during the time of our surveys. Because our analyses apply to habitats considered likely manatee habitats, our inference is restricted to these sites and to the time frame of our surveys. Given that manatees may be hard to see during aerial surveys, it was important to account for imperfect detection. The approach that we described can be useful for determining the best allocation of resources for monitoring and conservation.	[Martin, Julien; Edwards, Holly H.; Koslovsky, Stacie M.; Ward-Geiger, Leslie I.; Fagan, Daniel E.; Reinert, Thomas R.] Fish & Wildlife Res Inst, Florida Fish & Wildlife Conservat Commiss, St Petersburg, FL 33701 USA; [Bled, Florent] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD USA; [Bled, Florent] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Fonnesbeck, Christopher J.] Vanderbilt Univ, Dept Biostat, Nashville, TN 37235 USA; [Dupuis, Jerome A.] Univ Toulouse 3, Lab Stat & Probabilites, F-31062 Toulouse, France; [Gardner, Beth] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA; [Aven, Allen M.; Carmichael, Ruth H.] Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Aven, Allen M.; Carmichael, Ruth H.] Univ S Alabama, Mobile, AL 36688 USA; [Ross, Monica A.] Sea Shore Alliance, Sarasota, FL USA	Florida Fish & Wildlife Conservation Commission; United States Department of the Interior; United States Geological Survey; Colorado State University; Vanderbilt University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of North Carolina; North Carolina State University; Dauphin Island Sea Lab; University of South Alabama	Martin, J (corresponding author), Fish & Wildlife Res Inst, Florida Fish & Wildlife Conservat Commiss, St Petersburg, FL 33701 USA.	julien.martin@myfwc.com		Carmichael, Ruth/0000-0002-6033-3777; Martin, Julien/0000-0002-7375-129X	Natural Resource Damage Assessment for the Deepwater Horizon oil spill	Natural Resource Damage Assessment for the Deepwater Horizon oil spill	This work was supported by funds provided as part of the Natural Resource Damage Assessment for the Deepwater Horizon oil spill. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bled F, 2011, BIODIVERS CONSERV, V20, P1203, DOI 10.1007/s10531-011-0023-2; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; Dorazio RM, 2013, ECOLOGY, V94, P1472, DOI 10.1890/0012-9658-94.7.1472; Dupuis JA, 2011, BIOMETRICS, V67, P290, DOI 10.1111/j.1541-0420.2010.01424.x; Edwards HH, 2007, J WILDLIFE MANAGE, V71, P2052, DOI 10.2193/2005-645; Fertl D., 2005, Gulf and Caribbean Research, V17, P69; Gelman A., 2004, BAYESIAN DATA ANAL; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Machlis GE, 2010, SCIENCE, V329, P1018, DOI 10.1126/science.1195382; Mackenzie DI, 2009, ECOLOGY, V90, P823, DOI 10.1890/08-0141.1; Martin J, 2011, METHODS ECOL EVOL, V2, P595, DOI 10.1111/j.2041-210X.2011.00113.x; Mascarelli A, 2010, NATURE, V467, P22, DOI 10.1038/467022a; Pabody Claire M., 2009, Gulf of Mexico Science, V27, P52; Royle J. A., 2008, HIERARCHICAL MODELIN; Runge M. C., 2007, 20071082 US GEOL SUR; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	16	8	8	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e91683	10.1371/journal.pone.0091683	http://dx.doi.org/10.1371/journal.pone.0091683			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670971	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677000025
J	Payne, EGI; Fletcher, TD; Russell, DG; Grace, MR; Cavagnaro, TR; Evrard, V; Deletic, A; Hatt, BE; Cook, PLM				Payne, Emily G. I.; Fletcher, Tim D.; Russell, Douglas G.; Grace, Michael R.; Cavagnaro, Timothy R.; Evrard, Victor; Deletic, Ana; Hatt, Belinda E.; Cook, Perran L. M.			Temporary Storage or Permanent Removal? The Division of Nitrogen between Biotic Assimilation and Denitrification in Stormwater Biofiltration Systems	PLOS ONE			English	Article							POLLUTANT REMOVAL; NUTRIENT RETENTION; NITRATE UPTAKE; BIORETENTION; WATER; NITRIFICATION; GROUNDWATER; ECOSYSTEMS; SATURATION; BIOFILTERS	The long-term efficacy of stormwater treatment systems requires continuous pollutant removal without substantial re-release. Hence, the division of incoming pollutants between temporary and permanent removal pathways is fundamental. This is pertinent to nitrogen, a critical water body pollutant, which on a broad level may be assimilated by plants or microbes and temporarily stored, or transformed by bacteria to gaseous forms and permanently lost via denitrification. Biofiltration systems have demonstrated effective removal of nitrogen from urban stormwater runoff, but to date studies have been limited to a 'black-box' approach. The lack of understanding on internal nitrogen processes constrains future design and threatens the reliability of long-term system performance. While nitrogen processes have been thoroughly studied in other environments, including wastewater treatment wetlands, biofiltration systems differ fundamentally in design and the composition and hydrology of stormwater inflows, with intermittent inundation and prolonged dry periods. Two mesocosm experiments were conducted to investigate biofilter nitrogen processes using the stable isotope tracer (NO3-)-N-15 (nitrate) over the course of one inflow event. The immediate partitioning of (NO3-)-N-15 between biotic assimilation and denitrification were investigated for a range of different inflow concentrations and plant species. Assimilation was the primary fate for NO3- under typical stormwater concentrations (similar to 1-2 mg N/L), contributing an average 89-99% of (NO3-)-N-15 processing in biofilter columns containing the most effective plant species, while only 0-3% was denitrified and 0-8% remained in the pore water. Denitrification played a greater role for columns containing less effective species, processing up to 8% of (NO3-)-N-15, and increased further with nitrate loading. This study uniquely applied isotope tracing to biofiltration systems and revealed the dominance of assimilation in stormwater biofilters. The findings raise important questions about nitrogen release upon plant senescence, seasonally and in the long term, which have implications on the management and design of biofiltration systems.	[Payne, Emily G. I.; Deletic, Ana; Hatt, Belinda E.] Monash Univ, Dept Civil Engn, Monash Water Liveabil, Clayton, Vic 3800, Australia; [Fletcher, Tim D.] Univ Melbourne, Melbourne Sch Land & Environm, Dept Resource Management & Geog, Melbourne, Vic 3010, Australia; [Russell, Douglas G.; Grace, Michael R.; Evrard, Victor; Cook, Perran L. M.] Monash Univ, Sch Chem, Water Studies Ctr, Clayton, Vic 3800, Australia; [Cavagnaro, Timothy R.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia	Monash University; University of Melbourne; Monash University; Monash University	Payne, EGI (corresponding author), Monash Univ, Dept Civil Engn, Monash Water Liveabil, Clayton, Vic 3800, Australia.	emily.payne@monash.edu	Cavagnaro, Timothy/HGC-7768-2022; Grace, Mike/AAE-3073-2022; Fletcher, Tim/AAB-8356-2019; Evrard, Victor/A-9264-2008; Grace, Mike/AAE-3376-2021; Deletic, Ana/CAG-2385-2022	Fletcher, Tim/0000-0001-8819-5567; Evrard, Victor/0000-0001-7650-3534; Grace, Mike/0000-0002-0982-8133; Deletic, Ana/0000-0002-3535-7451; Cook, Perran/0000-0002-0444-3488; Cavagnaro, Timothy/0000-0002-9922-5677	Australian Research Council [LP0990153]; Melbourne Water; Western Australia Department of Water; ARC Future Fellowship [FT100100144]	Australian Research Council(Australian Research Council); Melbourne Water; Western Australia Department of Water; ARC Future Fellowship(Australian Research Council)	This research was supported by funding from the Australian Research Council (LP0990153)(http://www.arc.gov.au/), Melbourne Water (http://www.melbournewater.com.au/Pages/home.aspx), and Western Australia Department of Water (http://www.water.wa.gov.au/). Fletcher is supported by an ARC Future Fellowship (FT100100144). The funders assisted with the study design and discussions of overall project results but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; [Anonymous], 2008, BIOGEOCHEMISTRY WETL; Bedard-Haughn A, 2005, J ENVIRON QUAL, V34, P1651, DOI 10.2134/jeq2005.0033; Bedard-Haughn A, 2004, J ENVIRON QUAL, V33, P2252, DOI 10.2134/jeq2004.2252; Bernot MJ, 2005, ECOSYSTEMS, V8, P442, DOI 10.1007/s10021-003-0143-y; Blecken GT, 2009, ECOL ENG, V35, P769, DOI 10.1016/j.ecoleng.2008.12.009; Bratieres K, 2008, WATER RES, V42, P3930, DOI 10.1016/j.watres.2008.06.009; Cavagnaro TR, 2001, NEW PHYTOL, V149, P105, DOI 10.1046/j.1469-8137.2001.00001.x; Collins KA, 2010, ECOL ENG, V36, P1507, DOI 10.1016/j.ecoleng.2010.03.015; COOPER AB, 1984, NEW ZEAL J MAR FRESH, V18, P441, DOI 10.1080/00288330.1984.9516065; Craft CB, 1996, WETLANDS ECOLOGY MAN, V4, P177, DOI DOI 10.1007/BF01879236; Davis AP, 2009, J ENVIRON ENG, V135, P109, DOI 10.1061/(ASCE)0733-9372(2009)135:3(109); Davis AP, 2006, WATER ENVIRON RES, V78, P284, DOI 10.2175/106143005X94376; Davis AP, 2001, WATER ENVIRON RES, V73, P5, DOI 10.2175/106143001X138624; Duncan H.P., 1999, DATABASE URBAN STORM; Facility for Advancing Water Biofiltration (FAWB), 2009, AD GUID STORMW BIOF; Fox J., 2019, R COMPANION APPL REG, V.; Gosselink J.G., 2000, WETLANDS; Gray SR, 2002, URBAN WATER, V4, P331, DOI DOI 10.1016/S1462-0758(02)00033-X; Hatt BE, 2008, ENVIRON SCI TECHNOL, V42, P2535, DOI 10.1021/es071264p; Hunt WF, 2008, J ENVIRON ENG-ASCE, V134, P403, DOI 10.1061/(ASCE)0733-9372(2008)134:5(403); JENKINSON DS, 1990, SOIL USE MANAGE, V6, P56, DOI 10.1111/j.1475-2743.1990.tb00800.x; Kadlec RH, 2005, ECOL ENG, V25, P365, DOI 10.1016/j.ecoleng.2005.06.009; Kim HH, 2003, WATER ENVIRON RES, V75, P355, DOI 10.2175/106143003X141169; Kirk GJD, 2005, ANN BOT-LONDON, V96, P639, DOI 10.1093/aob/mci216; Kreiling RM, 2011, BIOGEOCHEMISTRY, V104, P309, DOI 10.1007/s10533-010-9503-9; Lee CG, 2009, ENG LIFE SCI, V9, P11, DOI 10.1002/elsc.200800049; Lin YF, 2002, ENVIRON POLLUT, V119, P413, DOI 10.1016/S0269-7491(01)00299-8; Lucas WC, 2008, J IRRIG DRAIN ENG, V134, P613, DOI 10.1061/(ASCE)0733-9437(2008)134:5(613); Lucas WC, 2011, WATER ENVIRON RES, V83, P692, DOI 10.2175/106143010X12780288628697; Matheson FE, 2002, ECOL ENG, V19, P249, DOI 10.1016/S0925-8574(02)00093-9; Minett DA, 2013, ECOL ENG, V58, P414, DOI 10.1016/j.ecoleng.2013.06.028; Mitsch WJ, 2005, ECOL ENG, V24, P267, DOI 10.1016/j.ecoleng.2005.02.005; NIELSEN LP, 1992, FEMS MICROBIOL ECOL, V86, P357, DOI 10.1016/0378-1097(92)90800-4; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Payne EGI, WATER SCI T IN PRESS; Payne EGI, CRITICAL RE IN PRESS; Pinay G, 1998, J N AM BENTHOL SOC, V17, P179, DOI 10.2307/1467961; POWLSON DS, 1993, SOIL USE MANAGE, V9, P86, DOI 10.1111/j.1475-2743.1993.tb00935.x; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Read J, 2010, INT J PHYTOREMEDIAT, V12, P34, DOI 10.1080/15226510902767114; REDDY KR, 1989, LIMNOL OCEANOGR, V34, P1004, DOI 10.4319/lo.1989.34.6.1004; Ritz C, 2005, J STAT SOFTWARE, V12; Roberts SJ, 2012, 7 INT C WAT SENS URB; SEITZINGER SP, 1988, LIMNOL OCEANOGR, V33, P702, DOI 10.4319/lo.1988.33.4_part_2.0702; Simek M, 2002, SOIL BIOL BIOCHEM, V34, P1227, DOI 10.1016/S0038-0717(02)00059-7; Tanner CC, 1996, ECOL ENG, V7, P59, DOI 10.1016/0925-8574(95)00066-6; Taylor GD, 2005, WATER RES, V39, P1982, DOI 10.1016/j.watres.2005.03.022; URBAN NR, 1988, LIMNOL OCEANOGR, V33, P1611, DOI 10.4319/lo.1988.33.6_part_2.1611; VITOUSEK PM, 1975, BIOSCIENCE, V25, P376, DOI 10.2307/1297148; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Vymazal J, 2007, SCI TOTAL ENVIRON, V380, P48, DOI 10.1016/j.scitotenv.2006.09.014; WEISS RF, 1980, MAR CHEM, V8, P347, DOI 10.1016/0304-4203(80)90024-9; Zhu WX, 2004, BIOGEOCHEMISTRY, V71, P177, DOI 10.1007/s10533-004-9683-2; Zinger T, 2007, OPTIMISATION NITROGE; Zinger Y, 2013, ECOL ENG, V51, P75, DOI 10.1016/j.ecoleng.2012.12.007	56	75	87	1	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e90890	10.1371/journal.pone.0090890	http://dx.doi.org/10.1371/journal.pone.0090890			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670377	Green Submitted, gold, Green Published			2022-12-27	WOS:000333677000012
J	Kovalenko, IL; Galyamina, AG; Smagin, DA; Michurina, TV; Kudryavtseva, NN; Enikolopov, G				Kovalenko, Irina L.; Galyamina, Anna G.; Smagin, Dmitry A.; Michurina, Tatyana V.; Kudryavtseva, Natalia N.; Enikolopov, Grigori			Extended Effect of Chronic Social Defeat Stress in Childhood on Behaviors in Adulthood	PLOS ONE			English	Article							HIPPOCAMPAL CELL-PROLIFERATION; INSTABILITY STRESS; ANIMAL-MODEL; FEMALE RATS; ADOLESCENCE; ANXIETY; NEUROGENESIS; NEUROENDOCRINE; EXPERIENCE; ALTERS	Individuals exposed to social stress in childhood are more predisposed to developing psychoemotional disorders in adulthood. Here we use an animal model to determine the influence of hostile social environment in adolescence on behavior during adult life. One-month-old adolescent male mice were placed for 2 weeks in a common cage with an adult aggressive male. Animals were separated by a transparent perforated partition, but the adolescent male was exposed daily to short attacks from the adult male. After exposure to social stress, some of the adolescent mice were placed for 3 weeks in comfortable conditions. Following this rest period, stressed young males and adult males were studied in a range of behavioral tests to evaluate the levels of anxiety, depressiveness, and communicativeness with an unfamiliar partner. In addition, adult mice exposed to social stress in adolescence were engaged in agonistic interactions. We found that 2 weeks of social stress result in a decrease of communicativeness in the home cage and diminished social interactions on the novel territory. Stressed adolescents demonstrated a high level of anxiety in the elevated plus-maze test and helplessness in the Porsolt test. Furthermore, the number of dividing (BrdU-positive) cells in the subgranular zone of the dentate gyrus was significantly lower in stressed adolescents. After 3 weeks of rest, most behavioral characteristics in different tests, as well as the number of BrdU-positive cells in the hippocampus, did not differ from those of the respective control mice. However, the level of anxiety remained high in adult males exposed to chronic social stress in childhood. Furthermore, these males were more aggressive in the agonistic interactions. Thus, hostile social environment in adolescence disturbs psychoemotional state and social behaviors of animals in adult life.	[Kovalenko, Irina L.; Galyamina, Anna G.; Smagin, Dmitry A.; Kudryavtseva, Natalia N.] Inst Cytol & Genet SD RAS, Novosibirsk, Russia; [Smagin, Dmitry A.; Michurina, Tatyana V.; Enikolopov, Grigori] Moscow Inst Phys & Technol, NBIC, Moscow, Russia; [Michurina, Tatyana V.; Enikolopov, Grigori] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Moscow Institute of Physics & Technology; Cold Spring Harbor Laboratory	Kudryavtseva, NN (corresponding author), Inst Cytol & Genet SD RAS, Novosibirsk, Russia.	n.n.kudryavtseva@gmail.com	Enikolopov, Grigori/P-5731-2019; Smagin, Dmitry A/Q-7886-2016; Kudryavtseva, Natalia/AAI-1127-2019	Enikolopov, Grigori/0000-0001-8178-8917; Smagin, Dmitriy/0000-0002-4017-7287; Galyamina, Anna/0000-0001-6101-2521	Russian Foundation for Basic Research [13-04-00072a]; Russian Academy of Sciences [6.25]; Russian Ministry of Education and Science [11.G34.31.0071]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation)	This work was supported by Russian Foundation for Basic Research, no. 13-04-00072a, "Molecular and Cellular Biology" Program of the Russian Academy of Sciences, grant no. 6.25, and by the Russian Ministry of Education and Science, grant no. 11.G34.31.0071. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avgustinovich D. F., 2004, Uspekhi Fiziologicheskikh Nauk, V35, P19; Baranyi J, 2005, PHYSIOL BEHAV, V84, P511, DOI 10.1016/j.physbeh.2005.01.005; Barha CK, 2011, HIPPOCAMPUS, V21, P1216, DOI 10.1002/hipo.20829; Barratt ES, 1972, CURRENT TRENDS THEOR, V1, P195; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bondar N. P., 2009, OPEN BEHAV SCI J, V3, P17, DOI DOI 10.2174/1874230000903010017; Bourke CH, 2011, HORM BEHAV, V60, P112, DOI 10.1016/j.yhbeh.2011.03.011; Boyarskikh UA, 2013, MOL NEUROBIOL, V48, P13, DOI 10.1007/s12035-013-8413-y; Buwalda B, 2011, NEUROSCI BIOBEHAV R, V35, P1713, DOI 10.1016/j.neubiorev.2010.10.004; Buwalda B, 2010, PHYSIOL BEHAV, V101, P719, DOI 10.1016/j.physbeh.2010.08.010; Coppens CM, 2012, PHYSIOL BEHAV, V105, P1156, DOI 10.1016/j.physbeh.2011.12.013; Czeh B, 2007, NEUROPSYCHOPHARMACOL, V32, P1490, DOI 10.1038/sj.npp.1301275; Delville Y, 1998, J NEUROSCI, V18, P2667; Dietz DM, 2011, BIOL PSYCHIAT, V70, P408, DOI 10.1016/j.biopsych.2011.05.005; Encinas JM, 2008, METHOD CELL BIOL, V85, P243, DOI 10.1016/S0091-679X(08)85011-X; Ferragud A, 2010, BEHAV BRAIN RES, V210, P134, DOI 10.1016/j.bbr.2010.02.013; Gutman David A, 2002, Semin Clin Neuropsychiatry, V7, P89, DOI 10.1053/scnp.2002.31781; Happe F, 2008, NEUROPSYCHOL REV, V18, P287, DOI 10.1007/s11065-008-9076-8; Hellemans KGC, 2004, DEV BRAIN RES, V150, P103, DOI 10.1016/j.devbrainres.2004.03.003; Herzog CJ, 2009, NEUROSCIENCE, V159, P982, DOI 10.1016/j.neuroscience.2009.01.059; Hollis F, 2010, PSYCHOPHARMACOLOGY, V211, P69, DOI 10.1007/s00213-010-1869-9; Hong SZ, 2012, PHYSIOL BEHAV, V105, P269, DOI 10.1016/j.physbeh.2011.08.036; Huang GB, 2013, INT J NEUROPSYCHOPH, V16, P1635, DOI 10.1017/S1461145713000060; Kenworthy CA, 2013, NEUROSCIENCE, DOI [10.1016/j.neuroscience.2013.01.024, DOI 10.1016/J.NEUR0SCIENCE.2013.01.024]; KOVALENKO IL, 2010, PSYCHOPHARMACOL BIOL, V10, P2624; Kubala KH, 2012, BEHAV BRAIN RES, V234, P278, DOI 10.1016/j.bbr.2012.06.027; Kudryavtseva NN, 2002, BEHAV BRAIN RES, V133, P83, DOI 10.1016/S0166-4328(01)00443-0; KUDRYAVTSEVA NN, 1994, BEHAV PROCESS, V32, P297, DOI 10.1016/0376-6357(94)90049-3; Lagace DC, 2010, P NATL ACAD SCI USA, V107, P4436, DOI 10.1073/pnas.0910072107; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; McCormick CM, 2008, BEHAV BRAIN RES, V187, P228, DOI 10.1016/j.bbr.2007.09.005; McCormick C.M., 2012, NEUROSCIENCE; McCormick CM, 2012, HIPPOCAMPUS, V22, P1300, DOI 10.1002/hipo.20966; McCormick CM, 2010, BEHAV BRAIN RES, V208, P23, DOI 10.1016/j.bbr.2009.11.003; McCormick CM, 2010, PHYSIOL BEHAV, V99, P194, DOI 10.1016/j.physbeh.2009.01.014; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Oines E, 2012, PHYSIOL BEHAV, V105, P1058, DOI 10.1016/j.physbeh.2011.11.024; Park JH, 2013, EUR J NEUROSCI, V37, P1987, DOI 10.1111/ejn.12249; Parmigiani S, 1999, NEUROSCI BIOBEHAV R, V23, P957, DOI 10.1016/S0149-7634(99)00029-9; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Paxinos G, 2001, MOUSE BRAIN STEREOTA, V2, DOI [10.1111/j.1469-7580.2004.00264.x, DOI 10.1111/J.1469-7580.2004.00264.X]; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; RODGERS RJ, 1994, ETHOLOGY AND PSYCHOPHARMACOLOGY, P9; Romeo RD, 2010, DEV PSYCHOBIOL, V52, P244, DOI 10.1002/dev.20437; Samuels BA, 2011, EUR J NEUROSCI, V33, P1152, DOI 10.1111/j.1460-9568.2011.07614.x; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; Schmidt MV, 2007, PSYCHONEUROENDOCRINO, V32, P417, DOI 10.1016/j.psyneuen.2007.02.011; Sterlemann V, 2010, HIPPOCAMPUS, V20, P540, DOI 10.1002/hipo.20655; Van Bokhoven P, 2011, EUR J NEUROSCI, V33, P1833, DOI 10.1111/j.1460-9568.2011.07668.x; Veenema AH, 2009, FRONT NEUROENDOCRIN, V30, P497, DOI 10.1016/j.yfrne.2009.03.003; Vidal J, 2011, BEHAV PROCESS, V88, P76, DOI 10.1016/j.beproc.2011.08.005; Vidal J, 2011, BEHAV PROCESS, V87, P176, DOI 10.1016/j.beproc.2011.03.004; Watt MJ, 2009, BEHAV NEUROSCI, V123, P564, DOI 10.1037/a0015752; Wommack JC, 2003, HORM BEHAV, V43, P229, DOI 10.1016/S0018-506X(02)00029-6; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	56	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e91762	10.1371/journal.pone.0091762	http://dx.doi.org/10.1371/journal.pone.0091762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SD	24667609	Green Accepted, gold, Green Published			2022-12-27	WOS:000333675600013
J	Lyu, XD; Xin, YP; Mi, RH; Ding, J; Wang, XW; Hu, JY; Fan, RH; Wei, XD; Song, YP; Zhao, RY				Lyu, Xiaodong; Xin, Yaping; Mi, Ruihua; Ding, Jing; Wang, Xianwei; Hu, Jieying; Fan, Ruihua; Wei, Xudong; Song, Yongping; Zhao, Richard Y.			Overexpression of Wilms Tumor 1 Gene as a Negative Prognostic Indicator in Acute Myeloid Leukemia	PLOS ONE			English	Article							WT1 PROTEIN; EXPRESSION; DIAGNOSIS; RECOMMENDATIONS; PROLIFERATION; SUPPRESSOR; INHIBIT; LEVEL; CELLS	Chromosomal aberrations are useful in assessing treatment options and clinical outcomes of acute myeloid leukemia (AML) patients. However, 40 similar to 50% of the AML patients showed no chromosomal abnormalities, i.e., with normal cytogenetics aka the CN-AML patients. Testing of molecular aberrations such as FLT3 or NPM1 can help to define clinical outcomes in the CN-AML patients but with various successes. Goal of this study was to test the possibility of Wilms' tumor 1 (WT1) gene overexpression as an additional molecular biomarker. A total of 103 CN-AML patients, among which 28% had overexpressed WT1, were studied over a period of 38 months. Patient's response to induction chemotherapy as measured by the complete remission (CR) rate, disease-free survival (DFS) and overall survival (OS) were measured. Our data suggested that WT1 overexpression correlated negatively with the CR rate, DFS and OS. Consistent with previous reports, CN-AML patients can be divided into three different risk subgroups based on the status of known molecular abnormalities, i.e., the favorable (NPM1(mt)/no FLT3(ITD)), the unfavorable (FLT3(ITD)) and the intermediate risk subgroups. The WT1 overexpression significantly reduced the CR, DFS and OS in both the favorable and unfavorable groups. As the results, patients with normal WT1 gene expression in the favorable risk group showed the best clinical outcomes and all survived with complete remission and disease-free survival over the 37 month study period; in contrast, patients with WT1 overexpression in the unfavorable risk group displayed the worst clinical outcomes. WT1 overexpression by itself is an independent and negative indicator for predicting CR rate, DFS and OS of the CN-AML patients; moreover, it increases the statistical power of predicting the same clinical outcomes when it is combined with the NPM1 mt or the FLT3(ITD) genotypes that are the good or poor prognostic markers of CN-AML.	[Lyu, Xiaodong; Mi, Ruihua; Ding, Jing; Wang, Xianwei; Hu, Jieying; Fan, Ruihua; Wei, Xudong; Song, Yongping] Zhengzhou Univ, Henan Inst Hematol, Affiliated Tumor Hosp, Zhengzhou 450052, Henan, Peoples R China; [Xin, Yaping] Zhengzhou Univ, Dept Endocrinol & Metab Dis, Affiliated Hosp 2, Zhengzhou 450052, Henan, Peoples R China; [Lyu, Xiaodong; Zhao, Richard Y.] Univ Maryland Sch Med, Div Mol Pathol, Dept Pathol, Baltimore, MD USA	Zhengzhou University; Zhengzhou University; University System of Maryland; University of Maryland Baltimore	Lyu, XD (corresponding author), Zhengzhou Univ, Henan Inst Hematol, Affiliated Tumor Hosp, Zhengzhou 450052, Henan, Peoples R China.	xiaodonglv2007@sina.com; RZhao@som.uamryland.edu		Zhao, Richard Y./0000-0003-3424-2852	Social Public Service Foundation of Henan Technology Department [072103810503]	Social Public Service Foundation of Henan Technology Department	This work was supported by the Social Public Service Foundation of Henan Technology Department [072103810503] to Xiaodong Lyu who was a visiting physician scientist in the RZ's laboratory at the University of Maryland School of Medicine when this manuscript was written. The authors would like to thank Ge Li for helpful discussions and revision. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 1996, ONCOGENE, V13, P2197; Barragan E, 2004, HAEMATOLOGICA, V89, P926; Bergmann L, 1997, LEUKEMIA LYMPHOMA, V25, P435, DOI 10.3109/10428199709039030; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Cilloni D, 2009, J CLIN ONCOL, V27, P5195, DOI 10.1200/JCO.2009.22.4865; Damm F, 2011, BLOOD, V117, P4561, DOI 10.1182/blood-2010-08-303479; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Gao SM, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-110; Garg M, 2003, BRIT J HAEMATOL, V123, P49, DOI 10.1046/j.1365-2141.2003.04552.x; Jono Hirofumi, 2010, Cancers (Basel), V2, P624, DOI 10.3390/cancers2020624; Lyu XD, 2013, J CLIN EXP PATHO, V3, P143; Ma ZH, 2013, J CANCER RES CLIN, V139, P557, DOI 10.1007/s00432-012-1357-1; Marcucci G, 2011, J CLIN ONCOL, V29, P475, DOI 10.1200/JCO.2010.30.2554; Miglino M, 2011, LEUKEMIA LYMPHOMA, V52, P1961, DOI 10.3109/10428194.2011.585673; Miyawaki S, 2010, LEUKEMIA LYMPHOMA, V51, P1855, DOI 10.3109/10428194.2010.507829; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; Oka Y, 2004, P NATL ACAD SCI USA, V101, P13885, DOI 10.1073/pnas.0405884101; Rau R, 2009, HEMATOL ONCOL, V27, P171, DOI 10.1002/hon.904; Spassov BV, 2011, HEMATOLOGY, V16, P37, DOI 10.1179/102453311X12902908411913; Tuna M, 2005, ONCOGENE, V24, P1648, DOI 10.1038/sj.onc.1208345; Werner H, 1996, J MOL NEUROSCI, V7, P111, DOI 10.1007/BF02736791; Yang L, 2007, LEUKEMIA, V21, P868, DOI 10.1038/sj.leu.2404624	22	28	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92470	10.1371/journal.pone.0092470	http://dx.doi.org/10.1371/journal.pone.0092470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667279	gold, Green Published, Green Submitted			2022-12-27	WOS:000333675600042
J	Smedley, J; Turkbey, B; Bernardo, ML; Del Prete, GQ; Estes, JD; Griffiths, GL; Kobayashi, H; Choyke, PL; Lifson, JD; Keele, BF				Smedley, Jeremy; Turkbey, Baris; Bernardo, Marcelino L.; Del Prete, Gregory Q.; Estes, Jacob D.; Griffiths, Gary L.; Kobayashi, Hisataka; Choyke, Peter L.; Lifson, Jeffrey D.; Keele, Brandon F.			Tracking the Luminal Exposure and Lymphatic Drainage Pathways of Intravaginal and Intrarectal Inocula Used in Nonhuman Primate Models of HIV Transmission	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; RHESUS MACAQUES; BLUE-DYE; INFECTION; SIVMAC251; VARIANTS	Over 80% of sexual HIV-1 transmissions originate from a single viral variant, but the underlying basis for this transmission bottleneck remains to be elucidated. Nonhuman primate models of mucosal virus transmission allow opportunities to gain insight into the basis of this mucosal bottleneck. We used simulated inocula consisting of either non-infectious vital dye or contrast dye with non-invasive magnetic resonance imaging (MRI) to visualize mucosal exposure and passive lymphatic drainage patterns following vaginal and rectal exposures in Indian origin rhesus macaques. Results revealed a limited overall distance of dye coverage from the anal verge following 1 ml (n = 8) intrarectally administered, which greatly increased with a 3 ml (n = 8) volume. Intravaginal dye exposure using 2 ml revealed complete coverage of the mucosa of the vagina and ectocervix, however dye was not detectable in the endocervix, uterus, fallopian tubes or ovaries in nuliparous sexually mature rhesus macaques (n = 9). In addition, following submucosal and intranodal injections of vital dye or MRI contrast dye in the rectum (n = 9), or distal and proximal vagina (n = 4), the lymphatic drainage pathways were identified as first the internal then common iliac chain followed by para-aortic lymph nodes. Drainage from the distal descending colon (n = 8) was via the para-colonic lymph nodes followed by the inferior mesenteric and para-aortic lymph nodes. Analysis after vaginal challenge with infectious SIVmac239 followed by euthanasia at day 3 revealed a pattern of viral dissemination consistent with the imaging results. These results provide insights into potential patterns of viral dissemination that can help guide efforts to better elucidate the earliest events of virus transmission and potential intervention strategies.	[Smedley, Jeremy] Frederick Natl Lab, Leidos Biomed Res Inc, Lab Anim Sci Program, Frederick, MD USA; [Turkbey, Baris; Bernardo, Marcelino L.; Kobayashi, Hisataka; Choyke, Peter L.] NCI, Mol Imaging Program, Bethesda, MD 20892 USA; [Del Prete, Gregory Q.; Estes, Jacob D.; Lifson, Jeffrey D.; Keele, Brandon F.] Frederick Natl Lab, AIDS & Canc Virus Program, Leidos Biomed Res Inc, Frederick, MD 21702 USA; [Griffiths, Gary L.] Frederick Natl Lab, Clin Monitoring Res Program, Leidos Biomed Res Inc, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Keele, BF (corresponding author), Frederick Natl Lab, AIDS & Canc Virus Program, Leidos Biomed Res Inc, Frederick, MD 21702 USA.	keelebf@mail.nih.gov		Smedley, Jeremy/0000-0003-3369-4662	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC010654] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Bostick P, 1999, ARCH SURG-CHICAGO, V134, P43, DOI 10.1001/archsurg.134.1.43; Carias AM, 2013, J VIROL, V87, P11388, DOI 10.1128/JVI.01377-13; CDC, 2011, 23 CDC; Cohen MS, 2007, CLIN INFECT DIS, V45, pS287, DOI 10.1086/522552; Del Prete GQ, 2013, J VIROL, V87, P4584, DOI 10.1128/JVI.03507-12; Gray H., 2000, ANATOMY HUMAN BODY; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Kearney M, 2009, J VIROL, V83, P2715, DOI 10.1128/JVI.01960-08; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keele BF, 2011, BLOOD, V118, P839, DOI 10.1182/blood-2010-12-325860; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Liu JY, 2010, J VIROL, V84, P10406, DOI 10.1128/JVI.01155-10; Ma ZM, 2011, AIDS RES HUM RETROV, V27, P1259, DOI 10.1089/aid.2011.0090; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; PARK JM, 1994, RADIOGRAPHICS, V14, P1309, DOI 10.1148/radiographics.14.6.7855343; Player AN, 2001, J HISTOCHEM CYTOCHEM, V49, P603, DOI 10.1177/002215540104900507; Shaw GM, 2012, HIV TRANSMISSION COL, V2; Shukair SA, 2013, MUCOSAL IMMUNOL, V6, P427, DOI 10.1038/mi.2012.87; Somashekhar SP, 2008, INDIAN J SURG, V70, P111, DOI 10.1007/s12262-008-0033-9; Stone M, 2010, J VIROL, V84, P7083, DOI 10.1128/JVI.00481-10; Thomsen R, 2006, PRIMATES, V47, P272, DOI 10.1007/s10329-005-0171-7; UNAIDS, 2013, AIDS NUMB; Vaccari M, 2013, J VIROL, V87, P3538, DOI 10.1128/JVI.02863-12; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002	26	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92830	10.1371/journal.pone.0092830	http://dx.doi.org/10.1371/journal.pone.0092830			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667371	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600084
J	Terada, K; Kojima, Y; Watanabe, T; Izumo, N; Chiba, K; Karube, Y				Terada, Kazuki; Kojima, Yoshitsugu; Watanabe, Takayuki; Izumo, Nobuo; Chiba, Koji; Karube, Yoshiharu			Inhibition of Nerve Growth Factor-Induced Neurite Outgrowth from PC12 Cells by Dexamethasone: Signaling Pathways through the Glucocorticoid Receptor and Phosphorylated Akt and ERK1/2	PLOS ONE			English	Article							NEUROTROPHIN RECEPTORS; KINASE PATHWAY; MESSENGER-RNA; TRK RECEPTORS; DIFFERENTIATION; EXPRESSION; NGF; TRANSDUCTION; STABILITY; P75	Glucocorticoids are important mediators of the stress response and are commonly employed as drugs for the suppression of immune rejection after organ transplantation. Previous investigations uncovered the possibility of mood depression in patients undergoing long-term treatment with synthetic glucocorticoids, including dexamethasone (DEX). Exogenous glucocorticoids and their synthetic derivatives can also adversely affect the development of the central nervous system. Although neurite extension from rat pheochromocytoma-derived PC12 cells and a variety of primary neurons is stimulated by nerve growth factor (NGF), and signaling pathways triggered by the binding of NGF to tyrosine kinase receptor type 1 (TrkA) function in both neurite outgrowth and neuronal survival, the effect of DEX on the activation of regulatory proteins and pathways downstream of TrkA has not been well characterized. To analyze the influence of DEX on NGF-induced neurite outgrowth and signaling, PC12 cells, a widely utilized model of neuronal differentiation, were pretreated with the glucocorticoid prior to NGF induction. NGF-induced neurite outgrowth was attenuated by pretreatment with DEX, even in the absence of DEX after the addition of NGF. Moreover, DEX suppressed the phosphorylation of Akt and extracellular-regulated kinase 1/2 (ERK1/2) in the neurite outgrowth signaling cascade initiated by NGF. Finally, the glucocorticoid receptor (GR) antagonist, RU38486, counteracted the inhibitory effect of DEX pretreatment, not only on the phosphorylation of Akt and ERK1/2, but also on neurite extension from PC12 cells. These results suggest that DEX binding to the GR impairs NGF-promoted neurite outgrowth by interfering with the activation/phosphorylation of Akt and ERK1/2. These novel findings are likely to be useful for elucidating the central nervous system depressive mechanism(s) of action of DEX and other glucocorticoids.	[Terada, Kazuki; Karube, Yoshiharu] Fukuoka Univ, Fac Pharmaceut Sci, Lab Drug Design & Drug Delivery, Fukuoka 81401, Japan; [Terada, Kazuki; Izumo, Nobuo; Chiba, Koji] Yokohama Coll Pharm, Lab Clin Pharmacol, Yokohama, Kanagawa, Japan; [Kojima, Yoshitsugu; Watanabe, Takayuki] Nippon Sigmax Co Ltd, Res & Dev Dept 2, Tokyo, Japan	Fukuoka University	Chiba, K (corresponding author), Yokohama Coll Pharm, Lab Clin Pharmacol, Yokohama, Kanagawa, Japan.	k.chiba@hamayaku.ac.jp			Nippon Sigmax Co., Ltd.	Nippon Sigmax Co., Ltd.	Nippon Sigmax Co., Ltd., provided support in the form of salaries for authors Y. Kojima & TW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Celano Christopher M, 2011, Dialogues Clin Neurosci, V13, P109; Cerezo-Guisado MI, 2007, BIOCHEM J, V401, P175, DOI 10.1042/BJ20060731; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; Davis EP, 2013, BIOL PSYCHIAT, V74, P647, DOI 10.1016/j.biopsych.2013.03.009; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; GILSTRAP LC, 1995, JAMA-J AM MED ASSOC, V273, P413, DOI 10.1001/jama.1995.03520290065031; Glick RD, 2000, J PEDIATR SURG, V35, P465, DOI 10.1016/S0022-3468(00)90216-1; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; GREENE LA, 1982, DEV BIOL, V91, P305, DOI 10.1016/0012-1606(82)90037-9; GREENE LA, 1995, CURR OPIN NEUROBIOL, V5, P579, DOI 10.1016/0959-4388(95)80062-X; Guroff G., 1985, CELL CULTURE NEUROSC, P245, DOI 10.1007/978-1-4613-2473-7_8; HALL RCW, 1978, J NERV MENT DIS, V166, P738, DOI 10.1097/00005053-197810000-00007; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Hughes AL, 2000, J BIOL CHEM, V275, P37829, DOI 10.1074/jbc.M003146200; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; Kim Y, 2004, MOL CELLS, V18, P353; KIMURA K, 1994, J BIOL CHEM, V269, P18961; Lecht S., 2007, OPEN PHARM J, V1, P19; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MCEWEN BS, 1986, PHYSIOL REV, V66, P1121, DOI 10.1152/physrev.1986.66.4.1121; Nishina A, 2013, NEUROCHEM RES, V38, P2397, DOI 10.1007/s11064-013-1152-7; PERRONEBIZZOZERO NI, 1993, J CELL BIOL, V120, P1263, DOI 10.1083/jcb.120.5.1263; POLLOCK JD, 1990, J NEUROSCI, V10, P2626; Price RD, 2003, BRIT J PHARMACOL, V140, P825, DOI 10.1038/sj.bjp.0705522; Rossi D, 2013, CHEMMEDCHEM, V8, P1514, DOI 10.1002/cmdc.201300218; Rossner S, 1998, J NEUROCHEM, V71, P757; Schaper C, 2009, REGUL PEPTIDES, V157, P3, DOI 10.1016/j.regpep.2009.07.004; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Wang Q, 2013, NEUROBIOL AGING, V34, P1662, DOI 10.1016/j.neurobiolaging.2012.11.019; Wigerius M, 2013, EUR J CELL BIOL, V92, P213, DOI 10.1016/j.ejcb.2013.07.002; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Yu CW, 2013, J MED CHEM, V56, P6775, DOI 10.1021/jm400564j; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	37	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93223	10.1371/journal.pone.0093223	http://dx.doi.org/10.1371/journal.pone.0093223			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667984	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600157
J	van der Steen, MC; van Vugt, FT; Keller, PE; Altenmuller, E				van der Steen, M. C.; van Vugt, Floris T.; Keller, Peter E.; Altenmueller, Eckart			Basic Timing Abilities Stay Intact in Patients with Musician's Dystonia	PLOS ONE			English	Article							FOCAL HAND DYSTONIA; SENSORIMOTOR SYNCHRONIZATION; PHASE-CORRECTION; WRITERS CRAMP; DISCRIMINATION; ABNORMALITIES; INTEGRATION; TEMPO; MOTOR; ADAPTATION	Task-specific focal dystonia is a movement disorder that is characterized by the loss of voluntary motor control in extensively trained movements. Musician's dystonia is a type of task-specific dystonia that is elicited in professional musicians during instrumental playing. The disorder has been associated with deficits in timing. In order to test the hypothesis that basic timing abilities are affected by musician's dystonia, we investigated a group of patients (N = 15) and a matched control group (N = 15) on a battery of sensory and sensorimotor synchronization tasks. Results did not show any deficits in auditory-motor processing for patients relative to controls. Both groups benefited from a pacing sequence that adapted to their timing (in a sensorimotor synchronization task at a stable tempo). In a purely perceptual task, both groups were able to detect a misaligned metronome when it was late rather than early relative to a musical beat. Overall, the results suggest that basic timing abilities stay intact in patients with musician's dystonia. This supports the idea that musician's dystonia is a highly task-specific movement disorder in which patients are mostly impaired in tasks closely related to the demands of actually playing their instrument.	[van der Steen, M. C.; Keller, Peter E.] Max Planck Inst Human Cognit & Brain Sci, Res Grp Mus Cognit & Act, Leipzig, Germany; [van der Steen, M. C.; van Vugt, Floris T.; Altenmueller, Eckart] Univ Mus Drama & Media, Inst Mus Physiol & Musicians Med, Hannover, Germany; [van Vugt, Floris T.] Univ Lyon 1, Lyon Neurosci Res Ctr CNRS UMR 5292, INSERM U1028, F-69365 Lyon, France; [Keller, Peter E.] Univ Western Sydney, MARCS Inst, Sydney, NSW, Australia	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Western Sydney University	van der Steen, MC (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Res Grp Mus Cognit & Act, Leipzig, Germany.	steen@cbs.mpg.de	van Vugt, Floris Tijmen/GWR-1052-2022; Altenmuller, Eckart/AAB-9948-2021	van Vugt, Floris Tijmen/0000-0003-1739-0175; Keller, Peter/0000-0001-7579-6515	European Community's Seventh Framework Programme under the EBRAMUS project [238157]	European Community's Seventh Framework Programme under the EBRAMUS project	This work was supported by funding from the European Community's Seventh Framework Programme under the EBRAMUS project - grant agreement no 238157. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese G, 2001, BRAIN, V124, P537, DOI 10.1093/brain/124.3.537; Altenmuller E, 2010, MED PROBL PERFORM AR, V25, P3; Avanzino L, 2013, BRAIN, V136, P444, DOI 10.1093/brain/aws328; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Beck S, 2011, EXP BRAIN RES, V210, P165, DOI 10.1007/s00221-011-2610-6; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Chang FCF, 2013, CURR NEUROPHARMACOL, V11, P41, DOI 10.2174/157015913804999531; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; Delmaire C, 2007, NEUROLOGY, V69, P376, DOI 10.1212/01.wnl.0000266591.49624.1a; Ehrle N, 2005, BRAIN COGNITION, V58, P133, DOI 10.1016/j.bandc.2004.09.014; Fairhurst MT, 2014, NEUROIMAGE, V84, P688, DOI 10.1016/j.neuroimage.2013.09.027; Fairhurst MT, 2012, CEREB CORTEX, V67, P313, DOI DOI 10.1093/CERC0R/BHS243; Fujii S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00771; Furuya S, 2013, NEUROSCIENCE, V247, P152, DOI 10.1016/j.neuroscience.2013.05.025; Grahn JA, 2009, CORTEX, V45, P54, DOI 10.1016/j.cortex.2008.01.005; Granert O, 2011, J NEUROL NEUROSUR PS, V82, P1225, DOI 10.1136/jnnp.2011.245811; GREEN DM, 1995, J ACOUST SOC AM, V97, P3749, DOI 10.1121/1.412390; GU X, 1994, J ACOUST SOC AM, V96, P93, DOI 10.1121/1.410378; HALLETT M, 1995, ANN NEUROL, V38, P139, DOI 10.1002/ana.410380203; Hu XY, 2006, CHINESE MED J-PEKING, V119, P1263, DOI 10.1097/00029330-200608010-00006; Hyde KL, 2004, PSYCHOL SCI, V15, P356, DOI 10.1111/j.0956-7976.2004.00683.x; Iversen J.R., 2008, P 10 INT C MUSIC PER, P465, DOI DOI 10.1016/J.HEARES.2007.10.007; Jabusch HC, 2005, MOVEMENT DISORD, V20, P1623, DOI 10.1002/mds.20631; Jabusch HC, 2004, MOVEMENT DISORD, V19, P171, DOI 10.1002/mds.10671; JANKOVIC J, 1989, SEMIN NEUROL, V9, P131, DOI 10.1055/s-2008-1041316; Jedynak PC, 2001, MOVEMENT DISORD, V16, P494, DOI 10.1002/mds.1094; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; Kadota H, 2010, J NEUROL, V257, P1092, DOI 10.1007/s00415-010-5468-9; Keller PE, 2008, EMERG COMMUN-STUD NE, V10, P205; Konvalinka I, 2010, Q J EXP PSYCHOL, V63, P2220, DOI 10.1080/17470218.2010.497843; Large EW, 2008, PSYCHOLOGY OF TIME, P189, DOI 10.1016/B978-0-08046-977-5.00006-5; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Launay J, 2014, PSYCHOL RES-PSYCH FO, V78, P721, DOI 10.1007/s00426-013-0513-9; Lebrun-Guillaud G, 2007, PERCEPT PSYCHOPHYS, V69, P1450, DOI 10.3758/BF03192959; Lim VK, 2003, J PSYCHOPHYSIOL, V17, P195, DOI 10.1027/0269-8803.17.4.195; Lim VK, 2003, MOVEMENT DISORD, V18, P1286, DOI 10.1002/mds.10528; MARSDEN CD, 1990, TRENDS NEUROSCI, V13, P148, DOI 10.1016/0166-2236(90)90007-W; McAuley JD, 1998, J EXP PSYCHOL HUMAN, V24, P1786, DOI 10.1037/0096-1523.24.6.1786; Moore RD, 2012, NEUROIMAGE, V61, P823, DOI 10.1016/j.neuroimage.2012.03.066; Pecenka N, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00380; Pecenka N, 2011, EXP BRAIN RES, V211, P505, DOI 10.1007/s00221-011-2616-0; Pecenka N, 2009, ANN NY ACAD SCI, V1169, P282, DOI 10.1111/j.1749-6632.2009.04785.x; Penel A, 1998, PSYCHOL RES-PSYCH FO, V61, P12, DOI 10.1007/PL00008161; Preibisch C, 2001, J NEUROL, V248, P10, DOI 10.1007/s004150170263; Pujol J, 2000, NEUROIMAGE, V12, P257, DOI 10.1006/nimg.2000.0615; Quartarone A, 2006, TRENDS NEUROSCI, V29, P192, DOI 10.1016/j.tins.2006.02.007; Repp BH, 1999, PERCEPT PSYCHOPHYS, V61, P529, DOI 10.3758/BF03211971; Repp BH, 2008, HUM MOVEMENT SCI, V27, P423, DOI 10.1016/j.humov.2008.02.016; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Repp BH, 2012, ACTA PSYCHOL, V139, P281, DOI 10.1016/j.actpsy.2011.11.002; Repp BH, 2010, HUM MOVEMENT SCI, V29, P200, DOI 10.1016/j.humov.2009.08.002; Rosenkranz K, 2005, BRAIN, V128, P918, DOI 10.1093/brain/awh402; Rosset-Llobet J, 2007, J NEUROL NEUROSUR PS, V78, P949, DOI 10.1136/jnnp.2006.107953; Sanger TD, 2001, MOVEMENT DISORD, V16, P94, DOI 10.1002/1531-8257(200101)16:1<94::AID-MDS1020>3.0.CO;2-O; Schwartze M, 2011, BEHAV BRAIN RES, V216, P685, DOI 10.1016/j.bbr.2010.09.015; Scontrini A, 2009, J NEUROL NEUROSUR PS, V80, P1315, DOI 10.1136/jnnp.2009.178236; SHEEHY MP, 1982, BRAIN, V105, P461, DOI 10.1093/brain/105.3.461; Stamelou M, 2012, BRAIN, V135, P1668, DOI 10.1093/brain/awr224; Tinazzi M, 2003, MOVEMENT DISORD, V18, P605, DOI 10.1002/mds.10398; van der Steen MC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00253; van Vugt FT, 2014, PARKINSONISM RELAT D, V20, P8, DOI 10.1016/j.parkreldis.2013.08.009; van Vugt FT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087176; Vorberg D, 2002, J MATH PSYCHOL, V46, P56, DOI 10.1006/jmps.2001.1375; Witt ST, 2008, NEUROIMAGE, V42, P343, DOI 10.1016/j.neuroimage.2008.04.025; Wu CC, 2010, J NEUROL NEUROSUR PS, V81, P659, DOI 10.1136/jnnp.2009.185637; Zelaznik HN, 2005, J MOTOR BEHAV, V37, P395, DOI 10.3200/JMBR.37.5.395-403; Zelaznik HN, 2002, J EXP PSYCHOL HUMAN, V28, P575, DOI 10.1037//0096-1523.28.3.575	67	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92906	10.1371/journal.pone.0092906	http://dx.doi.org/10.1371/journal.pone.0092906			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SD	24667273	gold, Green Published			2022-12-27	WOS:000333675600101
J	Flegr, J; Prandota, J; Sovickova, M; Israili, ZH				Flegr, Jaroslav; Prandota, Joseph; Sovickova, Michaela; Israili, Zafar H.			Toxoplasmosis - A Global Threat. Correlation of Latent Toxoplasmosis with Specific Disease Burden in a Set of 88 Countries	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; OBSESSIVE-COMPULSIVE DISORDER; CHRONIC MURINE TOXOPLASMOSIS; CENTRAL DIABETES-INSIPIDUS; PRIMARY BILIARY-CIRRHOSIS; GONDII ANTIBODY-TITERS; INFANT-DEATH-SYNDROME; PREGNANT-WOMEN; CONGENITAL TOXOPLASMOSIS	Background: Toxoplasmosis is becoming a global health hazard as it infects 30-50% of the world human population. Clinically, the life-long presence of the parasite in tissues of a majority of infected individuals is usually considered asymptomatic. However, a number of studies show that this 'asymptomatic infection' may also lead to development of other human pathologies. Aims of the Study: The purpose of the study was to collect available geoepidemiological data on seroprevalence of toxoplasmosis and search for its relationship with mortality and disability rates in different countries. Methods and Findings: Prevalence data published between 1995-2008 for women in child-bearing age were collected for 88 countries (29 European). The association between prevalence of toxoplasmosis and specific disease burden estimated with age-standardized Disability Adjusted Life Year (DALY) or with mortality, was calculated using General Linear Method with Gross Domestic Product per capita (GDP), geolatitude and humidity as covariates, and also using nonparametric partial Kendall correlation test with GDP as a covariate. The prevalence of toxoplasmosis correlated with specific disease burden in particular countries explaining 23% of variability in disease burden in Europe. The analyses revealed that for example, DALY of 23 of 128 analyzed diseases and disease categories on the WHO list showed correlations (18 positive, 5 negative) with prevalence of toxoplasmosis and another 12 diseases showed positive trends (p < 0.1). For several obtained significant correlations between the seroprevalence of toxoplasmosis and specific diseases/clinical entities, possible pathophysiological, biochemical and molecular explanations are presented. Conclusions: The seroprevalence of toxoplasmosis correlated with various disease burden. Statistical associations does not necessarily mean causality. The precautionary principle suggests however that possible role of toxoplasmosis as a triggering factor responsible for development of several clinical entities deserves much more attention and financial support both in everyday medical practice and future clinical research.	[Flegr, Jaroslav; Sovickova, Michaela] Charles Univ Prague, Fac Sci, Dept Biol, Prague, Czech Republic; [Prandota, Joseph] Wroclaw Med Univ, Fac Hlth Sci, Dept Social Pediat, Wroclaw, Poland; [Israili, Zafar H.] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA	Charles University Prague; Wroclaw Medical University; Emory University	Flegr, J (corresponding author), Charles Univ Prague, Fac Sci, Dept Biol, Prague, Czech Republic.	flegr@cesnet.cz	Flegr, Jaroslav/A-1564-2008; Flegr, Jaroslav/AAG-7568-2021	Flegr, Jaroslav/0000-0002-0822-0126; Flegr, Jaroslav/0000-0002-0822-0126	Grand Agency of the Czech Republic [P303/11/1398]; Charles University of Prague [UNCE 204004]	Grand Agency of the Czech Republic; Charles University of Prague	The authors' work was supported by the Grand Agency of the Czech Republic (Grant No. P303/11/1398) and Charles University of Prague (grant UNCE 204004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoli A, 2012, ANDROLOGIA, V44, P679, DOI 10.1111/j.1439-0272.2011.01249.x; Abu-Madi MA, 2010, AM J TROP MED HYG, V82, P626, DOI 10.4269/ajtmh.2010.09-0530; Addebbous A, 2012, ACTA TROP, V123, P49, DOI 10.1016/j.actatropica.2012.02.070; Agmon-Levin N, 2009, J AUTOIMMUN, V32, P261, DOI 10.1016/j.jaut.2009.02.017; Carneiro ACAV, 2013, J CLIN MICROBIOL, V51, P901, DOI 10.1128/JCM.02502-12; Ahmed M. U., 1997, JCPSP, Journal of the College of Physicians and Surgeons - Pakistan, V7, P156; Ajzenberg D, 2002, J INFECT DIS, V186, P684, DOI 10.1086/342663; Akanmu A S, 2010, Nig Q J Hosp Med, V20, P1; Al-Gazali LI, 2001, AM J MED GENET, V103, P128, DOI 10.1002/ajmg.1509; Al-Masri AN, 2006, J PEDIATR SURG, V41, P1139, DOI 10.1016/j.jpedsurg.2006.02.022; Alibek K, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-7; AlMuhaimeed H, 1996, INT J PEDIATR OTORHI, V34, P1, DOI 10.1016/0165-5876(95)01223-0; Alvarado-Esquivel C, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-178; Alvarado-Esquivel C, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-112; Ancelle T., 1996, Bulletin Epidemiologique Hebdomadaire, P227; Andrade Glaucia Manzan Queiroz de, 2008, Braz J Otorhinolaryngol, V74, P21; [Anonymous], 2011, MED J ISLAMIC WORLD; ANSHER SS, 1994, HEPATOLOGY, V20, P984, DOI 10.1002/hep.1840200430; Antoniou M, 2004, EUR J OBSTET GYN R B, V117, P138, DOI 10.1016/j.ejogrb.2004.03.001; Appenzeller S, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/683212; Arantes TP, 2009, EXP PARASITOL, V123, P190, DOI 10.1016/j.exppara.2009.07.003; Araujo FG, 2003, INFECT IMMUN, V71, P4171, DOI 10.1128/IAI.71.7.4171-4174.2003; Arciszewski M, 2005, DIGEST DIS SCI, V50, P1661, DOI 10.1007/s10620-005-2912-2; Arias ML, 1996, REV BIOL TROP, V44, P377; Arieli G, 1979, Harefuah, V96, P338; Arling TA, 2009, J NERV MENT DIS, V197, P905, DOI 10.1097/NMD.0b013e3181c29a23; Arnson Y, 2009, ANN NY ACAD SCI, V1173, P627, DOI 10.1111/j.1749-6632.2009.04808.x; Arsenijevic D, 2001, EUR CYTOKINE NETW, V12, P518; Arsenijevic D, 1998, AM J PHYSIOL-ENDOC M, V274, pE439, DOI 10.1152/ajpendo.1998.274.3.E439; Arsenijevic D, 1997, AM J PHYSIOL-ENDOC M, V35, P908; Ashrafunnessa, 1998, J OBSTET GYNAECOL RE, V24; Asthana SP, 2006, J PARASITOL, V92, P644, DOI 10.1645/GE-762R.1; Attia Raifa A., 1995, Journal of the Egyptian Society of Parasitology, V25, P877; BALLEARI E, 1991, CLIN RHEUMATOL, V10, P326, DOI 10.1007/BF02208701; Barber N, 2004, SOC BIOL, V51, P71; BARS L, 1978, MED CHIR DIG, V7, P485; Batet CM, 2004, MED CLIN-BARCELONA, V123, P12; BEALE MG, 1979, AM J DIS CHILD, V133, P842, DOI 10.1001/archpedi.1979.02130080082017; Beaver PC, 1984, CLIN PARASITOLOGY, Vviii; BEHAN WMH, 1983, ACTA NEUROPATHOL, V61, P246, DOI 10.1007/BF00691993; Sitoe SPBL, 2010, REV INST MED TROP SP, V52, P291, DOI 10.1590/S0036-46652010000600002; Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; Berlin T, 2007, ANN NY ACAD SCI, V1108, P584, DOI 10.1196/annals.1422.061; BERMUDEZ LE, 1993, INFECT IMMUN, V61, P4126, DOI 10.1128/IAI.61.10.4126-4130.1993; BERTOLI F, 1995, ARCH PATHOL LAB MED, V119, P214; Bierly AL, 2008, J IMMUNOL, V181, P8485, DOI 10.4049/jimmunol.181.12.8485; Birgisdottir A, 2006, SCAND J INFECT DIS, V38, P625, DOI 10.1080/00365540600606556; Blomstrom A, 2012, SCHIZOPHR RES, V140, P25, DOI 10.1016/j.schres.2012.06.035; Bobic B, 2011, WIEN KLIN WOCHENSCHR, V123, P2, DOI 10.1007/s00508-011-0052-6; Borkakoty B J, 2007, Indian J Med Microbiol, V25, P431; Borthwick LA, 2013, BBA-MOL BASIS DIS, V1832, P1049, DOI 10.1016/j.bbadis.2012.09.014; Breugelmans M, 2004, J PERINAT MED, V32, P211, DOI 10.1515/JPM.2004.039; Brynska A, 2001, EUR CHILD ADOLES PSY, V10, P200, DOI 10.1007/s007870170027; Buchy P, 2003, Bull Soc Pathol Exot, V96, P46; Caballero-Ortega H, 2012, T ROY SOC TROP MED H, V106, P653, DOI 10.1016/j.trstmh.2012.08.004; Calderon-Margalit R, 2006, CLIN CHEM, V52, P845, DOI 10.1373/clinchem.2005.059857; Camossi LG, 2011, VET PARASITOL, V177, P256, DOI 10.1016/j.vetpar.2010.12.007; CANTELLA R, 1974, TROP GEOGR MED, V26, P204; Carter CJ, 2013, J PATHOG, V2013, DOI 10.1155/2013/965046; Chan WFN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045592; Chan WFN, 2012, ARTHRITIS RHEUM-US, V64, P380, DOI 10.1002/art.33358; Channon JY, 2000, INFECT IMMUN, V68, P4822, DOI 10.1128/IAI.68.8.4822-4826.2000; Charron AJ, 2002, J CELL SCI, V115, P3049; Coash M, 2012, J FORMOS MED ASSOC, V111, P3, DOI 10.1016/j.jfma.2011.11.023; CONLEY FK, 1981, INFECT IMMUN, V31, P1184, DOI 10.1128/IAI.31.3.1184-1192.1981; CONNOR TB, 1989, J CLIN INVEST, V83, P1661, DOI 10.1172/JCI114065; Contreras MC, 2009, REV INST MED TROP SP, V38, P431; Coppens I, 2006, CELL MICROBIOL, V8, P1, DOI 10.1111/j.1462-5822.2005.00647.x; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; Courret N, 2006, BLOOD, V107, P309, DOI 10.1182/blood-2005-02-0666; CRITCHLEY EMR, 1982, EPILEPSIA, V23, P315, DOI 10.1111/j.1528-1157.1982.tb06197.x; Crucerescu E, 1998, Bacteriol Virusol Parazitol Epidemiol, V43, P147; Cuomo G, 2013, INFECTION, V41, P859, DOI 10.1007/s15010-013-0427-x; Cuturic M, 1997, NEUROMUSCULAR DISORD, V7, P390, DOI 10.1016/S0960-8966(97)00098-9; Da Gama LM, 2004, MICROBES INFECT, V6, P1287, DOI 10.1016/j.micinf.2004.07.008; Da Silva AS, 2013, PATHOL RES PRACT, V209, P95, DOI 10.1016/j.prp.2012.10.007; Dama MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046169; Dar FK, 1997, EUR J EPIDEMIOL, V13, P567, DOI 10.1023/A:1007392703037; Das UN, 2007, MED SCI MONITOR, V13, pRA214; Das UN, 2012, ANN HEPATOL, V11, P409, DOI 10.1016/S1665-2681(19)30940-8; de Oliveira FD, 2010, J PEDIATR SURG, V45, P1784, DOI 10.1016/j.jpedsurg.2010.04.007; De Paschale M, 2008, CLIN MICROBIOL INFEC, V14, P186, DOI 10.1111/j.1469-0691.2007.01883.x; DENIAU M, 1991, B SOC PATHOL EXOT, V84, P664; Derouin F, 2008, CLIN MICROBIOL INFEC, V14, P1089, DOI 10.1111/j.1469-0691.2008.02091.x; Diaconu G, 2009, J CLIN PSYCHIAT, V70, P1551, DOI 10.4088/JCP.08m04636; Dimier IH, 1998, IMMUNOLOGY, V94, P488, DOI 10.1046/j.1365-2567.1998.00553.x; DOEHRING E, 1995, AM J TROP MED HYG, V52, P546, DOI 10.4269/ajtmh.1995.52.546; Dubey JP, 2012, EPIDEMIOL INFECT, V140, P1935, DOI 10.1017/S0950268812001392; Dubey JP, 2012, PARASITOLOGY, V139, P1, DOI 10.1017/S0031182011001673; Dubey J.P., 1988, P1; Dubey JP, 1998, INT J PARASITOL, V28, P1019, DOI 10.1016/S0020-7519(98)00023-X; Edvinsson B, 2008, APMIS, V116, P345, DOI 10.1111/j.1600-0463.2008.00871.x; el Hady H M, 1991, J Egypt Soc Parasitol, V21, P811; El Mansouri B, 2007, Bull Soc Pathol Exot, V100, P289; Elhence P, 2010, TRANSFUS APHER SCI, V43, P37, DOI 10.1016/j.transci.2010.05.004; Elnahas A, 2003, SAUDI MED J, V24, P868; Elsheikha HM, 2008, PUBLIC HEALTH, V122, P335, DOI 10.1016/j.puhe.2007.08.009; Emelia O, 2012, TROP BIOMED, V29, P151; Evengard B, 2001, EPIDEMIOL INFECT, V127, P121, DOI 10.1017/S0950268801005775; Fallah M., 2008, Eastern Mediterranean Health Journal, V14, P163; FANTUZZI G, 1994, INFECT IMMUN, V62, P29, DOI 10.1128/IAI.62.1.29-32.1994; Faye O, 1998, B SOC PATHOL EXOT, V91, P249; Ferguson DJP, 2009, INT J PARASITOL, V39, P871, DOI 10.1016/j.ijpara.2009.01.003; Ferguson W, 2008, Ir Med J, V101, P220; Fiedler K, 1999, Zentralbl Gynakol, V121, P239; Fischer SA, 2006, SURG CLIN N AM, V86, P1127, DOI 10.1016/j.suc.2006.06.005; FITZGERALD JF, 1988, PEDIATR CLIN N AM, V35, P357; Flegr J, 2000, BIOL PSYCHOL, V53, P57, DOI 10.1016/S0301-0511(00)00034-X; Flegr J, 2008, PARASITOLOGY, V135, P427, DOI 10.1017/S0031182007004064; Flegr J, 2008, AM J PHYS ANTHROPOL, V137, P479, DOI 10.1002/ajpa.20888; Flegr J, 2008, NEUROENDOCRINOL LETT, V29, P475; Flegr J, 2013, TRENDS PARASITOL, V29, P156, DOI 10.1016/j.pt.2013.01.007; Flegr J, 2012, NEUROENDOCRINOL LETT, V33, P224; Flegr J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-72; Fond G, 2013, ENCEPHALE, V39, P38, DOI 10.1016/j.encep.2012.06.014; Fonseca AL, 2012, REV SOC BRAS MED TRO, V45, P357, DOI 10.1590/S0037-86822012000300015; FRANKLIN DM, 1993, ISRAEL J MED SCI, V29, P285; FRENKEL JK, 1980, NEW ENGL J MED, V302, P178, DOI 10.1056/NEJM198001173020316; FRENKEL JK, 1953, AM J TROP MED HYG, V2, P390, DOI 10.4269/ajtmh.1953.2.390; Fricker-Hidalgo H, 2009, CLIN INFECT DIS, V48, pE9, DOI 10.1086/595709; Fugazzola L, 2011, NAT REV ENDOCRINOL, V7, P89, DOI 10.1038/nrendo.2010.216; Fuks JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003051; FURTADO GD, 1992, INFECT IMMUN, V60, P4925, DOI 10.1128/IAI.60.11.4925-4931.1992; Furtado JM, 2011, J GLOB INFECT DIS, V3, P281, DOI 10.4103/0974-777X.83536; Galofre JC, 2012, J THYROID RES, V2012; GHERARDI R, 1992, ANN NEUROL, V32, P535, DOI 10.1002/ana.410320409; Gilbert RE, 2000, BRIT J OPHTHALMOL, V84, P224, DOI 10.1136/bjo.84.2.224; GLASNER PD, 1992, AM J OPHTHALMOL, V114, P136, DOI 10.1016/S0002-9394(14)73976-5; GLASSMAN MS, 1991, J PEDIATR GASTR NUTR, V13, P298, DOI 10.1097/00005176-199110000-00011; Gokce C, 2008, NATL MED J INDIA, V21, P51; Gomes AF, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-110; Groer MW, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.004; GRUDZIEN M, 1968, Polski Tygodnik Lekarski, V23, P54; Gupta A, 2010, CLIN DERMATOL, V28, P287, DOI 10.1016/j.clindermatol.2010.04.003; Hafid J., 2005, American Journal of Immunology, V1, P1; Hamidou MA, 1999, J RHEUMATOL, V26, P443; Harma Muge, 2004, Journal of the Egyptian Society of Parasitology, V34, P519; HASKELL L, 1989, AM J MED SCI, V298, P185, DOI 10.1097/00000441-198909000-00008; Hassene A, 2008, JOINT BONE SPINE, V75, P603, DOI 10.1016/j.jbspin.2007.08.009; Havelaar AH, 2007, CLIN INFECT DIS, V44, P1467, DOI 10.1086/517511; Hayashida M, 2007, J PEDIATR SURG, V42, P2097, DOI 10.1016/j.jpedsurg.2007.08.039; Herold MA, 2009, INFECTION, V37, P551, DOI 10.1007/s15010-009-9007-5; Hinze-Selch D, 2010, FOLIA PARASIT, V57, P129, DOI 10.14411/fp.2010.016; Hippe D, 2006, INT J MED MICROBIOL, V296, P105; Hippe D, 2008, INFECT IMMUN, V76, P2905, DOI 10.1128/IAI.01546-07; Hippe D, 2009, J CELL SCI, V122, P3511, DOI 10.1242/jcs.050963; Hiramoto RM, 2001, REV SAUDE PUBL, V35, P113, DOI 10.1590/S0034-89102001000200002; Hollander E., 1998, CNS SPECTRUMS, V3, P48, DOI [10.1017/S1092852900007239, DOI 10.1017/S1092852900007239]; HOSTOMSKA L, 1957, Cesk Pediatr, V12, P713; Hung CC, 2007, T ROY SOC TROP MED H, V101, P134, DOI 10.1016/j.trstmh.2006.04.012; Huu SN, 2009, AM J PATHOL, V174, P630, DOI 10.2353/ajpath.2009.080566; Hwang IY, 2010, PARASITOL RES, V107, P1313, DOI 10.1007/s00436-010-1999-3; Iqbal J, 2003, CLIN MICROBIOL INFEC, V9, P336; JACOBS L, 1956, ANN NY ACAD SCI, V64, P154, DOI 10.1111/j.1749-6632.1956.tb36612.x; Jenum PA, 1998, EPIDEMIOL INFECT, V120, P87, DOI 10.1017/S0950268897008480; JOHNSON MD, 1993, HUM PATHOL, V24, P457, DOI 10.1016/0046-8177(93)90156-B; JOINER KA, 1993, INFECT IMMUN, V61, P1169, DOI 10.1128/IAI.61.4.1169-1172.1993; Jokelainen P, 2010, VET PARASITOL, V171, P331, DOI 10.1016/j.vetpar.2010.04.008; Jones JL, 2007, AM J TROP MED HYG, V77, P405, DOI 10.4269/ajtmh.2007.77.405; Jones JL, 2010, AM J TROP MED HYG, V82, P464, DOI 10.4269/ajtmh.2010.09-0664; Jones JL, 2009, CLIN INFECT DIS, V49, P878, DOI 10.1086/605433; Jones JL, 2001, AM J EPIDEMIOL, V154, P357, DOI 10.1093/aje/154.4.357; Jumaian N F, 2005, East Mediterr Health J, V11, P45; Kamath P, 2007, J CLIN PSYCHIAT, V68, P1741, DOI 10.4088/JCP.v68n1114; Kankova S, 2007, PARASITOLOGY, V134, P1709, DOI 10.1017/S0031182007003253; Kankova S, 2007, NATURWISSENSCHAFTEN, V94, P122, DOI 10.1007/s00114-006-0166-2; Kankova S, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-114; Kankova S, 2012, EARLY HUM DEV, V88, P879, DOI 10.1016/j.earlhumdev.2012.07.001; Kankova S, 2011, EXP PARASITOL, V128, P181, DOI 10.1016/j.exppara.2011.03.014; Kapoor S, 2012, REV INST MED TROP SP, V54, P318, DOI 10.1590/S0036-46652012000600011; KARASAWA T, 1981, ACTA PATHOL JAPON, V31, P675; Karunajeewa H, 2001, AUST NZ J OBSTET GYN, V41, P23, DOI 10.1111/j.1479-828X.2001.tb01289.x; Khan A, 2007, P NATL ACAD SCI USA, V104, P14872, DOI 10.1073/pnas.0702356104; Khan A, 2006, EMERG INFECT DIS, V12, P942, DOI 10.3201/eid1206.060025; Kim DS, 2004, INT J BIOCHEM CELL B, V36, P1482, DOI 10.1016/j.biocel.2003.10.023; Kim JY, 2006, YONSEI MED J, V47, P862, DOI 10.3349/ymj.2006.47.6.862; King MD, 2003, INT J TOXICOL, V22, P53, DOI 10.1080/10915810305075; Klaren VNA, 2002, OCUL IMMUNOL INFLAMM, V10, P1, DOI 10.1076/ocii.10.1.1.10330; KLUFIO CA, 1993, PAPUA NEW GUINEA MED, V36, P4; Kodym P, 2000, INT J PARASITOL, V30, P11; Kolbekova P, 2007, CLIN MICROBIOL INFEC, V13, P1012, DOI 10.1111/j.1469-0691.2007.01771.x; Konishi E, 2000, JPN J INFECT DIS, V53, P238; Kortbeek LM, 2004, EPIDEMIOL INFECT, V132, P839, DOI 10.1017/S0950268804002535; Koseoglu E, 2009, AM J MED SCI, V338, P120, DOI 10.1097/MAJ.0b013e31819f8cac; KOSKINIEMI M, 1992, SCAND J INFECT DIS, P70; Krause I, 2009, ANN NY ACAD SCI, V1173, P633, DOI 10.1111/j.1749-6632.2009.04619.x; Kusbeci OY, 2011, ALZ DIS ASSOC DIS, V25, P1, DOI 10.1097/WAD.0b013e3181f73bc2; Lafferty KD, 2006, P ROY SOC B-BIOL SCI, V273, P2749, DOI 10.1098/rspb.2006.3641; Laibe S, 2006, J CLIN MICROBIOL, V44, P646, DOI 10.1128/JCM.44.2.646-648.2006; Lam C, 1999, PEDIATR NEPHROL, V13, P850, DOI 10.1007/s004670050714; Lambert H, 2006, CELL MICROBIOL, V8, P1611, DOI 10.1111/j.1462-5822.2006.00735.x; Lambert H, 2010, CELL MICROBIOL, V12, P292, DOI 10.1111/j.1462-5822.2009.01417.x; Lambert H, 2009, INFECT IMMUN, V77, P1679, DOI 10.1128/IAI.01289-08; Lampon N, 2012, ANN HEPATOL, V11, P356, DOI 10.1016/S1665-2681(19)30932-9; Lappin MR, 2010, TOP COMPANION ANIM M, V25, P136, DOI 10.1053/j.tcam.2010.07.002; Lebech M, 1999, LANCET, V353, P1834, DOI 10.1016/S0140-6736(98)11281-3; LELONG B, 1995, B SOC PATHOL EXOT, V88, P46; Lester D, 2012, PSYCHOL REP, V111, P196, DOI 10.2466/12.15.16.PR0.111.4.196-197; Lester D, 2010, PSYCHOL REP, V107, P713, DOI 10.2466/12.19.PR0.107.6.713-714; Lidar M, 2009, ANN NY ACAD SCI, V1173, P649, DOI 10.1111/j.1749-6632.2009.04641.x; Lidar M, 2009, ANN NY ACAD SCI, V1173, P640, DOI 10.1111/j.1749-6632.2009.04673.x; Lim A, 2013, MOL ECOL, V22, P102, DOI 10.1111/mec.12042; Lim H, 2012, KOREAN J PARASITOL, V50, P287, DOI 10.3347/kjp.2012.50.4.287; Lindsay DS, 2011, PARASITOLOGY, V138, P1829, DOI 10.1017/S0031182011001478; Ling VJ, 2011, BIOL PSYCHIAT, V69, p149S; Liu Q, 2009, T ROY SOC TROP MED H, V103, P162, DOI 10.1016/j.trstmh.2008.07.008; Logar J, 2002, SCAND J INFECT DIS, V34, P201, DOI 10.1080/00365540110080386; Lopes AP, 2012, EPIDEMIOL INFECT, V140, P872, DOI 10.1017/S0950268811001658; Lopes WDZ, 2011, PARASITOL RES, V109, P405, DOI 10.1007/s00436-011-2268-9; Lopes Welber Daniel Zanetti, 2009, J Parasitol Res, V2009, DOI 10.1155/2009/602803; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; MACSWEEN RN, 1973, CLIN EXP IMMUNOL, V15, P35; Maggi P, 2009, NEW MICROBIOL, V32, P89; Mahdi NK, 2002, J BAHRAIN MED SOC, V14, P148; Makuwa M., 1992, Medecine d'Afrique Noire, V39, P493; Many A, 2006, CAN FAM PHYSICIAN, V52, P29; Marani L, 1986, Minerva Med, V77, P805; MASSA G, 1989, EUR J PEDIATR, V148, P742, DOI 10.1007/BF00443099; MASSIERE JP, 1989, PRESSE MED, V18, P1393; Massimine KM, 2005, MOL BIOCHEM PARASIT, V144, P44, DOI 10.1016/j.molbiopara.2005.07.006; McLeod R, 2012, CLIN INFECT DIS, V54, P1595, DOI 10.1093/cid/cis258; McMartin KI, 2002, J PEDIATR-US, V140, P205, DOI 10.1067/mpd.2002.121937; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mercier A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000876; MICHALOWICZ R, 1988, Acta Paediatrica Hungarica, V29, P337; Milerad J, 1998, J PEDIATR-US, V133, P232, DOI 10.1016/S0022-3476(98)70225-2; Milovanovic I, 2009, MEM I OSWALDO CRUZ, V104, P175, DOI 10.1590/S0074-02762009000200008; Miman O, 2010, NEUROSCI LETT, V475, P129, DOI 10.1016/j.neulet.2010.03.057; Miman O, 2010, PSYCHIAT RES, V177, P263, DOI 10.1016/j.psychres.2009.12.013; Moese J R, 1998, Cent Eur J Public Health, V6, P261; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Morris Arthur, 2004, N Z Med J, V117, pU770; Mortensen PB, 2011, BIPOLAR DISORD, V13, P624, DOI 10.1111/j.1399-5618.2011.00962.x; MOUSA M A, 1988, Journal of the Egyptian Society of Parasitology, V18, P345; Murakami T, 2000, INTERNAL MED, V39, P1111, DOI 10.2169/internalmedicine.39.1111; Nabias R, 1998, B SOC PATHOL EXOT, V91, P318; Nagineni CN, 2002, CLIN EXP IMMUNOL, V128, P372, DOI 10.1046/j.1365-2249.2002.01815.x; Nash JQ, 2005, EPIDEMIOL INFECT, V133, P475, DOI 10.1017/S0950268804003620; Ndong-Obame T, 1997, B SOC FR PARASITOL, V15, P141; NDUMBE PM, 1992, MED MICROBIOL IMMUN, V181, P127, DOI 10.1007/BF00202052; Nejad MR, 2011, AM J GASTROENTEROL, V106, P548, DOI 10.1038/ajg.2010.425; Nelson MM, 2008, INFECT IMMUN, V76, P828, DOI 10.1128/IAI.01115-07; Nicolle C, 1908, CR HEBD ACAD SCI, V147, P763; Nigro G, 1999, PRENATAL DIAG, V19, P401, DOI 10.1002/(SICI)1097-0223(199905)19:5&lt;401::AID-PD559&gt;3.0.CO;2-X; Nissapatorn V, 2003, J Obstet Gynaecol, V23, P618, DOI 10.1080/01443610310001604376; Nitta A, 2006, J PEDIATR-US, V148, P283, DOI 10.1016/j.jpeds.2005.05.030; Novotna M, 2008, PARASITOLOGY, V135, P1253, DOI 10.1017/S003118200800485X; Nowakowska D, 2006, CLIN MICROBIOL INFEC, V12, P913, DOI 10.1111/j.1469-0691.2006.01513.x; Okusaga O, 2011, SCHIZOPHR RES, V133, P150, DOI 10.1016/j.schres.2011.08.006; ONADEKO MO, 1992, J TROP MED HYG, V95, P143; Orefice JL, 2007, BRIT J OPHTHALMOL, V91, P773, DOI 10.1136/bjo.2006.108068; Ortiz-Munoz A B, 1984, Rev Esp Oncol, V31, P237; OSEROFF A, 1988, SOUTHERN MED J, V81, P95, DOI 10.1097/00007611-198801000-00022; Overfield J, 2007, INTRO RH BLOOD GROUP; Oygur N, 1998, AM J PERINAT, V15, P191, DOI 10.1055/s-2007-993924; Packard KA, 2003, INT IMMUNOPHARMACOL, V3, P909, DOI 10.1016/S1567-5769(02)00235-7; Palmer BS, 2007, SEIZURE-EUR J EPILEP, V16, P657, DOI 10.1016/j.seizure.2007.05.010; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Parness-Yossifon R, 2008, J CHILD NEUROL, V23, P447, DOI 10.1177/0883073807308709; Paspalaki P K, 2001, BMC Musculoskelet Disord, V2, P8, DOI 10.1186/1471-2474-2-8; Patja A, 2000, PEDIATR INFECT DIS J, V19, P1127, DOI 10.1097/00006454-200012000-00002; Pavlov VA, 2008, INT J CLIN EXP MED, V1, P203; Pawlowska-Kamieniak A, 1998, Pol Merkur Lekarski, V4, P217; Pawlowski Z, 1994, OUTLINE INFECT DIS C, P214; Pearce BD, 2012, BIOL PSYCHIAT, V72, P290, DOI 10.1016/j.biopsych.2012.01.003; Pedersen MG, 2012, ARCH GEN PSYCHIAT, V69, P1123, DOI 10.1001/archgenpsychiatry.2012.668; Persson CM, 2009, INFECT IMMUN, V77, P970, DOI 10.1128/IAI.00833-08; Petersen E, 2010, ZOONOSES PUBLIC HLTH, V57, P8, DOI 10.1111/j.1863-2378.2009.01278.x; Pleyer U, 2007, OPHTHALMOLOGE, V104, P603, DOI 10.1007/s00347-007-1535-8; PORTER SB, 1992, NEW ENGL J MED, V327, P1643, DOI 10.1056/NEJM199212033272306; PRABHAKAR P, 1991, W INDIAN MED J, V40, P166; Prandota J, 2012, NEUROINFLAMMATION PA, P447; Prandota J., 2012, SCI REP, V1, P256, DOI [10.4172/scientificreports.256, DOI 10.4172/SCIENTIFICREPORTS.256]; Prandota J., 2012, NEUROINFLAMMATION PA, P423; Prandota Joseph, 2004, Am J Ther, V11, P344, DOI 10.1097/01.mjt.0000117501.97441.c92004; Prandota Joseph, 2004, Am J Ther, V11, P517, DOI 10.1097/01.mjt.0000140648.30948.bd; Prandota J, 2013, J DIABETES METAB, V4, DOI 10.4172/2155-6156.1000241; Prandota J, 2011, RES AUTISM SPECT DIS, V5, P14, DOI 10.1016/j.rasd.2010.03.009; Prandota J, 2010, INT J NEUROSCI, V120, P81, DOI 10.3109/00207450903458647; Prandota J, 2010, RES AUTISM SPECT DIS, V4, P119, DOI 10.1016/j.rasd.2009.09.011; Prandota J, 2010, RES AUTISM SPECT DIS, V4, P103, DOI 10.1016/j.rasd.2009.09.007; Prandota J, 2009, INT J NEUROSCI, V119, P2144, DOI 10.3109/00207450903149217; Prandota J, 2009, INT J NEUROSCI, V119, P1655, DOI 10.1080/00207450802480044; Prandota Joseph, 2007, Am J Ther, V14, P63, DOI 10.1097/01.mjt.0000208272.42379.aa; Prestrud KW, 2010, ACTA VET SCAND S1, P57; Punda-Polic V, 2000, EUR J EPIDEMIOL, V16, P875, DOI 10.1023/A:1007606501923; Radford A, 2012, BRAIN BEHAV IMMUNITY, V26; Rai Shiba Kumar, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P739; Ramsewak S, 2008, REV PANAM SALUD PUBL, V23, P164, DOI 10.1590/S1020-49892008000300003; Rao AA, 2007, MED HYPOTHESES, V69, P1272, DOI 10.1016/j.mehy.2007.03.032; Renne C, 2004, J CLIN ENDOCR METAB, V89, P5810, DOI 10.1210/jc.2004-1049; Ribeiro DA, 2004, MUTAT RES-GEN TOX EN, V559, P169, DOI 10.1016/j.mrgentox.2004.01.007; Rickard E, 1999, CLIN MICROBIOL INFEC, V5, P171; Riga M, 2011, EUR ARCH OTO-RHINO-L, V268, P1087, DOI 10.1007/s00405-011-1499-9; Robert-Gangneux F, 2011, CLIN IMMUNOL, V138, P129, DOI 10.1016/j.clim.2010.12.004; ROCA B, 1992, MED CLIN-BARCELONA, V99, P595; Rockiene L, 1997, HYGIENA EPIDEMIOL, V58, P39; RODIER MH, 1995, ACTA TROP, V59, P271, DOI 10.1016/0001-706X(95)00087-U; Rosso F, 2008, AM J TROP MED HYG, V78, P504, DOI 10.4269/ajtmh.2008.78.504; RYAN P, 1993, INT J EPIDEMIOL, V22, P412, DOI 10.1093/ije/22.3.412; Sakikawa M, 2012, CLIN VACCINE IMMUNOL, V19, P365, DOI 10.1128/CVI.05486-11; Sanchez-Gutierrez A, 2003, BIOQUIMIA, V28, P3; Sanchis-Belenguer R, 1984, Rev Esp Oncol, V31, P247; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; SCHRODER J, 1974, TRANSPLANTATION, V17, P346, DOI 10.1097/00007890-197404000-00003; Seabra SH, 2004, BIOCHEM BIOPH RES CO, V324, P744, DOI 10.1016/j.bbrc.2004.09.114; Sehgal A, 2005, TRAFFIC, V6, P1125, DOI 10.1111/j.1600-0854.2005.00348.x; SHAHIN B, 1974, J PEDIATR-US, V85, P366, DOI 10.1016/S0022-3476(74)80117-4; Shapira Y, 2012, EXP MOL PATHOL, V93, P386, DOI 10.1016/j.yexmp.2012.09.012; Shapira Y, 2012, J AUTOIMMUN, V39, P112, DOI 10.1016/j.jaut.2012.01.001; Sheets CW, 2009, J GLAUCOMA, V18, P129, DOI 10.1097/IJG.0b013e318179f83f; Siahanidou T, 2006, J PEDIATR ENDOCR MET, V19, P1363; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Signorell LM, 2006, PEDIATR INFECT DIS J, V25, P123, DOI 10.1097/01.inf.0000195542.43369.96; Silveira C, 2003, AM J OPHTHALMOL, V136, P370, DOI 10.1016/S0002-9394(03)00191-0; Silveira C, 2011, BRIT J OPHTHALMOL, V95, P396, DOI 10.1136/bjo.2008.148205; Soares JAS, 2012, REV SOC BRAS MED TRO, V45, P55, DOI 10.1590/S0037-86822012000100011; Simpore J, 2006, J MED VIROL, V78, P730, DOI 10.1002/jmv.20615; SINGH S, 1994, INDIAN J MED RES, V99, P27; Singh S, 1993, INT C AIDS, V9, P490; Slosarkova S, 1999, VET PARASITOL, V81, P89, DOI 10.1016/S0304-4017(98)00244-1; Smith Justine R, 2002, Curr Opin Ophthalmol, V13, P387, DOI 10.1097/00055735-200212000-00008; Sroka J, 2001, ANN AGR ENV MED, V8, P25; STAHL W, 1995, PARASITOL RES, V81, P114, DOI 10.1007/BF00931615; STAHL W, 1995, PARASITOL RES, V81, P109, DOI 10.1007/BF00931614; STAHL W, 1988, ANN TROP MED PARASIT, V82, P35, DOI 10.1080/00034983.1988.11812206; Stommel EW, 2001, EPILEPSIA, V42, P436, DOI 10.1046/j.1528-1157.2001.25500.x; Studenicova C., 2008, Epidemiologie Mikrobiologie Imunologie, V57, P8; Szenasi Z, 2005, WIEN KLIN WOCHENSCHR, V117, P29, DOI 10.1007/s00508-005-0444-6; Szenasi Z, 1997, INT J EPIDEMIOL, V26, P428, DOI 10.1093/ije/26.2.428; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Tabbara KS, 2005, SAUDI MED J, V26, P1383; Tedla Yared, 2011, Ethiop Med J, V49, P211; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Terpsidis KI, 2009, EXP PARASITOL, V121, P238, DOI 10.1016/j.exppara.2008.11.006; Thirugnanam S, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-8; Thomas F, 2012, BIOL LETTERS, V8, P101, DOI 10.1098/rsbl.2011.0588; Thompson B., 2006, FDN BEHAV STAT INSIG; Tomairek H A, 1982, J Egypt Soc Parasitol, V12, P17; Toporovski J, 2012, REV INST MED TROP SP, V54, P61, DOI 10.1590/S0036-46652012000200001; Torres AR, 2006, AM J PSYCHIAT, V163, P1978, DOI 10.1176/appi.ajp.163.11.1978; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P729, DOI 10.1093/schbul/sbl050; Torrey EF, 2001, BRAIN BEHAV IMMUN, V15, P401, DOI 10.1006/brbi.2001.0649; Tozzoli R, 2008, AUTOIMMUN REV, V8, P112, DOI 10.1016/j.autrev.2008.07.013; Triolo-Mieses María, 2006, Kasmera, V34, P07; Ustun S, 2004, WORLD J GASTROENTERO, V10, P452; Vaillant V, 2005, FOODBORNE PATHOG DIS, V2, P221, DOI 10.1089/fpd.2005.2.221; van Velthuysen MLF, 2000, CLIN MICROBIOL REV, V13, P55, DOI 10.1128/CMR.13.1.55-66.2000; vanVelthuysen MLF, 1996, PARASITOL TODAY, V12, P102, DOI 10.1016/0169-4758(96)80669-7; Vasquez-Garibay EM, 2009, COMPREHENSIVE HANDBOOK OF IODINE: NUTRITIONAL, BIOCHEMICAL, PATHOLOGICAL AND THERAPEUTIC ASPECTS, P499, DOI 10.1016/B978-0-12-374135-6.00052-2; VETHANYAGAM A, 1976, T ROY SOC TROP MED H, V70, P524, DOI 10.1016/0035-9203(76)90142-5; Vittecoq M, 2012, INFECT GENET EVOL, V12, P496, DOI 10.1016/j.meegid.2012.01.013; VOS GH, 1987, S AFR MED J, V71, P78; Vyas A, 2013, J EXP BIOL, V216, P120, DOI 10.1242/jeb.072983; WALTON BC, 1966, AM J TROP MED HYG, V15, P492, DOI 10.4269/ajtmh.1966.15.492; Wasserman EE, 2009, AUTOIMMUNITY, V42, P439, DOI 10.1080/08916930902787716; Webster JP, 2006, P ROY SOC B-BIOL SCI, V273, P1023, DOI 10.1098/rspb.2005.3413; Weight CM, 2012, ANN NY ACAD SCI, V1258, P135, DOI 10.1111/j.1749-6632.2012.06534.x; Weiss LM, 2009, INT J PARASITOL, V39, P895, DOI 10.1016/j.ijpara.2009.02.004; WEITBERG AB, 1979, NEW ENGL J MED, V300, P1093, DOI 10.1056/NEJM197905103001907; WICKBOM B, 1972, ACTA PAEDIATR SCAND, V61, P470, DOI 10.1111/j.1651-2227.1972.tb15866.x; WILCOX MH, 1990, ANN RHEUM DIS, V49, P254, DOI 10.1136/ard.49.4.254; Wilson GS, 1967, HAZARDS IMMUNIZATION, P265; Wong A., 2000, SMJ, V41, P151; World Health Organization, 2008, GLOB BURD DIS 2004 U; WRENSCH M, 1993, J NEURO-ONCOL, V17, P47, DOI 10.1007/BF01054274; Yagmur F, 2010, FORENSIC SCI INT, V199, P15, DOI 10.1016/j.forsciint.2010.02.020; Yamakawa R, 1996, BRAIN DEV-JPN, V18, P75, DOI 10.1016/0387-7604(95)00099-2; Yazar S, 2006, J MED MICROBIOL, V55, P89, DOI 10.1099/jmm.0.46255-0; Yazar S, 2004, J MED MICROBIOL, V53, P1183, DOI 10.1099/jmm.0.45587-0; Yazar S, 2003, SEIZURE-EUR J EPILEP, V12, P107, DOI 10.1016/S1059-1311(02)00256-X; Yazar Suleyman, 2006, Ethiop Med J, V44, P257; Zhu S, 2009, MED HYPOTHESES, V73, P799, DOI 10.1016/j.mehy.2009.04.013	373	321	344	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e90203	10.1371/journal.pone.0090203	http://dx.doi.org/10.1371/journal.pone.0090203			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662942	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900007
J	Gong, Z; Zhao, YJ; Chen, CJ; Duan, Y; Xiao, Y				Gong, Zhou; Zhao, Yunjie; Chen, Changjun; Duan, Yong; Xiao, Yi			Insights into Ligand Binding to PreQ(1) Riboswitch Aptamer from Molecular Dynamics Simulations	PLOS ONE			English	Article							CONTROLS GENE-EXPRESSION; MESSENGER-RNA STRUCTURE; AMBER FORCE-FIELD; ADD A-RIBOSWITCH; PURINE RIBOSWITCH; MODIFIED PYRIMIDINES; STRUCTURAL INSIGHTS; GLYCINE RIBOSWITCH; SENSING RIBOSWITCH; BACILLUS-SUBTILIS	Riboswitches play roles in transcriptional or translational regulation through specific ligand binding of their aptamer domains. Although a number of ligand-bound aptamer complex structures have been solved, it is important to know ligand-free conformations of the aptamers in order to understand the mechanism of specific binding by ligands. In this paper, preQ(1) riboswitch aptamer domain from Bacillus subtilis is studied by overall 1.5 mu s all-atom molecular dynamics simulations We found that the ligand-free aptamer has a stable state with a folded P1-L3 and open binding pocket. The latter forms a cytosine-rich pool in which the nucleotide C19 oscillates between close and open positions, making it a potential conformation for preQ(1) entrance. The dynamic picture further suggests that the specific recognition of preQ(1) by the aptamer domain is not only facilitated by the key nucleotide C19 but also aided and enhanced by other cytosines around the binding pocket. These results should help to understand the details of preQ(1) binding.	[Gong, Zhou; Zhao, Yunjie; Chen, Changjun; Duan, Yong; Xiao, Yi] Huazhong Univ Sci & Technol, Dept Phys, Biomol Phys & Modeling Grp, Wuhan 430074, Hubei, Peoples R China; [Duan, Yong] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Duan, Yong] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	Huazhong University of Science & Technology; University of California System; University of California Davis; University of California System; University of California Davis	Xiao, Y (corresponding author), Huazhong Univ Sci & Technol, Dept Phys, Biomol Phys & Modeling Grp, Wuhan 430074, Hubei, Peoples R China.	yxiao@mail.hust.edu.cn	Duan, Yong/D-3475-2013	Duan, Yong/0000-0003-3793-5099	National High Technology Research and Development Program of China [2012AA020402]; National Science Foundation of China [11374113]; NIH [GM 067168]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067168] Funding Source: NIH RePORTER	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the National High Technology Research and Development Program of China [2012AA020402] and the National Science Foundation of China under Grant No. 11374113, and NIH (GM 067168 to YD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqvist J, 1990, J PHYS CHEM, V94; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Butler EB, 2011, CHEM BIOL, V18, P293, DOI 10.1016/j.chembiol.2011.01.013; Case D.A., 2022, AMBER 2020; Cicmil N, 2008, PROTEINS, V72, P1084, DOI 10.1002/prot.22098; Daldrop P, 2011, CHEM BIOL, V18, P324, DOI 10.1016/j.chembiol.2010.12.020; Edwards AL, 2010, RNA, V16, P2144, DOI 10.1261/rna.2341610; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Garcia GA, 2005, BIOORG CHEM, V33, P229, DOI 10.1016/j.bioorg.2005.01.001; Gilbert SD, 2006, J AM CHEM SOC, V128, P14214, DOI 10.1021/ja063645t; Gong Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045239; Gong Z, 2011, J BIOMOL STRUCT DYN, V29, P403, DOI 10.1080/07391102.2011.10507394; Gong Z, 2010, J BIOMOL STRUCT DYN, V28, P431, DOI 10.1080/07391102.2010.10507372; Huang LL, 2011, P NATL ACAD SCI USA, V108, P14801, DOI 10.1073/pnas.1111701108; Huang LL, 2010, MOL CELL, V40, P774, DOI 10.1016/j.molcel.2010.11.026; Hubbard S. J., 1993, NACESS COMPUTER PROG; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jakalian A, 2000, J COMPUT CHEM, V21, P132, DOI 10.1002/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P; Jenkins JL, 2011, J BIOL CHEM, V286, P24626, DOI 10.1074/jbc.M111.230375; Kang M, 2009, MOL CELL, V33, P784, DOI 10.1016/j.molcel.2009.02.019; Klein DJ, 2009, NAT STRUCT MOL BIOL, V16, P343, DOI 10.1038/nsmb.1563; Leipply D, 2011, BIOCHEMISTRY-US, V50, P2790, DOI 10.1021/bi101948k; Liberman JA, 2011, WILEY INTERDISCIP RE; Ling BP, 2009, J MOL GRAPH MODEL, V28, P37, DOI 10.1016/j.jmgm.2009.03.005; LONCHARICH RJ, 1992, BIOPOLYMERS, V32, P523, DOI 10.1002/bip.360320508; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Noeske J, 2005, P NATL ACAD SCI USA, V102, P1372, DOI 10.1073/pnas.0406347102; Pande VS, 1999, P NATL ACAD SCI USA, V96, P9062, DOI 10.1073/pnas.96.16.9062; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roth A, 2007, NAT STRUCT MOL BIOL, V14, P308, DOI 10.1038/nsmb1224; Ryckaert JP, 1977, J COMPUT PHYS; Santner T, 2012, J AM CHEM SOC, V134, P11928, DOI 10.1021/ja3049964; Schneider B, 2004, NUCLEIC ACIDS RES, V32, P1666, DOI 10.1093/nar/gkh333; Serganov A, 2008, NATURE, V455, P1263, DOI 10.1038/nature07326; Sharma M, 2009, RNA, V15, P1673, DOI 10.1261/rna.1675809; Sudarsan N, 2003, RNA, V9, P644, DOI 10.1261/rna.5090103; Sudarsan N, 2003, GENE DEV, V17, P2688, DOI 10.1101/gad.1140003; Suddala KC, 2013, NUCLEIC ACIDS RES, V41, P10462, DOI 10.1093/nar/gkt798; Suess B, 2004, NUCLEIC ACIDS RES, V32, P1610, DOI 10.1093/nar/gkh321; Villa A, 2009, NUCLEIC ACIDS RES, V37, P4774, DOI 10.1093/nar/gkp486; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; William L., 1983, J CHEM PHYS, V79; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899; Winkler WC, 2003, NAT STRUCT BIOL, V10, P701, DOI 10.1038/nsb967; Yildirim I, 2010, J CHEM THEORY COMPUT, V6, P1520, DOI 10.1021/ct900604a; Zhang Q, 2011, J AM CHEM SOC, V133, P5190, DOI 10.1021/ja111769g	50	20	21	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92247	10.1371/journal.pone.0092247	http://dx.doi.org/10.1371/journal.pone.0092247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663240	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900047
J	Horowitz, E; Bergman, LC; Ashkenazy, C; Moscona-Hurvitz, I; Grinvald-Fogel, H; Magnezi, R				Horowitz, Einav; Bergman, Lisa Carroll; Ashkenazy, Charna; Moscona-Hurvitz, Irit; Grinvald-Fogel, Haya; Magnezi, Racheli			Off-Label Use of Sodium Valproate for Schizophrenia	PLOS ONE			English	Article							MOOD STABILIZERS; SCHIZOAFFECTIVE DISORDER; ACUTE EXACERBATIONS; BIPOLAR DISORDER; DIVALPROEX; OLANZAPINE; ANTIPSYCHOTICS; PRESCRIPTION; RISPERIDONE; GUIDELINES	Background: Off-label use of a drug not according to its regulatory labeling has become common in medicine, especially in the field of psychiatry. Mood stabilizers are intended to be used to attenuate mood fluctuations in bipolar disorder, but their use has spread to patients with schizophrenia, as it provides greater control of impulsivity and aggressiveness. Sodium valproate is one of the most frequently used mood stabilizers in psychiatry. This study determined the prevalence of off-label use of sodium valproate for schizophrenia and schizoaffective disorder in Abarbanel Psychiatric Hospital and the demographic and clinical characteristics associated with its use. Methods: Retrospective study of patients hospitalized in 2011-2012 with a diagnosis of schizophrenia or schizoaffective disorder in one of three general psychiatric wards. Results: Valproate use was significantly lower in the geriatric group (11.6% vs. 20.1%, chi square = 4.7, p = .03), in patients with schizophrenia (14.1% vs. schizoaffective disorder (35.2%), chi square = 29, p<.001) and in patients receiving both atypical and typical antipsychotics (23.3% vs. 16.4%, p = .04). In multivariate logistic regression analysis, diagnosis and the combination of atypical and typical antipsychotics predicted the use of sodium valproate. The number of other medications prescribed did not predict sodium valproate use. Conclusions: Off-label use of sodium valproate in psychiatric patients with schizophrenia or schizoaffective disorder is extensive, especially in younger patients and those with schizoaffective disorder. More research is needed to determine whether it is being prescribed appropriately.	[Horowitz, Einav] Haim Sheba Med Ctr, Gertner Inst, Israeli Ctr Technol Assessment Hlth Care, Ramat Gan, Israel; [Bergman, Lisa Carroll; Grinvald-Fogel, Haya; Magnezi, Racheli] Bar Ilan Univ, Publ Hlth & Hlth Syst Management Program, Ramat Gan, Israel; [Ashkenazy, Charna] Abarbanel Mental Hlth Ctr, Bat Yam, Israel; [Moscona-Hurvitz, Irit] Teva Pharmaceut Ind Ltd, Petah Tiqwa, Israel	Chaim Sheba Medical Center; Bar Ilan University; Teva Pharmaceutical Industries	Horowitz, E (corresponding author), Haim Sheba Med Ctr, Gertner Inst, Israeli Ctr Technol Assessment Hlth Care, Ramat Gan, Israel.	EinavH@gertner.health.gov.il						Abou-Setta AM, 2012, AHRQ COMP EFFECTIVEN; Benabarre A, 2001, EUR PSYCHIAT, V16, P167, DOI 10.1016/S0924-9338(01)00559-4; Buchanan RW, 2010, SCHIZOPHRENIA BULL, V36, P71, DOI 10.1093/schbul/sbp116; Casey DE, 2009, NEUROPSYCHOPHARMACOL, V34, P1330, DOI 10.1038/npp.2008.209; Chen DT, 2009, PHARMACOEPIDEM DR S, V18, P1094, DOI 10.1002/pds.1825; Chen H, 2007, CURR MED RES OPIN, V23, P1351, DOI 10.1185/030079907X187883; Citrome L, 2004, PSYCHIAT SERV, V55, P290, DOI 10.1176/appi.ps.55.3.290; Citrome L, 2002, PSYCHIATR SERV, V53, P1212, DOI 10.1176/appi.ps.53.10.1212; Citrome L, 2000, PSYCHIATR SERV, V51, P634, DOI 10.1176/appi.ps.51.5.634; Citrome L., 2004, CURR PSYCHIAT, V3, P23; Citrome L, 2009, EXPERT REV NEUROTHER, V9, P55, DOI 10.1586/14737175.9.1.55; Conley RR, 2001, BIOL PSYCHIAT, V50, P898, DOI 10.1016/S0006-3223(01)01271-9; Davids E, 2006, PROG NEURO-PSYCHOPH, V30, P1109, DOI 10.1016/j.pnpbp.2006.04.015; European Medicines Agency, 2013, VALPR; Falkai P, 2005, WORLD J BIOL PSYCHIA, V6, P132, DOI 10.1080/15622970510030090; Gallego JA, 2012, SCHIZOPHR RES, V138, P18, DOI 10.1016/j.schres.2012.03.018; Hartling L, 2012, ANN INTERN MED, V157, P498, DOI 10.7326/0003-4819-157-7-201210020-00525; Haw C, 2005, J PSYCHOPHARMACOL, V19, P402, DOI 10.1177/0269881105053307; Healy D, 1998, PSYCHIAT B, V22, P680; Kelly DL, 2006, PSYCHIAT QUART, V77, P81, DOI 10.1007/s11126-006-7963-9; Lehman AF, 2004, AM J PSYCHIAT, V161, P1; Leslie DL, 2009, PSYCHIAT SERV, V60, P1174, DOI 10.1176/ps.2009.60.9.1175; Levinson DF, 1999, AM J PSYCHIAT, V156, P1138; Lonergan E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003945.pub3; McGorry P, 2005, AUST NZ J PSYCHIAT, V39, P1; Meltzer HY, 2011, J CLIN PSYCHIAT, V72, P1602, DOI 10.4088/JCP.10m05997; Moore TA, 2007, J CLIN PSYCHIAT, V68, P1751, DOI 10.4088/JCP.v68n1115; Murru A, 2011, EUR NEUROPSYCHOPHARM, V21, P680, DOI 10.1016/j.euroneuro.2011.03.001; National Institute for Clinical Excellence, 2003, SCHIZ FULL NAT GUID; Olfson M, 2009, PSYCHIAT SERV, V60, P210, DOI 10.1176/appi.ps.60.2.210; Pickar D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003150; Qian K, 2012, ADV EXP MED BIOL, V736, P563, DOI 10.1007/978-1-4419-7210-1_33; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Schwarz C, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004028.pub3; Sim K, 2011, INT J NEUROPSYCHOPH, V14, P1157, DOI 10.1017/S1461145711000563; Suzuki T, 2009, HUM PSYCHOPHARM CLIN, V24, P628, DOI 10.1002/hup.1073; Wassef AA, 2000, J CLIN PSYCHOPHARM, V20, P357, DOI 10.1097/00004714-200006000-00011; Wessels T, 2007, PSYCHIAT QUART, V78, P91, DOI 10.1007/s11126-006-9030-y; Wittich CM, 2012, MAYO CLIN PROC, V87, P982, DOI 10.1016/j.mayocp.2012.04.017	39	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92573	10.1371/journal.pone.0092573	http://dx.doi.org/10.1371/journal.pone.0092573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664210	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900078
J	Linse, K; Jackson, JA; Malyutina, MV; Brandt, A				Linse, Katrin; Jackson, Jennifer A.; Malyutina, Marina V.; Brandt, Angelika			Shallow-Water Northern Hemisphere Jaera (Crustacea, Isopoda, Janiridae) Found on Whale Bones in the Southern Ocean Deep Sea: Ecology and Description of Jaera tyleri sp nov.	PLOS ONE			English	Article							ALBIFRONS GROUP; REPRODUCTIVE-BIOLOGY; INTERTIDAL ISOPOD; FALL; ASELLOTA; SIZE; RNA; ECOSYSTEMS; DIVERSITY; EVOLUTION	The skeleton of a natural whale fall discovered in the Southern Ocean at 1,445 m was densely covered by one small, janirid isopod. Jaera tyleri sp. nov. is the first of its genus found in the southern hemisphere and in the deep sea and is described herein. Morphological and molecular investigations revealed the systematic position of this species new to science. Phylogenetic analysis of the 18S locus confirms that this species falls in a strongly supported monophyletic clade of Jaera species. The whale bone habitat of J. tyleri sp. nov. is quite different from those of other species of the genus Jaera. The analysis of bathymetric and distribution patterns of the Janiridae in general and Jaera specifically confirm the unusualness of the habitat for this isopod species. The abundance of J. tyleri sp. nov. on the whale bones and its absence from other nearby habitats suggests it to be a whale-fall specialist. The analysis of the size-frequency distributions of J. tyleri sp. nov. suggests multimodal population structure with continuous breeding activity throughout the year. The fecundity of the species is low but in line with reduced fecundity observed in polar and small-sized isopods.	[Linse, Katrin; Jackson, Jennifer A.] British Antarctic Survey, Cambridge CB3 0ET, England; [Malyutina, Marina V.] Russian Acad Sci, Far Eastern Branch, AV Zhirmunsky Inst Marine Biol, Vladivostok 690022, Russia; [Brandt, Angelika] Univ Hamburg, Bioctr Grindel, Hamburg, Germany; [Brandt, Angelika] Univ Hamburg, Zool Museum, Hamburg, Germany	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; University of Hamburg; University of Hamburg	Linse, K (corresponding author), British Antarctic Survey, Cambridge CB3 0ET, England.	kl@bas.ac.uk	Brandt, Angelika/C-1630-2018; Malyutina, Marina/A-6839-2014	Malyutina, Marina/0000-0003-2161-3917; Linse, Katrin/0000-0003-3477-3047	German Science Foundation [DFG Br 1121/38-1, 1121/43-1]; Russian Foundation of Basis Research [11-04-98586]; Ministry of Education and Science of Russian Federation [11.G34.31.0010]; British Antarctic Survey Polar Science; Natural Environment Research Council (NERC); ChEsSO research programme; NERC Consortium Grant [NE/DO1249X/1]; NERC [NE/D01249X/1, bas0100026, NE/D013852/1, NE/D010470/2] Funding Source: UKRI; Natural Environment Research Council [NE/D013852/1, bas0100026, NE/D010470/2, NE/D01249X/1] Funding Source: researchfish	German Science Foundation(German Research Foundation (DFG)); Russian Foundation of Basis Research; Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation); British Antarctic Survey Polar Science; Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ChEsSO research programme; NERC Consortium Grant; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	AB and MM were supported by the German Science Foundation for financial support (DFG Br 1121/38-1, 1121/43-1), the Russian Foundation of Basis Research (project 11-04-98586) and Ministry of Education and Science of Russian Federation (grant 11.G34.31.0010). KL was supported by the British Antarctic Survey Polar Science for Planet Earth Programme funded by The Natural Environment Research Council (NERC), as well as part of the ChEsSO research programme was funded by NERC Consortium Grant (NE/DO1249X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon DJ, 2013, DEEP-SEA RES PT II, V92, P87, DOI 10.1016/j.dsr2.2013.01.028; Borza P, 2012, ZOOTAXA, P67; BOWMAN TE, 1988, P BIOL SOC WASH, V101, P171; Braby CE, 2007, DEEP-SEA RES PT I, V54, P1773, DOI 10.1016/j.dsr.2007.05.014; Brandt A, 2004, DEEP-SEA RES PT II, V51, P1753, DOI 10.1016/j.dsr2.2004.06.033; Brandt A, 2007, DEEP-SEA RES PT II, V54, P1760, DOI 10.1016/j.dsr2.2007.07.015; Brandt A, 2009, DEEP-SEA RES PT I, V56, P2013, DOI 10.1016/j.dsr.2009.06.007; CLARKE A, 1992, POLAR BIOL, V12, P129; DELL R K, 1987, National Museum of New Zealand Records, V3, P17; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Forsman Bror, 1944, ARKIV ZOOL [STOCKHOLM], V35A, P1; Fujiwara Y, 2007, MAR ECOL-EVOL PERSP, V28, P219, DOI 10.1111/j.1439-0485.2007.00150.x; Glover AG, 2010, ADV MAR BIOL, V58, P1, DOI [10.1016/B978-0-12-381015-1.00001-0, 10.1016/S0065-2881(10)58001-5]; Glover AG, 2005, MAR ECOL-EVOL PERSP, V26, P223, DOI 10.1111/j.1439-0485.2005.00060.x; Goffredi SK, 2004, DEEP-SEA RES PT I, V51, P1295, DOI 10.1016/j.dsr.2004.05.009; Gruner H.-E., 1993, LEHRBUCH SPEZIELLEN, V1; HAAHTELA I, 1965, J MAR BIOL ASSOC UK, V45, P367, DOI 10.1017/S0025315400054898; HARRISON K, 1988, J NAT HIST, V22, P175, DOI 10.1080/00222938800770131; Harvey C. E., 1968, Crustaceana, V14, P185, DOI 10.1163/156854068X00584; HENDRIKS L, 1989, SYST APPL MICROBIOL, V12, P223, DOI 10.1016/S0723-2020(89)80066-9; International Commission on Zoological Nomenclature, 2012, ZOOKEYS, V219, P1; JAUME D, 1995, CONTRIB ZOOL, V65, P177; JONES MB, 1972, MAR BIOL, V14, P264; JONES MB, 1971, MAR BIOL, V10, P265, DOI 10.1007/BF00352817; JONES MB, 1971, J ZOOL, V165, P183; Jones MB, 1972, J MAR BIOL ASSOC UK, V54, P727; JUILFS HB, 1987, MAR BIOL, V95, P493, DOI 10.1007/BF00393092; Kaiser S, 2007, DEEP-SEA RES PT II, V54, P1776, DOI 10.1016/j.dsr2.2007.07.006; Khaitov VM, 2007, MAR BIOL, V150, P1205, DOI 10.1007/s00227-006-0450-x; Kuzmin AA, 2005, BIOLOGY, V2005, P26; Levin Lisa A., 1994, P261; Lundsten L, 2010, DEEP-SEA RES PT I, V57, P918, DOI 10.1016/j.dsr.2010.04.006; Malyutina M, 2007, DEEP-SEA RES PT II, V54, P1790, DOI 10.1016/j.dsr2.2007.07.017; MARGALEF RAM0N, 1952, HYDROBIOLOGIA, V4, P209, DOI 10.1007/BF00052900; Marshall J., 1900, J MALACOLOGY, V7, P167; Piertney SB, 1996, J MAR BIOL ASSOC UK, V76, P825, DOI 10.1017/S0025315400031490; Ramirez-Llodra E., 2010, BIOGEOSCI DISCUSS, V7, P2361, DOI DOI 10.5194/BGD-7-2361-2010; Raupach MJ, 2009, P ROY SOC B-BIOL SCI, V276, P799, DOI 10.1098/rspb.2008.1063; Rey P, 2005, SCHRIFTENREIHE UMWEL, V380, P1; Rogers AD, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001234; Rowe G.T., 1979, Ambio Special Report, P19, DOI 10.2307/25099603; Savill NJ, 2001, GENETICS, V157, P399; Schotte M, 2010, WORLD MARINE FRESHWA; Sjoberg B., 1969, Limnologica Berlin, V7, P69; SJOBERG B, 1970, OIKOS, V21, P241, DOI 10.2307/3543680; SJOBERG BIRGITTA, 1967, SARSIA, V29, P321; Smith CR, 1998, CAH BIOL MAR, V39, P345; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; SMITH CR, 1989, NATURE, V341, P27, DOI 10.1038/341027a0; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; STEELE DH, 1972, CAN J ZOOLOG, V50, P205, DOI 10.1139/z72-030; Stocsits RR, 2009, NUCLEIC ACIDS RES, V37, P6184, DOI 10.1093/nar/gkp600; SVAVARSSON J, 1982, SARSIA, V67, P223, DOI 10.1080/00364827.1982.10421337; Sye CG, 1887, BEITRAGE ANATOMIE HI; Tobias Wolfgang, 2005, P5; VEUILLE M, 1980, BIOL J LINN SOC, V13, P89, DOI 10.1111/j.1095-8312.1980.tb00072.x; WAGELE JW, 1987, POLAR BIOL, V7, P11, DOI 10.1007/BF00286819; WAGELE JW, 1990, POLAR BIOL, V10, P521, DOI 10.1007/BF00233701; WILMOTTE A, 1993, FEBS LETT, V317, P96, DOI 10.1016/0014-5793(93)81499-P; WILSON G.D.F, 1989, B SCRIPPS I OCEAN SA, V27, P1, DOI DOI 10.1163/193724090X00500; WILSON GDF, 1987, ANNU REV ECOL SYST, V18, P185, DOI 10.1146/annurev.es.18.110187.001153; Wilson George D. F., 1994, Invertebrate Taxonomy, V8, P749, DOI 10.1071/IT9940749; Wilson George D. F., 1994, Invertebrate Taxonomy, V8, P683, DOI 10.1071/IT9940683; WOLFF T, 1979, SARSIA, V64, P117, DOI 10.1080/00364827.1979.10411373; Wolff T., 1962, GALATHEA REP, V6, P7	66	13	13	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93018	10.1371/journal.pone.0093018	http://dx.doi.org/10.1371/journal.pone.0093018			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663246	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000333459900144
J	Mietens, A; Tasch, S; Stammler, A; Konrad, L; Feuerstacke, C; Middendorff, R				Mietens, Andrea; Tasch, Sabine; Stammler, Angelika; Konrad, Lutz; Feuerstacke, Caroline; Middendorff, Ralf			Time-Lapse Imaging as a Tool to Investigate Contractility of the Epididymal Duct - Effects of Cgmp Signaling	PLOS ONE			English	Article							NATRIURETIC PEPTIDE RECEPTOR; NITRIC-OXIDE SYNTHASE; RAT EPIDIDYMIS; VAS-DEFERENS; IN-VITRO; FUNCTIONAL-ACTIVITY; CAPUT EPIDIDYMIDIS; DIFFERENT REGIONS; LUMINAL CONTENTS; GENE-EXPRESSION	The well orchestrated function of epididymal smooth muscle cells ensures transit of spermatozoa through the epididymal duct during which spermatozoa acquire motility and fertilizing capacity. Relaxation of smooth muscle cells is mediated by cGMP signaling and components of this pathway are found within the male reproductive tract. Whereas contractile function of caudal parts of the rat epididymal duct can be examined in organ bath studies, caput and corpus regions are fragile and make it difficult to mount them in an organ bath. We developed an ex vivo time-lapse imaging-based approach to investigate the contractile pattern in these parts of the epididymal duct. Collagen-embedding allowed immobilization without impeding contractility or diffusion of drugs towards the duct and therefore facilitated subsequent movie analyses. The contractile pattern was made visible by placing virtual sections through the acquired image stack to track wall movements over time. By this, simultaneous evaluation of contractile activity at different positions of the observed duct segment was possible. With each contraction translating into a spike, drug-induced alterations in contraction frequency could be assessed easily. Peristaltic contractions were also detectable and throughout all regions in the proximal epididymis we found regular spontaneous contractile activity that elicited movement of intraluminal contents. Stimulating cGMP production by natriuretic peptide ANP or inhibiting degradation of cGMP by the phosphodiesterase 5 inhibitor sildenafil significantly reduced contractile frequency in isolated duct segments from caput and corpus. RT-PCR analysis after laser-capture microdissection localized the corresponding molecules to the smooth muscle layer of the duct. Our time-lapse imaging approach proved to be feasible to assess contractile function in all regions of the epididymal duct under near physiological conditions and provides a tool to evaluate acute (side) effects of drugs and to investigate various signaling pathways.	[Mietens, Andrea; Tasch, Sabine; Stammler, Angelika; Feuerstacke, Caroline; Middendorff, Ralf] Univ Giessen, Inst Anat & Cell Biol, D-35390 Giessen, Germany; [Konrad, Lutz] Univ Giessen, Dept Gynecol & Obstet, D-35390 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Middendorff, R (corresponding author), Univ Giessen, Inst Anat & Cell Biol, D-35390 Giessen, Germany.	Ralf.Middendorff@anatomie.med.uni-giessen.de			DFG [KFO 181]; State of Hesse, Germany (LOEWE: MIBIE); von Behring-Roentgen-Stiftung	DFG(German Research Foundation (DFG)); State of Hesse, Germany (LOEWE: MIBIE); von Behring-Roentgen-Stiftung	This investigation was funded by DFG (KFO 181), the State of Hesse, Germany (LOEWE: MIBIE) and the "von Behring-Roentgen-Stiftung". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUMGARTEN HG, 1971, Z ZELLFORSCH MIK ANA, V120, P37, DOI 10.1007/BF00331243; Boselli C, 1998, J AUTON PHARMACOL, V18, P297, DOI 10.1046/j.1365-2680.1998.18598.x; Carvajal JA, 2000, J CELL PHYSIOL, V184, P409, DOI 10.1002/1097-4652(200009)184:3<409::AID-JCP16>3.3.CO;2-B; Chaturapanich G, 2002, REPRODUCTION, V124, P887, DOI 10.1530/reprod/124.6.887; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; COSENTINO MJ, 1986, UROL RES, V14, P229; COSENTINO MJ, 1984, J ANDROL, V5, P216; EHREN I, 1994, UROL RES, V22, P287, DOI 10.1007/BF00297196; Einspanier A, 1997, BIOL REPROD, V56, P416, DOI 10.1095/biolreprod56.2.416; Filippi S, 2002, MOL CELL ENDOCRINOL, V193, P89, DOI 10.1016/S0303-7207(02)00101-6; Ghofrani HA, 2006, DEUT MED WOCHENSCHR, V131, pS311, DOI 10.1055/s-2006-957199; HOFFER AP, 1973, ANAT REC, V175, P169, DOI 10.1002/ar.1091750205; Ivell R, 1998, J REPROD FERTIL, P33; JAAKKOLA UM, 1983, J REPROD FERTIL, V68, P465, DOI 10.1530/jrf.0.0680465; JAAKKOLA UM, 1983, J PHYSIOL-LONDON, V336, P453, DOI 10.1113/jphysiol.1983.sp014590; Kim SZ, 2000, GEN COMP ENDOCR, V118, P26, DOI 10.1006/gcen.1999.7445; Medina P, 2000, UROLOGY, V55, P592, DOI 10.1016/S0090-4295(99)00535-X; Mewe M, 2006, ENDOCRINOLOGY, V147, P2051, DOI 10.1210/en.2005-1324; Mewe M, 2008, AM J PHYSIOL-REG I, V294, pR895, DOI 10.1152/ajpregu.00521.2007; Mewe M, 2007, REPRODUCTION, V134, P493, DOI 10.1530/REP-07-0220; Mewe M, 2006, BIOL REPROD, V75, P651, DOI 10.1095/biolreprod.106.054577; Mietens A, 2012, MOL CELL ENDOCRINOL, V349, P145, DOI 10.1016/j.mce.2011.09.039; Morelli A, 2004, ENDOCRINOLOGY, V145, P2253, DOI 10.1210/en.2003-1699; Muller D, 2011, REPRODUCTION, V142, P333, DOI 10.1530/REP-10-0517; Muller D, 2000, MOL BRAIN RES, V75, P321, DOI 10.1016/S0169-328X(99)00324-1; Muller D, 2002, ENDOCRINOLOGY, V143, P23, DOI 10.1210/en.143.1.23; Nielsen SJ, 2008, REGUL PEPTIDES, V146, P204, DOI 10.1016/j.regpep.2007.09.022; Peri A, 1997, J CLIN ENDOCR METAB, V82, P3797, DOI 10.1210/jc.82.11.3797; PHOLPRAMOOL C, 1984, J REPROD FERTIL, V71, P173, DOI 10.1530/jrf.0.0710173; Ricker DD, 1996, INT J ANDROL, V19, P371, DOI 10.1111/j.1365-2605.1996.tb00530.x; Ricker DD, 1998, J ANDROL, V19, P1; Robaire B, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1071; Studdard PW, 2002, INT J ANDROL, V25, P65, DOI 10.1046/j.1365-2605.2002.00323.x; SUJARIT S, 1985, J REPROD FERTIL, V74, P497, DOI 10.1530/jrf.0.0740497; TALO A, 1979, J REPROD FERTIL, V57, P423, DOI 10.1530/jrf.0.0570423; Thong A, 2013, MOL CELL ENDOCRINOL, V382, P234; Turner TT, 2007, ASIAN J ANDROL, V9, P565, DOI 10.1111/j.1745-7262.2007.00302.x; Weissgerber P, 2011, SCI SIGNAL, V4, P6, DOI 10.1126/scisignal.2001791; Zini A, 1996, BIOL REPROD, V55, P935, DOI 10.1095/biolreprod55.5.935	39	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92603	10.1371/journal.pone.0092603	http://dx.doi.org/10.1371/journal.pone.0092603			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662987	Green Submitted, Green Published, gold			2022-12-27	WOS:000333459900082
J	Nistelberger, H; Byrne, M; Coates, D; Roberts, JD				Nistelberger, Heidi; Byrne, Margaret; Coates, David; Roberts, J. Dale			Strong Phylogeographic Structure in a Millipede Indicates Pleistocene Vicariance between Populations on Banded Iron Formations in Semi-Arid Australia	PLOS ONE			English	Article							MICROSATELLITE LOCI; PLANT-COMMUNITIES; COMPUTER-PROGRAM; CONSERVATION; GENETICS; DNA; DIVERGENCE; EVOLUTION; DIVERSE; MODEL	The Yilgarn Banded Iron Formations of Western Australia are topographical features that behave as terrestrial islands within the otherwise flat, semi-arid landscape. The formations are characterised by a high number of endemic species, some of which are distributed across multiple formations without inhabiting the intervening landscape. These species provide an ideal context for phylogeographic analysis, to investigate patterns of genetic variation at both spatial and temporal scales. We examined genetic variation in the spirostreptid millipede, Atelomastix bamfordi, found on five of these Banded Iron Formations at two mitochondrial loci and 11 microsatellite loci. Strong phylogeographic structuring indicated the five populations became isolated during the Pleistocene, a period of intensifying aridity in this landscape, when it appears populations have been restricted to pockets of moist habitat provided by the formations. The pattern of reciprocal monophyly identified within the mtDNA and strong differentiation within the nuclear microsatellite data highlight the evolutionary significance of these divergent populations and we suggest the degree of differentiation warrants designation of each as a conservation unit.	[Nistelberger, Heidi; Roberts, J. Dale] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia; [Byrne, Margaret; Coates, David] Dept Pk & Wildlife, Div Sci, Bentley, WA, Australia	University of Western Australia	Nistelberger, H (corresponding author), Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia.	heidi.nistelberger@grs.uwa.edu.au	Byrne, Margaret/H-8198-2015	Byrne, Margaret/0000-0002-7197-5409; Nistelberger, Heidi/0000-0003-2957-5425	Cliffs Natural Resources	Cliffs Natural Resources	The authors would like to confirm that Cliffs Natural Resources, a commercial company contributed funding to this study. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allendorf F, 2013, CONSERV GENET, V2nd; Anand RR, 2002, AUST J EARTH SCI, V49, P3, DOI 10.1046/j.1440-0952.2002.00912.x; AVISE JC, 1989, EVOLUTION, V43, P1192, DOI [10.1111/j.1558-5646.1989.tb02568.x, 10.2307/2409356]; AVISE JC, 1983, MOL BIOL EVOL, V1, P38; BASKIN JM, 1988, J BIOGEOGR, V15, P829, DOI 10.2307/2845343; Beheregaray LB, 2004, P NATL ACAD SCI USA, V101, P6514, DOI 10.1073/pnas.0400393101; Bennelongia, 2008, 200850 BENN ENV CONS; Beveridge M, 2004, MOL ECOL NOTES, V4, P379, DOI 10.1111/j.1471-8286.2004.00659.x; Biota, 2009, COMMUNICATION; BOWLER JM, 1982, EVOLUTION FLORA FAUN, P35; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Buckley TR, 2001, SYST BIOL, V50, P67, DOI 10.1080/106351501750107495; Burke A, 2003, DIVERS DISTRIB, V9, P375, DOI 10.1046/j.1472-4642.2003.00035.x; Byrne M, 2007, AUST J BOT, V55, P316, DOI 10.1071/BT06072; Byrne M, 2008, BIOL J LINN SOC, V93, P177, DOI 10.1111/j.1095-8312.2007.00946.x; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Clark PU, 2006, QUATERNARY SCI REV, V25, P3150, DOI 10.1016/j.quascirev.2006.07.008; Cooper SJB, 2011, MOL ECOL, V20, P3219, DOI 10.1111/j.1365-294X.2011.05160.x; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; DeChaine EG, 2005, AM J BOT, V92, P477, DOI 10.3732/ajb.92.3.477; DeChaine EG, 2004, EVOLUTION, V58, P113, DOI 10.1111/j.0014-3820.2004.tb01578.x; Dobzhansky T, 1970, GENETICS EVOLUTIONAR; Dodson JR, 2004, GLOBAL PLANET CHANGE, V41, P285, DOI 10.1016/j.gloplacha.2004.01.013; Driscoll DA, 1998, EVOLUTION, V52, P1147, DOI 10.1111/j.1558-5646.1998.tb01841.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edward KL, 2010, ZOOTAXA, P1; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Floyd CH, 2005, ECOLOGY, V86, P2145, DOI 10.1890/04-1227; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gibson Neil, 2007, Nuytsia, V17, P1; Gibson N, 2010, BIODIVERS CONSERV, V19, P3951, DOI 10.1007/s10531-010-9939-1; Goldstein DB, 1997, J HERED, V88, P335, DOI 10.1093/oxfordjournals.jhered.a023114; Harvey MS, 2002, INVERTEBR SYST, V16, P555, DOI 10.1071/IS02009; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Hocking R. S., 2007, GEOLOGICAL SURVEY W, V2007/8, P19; Hopper SD., 2000, INSELBERGS, P391, DOI DOI 10.1007/978-3-642-59773-2_18; Hopper Stephen D., 1996, P1; Hughes L, 2003, AUSTRAL ECOL, V28, P423, DOI 10.1046/j.1442-9993.2003.01300.x; Jacobi CM, 2007, BIODIVERS CONSERV, V16, P2185, DOI 10.1007/s10531-007-9156-8; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Ji YJ, 2003, MOL ECOL NOTES, V3, P581, DOI 10.1046/j.1471-8286.2003.00519.x; Jones AW, 2008, BIOL J LINN SOC, V95, P620, DOI 10.1111/j.1095-8312.2008.01073.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; KIMURA M, 1964, GENETICS, V49, P561; Langella O, 2000, POPULATIONS 1 2 19 P; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martin HA, 2006, J ARID ENVIRON, V66, P533, DOI 10.1016/j.jaridenv.2006.01.009; Masta SE, 2000, EVOLUTION, V54, P1699; McLoughlin S, 2001, AUST J BOT, V49, P271, DOI 10.1071/BT00023; Mesibov Robert, 1994, Memoirs of the Queensland Museum, V36, P133; Moir ML, 2009, J BIOGEOGR, V36, P1958, DOI 10.1111/j.1365-2699.2009.02137.x; MORAN GF, 1983, AUST J BOT, V31, P161, DOI 10.1071/BT9830161; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Nistelberger H, 2013, CONSERV GENET RESOUR, V5, P533, DOI 10.1007/s12686-012-9845-9; Paetkau D, 1999, CONSERV BIOL, V13, P1507, DOI 10.1046/j.1523-1739.1999.98507.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pons J, 2010, MOL PHYLOGENET EVOL, V56, P796, DOI 10.1016/j.ympev.2010.02.007; R Core Team, 2021, R LANGUAGE ENV STAT; Raxworthy CJ, 2002, NATURE, V415, P784, DOI 10.1038/415784a; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Robin VV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013321; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Salerno PE, 2012, EVOLUTION, V66, P3000, DOI 10.1111/j.1558-5646.2012.01666.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith CI, 2005, MOL ECOL, V14, P3049, DOI 10.1111/j.1365-294X.2005.02647.x; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Wesener T, 2010, MOL PHYLOGENET EVOL, V57, P1184, DOI 10.1016/j.ympev.2010.08.023; Whittaker RJ, 1998, ISLAND BIOGEOGRAPHY; Wright S, 1929, AM NAT, V63, P556, DOI 10.1086/280290; Yates CJ, 2011, AUST J BOT, V59, P691, DOI 10.1071/BT11199	78	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93038	10.1371/journal.pone.0093038	http://dx.doi.org/10.1371/journal.pone.0093038			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663390	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900146
J	Nobile, MS; Cazzaniga, P; Besozzi, D; Pescini, D; Mauri, G				Nobile, Marco S.; Cazzaniga, Paolo; Besozzi, Daniela; Pescini, Dario; Mauri, Giancarlo			cuTauLeaping: A GPU-Powered Tau-Leaping Stochastic Simulator for Massive Parallel Analyses of Biological Systems	PLOS ONE			English	Article							RAS/CAMP/PKA PATHWAY; SENSITIVITY-ANALYSIS; BISTABILITY; MODELS; STREAMS; COPASI; MSN2	Tau-leaping is a stochastic simulation algorithm that efficiently reconstructs the temporal evolution of biological systems, modeled according to the stochastic formulation of chemical kinetics. The analysis of dynamical properties of these systems in physiological and perturbed conditions usually requires the execution of a large number of simulations, leading to high computational costs. Since each simulation can be executed independently from the others, a massive parallelization of tau-leaping can bring to relevant reductions of the overall running time. The emerging field of General Purpose Graphic Processing Units (GPGPU) provides power-efficient high-performance computing at a relatively low cost. In this work we introduce cuTauLeaping, a stochastic simulator of biological systems that makes use of GPGPU computing to execute multiple parallel tau-leaping simulations, by fully exploiting the Nvidia's Fermi GPU architecture. We show how a considerable computational speedup is achieved on GPU by partitioning the execution of tau-leaping into multiple separated phases, and we describe how to avoid some implementation pitfalls related to the scarcity of memory resources on the GPU streaming multiprocessors. Our results show that cuTauLeaping largely outperforms the CPU-based tau-leaping implementation when the number of parallel simulations increases, with a break-even directly depending on the size of the biological system and on the complexity of its emergent dynamics. In particular, cuTauLeaping is exploited to investigate the probability distribution of bistable states in the Schlogl model, and to carry out a bidimensional parameter sweep analysis to study the oscillatory regimes in the Ras/cAMP/PKA pathway in S. cerevisiae.	[Nobile, Marco S.; Mauri, Giancarlo] Univ Milano Bicocca, Dipartimento Informat Sistemist & Comunicaz, Milan, Italy; [Cazzaniga, Paolo] Univ Bergamo, Dipartimento Sci Umane & Sociali, Bergamo, Italy; [Besozzi, Daniela] Univ Milan, Dipartimento Informat, Milan, Italy; [Pescini, Dario] Univ Milano Bicocca, Dipartimento Stat & Metodi Quantitativi, Milan, Italy; [Cazzaniga, Paolo; Besozzi, Daniela] CNR, Ist Anal Sistemi & Informat Antonio Ruberti, Rome, Italy; [Nobile, Marco S.; Cazzaniga, Paolo; Besozzi, Daniela; Pescini, Dario; Mauri, Giancarlo] SYSBIO Ctr Syst Biol, Milan, Italy	University of Milano-Bicocca; University of Bergamo; University of Milan; University of Milano-Bicocca; Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR)	Nobile, MS (corresponding author), Univ Milano Bicocca, Dipartimento Informat Sistemist & Comunicaz, Milan, Italy.	nobile@disco.unimib.it; paolo.cazzaniga@unibg.it	Mauri, Giancarlo/M-3258-2013; Nobile, Marco S./AAH-4584-2020; Pescini, Dario/H-4866-2017; Nobile, Marco S./AAP-3441-2020	Mauri, Giancarlo/0000-0003-3520-4022; Pescini, Dario/0000-0002-3090-4823; Nobile, Marco/0000-0002-7692-7203	Research Infrastructure "SYSBIO Centre of Systems Biology''	Research Infrastructure "SYSBIO Centre of Systems Biology''	This work is supported by Research Infrastructure "SYSBIO Centre of Systems Biology'' (http://www.sysbio.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497; Besozzi D, 2013, ELECTRON P THEOR COM, P87, DOI 10.4204/EPTCS.130.14; Besozzi D, 2012, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2012-10; Burrage K, 2006, PARALLEL COMPUTING B, P79; BURRAGE K., 2006, P AA MARK 150 ANN M, P21; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Cao Y, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2745299; Carrillo S, 2009, CF'09: CONFERENCE ON COMPUTING FRONTIERS & WORKSHOPS, P147; Cazzaniga P, 2008, J BIOTECHNOL, V133, P377, DOI 10.1016/j.jbiotec.2007.09.019; Chis OT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027755; Cho Y.J., 2008, P 14 ACM INT C KNOWL, P142; Chou IC, 2009, MATH BIOSCI, V219, P57, DOI 10.1016/j.mbs.2009.03.002; Craciun G, 2006, P NATL ACAD SCI USA, V103, P8697, DOI 10.1073/pnas.0602767103; Dreger A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-5; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Garmendia-Torres C, 2007, CURR BIOL, V17, P1044, DOI 10.1016/j.cub.2007.05.032; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; Gillespie DT, 2008, LECT NOTES COMPUT SC, V5016, P125; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GILLESPIE DT, 1992, PHYSICA A, V188, P404, DOI 10.1016/0378-4371(92)90283-V; Gunawan R, 2005, BIOPHYS J, V88, P2530, DOI 10.1529/biophysj.104.053405; Hellander A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2897976; Hill DRC, 2013, CONCURR COMP-PRACT E, V25, P1427, DOI 10.1002/cpe.2942; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hyduke DR, 2010, NAT REV GENET, V11, P297, DOI 10.1038/nrg2750; IBA J. KITAGAWA AND H., 2003, EVOLUTIONARY COMPUTA, P255; Kent E, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-91; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Klingbeil G, 2011, BIOINFORMATICS, V27, P1170, DOI 10.1093/bioinformatics/btr068; Komarov I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037370; L'ecuyer P, 2002, OPER RES, V50, P1073, DOI 10.1287/opre.50.6.1073.358; L'Ecuyer P, 2007, ACM T MATH SOFTWARE, V33, DOI 10.1145/1268776.1268777; Leier A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2919124; Li C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-92; Li H., 2006, TECHNICAL REPORT; Li H, 2010, INT J HIGH PERFORM C, V24, P107, DOI 10.1177/1094342009106066; Lipkow K, 2005, J BACTERIOL, V187, P45, DOI 10.1128/JB.187.1.45-53.2005; Macchiarulo L, 2008, IEEE ENG MED BIO, P1343, DOI 10.1109/IEMBS.2008.4649413; Marquez-Lago TT, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2771548; Marsaglia G., 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i14, DOI 10.18637/JSS.V008.I18, 10.18637/jss.v008.i18]; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Moles CG, 2003, GENOME RES, V13, P2467, DOI 10.1101/gr.1262503; Munsky B, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2145882; Nandapalan N, 2012, LECT NOTES COMPUT SC, V7203, P609, DOI 10.1007/978-3-642-31464-3_62; Nelson D.L., 2004, PRINCIPLES BIOCH, V4th; Nobile Marco S., 2012, Evolutionary Computation, Machine Learning and Data Mining in Bioinformatics. Proceedings of the 10th European Conference, EvoBIO 2012, P74, DOI 10.1007/978-3-642-29066-4_7; Nobile MS, 2012, PROCEEDINGS OF THE FOURTEENTH INTERNATIONAL CONFERENCE ON GENETIC AND EVOLUTIONARY COMPUTATION COMPANION (GECCO'12), P1421; Nobile MS, 2013, 2013 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P1594; NVIDIA, 2012, CUDA TOOLK 5 0 CURAN; NVidia, 2012, NVIDIA CUDA C PROGR; NVIDIA, 2011, TUN CUDA APPL FERM; Pahle J, 2009, BRIEF BIOINFORM, V10, P53, DOI 10.1093/bib/bbn050; Papin JA, 2005, NAT REV MOL CELL BIO, V6, P99, DOI 10.1038/nrm1570; Pescini D, 2012, BIOTECHNOL ADV, V30, P99, DOI 10.1016/j.biotechadv.2011.06.014; Plyasunov S, 2007, J COMPUT PHYS, V221, P724, DOI 10.1016/j.jcp.2006.06.047; Pomerening JR, 2008, CURR OPIN BIOTECH, V19, P381, DOI 10.1016/j.copbio.2008.06.009; Raue A, 2010, CHAOS, V20, DOI 10.1063/1.3528102; Ryoo S, 2008, PPOPP'08: PROCEEDINGS OF THE 2008 ACM SIGPLAN SYMPOSIUM ON PRINCIPLES AND PRACTICE OF PARALLEL PROGRAMMING, P73, DOI 10.1145/1345206.1345220; Salis H, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1835951; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; SCHLOGL F, 1972, Z PHYS, V253, P147, DOI 10.1007/BF01379769; Sidje RB, 2007, SIAM J SCI COMPUT, V29, P2562, DOI 10.1137/060662629; Slepoy A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2919546; Srinath S, 2010, J BIOTECHNOL, V149, P132, DOI 10.1016/j.jbiotec.2010.02.019; Stelling J, 2004, CURR OPIN MICROBIOL, V7, P513, DOI 10.1016/j.mib.2004.08.004; Steuer R, 2003, BIOSYSTEMS, V72, P241, DOI 10.1016/j.biosystems.2003.07.001; Stewart W, 2010, INTRO NUMERICAL SOLU; Tian TH, 2004, J CHEM PHYS, V121, P10356, DOI 10.1063/1.1810475; Tian TH, 2005, Eighth International Conference on High-Performance Computing in Asia-Pacific Region, Proceedings, P621, DOI 10.1109/HPCASIA.2005.67; van Kampen N.G., 2001, STOCHASTIC PROCESSES; Vellela M, 2009, J R SOC INTERFACE, V6, P925, DOI 10.1098/rsif.2008.0476; Vigelius M, 2011, BIOINFORMATICS, V27, P288, DOI 10.1093/bioinformatics/btq622; Wang LL, 2004, MICROBIOL-SGM, V150, P3383, DOI 10.1099/mic.0.27162-0; Wang YF, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-99; Wen-mei W Hwu, 2011, GPU COMPUTING GEMS J; Widder S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005399; Wilhelm T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-90; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Wolf V, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-42; Zaman S, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.2; Zhang HX, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3563539; ZHANG J, 2007, TR0731 VIRG TECH	86	21	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91963	10.1371/journal.pone.0091963	http://dx.doi.org/10.1371/journal.pone.0091963			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663957	Green Submitted, Green Published, gold			2022-12-27	WOS:000333459900036
J	Plocinski, P; Laubitz, D; Cysewski, D; Stodus, K; Kowalska, K; Dziembowski, A				Plocinski, Przemyslaw; Laubitz, Daniel; Cysewski, Dominik; Stodus, Krystian; Kowalska, Katarzyna; Dziembowski, Andrzej			Identification of Protein Partners in Mycobacteria Using a Single-Step Affinity Purification Method	PLOS ONE			English	Article							INTERACTION MAP; TUBERCULOSIS; DNA; REPAIR; MODULATION; COMPLEXES; PEPTIDES; BINDING; TAGS	Tuberculosis is a leading cause of death in developing countries. Efforts are being made to both prevent its spread and improve curability rates. Understanding the biology of the bacteria causing the disease, Mycobacterium tuberculosis (M. tuberculosis), is thus vital. We have implemented improved screening methods for protein-protein interactions based on affinity purification followed by high-resolution mass spectrometry. This method can be efficiently applied to both medium-and high-throughput studies aiming to characterize protein-protein interaction networks of tubercle bacilli. Of the 4 tested epitopes FLAG, enhanced green fluorescent protein (eGFP), protein A and haemagglutinin, the eGFP tag was found to be most useful on account of its easily monitored expression and its ability to function as a simultaneous tool for subcellular localization studies. It presents a relatively low background with cost-effective purification. RNA polymerase subunit A (RpoA) was used as a model for investigation of a large protein complex. When used as bait, it co-purified with all remaining RNA polymerase core subunits as well as many accessory proteins. The amount of RpoA strongly correlated with the amount of quantification peptide used as part of the tagging system in this study (SH), making it applicable for semiquantification studies. Interactions between the components of the RpoA-eGFP protein complex were further confirmed using protein cross-linking. Dynamic changes in the composition of protein complexes under induction of UV damage were observed when UvrA-eGFP expressing cells treated with UV light were used to co-purify UvrA interaction partners.	[Plocinski, Przemyslaw; Laubitz, Daniel; Cysewski, Dominik; Stodus, Krystian; Kowalska, Katarzyna; Dziembowski, Andrzej] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Dziembowski, Andrzej] Univ Warsaw, Fac Biol, Dept Genet & Biotechnol, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw	Dziembowski, A (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	andrzejd@ibb.waw.pl	Cysewski, Dominik/U-1352-2019; Płociński, Przemysław A/S-5587-2017	Cysewski, Dominik/0000-0001-6206-0672; Płociński, Przemysław A/0000-0002-6623-3494; Prokop, Katarzyna/0000-0002-8107-185X; Dziembowski, Andrzej/0000-0001-8492-7572; Laubitz, Daniel/0000-0002-7482-8500; Bijata, Krystian/0000-0002-7535-0457	European Community [241587]; Polish Ministry of Science and Higher Education	European Community(European Commission); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (Health) under Grant No. 241587, SysteMTb. D.C. is a recipient of a Diamond Grant from the Polish Ministry of Science and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn B, 2000, MOL CELLS, V10, P592, DOI 10.1007/s100590000017; BRIZZARD BL, 1994, BIOTECHNIQUES, V16, P730; Dziedzic R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011058; Fabisiewicz A, 1998, MUTAT RES-FUND MOL M, V402, P59, DOI 10.1016/S0027-5107(97)00282-0; Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; HOCHULI E, 1987, J CHROMATOGR, V411, P177, DOI 10.1016/S0021-9673(00)93969-4; Huang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038276; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kelkar DS, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.011627, 10.1074/mcp.M111.011445]; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Li YF, 2011, PROTEIN SCI, V20, P140, DOI 10.1002/pro.546; Lichty JJ, 2005, PROTEIN EXPRES PURIF, V41, P98, DOI 10.1016/j.pep.2005.01.019; Luo J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.008318; Mao YH, 2003, DNA REPAIR, V2, P1115, DOI 10.1016/S1568-7864(03)00122-8; Mostowy S, 2002, J INFECT DIS, V186, P74, DOI 10.1086/341068; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Nesvizhskii AI, 2012, PROTEOMICS, V12, P1639, DOI 10.1002/pmic.201100537; Opalka N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000483; ORREN DK, 1990, J BIOL CHEM, V265, P15796; Padiadpu Jyothi, 2010, Syst Synth Biol, V4, P311, DOI 10.1007/s11693-011-9076-5; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; SCHURIG H, 1995, EMBO J, V14, P442, DOI 10.1002/j.1460-2075.1995.tb07020.x; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; STOFKOHAHN RE, 1992, FEBS LETT, V302, P274, DOI 10.1016/0014-5793(92)80458-S; Tagami S, 2010, NATURE, V468, P978, DOI 10.1038/nature09573; Tharad M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027503; Tomecki R, 2010, EMBO J, V29, P2342, DOI 10.1038/emboj.2010.121; Van Houten B, 2005, MUTAT RES-FUND MOL M, V577, P92, DOI 10.1016/j.mrfmmm.2005.03.013; Wang HY, 2003, P NATL ACAD SCI USA, V100, P478, DOI 10.1073/pnas.0236088100; Wang Y, 2010, J PROTEOME RES, V9, P6665, DOI 10.1021/pr100808n; Wepf A, 2009, NAT METHODS, V6, P203, DOI [10.1038/NMETH.1302, 10.1038/nmeth.1302]; Williams KJ, 2010, PLASMID, V64, P69, DOI 10.1016/j.plasmid.2010.04.003; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Young CL, 2012, BIOTECHNOL J, V7, P620, DOI 10.1002/biot.201100155; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhou HF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S20	42	13	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91380	10.1371/journal.pone.0091380	http://dx.doi.org/10.1371/journal.pone.0091380			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664103	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900020
J	Rohani, MG; Chow, YH; Razumova, MV; Ash, S; Hung, CF; Schnapp, LM				Rohani, Maryam G.; Chow, Yu-Hua; Razumova, Maria V.; Ash, Samuel; Hung, Chi F.; Schnapp, Lynn M.			uPARAP Function in Cutaneous Wound Repair	PLOS ONE			English	Article							RECEPTOR-ASSOCIATED PROTEIN; COLLAGEN GEL CONTRACTION; PROCOLLAGEN SYNTHESIS; ENDOCYTIC RECEPTOR; MANNOSE RECEPTOR; MATRIX TURNOVER; PHOTOAGED SKIN; IN-VITRO; DEGRADATION; PATHWAY	Optimal skin wound healing relies on tight balance between collagen synthesis and degradation in new tissue formation and remodeling phases. The endocytic receptor uPARAP regulates collagen uptake and intracellular degradation. In this study we examined cutaneous wound repair response of uPARAP null (uPARAP(-/-)) mice. Full thickness wounds were created on dorsal surface of uPARAP(-/-) or their wildtype littermates. Wound healing evaluation was done by macroscopic observation, histology, gene transcription and biochemical analysis at specific intervals. We found that absence of uPARAP delayed re-epithelialization during wound closure, and altered stiffness of the scar tissue. Despite the absence of the uPARAP-mediated intracellular pathway for collagen degradation, there was no difference in total collagen content of the wounds in uPARAP(-/-) compared to wildtype mice. This suggests in the absence of uPARAP, a compensatory feedback mechanism functions to keep net collagen in balance.	[Rohani, Maryam G.; Chow, Yu-Hua; Ash, Samuel; Hung, Chi F.; Schnapp, Lynn M.] Univ Washington, Dept Med, Div Pulm & Crit Care Med, Ctr Lung Biol, Seattle, WA 98195 USA; [Razumova, Maria V.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rohani, MG (corresponding author), Univ Washington, Dept Med, Div Pulm & Crit Care Med, Ctr Lung Biol, Seattle, WA 98195 USA.	mrohani@uw.edu			NIH [F32 AR060157, HL083481, K24HL068796]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR060157] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH grant F32 AR060157 (MGR), American Heart Association Grant-in-Aid (LMS), NIH HL083481 (LMS), and K24HL068796 (LMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrendt N, 2004, BIOL CHEM, V385, P103, DOI 10.1515/BC.2004.031; Behrendt N, 2000, J BIOL CHEM, V275, P1993, DOI 10.1074/jbc.275.3.1993; Bundesmann MM, 2012, AM J RESP CELL MOL, V46, P233, DOI 10.1165/rcmb.2010-0485OC; Curino AC, 2005, J CELL BIOL, V169, P977, DOI 10.1083/jcb.200411153; East L, 2003, EMBO REP, V4, P710, DOI 10.1038/sj.embor.embor882; Eddy AA, 2009, THROMB HAEMOSTASIS, V101, P656, DOI 10.1160/TH08-12-0779; Engelholm LH, 2003, J CELL BIOL, V160, P1009, DOI 10.1083/jcb.200211091; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hung CF, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-102; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Madsen DH, 2007, J BIOL CHEM, V282, P27037, DOI 10.1074/jbc.M701088200; Madsen DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071261; Madsen DH, 2013, J CELL BIOL, V202, P951, DOI 10.1083/jcb.201301081; Madsen DH, 2012, J PATHOL, V227, P94, DOI 10.1002/path.3981; Madsen DH, 2011, J BIOL CHEM, V286, P26996, DOI 10.1074/jbc.M110.208033; McNulty M, 2006, J HUM HYPERTENS, V20, P867, DOI 10.1038/sj.jhh.1002015; Messaritou G, 2009, J CELL SCI, V122, P4042, DOI 10.1242/jcs.044305; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Ngo P, 2006, METH MOL B, V341, P103; Nielsen BS, 2002, INT J CANCER, V98, P656, DOI 10.1002/ijc.10227; Nishiyama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018410; PHAN SH, 1985, J CLIN INVEST, V76, P241, DOI 10.1172/JCI111953; Rodero MP, 2010, INT J CLIN EXP PATHO, V3, P643; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sheikh H, 2000, J CELL SCI, V113, P1021; Smith L, 2008, GENE EXPR PATTERNS, V8, P486, DOI 10.1016/j.gep.2008.06.006; Sulek J, 2007, J HISTOCHEM CYTOCHEM, V55, P347, DOI 10.1369/jhc.6A7133.2006; Tang S, 2013, J DERMATOL SCI, V70, P42, DOI 10.1016/j.jdermsci.2013.01.008; TINGSTROM A, 1992, J CELL SCI, V102, P315; Varani J, 2002, J INVEST DERMATOL, V119, P122, DOI 10.1046/j.1523-1747.2002.01810.x; Varani J, 2001, AM J PATHOL, V158, P931, DOI 10.1016/S0002-9440(10)64040-0; Vernon RB, 2002, IN VITRO CELL DEV-AN, V38, P97, DOI 10.1290/1071-2690(2002)038<0097:AIMFTC>2.0.CO;2; Wagenaar-Miller RA, 2007, MOL CELL BIOL, V27, P6309, DOI 10.1128/MCB.00291-07; Wang XS, 2013, NAT PROTOC, V8, P302, DOI 10.1038/nprot.2013.002; Wienke D, 2003, MOL BIOL CELL, V14, P3592, DOI 10.1091/mbc.E02-12-0814	41	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92660	10.1371/journal.pone.0092660	http://dx.doi.org/10.1371/journal.pone.0092660			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663959	Green Submitted, Green Published, gold			2022-12-27	WOS:000333459900092
J	Sanz-Aguilar, A; Tavecchia, G; Afan, I; Ramirez, F; Doxa, A; Bertolero, A; Gutierrez-Exposito, C; Forero, MG; Oro, D				Sanz-Aguilar, Ana; Tavecchia, Giacomo; Afan, Isabel; Ramirez, Francisco; Doxa, Aggeliki; Bertolero, Albert; Gutierrez-Exposito, Carlos; Forero, Manuela G.; Oro, Daniel			Living on the Edge: Demography of the Slender-Billed Gull in the Western Mediterranean	PLOS ONE			English	Article							POPULATION-DYNAMICS; COLONIAL CHARADRIIFORMES; PHOENICOPTERUS-ROSEUS; BREEDING DISPERSAL; MODELING SURVIVAL; GREATER FLAMINGO; SPATIAL SCALES; EBRO-DELTA; SEABIRD; RANGE	Small and peripheral populations are typically vulnerable to local extinction processes but important for the metapopulation dynamics of species. The Slender-billed gull (Chroicocephalus genei) is a long-lived species breeding in unstable ephemeral coastal habitats. Their Western Mediterranean populations are relatively small and represent the edge of their global geographical distribution. At a local scale, using long-term data (14 years) on annual breeding success and capture-resights of marked individuals, we estimated and compared the vital rates and evaluated the connectivity of two Spanish populations (Ebro Delta and Donana) varying in their local environmental conditions. At a metapopulation scale, we analyzed 22 years of data on breeding numbers to predict their future prospects by means of population demographic models. Local survival and breeding success of gulls from the Ebro Delta was lower than those from Donana, which is likely the result of higher permanent emigration and/or winter mortality in the former. Gulls from the Ebro Delta wintered mostly in Mediterranean areas whereas those from Donana did so in Atlantic coasts, where food availability is higher. Whereas adult local survival was constant, juvenile local survival showed temporal parallel variations between colonies, probably related to natal dispersal to other breeding colonies. Our results suggested that dispersal was higher at the Ebro Delta and gulls emigrating from their natal colonies settled preferentially in close patches. We found large fluctuations in breeding numbers among local populations probably related to the fact that the Slender-billed gull is a species adapted to unstable and unpredictable habitats with high abilities to disperse between suitable patches depending on environmental stochastic conditions during breeding.	[Sanz-Aguilar, Ana; Ramirez, Francisco; Gutierrez-Exposito, Carlos; Forero, Manuela G.] CSIC, Estn Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain; [Sanz-Aguilar, Ana; Tavecchia, Giacomo; Doxa, Aggeliki; Oro, Daniel] IMEDEA CSIC UIB, Populat Ecol Grp, Inst Mediterrani Estudis Avancats, Esporles, Spain; [Afan, Isabel] CSIC, Estn Biol Donana, Lab SIG & Teledetecc LAST EBD, E-41080 Seville, Spain; [Doxa, Aggeliki] Univ Montpellier 2, CNRS, UMR 5554, Inst Sci Evolut, Montpellier, France; [Bertolero, Albert] Inst Res & Tecnol Agroalimentaries, Unitat Ecosistemes Aquat, St Carlos De La Rapita, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; IRTA	Sanz-Aguilar, A (corresponding author), CSIC, Estn Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain.	ana.sanzaguilar@ebd.csic.es	Gutiérrez-Expósito, Carlos/H-3478-2016; Ramírez, Francisco/I-3553-2014; Oro, Daniel/H-4208-2012; Tavecchia, Giacomo/N-3961-2014; Afán, Isabel/F-4783-2015; Bertolero, Albert/I-6448-2019; Sanz-Aguilar, Ana/D-3778-2014	Gutiérrez-Expósito, Carlos/0000-0002-2907-7998; Ramírez, Francisco/0000-0001-9670-486X; Oro, Daniel/0000-0003-4782-3007; Tavecchia, Giacomo/0000-0001-5435-2691; Afán, Isabel/0000-0003-3874-0461; Bertolero, Albert/0000-0002-6834-2600; Sanz-Aguilar, Ana/0000-0002-4177-9749; Doxa, Aggeliki/0000-0003-4279-1499	Regional Government of Balearic Islands; FEDER; Spanish Government [JCI-2011-09085, REN2002-0045, CGL2009-09801, CGL2006-02247/BOS]	Regional Government of Balearic Islands; FEDER(European Commission); Spanish Government(Spanish GovernmentEuropean Commission)	Research funds were partially provided by the Regional Government of Balearic Islands and FEDER funding, and the Spanish Government (JCI-2011-09085, REN2002-0045, CGL2009-09801 and CGL2006-02247/BOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaraz P, 2011, ECOLOGY, V92, P1948, DOI 10.1890/11-0181.1; Balkiz O, 2007, J ORNITHOL, V148, P347, DOI 10.1007/s10336-007-0136-2; Bechet A, 2008, IBIS, V150, P69, DOI 10.1111/j.1474-919X.2007.00740.x; Boulinier T, 2008, BIOL LETTERS, V4, P538, DOI 10.1098/rsbl.2008.0291; Breton AR, 2008, WATERBIRDS, V31, P15, DOI 10.1675/1524-4695(2008)31[15:SOAHGL]2.0.CO;2; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Bustamante J, 2009, J ENVIRON MANAGE, V90, P2219, DOI 10.1016/j.jenvman.2007.08.021; Cam E, 2004, J ANIM ECOL, V73, P723, DOI 10.1111/j.0021-8790.2004.00848.x; Cama A, 2012, MAR ECOL PROG SER, V463, P285, DOI 10.3354/meps09861; Chokri M, 2008, THESIS; Chokri MA, 2012, OSTRICH, V83, P13, DOI 10.2989/00306525.2012.659226; Chokri MA, 2011, BIRD STUDY, V58, P443, DOI 10.1080/00063657.2011.602957; Chokri MA, 2008, REV ECOL-TERRE VIE, V63, P351; Choquet R, 2009, ENVIRON ECOL STAT SE, V3, P845, DOI 10.1007/978-0-387-78151-8_39; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Cramp S, 1983, HDB BIRDS EUROPE MID, V3; Crone EE, 2001, EVOLUTION, V55, P2611; Cubaynes S, 2011, BIOL LETTERS, V7, P303, DOI 10.1098/rsbl.2010.0778; DENNIS B, 1991, ECOL MONOGR, V61, P115, DOI 10.2307/1943004; Dies Jose Ignacio, 2000, Ardeola, V47, P255; Doxa A, 2013, ANIM CONSERV, V16, P684, DOI 10.1111/acv.12048; Engen S, 2005, MATH BIOSCI, V195, P210, DOI 10.1016/j.mbs.2005.02.003; Fernandez-Chacon A, 2013, ECOGRAPHY, V36, P1117, DOI 10.1111/j.1600-0587.2013.00246.x; Frederiksen M, 2005, OIKOS, V111, P209, DOI 10.1111/j.0030-1299.2005.13746.x; Frederiksen M, 2004, J APPL ECOL, V41, P1129, DOI 10.1111/j.0021-8901.2004.00966.x; Frederiksen M, 2012, DIVERS DISTRIB, V18, P530, DOI 10.1111/j.1472-4642.2011.00864.x; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gaston KJ, 2009, P ROY SOC B-BIOL SCI, V276, P1391, DOI [10.1098/rspb.2009.0100, 10.1098/rspb.2008.1480]; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Grosbois V, 2008, BIOL REV, V83, P357, DOI 10.1111/j.1469-185X.2008.00047.x; Grosbois V, 2009, ECOLOGY, V90, P2922, DOI 10.1890/08-1657.1; Hanski I, 1999, METAPOPULATION ECOLO; HARRISON S, 1989, OIKOS, V56, P293, DOI 10.2307/3565613; HOEPFFNER N, 1994, OCEANOL ACTA, V17, P431; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Isenmann P, 1993, P 2 S MEDMARAVIS SEO, P65; Jenouvrier S, 2005, OIKOS, V108, P511, DOI 10.1111/j.0030-1299.2005.13351.x; Karvonen J, 2012, J AVIAN BIOL, V43, P102, DOI 10.1111/j.1600-048X.2011.05376.x; Kloskowski J, 2009, AQUAT CONSERV, V19, P815, DOI 10.1002/aqc.1027; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Lewison R., 2012, Endangered Species Research, V17, P93, DOI 10.3354/esr00419; Morris W. F., 2002, QUANTITATIVE CONSERV; Oro D, 1997, ICES J MAR SCI, V54, P695, DOI 10.1006/jmsc.1997.0246; Oro D, 2004, P ROY SOC B-BIOL SCI, V271, P387, DOI 10.1098/rspb.2003.2609; Oro D, 2003, SCI MAR, V67, P13, DOI 10.3989/scimar.2003.67s213; Oro D, 2002, WATERBIRDS, V25, P67, DOI 10.1675/1524-4695(2002)025[0067:BBAPDO]2.0.CO;2; Oro D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042753; Oro D, 2011, BIOL CONSERV, V144, P851, DOI 10.1016/j.biocon.2010.11.018; Oro D, 2009, BIOL CONSERV, V142, P1830, DOI 10.1016/j.biocon.2009.03.023; Parejo D, 2006, IBIS, V148, P146, DOI 10.1111/j.1474-919X.2006.00494.x; Peron G, 2010, OIKOS, V119, P524, DOI 10.1111/j.1600-1706.2009.17882.x; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Ramirez F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047551; Rappole JH, 2002, ARDEA, V90, P525; Rendon MA, 2008, BIOL CONSERV, V141, P1371, DOI 10.1016/j.biocon.2008.03.006; Roff Derek A., 1992; Sadoul N, 1996, COLON WATERBIRD, V19, P46, DOI 10.2307/1521945; Sadoul N, 1997, COLON WATERBIRD, V20, P330, DOI 10.2307/1521701; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; SAFRIEL UN, 1995, ISR J ZOOL, V41, P417; Sanz-Aguilar A, 2012, J ANIM ECOL, V81, P1171, DOI 10.1111/j.1365-2656.2012.01997.x; Sanz-Aguilar A, 2009, ECOGRAPHY, V32, P637, DOI 10.1111/j.1600-0587.2009.05596.x; SCHREIBER E.A., 2001, BIOL MARINE BIRDS, V1st; Sergio F, 2011, OECOLOGIA, V166, P79, DOI 10.1007/s00442-010-1795-x; Skalski J.R., 1993, P9; Sousa PM, 2011, NAT HAZARD EARTH SYS, V11, P33, DOI 10.5194/nhess-11-33-2011; Tavecchia G, 2002, IBIS, V144, pE79, DOI 10.1046/j.1474-919X.2002.00059.x; Tavecchia G, 2008, ECOLOGY, V89, P77, DOI 10.1890/06-0326.1; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; WOLFF WJ, 1993, HYDROBIOLOGIA, V258, P211, DOI 10.1007/BF00006198	72	8	8	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92674	10.1371/journal.pone.0092674	http://dx.doi.org/10.1371/journal.pone.0092674			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664115	Green Submitted, Green Published, gold			2022-12-27	WOS:000333459900094
J	Sui, HS; Gui, T; Jia, L; Guo, W; Han, JW; Liu, YJ; Bao, ZY; Li, HP; Li, JY; Li, L				Sui, Hongshuai; Gui, Tao; Jia, Lei; Guo, Wei; Han, Jingwan; Liu, Yongjian; Bao, Zuoyi; Li, Hanping; Li, Jingyun; Li, Lin			Different Frequencies of Drug Resistance Mutations among HIV-1 Subtypes Circulating in China: A Comprehensive Study	PLOS ONE			English	Article							EFAVIRENZ CONCENTRATIONS; REVERSE-TRANSCRIPTASE; GENETIC DIVERSITY; VIRUS; INDIVIDUALS; DISTINCT; PLASMA; CYP2B6; TYPE-1; POLYMORPHISM	The rapid spreading of HIV drug resistance is threatening the overall success of free HAART in China. Much work has been done on drug-resistant mutations, however, most of which were based on subtype B. Due to different genetic background, subtypes difference would have an effect on the development of drug-resistant mutations, which has already been proved by more and more studies. In China, the main epidemic subtypes are CRF07_BC, CRF08_BC, Thai B and CRF01_AE. The depiction of drug resistance mutations in those subtypes will be helpful for the selection of regimens for Chinese. In this study, the distributions difference of amino acids at sites related to HIV drug resistance were compared among subtype B, CRF01_AE, CRF07_BC and CRF08_BC strains prevalent in China. The amino acid composition of sequences belonging to different subtypes, which were obtained from untreated and treated individuals separately, were also compared. The amino acids proportions of 19 sites in RT among subtype B, CRF01_AE and CRF08_BC have significant difference in drug resistance groups (chi-square test, p<0.05). Genetic barriers analysis revealed that sites 69, 138, 181, 215 and 238 were significantly different among subtypes (Kruskal Wallis test, p<0.05). All subtypes shared three highest prevalent drug resistance sites 103, 181 and 184 in common. Many drug resistant sites in protease show surprising high proportions in almost all subtypes in drug-naive patients. This is the first comprehensive study in China on different development of drug resistance among different subtypes. The detailed data will lay a foundation for HIV treatment regimens design and improve HIV therapy in China.	[Sui, Hongshuai; Gui, Tao; Jia, Lei; Guo, Wei; Han, Jingwan; Liu, Yongjian; Bao, Zuoyi; Li, Hanping; Li, Jingyun; Li, Lin] Beijing Inst Microbiol & Epidemiol, Dept AIDS Res, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Sui, Hongshuai] Beidaihe 281 Hosp, Clin Lab, Qinhuangdao, Hebei Province, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Li, JY (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept AIDS Res, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	lijy@nic.bmi.ac.cn; dearwood@sina.com			National Natural Science Foundation Key Project [30830088]	National Natural Science Foundation Key Project	National Natural Science Foundation Key Project, grant numbers is 30830088 and the URL of the funder's website is http://npd.nsfc.gov.cn/anywordSearch!search.action. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benish RL, 2010, INFECT GENET EVOL, V10, P60, DOI 10.1016/j.meegid.2009.09.018; Boffito M, 2005, CURR OPIN INFECT DIS, V18, P543, DOI 10.1097/01.qco.0000191507.48481.10; Brown KC, 2012, PHARMACOGENOMICS, V13, P113, DOI [10.2217/pgs.11.132, 10.2217/PGS.11.132]; Calcagno A, 2012, BRIT J CLIN PHARMACO, V74, P134, DOI 10.1111/j.1365-2125.2012.04163.x; Carr DF, 2010, J ANTIMICROB CHEMOTH, V65, P1889, DOI 10.1093/jac/dkq260; de la Tribonniere X, 2008, HIV CLIN TRIALS, V9, P192, DOI 10.1310/hct0903-192; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Faria N, 2012, PERFORMANCE SUBTYPIN; Foley BT, 2013, HIV SEQUENCE COMPEND, P13; FuJie Z, 2008, CHINAS NATL FREE ANT, P33; GALLO RC, 1983, SCIENCE, V220, P865, DOI 10.1126/science.6601823; Gandhi M, 2012, J INFECT DIS, V206, P1453, DOI 10.1093/infdis/jis508; Gatanaga H, 2007, CLIN INFECT DIS, V45, P1230, DOI 10.1086/522175; Haaland RE, 2013, PUBLIC HEALTH GENOM, V16, P31, DOI 10.1159/000345935; Haase AT, 1999, ANNU REV IMMUNOL, V17, P625, DOI 10.1146/annurev.immunol.17.1.625; Julg B, 2005, INFECTION, V33, P299, DOI 10.1007/s15010-005-6405-1; KALISH ML, 1994, AIDS RES HUM RETROV, V10, P1573, DOI 10.1089/aid.1994.10.1573; Kantor R, 2005, PLOS MED, V2, P325, DOI 10.1371/journal.pmed.0020112; Lehr T, 2011, PHARMACOGENET GENOM, V21, P721, DOI 10.1097/FPC.0b013e32834a522e; Lemey P, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P1; Lubomirov R, 2007, PHARMACOGENOMICS, V8, P623, DOI 10.2217/14622416.8.6.623; OU CY, 1993, LANCET, V341, P1171, DOI 10.1016/0140-6736(93)91001-3; Pai NP, 2012, JAIDS-J ACQ IMM DEF, V59, P382, DOI 10.1097/QAI.0b013e31824a0628; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Pieniazek D, 2000, AIDS, V14, P1489, DOI 10.1097/00002030-200007280-00004; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Preissner S, 2010, NUCLEIC ACIDS RES, V38, pD237, DOI 10.1093/nar/gkp970; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Rhee SY, 2006, AIDS, V20, P643, DOI 10.1097/01.aids.0000216363.36786.2b; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Santos AF, 2010, VIRUSES-BASEL, V2, P503, DOI 10.3390/v2020503; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Shafer RW, 2007, AIDS, V21, P215, DOI 10.1097/QAD.0b013e328011e691; Simon F, 1998, NAT MED, V4, P1032, DOI 10.1038/2017; Stuart L, 2004, STANDARD OPERATING P; Subbarao S, 1998, AIDS RES HUM RETROV, V14, P319, DOI 10.1089/aid.1998.14.319; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Vallari A, 2011, J VIROL, V85, P1403, DOI 10.1128/JVI.02005-10; van de Vijver DA, 2006, JAIDS-J ACQ IMM DEF, V41, P352, DOI 10.1097/01.qai.0000209899.05126.e4; Vandamme AM, 1999, DRUGS, V57, P337; Wainberg MA, 2010, VIRUSES-BASEL, V2, P2493, DOI 10.3390/v2112493; YiMing S, 2010, THESTRATEGY METHODOL	42	19	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91803	10.1371/journal.pone.0091803	http://dx.doi.org/10.1371/journal.pone.0091803			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663120	gold, Green Submitted, Green Published			2022-12-27	WOS:000333459900029
J	da Costa, OP; Hoffman, A; Rey, JW; Mansmann, U; Buch, T; Tresch, A				da Costa, Olivia Prazeres; Hoffman, Arthur; Rey, Johannes W.; Mansmann, Ulrich; Buch, Thorsten; Tresch, Achim			Selection of Higher Order Regression Models in the Analysis of Multi-Factorial Transcription Data	PLOS ONE			English	Article							YERSINIA-ENTEROCOLITICA; INFECTION; RESISTANT; NETWORK	Introduction: Many studies examine gene expression data that has been obtained under the influence of multiple factors, such as genetic background, environmental conditions, or exposure to diseases. The interplay of multiple factors may lead to effect modification and confounding. Higher order linear regression models can account for these effects. We present a new methodology for linear model selection and apply it to microarray data of bone marrow-derived macrophages. This experiment investigates the influence of three variable factors: the genetic background of the mice from which the macrophages were obtained, Yersinia enterocolitica infection (two strains, and a mock control), and treatment/non-treatment with interferon-c. Results: We set up four different linear regression models in a hierarchical order. We introduce the eruption plot as a new practical tool for model selection complementary to global testing. It visually compares the size and significance of effect estimates between two nested models. Using this methodology we were able to select the most appropriate model by keeping only relevant factors showing additional explanatory power. Application to experimental data allowed us to qualify the interaction of factors as either neutral (no interaction), alleviating (co-occurring effects are weaker than expected from the single effects), or aggravating (stronger than expected). We find a biologically meaningful gene cluster of putative C2TA target genes that appear to be co-regulated with MHC class II genes. Conclusions: We introduced the eruption plot as a tool for visual model comparison to identify relevant higher order interactions in the analysis of expression data obtained under the influence of multiple factors. We conclude that model selection in higher order linear regression models should generally be performed for the analysis of multi-factorial microarray data.	[da Costa, Olivia Prazeres; Buch, Thorsten] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany; [Hoffman, Arthur] St Marys Hosp, Dept Med, Frankfurt, Germany; [Hoffman, Arthur; Rey, Johannes W.] Johannes Gutenberg Univ Mainz, Dept Med, D-55122 Mainz, Germany; [Mansmann, Ulrich] Univ Munich, Inst Med Informat Biometry & Epidemiol IBE, Munich, Germany; [Tresch, Achim] Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Cologne, Germany; [Tresch, Achim] Univ Cologne, Inst Genet, Cologne, Germany	Technical University of Munich; St. Marien Hospital; Johannes Gutenberg University of Mainz; University of Munich; Max Planck Society; University of Cologne	da Costa, OP (corresponding author), Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany.	olivia.dacosta@mikrobio.med.tum.de	Buch, Thorsten/P-1659-2019	Buch, Thorsten/0000-0002-2236-9074	Max Planck Gesellschaft	Max Planck Gesellschaft(Max Planck Society)	This work is funded by the Max Planck Gesellschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUTENRIETH IB, 1994, INFECT IMMUN, V62, P2590, DOI 10.1128/IAI.62.6.2590-2599.1994; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Breslow N E, 1980, IARC Sci Publ, P5; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Defrance M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-396; Dumcke S, 2012, NUCLEIC ACIDS RES, V40, P8883, DOI 10.1093/nar/gks695; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; HANCOCK GE, 1986, INFECT IMMUN, V53, P26, DOI 10.1128/IAI.53.1.26-31.1986; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hummel M, 2008, BIOINFORMATICS, V24, P78, DOI 10.1093/bioinformatics/btm531; Jaimovich A, 2010, BIOINFORMATICS, V26, pi228, DOI 10.1093/bioinformatics/btq197; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Krawczyk M, 2006, TISSUE ANTIGENS, V67, P183, DOI 10.1111/j.1399-0039.2006.00557.x; Li WT, 2012, J BIOINF COMPUT BIOL, V10, DOI 10.1142/S0219720012310038; Marcinowski L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002908; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Spitzer M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.31; Thomas-Chollier M, 2011, NUCLEIC ACIDS RES, V39, pW86, DOI 10.1093/nar/gkr377; Trulzsch K, 2003, INT J MED MICROBIOL, V293, P167, DOI 10.1078/1438-4221-00251; van Erp K, 2006, PHYSIOL GENOMICS, V25, P75, DOI 10.1152/physiolgenomics.00188.2005; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P863, DOI 10.1097/EDE.0b013e3181ba333c; Warringer Jonas, 2008, BMC Chemical Biology, V8, P3, DOI 10.1186/1472-6769-8-3; Zhang J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.80	27	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91840	10.1371/journal.pone.0091840	http://dx.doi.org/10.1371/journal.pone.0091840			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658540	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300041
J	Issan, Y; Kornowski, R; Aravot, D; Shainberg, A; Laniado-Schwartzman, M; Sodhi, K; Abraham, NG; Hochhauser, E				Issan, Yossi; Kornowski, Ran; Aravot, Dan; Shainberg, Asher; Laniado-Schwartzman, Michal; Sodhi, Komal; Abraham, Nader G.; Hochhauser, Edith			Heme Oxygenase-1 Induction Improves Cardiac Function following Myocardial Ischemia by Reducing Oxidative Stress	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; REPERFUSION INJURY; ADIPOSE-TISSUE; DIABETIC MICE; ADIPONECTIN; PROTECTS; PORE; GENE; TARGET; INFLAMMATION	Background: Oxidative stress plays a key role in exacerbating diabetes and cardiovascular disease. Heme oxygenase-1 (HO-1), a stress response protein, is cytoprotective, but its role in post myocardial infarction (MI) and diabetes is not fully characterized. We aimed to investigate the protection and the mechanisms of HO-1 induction in cardiomyocytes subjected to hypoxia and in diabetic mice subjected to LAD ligation. Methods: In vitro: cultured cardiomyocytes were treated with cobalt-protoporphyrin (CoPP) and tin protoporphyrin (SnPP) prior to hypoxic stress. In vivo: CoPP treated streptozotocin-induced diabetic mice were subjected to LAD ligation for 2/24 h. Cardiac function, histology, biochemical damage markers and signaling pathways were measured. Results: HO-1 induction lowered release of lactate dehydrogenase (LDH) and creatine phospho kinase (CK), decreased propidium iodide staining, improved cell morphology and preserved mitochondrial membrane potential in cardiomyocytes. In diabetic mice, Fractional Shortening (FS) was lower than non-diabetic mice (35 +/- 1% vs. 41 +/- 2, respectively p<0.05). CoPP-treated diabetic animals improved cardiac function (43 +/- 2% p<0.01), reduced CK, Troponin T levels and infarct size compared to non-treated diabetic mice (P<0.01, P<0.001, P<0.01 respectively). CoPP-enhanced HO-1 protein levels and reduced oxidative stress in diabetic animals, as indicated by the decrease in superoxide levels in cardiac tissues and plasma TNF alpha levels (p<0.05). The increased levels of HO-1 by CoPP treatment after LAD ligation led to a shift of the Bcl-2/bax ratio towards the antiapoptotic process (p<0.05). CoPP significantly increased the expression levels of pAKT and pGSK3 beta (p<0.05) in cardiomyocytes and in diabetic mice with MI. SnPP abolished CoPP's cardioprotective effects. Conclusions: HO-1 induction plays a role in cardioprotection against hypoxic damage in cardiomyocytes and in reducing post ischemic cardiac damage in the diabetic heart as proved by the increased levels of pAKT with a concomitant inhibition of pGSK3 beta leading to preserved mitochondrial membrane potential.	[Issan, Yossi; Kornowski, Ran; Aravot, Dan; Hochhauser, Edith] Tel Aviv Univ, Felsenstein Med Res Inst, Cardiac Res Lab, Petah Tiqwa, Israel; [Kornowski, Ran] Tel Aviv Univ, Rabin Med Ctr, Dept Cardiol, Petah Tiqwa, Israel; [Aravot, Dan] Tel Aviv Univ, Rabin Med Ctr, Dept Cardiac Surg, Petah Tiqwa, Israel; [Shainberg, Asher] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel; [Laniado-Schwartzman, Michal] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA; [Sodhi, Komal; Abraham, Nader G.] Marshall Univ, Joan C Edwards Sch Med, Dept Internal Med, Huntington, WV USA	Tel Aviv University; Rabin Medical Center; Tel Aviv University; Rabin Medical Center; Tel Aviv University; Bar Ilan University; New York Medical College; Marshall University	Hochhauser, E (corresponding author), Tel Aviv Univ, Felsenstein Med Res Inst, Cardiac Res Lab, Petah Tiqwa, Israel.	hochhaus@post.tau.ac.il			National Institutes of Health [DK56601, HL-34300]; Brick Street Foundation Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brick Street Foundation Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partially supported by National Institutes of Health grants DK56601, HL-34300 and Brick Street Foundation Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2008, CURR PHARM DESIGN, V14, P412, DOI 10.2174/138161208783597371; Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Abraham NG, 2004, AM J PHYSIOL-HEART C, V287, pH2468, DOI 10.1152/ajpheart.01187.2003; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Borger DR, 1998, AM J PHYSIOL-HEART C, V274, pH965, DOI 10.1152/ajpheart.1998.274.3.H965; Cai CX, 2012, J BIOL CHEM, V287, P33720, DOI 10.1074/jbc.M112.385542; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; CROMPTON M, 1987, BIOCHEM J, V245, P915, DOI 10.1042/bj2450915; Emanuelov AK, 2010, BIOCHEM PHARMACOL, V79, P180, DOI 10.1016/j.bcp.2009.08.010; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Halestrap AP, 1999, BIOCHEM SOC SYMP, V66, P181, DOI 10.1042/bss0660181; Hill-Kapturczak N, 2002, DNA CELL BIOL, V21, P307, DOI 10.1089/104454902753759726; Hochhauser E, 2007, CELL BIOCHEM BIOPHYS, V47, P11, DOI 10.1385/CBB:47:1:11; Hochhauser E, 2003, AM J PHYSIOL-HEART C, V284, pH2351, DOI 10.1152/ajpheart.00783.2002; Hori R, 2002, J BIOL CHEM, V277, P10712, DOI 10.1074/jbc.M107749200; Hosick PA, 2012, AM J PHYSIOL-REG I, V302, pR207, DOI 10.1152/ajpregu.00517.2011; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P468, DOI 10.1016/0003-9861(79)90373-4; Issan Y, 2012, CAN J CARDIOL, V28, P728, DOI 10.1016/j.cjca.2012.01.013; Javadov S, 2009, J PHARMACOL EXP THER, V330, P670, DOI 10.1124/jpet.109.153213; Juhaszova M, 2009, CIRC RES, V104, P1240, DOI 10.1161/CIRCRESAHA.109.197996; Kawamoto S, 2011, TISSUE ENG PT A, V17, P1605, DOI 10.1089/ten.tea.2010.0447; Kleschyov AL, 2002, CIRCULATION, V105, pA196; Kruger AL, 2005, CIRCULATION, V111, P3126, DOI 10.1161/CIRCULATIONAHA.104.517102; Kusmic C, 2010, J CELL BIOCHEM, V109, P1033, DOI 10.1002/jcb.22486; L'Abbate A, 2007, AM J PHYSIOL-HEART C, V293, pH3532, DOI 10.1152/ajpheart.00826.2007; Li M, 2008, DIABETES, V57, P1526, DOI 10.2337/db07-1764; Melo LG, 2002, CIRCULATION, V105, P602, DOI 10.1161/hc0502.103363; Ohashi K, 2006, HYPERTENSION, V47, P1108, DOI 10.1161/01.HYP.0000222368.43759.a1; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Quarrie R, 2012, J SURG RES, V178, P8, DOI 10.1016/j.jss.2012.05.090; Reilly MP, 2003, CIRCULATION, V108, P1546, DOI 10.1161/01.CIR.0000088846.10655.E0; SARDANA MK, 1987, P NATL ACAD SCI USA, V84, P2464, DOI 10.1073/pnas.84.8.2464; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Sharma HS, 1996, MOL CELL BIOCHEM, V157, P111; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shmist YA, 2005, J PHARMACOL EXP THER, V313, P1046, DOI 10.1124/jpet.104.081281; Shneyvays V, 2005, AM J PHYSIOL-HEART C, V288, pH2792, DOI 10.1152/ajpheart.01157.2004; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Tompkins AJ, 2006, BBA-MOL BASIS DIS, V1762, P223, DOI 10.1016/j.bbadis.2005.10.001; Toshima S, 2000, ARTERIOSCL THROM VAS, V20, P2243, DOI 10.1161/01.ATV.20.10.2243; Wang GW, 2010, CIRCULATION, V121, P1912, DOI 10.1161/CIRCULATIONAHA.109.905471; Xu A, 2010, AM J PHYSIOL-HEART C, V302, pH1231; Zhu WD, 2008, CLIN SCI, V114, P361, DOI 10.1042/CS20070347	47	58	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92246	10.1371/journal.pone.0092246	http://dx.doi.org/10.1371/journal.pone.0092246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658657	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300065
J	Liu, YH; Chen, CC; Yang, CM; Chen, YJ; Tsai, FJ				Liu, Yu-Huei; Chen, Ching-Chu; Yang, Chen-Ming; Chen, Yi-Ju; Tsai, Fuu-Jen			Dual Effect of a Polymorphism in the Macrophage Migration Inhibitory Factor Gene Is Associated with New-Onset Graves Disease in a Taiwanese Chinese Population	PLOS ONE			English	Article							MULTIFACTOR DIMENSIONALITY REDUCTION; AUTOIMMUNE THYROID-DISEASE; FACTOR MIF; RHEUMATOID-ARTHRITIS; CTLA4 GENE; OPHTHALMOPATHY; SUSCEPTIBILITY; EXPRESSION; SEVERITY; LOCI	Graves disease (GD) is an autoimmune disease. Macrophage migration inhibitory factor (MIF) is a potent cytokine that plays an important role in the regulation of immune responses. Two polymorphisms in the promoter region of MIF, rs5844572 and rs755622, are known to affect MIF expression. The purpose of this study was to investigate the relationship between polymorphisms in the MIF gene promoter and the severity of GD. A total of 677 individuals, including 481 GD patients and 196 ethnically matched healthy controls, were genotyped to identify differences in the distribution of the MIF polymorphisms rs5844572 and rs755622. Although there were no significant differences in the allele or genotype distributions among patients with different grades of goiter in GD and healthy controls, the distribution of the C allele, especially C/C genotype, of the rs755622 single nucleotide polymorphism (SNP) in MIF, may be as a risk factor for goiter initiation whereas a protector against development of severe goiter in patients with untreated GD (p<0.05). A goiter-developmental model incorporating genetic (MIF SNP rs755622) and environmental risk factors (gender, radioiodine treatment, thyroid gland surgery and vitiligo) significantly increased the prediction accuracy. Further studies are required to address the role of MIF polymorphisms, as well as their association with other candidate genes, in GD.	[Liu, Yu-Huei; Yang, Chen-Ming; Chen, Yi-Ju; Tsai, Fuu-Jen] China Med Univ Hosp, Dept Med Genet & Med Res, Taichung, Taiwan; [Liu, Yu-Huei] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Chen, Ching-Chu] China Med Univ Hosp, Div Endocrinol & Metab, Dept Med, Taichung, Taiwan; [Chen, Ching-Chu] China Med Univ, Dept Endocrinol & Metab, Coll Chinese Med, Taichung, Taiwan; [Tsai, Fuu-Jen] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Tsai, Fuu-Jen] China Med Univ Hosp, Dept Pediat, Taichung, Taiwan; [Tsai, Fuu-Jen] China Med Univ, Sch Postbaccalaureate Chinese Med, Taichung, Taiwan; [Tsai, Fuu-Jen] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Tsai, Fuu-Jen] Asia Univ, Dept Biotechnol & Bioinformat, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan; Asia University Taiwan	Tsai, FJ (corresponding author), China Med Univ Hosp, Dept Med Genet & Med Res, Taichung, Taiwan.	d0704@mail.cmuh.org.tw	Liu, Yu-Huei/D-2539-2014; Tsai, Fuu-Jen/J-4140-2015	Liu, Yu-Huei/0000-0002-3603-868X; 	National Science Council of Taiwan [NSC 100-2314-B-039-031-]; China Medical University [CMU-101-N1-08]; China Medical University Hospital [DMR-100-162]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University); China Medical University Hospital	This publication was supported by grants from the National Science Council of Taiwan (NSC 100-2314-B-039-031-), China Medical University (CMU-101-N1-08) and China Medical University Hospital (DMR-100-162). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Abed Y, 2011, P NATL ACAD SCI USA, V108, P8224, DOI 10.1073/pnas.1017624108; Atsumi T, 2007, J IMMUNOL, V179, P5399, DOI 10.4049/jimmunol.179.8.5399; Bacher M, 1997, AM J PATHOL, V150, P235; BAHN RS, 1993, NEW ENGL J MED, V329, P1468; Baugh JA, 2002, GENES IMMUN, V3, P170, DOI 10.1038/sj.gene.6363867; Berdeli A, 2005, PEDIATR NEPHROL, V20, P1566, DOI 10.1007/s00467-005-1930-9; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Brand OJ, 2009, HUM MOL GENET, V18, P1704, DOI 10.1093/hmg/ddp087; Brent GA, 2008, NEW ENGL J MED, V358, P2594, DOI 10.1056/NEJMcp0801880; Brown RS, 2009, CURR OPIN PEDIATR, V21, P523, DOI 10.1097/MOP.0b013e32832cf824; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Canning MO, 2003, AUTOIMMUNITY, V36, P429, DOI 10.1080/0891630310001602984; Chu X, 2011, NAT GENET, V43, P897, DOI 10.1038/ng.898; Colobran R, 2011, HUM MOL GENET, V20, P3415, DOI 10.1093/hmg/ddr247; Dechairo BM, 2005, EUR J HUM GENET, V13, P1223, DOI 10.1038/sj.ejhg.5201485; Donn R, 2004, ARTHRITIS RHEUM-US, V50, P1604, DOI 10.1002/art.20178; Donn R, 2002, ARTHRITIS RHEUM-US, V46, P2402, DOI 10.1002/art.10492; Donn RP, 2001, ARTHRITIS RHEUM-US, V44, P1782, DOI 10.1002/1529-0131(200108)44:8<1782::AID-ART314>3.0.CO;2-#; Greven D, 2010, EXPERT OPIN THER TAR, V14, P253, DOI 10.1517/14728220903551304; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Han SZ, 2006, INT J IMMUNOGENET, V33, P281, DOI 10.1111/j.1744-313X.2006.00614.x; Kochi Y, 2009, J IMMUNOL, V183, P5502, DOI 10.4049/jimmunol.0901982; Kotake Satoshi, 2002, International Ophthalmology Clinics, V42, P99; Kouki T, 2000, J IMMUNOL, V165, P6606, DOI 10.4049/jimmunol.165.11.6606; Kozaci LD, 2010, MOD RHEUMATOL, V20, P34, DOI 10.1007/s10165-009-0230-9; LAMKI L, 1973, J CLIN ENDOCR METAB, V36, P358, DOI 10.1210/jcem-36-2-358; Lan HY, 2000, KIDNEY INT, V57, P499, DOI 10.1046/j.1523-1755.2000.00869.x; Leech M, 1999, ARTHRITIS RHEUM, V42, P1601, DOI 10.1002/1529-0131(199908)42:8<1601::AID-ANR6>3.0.CO;2-B; Ling V, 1999, GENOMICS, V60, P341, DOI 10.1006/geno.1999.5930; Liu YH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-97; Liu YH, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-71; Liu YH, 2010, INVEST OPHTH VIS SCI, V51, P6238, DOI 10.1167/iovs.09-4965; Liu YH, 2010, OPHTHALMOLOGY, V117, P1645, DOI 10.1016/j.ophtha.2009.12.037; Lolis Elias, 2001, Current Opinion in Pharmacology, V1, P662, DOI 10.1016/S1471-4892(01)00112-6; Maa MC, 2011, BIOMEDICINE-TAIWAN, V1, P11, DOI 10.1016/j.biomed.2011.10.002; Metz CN, 1997, ADV IMMUNOL, V66, P197, DOI 10.1016/S0065-2776(08)60598-2; Morshed SA, 2012, IMMUNOL RES, V54, P191, DOI 10.1007/s12026-012-8312-8; Nakabayashi K, 2011, J HUM GENET, V56, P772, DOI 10.1038/jhg.2011.99; Nalbantoglu S, 2013, CYTOKINE, V62, P160, DOI 10.1016/j.cyto.2013.02.024; Newby PR, 2010, EUR J HUM GENET, V18, P1021, DOI 10.1038/ejhg.2010.55; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Nishihira J, 2003, ANN NY ACAD SCI, V995, P171, DOI 10.1111/j.1749-6632.2003.tb03220.x; Onodera S, 2000, J BIOL CHEM, V275, P444, DOI 10.1074/jbc.275.1.444; Ostergaard C, 2009, CRIT CARE, V13, DOI 10.1186/cc7933; Powell ND, 2005, J IMMUNOL, V175, P5611, DOI 10.4049/jimmunol.175.9.5611; Radstake TRDJ, 2005, ARTHRITIS RHEUM, V52, P3020, DOI 10.1002/art.21285; Renner P, 2012, FASEB J, V26, P907, DOI 10.1096/fj.11-195065; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Sanchez E, 2006, GENES IMMUN, V7, P433, DOI 10.1038/sj.gene.6364310; Santos L, 2001, CLIN EXP IMMUNOL, V123, P309, DOI 10.1046/j.1365-2249.2001.01423.x; Santos LL, 2011, ARTHRITIS RHEUM-US, V63, P960, DOI 10.1002/art.30203; Shimizu T, 2001, J INVEST DERMATOL, V116, P989, DOI 10.1046/j.0022-202x.2001.01366.x; Sreih A, 2011, ARTHRITIS RHEUM-US, V63, P3942, DOI 10.1002/art.30624; Stosic-Grujicic S, 2009, AUTOIMMUN REV, V8, P244, DOI 10.1016/j.autrev.2008.07.037; Swainson LA, 2010, J IMMUNOL, V184, P3639, DOI 10.4049/jimmunol.0903943; Swanberg M, 2010, BONE, V47, P424, DOI 10.1016/j.bone.2010.05.009; Taylor JC, 2006, J CLIN ENDOCR METAB, V91, P646, DOI 10.1210/jc.2005-0686; Thorsby E, 1997, HUM IMMUNOL, V53, P1, DOI 10.1016/S0198-8859(97)00024-4; Wendt M, 2013, MOL MED, V19, P109, DOI 10.2119/molmed.2012.00352; Yende S, 2009, FASEB J, V23, P2403, DOI 10.1096/fj.09-129445; Zhao SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057758; Zhao SX, 2013, HUM MOL GENET	64	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92849	10.1371/journal.pone.0092849	http://dx.doi.org/10.1371/journal.pone.0092849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667663	Green Submitted, Green Published, gold			2022-12-27	WOS:000333675600090
J	McClure, MC; Bickhart, D; Null, D; VanRaden, P; Xu, LY; Wiggans, G; Liu, G; Schroeder, S; Glasscock, J; Armstrong, J; Cole, JB; Van Tassell, CP; Sonstegard, TS				McClure, Matthew C.; Bickhart, Derek; Null, Dan; VanRaden, Paul; Xu, Lingyang; Wiggans, George; Liu, George; Schroeder, Steve; Glasscock, Jarret; Armstrong, Jon; Cole, John B.; Van Tassell, Curtis P.; Sonstegard, Tad S.			Bovine Exome Sequence Analysis and Targeted SNP Genotyping of Recessive Fertility Defects BH1, HH2, and HH3 Reveal a Putative Causative Mutation in SMC2 for HH3	PLOS ONE			English	Article							CATTLE	The recent discovery of bovine haplotypes with negative effects on fertility in the Brown Swiss, Holstein, and Jersey breeds has allowed producers to identify carrier animals using commercial single nucleotide polymorphism (SNP) genotyping assays. This study was devised to identify the causative mutations underlying defective bovine embryo development contained within three of these haplotypes (Brown Swiss haplotype 1 and Holstein haplotypes 2 and 3) by combining exome capture with next generation sequencing. Of the 68,476,640 sequence variations (SV) identified, only 1,311 genome-wide SNP were concordant with the haplotype status of 21 sequenced carriers. Validation genotyping of 36 candidate SNP identified only 1 variant that was concordant to Holstein haplotype 3 (HH3), while no variants located within the refined intervals for HH2 or BH1 were concordant. The variant strictly associated with HH3 is a non-synonymous SNP (T/C) within exon 24 of the Structural Maintenance of Chromosomes 2 (SMC2) on Chromosome 8 at position 95,410,507 (UMD3.1). This polymorphism changes amino acid 1135 from phenylalanine to serine and causes a non-neutral, non-tolerated, and evolutionarily unlikely substitution within the NTPase domain of the encoded protein. Because only exome capture sequencing was used, we could not rule out the possibility that the true causative mutation for HH3 might lie in a non-exonic genomic location. Given the essential role of SMC2 in DNA repair, chromosome condensation and segregation during cell division, our findings strongly support the non-synonymous SNP (T/C) in SMC2 as the likely causative mutation. The absence of concordant variations for HH2 or BH1 suggests either the underlying causative mutations lie within a non-exomic region or in exome regions not covered by the capture array.	[McClure, Matthew C.; Xu, Lingyang; Liu, George; Schroeder, Steve; Van Tassell, Curtis P.; Sonstegard, Tad S.] ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD 20705 USA; [Bickhart, Derek; Null, Dan; VanRaden, Paul; Wiggans, George; Cole, John B.] ARS, USDA, Anim Improvement Programs Lab, Beltsville, MD USA; [Glasscock, Jarret; Armstrong, Jon] Cofactor Genom, St Louis, MO USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Sonstegard, TS (corresponding author), ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD 20705 USA.	Tad.sonstegard@ars.usda.gov	Xu, Lingyang/W-8664-2019; Liu, George/K-3371-2019; Cole, John B./J-8571-2014; Van Tassell, Curtis P./O-4247-2019; Telezhenko, Liubov/O-8034-2018; Krusir, Galina/F-1312-2016	Liu, George/0000-0003-0192-6705; Cole, John B./0000-0003-1242-4401; Van Tassell, Curtis P./0000-0002-8416-2087; Telezhenko, Liubov/0000-0001-6675-2625; Krusir, Galina/0000-0001-6464-5754; Bickhart, Derek/0000-0003-2223-9285; Schroeder, Steven/0000-0001-9103-5150	Animal Improvement Programs [1245-31000-101-00]; Bovine Functional Genomics Laboratories [1265-31000-104-00]; ARS [ARS-0423740] Funding Source: Federal RePORTER	Animal Improvement Programs; Bovine Functional Genomics Laboratories; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The contribution by scientists in the Animal Improvement Programs and Bovine Functional Genomics Laboratories are supported by appropriated projects 1245-31000-101-00 and 1265-31000-104-00, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams H. A., 2012, PLANT AN GEN 20 C SA; Center for Bioinformatics and Computational Biology, 2013, UMD 3 1 BOST ASS; Charlier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043085; Cole JB, 2009, J DAIRY SCI, V92, P2931, DOI 10.3168/jds.2008-1762; Faculty of Veterinary Science University of Sydney, 2013, ONL MEND INH AN; Fritz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065550; Georgieva L, 2006, P NATL ACAD SCI USA, V103, P12469, DOI 10.1073/pnas.0603029103; Hayes B, 2013, PLANT AN GEM 21 C SA; Hou YL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-127; Illumina Inc, 2010, BOVINEHD GEN BEADCH; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Schwarzenbacher H., 2012, 63 EAAP M BRAT SLOV, P170; Sonstegard TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054872; VanRaden PM, 2011, J DAIRY SCI, V94, P6153, DOI 10.3168/jds.2011-4624; VanRaden P.M., 2011, FINDHAP F90; VanRaden PM, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-10; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907	19	53	62	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92769	10.1371/journal.pone.0092769	http://dx.doi.org/10.1371/journal.pone.0092769			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667746	gold, Green Published, Green Submitted			2022-12-27	WOS:000333675600072
J	Mohamed, AAM; Wang, QS; Bembenek, J; Ichihara, N; Hiragaki, S; Suzuki, T; Takeda, M				Mohamed, Ahmed A. M.; Wang, Qiushi; Bembenek, Jadwiga; Ichihara, Naoyuki; Hiragaki, Susumu; Suzuki, Takeshi; Takeda, Makio			N-acetyltransferase (nat) Is a Critical Conjunct of Photoperiodism between the Circadian System and Endocrine Axis in Antheraea pernyi	PLOS ONE			English	Article							DROSOPHILA CLOCK GENE; PERIOD PROTEIN; POSTTRANSLATIONAL REGULATION; DOUBLE-TIME; MELATONIN; BRAIN; LIGHT; PHOSPHORYLATION; DIAPAUSE; CRICKET	Since its discovery in 1923, the biology of photoperiodism remains a mystery in many ways. We sought the link connecting the circadian system to an endocrine switch, using Antheraea pernyi. PER-, CLK- and CYC-ir were co-expressed in two pairs of dorsolateral neurons of the protocerebrum, suggesting that these are the circadian neurons that also express melatonin-, NAT- and HIOMT-ir. The results suggest that a melatonin pathway is present in the circadian neurons. Melatonin receptor (MT2 or MEL-1B-R)-ir in PTTH-ir neurons juxtaposing clock neurons suggests that melatonin gates PTTH release. RIA showed a melatonin rhythm with a peak four hours after lights off in adult brain both under LD16:8 (LD) and LD12:12 (SD), and both the peak and the baseline levels were higher under LD than SD, suggesting a photoperiodic influence. When pupae in diapause were exposed to 10 cycles of LD, or stored at 4 degrees C for 4 months under constant darkness, an increase of NAT activity was observed when PTTH released ecdysone. DNA sequence upstream of nat contained E-boxes to which CYC/CLK could bind, and nat transcription was turned off by clk or cyc dsRNA. dsRNA(NAT) caused dysfunction of photoperiodism. dsRNA(PER) upregulated nat transcription as anticipated, based on findings in the Drosophila melanogaster circadian system. Transcription of nat, cyc and clk peaked at ZT12. RIA showed that dsRNA(NAT) decreased melatonin while dsRNA(PER) increased melatonin. Thus nat, a clock controlled gene, is the critical link between the circadian clock and endocrine switch. MT-binding may release PTTH, resulting in termination of diapause. This study thus examined all of the basic functional units from the clock: a photoperiodic counter as an accumulator of mRNA(NAT), to endocrine switch for photoperiodism in A. pernyi showing this system is self-complete without additional device especially for photoperiodism.	[Mohamed, Ahmed A. M.; Wang, Qiushi; Suzuki, Takeshi; Takeda, Makio] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 657, Japan; [Bembenek, Jadwiga; Ichihara, Naoyuki; Hiragaki, Susumu; Takeda, Makio] Kobe Univ, Grad Sch Sci & Technol, Kobe, Hyogo 657, Japan	Kobe University; Kobe University	Takeda, M (corresponding author), Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 657, Japan.	mtakeda@kobe-u.ac.jp	Suzuki, Takeshi/F-7548-2012; Suzuki, Takeshi/G-4845-2014	Suzuki, Takeshi/0000-0002-7930-1425; 	JSPS [B 18380042]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	JSPS Grant-in-Aid for Scientific Research (B 18380042) was provided to Makio Takeda. URL: http://www.jsps.go.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akten B, 2003, NAT NEUROSCI, V6, P251, DOI 10.1038/nn1007; BINKLEY S, 1988, J PINEAL RES, V5, P87, DOI 10.1111/j.1600-079X.1988.tb00771.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang DC, 2003, J BIOL CHEM, V278, P38149, DOI 10.1074/jbc.M306937200; Dardente H, 2010, CURR BIOL, V20, P2193, DOI 10.1016/j.cub.2010.10.048; Fang YS, 2007, GENE DEV, V21, P1506, DOI 10.1101/gad.1541607; Foulkes NS, 1996, P NATL ACAD SCI USA, V93, P14140, DOI 10.1073/pnas.93.24.14140; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Hall JC, 2003, ADV GENET, V48, P1, DOI 10.1016/S0065-2660(03)48000-0; Han B, 2009, J INSECT PHYSIOL, V55, P415, DOI 10.1016/j.jinsphys.2009.01.005; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Hiragaki S, 2009, CELL TISSUE RES, V335, P607, DOI 10.1007/s00441-008-0747-9; Hut RA, 2010, CURR BIOL, V21, pR21; Ichihara N, 2000, THESIS KOBE U JAPAN; Ikeno T, 2011, BIOCHEM BIOPH RES CO, V410, P394, DOI 10.1016/j.bbrc.2011.05.142; Ikeno T, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-116; Imaizumi T, 2010, CURR OPIN PLANT BIOL, V13, P83, DOI 10.1016/j.pbi.2009.09.007; ITOH MT, 1995, MOL CELL ENDOCRINOL, V115, P59, DOI 10.1016/0303-7207(95)03670-3; KAPPERS JA, 1978, J NEURAL TRANSM, P13; Kim EY, 2006, P NATL ACAD SCI USA, V103, P6178, DOI 10.1073/pnas.0511215103; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Kobelkova A, 2010, J BIOL RHYTHM, V25, P399, DOI 10.1177/0748730410385283; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Lin JM, 2005, J NEUROSCI, V25, P11175, DOI 10.1523/JNEUROSCI.2159-05.2005; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; LIU X, 1992, J NEUROSCI, V12, P2735; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Masumoto K, 2010, CURR BIOL, V20, P2199, DOI 10.1016/j.cub.2010.11.038; Matsui T, 2009, PHYSIOL BEHAV, V96, P548, DOI 10.1016/j.physbeh.2008.12.009; Matsumoto M, 2002, J INSECT PHYSIOL, V48, P765, DOI 10.1016/S0022-1910(02)00102-6; Mito T, 2011, ENTOMOL SCI, V14, P1, DOI 10.1111/j.1479-8298.2010.00408.x; Pavelka J, 2003, EUR J ENTOMOL, V100, P255, DOI 10.14411/eje.2003.041; Peschel N, 2006, P NATL ACAD SCI USA, V103, P17313, DOI 10.1073/pnas.0606675103; PITTENDRIGH CS, 1972, P NATL ACAD SCI USA, V69, P2734, DOI 10.1073/pnas.69.9.2734; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Richter K, 1999, EUR J ENTOMOL, V96, P341; Rothenfluh A, 2000, NEURON, V26, P505, DOI 10.1016/S0896-6273(00)81182-4; Rubin EB, 2006, GENOME RES, V16, P1352, DOI 10.1101/gr.5094806; Sakamoto T, 2009, J BIOL RHYTHM, V24, P379, DOI 10.1177/0748730409341523; Sandrelli F, 2008, INSECT MOL BIOL, V17, P447, DOI 10.1111/j.1365-2583.2008.00832.x; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; Sauman I, 1996, NEURON, V17, P889, DOI 10.1016/S0896-6273(00)80220-2; SAUNDERS DS, 1971, J INSECT PHYSIOL, V17, P801, DOI 10.1016/0022-1910(71)90098-9; Sehadova H, 2004, J BIOL RHYTHM, V19, P466, DOI 10.1177/0748730404269153; Shao QM, 2008, CELL TISSUE RES, V331, P435, DOI 10.1007/s00441-007-0534-z; SOKOLOVE PG, 1975, BRAIN RES, V87, P13, DOI 10.1016/0006-8993(75)90775-1; Stehlik J, 2008, J BIOL RHYTHM, V23, P129, DOI 10.1177/0748730407313364; Takeda Makio, 2011, International Journal of Wild Silkmoth & Silk, V16, P97; Tschuch C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-60; Tsugehara T, 2013, COMP BIOCHEM PHYS C, V157, P93, DOI 10.1016/j.cbpc.2012.10.003; Vafopoulou X, 2010, J COMP NEUROL, V518, P1264, DOI 10.1002/cne.22274; VIVIENROELS B, 1984, NEUROSCI LETT, V49, P153, DOI 10.1016/0304-3940(84)90152-6; Wang Q, 2014, ENTOMOL SCI IN PRESS; Wang QS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079381; Yamada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027493; Yamano H, 2001, J INSECT PHYSIOL, V47, P943, DOI 10.1016/S0022-1910(01)00067-1; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135; Yu WJ, 2006, GENE DEV, V20, P723, DOI 10.1101/gad.1404406; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zhang Y, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P513, DOI 10.1016/B978-0-12-384747-8.10015-7; Zheng XZ, 2008, GENETICS, V178, P1147, DOI 10.1534/genetics.107.088658	62	34	37	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92680	10.1371/journal.pone.0092680	http://dx.doi.org/10.1371/journal.pone.0092680			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667367	Green Submitted, Green Published, gold			2022-12-27	WOS:000333675600064
J	Peng, F; Xiao, XQ; Jiang, YF; Luo, KZ; Tian, Y; Peng, ML; Zhang, M; Xu, Y; Gong, GZ				Peng, Feng; Xiao, Xinqiang; Jiang, Yongfang; Luo, Kaizhong; Tian, Yi; Peng, Milin; Zhang, Min; Xu, Yun; Gong, Guozhong			HBx Down-Regulated Gld2 Plays a Critical Role in HBV-Related Dysregulation of miR-122	PLOS ONE			English	Article							LIPID-METABOLISM; VIRUS; EXPRESSION; MICRORNA; PROTEIN; STABILIZATION; REPLICATION; GENE	miR-122 is a liver-rich-specific microRNA that plays an important role in hepatic gene expression via post-transcription regulation, and it is potentially associated with the development of hepatocellular carcinoma. It has been confirmed that miR-122 is down-regulated during HBV infection; however, how HBV affects miR-122 is still debated. One research provided evidence that HBx could reduce the miR-122 transcription level, but the other insisted that HBV had no significant effect on miR-122 transcription level but reduce miR-122 level via binding and sequestering endogenous miR-122. It is determinate that Gld2 could increase the specific miRNA stabilization by monoadenylation which was a post-transcription regulation. In this study, we aimed to investigate the mechanism of HBV-induced reduction of miR-122 and examine whether Gld2 is involved in it. According to the results of a microRNA microarray, we found miR-122 was the most down-regulated microRNA in HepG2.2.15 compared to HepG2. As revealed by qRT-PCR and western blotting analyses, both miR-122 and Gld2 levels were reduced in hepatic cell lines with expression of HBV or HBx but not other proteins of HBV, and overexpression of Gld2 could abolish the effect of HBV and HBx on the miR-122 level. What's more, both HBV and HBx have no significant effect on pre-miR-122 levels. And the dual-luciferase assay implicated that HBx could reduce the Gld2 promoter activity but had no significant effect on miR-122 promoter activity. In conclusion, HBx is a critical protein derived from HBV, which regulates miR-122 via down-regulating Gld2.	[Peng, Feng; Xiao, Xinqiang; Jiang, Yongfang; Luo, Kaizhong; Tian, Yi; Peng, Milin; Zhang, Min; Xu, Yun; Gong, Guozhong] Cent South Univ, Xiangya Hosp 2, Dept Infect Dis, Changsha, Hunan, Peoples R China	Central South University	Gong, GZ (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Infect Dis, Changsha, Hunan, Peoples R China.	guozhonggong@yahoo.com			Chinese National Key Clinical Specialty Project [2013]; Chinese National Science and Technology Major Project [2008ZX10202]	Chinese National Key Clinical Specialty Project; Chinese National Science and Technology Major Project	This work was supported by grants from both the Chinese National Key Clinical Specialty Project (NO. 2013) and the Chinese National Science and Technology Major Project (NO. 2008ZX10202, http://www.nmp.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Burns DM, 2011, NATURE, V473, P105, DOI 10.1038/nature09908; Chang JH, 2008, J VIROL, V82, P8215, DOI 10.1128/JVI.02575-07; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; D'Ambrogio A, 2012, CELL REP, V2, P1537, DOI 10.1016/j.celrep.2012.10.023; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Glahder JA, 2011, APMIS, V119, P769, DOI 10.1111/j.1600-0463.2011.02804.x; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Hu J, 2012, PROTEIN CELL, V3, P364, DOI 10.1007/s13238-012-2036-3; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kutay H, 2011, J CELL BIOCHEM, V99, P671, DOI [10.1002/jcb.20982.Downregulation, DOI 10.1002/JCB.20982.D0WNREGULATI0N]; Kwak JE, 2004, P NATL ACAD SCI USA, V101, P4407, DOI 10.1073/pnas.0400779101; Li CF, 2013, J VIROL, V87, P2193, DOI 10.1128/JVI.02831-12; Li ZY, 2011, J HEPATOL, V55, P602, DOI 10.1016/j.jhep.2010.12.023; Lin CJF, 2008, BIOCHEM BIOPH RES CO, V375, P315, DOI 10.1016/j.bbrc.2008.07.154; Ma LN, 2010, CANCER BIOL THER, V9, P554, DOI 10.4161/cbt.9.7.11267; Maeda Y, 2006, BIOCHEM J, V400, P303, DOI 10.1042/BJ20060614; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Murakami S, 1999, INTERVIROLOGY, V42, P81, DOI 10.1159/000024969; Ren M, 2012, ANTIVIR RES, V94, P225, DOI 10.1016/j.antiviral.2012.04.004; Song K, 2013, HEPATOLOGY, V58, P1681, DOI 10.1002/hep.26514; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Waidmann O, 2012, J VIRAL HEPATITIS, V19, pE58, DOI 10.1111/j.1365-2893.2011.01536.x; Wang SF, 2012, HEPATOLOGY, V55, P730, DOI 10.1002/hep.24809; Wen J, 2012, J CLIN INVEST, V122, P2773, DOI 10.1172/JCI63966	30	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92998	10.1371/journal.pone.0092998	http://dx.doi.org/10.1371/journal.pone.0092998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667324	gold, Green Published, Green Submitted			2022-12-27	WOS:000333675600121
J	Yamaguchi, K; Inoue, Y; Ohki, N; Satoya, N; Inoue, F; Maeda, Y; Sekiguchi, H; Suzuki, M; Tsuji, T; Aoshiba, K; Nagai, A				Yamaguchi, Kazuhiro; Inoue, Yuji; Ohki, Noboru; Satoya, Natsumi; Inoue, Fukumi; Maeda, Yoshiko; Sekiguchi, Haruki; Suzuki, Mayumi; Tsuji, Takao; Aoshiba, Kazutetsu; Nagai, Atsushi			Gender-Specific Impacts of Apnea, Age, and BMI on Parasympathetic Nerve Dysfunction during Sleep in Patients with Obstructive Sleep Apnea	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; RESPIRATORY SINUS ARRHYTHMIA; SYSTEM ACTIVITY; INDEXES; MECHANISMS; SEVERITY; OBESITY	Background: The gender-specific influences of various confounding factors, including apnea, age, BMI, and cigarette consumption, on the function of the parasympathetic nerve system (PNS) during sleep in OSA patients has never been investigated. Methods: One hundred ninety-seven males and 63 females with OSA were subjected to full PSG examinations including assessment of R-R intervals (RRIs) during an overnight ECG. The PNS-derived modulatory effect on the RRIs and the variability of this effect were quantified during REM and NREM using instantaneous time-frequency analysis with complex demodulation. The spectral domain with the maximum instantaneous amplitude in the high-frequency band between 0.15 and 0.4 Hz was defined as the main HF peak and used as a surrogate marker of PNS discharge. Based on density-spectrum-array maps of the main HF peaks (HF-DSA map), shifts in the central frequency of the main HF peak over time were continuously observed. When the main HF peaks on the HF-DSA maps maintained the same central frequency for more than 20 sec or 5 min, the PNS functions were considered to be "stable" or "very stable", respectively. Results: Apneas enhanced PNS-derived cardiac-modulation during REM in males, but more importantly, they made PNS-function unstable during both REM and NREM in males and during NREM in females. Aging blunted the PNS-derived cardiac-modulation during both REM and NREM regardless of gender, but aging had no impact on the stability of PNS-function. BMI blunted PNS-eliciting cardiac-modulation during REM in males and during NREM in both males and females. BMI made the PNS unstable during REM in females. Neither height nor cigarette consumption influenced any PNS-related parameter. Conclusions: The PNS-derived cardiac-modulation was generally inhibited by aging and obesity, in which the effect of obesity was gender-specific. The PNS instability at nighttime was mainly induced by apneas but by obesity particularly during REM in females.	[Yamaguchi, Kazuhiro; Inoue, Yuji; Satoya, Natsumi; Inoue, Fukumi; Suzuki, Mayumi] Tokyo Womens Med Univ, Aoyama Hosp, Comprehens Med Ctr Sleep Disorders, Minato Ku, Tokyo, Japan; [Ohki, Noboru] NoruPro Light Syst Inc, Kokubunji, Tokyo, Japan; [Maeda, Yoshiko] Tokyo Womens Med Univ, Aoyama Hosp, Dept Urol, Minato Ku, Tokyo, Japan; [Sekiguchi, Haruki] Tokyo Womens Med Univ, Aoyama Hosp, Dept Cardiol, Minato Ku, Tokyo, Japan; [Tsuji, Takao; Aoshiba, Kazutetsu] Tokyo Med Univ Ibaraki Med Ctr, Dept Resp Med, Inashiki, Ibaraki, Japan; [Nagai, Atsushi] Tokyo Womens Med Univ, Dept Med 1, Shinjuku Ku, Tokyo, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University; Tokyo Women's Medical University; Tokyo Women's Medical University	Yamaguchi, K (corresponding author), Tokyo Womens Med Univ, Aoyama Hosp, Comprehens Med Ctr Sleep Disorders, Minato Ku, Tokyo, Japan.	yamaguc@sirius.ocn.ne.jp			Teijin Home Healthcare; GSK; AstraZeneca; Boeringer Ingelheim; Eisai Global; Daiichi Sankyo; Otsuka; Ono; Air Water	Teijin Home Healthcare; GSK(GlaxoSmithKline); AstraZeneca(AstraZeneca); Boeringer Ingelheim; Eisai Global; Daiichi Sankyo(Daiichi Sankyo Company Limited); Otsuka(Otsuka Pharmaceutical); Ono; Air Water	KY was supported by the funds donated from the companies including Teijin Home Healthcare, GSK, AstraZeneca, Boeringer Ingelheim, Eisai Global, Daiichi Sankyo, Otsuka, Ono, and Air Water. These funders, excepting Teijin Home Healthcare, did not fund this study. All the funders, including Teijin Home Healthcare, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Arnardottir ES, 2009, SLEEP, V32, P447, DOI 10.1093/sleep/32.4.447; Balachandran JS, 2012, AM J CARDIOL, V109, P140, DOI 10.1016/j.amjcard.2011.07.071; Barutcu I, 2005, ANN NONINVAS ELECTRO, V10, P324, DOI 10.1111/j.1542-474X.2005.00636.x; BERGER RD, 1989, AM J PHYSIOL, V256, pH142, DOI 10.1152/ajpheart.1989.256.1.H142; BERNTSON GG, 1993, PSYCHOPHYSIOLOGY, V30, P183, DOI 10.1111/j.1469-8986.1993.tb01731.x; Camm AJ, 1996, CIRCULATION, V93, P1043; Gula LJ, 2003, ANN NONINVAS ELECTRO, V8, P144, DOI 10.1046/j.1542-474X.2003.08209.x; HAYANO J, 1994, J APPL PHYSIOL, V77, P2879, DOI 10.1152/jappl.1994.77.6.2879; HAYANO J, 1993, AM J PHYSIOL, V264, pH1229, DOI 10.1152/ajpheart.1993.264.4.H1229; Hayano J, 2010, CARDIAC DIS AUTONOMI, P71; Hilton MF, 2001, EUR RESPIR J, V17, P1258, DOI 10.1183/09031936.01.00009301; HRUSHESKY WJM, 1984, SCIENCE, V224, P1001, DOI 10.1126/science.6372092; JensenUrstad K, 1997, ACTA PHYSIOL SCAND, V160, P235, DOI 10.1046/j.1365-201X.1997.00142.x; Khoo MCK, 1999, SLEEP, V22, P443, DOI 10.1093/sleep/22.4.443; Kim JA, 2005, J AM BOARD FAM PRACT, V18, P97, DOI 10.3122/jabfm.18.2.97; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Molfino A, 2009, EUR J CLIN NUTR, V63, P1263, DOI 10.1038/ejcn.2009.35; Muralikrishnan Krishnan, 2013, Indian J Physiol Pharmacol, V57, P31; Nagai N, 2003, OBES RES, V11, P25, DOI 10.1038/oby.2003.6; O'brien I, 1987, BRIT HEART J, V55, P348; Park DH, 2008, J KOREAN MED SCI, V23, P226, DOI 10.3346/jkms.2008.23.2.226; Piestrzeniewicz Katarzyna, 2008, Cardiol J, V15, P43; Rajalakshmi R, 2012, PAK J PHYSL, V8, P39; Reardon M, 1996, PACE, V19, P1863, DOI 10.1111/j.1540-8159.1996.tb03241.x; SHANNON DC, 1987, AM J PHYSIOL, V253, pH874, DOI 10.1152/ajpheart.1987.253.4.H874; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; Song MK, 2012, PSYCHIAT INVEST, V9, P65, DOI 10.4306/pi.2012.9.1.65; Stein PK, 1997, AM J CARDIOL, V80, P302, DOI 10.1016/S0002-9149(97)00350-0; Stein PK, 2005, J CARDIOVASC ELECTR, V16, P13, DOI 10.1046/j.1540-8167.2005.04358.x; TAHA BH, 1995, J APPL PHYSIOL, V78, P638, DOI 10.1152/jappl.1995.78.2.638; Vanninen E, 1996, CLIN PHYSIOL, V16, P209, DOI 10.1111/j.1475-097X.1996.tb00569.x; Yamaguchi K, 2014, SLEEP MED, V15, P33, DOI 10.1016/j.sleep.2013.10.005; Yasuma F, 2004, CHEST, V125, P683, DOI 10.1378/chest.125.2.683; Zhang J, 2013, SCIENCE, V341, P28	35	5	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92808	10.1371/journal.pone.0092808	http://dx.doi.org/10.1371/journal.pone.0092808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667894	gold, Green Submitted, Green Published			2022-12-27	WOS:000333675600078
J	Alwan, H; Pruijm, M; Ponte, B; Ackermann, D; Guessous, I; Ehret, G; Staessen, JA; Asayama, K; Vuistiner, P; Younes, SE; Paccaud, F; Wuerzner, G; Pechere-Bertschi, A; Mohaupt, M; Vogt, B; Martin, PY; Burnier, M; Bochud, M				Alwan, Heba; Pruijm, Menno; Ponte, Belen; Ackermann, Daniel; Guessous, Idris; Ehret, Georg; Staessen, Jan A.; Asayama, Kei; Vuistiner, Philippe; Younes, Sandrine Estoppey; Paccaud, Fred; Wuerzner, Gregoire; Pechere-Bertschi, Antoinette; Mohaupt, Markus; Vogt, Bruno; Martin, Pierre-Yves; Burnier, Michel; Bochud, Murielle			Epidemiology of Masked and White-Coat Hypertension: The Family-Based SKIPOGH Study	PLOS ONE			English	Article							BLOOD-PRESSURE-MEASUREMENT; ISOLATED OFFICE HYPERTENSION; 10-YEAR FOLLOW-UP; SUSTAINED HYPERTENSION; GENERAL-POPULATION; TRUE NORMOTENSION; HOME HYPERTENSION; EUROPEAN-SOCIETY; RISK-FACTORS; DETERMINANTS	Objective: We investigated factors associated with masked and white-coat hypertension in a Swiss population-based sample. Methods: The Swiss Kidney Project on Genes in Hypertension is a family-based cross-sectional study. Office and 24-hour ambulatory blood pressure were measured using validated devices. Masked hypertension was defined as office blood pressure<140/90 mmHg and daytime ambulatory blood pressure >= 135/85 mmHg. White-coat hypertension was defined as office blood pressure >= 140/90 mmHg and daytime ambulatory blood pressure<135/85 mmHg. Mixed-effect logistic regression was used to examine the relationship of masked and white-coat hypertension with associated factors, while taking familial correlations into account. High-normal office blood pressure was defined as systolic/diastolic blood pressure within the 130-139/85-89 mmHg range. Results: Among the 652 participants included in this analysis, 51% were female. Mean age (+/- SD) was 48 (+/- 18) years. The proportion of participants with masked and white coat hypertension was respectively 15.8% and 2.6%. Masked hypertension was associated with age (odds ratio (OR) = 1.02, p = 0.012), high-normal office blood pressure (OR = 6.68, p<0.001), and obesity (OR = 3.63, p = 0.001). White-coat hypertension was significantly associated with age (OR = 1.07, p<0 .001) but not with education, family history of hypertension, or physical activity. Conclusions: Our findings suggest that physicians should consider ambulatory blood pressure monitoring for older individuals with high-normal office blood pressure and/or who are obese.	[Alwan, Heba; Guessous, Idris; Vuistiner, Philippe; Younes, Sandrine Estoppey; Paccaud, Fred; Bochud, Murielle] Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Pruijm, Menno; Wuerzner, Gregoire; Burnier, Michel] Univ Lausanne Hosp, Serv Nephrol, Lausanne, Switzerland; [Ponte, Belen; Martin, Pierre-Yves] Univ Hosp Geneva, Dept Specialties, Serv Nephrol, Geneva, Switzerland; [Ackermann, Daniel; Mohaupt, Markus; Vogt, Bruno] Univ Hosp Bern, Clin Nephrol Hypertens & Clin Pharmacol, Inselspital, CH-3010 Bern, Switzerland; [Ackermann, Daniel; Mohaupt, Markus; Vogt, Bruno] Univ Bern, Bern, Switzerland; [Guessous, Idris] Univ Hosp Geneva, Unit Populat Epidemiol, Geneva, Switzerland; [Ehret, Georg] Univ Hosp Geneva, Dept Cardiol, Geneva, Switzerland; [Staessen, Jan A.; Asayama, Kei] Univ Leuven, Studies Coordinating Ctr, Dept Cardiovasc Dis, Div Hypertens & Cardiovasc Rehabil, Louvain, Belgium; [Staessen, Jan A.] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands; [Asayama, Kei] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi 980, Japan; [Pechere-Bertschi, Antoinette] Univ Hosp Geneva, Dept Community Med & Primary Care & Emergency Med, Geneva, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Bern; University Hospital of Bern; University of Bern; University of Geneva; University of Geneva; KU Leuven; Maastricht University; Tohoku University; University of Geneva	Bochud, M (corresponding author), Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland.	murielle.bochud@chuv.ch	EHRET, Georg B/A-9532-2009; Mohaupt, Markus/AAE-3368-2020; Pruijm, Menno/AAA-4281-2020; Vogt, Bruno/AAS-2876-2020; Bochud, Murielle/A-3981-2010; paccaud, fred/M-7516-2019; Staessen, Jan A/A-1065-2011; Asayama, Kei/H-5598-2011; Vuistiner, Philippe/AAD-5010-2020	EHRET, Georg B/0000-0002-5730-0675; Pruijm, Menno/0000-0003-1027-1851; Vogt, Bruno/0000-0002-1548-6387; Bochud, Murielle/0000-0002-5727-0218; Staessen, Jan A/0000-0002-3026-1637; Asayama, Kei/0000-0003-3365-0547; Ackermann, Daniel/0000-0003-0550-354X; Alwan, Heba/0000-0001-5516-6022; Vuistiner, Philippe/0000-0002-2661-4970; Wuerzner, Gregoire/0000-0002-6424-7630	Swiss National Science Foundation [FN 33CM30-124087, FN 33CM30-140331]; Swiss School of Public Health Plus	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss School of Public Health Plus	The study is supported by the Swiss National Science Foundation FN 33CM30-124087 and FN 33CM30-140331, with specific funding for Daniel Ackermann, Heba Alwan, Georg Ehret, Idris Guessous, Belen Ponte, and Menno Pruijm. Murielle Bochud was supported by the Swiss School of Public Health Plus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli F, 2010, AM J HYPERTENS, V23, P941, DOI 10.1038/ajh.2010.112; Bidlingmeyer I, 1996, J HYPERTENS, V14, P327, DOI 10.1097/00004872-199603000-00009; Bjorklund K, 2003, CIRCULATION, V107, P1297, DOI 10.1161/01.CIR.0000054622.45012.12; Bobrie G, 2001, ARCH INTERN MED, V161, P2205, DOI 10.1001/archinte.161.18.2205; Bobrie G, 2008, J HYPERTENS, V26, P1715, DOI 10.1097/HJH.0b013e3282fbcedf; Cacciolati C, 2013, AM J HYPERTENS, V26, P367, DOI 10.1093/ajh/hps054; Cacciolati C, 2011, AM J HYPERTENS, V24, P674, DOI 10.1038/ajh.2011.23; Fagard RH, 2007, J HYPERTENS, V25, P2280, DOI 10.1097/HJH.0b013e3282efc1fe; Fagard RH, 2007, J HYPERTENS, V25, P2193, DOI 10.1097/HJH.0b013e3282ef6185; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Grassi G, 2007, HYPERTENSION, V50, P537, DOI 10.1161/HYPERTENSIONAHA.107.092528; Guessous I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039877; Gustavsen PH, 2003, J HUM HYPERTENS, V17, P811, DOI 10.1038/sj.jhh.1001643; Hanninen MRA, 2011, J HYPERTENS, V29, P1880, DOI 10.1097/HJH.0b013e32834a98ba; Hanninen MRA, 2010, J HYPERTENS, V28, P709, DOI 10.1097/HJH.0b013e3283369faa; Hansen TW, 2006, AM J HYPERTENS, V19, P243, DOI 10.1016/j.amjhyper.2005.09.018; Kuznetsova T, 2002, BLOOD PRESS MONIT, V7, P215, DOI 10.1097/00126097-200208000-00003; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Mancia G, 2011, NAT REV CARDIOL, V8, P686, DOI 10.1038/nrcardio.2011.115; Mancia G, 2009, HYPERTENSION, V54, P226, DOI 10.1161/HYPERTENSIONAHA.109.129882; O'Brien E, 2003, J HYPERTENS, V21, P821, DOI 10.1097/00004872-200305000-00001; O'Brien E, 2001, BMJ-BRIT MED J, V322, P531, DOI 10.1136/bmj.322.7285.531; Obara T, 2005, J HYPERTENS, V23, P1653, DOI 10.1097/01.hjh.0000178334.33352.56; Ohkubo T, 2005, J AM COLL CARDIOL, V46, P508, DOI 10.1016/j.jacc.2005.03.070; Pickering TG, 2002, HYPERTENSION, V40, P795, DOI 10.1161/01.HYP.0000038733.08436.98; Ponte B, 2013, HYPERTENSION; Pruijm M, 2013, EUR RADIOL, V23, P2899, DOI 10.1007/s00330-013-2900-4; Pruijm MT, 2010, BLOOD PRESS MONIT, V15, P322, DOI 10.1097/MBP.0b013e32833f56a8; Sarafidis PA, 2008, AM J NEPHROL, V28, P324, DOI 10.1159/000111825; Schoenthaler AM, 2010, AM J HYPERTENS, V23, P1082, DOI 10.1038/ajh.2010.141; Sega R, 2001, CIRCULATION, V104, P1385, DOI 10.1161/hc3701.096100; Sehestedt T, 2012, J HYPERTENS, V30, P513, DOI 10.1097/HJH.0b013e32834f6f60; Shimbo D, 2012, AM J HYPERTENS, V25, P664, DOI 10.1038/ajh.2012.15; Stergiou GS, 2008, BLOOD PRESS MONIT, V13, P37, DOI 10.1097/MBP.0b013e3282c9acb0; Stergiou GS, 2007, J HYPERTENS, V25, P1590, DOI 10.1097/HJH.0b013e3281ab6c69; Trudel X, 2009, J HYPERTENS, V27, P1560, DOI 10.1097/HJH.0b013e32832cb036; Verdecchia P, 2005, HYPERTENSION, V45, P203, DOI 10.1161/01.HYP.0000151623.49780.89; Wang GL, 2007, J HYPERTENS, V25, P2398, DOI 10.1097/HJH.0b013e3282efeee7; Winnicki M, 1997, AM J HYPERTENS, V10, P419	41	43	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92522	10.1371/journal.pone.0092522	http://dx.doi.org/10.1371/journal.pone.0092522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663506	gold, Green Published			2022-12-27	WOS:000333459900070
J	Amann, A; Zwierzina, M; Gamerith, G; Bitsche, M; Huber, JM; Vogel, GF; Blumer, M; Koeck, S; Pechriggl, EJ; Kelm, JM; Hilbe, W; Zwierzina, H				Amann, Arno; Zwierzina, Marit; Gamerith, Gabriele; Bitsche, Mario; Huber, Julia M.; Vogel, Georg F.; Blumer, Michael; Koeck, Stefan; Pechriggl, Elisabeth J.; Kelm, Jens M.; Hilbe, Wolfgang; Zwierzina, Heinz			Development of an Innovative 3D Cell Culture System to Study Tumour - Stroma Interactions in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; FIBROBLASTS; SPHEROIDS; THERAPY; ACTIVATION; GENERATION; BIOLOGY; GROWTH	Introduction: We describe a novel 3D co-culture model using non-small cell lung cancer (NSCLC) cell lines in combination with lung fibroblasts. This model allows the investigation of tumour-stroma interactions and addresses the importance of having a more in vivo like cell culture model. Methods: Automation-compatible multi-well hanging drop microtiter plates were used for the production of 3D mono-and co-cultures. In these hanging drops the two NSCLC cell lines A549 and Colo699 were cultivated either alone or co-cultured with lung fibroblasts. The viability of tumour spheroids was confirmed after five and ten days by using Annexin V/Propidium Iodide staining for flow-cytometry. Tumour fibroblast spheroid formation was characterized by scanning electron microscope (SEM), semi-thin sections, fluorescence microscope and immunohistochemistry (IHC). In addition to conventional histology, protein expression of E-Cadherin, vimentin, Ki67, fibronectin, cytokeratin 7 and alpha-smooth muscle actin (alpha-SMA) was investigated by IHC. Results: Lower viability was observed in A549 monocultures compared to co-cultures, whereas Colo699 monocultures showed better viability compared to co-cultures. Ki67 expression varied significantly between mono-and co-cultures in both tumour cell lines. An increase of vimentin and decreased E-Cadherin expression could be detected during the course of the cultivation suggesting a transition to a more mesenchymal phenotype. Furthermore, the fibroblast cell line showed an expression of a-SMA only in co-culture with the cancer cell line A549, thereby indicating a mesenchymal to mesenchymal shift to an even more myofibroblast phenotype. Conclusion: We demonstrate that our method is a promising tool for the generation of tumour spheroid co-cultures. Furthermore, these spheroids allow the investigation of tumour-stroma interactions and a better reflection of in vivo conditions of cancer cells in their microenvironment. Our method holds potential to contribute to the development of anti-cancer agents and support the search for biomarkers.	[Amann, Arno; Gamerith, Gabriele; Huber, Julia M.; Koeck, Stefan; Hilbe, Wolfgang; Zwierzina, Heinz] Med Univ Innsbruck, Dept Internal Med 5, A-6020 Innsbruck, Tyrol, Austria; [Zwierzina, Marit; Bitsche, Mario; Vogel, Georg F.; Blumer, Michael; Pechriggl, Elisabeth J.] Med Univ Innsbruck, Dept Anat Histol & Embryol, A-6020 Innsbruck, Tyrol, Austria; [Kelm, Jens M.] InSphero AG, Schlieren, Canton Of Zuric, Switzerland	Medical University of Innsbruck; Medical University of Innsbruck; InSphero AG	Amann, A (corresponding author), Med Univ Innsbruck, Dept Internal Med 5, A-6020 Innsbruck, Tyrol, Austria.	arno.amann@i-med.ac.at		Vogel, Georg-Friedrich/0000-0002-2515-4490	Austrian Society of Haematology and Oncology (OeGHO); Verein fur Tumorfoschung	Austrian Society of Haematology and Oncology (OeGHO); Verein fur Tumorfoschung	This work was funded by means of a Ph.D grant of the Austrian Society of Haematology and Oncology (OeGHO) and further financially supported by the Verein fur Tumorfoschung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; Arteaga CL, 2003, BREAST CANCER RES, V5, P96, DOI 10.1186/bcr574; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Botchkina GI, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-192; Byrne HM, 2010, NAT REV CANCER, V10, P221, DOI 10.1038/nrc2808; Chen L, 2012, BIOMATERIALS, V33, P1437, DOI 10.1016/j.biomaterials.2011.10.056; Dacic S, 2011, ARCH PATHOL LAB MED, V135, P622, DOI 10.1043/2010-0625-RAIR.1; Drewitz M, 2011, BIOTECHNOL J, V6, P1488, DOI 10.1002/biot.201100290; Dudas J, 2011, EXP CELL RES, V317, P2222, DOI 10.1016/j.yexcr.2011.05.023; FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745; Forde PM, 2012, EXPERT OPIN PHARMACO, V13, P1195, DOI 10.1517/14656566.2012.688029; Friedrich J, 2007, INT J RADIAT BIOL, V83, P849, DOI 10.1080/09553000701727531; Giannoni E, 2010, CANCER RES, V70, P6945, DOI 10.1158/0008-5472.CAN-10-0785; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Hazlehurst LA, 2000, ONCOGENE, V19, P4319, DOI 10.1038/sj.onc.1203782; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hess MW, 2010, METHOD CELL BIOL, V96, P649, DOI 10.1016/S0091-679X(10)96027-5; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kelm JM, 2004, TRENDS BIOTECHNOL, V22, P195, DOI 10.1016/j.tibtech.2004.02.002; Kerbel R S, 1996, Hum Cell, V9, P257; Khaitan D, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-12; Kotsakis A, 2010, EXPERT OPIN PHARMACO, V11, P2363, DOI 10.1517/14656566.2010.498581; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Pearson Rachel, 2012, J Oncol Pharm Pract, V18, P271, DOI 10.1177/1078155211417477; Rasanen K, 2010, EXP CELL RES, V316, P2713, DOI 10.1016/j.yexcr.2010.04.032; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Seemayer CA, 2003, AM J PATHOL, V162, P1549, DOI 10.1016/S0002-9440(10)64289-7; Subramanian J, 2010, J THORAC ONCOL, V5, P1116, DOI 10.1097/JTO.0b013e3181e76159; Weigelt B, 2010, BREAST CANCER RES TR, V122, P35, DOI 10.1007/s10549-009-0502-2; WOBUS AM, 1991, DIFFERENTIATION, V48, P173, DOI 10.1111/j.1432-0436.1991.tb00255.x	33	117	120	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92511	10.1371/journal.pone.0092511	http://dx.doi.org/10.1371/journal.pone.0092511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663399	gold, Green Published, Green Submitted			2022-12-27	WOS:000333459900068
J	Cambien, B; Franken, PR; Lamit, A; Mauxion, T; Richard-Fiardo, P; Guglielmi, J; Crescence, L; Mari, B; Pourcher, T; Darcourt, J; Bardies, M; Vassaux, G				Cambien, Beatrice; Franken, Philippe R.; Lamit, Audrey; Mauxion, Thibault; Richard-Fiardo, Peggy; Guglielmi, Julien; Crescence, Lydie; Mari, Bernard; Pourcher, Thierry; Darcourt, Jacques; Bardies, Manuel; Vassaux, Georges			(TcO4-)-Tc-99m-, Auger-Mediated Thyroid Stunning: Dosimetric Requirements and Associated Molecular Events	PLOS ONE			English	Article							SODIUM-IODIDE SYMPORTER; CELLS IN-VITRO; INTRACELLULAR UPTAKE; CLONOGENIC SURVIVAL; RADIONUCLIDE THERAPY; SIMULATION TOOLKIT; GENE-EXPRESSION; POSITIVE CELLS; BREAST-CANCER; DNA-DAMAGE	Low-energy Auger and conversion electrons deposit their energy in a very small volume (a few nm(3)) around the site of emission. From a radiotoxicological point of view the effects of low-energy electrons on normal tissues are largely unknown, understudied, and generally assumed to be negligible. In this context, the discovery that the low-energy electron emitter, Tc-99m, can induce stunning on primary thyrocytes in vitro, at low absorbed doses, is intriguing. Extrapolated in vivo, this observation suggests that a radioisotope as commonly used in nuclear medicine as Tc-99m may significantly influence thyroid physiology. The aims of this study were to determine whether Tc-99m pertechnetate ((TcO4-)-Tc-99m) is capable of inducing thyroid stunning in vivo, to evaluate the absorbed dose of (TcO4-)-Tc-99m required to induce this stunning, and to analyze the biological events associated/concomitant with this effect. Our results show that (TcO4-)-Tc-99m-mediated thyroid stunning can be observed in vivo in mouse thyroid. The threshold of the absorbed dose in the thyroid required to obtain a significant stunning effect is in the range of 20 Gy. This effect is associated with a reduced level of functional Na/I symporter (NIS) protein, with no significant cell death. It is reversible within a few days. At the cellular and molecular levels, a decrease in NIS mRNA, the generation of double-strand DNA breaks, and the activation of the p53 pathway are observed. Low-energy electrons emitted by Tc-99m can, therefore, induce thyroid stunning in vivo in mice, if it is exposed to an absorbed dose of at least 20 Gy, a level unlikely to be encountered in clinical practice. Nevertheless this report presents an unexpected effect of low-energy electrons on a normal tissue in vivo, and provides a unique experimental setup to understand the fine molecular mechanisms involved in their biological effects.	[Cambien, Beatrice; Franken, Philippe R.; Lamit, Audrey; Richard-Fiardo, Peggy; Guglielmi, Julien; Crescence, Lydie; Pourcher, Thierry; Darcourt, Jacques; Vassaux, Georges] CEA, DSV, iBEB, Lab TIRO,UMRE 4320, Nice, France; [Cambien, Beatrice; Franken, Philippe R.; Lamit, Audrey; Richard-Fiardo, Peggy; Guglielmi, Julien; Crescence, Lydie; Mari, Bernard; Pourcher, Thierry; Darcourt, Jacques; Vassaux, Georges] Univ Nice Sophia Antipolis, F-06189 Nice, France; [Cambien, Beatrice; Franken, Philippe R.; Lamit, Audrey; Richard-Fiardo, Peggy; Guglielmi, Julien; Crescence, Lydie; Pourcher, Thierry; Darcourt, Jacques; Vassaux, Georges] Ctr Antoine Lacassagne, Dept Nucl Med, F-06054 Nice, France; [Mauxion, Thibault; Bardies, Manuel] Ctr Rech Cancerol, UMR INSERM UPS 1037, Toulouse, France; [Mari, Bernard] CNRS UMR 7275, Inst Pharmacol Mol & Cellulaire IPMC, Sophia Antipolis, France	CEA; UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur	Cambien, B (corresponding author), CEA, DSV, iBEB, Lab TIRO,UMRE 4320, Nice, France.	cambien@unice.fr	Mari, Bernard P/GVS-3100-2022; Cambien, Béatrice/AAD-8973-2021; Vassaux, Georges/N-9724-2016; Mari, Bernard/Q-5832-2019; Mari, Bernard P/D-7445-2015; Mari, Bernard P/F-8960-2013; Bardies, Manuel/L-3136-2014	Mari, Bernard P/0000-0002-0422-9182; Cambien, Béatrice/0000-0002-6914-0525; Vassaux, Georges/0000-0002-1149-7716; Mari, Bernard/0000-0002-0422-9182; Mari, Bernard P/0000-0002-0422-9182; Mari, Bernard P/0000-0002-0422-9182; Bardies, Manuel/0000-0002-1766-727X; Pourcher, Thierry/0000-0003-2839-4622	"Agence Nationale de la Recherche'' (ANR)	"Agence Nationale de la Recherche'' (ANR)(French National Research Agency (ANR))	This work is supported by grants from the "Agence Nationale de la Recherche'' (ANR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Allman KC, 2003, J NUCL MED, V44, P1194; Association NEM, 2007, PERF MEAS GAMM CAM; Barton KN, 2008, MOL THER, V16, P1761, DOI 10.1038/mt.2008.172; Barton KN, 2011, MOL THER, V19, P1353, DOI 10.1038/mt.2011.89; BLOOMER WD, 1977, NATURE, V265, P620, DOI 10.1038/265620a0; Brenner W, 2002, J NUCL MED, V43, P835; Cornelissen B, 2011, J NUCL MED, V52, P776, DOI 10.2967/jnumed.110.084392; Cornelissen Bart, 2010, Curr Drug Discov Technol, V7, P263, DOI 10.2174/157016310793360657; Costantini DL, 2007, J NUCL MED, V48, P1357, DOI 10.2967/jnumed.106.037937; Cristy M., 1987, REPORT ORNLTM 8381; Eckerman KF, 2008, MIRD RADIONUCLIDE DA; Freudenberg R, 2012, INT J RADIAT BIOL, V88, P991, DOI 10.3109/09553002.2012.728303; Ginj M, 2005, CLIN CANCER RES, V11, P1136; Huc-Brandt S, 2011, BBA-BIOMEMBRANES, V1808, P65, DOI 10.1016/j.bbamem.2010.08.013; Jan S, 2004, PHYS MED BIOL, V49, P4543, DOI 10.1088/0031-9155/49/19/007; Jan S, 2011, PHYS MED BIOL, V56, P881, DOI 10.1088/0031-9155/56/4/001; Kassis AI, 2011, RADIAT PROT DOSIM, V143, P241, DOI 10.1093/rpd/ncq385; Kotzerke J, 2012, NUKLEARMED-NUCL MED, V51, P170, DOI 10.3413/Nukmed-0506-12-05; Le Brigand K, 2007, BIOINFORMATICS, V23, P1304, DOI 10.1093/bioinformatics/btm106; Leoni SG, 2011, MOL ENDOCRINOL, V25, P1924, DOI 10.1210/me.2011-0038; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Loevinger R, 1991, MIRD PRIMER ABSORBED; Lundh C, 2007, J NUCL MED, V48, P481; Lundh C, 2009, J NUCL MED, V50, P1161, DOI 10.2967/jnumed.108.061150; Mariotti LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079541; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; McDougall IR, 2011, SEMIN NUCL MED, V41, P105, DOI 10.1053/j.semnuclmed.2010.10.004; Medvedec M, 2001, J NUCL MED, V42, P1129; Meller B, 2008, EUR J NUCL MED MOL I, V35, P1204, DOI 10.1007/s00259-007-0666-0; Merron A, 2010, EUR J NUCL MED MOL I, V37, P1377, DOI 10.1007/s00259-009-1379-3; MOORE FD, 1982, P NATL ACAD SCI-BIOL, V79, P3556, DOI 10.1073/pnas.79.11.3556; Norden MM, 2007, CANCER RES, V67, P7512, DOI 10.1158/0008-5472.CAN-07-0823; Paquet F, 2013, J RADIOL PROT, V33, pR1, DOI 10.1088/0952-4746/33/1/R1; Peerlinck I, 2009, CLIN CANCER RES, V15, P6595, DOI 10.1158/1078-0432.CCR-09-0262; Peyrottes I, 2009, EUR J ENDOCRINOL, V160, P215, DOI 10.1530/EJE-08-0505; Postgard P, 2002, J NUCL MED, V43, P828; Reilly RM, 2000, J NUCL MED, V41, P429; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; Richard-Fiardo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034086; Richard-Fiardo P, 2011, EXPERT OPIN BIOL TH, V11, P1273, DOI 10.1517/14712598.2011.588596; Rudqvist N, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-32; Segars WP, 2004, MOL IMAGING BIOL, V6, P149, DOI 10.1016/j.mibio.2004.03.002; Sisson JC, 2006, J NUCL MED, V47, P1406; Tran L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062191; Wendisch M, 2010, NUKLEARMED-NUCL MED, V49, P154, DOI 10.3413/nukmed-0300; Wunderlich G, 2012, NUKLEARMED-NUCL MED, V51, P179, DOI 10.3413/Nukmed-0450-11-12; Zuckier LS, 2004, J NUCL MED, V45, P500	48	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92729	10.1371/journal.pone.0092729	http://dx.doi.org/10.1371/journal.pone.0092729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663284	Green Submitted, Green Published, gold			2022-12-27	WOS:000333459900105
J	Levin, AM; Iannuzzi, MC; Montgomery, CG; Trudeau, S; Datta, I; Adrianto, I; Chitale, DA; McKeigue, P; Rybicki, BA				Levin, Albert M.; Iannuzzi, Michael C.; Montgomery, Courtney G.; Trudeau, Sheri; Datta, Indrani; Adrianto, Indra; Chitale, Dhananjay A.; McKeigue, Paul; Rybicki, Benjamin A.			Admixture Fine-Mapping in African Americans Implicates XAF1 as a Possible Sarcoidosis Risk Gene	PLOS ONE			English	Article							X-LINKED INHIBITOR; LOCUS; EXPRESSION; APOPTOSIS; INFERENCE; FAMILY; SUSCEPTIBILITY; ASSOCIATIONS	Sarcoidosis is a complex, multi-organ granulomatous disease with a likely genetic component. West African ancestry confers a higher risk for sarcoidosis than European ancestry. Admixture mapping provides the most direct method to locate genes that underlie such ethnic variation in disease risk. We sought to identify genetic risk variants within four previously-identified ancestry-associated regions-6p24.3-p12.1, 17p13.3-13.1, 2p13.3-q12.1, and 6q23.3-q25.2-in a sample of 2,727 African Americans. We used logistic regression fit by generalized estimating equations and the MIX score statistic to determine which variants within ancestry-associated regions were associated with risk and responsible for the admixture signal. Fine mapping was performed by imputation, based on a previous genome-wide association study; significant variants were validated by direct genotyping. Within the 6p24.3-p12.1 locus, the most significant ancestry-adjusted SNP was rs74318745 (p = 9.4* 10(-11)), an intronic SNP within the HLA-DRA gene that did not solely explain the admixture signal, indicating the presence of more than a single risk variant within this well-established sarcoidosis risk region. The locus on chromosome 17p13.3-13.1 revealed a novel sarcoidosis risk SNP, rs6502976 (p = 9.5* 10(-6)), within intron 5 of the gene X-linked Inhibitor of Apoptosis Associated Factor 1 (XAF1) that accounted for the majority of the admixture linkage signal. Immunohistochemical expression studies demonstrated lack of expression of XAF1 and a corresponding high level of expression of its downstream target, X-linked Inhibitor of Apoptosis (XIAP) in sarcoidosis granulomas. In conclusion, ancestry and association fine mapping revealed a novel sarcoidosis susceptibility gene, XAF1, which has not been identified by previous genome-wide association studies. Based on the known biology of the XIAP/XAF1 apoptosis pathway and the differential expression patterns of XAF1 and XIAP in sarcoidosis granulomas, we suggest that this pathway may play a role in the maintenance of sarcoidosis granulomas.	[Levin, Albert M.; Trudeau, Sheri; Datta, Indrani; Rybicki, Benjamin A.] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Iannuzzi, Michael C.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA; [Montgomery, Courtney G.; Adrianto, Indra] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, Oklahoma City, OK 73104 USA; [Chitale, Dhananjay A.] Henry Ford Hlth Syst, Dept Pathol, Detroit, MI USA; [McKeigue, Paul] Univ Edinburgh, Sch Med, Publ Hlth Sci Sect, Edinburgh, Midlothian, Scotland	Henry Ford Health System; Henry Ford Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Oklahoma Medical Research Foundation; Henry Ford Health System; Henry Ford Hospital; University of Edinburgh	Rybicki, BA (corresponding author), Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI 48202 USA.	brybick1@hfhs.org	Rybicki, Benjamin/L-4614-2019; Adrianto, Indra/D-4214-2013	Rybicki, Benjamin/0000-0003-3190-3467; Adrianto, Indra/0000-0002-9973-3057; Chitale, Dhananjay/0000-0002-4421-6431; Montgomery, Courtney/0000-0002-9606-3772	National Institutes of Health [R56-AI072727, R01-HL092576, R01-HL54306, U01-HL060263, 1RC2HL101499, R01HL113326, P20GM103456]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101499, U01HL060263, R01HL054306, R01HL113326, R01HL092576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI072727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Grant funding sources included National Institutes of Health grant numbers: R56-AI072727 and R01-HL092576 (BAR); R01-HL54306, U01-HL060263 (MCI), 1RC2HL101499, R01HL113326 (CGM); P20GM103456 (IA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrianto I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043907; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], 1999, Am J Respir Crit Care Med, V160, P736; Arora V, 2007, J BIOL CHEM, V282, P26202, DOI 10.1074/jbc.M700776200; Baughman RP, 1999, J CLIN EPIDEMIOL, V52, P1173; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Crouser ED, 2009, AM J RESP CRIT CARE, V179, P929, DOI 10.1164/rccm.200803-490OC; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; EDMONDSTONE WM, 1985, BRIT J DIS CHEST, V79, P27, DOI 10.1016/0007-0971(85)90004-X; Facco M, 2011, THORAX, V66, P144, DOI 10.1136/thx.2010.140319; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hama H, 2010, BBA-MOL CELL BIOL L, V1801, P405, DOI 10.1016/j.bbalip.2009.12.004; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Iannuzzi MC, 2003, AM J RESP CRIT CARE, V167, P1225, DOI 10.1164/rccm.200209-1097OC; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Johns CJ, 1986, MED SECT P, P19; Judson MA, 2003, SARCOIDOSIS VASC DIF, V20, P204; Kunitake R, 1999, EUR RESPIR J, V13, P1329, DOI 10.1183/09031936.99.13613389; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lee YH, 2012, MOL BIOL REP; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liston P, 2001, NAT CELL BIOL, V3, P128, DOI 10.1038/35055027; Ludes-Meyers JH, 2003, CYTOGENET GENOME RES, V100, P101, DOI 10.1159/000072844; Lynch JP, 2003, SEMIN RESP CRIT CARE, V24, P393; MANA J, 1995, THORAX, V50, P1264, DOI 10.1136/thx.50.12.1264; Manichaikul A, 2012, PLOS GENET, V8, P285, DOI 10.1371/journal.pgen.1002640; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; McKeigue PM, 2013, GENET EPIDEMIOL, V37, P256, DOI 10.1002/gepi.21710; McKeigue PM, 2013, GENET EPIDEMIOL; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nonas SA, 2007, AM J PHYSIOL-LUNG C, V293, pL292, DOI 10.1152/ajplung.00481.2006; Park MS, 2012, AM J RESP CRIT CARE, V186, P72, DOI 10.1164/rccm.201109-1593OC; Pasaniuc B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001371; Pasaniuc B, 2009, BIOINFORMATICS, V25, pI213, DOI 10.1093/bioinformatics/btp197; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rasmussen A, 2011, RHEUMATOLOGY, V50, P47, DOI 10.1093/rheumatology/keq302; Reich JM, 2002, CHEST, V121, P32, DOI 10.1378/chest.121.1.32; Rybicki BA, 2011, GENES IMMUN, V12, P67, DOI 10.1038/gene.2010.56; Rybicki BA, 2005, SARCOIDOSIS VASC DIF, V22, P115; Rybicki BA, 1997, AM J EPIDEMIOL, V145, P234, DOI 10.1093/oxfordjournals.aje.a009096; Sankararaman S, 2008, GENOME RES, V18, P668, DOI 10.1101/gr.072751.107; SCADDING JG, 1961, BRIT MED J, V2, P1165, DOI 10.1136/bmj.2.5261.1165; Shikuwa C, 2002, RESPIRATION, V69, P242, DOI 10.1159/000063627; Smith DI, 1998, INT J ONCOL, V12, P187; Smith MW, 2005, NAT REV GENET, V6, P623, DOI 10.1038/nrg1657; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Straszewski-Chavez SL, 2007, J BIOL CHEM, V282, P13059, DOI 10.1074/jbc.M609038200; Winkler CA, 2010, ANNU REV GENOM HUM G, V11, P65, DOI 10.1146/annurev-genom-082509-141523; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang L, 2013, HUM MOL GENET; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Zhang KX, 2005, BIOL REPROD, V73, P1064, DOI 10.1095/biolreprod.105.041889	62	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92646	10.1371/journal.pone.0092646	http://dx.doi.org/10.1371/journal.pone.0092646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663488	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900089
J	Ning, PG; Zhu, SC; Shi, DP; Guo, Y; Sun, MH				Ning, Peigang; Zhu, Shaocheng; Shi, Dapeng; Guo, Ying; Sun, Minghua			X-Ray Dose Reduction in Abdominal Computed Tomography Using Advanced Iterative Reconstruction Algorithms	PLOS ONE			English	Article							IMPROVED IMAGE QUALITY; CT; FEASIBILITY; PHANTOM	Objective: This work aims to explore the effects of adaptive statistical iterative reconstruction (ASiR) and model-based iterative reconstruction (MBIR) algorithms in reducing computed tomography (CT) radiation dosages in abdominal imaging. Methods: CT scans on a standard male phantom were performed at different tube currents. Images at the different tube currents were reconstructed with the filtered back-projection (FBP), 50% ASiR and MBIR algorithms and compared. The CT value, image noise and contrast-to-noise ratios (CNRs) of the reconstructed abdominal images were measured. Volumetric CT dose indexes (CTDIvol) were recorded. Results: At different tube currents, 50% ASiR and MBIR significantly reduced image noise and increased the CNR when compared with FBP. The minimal tube current values required by FBP, 50% ASiR, and MBIR to achieve acceptable image quality using this phantom were 200, 140, and 80 mA, respectively. At the identical image quality, 50% ASiR and MBIR reduced the radiation dose by 35.9% and 59.9% respectively when compared with FBP. Conclusions: Advanced iterative reconstruction techniques are able to reduce image noise and increase image CNRs. Compared with FBP, 50% ASiR and MBIR reduced radiation doses by 35.9% and 59.9%, respectively.	[Ning, Peigang; Zhu, Shaocheng; Shi, Dapeng; Guo, Ying; Sun, Minghua] Henan Prov Peoples Hosp, Dept Radiol, Zhengzhou, Henan, Peoples R China	Zhengzhou University	Zhu, SC (corresponding author), Henan Prov Peoples Hosp, Dept Radiol, Zhengzhou, Henan, Peoples R China.	zsc2686@163.com						Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Hall EJ, 2008, BRIT J RADIOL, V81, P362, DOI 10.1259/bjr/01948454; Hara AK, 2009, AM J ROENTGENOL, V193, P764, DOI 10.2214/AJR.09.2397; Husarik DB, 2012, INVEST RADIOL, V47, P468, DOI 10.1097/RLI.0b013e318251eafd; ICRP, 1990, ANN ICRP, V55, DOI [10.1177/ANIB_20_4, DOI 10.1177/ANIB_20_4]; ICRP, 1990, ICRP PUBL, V55; IMV, 2006, IMV 2006 CT MARK SUM; Katsura M, 2012, EUR RADIOL, V22, P1613, DOI 10.1007/s00330-012-2452-z; Launders Jason, 2011, Biomed Instrum Technol, V45, P453, DOI 10.2345/0899-8205-45.6.453; Leipsic J, 2010, AM J ROENTGENOL, V195, P649, DOI 10.2214/AJR.10.4285; Marin D, 2010, RADIOLOGY, V254, P145, DOI 10.1148/radiol.09090094; McCollough CH, 2009, RADIOL CLIN N AM, V47, P27, DOI 10.1016/j.rcl.2008.10.006; Mieville FA, 2013, PHYS MEDICA, V29, P99, DOI 10.1016/j.ejmp.2011.12.004; Min James K, 2009, J Cardiovasc Comput Tomogr, V3, P246, DOI 10.1016/j.jcct.2009.06.006; Nelson RC, 2011, J CARDIOVASC COMPUT, V5, P286, DOI 10.1016/j.jcct.2011.07.001; Prakash P, 2010, INVEST RADIOL, V45, P202, DOI 10.1097/RLI.ob013e3181dzfeec; Schindera ST, 2011, RADIOLOGY, V260, P454, DOI 10.1148/radiol.11102217; Silva AC, 2010, AM J ROENTGENOL, V194, P191, DOI 10.2214/AJR.09.2953; Singh S, 2012, J COMPUT ASSIST TOMO, V36, P347, DOI 10.1097/RCT.0b013e31824e639e; Singh S, 2010, RADIOLOGY, V257, P373, DOI 10.1148/radiol.10092212; Thibault JB, 2007, MED PHYS, V34, P4526, DOI 10.1118/1.2789499; Vorona GA, 2011, PEDIATR RADIOL, V41, P1174, DOI 10.1007/s00247-011-2063-x; Wang G, 2008, MED PHYS, V35, P1051, DOI 10.1118/1.2836950	23	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92568	10.1371/journal.pone.0092568	http://dx.doi.org/10.1371/journal.pone.0092568			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664174	Green Submitted, Green Published, gold			2022-12-27	WOS:000333459900077
J	Sasi, SP; Bae, S; Song, J; Perepletchikov, A; Schneider, D; Carrozza, J; Yan, XH; Kishore, R; Enderling, H; Goukassian, DA				Sasi, Sharath P.; Bae, Sanggyu; Song, Jin; Perepletchikov, Aleksandr; Schneider, Douglas; Carrozza, Joseph; Yan, Xinhua; Kishore, Raj; Enderling, Heiko; Goukassian, David A.			Therapeutic Non-Toxic Doses of TNF Induce Significant Regression in TNFR2-p75 Knockdown Lewis Lung Carcinoma Tumor Implants	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; RECEIVING CONCOMITANT METHOTREXATE; ISOLATED LIMB PERFUSION; MONOCLONAL-ANTIBODY; RECEPTOR; EXPRESSION; P75; ETANERCEPT; P55; INHIBITION	Tumor necrosis factor-alpha (TNF) binds to two receptors: TNFR1/p55-cytotoxic and TNFR2/p75-pro-survival. We have shown that tumor growth in p75 knockout (KO) mice was decreased more than 2-fold in Lewis lung carcinoma (LLCs). We hypothesized that selective blocking of TNFR2/p75 LLCs may sensitize them to TNF-induced apoptosis and affect the tumor growth. We implanted intact and p75 knockdown (KD)-LLCs (>90%, using shRNA) into wild type (WT) mice flanks. On day 8 post-inoculation, recombinant murine (rm) TNF-alpha(12.5 ng/gr of body weight) or saline was injected twice daily for 6 days. Tumor volumes (tV) were measured daily and tumor weights (tW) on day 15, when study was terminated due to large tumors in LLC+TNF group. Tubular bones, spleens and peripheral blood (PB) were examined to determine possible TNF toxicity. There was no significant difference in tV or tW between LLC minus (-) TNF and p75KD/LLC-TNF tumors. Compared to 3 control groups, p75KD/LLC+TNF showed >2-5-fold decreases in tV (p<0.001) and tW (p<0.0001). There was no difference in tV or tW end of study vs. before injections in p75KD/LLC+TNF group. In 3 other groups tV and tW were increased 2.7-4.5-fold (p<0.01, p<0.0002 and p<0.0001). Pathological examination revealed that 1/3 of p75KD/LLC+rmTNF tumors were 100% necrotic, the remaining revealed 40-60% necrosis. No toxicity was detected in bone marrow, spleen and peripheral blood. We concluded that blocking TNFR2/p75 in LLCs combined with intra-tumoral rmTNF injections inhibit LLC tumor growth. This could represent a novel and effective therapy against lung neoplasms and a new paradigm in cancer therapeutics.	[Sasi, Sharath P.; Bae, Sanggyu; Song, Jin; Yan, Xinhua; Goukassian, David A.] GeneSys Res Inst, Cardiovasc Res Ctr, Boston, MA 02135 USA; [Bae, Sanggyu; Perepletchikov, Aleksandr; Schneider, Douglas; Carrozza, Joseph] Steward St Elizabeth Med Ctr, Dept Med, Boston, MA USA; [Bae, Sanggyu; Perepletchikov, Aleksandr; Schneider, Douglas; Carrozza, Joseph] Steward St Elizabeth Med Ctr, Dept Pathol, Boston, MA USA; [Perepletchikov, Aleksandr; Schneider, Douglas; Carrozza, Joseph; Yan, Xinhua; Goukassian, David A.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Kishore, Raj] Northwestern Univ, Feinberg Cardiovasc Inst, Chicago, IL 60611 USA; [Enderling, Heiko] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	St. Elizabeth's Medical Center; St. Elizabeth's Medical Center; Tufts University; Northwestern University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Goukassian, DA (corresponding author), GeneSys Res Inst, Cardiovasc Res Ctr, Boston, MA 02135 USA.	david.goukassian@tufts.edu	Enderling, Heiko/AAA-2423-2021	Enderling, Heiko/0000-0002-9696-6410; Goukassian, David/0000-0001-5270-5270	National Aeronautic and Space Administration [NNJ10ZSA001N]; AHA [10GRNT4710003]; NHLBI [HL106098]; NIH [HL091983]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL106098, R01HL091983] Funding Source: NIH RePORTER	National Aeronautic and Space Administration(National Aeronautics & Space Administration (NASA)); AHA(American Heart Association); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This material is based upon work supported by the National Aeronautic and Space Administration under Grant No. NNJ10ZSA001N to D.A.G., and in part by grants from AHA 10GRNT4710003 and NHLBI HL106098 to X.Y. and NIH HL091983 to R.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah LN, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-3; Aggarwal Bharat B., 2002, Current Drug Targets - Inflammation and Allergy, V1, P327, DOI 10.2174/1568010023344571; Arnott CH, 2002, ONCOGENE, V21, P4728, DOI 10.1038/sj.onc.1205588; Arnott CH, 2004, ONCOGENE, V23, P1902, DOI 10.1038/sj.onc.1207317; Bathon JM, 2000, NEW ENGL J MED, V343, P1586, DOI 10.1056/NEJM200011303432201; Bhardwaj A, 2003, J CLIN IMMUNOL, V23, P317, DOI 10.1023/A:1025319031417; Bossola M, 2007, EXPERT OPIN INV DRUG, V16, P1241, DOI 10.1517/13543784.16.8.1241; Botchkina GI, 1997, MOL MED, V3, P765, DOI 10.1007/BF03401714; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen X, 2008, J IMMUNOL, V180, P6467, DOI 10.4049/jimmunol.180.10.6467; Faustman D, 2010, NAT REV DRUG DISCOV, V9, P482, DOI 10.1038/nrd3030; Gatenby RA, 2009, CANCER RES, V69, P4894, DOI 10.1158/0008-5472.CAN-08-3658; Goukassian DA, 2007, CIRCULATION, V115, P752, DOI 10.1161/CIRCULATIONAHA.106.647255; Harousseau Jean-Luc, 2006, Future Oncol, V2, P577, DOI 10.2217/14796694.2.5.577; Hasan Umbreen, 2006, N Z Med J, V119, pU2336; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Hohenberger P, 2003, ANN SURG ONCOL, V10, P562, DOI 10.1245/ASO.2003.10.005; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KALTHOFF H, 1993, J BIOL CHEM, V268, P2762; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; KOMORI A, 1993, CANCER RES, V53, P1982; Laurenzi L, 2004, J EXP CLIN CANC RES, V23, P225; LEEUWENBERG JFM, 1995, CYTOKINE, V7, P457, DOI 10.1006/cyto.1995.0062; Lejeune Ferdy J, 2006, Cancer Immun, V6, P6; Li B, 2009, CANCER RES, V69, P338, DOI 10.1158/0008-5472.CAN-08-1565; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; Madhusudan S, 2004, CLIN CANCER RES, V10, P6528, DOI 10.1158/1078-0432.CCR-04-0730; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Meng YR, 2010, CANCER RES, V70, P1534, DOI 10.1158/0008-5472.CAN-09-2995; Mirsadraee S, 2012, WORLD J RADIOL, V4, P128, DOI 10.4329/wjr.v4.i4.128; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Nair B, 2007, AM J HEMATOL, V82, P1022, DOI 10.1002/ajh.20926; Sasi SP, 2012, ONCOGENE, V31, P4117, DOI 10.1038/onc.2011.567; Scott KA, 2003, MOL CANCER THER, V2, P445; Suganuma M, 1999, CANCER RES, V59, P4516; Szlosarek P, 2006, EUR J CANCER, V42, P745, DOI 10.1016/j.ejca.2006.01.012; ZABEL P, 1993, IMMUNOBIOLOGY, V187, P447, DOI 10.1016/S0171-2985(11)80356-6	37	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92373	10.1371/journal.pone.0092373	http://dx.doi.org/10.1371/journal.pone.0092373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664144	gold, Green Published			2022-12-27	WOS:000333459900057
J	Le Moyec, L; Robert, C; Triba, MN; Billat, VL; Mata, X; Schibler, L; Barrey, E				Le Moyec, Laurence; Robert, Celine; Triba, Mohamed N.; Billat, Veronique L.; Mata, Xavier; Schibler, Laurent; Barrey, Eric			Protein Catabolism and High Lipid Metabolism Associated with Long-Distance Exercise Are Revealed by Plasma NMR Metabolomics in Endurance Horses	PLOS ONE			English	Article							BLOOD-SERUM	During long distance endurance races, horses undergo high physiological and metabolic stresses. The adaptation processes involve the modulation of the energetic pathways in order to meet the energy demand. The aims were to evaluate the effects of long endurance exercise on the plasma metabolomic profiles and to investigate the relationships with the individual horse performances. The metabolomic profiles of the horses were analyzed using the non-dedicated methodology, NMR spectroscopy and statistical multivariate analysis. The advantage of this method is to investigate several metabolomic pathways at the same time in a single sample. The plasmas were obtained before exercise (BE) and post exercise (PE) from 69 horses competing in three endurance races at national level (130-160 km). Biochemical assays were also performed on the samples taken at PE. The proton NMR spectra were compared using the supervised orthogonal projection on latent structure method according to several factors. Among these factors, the race location was not significant whereas the effect of the race exercise (sample BE vs PE of same horse) was highly discriminating. This result was confirmed by the projection of unpaired samples (only BE or PE sample of different horses). The metabolomic profiles proved that protein, energetic and lipid metabolisms as well as glycoproteins content are highly affected by the long endurance exercise. The BE samples from finisher horses could be discriminated according to the racing speed based on their metabolomic lipid content. The PE samples could be discriminated according to the horse ranking position at the end of the race with lactate as unique correlated metabolite. As a conclusion, the metabolomic profiles of plasmas taken before and after the race provided a better understanding of the high energy demand and protein catabolism pathway that could expose the horses to metabolic disorders.	[Le Moyec, Laurence; Billat, Veronique L.; Barrey, Eric] Univ Evry Val Essonne, INSERM, Unite Biol Integrat & Adaptat Exercice, Evry, France; [Robert, Celine; Mata, Xavier; Schibler, Laurent; Barrey, Eric] INRA, Genet Anim & Biol Integrat, Jouy En Josas, France; [Triba, Mohamed N.] Univ Paris 13, Sorbonne Paris Cite, CNRS, Bobigny, France; [Robert, Celine] Univ Paris Est, Ecole Natl Vet Alfort, Maisons Alfort, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Paris 13; Ecole Nationale Veterinaire d'Alfort (ENVA)	Le Moyec, L (corresponding author), Univ Evry Val Essonne, INSERM, Unite Biol Integrat & Adaptat Exercice, Evry, France.	laurence.lemoyec@univ-evry.fr	Billat, Veronique/GNP-2073-2022; Robert, Céline/AAD-6158-2020; SCHIBLER, laurent/AAQ-2630-2021; Billat, Véronique/U-4398-2019	Billat, Véronique/0000-0002-6085-998X; SCHIBLER, Laurent/0000-0003-3137-0859; ROBERT, Celine/0000-0002-3899-1060	French Institute of Horse and Equitation (IFCE); Eperon funds; Arabian Horse Association (ACA); Institut National de recherche en Agronomie (INRA); Ecole Nationale Veterinaire d'Alfort (ENVA); Region Ile de France (SESAME project)	French Institute of Horse and Equitation (IFCE); Eperon funds; Arabian Horse Association (ACA); Institut National de recherche en Agronomie (INRA); Ecole Nationale Veterinaire d'Alfort (ENVA); Region Ile de France (SESAME project)(Region Ile-de-France)	This work was supported by the French Institute of Horse and Equitation (IFCE), Eperon funds, Arabian Horse Association (ACA), Institut National de recherche en Agronomie (INRA), Ecole Nationale Veterinaire d'Alfort (ENVA), and The Region Ile de France (SESAME project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assenza A, 2004, J ANIM PHYSIOL AN N, V88, P172, DOI 10.1111/j.1439-0396.2004.00493.x; Barrey E, 2006, Equine Vet J Suppl, P43; Bergero D, 2005, J ANIM PHYSIOL AN N, V89, P146, DOI 10.1111/j.1439-0396.2005.00556.x; Capomaccio S, 2010, ANIM GENET, V41, P166, DOI 10.1111/j.1365-2052.2010.02129.x; Castejon F, 2006, Equine Vet J Suppl, P70; Essen-Gustavsson B, 2002, EQUINE VET J, V34, P209; Hodavance MS, 2007, ANAL BIOANAL CHEM, V387, P533, DOI 10.1007/s00216-006-0979-z; Huang CC, 2013, J VASC SURG; Keller MD, 2011, EQUINE VET J, V43, P737, DOI 10.1111/j.2042-3306.2010.00336.x; Kohl SM, 2012, METABOLOMICS, V8, pS146, DOI 10.1007/s11306-011-0350-z; Le Moyec L, 2012, ANAL BIOANAL CHEM, V404, P593, DOI 10.1007/s00216-012-6165-6; Munoz A, 2010, EQUINE VET J, V42, P83, DOI 10.1111/j.2042-3306.2010.00211.x; Nahon P, 2012, CLIN CANCER RES, V18, P6714, DOI 10.1158/1078-0432.CCR-12-1099; Pechlivanis A, 2013, J PROTEOME RES, V12, P470, DOI 10.1021/pr300846x; Schott H C 2nd, 2006, Equine Vet J Suppl, P37; Serrano MG, 2002, EQUINE VET J, V34, P135; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Treiber K H, 2006, Equine Vet J Suppl, P631; Trigo P, 2010, EQUINE VET J, V42, P142, DOI 10.1111/j.2042-3306.2010.00238.x; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; van den Hoven R, 2011, J ANIM PHYSIOL AN N, V95, P664, DOI 10.1111/j.1439-0396.2010.01097.x; Waller AP, 2010, EQUINE VET J, V42, P274, DOI 10.2746/042516409X479603; Westermann CM, 2008, AM J VET RES, V69, P1469, DOI 10.2460/ajvr.69.11.1469	23	24	24	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e90730	10.1371/journal.pone.0090730	http://dx.doi.org/10.1371/journal.pone.0090730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658361	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300019
J	Apprill, A; Robbins, J; Eren, AM; Pack, AA; Reveillaud, J; Mattila, D; Moore, M; Niemeyer, M; Moore, KMT; Mincer, TJ				Apprill, Amy; Robbins, Jooke; Eren, A. Murat; Pack, Adam A.; Reveillaud, Julie; Mattila, David; Moore, Michael; Niemeyer, Misty; Moore, Kathleen M. T.; Mincer, Tracy J.			Humpback Whale Populations Share a Core Skin Bacterial Community: Towards a Health Index for Marine Mammals?	PLOS ONE			English	Article							DOLPHIN TURSIOPS-TRUNCATUS; SOLE SOLEA-SENEGALENSIS; TIDAL FLAT SEDIMENT; SP-NOV.; MEGAPTERA-NOVAEANGLIAE; NORTH PACIFIC; SEQUENCE DATA; SEA; HALOTOLERANT; MICROBIOTA	Microbes are now well regarded for their important role in mammalian health. The microbiology of skin - a unique interface between the host and environment - is a major research focus in human health and skin disorders, but is less explored in other mammals. Here, we report on a cross-population study of the skin-associated bacterial community of humpback whales (Megaptera novaeangliae), and examine the potential for a core bacterial community and its variability with host (endogenous) or geographic/environmental (exogenous) specific factors. Skin biopsies or freshly sloughed skin from 56 individuals were sampled from populations in the North Atlantic, North Pacific and South Pacific oceans and bacteria were characterized using 454 pyrosequencing of SSU rRNA genes. Phylogenetic and statistical analyses revealed the ubiquity and abundance of bacteria belonging to the Flavobacteria genus Tenacibaculum and the Gammaproteobacteria genus Psychrobacter across the whale populations. Scanning electron microscopy of skin indicated that microbial cells colonize the skin surface. Despite the ubiquity of Tenacibaculum and Psychrobater spp., the relative composition of the skin-bacterial community differed significantly by geographic area as well as metabolic state of the animals (feeding versus starving during migration and breeding), suggesting that both exogenous and endogenous factors may play a role in influencing the skin-bacteria. Further, characteristics of the skin bacterial community from these free-swimming individuals were assembled and compared to two entangled and three dead individuals, revealing a decrease in the central or core bacterial community members (Tenacibaculum and Psychrobater spp.), as well as the emergence of potential pathogens in the latter cases. This is the first discovery of a cross-population, shared skin bacterial community. This research suggests that the skin bacteria may be connected to humpback health and immunity and could possibly serve as a useful index for health and skin disorder monitoring of threatened and endangered marine mammals.	[Apprill, Amy; Moore, Michael; Mincer, Tracy J.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Robbins, Jooke] Ctr Coastal Studies, Provincetown, MA USA; [Eren, A. Murat; Reveillaud, Julie] Josephine Bay Paul Ctr, Marine Biol Lab, Woods Hole, MA USA; [Pack, Adam A.] Univ Hawaii, Hilo, HI 96720 USA; [Pack, Adam A.] Dolphin Inst, Honolulu, HI USA; [Mattila, David] Hawaiian Isl Humpback Whale Natl Marine Sanctuary, Kihei, HI USA; [Niemeyer, Misty; Moore, Kathleen M. T.] Int Fund Anim Welf, Yarmouth Port, MA USA	Woods Hole Oceanographic Institution; Marine Biological Laboratory - Woods Hole; University of Hawaii System; University Hawaii Hilo; National Oceanic Atmospheric Admin (NOAA) - USA	Apprill, A (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	apprill@whoi.edu; tmincer@whoi.edu	Moore, Michael/E-1707-2015; Eren, A. Murat/Q-5497-2019; Eren, A. Murat/J-3408-2014	Moore, Michael/0000-0003-3074-6631; Eren, A. Murat/0000-0001-9013-4827; Eren, A. Murat/0000-0001-9013-4827; Mincer, Tracy/0000-0002-4644-5609; Robbins, Jooke/0000-0002-6382-722X	WHOI Ocean Life Institute; Woods Hole Oceanographic Institution's (WHOI) Marine Mammal Center; Direct For Education and Human Resources [1345247] Funding Source: National Science Foundation	WHOI Ocean Life Institute; Woods Hole Oceanographic Institution's (WHOI) Marine Mammal Center; Direct For Education and Human Resources(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU))	A.A. was funded by a WHOI Ocean Life Institute post-doctoral scholar award, and this research was supported by a grant to A.A. and T.J.M. from Woods Hole Oceanographic Institution's (WHOI) Marine Mammal Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apprill A, 2013, ENVIRON MICROBIOL, V15, P2063, DOI 10.1111/1462-2920.12107; Apprill A, 2011, ENV MICROBIOL REP, V3, P223, DOI 10.1111/j.1758-2229.2010.00213.x; Ayala-del-Rio HL, 2010, APPL ENVIRON MICROB, V76, P2304, DOI 10.1128/AEM.02101-09; BAKER CS, 1986, MAR ECOL PROG SER, V31, P105, DOI 10.3354/meps031105; Banning EC, 2010, FEMS MICROBIOL ECOL, V73, P254, DOI 10.1111/j.1574-6941.2010.00897.x; Bernhard AE, 2005, FEMS MICROBIOL ECOL, V52, P115, DOI 10.1016/j.femsec.2004.10.016; Berube M, 1996, MOL ECOL, V5, P602, DOI 10.1046/j.1365-294X.1996.00602.x; Bowers RM, 2012, ATMOS ENVIRON, V50, P41, DOI 10.1016/j.atmosenv.2012.01.005; Bowman JP, 1997, SYST APPL MICROBIOL, V20, P209, DOI 10.1016/S0723-2020(97)80067-7; Bowman JP, 1996, INT J SYST BACTERIOL, V46, P841, DOI 10.1099/00207713-46-4-841; BROWN WR, 1983, CAN J ZOOL, V61, P1587, DOI 10.1139/z83-213; Cassoff RM, 2011, DIS AQUAT ORGAN, V96, P175, DOI 10.3354/dao02385; CHITTLEBOROUGH R. G., 1965, AUSTRALIAN J MAR FRESHWATER RES, V16, P33; Choi DH, 2006, INT J SYST EVOL MICR, V56, P635, DOI 10.1099/ijs.0.64044-0; CLAPHAM PJ, 1993, MAR MAMMAL SCI, V9, P213, DOI 10.1111/j.1748-7692.1993.tb00448.x; Clapham PJ, 2000, CETACEAN SOCIETIES, P173; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2010, ISME J, V4, P1375, DOI 10.1038/ismej.2010.71; Craig AS, 2003, BEHAVIOUR, V140, P981, DOI 10.1163/156853903322589605; Dawbin W.H., 1966, WHALES DOLPHINS PORP, P145; DeLong EF, 1999, APPL ENVIRON MICROB, V65, P5554; Demling RH., 2009, EPLASTY, V9, P9; Denner EBM, 2001, SYST APPL MICROBIOL, V24, P44, DOI 10.1078/0723-2020-00006; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Eren AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026732; Eren AM, 2013, METHODS ECOL EVOL, V4, P1111, DOI 10.1111/2041-210X.12114; Fleming A, 2011, NOAA TECHNICAL MEMOR; Frette L, 2004, INT J SYST EVOL MICR, V54, P519, DOI 10.1099/ijs.0.02398-0; Geraci J.R., 1986, P3; Glockner DA., 1983, COMMUNICATION BEHAV, P447; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Gulland Frances M. D., 2008, Aquatic Mammals, V34, P182, DOI 10.1578/AM.34.2.2008.182; Hanski I, 2012, P NATL ACAD SCI; Harrison R.J., 1974, P45; Heindl H, 2008, INT J SYST EVOL MICR, V58, P542, DOI 10.1099/ijs.0.65383-0; HICKS BD, 1985, J INVEST DERMATOL, V85, P60, DOI 10.1111/1523-1747.ep12275348; Johnson WR, 2009, ENV MICROBIOL REP, V1, P555, DOI 10.1111/j.1758-2229.2009.00080.x; Jung SY, 2006, INT J SYST EVOL MICR, V56, P1577, DOI 10.1099/ijs.0.64302-0; KATONA S. K., 1990, REPORT INT WHALING C, P295; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Mathieu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065288; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McLellan SL, 2013, ENVIRON MICROBIOL, V15, P2213, DOI 10.1111/1462-2920.12092; Mouton M., 2012, CUTANEOUS LESIONS CE; MUSCATINE L, 1969, BIOL BULL-US, V137, P506, DOI 10.2307/1540172; Nixon PGF, 1989, CHANGING IDEAS HLTH; Palsboll P.J., 1991, Reports of the International Whaling Commission Special Issue, P71; Pettis HM, 2004, CAN J ZOOL, V82, P8, DOI [10.1139/z03-207, 10.1139/Z03-207]; Pineiro-Vidal M, 2008, INT J SYST EVOL MICR, V58, P881, DOI 10.1099/ijs.0.65539-0; Pineiro-Vidal M, 2008, INT J SYST EVOL MICR, V58, P21, DOI 10.1099/ijs.0.65397-0; Pineiro-Vidal M, 2012, INT J SYST EVOL MICR, V62, P425, DOI 10.1099/ijs.0.025122-0; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Robbins Jooke, 2011, Endangered Species Research, V13, P117, DOI 10.3354/esr00328; Romanenko LA, 2002, INT J SYST EVOL MICR, V52, P1291, DOI [10.1099/ijs.0.02087-0, 10.1099/00207713-52-4-1291]; Scharschmidt Tiffany C, 2013, Drug Discov Today Dis Mech, V10; Scharschmidt TC, 2009, J INVEST DERMATOL, V129, P2435, DOI 10.1038/jid.2009.104; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Wang JT, 2008, INT J SYST EVOL MICR, V58, P761, DOI 10.1099/ijs.0.65437-0; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Yeo SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056207; Yoon JH, 2005, INT J SYST EVOL MICR, V55, P793, DOI 10.1099/ijs.0.63416-0; Zabka TS, 2003, ANAT REC PART A, V273A, P636, DOI 10.1002/ar.a.10077	67	78	78	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e90785	10.1371/journal.pone.0090785	http://dx.doi.org/10.1371/journal.pone.0090785			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671052	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000010
J	Boye, SE; Huang, WC; Roman, AJ; Sumaroka, A; Boye, SL; Ryals, RC; Olivares, MB; Ruan, Q; Tucker, BA; Stone, EM; Swaroop, A; Cideciyan, AV; Hauswirth, WW; Jacobson, SG				Boye, Shannon E.; Huang, Wei-Chieh; Roman, Alejandro J.; Sumaroka, Alexander; Boye, Sanford L.; Ryals, Renee C.; Olivares, Melani B.; Ruan, Qing; Tucker, Budd A.; Stone, Edwin M.; Swaroop, Anand; Cideciyan, Artur V.; Hauswirth, William W.; Jacobson, Samuel G.			Natural History of Cone Disease in the Murine Model of Leber Congenital Amaurosis Due to CEP290 Mutation: Determining the Timing and Expectation of Therapy	PLOS ONE			English	Article							HUMAN GENE-THERAPY; TRANSSPLICING VECTORS EXPAND; ADENOASSOCIATED VIRUS; RETINAL DEGENERATION; VIRAL VECTORS; SUBRETINAL INJECTION; LENTIVIRAL VECTOR; RPE65 MUTATIONS; MOUSE MODEL; PHOTORECEPTORS	Background: Mutations in the CEP290 (cilia-centrosomal protein 290 kDa) gene in Leber congenital amaurosis (LCA) cause early onset visual loss but retained cone photoreceptors in the fovea, which is the potential therapeutic target. A cone-only mouse model carrying a Cep290 gene mutation, rd16;Nrl(-/-), was engineered to mimic the human disease. In the current study, we determined the natural history of retinal structure and function in this murine model to permit design of preclinical proof-of-concept studies and allow progress to be made toward human therapy. Analyses of retinal structure and visual function in CEP290-LCA patients were also performed for comparison with the results in the model. Methods: Rd16;Nrl(-/-) mice were studied in the first 90 days of life with optical coherence tomography (OCT), electroretinography (ERG), retinal histopathology and immunocytochemistry. Structure and function data from a cohort of patients with CEP290-LCA (n = 15; ages 7-48) were compared with those of the model. Results: CEP290-LCA patients retain a central island of photoreceptors with normal thickness at the fovea (despite severe visual loss); the extent of this island declined slowly with age. The rd16; Nrl(-/-) model also showed a relatively slow photoreceptor layer decline in thickness with similar to 80% remaining at 3 months. The number of pseudorosettes also became reduced. By comparison to single mutant Nrl(-/-) mice, UV- and M-cone ERGs of rd16; Nrl(-/-) were at least 1 log unit reduced at 1 month of age and declined further over the 3 months of monitoring. Expression of GNAT2 and S-opsin also decreased with age. Conclusions: The natural history of early loss of photoreceptor function with retained cone cell nuclei is common to both CEP290-LCA patients and the rd16; Nrl(-/-) murine model. Pre-clinical proof-of-concept studies for uniocular therapies would seem most appropriate to begin with intervention at P35-40 and re-study after one month by assaying interocular difference in the UV-cone ERG.	[Boye, Shannon E.; Boye, Sanford L.; Ryals, Renee C.; Ruan, Qing; Hauswirth, William W.] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA; [Huang, Wei-Chieh; Roman, Alejandro J.; Sumaroka, Alexander; Olivares, Melani B.; Cideciyan, Artur V.; Jacobson, Samuel G.] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Tucker, Budd A.; Stone, Edwin M.] Univ Iowa, Carver Coll Med, Stephen A Wynn Inst Vis Res, Iowa City, IA USA; [Stone, Edwin M.] Univ Iowa, Howard Hughes Med Inst, Carver Coll Med, Iowa City, IA 52242 USA; [Swaroop, Anand] NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA	State University System of Florida; University of Florida; University of Pennsylvania; Pennsylvania Medicine; University of Iowa; Howard Hughes Medical Institute; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Boye, SE (corresponding author), Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA.	shaire@ufl.edu; jacobsos@mail.med.upenn.edu	Cideciyan, Artur V/A-1075-2007	Cideciyan, Artur V/0000-0002-2018-0905; Stone, Edwin M./0000-0003-3343-4414; Boye, Shannon/0000-0002-7312-3197; Tucker, Budd/0000-0003-2178-1742; Swaroop, Anand/0000-0002-1975-1141; hauswirth, william/0000-0002-3244-4947; Jacobson, Samuel/0000-0003-2122-169X	Grousbeck Foundation; NEI intramural research program; Foundation Fighting Blindness; Macula Vision Research Foundation; Hope for Vision; NATIONAL EYE INSTITUTE [P30EY021721, ZIAEY000473, ZIAEY000546] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007483] Funding Source: NIH RePORTER	Grousbeck Foundation; NEI intramural research program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Foundation Fighting Blindness(European Commission); Macula Vision Research Foundation; Hope for Vision; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants from the Grousbeck Foundation, The Foundation Fighting Blindness, Macula Vision Research Foundation, Hope for Vision, and the NEI intramural research program. AVC is a RPB (Research to Prevent Blindness) Senior Scientific Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmedov NB, 2000, P NATL ACAD SCI USA, V97, P5551, DOI 10.1073/pnas.97.10.5551; Aleman TS, 2011, INVEST OPHTH VIS SCI, V52, P6898, DOI 10.1167/iovs.11-7701; Alexander JJ, 2007, NAT MED, V13, P685, DOI 10.1038/nm1596; Allocca M, 2008, J CLIN INVEST, V118, P1955, DOI 10.1172/JCI34316; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bainbridge JWB, 2001, GENE THER, V8, P1665, DOI 10.1038/sj.gt.3301574; Balaggan KS, 2006, J GENE MED, V8, P275, DOI 10.1002/jgm.845; Baye LM, 2011, HUM MOL GENET, V20, P1467, DOI 10.1093/hmg/ddr025; Bemelmans AP, 2005, J GENE MED, V7, P1367, DOI 10.1002/jgm.788; Binley K, 2013, INVEST OPHTH VIS SCI, V54, P4061, DOI 10.1167/iovs.13-11871; Boye SL, 2011, INVEST OPHTH VIS SCI, V52, P7098, DOI 10.1167/iovs.11-7867; Boye SE, 2013, MOL THER, V21, P509, DOI 10.1038/mt.2012.280; Boye SE, 2012, HUM GENE THER, V23, P1101, DOI 10.1089/hum.2012.125; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Cheng H, 2006, HUM MOL GENET, V15, P2588, DOI 10.1093/hmg/ddl185; Cideciyan AV, 2007, HUM MUTAT, V28, P1074, DOI 10.1002/humu.20565; Cideciyan AV, 2011, HUM MOL GENET, V20, P1411, DOI 10.1093/hmg/ddr022; Cideciyan AV, 2010, PROG RETIN EYE RES, V29, P398, DOI 10.1016/j.preteyeres.2010.04.002; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Colella P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072027; Conley SM, 2012, BBA-MOL BASIS DIS, V1822, P1169, DOI 10.1016/j.bbadis.2011.10.007; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Dong BA, 2010, MOL THER, V18, P87, DOI 10.1038/mt.2009.258; Drack AV, 2010, AM J OPHTHALMOL, V149, P10, DOI 10.1016/j.ajo.2009.08.038; Drivas TG, 2013, J CLIN INVEST, V123, P4525, DOI 10.1172/JCI69448; Duan Dongsheng, 2003, Methods Mol Med, V76, P287; Duan DS, 2001, MOL THER, V4, P383, DOI 10.1006/mthe.2001.0456; Feathers KL, 2008, INVEST OPHTH VIS SCI, V49, P1126, DOI 10.1167/iovs.07-1234; Fisher SK, 2005, PROG RETIN EYE RES, V24, P395, DOI 10.1016/j.preteyeres.2004.10.004; Greenberg KP, 2006, ADV EXP MED BIOL, V572, P255; Halbert CL, 2002, NAT BIOTECHNOL, V20, P697, DOI 10.1038/nbt0702-697; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Huang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075735; Huang WC, 2012, INVEST OPHTH VIS SCI, V53, P5594, DOI 10.1167/iovs.12-10070; Jacobson SG, 2013, CLIN GENET, V84, P175, DOI 10.1111/cge.12165; Jacobson SG, 2008, HUM MOL GENET, V17, P2405, DOI 10.1093/hmg/ddn140; Jacobson SG, 2005, P NATL ACAD SCI USA, V102, P6177, DOI 10.1073/pnas.0500646102; Kapranov P, 2012, HUM GENE THER, V23, P46, DOI 10.1089/hum.2011.160; Khani SC, 2007, INVEST OPHTH VIS SCI, V48, P3954, DOI 10.1167/iovs.07-0257; Komaromy AM, 2010, HUM MOL GENET, V19, P2581, DOI 10.1093/hmg/ddq136; Kong J, 2008, GENE THER, V15, P1311, DOI 10.1038/gt.2008.78; Lai Y, 2005, NAT BIOTECHNOL, V23, P1435, DOI 10.1038/nbt1153; Lai Y, 2010, MOL THER, V18, P75, DOI 10.1038/mt.2009.256; Lai Yi, 2008, V433, P259, DOI 10.1007/978-1-59745-237-3_16; Lopes VS, 2013, GENE THER, V20, P824, DOI 10.1038/gt.2013.3; Lostal W, 2010, HUM MOL GENET, V19, P1897, DOI 10.1093/hmg/ddq065; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mancuso K, 2009, NATURE, V461, P784, DOI 10.1038/nature08401; McAnany JJ, 2013, JAMA OPHTHALMOL, V131, P178, DOI 10.1001/2013.jamaophthalmol.354; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Miyoshi H, 1997, P NATL ACAD SCI USA, V94, P10319, DOI 10.1073/pnas.94.19.10319; Murga-Zamalloa CA, 2011, J BIOL CHEM, V286, P28276, DOI 10.1074/jbc.M111.237560; Nicoud M, 2007, J GENE MED, V9, P1015, DOI 10.1002/jgm.1115; Pang J, 2013, INVEST OPHTHALMOL VI, V54; Pang JJ, 2006, MOL VIS, V12, P756; Pasadhika S, 2010, INVEST OPHTH VIS SCI, V51, P2608, DOI 10.1167/iovs.09-3734; Rachel Rivka A, 2012, Cilia, V1, P22, DOI 10.1186/2046-2530-1-22; Roger JE, 2012, J NEUROSCI, V32, P528, DOI 10.1523/JNEUROSCI.3591-11.2012; Roman AJ, 2007, MOL VIS, V13, P1701; Ruggeri M, 2007, INVEST OPHTH VIS SCI, V48, P1808, DOI 10.1167/iovs.06-0815; Schafer T, 2008, HUM MOL GENET, V17, P3655, DOI 10.1093/hmg/ddn260; Wenzel A, 2007, INVEST OPHTH VIS SCI, V48, P534, DOI 10.1167/iovs.06-0652; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255; Yan ZY, 2000, P NATL ACAD SCI USA, V97, P6716, DOI 10.1073/pnas.97.12.6716; Yan ZY, 2002, METHOD ENZYMOL, V346, P334; Yzer S, 2012, MOL VIS, V18, P412; Zhang YD, 2012, HUM GENE THER, V23, P98, DOI 10.1089/hum.2011.131	68	21	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92928	10.1371/journal.pone.0092928	http://dx.doi.org/10.1371/journal.pone.0092928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671090	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000093
J	Close, H; Reilly, J; Mason, JM; Kripalani, M; Wilson, D; Main, J; Hungin, APS				Close, Helen; Reilly, Joe; Mason, James M.; Kripalani, Mukesh; Wilson, Douglas; Main, John; Hungin, A. Pali S.			Renal Failure in Lithium-Treated Bipolar Disorder: A Retrospective Cohort Study	PLOS ONE			English	Article							MOOD DISORDERS; TERM; KIDNEY; RISK; DISEASE; PREVENTION; NEPHROTOXICITY; METAANALYSIS; NEPHROPATHY; WITHDRAWAL	Objective: Lithium users are offered routine renal monitoring but few studies have quantified the risk to renal health. The aim of this study was to assess the association between use of lithium carbonate and incidence of renal failure in patients with bipolar disorder. Methods: This was a retrospective cohort study using the General Practice Research Database (GPRD) and a nested validation study of lithium exposure and renal failure. A cohort of 6360 participants aged over 18 years had a first recorded diagnosis of bipolar disorder between January 1, 1990 and December 31, 2007. Data were examined from electronic primary care records from 418 general practices across the UK. The primary outcome was the hazard ratio for renal failure in participants exposed to lithium carbonate as compared with non-users of lithium, adjusting for age, gender, co-morbidities, and poly-pharmacy. Results: Ever use of lithium was associated with a hazard ratio for renal failure of 2.5 (95% confidence interval 1.6 to 4.0) adjusted for known renal risk factors. Absolute risk was age dependent, with patients of 50 years or older at particular risk of renal failure: Number Needed to Harm (NNH) was 44 (21 to 150). Conclusions: Lithium is associated with an increased risk of renal failure, particularly among the older age group. The absolute risk of renal failure associated with lithium use remains small.	[Close, Helen; Mason, James M.; Wilson, Douglas] Univ Durham, Sch Med Pharm & Hlth, Wolfson Res Inst, Durham Clin Trials Unit, Stockton On Tees, England; [Reilly, Joe; Hungin, A. Pali S.] Univ Durham, Sch Med Pharm & Hlth, Wolfson Res Inst, Stockton On Tees, England; [Reilly, Joe; Kripalani, Mukesh] Tees Esk & Wear Valleys NHS Fdn Trust, West Pk Hosp, Darlington, Durham, England; [Main, John] South Tees Hosp NHS Fdn Trust, Middlesbrough, Cleveland, England	Durham University; Durham University	Reilly, J (corresponding author), Univ Durham, Sch Med Pharm & Hlth, Wolfson Res Inst, Queens Campus, Stockton On Tees, England.	j.g.reilly@durham.ac.uk	Mason, James M/D-9904-2011	Mason, James M/0000-0001-9210-4082; hungin, amritpal Pali/0000-0001-7275-8927	British Renal Society [07/010]	British Renal Society	An unrestricted academic grant from the British Renal Society http://www. britishrenal.org/ (grant no. 07/010). All authors are independent from the funding body. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2002, TREATM PAT BIP DIS, DOI [10.1176/appi.books.9780890423363.50051, DOI 10.1176/APPI.B00KS.9780890423363.50051]; [Anonymous], 2009, STAT VERS 10 0IC; [Anonymous], SPSS VERS 15 WIND; [Anonymous], 2008, WHO DEF DAIL DOS DRU; Bendz H, 1996, NEPHROL DIAL TRANSPL, V11, P457; BENDZ H, 1985, ACTA PSYCHIAT SCAND, V72, P451, DOI 10.1111/j.1600-0447.1985.tb02639.x; Bendz H, 2001, EUR PSYCHIAT, V16, P199, DOI 10.1016/S0924-9338(01)00565-X; Bocchetta A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-33; BOTON R, 1987, AM J KIDNEY DIS, V10, P329, DOI 10.1016/S0272-6386(87)80098-7; Cipriani A, 2005, AM J PSYCHIAT, V162, P1805, DOI 10.1176/appi.ajp.162.10.1805; Cipriani A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3646; Communities and Local Government, 2007, IND DEPR; Coskunol H, 1997, J AFFECT DISORDERS, V43, P5, DOI 10.1016/S0165-0327(96)00046-8; COX DR, 1972, J R STAT SOC B, V34, P187; Farres MT, 2003, RADIOLOGY, V229, P570, DOI 10.1148/radiol.2292020758; Geddes JR, 2010, LANCET, V375, P385, DOI 10.1016/S0140-6736(09)61828-6; Gitlin M, 1999, DRUG SAFETY, V20, P231, DOI 10.2165/00002018-199920030-00004; Grunfeld JP, 2009, NAT REV NEPHROL, V5, P270, DOI 10.1038/nrneph.2009.43; HETMAR O, 1987, ACTA PSYCHIAT SCAND, V76, P193, DOI 10.1111/j.1600-0447.1987.tb02883.x; HETMAR O, 1987, J PSYCHIAT RES, V21, P279, DOI 10.1016/0022-3956(87)90029-X; HETMAR O, 1989, J PSYCHIAT RES, V23, P285, DOI 10.1016/0022-3956(89)90034-4; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; HULLIN RP, 1979, BRIT MED J, V1, P1457, DOI 10.1136/bmj.1.6176.1457; KALLNER G, 1995, ACTA PSYCHIAT SCAND, V91, P48, DOI 10.1111/j.1600-0447.1995.tb09741.x; Kripalani M, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2452; Lepkifker E, 2004, J CLIN PSYCHIAT, V65, P850; Markowitz GS, 2000, J AM SOC NEPHROL, V11, P1439, DOI 10.1681/ASN.V1181439; McKnight RF, 2012, LANCET, V379, P721, DOI 10.1016/S0140-6736(11)61516-X; National Institute for Health and Clinical Excellence, 2006, MAN BIP DIS AD CHILD, V38; NHS Information Centre, 2007, QUAL OUTC FRAM SUMM; Oakley PW, 2001, AUST NZ J PSYCHIAT, V35, P833, DOI 10.1046/j.1440-1614.2001.00963.x; Paul R, 2010, J PSYCHOPHARMACOL, V24, P1425, DOI 10.1177/0269881109104930; SCHOU M, 1989, PHARMACOPSYCHIATRY, V22, P101, DOI 10.1055/s-2007-1014588; Suissa S, 2008, AM J EPIDEMIOL, V168, P329, DOI 10.1093/aje/kwn135; Turan T, 2002, PROG NEURO-PSYCHOPH, V26, P561, DOI 10.1016/S0278-5846(01)00308-6; Van Staa TP, 2004, GASTROENTEROLOGY, V126, P1733, DOI 10.1053/j.gastro.2004.03.016; Werneke U, 2012, ACTA PSYCHIAT SCAND, V126, P186, DOI 10.1111/j.1600-0447.2012.01847.x	38	59	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e90169	10.1371/journal.pone.0090169	http://dx.doi.org/10.1371/journal.pone.0090169			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670976	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000333677000006
J	Goldberg, JF; Hebblewhite, M; Bardsley, J				Goldberg, Joshua F.; Hebblewhite, Mark; Bardsley, John			Consequences of a Refuge for the Predator-Prey Dynamics of a Wolf-Elk System in Banff National Park, Alberta, Canada	PLOS ONE			English	Article							POPULATION-DYNAMICS; SPATIAL HETEROGENEITY; APPARENT COMPETITION; YELLOWSTONE ASPEN; LANDSCAPE-SCALE; KILL RATES; TRADE-OFFS; RED DEER; CONSERVATION; WOLVES	Refugia can affect predator-prey dynamics via movements between refuge and non-refuge areas. We examine the influence of a refuge on population dynamics in a large mammal predator-prey system. Wolves (Canis lupus) have recolonized much of their former range in North America, and as a result, ungulate prey have exploited refugia to reduce predation risk with unknown impacts on wolf-prey dynamics. We examined the influence of a refuge on elk (Cervus elaphus) and wolf population dynamics in Banff National Park. Elk occupy the Banff townsite with little predation, whereas elk in the adjoining Bow Valley experience higher wolf predation. The Banff refuge may influence Bow Valley predator-prey dynamics through source-sink movements. To test this hypothesis, we used 26 years of wolf and elk population counts and the Delayed Rejection Adaptive Metropolis Markov chain Monte Carlo method to fit five predator-prey models: 1) with no source-sink movements, 2) with elk density-dependent dispersal from the refuge to the non-refuge, 3) with elk predation risk avoidance movements from the non-refuge to the refuge, 4) with differential movement rates between refuge and non-refuge, and 5) with short-term, source-sink wolf movements. Model 1 provided the best fit of the data, as measured by Akaike Information Criterion (AIC). In the top model, Banff and Bow Valley elk had median growth rates of 0.08 and 0.03 (95% credibility intervals [CIs]: 0.027-0.186 and 0.001-0.143), respectively, Banff had a median carrying capacity of 630 elk (95% CI: 471.9-2676.9), Bow Valley elk had a median wolf encounter rate of 0.02 (95% CI: 0.013-0.030), and wolves had a median death rate of 0.23 (95% CI: 0.146-0.335) and a median conversion efficiency of 0.07 (95% CI: 0.031-0.124). We found little evidence for potential source-sink movements influencing the predator-prey dynamics of this system. This result suggests that the refuge was isolated from the non-refuge.	[Goldberg, Joshua F.; Hebblewhite, Mark] Univ Montana, Coll Forestry & Conservat, Dept Ecosyst & Conservat Sci, Wildlife Biol Program, Missoula, MT 59812 USA; [Bardsley, John] Univ Montana, Dept Math & Stat, Missoula, MT 59812 USA	University of Montana System; University of Montana; University of Montana System; University of Montana	Goldberg, JF (corresponding author), Univ Montana, Coll Forestry & Conservat, Dept Ecosyst & Conservat Sci, Wildlife Biol Program, Missoula, MT 59812 USA.	joshua.goldberg@umontana.edu	hebblewhite, mark/G-6164-2013; Hebblewhite, Mark/AAI-8101-2020	Hebblewhite, Mark/0000-0001-5382-1361	Parks Canada; University of Montana; NASA [NNX11AO47G]; Montana Integrative Learning Experience for Students (MILES)	Parks Canada; University of Montana; NASA(National Aeronautics & Space Administration (NASA)); Montana Integrative Learning Experience for Students (MILES)	Funding for this study was provided by Parks Canada, the University of Montana, NASA (grant #NNX11AO47G)and Montana Integrative Learning Experience for Students (MILES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1997, EVOLUTION, V51, P1742, DOI 10.1111/j.1558-5646.1997.tb05098.x; Abrams PA, 1996, ECOLOGY, V77, P1125, DOI 10.2307/2265581; Andreasen AM, 2012, MOL ECOL, V21, P5689, DOI 10.1111/j.1365-294X.2012.05740.x; Bangs EE, 1996, WILDLIFE SOC B, V24, P402; Beyer HL, 2007, ECOL APPL, V17, P1563, DOI 10.1890/06-1254.1; BOUSKILA A, 1995, ECOLOGY, V76, P165, DOI 10.2307/1940639; Boyce MS, 2000, METH C CONS, P253; Brawn JD, 1996, ECOLOGY, V77, P3, DOI 10.2307/2265649; Burcham M, 1999, WILDLIFE SOC B, V27, P833; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Callaghan CJ, 2003, ECOLOGY GRAY WOLF CA; Canada P, 1999, ELK MANAGEMENT STRAT; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Clark J. S, 2007, MODELS ECOLOGICAL DA; Clevenger AP, 2001, WILDLIFE SOC B, V29, P646; COLLINGS JB, 1995, B MATH BIOL, V57, P63, DOI 10.1016/0092-8240(94)00024-7; Cowlishaw G, 1997, ANIM BEHAV, V53, P667, DOI 10.1006/anbe.1996.0298; Creel S, 2009, ECOLOGY, V90, P2454, DOI 10.1890/08-2017.1; CROWLEY PH, 1981, AM NAT, V118, P673, DOI 10.1086/283861; De Valpine P, 2003, ECOLOGY, V84, P3064, DOI 10.1890/02-0039; DICKMAN CR, 1992, ECOLOGY, V73, P313, DOI 10.2307/1938742; Eberhardt LL, 1998, CAN J ZOOL, V76, P380, DOI 10.1139/cjz-76-2-380; Ellner SP, 2001, NATURE, V412, P538, DOI 10.1038/35087580; FESTABIANCHET M, 1988, OECOLOGIA, V75, P580, DOI 10.1007/BF00776423; Fuller Todd K., 2003, P161; Garrott RA, 2005, WILDLIFE SOC B, V33, P1245, DOI 10.2193/0091-7648(2005)33[1245:GWEATG]2.0.CO;2; Gause G. F., 1934, STRUGGLE EXISTENCE; Getz WM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000209; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; Gonzalez-Olivares E, 2003, ECOL MODEL, V166, P135, DOI 10.1016/S0304-3800(03)00131-5; Green PJ, 2001, BIOMETRIKA, V88, P1035, DOI 10.1093/biomet/88.4.1035; Gude JA, 2006, ECOL APPL, V16, P285, DOI 10.1890/04-0623; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0; Haugen TO, 2006, P ROY SOC B-BIOL SCI, V273, P2917, DOI 10.1098/rspb.2006.3659; Hebblewhite M, 2005, ECOLOGY, V86, P2135, DOI 10.1890/04-1269; Hebblewhite M, 2003, WILDLIFE SOC B, V31, P933; Hebblewhite M, 2010, CONSERV BIOL, V24, P341, DOI 10.1111/j.1523-1739.2009.01343.x; Hebblewhite M, 2002, CAN J ZOOL, V80, P789, DOI 10.1139/Z02-058; Hebblewhite M, 2013, POPULATION ECOLOGY; Hebblewhite M., 2000, WOLF ELK PREDATOR PR; Hebblewhite M, 2014, WOLF ELK WINTER COUN; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; Higgins SI, 2010, ECOLOGY, V91, P1682, DOI 10.1890/08-1368.1; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; HOLT RD, 1984, AM NAT, V124, P377, DOI 10.1086/284280; HOLT RD, 1987, AM NAT, V130, P412, DOI 10.1086/284718; IVES AR, 1987, AM NAT, V130, P431, DOI 10.1086/284719; Jost C, 2000, THEOR POPUL BIOL, V57, P325, DOI 10.1006/tpbi.2000.1463; Jost C, 2001, POPUL ECOL, V43, P229, DOI 10.1007/s10144-001-8187-3; Kauffman MJ, 2007, ECOL LETT, V10, P690, DOI 10.1111/j.1461-0248.2007.01059.x; Kauffman MJ, 2010, ECOLOGY, V91, P2742, DOI 10.1890/09-1949.1; Kloppers EL, 2005, ECOL SOC, V10; KOTLER BP, 1991, ECOLOGY, V72, P2249, DOI 10.2307/1941575; Kristan WB, 2004, WILDLIFE SOC B, V32, P244, DOI 10.2193/0091-7648(2004)32[244:DCOCRA]2.0.CO;2; Lame M, 2008, MCMC TOOLBOX MATLAB; Letnic M, 2009, ANIM CONSERV, V12, P302, DOI 10.1111/j.1469-1795.2009.00250.x; Lotka A. J., 1925, ELEMENTS PHYS BIOL, DOI 10.1038/116461b0; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Mathworks T, 2011, MATLAB; McKenzie J., 2001, SELECTIVE ADVANTAGE; MCNAIR JN, 1986, THEOR POPUL BIOL, V29, P38, DOI 10.1016/0040-5809(86)90004-3; MECH LD, 1995, CONSERV BIOL, V9, P270, DOI 10.1046/j.1523-1739.1995.9020270.x; Mira A, 2001, STAT SCI, V16, P340, DOI 10.1214/ss/1015346319; Mira A., 2001, METRON, V59, P231; Muhly TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064311; Musiani M, 2010, ECOL MODEL, V221, P2374, DOI 10.1016/j.ecolmodel.2010.06.019; Naranjo EJ, 2007, BIOL CONSERV, V138, P412, DOI 10.1016/j.biocon.2007.05.010; Orrock JL, 2008, ECOLOGY, V89, P1168, DOI 10.1890/07-0223.1; Orrock JL, 2010, OIKOS, V119, P101, DOI 10.1111/j.1600-0706.2009.17831.x; Pachepsky E, 2008, ECOLOGY, V89, P280, DOI 10.1890/07-0641.1; PERSSON L, 1995, ECOLOGY, V76, P70, DOI 10.2307/1940632; Poggiale JC, 2004, CR BIOL, V327, P1058, DOI 10.1016/j.crvi.2004.06.006; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Putman RJ, 2012, EUR J WILDLIFE RES, V58, P781, DOI 10.1007/s10344-012-0624-4; Rand TA, 2006, CONSERV BIOL, V20, P1720, DOI 10.1111/j.1523-1739.2006.00507.x; Ripple WJ, 2007, BIOL CONSERV, V138, P514, DOI 10.1016/j.biocon.2007.05.006; Ripple WJ, 2001, BIOL CONSERV, V102, P227, DOI 10.1016/S0006-3207(01)00107-0; ROBERTSON BA, 2007, CONDOR, V109, P109; Rodewald AD, 2011, ECOL APPL, V21, P936, DOI 10.1890/10-0863.1; Rogala JK, 2011, ECOL SOC, V16, DOI 10.5751/ES-04251-160316; Runge JP, 2006, AM NAT, V167, P925, DOI 10.1086/503531; Sand H, 2008, OECOLOGIA, V156, P53, DOI 10.1007/s00442-008-0969-2; Schauber EM, 2009, ECOLOGY, V90, P240, DOI 10.1890/07-0980.1; SCHMITT RJ, 1987, ECOLOGY, V68, P1887, DOI 10.2307/1939880; Sepulveda AJ, 2011, OECOLOGIA, V166, P1043, DOI 10.1007/s00442-011-1935-y; Shampine LF, 1999, SIAM REV, V41, P538, DOI 10.1137/S003614459933425X; Sharp A, 2011, ECOL APPL, V21, P1024, DOI 10.1890/10-1449.1; SIH A, 1992, AM NAT, V139, P1052, DOI 10.1086/285372; Sinclair ARE, 1998, CONSERV BIOL, V12, P564, DOI 10.1046/j.1523-1739.1998.97030.x; Sinclair ARE, 2006, J ANIM ECOL, V75, P64, DOI 10.1111/j.1365-2656.2006.01036.x; Singh A, 2007, J THEOR BIOL, V247, P733, DOI 10.1016/j.jtbi.2007.04.004; Soetaert K., 2010, J STAT SOFTWARE, V33, P1; Thompson MJ, 1998, WILDLIFE SOC B, V26, P477; Turgeon K, 2012, J ANIM ECOL, V81, P1161, DOI 10.1111/j.1365-2656.2012.01990.x; Volterra V, 1926, NATURE, V118, P558, DOI 10.1038/118558a0; Vucetich JA, 2004, OIKOS, V107, P309, DOI 10.1111/j.0030-1299.2004.13483.x; Vucetich JA, 2002, ECOLOGY, V83, P3003; Waber K, 2013, J WILDLIFE MANAGE, V77, P726, DOI 10.1002/jwmg.530; Wang Y, 2012, NONLINEAR DYNAM, V67, P191, DOI 10.1007/s11071-011-9971-z; Wolfe LL, 2002, J WILDLIFE MANAGE, V66, P564, DOI 10.2307/3803124; Woods J.G., 1991, ECOLOGY PARTIALLY MI	102	16	16	3	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e91417	10.1371/journal.pone.0091417	http://dx.doi.org/10.1371/journal.pone.0091417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670632	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000019
J	Khan, U; Nicell, JA				Khan, Usman; Nicell, Jim A.			Contraceptive Options and Their Associated Estrogenic Environmental Loads: Relationships and Trade-Offs	PLOS ONE			English	Article							UNITED-STATES; UNINTENDED PREGNANCY; ENDOCRINE DISRUPTION; AQUATIC ENVIRONMENT; COST-EFFECTIVENESS; STEROID ESTROGENS; URINARY-EXCRETION; DRINKING-WATER; WILD FISH; ETHINYLESTRADIOL	This work explores the relationships between a user's choice of a given contraceptive option and the load of steroidal estrogens that can be associated with that choice. Family planning data for the USA served as a basis for the analysis. The results showed that collectively the use of contraception in the USA conservatively averts the release of approximately 4.8 tonnes of estradiol equivalents to the environment. 35% of the estrogenic load released over the course of all experienced pregnancies events and 34% the estrogenic load represented by all resultant legacies are a result of contraception failure and the non-use of contraception. A scenario analysis conducted to explore the impacts of discontinuing the use of ethinylestradiol-based oral contraceptives revealed that this would not only result in a 1.7-fold increase in the estrogenic loading of the users, but the users would also be expected to experience undesired family planning outcomes at a rate that is 3.3 times higher. Additional scenario analyses in which ethinylestradiol-based oral contraceptive users were modeled as having switched entirely to the use of male condoms, diaphragms or copper IUDs suggested that whether a higher or lower estrogenic load can be associated with the switching population depends on the typical failure rates of the options adopted following discontinuation. And, finally, it was estimated that, in the USA, at most 13% of the annual estrogenic load can be averted by fully meeting the contraceptive needs of the population. Therefore, while the issue of estrogen impacts on the environment cannot be addressed solely by meeting the population's contraceptive needs, a significant fraction of the estrogenic mass released to environment can be averted by improving the level with which their contraceptive needs are met.	[Khan, Usman; Nicell, Jim A.] McGill Univ, Dept Civil Engn & Appl Mech, Montreal, PQ H3A 2K6, Canada	McGill University	Nicell, JA (corresponding author), McGill Univ, Dept Civil Engn & Appl Mech, Montreal, PQ H3A 2K6, Canada.	jim.nicell@mcgill.ca		Nicell, Jim/0000-0003-0119-2967	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by the Natural Sciences and Engineering Research Council of Canada (see www.nserc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerni HR, 2004, ANAL BIOANAL CHEM, V378, P688, DOI 10.1007/s00216-003-2276-4; Anderson PD, 2012, ENVIRON TOXICOL CHEM, V31, P1407, DOI 10.1002/etc.1824; [Anonymous], 2010, MED LETT DRUGS THER, V52, P71; [Anonymous], 2012, FACTS UN PREGN US; [Anonymous], 2012, NATURE, V491, P496; Atkinson SK, 2011, ARCH ENVIRON CON TOX, V60, P1, DOI 10.1007/s00244-010-9515-4; Barber LB, 2011, SCI TOTAL ENVIRON, V409, P4720, DOI 10.1016/j.scitotenv.2011.06.039; BERG FD, 1992, ARCH GYNECOL OBSTET, V251, P17, DOI 10.1007/BF02718274; Caldwell DJ, 2012, ENVIRON TOXICOL CHEM, V31, P1396, DOI 10.1002/etc.1825; Caldwell DJ, 2010, ENVIRON HEALTH PERSP, V118, P338, DOI 10.1289/ehp.0900654; DeQuattro ZA, 2012, ENVIRON TOXICOL CHEM, V31, P851, DOI 10.1002/etc.1754; Desbrow C, 1998, ENVIRON SCI TECHNOL, V32, P1549, DOI 10.1021/es9707973; Desforges JPW, 2010, ENVIRON POLLUT, V158, P3279, DOI 10.1016/j.envpol.2010.07.017; EMA, 2012, IOA ASS REP; Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Finer LB, 2012, FERTIL STERIL, V98, P893, DOI 10.1016/j.fertnstert.2012.06.027; Gilbert N, 2012, NATURE, V491, P503, DOI 10.1038/491503a; Goldhaber M K, 1991, Epidemiology, V2, P33; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Institute for Health Metrics and Evaluation, 2010, INF CHILD MORT EST C; Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870; Johnson AC, 2004, ENVIRON SCI TECHNOL, V38, P3649, DOI 10.1021/es035342u; Johnson AC, 2013, ENVIRON SCI TECHNOL, V47, P12297, DOI 10.1021/es4030035; Johnson AC, 2011, ENVIRON SCI TECHNOL, V45, P1028, DOI 10.1021/es103358t; JOHNSON DW, 1979, CLIN CHIM ACTA, V94, P207, DOI 10.1016/0009-8981(79)90015-9; Jurgens MD, 2002, ENVIRON TOXICOL CHEM, V21, P480, DOI 10.1002/etc.5620210302; Kase R, 2011, WASTE WATER EVALUATI; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Kiley JW, 2011, INT J WOMENS HEALTH, V3, P281, DOI 10.2147/IJWH.S22645; Kostich M, 2010, SETAC N AM 2010 ANN; McKie R, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4029; Mosher William D, 2010, Vital Health Stat 23, P1; Owen R, 2012, NATURE, V485, P441, DOI 10.1038/485441a; Owens R., 2013, LATE LESSONS EARLY W, p[279, 292]; Paulos PM, 2011, THESIS U N TEXAS; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rosenberg MJ, 1998, AM J OBSTET GYNECOL, V179, P577, DOI 10.1016/S0002-9378(98)70047-X; Runnalls TJ, 2013, ENVIRON SCI TECHNOL, V47, P2077, DOI 10.1021/es3048834; Runnalls TJ, 2010, HUM ECOL RISK ASSESS, V16, P1318, DOI 10.1080/10807039.2010.526503; Sinclair CJ, 2006, ENVIRON SCI TECHNOL, V40, P7283, DOI 10.1021/es0603507; Sumpter JP, 2008, J ENVIRON MONITOR, V10, P1476, DOI 10.1039/b815741n; Tanna RN, 2013, ENVIRON TOXICOL CHEM, V32, P1981, DOI 10.1002/etc.2262; Tetreault GR, 2011, AQUAT TOXICOL, V104, P278, DOI 10.1016/j.aquatox.2011.05.008; Thorpe KL, 2001, ENVIRON SCI TECHNOL, V35, P2476, DOI 10.1021/es001767u; TIKKANEN MJ, 1973, J STEROID BIOCHEM, V4, P57, DOI 10.1016/0022-4731(73)90080-0; Trudeau VL, 2011, FRONT EXP ENDOCRINOL, DOI DOI 10.3389/FEND0.2011.00083/FULL.ACCESSED; Trussell J, 2008, EUR J CONTRACEP REPR, V13, P219, DOI 10.1080/13625180802359263; Trussell J, 2007, CONTRACEPTION, V75, P168, DOI 10.1016/j.contraception.2006.11.009; Trussell J, 2013, CONTRACEPTION, V87, P154, DOI 10.1016/j.contraception.2012.07.016; Trussell J, 2012, CONTRACEPTION, V85, P218, DOI 10.1016/j.contraception.2011.06.011; Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021; Trussell J, 2009, CONTRACEPTION, V79, P5, DOI 10.1016/j.contraception.2008.08.003; Vajda AM, 2008, ENVIRON SCI TECHNOL, V42, P3407, DOI 10.1021/es0720661; Vajda AM, 2011, AQUAT TOXICOL, V103, P213, DOI 10.1016/j.aquatox.2011.02.007; Ventura Stephanie J, 2012, Natl Vital Stat Rep, V60, P1; Whidbey CM, 2012, WATER RES, V46, P5287, DOI 10.1016/j.watres.2012.07.016; Williams RJ, 2009, ENVIRON TOXICOL CHEM, V28, P220, DOI 10.1897/08-047.1; Wise A, 2011, ENVIRON SCI TECHNOL, V45, P51, DOI 10.1021/es1014482; Worstall Tim, 2012, FORBES; Yamamoto T. O., 1969, P117; YAMAMOTO TO, 1965, GEN COMP ENDOCR, V5, P527, DOI 10.1016/0016-6480(65)90041-9; Zeilinger J, 2009, ENVIRON TOXICOL CHEM, V28, P2663, DOI 10.1897/08-485.1	62	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92630	10.1371/journal.pone.0092630	http://dx.doi.org/10.1371/journal.pone.0092630			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670973	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677000059
J	Sahlean, TC; Gherghel, I; Papes, M; Strugariu, A; Zamfirescu, SR				Sahlean, Tiberiu C.; Gherghel, Iulian; Papes, Monica; Strugariu, Alexandru; Zamfirescu, Stefan R.			Refining Climate Change Projections for Organisms with Low Dispersal Abilities: A Case Study of the Caspian Whip Snake	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; LAND-USE CHANGE; GEOGRAPHIC DISTRIBUTIONS; ECOLOGICAL NICHES; EXTINCTION RATES; ENVELOPE MODELS; IMPACT; PLANT; DIVERSITY; HISTORY	Climate warming is one of the most important threats to biodiversity. Ectothermic organisms such as amphibians and reptiles are especially vulnerable as climatic conditions affect them directly. Ecological niche models (ENMs) are increasingly popular in ecological studies, but several drawbacks exist, including the limited ability to account for the dispersal potential of the species. In this study, we use ENMs to explore the impact of global climate change on the Caspian whip snake (Dolichophis caspius) as model for organisms with low dispersal abilities and to quantify dispersal to novel areas using GIS techniques. Models generated using Maxent 3.3.3 k and GARP for current distribution were projected on future climatic scenarios. A cost-distance analysis was run in ArcGIS 10 using geomorphological features, ecological conditions, and human footprint as "costs'' to dispersal of the species to obtain a Maximum Dispersal Range (MDR) estimate. All models developed were statistically significant (P < 0.05) and recovered the currently known distribution of D. caspius. Models projected on future climatic conditions using Maxent predicted a doubling of suitable climatic area, while GARP predicted a more conservative expansion. Both models agreed on an expansion of suitable area northwards, with minor decreases at the southern distribution limit. The MDR area calculated using the Maxent model represented a third of the total area of the projected model. The MDR based on GARP models recovered only about 20% of the total area of the projected model. Thus, incorporating measures of species' dispersal abilities greatly reduced estimated area of potential future distributions.	[Sahlean, Tiberiu C.] Univ Bucharest, Fac Biol, Bucharest, Romania; [Sahlean, Tiberiu C.] Grigore Antipa Natl Museum Nat Hist, Dept Terr Fauna, Bucharest, Romania; [Gherghel, Iulian; Papes, Monica] Oklahoma State Univ, Dept Zool, Stillwater, OK 74078 USA; [Strugariu, Alexandru; Zamfirescu, Stefan R.] Alexandru Ioan Cuza Univ, Fac Biol, Iasi, Romania	University of Bucharest; Oklahoma State University System; Oklahoma State University - Stillwater; Alexandru Ioan Cuza University	Gherghel, I (corresponding author), Oklahoma State Univ, Dept Zool, Stillwater, OK 74078 USA.	iulian.gherghel@okstate.edu	Sahlean, Tiberiu/A-9727-2010; Gherghel, Iulian/C-6478-2009; Gherghel, Iulian/K-8074-2019; Zamfirescu, Stefan Remus/B-8771-2011	Sahlean, Tiberiu/0000-0001-9014-9084; Gherghel, Iulian/0000-0001-7963-6498; Strugariu, Alexandru/0000-0001-7866-6732; Zamfirescu, Stefan/0000-0002-8746-5120				Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; [Anonymous], CARTEA ROSIE VERTEBR; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Bombi P, 2009, AMPHIBIA-REPTILIA, V30, P413, DOI 10.1163/156853809788795173; Bonnet X, 1999, BIOL CONSERV, V89, P39, DOI 10.1016/S0006-3207(98)00140-2; Both C, 2005, GLOBAL CHANGE BIOL, V11, P1606, DOI 10.1111/j.1365-2486.2005.01038.x; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Cowling SA, 2001, QUATERNARY RES, V55, P140, DOI 10.1006/qres.2000.2197; Cremene C, 2005, CONSERV BIOL, V19, P1606, DOI 10.1111/j.1523-1739.2005.00084.x; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; DeMatteo KE, 2008, BIOL CONSERV, V141, P2494, DOI 10.1016/j.biocon.2008.07.010; Doko T, 2011, ECOL MODEL, V222, P748, DOI 10.1016/j.ecolmodel.2010.11.005; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Driscoll DA, 2004, ECOL APPL, V14, P220, DOI 10.1890/02-5248; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; ESRI, 2011, ARCGIS DESKT REL 10; FAO, 2005, GRASSL WORLD; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Foufopoulos J, 2011, AM NAT, V177, P119, DOI 10.1086/657624; Fuhn I. E., 1961, REPTILIA FAUNA PEOPL; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hays GC, 2003, GLOBAL CHANGE BIOL, V9, P642, DOI 10.1046/j.1365-2486.2003.00606.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Ihlow F, 2012, GLOBAL CHANGE BIOL, V18, P1520, DOI 10.1111/j.1365-2486.2011.02623.x; Iverson LR, 1999, ECOL MODEL, V115, P77, DOI 10.1016/S0304-3800(98)00200-2; Jaggi C, 1999, AMPHIBIA-REPTILIA, V20, P25, DOI 10.1163/156853899506870; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Keith K, 2008, CALIF FISH GAME, V94, P75; Kiesecker JM, 2001, NATURE, V410, P681, DOI 10.1038/35070552; Kovacs-Lang E, 2000, PHYTOCOENOLOGIA, V30, P385; Lee DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042466; Malcolm JR, 2002, J BIOGEOGR, V29, P835, DOI 10.1046/j.1365-2699.2002.00702.x; McLaughlin JF, 2002, P NATL ACAD SCI USA, V99, P6070, DOI 10.1073/pnas.052131199; Moreira F, 2007, LANDSCAPE ECOL, V22, P1461, DOI 10.1007/s10980-007-9125-3; Mosier AR, 1997, NUTR CYCL AGROECOSYS, V49, P71, DOI 10.1023/A:1009754207548; Moussalli A, 2009, MOL ECOL, V18, P483, DOI 10.1111/j.1365-294X.2008.04035.x; Nagy ZT, 2010, AMPHIBIA-REPTILIA, V31, P455, DOI 10.1163/017353710X518397; Nix H., 1986, ATLAS ELAPID SNAKES; Owens HL, 2012, BIODIVERS CONSERV, V21, P577, DOI 10.1007/s10531-011-0202-1; Papes M, 2007, DIVERS DISTRIB, V13, P890, DOI 10.1111/j.1472-4642.2007.00392.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2005, BIOL CONSERV, V123, P389, DOI 10.1016/j.biocon.2004.12.006; Pearson RG, 2002, ECOL MODEL, V154, P289, DOI 10.1016/S0304-3800(02)00056-X; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 2003, WEED SCI, V51, P863, DOI 10.1614/P2002-081; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2001, ECOL MODEL, V144, P21, DOI 10.1016/S0304-3800(01)00345-3; Peterson AT, 2001, CONDOR, V103, P599, DOI 10.1650/0010-5422(2001)103[0599:PSGDBO]2.0.CO;2; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pitelka LF, 1997, AM SCI, V85, P464; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Puschendorf R, 2009, DIVERS DISTRIB, V15, P401, DOI 10.1111/j.1472-4642.2008.00548.x; Ramirez J, 2008, HIGH RESOLUTION STAT; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Reading CJ, 2010, BIOL LETTERS, V6, P777, DOI 10.1098/rsbl.2010.0373; Renner IW, 2013, BIOMETRICS, V69, P274, DOI 10.1111/j.1541-0420.2012.01824.x; Richardson, 2005, WORLDCLIM VERSION 13; RICHMAN AD, 1988, AM NAT, V131, P611, DOI 10.1086/284810; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Scachetti-Pereira R., 2001, DESKTOP GARP; Schcherbak N.N., 1993, HDB REPTILIEN AMPHIB, V3/I, P83; Sillero N, 2011, ECOL MODEL, V222, P1343, DOI 10.1016/j.ecolmodel.2011.01.018; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Sinsch U, 2007, CAN J ZOOL, V85, P665, DOI 10.1139/Z07-046; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Solomon S, 2007, CONTRIBUTION WORKING; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Strugariu A, 2007, HERPETOLOGICA ROMANI, V1, P31; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2004, J BIOGEOGR, V31, P353, DOI 10.1046/j.0305-0270.2003.00991.x; Tibu PL, 2007, NORTH-WEST J ZOOL, V3, P62; Travis JMJ, 2003, P ROY SOC B-BIOL SCI, V270, P467, DOI 10.1098/rspb.2002.2246; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wiens JJ, 2004, AM NAT, V163, P914, DOI 10.1086/386552; Wiens JJ, 2011, Q REV BIOL, V86, P75, DOI 10.1086/659883; Wilson JJ, 2010, FOREST POLICY ECON, V12, P94, DOI 10.1016/j.forpol.2009.08.005; Winkler DW, 2002, P NATL ACAD SCI USA, V99, P13595, DOI 10.1073/pnas.212251999; Woodward FI, 1997, GLOBAL ECOL BIOGEOGR, V6, P413, DOI 10.2307/2997350; Zinner H, 1972, SYSTEMATICS EVOLUTIO	103	35	38	4	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e91994	10.1371/journal.pone.0091994	http://dx.doi.org/10.1371/journal.pone.0091994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670422	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677000029
J	Bhattacharyya, N; Hu, X; Chen, CZ; Griner, LAM; Zheng, W; Inglese, J; Austin, CP; Marugan, JJ; Southall, N; Neumann, S; Northup, JK; Ferrer, M; Collins, MT				Bhattacharyya, Nisan; Hu, Xin; Chen, Catherine Z.; Griner, Lesley A. Mathews; Zheng, Wei; Inglese, James; Austin, Christopher P.; Marugan, Juan J.; Southall, Noel; Neumann, Susanne; Northup, John K.; Ferrer, Marc; Collins, Michael T.			A High Throughput Screening Assay System for the Identification of Small Molecule Inhibitors of gsp	PLOS ONE			English	Article							MCCUNE-ALBRIGHT SYNDROME; STIMULATORY G-PROTEIN; ADENYLYL-CYCLASE; ALPHA; MUTATIONS	Mis-sense mutations in the alpha-subunit of the G-protein, G(s)alpha, cause fibrous dysplasia of bone/McCune-Albright syndrome. The biochemical outcome of these mutations is constitutively active Gsa and increased levels of cAMP. The aim of this study was to develop an assay system that would allow the identification of small molecule inhibitors specific for the mutant G(s)alpha protein, the so-called gsp oncogene. Commercially available Chinese hamster ovary cells were stably transfected with either wild-type (WT) or mutant G(s)alpha proteins (R201C and R201H). Stable cell lines with equivalent transfected G(s)alpha protein expression that had relatively lower (WT) or higher (R201C and R201H) cAMP levels were generated. These cell lines were used to develop a fluorescence resonance energy transfer (FRET)-based cAMP assay in 1536-well microplate format for high throughput screening of small molecule libraries. A small molecule library of 343,768 compounds was screened to identify modulators of gsp activity. A total of 1,356 compounds with inhibitory activity were initially identified and reconfirmed when tested in concentration dose responses. Six hundred eighty-six molecules were selected for further analysis after removing cytotoxic compounds and those that were active in forskolin-induced WT cells. These molecules were grouped by potency, efficacy, and structural similarities to yield 22 clusters with more than 5 of structurally similar members and 144 singleton molecules. Seven chemotypes of the major clusters were identified for further testing and analyses.	[Bhattacharyya, Nisan; Collins, Michael T.] Natl Inst Dent & Craniofacial Res, Skeletal Clin Studies Unit, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD 20892 USA; [Hu, Xin; Chen, Catherine Z.; Griner, Lesley A. Mathews; Zheng, Wei; Inglese, James; Austin, Christopher P.; Marugan, Juan J.; Southall, Noel; Ferrer, Marc] NIH, Dept Preclin Innovat, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Neumann, Susanne] NIDDK, Clin Endocrinol Branch, Lab Endocrinol & Receptor Biol, NIH, Bethesda, MD 20892 USA; [Northup, John K.] NIAAA, Lab Membrane Biochem & Biophys, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Collins, MT (corresponding author), Natl Inst Dent & Craniofacial Res, Skeletal Clin Studies Unit, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD 20892 USA.	mc247k@nih.gov	Zheng, Wei/GOE-5990-2022; Southall, Noel T/H-8991-2012; Zheng, Wei/J-8889-2014	Southall, Noel T/0000-0003-4500-880X; Zheng, Wei/0000-0003-1034-0757	Division of Intramural Research, National Institute of Dental Research, National Center for Advancing Translational Sciences; National Institute of Diabetes, Digestive and Kidney Diseases; National Institute of Alcoholism and Alcohol Abuse, National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004, ZIATR000052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000649] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Dental Research, National Center for Advancing Translational Sciences; National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Alcoholism and Alcohol Abuse, National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by the Division of Intramural Research, National Institute of Dental Research, National Center for Advancing Translational Sciences, National Institute of Diabetes, Digestive and Kidney Diseases, and National Institute of Alcoholism and Alcohol Abuse, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Bianco P, 1998, J CLIN INVEST, V101, P1737, DOI 10.1172/JCI2361; Celi FS, 2008, J CLIN ENDOCR METAB, V93, P2383, DOI 10.1210/jc.2007-2237; CHANSON P, 1994, EUR J ENDOCRINOL, V131, P229, DOI 10.1530/eje.0.1310229; Collins MT, 2011, ORPHANET J IN PRESS; Dumitrescu CE, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-12; Ham J, 1997, MOL CELL ENDOCRINOL, V127, P41, DOI 10.1016/S0303-7207(96)03987-1; HAPPLE R, 1986, CLIN GENET, V29, P321; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Kim Eunhee, 2005, Pituitary, V8, P155, DOI 10.1007/s11102-005-5245-4; Kim IS, 1999, HORM RES, V52, P235, DOI 10.1159/000023467; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LAWRENCE TS, 1979, J CELL BIOL, V80, P21, DOI 10.1083/jcb.80.1.21; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Robey Pamela Gehron, 2007, Pediatr Endocrinol Rev, V4 Suppl 4, P386; SCHWINDINGER WF, 1992, P NATL ACAD SCI USA, V89, P5152, DOI 10.1073/pnas.89.11.5152; Seifert R, 2012, TRENDS PHARMACOL SCI, V33, P64, DOI 10.1016/j.tips.2011.10.006; Wang Yuhong, 2010, Curr Chem Genomics, V4, P57, DOI 10.2174/1875397301004010057; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543	23	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e90766	10.1371/journal.pone.0090766	http://dx.doi.org/10.1371/journal.pone.0090766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667240	gold, Green Published, Green Submitted			2022-12-27	WOS:000333675600003
J	Dalenberg, JR; Nanetti, L; Renken, RJ; de Wijk, RA; ter Horst, GJ				Dalenberg, Jelle R.; Nanetti, Luca; Renken, Remco J.; de Wijk, Rene A.; ter Horst, Gert J.			Dealing with Consumer Differences in Liking during Repeated Exposure to Food; Typical Dynamics in Rating Behavior	PLOS ONE			English	Article							IN-HOME CONSUMPTION; K-MEANS; ELDERLY ADULTS; MERE EXPOSURE; ACCEPTANCE; INTENSITY; FLAVOR; YOUNG; PLEASANTNESS; PREFERENCES	Consumers show high interindividual variability in food liking during repeated exposure. To investigate consumer liking during repeated exposure, data is often interpreted on a product level by averaging results over all consumers. However, a single product may elicit inconsistent behaviors in consumers; averaging will mix and hide possible subgroups of consumer behaviors, leading to a misinterpretation of the results. To deal with the variability in consumer liking, we propose to use clustering on data from consumer-product combinations to investigate the nature of the behavioral differences within the complete dataset. The resulting behavioral clusters can then be used to describe product acceptance. To test this approach we used two independent data sets in which young adults were repeatedly exposed to drinks and snacks, respectively. We found that five typical consumer behaviors existed in both datasets. These behaviors differed both in the average level of liking as well as its temporal dynamics. By investigating the distribution of a single product across typical consumer behaviors, we provide more precise insight in how consumers divide in subgroups based on their product liking (i.e. product modality). This work shows that taking into account and using interindividual differences can unveil information about product acceptance that would otherwise be ignored.	[Dalenberg, Jelle R.; Nanetti, Luca; Renken, Remco J.; de Wijk, Rene A.; ter Horst, Gert J.] Top Inst Food & Nutr, Wageningen, Netherlands; [Dalenberg, Jelle R.; Nanetti, Luca; Renken, Remco J.; ter Horst, Gert J.] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr Groningen, NL-9713 AV Groningen, Netherlands; [de Wijk, Rene A.] Univ Wageningen & Res Ctr, Ctr Innovat Consumer Studies, Wageningen, Netherlands	Top Institute Food & Nutrition; University of Groningen; Wageningen University & Research	Dalenberg, JR (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	j.r.dalenberg@umcg.nl		Dalenberg, Jelle R./0000-0001-8580-5358; Renken, Remco Jan/0000-0002-7777-9484	TI Food and Nutrition	TI Food and Nutrition	Funding for this work was realized by TI Food and Nutrition (http://www.tifn.nl/). The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. The sponsors Danone and FrieslandCampina did have a role in the study design, more specifically: the choice of stimuli, which were produced by these sponsors.	Baayen R. H., 2008, ANAL LINGUISTIC DATA; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; BIRCH LL, 1982, APPETITE, V3, P353, DOI 10.1016/S0195-6663(82)80053-6; BORNSTEIN RF, 1989, PSYCHOL BULL, V106, P265, DOI 10.1037/0033-2909.106.2.265; Cooke L, 2007, J HUM NUTR DIET, V20, P294, DOI 10.1111/j.1365-277X.2007.00804.x; Cox D, 2002, J ACAD MARKET SCI, V30, P119, DOI 10.1177/03079459994371; Essed NH, 2006, PHYSIOL BEHAV, V89, P335, DOI 10.1016/j.physbeh.2006.06.016; Everitt B. S., 2006, HDB STAT ANAL USING; Fraley C, 2006, MCLUST VERSION 3 R N; Fraley C, 2007, J CLASSIF, V24, P155, DOI [10.1007/s00357-007-0004-5, 10.1007/s00357-007-0004-z]; Goutte C, 2001, HUM BRAIN MAPP, V13, P165, DOI 10.1002/hbm.1031; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hetherington MM, 2002, APPETITE, V38, P19, DOI 10.1006/appe.2001.0442; Hoek AC, 2013, FOOD QUAL PREFER, V28, P253, DOI 10.1016/j.foodqual.2012.07.002; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Jonsson P, 2004, 10TH INTERNATIONAL SYMPOSIUM ON SOFTWARE METRICS, PROCEEDINGS, P108, DOI 10.1109/METRIC.2004.1357895; Koster EP, 2003, FOOD QUAL PREFER, V14, P359, DOI 10.1016/S0950-3293(03)00017-X; Koster EP, 2003, FOOD QUAL PREFER, V14, P165, DOI 10.1016/S0950-3293(02)00075-7; Kremer S, 2013, FOOD QUAL PREFER, V27, P179, DOI 10.1016/j.foodqual.2012.06.002; Levy CM, 1999, FOOD QUAL PREFER, V10, P185, DOI 10.1016/S0950-3293(99)00016-6; Liem DG, 2004, PHYSIOL BEHAV, V83, P421, DOI 10.1016/j.physbeh.2004.08.028; Liem DG, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-38; Marks LE, 2012, PHYSIOL BEHAV, V105, P443, DOI 10.1016/j.physbeh.2011.08.039; MCBRIDE RL, 1985, APPETITE, V6, P125, DOI 10.1016/S0195-6663(85)80033-7; Nanetti L, 2013, 19 ANN M ORG HUM BRA; Nanetti L, 2009, NEUROIMAGE, V47, P1666, DOI 10.1016/j.neuroimage.2009.06.014; Pelchat ML, 2000, PHYSIOL BEHAV, V68, P353, DOI 10.1016/S0031-9384(99)00190-0; Pinheiro J, 2001, MIXED EFFECTS MODELS; PLINER P, 1982, APPETITE, V3, P283, DOI 10.1016/S0195-6663(82)80026-3; POULTON EC, 1975, AM J PSYCHOL, V88, P3, DOI 10.2307/1421662; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Steinley D, 2006, BRIT J MATH STAT PSY, V59, P1, DOI 10.1348/000711005X48266; SULLIVAN SA, 1994, PEDIATRICS, V93, P271; Sulmont-Rosse C, 2008, FOOD QUAL PREFER, V19, P412, DOI 10.1016/j.foodqual.2007.12.003; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tremblay A, 2011, MENT LEX, V6, P302, DOI 10.1075/ml.6.2.04tre; van Rijn H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051134; Wardle J, 2003, APPETITE, V40, P155, DOI 10.1016/S0195-6663(02)00135-6; Weijzen PLG, 2008, FOOD QUAL PREFER, V19, P349, DOI 10.1016/j.foodqual.2007.11.003; Witvliet CVO, 2007, COGNITION EMOTION, V21, P3, DOI 10.1080/02699930601000672; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848; Zandstra EH, 2000, APPETITE, V35, P113, DOI 10.1006/appe.2000.0342; Zandstra EH, 2004, FOOD QUAL PREFER, V15, P549, DOI 10.1016/j.foodqual.2003.12.001	43	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93350	10.1371/journal.pone.0093350	http://dx.doi.org/10.1371/journal.pone.0093350			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SD	24667832	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600173
J	Fan, Y; Wei, CG; Xiao, WZ; Zhang, WJ; Wang, NS; Chuang, PY; He, JC				Fan, Ying; Wei, Chengguo; Xiao, Wenzhen; Zhang, Weijia; Wang, Niansong; Chuang, Peter Y.; He, John Cijiang			Temporal Profile of the Renal Transcriptome of HIV-1 Transgenic Mice during Disease Progression	PLOS ONE			English	Article							F-SPONDIN; EXPRESSION; GENES; GLOMERULOSCLEROSIS; NEPHROPATHY; VARIANT; INJURY	Profiling of temporal changes of gene expression in the same kidney over the course of renal disease progression is challenging because repeat renal biopsies are rarely indicated in clinical practice. Here, we profiled the temporal change in renal transcriptome of HIV-1 transgenic mice (Tg26), an animal model for human HIV-associated nephropathy (HIVAN), and their littermates at three different time points (4, 8, and 12 weeks of age) representing early, middle, and late stages of renal disease by serial kidney biopsy. We analyzed both static levels of gene expression at three stages of disease and dynamic changes in gene expression between different stages. Analysis of static and dynamic changes in gene expression revealed that up-regulated genes at the early and middle stages are mostly involved in immune response and inflammation, whereas down-regulated genes mostly related to fatty acid and retinoid metabolisms. We validated the expression of a selected panel of genes that are up-regulated at the early stage (CCL2, CCL5, CXCL11, Ubd, Anxa1, and Spon1) by real-time PCR. Among these up-regulated genes, Spon1, which is a previously identified candidate gene for hypertension, was found to be up-regulated in kidney of human with diabetic nephropathy. Immunostaining of human biopsy samples demonstrated that protein expression of Spon1 was also markedly increased in kidneys of patients with both early and late HIVAN and diabetic nephropathy. Our studies suggest that analysis of both static and dynamic changes of gene expression profiles in disease progression avails another layer of information that could be utilized to gain a more comprehensive understanding of disease progression and identify potential biomarkers and drug targets.	[Fan, Ying; Xiao, Wenzhen; Wang, Niansong] Shanghai Jiao Tong Univ, Dept Nephrol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Wei, Chengguo; Zhang, Weijia; Chuang, Peter Y.; He, John Cijiang] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA	Shanghai Jiao Tong University; Icahn School of Medicine at Mount Sinai	He, JC (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA.	cijiang.he@mssm.edu	Xiao, Wenzhen/J-5167-2017		NIH [R01-DK-88541, P01-DK-56492, R01-DK-78897]; Chinese 973 fund [2012CB517601]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088541, R01DK078897, K08DK065495, P01DK056492] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 973 fund(National Basic Research Program of China); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is funded by NIH (R01-DK-88541, P01-DK-56492, and R01-DK-78897) http://report.nih.gov/ and Chinese 973 fund (2012CB517601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel LJ, 2008, ARCH INTERN MED, V168, P832, DOI 10.1001/archinte.168.8.832; Araujo LP, 2010, AM J NEPHROL, V31, P527, DOI 10.1159/000309756; Bar-Joseph Z, 2004, BIOINFORMATICS, V20, P2493, DOI 10.1093/bioinformatics/bth283; Berger Dave K., 2007, V382, P177, DOI 10.1007/978-1-59745-304-2_12; Berthier CC, 2009, DIABETES, V58, P469, DOI 10.2337/db08-1328; Bhavnani SK, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S9-S3; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Clemitson JR, 2007, CIRC RES, V100, P992, DOI 10.1161/01.RES.0000261961.41889.9c; DICKIE P, 1991, VIROLOGY, V185, P109, DOI 10.1016/0042-6822(91)90759-5; Feng X, 2009, J AM SOC NEPHROL; Gong PF, 2010, J AM SOC NEPHROL, V21, P316, DOI 10.1681/ASN.2009050479; Hodgin JB, 2010, AM J PATHOL, V177, P1674, DOI 10.2353/ajpath.2010.090746; Jahanshad N, 2013, P NATL ACAD SCI USA, V110, P4768, DOI 10.1073/pnas.1216206110; Ju WJ, 2009, AM J PATHOL, V174, P2073, DOI 10.2353/ajpath.2009.080888; KOPP JB, 1992, P NATL ACAD SCI USA, V89, P1577, DOI 10.1073/pnas.89.5.1577; Krensky AM, 2007, NAT CLIN PRACT NEPHR, V3, P164, DOI 10.1038/ncpneph0418; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu TC, 2006, CURR OPIN NEPHROL HY, V15, P233, DOI 10.1097/01.mnh.0000222688.69217.8e; Martini S, 2008, REV ENDOCR METAB DIS, V9, P267, DOI 10.1007/s11154-008-9103-3; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oka H, 2011, J PERIODONTOL, V82, P1776, DOI 10.1902/jop.2011.110111; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ratnam KK, 2011, KIDNEY INT, V79, P624, DOI 10.1038/ki.2010.470; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Sharma P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007751.pub2; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tan K, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-22; Tesch GH, 2008, AM J PHYSIOL-RENAL, V294, pF697, DOI 10.1152/ajprenal.00016.2008; Wang HP, 2010, AM J PHYSIOL-RENAL, V298, pF754, DOI 10.1152/ajprenal.00439.2009; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181	32	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93019	10.1371/journal.pone.0093019	http://dx.doi.org/10.1371/journal.pone.0093019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667548	Green Submitted, Green Published, gold			2022-12-27	WOS:000333675600127
J	Kosiorek, M; Zylinska, L; Zablocki, K; Pikula, S				Kosiorek, Michalina; Zylinska, Ludmila; Zablocki, Krzysztof; Pikula, Slawomir			Calcineurin/NFAT Signaling Represses Genes Vamp1 and Vamp2 via PMCA-Dependent Mechanism during Dopamine Secretion by Pheochromocytoma Cells	PLOS ONE			English	Article							NUCLEAR FACTOR; TRANSCRIPTIONAL REGULATION; CATECHOLAMINE SECRETION; CARDIAC-HYPERTROPHY; NA+/CA2+ EXCHANGER; CALCIUM; NFAT; EXPRESSION; CA2+; PROTEIN	Background: Plasma membrane Ca2+-ATPases (PMCA) extrude Ca2+ ions out of the cell and contribute to generation of calcium oscillations. Calcium signaling is crucial for transcriptional regulation of dopamine secretion by neuroendocrine PC12 cells. Low resting [Ca2+](c) in PC12 cells is maintained mainly by two Ca2+-ATPases, PMCA2 and PMCA3. Recently, we found that Ca2+ dependent phosphatase calcineurin was excessively activated under conditions of experimental downregulation of PMCA2 or PMCA3. Thus, the aim of this study was to explain if, via modulation of the Ca2+/calcineurin-dependent nuclear factor of activated T cells (NFAT) pathway, PMCA2 and PMCA3 affect intracellular signaling in pheochromocytoma/neuronal cells/PC12 cells. Secondly, we tested whether this might influence dopamine secretion by PC12 cells. Results: PMCA2- and PMCA3-deficient cells displayed profound decrease in dopamine secretion accompanied by a permanent increase in [Ca2+](c). Reduction in secretion might result from changes in NFAT signaling, following altered PMCA pattern. Consequently, activation of NFAT1 and NFAT3 transcription factors was observed in PMCA2-or PMCA3-deficient cells. Furthermore, chromatin immunoprecipitation assay indicated that NFATs could be involved in repression of Vamp genes encoding vesicle associated membrane proteins (VAMP). Conclusions: PMCA2 and PMCA3 are crucial for dopamine secretion in PC12 cells. Reduction in PMCA2 or PMCA3 led to calcium-dependent activation of calcineurin/NFAT signaling and, in consequence, to repression of the Vamp gene and deterioration of the SNARE complex formation in PC12 cells.	[Kosiorek, Michalina; Zablocki, Krzysztof; Pikula, Slawomir] PAS, Nencki Inst Expt Biol, Dept Biochem, Warsaw, Poland; [Kosiorek, Michalina] Mossakowski Med Res Ctr PAS, Dept Neurodegenerat Disorders, Neurogenet Lab, Warsaw, Poland; [Zylinska, Ludmila] Med Univ Lodz, Dept Mol Neurochem, Lodz, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Medical University Lodz	Kosiorek, M (corresponding author), PAS, Nencki Inst Expt Biol, Dept Biochem, Warsaw, Poland.	mkosiorek@imdik.pan.pl; s.pikula@nencki.gov.pl	Zylinska, Ludmila/ABE-9113-2020; Wężyk, Michalina Maria/R-2208-2018; Zablocki, Krzysztof/R-4181-2016	Zylinska, Ludmila/0000-0002-3876-8942; Wężyk, Michalina Maria/0000-0001-7498-4610; Zablocki, Krzysztof/0000-0002-9987-1257; Pikula, Slawomir/0000-0003-4640-3094	Polish National Science Center [401533340]; Nencki Instyitute of Experimental Biology	Polish National Science Center; Nencki Instyitute of Experimental Biology	This work is supported by Grant No. 401533340 from the Polish National Science Center and by the Nencki Instyitute of Experimental Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahmani A, 2006, BIOCHEM SOC T, V34, P696, DOI 10.1042/BST0340696; Abdul Hafiz Mohmmad, 2010, Mol Cell Pharmacol, V2, P7; Ago T, 2010, J CARDIOVASC TRANSL, V3, P304, DOI 10.1007/s12265-010-9182-x; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Asai M, 2004, MOL ENDOCRINOL, V18, P3011, DOI 10.1210/me.2003-0471; Barbado M, 2009, BBA-MOL CELL RES, V1793, P1096, DOI 10.1016/j.bbamcr.2009.02.004; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Belfield JL, 2006, J BIOL CHEM, V281, P27724, DOI 10.1074/jbc.M601485200; Benedito AB, 2005, J BIOL CHEM, V280, P2818, DOI 10.1074/jbc.M408741200; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; Brini M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004168; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Buch MH, 2005, J BIOL CHEM, V280, P29479, DOI 10.1074/jbc.M501326200; BURGOYNE RD, 1995, J PHYSIOL PHARMACOL, V46, P273; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Canellada A, 2008, GLIA, V56, P709, DOI 10.1002/glia.20647; CARAFOLI E, 1992, J BIOL CHEM, V267, P2115; Choo MK, 2009, BONE, V45, P579, DOI 10.1016/j.bone.2009.05.009; Dermitzaki E, 2012, J CELL PHYSIOL, V227, P1861, DOI 10.1002/jcp.22914; Domi T, 2007, ANN NY ACAD SCI, V1099, P237, DOI 10.1196/annals.1387.043; Dubois LA, 2005, WORLD J SURG, V29, P909, DOI 10.1007/s00268-005-7860-7; Duman JG, 2008, J GEN PHYSIOL, V131, P307, DOI 10.1085/jgp.200709915; DUTZ JP, 1993, J IMMUNOL, V150, P2591; Elloumi HZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034172; Gao H, 2012, J MOL CELL CARDIOL, V53, P657, DOI 10.1016/j.yjmcc.2012.08.005; Garcia AG, 2006, PHYSIOL REV, V86, P1093, DOI 10.1152/physrev.00039.2005; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Haberman A, 2012, J CELL BIOL, V196, P261, DOI 10.1083/jcb.201108088; HAMMES A, 1994, FASEB J, V8, P428, DOI 10.1096/fasebj.8.6.8168693; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Hernandez-Ochoa EO, 2007, CELL CALCIUM, V41, P559, DOI 10.1016/j.ceca.2006.10.006; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Horiba M, 2008, LIFE SCI, V82, P554, DOI 10.1016/j.lfs.2007.11.010; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jena BP, 2011, ADV EXP MED BIOL, V713, P13, DOI 10.1007/978-94-007-0763-4_3; Jordan JA, 2010, J VIROL, V84, P1722, DOI 10.1128/JVI.01918-09; Jordan MC, 2002, ANN NY ACAD SCI, V976, P259; Joyce JN, 1998, NEUROPSYCHOPHARMACOL, V19, P472, DOI 10.1016/S0893-133X(98)00044-X; Kamagate A, 2002, DIABETES, V51, P2773, DOI 10.2337/diabetes.51.9.2773; Kamagate A, 2000, CELL CALCIUM, V27, P231, DOI 10.1054/ceca.2000.0116; Kao SC, 2009, SCIENCE, V323, P651, DOI 10.1126/science.1166562; Katanosaka Y, 2005, J BIOL CHEM, V280, P5764, DOI 10.1074/jbc.M410240200; Kim HJ, 2012, J CELL BIOL, V199, P1145, DOI 10.1083/jcb.201204067; Kosiorek M, 2011, BIOCHEM BIOPH RES CO, V411, P235, DOI 10.1016/j.bbrc.2011.06.098; Kubista H, 2004, J CELL SCI, V117, P955, DOI 10.1242/jcs.00941; Lai NS, 2012, CLIN EXP IMMUNOL, V168, P78, DOI 10.1111/j.1365-2249.2012.04563.x; Li L, 2000, J BIOL CHEM, V275, P20903, DOI 10.1074/jbc.M000995200; Li Ruizhao, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P1022; Martin R, 2007, BONE, V40, P1203, DOI 10.1016/j.bone.2006.12.060; Meyer MZ, 2006, J BIOL CHEM, V281, P7919, DOI 10.1074/jbc.M600081200; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nakayama H, 2006, FASEB J, V20, P1660, DOI 10.1096/fj.05-5560com; Nguyen T, 2009, J BIOL CHEM, V284, P18816, DOI 10.1074/jbc.M109.015719; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Pan S, 2000, BIOCHEM BIOPH RES CO, V272, P765, DOI 10.1006/bbrc.2000.2831; Rana ZA, 2009, J MUSCLE RES CELL M, V30, P255, DOI 10.1007/s10974-010-9200-2; Ranger AM, 2000, J EXP MED, V191, P9, DOI 10.1084/jem.191.1.9; Reinhardt TA, 2000, AM J PHYSIOL-CELL PH, V279, pC1595, DOI 10.1152/ajpcell.2000.279.5.C1595; Reinhardt TA, 2009, BIOCHEM BIOPH RES CO, V378, P99, DOI 10.1016/j.bbrc.2008.11.004; Ritchie MF, 2012, EMBO J, V31, P1123, DOI 10.1038/emboj.2011.495; Santana LF, 2008, CIRC RES, V103, P681, DOI 10.1161/CIRCRESAHA.108.185090; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Shigekawa M, 2007, ANN NY ACAD SCI, V1099, P53, DOI 10.1196/annals.1387.059; Shirasu M, 2000, NEUROSCI RES, V37, P265, DOI 10.1016/S0168-0102(00)00125-5; Sillitoe RV, 2008, SCHIZOPHRENIA BULL, V34, P212, DOI 10.1093/schbul/sbm170; Ulrich JD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.365197; van Rooij E, 2002, J BIOL CHEM, V277, P48617, DOI 10.1074/jbc.M206532200; Varadi A, 1996, BIOCHEM J, V314, P663, DOI 10.1042/bj3140663; Vashishta A, 2009, J NEUROSCI, V29, P15331, DOI 10.1523/JNEUROSCI.4873-09.2009; Wu X, 2010, P NATL ACAD SCI USA, V107, P7000, DOI 10.1073/pnas.1001825107; Wu X, 2009, J CLIN INVEST, V119, P976, DOI 10.1172/JCI36693; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zawawi MSF, 2012, BIOCHEM BIOPH RES CO, V427, P404, DOI 10.1016/j.bbrc.2012.09.077; Zylinska L, 2007, ANN NY ACAD SCI, V1099, P254, DOI 10.1196/annals.1387.008	77	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92176	10.1371/journal.pone.0092176	http://dx.doi.org/10.1371/journal.pone.0092176			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667359	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600026
J	Tang, NKY; Sanborn, AN				Tang, Nicole K. Y.; Sanborn, Adam N.			Better Quality Sleep Promotes Daytime Physical Activity in Patients with Chronic Pain? A Multilevel Analysis of the Within-Person Relationship	PLOS ONE			English	Article							ELECTRONIC DIARY ASSESSMENT; LOW-BACK-PAIN; FEAR-AVOIDANCE; INDIVIDUAL-DIFFERENCES; MUSCULOSKELETAL PAIN; MOOD DISTURBANCE; INSOMNIA; CONSEQUENCES; VALIDATION; ACTIGRAPHY	Background: Promoting physical activity is key to the management of chronic pain, but little is understood about the factors facilitating an individual's engagement in physical activity on a day-to-day basis. This study examined the within-person effect of sleep on next day physical activity in patients with chronic pain and insomnia. Methods: 119 chronic pain patients monitored their sleep and physical activity for a week in their usual sleeping and living environment. Physical activity was measured using actigraphy to provide a mean activity score each hour. Sleep was estimated with actigraphy and an electronic diary, providing an objective and subjective index of sleep efficiency (A-SE, SE) and a sleep quality rating (SQ). The individual and relative roles of these sleep parameters, as well as morning ratings of pain and mood, in predicting subsequent physical activity were examined in multilevel models that took into account variations in relationships at the 'Day' and 'Participant' levels. Results: Of the 5 plausible predictors SQ was the only significant within-person predictor of subsequent physical activity, such that nights of higher sleep quality were followed by days of more physical activity, from noon to 11 pm. The temporal association was not explained by potential confounders such as morning pain, mood or effects of the circadian rhythm. Conclusions: In the absence of interventions, chronic pain patients spontaneously engaged in more physical activity following a better night of sleep. Improving nighttime sleep may well be a novel avenue for promoting daytime physical activity in patients with chronic pain.	[Tang, Nicole K. Y.; Sanborn, Adam N.] Univ Warwick, Dept Psychol, Coventry CV4 7AL, W Midlands, England	University of Warwick	Sanborn, AN (corresponding author), Univ Warwick, Dept Psychol, Coventry CV4 7AL, W Midlands, England.	n.tang@warwick.ac.uk	Sanborn, Adam/G-3715-2010; Tang, Nicole KY/B-9998-2009	Sanborn, Adam/0000-0003-0442-4372; Tang, Nicole KY/0000-0001-7836-9965	National Institute for Health Research, UK [PDA/02/06/085]	National Institute for Health Research, UK(National Institute for Health Research (NIHR))	The study was funded by a personal award to NT from the National Institute for Health Research, UK (PDA/02/06/085). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron LA, 2005, J PAIN, V6, P107, DOI 10.1016/j.jpain.2004.11.003; AFFLECK G, 1991, HEALTH PSYCHOL, V10, P419, DOI 10.1037/0278-6133.10.6.419; AFFLECK G, 1994, J PERS SOC PSYCHOL, V66, P329, DOI 10.1037/0022-3514.66.2.329; Affleck G, 1999, J CONSULT CLIN PSYCH, V67, P746, DOI 10.1037/0022-006X.67.5.746; AKERSTEDT T, 1994, PERCEPT MOTOR SKILL, V79, P287, DOI 10.2466/pms.1994.79.1.287; Asmundson GJG, 1999, CLIN PSYCHOL REV, V19, P97, DOI 10.1016/S0272-7358(98)00034-8; Asmundson GJG, 1998, J ANXIETY DISORD, V12, P57, DOI 10.1016/S0887-6185(97)00049-2; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bolger N, 2003, ANNU REV PSYCHOL, V54, P579, DOI 10.1146/annurev.psych.54.101601.145030; Booth JN, 2012, OBESITY, V20, P278, DOI 10.1038/oby.2011.306; Carney CE, 2012, SLEEP, V35, P287, DOI 10.5665/sleep.1642; Dam TTL, 2008, J AM GERIATR SOC, V56, P1665, DOI 10.1111/j.1532-5415.2008.01846.x; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Edinger J.D., 2006, DUKE STRUCTURED INTE; Edinger JD, 2004, SLEEP, V27, P1567, DOI 10.1093/sleep/27.8.1567; Goldman SE, 2007, SLEEP, V30, P1317, DOI 10.1093/sleep/30.10.1317; Haack M, 2005, PAIN, V119, P56, DOI 10.1016/j.pain.2005.09.011; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Harris S, 2003, PAIN, V105, P363, DOI 10.1016/S0304-3959(03)00251-3; Harvey AG, 2008, SLEEP, V31, P383, DOI 10.1093/sleep/31.3.383; HASENBRING M, 1994, SPINE, V19, P2759, DOI 10.1097/00007632-199412150-00004; Hasenbring MI, 2010, CLIN J PAIN, V26, P747, DOI 10.1097/AJP.0b013e3181e104f2; HAYTHORNTHWAITE JA, 1991, J PAIN SYMPTOM MANAG, V6, P65, DOI 10.1016/0885-3924(91)90520-E; Helmus M, 2012, EUR J PAIN, V16, P1158, DOI 10.1002/j.1532-2149.2011.00109.x; Huijnen IPJ, 2011, EUR J PAIN, V15, P748, DOI 10.1016/j.ejpain.2010.11.015; Huijnen IPJ, 2010, PAIN, V150, P161, DOI 10.1016/j.pain.2010.04.021; Keklund G, 1997, J SLEEP RES, V6, P217, DOI 10.1111/j.1365-2869.1997.00217.x; Lentz MJ, 1999, J RHEUMATOL, V26, P1586; Leonhardt C, 2009, GMS PSYCHOSOCIAL MED, V6; LETHEM J, 1983, BEHAV RES THER, V21, P401, DOI 10.1016/0005-7967(83)90009-8; Lichstein KL, 2006, SLEEP, V29, P232; MOLDOFSKY H, 1976, PSYCHOSOM MED, V38, P35, DOI 10.1097/00006842-197601000-00006; Morgenthaler T, 2007, SLEEP, V30, P519, DOI 10.1093/sleep/30.4.519; Morin CM, 1998, CLIN J PAIN, V14, P311, DOI 10.1097/00002508-199812000-00007; National Institute for Clinical Excellence, 2013, PH44 PHYS ACT BRIEF; National Institute for Clinical Excellence, 2012, PH41 WALK CYCL GUID; National Institute for Clinical Excellence, 2006, PH2 4 COMM US METH I; Peters ML, 2000, PAIN, V84, P181, DOI 10.1016/S0304-3959(99)00206-7; PHILIPS HC, 1987, BEHAV RES THER, V25, P273, DOI 10.1016/0005-7967(87)90005-2; Pilsworth SN, 2001, SLEEP, V24, pA106; Pincus T, 2001, PSYCHOL BULL, V127, P599, DOI 10.1037//0033-2909.127.5.599; Roehrs T, 2006, SLEEP, V29, P145, DOI 10.1093/sleep/29.2.145; Smith MT, 2007, SLEEP, V30, P494, DOI 10.1093/sleep/30.4.494; Smith MT, 2009, CURR PAIN HEADACHE R, V13, P447, DOI 10.1007/s11916-009-0073-2; Stone AA, 2003, CONTROL CLIN TRIALS, V24, P182, DOI 10.1016/S0197-2456(02)00320-3; Tang NKY, 2007, J SLEEP RES, V16, P85, DOI 10.1111/j.1365-2869.2007.00571.x; Tang NKY, 2012, SLEEP, V35, P675, DOI 10.5665/sleep.1830; The IASP Taxonomy Working Group, 2013, CLASS CHRON PAIN DES; Van Damme S, 2010, NEUROSCI BIOBEHAV R, V34, P204, DOI 10.1016/j.neubiorev.2009.01.005; Vendrig AA, 1997, PAIN, V73, P71, DOI 10.1016/S0304-3959(97)00075-4; Verbunt J, 2004, UNDERSTANDING TREATI, P139; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1	55	50	51	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92158	10.1371/journal.pone.0092158	http://dx.doi.org/10.1371/journal.pone.0092158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SD	24667276	gold, Green Published, Green Submitted			2022-12-27	WOS:000333675600023
J	Yamanaka, A; Iwakiri, A; Yoshikawa, T; Sakai, K; Singh, H; Himeji, D; Kikuchi, I; Ueda, A; Yamamoto, S; Miura, M; Shioyama, Y; Kawano, K; Nagaishi, T; Saito, M; Minomo, M; Iwamoto, N; Hidaka, Y; Sohma, H; Kobayashi, T; Kanai, Y; Kawagishi, T; Nagata, N; Fukushi, S; Mizutani, T; Tani, H; Taniguchi, S; Fukuma, A; Shimojima, M; Kurane, I; Kageyama, T; Odagiri, T; Saijo, M; Morikawa, S				Yamanaka, Atsushi; Iwakiri, Akira; Yoshikawa, Tomoki; Sakai, Kouji; Singh, Harpal; Himeji, Daisuke; Kikuchi, Ikuo; Ueda, Akira; Yamamoto, Seigo; Miura, Miho; Shioyama, Yoko; Kawano, Kimiko; Nagaishi, Tokiko; Saito, Minako; Minomo, Masumi; Iwamoto, Naoyasu; Hidaka, Yoshio; Sohma, Hirotoshi; Kobayashi, Takeshi; Kanai, Yuta; Kawagishi, Takehiro; Nagata, Noriyo; Fukushi, Shuetsu; Mizutani, Tetsuya; Tani, Hideki; Taniguchi, Satoshi; Fukuma, Aiko; Shimojima, Masayuki; Kurane, Ichiro; Kageyama, Tsutomu; Odagiri, Takato; Saijo, Masayuki; Morikawa, Shigeru			Imported Case of Acute Respiratory Tract Infection Associated with a Member of Species Nelson Bay Orthoreovirus	PLOS ONE			English	Article							VIRAL-RNA SEQUENCES; FRUIT BATS; FAMILY PARAMYXOVIRIDAE; RAPID-DETERMINATION; VIRUS; REOVIRUS; HUMANS; DISEASE	A Japanese man suffered from acute respiratory tract infection after returning to Japan from Bali, Indonesia in 2007. Miyazaki-Bali/2007, a strain of the species of Nelson Bay orthoreovirus, was isolated from the patient's throat swab using Vero cells, in which syncytium formation was observed. This is the sixth report describing a patient with respiratory tract infection caused by an orthoreovirus classified to the species of Nelson Bay orthoreovirus. Given the possibility that all of the patients were infected in Malaysia and Indonesia, prospective surveillance on orthoreovirus infections should be carried out in Southeast Asia. Furthermore, contact surveillance study suggests that the risk of human-to-human infection of the species of Nelson Bay orthoreovirus would seem to be low.	[Yamanaka, Atsushi; Himeji, Daisuke; Kikuchi, Ikuo; Ueda, Akira] Miyazaki Prefectural Miyazaki Hosp, Dept Internal Med, Miyazaki, Japan; [Iwakiri, Akira; Yamamoto, Seigo; Miura, Miho; Shioyama, Yoko; Kawano, Kimiko] Miyazaki Prefectural Inst Publ Hlth & Environm, Dept Microbiol, Miyazaki, Japan; [Yoshikawa, Tomoki; Sakai, Kouji; Singh, Harpal; Fukushi, Shuetsu; Mizutani, Tetsuya; Tani, Hideki; Taniguchi, Satoshi; Fukuma, Aiko; Shimojima, Masayuki; Kurane, Ichiro; Saijo, Masayuki; Morikawa, Shigeru] Natl Inst Infect Dis, Special Pathogens Lab, Dept Virol 1, Tokyo, Japan; [Nagaishi, Tokiko; Saito, Minako; Minomo, Masumi; Iwamoto, Naoyasu] Nichinan Publ Hlth Off Miyazaki Prefecture, Nichinan, Miyzakaki, Japan; [Hidaka, Yoshio] Miyazaki City Publ Hlth Off, Miyazaki, Japan; [Sohma, Hirotoshi] Miyazaki Prefecture Govt, Hlth Promot Div, Miyazaki, Japan; [Kobayashi, Takeshi; Kanai, Yuta; Kawagishi, Takehiro] Osaka Univ, Microbial Dis Res Inst, Lab Viral Replicat, Int Res Ctr Infect Dis, Suita, Osaka 565, Japan; [Nagata, Noriyo] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Kageyama, Tsutomu; Odagiri, Takato] Natl Inst Infect Dis, Influenza Virus Res Ctr, Tokyo, Japan; [Morikawa, Shigeru] Natl Inst Infect Dis, Deot Vet Sci, Shinjuku Ku, Tokyo 1628640, Japan	National Institute of Infectious Diseases (NIID); Osaka University; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID)	Saijo, M (corresponding author), Natl Inst Infect Dis, Special Pathogens Lab, Dept Virol 1, Tokyo, Japan.	msaijo@nih.go.jp	MIZUTANI, Tetsuya/G-1086-2013; Saijo, Masayuki/L-2697-2019; Kanai, Yuta/Q-3372-2019; SAKAI, KOUJI/J-4436-2018	MIZUTANI, Tetsuya/0000-0003-2570-0452; Kanai, Yuta/0000-0002-5102-6951; MORIKAWA, SHIGERU/0000-0001-6249-6716; Saijo, Masayuki/0000-0001-5458-7298; Yamanaka, Atsushi/0000-0002-4025-8650; Yoshikawa, Tomoki/0000-0001-7601-4036	Ministry of Health, Labor and Welfare [H22-Shinko-Ippan-006, H24-Shinko-Ippan-006, H25-Shinko-Ippan-004]; Grants-in-Aid for Scientific Research [24780303, 26292149] Funding Source: KAKEN	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was financially supported by Grants-in-Aid from the Ministry of Health, Labor and Welfare Science Research Grant(s) (H22-Shinko-Ippan-006, H24-Shinko-Ippan-006, and H25-Shinko-Ippan-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chant K, 1998, EMERG INFECT DIS, V4, P273, DOI 10.3201/eid0402.980215; Cheng P, 2009, J CLIN VIROL, V45, P79, DOI 10.1016/j.jcv.2009.03.001; Chua KB, 2007, P NATL ACAD SCI USA, V104, P11424, DOI 10.1073/pnas.0701372104; Chua KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025434; Chua KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003803; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2003, MICROBES INFECT, V5, P487, DOI 10.1016/S1286-4579(03)00067-4; Du LF, 2010, ARCH VIROL, V155, P1295, DOI 10.1007/s00705-010-0690-4; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; GARD G, 1970, J VIROL, V6, P100, DOI 10.1128/JVI.6.1.100-106.1970; Key T, 2013, J GEN VIROL, V94, P1039, DOI 10.1099/vir.0.048637-0; Kobayashi T, 2007, CELL HOST MICROBE, V1, P147, DOI 10.1016/j.chom.2007.03.003; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Mizutani T, 2007, EMERG INFECT DIS, V13, P322, DOI 10.3201/eid1302.061032; MOSS SR, 1988, J GEN VIROL, V69, P2721, DOI 10.1099/0022-1317-69-11-2721; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; Ooms LS, 2010, J BIOL CHEM, V285, P41604, DOI 10.1074/jbc.M110.176255; Philbey AW, 1998, EMERG INFECT DIS, V4, P269, DOI 10.3201/eid0402.980214; Pritchard LI, 2006, ARCH VIROL, V151, P229, DOI 10.1007/s00705-005-0644-4; Sakai K, 2007, ARCH VIROL, V152, P1763, DOI 10.1007/s00705-007-0999-9; Sakai K, 2009, VET MICROBIOL, V134, P227, DOI 10.1016/j.vetmic.2008.08.022; Schiff L.A., 2007, FIELDS VIROLOGY, V2, P1853; Speare R, 1997, Commun Dis Intell, V21, P117; TAKASE K, 1985, JPN J VET SCI, V47, P567; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Watanabe S, 2008, J CLIN VIROL, V43, P56, DOI 10.1016/j.jcv.2008.05.004; Watanabe S, 2010, EMERG INFECT DIS, V16, P1217, DOI 10.3201/eid1608.100208; Wong AH, 2012, EMERG INFECT DIS, V18, P944, DOI 10.3201/eid1806.111688; Yamao T, 2009, ARCH VIROL, V154, P153, DOI 10.1007/s00705-008-0285-5	30	34	40	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92777	10.1371/journal.pone.0092777	http://dx.doi.org/10.1371/journal.pone.0092777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667794	gold, Green Submitted, Green Published			2022-12-27	WOS:000333675600073
J	Zarubin, M; Farstey, V; Wold, A; Falk-Petersen, S; Genin, A				Zarubin, Margarita; Farstey, Viviana; Wold, Anette; Falk-Petersen, Stig; Genin, Amatzia			Intraspecific Differences in Lipid Content of Calanoid Copepods across Fine-Scale Depth Ranges within the Photic Layer	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; NORTHERN RED-SEA; FEEDING CURRENTS; WAX ESTERS; MESOZOOPLANKTON DISTRIBUTION; BIOLOGICAL PROCESSES; COMMUNITY STRUCTURE; MARINE COPEPODS; ZOOPLANKTON; GULF	Copepods are among the most abundant and diverse groups of mesozooplankton in the world's oceans. Each species has a certain depth range within which different individuals (of the same life stage and sex) are found. Lipids are accumulated in many calanoid copepods for energy storage and reproduction. Lipid content in some species increases with depth, however studies so far focused mostly on temperate and high-latitude seasonal vertically migrating copepods and compared lipid contents among individuals either from coarse layers or between diapausing, deep-dwelling copepods and individuals found in the photic, near-surface layer. Here we examined whether lipid contents of individual calanoid copepods of the same species, life stage/sex differ between finer depth layers within the upper water column of subtropical and Arctic seas. A total of 6 calanoid species were collected from samples taken at precise depths within the photic layer in both cold eutrophic and warm oligotrophic environments using SCUBA diving, MOCNESS and Multinet. Measurements of lipid content were obtained from digitized photographs of the collected individuals. The results revealed significant differences in lipid content across depth differences as small as 12-15 meters for Mecynocera clausi C5 and Ctenocalanus vanus C5 (Red Sea), Clausocalanus furcatus males and two clausocalanid C5s (Mediterranean Sea), and Calanus glacialis C5 (Arctic). We suggest two possible explanations for the differences in lipid content with depth on such a fine scale: predator avoidance and buoyancy.	[Zarubin, Margarita; Farstey, Viviana; Genin, Amatzia] Interuniv Inst Marine Sci, Elat, Israel; [Zarubin, Margarita; Genin, Amatzia] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Ecol Evolut & Behav, Jerusalem, Israel; [Wold, Anette; Falk-Petersen, Stig] Akvaplan Niva, Fram Ctr, Tromso, Norway; [Falk-Petersen, Stig] Univ Tromso, Fac Biosci Fisheries & Econ, Dept Arctic & Marine Biol, Tromso, Norway; [Falk-Petersen, Stig] Norwegian Polar Res Inst, Tromso, Norway	Hebrew University of Jerusalem; Akvaplan-niva; UiT The Arctic University of Tromso; Norwegian Polar Institute	Zarubin, M (corresponding author), Interuniv Inst Marine Sci, Elat, Israel.	margaritazarubin@gmail.com			Israel Science Foundation [ISF 527/10]	Israel Science Foundation(Israel Science Foundation)	This work was supported by the Israel Science Foundation [grant number ISF 527/10 to AG]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1984, ECOL STUD; AZOV Y, 1991, MAR POLLUT BULL, V23, P225, DOI 10.1016/0025-326X(91)90679-M; BANSE K., 1964, PROGR OCEANOGR, V2, P53, DOI 10.1016/0079-6611(64)90003-5; Berges JA, 1997, LIMNOL OCEANOGR, V42, P1006, DOI 10.4319/lo.1997.42.5.1006; Bjornberg T.K.S., 1981, P587; Bottger-Schnack R, 2008, J PLANKTON RES, V30, P529, DOI 10.1093/plankt/fbn018; BRADFORD JM, 1972, NZ OCEANOGR I MEM, V54, P1; Campbell RW, 2003, MAR ECOL PROG SER, V263, P93, DOI 10.3354/meps263093; Castro LR, 2007, PROG OCEANOGR, V75, P486, DOI 10.1016/j.pocean.2007.08.012; CASTRO LR, 1991, ESTUAR COAST SHELF S, V32, P243, DOI 10.1016/0272-7714(91)90018-7; Cottier FR, 2010, GEOL SOC SPEC PUBL, V344, P35, DOI 10.1144/SP344.4; DAM HG, 1991, MAR ECOL PROG SER, V71, P113, DOI 10.3354/meps071113; Dupont N, 2012, J PLANKTON RES, V34, P263, DOI 10.1093/plankt/fbr096; ECHELMAN T, 1990, MAR BIOL, V107, P179, DOI 10.1007/BF01313255; Falk-Petersen S, 2009, MAR BIOL RES, V5, P18, DOI 10.1080/17451000802512267; Farstey V, 2002, MAR ECOL PROG SER, V238, P91, DOI 10.3354/meps238091; FRAGOPOULU N, 1990, MAR BIOL, V104, P381, DOI 10.1007/BF01314340; Frost B., 1968, Bulletin Scripps Institution of Oceanography Technical Series, V12, P1; Genin A, 2005, SCIENCE, V308, P860, DOI 10.1126/science.1107834; GISKE J, 1990, SARSIA, V75, P65, DOI 10.1080/00364827.1990.10413442; Hays GC, 2001, LIMNOL OCEANOGR, V46, P2050, DOI 10.4319/lo.2001.46.8.2050; Herman W, 1983, LIMNOL OCEANOGR, V28, P709; HOLM S, 1979, SCAND J STAT, V6, P65; HUNTLEY M, 1982, MAR BIOL, V71, P23, DOI 10.1007/BF00396989; Incze LS, 2001, MAR ECOL PROG SER, V213, P229, DOI 10.3354/meps213229; Irigoien X, 2004, J PLANKTON RES, V26, P259, DOI 10.1093/plankt/fbh030; Jiang HS, 2005, J PLANKTON RES, V27, P1003, DOI 10.1093/plankt/fbi087; Jonasdottir Sigrun H., 1999, Fisheries Oceanography, V8, P61, DOI 10.1046/j.1365-2419.1999.00003.x; Jonasdottir SH, 2011, J PLANKTON RES, V33, P85, DOI 10.1093/plankt/fbq085; Kattner G, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P257, DOI 10.1007/978-0-387-89366-2_11; KOEHL MAR, 1981, LIMNOL OCEANOGR, V26, P1062, DOI 10.4319/lo.1981.26.6.1062; Koski M, 2011, J PLANKTON RES, V33, P63, DOI 10.1093/plankt/fbq084; Lagadeuc Y, 1997, J PLANKTON RES, V19, P1183, DOI 10.1093/plankt/19.9.1183; LEE RF, 1971, DEEP-SEA RES, V18, P1147, DOI 10.1016/0011-7471(71)90023-4; LEE RF, 1973, LIMNOL OCEANOGR, V18, P227, DOI 10.4319/lo.1973.18.2.0227; Lee RF, 2006, MAR ECOL PROG SER, V307, P273, DOI 10.3354/meps307273; LEE RF, 1974, MAR BIOL, V26, P313, DOI 10.1007/BF00391515; Leu E, 2011, PROG OCEANOGR, V90, P18, DOI 10.1016/j.pocean.2011.02.004; Lischka S, 2007, MAR BIOL, V150, P443, DOI 10.1007/s00227-006-0359-4; Mauchline J., 1998, ADV MAR BIOL, V33, P1, DOI DOI 10.1163/156854008784513492; Mazzocchi MG, 1997, OCEANOL ACTA, V20, P521; Mazzocchi MG, 1999, J PLANKTON RES, V21, P1501, DOI 10.1093/plankt/21.8.1501; Miller CB, 2000, ICES J MAR SCI, V57, P1786, DOI 10.1006/jmsc.2000.0975; Miller CB, 1998, LIMNOL OCEANOGR, V43, P488, DOI 10.4319/lo.1998.43.3.0488; Ohman MD, 1996, MAR ECOL PROG SER, V130, P295, DOI 10.3354/meps130295; Paffenhofer GA, 2003, J PLANKTON RES, V25, P1139, DOI 10.1093/plankt/25.9.1139; Paffenhofer GA, 1982, MAR BIOL, V67, P193; Pearre S, 2003, BIOL REV, V78, P1, DOI 10.1017/S146479310200595X; Pond DW, 2012, J PLANKTON RES, V34, P443, DOI 10.1093/plankt/fbs027; Pond DW, 2011, LIMNOL OCEANOGR, V56, P1310, DOI 10.4319/lo.2011.56.4.1310; R Development Core Team, 2011, R LANG ENV STAT COMP; Sartoris FJ, 2010, LIMNOL OCEANOGR, V55, P1860, DOI 10.4319/lo.2010.55.5.1860; SiokouFrangou I, 1997, OCEANOL ACTA, V20, P537; Sommer U, 2002, MAR ECOL PROG SER, V239, P251, DOI 10.3354/meps239251; Soreide JE, 2010, GLOBAL CHANGE BIOL, V16, P3154, DOI 10.1111/j.1365-2486.2010.02175.x; STRICKLER JR, 1982, SCIENCE, V218, P158, DOI 10.1126/science.218.4568.158; Visser AW, 2009, J PLANKTON RES, V31, P121, DOI 10.1093/plankt/fbn109; Visser Andre W., 1999, Fisheries Oceanography, V8, P100, DOI 10.1046/j.1365-2419.1999.00001.x; Vogedes D, 2010, J PLANKTON RES, V32, P1471, DOI 10.1093/plankt/fbq068; Wallace MI, 2010, LIMNOL OCEANOGR, V55, P831, DOI 10.4319/lo.2009.55.2.0831; Wheeler B, 2010, IMPERM PERMUTATION T; YACOBI YZ, 1995, J MARINE SYST, V6, P179, DOI 10.1016/0924-7963(94)00028-A; YAYANOS AA, 1978, DEEP-SEA RES, V25, P257, DOI 10.1016/0146-6291(78)90591-X	63	21	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92935	10.1371/journal.pone.0092935	http://dx.doi.org/10.1371/journal.pone.0092935			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667529	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600107
J	Ajendra, J; Specht, S; Neumann, AL; Gondorf, F; Schmidt, D; Gentil, K; Hoffmann, WH; Taylor, MJ; Hoerauf, A; Hubner, MP				Ajendra, Jesuthas; Specht, Sabine; Neumann, Anna-Lena; Gondorf, Fabian; Schmidt, David; Gentil, Katrin; Hoffmann, Wolfgang H.; Taylor, Mark J.; Hoerauf, Achim; Huebner, Marc P.			ST2 Deficiency Does Not Impair Type 2 Immune Responses during Chronic Filarial Infection but Leads to an Increased Microfilaremia Due to an Impaired Splenic Microfilarial Clearance	PLOS ONE			English	Article							LITOMOSOIDES-SIGMODONTIS; MURINE FILARIASIS; MAST-CELLS; MICE; IL-33; INTERLEUKIN-5; RECEPTOR; SUSCEPTIBILITY; CYTOKINE; ABSENCE	Background: Interactions of the Th2 cytokine IL-33 with its receptor ST2 lead to amplified Type 2 immune responses. As Type 2 immune responses are known to mediate protection against helminth infections we hypothesized that the lack of ST2 would lead to an increased susceptibility to filarial infections. Methodology/Principal Finding: ST2 deficient and immunocompetent BALB/c mice were infected with the filarial nematode Litomosoides sigmodontis. At different time points after infection mice were analyzed for worm burden and their immune responses were examined within the thoracic cavity, the site of infection, and systemically using spleen cells and plasma. Absence of ST2 led to significantly increased levels of peripheral blood microfilariae, the filarial progeny, whereas L. sigmodontis adult worm burden was not affected. Development of local and systemic Type 2 immune responses were not impaired in ST2 deficient mice after the onset of microfilaremia, but L. sigmodontis infected ST2-ko mice had significantly reduced total numbers of cells within the thoracic cavity and spleen compared to infected immunocompetent controls. Pronounced microfilaremia in ST2-ko mice did not result from an increased microfilariae release by adult female worms, but an impaired splenic clearance of microfilariae. Conclusions/Significance: Our findings suggest that the absence of ST2 does not impair the establishment of adult L. sigmodontis worms, but is important for the splenic clearance of microfilariae from peripheral blood. Thus, ST2 interactions may be important for therapies that intend to block the transmission of filarial disease.	[Ajendra, Jesuthas; Specht, Sabine; Neumann, Anna-Lena; Gondorf, Fabian; Schmidt, David; Gentil, Katrin; Hoerauf, Achim; Huebner, Marc P.] Univ Hosp Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany; [Hoffmann, Wolfgang H.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Taylor, Mark J.] Univ Liverpool, Liverpool Sch Trop Med, Dept Parasitol, Filariasis Res Lab, Liverpool L3 5QA, Merseyside, England	University of Bonn; Eberhard Karls University of Tubingen; Liverpool School of Tropical Medicine; University of Liverpool	Hubner, MP (corresponding author), Univ Hosp Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany.	huebner@microbiology-bonn.de	Hübner, Marc P/O-1684-2019; Hübner, Marc P/W-9529-2018; Hoffmann, Wolfgang H/C-9696-2010	Hübner, Marc P/0000-0001-8885-418X; Hübner, Marc P/0000-0001-8885-418X; Taylor, Mark/0000-0003-3396-9275; Ajendra, Jesuthas/0000-0002-9256-5396	European Commission: Enhanced Protective Immunity Against Filariasis (EPIAF) [242131]; German Research Foundation [HU 2144/1-1]; University Hospital Bonn (BONFOR) [2010-1-16, 2011-1-10]; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme under Research Executive Agency Grant [GA 276704]	European Commission: Enhanced Protective Immunity Against Filariasis (EPIAF); German Research Foundation(German Research Foundation (DFG)); University Hospital Bonn (BONFOR); People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme under Research Executive Agency Grant	This work was funded by the European Commission: Enhanced Protective Immunity Against Filariasis (EPIAF), agreement number 242131, by the German Research Foundation (HU 2144/1-1), intramural funding by the University Hospital Bonn (BONFOR, 2010-1-16 and 2011-1-10), and the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013 under Research Executive Agency Grant GA 276704. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qaoud KM, 1998, INT IMMUNOL, V10, P17, DOI 10.1093/intimm/10.1.17; Al-Qaoud KM, 2000, INT IMMUNOL, V12, P899, DOI 10.1093/intimm/12.6.899; Allen JE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000217; Bouchery T, 2012, PARASITE, V19, P351, DOI 10.1051/parasite/2012194351; Bourgeois E, 2009, EUR J IMMUNOL, V39, P1046, DOI 10.1002/eji.200838575; Carter T, 2007, J IMMUNOL, V178, P5116, DOI 10.4049/jimmunol.178.8.5116; CHANDRASHEKAR R, 1984, J HELMINTHOL, V58, P69, DOI 10.1017/S0022149X00028078; Gray CA, 2002, EUR J IMMUNOL, V32, P1114, DOI 10.1002/1521-4141(200204)32:4<1114::AID-IMMU1114>3.0.CO;2-B; HAAS B, 1981, T ROY SOC TROP MED H, V75, P143, DOI 10.1016/0035-9203(81)90046-8; Hardman CS, 2013, EUR J IMMUNOL, V43, P488, DOI 10.1002/eji.201242863; HAWKING F, 1962, ANN TROP MED PARASIT, V56, P168, DOI 10.1080/00034983.1962.11686104; Hoffmann WH, 2001, PARASITOLOGY, V122, P641, DOI 10.1017/S0031182001007892; Hoffmann WH, 2000, PARASITOL TODAY, V16, P387, DOI 10.1016/S0169-4758(00)01738-5; HOOK WA, 1974, INFECT IMMUN, V9, P903, DOI 10.1128/IAI.9.5.903-908.1974; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Hsu CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011944; Hubner MP, 2009, IMMUNOLOGY, V127, P512, DOI 10.1111/j.1365-2567.2008.02958.x; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Hung LY, 2012, P NATL ACAD SCI USA; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Martin C, 2000, INFECT IMMUN, V68, P3651, DOI 10.1128/IAI.68.6.3651-3656.2000; Martin C, 2000, MED MICROBIOL IMMUN, V189, P67, DOI 10.1007/PL00008258; Moritz DR, 1998, J IMMUNOL, V161, P4866; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Saeftel M, 2003, INFECT IMMUN, V71, P6978, DOI 10.1128/IAI.71.12.6978-6985.2003; Saeftel M, 2001, MICROBES INFECT, V3, P203, DOI 10.1016/S1286-4579(01)01372-7; Scalfone LK, 2013, INFECT IMMUN, V81, P1354, DOI 10.1128/IAI.01307-12; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Simons JE, 2010, PARASITE IMMUNOL, V32, P473, DOI 10.1111/j.1365-3024.2010.01210.x; Simons JE, 2005, EUR J IMMUNOL, V35, P189, DOI 10.1002/eji.200425541; Specht S, 2006, INFECT IMMUN, V74, P5236, DOI 10.1128/IAI.00329-06; Suzukawa M, 2008, J IMMUNOL, V181, P5981, DOI 10.4049/jimmunol.181.9.5981; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Volkmann L, 2003, MED MICROBIOL IMMUN, V192, P23, DOI 10.1007/S00430-002-0155-9; WENK P, 1993, TROP MED PARASITOL, V44, P299; Wills-Karp M, 2012, J EXP MED, V209, P607, DOI 10.1084/jem.20110079; Yasuda K, 2012, P NATL ACAD SCI USA, V109, P3451, DOI 10.1073/pnas.1201042109; Ziewer S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001558	41	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93072	10.1371/journal.pone.0093072	http://dx.doi.org/10.1371/journal.pone.0093072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663956	gold, Green Published, Green Accepted			2022-12-27	WOS:000333459900150
J	Bottero, J; Boyd, A; Lemoine, M; Carrat, F; Gozlan, J; Collignon, A; Boo, N; Dhotte, P; Varsat, B; Muller, G; Cha, O; Valin, N; Nau, J; Campa, P; Silbermann, B; Bary, M; Girard, PM; Lacombe, K				Bottero, Julie; Boyd, Anders; Lemoine, Maud; Carrat, Fabrice; Gozlan, Joel; Collignon, Anne; Boo, Nicolas; Dhotte, Philippe; Varsat, Brigitte; Muller, Gerard; Cha, Olivier; Valin, Nadia; Nau, Jean; Campa, Pauline; Silbermann, Benjamin; Bary, Marc; Girard, Pierre-Marie; Lacombe, Karine			Current State of and Needs for Hepatitis B Screening: Results of a Large Screening Study in a Low-Prevalent, Metropolitan Region	PLOS ONE			English	Article							VIRUS INFECTION; MANAGEMENT; IMPACT	Background: In low hepatitis B virus (HBV)-prevalent countries, most HBV-infected persons are unaware of their status. We aimed to evaluate whether (i) previous HBV-testing, (ii) physicians decision to screen, and (iii) CDC's recommendations identified infected individuals and which risk-factor groups needing testing. Methods: During a mass, multi-center HBV-screening study from September 2010-August 2011, 3929 participants were screened for hepatitis B surface antigen (HBsAg), anti-HBs and anti-Hepatitis B core antibodies (anti-HBcAb). Questions on HBV risk-factors and testing practices were asked to participants, while participants' eligibility for HBV-testing was asked to study medical professionals. Results: 85 (2.2%) participants were HBsAg-positive, while 659 (16.8%) had either resolved HBV infection or isolated anti-HBcAb. When comparing practices, HBV-testing was more likely to occur in HBV-infected participants if Centers for Disease Control and Prevention (CDC) recommendations were used (Sensitivity = 100%, 95%CI: 95.8-100) than physicians' discretion (Sensitivity = 87.1%, 95%CI: 78.0-93.4) or previous HBV-test (Sensitivity = 36.5%, 95%CI: 26.3-47.6) (p<0.0001). Nevertheless, many non-infected individuals would still have been screened using CDC-recommendations (Specificity = 31.1%, 95%CI: 29.6-32.6). Using multivariable logistic regression, HBsAg-positive status was significantly associated with the following: males, originating from high HBV-endemic region, contact with HBV-infected individual, without national healthcare, and intravenous-drug user (IDU). Of these risk-factors, physician's discretion for testing HBV was not significantly associated with participants' geographical origin or IDU. Conclusions: Missed opportunities of HBV-screening are largely due to underestimating country of origin as a risk-factor. Applying CDC-recommendations could improve HBV-screening, but with the disadvantage of many tests. Further development of HBV-testing strategies is necessary, especially before severe disease occurs.	[Bottero, Julie; Boyd, Anders; Carrat, Fabrice; Girard, Pierre-Marie; Lacombe, Karine] Inserm UMR S707, Paris, France; [Bottero, Julie; Carrat, Fabrice; Girard, Pierre-Marie; Lacombe, Karine] Univ Paris 06, Paris, France; [Bottero, Julie; Valin, Nadia; Campa, Pauline; Girard, Pierre-Marie; Lacombe, Karine] Hop St Antoine, AP HP, Serv Malad Infect, F-75571 Paris, France; [Lemoine, Maud] Hop St Antoine, AP HP, Serv Hepatol, F-75571 Paris, France; [Carrat, Fabrice] Hop St Antoine, AP HP, Unite Sante Publ, F-75571 Paris, France; [Gozlan, Joel] Hop St Antoine, AP HP, Virol Lab, F-75571 Paris, France; [Collignon, Anne] Mairie Paris, Lab St Marcel, Paris, France; [Boo, Nicolas] Mairie Paris, Direct Act Sociale Enfance & Sante, Paris, France; [Dhotte, Philippe] Mairie Paris, Ctr Depistage Anonyme & Gratuit CDAG Figuier, Paris, France; [Varsat, Brigitte] CPAM Paris, Dept Examens Period Sante, Paris, France; [Muller, Gerard] CDAG Belleville, Paris, France; [Cha, Olivier] Hop St Antoine, AP HP, Policlin Baudelaire, F-75571 Paris, France; [Nau, Jean] Med Monde, Ctr Accueil Soins & Orientat, Paris, France; [Silbermann, Benjamin] Maison Arret Sante, Unite Consultat & Soins Ambulatoires, Paris, France; [Bary, Marc] Ctr Croix Rouge Moulin Joly, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Bottero, J (corresponding author), Inserm UMR S707, Paris, France.	julie.bottero@sat.aphp.fr	GOZLAN, Joël/P-6014-2017; Boyd, Anders/GLQ-8906-2022; Carrat, Fabrice/AAU-8480-2020	Boyd, Anders/0000-0001-9512-8928; Carrat, Fabrice/0000-0002-8672-7918	Agence Nationale de Recherche sur le Sida et les Hepatites virales [2010-334]; Gilead Sciences; Roche; ANRS	Agence Nationale de Recherche sur le Sida et les Hepatites virales(ANRSFrench National Research Agency (ANR)); Gilead Sciences(Gilead Sciences); Roche(Roche Holding); ANRS(ANRSFrench National Research Agency (ANR))	This study was funded largely in part by the Agence Nationale de Recherche sur le Sida et les Hepatites virales (grant number: 2010-334), Gilead Sciences and Roche. Material support was also provided from the Mairie de Paris. AB was awarded a post-doctoral fellowship from the ANRS. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], HEP LIV CANC NAT STR; Bottero J, 2013, J HEPATOL, V58, P473, DOI 10.1016/j.jhep.2012.11.016; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Crutzen Rik, 2012, J Infect Public Health, V5, P195, DOI 10.1016/j.jiph.2011.12.001; d'Almeida KW, 2012, ARCH INTERN MED, V172, P12, DOI 10.1001/archinternmed.2011.535; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Direction generale de la sante (DGS), 2009, PLAN NAT LUTT HEP B; ECDC, 2010, SURV PREV HEP B C EU; ELPA, 2010, REP HEP PAT SELF HEL; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Hatzakis A, 2011, J VIRAL HEPATITIS, V18, P1, DOI 10.1111/j.1365-2893.2011.01499.x; Hu DJ, 2013, HEPATOLOGY; IGF, 2010, AN EV DEP TITR AID M; Insee, 2009, REC 2009 EXPL PRINC; Insee, 2010, EV AG MOYEN AG MED P; Meffre C, 2006, PREVALENCE HEPATITES; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Perumalswami PV, 2013, J HEPATOL, V58, P890, DOI 10.1016/j.jhep.2013.01.004; Scott C, 2010, J INFECTION, V60, P351, DOI 10.1016/j.jinf.2010.01.013; Spenatto N, 2013, J HEPATOL, V58, P690, DOI 10.1016/j.jhep.2012.11.044; Tosini S, 2009, B EPIDEMIOL HEBD, V20-21, P217; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; WHO, 2002, HEP B; WHO, 2012, HEP B WHO FACT SHEET; Wong WWL, 2011, LIVER INT, V31, P1179, DOI 10.1111/j.1478-3231.2011.02559.x; Xiong M, 2013, J IMMIGR MINOR HLTH	26	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92266	10.1371/journal.pone.0092266	http://dx.doi.org/10.1371/journal.pone.0092266			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663387	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900049
J	Mamik, MK; Ghorpade, A				Mamik, Manmeet K.; Ghorpade, Anuja			Chemokine CXCL8 Promotes HIV-1 Replication in Human Monocyte-Derived Macrophages and Primary Microglia via Nuclear Factor-kappa B Pathway	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CENTRAL-NERVOUS-SYSTEM; POLYMERASE-CHAIN-REACTION; BLOOD-BRAIN-BARRIER; IN-VITRO; MONONUCLEAR PHAGOCYTES; TYPE-1 REPLICATION; MULTIPLE-SCLEROSIS; NEURONAL INJURY; RECEPTORS CCR3	Background: Chemokine CXCL8 is an important neutrophil chemoattractant implicated in various neurodegenerative disorders. Cytokine/chemokine imbalance, with an increase in proinflammatory cytokines like interleukin-1 beta and tumor necrosis factor-a within the central nervous system, is a hallmark of human immunodeficiency virus (HIV)-1 infection. We previously reported that HIV-1 infection is linked to upregulation of CXCL8 in brain tissues and human astrocytes. Chemokines play crucial roles in trafficking of leukocytes and trafficking of HIV-1-infected across the blood-brain barrier play an important role in HIV-1 central nervous system disease. In the post-antiretroviral therapy era, low level of productive replication of HIV-1 in brain is a critical component of neuropathogenesis regulation. The present study investigated the effect of CXCL8 on productive infection of HIV-1 in human monocytes-derived macrophages (MDM) and primary human microglia. Results: Human MDM and microglia were infected with the blood or brain derived HIV-1 isolates, HIV-1(ADA) or HIV-1(JRFL). Treatment with CXCL8 significantly upregulated HIV-1p24 levels in supernatants of both HIV-1-infected MDM as well as microglia. In addition, the formation of 2-long terminal repeat (LTR) circles, a measure of viral genome integration, was significantly higher in CXCL8-treated, HIV-1-infected MDM and microglia. Transient transfection of U937 cells with HIV-1 LTR luciferase reporter construct resulted in increased promoter activity when treated with CXCL8. Moreover, increased nuclear translocation of nuclear factor-kappa B was seen in HIV-1-infected MDM following CXCL8 treatment. Blocking CXCL8 receptors CXCR1 and CXCR2 abrogated the CXCL8-mediated enhanced HIV-1 replication. Conclusion: Our results show that CXCL8 mediates productive infection of HIV-1 in MDM and microglia via receptors CXCR1 and CXCR2. These results demonstrate that CXCL8 exerts its downstream effects by increasing translocation of nuclear factor-kappa B into the nucleus, thereby promotin g HIV-1 LTR activity.	[Mamik, Manmeet K.; Ghorpade, Anuja] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Immunol, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center	Ghorpade, A (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Immunol, Ft Worth, TX 76107 USA.	anuja.ghorpade@unthsc.edu	Mamik, Manmeet/E-2534-2016	Mamik, Manmeet/0000-0002-7212-5430	NIMH [R01MH087345]; NIH from the Eunice Kennedy Shriver National Institute of Child Health & Human Development [5R24HD0008836]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD000836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087345] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH from the Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by R01MH087345 from NIMH to A. Ghorpade. The project entitled 'Laboratory of Developmental Biology' was supported by NIH Award Number 5R24HD0008836 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The content does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Bachu M, 2012, AIDS RES HUM RETROV, V28, P1362, DOI 10.1089/aid.2011.0388; Bagasra O, 1996, AIDS, V10, P573, DOI 10.1097/00002030-199606000-00002; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Bergamini A, 1999, J INFECT DIS, V179, P832, DOI 10.1086/314662; Borgmann Kathleen, 2005, Methods Mol Biol, V304, P49; Brosnan CF, 2013, GLIA, V61, P453, DOI 10.1002/glia.22443; Burkala EJ, 2005, AIDS, V19, P675, DOI 10.1097/01.aids.0000166090.31693.aa; Butler SL, 2002, J VIROL, V76, P3739, DOI 10.1128/JVI.76.8.3739-3747.2002; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Carrol ED, 2007, JAIDS-J ACQ IMM DEF, V44, P443, DOI 10.1097/QAI.0b013e31802f8390; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Chun TW, 1998, J EXP MED, V188, P83, DOI 10.1084/jem.188.1.83; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Coffey MJ, 1997, AM J PHYSIOL-LUNG C, V272, pL1025, DOI 10.1152/ajplung.1997.272.5.L1025; Coltart I, 2013, ARCH BIOCHEM BIOPHYS, V536, P189, DOI 10.1016/j.abb.2013.03.016; Copeland KFT, 1998, CLIN EXP IMMUNOL, V114, P87; Cosenza-Nashat M, 2007, J NEUROVIROL, V13, P536, DOI 10.1080/13550280701549417; Cota M, 2000, J NEUROVIROL, V6, P75, DOI 10.3109/13550280009006384; D'Aversa TG, 2008, J NEUROSCI RES, V86, P630, DOI 10.1002/jnr.21525; D'Aversa TG, 2004, J NEUROVIROL, V10, P86, DOI 10.1080/13550280490279807; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Dolei A, 1998, AIDS, V12, P183, DOI 10.1097/00002030-199802000-00008; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Evans MC, 2013, MOL CELL NEUROSCI, V53, P34, DOI 10.1016/j.mcn.2012.10.008; Fassati A, 2001, J VIROL, V75, P3626, DOI 10.1128/JVI.75.8.3626-3635.2001; Garau A, 2005, CYTOKINE, V30, P125, DOI 10.1016/j.cyto.2004.12.014; Gartner S, 2002, J NEUROVIROL, V8, P69, DOI 10.1080/13550280290049525; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; Ghorpade A, 2005, J NEUROIMMUNOL, V163, P135, DOI 10.1016/j.jneuroim.2005.01.021; Ghorpade A, 2005, J NEUROIMMUNOL, V163, P145, DOI 10.1016/j.jneuroim.2005.01.022; Ghorpade A, 1998, J VIROL, V72, P3351, DOI 10.1128/JVI.72.4.3351-3361.1998; Ghorpade A, 1998, J VIROL, V72, P3340, DOI 10.1128/JVI.72.4.3340-3350.1998; Ghorpade A, 2001, J VIROL, V75, P6572, DOI 10.1128/JVI.75.14.6572-6583.2001; Giovannelli A, 1998, J NEUROIMMUNOL, V92, P122, DOI 10.1016/S0165-5728(98)00192-1; Goczalik I, 2008, INVEST OPHTH VIS SCI, V49, P4578, DOI 10.1167/iovs.08-1887; Gordon CJ, 1999, J VIROL, V73, P684, DOI 10.1128/JVI.73.1.684-694.1999; Gouwy M, 2008, MOL PHARMACOL, V74, P485, DOI 10.1124/mol.108.045146; Huang YL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005397; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; Jones MV, 2000, AIDS, V14, P2709, DOI 10.1097/00002030-200012010-00010; Julias JG, 2001, J VIROL, V75, P6537, DOI 10.1128/JVI.75.14.6537-6546.2001; Kandel E.R., 2000, PRINCIPLES NEURAL SC, Vxli, P1414; KARAGEORGOS L, 1993, AIDS RES HUM RETROV, V9, P817, DOI 10.1089/aid.1993.9.817; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 2006, CURR HIV RES, V4, P307, DOI 10.2174/157016206777709384; Kim YK, 2006, EMBO J, V25, P3596, DOI 10.1038/sj.emboj.7601248; KLAVER B, 1994, J VIROL, V68, P3830, DOI 10.1128/JVI.68.6.3830-3840.1994; Kostic M, 2013, REV NEUROSCIENCE, V24, P71, DOI 10.1515/revneuro-2012-0062; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Lamers SL, 2012, INT REV IMMUNOL, V31, P432, DOI 10.3109/08830185.2012.737073; Lane BR, 2001, J VIROL, V75, P8195, DOI 10.1128/JVI.75.17.8195-8202.2001; Langford D, 2001, BRAIN PATHOL, V11, P306; Li MH, 2012, INT IMMUNOPHARMACOL, V12, P643, DOI 10.1016/j.intimp.2011.12.022; Mamik MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045596; Mandal Dibyakanti, 2009, V485, P73, DOI 10.1007/978-1-59745-170-3_6; MANTHORPE M, 1986, DEV BRAIN RES, V25, P191, DOI 10.1016/0165-3806(86)90208-7; MATSUMOTO T, 1993, CLIN EXP IMMUNOL, V93, P149; Miller-Jensen K, 2012, INTEGR BIOL-UK, V4, P661, DOI 10.1039/c2ib20009k; Mirani M, 2002, J IMMUNOL, V169, P6361, DOI 10.4049/jimmunol.169.11.6361; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Munkanta M, 2005, AIDS RES HUM RETROV, V21, P901, DOI 10.1089/aid.2005.21.901; Naghavi MH, 1999, AIDS RES HUM RETROV, V15, P1293, DOI 10.1089/088922299310197; Nagira M, 1999, VIROLOGY, V264, P422, DOI 10.1006/viro.1999.0011; OBRIEN WA, 1990, NATURE, V348, P69, DOI 10.1038/348069a0; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Pierson TC, 2002, J VIROL, V76, P4138, DOI 10.1128/JVI.76.8.4138-4144.2002; Puma C, 2001, J NEUROCHEM, V78, P960, DOI 10.1046/j.1471-4159.2001.00469.x; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; RICH EA, 1992, J CLIN INVEST, V89, P176, DOI 10.1172/JCI115559; Roth AD, 2005, BIOL RES, V38, P381, DOI 10.4067/S0716-97602005000400011; Sanders VJ, 1998, AIDS, V12, P1021, DOI 10.1097/00002030-199809000-00008; Schnell G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002286; Schraufstatter IU, 2001, AM J PHYSIOL-LUNG C, V280, pL1094, DOI 10.1152/ajplung.2001.280.6.L1094; Sharkey ME, 2000, NAT MED, V6, P76, DOI 10.1038/71569; Sopper S, 1996, VIROLOGY, V220, P320, DOI 10.1006/viro.1996.0320; Stroud JC, 2009, J MOL BIOL, V393, P98, DOI 10.1016/j.jmb.2009.08.023; Takahashi K, 1996, ANN NEUROL, V39, P705, DOI 10.1002/ana.410390606; Thea DM, 1996, ANN INTERN MED, V124, P757, DOI 10.7326/0003-4819-124-8-199604150-00009; Trkola A, 1999, J VIROL, V73, P6370, DOI 10.1128/JVI.73.8.6370-6379.1999; Tufekci KU, 2012, ADV PROTEIN CHEM STR, V88, P69, DOI 10.1016/B978-0-12-398314-5.00004-0; Vogel CFA, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-17; Weinstein James D, 2013, Consult Pharm, V28, P443, DOI 10.4140/TCP.n.2013.443; Wires ES, 2012, J NEUROVIROL, V18, P400, DOI 10.1007/s13365-012-0103-4; Xing HQ, 2009, NEUROPATHOLOGY, V29, P433, DOI 10.1111/j.1440-1789.2008.00996.x; Yim HCH, 2009, AIDS, V23, P1473, DOI 10.1097/QAD.0b013e32832d7abe; Zhang Xia, 2009, V531, P123, DOI 10.1007/978-1-59745-396-7_9; Zheng JC, 2008, J NEUROIMMUNOL, V200, P100, DOI 10.1016/j.jneuroim.2008.06.015; Zhu TF, 2002, J VIROL, V76, P707, DOI 10.1128/JVI.76.2.707-716.2002	90	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92145	10.1371/journal.pone.0092145	http://dx.doi.org/10.1371/journal.pone.0092145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662979	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900043
J	Nordey, T; Lechaudel, M; Saudreau, M; Joas, J; Genard, M				Nordey, Thibault; Lechaudel, Mathieu; Saudreau, Marc; Joas, Jacques; Genard, Michel			Model-Assisted Analysis of Spatial and Temporal Variations in Fruit Temperature and Transpiration Highlighting the Role of Fruit Development	PLOS ONE			English	Article							VAPOR-PRESSURE DEFICIT; MANGIFERA-INDICA L.; MANGO FRUIT; RESPIRATION RATE; TOMATO FRUITS; PEACH FRUIT; APPLE FRUIT; SURFACE CONDUCTANCE; AEROBIC CONDITIONS; SIMULATION-MODEL	Fruit physiology is strongly affected by both fruit temperature and water losses through transpiration. Fruit temperature and its transpiration vary with environmental factors and fruit characteristics. In line with previous studies, measurements of physical and thermal fruit properties were found to significantly vary between fruit tissues and maturity stages. To study the impact of these variations on fruit temperature and transpiration, a modelling approach was used. A physical model was developed to predict the spatial and temporal variations of fruit temperature and transpiration according to the spatial and temporal variations of environmental factors and thermal and physical fruit properties. Model predictions compared well to temperature measurements on mango fruits, making it possible to accurately simulate the daily temperature variations of the sunny and shaded sides of fruits. Model simulations indicated that fruit development induced an increase in both the temperature gradient within the fruit and fruit water losses, mainly due to fruit expansion. However, the evolution of fruit characteristics has only a very slight impact on the average temperature and the transpiration per surface unit. The importance of temperature and transpiration gradients highlighted in this study made it necessary to take spatial and temporal variations of environmental factors and fruit characteristics into account to model fruit physiology.	[Nordey, Thibault; Lechaudel, Mathieu] CIRAD, UPR HORTSYS, St Pierre, Reunion, France; [Saudreau, Marc] INRA, UMR PIAF 547, F-10448 Clermont Ferrand, France; [Joas, Jacques] CIRAD, UMR QUALISUD, Montpellier, France; [Genard, Michel] INRA, UR 1115, Avignon, France	CIRAD; INRAE; CIRAD; Universite de Montpellier; INRAE	Nordey, T (corresponding author), CIRAD, UPR HORTSYS, St Pierre, Reunion, France.	thibault.nordey@cirad.fr			CIRAD	CIRAD	The CIRAD (http://www.cirad.fr/) has supported this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SR, 2001, ANN BOT-LONDON, V88, P869, DOI 10.1006/anbo.2001.1524; Ahrens J., 2005, VISUALIZATION HDB, P717, DOI [10.1016/B978-012387582-2/50038-1, DOI 10.1016/B978-012387582-2/50038-1]; Ayala-Silva T, 2005, PROC FL STATE HORTIC, V118, P253; Bally ISE, 1999, SCI HORTIC-AMSTERDAM, V79, P13, DOI 10.1016/S0304-4238(98)00159-9; Bengtsson H, 2011, R MATLAB READ WRITE; BUCK AL, 1981, J APPL METEOROL, V20, P1527, DOI 10.1175/1520-0450(1981)020<1527:NEFCVP>2.0.CO;2; CELLIER P, 1993, AGR FOREST METEOROL, V63, P35, DOI 10.1016/0168-1923(93)90021-9; Courant R, 1928, MATH ANN, V100, P32, DOI 10.1007/BF01448839; da Luz BR, 2006, NEW PHYTOL, V172, P305, DOI 10.1111/j.1469-8137.2006.01823.x; Fishman S, 1998, PLANT CELL ENVIRON, V21, P739, DOI 10.1046/j.1365-3040.1998.00322.x; Fonseca SC, 2002, J FOOD ENG, V52, P99, DOI 10.1016/S0260-8774(01)00106-6; Gautier H, 2008, J AGR FOOD CHEM, V56, P1241, DOI 10.1021/jf072196t; GENARD M, 1992, SCI HORTIC-AMSTERDAM, V52, P37, DOI 10.1016/0304-4238(92)90006-X; Genard M, 1996, J AM SOC HORTIC SCI, V121, P1122, DOI 10.21273/JASHS.121.6.1122; Gibert C, 2010, FUNCT PLANT BIOL, V37, P264, DOI 10.1071/FP09118; GROSSMAN YL, 1994, TREE PHYSIOL, V14, P329, DOI 10.1093/treephys/14.4.329; Guichard S, 2005, J PLANT GROWTH REGUL, V24, P201, DOI 10.1007/s00344-005-0040-z; Guilioni L, 2006, AGR FOREST METEOROL, V138, P258, DOI 10.1016/j.agrformet.2006.05.010; HAMBY DM, 1994, ENVIRON MONIT ASSESS, V32, P135, DOI 10.1007/BF00547132; Hetherington SE, 1997, J HORTIC SCI, V72, P755, DOI 10.1080/14620316.1997.11515568; Hewett E. W., 2006, International Journal of Postharvest Technology and Innovation, V1, P4, DOI 10.1504/IJPTI.2006.009178; Ho QT, 2010, J EXP BOT, V61, P2745, DOI 10.1093/jxb/erq108; Ho QT, 2010, J EXP BOT, V61, P2071, DOI 10.1093/jxb/erq026; Honda C, 2002, PLANT PHYSIOL BIOCH, V40, P955, DOI 10.1016/S0981-9428(02)01454-7; Ihaka Ross, 2012, COLORSPACE COLOR SPA; Jordan RB, 2000, POSTHARVEST BIOL TEC, V20, P163, DOI 10.1016/S0925-5214(00)00125-3; Kang SP, 2008, POSTHARVEST BIOL TEC, V49, P77, DOI 10.1016/j.postharvbio.2007.12.011; Khabba S, 2001, EUR J AGRON, V14, P197, DOI 10.1016/S1161-0301(00)00095-2; Lancaster JE, 1997, J AM SOC HORTIC SCI, V122, P594, DOI 10.21273/JASHS.122.4.594; Lechaudel M, 2005, TREE PHYSIOL, V25, P583, DOI 10.1093/treephys/25.5.583; Lechaudel M, 2002, J HORTIC SCI BIOTECH, V77, P773, DOI 10.1080/14620316.2002.11511571; Lechaudel M, 2012, J PLANT PHYSL; Léchaudel Mathieu, 2007, Braz. J. Plant Physiol., V19, P287, DOI 10.1590/S1677-04202007000400004; Lechaudel M, 2007, TREE PHYSIOL, V27, P219, DOI 10.1093/treephys/27.2.219; Leonardi C, 2000, SCI HORTIC-AMSTERDAM, V84, P285, DOI 10.1016/S0304-4238(99)00127-2; Leonardi C, 2000, SCI HORTIC-AMSTERDAM, V84, P297, DOI 10.1016/S0304-4238(99)00130-2; Lescourret F, 2001, TREE PHYSIOL, V21, P735, DOI 10.1093/treephys/21.11.735; Lewicki PP, 2004, J FOOD ENG, V61, P483, DOI 10.1016/S0260-8774(03)00219-X; Maguire KM, 1999, POSTHARVEST BIOL TEC, V17, P11, DOI 10.1016/S0925-5214(99)00034-4; Mangaraj S, 2011, FOOD BIOPROCESS TECH, V4, P272, DOI 10.1007/s11947-008-0145-z; Maxwell E. L., 1987, SERITR2153087, P35; MCDONALD RE, 1993, HORTSCIENCE, V28, P311, DOI 10.21273/HORTSCI.28.4.311; MEDLICOTT AP, 1986, ANN APPL BIOL, V109, P651, DOI 10.1111/j.1744-7348.1986.tb03222.x; Merzlyak MN, 2003, POSTHARVEST BIOL TEC, V27, P197, DOI 10.1016/S0925-5214(02)00066-2; Montanaro G, 2006, PLANT SCI, V170, P520, DOI 10.1016/j.plantsci.2005.10.004; Montanaro G, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls036; Montanaro G, 2010, J PLANT NUTR SOIL SC, V173, P618, DOI 10.1002/jpln.200900376; Monteith J.L., 1990, PRINCIPLES ENV PHYS, V2nd; Morandi B, 2007, J EXP BOT, V58, P3941, DOI 10.1093/jxb/erm248; NORDBY HE, 1995, J AGR FOOD CHEM, V43, P1828, DOI 10.1021/jf00055a015; Normand F, 2001, J HORTIC SCI BIOTECH, V76, P541; Paull RE, 2000, POSTHARVEST BIOL TEC, V21, P21, DOI 10.1016/S0925-5214(00)00162-9; Picard A, 2008, METROLOGIA, V45, P149, DOI 10.1088/0026-1394/45/2/004; PROCTOR JTA, 1969, PHYTOCHEMISTRY, V8, P2108, DOI 10.1016/S0031-9422(00)88106-6; Ravindra MR, 2008, BIOSYST ENG, V99, P239, DOI 10.1016/j.biosystemseng.2007.10.005; Reda I, 2004, SOL ENERGY, V76, P577, DOI 10.1016/j.solener.2003.12.003; Richter A, 2012, INT J HEAT MASS TRAN, V55, P1343, DOI 10.1016/j.ijheatmasstransfer.2011.09.005; Saudreau M, 2009, AGR FOREST METEOROL, V149, P362, DOI 10.1016/j.agrformet.2008.09.001; Saudreau M, 2007, AGR FOREST METEOROL, V147, P1, DOI 10.1016/j.agrformet.2007.06.006; Siebel JE., 1982, ICE REFRIGERATION, V2, P256; Steyn WJ, 2009, PHYSIOL PLANTARUM, V136, P461, DOI 10.1111/j.1399-3054.2009.01246.x; Team RC, 2012, R LANG ENV STAT COMP; Valente M, 1990, ENG FOOD PHYS PROPER, V1, P432; Verboven P, 2008, PLANT PHYSIOL, V147, P518, DOI 10.1104/pp.108.118935; Vogg G, 2004, J EXP BOT, V55, P1401, DOI 10.1093/jxb/erh149; WALTER WM, 1990, J AM SOC HORTIC SCI, V115, P444, DOI 10.21273/JASHS.115.3.444; WHITAKER S, 1972, AICHE J, V18, P361, DOI 10.1002/aic.690180219; Woolf AB, 1999, POSTHARVEST BIOL TEC, V15, P143, DOI 10.1016/S0925-5214(98)00077-5	68	13	13	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92532	10.1371/journal.pone.0092532	http://dx.doi.org/10.1371/journal.pone.0092532			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663687	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900071
J	Stimpson, KM; Sullivan, LL; Kuo, ME; Sullivan, BA				Stimpson, Kaitlin M.; Sullivan, Lori L.; Kuo, Molly E.; Sullivan, Beth A.			Nucleolar Organization, Ribosomal DNA Array Stability, and Acrocentric Chromosome Integrity Are Linked to Telomere Function	PLOS ONE			English	Article							RNA-POLYMERASE-I; BETA-SATELLITE DNA; MAMMALIAN TELOMERES; FACTOR UBF; TRANSCRIPTION; TRF2; LOCALIZATION; PROTEINS; BINDING; GENOME	The short arms of the ten acrocentric human chromosomes share several repetitive DNAs, including ribosomal RNA genes (rDNA). The rDNA arrays correspond to nucleolar organizing regions that coalesce each cell cycle to form the nucleolus. Telomere disruption by expressing a mutant version of telomere binding protein TRF2 (dnTRF2) causes non-random acrocentric fusions, as well as large-scale nucleolar defects. The mechanisms responsible for acrocentric chromosome sensitivity to dysfunctional telomeres are unclear. In this study, we show that TRF2 normally associates with the nucleolus and rDNA. However, when telomeres are crippled by dnTRF2 or RNAi knockdown of TRF2, gross nucleolar and chromosomal changes occur. We used the controllable dnTRF2 system to precisely dissect the timing and progression of nucleolar and chromosomal instability induced by telomere dysfunction, demonstrating that nucleolar changes precede the DNA damage and morphological changes that occur at acrocentric short arms. The rDNA repeat arrays on the short arms decondense, and are coated by RNA polymerase I transcription binding factor UBF, physically linking acrocentrics to one another as they become fusogenic. These results highlight the importance of telomere function in nucleolar stability and structural integrity of acrocentric chromosomes, particularly the rDNA arrays. Telomeric stress is widely accepted to cause DNA damage at chromosome ends, but our findings suggest that it also disrupts chromosome structure beyond the telomere region, specifically within the rDNA arrays located on acrocentric chromosomes. These results have relevance for Robertsonian translocation formation in humans and mechanisms by which acrocentric-acrocentric fusions are promoted by DNA damage and repair.	[Stimpson, Kaitlin M.; Sullivan, Lori L.; Sullivan, Beth A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; [Stimpson, Kaitlin M.; Kuo, Molly E.; Sullivan, Beth A.] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA; [Sullivan, Beth A.] Duke Univ, Div Human Genet, Durham, NC USA	Duke University; Duke University; Duke University	Sullivan, BA (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.	beth.sullivan@duke.edu	Sullivan, Beth A/Q-3456-2017	Sullivan, Beth A/0000-0001-5216-4603	NIH grants [F31 AG034749, R01 GM098500]; March of Dimes Research Grant [6-FY10-294]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG034749] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Research Grant(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants F31 AG034749 (to KMS) and R01 GM098500 (to BAS) and March of Dimes Research Grant 6-FY10-294 (to BAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Amato A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-119; ANASTASSOVAKRISTEVA M, 1977, J CELL SCI, V25, P103; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Bell P, 1997, J CELL SCI, V110, P2053; BENAVENTE R, 1987, J CELL BIOL, V105, P1483, DOI 10.1083/jcb.105.4.1483; Bradshaw PS, 2005, NAT GENET, V37, P193, DOI 10.1038/ng1506; Bridger JM, 1998, CHROMOSOME RES, V6, P13, DOI 10.1023/A:1009210206855; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; BROSS K, 1973, HUMANGENETIK, V18, P71; BUSCH H, 1963, EXP CELL RES, P150; CHOO KHA, 1992, AM J HUM GENET, V50, P706; Csonka E, 2000, J CELL SCI, V113, P3207; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031; de Planell-Saguer M, 2010, NAT PROTOC, V5, P1061, DOI 10.1038/nprot.2010.62; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Fouche N, 2006, J BIOL CHEM, V281, P37486, DOI 10.1074/jbc.M608778200; Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; GREIG GM, 1992, GENOMICS, V12, P573, DOI 10.1016/0888-7543(92)90450-7; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Haaf T, 1996, EXP CELL RES, V224, P163, DOI 10.1006/excr.1996.0124; HAMERTON JL, 1975, CLIN GENET, V8, P223; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Heliot L, 1997, MOL BIOL CELL, V8, P2199, DOI 10.1091/mbc.8.11.2199; HENDERSON AS, 1972, P NATL ACAD SCI USA, V69, P3394, DOI 10.1073/pnas.69.11.3394; JIMENEZGARCIA LF, 1994, MOL BIOL CELL, V5, P955, DOI 10.1091/mbc.5.9.955; Karlseder J, 2004, PLOS BIOL, V2, P1150, DOI 10.1371/journal.pbio.0020240; Krystosek A, 1998, EXP CELL RES, V241, P202, DOI 10.1006/excr.1998.4046; Mais C, 2005, GENE DEV, V19, P50, DOI 10.1101/gad.310705; Marciniak RA, 1998, P NATL ACAD SCI USA, V95, P6887, DOI 10.1073/pnas.95.12.6887; Moore HM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009241; Mravinac B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006602; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Pondarre C, 1997, NUCLEIC ACIDS RES, V25, P4111, DOI 10.1093/nar/25.20.4111; Samoshkin A, 2012, CHROMOSOMA, V121, P191, DOI 10.1007/s00412-011-0353-6; Sanij E, 2009, EPIGENETICS-US, V4, P274, DOI 10.4161/epi.4.6.9449; Shiels C, 1997, CYTOGENET CELL GENET, V76, P20, DOI 10.1159/000134504; Simonet T, 2011, CELL RES, V21, P1028, DOI 10.1038/cr.2011.40; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; SPADARI S, 1973, MOL GEN GENET, V127, P57, DOI 10.1007/BF00267783; Stansel RM, 2001, EMBO J, V20, P5532; Stimpson KM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001061; SULLIVAN BA, 1995, HUM MOL GENET, V4, P2189, DOI 10.1093/hmg/4.12.2189; TROWELL HE, 1993, HUM MOL GENET, V2, P1639, DOI 10.1093/hmg/2.10.1639; Tsai RYL, 2009, CELL CYCLE, V8, P2912; Tsang CK, 2007, EMBO J, V26, P448, DOI 10.1038/sj.emboj.7601488; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; WARBURTON PE, 1991, GENOMICS, V11, P324, DOI 10.1016/0888-7543(91)90139-6; WAYE JS, 1989, P NATL ACAD SCI USA, V86, P6250, DOI 10.1073/pnas.86.16.6250; WEIER HUG, 1991, CHROMOSOMA, V100, P371, DOI 10.1007/BF00337515; Yang D, 2011, CELL RES, V21, P1013, DOI 10.1038/cr.2011.39; Yankiwski V, 2000, P NATL ACAD SCI USA, V97, P5214, DOI 10.1073/pnas.090525897; ZATSEPINA OV, 1993, CHROMOSOMA, V102, P599, DOI 10.1007/BF00352307; Zhang SS, 2004, J CELL SCI, V117, P3935, DOI 10.1242/jcs.01249	58	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92432	10.1371/journal.pone.0092432	http://dx.doi.org/10.1371/journal.pone.0092432			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662969	gold, Green Submitted, Green Published			2022-12-27	WOS:000333459900062
J	Tripathi, VK; Kumar, V; Singh, AK; Kashyap, MP; Jahan, S; Pandey, A; Alam, S; Khan, F; Khanna, VK; Yadav, S; Lohani, M; Pant, AB				Tripathi, Vinay K.; Kumar, Vivek; Singh, Abhishek K.; Kashyap, Mahendra P.; Jahan, Sadaf; Pandey, Ankita; Alam, Sarfaraz; Khan, Feroz; Khanna, Vinay K.; Yadav, Sanjay; Lohani, Mohtshim; Pant, Aditya B.			Monocrotophos Induces the Expression and Activity of Xenobiotic Metabolizing Enzymes in Pre-Sensitized Cultured Human Brain Cells	PLOS ONE			English	Article							HEPATIC CYTOCHROME P450S; RAT-BRAIN; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; DRUG-METABOLISM; GENE-EXPRESSION; HEPG2 CELLS; GLIAL-CELLS; IN-VITRO; ETHANOL	The expression and metabolic profile of cytochrome P450s (CYPs) is largely missing in human brain due to non-availability of brain tissue. We attempted to address the issue by using human brain neuronal (SH-SY5Y) and glial (U373-MG) cells. The expression and activity of CYP1A1, 2B6 and 2E1 were carried out in the cells exposed to CYP inducers viz., 3-methylcholanthrene (3-MC), cyclophosphamide (CPA), ethanol and known neurotoxicant- monocrotophos (MCP), a widely used organophosphorous pesticide. Both the cells show significant induction in the expression and CYP-specific activity against classical inducers and MCP. The induction level of CYPs was comparatively lower in MCP exposed cells than cells exposed to classical inducers. Pre-exposure (12 h) of cells to classical inducers significantly added the MCP induced CYPs expression and activity. The findings were concurrent with protein ligand docking studies, which show a significant modulatory capacity of MCP by strong interaction with CYP regulators-CAR, PXR and AHR. Similarly, the known CYP inducers- 3-MC, CPA and ethanol have also shown significantly high docking scores with all the three studied CYP regulators. The expression of CYPs in neuronal and glial cells has suggested their possible association with the endogenous physiology of the brain. The findings also suggest the xenobiotic metabolizing capabilities of these cells against MCP, if received a pre-sensitization to trigger the xenobiotic metabolizing machinery. MCP induced CYP-specific activity in neuronal cells could help in explaining its effect on neurotransmission, as these CYPs are known to involve in the synthesis/transport of the neurotransmitters. The induction of CYPs in glial cells is also of significance as these cells are thought to be involved in protecting the neurons from environmental insults and safeguard them from toxicity. The data provide better understanding of the metabolizing capability of the human brain cells against xenobiotics.	[Tripathi, Vinay K.; Kumar, Vivek; Singh, Abhishek K.; Kashyap, Mahendra P.; Jahan, Sadaf; Pandey, Ankita; Khanna, Vinay K.; Yadav, Sanjay; Pant, Aditya B.] CSIR, Indian Inst Toxicol Res, In Vitro Toxicol Lab, Lucknow, Uttar Pradesh, India; [Alam, Sarfaraz; Khan, Feroz] CSIR, Cent Inst Med & Aromat Plants, Metab & Struct Biol Dept, Lucknow, Uttar Pradesh, India; [Tripathi, Vinay K.; Kumar, Vivek; Lohani, Mohtshim] Integral Univ, Dept Biotechnol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Integral University	Pant, AB (corresponding author), CSIR, Indian Inst Toxicol Res, In Vitro Toxicol Lab, Lucknow, Uttar Pradesh, India.	abpant@rediffmail.com	Lohani, Mohtashim/AAR-3394-2021; Alam, Sarfaraz/H-2802-2019; Alam, Sarfaraz/A-9180-2012; Khan, Feroz/AHC-3474-2022; Jahan, Sadaf/AAY-5713-2020	Alam, Sarfaraz/0000-0002-7246-8687; Alam, Sarfaraz/0000-0002-7246-8687; Khan, Feroz/0000-0002-2704-5925; Jahan, Sadaf/0000-0002-6976-5672; Singh, Abhishek Kumar/0000-0002-3186-9898; Lohani, Mohtashim/0000-0001-9414-4539	Department of Biotechnology, Ministry of Science & Technology, Government of India, New Delhi, India [102/IFD/SAN/PR1524/2010-2011]; Department of Science and Technology, Ministry of Science & Technology, Government of India, New Delhi, India [SR/SO/Z 36/2007/91/10]; Council of Scientific & Industrial Research, Government of India, New Delhi, India [BSC0111/INDEPTH/CSIR]	Department of Biotechnology, Ministry of Science & Technology, Government of India, New Delhi, India; Department of Science and Technology, Ministry of Science & Technology, Government of India, New Delhi, India; Council of Scientific & Industrial Research, Government of India, New Delhi, India	Financial support from Department of Biotechnology, Ministry of Science & Technology, Government of India, New Delhi, India [Grant No. 102/IFD/SAN/PR1524/2010-2011]; Department of Science and Technology, Ministry of Science & Technology, Government of India, New Delhi, India [Grant No. SR/SO/Z 36/2007/91/10]; and Council of Scientific & Industrial Research, Government of India, New Delhi, India [Grant No. BSC0111/INDEPTH/CSIR Network Project] is acknowledged. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar M, 2005, DRUG METAB REV, V37, P379, DOI 10.1081/DMR-200046136; Aleksunes LM, 2012, DRUG METAB DISPOS, V40, P1366, DOI 10.1124/dmd.112.045112; Antherieu S, 2010, DRUG METAB DISPOS, V38, P516, DOI 10.1124/dmd.109.030197; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baillie TA, 2011, DRUG METAB PHARMACOK, V26, P15, DOI 10.2133/dmpk.DMPK-10-RV-089; Benowitz NL, 2009, ANNU REV PHARMACOL, V49, P57, DOI 10.1146/annurev.pharmtox.48.113006.094742; Bromek E, 2010, EUR J PHARMACOL, V626, P171, DOI 10.1016/j.ejphar.2009.09.062; Cederbaum AI, 2001, FREE RADICAL BIO MED, V31, P1539, DOI 10.1016/S0891-5849(01)00743-2; Chandrasekaran K, 2010, TOXICOL IN VITRO, V24, P387, DOI 10.1016/j.tiv.2009.10.020; Dauchy S, 2008, J NEUROCHEM, V107, P1518, DOI 10.1111/j.1471-4159.2008.05720.x; Dayal M, 2003, FOOD CHEM TOXICOL, V41, P431, DOI 10.1016/S0278-6915(02)00249-1; Dutheil F, 2009, DRUG METAB DISPOS, V37, P1528, DOI 10.1124/dmd.109.027011; Ekins S, 2008, CURR DRUG METAB, V9, P363, DOI 10.2174/138920008784746346; Ferguson CS, 2011, TRENDS PHARMACOL SCI, V32, P708, DOI 10.1016/j.tips.2011.08.005; Franco R, 2010, CHEM-BIOL INTERACT, V188, P289, DOI 10.1016/j.cbi.2010.06.003; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; Ghosh C, 2010, EPILEPSIA, V51, P1408, DOI 10.1111/j.1528-1167.2009.02428.x; Gilot D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018261; Gu J, 2008, CANCER EPIDEM BIOMAR, V17, P2445, DOI 10.1158/1055-9965.EPI-07-2890; Hagemeyer CE, 2003, NEUROSCIENCE, V117, P521, DOI 10.1016/S0306-4522(02)00955-7; Hipolito L, 2007, CURR DRUG METAB, V8, P716, DOI 10.2174/138920007782109797; Howard LA, 2003, BRIT J PHARMACOL, V138, P1376, DOI 10.1038/sj.bjp.0705146; Ingelman-Sundberg Magnus, 2010, Hum Genomics, V4, P402; Jeffrey P, 2010, NEUROBIOL DIS, V37, P33, DOI 10.1016/j.nbd.2009.07.033; Johansson I, 2011, TOXICOL SCI, V120, P1, DOI 10.1093/toxsci/kfq374; Johri A, 2008, TOXICOL APPL PHARM, V231, P10, DOI 10.1016/j.taap.2008.03.019; Johri A, 2006, EUR J PHARMACOL, V544, P58, DOI 10.1016/j.ejphar.2006.06.042; Kapoor N, 2007, MOL CELL BIOCHEM, V305, P199, DOI 10.1007/s11010-007-9544-0; Kapoor N, 2006, LIFE SCI, V79, P2387, DOI 10.1016/j.lfs.2006.08.002; Kapoor N, 2006, LIFE SCI, V79, P1514, DOI 10.1016/j.lfs.2006.04.023; Kashyap MP, 2010, CHEM RES TOXICOL, V23, P1663, DOI 10.1021/tx100234m; Kashyap MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017757; Kaur P, 2007, NEUROTOXICOLOGY, V28, P1208, DOI 10.1016/j.neuro.2007.08.001; Kazi AI, 2012, NEUROTOXICOLOGY, V33, P1284, DOI 10.1016/j.neuro.2012.07.010; Kessova I, 2003, CURR MOL MED, V3, P509, DOI 10.2174/1566524033479609; Khokhar JY, 2011, NEUROPSYCHOPHARMACOL, V36, P692, DOI 10.1038/npp.2010.202; Kirby ML, 1999, PESTIC BIOCHEM PHYS, V65, P160, DOI 10.1006/pest.1999.2440; Konstandi M, 2005, BIOCHEM PHARMACOL, V69, P277, DOI 10.1016/j.bcp.2004.09.024; Kumar S, 2010, EXPERT OPIN DRUG MET, V6, P115, DOI 10.1517/17425250903431040; Malaplate-Armand C, 2004, REV NEUROL-FRANCE, V160, P651, DOI 10.1016/S0035-3787(04)71014-0; Masoud A, 2009, CELL MOL NEUROBIOL, V29, P1245, DOI 10.1007/s10571-009-9420-4; Meyer RP, 2007, CURR DRUG METAB, V8, P297, DOI 10.2174/138920007780655478; Meyer RP, 2010, EXPERT OPIN DRUG MET, V6, P675, DOI 10.1517/17425251003680791; Meyer RP, 2001, EXP NEUROL, V167, P376, DOI 10.1006/exnr.2000.7553; Miksys S, 2006, J NEURAL TRANSM-SUPP, P177; Miksys S, 2003, NEUROPHARMACOLOGY, V45, P122, DOI 10.1016/S0028-3908(03)00136-9; Miksys S, 2004, DRUG METAB REV, V36, P313, DOI 10.1081/DMR-120034149; Miksys S, J PSYCHIAT NEUROSCI, V37; Miksys S, 2009, NEUROPSYCHOPHARMACOL, V34, P634, DOI 10.1038/npp.2008.110; Mo SL, 2009, CURR DRUG METAB, V10, P730, DOI 10.2174/138920009789895534; Mohri T, 2010, BIOCHEM PHARMACOL, V79, P1045, DOI 10.1016/j.bcp.2009.11.015; Murphy TH, 2001, J NEUROCHEM, V76, P1670, DOI 10.1046/j.1471-4159.2001.00157.x; NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416; Niestroy J, 2011, TOXICOL IN VITRO, V25, P671, DOI 10.1016/j.tiv.2011.01.008; Nissbrandt H, 2001, SYNAPSE, V40, P294, DOI 10.1002/syn.1052; Nobre HV, 2009, OXID MED CELL LONGEV, V2, P130, DOI 10.4161/oxim.2.3.8488; Novak RF, 2000, ARCH PHARM RES, V23, P267, DOI 10.1007/BF02975435; Pal D, 2011, LIFE SCI, V88, P959, DOI 10.1016/j.lfs.2010.09.012; Patel S, 2007, TOXICOL IN VITRO, V21, P1409, DOI 10.1016/j.tiv.2007.05.009; Ravindranath V, 2013, EXPERT OPIN DRUG MET, V9, P551, DOI 10.1517/17425255.2013.759208; Rodriguez-Antona C, 2010, HUM GENET, V127, P1, DOI 10.1007/s00439-009-0748-0; Sanchez-Catalan MJ, 2008, ALCOHOL ALCOHOLISM, V43, P401, DOI 10.1093/alcalc/agn012; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Seliskar M, 2007, BBA-GEN SUBJECTS, V1770, P458, DOI 10.1016/j.bbagen.2006.09.016; Shahabi HN, 2008, SYNAPSE, V62, P379, DOI 10.1002/syn.20505; Shao J, 2007, DRUG METAB DISPOS, V35, P168, DOI 10.1124/dmd.106.012757; Singh AK, 2012, TOXICOL SCI, V129, P392, DOI 10.1093/toxsci/kfs213; Singh Mohan, 2004, Indian Journal of Experimental Biology, V42, P292; Singh S, 2004, NEUROL INDIA, V52, P525; Sjogren E, 2012, DRUG METAB DISPOS, V40, P2273, DOI 10.1124/dmd.112.047373; Slotkin TA, 2002, DEV BRAIN RES, V133, P163, DOI 10.1016/S0165-3806(02)00284-5; Stejskalova L, 2011, CURR DRUG METAB, V12, P198, DOI 10.2174/138920011795016818; Takahashi Shinichi, 2012, Rinsho Shinkeigaku, V52, P41; Trafalis DT, 2010, EXPERT OPIN DRUG MET, V6, P307, DOI 10.1517/17425250903540238; Turesky RJ, 2011, CHEM RES TOXICOL, V24, P1169, DOI 10.1021/tx200135s; Vaglini F, 2004, J NEUROCHEM, V91, P285, DOI 10.1111/j.1471-4159.2004.02720.x; Zanger UM, 2008, ANAL BIOANAL CHEM, V392, P1093, DOI 10.1007/s00216-008-2291-6; Zimatkin SM, 2006, ALCOHOL CLIN EXP RES, V30, P1500, DOI 10.1111/j.1530-0277.2006.00181.x	78	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91946	10.1371/journal.pone.0091946	http://dx.doi.org/10.1371/journal.pone.0091946			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663500	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900034
J	Zhang, H; Chen, J; Liu, FH; Gao, CT; Wang, XC; Zhao, TS; Liu, JC; Gao, S; Zhao, X; Ren, H; Hao, JH				Zhang, Huan; Chen, Jing; Liu, Fenghua; Gao, Chuntao; Wang, Xiuchao; Zhao, Tiansuo; Liu, Jingcheng; Gao, Song; Zhao, Xiao; Ren, He; Hao, Jihui			CypA, a Gene Downstream of HIF-1 alpha, Promotes the Development of PDAC	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; EPIDERMAL-GROWTH-FACTOR; PANCREATIC-CANCER; CYCLOPHILIN-A; CROSS-TALK; KAPPA-B; CYCLOSPORINE; EXPRESSION; AGENTS; CELLS	Hypoxia-inducible factor-1 alpha (HIF-1 alpha) is a highly important transcription factor involved in cell metabolism. HIF-1 alpha promotes glycolysis and inhibits of mitochondrial respiration in pancreatic ductal adenocarcinoma (PDAC). In response to tumor hypoxia, cyclophilin A (CypA) is over-expressed in various cancer types, and is associated with cell apoptosis, tumor invasion, metastasis, and chemoresistance in PDAC. In this study, we showed that both HIF-1 alpha and CypA expression were significantly associated with lymph node metastasis and tumor stage. The expression of CypA was correlated with HIF-1 alpha. Moreover, the mRNA and protein expression of CypA markedly decreased or increased following the suppression or overexpression of HIF-1 alpha in vitro. Chromatin immunoprecipitation analysis showed that HIF-1 alpha could directly bind to the hypoxia response element (HRE) in the CypA promoter regions and regulated CypA expression. Consistent with other studies, HIF-1 alpha and CypA promoted PDAC cell proliferation and invasion, and suppressed apoptosis in vitro. Furthermore, we proved the combination effect of 2-methoxyestradiol and cyclosporin A both in vitro and in vivo. These results suggested that, CypA, a gene downstream of HIF-1 alpha, could promote the development of PDAC. Thus, CypA might serve as a potential therapeutic target for PDAC.	[Zhang, Huan; Chen, Jing; Liu, Fenghua; Gao, Chuntao; Wang, Xiuchao; Zhao, Tiansuo; Liu, Jingcheng; Gao, Song; Zhao, Xiao; Ren, He; Hao, Jihui] Tianjin Med Univ Canc Inst & Hosp, Dept Pancreat Canc, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China	Tianjin Medical University	Ren, H (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Dept Pancreat Canc, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China.	renhe@tjmuch.com; haojihui@tjmuch.com			National Natural Science Foundation of China [81302082, 81272685, 31301151, 81172355]; Doctoral Fund of Ministry of Education of China [20101202110002]; Key program of Natural Science Foundation of Tianjin [09JCZDJC17100, 11JCZDJC18400]; major anticancer Technologies R & D Program of Tianjin [12ZCDZSY16700]; Tianjin Educational Commission [20100123]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Key program of Natural Science Foundation of Tianjin; major anticancer Technologies R & D Program of Tianjin; Tianjin Educational Commission	Funding: National Natural Science Foundation of China (Grant No. 81302082, 81272685, 31301151, 81172355); Doctoral Fund of Ministry of Education of China (Grant No. 20101202110002; Key program of Natural Science Foundation of Tianjin (Grant No. 09JCZDJC17100, 11JCZDJC18400); major anticancer Technologies R & D Program of Tianjin (Grant No. 12ZCDZSY16700); project of Tianjin Educational Commission (Grant No. 20100123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Y, 2009, BRIT J CANCER, V101, P1307, DOI 10.1038/sj.bjc.6605312; Andre N, 2004, MED HYPOTHESES, V63, P647, DOI 10.1016/j.mehy.2004.03.030; Bane FT, 2009, J PHARMACOL EXP THER, V329, P38, DOI 10.1124/jpet.108.148130; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Chen S, 2008, CANCER CHEMOTH PHARM, V61, P459, DOI 10.1007/s00280-007-0491-y; Choi KJ, 2007, CANCER RES, V67, P3654, DOI 10.1158/0008-5472.CAN-06-1759; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Fong GH, 2008, ANGIOGENESIS, V11, P121, DOI 10.1007/s10456-008-9107-3; Grigoryeva ES, 2013, PATHOL ONCOL RES; Hamel E, 2003, CELL BIOCHEM BIOPHYS, V38, P1, DOI 10.1385/CBB:38:1:1; Han XZ, 2010, ONCOL REP, V23, P1053, DOI 10.3892/or_00000732; Han ZB, 2008, CARCINOGENESIS, V29, P1853, DOI 10.1093/carcin/bgn066; Hao JH, 2004, CANCER RES, V64, P3607, DOI 10.1158/0008-5472.CAN-03-3648; Hu YZ, 2013, J CELL BIOCHEM, V114, P498, DOI 10.1002/jcb.24390; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Lee J, 2010, ARCH PHARM RES, V33, P1401, DOI 10.1007/s12272-010-0914-x; Lee J, 2010, ARCH PHARM RES, V33, P181, DOI 10.1007/s12272-010-0200-y; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Levy G, 2002, TRANSPLANTATION, V73, P953, DOI 10.1097/00007890-200203270-00022; Li L, 2013, CLIN CANCER RES, V19, P6703, DOI 10.1158/1078-0432.CCR-13-0621; Meijer TWH, 2012, CLIN CANCER RES, V18, P5585, DOI 10.1158/1078-0432.CCR-12-0858; Miyake K, 2008, PANCREAS, V36, pE1, DOI 10.1097/MPA.0b013e31815f2c2a; Miyake K, 2012, EXP CELL RES, V318, P1554, DOI 10.1016/j.yexcr.2012.03.013; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Mueck AO, 2010, STEROIDS, V75, P625, DOI 10.1016/j.steroids.2010.02.016; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Obchoei S, 2009, MED SCI MONITOR, V15, pRA221; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Peng XH, 2006, J BIOL CHEM, V281, P25903, DOI 10.1074/jbc.M603414200; Philip PA, 2009, J CLIN ONCOL, V27, P5660, DOI 10.1200/JCO.2009.21.9022; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Qi YJ, 2008, J CELL BIOCHEM, V104, P1625, DOI 10.1002/jcb.21727; Schneiderhan W, 2009, GUT, V58, P1391, DOI 10.1136/gut.2009.181412; Singh AK, 2011, J TRANSPLANT, V2011, DOI 10.1155/2011/480642; Song FJ, 2008, CANCER CAUSE CONTROL, V19, P443, DOI 10.1007/s10552-007-9105-6; Sun HC, 2007, INT J ONCOL, V30, P1359; Tamesa MS, 2009, ELECTROPHORESIS, V30, P2168, DOI 10.1002/elps.200800675; Vakeva L, 2008, ACTA DERM-VENEREOL, V88, P117, DOI 10.2340/00015555-0360; Verenich S, 2010, MOL PHARMACEUT, V7, P2030, DOI 10.1021/mp100190f; Weischer M, 2007, EXP DERMATOL, V16, P385, DOI 10.1111/j.1600-0625.2007.00555.x; Yang L, 2008, YONSEI MED J, V49, P295, DOI 10.3349/ymj.2008.49.2.295; Yu G, 2014, BIOCHEM BIOPH RES CO, V444, P75, DOI 10.1016/j.bbrc.2014.01.015; Zhu ZN, 2012, ONCOL REP, V27, P1567, DOI 10.3892/or.2012.1697	43	19	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92824	10.1371/journal.pone.0092824	http://dx.doi.org/10.1371/journal.pone.0092824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662981	Green Submitted, gold, Green Published			2022-12-27	WOS:000333459900121
J	Takamatsu, A; Ohkawara, B; Ito, M; Masuda, A; Sakai, T; Ishiguro, N; Ohno, K				Takamatsu, Akira; Ohkawara, Bisei; Ito, Mikako; Masuda, Akio; Sakai, Tadahiro; Ishiguro, Naoki; Ohno, Kinji			Verapamil Protects against Cartilage Degradation in Osteoarthritis by Inhibiting Wnt/beta-Catenin Signaling	PLOS ONE			English	Article							BETA-CATENIN; ARTICULAR-CARTILAGE; CHONDROCYTE DIFFERENTIATION; HIP OSTEOARTHRITIS; JOINT DEGENERATION; HYALURONAN EXPORT; GROWTH; PATHWAY; SOX9; EXPRESSION	In past years, the canonical Wnt/beta-catenin signaling pathway has emerged as a critical regulator of cartilage development and homeostasis. FRZB, a soluble antagonist of Wnt signaling, has been studied in osteoarthritis (OA) animal models and OA patients as a modulator of Wnt signaling. We screened for FDA-approved drugs that induce FRZB expression and suppress Wnt/beta-catenin signaling. We found that verapamil, a widely prescribed L-type calcium channel blocker, elevated FRZB expression and suppressed Wnt/beta-catenin signaling in human OA chondrocytes. Expression and nuclear translocation of beta-catenin was attenuated by verapamil in OA chondrocytes. Lack of the verapamil effects in LiCl-treated and FRZB-downregulated OA chondrocytes also suggested that verpamil suppressed Wnt signaling by inducing FRZB. Verapamil enhanced gene expressions of chondrogenic markers of ACAN encoding aggrecan, COL2A1 encoding collagen type II alpha 1, and SOX9, and suppressed Wnt-responsive AXIN2 and MMP3 in human OA chondrocytes. Verapamil ameliorated Wnt3A-induced proteoglycan loss in chondrogenically differentiated ATDC5 cells. Verapamil inhibited hypertrophic differentiation of chondrocytes in the explant culture of mouse tibiae. Intraarticular injection of verapamil inhibited OA progression as well as nuclear localizations of b-catenin in a rat OA model. We propose that verapamil holds promise as a potent therapeutic agent for OA by upregulating FRZB and subsequently downregulating Wnt/beta-catenin signaling.	[Takamatsu, Akira; Ohkawara, Bisei; Ito, Mikako; Masuda, Akio; Ohno, Kinji] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Neurogenet, Nagoya, Aichi 4648601, Japan; [Takamatsu, Akira; Sakai, Tadahiro; Ishiguro, Naoki] Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Ohno, K (corresponding author), Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Neurogenet, Nagoya, Aichi 4648601, Japan.	ohnok@med.nagoya-u.ac.jp	Masuda, Akio/H-6323-2012; Ito, Mikako/I-1941-2012; Ohno, Kinji/H-4020-2012; Ishiguro, Naoki/I-1563-2012; Ohno, Kinji/ABD-5787-2020	Ohno, Kinji/0000-0002-1529-2750; Ohno, Kinji/0000-0002-1529-2750; Ohkawara, Bisei/0000-0002-1987-458X	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Ministry of Health, Labor and Welfare (MHLW) of Japan; Hori Sciences & Arts foundation; Grants-in-Aid for Scientific Research [23710253] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare (MHLW) of Japan(Ministry of Health, Labour and Welfare, Japan); Hori Sciences & Arts foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Ministry of Health, Labor and Welfare (MHLW) of Japan, and the Hori Sciences & Arts foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2002, NATURE, V417, P109, DOI 10.1038/417109a; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Beck E, 2005, AM FAM PHYSICIAN, V71, P717; Bian Y, 2009, HUM MOL GENET, V18, P1229, DOI 10.1093/hmg/ddp023; Chan BY, 2011, OSTEOARTHR CARTILAGE, V19, P874, DOI 10.1016/j.joca.2011.04.014; Correa S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-303; De Luca F, 2001, ENDOCRINOLOGY, V142, P430, DOI 10.1210/en.142.1.430; Furman BD, 2007, J ORTHOP RES, V25, P578, DOI 10.1002/jor.20331; HAMERMAN D, 1986, J CELL PHYSIOL, V127, P317, DOI 10.1002/jcp.1041270220; Hens JR, 2005, J BONE MINER RES, V20, P1103, DOI 10.1359/JBMR.050210; Hoang B, 1996, J BIOL CHEM, V271, P26131, DOI 10.1074/jbc.271.42.26131; Hunter DJ, 2006, BMJ-BRIT MED J, V332, P639, DOI 10.1136/bmj.332.7542.639; Hwang SG, 2005, J BIOL CHEM, V280, P12758, DOI 10.1074/jbc.M413367200; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Kumar D, 2009, MOL CELL BIOL, V29, P4262, DOI 10.1128/MCB.01779-08; Lane NE, 2007, ARTHRITIS RHEUM-US, V56, P3319, DOI 10.1002/art.22867; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Leijten JCH, 2012, ARTHRITIS RHEUM-US, V64, P3302, DOI 10.1002/art.34535; Little CB, 2010, CURR DRUG TARGETS, V11, P561; Lories RJU, 2007, ARTHRITIS RHEUM-US, V56, P4095, DOI 10.1002/art.23137; Loughlin J, 2004, P NATL ACAD SCI USA, V101, P9757, DOI 10.1073/pnas.0403456101; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Nalesso G, 2011, J CELL BIOL, V193, P551, DOI 10.1083/jcb.201011051; Ouskova G, 2004, GLYCOBIOLOGY, V14, P931, DOI 10.1093/glycob/cwh115; Prehm P, 2004, BIOCHEM PHARMACOL, V68, P1401, DOI 10.1016/j.bcp.2004.06.017; Prehm P, 2005, J RHEUMATOL, V32, P690; Ryu JH, 2002, DEVELOPMENT, V129, P5541, DOI 10.1242/dev.00110; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Stewart AJ, 2006, J CELL PHYSIOL, V206, P435, DOI 10.1002/jcp.20481; Strazielle N, 2013, MOL PHARMACEUT, V10, P1473, DOI 10.1021/mp300518e; TAKIGAWA M, 1989, CANCER RES, V49, P3996; Thomas RS, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3536; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Weng LH, 2012, ARTHRITIS RHEUM-US, V64, P3267, DOI 10.1002/art.34602; Yan W, 2004, BONE, V35, P1273, DOI 10.1016/j.bone.2004.09.009; Yuasa T, 2008, LAB INVEST, V88, P264, DOI 10.1038/labinvest.3700747; Zhu M, 2008, ARTHRITIS RHEUM-US, V58, P2053, DOI 10.1002/art.23614; Zhu M, 2009, J BONE MINER RES, V24, P12, DOI 10.1359/JBMR.080901	42	54	57	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92699	10.1371/journal.pone.0092699	http://dx.doi.org/10.1371/journal.pone.0092699			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658359	gold, Green Published, Green Submitted			2022-12-27	WOS:000333355300118
J	Britton, D; Zen, Y; Quaglia, A; Selzer, S; Mitra, V; Lossner, C; Jung, S; Bohm, G; Schmid, P; Prefot, P; Hoehle, C; Koncarevic, S; Gee, J; Nicholson, R; Ward, M; Castellano, L; Stebbing, J; Zucht, HD; Sarker, D; Heaton, N; Pike, I				Britton, David; Zen, Yoh; Quaglia, Alberto; Selzer, Stefan; Mitra, Vikram; Loessner, Christopher; Jung, Stephan; Boehm, Gitte; Schmid, Peter; Prefot, Petra; Hoehle, Claudia; Koncarevic, Sasa; Gee, Julia; Nicholson, Robert; Ward, Malcolm; Castellano, Leandro; Stebbing, Justin; Zucht, Hans Dieter; Sarker, Debashis; Heaton, Nigel; Pike, Ian			Quantification of Pancreatic Cancer Proteome and Phosphorylome: Indicates Molecular Events Likely Contributing to Cancer and Activity of Drug Targets	PLOS ONE			English	Article							CELL-MIGRATION; TYROSINE PHOSPHORYLATION; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; BETA-CATENIN; KINASE; EXPRESSION; GENE; GROWTH; DOMAIN	Objective: LC-MS/MS phospho-proteomics is an essential technology to help unravel the complex molecular events that lead to and propagate cancer. We have developed a global phospho-proteomic workflow to determine activity of signaling pathways and drug targets in pancreatic cancer tissue for clinical application. Methods: Peptides resulting from tryptic digestion of proteins extracted from frozen tissue of pancreatic ductal adenocarcinoma and background pancreas (n = 12), were labelled with tandem mass tags (TMT 8-plex), separated by strong cation exchange chromatography, then were analysed by LC-MS/MS directly or first enriched for phosphopeptides using IMAC and TiO2, prior to analysis. In-house, commercial and freeware bioinformatic platforms were used to identify relevant biological events from the complex dataset. Results: Of 2,101 proteins identified, 152 demonstrated significant difference in abundance between tumor and non-tumor tissue. They included proteins that are known to be up-regulated in pancreatic cancer (e.g. Mucin-1), but the majority were new candidate markers such as HIPK1 & MLCK. Of the 6,543 unique phosphopeptides identified (6,284 unique phosphorylation sites), 635 showed significant regulation, particularly those from proteins involved in cell migration (Rho guanine nucleotide exchange factors & MRCK alpha) and formation of focal adhesions. Activator phosphorylation sites on FYN, AKT1, ERK2, HDAC1 and other drug targets were found to be highly modulated (>= 2 fold) in different cases highlighting their predictive power. Conclusion: Here we provided critical information enabling us to identify the common and unique molecular events likely contributing to cancer in each case. Such information may be used to help predict more bespoke therapy suitable for an individual case.	[Britton, David; Selzer, Stefan; Mitra, Vikram; Loessner, Christopher; Jung, Stephan; Boehm, Gitte; Schmid, Peter; Prefot, Petra; Hoehle, Claudia; Koncarevic, Sasa; Ward, Malcolm; Zucht, Hans Dieter; Pike, Ian] Proteome Sci Plc, Cobham, England; [Zen, Yoh; Quaglia, Alberto; Sarker, Debashis; Heaton, Nigel] Kings Coll Hosp London, Inst Liver Studies, London SE5 8RX, England; [Castellano, Leandro; Stebbing, Justin] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, London, England; [Gee, Julia; Nicholson, Robert] Cardiff Univ, Cardiff Sch Pharm & Pharmaceut Sci, Cardiff CF10 3AX, S Glam, Wales	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Imperial College London; Cardiff University	Britton, D (corresponding author), Proteome Sci Plc, Cobham, England.	david.britton@proteomics.com	Heaton, Nigel/AAK-8363-2020; Castellano, Leandro/AAE-1366-2021; Gee, Julia MW/N-3995-2014	Gee, Julia MW/0000-0001-6483-2015; Stebbing, Justin/0000-0002-1117-6947; Ward, Malcolm/0000-0003-2164-6938; Pike, Ian/0000-0002-3071-0041; Castellano, Leandro/0000-0002-3059-4829; Sarker, Debashis/0000-0003-4814-8429	Institute of Liver Studies, King's College Hospital; Proteome Sciences plc; Cancer Research UK [14549, 16057] Funding Source: researchfish; Medical Research Council [MR/J006742/1] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-011-053] Funding Source: researchfish	Institute of Liver Studies, King's College Hospital; Proteome Sciences plc; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	All works carried out in this study were jointly funded by Institute of Liver Studies, King's College Hospital and Proteome Sciences plc. The funders employed the scientists and clinicians who played key roles in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Berber S, 2013, DEV DYNAM, V242, P1250, DOI 10.1002/dvdy.24023; Bond-Smith G, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2476; Bononi A, 2011, ENZYME RES, V2011, DOI [10.4061/2011/329098, DOI 10.4061/2011/329098]; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cook D. R., 2013, ONCOGENE IN PRESS; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; di Magliano MP, 2013, GASTROENTEROLOGY, V144, P1220, DOI 10.1053/j.gastro.2013.01.071; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Engholm-Keller K, 2013, PROTEOMICS, V13, P910, DOI 10.1002/pmic.201200484; Fu L, 2007, CANCER-AM CANCER SOC, V110, P2672, DOI 10.1002/cncr.23110; Germain EC, 2009, MOL BIOL CELL, V20, P56, DOI 10.1091/mbc.E08-06-0646; Goicoechea SM, 2009, ONCOGENE, V28, P587, DOI 10.1038/onc.2008.408; Grunewald TGP, 2007, BRIT J CANCER, V96, P296, DOI 10.1038/sj.bjc.6603545; Haynes J, 2011, MOL BIOL CELL, V22, P4750, DOI 10.1091/mbc.E11-02-0119; Hirasawa Y, 2006, ONCOLOGY-BASEL, V71, P77, DOI 10.1159/000100475; Iden S, 2012, J CELL BIOL, V196, P623, DOI 10.1083/jcb.201104143; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Jung CR, 2010, J CLIN INVEST, V120, P4493, DOI 10.1172/JCI42674; Kelly KA, 2008, PLOS MED, V5, P657, DOI 10.1371/journal.pmed.0050085; Kim DH, 2013, FASEB J, V27, P1351, DOI 10.1096/fj.12-220160; Kondo S, 2003, P NATL ACAD SCI USA, V100, P5431, DOI 10.1073/pnas.0530308100; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Langer T, 2004, CHEMBIOCHEM, V5, P1508, DOI 10.1002/cbic.200400129; Lee D, 2012, EMBO REP, V13, P163, DOI 10.1038/embor.2011.235; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mann M, 2013, MOL CELL, V49, P583, DOI 10.1016/j.molcel.2013.01.029; Mayanagi T, 2008, J BIOL CHEM, V283, P31183, DOI 10.1074/jbc.M801606200; McAlister GC, 2012, ANAL CHEM, V84, P7469, DOI 10.1021/ac301572t; Michl P, 2013, GUT, V62, P317, DOI 10.1136/gutjnl-2012-303588; Miyasaka KY, 2007, P NATL ACAD SCI USA, V104, P11274, DOI 10.1073/pnas.0702000104; Morohashi Y, 2010, BIOCHEM J, V427, P401, DOI 10.1042/BJ20091681; Ren J, 2002, J BIOL CHEM, V277, P17616, DOI 10.1074/jbc.M200436200; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rinaldo C, 2008, BBA-MOL CELL RES, V1783, P2124, DOI 10.1016/j.bbamcr.2008.06.006; Rinaldo C, 2007, BIOCHEM CELL BIOL, V85, P411, DOI 10.1139/O07-071; Rivera AL, 2010, NEURO-ONCOLOGY, V12, P116, DOI 10.1093/neuonc/nop020; Schramek H, 1997, AM J PHYSIOL-CELL PH, V272, pC383, DOI 10.1152/ajpcell.1997.272.2.C383; Schwappacher R, 2013, J CELL SCI, V126, P1626, DOI 10.1242/jcs.118190; Shin DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007451; SMART JE, 1981, P NATL ACAD SCI-BIOL, V78, P6013, DOI 10.1073/pnas.78.10.6013; Wang H, 2010, J PROTEOME RES, V9, P1032, DOI 10.1021/pr900927y; Wei XL, 2007, CANCER RES, V67, P1853, DOI 10.1158/0008-5472.CAN-06-3063; Weitzdoerfer R, 2001, J NEURAL TRANSM-SUPP, P95; Werner T, 2012, ANAL CHEM, V84, P7188, DOI 10.1021/ac301553x; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yeo MG, 2011, J CELL PHYSIOL, V226, P236, DOI 10.1002/jcp.22335; Yonezawa S, 2011, PATHOL INT, V61, P697, DOI 10.1111/j.1440-1827.2011.02734.x; Zhang J, 2007, J CLIN INVEST, V117, P2962, DOI 10.1172/JCI30710; Zhang YB, 2010, CANCER SCI, V101, P523, DOI 10.1111/j.1349-7006.2009.01424.x; Zhao LA, 2010, GUT, V59, P1226, DOI 10.1136/gut.2009.202739	54	38	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e90948	10.1371/journal.pone.0090948	http://dx.doi.org/10.1371/journal.pone.0090948			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670416	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000333677000014
J	Miyagawa-Yamaguchi, A; Kotani, N; Honke, K				Miyagawa-Yamaguchi, Arisa; Kotani, Norihiro; Honke, Koichi			Expressed Glycosylphosphatidylinositol-Anchored Horseradish Peroxidase Identifies Co-Clustering Molecules in Individual Lipid Raft Domains	PLOS ONE			English	Article							ENZYME-MEDIATED ACTIVATION; DECAY-ACCELERATING FACTOR; CELL-SURFACE; INTRACELLULAR TRAFFICKING; SIGNAL-TRANSDUCTION; MEMBRANE; PROTEINS; TRANSPORT; OLIGOMERIZATION; MECHANISMS	Lipid rafts that are enriched in glycosylphosphatidylinositol (GPI)-anchored proteins serve as a platform for important biological events. To elucidate the molecular mechanisms of these events, identification of co-clustering molecules in individual raft domains is required. Here we describe an approach to this issue using the recently developed method termed enzyme-mediated activation of radical source (EMARS), by which molecules in the vicinity within 300 nm from horseradish peroxidase (HRP) set on the probed molecule are labeled. GPI-anchored HRP fusion proteins (HRP-GPIs), in which the GPI attachment signals derived from human decay accelerating factor and Thy-1 were separately connected to the C-terminus of HRP, were expressed in HeLa S3 cells, and the EMARS reaction was catalyzed by these expressed HRP-GPIs under a living condition. As a result, these different HRP-GPIs had differences in glycosylation and localization and formed distinct clusters. This novel approach distinguished molecular clusters associated with individual GPI-anchored proteins, suggesting that it can identify co-clustering molecules in individual raft domains.	[Miyagawa-Yamaguchi, Arisa; Kotani, Norihiro; Honke, Koichi] Kochi Univ, Sch Med, Kochi Syst Glycobiol Ctr, Nankoku, Kochi, Japan; [Miyagawa-Yamaguchi, Arisa; Kotani, Norihiro; Honke, Koichi] Kochi Univ, Sch Med, Ctr Innovate & Translat Med, Nankoku, Kochi, Japan; [Kotani, Norihiro] Saitama Med Univ, Dept Biochem, Moroyama, Saitama, Japan; [Honke, Koichi] Kochi Univ, Sch Med, Dept Biochem, Nankoku, Kochi, Japan	Kochi University; Kochi University; Saitama Medical University; Kochi University	Honke, K (corresponding author), Kochi Univ, Sch Med, Kochi Syst Glycobiol Ctr, Nankoku, Kochi, Japan.	khonke@kochi-u.ac.jp		Kotani, Norihiro/0000-0003-3739-6478				Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Chen R, 2002, J CELL BIOCHEM, V84, P68, DOI 10.1002/jcb.1267; CONNOLLY CN, 1994, J CELL BIOL, V127, P641, DOI 10.1083/jcb.127.3.641; DAVITZ MA, 1986, J EXP MED, V163, P1150, DOI 10.1084/jem.163.5.1150; De Angelis DA, 1998, P NATL ACAD SCI USA, V95, P12312, DOI 10.1073/pnas.95.21.12312; Eisenhaber B, 1998, PROTEIN ENG, V11, P1155, DOI 10.1093/protein/11.12.1155; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Fujita A, 2009, BBA-MOL CELL BIOL L, V1791, P388, DOI 10.1016/j.bbalip.2009.01.008; Fujita M, 2012, BBA-MOL CELL BIOL L, V1821, P1050, DOI 10.1016/j.bbalip.2012.01.004; Fujita M, 2009, CELL, V139, P352, DOI 10.1016/j.cell.2009.08.040; Harris TJC, 2002, BIOESSAYS, V24, P996, DOI 10.1002/bies.10172; Hashimoto N, 2012, PROTEOMICS, V12, P3154, DOI 10.1002/pmic.201200279; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Honke K, 2012, SENSORS-BASEL, V12, P16037, DOI 10.3390/s121216037; Honke K, 2011, J NEUROCHEM, V116, P690, DOI 10.1111/j.1471-4159.2010.07027.x; Imjeti NS, 2011, MOL BIOL CELL, V22, P4621, DOI 10.1091/mbc.E11-04-0320; Ishiura Y, 2010, BIOCHEM BIOPH RES CO, V396, P329, DOI 10.1016/j.bbrc.2010.04.092; Jiang SL, 2012, PROTEOMICS, V12, P54, DOI 10.1002/pmic.201100551; Kotani N, 2008, P NATL ACAD SCI USA, V105, P7405, DOI 10.1073/pnas.0710346105; Kotani N, 2012, J BIOL CHEM, V287, P37109, DOI 10.1074/jbc.M112.404178; Kusumi A, 2012, SEMIN CELL DEV BIOL, V23, P126, DOI 10.1016/j.semcdb.2012.01.018; Legler DF, 2004, FASEB J, V18, P73, DOI 10.1096/fj.03-1338fje; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Magalhaes AC, 2002, J BIOL CHEM, V277, P33311, DOI 10.1074/jbc.M203661200; Matsui T, 2003, APPL MICROBIOL BIOT, V62, P517, DOI 10.1007/s00253-003-1273-z; Mayor S, 1998, EMBO J, V17, P4626, DOI 10.1093/emboj/17.16.4626; MORGAN BP, 1993, EUR J IMMUNOL, V23, P2841, DOI 10.1002/eji.1830231118; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Paladino S, 2004, J CELL BIOL, V167, P699, DOI 10.1083/jcb.200407094; Paladino S, 2008, J CELL SCI, V121, P4001, DOI 10.1242/jcs.036038; Schikorski T, 2007, J NEUROSCI METH, V165, P210, DOI 10.1016/j.jneumeth.2007.06.004; SHENOYSCARIA AM, 1992, J IMMUNOL, V149, P3535; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Solomon KR, 1996, P NATL ACAD SCI USA, V93, P6053, DOI 10.1073/pnas.93.12.6053; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Vereb G, 2003, P NATL ACAD SCI USA, V100, P8053, DOI 10.1073/pnas.1332550100; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; WELINDER KG, 1976, FEBS LETT, V72, P19, DOI 10.1016/0014-5793(76)80804-6; Yamashita R, 2011, J BIOCHEM, V149, P347, DOI 10.1093/jb/mvq148; Yao F, 1998, HUM GENE THER, V9, P1939, DOI 10.1089/hum.1998.9.13-1939	45	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93054	10.1371/journal.pone.0093054	http://dx.doi.org/10.1371/journal.pone.0093054			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671047	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000108
J	Rychlowska, M; Canadas, E; Wood, A; Krumhuber, EG; Fischer, A; Niedenthal, PM				Rychlowska, Magdalena; Canadas, Elena; Wood, Adrienne; Krumhuber, Eva G.; Fischer, Agneta; Niedenthal, Paula M.			Blocking Mimicry Makes True and False Smiles Look the Same	PLOS ONE			English	Article							FACIAL MIMICRY; PERCEPTION; DYNAMICS; RECOGNITION; EXPRESSION; DUCHENNE; ENJOYMENT; EMOTION	Recent research suggests that facial mimicry underlies accurate interpretation of subtle facial expressions. In three experiments, we manipulated mimicry and tested its role in judgments of the genuineness of true and false smiles. Experiment 1 used facial EMG to show that a new mouthguard technique for blocking mimicry modifies both the amount and the time course of facial reactions. In Experiments 2 and 3, participants rated true and false smiles either while wearing mouthguards or when allowed to freely mimic the smiles with or without additional distraction, namely holding a squeeze ball or wearing a finger-cuff heart rate monitor. Results showed that blocking mimicry compromised the decoding of true and false smiles such that they were judged as equally genuine. Together the experiments highlight the role of facial mimicry in judging subtle meanings of facial expressions.	[Rychlowska, Magdalena; Wood, Adrienne; Niedenthal, Paula M.] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA; [Rychlowska, Magdalena] Univ Blaise Pascal, Clermont Ferrand, France; [Canadas, Elena] Univ Neuchatel, Inst Psychol Travail & Org, Neuchatel, Switzerland; [Krumhuber, Eva G.] UCL, Div Psychol & Language Sci, London, England; [Fischer, Agneta] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands	University of Wisconsin System; University of Wisconsin Madison; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); University of Neuchatel; University of London; University College London; University of Amsterdam	Rychlowska, M (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	magdalena.rychlowska@gmail.com	Wood, Adrienne/AAQ-2072-2020	Wood, Adrienne/0000-0003-4773-4493; Krumhuber, Eva/0000-0003-1894-2517	Open Research Area (ORA) in Europe for the Social Sciences (ANR-DFG-ESRC-NOW); Division Of Behavioral and Cognitive Sci [1251101] Funding Source: National Science Foundation	Open Research Area (ORA) in Europe for the Social Sciences (ANR-DFG-ESRC-NOW)(French National Research Agency (ANR)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported by a grant from Open Research Area (ORA) in Europe for the Social Sciences (ANR-DFG-ESRC-NOW) - "The Body in Embodiment: Specifying the Role of Peripheral Input in Grounded Cognition''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cross KA, 2013, NEUROIMAGE, V83, P493, DOI 10.1016/j.neuroimage.2013.06.060; Cross KE, 2013, THESIS; Dimberg U, 1998, SCAND J PSYCHOL, V39, P39, DOI 10.1111/1467-9450.00054; Dimberg U, 1997, J PSYCHOPHYSIOL, V11, P115; EKMAN P, 1990, J PERS SOC PSYCHOL, V58, P342, DOI 10.1037/0022-3514.58.2.342; Ekman P., 2002, MANUAL INVESTIGATORS; Ekman P., 1972, NEBRASKA S MOTIVATIO, P207, DOI DOI 10.1037/0022-3514.53.4.712; Ekman P., 2006, DARWIN FACIAL EXPRES, P169, DOI DOI 10.1371/J0URNAL.P0NE.0014679; Elfenbein HA, 2007, EMOTION, V7, P131, DOI 10.1037/1528-3542.7.1.131; FRANK MG, 1993, J PERS SOC PSYCHOL, V64, P83, DOI 10.1037/0022-3514.64.1.83; FRANK MG, 1993, HUMOR, V6, P9, DOI 10.1515/humr.1993.6.1.9; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; GEORGE MS, 1993, J NEUROPSYCH CLIN N, V5, P384; Hennenlotter A, 2005, NEUROIMAGE, V26, P581, DOI 10.1016/j.neuroimage.2005.01.057; Hennenlotter A, 2009, CEREB CORTEX, V19, P537, DOI 10.1093/cercor/bhn104; Hess U, 2013, PERS SOC PSYCHOL REV, V17, P142, DOI 10.1177/1088868312472607; Jabbi M, 2008, EMOTION, V8, P775, DOI 10.1037/a0014194; Johnston L, 2010, BRIT J SOC PSYCHOL, V49, P107, DOI 10.1348/014466609X412476; Kamen G, 2009, ESSENTIALS ELECTROMY; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Konrad P., 2005, ELECTROMYOGRAPHY, P1, DOI DOI 10.1016/J.JACC.2008.05.066; Krumhuber E, 2005, J NONVERBAL BEHAV, V29, P3, DOI 10.1007/s10919-004-0887-x; Krumhuber E, 2007, EMOTION, V7, P730, DOI 10.1037/1528-3542.7.4.730; Krumhuber E, 2007, J NONVERBAL BEHAV, V31, P39, DOI 10.1007/s10919-006-0019-x; Krumhuber EG, 2014, J NONVERBAL BEHAV, V38, P1, DOI 10.1007/s10919-013-0167-8; Krumhuber EG, 2009, EMOTION, V9, P807, DOI 10.1037/a0017844; LaFrance M., 2011, LIP SERVICE SMILES L; Littlewort G., 2011, Proceedings 2011 IEEE International Conference on Automatic Face & Gesture Recognition (FG 2011), P298, DOI 10.1109/FG.2011.5771414; Manera V, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00006; Maringer M, 2011, EMOTION, V11, P181, DOI 10.1037/a0022596; Meister IG, 2012, EUR J NEUROSCI, V36, P2391, DOI 10.1111/j.1460-9568.2012.08134.x; Messinger DS, 2008, J NONVERBAL BEHAV, V32, P133, DOI 10.1007/s10919-008-0048-8; Miellet S., 2012, J VISION, V12, P824, DOI DOI 10.1167/12.9.824; Myers L., 2004, ENCY STAT SCI, DOI [10.1002/0471667196.ess5050, DOI 10.1002/0471667196.ESS5050]; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Niedenthal PM, 2010, BEHAV BRAIN SCI, V33, P417, DOI 10.1017/S0140525X10000865; Niedenthal PM, 2001, COGNITION EMOTION, V15, P853, DOI 10.1080/02699930143000194; Oberman LM, 2007, SOC NEUROSCI-UK, V2, P167, DOI 10.1080/17470910701391943; Pierce M, 2009, ALL HANDS M TEMP DYN; Pitcher D, 2008, J NEUROSCI, V28, P8929, DOI 10.1523/JNEUROSCI.1450-08.2008; Ponari M, 2012, EMOTION, V12, P1398, DOI 10.1037/a0028588; Proffitt DR, 2006, PERSPECT PSYCHOL SCI, V1, P110, DOI 10.1111/j.1745-6916.2006.00008.x; Pulvermuller F, 2010, NAT REV NEUROSCI, V11, P351, DOI 10.1038/nrn2811; Shore DM, 2011, EMOTION, V11, P169, DOI 10.1037/a0022601; Slessor G, EMOTION IN PRESS; SMITH JD, 1995, NEUROPSYCHOLOGIA, V33, P1433, DOI 10.1016/0028-3932(95)00074-D; STRACK F, 1988, J PERS SOC PSYCHOL, V54, P768, DOI 10.1037/0022-3514.54.5.768; Surakka V, 1998, INT J PSYCHOPHYSIOL, V29, P23, DOI 10.1016/S0167-8760(97)00088-3; Vernon D, 2008, IMAGE VISION COMPUT, V26, P127, DOI 10.1016/j.imavis.2005.08.009; Wang Y, 2011, J NEUROSCI, V31, P12001, DOI 10.1523/JNEUROSCI.0845-11.2011; Whitehill J, 2009, IEEE T PATTERN ANAL, V31, P2106, DOI 10.1109/TPAMI.2009.42	52	68	68	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e90876	10.1371/journal.pone.0090876	http://dx.doi.org/10.1371/journal.pone.0090876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SR	24670316	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000333677000011
J	Head, GA; Andrianopoulos, N; McGrath, BP; Martin, CA; Carrington, MJ; Lukoshkova, EV; Davern, PJ; Jennings, GL; Reid, CM				Head, Geoffrey A.; Andrianopoulos, Nick; McGrath, Barry P.; Martin, Catherine A.; Carrington, Melinda J.; Lukoshkova, Elena V.; Davern, Pamela J.; Jennings, Garry L.; Reid, Christopher M.			Predictors of Mean Arterial Pressure Morning Rate of Rise and Power Function in Subjects Undergoing Ambulatory Blood Pressure Recording	PLOS ONE			English	Article							DOUBLE-LOGISTIC ANALYSIS; RECEPTOR KNOCKOUT MICE; CIRCADIAN VARIATION; OXIDATIVE STRESS; CEREBROVASCULAR-DISEASE; CHOLESTEROL LEVELS; SURGE; SILENT; LIPIDS; ONSET	Background: We determined clinical predictors of the rate of rise (RoR) in blood pressure in the morning as well as a novel measure of the power of the BP surge (BPpower) derived from ambulatory blood pressure recordings. Methods: BPpower and RoR were calculated from 409 ambulatory blood pressure (ABP) recordings from subjects attending a cardiovascular risk clinic. Anthropometric data, blood biochemistry, and history were recorded. The 409 subjects were 20-82 years old (average 57, SD = 13), 46% male, 9% with hypertension but not on medication and 34% on antihypertensive medication. Results: Average RoR was 11.1 mmHg/hour (SD = 8) and BPpower was 273 mmHg(2)/hour (SD = 235). Only cholesterol, low density lipoprotein and body mass index (BMI) were associated with higher BPpower and RoR (P < 0.05) from 25 variables assessed. BPpower was lower in those taking beta-blockers or diuretics. Multivariate analysis identified that only BMI was associated with RoR (4.2% increase/unit BMI, P = 0.020) while cholesterol was the only remaining associated variable with BPpower (17.5% increase/mmol/L cholesterol, P = 0.047). A follow up of 213 subjects with repeated ABP after an average 1.8 years identified that baseline cholesterol was the only predictor for an increasing RoR and BPpower (P < 0.05). 37 patients who commenced statin subsequently had lower BPpower whereas 90 age and weight matched controls had similar BPpower on follow-up. Conclusions: Cholesterol is an independent predictor of a greater and more rapid rise in morning BP as well as of further increases over several years. Reduction of cholesterol with statin therapy is very effective in reducing the morning blood pressure surge.	[Head, Geoffrey A.; Carrington, Melinda J.; Davern, Pamela J.; Jennings, Garry L.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Head, Geoffrey A.; Carrington, Melinda J.; Davern, Pamela J.; Jennings, Garry L.] Alfred Hosp, Dept Cardiovasc Med, Melbourne, Vic, Australia; [Andrianopoulos, Nick; Reid, Christopher M.] Monash Univ, NHMRC Ctr Clin Res Excellence Therapeut, Melbourne, Vic 3004, Australia; [McGrath, Barry P.; Martin, Catherine A.] Monash Hlth Dandenong Australia, Melbourne, Vic, Australia; [McGrath, Barry P.; Martin, Catherine A.] Monash Univ, Melbourne, Vic 3004, Australia; [Martin, Catherine A.] Australian Catholic Univ, Fitzroy, Vic, Australia; [Lukoshkova, Elena V.] Natl Cardiol Res Ctr, Moscow, Russia	Baker Heart and Diabetes Institute; Florey Institute of Neuroscience & Mental Health; Monash University; Monash University; Australian Catholic University; National Medical Research Center of Cardiology	Head, GA (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia.	geoff.head@baker.edu.au	Reid, Christopher M/AAP-8135-2021; Lukoshkova, Elena/ABG-1274-2020; Head, Geoffrey A./B-2177-2010; Jennings, Garry/B-3914-2009	Head, Geoffrey A./0000-0002-7623-137X; Lukoshkova, Elena/0000-0002-1564-3469; Carrington, Melinda J/0000-0003-3865-1645; Jennings, Garry/0000-0002-7865-5483; Reid, Christopher/0000-0001-9173-3944	National Health & Medical Research Council of Australia (NHMRC) [317826, 1049610, 546272]; Baker IDI Heart and Diabetes Institute; Victorian Government's OIS Program; NHMRC [1002186, 1045862, 1032934]; NHMRC/NHF [1012881]	National Health & Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Baker IDI Heart and Diabetes Institute; Victorian Government's OIS Program; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC/NHF(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health & Medical Research Council of Australia (NHMRC, www.nhmrc.gov.au) (project grant 317826 and 1049610; program grant 546272), the Baker IDI Heart and Diabetes Institute, and in part by the Victorian Government's OIS Program (http://www.business.vic.gov.au/industries/science-technology-and-innovation/programs/medical-research-operational-infrastructure-program). Investigators were supported by a NHMRC Principal Research Fellowship (1002186 to GAH), Senior Research Fellowship (1045862 to CMR), NHMRC/NHF Postdoctoral Fellowship 1012881 to PJD, and NHMRC career development award 1032934 to MJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGENTINO C, 1990, STROKE, V21, P387, DOI 10.1161/01.STR.21.3.387; BEVAN AT, 1969, CLIN SCI, V36, P329; BONAA KH, 1991, CIRCULATION, V83, P1305, DOI 10.1161/01.CIR.83.4.1305; Borghi C, 2007, J HYPERTENS, V25, P2051, DOI 10.1097/HJH.0b013e32827759a6; Campos RR, 2011, CLIN EXP PHARMACOL P, V38, P144, DOI 10.1111/j.1440-1681.2010.05437.x; de Oliveira J, 2011, NEUROSCIENCE, V197, P99, DOI 10.1016/j.neuroscience.2011.09.009; Ekstedt M, 2004, PSYCHOSOM MED, V66, P925, DOI 10.1097/01.psy.0000145821.25453.f7; Elliott WJ, 1998, STROKE, V29, P992, DOI 10.1161/01.STR.29.5.992; Evangelho JS, 2011, AUTON NEUROSCI-BASIC, V159, P98, DOI 10.1016/j.autneu.2010.07.010; Fujita M, 2005, HYPERTENSION, V45, P1165, DOI 10.1161/01.HYP.0000165690.85505.37; Fujita M, 2007, HYPERTENSION, V50, P360, DOI 10.1161/HYPERTENSIONAHA.107.091009; Head GA, 2005, J APPL PHYSIOL, V98, P1511, DOI 10.1152/japplphysiol.00647.2004; Head GA, 2004, J HYPERTENS, V22, P2075, DOI 10.1097/00004872-200411000-00008; Head GA, 2008, CLIN EXP PHARMACOL P, V35, P516, DOI 10.1111/j.1440-1681.2008.04908.x; Head GA, 2006, AM J HYPERTENS, V19, P1010, DOI 10.1016/j.amjhyper.2006.03.014; Head GA, 2010, AM J HYPERTENS, V23, P1074, DOI 10.1038/ajh.2010.126; KANNEL WB, 1985, AM HEART J, V110, P1100, DOI 10.1016/0002-8703(85)90224-8; Kario K, 1996, ARTERIOSCL THROM VAS, V16, P734, DOI 10.1161/01.ATV.16.6.734; Kario K, 2004, AM J HYPERTENS, V17, P668, DOI 10.1016/j.amjhyper.2004.04.001; Kario K, 2003, J CARDIOVASC PHARM, V41, pS61; Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA; Kario K, 2006, AM J HYPERTENS, V19, P1018, DOI 10.1016/j.amjhyper.2006.05.014; Kario K, 2010, HYPERTENSION, V56, P765, DOI 10.1161/HYPERTENSIONAHA.110.157149; Kishi T, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/406897; Lambert E, 2013, AM J HYPERT IN PRESS; Lambert E, 2013, AM J HYPERTENS, V26, P250, DOI 10.1093/ajh/hps016; MACMAHON SW, 1985, ARTERIOSCLEROSIS, V5, P391, DOI 10.1161/01.ATV.5.4.391; Marques FZ, 2011, PHYSIOL GENOMICS, V43, P766, DOI 10.1152/physiolgenomics.00009.2011; Martin CA, 2013, J HUM HYPERTENS, V27, P315, DOI 10.1038/jhh.2012.44; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; NADEMANEE K, 1987, AM J CARDIOL, V60, P494, DOI 10.1016/0002-9149(87)90292-X; Nagae A, 2009, CIRCULATION, V119, P978, DOI 10.1161/CIRCULATIONAHA.108.824730; Nakazato T, 1998, J AUTONOM NERV SYST, V70, P32, DOI 10.1016/S0165-1838(98)00024-1; Nickenig G, 1997, AM J PHYSIOL-HEART C, V272, pH2701, DOI 10.1152/ajpheart.1997.272.6.H2701; Oliveira-Sales EB, 2009, AM J HYPERTENS, V22, P484, DOI 10.1038/ajh.2009.17; Paim BA, 2008, FREE RADICAL BIO MED, V44, P444, DOI 10.1016/j.freeradbiomed.2007.10.005; PANZA JA, 1991, NEW ENGL J MED, V325, P986, DOI 10.1056/NEJM199110033251402; Shaw JA, 2001, CIRCULATION, V103, P806, DOI 10.1161/01.CIR.103.6.806; SIRGO MA, 1988, ARCH INTERN MED, V148, P2547, DOI 10.1001/archinte.148.12.2547; Strehlow K, 2000, ANN MED, V32, P386, DOI 10.3109/07853890008995944; WILLICH SN, 1990, AM J CARDIOL, V66, pG15, DOI 10.1016/0002-9149(90)90387-G; WILLICH SN, 1987, AM J CARDIOL, V60, P801, DOI 10.1016/0002-9149(87)91027-7	42	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93186	10.1371/journal.pone.0093186	http://dx.doi.org/10.1371/journal.pone.0093186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667944	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600156
J	Jamin, Y; Glass, L; Hallsworth, A; George, R; Koh, DM; Pearson, ADJ; Chesler, L; Robinson, SP				Jamin, Yann; Glass, Laura; Hallsworth, Albert; George, Rani; Koh, Dow-Mu; Pearson, Andrew D. J.; Chesler, Louis; Robinson, Simon P.			Intrinsic Susceptibility MRI Identifies Tumors with ALK(F1174L) Mutation in Genetically-Engineered Murine Models of High-Risk Neuroblastoma	PLOS ONE			English	Article							VASCULAR ARCHITECTURE; ACTIVATING MUTATIONS; ALK KINASE; MYCN; ANGIOGENESIS; HYPOXIA; CANCER; RECEPTOR; BIOLOGY	The early identification of children presenting ALK(F1174L)-mutated neuroblastoma, which are associated with resistance to the promising ALK inhibitor crizotinib and a marked poorer prognosis, has become a clinical priority. In comparing the radiology of the novel Th-ALK(F1174L)/Th-MYCN and the well-established Th-MYCN genetically-engineered murine models of neuroblastoma using MRI, we have identified a marked ALK(F1174L)-driven vascular phenotype. We demonstrate that quantitation of the transverse relaxation rate R-2* (s(-1)) using intrinsic susceptibility-MRI under baseline conditions and during hyperoxia, can robustly discriminate this differential vascular phenotype, and identify MYCN-driven tumors harboring the ALK(F1174L) mutation with high specificity and selectivity. Intrinsic susceptibility-MRI could thus potentially provide a non-invasive and clinically-exploitable method to help identifying children with MYCN-driven neuroblastoma harboring the ALK(F1174L) mutation at the time of diagnosis.	[Jamin, Yann; Glass, Laura; Koh, Dow-Mu; Chesler, Louis; Robinson, Simon P.] Inst Canc Res, Div Radiotherapy & Imaging, London SW3 6JB, England; [Jamin, Yann; Glass, Laura; Koh, Dow-Mu; Chesler, Louis; Robinson, Simon P.] Royal Marsden NHS Fdn Trust, London, England; [Glass, Laura; Hallsworth, Albert; Chesler, Louis] Inst Canc Res, Div Canc Therapeut, London SW3 6JB, England; [Glass, Laura; Chesler, Louis] Inst Canc Res, Div Mol Pathol, London SW3 6JB, England; [Glass, Laura; Pearson, Andrew D. J.; Chesler, Louis] Inst Canc Res, Div Clin Studies, London SW3 6JB, England; [George, Rani] Dana Farber Canc Inst, Dept Pediat Haematol & Oncol, Boston, MA 02115 USA; [George, Rani] Harvard Univ, Childrens Hosp, Sch Med, Boston, MA 02115 USA	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard Medical School	Jamin, Y (corresponding author), Inst Canc Res, Div Radiotherapy & Imaging, London SW3 6JB, England.	yann.jamin@icr.ac.uk	George, Rani/AAG-7635-2019	Jamin, yann/0000-0003-0350-3757; Koh, Dow-Mu/0000-0001-7654-8011; Robinson, Simon/0000-0003-4101-7274; Chesler, Louis/0000-0001-7842-2068; Glass, Laura/0000-0003-2072-7365	Institute of Cancer Research CR-UK; EPSRC Cancer Imaging Centre; MRC; Department of Health (England) [C1060/A10334]; NHS; Cancer Research-UK project grants [C16412/A6269]; Wellcome Trust [091763Z/10/Z]; Medical Research Council [G1000391]; Neuroblastoma Society; SPARKS charity; Medical Research Council NC3R [G1000121/94513]; National Institutes of Health [R01 CA148688]; Cancer Research UK [14610, 16464] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H046526/1] Funding Source: researchfish; Medical Research Council [G0701533] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA148688] Funding Source: NIH RePORTER; EPSRC [EP/H046526/1] Funding Source: UKRI; MRC [G0701533] Funding Source: UKRI	Institute of Cancer Research CR-UK(Cancer Research UK); EPSRC Cancer Imaging Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health (England); NHS; Cancer Research-UK project grants; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Neuroblastoma Society; SPARKS charity; Medical Research Council NC3R(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors acknowledge support received for The Institute of Cancer Research CR-UK (http://www.cancerresearchuk.org/) and EPSRC (http://www.epsrc.ac.uk) Cancer Imaging Centre, in association with the MRC (http://www.epsrc.ac.uk) and Department of Health (England) (https://www.gov.uk/government/organisations/department-of-health) grant C1060/A10334, and NHS funding to the NIHR Biomedical Research Centre. This work was supported by Cancer Research-UK project grants C16412/A6269, The Wellcome Trust (grant #091763Z/10/Z) (http://www.wellcome.ac.uk), and the Medical Research Council (grant #G1000391). Pre-clinical development of the TH-ALKF1174L/TH-MYCN model was funded by grants from The Neuroblastoma Society (http://www.nsoc.co.uk), the SPARKS charity (http://www.sparks.org.uk), Medical Research Council NC3R (grant #G1000121/94513)(http://www.nc3rs.org.uk/), and the National Institutes of Health (R01 CA148688) (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsson A, 2002, CIRCULATION, V105, P112, DOI 10.1161/hc0102.101437; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Berry T, 2012, CANCER CELL, V22, P117, DOI 10.1016/j.ccr.2012.06.001; Bresler SC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002950; Brisse HJ, 2011, RADIOLOGY, V261, P243, DOI 10.1148/radiol.11101352; Carpenter EL, 2012, ONCOGENE, V31, P4888, DOI 10.1038/onc.2012.208; Carpenter EL, 2012, NAT REV CLIN ONCOL, V9, P391, DOI 10.1038/nrclinonc.2012.72; Chantrain CF, 2004, CANCER RES, V64, P1675, DOI 10.1158/0008-5472.CAN-03-0160; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Chesler L, 2011, SEMIN CANCER BIOL, V21, P245, DOI 10.1016/j.semcancer.2011.09.011; Christen T, 2012, RADIOLOGY, V262, P495, DOI 10.1148/radiol.11110518; Comstock JM, 2009, AM J CLIN PATHOL, V132, P69, DOI 10.1309/AJCPN76VTIGWPOAG; De Brouwer S, 2010, CLIN CANCER RES, V16, P4353, DOI 10.1158/1078-0432.CCR-09-2660; Di Paolo D, 2011, MOL THER, V19, P2201, DOI 10.1038/mt.2011.142; Fox E, 2010, J CLIN ONCOL, V28, P5174, DOI 10.1200/JCO.2010.30.9674; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Goo HW, 2010, EUR J RADIOL, V75, P306, DOI 10.1016/j.ejrad.2009.09.014; Heukamp LC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003967; Hoskin PJ, 2007, INT J RADIAT ONCOL, V68, P1065, DOI 10.1016/j.ijrobp.2007.01.018; Jamin Y, 2013, RADIOLOGY, V266, P130, DOI 10.1148/radiol.12120128; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; McDonald DM, 2003, NAT MED, V9, P713, DOI 10.1038/nm0603-713; McPhail LD, 2010, RADIOLOGY, V254, P110, DOI 10.1148/radiol.2541090395; Meitar D, 1996, J CLIN ONCOL, V14, P405, DOI 10.1200/JCO.1996.14.2.405; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Robinson SP, 2003, J MAGN RESON IMAGING, V17, P445, DOI 10.1002/jmri.10274; Robinson SP, 2006, NEW TECHNIQUES ONCOL, P257; Sasaki T, 2010, EUR J CANCER, V46, P1773, DOI 10.1016/j.ejca.2010.04.002; Stephens MA, 1986, GOODNESS OF FIT TECH; Tatum JL, 2006, INT J RADIAT BIOL, V82, P699, DOI 10.1080/09553000601002324; Walker-Samuel S, 2010, MAGN RESON MED, V64, P914, DOI 10.1002/mrm.22478; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Zhu SZ, 2012, CANCER CELL, V21, P362, DOI 10.1016/j.ccr.2012.02.010	35	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92886	10.1371/journal.pone.0092886	http://dx.doi.org/10.1371/journal.pone.0092886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667968	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600099
J	Laurence, A; Lumineau, S; Calandreau, L; Arnould, C; Leterrier, C; Boissy, A; Houdelier, C				Laurence, Agathe; Lumineau, Sophie; Calandreau, Ludovic; Arnould, Cecile; Leterrier, Christine; Boissy, Alain; Houdelier, Cecilia			Short- and Long-Term Effects of Unpredictable Repeated Negative Stimuli on Japanese Quail's Fear of Humans	PLOS ONE			English	Article							DOMESTIC CHICKS FEAR; HUMAN-BEINGS; CHRONIC STRESS; COTURNIX-COTURNIX; EMOTIONAL REACTIVITY; BEHAVIORAL-RESPONSES; MODIFY RESPONSES; TONIC IMMOBILITY; HUMAN CONTACT; LAYING HENS	Numerous aversive events occur in poultry production, and if repeated and unpredictable, can result in an impaired welfare. Some events such as handling can be perceived negatively and it is of interest to understand how humans' behaviour could affect poultry's behaviours and especially its avoidance of humans. Our aim was to evaluate short-and long-lasting effects of a 3-week procedure involving unpredictable repeated negative stimuli (URNS) applied during the post-juvenile period on quail's reactivity to humans. We compared the reactions of two sets of quail: URNS was applied to one set (treated quail) and the other set was left undisturbed (control quail). When two weeks old, treated quail were exposed to a variety of negative stimuli, either applied automatically or involving human presence. One and seven weeks after the termination of the procedure, the reactivity of control and treated quail to a passive human being was evaluated. Furthermore, the experimenter with her hand on a trough containing a mealworm assessed the propensity of quail of both groups to habituate to feed close to a human being. In the presence of a seated observer, treated quail were more inhibited and more alert than control quail. Likewise, seven weeks after the end of the URNS procedure, more treated than control quail adopted a fear posture. Moreover, whereas control quail spent as much time in the different areas of their cages, treated quail spent more time in the rear part of their cages. Finally, whereas control quail habituated gradually to feed near the experimenter's hand, treated quail did not. All these tests evidence negative short-and long-term effects on treated quail's reactivity to a passive human being and on their habituation to a human being when her presence is positively reinforced. This highlights the importance of young poultry's experience with humans in production.	[Laurence, Agathe; Lumineau, Sophie; Houdelier, Cecilia] Univ Rennes 1, CNRS, UMR 6552, Ethos, Rennes, France; [Calandreau, Ludovic; Arnould, Cecile; Leterrier, Christine] INRA, UMR Physiol Reprod & Comportements 85, F-37380 Nouzilly, France; [Calandreau, Ludovic; Arnould, Cecile; Leterrier, Christine] CNRS, UMR 6175, Nouzilly, France; [Calandreau, Ludovic; Arnould, Cecile; Leterrier, Christine] Univ Tours, Tours, France; [Calandreau, Ludovic; Arnould, Cecile; Leterrier, Christine] IFCE, Nouzilly, France; [Boissy, Alain] INRA Vet Agro Sup, INRA UMR 1213, Unite Rech Herbivores, St Genes Champanelle, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; Universite de Tours; INRAE	Lumineau, S (corresponding author), Univ Rennes 1, CNRS, UMR 6552, Ethos, Rennes, France.	sophie.lumineau@univ-rennes1.fr	Leterrier, Christine/AAY-7201-2020	Lumineau, Sophie/0000-0002-2076-9947	French National Research Agency (ANR), Emofarm Program [ANR-09BLAN-0339]	French National Research Agency (ANR), Emofarm Program(French National Research Agency (ANR))	This work was supported by the French National Research Agency (ANR), Emofarm Program (ANR-09BLAN-0339). Website: http://www.agence-nationale-recherche.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNETT JL, 1994, APPL ANIM BEHAV SCI, V41, P87, DOI 10.1016/0168-1591(94)90054-X; BARNETT JL, 1993, APPL ANIM BEHAV SCI, V37, P139, DOI 10.1016/0168-1591(93)90106-Y; BARNETT JL, 1992, BRIT POULTRY SCI, V33, P699, DOI 10.1080/00071669208417510; Bertin A, 2004, APPL ANIM BEHAV SCI, V89, P215, DOI 10.1016/j.applanim.2004.06.004; BLOKHUIS HJ, 1984, APPL ANIM BEHAV SCI, V12, P289, DOI 10.1016/0168-1591(84)90121-7; BLOKHUIS HJ, 1983, WORLD POULTRY SCI J, V39, P33, DOI 10.1079/WPS19830003; Bredbacka P., 1988, Proceedings of the International Congress on Applied Ethology in Farm Animals, Skara, 1988., P74; Calandreau L, 2011, BEHAV BRAIN RES, V225, P505, DOI 10.1016/j.bbr.2011.08.010; Calandreau L, 2011, BEHAV BRAIN RES, V217, P104, DOI 10.1016/j.bbr.2010.10.004; Cransberg PH, 2000, BRIT POULTRY SCI, V41, P272, DOI 10.1080/713654939; Davis H, 2001, BRIT POULTRY SCI, V42, P276, DOI 10.1080/00071660120048564; Destrez A, 2013, APPL ANIM BEHAV SCI, V148, P28, DOI 10.1016/j.applanim.2013.07.016; DUNCAN IJH, 1990, CURR T VET, V53, P121; Fairhurst GD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017663; HEMSWORTH PH, 1994, APPL ANIM BEHAV SCI, V41, P101, DOI 10.1016/0168-1591(94)90055-8; Henry S, 2006, DEV PSYCHOBIOL, V48, P712, DOI 10.1002/dev.20189; HUGHES BO, 1976, BRIT POULTRY SCI, V17, P135, DOI 10.1080/00071667608416258; Jones R. B., 1995, INT J COMP PSYCHOL, V8, P88; JONES RB, 1993, ANIM BEHAV, V46, P991, DOI 10.1006/anbe.1993.1280; Jones RB, 1996, WORLD POULTRY SCI J, V52, P131, DOI 10.1079/WPS19960013; JONES RB, 1994, APPL ANIM BEHAV SCI, V42, P129, DOI 10.1016/0168-1591(94)90153-8; JONES RB, 1993, APPL ANIM BEHAV SCI, V36, P185, DOI 10.1016/0168-1591(93)90009-E; Laurence A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047475; Le Neindre P, 1994, RUMINANTS HOMME VIEU, P91; Martin LB, 2005, CAN J ZOOL, V83, P780, DOI 10.1139/Z05-062; Mignon-Grasteau S, 2003, BEHAV PROCESS, V61, P69, DOI 10.1016/S0376-6357(02)00162-6; MILLS AD, 1991, J COMP PSYCHOL, V105, P25, DOI 10.1037/0735-7036.105.1.25; Mills AD, 2000, APPL ANIM BEHAV SCI, V69, P125, DOI 10.1016/S0168-1591(00)00126-X; MURPHY LB, 1978, APPL ANIM ETHOL, V4, P5, DOI 10.1016/0304-3762(78)90089-5; MURPHY LB, 1977, APPL ANIM ETHOL, V3, P321, DOI 10.1016/0304-3762(77)90057-8; MURPHY ME, 1992, ORNIS SCAND, V23, P304, DOI 10.2307/3676654; Nazar FN, 2011, STRESS, V14, P166, DOI 10.3109/10253890.2010.523093; Piato AL, 2011, PROG NEURO-PSYCHOPH, V35, P561, DOI 10.1016/j.pnpbp.2010.12.018; Rich EL, 2005, AM J PHYSIOL-REG I, V288, pR1628, DOI 10.1152/ajpregu.00484.2004; Richard S, 2010, BEHAV PROCESS, V85, P18, DOI 10.1016/j.beproc.2010.05.009; Rushen J, 1999, APPL ANIM BEHAV SCI, V65, P285, DOI 10.1016/S0168-1591(99)00089-1; Saint-Dizier H, 2008, APPL ANIM BEHAV SCI, V112, P297, DOI 10.1016/j.applanim.2007.09.005; SAINTJALME M, 1995, IBIS, V137, P570; Satterlee DG, 1997, POULTRY SCI, V76, P469, DOI 10.1093/ps/76.3.469; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; WINGFIELD JC, 1986, HORM BEHAV, V20, P405, DOI 10.1016/0018-506X(86)90003-6; Zulkifli I, 2004, APPL ANIM BEHAV SCI, V88, P77, DOI 10.1016/j.applanim.2004.02.014	43	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93259	10.1371/journal.pone.0093259	http://dx.doi.org/10.1371/journal.pone.0093259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24668017	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600159
J	Rodriguez-Menocal, L; Salgado, M; Davis, S; Waibel, J; Shabbir, A; Cox, A; Badiavas, EV				Rodriguez-Menocal, Luis; Salgado, Marcela; Davis, Stephen; Waibel, Jill; Shabbir, Arsalan; Cox, Audrey; Badiavas, Evangelos V.			Percutaneous Bone Marrow Transplantation Using Fractional Ablative Erbium:YAG Laser	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; DRUG-DELIVERY; HUMAN SKIN	Topical application of therapeutic agents has been a mainstay in Dermatology for the treatment of skin disorders but is not commonly used for systemic delivery. For a topically applied agent to reach distant body sites it must first overcome the barrier function of the skin and then penetrate into deeper structures before reaching the systemic circulation. This has limited the use of topically applied agents to those having specific charge, solubility and size restrictions. Pretreatment of the skin with ablative fractional laser appears to enhance the uptake of some topically applied drugs but the ability to effectively deliver agents to distant sites is largely unproven. In this report we used a fractional ablative Erb:YAG (Erbium/Yttrium Aluminum Garnet) laser to facilitate the transfer of bone marrow stem cells through the skin in a murine bone marrow transplant model. Chimerism could be detected in the peripheral blood of recipient C57BL/6 mice that were pretreated with ablative fractional laser and had topically applied enhanced green fluorescent protein (GFP) labeled bone marrow cells from syngeneic donor transgenic mice. This study indicates that fractional laser can be used to deliver stem cells through the skin and remain functionally intact.	[Rodriguez-Menocal, Luis; Salgado, Marcela; Davis, Stephen; Waibel, Jill; Shabbir, Arsalan; Cox, Audrey; Badiavas, Evangelos V.] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA; [Rodriguez-Menocal, Luis; Salgado, Marcela; Badiavas, Evangelos V.] Univ Miami, Miller Sch Med, Interdiscipinary Stem Cell Inst, Miami, FL 33136 USA	University of Miami; University of Miami	Badiavas, EV (corresponding author), Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA.	ebadiavas@med.miami.edu	Rodriguez-Menocal, Luis/AGL-5931-2022		internal University of Miami funding sources	internal University of Miami funding sources	This work was supported by internal University of Miami funding sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badiavas AR, 2011, EXPERT OPIN BIOL TH, V11, P1447, DOI 10.1517/14712598.2011.606212; Badiavas EV, 2007, WOUND REPAIR REGEN, V15, P856, DOI 10.1111/j.1524-475X.2007.00305.x; Fathke C, 2004, STEM CELLS, V22, P812, DOI 10.1634/stemcells.22-5-812; Genina EA, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.11.111406; Haak CS, 2012, J CONTROL RELEASE, V163, P335, DOI 10.1016/j.jconrel.2012.09.008; Hunzeker CM, 2009, AESTHET SURG J, V29, P317, DOI 10.1016/j.asj.2009.05.004; Kim JE, 2013, DERMATOL SURG, V39, P1033, DOI 10.1111/dsu.12170; Laubach HJ, 2006, LASER SURG MED, V38, P142, DOI 10.1002/lsm.20254; Lee WR, 2011, J CONTROL RELEASE, V153, P240, DOI 10.1016/j.jconrel.2011.03.015; Quesenberry PJ, 2010, STEM CELLS DEV, V19, P453, DOI 10.1089/scd.2009.0283; Reilly MJ, 2010, ARCH FACIAL PLAST S, V12, P321, DOI 10.1001/archfacial.2010.38; Waibel J, 2008, J DRUGS DERMATOL, V7, P59; Waibel Jill, 2009, J Drugs Dermatol, V8, P294; Waibel JS, 2013, LASER SURG MED, V45, P135, DOI 10.1002/lsm.22120; Wognum AW, 2003, ARCH MED RES, V34, P461, DOI 10.1016/j.arcmed.2003.09.008; Zelickson BD, 2009, LASER SURG MED, V41, P634, DOI 10.1002/lsm.20843	16	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93004	10.1371/journal.pone.0093004	http://dx.doi.org/10.1371/journal.pone.0093004			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667438	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600124
J	Zhang, K; Duan, LT; Ong, QX; Lin, ZL; Varman, PM; Sung, KJ; Cui, BX				Zhang, Kai; Duan, Liting; Ong, Qunxiang; Lin, Ziliang; Varman, Pooja Mahendra; Sung, Kijung; Cui, Bianxiao			Light-Mediated Kinetic Control Reveals the Temporal Effect of the Raf/MEK/ERK Pathway in PC12 Cell Neurite Outgrowth	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; LIVING CELLS; NEURONAL DIFFERENTIATION; SIGNALING PATHWAYS; MAP KINASE; PHEOCHROMOCYTOMA CELLS; NUCLEAR TRANSLOCATION; MAMMALIAN-CELLS; PLASMA-MEMBRANE	It has been proposed that differential activation kinetics allows cells to use a common set of signaling pathways to specify distinct cellular outcomes. For example, nerve growth factor (NGF) and epidermal growth factor (EGF) induce different activation kinetics of the Raf/MEK/ERK signaling pathway and result in differentiation and proliferation, respectively. However, a direct and quantitative linkage between the temporal profile of Raf/MEK/ERK activation and the cellular outputs has not been established due to a lack of means to precisely perturb its signaling kinetics. Here, we construct a light-gated protein-protein interaction system to regulate the activation pattern of the Raf/MEK/ERK signaling pathway. Light-induced activation of the Raf/MEK/ERK cascade leads to significant neurite outgrowth in rat PC12 pheochromocytoma cell lines in the absence of growth factors. Compared with NGF stimulation, light stimulation induces longer but fewer neurites. Intermittent on/off illumination reveals that cells achieve maximum neurite outgrowth if the off-time duration per cycle is shorter than 45 min. Overall, light-mediated kinetic control enables precise dissection of the temporal dimension within the intracellular signal transduction network.	[Zhang, Kai; Duan, Liting; Ong, Qunxiang; Varman, Pooja Mahendra; Cui, Bianxiao] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Lin, Ziliang] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Sung, Kijung] Stanford Univ, Biophys Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Cui, BX (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	bcui@stanford.edu	Zhang, Kai/ABD-1498-2021; Zhang, Kai/G-6437-2010	Zhang, Kai/0000-0002-6687-4558; Zhang, Kai/0000-0002-6687-4558	US National Institute of Health [DP2-NS082125]; Searle Scholar Award; Packard Science and Engineering Fellowship; Dreyfus New Faculty Award; American Cancer Society [PF-13-030-01-DDC]; Pre-doctoral Fellowship from the Agency for Science, Technology and Research (A*STAR) Singapore	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholar Award; Packard Science and Engineering Fellowship; Dreyfus New Faculty Award; American Cancer Society(American Cancer Society); Pre-doctoral Fellowship from the Agency for Science, Technology and Research (A*STAR) Singapore	B. Cui is supported by the US National Institute of Health (DP2-NS082125), Searle Scholar Award, the Packard Science and Engineering Fellowship, and the Dreyfus New Faculty Award. K. Zhang, PhD was supported by a Postdoctoral Fellowship, PF-13-030-01-DDC from the American Cancer Society. Q. Ong was supported by a Pre-doctoral Fellowship from the Agency for Science, Technology and Research (A*STAR) Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Bugaj LJ, 2013, NAT METHODS, V10, P249, DOI 10.1038/nmeth.2360; Castellano F, 2000, METHOD ENZYMOL, V325, P285; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Chen X, 2001, J BIOL CHEM, V276, P34617, DOI 10.1074/jbc.M103995200; Cheung Eric C C, 2004, Sci STKE, V2004, pPE45; Chung JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009011; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Ganesan A, 2012, PROTEIN SCI, V21, P918, DOI 10.1002/pro.2089; Gautier A, 2011, J AM CHEM SOC, V133, P2124, DOI 10.1021/ja1109979; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; HEASLEY LE, 1992, MOL BIOL CELL, V3, P545, DOI 10.1091/mbc.3.5.545; Herbst KJ, 2011, MOL CELL BIOL, V31, P4063, DOI 10.1128/MCB.05459-11; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; HUFF K, 1981, J CELL BIOL, V88, P189, DOI 10.1083/jcb.88.1.189; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Ji YY, 2010, NAT NEUROSCI, V13, P302, DOI 10.1038/nn.2505; Karginov AV, 2010, NAT BIOTECHNOL, V28, P743, DOI 10.1038/nbt.1639; Karginov AV, 2010, J AM CHEM SOC; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Lidke DS, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.064972; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Liu J, 2007, MOL BIOL CELL, V18, P1375, DOI 10.1091/mbc.E06-08-0725; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; New LG, 2001, J CELL BIOCHEM, V83, P585, DOI 10.1002/jcb.1253; NGUYEN TT, 1993, J BIOL CHEM, V268, P9803; Pollock R, 2002, CURR OPIN BIOTECH, V13, P459, DOI 10.1016/S0958-1669(02)00373-7; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Ren HY, 2010, DEV BIOL, V345, P144, DOI 10.1016/j.ydbio.2010.07.002; Saito TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057037; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; SEEDORF K, 1995, METABOLISM, V44, P24, DOI 10.1016/0026-0495(95)90217-1; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; Strickland D, 2010, NAT METHODS, V7, P623, DOI [10.1038/NMETH.1473, 10.1038/nmeth.1473]; Subramaniam S, 2004, J CELL BIOL, V165, P357, DOI 10.1083/jcb.200403028; Toettcher JE, 2013, CELL, V155, P1422, DOI 10.1016/j.cell.2013.11.004; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Wang L, 2011, MOL BIOL CELL, V22, P3853, DOI 10.1091/mbc.E11-03-0277; Watanabe K, 2012, J CELL SCI, V125, P2198, DOI 10.1242/jcs.097709; Wend S., 2013, ACS SYNTH BIOL; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; WOOD KW, 1993, P NATL ACAD SCI USA, V90, P5016, DOI 10.1073/pnas.90.11.5016; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	62	61	64	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92917	10.1371/journal.pone.0092917	http://dx.doi.org/10.1371/journal.pone.0092917			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667437	gold, Green Submitted, Green Published			2022-12-27	WOS:000333675600105
J	Bona, S; Silvanto, J				Bona, Silvia; Silvanto, Juha			Accuracy and Confidence of Visual Short-Term Memory Do Not Go Hand-In-Hand: Behavioral and Neural Dissociations	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; POSTERIOR PARIETAL CORTEX; NONINVASIVE BRAIN-STIMULATION; TRANSCRANIAL DC-STIMULATION; IMPROVING WORKING-MEMORY; HUMAN MOTOR CORTEX; PREFRONTAL CORTEX; RECOGNITION MEMORY; JUDGMENTS; METAMEMORY	Currently influential models of working memory posit that memory content is highly accessible to conscious inspection. These models predict that metacognition of memory performance should go hand-in-hand with the accuracy of the underlying memory representation. To test this view, we investigated how visual information presented during the maintenance period affects VSTM accuracy and confidence. We used a delayed cue-target orientation discrimination task in which participants were asked to hold in memory a grating, and during the maintenance period a second memory cue could be presented. VSTM accuracy of the first memory cue was impaired when the orientation of the second memory cue was sufficiently different. However, participants' response confidence was reduced whenever the second memory cue was presented; thus VSTM accuracy and confidence were dissociated. In a second experiment, we applied transcranial direct current stimulation (tDCS) over the right dorsolateral prefrontal cortex (DLPFC) to investigate the causal role of this region in VSTM metacognition. Relative to the sham condition, anodal tDCS induced a general reduction in confidence ratings but did not affect VSTM accuracy. Overall, these results indicate that our metacognition of memory performance is influenced by factors other than the accuracy of the underlying memory representation.	[Bona, Silvia; Silvanto, Juha] Aalto Univ, Sch Sci, Brain Res Unit, OV Lounasmaa Lab, Espoo, Finland; [Bona, Silvia] Univ Helsinki, Cent Hosp, HUS Med Imaging Ctr, BioMag Lab, Helsinki, Finland; [Bona, Silvia] Univ Helsinki, Dept Behav Sci, Helsinki, Finland; [Silvanto, Juha] Univ Westminster, Fac Sci & Technol, Dept Psychol, London W1R 8AL, England	Aalto University; Hyvinkaan Sairaala; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Westminster	Bona, S (corresponding author), Aalto Univ, Sch Sci, Brain Res Unit, OV Lounasmaa Lab, Espoo, Finland.	silvia.bona@aalto.fi		Silvanto, Juha/0000-0001-6044-5296	Academy of Finland [137485]; Emil Aaltonen Foundation	Academy of Finland(Academy of Finland); Emil Aaltonen Foundation	JS is supported by Academy of Finland (137485) and Emil Aaltonen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus GG, 2011, NEUROPSYCHOLOGIA, V49, P1974, DOI 10.1016/j.neuropsychologia.2011.03.026; Andrews SC, 2011, BRAIN STIMUL, V4, P84, DOI 10.1016/j.brs.2010.06.004; Antal A, 2003, EXP BRAIN RES, V150, P375, DOI 10.1007/s00221-003-1459-8; Antal A, 2008, PERCEPTION, V37, P367, DOI 10.1068/p5872; Baars BJ, 2003, TRENDS COGN SCI, V7, P166, DOI 10.1016/S1364-6613(03)00056-1; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Beck DM, 2006, CEREB CORTEX, V16, P712, DOI 10.1093/cercor/bhj017; Berryhill ME, 2008, NEUROPSYCHOLOGIA, V46, P1767, DOI 10.1016/j.neuropsychologia.2008.01.009; Berryhill ME, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00031; Berryhill ME, 2010, NEUROSCI LETT, V479, P312, DOI 10.1016/j.neulet.2010.05.087; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Boggio PS, 2007, J AFFECT DISORDERS, V101, P91, DOI 10.1016/j.jad.2006.10.026; Bona S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00062; Bradfield AL, 2002, J APPL PSYCHOL, V87, P112, DOI 10.1037//0021-9010.87.1.112; BURKE DM, 1991, J MEM LANG, V30, P542, DOI 10.1016/0749-596X(91)90026-G; Busey TA, 2000, PSYCHON B REV, V7, P26, DOI 10.3758/BF03210724; Cabeza Roberto, 2000, Current Opinion in Neurology, V13, P415, DOI 10.1097/00019052-200008000-00008; CAMPBELL FW, 1971, VISION RES, V11, P833, DOI 10.1016/0042-6989(71)90005-8; Cattaneo Z, 2011, NEUROSCIENCE, V183, P64, DOI 10.1016/j.neuroscience.2011.03.058; CHANDLER CC, 1994, MEM COGNITION, V22, P273, DOI 10.3758/BF03200854; Chua EF, 2006, NEUROIMAGE, V29, P1150, DOI 10.1016/j.neuroimage.2005.09.058; Chua EF, 2009, J COGNITIVE NEUROSCI, V21, P1751, DOI 10.1162/jocn.2009.21123; Courtney Susan M., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P501, DOI 10.3758/CABN.4.4.501; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; DaSilva AF, 2011, JOVE-J VIS EXP, DOI 10.3791/2744; Dockery CA, 2009, J NEUROSCI, V29, P7271, DOI 10.1523/JNEUROSCI.0065-09.2009; Ferrucci R, 2013, CEREBELLUM, V12, P485, DOI 10.1007/s12311-012-0436-9; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Fleck MS, 2006, CEREB CORTEX, V16, P1623, DOI 10.1093/cercor/bhj097; Fleming SM, 2012, PHILOS T R SOC B, V367, P1338, DOI 10.1098/rstb.2011.0417; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Floel A, 2008, J COGNITIVE NEUROSCI, V20, P1415, DOI 10.1162/jocn.2008.20098; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Fregni F, 2007, NAT CLIN PRACT NEURO, V3, P383, DOI 10.1038/ncpneuro0530; GREENLEE MW, 1988, VISION RES, V28, P1303, DOI 10.1016/0042-6989(88)90061-2; HART JT, 1967, J VERB LEARN VERB BE, V6, P685, DOI 10.1016/S0022-5371(67)80072-0; Henson RNA, 2000, J COGNITIVE NEUROSCI, V12, P913, DOI 10.1162/08989290051137468; Hsu TY, 2011, NEUROIMAGE, V56, P2249, DOI 10.1016/j.neuroimage.2011.03.059; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; Jeon SY, 2012, ANN REHABIL MED-ARM, V36, P585, DOI 10.5535/arm.2012.36.5.585; Jonsson AC, 2003, PERS INDIV DIFFER, V34, P559, DOI 10.1016/S0191-8869(02)00028-4; Kao YC, 2005, NAT NEUROSCI, V8, P1776, DOI 10.1038/nn1595; KELLEY CM, 1993, J MEM LANG, V32, P1, DOI 10.1006/jmla.1993.1001; Kikyo H, 2004, NEUROIMAGE, V23, P1348, DOI 10.1016/j.neuroimage.2004.08.013; KING JF, 1980, AM J PSYCHOL, V93, P329, DOI 10.2307/1422236; Koriat A, 1997, J EXP PSYCHOL GEN, V126, P349, DOI 10.1037/0096-3445.126.4.349; Ladeira A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025399; Lang N, 2003, SUPPL CLIN NEUROPHYS, V56, P277; Lau HC, 2006, P NATL ACAD SCI USA, V103, P18763, DOI 10.1073/pnas.0607716103; LEONESIO RJ, 1990, J EXP PSYCHOL LEARN, V16, P464, DOI 10.1037/0278-7393.16.3.464; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Magnussen S, 1999, PSYCHOL RES-PSYCH FO, V62, P81, DOI 10.1007/s004260050043; MAGNUSSEN S, 1991, VISION RES, V31, P1213, DOI 10.1016/0042-6989(91)90046-8; Magnussen S, 1988, J EXP PSYCHOL HUMAN, V24, P707; Magnussen S, 2009, SCAND J PSYCHOL, V50, P535, DOI 10.1111/j.1467-9450.2009.00783.x; Maniscalco B, 2012, CONSCIOUS COGN, V21, P422, DOI 10.1016/j.concog.2011.09.021; Marshall L, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-23; Monti A, 2008, J NEUROL NEUROSUR PS, V79, P451, DOI 10.1136/jnnp.2007.135277; Moos K, 2012, J NEUROSCI, V32, P16360, DOI 10.1523/JNEUROSCI.6233-11.2012; Moritz S, 2006, NEUROIMAGE, V33, P1188, DOI 10.1016/j.neuroimage.2006.08.003; Mulquiney PG, 2011, CLIN NEUROPHYSIOL, V122, P2384, DOI 10.1016/j.clinph.2011.05.009; Nelson T.O., 1990, PSYCHOL LEARNING MOT, V26, P125, DOI [10.1016/S0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5, 10.1016/s0079-7421(08)60053-5]; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P2220, DOI 10.1016/S1388-2457(03)00235-9; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Olson IR, 2009, NEUROBIOL LEARN MEM, V91, P155, DOI 10.1016/j.nlm.2008.09.006; Pannu JK, 2005, NEUROPSYCHOL REV, V15, P105, DOI 10.1007/s11065-005-7091-6; Peters MAK, 2013, NEUROPSYCHOLOGIA, V51, P1234, DOI 10.1016/j.neuropsychologia.2013.03.013; Poreisz C, 2007, BRAIN RES BULL, V72, P208, DOI 10.1016/j.brainresbull.2007.01.004; Rademaker RL, 2012, J VISION, V12, DOI 10.1167/12.13.21; Rounis E, 2010, COGN NEUROSCI-UK, V1, P165, DOI 10.1080/17588921003632529; Sahraie A, 1997, P NATL ACAD SCI USA, V94, P9406, DOI 10.1073/pnas.94.17.9406; Schnyer DM, 2005, J COGNITIVE NEUROSCI, V17, P832, DOI 10.1162/0898929053747694; Schnyer DM, 2004, NEUROPSYCHOLOGIA, V42, P957, DOI 10.1016/j.neuropsychologia.2003.11.020; Shaw JS, 2003, LAW HUMAN BEHAV, V27, P315, DOI 10.1023/A:1023487908640; Shields WE, 2005, J GEN PSYCHOL, V132, P165; Silvanto J, 2012, NEUROIMAGE, V59, P840, DOI 10.1016/j.neuroimage.2011.07.062; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; Teo Florence, 2011, Front Psychiatry, V2, P45, DOI 10.3389/fpsyt.2011.00045; Tseng P, 2012, J NEUROSCI, V32, P10554, DOI 10.1523/JNEUROSCI.0362-12.2012; Tseng P, 2010, NEUROPSYCHOLOGIA, V48, P1063, DOI 10.1016/j.neuropsychologia.2009.12.005; TULVING E, 1981, J VERB LEARN VERB BE, V20, P479, DOI 10.1016/S0022-5371(81)90129-8; VESONDER GT, 1985, J MEM LANG, V24, P363, DOI 10.1016/0749-596X(85)90034-8; Walter H, 2003, CORTEX, V39, P897, DOI 10.1016/S0010-9452(08)70869-4; WELLS GL, 1981, J APPL PSYCHOL, V66, P688, DOI 10.1037/0021-9010.66.6.688; Yokoyama O, 2010, NEUROSCI RES, V68, P199, DOI 10.1016/j.neures.2010.07.2041; YONELINAS AP, 1994, J EXP PSYCHOL LEARN, V20, P1341, DOI 10.1037/0278-7393.20.6.1341; Zaehle T, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-2	90	27	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e90808	10.1371/journal.pone.0090808	http://dx.doi.org/10.1371/journal.pone.0090808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD7QO	24663094	gold, Green Published, Green Submitted			2022-12-27	WOS:000333459900010
J	Bratanic, B; Pernus, F; Likar, B; Tomazevic, D				Bratanic, Blaz; Pernus, Franjo; Likar, Bostjan; Tomazevic, Dejan			Real-Time Rotation Estimation Using Histograms of Oriented Gradients	PLOS ONE			English	Article							AUTOMATED VISUAL INSPECTION	This paper focuses on real-time rotation estimation for model-based automated visual inspection. In the case of model-based inspection, spatial alignment is essential to distinguish visual defects from normal appearance variations. Defects are detected by comparing the inspected object with its spatially aligned ideal reference model. Rotation estimation is crucial for the inspection of rotationally symmetric objects where mechanical manipulation is unable to ensure the correct object rotation. We propose a novel method for in-plane rotation estimation. Rotation is estimated with an ensemble of nearest-neighbor estimators. Each estimator contains a spatially local representation of an object in a feature space for all rotation angles and is constructed with a semi-supervised self-training approach from a set of unlabeled training images. An individual representation in a feature space is obtained by calculating the Histograms of Oriented Gradients (HOG) over a spatially local region. Each estimator votes separately for the estimated angle; all votes are weighted and accumulated. The final estimation is the angle with the most votes. The method was evaluated on several datasets of pharmaceutical tablets varying in size, shape, and color. The results show that the proposed method is superior in robustness with comparable speed and accuracy to previously proposed methods for rotation estimation of pharmaceutical tablets. Furthermore, all evaluations were performed with the same set of parameters, which implies that the method requires minimal human intervention. Despite the evaluation focused on pharmaceutical tablets, we consider the method useful for any application that requires robust real-time in-plane rotation estimation.	[Bratanic, Blaz; Pernus, Franjo; Likar, Bostjan; Tomazevic, Dejan] Sensum, Comp Vis Syst, Ljubljana, Slovenia; [Pernus, Franjo; Likar, Bostjan; Tomazevic, Dejan] Univ Ljubljana, Fac Elect Engn, Lab Imaging Technol, Ljubljana, Slovenia	University of Ljubljana	Bratanic, B (corresponding author), Sensum, Comp Vis Syst, Ljubljana, Slovenia.	blaz.bratanic@sensum.eu			Ministry of Higher Education, Science, and Technology, Republic of Slovenia [L2-4072, L2-5472]; Sensum, Computer Vision Systems; European Union, European Social Fund	Ministry of Higher Education, Science, and Technology, Republic of Slovenia; Sensum, Computer Vision Systems; European Union, European Social Fund(European Social Fund (ESF))	This work was supported by the Ministry of Higher Education, Science, and Technology, Republic of Slovenia under grants L2-4072 and L2-5472, by Sensum, Computer Vision Systems, and by the European Union, European Social Fund. Bostjan Likar and Franjo Pernus. (two co-authors of this manuscript) are co-owners of the commercial funder of this research, Sensum, Computer Vision Systems. Bostjan Likar and Franjo Pernus. had a role in study design and preparation of the manuscript.	ALPERT NM, 1990, J NUCL MED, V31, P1717; BENTLEY JL, 1975, COMMUN ACM, V18, P509, DOI 10.1145/361002.361007; Bukovec M, 2007, MEAS SCI TECHNOL, V18, P2921, DOI 10.1088/0957-0233/18/9/023; Bunn G, 2006, GOOD MANUFACTURING P, V169; Chen FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054328; CHIN RT, 1982, IEEE T PATTERN ANAL, V4, P557, DOI 10.1109/TPAMI.1982.4767309; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Ferreira AJ, 2012, ENSEMBLE MACHINE LEARNING: METHODS AND APPLICATIONS, P35, DOI 10.1007/978-1-4419-9326-7_2; Garcia-Pedrajas N, 2005, IEEE T EVOLUT COMPUT, V9, P271, DOI 10.1109/TEVC.2005.844158; Goshtasby AA, 2011, IMAGE REGISTRATION FOR REMOTE SENSING, P153; Hill DLG, 2001, PHYS MED BIOL, V46, pR1, DOI 10.1088/0031-9155/46/3/201; Holden M, 2008, IEEE T MED IMAGING, V27, P111, DOI 10.1109/TMI.2007.904691; Maintz J B, 1998, Med Image Anal, V2, P1, DOI 10.1016/S1361-8415(01)80026-8; Mendes-Moreira J, 2012, ACM COMPUT SURV, V45, DOI 10.1145/2379776.2379786; Mikolajczyk K, 2005, INT J COMPUT VISION, V65, P43, DOI 10.1007/s11263-005-3848-x; Mikolajczyk K, 2005, IEEE T PATTERN ANAL, V27, P1615, DOI 10.1109/TPAMI.2005.188; Mozina M, 2011, MACH VISION APPL, P1; Mozina M, 2011, MACH VISION APPL, V22, P145, DOI 10.1007/s00138-009-0218-7; Muja M, 2009, VISAPP 2009: PROCEEDINGS OF THE FOURTH INTERNATIONAL CONFERENCE ON COMPUTER VISION THEORY AND APPLICATIONS, VOL 1, P331; NEWMAN TS, 1995, COMPUT VIS IMAGE UND, V61, P231, DOI 10.1006/cviu.1995.1017; Spiclin Z, 2011, MACH VISION APPL, V22, P197, DOI 10.1007/s00138-007-0104-0; Zhou L, 2013, PATTERN RECOGN, V46, P424, DOI 10.1016/j.patcog.2012.07.017; Zhu Qiang, 2006, CVPR, DOI DOI 10.1109/CVPR.2006.119; Zhu X., 2005, 1530 U WISC	24	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92137	10.1371/journal.pone.0092137	http://dx.doi.org/10.1371/journal.pone.0092137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662954	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900042
J	Jawad, M; Lee, JT; Millett, C				Jawad, Mohammed; Lee, John Tayu; Millett, Christopher			The Relationship between Waterpipe and Cigarette Smoking in Low and Middle Income Countries: Cross-Sectional Analysis of the Global Adult Tobacco Survey	PLOS ONE			English	Article							MEDICAL-STUDENTS; HOOKAH USE; ATTITUDES; PIPE; PREVALENCE; BELIEFS	Introduction: Waterpipe tobacco smoking is receiving growing attention due to accumulating evidence suggesting increasing prevalence in some populations and deleterious health effects. Nevertheless, the relationship between waterpipe and cigarette smoking remain unknown, particularly in low and middle income countries. Materials and Methods: We analysed waterpipe and cigarette smoking using data from Global Adult Tobacco Survey, a household survey of adults aged >= 15 years conducted between 2008-2010 in LMICs. Factors associated with waterpipe and cigarette use were assessed using multiple logistic regression. Factors associated with the quantity of waterpipe and cigarette smoking were assessed using log-linear regression models. Results: After adjusting for age, gender, residence, education, occupation and smokeless tobacco use, waterpipe smoking was significantly higher among cigarette users than in non-cigarette users in India (5.6% vs. 0.6%, AOR 13.12, 95% CI 7.41-23.23) and Russia (6.7% vs. 0.2%, AOR 27.73, 95% CI 11.41-67.43), but inversely associated in Egypt (2.6% vs. 3.4%, AOR 0.21, 95% CI 0.15-0.30) and not associated in Vietnam (13.3% vs. 4.7%, AOR 0.96, 95% CI 0.74-1.23). Compared to non-cigarette smokers, waterpipe smokers who also used cigarettes had more waterpipe smoking sessions per week in Russia (1.3 vs. 2.9, beta coefficient 0.31, 95% CI 0.06, 0.57), but less in Egypt (18.2 vs. 10.7, beta coefficient -0.45, 95% CI -0.73, -0.17) and Vietnam (102.0 vs. 79.3, beta coefficient -0.31, 95% CI -0.56, -0.06) and similar amounts in India (29.4 vs. 32.6, beta coefficient -0.12, 95% CI -0.46, 0.22). Conclusions: Waterpipe smoking is low in most LMICs but important country-level differences in use, including concurrent cigarette smoking, should be taken into account when designing and evaluating tobacco control interventions.	[Jawad, Mohammed; Lee, John Tayu; Millett, Christopher] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London, England; [Millett, Christopher] Publ Hlth Fdn India, New Delhi, India	Imperial College London; Public Health Foundation of India	Jawad, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London, England.	mohammed.jawad06@imperial.ac.uk	Jawad, Mohammed/I-6919-2019	Jawad, Mohammed/0000-0002-1051-2136; Millett, Christopher/0000-0002-0793-9884; Lee, John Tayu/0000-0002-1551-4923	Bloomberg initiative, program of Bloomberg Philanthropies; Higher Education Funding Council for England; National Institute for Health Research; National Institute for Health Research [ACF-2014-26-003] Funding Source: researchfish	Bloomberg initiative, program of Bloomberg Philanthropies; Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Funding for the GATS is provided by the Bloomberg initiative to reduce tobacco use, a program of Bloomberg Philanthropies. CM is funded by the Higher Education Funding Council for England and National Institute for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl EA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-244; Akl EA, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-12; Akl EA, 2010, INT J EPIDEMIOL, V39, P834, DOI 10.1093/ije/dyq002; Almerie MQ, 2008, INT J TUBERC LUNG D, V12, P1085; BENOWITZ NL, 1994, NEW ENGL J MED, V331, P123, DOI 10.1056/NEJM199407143310212; Blank MD, 2013, NICOTINE TOBACCO RES; Carroll T, 2008, AUST NZ J PUBL HEAL, V32, P490, DOI 10.1111/j.1753-6405.2008.00287.x; Cobb CO, 2013, TOB CONTROL, V22, P338, DOI 10.1136/tobaccocontrol-2011-050350; Jawad M, 2013, INT J TUBERC LUNG D, V17, P137, DOI 10.5588/ijtld.12.0175; Jawad M, 2013, NICOTINE TOB RES, V15, P2069, DOI 10.1093/ntr/ntt103; Jensen PD, 2010, SUBST USE MISUSE, V45, P1245, DOI 10.3109/10826081003682909; Kalsbeek W.D., 2010, GLOBAL ADULT TOBACCO; Knishkowy B, 2005, PEDIATRICS, V116, pE113, DOI 10.1542/peds.2004-2173; Manderski MTB, 2012, AM J HEALTH BEHAV, V36, P693, DOI 10.5993/AJHB.36.5.11; Martin R, 2013, INT J ENV RES PUB HE, V10, P2120, DOI 10.3390/ijerph10062120; Maziak W, 2005, PUBLIC HEALTH, V119, P400, DOI 10.1016/j.puhe.2004.08.002; Morris DS, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120082; Morton J, 2013, TOBACCO CONTROL; Mzayek F, 2012, NICOTINE TOB RES, V14, P448, DOI 10.1093/ntr/ntr234; Nakkash R, 2010, TOB CONTROL, V19, P235, DOI 10.1136/tc.2009.031773; Nazar GP, 2014, PREV MED, V59, P47, DOI 10.1016/j.ypmed.2013.11.017; Neergaard J, 2007, NICOTINE TOB RES, V9, P987, DOI 10.1080/14622200701591591; Primack B. A., 2012, American Journal of Public Health, V102, pe47, DOI 10.2105/AJPH.2012.300838; Rath JM, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/679134; Roskin J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-10; She J, 2012, CHEST, V142; Shihadeh A, 2003, FOOD CHEM TOXICOL, V41, P143, DOI 10.1016/S0278-6915(02)00220-X; Smith JR, 2011, AM J PUBLIC HEALTH, V101, P1876, DOI 10.2105/AJPH.2011.300196; Smith-Simone S, 2008, NICOTINE TOB RES, V10, P393, DOI 10.1080/14622200701825023; Ward KD, 2007, NICOTINE TOB RES, V9, P1339, DOI 10.1080/14622200701705019; WHO, 2005, WHO TOBREG WAT PIP T	31	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93097	10.1371/journal.pone.0093097	http://dx.doi.org/10.1371/journal.pone.0093097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD7QO	24664109	gold, Green Published			2022-12-27	WOS:000333459900152
J	Kelly, CE; Cheong, JLY; Molloy, C; Anderson, PJ; Lee, KJ; Burnett, AC; Connelly, A; Doyle, LW; Thompson, DK				Kelly, Claire E.; Cheong, Jeanie L. Y.; Molloy, Carly; Anderson, Peter J.; Lee, Katherine J.; Burnett, Alice C.; Connelly, Alan; Doyle, Lex W.; Thompson, Deanne K.		Victorian Infant Collaborative Stu	Neural Correlates of Impaired Vision in Adolescents Born Extremely Preterm and/or Extremely Low Birthweight	PLOS ONE			English	Article							POSTNATAL DEXAMETHASONE THERAPY; HUMAN CEREBRAL-CORTEX; VISUAL FUNCTION; DIFFUSION TRACTOGRAPHY; CHILDREN BORN; BRAIN-DEVELOPMENT; WEEKS GESTATION; EARLY-CHILDHOOD; LUNG-DISEASE; SCHOOL-AGE	Background: Adolescents born extremely preterm (EP; <28 weeks' gestation) and/or extremely low birthweight (ELBW; <1000 g) experience high rates of visual impairments, however the potential neural correlates of visual impairments in EP/ELBW adolescents require further investigation. This study aimed to: 1) compare optic radiation and primary visual cortical structure between EP/ELBW adolescents and normal birthweight controls; 2) investigate associations between perinatal factors and optic radiation and primary visual cortical structure in EP/ELBW adolescents; 3) investigate associations between optic radiation and primary visual cortical structure in EP/ELBW adolescents and the odds of impaired vision. Methods: 196 EP/ELBW adolescents and 143 controls underwent magnetic resonance imaging at a mean age of 18 years. Optic radiations were delineated using constrained spherical deconvolution based probabilistic tractography. Primary visual cortices were segmented using FreeSurfer software. Diffusion tensor variables and tract volume of the optic radiations, as well as volume, surface area and thickness of the primary visual cortices, were estimated. Results: Axial, radial and mean diffusivities within the optic radiations, and primary visual cortical thickness, were higher in the EP/ELBW adolescents than controls. Within EP/ELBW adolescents, postnatal corticosteroid exposure was associated with altered optic radiation diffusion values and lower tract volume, while decreasing gestational age at birth was associated with increased primary visual cortical volume, area and thickness. Furthermore, decreasing optic radiation fractional anisotropy and tract volume, and increasing optic radiation diffusivity in EP/ELBW adolescents were associated with increased odds of impaired vision, whereas primary visual cortical measures were not associated with the odds of impaired vision. Conclusions: Optic radiation and primary visual cortical structure are altered in EP/ELBW adolescents compared with controls, with the greatest alterations seen in those exposed to postnatal corticosteroids and those born earliest. Structural alterations to the optic radiations may increase the risk of impaired vision in EP/ELBW adolescents.	[Kelly, Claire E.; Cheong, Jeanie L. Y.; Molloy, Carly; Anderson, Peter J.; Lee, Katherine J.; Burnett, Alice C.; Doyle, Lex W.; Thompson, Deanne K.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Cheong, Jeanie L. Y.; Molloy, Carly; Burnett, Alice C.; Doyle, Lex W.] Royal Womens Hosp, Melbourne, Vic, Australia; [Cheong, Jeanie L. Y.; Doyle, Lex W.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Anderson, Peter J.; Lee, Katherine J.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Burnett, Alice C.] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Connelly, Alan] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health	Kelly, CE (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.	claire.armstrongkell@mcri.edu.au	Lee, Katherine J/A-2519-2016; Anderson, Peter John/O-5302-2019; Connelly, Alan/A-9065-2013; Thompson, Deanne/W-7177-2019; Anderson, Peter J/B-6839-2015; Thompson, Deanne K/A-9502-2018; Doyle, Lex/AAJ-5205-2021	Anderson, Peter John/0000-0001-7430-868X; Connelly, Alan/0000-0001-7159-8079; Thompson, Deanne/0000-0001-8017-5756; Anderson, Peter J/0000-0001-7430-868X; Thompson, Deanne K/0000-0001-8017-5756; Doyle, Lex/0000-0002-7667-7312; Kelly, Claire/0000-0002-6564-0872; Cheong, Jeanie/0000-0001-5901-0455	Victorian Government's Operational Infrastructure Support Program, a Centre of Clinical Research Excellence Grant from the Australian National Health and Medical Research Council [546519, 491246]	Victorian Government's Operational Infrastructure Support Program, a Centre of Clinical Research Excellence Grant from the Australian National Health and Medical Research Council	This study was funded in part by the Victorian Government's Operational Infrastructure Support Program, a Centre of Clinical Research Excellence Grant (ID 546519) and a Project Grant (ID 491246) from the Australian National Health and Medical Research Council - the following were successful applicants for the Project Grant: Lex Doyle, Peter Anderson, Stephen Wood, Colin Robertson, Sarah Hope, Doug Hacking, Jeanie Cheong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264; Bassi L, 2008, BRAIN, V131, P573, DOI 10.1093/brain/awm327; Benjamin CFA, 2014, HUM BRAIN MAPP, V35, P683, DOI 10.1002/hbm.22204; Berman JI, 2009, AM J NEURORADIOL, V30, P120, DOI 10.3174/ajnr.A1304; Chaturvedi V, 2000, EXP BRAIN RES, V132, P72, DOI 10.1007/s002219900221; Cheong JLY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077475; Cheong JLY, 2013, J PEDIAT IN PRESS; Ciccarelli O, 2003, NEUROIMAGE, V18, P348, DOI 10.1016/S1053-8119(02)00042-3; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; de Kieviet JF, 2012, DEV MED CHILD NEUROL, V54, P313, DOI 10.1111/j.1469-8749.2011.04216.x; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Doyle LW, 1997, J PAEDIATR CHILD H, V33, P161; Doyle LW, 2001, PEDIATRICS, V108, P134, DOI 10.1542/peds.108.1.134; Evensen KAI, 2009, EUR J PAEDIATR NEURO, V13, P47, DOI 10.1016/j.ejpn.2008.02.009; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Glass HC, 2010, AM J NEURORADIOL, V31, P1424, DOI 10.3174/ajnr.A2110; Hard AL, 2000, DEV MED CHILD NEUROL, V42, P100, DOI 10.1017/S0012162200000207; Hayes GJ, 1998, OPTOMETRY VISION SCI, V75, P506, DOI 10.1097/00006324-199807000-00019; Hou C, 2011, INVEST OPHTH VIS SCI, V52, P9091, DOI 10.1167/iovs.11-7458; Jacobson L, 2002, Strabismus, V10, P179; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; JULESZ B, 1964, SCIENCE, V145, P356, DOI 10.1126/science.145.3630.356; Kesler SR, 2004, PEDIATR NEUROL, V31, P318, DOI 10.1016/j.pediatrneurol.2004.06.008; Kok JH, 2007, PEDIATRICS, V119, pE1342, DOI 10.1542/peds.2005-2857; Kozeis N, 2012, AM J PERINAT, V29, P747, DOI 10.1055/s-0032-1316446; Leemans A., 2009, P 17 ANN M INT SOC M, P3537; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Martin N., 2006, TEST VISUAL PERCEPTU; Melhem ER, 2000, AM J NEURORADIOL, V21, P1813; Molloy CS, 2013, PEDIATRICS, V132, pE704, DOI 10.1542/peds.2013-0040; Mukherjee P, 2006, NEUROIMAG CLIN N AM, V16, P19, DOI 10.1016/j.nic.2005.11.004; Murphy BP, 2001, PEDIATRICS, V107, P217, DOI 10.1542/peds.107.2.217; Nagy Z, 2011, CEREB CORTEX, V21, P300, DOI 10.1093/cercor/bhq095; Nie JX, 2013, NEUROIMAGE, V76, P216, DOI 10.1016/j.neuroimage.2013.03.021; Nosarti C, 2008, BRAIN, V131, P205, DOI 10.1093/brain/awm282; Palmer EA, 2005, ARCH OPHTHALMOL-CHIC, V123, P311; Parikh NA, 2007, PEDIATRICS, V119, P265, DOI 10.1542/peds.2006-1354; Shah DK, 2006, INVEST OPHTH VIS SCI, V47, P3366, DOI 10.1167/iovs.05-0811; Shah MB, 1995, DOC OPHTHALMOL, V91, P265, DOI 10.1007/BF01204177; Stephenson T, 2007, ARCH DIS CHILD-FETAL, V92, P265, DOI 10.1136/adc.2006.104000; Takao H, 2011, NEUROIMAGE, V57, P958, DOI 10.1016/j.neuroimage.2011.05.019; TAYLOR HR, 1978, AM J OPTOM PHYS OPT, V55, P348; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089; Yu B, 2011, KOREAN J RADIOL, V12, P463, DOI 10.3348/kjr.2011.12.4.463; Zellers J A, 1984, J Am Optom Assoc, V55, P31; Zubiaurre-Elorza L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042148	51	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93188	10.1371/journal.pone.0093188	http://dx.doi.org/10.1371/journal.pone.0093188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663006	Green Published, gold			2022-12-27	WOS:000333459900161
J	Madinier, A; Quattromani, MJ; Sjolund, C; Ruscher, K; Wieloch, T				Madinier, Alexandre; Quattromani, Miriana Jlenia; Sjolund, Carin; Ruscher, Karsten; Wieloch, Tadeusz			Enriched Housing Enhances Recovery of Limb Placement Ability and Reduces Aggrecan-Containing Perineuronal Nets in the Rat Somatosensory Cortex after Experimental Stroke	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCANS; INDUCED MOVEMENT THERAPY; TRAUMATIC BRAIN-INJURY; FORCED ARM USE; ENVIRONMENTAL ENRICHMENT; PHOTOTHROMBOTIC STROKE; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; NEUROTROPHIC FACTOR; MOTOR RECOVERY	Stroke causes life long disabilities where few therapeutic options are available. Using electrical and magnetic stimulation of the brain and physical rehabilitation, recovery of brain function can be enhanced even late after stroke. Animal models support this notion, and housing rodents in an enriched environment (EE) several days after experimental stroke stimulates lost brain function by multisensory mechanisms. We studied the dynamics of functional recovery of rats with a lesion to the fore and hind limb motor areas induced by photothrombosis (PT), and with subsequent housing in either standard (STD) or EE. In this model, skilled motor function is not significantly enhanced by enriched housing, while the speed of recovery of sensori-motor function substantially improves over the 9-week study period. In particular, this stroke lesion completely obliterates the fore and hind limb placing ability when visual and whisker guidance is prevented, a deficit that persists for up to 9 weeks of recovery, but that is markedly restored within 2 weeks by enriched housing. Enriched housing after stroke also leads to a significant loss of perineuronal net (PNN) immunoreactivity; detection of aggrecan protein backbone with AB1031 antibody was decreased by 13-22%, and labelling of a glycan moiety of aggrecan with Cat-315 antibody was reduced by 25-30% in the peri-infarct area and in the somatosensory cortex, respectively. The majority of these cells are parvalbumin/GABA inhibitory interneurons that are important in sensori-information processing. We conclude that damage to the fore and hind limb motor areas provides a model of loss of limb placing response without visual guidance, a deficit also seen in more than 50% of stroke patients. This loss is amenable to recovery induced by multiple sensory stimulation and correlates with a decrease in aggrecan-containing PNNs around inhibitory interneurons. Modulating the PNN structure after ischemic damage may provide new therapies enhancing tactile/proprioceptive function after stroke.	[Madinier, Alexandre; Quattromani, Miriana Jlenia; Sjolund, Carin; Ruscher, Karsten; Wieloch, Tadeusz] Lund Univ, Dept Clin Sci, Expt Brain Res Lab, Div Neurosurg, Lund, Sweden	Lund University	Wieloch, T (corresponding author), Lund Univ, Dept Clin Sci, Expt Brain Res Lab, Div Neurosurg, Lund, Sweden.	tadeusz.wieloch@med.lu.se		Wieloch, Tadeusz/0000-0002-7669-2520	Swedish Research Council [2011-2652, 2011-2684]; EU through the European Stroke Network [201024]; Hans-Christian and Alice Wachtmeister Foundation; Swedish Brain Fund; Greta och Johan Kocks Stiftelser; Thorsten och Elsa Segerfalk Stiftelse; Crafoord Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); EU through the European Stroke Network; Hans-Christian and Alice Wachtmeister Foundation; Swedish Brain Fund; Greta och Johan Kocks Stiftelser; Thorsten och Elsa Segerfalk Stiftelse; Crafoord Foundation	This study was supported by the Swedish Research Council grants no. 2011-2652 (TW) and no. 2011-2684 (KR), the EU 7th work program through the European Stroke Network grant no. 201024, the Hans-Christian and Alice Wachtmeister Foundation (TW, KR), the Swedish Brain Fund (TW), the Greta och Johan Kocks Stiftelser (KR), the Thorsten och Elsa Segerfalk Stiftelse (KR) and the Crafoord Foundation (KR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendash GW, 2004, NEUROREPORT, V15, P1751, DOI 10.1097/01.wnr.0000137183.68847.4e; Ballermann M, 2001, J NEUROSCI METH, V106, P39, DOI 10.1016/S0165-0270(01)00326-0; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Bezard E, 2003, J NEUROSCI, V23, P10999; Biernaskie J, 2001, J NEUROSCI, V21, P5272, DOI 10.1523/JNEUROSCI.21-14-05272.2001; Carey LM, 2011, NEUROREHAB NEURAL RE, V25, P443, DOI 10.1177/1545968310395777; Carey LM, 1996, ARCH PHYS MED REHAB, V77, P1271, DOI 10.1016/S0003-9993(96)90192-6; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Celio MR, 1998, TRENDS NEUROSCI, V21, P510, DOI 10.1016/S0166-2236(98)01298-3; Dahlqvist P, 2003, NEUROSCIENCE, V119, P643, DOI 10.1016/S0306-4522(03)00195-7; Dancause N, 2006, REV NEUROSCIENCE, V17, P561; DERYCK M, 1992, BRAIN RES, V573, P44; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; Diederich K, 2012, STROKE, V43, P185, DOI 10.1161/STROKEAHA.111.622159; Dino MR, 2006, NEUROSCIENCE, V142, P1055, DOI 10.1016/j.neuroscience.2006.07.054; DONOGHUE JP, 1994, J CLIN NEUROPHYSIOL, V11, P382; DUNCAN PW, 1992, STROKE, V23, P1084, DOI 10.1161/01.STR.23.8.1084; Edwardson MA, 2013, EXP BRAIN RES, V224, P335, DOI 10.1007/s00221-012-3315-1; Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010; Foscarin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016666; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Frischknecht R, 2012, ADV EXP MED BIOL, V970, P153, DOI 10.1007/978-3-7091-0932-8_7; Gherardini L., 2013, CEREB CORTEX; Giamanco KA, 2010, NEUROSCIENCE, V170, P1314, DOI 10.1016/j.neuroscience.2010.08.032; GUIMARAES A, 1990, J NEUROSCI, V10, P3014; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; Harris NG, 2009, J NEUROSCI RES, V87, P2937, DOI 10.1002/jnr.22115; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; HARTIG W, 1994, BRAIN RES, V635, P307, DOI 10.1016/0006-8993(94)91452-4; Hebb D.O., 1947, AM PSYCHOL, V2, P306; Hill JJ, 2012, P NATL ACAD SCI USA, V109, P9155, DOI 10.1073/pnas.1205697109; Hobohm C, 2005, J NEUROSCI RES, V80, P539, DOI 10.1002/jnr.20459; HOCKFIELD S, 1990, COLD SPRING HARB SYM, V55, P505; HOCKFIELD S, 1983, P NATL ACAD SCI-BIOL, V80, P5758, DOI 10.1073/pnas.80.18.5758; Hockly E, 2002, ANN NEUROL, V51, P235, DOI 10.1002/ana.10094; Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F; Inacio AR, 2011, NEUROBIOL DIS, V41, P270, DOI 10.1016/j.nbd.2010.09.015; Jablonka JA, 2010, NEUROSCIENCE, V165, P90, DOI 10.1016/j.neuroscience.2009.09.074; Janssen H, 2010, NEUROREHAB NEURAL RE, V24, P802, DOI 10.1177/1545968310372092; Jin Z, 2010, BRAIN RES, V1363, P191, DOI 10.1016/j.brainres.2010.09.081; Johansson BB, 2002, J CEREBR BLOOD F MET, V22, P89, DOI 10.1097/00004647-200201000-00011; JONES TA, 1992, BEHAV BRAIN RES, V51, P1, DOI 10.1016/S0166-4328(05)80306-7; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P399, DOI 10.1016/S0003-9993(95)80567-2; Karetko-Sysa M, 2011, EXP NEUROL, V231, P113, DOI 10.1016/j.expneurol.2011.05.022; Katsman D, 2003, J CEREBR BLOOD F MET, V23, P997, DOI 10.1097/01.WCB.0000084252.20114.BE; Keyvani K, 2004, J NEUROPATH EXP NEUR, V63, P598, DOI 10.1093/jnen/63.6.598; Kitago T, 2013, NEUROREHAB NEURAL RE, V27, P99, DOI 10.1177/1545968312452631; Knieling M, 2009, NEUROSCIENCE, V163, P759, DOI 10.1016/j.neuroscience.2009.07.004; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Lander C, 1997, J NEUROSCI, V17, P1928; Lendvai D, 2013, ACTA NEUROPATHOL, V125, P215, DOI 10.1007/s00401-012-1042-0; Lenzlinger PM, 2004, RESTOR NEUROL NEUROS, V22, P73; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Martinez-Cue C, 2005, BEHAV BRAIN RES, V163, P174, DOI 10.1016/j.bbr.2005.04.016; Matthews RT, 2002, J NEUROSCI, V22, P7536; McRae PA, 2007, J NEUROSCI, V27, P5405, DOI 10.1523/JNEUROSCI.5425-06.2007; Moon SK, 2009, EXP NEUROL, V218, P145, DOI 10.1016/j.expneurol.2009.04.021; Morawski M, 2012, INT J BIOCHEM CELL B, V44, P690, DOI 10.1016/j.biocel.2012.01.010; Muller HD, 2008, STROKE, V39, P1012, DOI 10.1161/STROKEAHA.107.495069; Muntner P, 2002, STROKE, V33, P1209, DOI 10.1161/01.STR.0000015031.57955.D1; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Overman JJ, 2014, NEUROSCIENTIST, V20, P15, DOI 10.1177/1073858413491146; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Restivo L, 2005, P NATL ACAD SCI USA, V102, P11557, DOI 10.1073/pnas.0504984102; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rogers DC, 1997, PHARMACOL BIOCHEM BE, V56, P747, DOI 10.1016/S0091-3057(96)00430-3; Rosell A, 2008, CURR OPIN PHARMACOL, V8, P82, DOI 10.1016/j.coph.2007.12.001; Ruscher K, 2011, BRAIN, V134, P732, DOI 10.1093/brain/awq367; Ruscher K, 2009, J CEREBR BLOOD F MET, V29, P1796, DOI 10.1038/jcbfm.2009.96; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Schabitz WR, 2004, STROKE, V35, P992, DOI 10.1161/01.STR.0000119754.85848.0D; Schulz R, 2013, NEUROPHARMACOLOGY, V64, P579, DOI 10.1016/j.neuropharm.2012.05.016; Shanina EV, 2006, NEUROSCIENCE, V139, P1495, DOI 10.1016/j.neuroscience.2006.01.016; Sigler A, 2008, J NEUROSCI METH, V170, P35, DOI 10.1016/j.jneumeth.2007.12.015; Soleman S, 2013, NEUROSCIENCE, V253, P194, DOI 10.1016/j.neuroscience.2013.08.050; Starkey ML, 2012, BRAIN, V135, P3265, DOI 10.1093/brain/aws270; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vandeputte C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-92; Viapiano MS, 2006, TRENDS MOL MED, V12, P488, DOI 10.1016/j.molmed.2006.08.007; Wang DF, 2012, CELL TISSUE RES, V349, P147, DOI 10.1007/s00441-012-1375-y; Wang YG, 2008, J CEREBR BLOOD F MET, V28, P1936, DOI 10.1038/jcbfm.2008.82; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Wood NI, 1996, BEHAV BRAIN RES, V78, P113, DOI 10.1016/0166-4328(95)00237-5; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690	89	51	52	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93121	10.1371/journal.pone.0093121	http://dx.doi.org/10.1371/journal.pone.0093121			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664200	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900155
J	Ramachandran, VK; Shearer, N; Thompson, A				Ramachandran, Vinoy K.; Shearer, Neil; Thompson, Arthur			The Primary Transcriptome of Salmonella enterica Serovar Typhimurium and Its Dependence on ppGpp during Late Stationary Phase	PLOS ONE			English	Article							PATHOGENICITY ISLAND 2; III SECRETION SYSTEM; VIRULENCE GENE-EXPRESSION; BACTERIAL SIGNAL MOLECULE; ESCHERICHIA-COLI; SMALL RNAS; MYCOBACTERIUM-TUBERCULOSIS; ENVIRONMENTAL-REGULATION; LEGIONELLA-PNEUMOPHILA; STRINGENT RESPONSE	We have used differential RNA-seq (dRNA-seq) to characterise the transcriptomic architecture of S. Typhimurium SL1344, and its dependence on the bacterial alarmone, guanosine tetraphosphate (ppGpp) during late stationary phase, (LSP). Under LSP conditions we were able to identify the transcriptional start sites (TSSs) for 53% of the S. Typhimurium open reading frames (ORFs) and discovered 282 candidate non-coding RNAs (ncRNAs). The mapping of LSP TSSs enabled a detailed comparison with a previous dRNA-seq study of the early stationary phase (ESP) transcriptional architecture of S. Typhimurium SL1344 and its dependence on ppGpp. For the purposes of this study, LSP was defined as an aerobic LB culture grown to a later optical density reading (OD600 = 3.6) compared to ESP (OD600 = 2.3). The precise nucleotide positions of the majority of S. Typhimurium TSSs at LSP agreed closely with those identified at ESP. However, the identification of TSSs at different positions, or where additional or fewer TSSs were found at LSP compared to ESP enabled the genome-wide categorisation of growth phase dependent changes in promoter structure, the first time such an analysis has been done on this scale. Comparison of the ppGpp-dependency LSP and ESP TSSs for mRNAs and ncRNAs revealed a similar breadth of ppGpp-activation and repression. However, we note several ncRNAs previously shown to be involved in virulence were highly ppGpp-dependent at LSP. Finally, although SPI1 was expressed at ESP, we found SPI1 was not as highly expressed at LSP, instead we observed elevated expression of SPI2 encoded genes. We therefore also report an analysis of SPI2 transcriptional architecture at LSP resulting in localisation of SsrB binding sites and identification of a previously unreported SPI2 TSS. We also show that ppGpp is required for nearly all of SPI2 expression at LSP as well as for expression of SPI1 at ESP.	[Ramachandran, Vinoy K.] Univ Oxford, Dept Plant Sci, Oxford, England; [Shearer, Neil; Thompson, Arthur] Inst Food Res, Norwich NR4 7UA, Norfolk, England	University of Oxford; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Thompson, A (corresponding author), Inst Food Res, Norwich NR4 7UA, Norfolk, England.	arthur.thompson@ifr.ac.uk			Biotechnology Biological Science Research Council (BBSRC), UK; BBSRC [BB/F00978X/1]; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR5885, BB/F00978X/1, BBS/E/F/00044404, BBS/E/T/000PR6193] Funding Source: researchfish; BBSRC [BBS/E/T/000PR5885, BBS/E/T/000PR6193, BBS/E/F/00044404] Funding Source: UKRI	Biotechnology Biological Science Research Council (BBSRC), UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	NS and AT were supported by a core funded programme from the Biotechnology Biological Science Research Council (BBSRC), UK. VKR was supported by BBSRC grant number BB/F00978X/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026896; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Beuzon CR, 1999, MOL MICROBIOL, V33, P806, DOI 10.1046/j.1365-2958.1999.01527.x; Bittner M, 2002, MICROBIOL-SGM, V148, P3789, DOI 10.1099/00221287-148-12-3789; Bustamante VH, 2008, P NATL ACAD SCI USA, V105, P14591, DOI 10.1073/pnas.0801205105; Cabeza ML, 2007, J BACTERIOL, V189, P7335, DOI 10.1128/JB.00801-07; Coombes BK, 2004, J BIOL CHEM, V279, P49804, DOI 10.1074/jbc.M404299200; Croucher NJ, 2010, CURR OPIN MICROBIOL, V13, P619, DOI 10.1016/j.mib.2010.09.009; Dalebroux ZD, 2012, NAT REV MICROBIOL, V10, P203, DOI 10.1038/nrmicro2720; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; Dukan S, 1999, J BIOL CHEM, V274, P26027, DOI 10.1074/jbc.274.37.26027; Erickson DL, 2004, INFECT IMMUN, V72, P5638, DOI 10.1128/IAI.72.10.5638-5645.2004; Fass E, 2009, CURR OPIN MICROBIOL, V12, P199, DOI 10.1016/j.mib.2009.01.004; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Feng XH, 2003, MOL MICROBIOL, V48, P1131, DOI 10.1046/j.1365-2958.2003.03502.x; Figueira R, 2012, MICROBIOL-SGM, V158, P1147, DOI 10.1099/mic.0.058115-0; Frohlich KS, 2012, NUCLEIC ACIDS RES, V40, P3623, DOI 10.1093/nar/gkr1156; Golubeva YA, 2012, GENETICS, V190, P79, DOI 10.1534/genetics.111.132779; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Guillier M, 2006, MOL MICROBIOL, V59, P231, DOI 10.1111/j.1365-2958.2005.04929.x; Guillier M, 2008, NUCLEIC ACIDS RES, V36, P6781, DOI 10.1093/nar/gkn742; Hammer BK, 2002, MOL MICROBIOL, V44, P107, DOI 10.1046/j.1365-2958.2002.02884.x; Haralalka S, 2003, J BACTERIOL, V185, P4672, DOI 10.1128/JB.185.16.4672-4682.2003; Haugen SP, 2006, CELL, V125, P1069, DOI 10.1016/j.cell.2006.04.034; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; Hensel M, 1999, MOL MICROBIOL, V31, P489, DOI 10.1046/j.1365-2958.1999.01190.x; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Humphreys S, 1999, INFECT IMMUN, V67, P1560; Ismail TM, 2003, J BIOL CHEM, V278, P32602, DOI 10.1074/jbc.M305994200; Jiang Huiyuan, 2010, Weishengwu Xuebao, V50, P1537; Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902; Jonas K, 2009, FEMS MICROBIOL LETT, V297, P80, DOI 10.1111/j.1574-6968.2009.01661.x; Klinkenberg LG, 2010, J INFECT DIS, V202, P1397, DOI 10.1086/656524; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Lee DJ, 2012, ANNU REV MICROBIOL, V66, P125, DOI 10.1146/annurev-micro-092611-150012; Lucchetti-Miganeh C, 2008, MICROBIOL-SGM, V154, P16, DOI 10.1099/mic.0.2007/012286-0; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Minagawa S, 2003, J BACTERIOL, V185, P3696, DOI 10.1128/JB.185.13.3696-3702.2003; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; Moest TP, 2013, CURR OPIN MICROBIOL, V16, P38, DOI 10.1016/j.mib.2012.11.006; Moon K, 2009, MOL MICROBIOL, V74, P1314, DOI 10.1111/j.1365-2958.2009.06944.x; Nagy G, 2006, INFECT IMMUN, V74, P5914, DOI 10.1128/IAI.00619-06; Nairz M, 2009, BLOOD, V114, P3642, DOI 10.1182/blood-2009-05-223354; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Nystrom T, 2004, ANNU REV MICROBIOL, V58, P161, DOI 10.1146/annurev.micro.58.030603.123818; Oliver HF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-641; Padalon-Brauch G, 2008, NUCLEIC ACIDS RES, V36, P1913, DOI 10.1093/nar/gkn050; Papenfort K, 2008, MOL MICROBIOL, V68, P890, DOI 10.1111/j.1365-2958.2008.06189.x; Papenfort K, 2006, MOL MICROBIOL, V62, P1674, DOI 10.1111/j.1365-2958.2006.05524.x; Perez JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000428; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Pfeiffer V, 2007, MOL MICROBIOL, V66, P1174, DOI 10.1111/j.1365-2958.2007.05991.x; Pizarro-Cerda J, 2004, MOL MICROBIOL, V52, P1827, DOI 10.1111/j.1365-2958.2004.04122.x; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Ramachandran VK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-25; Ross W, 2013, MOL CELL, V50, P420, DOI 10.1016/j.molcel.2013.03.021; Sharma CM, 2007, GENE DEV, V21, P2804, DOI 10.1101/gad.447207; Sharma CM, 2011, MOL MICROBIOL, V81, P1144, DOI 10.1111/j.1365-2958.2011.07751.x; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Shi Liang, 2009, J Proteomics Bioinform, V2, P388; Song M, 2010, J MICROBIOL, V48, P89, DOI 10.1007/s12275-009-0179-6; Song MY, 2004, J BIOL CHEM, V279, P34183, DOI 10.1074/jbc.M313491200; Tani TH, 2002, P NATL ACAD SCI USA, V99, P13471, DOI 10.1073/pnas.212510999; Taylor CA, 2002, J BACTERIOL, V184, P621, DOI 10.1128/JB.184.3.621-628.2002; Thompson A, 2006, J BIOL CHEM, V281, P30112, DOI 10.1074/jbc.M605616200; Timmermans J, 2010, CELL MOL LIFE SCI, V67, P2897, DOI 10.1007/s00018-010-0381-z; Tomljenovic-Berube AM, PLOS GENET, V6; TORRIANI AM, 1990, BIOESSAYS, V12, P371, DOI 10.1002/bies.950120804; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; Walthers D, 2007, MOL MICROBIOL, V65, P477, DOI 10.1111/j.1365-2958.2007.05800.x; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Zhou YN, 1998, P NATL ACAD SCI USA, V95, P2908, DOI 10.1073/pnas.95.6.2908; Zusman T, 2002, J BACTERIOL, V184, P67, DOI 10.1128/JB.184.1.67-75.2002	77	25	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92690	10.1371/journal.pone.0092690	http://dx.doi.org/10.1371/journal.pone.0092690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664308	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900098
J	Tseng, MN; Chung, CL; Tzean, SS				Tseng, Min-Nan; Chung, Chia-Ling; Tzean, Shean-Shong			Mechanisms Relevant to the Enhanced Virulence of a Dihydroxynaphthalene-Melanin Metabolically Engineered Entomopathogen	PLOS ONE			English	Article							FUNGUS METARHIZIUM-ANISOPLIAE; BEAUVERIA-BASSIANA; PAECILOMYCES-FUMOSOROSEUS; COLLETOTRICHUM-LAGENARIUM; MAGNAPORTHE-GRISEA; BIOSYNTHESIS GENES; PATHOGENIC FUNGUS; FONSECAEA-PEDROSOI; STRESS TOLERANCE; TURGOR PRESSURE	The entomopathogenic fungus Metarhizium anisopliae MA05-169 is a transformant strain that has been metabolically engineered to express dihydroxynaphthalene-melanin biosynthesis genes. In contrast to the wild type strain, the transformant displays a greater resistance to environmental stress and a higher virulence toward target insect host. However, the underlying mechanisms for these characteristics remain unclear; hence experiments were initiated to explore the possible mechanism(s) through physiological and molecular approaches. Although both transformant and wild type strains could infect and share the same insect host range, the former germinated faster and produced more appressoria than the latter, both in vivo and in vitro. The transformant showed a significantly shorter median lethal time (LT50) when infecting the diamondback moth (Plutella xylostella) and the striped flea beetle (Phyllotreta striolata), than the wild type. Additionally, the transformant was more tolerant to reactive oxygen species (ROS), produced 40-fold more orthosporin and notably overexpressed the transcripts of the pathogenicity-relevant hydrolytic enzymes (chitinase, protease, and phospholipase) genes in vivo. In contrast, appressorium turgor pressure and destruxin A content were slightly decreased compared to the wild type. The transformant's high anti-stress tolerance, its high virulence against five important insect pests (cowpea aphid Aphis craccivora, diamondback moth Pl. xylostella, striped flea beetle Ph. striolata, and silverleaf whitefly Bemisia argentifolii) and its capacity to colonize the root system are key properties for its potential bio-control field application.	[Tseng, Min-Nan; Chung, Chia-Ling; Tzean, Shean-Shong] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan; [Tseng, Min-Nan] Council Agr, Execut Yuan, Kaohsiung Dist Agr Res & Extens Stn, Div Plant Protect, Pingtung, Taiwan	National Taiwan University	Tzean, SS (corresponding author), Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan.	sst@ntu.edu.tw		CHUNG, CHIA-LIN/0000-0002-1612-0109	National Science Council, Taiwan [NSC 102-2313-B002-006]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thanks the financial support from National Science Council, Taiwan by a grant (NSC 102-2313-B002-006).	Altre JA, 1999, J INVERTEBR PATHOL, V73, P332, DOI 10.1006/jipa.1999.4844; Altre JA, 2001, J INVERTEBR PATHOL, V78, P81, DOI 10.1006/jipa.2001.5046; Amparyup P, 2010, DEV COMP IMMUNOL, V34, P168, DOI 10.1016/j.dci.2009.09.004; Andre CM, 2010, CURR NUTR FOOD SCI, V6, P2, DOI 10.2174/157340110790909563; Arruda W, 2005, EXP APPL ACAROL, V37, P231, DOI 10.1007/s10493-005-3818-6; Bagga S, 2004, GENE, V324, P159, DOI 10.1016/j.gene.2003.09.031; Barnes SE, 1997, MYCOL RES, V101, P662, DOI 10.1017/S0953756296003152; Bechinger C, 1999, SCIENCE, V285, P1896, DOI 10.1126/science.285.5435.1896; Bergin D, 2005, INFECT IMMUN, V73, P4161, DOI 10.1128/IAI.73.7.4161-4170.2005; Bogo MR, 1998, CURR MICROBIOL, V37, P221, DOI 10.1007/s002849900368; Boucias D.G., 1991, P101; BOUCIAS DG, 1988, APPL ENVIRON MICROB, V54, P1795, DOI 10.1128/AEM.54.7.1795-1805.1988; Boucias DG, 2012, BIOCOMMUNICATION FUN, P305, DOI DOI 10.1007/978-94-007-4264-2_20; Braga GUL, 2001, PHOTOCHEM PHOTOBIOL, V74, P734, DOI 10.1562/0031-8655(2001)074&lt;0734:BSUAUR&gt;2.0.CO;2; Broetto L, 2010, FEMS MICROBIOL LETT, V312, P101, DOI 10.1111/j.1574-6968.2010.02103.x; BUTT TM, 1995, MYCOL RES, V99, P945, DOI 10.1016/S0953-7562(09)80754-5; Campos RA, 2005, CURR MICROBIOL, V50, P257, DOI 10.1007/s00284-004-4460-y; Chen ZJ, 2004, MYCOLOGIA, V96, P1199, DOI 10.2307/3762135; Cosentino-Gomes D, 2013, CURR MICROBIOL, V66, P467, DOI 10.1007/s00284-012-0296-z; Cunha MML, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-80; Cunha MML, 2005, MICROSC RES TECHNIQ, V68, P377, DOI 10.1002/jemt.20260; Czarna M, 2005, FEBS LETT, V579, P3136, DOI 10.1016/j.febslet.2005.04.081; Devi KU, 2012, BIOTECHNOLOGY OF FUNGAL GENES, P343; Doering TL, 1999, MED MYCOL, V37, P175, DOI 10.1046/j.1365-280X.1999.00218.x; Eisenman HC, 2012, APPL MICROBIOL BIOT, V93, P931, DOI 10.1007/s00253-011-3777-2; Engh I, 2007, FEMS MICROBIOL LETT, V275, P62, DOI 10.1111/j.1574-6968.2007.00867.x; ENOCHS WS, 1993, PIGM CELL RES, V6, P91, DOI 10.1111/j.1600-0749.1993.tb00587.x; Entz SC, 2008, BIOCONTROL, V53, P327, DOI 10.1007/s10526-006-9061-1; Fang WG, 2010, FUNGAL GENET BIOL, V47, P602, DOI 10.1016/j.fgb.2010.03.011; Fang WG, 2005, APPL ENVIRON MICROB, V71, P363, DOI 10.1128/AEM.71.1.363-370.2005; FROYD JD, 1976, PHYTOPATHOLOGY, V66, P1135, DOI 10.1094/Phyto-66-1135; Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000; Gorb S., 2001, ATTACHMENT DEVICES I; Gorman MJ, 2001, INSECT BIOCHEM MOLEC, V31, P257, DOI 10.1016/S0965-1748(00)00145-4; HALLOCK YF, 1988, PHYTOCHEMISTRY, V27, P3123, DOI 10.1016/0031-9422(88)80012-8; Harris JP, 2001, PHYTOCHEMISTRY, V57, P165, DOI 10.1016/S0031-9422(01)00004-8; Hillyer JF, 2010, DEV COMP IMMUNOL, V34, P141, DOI 10.1016/j.dci.2009.08.014; HOCH HC, 1987, SCIENCE, V235, P1659, DOI 10.1126/science.235.4796.1659; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; Hunt VL, 2011, J INSECT PHYSIOL, V57, P1341, DOI 10.1016/j.jinsphys.2011.06.008; Inyang EN, 1999, MYCOL RES, V103, P419, DOI 10.1017/S0953756298007333; Jacobson ES, 2005, MED MYCOL, V43, P327, DOI 10.1080/13693780412331271081; James RR, 2003, J INVERTEBR PATHOL, V84, P67, DOI 10.1016/j.jip.2003.08.006; Kavanagh K, 2004, FEMS MICROBIOL REV, V28, P101, DOI 10.1016/j.femsre.2003.09.002; KERRIGAN JE, 1995, J MED CHEM, V38, P544, DOI 10.1021/jm00003a017; Kershaw MJ, 1999, J INVERTEBR PATHOL, V74, P213, DOI 10.1006/jipa.1999.4884; Kihara J, 2008, FEMS MICROBIOL LETT, V281, P221, DOI 10.1111/j.1574-6968.2008.01101.x; Kubo Y, 1998, DEV PLANT PATHOL, V13, P253; KUBO Y, 1982, PHYTOPATHOLOGY, V72, P1198, DOI 10.1094/Phyto-77-1198; Kumar Susheel, 2008, V3, P365, DOI 10.1007/978-1-4020-8571-0_17; Lee In-Kyoung, 2006, Mycobiology, V34, P38, DOI 10.4489/MYCO.2006.34.1.038; Leger R, 1987, J GEN MICROBIOL, V133, P1371; LIU ZY, 1993, J INVERTEBR PATHOL, V62, P248, DOI 10.1006/jipa.1993.1107; Ment D, 2010, APPL ENVIRON MICROB, V76, P3521, DOI 10.1128/AEM.02596-09; Meyer EE, 2006, P NATL ACAD SCI USA, V103, P15739, DOI 10.1073/pnas.0606422103; Moon YS, 2008, APPL ENVIRON MICROB, V74, P4366, DOI 10.1128/AEM.00285-08; Nakazawa T, 2012, CHEMBIOCHEM, V13, P855, DOI 10.1002/cbic.201200107; Nappi AJ, 1995, EUR J CELL BIOL, V68, P450; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Nosanchuk JD, 2006, ANTIMICROB AGENTS CH, V50, P3519, DOI 10.1128/AAC.00545-06; Pochet L, 2004, CURR PHARM DESIGN, V10, P3781, DOI 10.2174/1381612043382684; Rangel DEN, 2006, J INVERTEBR PATHOL, V93, P170, DOI 10.1016/j.jip.2006.06.008; Rozanowska M, 1999, FREE RADICAL BIO MED, V26, P518, DOI 10.1016/S0891-5849(98)00234-2; Shah FA, 2005, FEMS MICROBIOL LETT, V251, P259, DOI 10.1016/j.femsle.2005.08.010; SMITH RJ, 1982, J INVERTEBR PATHOL, V39, P15, DOI 10.1016/0022-2011(82)90153-7; St Leger RJ, 2001, FUNGI BIOCONTROL AGE, P219; St Leger RJ, 2000, MYCOL RES; StLeger RJ, 1996, P NATL ACAD SCI USA, V93, P6349, DOI 10.1073/pnas.93.13.6349; Taborda CP, 2008, MYCOPATHOLOGIA, V165, P331, DOI 10.1007/s11046-007-9061-4; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; Tseng MN, 2011, APPL ENVIRON MICROB, V77, P4508, DOI 10.1128/AEM.02033-10; Tsuji G, 2000, MOL MICROBIOL, V38, P940, DOI 10.1046/j.1365-2958.2000.02181.x; Wang B, 2012, P NATL ACAD SCI USA, V109, P1287, DOI 10.1073/pnas.1115983109; Wang CS, 2007, J BIOL CHEM, V282, P21110, DOI 10.1074/jbc.M609592200; Wang CS, 2007, EUKARYOT CELL, V6, P808, DOI 10.1128/EC.00409-06; Wang QX, 2012, FITOTERAPIA, V83, P209, DOI 10.1016/j.fitote.2011.10.013; WANG YL, 1994, INFECT IMMUN, V62, P3004, DOI 10.1128/IAI.62.7.3004-3007.1994; Wheeler M, 2000, INFECT IMMUN, V68, P3696, DOI 10.1128/IAI.68.6.3696-3703.2000; WHITE LP, 1958, NATURE, V182, P1427, DOI 10.1038/1821427a0	81	15	16	8	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e90473	10.1371/journal.pone.0090473	http://dx.doi.org/10.1371/journal.pone.0090473			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662974	gold, Green Submitted, Green Published			2022-12-27	WOS:000333459900008
J	Wang, GF; Peng, DL; Gao, BL; Huang, WK; Kong, LG; Long, HB; Peng, H; Jian, H				Wang, Gaofeng; Peng, Deliang; Gao, Bingli; Huang, Wenkun; Kong, Lingan; Long, Haibo; Peng, Huan; Jian, Heng			Comparative Transcriptome Analysis of Two Races of Heterodera glycines at Different Developmental Stages	PLOS ONE			English	Article							SOYBEAN CYST-NEMATODE; GENE-EXPRESSION; RESISTANCE; HOST; IDENTIFICATION; INFECTION; SCHEME; DNA	The soybean cyst nematode, Heterodera glycines, is an important pest of soybeans. Although resistance is available against this nematode, selection for virulent races can occur, allowing the nematode to overcome the resistance of cultivars. There are abundant field populations, however, little is known about their genetic diversity. In order to elucidate the differences between races, we investigated the transcriptional diversity within race 3 and race 4 inbred lines during their compatible interactions with the soybean host Zhonghuang 13. Six different race-enriched cDNA libraries were constructed with limited nematode samples collected from the three sedentary stages, parasitic J2, J3 and J4 female, respectively. Among 689 putative race-enriched genes isolated from the six libraries with functional annotations, 92 were validated by quantitative RT-PCR (qRT-PCR), including eight putative effector encoding genes. Further race-enriched genes were validated within race 3 and race 4 during development in soybean roots. Gene Ontology (GO) analysis of all the race-enriched genes at J3 and J4 female stages showed that most of them functioned in metabolic processes. Relative transcript level analysis of 13 selected race-enriched genes at four developmental stages showed that the differences in their expression abundance took place at either one or more developmental stages. This is the first investigation into the transcript diversity of H. glycines races throughout their sedentary stages, increasing the understanding of the genetic diversity of H. glycines.	[Wang, Gaofeng; Peng, Deliang; Huang, Wenkun; Kong, Lingan; Long, Haibo; Peng, Huan] Chinese Acad Agr Sci, Inst Plant Protect, Key Lab Biol Insect Pests & Plant Dis, Beijing 100193, Peoples R China; [Wang, Gaofeng; Jian, Heng] China Agr Univ, Dept Plant Pathol, Beijing 100094, Peoples R China; [Gao, Bingli] Chinese Acad Sci, Shanghai Inst Biol Sci, Huzhou Modem Agr Biotechnol Innovat Ctr, Huzhou, Zhejiang, Peoples R China; [Long, Haibo] Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Key Lab Pests Comprehens Governance Trop Crops, Danzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; China Agricultural University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Tropical Agricultural Sciences	Peng, DL (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Key Lab Biol Insect Pests & Plant Dis, Beijing 100193, Peoples R China.	dlpeng@ippcaas.cn	Jian, Heng/Y-2845-2019		National Key Basic Research Program of China (973 Program) [2013CB127502]; Special Fund for Agro-scientific Research in the Public Interest [200903040]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest	This research work were supported by the National Key Basic Research Program of China (973 Program, 2013CB127502), the Special Fund for Agro-scientific Research in the Public Interest (No. 200903040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekal S, 2008, MOL GENET GENOMICS, V279, P535, DOI 10.1007/s00438-008-0331-8; Bellafiore S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000192; CALDWELL B. E., 1960, AGRON JOUR, V52, P635; Chang W, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-233; Concibido VC, 2004, CROP SCI, V44, P1121, DOI 10.2135/cropsci2004.1121; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; DeBoer JM, 1996, FUND APPL NEMATOL, V19, P545; Dubreuil G, 2007, NEW PHYTOL, V176, P426, DOI 10.1111/j.1469-8137.2007.02181.x; Elling AA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-58; Gao BL, 2004, MOL PLANT PATHOL, V5, P93, DOI 10.1111/J.1364-3703.2004.00209.X; GOLDEN A. M., 1970, Plant Disease Reporter, V54, P544; Grundler FMW, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P423, DOI 10.1007/978-94-007-0434-3_20; Hofmann J, 2010, PLANT J, V62, P1058, DOI 10.1111/j.1365-313X.2010.04217.x; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P293, DOI 10.1094/MPMI-20-3-0293; Klink VP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-111; Kong LA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002526; Li JB, 1996, FUND APPL NEMATOL, V19, P143; Liu SM, 2012, NATURE, V492, P256, DOI 10.1038/nature11651; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maier TR, 2013, MOL PLANT MICROBE IN, V26, P31, DOI 10.1094/MPMI-05-12-0121-FI; Niblack TL, 2002, J NEMATOL, V34, P279; POZDOL RF, 1984, J NEMATOL, V16, P332; RAOARELLI AP, 1992, CROP SCI, V32, P862, DOI 10.2135/cropsci1992.0011183X003200040005x; RAOARELLI AP, 1994, PLANT DIS, V78, P898, DOI 10.1094/PD-78-0898; Replogle A, 2011, PLANT J, V65, P430, DOI 10.1111/j.1365-313X.2010.04433.x; RIGGS RD, 1988, J NEMATOL, V20, P392; Schuster I, 2001, THEOR APPL GENET, V102, P91, DOI 10.1007/s001220051622; Shinya R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067377; Turner Susan J., 1998, P7; Wang CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015148; Wang JY, 2011, MOL PLANT PATHOL, V12, P177, DOI 10.1111/j.1364-3703.2010.00660.x; Wang JY, 2010, NEW PHYTOL, V187, P1003, DOI 10.1111/j.1469-8137.2010.03300.x; Wrather JA, 2006, J NEMATOL, V38, P173; Zheng JW, 2006, J NEMATOL, V38, P383	34	11	12	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91634	10.1371/journal.pone.0091634	http://dx.doi.org/10.1371/journal.pone.0091634			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662955	gold, Green Published, Green Submitted			2022-12-27	WOS:000333459900026
J	Wang, JM; Su, HX; Zhang, T; Du, J; Cui, S; Yang, F; Jin, Q				Wang, Jianmin; Su, Haoxiang; Zhang, Ting; Du, Jiang; Cui, Sheng; Yang, Fan; Jin, Qi			Inhibition of Enterovirus 71 Replication by 7-Hydroxyflavone and Diisopropyl-Flavon7-yl Phosphate	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; 3C PROTEASE; ANTIVIRAL ACTIVITY; MOUTH-DISEASE; IN-VITRO; CRYSTAL-STRUCTURE; VIRUS; PROTEINASE; INFECTION; RESPONSES	Enterovirus 71 (EV71) is the major causative agent of hand, foot, and mouth disease, which has been continuously prevalent in Asia in recent years. In children, severe cases can lead to death, and no prophylactic or therapeutic measures against EV71 infection are available. The 3C proteases of EV71 play an important role in viral replication and are an ideal drug target. In previous work, we resolved the crystal structure for EV71 3C(pro). In this report, we took advantage of the automated docking program AutoDock 4.0 to simulate EV71 3C(pro)-ligand conformation. 7-hydroxyflavone (HF) and its phosphate ester(FIP) were predicted to bind with EV71 3C(pro). In an in vitro protease inhibition assay, FIP inhibited EV71 3C(pro) protease activity. Both flavones were highly active against EV71, protecting cells from EV71 infection. Replication of viral RNA and formation of EV71 plaque were all strongly inhibited in cells. These results indicated that HF and FIP may serve as potential protective agents in the treatment of patients with chronic EV71 infection.	[Yang, Fan] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yang, F (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	ymf129@163.com; zdsys@vip.sina.com	Zhang, Ting/S-8215-2019; wang, jian/GVS-0711-2022; Sheng, CUI/M-6405-2013	Sheng, CUI/0000-0001-6329-3582	National Science and Technology Major Project of China [2013ZX10004-601, 2011ZX10004-001, 2013ZX10004-101]	National Science and Technology Major Project of China	The work was supported by the National Science and Technology Major Project of China (Project No. 2013ZX10004-601, No. 2011ZX10004-001 and No. 2013ZX10004-101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; ALLAIRE M, 1994, NATURE, V369, P72, DOI 10.1038/369072a0; Birtley JR, 2005, J BIOL CHEM, V280, P11520, DOI 10.1074/jbc.M413254200; Chen Xiao-lan, 2007, Yaoxue Xuebao, V42, P396; Chen XL, 2004, ANAL CHEM, V76, P211, DOI 10.1021/ac035027q; Cui S, 2011, J MOL BIOL, V408, P449, DOI 10.1016/j.jmb.2011.03.007; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; HARRIS KS, 1992, J VIROL, V66, P7481, DOI 10.1128/JVI.66.12.7481-7489.1992; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hu YC, 2003, BIOTECHNOL LETT, V25, P919, DOI 10.1023/A:1024071514438; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Hwang YC, 2006, APPL ENVIRON MICROB, V72, P3710, DOI 10.1128/AEM.72.5.3710-3715.2006; Johari J, 2012, INT J MOL SCI, V13, P16785, DOI 10.3390/ijms131216785; Jung HA, 2012, CHEM-BIOL INTERACT, V197, P110, DOI 10.1016/j.cbi.2012.04.004; Kehle J, 2003, J NEUROVIROL, V9, P126, DOI 10.1080/13550280390173364; Kuo CJ, 2008, BIOORGAN MED CHEM, V16, P7388, DOI 10.1016/j.bmc.2008.06.015; Lee CC, 2009, J BIOL CHEM, V284, P7646, DOI 10.1074/jbc.M807947200; Lei XB, 2013, J VIROL, V87, P1690, DOI 10.1128/JVI.01855-12; Lei XB, 2011, J VIROL, V85, P8811, DOI 10.1128/JVI.00447-11; Lei XB, 2010, J VIROL, V84, P8051, DOI 10.1128/JVI.02491-09; Li ML, 2002, VIROLOGY, V293, P386, DOI 10.1006/viro.2001.1310; Liu AL, 2008, BIOORGAN MED CHEM, V16, P7141, DOI 10.1016/j.bmc.2008.06.049; Lu GW, 2011, J VIROL, V85, P10319, DOI 10.1128/JVI.00787-11; Lyu SY, 2005, ARCH PHARM RES, V28, P1293, DOI 10.1007/BF02978215; MALCOLM BA, 1995, PROTEIN SCI, V4, P1439, DOI 10.1002/pro.5560040801; Malich G, 1997, TOXICOLOGY, V124, P179, DOI 10.1016/S0300-483X(97)00151-0; Matthews DA, 1999, P NATL ACAD SCI USA, V96, P11000, DOI 10.1073/pnas.96.20.11000; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mosimann SC, 1997, J MOL BIOL, V273, P1032, DOI 10.1006/jmbi.1997.1306; Nolan MA, 2003, NEUROLOGY, V60, P1651, DOI 10.1212/01.WNL.0000066810.62490.FF; Parsley TB, 1997, RNA, V3, P1124; Plevka P, 2012, SCIENCE, V336, P1274, DOI 10.1126/science.1218713; REED L. J., 1938, AMER JOUR HYG, V27, P493; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tyler KL, 2009, ARCH NEUROL-CHICAGO, V66, P939, DOI 10.1001/archneurol.2009.153; Wang JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038035; Wang J, 2011, J VIROL, V85, P10021, DOI 10.1128/JVI.05107-11; Wang XX, 2012, NAT STRUCT MOL BIOL, V19, P424, DOI 10.1038/nsmb.2255; Weng KF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000593; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Zandi K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-560; Zhang Shou-Bin, 2008, Zhongguo Dang Dai Er Ke Za Zhi, V10, P38; Zhang T, 2004, BIOORGAN MED CHEM, V12, P6097, DOI 10.1016/j.bmc.2004.09.013; Zhang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030259	46	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92565	10.1371/journal.pone.0092565	http://dx.doi.org/10.1371/journal.pone.0092565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664133	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900076
J	Li, LM; Yan, H; Feng, LP; Li, YL; Lu, P; Hu, YB; Chen, SY				Li, Lamei; Yan, Huan; Feng, Lipeng; Li, Yunlong; Lu, Pei; Hu, Yangbo; Chen, Shiyun			LcrQ Blocks the Role of LcrF in Regulating the Ysc-Yop Type III Secretion Genes in Yersinia pseudotuberculosis	PLOS ONE			English	Article							LOW-CALCIUM RESPONSE; TRANSCRIPTIONAL ACTIVATOR; VIRULENCE PLASMID; ESCHERICHIA-COLI; ARABINOSE OPERON; PYV PLASMID; ENTEROCOLITICA; EXPRESSION; PESTIS; SYSTEM	Pathogenic Yersinia species employ the Ysc-Yop type III secretion system (T3SS) encoded by a highly conserved pYV virulence plasmid to export the virulence effectors into host cells. The Ysc-Yop T3SS is tightly regulated by multiple contributing proteins that function at different levels. However, systematic transcriptional regulation analysis of Ysc-Yop T3SS is lacking and the detailed mechanism under this regulation process is still elusive. Aimed at systematically characterizing transcriptional regulations of all T3SS genes in Y. pseudotuberculosis, we amplified 97 non-coding fragments from the pYV plasmid and analyzed transcriptional responses of the T3SS genes under different growth conditions. Transcriptions of T3SS genes were induced at 37 degrees C and genes encoding T3SS effectors were highly induced by further depletion of Ca2+. The temperature induced gene transcription process is mediated by modules encoded on the chromosome, while the Ca2+ depletion-induced process is controlled by the positive regulatory protein LcrF as well as the negative regulatory protein LcrQ. In this process, LcrQ shares the same targets with LcrF and the effect of LcrQ is dependent on the presence of LcrF. Furthermore, over-expression of LcrF showed the same phenotype as that of the lcrQ mutant strain and intracellular amount balance of LcrQ and LcrF is important in T3SS regulation. When the expression level of LcrF exceeds LcrQ, expression of the Ysc-Yop T3SS genes is activated and vice versa. Together, these data support a model in which LcrQ blocks the activation role of LcrF in regulating the transcription of T3SS genes in Yersinia.	[Li, Lamei; Yan, Huan; Feng, Lipeng; Li, Yunlong; Lu, Pei; Hu, Yangbo; Chen, Shiyun] Chinese Acad Sci, Ctr Emerging Infect Dis, Wuhan Inst Virol, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Hu, YB (corresponding author), Chinese Acad Sci, Ctr Emerging Infect Dis, Wuhan Inst Virol, Wuhan, Peoples R China.	ybhu@wh.iov.cn; sychen@wh.iov.cn		hu, yang bo/0000-0001-6153-1348; chen, shi yun/0000-0002-6224-2975; Feng, Lipeng/0000-0003-1696-6435	National Science Foundation of China [31170133]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funded by the National Science Foundation of China (#31170133). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer AAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077767; Axler-DiPerte GL, 2006, J BACTERIOL, V188, P8033, DOI 10.1128/JB.01159-06; Axler-DiPerte GL, 2009, J BACTERIOL, V191, P514, DOI 10.1128/JB.01305-08; Balada-Llasat JM, 2006, PLOS PATHOG, V2, P816, DOI 10.1371/journal.ppat.0020086; Bohme K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002518; Cambronne ED, 2000, MOL MICROBIOL, V37, P263, DOI 10.1046/j.1365-2958.2000.01974.x; Cambronne ED, 2004, J BACTERIOL, V186, P829, DOI 10.1128/JB.186.3.829-841.2004; Cambronne ED, 2002, J BACTERIOL, V184, P5880, DOI 10.1128/JB.184.21.5880-5893.2002; Chen YQ, 2011, MOL MICROBIOL, V80, P966, DOI 10.1111/j.1365-2958.2011.07623.x; Cheng LW, 2000, J BACTERIOL, V182, P3183, DOI 10.1128/JB.182.11.3183-3190.2000; CHINA B, 1990, MOL MICROBIOL, V4, P1585, DOI 10.1111/j.1365-2958.1990.tb02070.x; CORNELIS G, 1989, J BACTERIOL, V171, P254, DOI 10.1128/jb.171.1.254-262.1989; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Costa TRD, 2010, J BIOL CHEM, V285, P25269, DOI 10.1074/jbc.M110.144311; Day JB, 2003, MOL MICROBIOL, V47, P807, DOI 10.1046/j.1365-2958.2003.03343.x; DEROUVROIT CL, 1992, MOL MICROBIOL, V6, P395, DOI 10.1111/j.1365-2958.1992.tb01483.x; Dewoody RS, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00004; HOE NP, 1992, J BACTERIOL, V174, P4275, DOI 10.1128/JB.174.13.4275-4286.1992; Hu YB, 2009, MICROBIOL-SGM, V155, P2522, DOI 10.1099/mic.0.028381-0; Jackson MW, 2004, MOL MICROBIOL, V54, P1364, DOI 10.1111/j.1365-2958.2004.04353.x; Joseph SS, 2007, ADV EXP MED BIOL, V603, P235; Juris SJ, 2002, CELL MICROBIOL, V4, P201, DOI 10.1046/j.1462-5822.2002.00182.x; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kopaskie KS, 2013, J BIOL CHEM, V288, P35478, DOI 10.1074/jbc.M113.504811; Lee VT, 1998, MOL MICROBIOL, V28, P593, DOI 10.1046/j.1365-2958.1998.00822.x; Li YL, 2014, MOL MICROBIOL, V91, P494, DOI 10.1111/mmi.12474; Navarro L, 2005, CURR OPIN MICROBIOL, V8, P21, DOI 10.1016/j.mib.2004.12.014; Nilles ML, 1997, J BACTERIOL, V179, P1307, DOI 10.1128/jb.179.4.1307-1316.1997; OToole R, 1996, MOL MICROBIOL, V19, P625, DOI 10.1046/j.1365-2958.1996.412927.x; RIMPILAINEN M, 1992, J BACTERIOL, V174, P3355, DOI 10.1128/jb.174.10.3355-3363.1992; Rohde JR, 1999, J BACTERIOL, V181, P4198, DOI 10.1128/JB.181.14.4198-4204.1999; ROHDE JR, 1994, MOL MICROBIOL, V12, P187, DOI 10.1111/j.1365-2958.1994.tb01008.x; Schiano CA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00129; Schleif R, 2010, FEMS MICROBIOL REV, V34, P779, DOI 10.1111/j.1574-6976.2010.00226.x; SKURNIK M, 1992, J BACTERIOL, V174, P2047, DOI 10.1128/jb.174.6.2047-2051.1992; Stainier I, 1997, MOL MICROBIOL, V26, P833, DOI 10.1046/j.1365-2958.1997.6281995.x; STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986; Urbanowski ML, 2005, P NATL ACAD SCI USA, V102, P9930, DOI 10.1073/pnas.0504405102; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; WATTIAU P, 1994, J BACTERIOL, V176, P3878, DOI 10.1128/JB.176.13.3878-3884.1994; Wulff-Strobel CR, 2002, MOL MICROBIOL, V43, P411, DOI 10.1046/j.1365-2958.2002.02752.x; YOTHER J, 1986, J BACTERIOL, V165, P443, DOI 10.1128/jb.165.2.443-447.1986	42	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92243	10.1371/journal.pone.0092243	http://dx.doi.org/10.1371/journal.pone.0092243			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658611	Green Submitted, Green Published, gold			2022-12-27	WOS:000333355300064
J	Park, MK; Cho, MK; Kang, SA; Park, HK; Kim, DH; Yu, HS				Park, Mi Kyung; Cho, Min Kyoung; Kang, Shin Ae; Park, Hye-Kyung; Kim, Dong-Hee; Yu, Hak Sun			Acanthamoeba Protease Activity Promotes Allergic Airway Inflammation via Protease-Activated Receptor 2	PLOS ONE			English	Article							DENDRITIC CELLS; EXPERIMENTAL SENSITIZATION; INDUCE; DIFFERENTIATION; EXPRESSION; SUBTILISIN; PHYSIOLOGY; CHEMOKINE; ADHESION; INNATE	Acanthamoeba is a free-living amoeba commonly present in the environment and often found in human airway cavities. Acanthamoeba possesses strong proteases that can elicit allergic airway inflammation. To our knowledge, the aeroallergenicity of Acanthamoeba has not been reported. We repeatedly inoculated mice with Acanthamoeba trophozoites or excretory-secretory (ES) proteins intra-nasally and evaluated symptoms and airway immune responses. Acanthamoeba trophozoites or ES proteins elicited immune responses in mice that resembled allergic airway inflammation. ES proteins had strong protease activity and activated the expression of several chemokine genes (CCL11, CCL17, CCL22, TSLP, and IL-25) in mouse lung epithelial cells. The serine protease inhibitor phenyl-methane-sulfonyl fluoride (PMSF) inhibited ES protein activity. ES proteins also stimulated dendritic cells and enhanced the differentiation of naive T cells into IL-4-secreting T cells. After repeated inoculation of the protease-activated receptor 2 knockout mouse with ES proteins, airway inflammation and Th2 immune responses were markedly reduced, but not to basal levels. Furthermore, asthma patients had higher Acanthamoeba-specific IgE titers than healthy controls and we found Acanthamoeba specific antigen from house dust in typical living room. Our findings suggest that Acanthamoeba elicits allergic airway symptoms in mice via a protease	[Park, Mi Kyung; Cho, Min Kyoung; Kang, Shin Ae; Yu, Hak Sun] Pusan Natl Univ, Sch Med, Dept Parasitol, Yangsan, South Korea; [Park, Mi Kyung; Kang, Shin Ae; Yu, Hak Sun] Immunoregulatory Therapeut Grp, Brain Busan Project 21, Pusan, South Korea; [Park, Hye-Kyung] Pusan Natl Univ, Sch Med, Dept Internal Med, Yangsan, South Korea; [Kim, Dong-Hee] Pusan Natl Univ, Coll Nursing, Dept Nursing, Yangsan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University	Yu, HS (corresponding author), Pusan Natl Univ, Sch Med, Dept Parasitol, Yangsan, South Korea.	hsyu@pusan.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012R1A1A2042979]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A2042979). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boitano S, 2011, AM J PHYSIOL-LUNG C, V300, pL605, DOI 10.1152/ajplung.00359.2010; Bouyer S, 2009, EXP PARASITOL, V123, P90, DOI 10.1016/j.exppara.2009.06.006; Chapman MD, 2007, CURR ALLERGY ASTHM R, V7, P363, DOI 10.1007/s11882-007-0055-6; Cho HJ, 2012, J ALLERGY CLIN IMMUN, V129, P529, DOI 10.1016/j.jaci.2011.11.024; CURSONS RTM, 1980, INFECT IMMUN, V29, P401; Dudley R, 2008, FEMS MICROBIOL LETT, V286, P9, DOI 10.1111/j.1574-6968.2008.01249.x; Feng T, 2010, J IMMUNOL, V185, P5915, DOI 10.4049/jimmunol.1001233; Ferreira GA, 2009, ACTA TROP, V112, P156, DOI 10.1016/j.actatropica.2009.07.015; HILLEBRAND JA, 1987, TOXICOL APPL PHARM, V89, P449, DOI 10.1016/0041-008X(87)90164-5; Imai T, 1999, INT IMMUNOL, V11, P81, DOI 10.1093/intimm/11.1.81; Jeong HJ, 2007, EXP PARASITOL, V117, P357, DOI 10.1016/j.exppara.2007.05.003; Jeong Hae Jin, 2005, Korean Journal of Parasitology, V43, P47, DOI 10.3347/kjp.2005.43.2.47; Kauffman HF, 2000, J ALLERGY CLIN IMMUN, V105, P1185, DOI 10.1067/mai.2000.106210; Kawabata A, 2005, J PHARMACOL SCI, V97, P20, DOI 10.1254/jphs.FMJ04005X4; Khan NA, 2000, J CLIN MICROBIOL, V38, P2858, DOI 10.1128/JCM.38.8.2858-2861.2000; Khan NA, 2006, FEMS MICROBIOL REV, V30, P564, DOI 10.1111/j.1574-6976.2006.00023.x; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kim Won-Tae, 2006, Korean Journal of Parasitology, V44, P321, DOI 10.3347/kjp.2006.44.4.321; Kim YS, 2013, CLIN EXP ALLERGY, V43, P443, DOI 10.1111/cea.12085; Leino MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071278; Lewkowich IP, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-122; Liang GQ, 2012, J ALLERGY CLIN IMMUN, V129, P1377, DOI 10.1016/j.jaci.2012.02.035; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Martinez AJ, 1996, MED MICROBIOLOGY; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; MITRO K, 1994, EXP PARASITOL, V78, P377, DOI 10.1006/expr.1994.1041; Muccioli M, 2011, JOVE-J VIS EXP, DOI 10.3791/2785; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Park HK, 2011, EXP PARASITOL, V127, P539, DOI 10.1016/j.exppara.2010.10.004; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Puxeddu I, 2006, J ALLERGY CLIN IMMUN, V117, P103, DOI 10.1016/j.jaci.2005.08.057; Ritter M, 2005, BIOCHEM BIOPH RES CO, V334, P254, DOI 10.1016/j.bbrc.2005.06.084; Roelandt T, 2008, J INVEST DERMATOL, V128, P1878, DOI 10.1038/jid.2008.168; Rothmeier AS, 2012, SEMIN IMMUNOPATHOL, V34, P133, DOI 10.1007/s00281-011-0289-1; Salazar F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00356; Schmidlin F, 2002, J IMMUNOL, V169, P5315, DOI 10.4049/jimmunol.169.9.5315; Serrano-Luna JD, 2006, CAN J MICROBIOL, V52, P16, DOI 10.1139/W05-114; Singh B, 2012, FEMS MICROBIOL REV, V36, P1122, DOI 10.1111/j.1574-6976.2012.00340.x; Sissons J, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-42; Takai T, 2005, INT ARCH ALLERGY IMM, V137, P194, DOI 10.1159/000086331; THORNE PS, 1986, TOXICOL APPL PHARM, V86, P112, DOI 10.1016/0041-008X(86)90404-7; Traynelis SF, 2007, CURR OPIN HEMATOL, V14, P230, DOI 10.1097/MOH.0b013e3280dce568; Tripathi P, 2011, IMMUNOBIOLOGY, V216, P402, DOI 10.1016/j.imbio.2010.06.009; Trujillo-Vargas CM, 2005, CLIN EXP ALLERGY, V35, P1003, DOI 10.1111/j.1365-2222.2005.02287.x; Vergnolle N, 1999, J IMMUNOL, V163, P5064; Yu HS, 2010, J KOREAN MED SCI, V25, P829, DOI 10.3346/jkms.2010.25.6.829; Zhou XX, 2012, J IMMUNOL, V188, P6046, DOI 10.4049/jimmunol.1102760	48	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92726	10.1371/journal.pone.0092726	http://dx.doi.org/10.1371/journal.pone.0092726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658532	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300122
J	Bui-Klimke, TR; Guclu, H; Kensler, TW; Yuan, JM; Wu, F				Bui-Klimke, Travis R.; Guclu, Hasan; Kensler, Thomas W.; Yuan, Jian-Min; Wu, Felicia			Aflatoxin Regulations and Global Pistachio Trade: Insights from Social Network Analysis	PLOS ONE			English	Article							EXPOSURE; RISK	Aflatoxins, carcinogenic toxins produced by Aspergillus fungi, contaminate maize, peanuts, and tree nuts in many regions of the world. Pistachios are the main source of human dietary aflatoxins from tree nuts worldwide. Over 120 countries have regulations for maximum allowable aflatoxin levels in food commodities. We developed social network models to analyze the association between nations' aflatoxin regulations and global trade patterns of pistachios from 1996-2010. The main pistachio producing countries are Iran and the United States (US), which together contribute to nearly 75% of the total global pistachio market. Over this time period, during which many nations developed or changed their aflatoxin regulations in pistachios, global pistachio trade patterns changed; with the US increasingly exporting to countries with stricter aflatoxin standards. The US pistachio crop has had consistently lower levels of aflatoxin than the Iranian crop over this same time period. As similar trading patterns have also been documented in maize, public health may be affected if countries without aflatoxin regulations, or with more relaxed regulations, continually import crops with higher aflatoxin contamination. Unlike the previous studies on maize, this analysis includes a dynamic element, examining how trade patterns change over time with introduction or adjustment of aflatoxin regulations.	[Bui-Klimke, Travis R.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Guclu, Hasan] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Guclu, Hasan] Univ Pittsburgh, Publ Hlth Dynam Lab, Pittsburgh, PA USA; [Kensler, Thomas W.] Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA; [Kensler, Thomas W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Yuan, Jian-Min] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Wu, Felicia] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [Wu, Felicia] Michigan State Univ, Dept Agr Food & Resource Econ, E Lansing, MI 48824 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Michigan State University; Michigan State University	Wu, F (corresponding author), Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA.	fwu@msu.edu	Bui, Travis/AAX-1983-2020; Kensler, Thomas W/D-8686-2014; Guclu, Hasan/B-7080-2008	Kensler, Thomas W/0000-0002-6676-261X; Guclu, Hasan/0000-0003-3582-9460; Yuan, Jian-Min/0000-0002-4620-3108	National Cancer Institute (NCI) of the National Institutes of Health (NIH) [5R01CA153073-2]; NATIONAL CANCER INSTITUTE [R01CA153073] Funding Source: NIH RePORTER	National Cancer Institute (NCI) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Cancer Institute (NCI) of the National Institutes of Health (NIH), Grant No. 5R01CA153073-2. The content is solely the responsibility of the authors and does not necessarily represent the official views of NCI or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay R, 2007, FOOD ADDIT CONTAM A, V24, P1109, DOI 10.1080/02652030701553251; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; De Nooy W., 2005, EXPLORATORY SOCIAL N; Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; FAO, 1997, WORLDW REG MYC 1995; FAO, 2004, WORLDW REG MYC FOOD; FAOSTAT, 2011, TOP PROD PIST 2010; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Groopman JD, 2008, ANNU REV PUBL HEALTH, V29, P187, DOI 10.1146/annurev.publhealth.29.020907.090859; International Agency for Research on Cancer (IARC), 2002, SOM TRAD HERB MED SO, V82, P171, DOI DOI 10.1016/J.CHEMOSPHERE.2009.12.012; JECFA (Joint FAO/WHO Expert Committee on Food Additives), 2007, WHO TECHN REP SER, V947; Kadushin C., 2012, UNDERSTANDING SOCIAL; Liu Y, 2012, EUR J CANCER, V48, P2125, DOI 10.1016/j.ejca.2012.02.009; Strosnider H, 2006, ENVIRON HEALTH PERSP, V114, P1898, DOI 10.1289/ehp.9302; [WHO] World Health Organization, 2013, GLOB HLTH OBS; Williams JH, 2004, AM J CLIN NUTR, V80, P1106, DOI 10.1093/ajcn/80.5.1106; Wu F, 2008, WORLD MYCOTOXIN J, V1, P95, DOI 10.3920/WMJ2008.x011; Wu F, 2004, ENVIRON SCI TECHNOL, V38, P4049, DOI 10.1021/es035353n; Wu F, 2013, RISK ANAL IN PRESS; Wu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045151	22	36	37	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92149	10.1371/journal.pone.0092149	http://dx.doi.org/10.1371/journal.pone.0092149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670581	Green Published, Green Accepted, gold			2022-12-27	WOS:000333677000032
J	Ignac, TM; Skupin, A; Sakhanenko, NA; Galas, DJ				Ignac, Tomasz M.; Skupin, Alexander; Sakhanenko, Nikita A.; Galas, David J.			Discovering Pair-Wise Genetic Interactions: An Information Theory-Based Approach	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MISSING HERITABILITY; EXPRESSION; PHENOTYPE; TRAIT	Phenotypic variation, including that which underlies health and disease in humans, results in part from multiple interactions among both genetic variation and environmental factors. While diseases or phenotypes caused by single gene variants can be identified by established association methods and family-based approaches, complex phenotypic traits resulting from multi-gene interactions remain very difficult to characterize. Here we describe a new method based on information theory, and demonstrate how it improves on previous approaches to identifying genetic interactions, including both synthetic and modifier kinds of interactions. We apply our measure, called interaction distance, to previously analyzed data sets of yeast sporulation efficiency, lipid related mouse data and several human disease models to characterize the method. We show how the interaction distance can reveal novel gene interaction candidates in experimental and simulated data sets, and outperforms other measures in several circumstances. The method also allows us to optimize case/control sample composition for clinical studies.	[Ignac, Tomasz M.; Skupin, Alexander; Galas, David J.] Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg; [Ignac, Tomasz M.; Sakhanenko, Nikita A.; Galas, David J.] Pacific Northwest Diabet Res Inst, Seattle, WA USA; [Skupin, Alexander] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA	University of Luxembourg; Pacific Northwest Diabetes Research Institute (PNDRI); University of California System; University of California San Diego	Ignac, TM (corresponding author), Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg.	tmignac@gmail.com		Sakhanenko, Nikita/0000-0001-6256-4643; SKUPIN, Alexander/0000-0002-8955-8304	"le plan Technologies de la Sante par le Gouvernment du Grand-Duche de Luxembourg" through Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg; NSF [IIS-1340619]	"le plan Technologies de la Sante par le Gouvernment du Grand-Duche de Luxembourg" through Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg; NSF(National Science Foundation (NSF))	This work has been funded by "le plan Technologies de la Sante par le Gouvernment du Grand-Duche de Luxembourg" through Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, and supported by NSF grant IIS-1340619. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Carter GW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100137; Carter GW, 2011, ENCY COMPLEXITY SYST, P9105; Chanda P, 2008, GENETICS, V180, P1191, DOI 10.1534/genetics.108.088542; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Drees BL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r38; Gerke J, 2009, SCIENCE, V323, P498, DOI 10.1126/science.1166426; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Guthery SL, 2007, AM J HUM GENET, V81, P1221, DOI 10.1086/522239; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Ignac T, 2012, P 9 INT WORKSH COMP, P39; Jakulin A., 2004, P 21 INT C MACH LEAR, P409; Li M, 2004, IEEE T INFORM THEORY, V50, P3250, DOI 10.1109/TIT.2004.838101; Li WT, 2000, HUM HERED, V50, P334, DOI 10.1159/000022939; Lorenz K, 2012, GENETICS, V192, P1123, DOI 10.1534/genetics.112.143107; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McGill WJ., 1954, PSYCHOMETRIKA, V19, P97, DOI 10.1007/BF02289159; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Sakhanenko N. A., 2011, P 8 INT WORKSH COMP, P161; Sakhanenko NA, 2010, J COMPUT BIOL, V17, P1491, DOI 10.1089/cmb.2010.0044; Tabangin Meredith E, 2009, BMC Proc, V3 Suppl 7, pS41, DOI 10.1186/1753-6561-3-S7-S41; TSUJISHITA T, 1995, ADV APPL MATH, V16, P269, DOI 10.1006/aama.1995.1013; Wang S, 2006, PLOS GENET, V2, P148, DOI 10.1371/journal.pgen.0020015; Wang SS, 2007, CIRC RES, V101, pE11, DOI 10.1161/CIRCRESAHA.107.152975; Zhu QQ, 2012, AM J HUM GENET, V91, P422, DOI 10.1016/j.ajhg.2012.07.010; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	29	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							c92310	10.1371/journal.pone.0092310	http://dx.doi.org/10.1371/journal.pone.0092310			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670935	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000038
J	Cui, R; Liu, ZQ; Xu, Q				Cui, Ran; Liu, Zhu-Qing; Xu, Qing			Blood alpha-Tocopherol, gamma-Tocopherol Levels and Risk of Prostate Cancer: A Meta-Analysis of Prospective Studies	PLOS ONE			English	Article							VITAMIN-E; SERUM MICRONUTRIENTS; TREND ESTIMATION; BETA-CAROTENE; RETINOL; ASSOCIATION; MEN	Background: Epidemiological studies that have examined the association of blood alpha-tocopherol and gamma-tocopherol (the principal bioactive form of vitamin E) levels with the risk of prostate cancer have yielded inconsistent results. In addition, a quantitative assessment of published studies is not available. Methods and Findings: In this meta-analysis, relevant studies were sought by a search of the PubMed and Embase databases for articles published up to October 2013, with no restrictions. Bibliographies from retrieved articles also were scoured to find further eligible studies. Prospective studies that reported adjusted relative risk (RR) estimates with 95% confidence intervals (CIs) for the association between blood tocopherol levels and the risk of prostate cancer were included. Nine nested case-control studies involving approximately 370,000 participants from several countries were eligible. The pooled RRs of prostate cancer for the highest versus lowest category of blood alpha-tocopherol levels were 0.79 (95% CI: 0.68-0.91), and those for gamma-tocopherol levels were 0.89 (95% CI: 0.71-1.12), respectively. Significant heterogeneity was present among the studies in terms of blood gamma-tocopherol levels (p = 0.008) but not in terms of blood alpha-tocopherol levels (p = 0.33). The risk of prostate cancer decreased by 21% for every 25-mg/L increase in blood alpha-tocopherol levels (RR: 0.79; 95% CI: 0.69-0.91). Conclusions: Blood alpha-tocopherol levels, but not gamma-tocopherol levels, were inversely associated with the risk of prostate cancer in this meta-analysis.	[Cui, Ran; Liu, Zhu-Qing; Xu, Qing] Tongji Univ, Sch Med, Dept Med Oncol, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China	Tongji University	Xu, Q (corresponding author), Tongji Univ, Sch Med, Dept Med Oncol, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China.	xuqingmd@gmail.com		XU, QING/0000-0002-4785-2994	National Natural Science Foundation of China [81374729]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This meta-analysis was supported by a grant (Grant No.: 81374729) from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brigelius-Flohe R, 2002, AM J CLIN NUTR, V76, P703, DOI 10.1093/ajcn/76.4.703; Chan JM, 1999, CANCER EPIDEM BIOMAR, V8, P893; Cheng TYD, 2011, J NUTR, V141, P1731, DOI 10.3945/jn.111.141713; Chopra RK, 1999, INT J VITAM NUTR RES, V69, P92, DOI 10.1024/0300-9831.69.2.92; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ERNSTER VL, 1994, PREV MED, V23, P587, DOI 10.1006/pmed.1994.1093; Ford ES, 2006, AM J CLIN NUTR, V84, P375; Gann PH, 1999, CANCER RES, V59, P1225; Gill Jasmeet K, 2009, Cancer Causes Control, V20, P1161, DOI 10.1007/s10552-009-9304-4; Goodman GE, 2003, CANCER EPIDEM BIOMAR, V12, P518; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Heinonen OP, 1998, J NATL CANCER I, V90, P440, DOI 10.1093/jnci/90.6.440; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HSING AW, 1990, J NATL CANCER I, V82, P941, DOI 10.1093/jnci/82.11.941; Huang HY, 2003, AM J EPIDEMIOL, V157, P335, DOI 10.1093/aje/kwf210; Jiang Q, 2001, AM J CLIN NUTR, V74, P714; Key TJ, 2007, AM J CLIN NUTR, V86, P672, DOI 10.1093/ajcn/86.3.672; Khandrika L, 2009, CANCER LETT, V282, P125, DOI 10.1016/j.canlet.2008.12.011; MEYDANI M, 1995, LANCET, V345, P170, DOI 10.1016/S0140-6736(95)90172-8; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nomura AMY, 1997, CANCER EPIDEM BIOMAR, V6, P487; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; PACKER L, 1991, AM J CLIN NUTR, V53, pS1050, DOI 10.1093/ajcn/53.4.1050S; Rodriguez C, 2004, CANCER EPIDEM BIOMAR, V13, P378; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Traber MG, 1999, ANNU REV NUTR, V19, P343, DOI 10.1146/annurev.nutr.19.1.343; Weinstein SJ, 2005, JNCI-J NATL CANCER I, V97, P396, DOI 10.1093/jnci/dji045; Weinstein SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040204	30	13	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93044	10.1371/journal.pone.0093044	http://dx.doi.org/10.1371/journal.pone.0093044			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667740	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600131
J	Lin, J; Yuan, YB; Zhang, MY				Lin, Jing; Yuan, Yongbo; Zhang, Mingyuan			Improved FTA Methodology and Application to Subsea Pipeline Reliability Design	PLOS ONE			English	Article								An innovative logic tree, Failure Expansion Tree (FET), is proposed in this paper, which improves on traditional Fault Tree Analysis (FTA). It describes a different thinking approach for risk factor identification and reliability risk assessment. By providing a more comprehensive and objective methodology, the rather subjective nature of FTA node discovery is significantly reduced and the resulting mathematical calculations for quantitative analysis are greatly simplified. Applied to the Useful Life phase of a subsea pipeline engineering project, the approach provides a more structured analysis by constructing a tree following the laws of physics and geometry. Resulting improvements are summarized in comparison table form.	[Lin, Jing; Yuan, Yongbo; Zhang, Mingyuan] Dalian Univ Technol, Dept Construct Management, Dalian, Peoples R China	Dalian University of Technology	Zhang, MY (corresponding author), Dalian Univ Technol, Dept Construct Management, Dalian, Peoples R China.	myzhang@dlut.edu.cn	ZHANG, Mingyuan/AAJ-4616-2020		National Natural Science Foundation of China [51208081]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This paper was funded by the National Natural Science Foundation of China under Grant No. 51208081. The authors also gratefully acknowledge the helpful comments and suggestions of the reviewers, which have improved the presentation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, 57605 BS; [Anonymous], 1992, PROC SAF MAN HIGHL H; Bhote KR, 2004, WORLD CLASS RELIABIL, P155; Ding YH, 2005, J LOSS PREVENT PROC, V18, P83, DOI 10.1016/j.jlp.2004.12.003; Ericson Clifton, 1999, 17 INT SYST SAF C; Gabaix X, 2006, Q J ECON, V121, P3; Heikkila AM, 1999, INHERENT SAFETY PROC, P32; Hoyle D, 2012, ISO 9000 QUALITY SYS; Javadi MS, 2011, INT J MULTIDISCIPLIN, V2, P6; Lin J, 2013, 2013 INT C IND ENG M; Morris D.V, 1991, P INT WORKSH OFFSH P; Muhlbauer W.K., 2004, PIPELINE RISK MANAGE; Peng D, 2008, RES SAFETY RELIABILI, P116; Peng k, 2007, APPL HUMAN ERROR ANA, P36; Rausand M, 2004, WILEY SERIES PROBABI, P50; Rausand M., 2004, WILEY SERIES PROBABI; Sarbes A, 1990, NUREG1150; Shingo S., 1986, ZERO QUALITY CONTROL; Wang Q, 2008, NATUR GASIND, V28, P5; Xie Y, 2007, RES RISK ASSESSMENT, p[12, 23]; Xie Yunjie, 2006, CHINA OFFSHORE OIL G, V18, P214; Xie Yunjie, 2007, RES RISK ASSESSMENT, P59; Xu PD, 2007, METHODOLOGY APPL RIS, P135; Zhou Q, 2012, FAILURE CAUSE EFFECT	24	8	8	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93042	10.1371/journal.pone.0093042	http://dx.doi.org/10.1371/journal.pone.0093042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667681	gold, Green Published, Green Submitted			2022-12-27	WOS:000333675600130
J	Lucas, CG; Griffiths, TL; Xu, F; Fawcett, C; Gopnik, A; Kushnir, T; Markson, L; Hu, JN				Lucas, Christopher G.; Griffiths, Thomas L.; Xu, Fei; Fawcett, Christine; Gopnik, Alison; Kushnir, Tamar; Markson, Lori; Hu, Jane			The Child as Econometrician: A Rational Model of Preference Understanding in Children	PLOS ONE			English	Article							DEMAND; LOGIT	Recent work has shown that young children can learn about preferences by observing the choices and emotional reactions of other people, but there is no unified account of how this learning occurs. We show that a rational model, built on ideas from economics and computer science, explains the behavior of children in several experiments, and offers new predictions as well. First, we demonstrate that when children use statistical information to learn about preferences, their inferences match the predictions of a simple econometric model. Next, we show that this same model can explain children's ability to learn that other people have preferences similar to or different from their own and use that knowledge to reason about the desirability of hidden objects. Finally, we use the model to explain a developmental shift in preference understanding.	[Lucas, Christopher G.] Univ Edinburgh, Sch Informat, Edinburgh, Midlothian, Scotland; [Griffiths, Thomas L.; Xu, Fei; Gopnik, Alison; Hu, Jane] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Fawcett, Christine] Uppsala Univ, Dept Psychol, Uppsala, Sweden; [Kushnir, Tamar] Cornell Univ, Dept Human Dev, Ithaca, NY USA; [Markson, Lori] Washington Univ, Dept Psychol, St Louis, MO 63130 USA	University of Edinburgh; University of California System; University of California Berkeley; Uppsala University; Cornell University; Washington University (WUSTL)	Lucas, CG (corresponding author), Univ Edinburgh, Sch Informat, Edinburgh, Midlothian, Scotland.	c.lucas@ed.ac.uk	Xu, Fei/AAP-9833-2021	Griffiths, Thomas/0000-0002-5138-7255; Fawcett, Christine/0000-0002-0898-9920; Kushnir, Tamar/0000-0002-7656-6292	AFOSR [FA9550-07-1-0351]; NSERC; SSHRC Canada; James S. McDonnell Foundation; National Science Foundation [IIS-0845410]; Direct For Social, Behav & Economic Scie [1023875] Funding Source: National Science Foundation	AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); SSHRC Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); James S. McDonnell Foundation; National Science Foundation(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported by AFOSR grant number FA9550-07-1-0351 (http://www.wpafb.af.mil/afrl/afosr/), NSERC (http://www.nserc-crsng.gc.ca/) and SSHRC (http://www.sshrc-crsh.gc.ca/Default.aspx) Canada, and the James S. McDonnell Foundation's Causal Learning Collaborative (http://www.jsmf.org/). In addition to the sources listed, it was funded by grant IIS-0845410 from the National Science Foundation (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J. R., 1990, ADAPTIVE CHARACTER T; Austerweil J.L., 2010, ADV NEURAL INFORM PR, V23, P82; Baker C., 2011, P 33 ANN C COGN SCI; Baker CL, 2009, COGNITION, V113, P329, DOI 10.1016/j.cognition.2009.07.005; Ben-Akiva M., 1997, MARKET LETT, V8, P273, DOI [10.1023/A:1007956429024, DOI 10.1023/A:1007956429024]; BOYD JH, 1980, TRANSPORT RES A-POL, V14, P367, DOI 10.1016/0191-2607(80)90055-2; Fawcett CA, 2010, DEV PSYCHOL, V46, P299, DOI 10.1037/a0018539; Goodman N. D., 2006, P 28 ANN C COGN SCI; Gopnik A, 2012, PSYCHOL BULL, V138, P1085, DOI 10.1037/a0028044; JEFFERYS WH, 1992, AM SCI, V80, P64; Kushnir T, 2010, PSYCHOL SCI, V21, P1134, DOI 10.1177/0956797610376652; Lucas CG., 2009, ADV NEURAL INFORM PR, P985; Luce R, 1959, INDIVIDUAL CHOICE BE; Ma LL, 2011, COGNITION, V120, P403, DOI 10.1016/j.cognition.2011.02.003; McFadden D, 1973, FRONTIERS ECONOMETRI; Repacholi BM, 1997, DEV PSYCHOL, V33, P12, DOI 10.1037/0012-1649.33.1.12; Revelt D, 1998, REV ECON STAT, V80, P647, DOI 10.1162/003465398557735; Seiver E, 2013, CHILD DEV, V84, P443, DOI 10.1111/j.1467-8624.2012.01865.x; SHEPARD RN, 1957, PSYCHOMETRIKA, V22, P325, DOI 10.1007/BF02288967; Skinner JD, 2002, J AM DIET ASSOC, V102, P1638, DOI 10.1016/S0002-8223(02)90349-4; TRAIN K, 1980, REV ECON STUD, V47, P357, DOI 10.2307/2296997; TRAIN KE, 1987, RAND J ECON, V18, P109, DOI 10.2307/2555538; TVERSKY A, 1972, PSYCHOL REV, V79, P281, DOI 10.1037/h0032955; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4	25	39	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92160	10.1371/journal.pone.0092160	http://dx.doi.org/10.1371/journal.pone.0092160			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SD	24667309	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000333675600024
J	Sharma, R; Panigrahi, P; Suresh, CG				Sharma, Ranu; Panigrahi, Priyabrata; Suresh, C. G.			In-Silico Analysis of Binding Site Features and Substrate Selectivity in Plant Flavonoid-3-O Glycosyltransferases (F3GT) through Molecular Modeling, Docking and Dynamics Simulation Studies	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CRYSTAL-STRUCTURES; ANTHOCYANIN BIOSYNTHESIS; UDP-GLUCOSE; AMINO-ACID; CLONING; CLASSIFICATION; EXPRESSION	Flavonoids are a class of plant secondary metabolites that act as storage molecules, chemical messengers, as well as participate in homeostasis and defense processes. They possess pharmaceutical properties important for cancer treatment such as antioxidant and anti-tumor activities. The drug-related properties of flavonoids can be improved by glycosylation. The enzymes glycosyltransferases (GTs) glycosylate acceptor molecules in a regiospecific manner with the help of nucleotide sugar donor molecules. Several plant GTs have been characterized and their amino acid sequences determined. However, three-dimensional structures of only a few are reported. Here, phylogenetic analysis using amino acid sequences have identified a group of GTs with the same regiospecific activity. The structures of these closely related GTs were modeled using homologous GT structures. Their substrate binding sites were elaborated by docking flavonoid acceptor and UDP-sugar donor molecules in the modeled structures. Eight regions near the acceptor binding site in the N- and C-terminal domain of GTs have been identified that bind and specifically glycosylate the 3-OH group of acceptor flavonoids. Similarly, a conserved motif in the C-terminal domain is known to bind a sugar donor substrate. In certain GTs, the substitution of a specific glutamine by histidine in this domain changes the preference of sugar from glucose to galactose as a result of changed pattern of interactions. The molecular modeling, docking, and molecular dynamics simulation studies have revealed the chemical and topological features of the binding site and thus provided insights into the basis of acceptor and donor recognition by GTs.	[Sharma, Ranu; Panigrahi, Priyabrata; Suresh, C. G.] Natl Chem Lab, CSIR, Div Biochem Sci, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Suresh, CG (corresponding author), Natl Chem Lab, CSIR, Div Biochem Sci, Pune, Maharashtra, India.	cg.suresh@ncl.res.in		Panigrahi, Priyabrata/0000-0002-2307-6337	Council of Scientific and Industrial Research (CSIR), New Delhi; CSIR-National Chemical Laboratory Centre of Excellence in Scientific Computing (CoESC)	Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India); CSIR-National Chemical Laboratory Centre of Excellence in Scientific Computing (CoESC)	1) Council of Scientific and Industrial Research (CSIR), New Delhi. 2) CSIR-National Chemical Laboratory Centre of Excellence in Scientific Computing (CoESC). The funding agencies have no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2012, SUIT 2012 LIGPREP VE; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gong ZZ, 1997, PLANT MOL BIOL, V35, P915, DOI 10.1023/A:1005959203396; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hirotani M, 2000, PLANTA, V210, P1006, DOI 10.1007/PL00008158; Hu YN, 2002, CHEM BIOL, V9, P1287, DOI 10.1016/S1074-5521(02)00295-8; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ikegami A, 2009, PLANTA, V230, P841, DOI 10.1007/s00425-009-0989-0; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kanadaswami C, 2005, IN VIVO, V19, P895; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li LN, 2007, J MOL BIOL, V370, P951, DOI 10.1016/j.jmb.2007.05.036; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Martonak R, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.075503; Masada S, 2007, FEBS LETT, V581, P2605, DOI 10.1016/j.febslet.2007.05.002; Mato M, 1998, PLANT CELL PHYSIOL, V39, P1145, DOI 10.1093/oxfordjournals.pcp.a029315; Miller KD, 1999, J BIOL CHEM, V274, P34011, DOI 10.1074/jbc.274.48.34011; Montefiori M, 2011, PLANT J, V65, P106, DOI 10.1111/j.1365-313X.2010.04409.x; Ogata J., 2004, PLANT BIOTECHNOL, V21, P367, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.21.367; Osmani SA, 2009, PHYTOCHEMISTRY, V70, P325, DOI 10.1016/j.phytochem.2008.12.009; Schrodinger Suite, 2011, SCHROD SUIT 2011 PRO; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shao H, 2005, PLANT CELL, V17, P3141, DOI 10.1105/tpc.105.035055; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka Y, 1996, PLANT CELL PHYSIOL, V37, P711, DOI 10.1093/oxfordjournals.pcp.a029004; Taniguchi N, 2003, HDB GLYCOSYLTRANSFER, V68, P707; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang XQ, 2009, FEBS LETT, V583, P3303, DOI 10.1016/j.febslet.2009.09.042; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yoshihara N, 2005, PLANT SCI, V169, P496, DOI 10.1016/j.plantsci.2005.04.007; Zhang ZD, 2003, PROTEIN SCI, V12, P2291, DOI 10.1110/ps.03131303	44	12	12	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92636	10.1371/journal.pone.0092636	http://dx.doi.org/10.1371/journal.pone.0092636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667893	Green Submitted, gold, Green Published			2022-12-27	WOS:000333675600057
J	Diao, HY; Cui, GY; Wei, YF; Chen, JN; Zuo, J; Cao, HC; Chen, Y; Yao, HP; Tian, ZG; Li, LJ				Diao, Hongyan; Cui, Guangying; Wei, Yingfeng; Chen, Jianing; Zuo, Jian; Cao, Hongcui; Chen, Yu; Yao, Hangping; Tian, Zhigang; Li, Lanjuan			Severe H7N9 Infection Is Associated with Decreased Antigen-Presenting Capacity of CD14(+) Cells	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; DR EXPRESSION; HLA-DR; PANDEMIC INFLUENZA; PERIPHERAL-BLOOD; VIRUS; H5N1; RESPONSES; FEATURES; IMMUNITY	The outbreak of H7N9 human infection has caused concern worldwide, but the immunological characteristics of infected patients and the determinants of diverse outcomes remain to be thoroughly understood. In this study, twenty-three patients with H7N9 infections were classified into severe and mild cases. We found that severe patients were commonly lymphopenic with significantly lower levels of T cells, monocytes and related cytokine levels compared to the mild cases. The expression of HLA-DR on CD14(+) cells were significantly lower in the severe infection group compared to the mild group (in acute phase: 34.65+/-4.88 vs. 10.37+/-1.69, p<0.001). Importantly, the expression of HLA-DR on CD14(+) cells was negatively correlated with H7N9 infection severity. Furthermore, although the phagocytosis capabilities of monocyte were similar between two groups, the monocytes of severe infection patients had a lower antigen-presenting capacity. And some in vitro experiments suggested that the impaired antigen-presenting function is associated with lower activation of T cells in responses to immune stimulation. Our present study suggested that the severe H7N9 patients were in a state of immune decrease which presented with general lymphopenia and low antigen-presenting capacity resulting in impaired T cell response. Additionally, HLA-DR levels of CD14(+) cells may be a potential biomarker for predicting H7N9 disease progression.	[Diao, Hongyan; Cui, Guangying; Wei, Yingfeng; Chen, Jianing; Zuo, Jian; Cao, Hongcui; Chen, Yu; Yao, Hangping; Li, Lanjuan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Diao, Hongyan; Cui, Guangying; Wei, Yingfeng; Chen, Jianing; Zuo, Jian; Cao, Hongcui; Chen, Yu; Yao, Hangping; Tian, Zhigang; Li, Lanjuan] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Tian, Zhigang] Univ Sci & Technol China, Med Ctr, Inst Immunol, Hefei 230026, Peoples R China	Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Diao, HY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	diaohy@zju.edu.cn; ljli@zju.edu.cn	Tian, Zhigang/J-3512-2013; Cao, Hongcui/AAE-1252-2019; Chen, Yi/HIR-2608-2022; Chen, Yu/Y-3292-2019	Cao, Hongcui/0000-0002-6604-6867; 	National Natural Science Foundation of China [81271810]; China National Mega-projects for Infectious Diseases [2012ZX10004-210]; Doctoral Fund of Ministry of Education of China [20120101110009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Mega-projects for Infectious Diseases; Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This study was funded by the National Natural Science Foundation of China (No. 81271810), the China National Mega-projects for Infectious Diseases (2012ZX10004-210), and Doctoral Fund of Ministry of Education of China (20120101110009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 2007, NAT IMMUNOL, V8, P1188, DOI 10.1038/ni1530; Antoniades CG, 2006, HEPATOLOGY, V44, P34, DOI 10.1002/hep.21240; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Challen K, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-33; Chen XR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073362; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cusick MF, 2009, J IMMUNOL, V183, P6432, DOI 10.4049/jimmunol.0901617; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fox A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031535; Gao HN, N ENGL J MED, V368, P2277; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; GIBBONS RA, 1989, CLIN EXP IMMUNOL, V75, P371; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Hynninen M, 2003, SHOCK, V20, P1, DOI 10.1097/01.shk.0000068322.08268.b4; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Liu Q, 2013, MICROBES INFECT, V15, P432, DOI 10.1016/j.micinf.2013.04.004; Margalit M, 2005, AM J PHYSIOL-GASTR L, V289, pG917, DOI 10.1152/ajpgi.00105.2005; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Peter J, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-37; Ramos I, 2012, VIRUSES-BASEL, V4, P3363, DOI 10.3390/v4123363; Sauty A, 1999, J IMMUNOL, V162, P3549; Tschaikowsky K, 2002, CRIT CARE MED, V30, P1015, DOI 10.1097/00003246-200205000-00010; Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111; WHO, 2014, WHO RISK ASS 21 JAN; Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhang DP, 2009, EUR J NEUROL, V16, P498, DOI 10.1111/j.1468-1331.2008.02512.x; Zhao Y, 2012, AM J RESP CRIT CARE, V186, P1292, DOI 10.1164/rccm.201207-1245OC; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379	30	32	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92823	10.1371/journal.pone.0092823	http://dx.doi.org/10.1371/journal.pone.0092823			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664315	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900120
J	Kim, SB; Yoon, M; Ku, NS; Kim, MH; Song, JE; Ahn, JY; Jeong, SJ; Kim, C; Kwon, HD; Lee, J; Smith, DM; Choi, JY				Kim, Sun Bean; Yoon, Myoungho; Ku, Nam Su; Kim, Min Hyung; Song, Je Eun; Ahn, Jin Young; Jeong, Su Jin; Kim, Changsoo; Kwon, Hee-Dae; Lee, Jeehyun; Smith, Davey M.; Choi, Jun Yong			Mathematical Modeling of HIV Prevention Measures Including Pre-Exposure Prophylaxis on HIV Incidence in South Korea	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; MORTALITY; MEN; INFECTION; EFFICACY; SAFETY; NEED; SEX	Background: Multiple prevention measures have the possibility of impacting HIV incidence in South Korea, including early diagnosis, early treatment, and pre-exposure prophylaxis (PrEP). We investigated how each of these interventions could impact the local HIV epidemic, especially among men who have sex with men (MSM), who have become the major risk group in South Korea. A mathematical model was used to estimate the effects of each these interventions on the HIV epidemic in South Korea over the next 40 years, as compared to the current situation. Methods: We constructed a mathematical model of HIV infection among MSM in South Korea, dividing the MSM population into seven groups, and simulated the effects of early antiretroviral therapy (ART), early diagnosis, PrEP, and combination interventions on the incidence and prevalence of HIV infection, as compared to the current situation that would be expected without any new prevention measures. Results: Overall, the model suggested that the most effective prevention measure would be PrEP. Even though PrEP effectiveness could be lessened by increased unsafe sex behavior, PrEP use was still more beneficial than the current situation. In the model, early diagnosis of HIV infection was also effectively decreased HIV incidence. However, early ART did not show considerable effectiveness. As expected, it would be most effective if all interventions (PrEP, early diagnosis and early treatment) were implemented together. Conclusions: This model suggests that PrEP and early diagnosis could be a very effective way to reduce HIV incidence in South Korea among MSM.	[Kim, Sun Bean; Ku, Nam Su; Kim, Min Hyung; Song, Je Eun; Ahn, Jin Young; Jeong, Su Jin; Choi, Jun Yong] Yonsei Univ, Coll Med, Dept Internal Med, Div Infect Dis,Severance Hosp, Seoul, South Korea; [Kim, Sun Bean; Ku, Nam Su; Kim, Min Hyung; Song, Je Eun; Ahn, Jin Young; Jeong, Su Jin; Choi, Jun Yong] Yonsei Univ, Coll Med, Severance Hosp, AIDS Res Inst, Seoul, South Korea; [Yoon, Myoungho] Yonsei Univ, Dept Math, Seoul 120749, South Korea; [Kim, Changsoo] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Kwon, Hee-Dae] Inha Univ, Dept Math, Inchon, South Korea; [Lee, Jeehyun] Yonsei Univ, Dept Computat Sci & Engn, Seoul 120749, South Korea; [Smith, Davey M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Smith, Davey M.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System; Inha University; Yonsei University; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Choi, JY (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Infect Dis,Severance Hosp, Seoul, South Korea.	SERAN@yuhs.ac		Choi, Jun Yong/0000-0002-2775-3315; Jeong, Su Jin/0000-0003-4025-4542; Kim, Sun Bean/0000-0002-8830-1144; Smith, Davey/0000-0003-3603-1733; a, gokul/0000-0003-2226-4691; Kim, Changsoo/0000-0002-5940-5649; Ku, Nam Su/0000-0002-9717-4327	National Research Foundation of Korea; Korean Government [NRF-2011-220-E00015, NRF-2012R1A1A2005605]; Chronic Infectious Disease Cohort from Korea Centers for Disease Control and Prevention [4800-4859-304-260]; NIH [DA034978, AI100665]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI100665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA034978] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government); Chronic Infectious Disease Cohort from Korea Centers for Disease Control and Prevention; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-2011-220-E00015). The work of HDK was supported by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-2012R1A1A2005605) and a grant from Chronic Infectious Disease Cohort (4800-4859-304-260) from Korea Centers for Disease Control and Prevention. DMS's involvement was supported by NIH grants DA034978 and AI100665. The funders had a major role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arasteh K, 2009, ANTIVIR THER, V14, P859, DOI 10.3851/IMP1301; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Choe KW, 2007, J KOREAN MED ASSOC, V50, P296, DOI 10.5124/jkma.2007.50.4.296; Choe PG, 2011, J INFECTION, V63, P60, DOI 10.1016/j.jinf.2011.05.002; Clements MS, 2004, JAIDS-J ACQ IMM DEF, V35, P401, DOI 10.1097/00126334-200404010-00010; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Costagliola D, 2012, LANCET INFECT DIS, V12, P119, DOI 10.1016/S1473-3099(11)70248-1; de Ven PV, 1999, AIDS, V13, P2289, DOI 10.1097/00002030-199911120-00011; Gilmour S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043473; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Ichikawa S, 2011, SEX HEALTH, V8, P123, DOI 10.1071/SH10073; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Katlama C, 2010, ANTIVIR THER, V15, P1045, DOI 10.3851/IMP1662; Kee MK, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-128; Keller SB, 2011, AIDS, V25, P2308, DOI 10.1097/QAD.0b013e32834d3cab; Korea Centers for Disease Control and Prevention (KCDC), 2012, AN HIV AIDS NOT KOR, P5; Korea Centers of Diseasce Control and Prevention, 2020, ANN REPORT NOTIFIED; 김명수, 2007, Infection and Chemotherapy, V39, P142; Law MG, 2001, AIDS, V15, P1287, DOI 10.1097/00002030-200107060-00011; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Li HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023431; Lodi S, 2011, CLIN INFECT DIS, V53, P817, DOI 10.1093/cid/cir494; Maxmen A, 2012, NATURE, V487, P283, DOI 10.1038/487283a; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Moore DM, 2005, JAIDS-J ACQ IMM DEF, V40, P288, DOI 10.1097/01.qai.0000182847.38098.d1; Myers GM, 2011, AIDS PATIENT CARE ST, V25, P63, DOI 10.1089/apc.2010.0222; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Siegfried N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008272.pub2; Smith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65; Van de Ven P, 2000, AIDS, V14, P2951, DOI 10.1097/00002030-200012220-00023; Yang BM, 2004, 7 INT AIDS S; Zhou JL, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/375217	34	40	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e90080	10.1371/journal.pone.0090080	http://dx.doi.org/10.1371/journal.pone.0090080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662776	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900005
J	Li, YH; Yu, B; Duan, ZZ; Akinyi, OM; Yu, JH; Zhou, K; Zhang, Y; Gao, XM				Li, Yu Hong; Yu, Bin; Duan, Zhen Zhen; Akinyi, Olunga Mary; Yu, Jia Hui; Zhou, Kun; Zhang, Yue; Gao, Xiu Mei			The Coronary Dilation Effect of Shen Fu Injection Was Mediated through NO	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ISCHEMIA/REPERFUSION INJURY; CARDIOVASCULAR-SYSTEM; ISCHEMIA-REPERFUSION; PERFUSION PRESSURE; ENDOTHELIAL-CELLS; CARDIAC-FUNCTION; GINSENOSIDE RB1; RAT-HEART; IN-VIVO	Objectives: Shen Fu Injection (SF), which consisted of Red ginseng extraction injection (RG) and prepared aconite extraction injection (RA), is a traditional Chinese medicine mainly used for various cardiac diseases. This study is to analyse SF's effects on cardiac performance and coronary circulation. And the coronary dilating effect and mechanism of the above three injections were also explored. Methods: Mature male guinea pigs were used as our animal model. We employed two types of perfusion methods (constant pressure and constant flow) in vitro, using Langendorff heart preparations to observe the cardiac function and coronary response to SF (1/200). The coronary dilation effects of the above three injections (1/800, 1/400 and 1/200) were recorded at basal coronary resting tone and when coronary vessels were pre-contracted with a thromboxane A2 analogue (U46619), in the presence or the absence of the inhibitor of nitric oxide synthesis (L-NAME, 10(-4) M), the blocker of Ca2+-activated potassium channel(TEA, 10(-3) M), or the blocker of adenosine triphosphate (ATP)-sensitive potassium channel (glybenclamide) (10(-5) M). Results: When perfused with constant pressure, SF significantly increased coronary flow, left ventricular developed pressure (LVDP) and the rate-pressure product (RPP). When perfused with constant flow, SF produced a significant reduction in the coronary perfusion pressure (CPP), LVDP and RPP. The coronary vasodilatation response of the above three injections can be reduced by L-NAME but was unaffected by TEA or glybenclamide when coronary vessels were pre-contracted with U46619 but not at resting tone. SF, RG and RA can all up-regulate eNOS expression in the human umbilical vein cells (EA.hy926). Conclusion: We demonstrated that SF does not contribute to the inotropic change of myocardium whose improvement is due to alternation of coronary flow. The coronary dilation effect of SF was mediated through RG and RA, via promoting NO release.	[Li, Yu Hong; Yu, Bin; Duan, Zhen Zhen; Akinyi, Olunga Mary; Yu, Jia Hui; Zhou, Kun; Zhang, Yue; Gao, Xiu Mei] Tianjin Univ Tradit Chinese Med, State Key Lab Modern Chinese Med, Tianjin, Peoples R China; [Li, Yu Hong; Yu, Bin; Duan, Zhen Zhen; Akinyi, Olunga Mary; Yu, Jia Hui; Zhou, Kun; Zhang, Yue; Gao, Xiu Mei] Tianjin Univ Tradit Chinese Med, Minist Educ, Key Lab Pharmacol Tradit Chinese Med Formulae, Tianjin, Peoples R China; [Li, Yu Hong; Yu, Bin; Duan, Zhen Zhen; Akinyi, Olunga Mary; Yu, Jia Hui; Zhou, Kun; Zhang, Yue; Gao, Xiu Mei] Tianjin Univ Tradit Chinese Med, Inst Tradit Chinese Med Res, Tianjin, Peoples R China; [Gao, Xiu Mei] Tianjin Univ Tradit Chinese Med, State Key Lab Modern Chinese Med, Minist Educ, Key Lab Pharmacol Tradit Chinese Med Formulae, Tianjin, Peoples R China	Tianjin University of Traditional Chinese Medicine; Tianjin University of Traditional Chinese Medicine; Tianjin University of Traditional Chinese Medicine; Tianjin University of Traditional Chinese Medicine	Gao, XM (corresponding author), Tianjin Univ Tradit Chinese Med, State Key Lab Modern Chinese Med, Tianjin, Peoples R China.	gaoxiumei@tjutcm.edu.cn			National Basic Research Program of China [2012CB518400, 2012CB518404]; National Natural Science Foundation of China [81202779]; Tianjin Science and Technology Developmeng Fund for Colleges and Universities [2011ZD01]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Science and Technology Developmeng Fund for Colleges and Universities	This work was supported by the financial support from the National Basic Research Program of China(2012CB518400) to (2012CB518404) http://www.973.gov.cn/AreaAppl.aspx; The National Natural Science Foundation of China (81202779); http://www.nsfc.gov.cn/Portal0/default166.htm. Tianjin Science and Technology Developmeng Fund for Colleges and Universities (2011ZD01). http://www.tstc.gov.cn/english. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD G, 1968, PFLUG ARCH EUR J PHY, V299, P339, DOI 10.1007/BF00602910; Bak MJ, 2012, MOLECULES, V17, P13769, DOI 10.3390/molecules171213769; Cao J, 2005, CHINESE MED J-PEKING, V118, P505; Chen IJ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/595271; Chen X, 1996, CLIN EXP PHARMACOL P, V23, P728, DOI 10.1111/j.1440-1681.1996.tb01767.x; Choi KT, 2008, ACTA PHARMACOL SIN, V29, P1109, DOI 10.1111/j.1745-7254.2008.00869.x; Chong Won-Seog, 1998, Korean Journal of Physiology and Pharmacology, V2, P323; Deng J, 2010, BIOL PHARM BULL, V33, P631, DOI 10.1248/bpb.33.631; DUBE GP, 1995, J PHARMACOL EXP THER, V272, P799; Favaloro JL, 2007, CARDIOVASC RES, V73, P587, DOI 10.1016/j.cardiores.2006.11.018; GREGG DE, 1963, CIRC RES, V13, P497, DOI 10.1161/01.RES.13.6.497; Guo Liang, 2009, Journal of Pharmacological and Toxicological Methods, V60, P130, DOI 10.1016/j.vascn.2009.07.002; Hambrecht R, 2003, CIRCULATION, V107, P3152, DOI 10.1161/01.CIR.0000074229.93804.5C; Han JY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/479016; Ji XF, 2011, SHOCK, V35, P530, DOI 10.1097/SHK.0b013e31820e2058; Montoya JJ, 2011, J CARDIOVASC PHARM, V58, P392, DOI 10.1097/FJC.0b013e318226bcf7; Li HX, 2012, PHYTOMEDICINE, V19, P477, DOI 10.1016/j.phymed.2012.01.002; Liao RL, 2012, AM J PHYSIOL-HEART C, V303, pH156, DOI 10.1152/ajpheart.00333.2012; Liu CH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/408187; Garcia-Villalon AL, 2011, EUR J PHARMACOL, V660, P394, DOI 10.1016/j.ejphar.2011.04.006; Luo X.Y., 2009, CHINESE J INTEGRATED, V8, P685; MANTELLI L, 1992, EUR J PHARMACOL, V213, P79, DOI 10.1016/0014-2999(92)90235-V; McLean PG, 2002, CIRC RES, V90, P465, DOI 10.1161/hh0402.105372; Meng XZ, 1997, SHOCK, V7, P111, DOI 10.1097/00024382-199702000-00007; Mishra RC, 2013, CARDIOVASC RES, V97, P339, DOI 10.1093/cvr/cvs326; Morrison RR, 2006, AM J PHYSIOL-HEART C, V291, pH1875, DOI 10.1152/ajpheart.00158.2005; NISHIDA M, 1993, AM J PHYSIOL, V264, pH639, DOI 10.1152/ajpheart.1993.264.2.H639; Niu C., 2004, ZHONG YAO YAO LI YU, V20, P23; Peng L, 2012, CARDIOVASC THER, V30, pe183, DOI 10.1111/j.1755-5922.2011.00271.x; Ponto LLB, 2004, J CLIN PHARMACOL, V44, P751, DOI 10.1177/0091270004265699; Popovich DG, 2011, INT J BIOMEDICAL PHA, V6, P56; SAKUMA I, 1989, CAN J PHYSIOL PHARM, V67, P943, DOI 10.1139/y89-148; SHIBATA S, 1963, CHEM PHARM BULL, V11, P762; Shouyuan T, 2009, CHINESE J INTEGRATIV, V7, P1317; Skrzypiec-Spring Monika, 2007, Journal of Pharmacological and Toxicological Methods, V55, P113, DOI 10.1016/j.vascn.2006.05.006; Stowe DF, 1996, AM J PHYSIOL-HEART C, V271, pH1884, DOI 10.1152/ajpheart.1996.271.5.H1884; Wen-Ting S, 2012, EVID-BASED COMPL ALT, V2012; Yang Fang-ju, 2003, Zhongguo Zhongyao Zazhi, V28, P259; Yi XQ, 2010, PHYTOMEDICINE, V17, P1006, DOI 10.1016/j.phymed.2010.06.012; Yoshimura M, 1998, HUM GENET, V103, P65, DOI 10.1007/s004390050785; Yoshizaki K, 2012, CHEM PHARM BULL, V60, P354, DOI 10.1248/cpb.60.354; Yu J, 2007, BIOCHEM BIOPH RES CO, V353, P764, DOI 10.1016/j.bbrc.2006.12.119; ZeLong H, 2001, CHINESE J INTEGRATIV, V21, P386; Zhao DD, 2012, J TRADIT CHIN MED, V32, P308, DOI 10.1016/S0254-6272(13)60030-8; Zheng CD, 2008, CHIN J INTEGR MED, V14, P10, DOI 10.1007/s11655-008-0010-y; Zhou Su-juan, 2003, Zhongguo Zhongyao Zazhi, V28, P910; Zhou W, 2005, J VASC SURG, V41, P861, DOI 10.1016/j.jvs.2005.01.054; Zhu J, 2013, PLOS ONE, V30, P8	48	14	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92415	10.1371/journal.pone.0092415	http://dx.doi.org/10.1371/journal.pone.0092415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662941	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900061
J	Al-Thani, R; Al-Najjar, MAA; Al-Raei, AM; Ferdelman, T; Thang, NM; Al Shaikh, I; Al-Ansi, M; de Beer, D				Al-Thani, Roda; Al-Najjar, Mohammad A. A.; Al-Raei, Abdul Munem; Ferdelman, Tim; Thang, Nguyen M.; Al Shaikh, Ismail; Al-Ansi, Mehsin; de Beer, Dirk			Community Structure and Activity of a Highly Dynamic and Nutrient-Limited Hypersaline Microbial Mat in Um Alhool Sabkha, Qatar	PLOS ONE			English	Article							SOLAR LAKE SINAI; SULFATE REDUCTION; EUKARYOTIC DIVERSITY; CYANOBACTERIAL MATS; OXYGEN-CONSUMPTION; MARINE-SEDIMENTS; MICROSENSOR; BACTERIAL; PHOTOSYNTHESIS; ARCHAEAL	The Um Alhool area in Qatar is a dynamic evaporative ecosystem that receives seawater from below as it is surrounded by sand dunes. We investigated the chemical composition, the microbial activity and biodiversity of the four main layers (L1-L4) in the photosynthetic mats. Chlorophyll a (Chl a) concentration and distribution (measured by HPLC and hyperspectral imaging, respectively), the phycocyanin distribution (scanned with hyperspectral imaging), oxygenic photosynthesis (determined by microsensor), and the abundance of photosynthetic microorganisms (from 16S and 18S rRNA sequencing) decreased with depth in the euphotic layer (L1). Incident irradiance exponentially attenuated in the same zone reaching 1% at 1.7-mm depth. Proteobacteria dominated all layers of the mat (24%-42% of the identified bacteria). Anoxygenic photosynthetic bacteria (dominated by Chloroflexus) were most abundant in the third red layer of the mat (L3), evidenced by the spectral signature of Bacteriochlorophyll as well as by sequencing. The deep, black layer (L4) was dominated by sulfate reducing bacteria belonging to the Deltaproteobacteria, which were responsible for high sulfate reduction rates (measured using S-35 tracer). Members of Halobacteria were the dominant Archaea in all layers of the mat (92%-97%), whereas Nematodes were the main Eukaryotes (up to 87%). Primary productivity rates of Um Alhool mat were similar to those of other hypersaline microbial mats. However, sulfate reduction rates were relatively low, indicating that oxygenic respiration contributes more to organic material degradation than sulfate reduction, because of bioturbation. Although Um Alhool hypersaline mat is a nutrient-limited ecosystem, it is interestingly dynamic and phylogenetically highly diverse. All its components work in a highly efficient and synchronized way to compensate for the lack of nutrient supply provided during regular inundation periods.	[Al-Thani, Roda] Qatar Univ, Dept Biol & Environm Sci, Doha, Qatar; [Al-Najjar, Mohammad A. A.; Al-Raei, Abdul Munem; Ferdelman, Tim; Thang, Nguyen M.; de Beer, Dirk] Max Planck Inst Marine Microbiol, Bremen, Germany; [Al Shaikh, Ismail; Al-Ansi, Mehsin] Qatar Univ, Ctr Environm Studies, Doha, Qatar	Qatar University; Max Planck Society; Qatar University	Al-Najjar, MAA (corresponding author), Max Planck Inst Marine Microbiol, Bremen, Germany.	mohammad.alnajjar@kaust.edu.sa	de Beer, Dirk/L-4840-2013; Ferdelman, Timothy G/A-3758-2013; AlNajjar, Mohammad/AAB-1377-2019	de Beer, Dirk/0000-0001-5274-1781; Ferdelman, Timothy G/0000-0002-9701-3793; Al-Najjar, Mohammad A. A./0000-0003-0001-6902	Qatar University [QUUG-CAS-BES-11/12-]; Max-Planck Institute for Marine Microbiology	Qatar University(Qatar National Research Fund (QNRF)); Max-Planck Institute for Marine Microbiology	Funding provided by Qatar University (www.qu.edu.qa), fund number QUUG-CAS-BES-11/12-, and Max-Planck Institute for Marine Microbiology (www.mpi-bremen.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Najjar MAA, 2012, ENVIRON MICROBIOL, V14, P982, DOI 10.1111/j.1462-2920.2011.02676.x; Al-Najjar MAA, 2010, ISME J, V4, P440, DOI 10.1038/ismej.2009.121; Al-Raei AM, 2009, OCEAN DYNAM, V59, P351, DOI 10.1007/s10236-009-0186-5; Allen MA, 2009, GEOBIOLOGY, V7, P82, DOI 10.1111/j.1472-4669.2008.00187.x; Bolhuis H, 2011, ISME J, V5, P1701, DOI [10.1038/Ismej.2011.52, 10.1038/ismej.2011.52]; CANFIELD DE, 1991, SCIENCE, V251, P1471, DOI 10.1126/science.11538266; CAUMETTE P, 1994, FEMS MICROBIOL ECOL, V13, P273, DOI 10.1016/0168-6496(94)90065-5; Chennu A, 2013, LIMNOL OCEANOGR-METH, V11, P511, DOI 10.4319/lom.2013.11.511; Cline JD, 1969, SPECTROPHOTOMETRIC D, P454; Couradeau E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028767; DasSarma P, 2012, J BACTERIOL, V194, P5530, DOI 10.1128/JB.01153-12; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Dupraz C, 2005, TRENDS MICROBIOL, V13, P429, DOI 10.1016/j.tim.2005.07.008; Earle SA, 2009, NATL GEOGRAPHIC; Feazel LM, 2008, APPL ENVIRON MICROB, V74, P329, DOI 10.1128/AEM.01448-07; Franks J, 2009, EARTH-SCI REV, V96, P163, DOI 10.1016/j.earscirev.2008.10.004; Garrity GM, 2003, TAXONOMIC OUTLINE PR; Guerrero R., 2002, International Microbiology, V5, P177; Hansell DA, 2009, OCEANOGRAPHY, V22, P202, DOI 10.5670/oceanog.2009.109; Ionescu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038319; Jonkers HM, 2003, FEMS MICROBIOL ECOL, V44, P175, DOI 10.1016/S0168-6496(02)00464-6; JORGENSEN BB, 1977, LIMNOL OCEANOGR, V22, P657, DOI 10.4319/lo.1977.22.4.0657; JORGENSEN BB, 1978, GEOMICROBIOL J, V1, P11; JORGENSEN BB, 1988, LIMNOL OCEANOGR, V33, P99, DOI 10.4319/lo.1988.33.1.0099; JORGENSEN BB, 1988, APPL ENVIRON MICROB, V54, P176; Kallmeyer J, 2004, LIMNOL OCEANOGR-METH, V2, P171, DOI 10.4319/lom.2004.2.171; KUHL M, 1992, APPL ENVIRON MICROB, V58, P1164; Kuhl M, 2008, AQUAT MICROB ECOL, V53, P99, DOI 10.3354/ame01224; LASSEN C, 1992, FEMS MICROBIOL ECOL, V86, P247, DOI 10.1111/j.1574-6968.1992.tb04816.x; Lovelock CE, 2010, WETL ECOL MANAG, V18, P37, DOI 10.1007/s11273-009-9146-6; Ludwig R, 2006, FEMS MICROBIOL ECOL, V57, P9, DOI 10.1111/j.1574-6941.2006.00109.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; McGregor GB, 2008, FEMS MICROBIOL ECOL, V63, P23, DOI 10.1111/j.1574-6941.2007.00405.x; Thang NM, 2013, ESTUAR COAST, V36, P98, DOI 10.1007/s12237-012-9557-0; Oremland RS, 2005, NAT REV MICROBIOL, V3, P572, DOI 10.1038/nrmicro1182; Pfeffer C, 2012, NATURE, V491, P218, DOI 10.1038/nature11586; Polerecky L, 2009, APPL ENVIRON MICROB, V75, P758, DOI 10.1128/AEM.00819-08; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; REVSBECH NP, 1983, LIMNOL OCEANOGR, V28, P749, DOI 10.4319/lo.1983.28.4.0749; Schneider D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066662; SHERWOOD JE, 1991, LIMNOL OCEANOGR, V36, P235, DOI 10.4319/lo.1991.36.2.0235; Stal L.J., 2000, ECOLOGY CYANOBACTERI, P61; Stolz JF, 2003, FOSSIL AND RECENT BIOFILMS, P65; Stolz JF, 2000, MICROBIAL SEDIMENTS, P1; Teske A, 1998, APPL ENVIRON MICROB, V64, P2943; van der Loeff MMR, 1999, METHODS SEAWATER ANA; Volkenborn N, 2010, LIMNOL OCEANOGR, V55, P1231, DOI 10.4319/lo.2010.55.3.1231; Wieland A, 2003, MICROB ECOL, V46, P371, DOI 10.1007/s00248-002-0108-2; WRIGHT SW, 1991, MAR ECOL PROG SER, V77, P183, DOI 10.3354/meps077183	50	18	18	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92405	10.1371/journal.pone.0092405	http://dx.doi.org/10.1371/journal.pone.0092405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658360	gold, Green Published, Green Submitted			2022-12-27	WOS:000333355300079
J	Schleifman, EB; Tam, R; Patel, R; Tsan, A; Sumiyoshi, T; Fu, L; Desai, R; Schoenbrunner, N; Myers, TW; Bauer, K; Smith, E; Raja, R				Schleifman, Erica B.; Tam, Rachel; Patel, Rajesh; Tsan, Alison; Sumiyoshi, Teiko; Fu, Ling; Desai, Rupal; Schoenbrunner, Nancy; Myers, Thomas W.; Bauer, Keith; Smith, Edward; Raja, Rajiv			Next Generation MUT-MAP, a High-Sensitivity High-Throughput Microfluidics Chip-Based Mutation Analysis Panel	PLOS ONE			English	Article							PREDICTIVE BIOMARKERS; KINASE INHIBITOR; COLON-CANCER; PIK3CA; DOMAIN; PTEN; GENE; KRAS; KIT	Molecular profiling of tumor tissue to detect alterations, such as oncogenic mutations, plays a vital role in determining treatment options in oncology. Hence, there is an increasing need for a robust and high-throughput technology to detect oncogenic hotspot mutations. Although commercial assays are available to detect genetic alterations in single genes, only a limited amount of tissue is often available from patients, requiring multiplexing to allow for simultaneous detection of mutations in many genes using low DNA input. Even though next-generation sequencing (NGS) platforms provide powerful tools for this purpose, they face challenges such as high cost, large DNA input requirement, complex data analysis, and long turnaround times, limiting their use in clinical settings. We report the development of the next generation mutation multianalyte panel (MUT-MAP), a high-throughput microfluidic, panel for detecting 120 somatic mutations across eleven genes of therapeutic interest (AKT1, BRAF, EGFR, FGFR3, FLT3, HRAS, KIT, KRAS, MET, NRAS, and PIK3CA) using allele-specific PCR (ASPCR) and Taqman technology. This mutation panel requires as little as 2 ng of high quality DNA from fresh frozen or 100 ng of DNA from formalin-fixed paraffin-embedded (FFPE) tissues. Mutation calls, including an automated data analysis process, have been implemented to run 88 samples per day. Validation of this platform using plasmids showed robust signal and low cross-reactivity in all of the newly added assays and mutation calls in cell line samples were found to be consistent with the Catalogue of Somatic Mutations in Cancer (COSMIC) database allowing for direct comparison of our platform to Sanger sequencing. High correlation with NGS when compared to the SuraSeq500 panel run on the Ion Torrent platform in a FFPE dilution experiment showed assay sensitivity down to 0.45%. This multiplexed mutation panel is a valuable tool for high-throughput biomarker discovery in personalized medicine and cancer drug development.	[Schleifman, Erica B.; Tam, Rachel; Patel, Rajesh; Sumiyoshi, Teiko; Fu, Ling; Desai, Rupal; Raja, Rajiv] Genentech Inc, Oncol Biomarker Dev, San Francisco, CA 94080 USA; [Tsan, Alison; Schoenbrunner, Nancy] Chem & Innovat Technol, Pleasanton, CA USA; [Myers, Thomas W.; Bauer, Keith; Smith, Edward] Roche Mol Syst Inc, Program Core Res, Pleasanton, CA USA	Roche Holding; Genentech; Roche Holding	Raja, R (corresponding author), Genentech Inc, Oncol Biomarker Dev, San Francisco, CA 94080 USA.	raja.rajiv@gene.com			Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	This study was funded by Genentech, Inc. The funders were responsible for the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Beadling C, 2008, CLIN CANCER RES, V14, P6821, DOI 10.1158/1078-0432.CCR-08-0575; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Di Renzo MF, 2000, ONCOGENE, V19, P1547, DOI 10.1038/sj.onc.1203455; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Fumagalli D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-101; Gallo V, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001117; Hadd AG, 2013, J MOL DIAGN, V15, P234, DOI 10.1016/j.jmoldx.2012.11.006; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Irahara N, 2010, DIAGN MOL PATHOL, V19, P157, DOI 10.1097/PDM.0b013e3181c93fd1; Janku F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022769; Kim MS, 2008, BRIT J CANCER, V98, P1533, DOI 10.1038/sj.bjc.6604212; Kompier LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013821; Ma PC, 2003, CANCER RES, V63, P6272; Mittempergher L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017163; Neumann J, 2009, PATHOL RES PRACT, V205, P858, DOI 10.1016/j.prp.2009.07.010; O'Brien C, 2010, CLIN CANCER RES, V16, P3670, DOI 10.1158/1078-0432.CCR-09-2828; Patel R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051153; Reichert F BK, 2012, US Patent, Patent No. [2011/0312041 A1, 03312041]; Rizzo S, 2010, CANCER TREAT REV, V36, pS56, DOI 10.1016/S0305-7372(10)70021-9; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schmidt L, 1998, CANCER RES, V58, P1719; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Tejpar S, 2010, ONCOLOGIST, V15, P390, DOI 10.1634/theoncologist.2009-0233; Vaughn CP, 2011, GENE CHROMOSOME CANC, V50, P307, DOI 10.1002/gcc.20854; Will SG, 2011, US Patent, Patent No. [2010/0099110A1, 20100099110]; Zheng R, 2011, ONCOGENE, V30, P4004, DOI 10.1038/onc.2011.110	30	19	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e90761	10.1371/journal.pone.0090761	http://dx.doi.org/10.1371/journal.pone.0090761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658394	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300020
J	Burdge, DA; Libourel, IGL				Burdge, David A.; Libourel, Igor G. L.			Open Source Software to Control Bioflo Bioreactors	PLOS ONE			English	Article							CLOSED-LOOP CONTROL; FED-BATCH CULTURES; SYSTEM; CULTIVATION; SUBSTRATE	Bioreactors are designed to support highly controlled environments for growth of tissues, cell cultures or microbial cultures. A variety of bioreactors are commercially available, often including sophisticated software to enhance the functionality of the bioreactor. However, experiments that the bioreactor hardware can support, but that were not envisioned during the software design cannot be performed without developing custom software. In addition, support for third party or custom designed auxiliary hardware is often sparse or absent. This work presents flexible open source freeware for the control of bioreactors of the Bioflo product family. The functionality of the software includes setpoint control, data logging, and protocol execution. Auxiliary hardware can be easily integrated and controlled through an integrated plugin interface without altering existing software. Simple experimental protocols can be entered as a CSV scripting file, and a Python-based protocol execution model is included for more demanding conditional experimental control. The software was designed to be a more flexible and free open source alternative to the commercially available solution. The source code and various auxiliary hardware plugins are publicly available for download from https://github.com/LibourelLab/BiofloSoftware. In addition to the source code, the software was compiled and packaged as a self-installing file for 32 and 64 bit windows operating systems. The compiled software will be able to control a Bioflo system, and will not require the installation of LabVIEW.	[Burdge, David A.; Libourel, Igor G. L.] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; [Libourel, Igor G. L.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Libourel, IGL (corresponding author), Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA.	libourel@umn.edu			NSF [NSF/MCB-1042335]; ONR [N000141310552]	NSF(National Science Foundation (NSF)); ONR(Office of Naval Research)	IGLL received funding support from: NSF(NSF/MCB-1042335), and ONR (N000141310552). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RKI, 2005, WORLD J MICROB BIOT, V21, P127, DOI 10.1007/s11274-004-3043-1; Diaz C, 1996, J BIOTECHNOL, V52, P135, DOI 10.1016/S0168-1656(96)01637-9; Fu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026306; GREGORY ME, 1994, J BIOTECHNOL, V33, P233, DOI 10.1016/0168-1656(94)90071-X; Hosek P, 2009, JALA-J ASSOC LAB AUT, V14, P59, DOI 10.1016/j.jala.2008.05.007; Huang HJ, 2005, CHEM ENG COMMUN, V192, P137, DOI 10.1080/00986440590473290; Huang SR, 2012, INT J HYDROGEN ENERG, V37, P15575, DOI 10.1016/j.ijhydene.2012.02.078; Jung BJ, 2002, APPL SPECTROSC, V56, P51, DOI 10.1366/0003702021954421; Kellerhals MB, 1999, BIOTECHNOL BIOENG, V65, P306, DOI 10.1002/(SICI)1097-0290(19991105)65:3<306::AID-BIT8>3.0.CO;2-0; Mkondweni N, 2005, INT J ENG EDUC, V21, P63; Muller O, 2010, CELL CALCIUM, V47, P224, DOI 10.1016/j.ceca.2009.11.012; Stoll TS, 1996, J BIOTECHNOL, V51, P37, DOI 10.1016/0168-1656(96)01559-3; Street J, 2012, T ASABE, V55, P1047; Topalov AA, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3660814; TURNER C, 1994, BIOTECHNOL BIOENG, V44, P819, DOI 10.1002/bit.260440707; Yue XC, 2008, IEEE T BIOMED CIRC S, V2, P66, DOI 10.1109/TBCAS.2008.925639	16	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92108	10.1371/journal.pone.0092108	http://dx.doi.org/10.1371/journal.pone.0092108			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667828	Green Submitted, Green Published, gold			2022-12-27	WOS:000333675600019
J	Kuo, PL; Huang, YL; Hsieh, CCJ; Lee, JC; Lin, BW; Hung, LY				Kuo, Pao-Lin; Huang, Yung-Ling; Hsieh, Christine Chin-Jung; Lee, Jenq-Chang; Lin, Bo-Wen; Hung, Liang-Yi			STK31 Is a Cell-Cycle Regulated Protein That Contributes to the Tumorigenicity of Epithelial Cancer Cells	PLOS ONE			English	Article							SPINDLE CHECKPOINT; GENE-EXPRESSION; CENTROSOME; IDENTIFICATION; INSTABILITY; MITOSIS; IMMUNOTHERAPY; DESTRUCTION; MEIOSIS; OPINION	Serine/threonine kinase 31 (STK31) is one of the novel cancer/testis antigens for which its biological functions remain largely unclear. Here, we demonstrate that STK31 is overexpressed in many human colorectal cancer cell lines and tissues. STK31 co-localizes with pericentrin in the centrosomal region throughout all phases of the cell cycle. Interestingly, when cells undergo mitosis, STK31 also localizes to the centromeres, central spindle, and midbody. This localization behavior is similar to that of chromosomal passenger proteins, which are known to be the important players of the spindle assembly checkpoint. The expression of STK31 is cell cycle-dependent through the regulation of a putative D-box near its C-terminal region. Ectopically-expressed STK31-GFP increases cell migration and invasive ability without altering the proliferation rate of cancer cells, whereas the knockdown expression of endogenous STK31 by lentivirus-derived shRNA results in microtubule assembly defects that prolong the duration of mitosis and lead to apoptosis. Taken together, our results suggest that the aberrant expression of STK31 contributes to tumorigenicity in somatic cancer cells. STK31 might therefore act as a potential therapeutic target in human somatic cancers.	[Kuo, Pao-Lin; Huang, Yung-Ling; Hsieh, Christine Chin-Jung] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci BioTechnol, Tainan 70101, Taiwan; [Hung, Liang-Yi] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Coll Biosci & Biotechnol, Tainan 70101, Taiwan; [Hung, Liang-Yi] Natl Cheng Kung Univ, Ctr Infect Dis & Signal Transduct Res, Tainan 70101, Taiwan; [Kuo, Pao-Lin] Natl Cheng Kung Univ Hosp, Dept Obstet & Gynecol, Tainan 70428, Taiwan; [Lee, Jenq-Chang; Lin, Bo-Wen] Natl Cheng Kung Univ Hosp, Dept Surg, Tainan 70428, Taiwan; [Hung, Liang-Yi] Taipei Med Univ, Inst Canc Biol & Drug Discovery, Coll Med Sci & Technol, Taipei, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Taipei Medical University	Hung, LY (corresponding author), Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Coll Biosci & Biotechnol, Tainan 70101, Taiwan.	lyhung@mail.ncku.edu.tw	Hung, Liang-Yi/AAG-4174-2019	, Liang-Yi/0000-0002-7284-2608	National Science Council [NSC101-2325-B-006-001, NSC102-2325-B-006-001]; Academia Sinica, Project of Promoting Academic Excellence and Developing World Class Research Centers [IBMS-CRC100-P01]; Center for Infectious Disease and Signaling Transduction Research, National Cheng Kung University	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica, Project of Promoting Academic Excellence and Developing World Class Research Centers; Center for Infectious Disease and Signaling Transduction Research, National Cheng Kung University	This work was supported by grants NSC101-2325-B-006-001 and NSC102-2325-B-006-001 from the National Science Council, grant IBMS-CRC100-P01 from Academia Sinica, Project of Promoting Academic Excellence and Developing World Class Research Centers, and the Center for Infectious Disease and Signaling Transduction Research, National Cheng Kung University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderhub SJ, 2012, CANCER LETT, V322, P8, DOI 10.1016/j.canlet.2012.02.006; Andersen SSL, 1999, INT REV CYTOL, V187, P51; Avidor-Reiss T, 2013, CURR OPIN CELL BIOL, V25, P72, DOI 10.1016/j.ceb.2012.10.016; Baillet A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-436; Bakhoum SF, 2012, J CLIN INVEST, V122, P1138, DOI 10.1172/JCI59954; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Campos SM, 2012, HEMATOL ONCOL CLIN N, V26, P607, DOI 10.1016/j.hoc.2012.01.007; Carmena M, 2009, CURR OPIN CELL BIOL, V21, P796, DOI 10.1016/j.ceb.2009.09.008; Duensing S, 2001, BBA-REV CANCER, V1471, pM81, DOI 10.1016/S0304-419X(00)00025-1; Fok KL, 2012, CARCINOGENESIS, V33, P2044, DOI 10.1093/carcin/bgs246; Hames RS, 2001, EMBO J, V20, P7117, DOI 10.1093/emboj/20.24.7117; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He J, 2013, MOL CELL, V50, P649, DOI 10.1016/j.molcel.2013.04.024; Kollareddy M, 2012, INVEST NEW DRUG, V30, P2411, DOI 10.1007/s10637-012-9798-6; Lake RA, 2005, NAT REV CANCER, V5, P397, DOI 10.1038/nrc1613; Lange BMH, 2002, CURR OPIN CELL BIOL, V14, P35, DOI 10.1016/S0955-0674(01)00291-5; Lin YH, 2006, FERTIL STERIL, V86, P1650, DOI 10.1016/j.fertnstert.2006.04.039; Mahen R, 2012, CURR OPIN CELL BIOL, V24, P14, DOI 10.1016/j.ceb.2011.12.012; Malumbres Marcos, 2006, Clin Transl Oncol, V8, P399, DOI 10.1007/s12094-006-0193-7; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; Manchado E, 2012, CELL DEATH DIFFER, V19, P369, DOI 10.1038/cdd.2011.197; Olesen C, 2007, CELL TISSUE RES, V328, P207, DOI 10.1007/s00441-006-0205-5; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Schmidt M, 2007, DRUG RESIST UPDATE, V10, P162, DOI 10.1016/j.drup.2007.06.003; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Tyler RK, 2007, CELL CYCLE, V6, P2846, DOI 10.4161/cc.6.22.4940; van Leuken R, 2008, BBA-REV CANCER, V1786, P49, DOI 10.1016/j.bbcan.2008.05.002; Vitre BD, 2012, CURR OPIN CELL BIOL, V24, P809, DOI 10.1016/j.ceb.2012.10.006; Vogt E, 2008, MUTAT RES-GEN TOX EN, V651, P14, DOI 10.1016/j.mrgentox.2007.10.015; Wasch R, 2010, RECENT RESULTS CANC, V184, P215, DOI 10.1007/978-3-642-01222-8_15; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Wu X, 2009, P NATL ACAD SCI USA, V106, P21672, DOI 10.1073/pnas.0912432106; Yee C, 2002, NAT REV CANCER, V2, P409, DOI 10.1038/nrc820; Yokoe T, 2008, CANCER RES, V68, P1074, DOI 10.1158/0008-5472.CAN-07-0964; Zang ZJ, 2011, CANCER RES, V71, P29, DOI 10.1158/0008-5472.CAN-10-1749	39	26	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93303	10.1371/journal.pone.0093303	http://dx.doi.org/10.1371/journal.pone.0093303			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667656	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600167
J	Martin, M; Vanichseni, S; Suntharasamai, P; Sangkum, U; Mock, PA; Leethochawalit, M; Chiamwongpaet, S; Gvetadze, RJ; Kittimunkong, S; Curlin, ME; Worrajittanon, D; McNicholl, JM; Paxton, LA; Choopanya, K				Martin, Michael; Vanichseni, Suphak; Suntharasamai, Pravan; Sangkum, Udomsak; Mock, Philip A.; Leethochawalit, Manoj; Chiamwongpaet, Sithisat; Gvetadze, Roman J.; Kittimunkong, Somyot; Curlin, Marcel E.; Worrajittanon, Dararat; McNicholl, Janet M.; Paxton, Lynn A.; Choopanya, Kachit		Bangkok Tenofovir Study Grp	Risk Behaviors and Risk Factors for HIV Infection among Participants in the Bangkok Tenofovir Study, an HIV Pre-Exposure Prophylaxis Trial among People Who Inject Drugs	PLOS ONE			English	Article							ANTIRETROVIRAL PROPHYLAXIS; VACCINE TRIAL; DOUBLE-BLIND; THAILAND; USERS; PRISON; INCARCERATION; TRANSMISSION; PREVENTION; NUMBER	Introduction: HIV spread rapidly among people who inject drugs in Bangkok in the late 1980s. In recent years, changes in drug use and HIV-associated risk behaviors have been reported. We examined data from the Bangkok Tenofovir Study, an HIV pre-exposure prophylaxis trial conducted among people who inject drugs, to assess participant risk behavior and drug use, and to identify risk factors for HIV infection. Methods: The Bangkok Tenofovir Study was a randomized, double-blind, placebo-controlled trial. HIV status was assessed monthly and risk behavior every 3 months. We used generalized estimating equations logistic regression to model trends of injecting, needle sharing, drugs injected, incarceration, and sexual activity reported at follow-up visits; and proportional hazards models to evaluate demographic characteristics, sexual activities, incarceration, drug injection practices, and drugs injected during follow-up as predictors of HIV infection. Results: The proportion of participants injecting drugs, sharing needles, and reporting sex with more than one partner declined during follow-up (p<0.001). Among participants who reported injecting at enrollment, 801 (53.2%) injected methamphetamine, 559 (37.1%) midazolam, and 527 (35.0%) heroin. In multivariable analysis, young age (i.e., 20-29 years) (p = 0.02), sharing needles (p<0.001), and incarceration in prison (p = 0.002) were associated with incident HIV infection. Participants reporting sex with an opposite sex partner, live-in partner, casual partner, or men reporting sex with male partners were not at a significantly higher risk of HIV infection compared to those who did not report these behaviors. Conclusion: Reports of HIV-associated risk behavior declined significantly during the trial. Young age, needle sharing, and incarceration were independently associated with HIV infection. Sexual activity was not associated with HIV infection, suggesting that the reduction in HIV incidence among participants taking daily oral tenofovir compared to those taking placebo was due to a decrease in parenteral HIV transmission.	[Martin, Michael; Mock, Philip A.; Curlin, Marcel E.; Worrajittanon, Dararat] Thailand MOPH US CDC Collaborat, Nonthaburi, Thailand; [Martin, Michael; Gvetadze, Roman J.; Curlin, Marcel E.; McNicholl, Janet M.; Paxton, Lynn A.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Vanichseni, Suphak; Suntharasamai, Pravan; Sangkum, Udomsak; Choopanya, Kachit] Bangkok Tenofovir Study Grp, Bangkok, Thailand; [Leethochawalit, Manoj; Chiamwongpaet, Sithisat] Bangkok Metropolitan Adm, Bangkok, Thailand; [Kittimunkong, Somyot] Thailand Minist Publ Hlth, Nonthaburi, Thailand	Centers for Disease Control & Prevention - USA; Ministry of Public Health - Thailand	Martin, M (corresponding author), Thailand MOPH US CDC Collaborat, Nonthaburi, Thailand.	Znd9@cdc.gov	Hendrix, Craig W/G-4182-2014	Hendrix, Craig W/0000-0002-5696-8665; Cherdtrakulkiat, Thitima/0000-0001-5006-6145	Bangkok Metropolitan Administration; U.S. Centers for Disease Control and Prevention	Bangkok Metropolitan Administration; U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The study was funded and supported by the Bangkok Metropolitan Administration and U.S. Centers for Disease Control and Prevention. The funders had a role in study design, data collection and analysis, and the decision to publish the manuscript.	Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Beyrer C, 2003, AIDS BEHAV, V7, P153, DOI 10.1023/A:1023946324822; BREWER TF, 1988, AIDS, V2, P363, DOI 10.1097/00002030-198810000-00005; Buavirat A, 2003, BRIT MED J, V326, P308, DOI 10.1136/bmj.326.7384.308; Choopanya K, 2002, J ACQ IMMUN DEF SYND, V29, P86, DOI 10.1097/00126334-200201010-00012; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; COX DR, 1972, J R STAT SOC B, V34, P187; Diggle PJ, 2002, ANAL LONGITUDINAL DA; Dolan K, 2003, ADDICTION, V98, P153, DOI 10.1046/j.1360-0443.2003.00309.x; Dolan K, 2007, LANCET INFECT DIS, V7, P32, DOI 10.1016/S1473-3099(06)70685-5; Family Health International Bureau of AIDS TB and STIs Department of Disease Control MOPH Thailand, 2008, AS EP MOD AEM PROJ H, P2008; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Johnston LG, 2013, SEX TRANSM DIS, V40, P304, DOI 10.1097/OLQ.0b013e31827fd650; KONINGS E, 1995, AIDS, V9, P375, DOI 10.1097/00002030-199509040-00009; Martin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025127; MASTRO TD, 1994, AM J PUBLIC HEALTH, V84, P1094, DOI 10.2105/AJPH.84.7.1094; Okie S, 2007, NEW ENGL J MED, V356, P105, DOI 10.1056/NEJMp068277; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Small W, 2005, SUBST USE MISUSE, V40, P831, DOI 10.1081/JA-200030795; Smith Dawn K., 2005, Morbidity and Mortality Weekly Report, V54, P1; Sungkanuparph S, 2010, ASIAN BIOMED, V4, P515, DOI 10.2478/abm-2010-0066; Suntharasamai P, 2009, ADDICTION, V104, P235, DOI 10.1111/j.1360-0443.2008.02436.x; TAYLOR A, 1995, BRIT MED J, V310, P289, DOI 10.1136/bmj.310.6975.289; Thailand Ministry of Public Health. National AIDS Prevention and Alleviation Committee, 2013, UNGASS COUNTR PROGR; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; van Griensven F, 2010, JAIDS-J ACQ IMM DEF, V53, P234, DOI 10.1097/QAI.0b013e3181c2fc86; Vanichseni S, 2001, AIDS, V15, P397, DOI 10.1097/00002030-200102160-00013; Wattana W, 2007, DRUG ALCOHOL DEPEN, V90, P228, DOI 10.1016/j.drugalcdep.2007.03.013; Weniger B G, 1991, AIDS, V5 Suppl 2, pS71, DOI 10.1097/00002030-199101001-00011; Wood E, 2005, LANCET, V366, P1834, DOI 10.1016/S0140-6736(05)67737-9; World Health Organisation (WHO), 2009, WHO UNODC UNAIDS TEC	32	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92809	10.1371/journal.pone.0092809	http://dx.doi.org/10.1371/journal.pone.0092809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667938	Green Submitted, Green Published, gold			2022-12-27	WOS:000333675600079
J	Ruckerbauer, DE; Jungreuthmayer, C; Zanghellini, J				Ruckerbauer, David E.; Jungreuthmayer, Christian; Zanghellini, Juergen			Design of Optimally Constructed Metabolic Networks of Minimal Functionality	PLOS ONE			English	Article							ELEMENTARY MODE ANALYSIS; PATHWAY ANALYSIS; KNOCKOUT STRATEGIES; STRAIN OPTIMIZATION; ESCHERICHIA-COLI; FLUX MODES; CUT SETS; CHEMICALS; YEAST; CELL	Background: Metabolic engineering aims to design microorganisms that will generate a product of interest at high yield. Thus, a variety of in silico modeling strategies has been applied successfully, including the concepts of elementary flux modes (EFMs) and constrained minimal cut sets (cMCSs). The EFMs (minimal, steady state pathways through the system) can be calculated given a metabolic model. cMCSs are sets of reaction deletions in such a network that will allow desired pathways to survive and disable undesired ones (e. g., those with low product secretion or low growth rates). Grouping the modes into desired and undesired categories had to be done manually until now. Results: Although the optimal solution for a given set of pathways will always be found with the currently available tools, manual selection may lead to a sub-optimal solution with respect to a metabolic engineering target. A small change in the selection of modes can reduce the number of necessary deletions while only slightly reducing production. Based on our recently introduced formulation of cut set calculations using binary linear programming, we suggest an algorithm that does not require manual selection of the desired pathways. Conclusions: We demonstrated the principle of our algorithm with the help of a small toy network and applied it to a model of E. coli using different design objectives. Furthermore we validated our method by reproducing previously obtained results without requiring manual grouping of modes.	[Ruckerbauer, David E.; Jungreuthmayer, Christian; Zanghellini, Juergen] Austrian Ctr Ind Biotechnol, Vienna, Austria; [Ruckerbauer, David E.; Jungreuthmayer, Christian; Zanghellini, Juergen] Univ Nat Resources & Life Sci, Dept Biotechnol, Vienna, Austria	Austrian Centre of Industrial Biotechnology; University of Natural Resources & Life Sciences, Vienna	Zanghellini, J (corresponding author), Austrian Ctr Ind Biotechnol, Vienna, Austria.	juergen.zanghellini@acib.at	Zanghellini, Jürgen/A-4635-2017	Zanghellini, Jürgen/0000-0002-1964-2455; Ruckerbauer, David/0000-0003-3374-8456	Federal Ministry of Economy, Family and Youth (BMWFJ); Federal Ministry of Traffic, Innovation and Technology (bmvit); Styrian Business Promotion Agency SFG; Standortagentur Tirol; ZIT - Technology Agency of the City of Vienna through the COMET-Funding Program	Federal Ministry of Economy, Family and Youth (BMWFJ); Federal Ministry of Traffic, Innovation and Technology (bmvit); Styrian Business Promotion Agency SFG; Standortagentur Tirol; ZIT - Technology Agency of the City of Vienna through the COMET-Funding Program	The authors gratefully acknowledge the support by the Federal Ministry of Economy, Family and Youth (BMWFJ), the Federal Ministry of Traffic, Innovation and Technology (bmvit), the Styrian Business Promotion Agency SFG, the Standortagentur Tirol and ZIT - Technology Agency of the City of Vienna through the COMET-Funding Program managed by the Austrian Research Promotion Agency FFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bordel S, 2010, METAB ENG, V12, P369, DOI 10.1016/j.ymben.2010.03.001; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Danna E, 2007, LECT NOTES COMPUT SC, V4513, P280; Fan ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031693; Feist AM, 2010, METAB ENG, V12, P173, DOI 10.1016/j.ymben.2009.10.003; Gasser B, 2013, FUTURE MICROBIOL, V8, P191, DOI [10.2217/fmb.12.133, 10.2217/FMB.12.133]; Gidijala L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008317; Hadicke O, 2011, METAB ENG, V13, P204, DOI 10.1016/j.ymben.2010.12.004; Hadicke O, 2010, J BIOTECHNOL, V147, P88, DOI 10.1016/j.jbiotec.2010.03.006; Jungreuthmayer C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-318; Jungreuthmayer C, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-103; Klamt S, 2002, MOL BIOL REP, V29, P233, DOI 10.1023/A:1020390132244; Lee JW, 2012, NAT CHEM BIOL, V8, P536, DOI [10.1038/NCHEMBIO.970, 10.1038/nchembio.970]; Lewis NE, 2012, NATURE REV MICROBIOL; McCloskey D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.18; Nielsen J, 2013, CURR OPIN BIOTECH, V24, P398, DOI 10.1016/j.copbio.2013.03.023; Otero JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054144; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Schuster S, 1999, TRENDS BIOTECHNOL, V17, P53, DOI 10.1016/S0167-7799(98)01290-6; Soons ZITA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061648; Tepper N, 2010, BIOINFORMATICS, V26, P536, DOI 10.1093/bioinformatics/btp704; Trinh CT, 2008, APPL ENVIRON MICROB, V74, P3634, DOI 10.1128/AEM.02708-07; Trinh CT, 2009, APPL MICROBIOL BIOT, V81, P813, DOI 10.1007/s00253-008-1770-1; Unrean P, 2010, METAB ENG, V12, P112, DOI 10.1016/j.ymben.2009.11.002; Zanghellini J, 2013, BIOTECHNOL J, V8, P1009, DOI 10.1002/biot.201200269; [No title captured], DOI DOI 10.1142/S0218339094000131	26	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92583	10.1371/journal.pone.0092583	http://dx.doi.org/10.1371/journal.pone.0092583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667792	Green Submitted, Green Published, gold			2022-12-27	WOS:000333675600052
J	Tryfona, T; Theys, TE; Wagner, T; Stott, K; Keegstra, K; Dupree, P				Tryfona, Theodora; Theys, Tina E.; Wagner, Tanya; Stott, Katherine; Keegstra, Kenneth; Dupree, Paul			Characterisation of FUT4 and FUT6 alpha-(1 -> 2)-Fucosyltransferases Reveals that Absence of Root Arabinogalactan Fucosylation Increases Arabidopsis Root Growth Salt Sensitivity	PLOS ONE			English	Article							MALDI-TOF/TOF-MS/MS; CELL-WALL; STRUCTURAL-ANALYSIS; CRUCIFEROUS PLANTS; YARIV REAGENT; ROSE CELLS; PROTEINS; THALIANA; POLYSACCHARIDE; LEAVES	Plant type II arabinogalactan (AG) polysaccharides are attached to arabinogalactan proteins (AGPs) at hydroxyproline residues, and they are very diverse and heterogeneous structures. The AG consists of a beta-(1 -> 3)-linked galactan backbone with beta-(1 -> 6)-galactan side chains that are modified mainly with arabinose, but they may also contain glucuronic acid, rhamnose or other sugars. Here, we studied the positions of fucose substitutions in AGPs, and we investigated the functions of this fucosylation. Monosaccharide analysis of Arabidopsis leaf AGP extracts revealed a significant reduction in L-Fucose content in the fut4 mutant, but not in the fut6 mutant. In addition, Fucose was reduced in the fut4 mutant in root AGP extracts and was absent in the fut4/fut6 mutant. Curiously, in all cases reduction of fucose was accompanied with a reduction in xylose levels. The fucosylated AGP structures in leaves and roots in wild type and fut mutant plants were characterised by sequential digestion with AG specific enzymes, analysis by Polysaccharide Analysis using Carbohydrate gel Electrophoresis, and Matrix Assisted Laser Desorption/Ionisation (MALDI)-Time of Flight Mass spectrometry (MS). We found that FUT4 is solely responsible for the fucosylation of AGPs in leaves. The Arabidopsis thaliana FUT4 and FUT6 genes have been previously proposed to be non-redundant AG-specific fucosyltransferases. Unexpectedly, FUT4 and FUT6 enzymes both fucosylate the same AGP structures in roots, suggesting partial redundancy to each other. Detailed structural characterisation of root AGPs with high energy MALDI-Collision Induced Dissociation MS and NMR revealed an abundant unique AG oligosaccharide structure consisting of terminal xylose attached to fucose. The loss of this structure in fut4/fut6 mutants explains the reduction of both fucose and xylose in AGP extracts. Under salt-stress growth conditions the fut4/fut6 mutant lacking AGP fucosylation exhibited a shorter root phenotype than wild type plants, implicating fucosylation of AGPs in maintaining proper cell expansion under these conditions.	[Tryfona, Theodora; Theys, Tina E.; Stott, Katherine; Dupree, Paul] Univ Cambridge, Dept Biochem, Sch Biol Sci, Cambridge CB2 1QW, England; [Wagner, Tanya; Keegstra, Kenneth] Michigan State Univ, DOE Plant Res Lab, E Lansing, MI 48824 USA	University of Cambridge; Michigan State University; United States Department of Energy (DOE)	Dupree, P (corresponding author), Univ Cambridge, Dept Biochem, Sch Biol Sci, Tennis Court Rd, Cambridge CB2 1QW, England.	p.dupree@bioc.cam.ac.uk	Dupree, Paul/T-2568-2018	Dupree, Paul/0000-0001-9270-6286; Stott, Katherine/0000-0002-4014-1188; Tryfona, Theodora/0000-0002-1618-3521	United Kingdom BBSRC Sustainable Bioenergy Centre (BSBEC) [BB/G016240/1]; BioMASS Programme of the centre [BB/G016216/1]; Plant Genome Research Program at the National Science Foundation; Energy Biosciences Program at the U.S. Department of Energy; BBSRC [BB/G016216/1, BB/G016240/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G016216/1, BB/G016240/1] Funding Source: researchfish	United Kingdom BBSRC Sustainable Bioenergy Centre (BSBEC); BioMASS Programme of the centre; Plant Genome Research Program at the National Science Foundation; Energy Biosciences Program at the U.S. Department of Energy; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors are grateful for the financial support for this research from the United Kingdom BBSRC Sustainable Bioenergy Centre (BSBEC, http://www.bbsrc.ac.uk/), working within the Cell Wall Sugars Programme (Grant BB/G016240/1), and the BioMASS Programme of the centre (Grant BB/G016216/1). This work was supported in part by grants from the Plant Genome Research Program at the National Science Foundation and the Energy Biosciences Program at the U.S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACIC A, 1986, PLANT PHYSIOL, V80, P771, DOI 10.1104/pp.80.3.771; BASKIN TI, 1992, AUST J PLANT PHYSIOL, V19, P427, DOI 10.1071/PP9920427; Bonin CP, 1997, P NATL ACAD SCI USA, V94, P2085, DOI 10.1073/pnas.94.5.2085; Borner GHH, 2003, PLANT PHYSIOL, V132, P568, DOI 10.1104/pp.103.021170; Cavanagh J., 1996, PROTEIN NMR SPECTROS; CHEUNG AY, 1995, CELL, V82, P383, DOI 10.1016/0092-8674(95)90427-1; Chun H, 2001, BIOL PHARM BULL, V24, P941, DOI 10.1248/bpb.24.941; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; CLARKE AE, 1979, PHYTOCHEMISTRY, V18, P521, DOI 10.1016/S0031-9422(00)84255-7; Currie HA, 2006, J CHROMATOGR A, V1128, P90, DOI 10.1016/j.chroma.2006.06.045; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; DONALDSON SP, 1993, PHYSIOL MOL PLANT P, V42, P177, DOI 10.1006/pmpp.1993.1016; Ellis M, 2010, PLANT PHYSIOL, V153, P403, DOI 10.1104/pp.110.156000; FINCHER GB, 1974, BIOCHEM J, V139, P535, DOI 10.1042/bj1390535; GANE AM, 1995, CARBOHYD RES, V277, P67, DOI 10.1016/0008-6215(95)00197-2; Gibeaut DM, 1997, PLANT PHYSIOL, V115, P317, DOI 10.1104/pp.115.2.317; Goubet F, 2002, ANAL BIOCHEM, V300, P53, DOI 10.1006/abio.2001.5444; Kang JS, 2008, P NATL ACAD SCI USA, V105, P5933, DOI 10.1073/pnas.0800237105; Kitazawa K, 2013, PLANT PHYSIOL, V161, P1117, DOI 10.1104/pp.112.211722; Konishi T, 2008, CARBOHYD RES, V343, P1191, DOI 10.1016/j.carres.2008.03.004; Kotake T, 2004, BIOCHEM J, V377, P749, DOI 10.1042/bj20031145; Lamport DTA, 2012, NEW PHYTOLOGIST; Liang Y, 2013, J EXP BOT, V64, P5537, DOI 10.1093/jxb/ert321; Lin LY, 2011, PHARM BIOL, V49, P319, DOI 10.3109/13880209.2010.516753; Maslen SL, 2007, CARBOHYD RES, V342, P724, DOI 10.1016/j.carres.2006.12.007; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAKAMURA K, 1984, AGR BIOL CHEM TOKYO, V48, P753, DOI 10.1080/00021369.1984.10866213; Nguema-Ona E, 2012, ANN BOT-LONDON, V110, P383, DOI 10.1093/aob/mcs143; Nyberg NT, 2005, J AM CHEM SOC, V127, P6154, DOI 10.1021/ja050878w; REITER WD, 1993, SCIENCE, V261, P1032, DOI 10.1126/science.261.5124.1032; Ridlova G, 2008, RAPID COMMUN MASS SP, V22, P2723, DOI 10.1002/rcm.3665; Roy SS, 2002, ANN BOT-LONDON, V89, P293, DOI 10.1093/aob/mcf040; Sarria R, 2001, PLANT PHYSIOL, V127, P1595, DOI 10.1104/pp.010596; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Seifert GJ, 2002, CURR BIOL, V12, P1840, DOI 10.1016/S0960-9822(02)01260-5; SERPE MD, 1995, PLANT PHYSIOL, V109, P1007, DOI 10.1104/pp.109.3.1007; Serpe MD, 1996, PLANT PHYSIOL, V112, P1261, DOI 10.1104/pp.112.3.1261; Shi HZ, 2003, PLANT CELL, V15, P19, DOI 10.1105/tpc.007872; Spina E, 2004, RAPID COMMUN MASS SP, V18, P392, DOI 10.1002/rcm.1350; STEVENSON TT, 1988, CARBOHYD RES, V182, P207, DOI 10.1016/0008-6215(88)84004-7; Takata R, 2010, CARBOHYD RES, V345, P2516, DOI 10.1016/j.carres.2010.09.006; Tan L, 2004, J BIOL CHEM, V279, P13156, DOI 10.1074/jbc.M311864200; Tan L, 2013, PLANT CELL ONLINE; Tan L, 2010, J BIOL CHEM, V285, P24575, DOI 10.1074/jbc.M109.100149; Tryfona T, 2012, PLANT PHYSIOL, V160, P653, DOI 10.1104/pp.112.202309; Tryfona T, 2010, CARBOHYD RES, V345, P2648, DOI 10.1016/j.carres.2010.09.018; Tryfona T, 2010, METHODS MOL BIOL, V658, P137, DOI 10.1007/978-1-60761-780-8_8; TSUMURAYA Y, 1984, AGR BIOL CHEM TOKYO, V48, P2915, DOI 10.1080/00021369.1984.10866619; TSUMURAYA Y, 1984, CARBOHYD RES, V134, P215, DOI 10.1016/0008-6215(84)85039-9; TSUMURAYA Y, 1990, J BIOL CHEM, V265, P7207; TSUMURAYA Y, 1988, PLANT PHYSIOL, V86, P155, DOI 10.1104/pp.86.1.155; van Hengel AJ, 2002, PHYSIOL PLANTARUM, V114, P637, DOI 10.1034/j.1399-3054.2002.1140418.x; van Hengel AJ, 2002, PLANT J, V32, P105, DOI 10.1046/j.1365-313X.2002.01406.x; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Willats WGT, 1996, PLANT J, V9, P919, DOI 10.1046/j.1365-313X.1996.9060919.x; Wu YY, 2010, J BIOL CHEM, V285, P13638, DOI 10.1074/jbc.M110.102715	56	43	44	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93291	10.1371/journal.pone.0093291	http://dx.doi.org/10.1371/journal.pone.0093291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667545	Green Submitted, Green Published, gold			2022-12-27	WOS:000333675600165
J	Wu, HZ; Zhang, K; Gong, PH; Qiao, FC; Wang, L; Cui, H; Sui, XY; Gao, JF; Fan, H				Wu, Huazhang; Zhang, Kun; Gong, Pihai; Qiao, Fengchang; Wang, Ling; Cui, He; Sui, Xinyuan; Gao, Jifan; Fan, Hong			A Novel Functional TagSNP Rs7560488 in the DNMT3A1 Promoter Is Associated with Susceptibility to Gastric Cancer by Modulating Promoter Activity	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE NUCLEOTIDE POLYMORPHISM; ABERRANT DNA METHYLATION; GENE; MUTATIONS; RISK; LOCI; METHYLTRANSFERASES; EPIGENETICS; STRATEGIES	DNA-methyltransferase (DNMT)-3A which contains DNMT3A1 and DNMT3A2 isoforms have been suggested to play a crucial role in carcinogenesis and showed aberrant expression in most cancers. Accumulated evidences also indicated that single nucleotide polymorphisms (SNP) in DNMT genes were associated with susceptibility to different tumors. We hypothesized that genetic variants in DNMT3A1 promoter region are associated with gastric cancer risk. We selected the tagSNPs from the HapMap database for the Chinese and genotyped in a case-control study to evaluate the association with gastric cancer (GC) in a Chinese population. We identified that the functional tagSNP rs7560488 T>C associated with a significantly increased risk of GC. In vitro functional analysis by luciferase reporter assay and EMSA indicated that the tagSNP rs7560488 T>C substantially altered transcriptional activity of DNMT3A1 gene via influencing the binding of some transcriptional factors, although a definite transcriptional factor remains to be established. Compared with TT homozygotes, subjects who were TC heterozygotes and CC homozygotes exhibited a reduced expression of DNMT3A1. Furthermore, stratified analysis showed that individuals who harbor TC or CC genotypes less than 60 years old were more susceptible to GC. Our results suggest that the genetic variations in the DNMT3A1 promoter contribute to the susceptibility to GC and also provide an insight that tagSNP rs7560488 T>C may be a promising biomarker for predicting GC genetic susceptibility and a valuable information in GC pathogenesis.	[Wu, Huazhang; Gong, Pihai; Qiao, Fengchang; Wang, Ling; Cui, He; Sui, Xinyuan; Gao, Jifan; Fan, Hong] Southeast Univ, Sch Med, Dept Med Genet, Key Lab Dev Genes & Human Dis,Minist Educ, Nanjing, Jiangsu, Peoples R China; [Wu, Huazhang; Gong, Pihai; Qiao, Fengchang; Wang, Ling; Cui, He; Sui, Xinyuan; Gao, Jifan; Fan, Hong] Southeast Univ, Sch Med, Dept Dev Biol, Key Lab Dev Genes & Human Dis,Minist Educ, Nanjing, Jiangsu, Peoples R China; [Zhang, Kun] Harbin Med Univ, Harbin Med Univ Canc Hosp, Affiliated Hosp 3, Harbin, Peoples R China	Southeast University - China; Southeast University - China; Harbin Medical University	Fan, H (corresponding author), Southeast Univ, Sch Med, Dept Med Genet, Key Lab Dev Genes & Human Dis,Minist Educ, Nanjing, Jiangsu, Peoples R China.	fanh@seu.edu.cn		Wu, Huazhang/0000-0002-5482-3761	National Natural Science Foundation of China [81171915, 91229107]; Scientific Research and Innovation Plan for College Graduates of Jiangsu Province, China [CXZZ13_0082]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research and Innovation Plan for College Graduates of Jiangsu Province, China	This work was supported by the National Natural Science Foundation of China (Grant No. 81171915 and No. 91229107) and the Scientific Research and Innovation Plan for College Graduates of Jiangsu Province, China (Grant No. CXZZ13_0082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Aung PP, 2005, ONCOL REP, V14, P1151; Balassiano K, 2011, CANCER LETT, V311, P85, DOI 10.1016/j.canlet.2011.06.038; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chang BL, 2009, HUM MOL GENET, V18, P1368, DOI 10.1093/hmg/ddp035; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Chung CC, 2010, CARCINOGENESIS, V31, P111, DOI 10.1093/carcin/bgp273; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fan H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-12; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hu JB, 2010, DIGEST DIS SCI, V55, P1011, DOI 10.1007/s10620-009-0831-3; Kanai Y, 1998, CANCER LETT, V122, P135, DOI 10.1016/S0304-3835(97)00380-7; Khatami F, 2009, ASIAN PAC J CANCER P, V10, P1177; Kim J, 2012, INT J CANCER, V130, P817, DOI 10.1002/ijc.26038; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kotini AG, 2011, MOL CELL BIOL, V31, P1577, DOI 10.1128/MCB.01093-10; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Menges M, 2009, J CANCER RES CLIN, V135, P29, DOI 10.1007/s00432-008-0425-z; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Saeki N, 2013, CANCER SCI, V104, P1, DOI 10.1111/cas.12042; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Stram Daniel O., 2005, Human Genomics, V2, P144; Tanikawa C, 2012, NAT GENET, V44, P430, DOI 10.1038/ng.1109; Turek-Plewa J, 2005, CELL MOL BIOL LETT, V10, P631; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Wang XL, 2011, CURR HYPERTENS REP, V13, P442, DOI 10.1007/s11906-011-0230-y; Weisenberger DJ, 2002, GENE, V298, P91, DOI 10.1016/S0378-1119(02)00976-9; Wu QY, 2012, MOL BIOL REP, V39, P10949, DOI 10.1007/s11033-012-1996-y; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Yang XX, 2012, INT J MOL SCI, V13, P8364, DOI 10.3390/ijms13078364; Zhao Z, 2012, ONCOL LETT, V3, P450, DOI 10.3892/ol.2011.488	41	18	18	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92911	10.1371/journal.pone.0092911	http://dx.doi.org/10.1371/journal.pone.0092911			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667323	gold, Green Submitted, Green Published			2022-12-27	WOS:000333675600102
J	Yao, GD; Shu, YM; Shi, SL; Peng, ZF; Song, WY; Jin, HX; Sun, YP				Yao, Gui-Dong; Shu, Yi-Min; Shi, Sen-Lin; Peng, Zhao-Feng; Song, Wen-Yan; Jin, Hai-Xia; Sun, Ying-Pu			Expression and Potential Roles of HLA-G in Human Spermatogenesis and Early Embryonic Development	PLOS ONE			English	Article							LEUKOCYTE ANTIGEN-G; CLASS-I; PREIMPLANTATION DEVELOPMENT; DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; SEMINAL PLASMA; MOUSE EMBRYOS; HUMAN OOCYTE; GERM-CELLS; TRANSCRIPTS	As one of the non-classical major histocompatibility complex(MHC)-1 antigens, Human Leukocyte Antigen G (HLA-G), has been suggested as a prognostic marker to identify the embryo developmental potential. In the present study, we investigated the potential roles of HLA-G in human spermatogenesis and early embryonic development. Quantitative real-time PCR analysis revealed that HLA-G's expression was increased with increased Johnsen score in testicular tissues. There was no significant difference in HLA-G mRNA expression between testicular tissues with Johnsen score of 8-9 and normal sperm from ejaculated semen. HLA-G mRNA expression was detected in human zygotes, embryos and blastocysts but not in unfertilized oocytes. In testicular tissues where sperm was obtained by testicular sperm extraction (Johnsen score was 8 to 9), there were no correlations between HLA-G mRNA expression and fertilization, cleavage and high-quality embryo rates. At 48-72 h post-fertilization, HLA-G expression was higher in fast growing embryos. HLA-G specific siRNA injection into zygotes not only slowed down embryonic cleavage rate at 48 h post-fertilization, but also down-regulated the expression of embryo metabolism related gene (SLC2A1) and cell cycle-regulated gene (CCND2). Taken together, our findings suggested that HLA-G plays significant roles in human spermatogenesis and early embryonic development.	[Yao, Gui-Dong; Shi, Sen-Lin; Peng, Zhao-Feng; Song, Wen-Yan; Jin, Hai-Xia; Sun, Ying-Pu] Zhengzhou Univ, Affiliated Hosp 1, Ctr Reprod Med, Zhengzhou 450052, Peoples R China; [Shu, Yi-Min] Stanford Univ Sch Med, Dept Obstet & Gynecol, Program Reprod & Stem Cell Biol, Stanford, CA USA	Zhengzhou University; Stanford University	Sun, YP (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Ctr Reprod Med, Zhengzhou 450052, Peoples R China.	syp2008@vip.sina.com	jin, haixia/HGA-9179-2022		Medical Science and Technology Research Projects in Henan Province [201203009]; National Natural Science Foundation [31271605]; Postdoctoral Science Foundation [2012014]; Youth Innovation Fund of the First Affiliated Hospital of Zhengzhou University	Medical Science and Technology Research Projects in Henan Province; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Youth Innovation Fund of the First Affiliated Hospital of Zhengzhou University	This work was supported by grants from the Medical Science and Technology Research Projects in Henan Province (201203009 to GDY), the National Natural Science Foundation (31271605 to YPS), the Postdoctoral Science Foundation funded project in Henan Province (2012014 to GDY), and the Youth Innovation Fund of the First Affiliated Hospital of Zhengzhou University (to GDY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Alvarez M, 2011, THERIOGENOLOGY, V75, P887, DOI 10.1016/j.theriogenology.2010.10.031; Brenol CV, 2012, REV BRAS REUMATOL, V52, P75, DOI 10.1590/S0482-50042012000100009; CHIANG MH, 1994, FERTIL STERIL, V61, P276; Choi D, 2000, J ASSIST REPROD GEN, V17, P574, DOI 10.1023/A:1026470825514; DESOYE G, 1991, LAB INVEST, V64, P306; DOHR GA, 1987, J IMMUNOL, V138, P3766; Ghanem N, 2011, REPRODUCTION, V142, P551, DOI 10.1530/REP-10-0476; Gomez E, 2009, REPRODUCTION, V137, P285, DOI 10.1530/REP-08-0220; Homer HA, 2005, MOL HUM REPROD, V11, P397, DOI 10.1093/molehr/gah184; Hutter H, 1998, J REPROD IMMUNOL, V38, P101, DOI 10.1016/S0165-0378(98)00032-1; JOHNSEN S G, 1970, Hormones (Basel), V1, P2, DOI 10.1159/000178170; Jurisicova A, 1999, HUM REPROD, V14, P1852, DOI 10.1093/humrep/14.7.1852; Jurisicova A, 1996, FERTIL STERIL, V65, P997, DOI 10.1016/S0015-0282(16)58276-4; Jurisicova A, 1996, P NATL ACAD SCI USA, V93, P161, DOI 10.1073/pnas.93.1.161; Langat DK, 2006, J REPROD IMMUNOL, V71, P75, DOI 10.1016/j.jri.2006.01.006; Larsen MH, 2011, MOL HUM REPROD, V17, P727, DOI 10.1093/molehr/gar052; Le Discorde M, 2003, HUM IMMUNOL, V64, P1039, DOI 10.1016/j.humimm.2003.08.346; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loustau M, 2013, TISSUE ANTIGENS, V81, P127, DOI 10.1111/tan.12053; Noci I, 2005, HUM REPROD, V20, P138, DOI 10.1093/humrep/deh572; Pantaleon M, 2001, BIOL REPROD, V64, P1247, DOI 10.1095/biolreprod64.4.1247; Rebmann V, 2010, HUM REPROD, V25, P1691, DOI 10.1093/humrep/deq120; Rizzo R, 2011, CELL MOL LIFE SCI, V68, P341, DOI 10.1007/s00018-010-0578-1; ROBERTS JM, 1992, IMMUNOLOGY, V75, P202; Robertson SA, 2005, CELL TISSUE RES, V322, P43, DOI 10.1007/s00441-005-1127-3; Ryan AF, 2002, J IMMUNOL, V169, P673, DOI 10.4049/jimmunol.169.2.673; Sun Li Li, 2011, J Reprod Infertil, V12, P215; Sun LL, 2008, FERTIL STERIL, V90, P2398, DOI 10.1016/j.fertnstert.2007.10.076; van Montfoort APA, 2008, MOL HUM REPROD, V14, P157, DOI 10.1093/molehr/gam088; Velker BAM, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096602; Yao GD, 2010, MOL ENDOCRINOL, V24, P540, DOI 10.1210/me.2009-0432; Yao YQ, 2005, J IMMUNOL, V175, P8379, DOI 10.4049/jimmunol.175.12.8379; Zidi I, 2011, MED HYPOTHESES, V77, P134, DOI 10.1016/j.mehy.2011.03.046	33	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92889	10.1371/journal.pone.0092889	http://dx.doi.org/10.1371/journal.pone.0092889			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667226	gold, Green Published, Green Submitted			2022-12-27	WOS:000333675600100
J	Busse, K; Strotmann, R; Strecker, K; Wegner, F; Devanathan, V; Gohla, A; Schoneberg, T; Schwarz, J				Busse, Kathy; Strotmann, Rainer; Strecker, Karl; Wegner, Florian; Devanathan, Vasudharani; Gohla, Antje; Schoeneberg, Torsten; Schwarz, Johannes			Adaptive Gene Regulation in the Striatum of RGS9-Deficient Mice	PLOS ONE			English	Article							LONG-TERM DEPRESSION; D-2 DOPAMINE-RECEPTORS; MEDIUM SPINY NEURONS; ADENYLYL-CYCLASE; AMPA RECEPTORS; ENDOCANNABINOID RELEASE; PARKINSONS-DISEASE; INDUCED DYSKINESIA; CA2+ CURRENTS; RAT	Background: RGS9-deficient mice show drug-induced dyskinesia but normal locomotor activity under unchallenged conditions. Results: Genes related to Ca2+ signaling and their functions were regulated in RGS9-deficient mice. Conclusion: Changes in Ca2+ signaling that compensate for RGS9 loss-of-function can explain the normal locomotor activity in RGS9-deficient mice under unchallenged conditions. Significance: Identified signaling components may represent novel targets in antidyskinetic therapy. The long splice variant of the regulator of G-protein signaling 9 (RGS9-2) is enriched in striatal medium spiny neurons and dampens dopamine D2 receptor signaling. Lack of RGS9-2 can promote while its overexpression prevents drug-induced dyskinesia. Other animal models of drug-induced dyskinesia rather pointed towards overactivity of dopamine receptor-mediated signaling. To evaluate changes in signaling pathways mRNA expression levels were determined and compared in wild-type and RGS9-deficient mice. Unexpectedly, expression levels of dopamine receptors were unchanged in RGS9-deficient mice, while several genes related to Ca2+ signaling and long-term depression were differentially expressed when compared to wild type animals. Detailed investigations at the protein level revealed hyperphosphorylation of DARPP32 at Thr34 and of ERK1/2 in striata of RGS9-deficient mice. Whole cell patch clamp recordings showed that spontaneous synaptic events are increased (frequency and size) in RGS9-deficient mice while long-term depression is reduced in acute brain slices. These changes are compatible with a Ca2+-induced potentiation of dopamine receptor signaling which may contribute to the drug-induced dyskinesia in RGS9-deficient mice.	[Busse, Kathy; Strecker, Karl; Wegner, Florian; Schwarz, Johannes] Univ Leipzig, Fac Med, Dept Neurol, D-04109 Leipzig, Germany; [Busse, Kathy; Strotmann, Rainer; Schoeneberg, Torsten] Univ Leipzig, Fac Med, Inst Biochem, D-04109 Leipzig, Germany; [Wegner, Florian; Schwarz, Johannes] Univ Leipzig, Translat Ctr Regenerat Med TRM, D-04109 Leipzig, Germany; [Devanathan, Vasudharani] Univ Tubingen, Inst Pharmacol & Toxicol, Tubingen, Germany; [Gohla, Antje] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Schwarz, Johannes] Tech Univ Munich, Dept Neurol, D-80290 Munich, Germany	Leipzig University; Leipzig University; Leipzig University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Wurzburg; Technical University of Munich	Busse, K (corresponding author), Univ Leipzig, Fac Med, Dept Neurol, D-04109 Leipzig, Germany.	kathy.busse@medizin.uni-leipzig.de; schoberg@medizin.uni-leipzig.de		Gohla, Antje/0000-0002-7442-1487	Deutsche Forschungsgemeinschaft [Schw 704/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Schw 704/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000664; Alcacer C, 2012, J NEUROSCI, V32, P5900, DOI 10.1523/JNEUROSCI.0837-12.2012; ANTONINI A, 1994, NEUROLOGY, V44, P1325, DOI 10.1212/WNL.44.7.1325; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Blundell J, 2008, BRAIN RES, V1190, P78, DOI 10.1016/j.brainres.2007.11.017; Brunk I, 2008, FASEB J, V22, P3736, DOI 10.1096/fj.08-111245; Burchett SA, 2000, J NEUROCHEM, V75, P1335, DOI 10.1046/j.1471-4159.2000.0751335.x; Cabrera-Vera TM, 2004, P NATL ACAD SCI USA, V101, P16339, DOI 10.1073/pnas.0407416101; Camarillo C, 2011, METHODS MOL BIOL, V698, P419, DOI 10.1007/978-1-60761-999-4_30; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Darmopil S, 2009, BIOL PSYCHIAT, V66, P603, DOI 10.1016/j.biopsych.2009.04.025; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Draghici S, 2003, NUCLEIC ACIDS RES, V31, P3775, DOI 10.1093/nar/gkg624; Fernandes AMAP, 2008, NEUROCHEM RES, V33, P1749, DOI 10.1007/s11064-008-9619-7; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Goel A, 2006, NAT NEUROSCI, V9, P1001, DOI 10.1038/nn1725; Gold SJ, 2007, J NEUROSCI, V27, P14338, DOI 10.1523/JNEUROSCI.4223-07.2007; GREIF GJ, 1995, J NEUROSCI, V15, P4533; HALLETT M, 1993, CAN J NEUROL SCI, V20, P177, DOI 10.1017/S0317167100047909; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; Holloway R, 2000, CLIN NEUROPHARMACOL, V23, P34; KEBABIAN JW, 1979, NATURE, V277, P93, DOI 10.1038/277093a0; Kovoor A, 2005, J NEUROSCI, V25, P2157, DOI 10.1523/JNEUROSCI.2840-04.2005; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Kunert R, 2005, P NATL ACAD SCI USA, V102, P5826, DOI 10.1073/pnas.0501316102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundblad M, 2004, NEUROBIOL DIS, V16, P110, DOI 10.1016/j.nbd.2004.01.007; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; Ogata H, 1998, BIOSYSTEMS, V47, P119, DOI 10.1016/S0303-2647(98)00017-3; Ouimet CC, 1998, BRAIN RES, V808, P8, DOI 10.1016/S0006-8993(98)00724-0; OUIMET CC, 1984, J NEUROSCI, V4, P111; Perreault ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033348; Perreault ML, 2010, J BIOL CHEM, V285, P36625, DOI 10.1074/jbc.M110.159954; Picconi B, 2003, NAT NEUROSCI, V6, P501, DOI 10.1038/nn1040; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P245, DOI 10.1016/S0968-0004(96)30027-3; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Rascol O, 2001, CLIN NEUROPHARMACOL, V24, P313, DOI 10.1097/00002826-200111000-00002; Rogojina A, 2003, MOL VIS, V9, P482; Rozen S, 2000, Methods Mol Biol, V132, P365; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; Santini E, 2007, J NEUROSCI, V27, P6995, DOI 10.1523/JNEUROSCI.0852-07.2007; Santini E, 2009, J NEUROCHEM, V108, P621, DOI 10.1111/j.1471-4159.2008.05831.x; Schliebe N, 2008, AM J PHYSIOL-RENAL, V295, pF1177, DOI 10.1152/ajprenal.00465.2007; Seeman P, 2007, SYNAPSE, V61, P303, DOI 10.1002/syn.20368; Seeman P, 2006, SYNAPSE, V60, P319, DOI 10.1002/syn.20303; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Stefani A, 1998, DEV NEUROSCI-BASEL, V20, P242, DOI 10.1159/000017318; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sung KW, 2001, J NEUROPHYSIOL, V86, P2405, DOI 10.1152/jn.2001.86.5.2405; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; TAUSSIG R, 1994, J BIOL CHEM, V269, P6093; Thomas EA, 1998, J NEUROSCI RES, V52, P118, DOI 10.1002/(SICI)1097-4547(19980401)52:1<118::AID-JNR11>3.0.CO;2-6; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Toyoda H, 2007, J CELL PHYSIOL, V211, P336, DOI 10.1002/jcp.20940; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Vonk A, 2008, J PHARMACOL SCI, V108, P63, DOI 10.1254/jphs.08019FP; Waszczak BL, 1998, P NATL ACAD SCI USA, V95, P11440, DOI 10.1073/pnas.95.19.11440; Westin JE, 2007, BIOL PSYCHIAT, V62, P800, DOI 10.1016/j.biopsych.2006.11.032; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005; Xie KQ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002922; Yan Z, 1997, J NEUROPHYSIOL, V77, P1003, DOI 10.1152/jn.1997.77.2.1003	67	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92605	10.1371/journal.pone.0092605	http://dx.doi.org/10.1371/journal.pone.0092605			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663062	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900083
J	Chu, LL; Xu, Y; Yang, JR; Hu, YA; Chang, HH; Lai, HY; Tseng, CC; Wang, HY; Johnson, MD; Wang, JK; Lin, CY				Chu, Li-Ling; Xu, Yuan; Yang, Jie-Ru; Hu, Yi-An; Chang, Hsiang-Hua; Lai, Hong-Yu; Tseng, Chun-Che; Wang, Hue-Yu; Johnson, Michael D.; Wang, Jehng-Kang; Lin, Chen-Yong			Human Cancer Cells Retain Modest Levels of Enzymatically Active Matriptase Only in Extracellular Milieu following Induction of Zymogen Activation	PLOS ONE			English	Article							TRANSMEMBRANE SERINE-PROTEASE; IN-VITRO; OVARIAN-CANCER; INHIBITION; PROSTATE; GROWTH; EXPRESSION; BIOMARKER; SURFACE; HAI-1	The type 2 transmembrane serine protease matriptase is broadly expressed in human carcinomas and hematological cancers. The proteolytic activity of matriptase is a potential target of drugs and imaging probes. We assessed the fate of active matriptase following the induction of matriptase zymogen activation. Exposing eight human carcinoma cells to pH 6.0 buffer induced robust matriptase zymogen activation followed by rapid inhibition of the nascent active matriptase by hepatocyte growth factor activator inhibitor (HAI)-1. Consequently, no enzymatically active matriptase was detected in these cells. Some active matriptase is, however, rapidly shed to the extracellular milieu by these carcinoma cells. The lack of cell-associated active matriptase and the shedding of active matriptase were also observed in two hematological cancer lines. Matriptase shedding is correlated closely with the induction of matriptase activation, suggesting that matriptase activation and shedding are kinetically coupled. The coupling allows a proportion of active matriptase to survive HAI-1 inhibition by rapid shedding from cell surface. Our study suggests that cellular free, active matriptase is scarce and might not be an effective target for in vivo imaging and drug development.	[Chu, Li-Ling; Wang, Hue-Yu] Chi Mei Med Ctr, Dept Pharm, Tainan, Taiwan; [Xu, Yuan; Chang, Hsiang-Hua; Lai, Hong-Yu; Tseng, Chun-Che; Johnson, Michael D.; Lin, Chen-Yong] Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC USA; [Yang, Jie-Ru; Hu, Yi-An; Chang, Hsiang-Hua] Natl Def Med Ctr, Dept Med, Taipei 10764, Taiwan; [Tseng, Chun-Che] Carleton Coll, Dept Biol, Northfield, MN 55057 USA; [Wang, Jehng-Kang] Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan	Chi Mei Hospital; Georgetown University; National Defense Medical Center; Carleton College; National Defense Medical Center	Wang, JK (corresponding author), Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan.	jkwang@ndmctsgh.edu.tw; lincy@georgetown.edu		johnson, Michael/0000-0001-6260-7586; Tseng, Chun-che/0000-0001-9637-4127	National Cancer Institute (NCI) [RO1 CA 123223]; Taiwan Department of Defense [MAB-102-08]; Chi-Mei Medical Center [CMNDMC-10211]; NATIONAL CANCER INSTITUTE [P30CA051008, R01CA123223] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000101] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Taiwan Department of Defense; Chi-Mei Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by National Cancer Institute (NCI) Grants RO1 CA 123223 (to M. Johnson and C.-Y. Lin); Taiwan Department of Defense Grant MAB-102-08 (to J.-K. Wang); and Chi-Mei Medical Center grant CMNDMC-10211 (to J.-K. Wang and L.-L. Chu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benaud C, 2002, J BIOL CHEM, V277, P10539, DOI 10.1074/jbc.M109064200; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Bugge TH, 2007, FRONT BIOSCI-LANDMRK, V12, P5060, DOI 10.2741/2448; Cary KC, 2013, THER ADV UROL, V5, P318, DOI 10.1177/1756287213495915; Chauhan D, 2005, MOL CANCER THER, V4, P686, DOI 10.1158/1535-7163.MCT-04-0338; Chen YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062826; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Cheng MF, 2007, EUR J DERMATOL, V17, P375; Cheng TS, 2013, CANCER PREV RES, V6, P495, DOI 10.1158/1940-6207.CAPR-12-0293-T; Cho EG, 2001, J BIOL CHEM, V276, P44581, DOI 10.1074/jbc.M107059200; Chou FP, 2013, AM J PATHOL, V183, P1306, DOI 10.1016/j.ajpath.2013.06.024; Darragh MR, 2010, CANCER RES, V70, P1505, DOI 10.1158/0008-5472.CAN-09-1640; Deng DW, 2013, BIOSENS BIOELECTRON, V49, P216, DOI 10.1016/j.bios.2013.05.018; Desilets A, 2006, FEBS LETT, V580, P2227, DOI 10.1016/j.febslet.2006.03.030; Enyedy IJ, 2001, J MED CHEM, V44, P1349, DOI 10.1021/jm000395x; Fang JD, 2011, J BIOL CHEM, V286, P5667, DOI 10.1074/jbc.M110.153866; Farady CJ, 2007, J MOL BIOL, V369, P1041, DOI 10.1016/j.jmb.2007.03.078; Fonovic M, 2007, CURR PHARM DESIGN, V13, P253, DOI 10.2174/138161207779313623; Forbs D, 2005, INT J ONCOL, V27, P1061; Galkin AV, 2004, PROSTATE, V61, P228, DOI 10.1002/pros.20094; Gao L, 2013, LEUKEMIA, V27, P1191, DOI 10.1038/leu.2012.289; Godiksen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077146; Hung RJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1159, DOI 10.1152/ajpcell.00400.2003; Ihara S, 2002, J BIOL CHEM, V277, P16960, DOI 10.1074/jbc.M200673200; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kiyomiya KI, 2006, AM J PHYSIOL-CELL PH, V291, pC40, DOI 10.1152/ajpcell.00351.2005; LeBeau AM, 2013, P NATL ACAD SCI USA, V110, P93, DOI 10.1073/pnas.1218694110; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1997, J BIOL CHEM, V272, P9147; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Long YQ, 2001, BIOORG MED CHEM LETT, V11, P2515, DOI 10.1016/S0960-894X(01)00493-0; Marverti G, 2008, J INORG BIOCHEM, V102, P699, DOI 10.1016/j.jinorgbio.2007.10.015; Milner JM, 2010, ARTHRITIS RHEUM-US, V62, P1955, DOI 10.1002/art.27476; Nimishakavi S, 2012, AM J PHYSIOL-LUNG C, V303, pL97, DOI 10.1152/ajplung.00303.2011; Oberst M, 2001, AM J PATHOL, V158, P1301, DOI 10.1016/S0002-9440(10)64081-3; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Oberst MD, 2002, CLIN CANCER RES, V8, P1101; Rajkumar SV, 2005, J CLIN ONCOL, V23, P630, DOI 10.1200/JCO.2005.11.030; Saleem M, 2006, CANCER EPIDEM BIOMAR, V15, P217, DOI 10.1158/1055-9965.EPI-05-0737; Seitz I, 2007, ARTERIOSCL THROM VAS, V27, P769, DOI 10.1161/01.ATV.0000258862.61067.14; Steinmetzer T, 2006, J MED CHEM, V49, P4116, DOI 10.1021/jm051272l; Tseng IC, 2008, AM J PHYSIOL-CELL PH, V295, pC423, DOI 10.1152/ajpcell.00164.2008; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Vogel LK, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-176; Welman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034182; Xu H, 2012, AM J PHYSIOL-CELL PH, V302, pC453, DOI 10.1152/ajpcell.00344.2011; Xu ZH, 2011, J MED CHEM, V54, P7567, DOI 10.1021/jm200920s	49	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92244	10.1371/journal.pone.0092244	http://dx.doi.org/10.1371/journal.pone.0092244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663123	gold, Green Published, Green Submitted			2022-12-27	WOS:000333459900046
J	Yu, Y; Lee, JS; Xie, N; Li, E; Hurtado-Coll, A; Fazli, L; Cox, M; Plymate, S; Gleave, M; Dong, XS				Yu, Yue; Lee, Jennifer Suehyun; Xie, Ning; Li, Estelle; Hurtado-Coll, Antonio; Fazli, Ladan; Cox, Michael; Plymate, Stephen; Gleave, Martin; Dong, Xuesen			Prostate Stromal Cells Express the Progesterone Receptor to Control Cancer Cell Mobility	PLOS ONE			English	Article							LIGAND-INDEPENDENT ACTIVATION; ANDROGEN RECEPTOR; MALIGNANT-TRANSFORMATION; SIGNALING PATHWAY; IN-VIVO; INTERLEUKIN-6; GROWTH; CXCR4; CXCL12; MICROENVIRONMENT	Background: Reciprocal interactions between epithelium and stroma play vital roles for prostate cancer development and progression. Enhanced secretions of cytokines and growth factors by cancer associated fibroblasts in prostate tumors create a favorable microenvironment for cancer cells to grow and metastasize. Our previous work showed that the progesterone receptor (PR) was expressed specifically in prostate stromal fibroblasts and smooth muscle cells. However, the expression levels of PR and its impact to tumor microenvironment in prostate tumors are poorly understood. Methods: Immunohistochemistry assays are applied to human prostate tissue biopsies. Cell migration, invasion and proliferation assays are performed using human prostate cells. Real-time PCR and ELISA are applied to measure gene expression at molecular levels. Results: Immunohistochemistry assays showed that PR protein levels were decreased in cancer associated stroma when compared with paired normal prostate stroma. Using in vitro prostate stromal cell models, we showed that conditioned media collected from PR positive stromal cells inhibited prostate cancer cell migration and invasion, but had minor suppressive impacts on cancer cell proliferation. PR suppressed the secretion of stromal derived factor-1 (SDF-1) and interlukin-6 (IL-6) by stromal cells independent to PR ligands. Blocking PR expression by siRNA or supplementation of exogenous SDF-1 or IL-6 to conditioned media from PR positive stromal cells counteracted the inhibitory effects of PR to cancer cell migration and invasion. Conclusions: Decreased expression of the PR in cancer associated stroma may contribute to the elevated SDF-1 and IL-6 levels in prostate tumors and enhance prostate tumor progression.	[Yu, Yue; Lee, Jennifer Suehyun; Xie, Ning; Li, Estelle; Hurtado-Coll, Antonio; Fazli, Ladan; Cox, Michael; Gleave, Martin; Dong, Xuesen] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada; [Plymate, Stephen] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Plymate, Stephen] VAPSHCS GRECC, Seattle, WA USA; [Dong, Xuesen] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada	University of British Columbia; University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; University of Toronto	Dong, XS (corresponding author), Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada.	xdong@prostatecentre.com	Dong, Xuesen/AGF-9228-2022	Gleave, Martin/0000-0003-4235-0167	Canadian Institutes of Health Research [MOP- 97934]; Prostate Cancer Canada; PNW Prostate Cancer SPORE pilot grant; NATIONAL CANCER INSTITUTE [P50CA097186] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Prostate Cancer Canada; PNW Prostate Cancer SPORE pilot grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by Canadian Institutes of Health Research Operating Grant (MOP- 97934), Rising Star Award and Discovery Grant from Prostate Cancer Canada to XSD and PNW Prostate Cancer SPORE pilot grant to XSD and MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao MF, 2007, CANCER RES, V67, P4244, DOI 10.1158/0008-5472.CAN-06-3946; Arnett-Mansfield RL, 2004, J CLIN ENDOCR METAB, V89, P1429, DOI 10.1210/jc.2003-031111; Chinni SR, 2006, PROSTATE, V66, P32, DOI 10.1002/pros.20318; Cunha GR, 2003, INT J CANCER, V107, P1, DOI 10.1002/ijc.11335; Daniel AR, 2009, P NATL ACAD SCI USA, V106, P14287, DOI 10.1073/pnas.0905118106; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Domanska UM, 2012, NEOPLASIA, V14, P709, DOI 10.1593/neo.12324; Domingo-Domenech J, 2006, CLIN CANCER RES, V12, P5578, DOI 10.1158/1078-0432.CCR-05-2767; Dong XS, 2007, MOL CELL BIOL, V27, P4863, DOI 10.1128/MCB.02144-06; Dong XS, 2009, MOL ENDOCRINOL, V23, P1147, DOI 10.1210/me.2008-0357; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Gabal Samia M, 2007, J Egypt Natl Canc Inst, V19, P239; Gao LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063563; George DJ, 2005, CLIN CANCER RES, V11, P1815, DOI 10.1158/1078-0432.CCR-04-1560; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Hardy DB, 2008, MOL ENDOCRINOL, V22, P1812, DOI 10.1210/me.2007-0443; Hartmann TN, 2005, ONCOGENE, V24, P4462, DOI 10.1038/sj.onc.1208621; Hayward SW, 2001, CANCER RES, V61, P8135; Henshall SM, 2001, CANCER RES, V61, P423; Hobisch A, 1998, CANCER RES, V58, P4640; Jacobsen BM, 2002, J BIOL CHEM, V277, P27793, DOI 10.1074/jbc.M202584200; Karlou M, 2010, NAT REV UROL, V7, P494, DOI 10.1038/nrurol.2010.134; Kasina S, 2012, MOL CELL ENDOCRINOL, V351, P249, DOI 10.1016/j.mce.2011.12.015; Kryczek I, 2005, CANCER RES, V65, P465; Kukreja P, 2005, CANCER RES, V65, P9891, DOI 10.1158/0008-5472.CAN-05-1293; Kurita T, 1998, ENDOCRINOLOGY, V139, P4708, DOI 10.1210/en.139.11.4708; Lai KP, 2012, EMBO MOL MED, V4, P791, DOI 10.1002/emmm.201101140; Lee SO, 2003, CLIN CANCER RES, V9, P370; Lee SO, 2004, PROSTATE, V60, P178, DOI 10.1002/pros.20045; Li YR, 2008, J CELL MOL MED, V12, P2790, DOI 10.1111/j.1582-4934.2008.00279.x; Lim CS, 1999, MOL ENDOCRINOL, V13, P366, DOI 10.1210/me.13.3.366; Liu LL, 2013, ONCOGENE; McPherson SJ, 2010, P NATL ACAD SCI USA, V107, P3123, DOI 10.1073/pnas.0905524107; Olapade-Alaopa EO, 1999, CLIN CANCER RES, V5, P569; Ricke WA, 2006, INT J CANCER, V118, P2123, DOI 10.1002/ijc.21614; Sethi T, 1999, NAT MED, V5, P662, DOI 10.1038/9511; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Sun YX, 2003, J CELL BIOCHEM, V89, P462, DOI 10.1002/jcb.10522; Sung ML, 2009, CIRC RES, V105, P755, DOI 10.1161/CIRCRESAHA.109.206524; Taichman RS, 2002, CANCER RES, V62, P1832; Tanner MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016027; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Ueda T, 2002, J BIOL CHEM, V277, P38087, DOI 10.1074/jbc.M203313200; Wang JH, 2005, CELL SIGNAL, V17, P1578, DOI 10.1016/j.cellsig.2005.03.022; Wang YZ, 2001, CANCER RES, V61, P6064; Wedel SA, 2008, MOL MED REP, V1, P257; Xie N, 2012, MOL ENDOCRINOL, V26, P1370, DOI 10.1210/me.2012-1088; YAN GC, 1993, MOL CELL BIOL, V13, P4513, DOI 10.1128/MCB.13.8.4513; Yu Y, 2013, J CLIN ENDOCRINOL ME	49	31	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92714	10.1371/journal.pone.0092714	http://dx.doi.org/10.1371/journal.pone.0092714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664419	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900100
J	Liew, YJ; Aranda, M; Carr, A; Baumgarten, S; Zoccola, D; Tambutte, S; Allemand, D; Micklem, G; Voolstra, CR				Liew, Yi Jin; Aranda, Manuel; Carr, Adrian; Baumgarten, Sebastian; Zoccola, Didier; Tambutte, Sylvie; Allemand, Denis; Micklem, Gos; Voolstra, Christian R.			Identification of MicroRNAs in the Coral Stylophora pistillata	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; GENE-EXPRESSION; CLIMATE-CHANGE; SMALL RNAS; PROTEIN; EVOLUTION; RESPONSES; STRESS; INTERPROSCAN; INSIGHTS	Coral reefs are major contributors to marine biodiversity. However, they are in rapid decline due to global environmental changes such as rising sea surface temperatures, ocean acidification, and pollution. Genomic and transcriptomic analyses have broadened our understanding of coral biology, but a study of the microRNA (miRNA) repertoire of corals is missing. miRNAs constitute a class of small non-coding RNAs of similar to 22 nt in size that play crucial roles in development, metabolism, and stress response in plants and animals alike. In this study, we examined the coral Stylophora pistillata for the presence of miRNAs and the corresponding core protein machinery required for their processing and function. Based on small RNA sequencing, we present evidence for 31 bona fide microRNAs, 5 of which (miR-100, miR-2022, miR-2023, miR-2030, and miR-2036) are conserved in other metazoans. Homologues of Argonaute, Piwi, Dicer, Drosha, Pasha, and HEN1 were identified in the transcriptome of S. pistillata based on strong sequence conservation with known RNAi proteins, with additional support derived from phylogenetic trees. Examination of putative miRNA gene targets indicates potential roles in development, metabolism, immunity, and biomineralisation for several of the microRNAs. Here, we present first evidence of a functional RNAi machinery and five conserved miRNAs in S. pistillata, implying that miRNAs play a role in organismal biology of scleractinian corals. Analysis of predicted miRNA target genes in S. pistillata suggests potential roles of miRNAs in symbiosis and coral calcification. Given the importance of miRNAs in regulating gene expression in other metazoans, further expression analyses of small non-coding RNAs in transcriptional studies of corals should be informative about miRNA-affected processes and pathways.	[Liew, Yi Jin; Aranda, Manuel; Baumgarten, Sebastian; Voolstra, Christian R.] KAUST, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Liew, Yi Jin; Carr, Adrian; Micklem, Gos] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England; [Liew, Yi Jin; Carr, Adrian; Micklem, Gos] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Zoccola, Didier; Tambutte, Sylvie; Allemand, Denis] Ctr Sci Monaco, Monaco, Monaco	King Abdullah University of Science & Technology; University of Cambridge; University of Cambridge	Micklem, G (corresponding author), Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England.	g.micklem@gen.cam.ac.uk; christian.voolstra@kaust.edu.sa	Aranda Lastra, Manuel/D-9530-2011; Voolstra, Christian R/H-7158-2014; Liew, Yi Jin/AAI-6307-2021; Zoccola, Didier/A-5997-2009	Aranda Lastra, Manuel/0000-0001-6673-016X; Voolstra, Christian R/0000-0003-4555-3795; Liew, Yi Jin/0000-0003-2553-8870; Zoccola, Didier/0000-0002-1524-8098; Micklem, Gos/0000-0002-6883-6168; Baumgarten, Sebastian/0000-0003-2646-7699	Cambridge Commonwealth Trust; Trinity Hall; Academic Excellence Alliance (AEA) Award [1000000533]	Cambridge Commonwealth Trust; Trinity Hall; Academic Excellence Alliance (AEA) Award	This project was partially funded by bursaries from Cambridge Commonwealth Trust and Trinity Hall to YJL, and an Academic Excellence Alliance (AEA) Award (Award Number 1000000533) to CRV and GM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Aranda M, 2011, MOL ECOL, V20, P2955, DOI 10.1111/j.1365-294X.2011.05153.x; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Babenko O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029441; BAK RPM, 1987, MAR POLLUT BULL, V18, P534, DOI 10.1016/0025-326X(87)90537-6; Banales JM, 2012, HEPATOLOGY, V56, P687, DOI 10.1002/hep.25691; Baumgarten S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-704; Benakanakere MR, 2009, J BIOL CHEM, V284, P23107, DOI 10.1074/jbc.M109.013862; Brown CT, 2012, ARXIV12034802; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Campo-Paysaa F, 2011, EVOL DEV, V13, P15, DOI 10.1111/j.1525-142X.2010.00452.x; Cao H, 2010, J DENT RES, V89, P779, DOI 10.1177/0022034510369304; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chen CZ, 2013, IMMUNOL REV, V253, P112, DOI 10.1111/imr.12060; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chen Y, 2013, BIOCHEM BIOPH RES CO, V438, P133, DOI 10.1016/j.bbrc.2013.07.040; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; DeSalvo MK, 2012, CORAL REEFS, V31, P215, DOI 10.1007/s00338-011-0833-4; DeSalvo MK, 2010, MOL ECOL, V19, P1174, DOI 10.1111/j.1365-294X.2010.04534.x; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erez J, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P151, DOI 10.1007/978-94-007-0114-4_10; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Fromm B, 2013, MOL BIOL EVOL, V30, P2619, DOI 10.1093/molbev/mst155; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Green EP, 2000, BIOL CONSERV, V96, P347, DOI 10.1016/S0006-3207(00)00073-2; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Horie T, 2009, BIOCHEM BIOPH RES CO, V389, P315, DOI 10.1016/j.bbrc.2009.08.136; Huang Y, 2009, NATURE, V461, P823, DOI 10.1038/nature08433; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jiao Y, 2014, MAR BIOTECHNOL, V16, P54, DOI 10.1007/s10126-013-9528-x; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Knowlton Nancy, 2010, P65, DOI 10.1002/9781444325508.ch4; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Li BH, 2011, EUR J CANCER, V47, P2166, DOI 10.1016/j.ejca.2011.04.037; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Maniar JM, 2011, CURR BIOL, V21, P449, DOI 10.1016/j.cub.2011.02.019; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Meyer E, 2011, MOL ECOL, V20, P3599, DOI 10.1111/j.1365-294X.2011.05205.x; Michalak P, 2008, GENOMICS, V91, P158, DOI 10.1016/j.ygeno.2007.10.013; Moran Y, 2013, MOL BIOL EVOL; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Moya A, 2012, MOL ECOL, V21, P2440, DOI 10.1111/j.1365-294X.2012.05554.x; Moya A, 2008, MAR BIOTECHNOL, V10, P653, DOI 10.1007/s10126-008-9101-1; Mukherjee K, 2013, MOL BIOL EVOL, V30, P627, DOI 10.1093/molbev/mss263; Mulder Nicola, 2007, V396, P59; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; PASTOROK RA, 1985, MAR ECOL PROG SER, V21, P175, DOI 10.3354/meps021175; Peterson KJ, 2009, BIOESSAYS, V31, P736, DOI 10.1002/bies.200900033; Philippe L, 2012, J IMMUNOL, V188, P454, DOI 10.4049/jimmunol.1102348; Polato NR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011221; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sempere LF, 2006, J EXP ZOOL PART B, V306B, P575, DOI 10.1002/jez.b.21118; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song XW, 2012, PLANT J, V71, P378, DOI 10.1111/j.1365-313X.2012.05001.x; Sun H, 2010, MOL BIOL REP, V37, P2951, DOI 10.1007/s11033-009-9861-3; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tarver JE, 2012, BIOESSAYS, V34, P857, DOI 10.1002/bies.201200055; van Wijnen AJ, 2013, CURR OSTEOPOROS REP, V11, P72, DOI 10.1007/s11914-013-0143-6; Vidal-Dupiol J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058652; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Voolstra CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-627; Voolstra CR, 2009, MOL ECOL, V18, P1823, DOI 10.1111/j.1365-294X.2009.04167.x; Wang K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.233; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zeng Y, 2012, FEBS LETT, V586, P2375, DOI 10.1016/j.febslet.2012.05.049; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zheng YS, 2012, ONCOGENE, V31, P80, DOI 10.1038/onc.2011.208; Zong J, 2009, GENE, V447, P29, DOI 10.1016/j.gene.2009.07.004	102	36	39	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91101	10.1371/journal.pone.0091101	http://dx.doi.org/10.1371/journal.pone.0091101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658574	gold, Green Published			2022-12-27	WOS:000333355300024
J	Soema, PC; Willems, GJ; van Twillert, K; van de Wijdeven, G; Boog, CJ; Kersten, GFA; Amorij, JP				Soema, Peter C.; Willems, Geert-Jan; van Twillert, Klaas; van de Wijdeven, Gijsbert; Boog, Claire J.; Kersten, Gideon F. A.; Amorij, Jean-Pierre			Solid Bioneedle-Delivered Influenza Vaccines Are Highly Thermostable and Induce Both Humoral and Cellular Immune Responses	PLOS ONE			English	Article							INACTIVATED VIRUS-VACCINE; SUBUNIT VACCINE; POWDER; IMMUNIZATION; MICE; IMMUNOGENICITY; QUANTIFICATION; HEMAGGLUTININ; CARRIERS; STORAGE	The potential of bioneedles to deliver influenza vaccines was investigated. Four influenza vaccine formulations were screened to determine the optimal formulation for use with bioneedles. The stability of the formulations after freeze-drying was checked to predict the stability of the influenza vaccines in the bioneedles. Subunit, split, virosomal and whole inactivated influenza (WIV) vaccine were formulated and lyophilized in bioneedles, and subsequently administered to C57BL/6 mice. Humoral and cellular immune responses were assessed after vaccination. The thermostability of lyophilized vaccines was determined after one-month storage at elevated temperatures. Bioneedle influenza vaccines induced HI titers that are comparable to those induced by intramuscular WIV vaccination. Delivery by bioneedles did not alter the type of immune response induced by the influenza vaccines. Stability studies showed that lyophilized influenza vaccines have superior thermostability compared to conventional liquid vaccines, and remained stable after one-month storage at 60 degrees C. Influenza vaccines delivered by bioneedles are a viable alternative to conventional liquid influenza vaccines. WIV was determined to be the most potent vaccine formulation for administration by bioneedles. Lyophilized influenza vaccines in bioneedles are independent of a cold-chain, due to their increased thermostability, which makes distribution and stockpiling easier.	[Soema, Peter C.; Willems, Geert-Jan; van Twillert, Klaas; Boog, Claire J.; Kersten, Gideon F. A.; Amorij, Jean-Pierre] Inst Translat Vaccinol Intravacc, Bilthoven, Netherlands; [van de Wijdeven, Gijsbert] Bioneedle Technol Grp BV, Eindhoven, Netherlands		Soema, PC (corresponding author), Inst Translat Vaccinol Intravacc, Bilthoven, Netherlands.	petersoema@gmail.com			Dutch Ministry of Health, Welfare and Sport	Dutch Ministry of Health, Welfare and Sport	This work was funded by the Dutch Ministry of Health, Welfare and Sport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorij JP, 2007, VACCINE, V25, P6447, DOI 10.1016/j.vaccine.2007.06.054; Amorij JP, 2008, PHARM RES-DORDR, V25, P1256, DOI 10.1007/s11095-008-9559-6; Amorij JP, 2010, LANCET INFECT DIS, V10, P699, DOI 10.1016/S1473-3099(10)70157-2; Bodewes R, 2010, J GEN VIROL, V91, P1743, DOI 10.1099/vir.0.020784-0; Budimir N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063163; BUDOWSKY EI, 1991, VACCINE, V9, P398, DOI 10.1016/0264-410X(91)90125-P; Chen DX, 2003, VACCINE, V21, P2830, DOI 10.1016/S0264-410X(03)00175-0; Choi HJ, 2013, J CONTROL RELEASE, V166, P159, DOI 10.1016/j.jconrel.2012.12.002; de Jonge J, 2007, EUR J PHARM SCI, V32, P33, DOI 10.1016/j.ejps.2007.05.112; de Jonge J, 2006, BBA-BIOMEMBRANES, V1758, P527, DOI 10.1016/j.bbamem.2006.03.011; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Geeraedts F, 2010, AAPS J, V12, P215, DOI 10.1208/s12248-010-9179-z; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; Geeraedts F, 2008, INFLUENZA OTHER RESP, V2, P41, DOI 10.1111/j.1750-2659.2008.00038.x; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Hagenaars N, 2008, VACCINE, V26, P6555, DOI 10.1016/j.vaccine.2008.09.057; Hillaire MLB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/939860; Hirschberg HJHB, 2008, VACCINE, V26, P2389, DOI 10.1016/j.vaccine.2008.02.067; Hirschberg HJHB, 2010, J CONTROL RELEASE, V147, P211, DOI 10.1016/j.jconrel.2010.06.028; Kapteyn JC, 2009, VACCINE, V27, P1468, DOI 10.1016/j.vaccine.2008.11.113; Martin RM, 1998, J IMMUNOL METHODS, V212, P187, DOI 10.1016/S0022-1759(98)00015-5; Mitragotri S, 2006, NAT REV DRUG DISCOV, V5, P543, DOI 10.1038/nrd2076; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nilsson CE, 2010, VACCINE, V28, P759, DOI 10.1016/j.vaccine.2009.10.070; Taddio A, 2012, VACCINE, V30, P4807, DOI 10.1016/j.vaccine.2012.05.011; The Committee for Proprietary Medicinal Products (CHMP), CHMPBWP21496; van de Wijdeven GGP, 2002, J CONTROL RELEASE, V85, P145, DOI 10.1016/S0168-3659(02)00283-3	28	14	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92806	10.1371/journal.pone.0092806	http://dx.doi.org/10.1371/journal.pone.0092806			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671048	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000078
J	Bargiela, A; Llamusi, B; Cerro-Herreros, E; Artero, R				Bargiela, Ariadna; Llamusi, Beatriz; Cerro-Herreros, Estefania; Artero, Ruben			Two Enhancers Control Transcription of Drosophila muscleblind in the Embryonic Somatic Musculature and in the Central Nervous System	PLOS ONE			English	Article							MYOTONIC-DYSTROPHY TYPE-1; GENE-EXPRESSION; NUCLEAR FOCI; PROTEINS; RNA; SPECIFICATION; LOCALIZATION; PROMOTERS; ELEMENT; CELLS	The phylogenetically conserved family of Muscleblind proteins are RNA-binding factors involved in a variety of gene expression processes including alternative splicing regulation, RNA stability and subcellular localization, and miRNA biogenesis, which typically contribute to cell-type specific differentiation. In humans, sequestration of Muscleblind-like proteins MBNL1 and MBNL2 has been implicated in degenerative disorders, particularly expansion diseases such as myotonic dystrophy type 1 and 2. Drosophila muscleblind was previously shown to be expressed in embryonic somatic and visceral muscle subtypes, and in the central nervous system, and to depend on Mef2 for transcriptional activation. Genomic approaches have pointed out candidate gene promoters and tissue-specific enhancers, but experimental confirmation of their regulatory roles was lacking. In our study, luciferase reporter assays in S2 cells confirmed that regions P1 (515 bp) and P2 (573 bp), involving the beginning of exon 1 and exon 2, respectively, were able to initiate RNA transcription. Similarly, transgenic Drosophila embryos carrying enhancer reporter constructs supported the existence of two regulatory regions which control embryonic expression of muscleblind in the central nerve cord (NE, neural enhancer; 830 bp) and somatic (skeletal) musculature (ME, muscle enhancer; 3.3 kb). Both NE and ME were able to boost expression from the Hsp70 heterologous promoter. In S2 cell assays most of the ME enhancer activation could be further narrowed down to a 1200 bp subregion (ME.3), which contains predicted binding sites for the Mef2 transcription factor. The present study constitutes the first characterization of muscleblind enhancers and will contribute to a deeper understanding of the transcriptional regulation of the gene.	[Bargiela, Ariadna; Llamusi, Beatriz; Cerro-Herreros, Estefania; Artero, Ruben] Univ Valencia, Dept Genet, Translat Genom Grp, Valencia, Spain; [Bargiela, Ariadna; Llamusi, Beatriz; Cerro-Herreros, Estefania; Artero, Ruben] INCLIVA Hlth Res Inst, Valencia, Spain	University of Valencia	Artero, R (corresponding author), Univ Valencia, Dept Genet, Translat Genom Grp, Valencia, Spain.	ruben.artero@uv.es	Bargiela, Ariadna/ABF-9125-2020; Herreros, Estefanía Cerro/AAD-6166-2021; llamusi, Beatriz/M-4449-2015; Artero, Ruben/K-6815-2014	Herreros, Estefanía Cerro/0000-0003-3247-5900; llamusi, Beatriz/0000-0002-2694-1293; Artero, Ruben/0000-0003-1596-047X; Bargiela, Ariadna/0000-0003-4336-2522	Genoma Espana Foundation; Generalitat Valenciana [Prometeo/2010/081]; Ministerio de Ciencia e Innovacion [BFU2009-10940]; Ministerio de Economia y Competitividad [SAF2012-36854]; Generalitat Valenciana; Genoma Espana; Geronimo Forteza grant from Generalitat Valenciana; Plan E; FEDER	Genoma Espana Foundation; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitividad(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Genoma Espana; Geronimo Forteza grant from Generalitat Valenciana; Plan E; FEDER(European Commission)	This work was supported by research grants from Genoma Espana Foundation, Generalitat Valenciana (Prometeo/2010/081), Ministerio de Ciencia e Innovacion (BFU2009-10940, including funds from Plan E), and Ministerio de Economia y Competitividad (SAF2012-36854, including funds from FEDER) to R. A. A. B. was supported by a Prometeo contract and a predoctoral fellowship from Generalitat Valenciana. B. L. was funded through Genoma Espana. E. C. H. was supported by a Geronimo Forteza grant from Generalitat Valenciana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adereth Y, 2005, NAT CELL BIOL, V7, P1240, DOI 10.1038/ncb1335; Artero R, 1998, DEV BIOL, V195, P131, DOI 10.1006/dbio.1997.8833; AWGULEWITSCH A, 1992, NATURE, V358, P341, DOI 10.1038/358341a0; Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; Begemann G, 1997, DEVELOPMENT, V124, P4321; BERMINGHAM JR, 1990, DEVELOPMENT, V109, P553; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROOK, 1992, CELL, V69, P385; Carlson JM, 2007, NUCLEIC ACIDS RES, V35, pW259, DOI 10.1093/nar/gkm310; Charizanis K, 2012, NEURON, V75, P437, DOI 10.1016/j.neuron.2012.05.029; Cunha PMF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001014; De Graeve F, 2004, DEV BIOL, V270, P122, DOI 10.1016/j.ydbio.2004.02.014; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fernandez-Costa JM, 2011, BIOL REV, V86, P947, DOI 10.1111/j.1469-185X.2011.00180.x; Fernandez-Costa JM, 2010, MOL CELLS, V30, P65, DOI 10.1007/s10059-010-0089-9; Fiszer A, 2013, J MOL MED, V91, P683, DOI 10.1007/s00109-013-1016-2; Goers ES, 2008, BIOCHEMISTRY-US, V47, P7284, DOI 10.1021/bi702252d; Han H, 2013, NATURE, V498, P241, DOI 10.1038/nature12270; Houseley JM, 2005, HUM MOL GENET, V14, P873, DOI 10.1093/hmg/ddi080; Irion U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034248; JAGLA K, 1993, GENE, V127, P165, DOI 10.1016/0378-1119(93)90715-F; Jiang H, 2004, HUM MOL GENET, V13, P3079, DOI 10.1093/hmg/ddh327; Juni N, 2009, J NEUROGENET, V23, P329, DOI 10.1080/01677060802471601; Kanadia RN, 2003, GENE EXPR PATTERNS, V3, P459, DOI 10.1016/S1567-133X(03)00064-4; KANIA A, 1995, GENETICS, V139, P1663; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lee KS, 2007, BIOCHEM BIOPH RES CO, V361, P151, DOI 10.1016/j.bbrc.2007.06.165; Lee KS, 2010, J BIOL CHEM, V285, P33779, DOI 10.1074/jbc.M110.124255; Li LB, 2010, TRENDS NEUROSCI, V33, P292, DOI 10.1016/j.tins.2010.03.004; Lin X, 2006, HUM MOL GENET; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Machuca-Tzili L, 2006, HUM GENET, V120, P487, DOI 10.1007/s00439-006-0228-8; Masuda A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00209; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Mykowska A, 2011, NUCLEIC ACIDS RES, V39, P8938, DOI 10.1093/nar/gkr608; Novotny T, 2002, DEVELOPMENT, V129, P1027; Ohler U, 2006, NUCLEIC ACIDS RES, V34, P5943, DOI 10.1093/nar/gkl608; Ohtsuki S, 1998, GENE DEV, V12, P547, DOI 10.1101/gad.12.4.547; Osborne RJ, 2009, HUM MOL GENET, V18, P1471, DOI 10.1093/hmg/ddp058; Picchio L, 2013, HUM MOL GENET, V22, P2795, DOI 10.1093/hmg/ddt127; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Poulos MG, 2013, HUM MOL GENET, V22, P3547, DOI 10.1093/hmg/ddt209; Rau F, 2011, NAT STRUCT MOL BIOL, V18, P840, DOI 10.1038/nsmb.2067; Romani S, 1996, MECH DEVELOP, V60, P95, DOI 10.1016/S0925-4773(96)00603-X; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Squillace RM, 2002, DEV BIOL, V250, P218, DOI 10.1006/dbio.2002.0798; Tabebordbar M, 2013, ANNU REV PATHOL-MECH, V8, P441, DOI 10.1146/annurev-pathol-011811-132450; Vicente M, 2007, DIFFERENTIATION, V75, P427, DOI 10.1111/j.1432-0436.2006.00156.x; Vicente-Crespo M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001613; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	58	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93125	10.1371/journal.pone.0093125	http://dx.doi.org/10.1371/journal.pone.0093125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667536	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600145
J	Miyazaki, S; Okada, Y; Miyakawa, H; Tokuda, G; Cornette, R; Koshikawa, S; Maekawa, K; Miura, T				Miyazaki, Satoshi; Okada, Yasukazu; Miyakawa, Hitoshi; Tokuda, Gaku; Cornette, Richard; Koshikawa, Shigeyuki; Maekawa, Kiyoto; Miura, Toru			Sexually Dimorphic Body Color Is Regulated by Sex-Specific Expression of Yellow Gene in Ponerine Ant, Diacamma Sp.	PLOS ONE			English	Article							EVOLUTION; PIGMENTATION; MECHANISMS; PROTEINS; PATTERNS; TRAITS; TAN	Most hymenopteran species exhibit conspicuous sexual dimorphism due to ecological differences between the sexes. As hymenopteran genomes, under the haplodiploid genetic system, exhibit quantitative differences between sexes while remaining qualitatively identical, sexual phenotypes are assumed to be expressed through sex-specific gene usage. In the present study, the molecular basis for expression of sexual dimorphism in a queenless ant, Diacamma sp., which exhibits a distinct color dimorphism, was examined. Worker females of the species appear bluish-black, while winged males exhibit a yellowish-brown body color. Initially, observations of the pigmentation processes during pupal development revealed that black pigmentation was present in female pupae but not in males, suggesting that sex-specific melanin synthesis was responsible for the observed color dimorphism. Therefore, five orthologs of the genes involved in the insect melanin synthesis (yellow, ebony, tan, pale and dopa decarboxylase) were subcloned and their spatiotemporal expression patterns were examined using real-time quantitative RT-PCR. Of the genes examined, yellow, which plays a role in black melanin synthesis in insects, was expressed at higher levels in females than in males throughout the entire body during the pupal stage. RNA interference of yellow was then carried out in order to determine the gene function, and produced females with a more yellowish, brighter body color similar to that of males. It was concluded that transcriptional regulation of yellow was responsible for the sexual color dimorphism observed in this species.	[Miyazaki, Satoshi; Okada, Yasukazu; Miyakawa, Hitoshi; Cornette, Richard; Koshikawa, Shigeyuki; Miura, Toru] Hokkaido Univ, Grad Sch Environm Sci, Lab Ecol Genet, Sapporo, Hokkaido, Japan; [Miyazaki, Satoshi; Maekawa, Kiyoto] Toyama Univ, Grad Sch Sci & Engn, Toyama 930, Japan; [Okada, Yasukazu] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan; [Miyakawa, Hitoshi] Natl Inst Basic Biol, Okazaki Inst Integrat Biosci, Okazaki, Aichi 444, Japan; [Tokuda, Gaku] Univ Ryukyus, Ctr Mol Biosci, Okinawa, Japan; [Cornette, Richard] Natl Inst Agrobiol Sci, Insect Mimet Res Unit, Tsukuba, Ibaraki, Japan; [Koshikawa, Shigeyuki] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA	Hokkaido University; University of Toyama; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); University of the Ryukyus; National Institute of Agrobiological Sciences - Japan; University of Wisconsin System; University of Wisconsin Madison	Miyazaki, S (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Lab Ecol Genet, Sapporo, Hokkaido, Japan.	ihsotasm@gmail.com	Tokuda, Gaku/I-3686-2013; Miura, Toru/P-2456-2019; Okada, Yasukazu/B-1590-2014; Koshikawa, Shigeyuki/D-3052-2012; Miyazaki, Satoshi/AAX-4796-2021	Tokuda, Gaku/0000-0003-0645-6191; Miura, Toru/0000-0002-7456-4402; Okada, Yasukazu/0000-0003-4528-2980; Koshikawa, Shigeyuki/0000-0003-2831-555X; Miyazaki, Satoshi/0000-0003-3309-1618; Maekawa, Kiyoto/0000-0002-2354-1059	Japan Society for the Promotion of Science Research Fellowships for Young Scientists; Ministry of Education, Culture, Sports, Science and Technology of Japan;  [25251041]; Grants-in-Aid for Scientific Research [25251041, 11J09207] Funding Source: KAKEN	Japan Society for the Promotion of Science Research Fellowships for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The present study was supported by a Grant-in-Aid for Scientific Research (No. 25251041 to TM) awarded by the Ministry of Education, Culture, Sports, Science and Technology of Japan. The first author was supported by the Japan Society for the Promotion of Science Research Fellowships for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakane Y, 2010, INSECT BIOCHEM MOLEC, V40, P259, DOI 10.1016/j.ibmb.2010.01.012; Arakane Y, 2009, J BIOL CHEM, V284, P16584, DOI 10.1074/jbc.M901629200; BAKER BS, 1980, GENETICS, V94, P383; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Cho S, 2007, GENETICS, V177, P1733, DOI 10.1534/genetics.107.078980; COSCHIGANO KT, 1993, GENE DEV, V7, P42, DOI 10.1101/gad.7.1.42; Drapeau MD, 2003, J NEUROBIOL, V55, P53, DOI 10.1002/neu.10196; Friggi-Grelin F, 2003, GENESIS, V35, P260, DOI 10.1002/gene.1082; Futahashi R, 2010, EVOL DEV, V12, P157, DOI 10.1111/j.1525-142X.2010.00401.x; Gempe T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000222; Gibert JM, 2007, PLOS GENET, V3, P266, DOI 10.1371/journal.pgen.0030030; Gompel N, 2003, NATURE, V424, P931, DOI 10.1038/nature01787; Hoffman EA, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-23; Holldobler B., 1990, pi; HOPKINS TL, 1992, ANNU REV ENTOMOL, V37, P273, DOI 10.1146/annurev.en.37.010192.001421; Hunt BG, 2011, P NATL ACAD SCI USA, V108, P15936, DOI 10.1073/pnas.1104825108; Jeong S, 2006, CELL, V125, P1387, DOI 10.1016/j.cell.2006.04.043; Johnson JK, 2001, INSECT BIOCHEM MOLEC, V31, P1125, DOI 10.1016/S0965-1748(01)00072-8; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; Majerus M, 1998, MELANISM EVOLUTION A; Nakata K, 1998, J INSECT BEHAV, V11, P869, DOI 10.1023/A:1020816227912; Ninomiya Y, 2007, FEBS J, V274, P1768, DOI 10.1111/j.1742-4658.2007.05724.x; Okada Y, 2006, SOCIOBIOLOGY, V48, P527; Ometto L, 2011, MOL BIOL EVOL, V28, P1381, DOI 10.1093/molbev/msq322; PEETERS C, 1989, NATURWISSENSCHAFTEN, V76, P177, DOI 10.1007/BF00366404; Reed RD, 2008, P R SOC B, V275, P37, DOI 10.1098/rspb.2007.1115; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; Shirangi TR, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000168; Shukla JN, 2012, SCI REPORTS, V2, P10; Stubblefield J. William, 1994, P71; Suzuki MG, 2005, EVOL DEV, V7, P58, DOI 10.1111/j.1525-142X.2005.05007.x; TAKAMIZAWA K, 2005, JAPANESE SOCIAL WASP; True JR, 2005, PLOS GENET, V1, P551, DOI 10.1371/journal.pgen.0010063; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; Tsuchida T, 2010, SCIENCE, V330, P1102, DOI 10.1126/science.1195463; Tsuji K, 1996, NATURWISSENSCHAFTEN, V83, P577; van Wilgenburg Ellen, 2006, Frontiers in Zoology, V3, P1, DOI 10.1186/1742-9994-3-1; Verhulst EC, 2010, CURR OPIN GENET DEV, V20, P376, DOI 10.1016/j.gde.2010.05.001; Verhulst EC, 2010, SCIENCE, V328, P620, DOI 10.1126/science.1185805; Walter MF, 1996, ARCH INSECT BIOCHEM, V31, P219, DOI 10.1002/(SICI)1520-6327(1996)31:2&lt;219::AID-ARCH9&gt;3.0.CO;2-U; WALTER MF, 1991, DEV BIOL, V147, P32, DOI 10.1016/S0012-1606(05)80005-3; Wheeler W. M., 1922, Psyche Boston Mass, V29, P203, DOI 10.1155/1922/80849; Williams TM, 2008, CELL, V134, P610, DOI 10.1016/j.cell.2008.06.052; Williams TM, 2009, NAT REV GENET, V10, P797, DOI 10.1038/nrg2687; Wittkopp PJ, 2009, SEMIN CELL DEV BIOL, V20, P65, DOI 10.1016/j.semcdb.2008.10.002; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849	46	18	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92875	10.1371/journal.pone.0092875	http://dx.doi.org/10.1371/journal.pone.0092875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667821	Green Published, gold			2022-12-27	WOS:000333675600095
J	Paskaleva, EE; Arra, M; Liu, YZ; Guo, HJ; Swartz, G; Kennedy, JS; Breneman, C; Shekhtman, A; Canki, M				Paskaleva, Elena E.; Arra, Manoj; Liu, Yanze; Guo, Huijun; Swartz, Glenn; Kennedy, Jeffrey S.; Breneman, Curt; Shekhtman, Alexander; Canki, Mario			Evaluation of Potential Genotoxicity of HIV Entry Inhibitors Derived from Natural Sources	PLOS ONE			English	Article							ERYTHROCYTE MICRONUCLEUS ASSAY; GENE MUTATION ASSAY; PALMITIC ACID; INTERNATIONAL WORKSHOP; PERIPHERAL-BLOOD; STEARIC-ACID; APOPTOSIS; ACCEPTANCE; PROTOCOL; DESIGN	AIDS is a global pandemic that has seen the development of novel and effective treatments to improve the quality of life of those infected and reduction of spread of the disease. Palmitic Acid (PA), which we identified and isolated from Sargassum fusiforme, is a naturally occurring fatty acid that specifically inhibits HIV entry by binding to a novel pocket on the CD4 receptor. We also identified a structural analogue, 2-bromopalmitate (2-BP), as a more effective HIV entry inhibitor with a 20-fold increase in efficacy. We have used the structure-activity relationship (SAR) of 2-BP as a platform to identify new small chemical molecules that fit into the various identified active sites in an effort to identify more potent CD4 entry inhibitors. To validate further drug development, we tested the PA and 2-BP scaffold molecules for genotoxic potential. The FDA and International Conference on Harmonisation (ICH) recommends using a standardized 3-test battery for testing compound genotoxicity consisting of the bacterial reverse mutation assay, mouse lymphoma assay, and rat micronucleus assay. PA and 2-BP and their metabolites tested negative in all three genotoxicty tests. 2-BP is the first derivative of PA to undergo preclinical screening, which will enable us to now test multiple simultaneous small chemical structures based on activity in scaffold modeling across the dimension of pre-clinical testing to enable transition to human testing.	[Paskaleva, Elena E.; Arra, Manoj; Shekhtman, Alexander; Canki, Mario] Palm Biol LLC, Albany, NY USA; [Paskaleva, Elena E.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA; [Arra, Manoj; Canki, Mario] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Liu, Yanze] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Liu, Yanze] Peking Union Med Coll, Beijing 100021, Peoples R China; [Guo, Huijun] Henan Univ Tradit Chinese Med, Affiliated Hosp 1, Zhengzhou, Peoples R China; [Swartz, Glenn] Adv Biosci Labs Inc, Rockville, MD USA; [Kennedy, Jeffrey S.] Albany Med Coll, Albany, NY 12208 USA; [Breneman, Curt] Rensselaer Polytech Inst, Dept Chem, Troy, NY USA; [Shekhtman, Alexander] SUNY Albany, Dept Chem, Albany, NY 12222 USA	Rensselaer Polytechnic Institute; Albany Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Henan University of Traditional Chinese Medicine; Albany Medical College; Rensselaer Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Canki, M (corresponding author), Palm Biol LLC, Albany, NY USA.	cankim@mail.amc.edu		Paskaleva, Elena/0000-0002-4291-9969; Shekhtman, Alexander/0000-0003-2649-2675	NIH/NIAID/DAIDS [HHSN272201000001C]	NIH/NIAID/DAIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a NIH/NIAID/DAIDS contract: "Comprehensive Resources for HIV Microbicides and Biomedical Prevention" (#HHSN272201000001C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1973, P NATL ACAD SCI USA, V70, P782, DOI 10.1073/pnas.70.3.782; Aparna V, 2012, CHEM BIOL DRUG DES, V80, P434, DOI 10.1111/j.1747-0285.2012.01418.x; Belosludtsev K, 2006, J BIOENERG BIOMEMBR, V38, P113, DOI 10.1007/s10863-006-9010-9; Clements J, 2000, MUTAT RES-FUND MOL M, V455, P97, DOI 10.1016/S0027-5107(00)00066-X; CLIVE D, 1972, MUTAT RES, V16, P77, DOI 10.1016/0027-5107(72)90066-8; Conner WE, 1999, AM J CLIN NUTR, V70, P951; Dyntar D, 2001, DIABETES, V50, P2105, DOI 10.2337/diabetes.50.9.2105; Fattore E, 2013, INT J FOOD SCI NUTR, V64, P648, DOI 10.3109/09637486.2013.768213; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; Hayashi M, 2000, ENVIRON MOL MUTAGEN, V35, P234, DOI 10.1002/(SICI)1098-2280(2000)35:3<234::AID-EM10>3.0.CO;2-L; Hayashi M, 2007, MUTAT RES-GEN TOX EN, V627, P10, DOI 10.1016/j.mrgentox.2006.08.010; HEDDLE JA, 1983, MUTAT RES, V123, P61, DOI 10.1016/0165-1110(83)90047-7; Huang CB, 2011, ARCH ORAL BIOL, V56, P650, DOI 10.1016/j.archoralbio.2011.01.011; KASTENBAUM MA, 1970, MUTAT RES, V9, P527, DOI 10.1016/0027-5107(70)90038-2; Krishna G, 2000, MUTAT RES-FUND MOL M, V455, P155, DOI 10.1016/S0027-5107(00)00117-2; Leach AR, 2010, J MED CHEM, V53, P539, DOI 10.1021/jm900817u; Lee DYW, 2009, AIDS RES HUM RETROV, V25, P1231, DOI 10.1089/aid.2009.0019; Lin XD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024803; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; MAVOURNIN KH, 1990, MUTAT RES, V239, P29, DOI 10.1016/0165-1110(90)90030-F; Moore MM, 2006, ENVIRON MOL MUTAGEN, V47, P1, DOI 10.1002/em.20159; Moore MM, 2003, MUTAT RES-GEN TOX EN, V540, P127, DOI 10.1016/j.mrgentox.2003.07.003; Mu YM, 2001, ENDOCRINOLOGY, V142, P3590, DOI 10.1210/en.142.8.3590; Paskaleva EE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012168; Paskaleva Elena E, 2006, AIDS Res Ther, V3, P15, DOI 10.1186/1742-6405-3-15; Paskaleva EE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-8; SCHEIG R, 1968, J AM OIL CHEM SOC, V45, P31, DOI 10.1007/BF02679042; Schisler MR, 2013, METHODS MOL BIOL, V1044, P27, DOI 10.1007/978-1-62703-529-3_2; Suzuki J, 2011, NEUROSCIENCE, V176, P188, DOI 10.1016/j.neuroscience.2010.11.035; Szkudelski T, 2011, LIFE SCI, V89, P450, DOI 10.1016/j.lfs.2011.07.010; Wakata A, 1998, ENVIRON MOL MUTAGEN, V32, P84, DOI 10.1002/(SICI)1098-2280(1998)32:1<84::AID-EM10>3.0.CO;2-K; Zhou BR, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/530429	33	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93108	10.1371/journal.pone.0093108	http://dx.doi.org/10.1371/journal.pone.0093108			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667334	gold, Green Submitted, Green Published			2022-12-27	WOS:000333675600141
J	Watanabe, M; Nakatsuka, A; Murakami, K; Inoue, K; Terami, T; Higuchi, C; Katayama, A; Teshigawara, S; Eguchi, J; Ogawa, D; Watanabe, E; Wada, J; Makino, H				Watanabe, Mayu; Nakatsuka, Atsuko; Murakami, Kazutoshi; Inoue, Kentaro; Terami, Takahiro; Higuchi, Chigusa; Katayama, Akihiro; Teshigawara, Sanae; Eguchi, Jun; Ogawa, Daisuke; Watanabe, Eijiro; Wada, Jun; Makino, Hirofumi			Pemt Deficiency Ameliorates Endoplasmic Reticulum Stress in Diabetic Nephropathy	PLOS ONE			English	Article							PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; KIDNEY-DISEASE; THERAPEUTIC APPROACH; HOMOCYSTEINE; APOPTOSIS; PATHWAY; CELLS; MICE; PHOSPHATIDYLCHOLINE; MECHANISMS	Phosphatidylethanolamine N-methyltransferase (Pemt) catalyzes the methylation of phosphatidylethanolamine (PE) to phosphatidylcholine (PC) mainly in the liver. Under an obese state, the upregulation of Pemt induces endoplasmic reticulum (ER) stress by increasing the PC/PE ratio in the liver. We targeted the Pemt gene in mice to explore the therapeutic impact of Pemt on the progression of diabetic nephropathy and diabetes, which was induced by the injection of streptozotocin (STZ). Although the blood glucose levels were similar in STZ-induced diabetic Pemt+/+ and Pemt-/-mice, the glomerular hypertrophy and albuminuria in Pemt-/- mice were significantly reduced. Pemt deficiency reduced the intraglomerular F4/80-positive macrophages, hydroethidine fluorescence, tubulointerstitial fibrosis and tubular atrophy. The expression of glucose-regulated protein-78 (GRP78) was enriched in the renal tubular cells in STZ-induced diabetic mice, and this was ameliorated by Pemt deficiency. In mProx24 renal proximal tubular cells, the treatment with ER-stress inducers, tunicamycin and thapsigargin, increased the expression of GRP78, which was reduced by transfection of a shRNA lentivirus for Pemt (shRNA-Pemt). The number of apoptotic cells in the renal tubules was significantly reduced in Pemt-/- diabetic mice, and shRNA-Pemt upregulated the phosphorylation of Akt and decreased the cleavage of caspase 3 and 7 in mProx24 cells. Taken together, these findings indicate that the inhibition of Pemt activity ameliorates the ER stress associated with diabetic nephropathy in a model of type 1 diabetes and corrects the functions of the three major pathways downstream of ER stress, i.e. oxidative stress, inflammation and apoptosis.	[Watanabe, Mayu; Nakatsuka, Atsuko; Murakami, Kazutoshi; Inoue, Kentaro; Terami, Takahiro; Higuchi, Chigusa; Katayama, Akihiro; Teshigawara, Sanae; Eguchi, Jun; Wada, Jun; Makino, Hirofumi] Okayama Univ, Dept Med & Clin Sci, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama, Japan; [Nakatsuka, Atsuko; Ogawa, Daisuke] Okayama Univ, Dept Diabet Nephropathy, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama, Japan; [Murakami, Kazutoshi] Okayama Univ, Dept Gen Med, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama, Japan; [Watanabe, Eijiro] Dainippon Sumitomo Pharma, Chuo Ku, Osaka, Japan	Okayama University; Okayama University; Okayama University	Nakatsuka, A (corresponding author), Okayama Univ, Dept Med & Clin Sci, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama, Japan.	atsuko-n@md.okayama-u.ac.jp; junwada@md.okayama-u.ac.jp	WADA, Jun/B-2023-2011; Murakami, Kazutoshi/AAV-1940-2020; Nakatsuka, Atsuko/L-2765-2017	WADA, Jun/0000-0003-1468-5170; Murakami, Kazutoshi/0000-0002-6042-8960; 	JSPS [24790926, 23390241, 25126716]; Health Labor Sciences Research Grant, Japan; Grants-in-Aid for Scientific Research [24790926] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health Labor Sciences Research Grant, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS Grant-in-Aid for Scientific Research, (Grant number 24790926, 23390241, 25126716) and Health Labor Sciences Research Grant, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandary B, 2013, INT J MOL SCI, V14, P434, DOI 10.3390/ijms14010434; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Brezniceanu ML, 2010, J AM SOC NEPHROL, V21, P943, DOI 10.1681/ASN.2009030242; Cunard R, 2011, AM J PHYSIOL-RENAL, V300, pF1054, DOI 10.1152/ajprenal.00021.2011; Cybulsky AV, 2010, KIDNEY INT, V77, P187, DOI 10.1038/ki.2009.389; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Dickhout JG, 2007, ANTIOXID REDOX SIGN, V9, P1863, DOI 10.1089/ars.2007.1780; Engin F, 2010, DIABETES OBES METAB, V12, P108, DOI 10.1111/j.1463-1326.2010.01282.x; Friedman AN, 2005, J AM SOC NEPHROL, V16, P3397, DOI 10.1681/ASN.2004100846; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Hartz CS, 2006, J NUTR, V136, P3005, DOI 10.1093/jn/136.12.3005; Inagi R, 2010, CURR OPIN PHARMACOL, V10, P156, DOI 10.1016/j.coph.2009.11.006; Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514; Kimura K, 2008, BIOCHEM BIOPH RES CO, V366, P1048, DOI 10.1016/j.bbrc.2007.12.098; Lindenmeyer MT, 2008, J AM SOC NEPHROL, V19, P2225, DOI 10.1681/ASN.2007121313; Liu GG, 2008, BIOCHEM BIOPH RES CO, V370, P651, DOI 10.1016/j.bbrc.2008.04.031; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Menon V, 2006, CIRCULATION, V113, P1572, DOI 10.1161/CIRCULATIONAHA.105.570127; Noga AA, 2003, J BIOL CHEM, V278, P21851, DOI 10.1074/jbc.M301982200; Ohse T, 2006, KIDNEY INT, V70, P1447, DOI 10.1038/sj.ki.5001704; Rane MJ, 2010, AM J PHYSIOL-RENAL, V298, pF49, DOI 10.1152/ajprenal.00032.2009; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tachibana H, 2012, J AM SOC NEPHROL, V23, P1835, DOI 10.1681/ASN.2012010022; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; Vance DE, 2013, BBA-MOL CELL BIOL L, V1831, P626, DOI 10.1016/j.bbalip.2012.07.017; Velagapudi C, 2011, J AM SOC NEPHROL, V22, P262, DOI 10.1681/ASN.2010040352; Wada J, 2013, CLIN SCI, V124, P139, DOI 10.1042/CS20120198; Yi F, 2008, AM J NEPHROL, V28, P254, DOI 10.1159/000110876; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang YL, 2006, J AM SOC NEPHROL, V17, P1090, DOI 10.1681/ASN.2005111148; Zhao Y, 2009, ARTERIOSCL THROM VAS, V29, P1349, DOI 10.1161/ATVBAHA.109.188672; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zou W, 2002, BBA-MOL CELL BIOL L, V1581, P49, DOI 10.1016/S1388-1981(02)00120-8	34	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92647	10.1371/journal.pone.0092647	http://dx.doi.org/10.1371/journal.pone.0092647			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667182	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600060
J	Zahiri, R; Lafontaine, D; Schmidt, BC; deWaard, JR; Zakharov, EV; Hebert, PDN				Zahiri, Reza; Lafontaine, Donald; Schmidt, B. Christian; deWaard, Jeremy R.; Zakharov, Evgeny V.; Hebert, Paul D. N.			A Transcontinental Challenge - A Test of DNA Barcode Performance for 1,541 Species of Canadian Noctuoidea (Lepidoptera)	PLOS ONE			English	Article							LEVEL CLASSIFICATION; CRYPTIC DIVERSITY; MOTHS LEPIDOPTERA; NATURAL-HISTORY; AMERICA NORTH; MITOCHONDRIAL; BIODIVERSITY; DELIMITATION; HYMENOPTERA; BUTTERFLIES	This study provides a first, comprehensive, diagnostic use of DNA barcodes for the Canadian fauna of noctuoids or "owlet" moths (Lepidoptera: Noctuoidea) based on vouchered records for 1,541 species (99.1% species coverage), and more than 30,000 sequences. When viewed from a Canada-wide perspective, DNA barcodes unambiguously discriminate 90% of the noctuoid species recognized through prior taxonomic study, and resolution reaches 95.6% when considered at a provincial scale. Barcode sharing is concentrated in certain lineages with 54% of the cases involving 1.8% of the genera. Deep intraspecific divergence exists in 7.7% of the species, but further studies are required to clarify whether these cases reflect an overlooked species complex or phylogeographic variation in a single species. Non-native species possess higher Nearest-Neighbour (NN) distances than native taxa, whereas generalist feeders have lower NN distances than those with more specialized feeding habits. We found high concordance between taxonomic names and sequence clusters delineated by the Barcode Index Number (BIN) system with 1,082 species (70%) assigned to a unique BIN. The cases of discordance involve both BIN mergers and BIN splits with 38 species falling into both categories, most likely reflecting bidirectional introgression. One fifth of the species are involved in a BIN merger reflecting the presence of 158 species sharing their barcode sequence with at least one other taxon, and 189 species with low, but diagnostic COI divergence. A very few cases (13) involved species whose members fell into both categories. Most of the remaining 140 species show a split into two or three BINs per species, while Virbia ferruginosa was divided into 16. The overall results confirm that DNA barcodes are effective for the identification of Canadian noctuoids. This study also affirms that BINs are a strong proxy for species, providing a pathway for a rapid, accurate estimation of animal diversity.	[Zahiri, Reza; deWaard, Jeremy R.; Zakharov, Evgeny V.; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Lafontaine, Donald] Agr & Agri Food Canada, Canadian Natl Collect Insects Arachnids & Nematod, Ottawa, ON, Canada; [Schmidt, B. Christian] Canadian Food Inspect Agcy, Canadian Natl Collect Insects Arachnids & Nematod, Ottawa, ON, Canada	University of Guelph; Agriculture & Agri Food Canada; Canadian Food Inspection Agency	Zahiri, R (corresponding author), Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada.	rzahiri@uoguelph.ca	deWaard, Jeremy R/G-8112-2014; Zakharov, Evgeny/G-9587-2014; Hebert, Paul DN/C-4161-2013; Zahiri, Reza/G-5797-2018; Schmidt, Christian/AAE-3069-2019	Hebert, Paul DN/0000-0002-3081-6700; Zahiri, Reza/0000-0001-6274-6973; Schmidt, Christian/0000-0003-4160-7629	Genome Canada; Ontario Genomics Institute; NSERC; Canada Foundation for Innovation	Genome Canada(Genome Canada); Ontario Genomics Institute; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	The work was funded by the following: Genome Canada, Ontario Genomics Institute, NSERC, Canada Foundation for Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes W., 1918, Mem Amer mus NH New York, V3; Butcher BA, 2012, ZOOTAXA, P7; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Crabo LG, 2013, ZOOKEYS, P85, DOI 10.3897/zookeys.264.4304; Dewaard JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018290; deWaard JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014280; DeWaard Jeremy R., 2008, V410, P275; Dinca V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1329; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Dupuis JR, 2012, MOL ECOL, V21, P4422, DOI 10.1111/j.1365-294X.2012.05642.x; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; Franclemont JG, 1983, CHECK LIST LEPIDOPTE, p[120, xxiv]; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Gall LF, 2010, ZOOKEYS, P37, DOI 10.3897/zookeys.39.425; Gwiazdowski RA, 2013, ANN ENTOMOL SOC AM, V106, P143, DOI 10.1603/AN12033; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Handfield L, 2011, PAPILLONS QUEBEC; Hanner R, 2005, CONSORTIUM BARCODE L; Hausmann A, 2011, SPIXIANA, V34, P47; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huemer P, 2011, ECO MONT, V3, P11, DOI 10.1553/eco.mont-3-1s11; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kvie KS, 2013, ECOL EVOL, V3, P126, DOI 10.1002/ece3.434; Lafontaine J.D., 2010, P489; Lafontaine J.D., 1997, Biological Survey of Canada Monograph Series, V2, P723; Lafontaine J Donald, 2013, Zookeys, P209, DOI 10.3897/zookeys.264.4441; Lafontaine JD, 2011, ZOOKEYS, P145, DOI 10.3897/zookeys.149.1805; Lafontaine JD, 2010, ZOOKEYS, P6, DOI 10.3897/zookeys.40.414; Linnen CR, 2007, EVOLUTION, V61, P1417, DOI 10.1111/j.1558-5646.2007.00114.x; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; Miller SE, 2013, P ENTOMOL SOC WASH, V115, P107, DOI 10.4289/0013-8797.115.1.107; Mitchell A, 2006, SYST ENTOMOL, V31, P21, DOI 10.1111/j.1365-3113.2005.00306.x; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Pohl GR, 2010, ZOOKEYS, P1; Poole RW, 1995, THE MOTHS OF AMERICA, V26; Powell J. A., 2009, MOTHS W N AM; Prentice RM, 1962, USITC PUBL, V2, P77; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Riedel A, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-15; Riedel A, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.280.3906; Riotte JCE, 1992, ANNOTATED LIST ONTAR; Rougerie R, 2013, J BIOGEOGRA IN PRESS; Rougerie R, 2010, ANN SOC ENTOMOL FR, V46, P477, DOI 10.1080/00379271.2010.10697684; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Schmidt BC, 2008, SYST ENTOMOL, V33, P613, DOI 10.1111/J.1365-3113.2008.00433.x; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036514; STEINER WWM, 1977, AM NAT, V111, P1037, DOI 10.1086/283236; Valade R, 2009, MOL ECOL, V18, P3458, DOI 10.1111/j.1365-294X.2009.04290.x; van Nieukerken EJ, 2012, CONTRIB ZOOL, V81, P1; van Valen L., 1965, AM NAT, V99, P377, DOI DOI 10.1086/282379; Wagner DL, 2011, OWLET CATERPILLARS E; Wilson John James, 2011, BMC Ecology, V11, P18, DOI 10.1186/1472-6785-11-18; Zahiri R, 2011, ZOOL SCR, V40, P158, DOI 10.1111/j.1463-6409.2010.00459.x; Zaspel J. M., 2008, Bulletin of the Florida Museum of Natural History, V48, P59; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	62	78	92	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92797	10.1371/journal.pone.0092797	http://dx.doi.org/10.1371/journal.pone.0092797			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667847	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600077
J	Cannon, EN; Yoo, KH; Vanderwert, RE; Ferrari, PF; Woodward, AL; Fox, NA				Cannon, Erin N.; Yoo, Kathryn H.; Vanderwert, Ross E.; Ferrari, Pier F.; Woodward, Amanda L.; Fox, Nathan A.			Action Experience, More than Observation, Influences Mu Rhythm Desynchronization	PLOS ONE			English	Article							HIGH-RESOLUTION EEG; PRIMARY MOTOR CORTEX; MIRROR NEURON SYSTEM; PREMOTOR CORTEX; ALPHA-RHYTHMS; TOOL-USE; PERCEPTION; INFANTS; OSCILLATIONS; ACTIVATION	Since the discovery of mirror neurons in premotor and parietal areas of the macaque monkey, the idea that action and perception may share the same neural code has been of central interest in social, developmental, and cognitive neurosciences. A fundamental question concerns how a putative human mirror neuron system may be tuned to the motor experiences of the individual. The current study tested the hypothesis that prior motor experience modulated the sensorimotor mu and beta rhythms. Specifically, we hypothesized that these sensorimotor rhythms would be more desynchronized after active motor experience compared to passive observation experience. To test our hypothesis, we collected EEG from adult participants during the observation of a relatively novel action: an experimenter used a claw-like tool to pick up a toy. Prior to EEG collection, we trained one group of adults to perform this action with the tool (performers). A second group comprised trained video coders, who only had experience observing the action (observers). Both the performers and the observers had no prior motor and visual experience with the action. A third group of novices was also tested. Performers exhibited the greatest mu rhythm desynchronization in the 8-13 Hz band, particularly in the right hemisphere compared to observers and novices. This study is the first to contrast active tool-use experience and observation experience in the mu rhythm and to show modulation with relatively shorter amounts of experience than prior mirror neuron expertise studies. These findings are discussed with respect to its broader implication as a neural signature for a mechanism of early social learning.	[Cannon, Erin N.; Yoo, Kathryn H.; Fox, Nathan A.] Univ Maryland, Dept Human Dev & Quantitat Methodol, College Pk, MD 20742 USA; [Vanderwert, Ross E.] Childrens Hosp Boston, Div Dev Med, Cognit Neurosci Lab, Boston, MA USA; [Ferrari, Pier F.] Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy; [Woodward, Amanda L.] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA	University System of Maryland; University of Maryland College Park; Harvard University; Boston Children's Hospital; University of Parma; University of Chicago	Cannon, EN (corresponding author), Univ Maryland, Dept Human Dev & Quantitat Methodol, College Pk, MD 20742 USA.	ecannon@umd.edu	Ferrari, Pier Francesco/G-5547-2017	Woodward, Amanda/0000-0002-9383-9969; Vanderwert, Ross/0000-0002-2280-8401	National Institutes of Health [P01HD064653]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD064653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by a grant from the National Institutes of Health P01HD064653. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnstein D, 2011, J NEUROSCI, V31, P14243, DOI 10.1523/JNEUROSCI.0963-11.2011; Avanzini P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037534; Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Babiloni C, 1999, NEUROIMAGE, V10, P658, DOI 10.1006/nimg.1999.0504; Babiloni C, 2002, NEUROIMAGE, V17, P559, DOI 10.1006/nimg.2002.1192; Babiloni C, 2008, J PHYSIOL-LONDON, V586, P131, DOI 10.1113/jphysiol.2007.141630; Baldwin J.M., 1897, SOCIAL ETHICAL INTER; Barresi J, 1996, BEHAV BRAIN SCI, V19, P107, DOI 10.1017/S0140525X00041790; Brune CW, 2007, J COGN DEV, V8, P133, DOI 10.1080/15248370701202331; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Cannon EN, 2012, DEVELOPMENTAL SCI, V15, P35, DOI 10.1111/j.1467-7687.2011.01095.x; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Cross ES, 2012, NEUROPSYCHOLOGIA, V50, P3207, DOI 10.1016/j.neuropsychologia.2012.09.028; Del Percio C, 2007, CLIN NEUROPHYSIOL, V118, P1711, DOI 10.1016/j.clinph.2007.04.029; Del Percio C, 2010, CLIN NEUROPHYSIOL, V121, P482, DOI 10.1016/j.clinph.2009.12.004; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Ferrari PF, 2005, J COGNITIVE NEUROSCI, V17, P212, DOI 10.1162/0898929053124910; Ferrari PF, TRENDS COGN IN PRESS, V1222; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gredeback G, 2010, EXP BRAIN RES, V202, P493, DOI 10.1007/s00221-009-2138-1; Hadjidimitriou SK, 2011, IEEE T BIO-MED ENG, V58, P1120, DOI 10.1109/TBME.2010.2047016; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Holmes P, 2006, J SPORT SCI, V24, P605, DOI 10.1080/02640410500244507; Jarvelainen J, 2004, NEUROIMAGE, V23, P187, DOI 10.1016/j.neuroimage.2004.06.010; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Lepage JF, 2010, NEUROREPORT, V21, P250, DOI 10.1097/WNR.0b013e328334ddcc; Marshall PJ, 2011, DEV COGN NEUROS-NETH, V1, P110, DOI 10.1016/j.dcn.2010.09.001; Marshall PJ, 2009, NEUROPSYCHOLOGIA, V47, P2100, DOI 10.1016/j.neuropsychologia.2009.03.022; McFarland DJ, 2000, BRAIN TOPOGR, V12, P177, DOI 10.1023/A:1023437823106; McGarry LM, 2012, EXP BRAIN RES, V218, P527, DOI 10.1007/s00221-012-3046-3; Meltzoff A.N., 2005, PERSPECTIVES IMITATI, V2, P55; Moore A, 2012, BEHAV BRAIN RES, V226, P309, DOI 10.1016/j.bbr.2011.07.048; Muthukumaraswamy SD, 2004, CLIN NEUROPHYSIOL, V115, P1760, DOI 10.1016/j.clinph.2004.03.004; Muthukumaraswamy SD, 2004, COGNITIVE BRAIN RES, V19, P195, DOI 10.1016/j.cogbrainres.2003.12.001; Muthukumaraswamy SD, 2004, PSYCHOPHYSIOLOGY, V41, P152, DOI 10.1046/j.1469-8986.2003.00129.x; Orgs G, 2008, EUR J NEUROSCI, V27, P3380, DOI 10.1111/j.1460-9568.2008.06271.x; Paulus M, 2012, DEV COGN NEUROS-NETH, V2, P90, DOI 10.1016/j.dcn.2011.05.006; Pfurtscheller G, 2003, EPILEPSIA, V44, P2, DOI 10.1111/j.0013-9580.2003.12001.x; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Piaget J., 1952, ORIGINS INTELLIGENCE; Pineda JOA, 2006, BRAIN RES, V1121, P128, DOI 10.1016/j.brainres.2006.08.128; Quandt LC, 2013, BRAIN RES, V1534, P55, DOI 10.1016/j.brainres.2013.08.043; Quandt LC, 2012, NEUROPSYCHOLOGIA, V50, P2745, DOI 10.1016/j.neuropsychologia.2012.08.005; Quandt LC, 2011, NEUROSCI LETT, V499, P37, DOI 10.1016/j.neulet.2011.05.028; RAY WJ, 1985, SCIENCE, V228, P750, DOI 10.1126/science.3992243; Ritter P, 2009, HUM BRAIN MAPP, V30, P1168, DOI 10.1002/hbm.20585; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Rochat MJ, 2010, EXP BRAIN RES, V204, P605, DOI 10.1007/s00221-010-2329-9; Ruther NN, 2014, BEHAV BRAIN RES, V261, P328, DOI 10.1016/j.bbr.2013.12.033; Sommerville JA, 2005, INFANCY, V8, P119, DOI 10.1207/s15327078in0802_2; Sommerville JA, 2008, DEV PSYCHOL, V44, P1249, DOI 10.1037/a0012296; Tomasello M, 1999, DEVELOPING THEORIES OF INTENTION, P63; Umilta MA, 2008, P NATL ACAD SCI USA, V105, P2209, DOI 10.1073/pnas.0705985105; van Elk M, 2008, NEUROIMAGE, V43, P808, DOI 10.1016/j.neuroimage.2008.07.057; Vanderwert RE, 2012, NEUROSCI LETT; Vernon PA, 1992, BIOL APPROACHES STUD; Vogt S, 2007, NEUROIMAGE, V37, P1371, DOI 10.1016/j.neuroimage.2007.07.005; Woodward A., CHILD DEV IN PRESS; Woodward AL, 2005, ADV CHILD DEV BEHAV, V33, P229, DOI 10.1016/S0065-2407(05)80009-6	62	61	63	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92002	10.1371/journal.pone.0092002	http://dx.doi.org/10.1371/journal.pone.0092002			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663967	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000333459900037
J	Dimant, H; Zhu, LY; Kibuuka, LN; Fan, Z; Hyman, BT; McLean, PJ				Dimant, Hemi; Zhu, Liya; Kibuuka, Laura N.; Fan, Zhanyun; Hyman, Bradley T.; McLean, Pamela J.			Direct Visualization of CHIP-Mediated Degradation of Alpha-Synuclein In Vivo: Implications for PD Therapeutics	PLOS ONE			English	Article							PARKINSONS-DISEASE; LEWY BODIES; C-TERMINUS; AGGREGATION; OLIGOMERS; TOXICITY; APOPTOSIS; PROTEINS; TARGETS	Parkinson's disease is a neurodegenerative disorder characterized by Lewy bodies, a pathological hallmark comprised mostly of aggregated alpha synuclein. Accumulating evidence demonstrates the association of smaller oligomeric aggregates to disease etiology and many therapeutic approaches are aimed at inhibiting and reducing the aggregation process. Molecular chaperones and co-chaperones play a key role in protein homeostasis and have potential as therapeutics to inhibit alpha synuclein associated toxicity. Here we use a gene therapy approach to evaluate the applicability of the Hsp70 co-chaperone CHIP (C-terminal Hsp70 interacting protein) as a therapeutic candidate and examine its direct effect on alpha synuclein aggregates in vivo. Utilizing a novel viral vector mediated rat model to directly detect alpha synuclein aggregates, we show that CHIP can mediate the degradation of alpha synuclein aggregates in vivo. However, our studies also reveal that CHIP may potentially degrade tyrosine hydroxylase which would compromise the applicability of CHIP as a therapeutic approach for Parkinson's disease.	[Dimant, Hemi; Zhu, Liya; Kibuuka, Laura N.; Fan, Zhanyun; Hyman, Bradley T.; McLean, Pamela J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGeneral Inst Neurodegenerat Dis,Dept Neurol, Charlestown, MA 02129 USA; [McLean, Pamela J.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	Harvard University; Massachusetts General Hospital; Mayo Clinic	McLean, PJ (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGeneral Inst Neurodegenerat Dis,Dept Neurol, Charlestown, MA 02129 USA.	mclean.pamela@mayo.edu		McLean, Pamela/0000-0003-4870-5715	NIH [NS063963]; Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073740, R01NS063963] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	PM is supported by NIH NS063963. HD is supported by Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Daubner SC, 2011, ARCH BIOCHEM BIOPHYS, V508, P1, DOI 10.1016/j.abb.2010.12.017; Dimant Hemi, 2013, Acta Neuropathol Commun, V1, P6, DOI 10.1186/2051-5960-1-6; Hwang JR, 2005, CELL STRESS CHAPERON, V10, P147, DOI 10.1379/CSC-90R.1; Irizarry MC, 1998, J NEUROPATH EXP NEUR, V57, P334, DOI 10.1097/00005072-199804000-00005; Kalia LV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014695; Kalia SK, 2010, CNS NEUROL DISORD-DR, V9, P741; McFarland NR, 2007, COMP ADENO ASS VIRAL; Miller VM, 2005, J NEUROSCI, V25, P9152, DOI 10.1523/JNEUROSCI.3001-05.2005; Outeiro TF, 2006, BIOCHEM BIOPH RES CO, V351, P631, DOI 10.1016/j.bbrc.2006.10.085; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Sahara N, 2005, J NEUROCHEM, V94, P1254, DOI 10.1111/j.1471-4159.2005.03272.x; Shin YG, 2005, J BIOL CHEM, V280, P23727, DOI 10.1074/jbc.M503326200; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Woo CH, 2010, FASEB J, V24, P4917, DOI 10.1096/fj.10-162636	19	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92098	10.1371/journal.pone.0092098	http://dx.doi.org/10.1371/journal.pone.0092098			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664141	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900040
J	Nakayoshi, T; Sasaki, K; Kajimoto, H; Koiwaya, H; Ohtsuka, M; Ueno, T; Chibana, H; Itaya, N; Sasaki, M; Yokoyama, S; Fukumoto, Y; Imaizumi, T				Nakayoshi, Takaharu; Sasaki, Ken-ichiro; Kajimoto, Hidemi; Koiwaya, Hiroshi; Ohtsuka, Masanori; Ueno, Takafumi; Chibana, Hidetoshi; Itaya, Naoki; Sasaki, Masahiro; Yokoyama, Shinji; Fukumoto, Yoshihiro; Imaizumi, Tsutomu			FOXO4-Knockdown Suppresses Oxidative Stress-Induced Apoptosis of Early Pro-Angiogenic Cells and Augments Their Neovascularization Capacities in Ischemic Limbs	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; BONE-MARROW-CELLS; THERAPEUTIC ANGIOGENESIS; MONONUCLEAR-CELLS; METABOLIC INTERVENTION; TRANSPLANTATION; PATHWAYS; DISEASE; HINDLIMB; REDOX	The effects of therapeutic angiogenesis by intramuscular injection of early pro-angiogenic cells (EPCs) to ischemic limbs are unsatisfactory. Oxidative stress in the ischemic limbs may accelerate apoptosis of injected EPCs, leading to less neovascularization. Forkhead transcription factor 4 (FOXO4) was reported to play a pivotal role in apoptosis signaling of EPCs in response to oxidative stress. Accordingly, we assessed whether FOXO4-knockdown EPCs (FOXO4(KD)-EPCs) could suppress the oxidative stress-induced apoptosis and augment the neovascularization capacity in ischemic limbs. We transfected small interfering RNA targeted against FOXO4 of human EPCs to generate FOXO4(KD)-EPCs and confirmed a successful knockdown. FOXO4(KD)-EPCs gained resistance to apoptosis in response to hydrogen peroxide in vitro. Oxidative stress stained by dihydroethidium was stronger for the immunodeficient rat ischemic limb tissue than for the rat non-ischemic one. Although the number of apoptotic EPCs injected into the rat ischemic limb was greater than that of apoptotic EPCs injected into the rat non-ischemic limb, FOXO4(KD)-EPCs injected into the rat ischemic limb brought less apoptosis and more neovascularization than EPCs. Taken together, the use of FOXO4(KD)-EPCs with resistance to oxidative stress-induced apoptosis may be a new strategy to augment the effects of therapeutic angiogenesis by intramuscular injection of EPCs.	[Nakayoshi, Takaharu; Sasaki, Ken-ichiro; Koiwaya, Hiroshi; Ohtsuka, Masanori; Ueno, Takafumi; Chibana, Hidetoshi; Itaya, Naoki; Sasaki, Masahiro; Yokoyama, Shinji; Fukumoto, Yoshihiro] Kurume Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, Fukuoka, Japan; [Sasaki, Ken-ichiro; Kajimoto, Hidemi] Kurume Univ, Cardiovasc Res Inst, Fukuoka, Japan; [Imaizumi, Tsutomu] Int Univ Hlth & Welf, Fukuoka, Japan	Kurume University; Kurume University; International University of Health & Welfare	Sasaki, K (corresponding author), Kurume Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, Fukuoka, Japan.	sasaken@med.kurume-u.ac.jp		Kajimoto, Hidemi/0000-0003-2624-7928	Strategic Research Foundation for Private Universities from MEXT, Japan; Kimura Memorial Heart Foundation;  [23791509]	Strategic Research Foundation for Private Universities from MEXT, Japan; Kimura Memorial Heart Foundation; 	This work was supported by the Grant-in-Aid from the Strategic Research Foundation for Private Universities from MEXT, Japan (http://www.mext.go.jp), to Kurume University; the Grant-in-Aid for Young Scientists (B) [23791509] to T.N; and the Grant from Kimura Memorial Heart Foundation (http://kimura-kinen.com/contents/zaidan/index.html) to T.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Alves WF, 2010, ANN VASC SURG, V24, P461, DOI 10.1016/j.avsg.2010.01.005; Balestrieri ML, 2010, ATHEROSCLEROSIS, V209, P403, DOI 10.1016/j.atherosclerosis.2009.10.022; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Clanton TL, 2007, J APPL PHYSIOL, V102, P2379, DOI 10.1152/japplphysiol.01298.2006; de Nigris F, 2007, J CARDIOVASC PHARM, V50, P424, DOI 10.1097/FJC.0b013e31812564e4; Gonzalez F. B., 1991, FREE RADIC BIOL MED, V10, P93, DOI DOI 10.1016/0891-5849(91)90002-K; Haddad JJ, 2004, INT IMMUNOPHARMACOL, V4, P475, DOI 10.1016/j.intimp.2004.02.002; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Koiwaya H, 2011, J MOL CELL CARDIOL, V51, P33, DOI 10.1016/j.yjmcc.2011.03.012; Krotz F, 2003, J VASC RES, V40, P425, DOI 10.1159/000073901; Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05; Matoba S, 2008, AM HEART J, V156, P1010, DOI 10.1016/j.ahj.2008.06.025; Moriya J, 2009, CIRC-CARDIOVASC INTE, V2, P245, DOI 10.1161/CIRCINTERVENTIONS.108.799361; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Pattillo CB, 2011, FREE RADICAL BIO MED, V50, P262, DOI 10.1016/j.freeradbiomed.2010.10.714; Saito Y, 2007, CIRC J, V71, P1187, DOI 10.1253/circj.71.1187; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Toyama Y, 2012, CARDIOVASC RES, V95, P448, DOI 10.1093/cvr/cvs173; Urao N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057618; Urbich C, 2005, FASEB J, V19, P974, DOI 10.1096/fj.04-2727fje; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Urbich C, 2011, J MOL CELL CARDIOL, V50, P333, DOI 10.1016/j.yjmcc.2010.11.022; Xu SJ, 2011, J PHARMACOL SCI, V117, P265, DOI 10.1254/jphs.11149FP	26	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92626	10.1371/journal.pone.0092626	http://dx.doi.org/10.1371/journal.pone.0092626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663349	gold, Green Submitted, Green Published			2022-12-27	WOS:000333459900087
J	Zhao, PM; Torcaso, A; Mariano, A; Xu, L; Mohsin, S; Zhao, LX; Han, RZ				Zhao, Piming; Torcaso, Audrey; Mariano, Andrew; Xu, Li; Mohsin, Sadia; Zhao, Lixia; Han, Renzhi			Anoctamin 6 Regulates C2C12 Myoblast Proliferation	PLOS ONE			English	Article							ACTIVATED CHLORIDE CHANNEL; CA2+-ACTIVATED CL-CHANNEL; CONTRIBUTES; FAMILY; DIFFERENTIATION; INHIBITION; EXPRESSION; KINASE; CELLS; ANO1	Anoctamin 6 (Ano6) belongs to a conserved gene family (TMEM16) predicted to code for eight transmembrane proteins with putative Ca2+-activated chloride channel (CaCC) activity. Recent work revealed that disruption of ANO6 leads to a blood coagulation defect and impaired skeletal development. However, its function in skeletal muscle cells remains to be determined. By using a RNA interference mediated (RNAi) loss-of-function approach, we show that Ano6 regulates C2C12 myoblast proliferation. Ano6 is highly expressed in C2C12 myoblasts and its expression decreases upon differentiation. Knocking down Ano6 significantly reduces C2C12 myoblast proliferation but has minimal effect on differentiation. Ano6 deficiency significantly reduces ERK/AKT phosphorylation, which has been shown to be involved in regulation of cancer cell proliferation by another Anoctamin member. Taken together, our data demonstrate for the first time that Ano6 plays an essential role in C2C12 myoblast proliferation, likely via regulating the ERK/AKT signaling pathway.	[Zhao, Piming; Torcaso, Audrey; Mariano, Andrew; Xu, Li; Mohsin, Sadia; Zhao, Lixia; Han, Renzhi] Loyola Univ, Dept Cell & Mol Physiol, Chicago Hlth Sci Div, Maywood, IL 60153 USA	Loyola University Chicago	Han, RZ (corresponding author), Loyola Univ, Dept Cell & Mol Physiol, Chicago Hlth Sci Div, Maywood, IL 60153 USA.	renhan@lumc.edu	xu, li/M-1661-2015	Han, Renzhi/0000-0002-8202-9186	American Heart Association [10SDG4140138]; Muscular Dystrophy Association [MDA171667]; NIH [R01 AR064241, R01 HL116546]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064241] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Muscular Dystrophy Association(Muscular Dystrophy Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was partially supported by the American Heart Association grant 10SDG4140138 to RH, the Muscular Dystrophy Association grant MDA171667 to RH, the NIH grants R01 AR064241 and R01 HL116546 to RH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Almaca J, 2009, J BIOL CHEM, V284, P28571, DOI 10.1074/jbc.M109.010074; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Duran C, 2011, ACTA PHARMACOL SIN, V32, P685, DOI 10.1038/aps.2011.48; Duvvuri U, 2012, CANCER RES, V72, P3270, DOI 10.1158/0008-5472.CAN-12-0475-T; Ehlen HWA, 2013, J BONE MINER RES, V28, P246, DOI 10.1002/jbmr.1751; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Grubb S, 2013, J GEN PHYSIOL, V141, P585, DOI 10.1085/jgp.201210861; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Kmit A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.135; Liu W, 2012, CANCER LETT, V326, P41, DOI 10.1016/j.canlet.2012.07.015; Martins JR, 2011, P NATL ACAD SCI USA, V108, P18168, DOI 10.1073/pnas.1108094108; Mazzone A, 2012, BIOCHEM BIOPH RES CO, V427, P248, DOI 10.1016/j.bbrc.2012.09.022; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Otsuka M, 2005, BIOL PHARM BULL, V28, P1707, DOI 10.1248/bpb.28.1707; Park SH, 2011, ACTA CRYSTALLOGR F, V67, P1250, DOI 10.1107/S1744309111027989; Saidu SP, 2013, J GEN PHYSIOL, V141, P691, DOI 10.1085/jgp.201210937; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Stanich JE, 2011, AM J PHYSIOL-GASTR L, V301, pG1044, DOI 10.1152/ajpgi.00196.2011; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Tian YM, 2012, J CELL SCI, V125, P4991, DOI 10.1242/jcs.109553; Wang M, 2012, CIRCULATION, V125, P697, DOI 10.1161/CIRCULATIONAHA.111.041806; Xu CX, 2013, MAT SCI ENG C-MATER, V33, P1783, DOI 10.1016/j.msec.2013.01.005; Xu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027884; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhang JM, 1999, EMBO J, V18, P926, DOI 10.1093/emboj/18.4.926	30	21	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92749	10.1371/journal.pone.0092749	http://dx.doi.org/10.1371/journal.pone.0092749			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663380	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900107
J	Aguilar, C; Schmid, N; Lardi, M; Pessi, G; Eberl, L				Aguilar, Claudio; Schmid, Nadine; Lardi, Martina; Pessi, Gabriella; Eberl, Leo			The IclR-Family Regulator BapR Controls Biofilm Formation in B-cenocepacia H111	PLOS ONE			English	Article							BURKHOLDERIA-CEPACIA; SP-NOV.; IDENTIFICATION; DIVERSITY; MEMBERS	In Burkholderia cenocepacia H111, the large surface protein BapA plays a crucial role in the formation of highly structured communities, known as biofilms. We have recently demonstrated that quorum sensing (QS) is necessary for the maximal expression of bapA. In this study we identify BapR, a protein from the IclR family of transcriptional regulators that, in conjunction with QS, controls biofilm formation by affecting the expression of bapA. We present evidence that, in addition to bapA, BapR influences the expression of extracellular proteases, swimming motility and has a profound impact in the incidence of persister cells, making this regulator an interesting target for persister cells and biofilm eradication.	[Aguilar, Claudio; Schmid, Nadine; Lardi, Martina; Pessi, Gabriella; Eberl, Leo] Univ Zurich, Inst Plant Biol, Dept Microbiol, CH-8008 Zurich, Switzerland	University of Zurich	Aguilar, C (corresponding author), Univ Zurich, Inst Plant Biol, Dept Microbiol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	claudio_aguilar@access.uzh.ch	Eberl, Leo/A-8380-2012; Pessi, Gabriella/AGW-2342-2022; Eberl, Leo/AAE-8165-2019	Eberl, Leo/0000-0002-7241-0864; Pessi, Gabriella/0000-0002-8138-5541; Aguilar, Claudio/0000-0001-8551-3347	Swiss National Science Foundation [31003A_143773]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (Project 31003A_143773). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BETTER M, 1983, CELL, V35, P479, DOI 10.1016/0092-8674(83)90181-2; CLARK DJ, 1967, J MOL BIOL, V23, P99, DOI 10.1016/S0022-2836(67)80070-6; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Huber B, 2002, MOL MICROBIOL, V46, P411, DOI 10.1046/j.1365-2958.2002.03182.x; Huber B, 2001, MICROBIOL-SGM, V147, P2517, DOI 10.1099/00221287-147-9-2517; Inhulsen S, 2012, MICROBIOLOGYOPEN, V1, P225, DOI 10.1002/mbo3.24; Lewenza S, 1999, J BACTERIOL, V181, P748, DOI 10.1128/JB.181.3.748-756.1999; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Molina-Henares AJ, 2006, FEMS MICROBIOL REV, V30, P157, DOI 10.1111/j.1574-6976.2005.00008.x; Ortega XP, 2007, J BACTERIOL, V189, P3639, DOI 10.1128/JB.00153-07; Parke JL, 2001, ANNU REV PHYTOPATHOL, V39, P225, DOI 10.1146/annurev.phyto.39.1.225; Sambrook J., 2001, MOL CLONING LAB MANU; Schmid N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049966; Suppiger A, 2013, VIRULENCE, V4, P400, DOI 10.4161/viru.25338; Van Acker H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058943; Vandamme P, 2007, INT J SYST EVOL MICR, V57, P2228, DOI 10.1099/ijs.0.65142-0; Vanlaere E, 2008, INT J SYST EVOL MICR, V58, P1580, DOI 10.1099/ijs.0.65634-0; Winsor GL, 2008, BIOINFORMATICS, V24, P2803, DOI 10.1093/bioinformatics/btn524	20	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92920	10.1371/journal.pone.0092920	http://dx.doi.org/10.1371/journal.pone.0092920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658785	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000333355300145
J	Canella, DS; Levy, RB; Martins, APB; Claro, RM; Moubarac, JC; Baraldi, LG; Cannon, G; Monteiro, CA				Canella, Daniela Silva; Levy, Renata Bertazzi; Bortoletto Martins, Ana Paula; Claro, Rafael Moreira; Moubarac, Jean-Claude; Baraldi, Larissa Galastri; Cannon, Geoffrey; Monteiro, Carlos Augusto			Ultra-Processed Food Products and Obesity in Brazilian Households (2008-2009)	PLOS ONE			English	Article							SWEETENED BEVERAGE CONSUMPTION; WEIGHT-GAIN; DIET; RISK	Background: Production and consumption of industrially processed food and drink products have risen in parallel with the global increase in overweight and obesity and related chronic non-communicable diseases. The objective of this study was to analyze the relationship between household availability of processed and ultra-processed products and the prevalence of excess weight (overweight plus obesity) and obesity in Brazil. Methods: The study was based on data from the 2008-2009 Household Budget Survey involving a probabilistic sample of 55,970 Brazilian households. The units of study were household aggregates (strata), geographically and socioeconomically homogeneous. Multiple linear regression models were used to assess the relationship between the availability of processed and ultra-processed products and the average of Body Mass Index (BMI) and the percentage of individuals with excess weight and obesity in the strata, controlling for potential confounders (socio-demographic characteristics, percentage of expenditure on eating out of home, and dietary energy other than that provided by processed and ultra-processed products). Predictive values for prevalence of excess weight and obesity were estimated according to quartiles of the household availability of dietary energy from processed and ultra-processed products. Results: The mean contribution of processed and ultra-processed products to total dietary energy availability ranged from 15.4% (lower quartile) to 39.4% (upper quartile). Adjusted linear regression coefficients indicated that household availability of ultra-processed products was positively associated with both the average BMI and the prevalence of excess weight and obesity, whereas processed products were not associated with these outcomes. In addition, people in the upper quartile of household consumption of ultra-processed products, compared with those in the lower quartile, were 37% more likely to be obese. Conclusion: Greater household availability of ultra-processed food products in Brazil is positively and independently associated with higher prevalence of excess weight and obesity in all age groups in this cross-sectional study.	[Canella, Daniela Silva; Bortoletto Martins, Ana Paula; Baraldi, Larissa Galastri; Monteiro, Carlos Augusto] Univ Sao Paulo, Fac Saude Publ, Dept Nutr, Sao Paulo, Brazil; [Canella, Daniela Silva; Levy, Renata Bertazzi; Bortoletto Martins, Ana Paula; Claro, Rafael Moreira; Moubarac, Jean-Claude; Baraldi, Larissa Galastri; Cannon, Geoffrey; Monteiro, Carlos Augusto] Univ Sao Paulo, Fac Saude Publ, Nucleo Pesquisas Epidemiol Nutr & Saude, Sao Paulo, Brazil; [Levy, Renata Bertazzi] Univ Sao Paulo, Fac Med, Dept Prevent Med, Sao Paulo, Brazil; [Claro, Rafael Moreira] Univ Fed Minas Gerais, Escola Enfermagem, Dept Nutr, Belo Horizonte, MG, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Minas Gerais	Canella, DS (corresponding author), Univ Sao Paulo, Fac Saude Publ, Dept Nutr, Sao Paulo, Brazil.	dcanella@usp.br	Cannon, Geoffrey/ABI-4713-2020; Baraldi, Larissa G/H-1525-2014; Claro, Rafael/F-8996-2012; Moubarac, Jean-Claude/ABE-6439-2020; Canella, Daniela/G-1553-2012; Baraldi, Larissa Galastri/K-9784-2019; Martins, Ana Paula Bortoletto/G-8807-2012; Levy, Renata Bertazzi/F-8931-2012; Bortoletto Martins, Ana Paula/AAX-2737-2021; Moubarac, Jean-Claude/J-8235-2014; Monteiro, Carlos Augusto/F-9892-2012	Baraldi, Larissa G/0000-0002-6793-7899; Canella, Daniela/0000-0001-9672-4983; Baraldi, Larissa Galastri/0000-0002-6793-7899; Martins, Ana Paula Bortoletto/0000-0003-3560-4472; Levy, Renata Bertazzi/0000-0001-5388-7002; Monteiro, Carlos Augusto/0000-0002-3777-1533; Claro, Rafael/0000-0001-9690-575X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [472162/2011-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - process number 472162/2011-0). DSC received a doctoral scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). APBM received a doctoral scholarship and JCM received a postdoctoral fellowship from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, PHYS STAT US INT ANT; Asfaw A, 2011, HEALTH ECON, V20, P194; Becker W, 2001, PUBLIC HEALTH NUTR, V4, P1177; Bezerra IN, 2012, BR J NUTR, V31, P1; Martins APB, 2013, REV SAUDE PUBL, V47, P656, DOI 10.1590/S0034-8910.2013047004968; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fung TT, 2009, AM J CLIN NUTR, V89, P1037, DOI 10.3945/ajcn.2008.27140; Hawkes C, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2801; Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036; *I BRAS GEOGR EST, 1996, TAB COMP AL; Instituto Brasileiro de Geografia e Estatistica, 2010, PESQ ORC FAM 2008 20; Kavey REW, 2010, J AM DIET ASSOC, V110, P1456, DOI 10.1016/j.jada.2010.07.028; Knuth AG, 2011, CIENC SAUDE COLETIVA, V16, P3697, DOI 10.1590/S1413-81232011001000007; Ludwig DS, 2008, JAMA-J AM MED ASSOC, V300, P1808, DOI 10.1001/jama.300.15.1808; Ludwig DS, 2011, JAMA-J AM MED ASSOC, V305, P1352, DOI 10.1001/jama.2011.380; Ministerio da Saude.Secretaria de Vigilancia em Saude, 2012, EST INF SAUD G; Monteiro CA, 2013, OBES REV, V14, P21, DOI 10.1111/obr.12107; MONTEIRO CA, 2012, WORLD NUTR, V12, P527; Monteiro Carlos A., 2003, Rev Panam Salud Publica, V14, P246, DOI 10.1590/S1020-49892003000900005; Monteiro CA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001252; Monteiro CA, 2010, AM J PUBLIC HEALTH, V100, P975, DOI 10.2105/AJPH.2009.187666; Monteiro CA, 2009, PUBLIC HEALTH NUTR, V12, P729, DOI 10.1017/S1368980009005291; Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241; Monteiro CA, 2010, CAD SAUDE PUBLICA, V26, P2039, DOI 10.1590/S0102-311X2010001100005; Moubarac J-C., 2012, WORLD NUTR, V3, P62; Moubarac JC, 2014, CAN J DIET PRACT RES, V75, P15, DOI 10.3148/75.1.2014.15; Moubarac JC, 2013, PUBLIC HEALTH NUTR, V16, P2240, DOI 10.1017/S1368980012005009; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Naska A, 2001, PUBLIC HEALTH NUTR, V4, P1159, DOI 10.1079/PHN2001237; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Romaguera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023384; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001235, 10.1371/journal.pmed.1001242]; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tavares LF, 2012, PUBLIC HEALTH NUTR, V15, P82, DOI 10.1017/S1368980011001571; Universidade Estadual de Campinas. Nucleo de Estudos e Pesquisas em Alimentacao, 2004, TAB BRAS COMP AL TAC; *USDA, 2002, USDA NAT NUTR DAT ST; WHO, 2003, DIET NUTR PREVENTION, V916; WHO, 2006, WHO CHILD GROWTH STA; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	40	267	279	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92752	10.1371/journal.pone.0092752	http://dx.doi.org/10.1371/journal.pone.0092752			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SD	24667658	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600070
J	Halasa, T; Boklund, A; Stockmarr, A; Enoe, C; Christiansen, LE				Halasa, Tariq; Boklund, Anette; Stockmarr, Anders; Enoe, Claes; Christiansen, Lasse E.			A Comparison between Two Simulation Models for Spread of Foot-and-Mouth Disease	PLOS ONE			English	Article							CONTROL STRATEGIES; EPIDEMIC; VACCINATION; OUTBREAK; UK	Two widely used simulation models of foot-and-mouth disease (FMD) were used in order to compare the models' predictions in term of disease spread, consequence, and the ranking of the applied control strategies, and to discuss the effect of the way disease spread is modeled on the predicted outcomes of each model. The DTU-DADS (version 0.100), and ISP (version 2.001.11) were used to simulate a hypothetical spread of FMD in Denmark. Actual herd type, movements, and location data in the period 1st October 2006 and 30th September 2007 was used. The models simulated the spread of FMD using 3 different control scenarios: 1) A basic scenario representing EU and Danish control strategies, 2) pre-emptive depopulation of susceptible herds within a 500 meters radius around the detected herds, and 3) suppressive vaccination of susceptible herds within a 1,000 meters radius around the detected herds. Depopulation and vaccination started 14 days following the detection of the first infected herd. Five thousand index herds were selected randomly, of which there were 1,000 cattle herds located in high density cattle areas and 1,000 in low density cattle areas, 1,000 swine herds located in high density swine areas and 1,000 in low density swine areas, and 1,000 sheep herds. Generally, DTU-DADS predicted larger, longer duration and costlier epidemics than ISP, except when epidemics started in cattle herds located in high density cattle areas. ISP supported suppressive vaccination rather than pre-emptive depopulation, while DTU-DADS was indifferent to the alternative control strategies. Nonetheless, the absolute differences between control strategies were small making the choice of control strategy during an outbreak to be most likely based on practical reasons.	[Halasa, Tariq; Boklund, Anette; Stockmarr, Anders; Enoe, Claes] Tech Univ Denmark, Natl Vet Inst, Epidemiol Sect, Copenhagen, Denmark; [Stockmarr, Anders; Christiansen, Lasse E.] Tech Univ Denmark, Dept Appl Math & Comp Sci, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Halasa, T (corresponding author), Tech Univ Denmark, Natl Vet Inst, Epidemiol Sect, Copenhagen, Denmark.	tahbh@vet.dtu.dk	Boklund, Anette/HGE-8502-2022	Halasa, Tariq/0000-0003-1112-0254; Stockmarr, Anders/0000-0002-8681-2370; Boklund, Anette/0000-0001-6359-3403; Christiansen, Lasse Engbo/0000-0001-5019-1931	Directorate for Food, Agriculture and Fisheries, Denmark [3304-FVFP-07-782-01]	Directorate for Food, Agriculture and Fisheries, Denmark	This study was financially supported by the Directorate for Food, Agriculture and Fisheries, Denmark (grant nr. 3304-FVFP-07-782-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backer JA, 2012, PREV VET MED, V107, P27, DOI 10.1016/j.prevetmed.2012.05.012; Bates TW, 2003, AM J VET RES, V64, P195, DOI 10.2460/ajvr.2003.64.195; Boklund A, 2013, PREV VET MED, V111, P206, DOI 10.1016/j.prevetmed.2013.05.008; Boklund A, 2009, PREV VET MED, V90, P180, DOI 10.1016/j.prevetmed.2009.04.008; Cox SJ, 2009, VET RES, V40, DOI 10.1051/vetres:2008051; Dube C, 2007, NEW ZEAL VET J, V55, P280, DOI 10.1080/00480169.2007.36782; Gibbens JC, 2001, VET REC, V149, P729, DOI 10.1136/vr.149.24.729; Gibbens JC, 2002, VET REC, V151, P407, DOI 10.1136/vr.151.14.407; Halasa T, 2013, PREV VET MED, V112, P194, DOI 10.1016/j.prevetmed.2013.09.003; Halasa T, 2011, PREV VET MED, V98, P1, DOI 10.1016/j.prevetmed.2010.08.005; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Martinez-Lopez B, 2010, PREV VET MED, V96, P19, DOI 10.1016/j.prevetmed.2010.05.015; Pendell D. L., 2007, Journal of Agricultural and Applied Economics, V39, P19; Pluimers FH, 2002, REV SCI TECH OIE, V21, P711, DOI 10.20506/rst.21.3.1371; R Development Core Team, 2011, R LANG ENV STAT COMP; Sanson RL, 2011, REV SCI TECH OIE, V30, P527; Sanson R.L., 1993, THESIS MASSEY U; Stern M., 2003, INTERSPREAD PLUS USE; Stevenson M, 2005, INTERSPREAD PLUS SPA; Stevenson MA, 2013, PREV VET MED, V109, P10, DOI 10.1016/j.prevetmed.2012.08.015; Taylor N., 2003, REV USE MODELS INFOR; Tildesley MJ, 2008, PREV VET MED, V85, P107, DOI 10.1016/j.prevetmed.2008.01.008; Velthuis AGJ, 2007, PREV VET MED, V82, P262, DOI 10.1016/j.prevetmed.2007.05.023; Westergaard JM, 1982, REPORD ERADICATION F	24	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92521	10.1371/journal.pone.0092521	http://dx.doi.org/10.1371/journal.pone.0092521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667525	gold, Green Published			2022-12-27	WOS:000333675600047
J	Hartman, ME; Librande, JR; Medvedev, IO; Ahmad, RN; Moussavi-Harami, F; Gupta, PP; Chien, WM; Chin, MT				Hartman, Matthew E.; Librande, Jason R.; Medvedev, Ivan O.; Ahmad, Rabiah N.; Moussavi-Harami, Farid; Gupta, Pritha P.; Chien, Wei-Ming; Chin, Michael T.			An Optimized and Simplified System of Mouse Embryonic Stem Cell Cardiac Differentiation for the Assessment of Differentiation Modifiers	PLOS ONE			English	Article							CONDUCTION SYSTEM; PROGENITOR CELLS; GENE-EXPRESSION; RAT BLASTOCYSTS; SELF-RENEWAL; CARDIOMYOCYTES; HEART; LINES; SPECIFICATION; MYOCARDIUM	Generating cardiomyocytes from embryonic stem cells is an important technique for understanding cardiovascular development, the origins of cardiovascular diseases and also for providing potential reagents for cardiac repair. Numerous methods have been published but often are technically challenging, complex, and are not easily adapted to assessment of specific gene contributions to cardiac myocyte differentiation. Here we report the development of an optimized protocol to induce the differentiation of mouse embryonic stem cells to cardiac myocytes that is simplified and easily adapted for genetic studies. Specifically, we made four critical findings that distinguish our protocol: 1) mouse embryonic stem cells cultured in media containing CHIR99021 and PD0325901 to maintain pluripotency will efficiently form embryoid bodies containing precardiac mesoderm when cultured in these factors at a reduced dosage, 2) low serum conditions promote cardiomyocyte differentiation and can be used in place of commercially prepared StemPro nutrient supplement, 3) the Wnt inhibitor Dkk-1 is dispensable for efficient cardiac differentiation and 4) tracking differentiation efficiency may be done with surface expression of PDGFR alpha alone. In addition, cardiac mesodermal precursors generated by this system can undergo lentiviral infection to manipulate the expression of specific target molecules to assess effects on cardiac myocyte differentiation and maturation. Using this approach, we assessed the effects of CHF1/Hey2 on cardiac myocyte differentiation, using both gain and loss of function. Overexpression of CHF1/Hey2 at the cardiac mesoderm stage had no apparent effect on cardiac differentiation, while knockdown of CHF1/Hey2 resulted in increased expression of atrial natriuretic factor and connexin 43, suggesting an alteration in the phenotype of the cardiomyocytes. In summary we have generated a detailed and simplified protocol for generating cardiomyocytes from mES cells that is optimized for investigating factors that affect cardiac differentiation.	[Hartman, Matthew E.; Librande, Jason R.; Medvedev, Ivan O.; Ahmad, Rabiah N.; Moussavi-Harami, Farid; Gupta, Pritha P.; Chien, Wei-Ming; Chin, Michael T.] Univ Washington, Dept Med, Div Cardiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Chin, MT (corresponding author), Univ Washington, Dept Med, Div Cardiol, Seattle, WA 98195 USA.	mtchin@u.washington.edu	Moussavi-Harami, Farid/AAD-4608-2020	Moussavi-Harami, Farid/0000-0002-0189-7214; Hartman, Matt/0000-0002-6238-1887	NIH [T32 HL07828]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007828] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Work in this manuscript was supported by a training grant T32 HL07828 from the NIH (www.nih.gov) to M. E. H., F. M. AND I.O.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Batlle-Morera L, 2008, GENESIS, V46, P758, DOI 10.1002/dvg.20442; Bezzina CR, 2013, NAT GENET, V45, P1044, DOI 10.1038/ng.2712; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Cao N, 2011, CELL RES, V21, P1316, DOI 10.1038/cr.2011.48; David R, 2011, CARDIOVASC RES, V92, P115, DOI 10.1093/cvr/cvr158; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Flaherty MP, 2008, TRENDS CARDIOVAS MED, V18, P260, DOI 10.1016/j.tcm.2008.12.001; Franco D, 1998, CARDIOVASC RES, V38, P25, DOI 10.1016/S0008-6363(97)00321-0; GOURDIE RG, 1993, J CELL SCI, V105, P985; Greener ID, 2011, J MOL CELL CARDIOL, V50, P642, DOI 10.1016/j.yjmcc.2010.12.017; Gutstein DE, 2001, CIRCULATION, V104, P1194, DOI 10.1161/hc3601.093990; Haigh J. J, 2008, ORGANOGENESIS, V4, P247, DOI DOI 10.4161/0RG.4.4.7415; Hirai H, 2011, BIOCHEM J, V438, P11, DOI 10.1042/BJ20102152; Hsiao EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002532; Hwang YS, 2009, P NATL ACAD SCI USA, V106, P16978, DOI 10.1073/pnas.0905550106; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; KELLY RG, 1999, HEART DEV, P333; Koibuchi N, 2007, CIRC RES, V100, P850, DOI 10.1161/01.RES.0000261693.13269.bf; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Monfredi O, 2010, PACE, V33, P1392, DOI 10.1111/j.1540-8159.2010.02838.x; Moorman AFM, 1998, CIRC RES, V82, P629, DOI 10.1161/01.RES.82.6.629; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Otrock ZK, 2007, BLOOD CELL MOL DIS, V38, P258, DOI 10.1016/j.bcmd.2006.12.003; Paige SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011134; Potta SP, 2010, CELL PHYSIOL BIOCHEM, V25, P595, DOI 10.1159/000315078; Telugu BPVL, 2010, INT J DEV BIOL, V54, P1703, DOI 10.1387/ijdb.103200bt; Thomas SA, 1998, CIRCULATION, V97, P686, DOI 10.1161/01.CIR.97.7.686; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yamamoto H, 2007, GENES CELLS, V12, P1215, DOI 10.1111/j.1365-2443.2007.01128.x; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhou BY, 2007, STEM CELLS, V25, P779, DOI 10.1634/stemcells.2006-0128	43	10	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93033	10.1371/journal.pone.0093033	http://dx.doi.org/10.1371/journal.pone.0093033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667642	gold, Green Published, Green Submitted			2022-12-27	WOS:000333675600129
J	Abduljaleel, Z; Al-Allaf, FA; Khan, W; Athar, M; Shahzad, N; Taher, MM; Elrobh, M; Alanazi, MS; El-Huneidi, W				Abduljaleel, Zainularifeen; Al-Allaf, Faisal A.; Khan, Wajahatullah; Athar, Mohammad; Shahzad, Naiyer; Taher, Mohiuddin M.; Elrobh, Mohamed; Alanazi, Mohammed S.; El-Huneidi, Waseem			Evidence of Trem2 Variant Associated with Triple Risk of Alzheimer's Disease	PLOS ONE			English	Article							IN-SILICO MUTAGENESIS; PROTEIN-STRUCTURE; MUTATIONS	Alzheimer's disease is one of the main causes of dementia among elderly individuals and leads to the neurodegeneration of different areas of the brain, resulting in memory impairments and loss of cognitive functions. Recently, a rare variant that is associated with 3-fold higher risk of Alzheimer's disease onset has been found. The rare variant discovered is a missense mutation in the loop region of exon 2 of Trem2 (rs75932628-T, Arg47His). The aim of this study was to investigate the evidence for potential structural and functional significance of Trem2 gene variant (Arg47His) through molecular dynamics simulations. Our results showed the alteration caused due to the variant in TREM2 protein has significant effect on the ligand binding affinity as well as structural configuration. Based on molecular dynamics (MD) simulation under salvation, the results confirmed that native form of the variant (Arg47His) might be responsible for improved compactness, hence thereby improved protein folding. Protein simulation was carried out at different temperatures. At 300K, the deviation of the theoretical model of TREM2 protein increased from 2.0 angstrom at 10 ns. In contrast, the deviation of the Arg47His mutation was maintained at 1.2 angstrom until the end of the simulation (t = 10 ns), which indicated that Arg47His had reached its folded state. The mutant residue was a highly conserved region and was similar to "immunoglobulin V-set" and "immunoglobulin-like folds". Taken together, the result from this study provides a biophysical insight on how the studied variant could contribute to the genetic susceptibility to Alzheimer's disease.	[Abduljaleel, Zainularifeen; Al-Allaf, Faisal A.; Athar, Mohammad; Taher, Mohiuddin M.] Umm Al Qura Univ, Fac Med, Dept Med Genet, Mecca, Saudi Arabia; [Khan, Wajahatullah; El-Huneidi, Waseem] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Sci & Hlth Profess, Dept Basic Sci, Riyadh, Saudi Arabia; [Shahzad, Naiyer] Umm Al Qura Univ, Fac Med, Dept Pharmacol & Toxicol, Mecca, Saudi Arabia; [Abduljaleel, Zainularifeen; Elrobh, Mohamed; Alanazi, Mohammed S.] King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair Unit, Riyadh 11451, Saudi Arabia	Umm Al Qura University; King Saud Bin Abdulaziz University for Health Sciences; Umm Al Qura University; King Saud University	Abduljaleel, Z (corresponding author), Umm Al Qura Univ, Fac Med, Dept Med Genet, Mecca, Saudi Arabia.	zainulbio@gmail.com	Athar, Mohammad/U-9467-2019; abduljaleel, zainularifeen/AAE-8036-2021; Elrobh, Mohamed S/H-5696-2012; EL-HUNEIDI, WASEEM/AAD-9698-2022	Athar, Mohammad/0000-0001-7874-7890; abduljaleel, zainularifeen/0000-0001-9791-1924; Shahzad, Naiyer/0000-0001-9125-8979; , Mohamed/0000-0003-1967-8850; AL-ALLAF, FAISAL/0000-0001-8430-3532; El-Huneidi, Waseem/0000-0002-1580-2589	Deanship of Scientific Research at King Saud University [RGP-VPP-200]	Deanship of Scientific Research at King Saud University(King Saud University)	The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding this work through the research group project No: RGP-VPP-200. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bowers KJ, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2191489; Bromberg Y, 2008, BIOINFORMATICS, V24, pI207, DOI 10.1093/bioinformatics/btn268; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Bromberg Y, 2009, FASEB J, V23, P3059, DOI 10.1096/fj.08-127530; Choi WC, 2005, FEBS LETT, V579, P3461, DOI 10.1016/j.febslet.2005.05.016; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Delarue M, 2004, P NATL ACAD SCI USA, V101, P6957, DOI 10.1073/pnas.0400301101; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kamal MZ, 2010, BBA-PROTEINS PROTEOM, V1804, P1850, DOI 10.1016/j.bbapap.2010.06.014; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Prlic A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-333; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; Schaefer C, 2012, BIOINFORMATICS, V28, P601, DOI 10.1093/bioinformatics/btr705; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Torkamani A, 2009, CANCER LETT, V281, P117, DOI 10.1016/j.canlet.2008.11.008; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Xu XJ, 2010, J HAZARD MATER, V175, P423, DOI 10.1016/j.jhazmat.2009.10.023	26	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92648	10.1371/journal.pone.0092648	http://dx.doi.org/10.1371/journal.pone.0092648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663666	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900090
J	Al-Sadi, R; Ye, DM; Boivin, M; Guo, SH; Hashimi, M; Ereifej, L; Ma, TY				Al-Sadi, Rana; Ye, Dongmei; Boivin, Michel; Guo, Shuhong; Hashimi, Mariam; Ereifej, Lisa; Ma, Thomas Y.			Interleukin-6 Modulation of Intestinal Epithelial Tight Junction Permeability Is Mediated by JNK Pathway Activation of Claudin-2 Gene	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; LIGHT-CHAIN KINASE; CULTURED CACO-2 CELLS; KAPPA-B ACTIVATION; BARRIER DYSFUNCTION; PROTEIN-KINASE; IN-VIVO; IL-6; MECHANISM; EXPRESSION	Defective intestinal epithelial tight junction (TJ) barrier has been shown to be a pathogenic factor in the development of intestinal inflammation. Interleukin-6 (IL-6) is a pleiotropic, pro-inflammatory cytokine which plays an important role in promoting inflammatory response in the gut and in the systemic circulation. Despite its key role in mediating variety inflammatory response, the effect of IL-6 on intestinal epithelial barrier remains unclear. The purpose of this study was to investigate the effect of IL-6 on intestinal epithelial TJ barrier and to delineate the intracellular mechanisms involved using in-vitro (filter-grown Caco-2 monolayers) and in-vivo model (mouse intestinal perfusion) systems. Our results indicated that IL-6 causes a site-selective increase in Caco-2 intestinal epithelia TJ permeability, causing an increase in flux of small-sized molecules having molecular radius < 4 angstrom. The size-selective increase in Caco-2 TJ permeability was regulated by protein-specific increase in claudin-2 expression. The IL-6 increase in TJ permeability required activation of JNK signaling cascade. The JNK pathway activation of AP-1 resulted in AP-1 binding to its binding sequence on the claudin-2 promoter region, leading to promoter activation and subsequent increase in claudin-2 gene transcription and protein synthesis and TJ permeability. Our in-vivo mouse perfusion showed that IL-6 modulation of mouse intestinal permeability was also mediated by AP-1 dependent increase in claudin-2 expression. In conclusion, our studies show for the first time that the IL-6 modulation of intestinal TJ permeability was regulated by JNK activation of AP-1 and AP-1 activation of claudin-2 gene.	[Al-Sadi, Rana; Ye, Dongmei; Boivin, Michel; Guo, Shuhong; Hashimi, Mariam; Ereifej, Lisa; Ma, Thomas Y.] Univ New Mexico, Sch Med, Dept Internal Med, Albuquerque, NM 87131 USA; [Al-Sadi, Rana; Guo, Shuhong; Ma, Thomas Y.] Albuquerque Vet Affairs Med Ctr, Albuquerque, NM USA	University of New Mexico	Ma, TY (corresponding author), Univ New Mexico, Sch Med, Dept Internal Med, Albuquerque, NM 87131 USA.	tma@salud.unm.edu		Al-Sadi, Rana/0000-0002-9826-5132	Veterans Affairs (VA) Merit Review grant from the VA Research Service and National Institute of Diabetes and Digestive and Kidney Diseases [RO 1-DK-81429-03]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081429] Funding Source: NIH RePORTER	Veterans Affairs (VA) Merit Review grant from the VA Research Service and National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research project was supported by a Veterans Affairs (VA) Merit Review grant from the VA Research Service and National Institute of Diabetes and Digestive and Kidney Diseases Grant RO 1-DK-81429-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sadi R, AM J PHYSL GASTROINT, V300, pG1054; Al-Sadi R, 2008, J IMMUNOL, V180, P5653, DOI 10.4049/jimmunol.180.8.5653; Al-Sadi R, 2009, FRONT BIOSCI-LANDMRK, V14, P2765, DOI 10.2741/3413; Al-Sadi RM, 2007, J IMMUNOL, V178, P4641, DOI 10.4049/jimmunol.178.7.4641; Boivin MA, 2007, AM J PHYSIOL-GASTR L, V292, pG590, DOI 10.1152/ajpgi.00252.2006; Choy EHS, 2002, ARTHRITIS RHEUM-US, V46, P3143, DOI 10.1002/art.10623; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; Fischer A, AM J PHYSL GASTROINT, V304, pG970; Garat C, 2003, CYTOKINE, V23, P31, DOI 10.1016/S1043-4666(03)00182-0; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Hershko DD, 2002, AM J PHYSIOL-REG I, V283, pR1140, DOI 10.1152/ajpregu.00161.2002; Hollander D, 1999, Curr Gastroenterol Rep, V1, P410, DOI 10.1007/s11894-999-0023-5; Hungness ES, 2000, SHOCK, V14, P386, DOI 10.1097/00024382-200014030-00025; Ito H, 2005, J GASTROENTEROL, V40, P32, DOI 10.1007/BF02990576; Laukoetter MG, 2007, J EXP MED, V204, P3067, DOI 10.1084/jem.20071416; Ma TY, 2000, AM J PHYSIOL-GASTR L, V279, pG875, DOI 10.1152/ajpgi.2000.279.5.G875; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Ma TY., 2012, PHYSL GASTROINTESTIN, V5; Mazzon E, 2002, MOL MED, V8, P353, DOI 10.1007/BF03402016; Nusrat A, 2000, AM J PHYSIOL-GASTR L, V279, pG851, DOI 10.1152/ajpgi.2000.279.5.G851; Pallua N, 2003, CRIT CARE MED, V31, P1495, DOI 10.1097/01.CCM.0000065725.80882.BD; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; RadfordSmith G, 1996, BAILLIERE CLIN GASTR, V10, P151, DOI 10.1016/S0950-3528(96)90045-7; Rittirsch D, AM J PHYSL LUNG CELL, V304, pL863; Rollwagen FM, 1998, CLIN IMMUNOL IMMUNOP, V89, P205, DOI 10.1006/clin.1998.4600; Romagnoli C, 2001, EUR J PEDIATR, V160, P345, DOI 10.1007/PL00008445; SCHLUTER B, 1991, J TRAUMA, V31, P1663, DOI 10.1097/00005373-199112000-00017; Seegert D, 2001, GUT, V48, P326, DOI 10.1136/gut.48.3.326; Severson EA, 2009, ANN NY ACAD SCI, V1165, P10, DOI 10.1111/j.1749-6632.2009.04034.x; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Tazuke Y, 2003, PEDIATR SURG INT, V19, P321, DOI 10.1007/s00383-003-1003-8; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; vanHogezand RA, 1996, NETH J MED, V48, P64, DOI 10.1016/0300-2977(95)00091-7; Wang LX, 2007, J BIOL CHEM, V282, P8219, DOI 10.1074/jbc.M604068200; Wang LX, 2003, J IMMUNOL, V171, P3194, DOI 10.4049/jimmunol.171.6.3194; Wang Q, 2008, SHOCK, V29, P531, DOI 10.1097/SHK.0b013e318150737f; Yang RK, 2003, AM J PHYSIOL-GASTR L, V285, pG621, DOI 10.1152/ajpgi.00177.2003; Ye D, GASTROENTEROLOGY, V141, P1323; Ye DM, 2006, AM J PHYSIOL-GASTR L, V290, pG496, DOI 10.1152/ajpgi.00318.2005; Ye D, 2008, J CELL MOL MED, V12, P1331, DOI 10.1111/j.1582-4934.2008.00302.x	43	147	156	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e85345	10.1371/journal.pone.0085345	http://dx.doi.org/10.1371/journal.pone.0085345			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662742	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900001
J	Do, AN; Rosenberg, ES; Sullivan, PS; Beer, L; Strine, TW; Schulden, JD; Fagan, JL; Freedman, MS; Skarbinski, J				Do, Ann N.; Rosenberg, Eli S.; Sullivan, Patrick S.; Beer, Linda; Strine, Tara W.; Schulden, Jeffrey D.; Fagan, Jennifer L.; Freedman, Mark S.; Skarbinski, Jacek			Excess Burden of Depression among HIV-Infected Persons Receiving Medical Care in the United States: Data from the Medical Monitoring Project and the Behavioral Risk Factor Surveillance System	PLOS ONE			English	Article							PATIENT HEALTH QUESTIONNAIRE; HUMAN-IMMUNODEFICIENCY-VIRUS; INJECTION-DRUG USERS; PSYCHIATRIC-DISORDERS; PUBLIC-HEALTH; ANTIRETROVIRAL THERAPY; IMMUNE FUNCTION; MOOD DISORDERS; PRIME-MD; PREVALENCE	Background: With increased life expectancy for HIV-infected persons, there is concern regarding comorbid depression because of its common occurrence and association with behaviors that may facilitate HIV transmission. Our objectives were to estimate the prevalence of current depression among HIV-infected persons receiving care and assess the burden of major depression, relative to that in the general population. Methods and Findings: We used data from the Medical Monitoring Project (MMP) and the Behavioral Risk Factors Surveillance System (BRFSS). The eight-item Patient Health Questionnaire was used to identify depression. To assess the burden of major depression among HIV-infected persons receiving care, we compared the prevalence of current major depression between the MMP and BRFSS populations using stratified analyses that simultaneously controlled for gender and, in turn, each of the potentially confounding demographic factors of age, race/ethnicity, education, and income. Each unadjusted comparison was summarized as a prevalence ratio (PR), and each of the adjusted comparisons was summarized as a standardized prevalence ratio (SPR). Among HIV-infected persons receiving care, the prevalence of a current episode of major depression and other depression, respectively, was 12.4% (95% CI: 11.2, 13.7) and 13.2% (95% CI: 12.0%, 14.4%). Overall, the PR comparing the prevalence of current major depression between HIV-infected persons receiving care and the general population was 3.1. When controlling for gender and each of the factors age, race/ethnicity, and education, the SPR (3.3, 3.0, and 2.9, respectively) was similar to the PR. However, when controlling for gender and annual household income, the SPR decreased to 1.5. Conclusions: Depression remains a common comorbidity among HIV-infected persons. The overall excess burden among HIV-infected persons receiving care is about three-times that among the general population and is associated with differences in annual household income between the two populations. Relevant efforts are needed to reduce this burden.	[Do, Ann N.; Beer, Linda; Fagan, Jennifer L.; Freedman, Mark S.; Skarbinski, Jacek] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA; [Rosenberg, Eli S.; Sullivan, Patrick S.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Strine, Tara W.] Ctr Dis Control & Prevent, Off Publ Hlth Preparedness & Response, Atlanta, GA USA; [Schulden, Jeffrey D.] NIDA, Rockville, MD USA	Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health; Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Do, AN (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA.	aad9@cdc.gov		Beer, Linda/0000-0002-5781-8626; Sullivan, Patrick Sean/0000-0002-7728-0587	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding was exclusively provided by the Centers for Disease Control and Prevention, which conceived the project, developed project-associated materials including data collection instruments, provided oversight of implementation, conducted analytic procedures, and developed this report.	Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; Adams JL, 2012, AIDS PATIENT CARE ST, V26, P647, DOI 10.1089/apc.2012.0113; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2012, BEH RISK FACT SURV S; [Anonymous], HIV SURV REP 2010; Asch SM, 2003, J GEN INTERN MED, V18, P450, DOI 10.1046/j.1525-1497.2003.20938.x; ATKINSON JH, 1988, ARCH GEN PSYCHIAT, V45, P859; Bhatia R, 2011, AIDS BEHAV, V15, P1161, DOI 10.1007/s10461-010-9778-9; Blair Janet M., 2011, Morbidity and Mortality Weekly Report, V60, P1; Bouhnik AD, 2005, ANTIVIR THER, V10, P53; BRUCE ML, 1991, ARCH GEN PSYCHIAT, V48, P470; Cassano P, 2002, J PSYCHOSOM RES, V53, P849, DOI 10.1016/S0022-3999(02)00304-5; Centers for Disease Control and Prevention, 1999, GUID PUBL HLTH RES P; Centers for Disease Control and Prevention, 2007, 2008 BEH RISK FACT S; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; Chander G, 2006, DRUGS, V66, P769, DOI 10.2165/00003495-200666060-00004; CHUANG HT, 1992, CAN J PSYCHIAT, V37, P109, DOI 10.1177/070674379203700207; Ciesla JA, 2001, AM J PSYCHIAT, V158, P725, DOI 10.1176/appi.ajp.158.5.725; Cook JA, 2004, AM J PUBLIC HEALTH, V94, P1133, DOI 10.2105/AJPH.94.7.1133; Corson K, 2004, AM J MANAG CARE, V10, P839; Cruess DG, 2003, CNS SPECTRUMS, V8, P52, DOI 10.1017/S1092852900023452; Davis L, 2008, CURR OPIN PSYCHIATR, V21, P14, DOI 10.1097/YCO.0b013e3282f32408; Denning Paul H., 2011, Morbidity and Mortality Weekly Report, V60, P1045; Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021; Evans DL, 2002, AM J PSYCHIAT, V159, P1752, DOI 10.1176/appi.ajp.159.10.1752; Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001; Fan AZ, 2008, PREV MED, V46, P445, DOI 10.1016/j.ypmed.2008.02.016; Frankel Martin R, 2012, Open AIDS J, V6, P67, DOI 10.2174/1874613601206010067; Frankel MR, 1999, HEALTH SERV RES, V34, P969; Fukunishi I, 1997, PSYCHOTHER PSYCHOSOM, V66, P248, DOI 10.1159/000289142; Goldman DA, 2000, STAT MED, V19, P1081, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1081::AID-SIM406>3.0.CO;2-A; Gonzalez O., 2011, Morbidity and Mortality Weekly Report, V60, P518; Gonzalez O., 2010, Morbidity and Mortality Weekly Report, V59, P1229; Grattan A, 2012, ANN FAM MED, V10, P304, DOI 10.1370/afm.1371; Holtgrave DR, 2003, SEX TRANSM INFECT, V79, P62, DOI 10.1136/sti.79.1.62; Holtzman D, 2004, COMMUNITY-BASED HEALTH RESEARCH: ISSUES AND METHODS, P115; Horberg MA, 2008, JAIDS-J ACQ IMM DEF, V47, P384, DOI 10.1097/QAI.0b013e318160d53e; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Huang FY, 2006, J GEN INTERN MED, V21, P547, DOI 10.1111/j.1525-1497.2006.00409.x; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; Johnson V, 2011, NAT HIV PERV C 5; KATON W, 1992, GEN HOSP PSYCHIAT, V14, P237, DOI 10.1016/0163-8343(92)90094-Q; Katon W, 2010, CONTEMP CLIN TRIALS, V31, P312, DOI 10.1016/j.cct.2010.03.009; Kelly B, 1998, AUST NZ J PSYCHIAT, V32, P441, DOI 10.3109/00048679809065539; Kessler RC, 2012, PSYCHIAT CLIN N AM, V35, P1, DOI 10.1016/j.psc.2011.11.005; Kiecolt-Glaser JK, 2002, J PSYCHOSOM RES, V53, P873, DOI 10.1016/S0022-3999(02)00309-4; King M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-70; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Lepine JP, 1997, INT CLIN PSYCHOPHARM, V12, P19, DOI 10.1097/00004850-199701000-00003; Leserman J, 2008, PSYCHOSOM MED, V70, P539, DOI 10.1097/PSY.0b013e3181777a5f; Lewis G, 2001, BRIT MED BULL, V57, P3, DOI 10.1093/bmb/57.1.3; Li CY, 2008, DIABETES CARE, V31, P105, DOI 10.2337/dc07-1154; Li CY, 2012, INT J PUBLIC HEALTH, V57, P225, DOI 10.1007/s00038-011-0253-9; Lichtenstein B, 2002, AIDS PATIENT CARE ST, V16, P27, DOI 10.1089/108729102753429370; Lichtman Judith H, 2009, Prog Cardiovasc Nurs, V24, P19, DOI 10.1111/j.1751-7117.2009.00028.x; Link MW, 2007, PUBLIC OPIN QUART, V71, P814, DOI 10.1093/poq/nfm051; LIPSITZ JD, 1994, AM J PSYCHIAT, V151, P1662; MAJ M, 1994, ARCH GEN PSYCHIAT, V51, P39; Martin A, 2006, GEN HOSP PSYCHIAT, V28, P71, DOI 10.1016/j.genhosppsych.2005.07.003; McNaghten AD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000550; Mohr DC, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1370; Mokdad Ali H, 2003, MMWR Recomm Rep, V52, P1; Mussell M, 2008, J PSYCHOSOM RES, V64, P605, DOI 10.1016/j.jpsychores.2008.02.019; Nease DE, 2011, GEN HOSP PSYCHIAT, V33, P279, DOI 10.1016/j.genhosppsych.2011.03.002; New York State Department of Health, 2010, DEPR MAN PAT HIV AID; PageShafer K, 1996, ANN EPIDEMIOL, V6, P420, DOI 10.1016/S1047-2797(96)00064-6; Perdue T, 2003, AIDS EDUC PREV, V15, P81, DOI 10.1521/aeap.15.1.81.23842; PERKINS DO, 1994, AM J PSYCHIAT, V151, P233; Pinto-Meza A, 2005, J GEN INTERN MED, V20, P738, DOI 10.1111/j.1525-1497.2005.0144.x; Poundstone KE, 2004, EPIDEMIOL REV, V26, P22, DOI 10.1093/epirev/mxh005; Rabkin JG, 1997, COMPR PSYCHIAT, V38, P146, DOI 10.1016/S0010-440X(97)90067-5; Rabkin Judith G, 2008, Curr HIV/AIDS Rep, V5, P163, DOI 10.1007/s11904-008-0025-1; RAO JNK, 1987, ANN STAT, V15, P385, DOI 10.1214/aos/1176350273; Razykov I, 2012, J PSYCHOSOM RES, V73, P163, DOI 10.1016/j.jpsychores.2012.06.001; Reeves William C., 2011, Morbidity and Mortality Weekly Report, V60, P1; Rief W, 2004, J AFFECT DISORDERS, V82, P271, DOI 10.1016/j.jad.2003.11.006; Risser J, 2010, AM J DRUG ALCOHOL AB, V36, P18, DOI 10.3109/00952990903544802; Rodkjaer L, 2010, HIV MED, V11, P46, DOI 10.1111/j.1468-1293.2009.00741.x; ROSENBERGER PH, 1993, COMPR PSYCHIAT, V34, P150, DOI 10.1016/0010-440X(93)90041-2; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Sadock BJ, 2009, KAPLAN SADOCKS COMPR, VI; Sandfort TGM, 2001, ARCH GEN PSYCHIAT, V58, P85, DOI 10.1001/archpsyc.58.1.85; Silverman MN, 2012, ANN NY ACAD SCI, V1261, P55, DOI 10.1111/j.1749-6632.2012.06633.x; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2000, AM J OBSTET GYNECOL, V183, P759, DOI 10.1067/mob.2000.106580; Stratford D, 2008, PUBLIC HEALTH REP, V123, P9, DOI 10.1177/003335490812300103; Traeger L, 2011, J BEHAV MED; Wells TS, 2012, J AFFECT DISORD; Williams CT, 2005, JAIDS-J ACQ IMM DEF, V38, P69, DOI 10.1097/00126334-200501010-00013; WILLIAMS JBW, 1991, ARCH GEN PSYCHIAT, V48, P124; Yun LWH, 2005, JAIDS-J ACQ IMM DEF, V38, P432, DOI 10.1097/01.qai.0000147524.19122.fd	93	155	155	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92842	10.1371/journal.pone.0092842	http://dx.doi.org/10.1371/journal.pone.0092842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD7QO	24663122	gold, Green Published, Green Submitted			2022-12-27	WOS:000333459900124
J	Ferraye, MU; Debu, B; Heil, L; Carpenter, M; Bloem, BR; Toni, I				Ferraye, Murielle Ursulla; Debu, Bettina; Heil, Lieke; Carpenter, Mark; Bloem, Bastiaan Roelof; Toni, Ivan			Using Motor Imagery to Study the Neural Substrates of Dynamic Balance	PLOS ONE			English	Article							PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PROGRESSIVE SUPRANUCLEAR PALSY; POSTERIOR PARIETAL CORTEX; PARKINSONS-DISEASE; BRAIN ACTIVATION; CORTICOPONTINE PROJECTION; POSTURAL INSTABILITY; GAIT DISTURBANCES; FUNCTIONAL MRI; OLDER-ADULTS	This study examines the cerebral structures involved in dynamic balance using a motor imagery (MI) protocol. We recorded cerebral activity with functional magnetic resonance imaging while subjects imagined swaying on a balance board along the sagittal plane to point a laser at target pairs of different sizes (small, large). We used a matched visual imagery (VI) control task and recorded imagery durations during scanning. MI and VI durations were differentially influenced by the sway accuracy requirement, indicating that MI of balance is sensitive to the increased motor control necessary to point at a smaller target. Compared to VI, MI of dynamic balance recruited additional cortical and subcortical portions of the motor system, including frontal cortex, basal ganglia, cerebellum and mesencephalic locomotor region, the latter showing increased effective connectivity with the supplementary motor area. The regions involved in MI of dynamic balance were spatially distinct but contiguous to those involved in MI of gait (Bakker et al., 2008; Snijders et al., 2011; Cremers et al., 2012), in a pattern consistent with existing somatotopic maps of the trunk (for balance) and legs (for gait). These findings validate a novel, quantitative approach for studying the neural control of balance in humans. This approach extends previous reports on MI of static stance (Jahn et al., 2004, 2008), and opens the way for studying gait and balance impairments in patients with neurodegenerative disorders.	[Ferraye, Murielle Ursulla; Heil, Lieke; Toni, Ivan] Radboud Univ Nijmegen, Ctr Cognit Neuroimaging, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Debu, Bettina] Univ Grenoble, INSERM U838, Grenoble Inst Neurosci, Grenoble, France; [Carpenter, Mark] Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada; [Bloem, Bastiaan Roelof] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of British Columbia; Radboud University Nijmegen	Bloem, BR (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6525 ED Nijmegen, Netherlands.	b.bloem@neuro.umcn.nl	Debû, Bettina/AAB-9935-2019; Bloem, Bastiaan/H-8013-2014; Toni, Ivan/D-1980-2009	Debû, Bettina/0000-0002-2195-8846; Bloem, Bastiaan/0000-0002-6371-3337; Toni, Ivan/0000-0003-0936-3601	Prinses Beatrix Fonds [W.OR10-35]; France Parkinson [R10078CC]; Netherlands Organisation for Scientific Research [825.10.031]	Prinses Beatrix Fonds; France Parkinson; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by Prinses Beatrix Fonds (W.OR10-35); France Parkinson (R10078CC for M.U.F.); and the Netherlands Organisation for Scientific Research (825.10.031 for M.U.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Aravamuthan BR, 2007, NEUROIMAGE, V37, P694, DOI 10.1016/j.neuroimage.2007.05.050; Aravamuthan B R, 2008, Br J Neurosurg, V22 Suppl 1, pS25, DOI 10.1080/02688690802448251; Ashburner J, 1997, NEUROIMAGE, V6, P209, DOI 10.1006/nimg.1997.0290; Bakker M, 2008, NEUROIMAGE, V41, P998, DOI 10.1016/j.neuroimage.2008.03.020; Bakker M, 2007, EXP BRAIN RES, V179, P497, DOI 10.1007/s00221-006-0807-x; Ballanger B, 2009, HUM BRAIN MAPP, V30, P3901, DOI 10.1002/hbm.20815; Barra J, 2010, BRAIN, V133, P3552, DOI 10.1093/brain/awq311; BRENIERE Y, 1988, CR ACAD SCI III-VIE, V307, P617; BRODAL P, 1978, BRAIN, V101, P251, DOI 10.1093/brain/101.2.251; Crawford JD, 2011, ANNU REV NEUROSCI, V34, P309, DOI 10.1146/annurev-neuro-061010-113749; Cremers J, 2012, MOVEMENT DISORD, V27, P1498, DOI 10.1002/mds.25139; Decety Jean, 1995, Behavioural Brain Research, V72, P127, DOI 10.1016/0166-4328(96)00141-6; DHANARAJAN P, 1977, NEUROSCIENCE, V2, P913, DOI 10.1016/0306-4522(77)90114-2; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Ferraye MU, 2010, BRAIN, V133, P205, DOI 10.1093/brain/awp229; Fink GR, 1997, J NEUROPHYSIOL, V77, P2164, DOI 10.1152/jn.1997.77.4.2164; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Fukuyama H, 1997, NEUROSCI LETT, V228, P183, DOI 10.1016/S0304-3940(97)00381-9; Gemba H, 2004, NEUROSCI LETT, V357, P68, DOI 10.1016/j.neulet.2003.12.033; Heed T, 2011, J NEUROSCI, V31, P3066, DOI 10.1523/JNEUROSCI.4370-10.2011; HIRSCH EC, 1987, P NATL ACAD SCI USA, V84, P5976, DOI 10.1073/pnas.84.16.5976; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Horak FB, 2005, EXP NEUROL, V193, P504, DOI 10.1016/j.expneurol.2004.12.008; HUMMELSHEIM H, 1986, EXP BRAIN RES, V65, P75; Jahn K, 2004, NEUROIMAGE, V22, P1722, DOI 10.1016/j.neuroimage.2004.05.017; Jahn K, 2008, NEUROIMAGE, V39, P786, DOI 10.1016/j.neuroimage.2007.09.047; JELLINGER K, 1988, J NEUROL NEUROSUR PS, V51, P540, DOI 10.1136/jnnp.51.4.540; KARNI A, 1995, NATURE, V377, P155; KEIZER K, 1989, EXP BRAIN RES, V74, P311; Koo BB, 2012, ARCH NEUROL-CHICAGO, V69, P733, DOI 10.1001/archneurol.2011.2272; la Fougere C, 2010, NEUROIMAGE, V50, P1589, DOI 10.1016/j.neuroimage.2009.12.060; Lund TE, 2005, NEUROIMAGE, V26, P960, DOI 10.1016/j.neuroimage.2005.02.021; Maillet A, 2012, J NEUROL NEUROSUR PS, V83, P986, DOI 10.1136/jnnp-2012-302461; Martinez-Gonzalez C, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00022; MASDEU JC, 1994, ANN NEUROL, V35, P619, DOI 10.1002/ana.410350517; MASDEU JC, 1988, ANN NEUROL, V23, P596, DOI 10.1002/ana.410230612; Matsumura M, 2000, NEUROSCIENCE, V98, P97, DOI 10.1016/S0306-4522(00)00099-3; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; Mori F., 2003, NEUROSCI RES, V46, pS157; MORI S, 1987, PROG NEUROBIOL, V28, P161, DOI 10.1016/0301-0082(87)90010-4; Moro E, 2010, BRAIN, V133, P215, DOI 10.1093/brain/awp261; Morton SM, 2004, NEUROSCIENTIST, V10, P247, DOI 10.1177/1073858404263517; Musienko PE, 2012, J NEUROSCI, V32, P17442, DOI 10.1523/JNEUROSCI.3757-12.2012; Muthusamy KA, 2007, J NEUROSURG, V107, P814, DOI 10.3171/JNS-07/10/0814; Ouchi Y, 1999, BRAIN, V122, P329, DOI 10.1093/brain/122.2.329; Pahapill PA, 2000, BRAIN, V123, P1767, DOI 10.1093/brain/123.9.1767; Penfield W, 1950, CEREBRAL CORTEX MAN; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Poser BA, 2006, MAGN RESON MED, V55, P1227, DOI 10.1002/mrm.20900; Preuss TM, 1996, J COMP NEUROL, V371, P649, DOI 10.1002/(SICI)1096-9861(19960805)371:4<649::AID-CNE12>3.0.CO;2-E; Roberts R, 2008, J SPORT EXERCISE PSY, V30, P200, DOI 10.1123/jsep.30.2.200; Rosano C, 2007, J GERONTOL A-BIOL, V62, P1048, DOI 10.1093/gerona/62.9.1048; Sahyoun C, 2004, NEUROIMAGE, V21, P568, DOI 10.1016/j.neuroimage.2003.09.065; Schweder PM, 2010, NEUROREPORT, V21, P914, DOI 10.1097/WNR.0b013e32833ce5f1; Sehm B, 2014, NEUROBIOL AGING, V35, P232, DOI 10.1016/j.neurobiolaging.2013.06.021; Slobounov S, 2006, MOTOR CONTROL, V10, P69, DOI 10.1123/mcj.10.1.69; Snijders AH, 2011, BRAIN, V134, P59, DOI 10.1093/brain/awq324; Takakusaki K, 2004, PROG BRAIN RES, V143, P231, DOI 10.1016/S0079-6123(03)43023-9; Takakusaki K, 2004, NEUROSCIENCE, V124, P467, DOI 10.1016/j.neuroscience.2003.12.016; Takakusaki K, 2008, J NEUROL, V255, P19, DOI 10.1007/s00415-008-4004-7; Thevathasan W, 2011, NEUROSURGERY, V69, P1248, DOI 10.1227/NEU.0b013e31822b6f71; Toni I, 2001, EXP BRAIN RES, V141, P359, DOI 10.1007/s002210100877; van Duinen H, 2005, NEUROIMAGE, V27, P240, DOI 10.1016/j.neuroimage.2005.04.003; Woollacott MH, 2000, J GERONTOL A-BIOL, V55, pM424, DOI 10.1093/gerona/55.8.M424; Zwergal A, 2011, NEUROLOGY, V77, P101, DOI 10.1212/WNL.0b013e318223c79d; Zwergal A, 2012, NEUROBIOL AGING, V33, P1073, DOI 10.1016/j.neurobiolaging.2010.09.022	70	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91183	10.1371/journal.pone.0091183	http://dx.doi.org/10.1371/journal.pone.0091183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663383	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900014
J	Lindfield, SJ; McIlwain, JL; Harvey, ES				Lindfield, Steven J.; McIlwain, Jennifer L.; Harvey, Euan S.			Depth Refuge and the Impacts of SCUBA Spearfishing on Coral Reef Fishes	PLOS ONE			English	Article							MARINE PROTECTED AREAS; STEREO-VIDEO; MANAGEMENT; PACIFIC; BIOMASS; PARROTFISHES; CONNECTIVITY; COMMUNITIES; MICRONESIA; POPULATION	In recent decades, spearfishing with SCUBA has emerged as an efficient method for targeting reef fish in deeper waters. However, deeper waters are increasingly recognised as a potential source of refuge that may help sustain fishery resources. We used a combination of historical catch data over a 20-year time period and fishery-independent surveys to investigate the effects of SCUBA spearfishing on coral reef fish populations in the southern Mariana Islands. Two jurisdictions were studied; Guam, where SCUBA spearfishing is practiced, and the nearby Commonwealth of Northern Mariana Islands (CNMI), where SCUBA spearfishing has been banned since 2003. Fishery-independent data were collected using baited remote underwater stereo-video systems (stereo-BRUVs) stratified by depth, marine protected area status and jurisdiction. Herbivores (primary consumers) dominated spearfishing catches, with parrotfish (scarines) and surgeonfish/unicornfish (acanthurids) the main groups harvested. However, the large, endangered humphead wrasse (Cheilinus undulatus) was the main species by weight landed by SCUBA spearfishers. SCUBA spearfishing was associated with declining size of scarines over time and catches shifting from a dominance of large parrotfishes to a mixed assemblage with increasing proportions of acanthurids. Comparisons between Guam and the nearby CNMI revealed differences in the assemblage of fished species and also greater size of scarines and acanthurids in deep water where SCUBA fishing is banned. These results suggest that SCUBA spearfishing impacts reef fish populations and that the restriction of this fishing method will ensure refuge for fish populations in deeper waters. We recommend a ban on SCUBA spearfishing to preserve or aid the recovery of large, functionally important coral reef species and to improve the sustainability of coral reef fisheries.	[Lindfield, Steven J.] Univ Western Australia, Fac Nat & Agr Sci, UWA Oceans Inst, Crawley, WA, Australia; [Lindfield, Steven J.] Univ Western Australia, Fac Nat & Agr Sci, Sch Plant Biol, Crawley, WA, Australia; [McIlwain, Jennifer L.; Harvey, Euan S.] Curtin Univ, Dept Environm & Agr, Bentley, WA, Australia	University of Western Australia; University of Western Australia; Curtin University	Lindfield, SJ (corresponding author), Univ Western Australia, Fac Nat & Agr Sci, UWA Oceans Inst, Crawley, WA, Australia.	steve.lindfield@yahoo.com	McIlwain, Jennifer L/J-9179-2012; Lindfield, Steven/HGE-5640-2022; Harvey, Euan/B-2896-2011	McIlwain, Jennifer L/0000-0002-7790-5081; Lindfield, Steven/0000-0002-7933-6206; Harvey, Euan/0000-0002-9069-4581	National Oceanic and Atmospheric Administration (NOAA) Coral Reef Initiative [CRI-GU-09/W090900011]	National Oceanic and Atmospheric Administration (NOAA) Coral Reef Initiative	Financial support was provided by the National Oceanic and Atmospheric Administration (NOAA) Coral Reef Initiative to the Guam Bureau of Statistics and Planning, grant number (CRI-GU-09/W090900011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The statements, findings, conclusions, and recommendations are those of the authors and do not necessarily reflect the views of the NOAA or the Guam Bureau of Statistics and Planning.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; [Anonymous], 2007, 116 U GUAM MAR LAB; Bejarano S, 2013, MAR ECOL PROG SER, V482, P197, DOI 10.3354/meps10270; Bellwood DR, 2012, P ROY SOC B-BIOL SCI, V279, P1621, DOI 10.1098/rspb.2011.1906; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Birkeland C, 2005, TRENDS ECOL EVOL, V20, P356, DOI 10.1016/j.tree.2005.03.015; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bridge TCL, 2013, NAT CLIM CHANGE, V3, P528, DOI 10.1038/nclimate1879; Burdick David, 2008, NOAA Technical Memorandum NOS NCCOS, V73, P465; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Cappo M, 2003, AQUATIC PROTECTED AR, P455; Chavarro SB, 2014, ANIM CONSERV, V17, P133, DOI 10.1111/acv.12066; Cheung WWL, 2007, MAR ECOL PROG SER, V333, P1, DOI 10.3354/meps333001; Christie P, 2007, MAR POLICY, V31, P239, DOI 10.1016/j.marpol.2006.08.001; Cinner JE, 2009, J APPL ECOL, V46, P724, DOI 10.1111/j.1365-2664.2009.01648.x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clua E, 2008, AQUAT LIVING RESOUR, V21, P339, DOI 10.1051/alr:2008036; Dalzell P, 1996, OCEANOGR MAR BIOL, V34, P395; Davis GW, 1998, 2 PAC COMM FISH MAN, V29; Dulvy NK, 2004, ANIM CONSERV, V7, P365, DOI 10.1017/S1367943004001519; Dulvy NK, 2004, CAN J FISH AQUAT SCI, V61, P466, DOI 10.1139/F03-169; Fitzpatrick BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039634; Flores T, 2006, OFFSHORE FISHERIES P; Frisch AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051938; Gillett R., 2006, SPEARFISHING PACIFIC; Gillett R., 2010, MONITORING MANAGEMEN; Godoy N, 2010, ECOL APPL, V20, P1504, DOI 10.1890/09-1806.1; Goetze JS, 2011, CORAL REEFS, V30, P507, DOI 10.1007/s00338-011-0732-8; Gorley C.K., 2006, GETTING STARTED PRIM; Green A., 2003, MONITORING CORAL REE, P38; Hamilton RJ, 2012, BIOL CONSERV, V145, P246, DOI 10.1016/j.biocon.2011.11.020; Hamilton RJ, 2012, FISH FISHERIES SERIE, P490; Harvey E, 2002, FISH RES, V57, P255, DOI 10.1016/S0165-7836(01)00356-3; Harvey ES, 1998, MAR TECHNOL SOC J, V32, P3; Harvey ES, 2007, MAR ECOL PROG SER, V350, P245, DOI 10.3354/meps07192; Harvey ES, 2010, MAR TECHNOL SOC J, V44, P75, DOI 10.4031/MTSJ.44.1.3; Hensley R.A., 1993, MAR FISH REV, V55, P129; Hoey AS, 2009, ECOSYSTEMS, V12, P1316, DOI 10.1007/s10021-009-9291-z; Horne JB, 2013, J HERED, V104, P532, DOI 10.1093/jhered/est021; Houk P, 2012, CORAL REEFS, V31, P13, DOI 10.1007/s00338-011-0826-3; IUCN, 2013, IUCN RED LIST CAT CR; Karpov KA, 1998, J SHELLFISH RES, V17, P863; Langlois TJ, 2010, AQUAT BIOL, V9, P155, DOI 10.3354/ab00235; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lloret J, 2008, FISH RES, V94, P84, DOI 10.1016/j.fishres.2008.07.002; Lokrantz J, 2008, CORAL REEFS, V27, P967, DOI 10.1007/s00338-008-0394-3; McClanahan TR, 2008, AQUAT CONSERV, V18, P493, DOI 10.1002/aqc.874; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McClanahan TR, 2005, FISHERIES MANAG ECOL, V12, P105, DOI 10.1111/j.1365-2400.2004.00431.x; Morato T, 2006, FISH FISH, V7, P24, DOI 10.1111/j.1467-2979.2006.00205.x; Mumby P. J., 2013, CONSERV LETT, P1; Mumby PJ, 2012, MAR ECOL PROG SER, V445, P13, DOI 10.3354/meps09450; Myers RF., 1993, MAR FISH REV, V55, P117; Nevill J, 2006, IMPACTS SPEARFISHING; Ong L, 2010, MAR BIOL, V157, P1313, DOI 10.1007/s00227-010-1411-y; Pacific Islands Benthic Habitat Mapping Center, 2022, COMMONWEALTH NO MARI; Page M, 1998, BIOL COMMUNITY STRUC; Priest MA, 2012, ECOL EVOL, V2, P3195, DOI 10.1002/ece3.260; Rhodes KL, 2008, CORAL REEFS, V27, P443, DOI 10.1007/s00338-007-0331-x; Rhodes KL, 2007, CORAL REEFS, V26, P335, DOI 10.1007/s00338-007-0202-5; Richards BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031374; Richmond Robert H., 2008, V1, P719, DOI 10.1007/978-1-4020-6847-8_19; Russ GR, 2010, OECOLOGIA, V163, P1103, DOI 10.1007/s00442-010-1692-3; Sabater MG, 2009, REV FISH SCI, V17, P318, DOI 10.1080/10641260802702872; Sadovy Y, 2003, REV FISH BIOL FISHER, V13, P327, DOI 10.1023/B:RFBF.0000033122.90679.97; Sandin SA, 2010, TROPHIC CLASSIFICATI; SAVIDGE JA, 1984, BIOL CONSERV, V30, P305, DOI 10.1016/0006-3207(84)90049-1; Seager J, 2013, MEASUREMENT SCI SPEC; Shin YJ, 2005, ICES J MAR SCI, V62, P384, DOI 10.1016/j.icesjms.2005.01.004; Slattery M, 2011, J EXP MAR BIOL ECOL, V408, P32, DOI 10.1016/j.jembe.2011.07.024; Taylor BM, 2014, J FISH BIOL, V84, P383, DOI 10.1111/jfb.12294; Taylor BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039599; Taylor BM, 2010, MAR ECOL PROG SER, V411, P243, DOI 10.3354/meps08672; Tyler EHM, 2009, BIOL CONSERV, V142, P652, DOI 10.1016/j.biocon.2008.11.017; van Oppen MJH, 2011, MOL ECOL, V20, P1647, DOI 10.1111/j.1365-294X.2011.05050.x; Williams I.D., 2012, STATUS CORAL REEF FI; Zeller D, 2007, FISH B-NOAA, V105, P266; Zgliczynski BJ, 2013, CORAL REEFS, V32, P637, DOI 10.1007/s00338-013-1018-0	80	78	79	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92628	10.1371/journal.pone.0092628	http://dx.doi.org/10.1371/journal.pone.0092628			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663400	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900088
J	Lindsay, RP; Shin, SS; Garfein, RS; Rusch, MLA; Novotny, TE				Lindsay, Ryan P.; Shin, Sanghyuk S.; Garfein, Richard S.; Rusch, Melanie L. A.; Novotny, Thomas E.			The Association between Active and Passive Smoking and Latent Tuberculosis Infection in Adults and Children in the United States: Results from NHANES	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; SERUM COTININE LEVELS; MYCOBACTERIUM-TUBERCULOSIS; CIGARETTE-SMOKING; TOBACCO-SMOKE; NATIONAL-HEALTH; RISK-FACTORS; EXPOSURE; PREVALENCE; POPULATION	Background: Few studies assessing the relationship between active and passive smoking and tuberculosis have used biomarkers to measure smoke exposure. We sought to determine the association between active and passive smoking and LTBI in a representative sample of US adults and children. Methods: We used the 1999-2000 US National Health and Nutrition Examination Survey (NHANES) dataset with tuberculin skin test (TST) data to assess the association between cotinine-confirmed smoke exposure and latent tuberculosis infection (LTBI) among adults ages >= 20 years (n = 3598) and children 3-19 years (n = 2943) and estimate the prevalence of smoke exposure among those with LTBI. Weighted multivariate logistic regression was used to measure the associations between active and passive smoking and LTBI. Results: LTBI prevalence in 1999-2000 among cotinine-confirmed active, passive, and non-smoking adults and children was 6.0%, 5.2%, 3.3% and 0.3%, 1.0%, 1.5%, respectively. This corresponds to approximately 3,556,000 active and 3,379,000 passive smoking adults with LTBI in the US civilian non-institutionalized population in 1999-2000. Controlling for age, gender, socioeconomic status, race, birthplace (US vs. foreign-born), household size, and having ever lived with someone with TB, adult active smokers were significantly more likely to have LTBI than non-smoking adults (AOR = 2.31 95% CI 1.17-4.55). Adult passive smokers also had a greater odds of LTBI compared with non-smokers, but this association did not achieve statistical significance (AOR = 2.00 95% CI 0.87-4.60). Neither active or passive smoking was associated with LTBI among children. Among only the foreign-born adults, both active (AOR = 2.56 (95% CI 1.20-5.45) and passive smoking (AOR = 2.27 95% CI 1.09-4.72) were significantly associated with LTBI. Conclusions: Active adult smokers and both foreign-born active and passive smokers in the United States are at elevated risk for LTBI. Targeted smoking prevention and cessation programs should be included in comprehensive national and international TB control efforts.	[Lindsay, Ryan P.] Univ Calif San Francisco, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA; [Shin, Sanghyuk S.] Univ Calif Los Angeles, David Geffen Sch Med, Program Global Hlth, Los Angeles, CA 90095 USA; [Garfein, Richard S.] Univ Calif San Diego, Dept Med, Div Global Publ Hlth, San Diego, CA 92103 USA; [Rusch, Melanie L. A.] Vancouver Isl Hlth Author, Victoria, BC, Canada; [Rusch, Melanie L. A.] Univ Victoria, Sch Publ Hlth & Social Policy, Victoria, BC, Canada; [Novotny, Thomas E.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA	University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Diego; Vancouver Island Health Authority; University of Victoria; California State University System; San Diego State University	Lindsay, RP (corresponding author), Univ Calif San Francisco, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA.	ryan.lindsay.phd@gmail.com		Lindsay, Ryan/0000-0002-4336-9305	National Institute on Drug Abuse [NIDA T32DA023356]; National Cancer Institute [NCI R25CA113710]; NIDA [1R36DA033152]; NATIONAL CANCER INSTITUTE [R25CA113710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH080634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA023356, R36DA033152] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Ryan Lindsay was supported in part by a trainee grants from the National Institute on Drug Abuse (NIDA T32DA023356) and the National Cancer Institute (NCI R25CA113710). Sanghyuk Shin received support from NIDA Dissertation Grant 1R36DA033152. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altet MN, 1996, TUBERCLE LUNG DIS, V77, P537, DOI 10.1016/S0962-8479(96)90052-0; Anderson RH, 1997, AM J PREV MED, V13, P175, DOI 10.1016/S0749-3797(18)30190-9; [Anonymous], 2010, Can Commun Dis Rep, V36, P1, DOI [10.14745/ccdr.v36i00as2, 10.14745/ccdr.v36i00a05, 10.14745/ccdr.v36i00as3]; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Bennett DE, 2008, AM J RESP CRIT CARE, V177, P348, DOI 10.1164/rccm.200701-057OC; Benowitz NL, 2009, AM J EPIDEMIOL, V169, P236, DOI 10.1093/aje/kwn301; Benowitz NL, 1996, EPIDEMIOL REV, V18, P188, DOI 10.1093/oxfordjournals.epirev.a017925; Bissell K, 2010, SMOKING CESSATION SM; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; Brunet L, 2011, EUR RESPIR J, V38, P139, DOI 10.1183/09031936.00137710; Caraballo RS, 2004, NICOTINE TOB RES, V6, P19, DOI 10.1080/14622200310001656821; Caraballo RS, 2001, AM J EPIDEMIOL, V153, P807, DOI 10.1093/aje/153.8.807; Centers for Disease Control and Prevention, 1999, NHANES 1999 2000 PUB; Chan ED, 2010, AM J RESP CRIT CARE, V182, P990, DOI 10.1164/rccm.201006-0861ED; Chang KC, 2004, INT J TUBERC LUNG D, V8, P1492; Cook DG, 1999, THORAX, V54, P357, DOI 10.1136/thx.54.4.357; CUMMINGS SR, 1988, AM J PUBLIC HEALTH, V78, P574, DOI 10.2105/AJPH.78.5.574; den Boon S, 2005, THORAX, V60, P555, DOI 10.1136/thx.2004.030924; den Boon S, 2007, PEDIATRICS, V119, P734, DOI 10.1542/peds.2006-1796; Domagala-Kulawik J, 2008, J PHYSIOL PHARMACOL, V59, P19; du Preez K, 2011, INT J TUBERC LUNG D, V15, P1490, DOI 10.5588/ijtld.10.0759; DYE JA, 1994, THORAX, V49, P825, DOI 10.1136/thx.49.8.825; Godoy P, 2013, INT J TUBERC LUNG D, V17, P771, DOI 10.5588/ijtld.12.0696; Hamari A, 2010, ANN MED, V42, P512, DOI 10.3109/07853890.2010.505933; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Horne DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049050; Kaufmann R. B., 2010, Morbidity and Mortality Weekly Report, V59, P1141; KUEMMERE.JM, 1967, AM REV RESPIR DIS, V96, P885; Lavigne M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-66; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lin HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077333; LOUDON RG, 1976, AM REV RESPIR DIS, V114, P1033; Max W, 2009, INT J ENV RES PUB HE, V6, P1633, DOI 10.3390/ijerph6051633; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; McCurdy SA, 1997, AM J IND MED, V32, P600, DOI 10.1002/(SICI)1097-0274(199712)32:6&lt;600::AID-AJIM5&gt;3.0.CO;2-T; NISAR M, 1993, THORAX, V48, P1257, DOI 10.1136/thx.48.12.1257; Plant AJ, 2002, EPIDEMIOL INFECT, V128, P37, DOI 10.1017/S0950268801006434; Schober S. E., 2008, Morbidity and Mortality Weekly Report, V57, P744; Shang SB, 2011, J INFECT DIS, V203, P1240, DOI 10.1093/infdis/jir009; Shin SS, 2013, INT J TUBERC LUNG D, V17, P1452, DOI 10.5588/ijtld.13.0311; Singh M, 2005, ARCH DIS CHILD, V90, P624, DOI 10.1136/adc.2003.044255; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; Solsona J, 2001, EUR J EPIDEMIOL, V17, P123, DOI 10.1023/A:1017580329538; Tipayamongkholgul Mathuros, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P145; Underner M, 2012, PRESSE MED, V41, P1171, DOI 10.1016/j.lpm.2012.02.037; World Health Organization, 2013, GLOB TUB CONTR 2013	46	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93137	10.1371/journal.pone.0093137	http://dx.doi.org/10.1371/journal.pone.0093137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664240	Green Published, gold			2022-12-27	WOS:000333459900156
J	Wegner, M; Koedijker, JM; Budde, H				Wegner, Mirko; Koedijker, Johan M.; Budde, Henning			The Effect of Acute Exercise and Psychosocial Stress on Fine Motor Skills and Testosterone Concentration in the Saliva of High School Students	PLOS ONE			English	Article							HAND SKILL; PERFORMANCE; FATIGUE; ACCURACY; CHOKING; KNOWLEDGE; RESPONSES; DECISION; STEROIDS; MODERATE	Little is known about the influence of different stressors on fine motor skills, the concentration of testosterone (T), and their interaction in adolescents. Therefore, 62 high school students aged 14-15 years were randomly assigned to two experimental groups (exercise, psychosocial stress) and a control group. Exercise stress was induced at 65-75% of the maximum heart rate by running for 15 minutes (n = 24). Psychosocial stress was generated by an intelligence test (HAWIK-IV), which was uncontrollable and characterized by social-evaluative-threat to the students (n = 21). The control group followed was part of a regular school lesson with the same duration (n = 28). Saliva was collected after a normal school lesson (pre-test) as well as after the intervention/control period (post-test) and was analyzed for testosterone. Fine motor skills were assessed pre- and post-intervention using a manual dexterity test (Flower Trail) from the Movement Assessment Battery for Children-2. A repeated measure ANCOVA including gender as a covariate revealed a significant group by test interaction, indicating an increase in manual dexterity only for the psychosocial stress group. Correlation analysis of all students shows that the change of testosterone from pre- to post-test was directly linked (r = -.31, p = .01) to the changes in manual dexterity performance. Participants showing high increases in testosterone from pre- to post-test made fewer mistakes in the fine motor skills task. Findings suggest that manual dexterity increases when psychosocial stress is induced and that improvement of manual dexterity performance corresponds with the increase of testosterone.	[Wegner, Mirko; Koedijker, Johan M.] Univ Bern, Inst Sport Sci, Bern, Switzerland; [Budde, Henning] Med Sch Hamburg, Fac Human Sci, Hamburg, Germany; [Budde, Henning] Reykjavik Univ, Sch Sci & Engn, Dept Sport Sci, Reykjavik, Iceland	University of Bern; University of Hamburg; University Medical Center Hamburg-Eppendorf; Reykjavik University	Wegner, M (corresponding author), Univ Bern, Inst Sport Sci, Bern, Switzerland.	mirko.wegner@ispw.unibe.ch; henning.budde@medicalschool-hamburg.de	Wegner, Mirko/AAT-1758-2020; Budde, Henning/AFB-9845-2022	Wegner, Mirko/0000-0002-0195-6819; Budde, Henning/0000-0003-3526-0569; Koedijker, Johan/0000-0001-5593-4992	Reykjavik University; German Research Foundation (DFG, Deutsche Forschungsgemeinschaft) [BU 1837/5-1]	Reykjavik University; German Research Foundation (DFG, Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	Henning Budde was supported by funding from the Reykjavik University and is further supported by the German Research Foundation (DFG, Deutsche Forschungsgemeinschaft); BU 1837/5-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2010, SURGERY, V147, P318, DOI 10.1016/j.surg.2009.10.007; BAUMEISTER RF, 1984, J PERS SOC PSYCHOL, V46, P610, DOI 10.1037/0022-3514.46.3.610; Beilock SL, 2001, J EXP PSYCHOL GEN, V130, P701, DOI 10.1037/0096-3445.130.4.701; Bonifazi M, 2004, BRAIN RES, V1011, P187, DOI 10.1016/j.brainres.2004.03.022; BOOTH A, 1989, HORM BEHAV, V23, P556, DOI 10.1016/0018-506X(89)90042-1; Budde H, 2010, NEUROSCI LETT, V483, P16, DOI 10.1016/j.neulet.2010.07.036; Budde H, 2010, NEUROSCI LETT, V474, P131, DOI 10.1016/j.neulet.2010.03.015; Budde H, 2010, PSYCHONEUROENDOCRINO, V35, P382, DOI 10.1016/j.psyneuen.2009.07.015; Cui R, 2012, EXP GERONTOL, V47, P67, DOI 10.1016/j.exger.2011.10.009; Davey PR, 2002, J SPORT SCI, V20, P311, DOI 10.1080/026404102753576080; DEVOOGD TJ, 1985, BRAIN RES, V329, P304, DOI 10.1016/0006-8993(85)90539-6; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; EASTERBROOK JA, 1959, PSYCHOL REV, V66, P183, DOI 10.1037/h0047707; Emborg ME, 1998, J COMP NEUROL, V401, P253; Fink B, 2004, BIOL PSYCHOL, V67, P375, DOI 10.1016/j.biopsycho.2004.03.012; Granger DA, 1999, HORM BEHAV, V35, P18, DOI 10.1006/hbeh.1998.1492; Hardy L, 1996, BRIT J PSYCHOL, V87, P621, DOI 10.1111/j.2044-8295.1996.tb02612.x; Henderson S., 1992, MOVEMENT ASSESSMENT; Herbst KL, 2004, CURR OPIN CLIN NUTR, V7, P271, DOI 10.1097/00075197-200405000-00006; ISEN AM, 1987, J PERS SOC PSYCHOL, V52, P1122, DOI 10.1037/0022-3514.52.6.1122; Johansen-Berg H, 2012, NEURON, V73, P1058, DOI 10.1016/j.neuron.2012.03.001; Josephs RA, 2006, J PERS SOC PSYCHOL, V90, P999, DOI 10.1037/0022-3514.90.6.999; Kivlighan KT, 2005, PSYCHONEUROENDOCRINO, V30, P58, DOI 10.1016/j.psyneuen.2004.05.009; Kudielka B. M., 2007, SOC NEUROSCI-UK, P56, DOI DOI 10.1007/978-1-4614-6852-3; Kuhl J., 2000, HDB SELF REGULATION, P111, DOI [DOI 10.1016/B978-012109890-2/50034-2, 10.1016/B978-012109890-2/50034-2]; Landers D.M., 2006, APPL SPORT PSYCHOL P, P260; LEGER L, 1989, CAN J SPORT SCI, V14, P21; Lennartsson AK, 2012, INT J PSYCHOPHYSIOL, V84, P246, DOI 10.1016/j.ijpsycho.2012.03.001; Lewis BP, 1997, PERS SOC PSYCHOL B, V23, P937, DOI 10.1177/0146167297239003; Lyons M, 2006, J STRENGTH COND RES, V20, P197, DOI 10.1519/00124278-200602000-00032; Lyons M, 2006, J SPORT SCI MED, V5, P215; MARTENS R, 1970, J PERS SOC PSYCHOL, V16, P29, DOI 10.1037/h0029787; MASTERS RSW, 1992, BRIT J PSYCHOL, V83, P343, DOI 10.1111/j.2044-8295.1992.tb02446.x; MAZUR A, 1992, SOC PSYCHOL QUART, V55, P70, DOI 10.2307/2786687; McCormack AL, 2004, J COMP NEUROL, V471, P387, DOI 10.1002/cne.20036; McGregor SJ, 1999, J SPORT SCI, V17, P895, DOI 10.1080/026404199365452; MCMORRIS T, 1994, PERCEPT MOTOR SKILL, V78, P123, DOI 10.2466/pms.1994.78.1.123; McMorris T, 2012, BRAIN COGNITION, V80, P338, DOI 10.1016/j.bandc.2012.09.001; Mehta PH, 2006, HORM BEHAV, V50, P684, DOI 10.1016/j.yhbeh.2006.07.001; Moorthy K, 2003, BMJ-BRIT MED J, V327, P1032, DOI 10.1136/bmj.327.7422.1032; Niemann C, MENTAL HLTH IN PRESS; Patchev VK, 2004, EXP GERONTOL, V39, P1651, DOI 10.1016/j.exger.2004.07.011; Petermann F., 2010, MOVEMENT ASSESSMENT; Petermann F, 2008, KINDH ENTWICKL, V17, P71, DOI 10.1026/0942-5403.17.2.71; Royal KA, 2006, J SPORT SCI, V24, P807, DOI 10.1080/02640410500188928; Soyupek F, 2008, UROL ONCOL-SEMIN ORI, V26, P141, DOI 10.1016/j.urolonc.2006.12.014; Storbeck J, 2005, PSYCHOL SCI, V16, P785, DOI 10.1111/j.1467-9280.2005.01615.x; Sullivan EA, 2005, PERCEPT MOTOR SKILL, V100, P681, DOI 10.2466/PMS.100.3.681-688; TAN U, 1990, INT J NEUROSCI, V53, P179, DOI 10.3109/00207459008986600; Vanttinen T, 2010, J SPORT SCI MED, V9, P547; VERMES I, 1979, NEUROENDOCRINOLOGY, V28, P386, DOI 10.1159/000122887; WALDRON EM, 1995, PERCEPT MOTOR SKILL, V80, P883, DOI 10.2466/pms.1995.80.3.883; Wegner M., CNS NEUROLO IN PRESS; Windisch C, 2012, ROUT RES SPORT EXERC, P61; Wood P, 2009, ANN CLIN BIOCHEM, V46, P183, DOI 10.1258/acb.2008.008208	55	22	22	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92953	10.1371/journal.pone.0092953	http://dx.doi.org/10.1371/journal.pone.0092953			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD7QO	24664108	Green Published, gold			2022-12-27	WOS:000333459900134
J	Zhai, WH; Huang, ZG; Chen, L; Feng, C; Li, B; Li, TS				Zhai, Wenhui; Huang, Zhigang; Chen, Li; Feng, Cong; Li, Bei; Li, Tanshi			Thyroid Endocrine Disruption in Zebrafish Larvae after Exposure to Mono-(2-Ethylhexyl) Phthalate (MEHP)	PLOS ONE			English	Article							POLYBROMINATED DIPHENYL ETHERS; DI-(2-ETHYLHEXYL) PHTHALATE; DI(2-ETHYLHEXYL) PHTHALATE; URINARY PHTHALATE; OXIDATIVE STRESS; ACID MONOESTERS; HORMONE LEVELS; BISPHENOL-A; GC-MS; MODEL	Phthalates are extensively used as plasticizers in a variety of daily-life products, resulting in widespread distribution in aquatic environments. However, limited information is available on the endocrine disrupting effects of phthalates in aquatic organisms. The aim of the present study was to examine whether exposure to mono-(2-ethylhexyl) phthalate (MEHP), the hydrolytic metabolite of di-(2-ethylhexyl) phthalate (DEHP) disrupts thyroid endocrine system in fish. In this study, zebrafish (Danio rerio) embryos were exposed to different concentrations of MEHP (1.6, 8, 40, and 200 mu g/L) from 2 h post-fertilization (hpf) to 168 hpf. The whole-body content of thyroid hormone and transcription of genes involved in the hypothalamic-pituitary-thyroid (HPT) axis were examined. Treatment with MEHP significantly decreased whole-body T4 contents and increased whole-body T3 contents, indicating thyroid endocrine disruption. The upregulation of genes related to thyroid hormone metabolism (Dio2 and UGT1ab) might be responsible for decreased T4 contents. Elevated gene transcription of Dio1 was also observed in this study, which might assist to degrade increased T3 contents. Exposure to MEHP also significantly induced transcription of genes involved in thyroid development (Nkx2.1 and Pax8) and thyroid hormone synthesis (TSH beta, NIS and TG). However, the genes encoding proteins involved in TH transport (transthyretin, TTR) was transcriptionally significantly down-regulated after exposure to MEHP. Overall, these results demonstrate that acute exposure to MEHP alters whole-body contents of thyroid hormones in zebrafish embryos/larvae and changes the transcription of genes involved in the HPT axis, thus exerting thyroid endocrine toxicity.	[Zhai, Wenhui; Chen, Li; Feng, Cong; Li, Bei; Li, Tanshi] Chinese Peoples Liberat Army Gen Hosp, Dept Emergency, Beijing, Peoples R China; [Zhai, Wenhui; Huang, Zhigang] PLA, Hosp 350, Dept Emergency, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Li, TS (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Emergency, Beijing, Peoples R China.	stujs58@163.com						ARBIN A, 1980, J CHROMATOGR, V193, P405, DOI 10.1016/S0021-9673(00)87740-7; Babu B, 2010, SCI TOTAL ENVIRON, V408, P4969, DOI 10.1016/j.scitotenv.2010.07.032; Boas M, 2012, MOL CELL ENDOCRINOL, V355, P240, DOI 10.1016/j.mce.2011.09.005; Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331; Briggs JP, 2002, AM J PHYSIOL-REG I, V282, pR3, DOI 10.1152/ajpregu.00589.2001; Carr JA, 2011, GEN COMP ENDOCR, V170, P299, DOI 10.1016/j.ygcen.2010.06.001; Chan WK, 2012, AQUAT TOXICOL, V108, P106, DOI 10.1016/j.aquatox.2011.10.013; Chen Q, 2012, AQUAT TOXICOL, V110, P141, DOI 10.1016/j.aquatox.2012.01.008; Cheng Z, 2013, ENVIRON INT, V57-58, P75, DOI 10.1016/j.envint.2013.04.005; Erkekoglu P, 2012, J ENVIRON PATHOL TOX, V31, P143, DOI 10.1615/JEnvironPatholToxicolOncol.v31.i2.60; Fernie KJ, 2005, TOXICOL SCI, V88, P375, DOI 10.1093/toxsci/kfi295; Fromme H, 2002, WATER RES, V36, P1429, DOI 10.1016/S0043-1354(01)00367-0; Fromme H, 2011, ENVIRON INT, V37, P715, DOI 10.1016/j.envint.2011.02.008; Gayathri NS, 2004, INDIAN J MED RES, V119, P139; Hallgren S, 2002, TOXICOLOGY, V177, P227, DOI 10.1016/S0300-483X(02)00222-6; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; Hines EP, 2009, ENVIRON HEALTH PERSP, V117, P86, DOI 10.1289/ehp.11610; HINTON RH, 1986, ENVIRON HEALTH PERSP, V70, P195, DOI 10.2307/3430356; Hood A, 2000, TOXICOL SCI, V55, P78, DOI 10.1093/toxsci/55.1.78; Howarth JA, 2001, TOXICOL LETT, V121, P35, DOI 10.1016/S0378-4274(01)00313-7; Ji C, 2012, TOXICOL APPL PHARM, V262, P149, DOI 10.1016/j.taap.2012.04.029; Kambe F, 1996, MOL ENDOCRINOL, V10, P801, DOI 10.1210/me.10.7.801; Kim S, 2014, SCI TOTAL ENVIRON, V472, P49, DOI 10.1016/j.scitotenv.2013.10.118; Kloas W, 2006, J CHROMATOGR A, V1130, P16, DOI 10.1016/j.chroma.2006.04.001; Latini G, 2006, TOXICOLOGY, V226, P90, DOI 10.1016/j.tox.2006.07.011; Lema SC, 2009, J ENDOCRINOL, V202, P43, DOI 10.1677/JOE-08-0472; Liu LP, 2012, ENVIRON INT, V42, P78, DOI 10.1016/j.envint.2011.04.005; Lowell Center for Sustainable Production, 2011, U L PHTHLAT THEIR AL; Magdouli S, 2013, J ENVIRON MANAGE, V127, P36, DOI 10.1016/j.jenvman.2013.04.013; Martinez-Arguelles DB, 2013, J STEROID BIOCHEM, V137, P5, DOI 10.1016/j.jsbmb.2013.01.007; Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1396, DOI 10.1289/ehp.1103582; Orozco A, 2005, THYROID, V15, P799, DOI 10.1089/thy.2005.15.799; Parng C, 2002, ASSAY DRUG DEV TECHN, V1, P41, DOI 10.1089/154065802761001293; Perkins EJ, 2013, ENVIRON HEALTH PERSP, V121, P1002, DOI 10.1289/ehp.1306638; Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6; Power DM, 2000, GEN COMP ENDOCR, V119, P241, DOI 10.1006/gcen.2000.7520; PRICE SC, 1988, TOXICOL LETT, V40, P37, DOI 10.1016/0378-4274(88)90181-6; Rudel RA, 2009, ATMOS ENVIRON, V43, P170, DOI 10.1016/j.atmosenv.2008.09.025; Scholz S, 2013, ARCH TOXICOL, V87, P767, DOI 10.1007/s00204-013-1044-2; Shea KM, 2003, PEDIATRICS, V111, P1467, DOI 10.1542/peds.111.6.1467; SHINTANI H, 1985, J CHROMATOGR, V337, P279, DOI 10.1016/0378-4347(85)80041-4; Suzuki T, 2001, ENVIRON SCI TECHNOL, V35, P3757, DOI 10.1021/es001860i; Szabo DT, 2009, TOXICOL SCI, V107, P27, DOI 10.1093/toxsci/kfn230; Tellez-Rojo MM, 2013, SCI TOTAL ENVIRON, V461, P386, DOI 10.1016/j.scitotenv.2013.05.021; Thienpont B, 2011, ENVIRON SCI TECHNOL, V45, P7525, DOI 10.1021/es202248h; Van der Geyten S, 2005, J ENDOCRINOL, V184, P467, DOI 10.1677/joe.1.05986; Wang AL, 2012, SOIL SEDIMENT CONTAM, V21, P996, DOI 10.1080/15320383.2012.712072; Wang QW, 2013, AQUAT TOXICOL, V126, P207, DOI 10.1016/j.aquatox.2012.11.009; Wenzel A, 2005, MOL CELL ENDOCRINOL, V244, P63, DOI 10.1016/j.mce.2005.02.008; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Yu L, 2013, AQUAT TOXICOL, V138, P35, DOI [10.1016/j.aquatox.2013.04.001, 10.1016/j.aquatox.2013.04.010]; Yu LQ, 2010, AQUAT TOXICOL, V97, P226, DOI 10.1016/j.aquatox.2009.10.022; Zhou T, 2001, TOXICOL SCI, V61, P76, DOI 10.1093/toxsci/61.1.76; Zoeller RT, 2007, CRIT REV TOXICOL, V37, P11, DOI 10.1080/10408440601123446	55	79	88	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92465	10.1371/journal.pone.0092465	http://dx.doi.org/10.1371/journal.pone.0092465			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658602	gold, Green Submitted, Green Published			2022-12-27	WOS:000333355300085
J	Zhao, MM; Ren, YW; Shen, L; Zhang, Y; Zhou, BS				Zhao, Mengmeng; Ren, Yangwu; Shen, Li; Zhang, Yue; Zhou, Baosen			Association between MTHFR C677T and A1298C Polymorphisms and NSCL/P Risk in Asians: A Meta-Analysis	PLOS ONE			English	Article							NONSYNDROMIC CLEFT-LIP; METHYLENETETRAHYDROFOLATE REDUCTASE; OROFACIAL CLEFTS; GENE POLYMORPHISMS; COMMON MUTATION; FOLATE INTAKE; ORAL CLEFTS; FOLIC-ACID; PALATE; SUSCEPTIBILITY	Objective: Several studies have reported the association between methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and nonsyndromic cleft lip with or without palate (NSCL/P) in Asian populations. However, findings have been conflicting. In order to investigate the association, a meta-analysis was performed. Methods: We searched Pubmed, MedLine and EmBase database to selected eligible studies. The pooled odds ratios (ORs) with 95% confidence intervals (95% CIs) were calculated using fixed effects model or random effects model to assess the association between MTHFR polymorphisms and NSCL/P in both Asian children and mothers. Results: Finally, nine case-control studies were included. Overall, the MTHFR C677T polymorphism and NSCL/P showed pooled ORs (95% CI) of 1.41(1.23-1.61) in Asian children, and 1.70(1.19-2.42) in Asian mothers. Subgroup analyses by geographical locations further identified the association in Eastern Asian children, Western/Central Asian children and mothers, but not in Eastern Asian mothers. However, no significant relationship between MTHFR A1298C polymorphism and NSCL/P was found in this meta-analysis. Conclusions: The MTHFR 677T allele was associated with an increased risk of NSCL/P in Asian populations.	[Zhao, Mengmeng; Ren, Yangwu; Shen, Li; Zhang, Yue; Zhou, Baosen] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang, Liaoning Provin, Peoples R China; [Zhao, Mengmeng; Ren, Yangwu; Shen, Li; Zhang, Yue; Zhou, Baosen] Univ Liaoning Prov, Key Lab Canc Etiol & Intervent, Shenyang, Peoples R China	China Medical University	Zhou, BS (corresponding author), China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang, Liaoning Provin, Peoples R China.	bszhou@mail.cmu.edu.cn			National Natural Science Foundation of China [81272293, 81102194]; Liaoning Provincial Department of Education [LS2010168]; China Medical Board [00726]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning Provincial Department of Education; China Medical Board	This study was supported by grant no. 81272293 and no. 81102194 from National Natural Science Foundation of China, grant no. LS2010168 from Liaoning Provincial Department of Education, and grant no. 00726 from China Medical Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2009, GENET TEST MOL BIOMA, V13, P355, DOI 10.1089/gtmb.2008.0115; Bailey LB, 1999, J NUTR, V129, P919, DOI 10.1093/jn/129.5.919; Boyles AL, 2008, AM J MED GENET A, V146A, P440, DOI 10.1002/ajmg.a.32162; Brandalize APC, 2007, BRAZ J MED BIOL RES, V40, P787, DOI 10.1590/S0100-879X2006005000112; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gaspar DA, 2004, EUR J HUM GENET, V12, P521, DOI 10.1038/sj.ejhg.5201187; Guo Jin-zhen, 2009, Beijing Da Xue Xue Bao Yi Xue Ban, V41, P432; Han Y, 2011, DNA CELL BIOL, V30, P1063, DOI 10.1089/dna.2010.1185; Hernandez-Diaz S, 2000, NEW ENGL J MED, V343, P1608, DOI 10.1056/NEJM200011303432204; Johnson CY, 2008, INT J EPIDEMIOL, V37, P1041, DOI 10.1093/ije/dyn098; Kumari P, 2013, J BIOSCIENCES, V38, P21, DOI 10.1007/s12038-013-9298-7; Luo YL, 2012, BIRTH DEFECTS RES A, V94, P237, DOI 10.1002/bdra.23005; Mills JL, 2008, BIRTH DEFECTS RES A, V82, P636, DOI 10.1002/bdra.20491; Mossey PA, 2012, FRONT ORAL BIOL, V16, P1, DOI 10.1159/000337464; Pan YC, 2012, AM J MED GENET A, V158A, P2162, DOI 10.1002/ajmg.a.35503; Schutte BC, 1999, HUM MOL GENET, V8, P1853, DOI 10.1093/hmg/8.10.1853; Semic-Jusufagic A, 2012, TURKISH J PEDIATR, V54, P617; Shotelersuk V, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.5.e64; TOLAROVA M, 1982, LANCET, V2, P217; Tolarova M, 1998, AM J HUM GENET, V63, pA27; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; van Rooij IALM, 2003, AM J EPIDEMIOL, V157, P583, DOI 10.1093/aje/kwg005; Verldeij-Hagoort A, 2007, AM J MED GENET A, V143A, P952, DOI 10.1002/ajmg.a.31684; Wan Wei-dong, 2006, Zhonghua Zheng Xing Wai Ke Za Zhi, V22, P8; Wang Su-mei, 2012, Zhonghua Yixue Yichuanxue Zazhi, V29, P464, DOI 10.3760/cma.j.issn.1003-9406.2012.04.019; World Health O, 2003, GLOB REG DAT CRAN AN	26	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e88242	10.1371/journal.pone.0088242	http://dx.doi.org/10.1371/journal.pone.0088242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658649	gold, Green Published, Green Submitted			2022-12-27	WOS:000333355300003
J	Goetzenich, A; Kraemer, S; Rossaint, R; Bleilevens, C; Dollo, F; Siry, L; Rajabi-Alampour, S; Beckers, C; Soppert, J; Lue, HQ; Rex, S; Bernhagen, J; Stoppe, C				Goetzenich, Andreas; Kraemer, Sandra; Rossaint, Rolf; Bleilevens, Christian; Dollo, Florian; Siry, Laura; Rajabi-Alampour, Setareh; Beckers, Christian; Soppert, Josefin; Lue, Hongqi; Rex, Steffen; Bernhagen, Juergen; Stoppe, Christian			The Role of Macrophage Migration Inhibitory Factor in Anesthetic-Induced Myocardial Preconditioning	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MITOCHONDRIAL-PERMEABILITY; CARDIOPROTECTION; MECHANISMS; ISCHEMIA; MIF; PROTECTION; SECRETION; EPSILON; PATHWAY	Introduction: Anesthetic-induced preconditioning (AIP) is known to elicit cardioprotective effects that are mediated at least in part by activation of the kinases AMPK and PKC epsilon as well as by inhibition of JNK. Recent data demonstrated that the pleiotropic cytokine macrophage migration inhibitory factor (MIF) provides cardioprotection through activation and/or inhibition of kinases that are also known to mediate effects of AIP. Therefore, we hypothesized that MIF could play a key role in the AIP response. Methods: Cardiomyocytes were isolated from rats and subjected to isoflurane preconditioning (4 h; 1.5 vol. %). Subsequently, MIF secretion and alterations in the activation levels of protective kinases were compared to a control group that was exposed to ambient air conditions. MIF secretion was quantified by ELISA and AIP-induced activation of protein kinases was assessed by Western blotting of cardiomyocyte lysates after isoflurane treatment. Results: In cardiomyocytes, preconditioning with isoflurane resulted in a significantly elevated secretion of MIF that followed a biphasic behavior (30 min vs. baseline: p = 0.020; 24 h vs. baseline p = 0.000). Moreover, quantitative polymerase chain reaction demonstrated a significant increase in MIF mRNA expression 8 h after AIP. Of note, activation of AMPK and PKCe coincided with the observed peaks in MIF secretion and differed significantly from baseline. Conclusions: These results suggest that the pleiotropic mediator MIF is involved in anesthetic-induced preconditioning of cardiomyocytes through stimulation of the protective kinases AMPK and PKC epsilon.	[Goetzenich, Andreas; Kraemer, Sandra; Beckers, Christian; Stoppe, Christian] Rhein Westfal TH Aachen, Dept Thorac Cardiac & Vasc Surg, Univ Hosp, D-52062 Aachen, Germany; [Kraemer, Sandra; Dollo, Florian; Siry, Laura; Rajabi-Alampour, Setareh; Soppert, Josefin; Lue, Hongqi; Bernhagen, Juergen; Stoppe, Christian] Rhein Westfal TH Aachen, Inst Biochem & Mol Cell Biol, Aachen, Germany; [Rossaint, Rolf; Bleilevens, Christian; Beckers, Christian] Rhein Westfal TH Aachen, Dept Anesthesiol, D-52062 Aachen, Germany; [Rex, Steffen] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Anesthesiol & Cardiovasc Sci, Leuven, Belgium	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University; KU Leuven; University Hospital Leuven	Bernhagen, J (corresponding author), Rhein Westfal TH Aachen, Inst Biochem & Mol Cell Biol, Aachen, Germany.	jbernhagen@ukaachen.de; christian.stoppe@gmail.com	Bleilevens, Christian/AAG-8034-2020	Bleilevens, Christian/0000-0002-2104-1843; , Ngobrolgame.com/0000-0001-6815-9112; Rex, Steffen/0000-0002-3536-9321	Deutsche Forschungsgemeinschaft (DFG) [Be1977/4-2 (TP1 of DFG-FOR809), DFG-IRTG1508/1-P13, Ra969/6-1]; Medical School of RWTH Aachen University	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Medical School of RWTH Aachen University	This study was supported by the Deutsche Forschungsgemeinschaft (DFG) grants Be1977/4-2 (TP1 of DFG-FOR809), DFG-IRTG1508/1-P13 and Ra969/6-1 to JB, and by a Rotation Program-and START Program grant of the Medical School of RWTH Aachen University to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bolli R, 1999, PHYSIOL REV, V79, P609, DOI 10.1152/physrev.1999.79.2.609; Bouwman RA, 2004, ANESTHESIOLOGY, V100, P506, DOI 10.1097/00000542-200403000-00008; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Crystal GJ, 2012, ACTA ANAESTH SCAND, V56, P39, DOI 10.1111/j.1399-6576.2011.02583.x; De Hert SG, 2005, ANESTH ANALG, V100, P1584, DOI 10.1213/01.ANE.0000153483.61170.0C; Feng JH, 2005, ANESTHESIOLOGY, V103, P987, DOI 10.1097/00000542-200511000-00013; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; Flieger O, 2003, FEBS LETT, V551, P78, DOI 10.1016/S0014-5793(03)00900-1; Frassdorf J, 2009, BRIT J ANAESTH, V103, P89, DOI 10.1093/bja/aep141; Gao XM, 2011, J MOL CELL CARDIOL, V50, P991, DOI 10.1016/j.yjmcc.2010.12.022; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kato R, 2002, CAN J ANAESTH, V49, P777, DOI 10.1007/BF03017409; Koga K, 2011, ANTIOXID REDOX SIGN, V14, P1191, DOI 10.1089/ars.2010.3163; Lamberts RR, 2009, CIRCULATION, V120, pS10, DOI 10.1161/CIRCULATIONAHA.108.828426; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Luedike P, 2012, CIRCULATION, V125, P1880, DOI 10.1161/CIRCULATIONAHA.111.069104; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Pagel PS, 2007, ANESTH ANALG, V105, P562, DOI 10.1213/01.ane.0000278083.31991.36; Pagel PS, 2010, J CARDIOTHOR VASC AN, V24, P143, DOI 10.1053/j.jvca.2009.03.016; Pravdic D, 2009, ANESTHESIOLOGY, V111, P267, DOI 10.1097/ALN.0b013e3181a91957; Qi D, 2009, J CLIN INVEST, V119, P3807, DOI 10.1172/JCI39738; REIMER KA, 1990, CIRCULATION, V82, P2266, DOI 10.1161/01.CIR.82.6.2266; Simons D, 2011, J CELL MOL MED, V15, P668, DOI 10.1111/j.1582-4934.2010.01041.x; Stoppe C, 2013, ANTIOXID REDOX SIGN, V19, P231, DOI 10.1089/ars.2012.5015; Stoppe C, 2012, MOL MED, V18, P843, DOI 10.2119/molmed.2012.00071; Takahashi M, 2001, CARDIOVASC RES, V52, P438, DOI 10.1016/S0008-6363(01)00408-4; Tanaka K, 2004, ANESTHESIOLOGY, V100, P707, DOI 10.1097/00000542-200403000-00035; Thiele M, 2005, ANTIOXID REDOX SIGN, V7, P1234, DOI 10.1089/ars.2005.7.1234; Weber N. C., 2008, V182, P187, DOI 10.1007/978-3-540-74806-9_9; Weber NC, 2005, EUR J ANAESTH, V22, P647, DOI 10.1017/S0265021505001080; Zimmermann WH, 2000, BIOTECHNOL BIOENG, V68, P106	36	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92827	10.1371/journal.pone.0092827	http://dx.doi.org/10.1371/journal.pone.0092827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667295	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600081
J	Huang, L; Bercovici, S; Rodriguez, JM; Batzoglou, S				Huang, Lin; Bercovici, Sivan; Rodriguez, Jesse M.; Batzoglou, Serafim			An Effective Filter for IBD Detection in Large Data Sets	PLOS ONE			English	Article							GENETIC-VARIATION; IDENTITY; DESCENT	Identity by descent (IBD) inference is the task of computationally detecting genomic segments that are shared between individuals by means of common familial descent. Accurate IBD detection plays an important role in various genomic studies, ranging from mapping disease genes to exploring ancient population histories. The majority of recent work in the field has focused on improving the accuracy of inference, targeting shorter genomic segments that originate from a more ancient common ancestor. The accuracy of these methods, however, is achieved at the expense of high computational cost, resulting in a prohibitively long running time when applied to large cohorts. To enable the study of large cohorts, we introduce SpeeDB, a method that facilitates fast IBD detection in large unphased genotype data sets. Given a target individual and a database of individuals that potentially share IBD segments with the target, SpeeDB applies an efficient opposite-homozygous filter, which excludes chromosomal segments from the database that are highly unlikely to be IBD with the corresponding segments from the target individual. The remaining segments can then be evaluated by any IBD detection method of choice. When examining simulated individuals sharing 4 cM IBD regions, SpeeDB filtered out 99.5% of genomic regions from consideration while retaining 99% of the true IBD segments. Applying the SpeeDB filter prior to detecting IBD in simulated fourth cousins resulted in an overall running time that was 10,000x faster than inferring IBD without the filter and retained 99% of the true IBD segments in the output.	[Huang, Lin; Bercovici, Sivan; Rodriguez, Jesse M.; Batzoglou, Serafim] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA	Stanford University	Huang, L (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.	linhuang@cs.stanford.edu			Pierre and Christine Lamond Stanford Graduate Fellowship; National Science Foundation Graduate Research Fellowship [DGE-1147470]; Stanford-KAUST alliance for academic excellence; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	Pierre and Christine Lamond Stanford Graduate Fellowship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Stanford-KAUST alliance for academic excellence; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	LH is supported by a Pierre and Christine Lamond Stanford Graduate Fellowship. This material is also based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE-1147470. This work is also supported by a grant from the Stanford-KAUST alliance for academic excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bercovici S, 2010, BIOINFORMATICS, V26, pi175, DOI 10.1093/bioinformatics/btq204; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Browning SR, 2012, GENETICS, V190, P1521, DOI 10.1534/genetics.111.136937; Browning SR, 2010, AM J HUM GENET, V86, P526, DOI 10.1016/j.ajhg.2010.02.021; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Haldane JBS, 1919, J GENET, V8, P299; He D, 2013, BIOINFORMATICS, V29, P162, DOI 10.1093/bioinformatics/btt237; Henn BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034267; Moltke I, 2011, GENOME RES, V21, P1168, DOI 10.1101/gr.115360.110; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; RODRIGUEZ JM, 2013, LNBI, V7821, P212; Wiliams AL, 2012, AM J HUM GENET, V91, P238, DOI 10.1016/j.ajhg.2012.06.013	17	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92713	10.1371/journal.pone.0092713	http://dx.doi.org/10.1371/journal.pone.0092713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667521	gold, Green Published, Green Submitted			2022-12-27	WOS:000333675600067
J	Oyen, J; Gjesdal, CG; Nygard, OK; Lie, SA; Meyer, HE; Apalset, EM; Ueland, PM; Pedersen, ER; Midttun, O; Vollset, SE; Tell, GS				Oyen, Jannike; Gjesdal, Clara Gram; Nygard, Ottar Kjell; Lie, Stein Atle; Meyer, Haakon E.; Apalset, Ellen Margrete; Ueland, Per Magne; Pedersen, Eva Ringdal; Midttun, Oivind; Vollset, Stein Emil; Tell, Grethe S.			Smoking and Body Fat Mass in Relation to Bone Mineral Density and Hip Fracture: The Hordaland Health Study	PLOS ONE			English	Article							CIGARETTE-SMOKING; RISK-FACTORS; POSTMENOPAUSAL WOMEN; TOBACCO SMOKING; ELDERLY-MEN; CHINESE MEN; LEAN MASS; OBESITY; INDEX; PREMENOPAUSAL	Lower bone mineral density (BMD) in smokers may be attributable to lower body weight or fat mass, rather than to a direct effect of smoking. We analyzed the effects of smoking exposure, assessed by plasma cotinine, and body fat on BMD and the risk of subsequent hip fracture. In the community-based Hordaland Health Study (HUSK), 3003 participants 46-49 years and 2091 subjects 71-74 years were included. Cotinine was measured in plasma and information on health behaviors was obtained from self-administered questionnaires. BMD and total body soft tissue composition were measured by dual X-ray absorptiometry. Information on hip fracture was obtained from computerized records containing discharge diagnoses for hospitalizations between baseline examinations 1997-2000 through December 31st, 2009. In the whole cohort, moderate and heavy smokers had stronger positive associations between fat mass and BMD compared to never smokers (differences in regression coefficient (95% CI) per % change in fat mass = 1.38 (0.24, 2.52) and 1.29 (0.17, 2.4), respectively). In moderate and heavy smokers there was a nonlinear association between BMD and fat mass with a stronger positive association at low compared to high levels of fat mass (Davies segmented test, p<0.001). In elderly women and men, heavy smokers had an increased risk of hip fracture compared to never smokers (hazard ratio = 3.31, 95% CI: 2.05, 5.35; p<0.001). In heavy smokers there was a tendency of a lower risk of hip fracture with higher percentage of fat mass. The deleterious effect of smoking on bone health is stronger in lean smokers than in smokers with high fat mass.	[Oyen, Jannike; Gjesdal, Clara Gram; Apalset, Ellen Margrete] Haukeland Hosp, Dept Rheumatol, N-5021 Bergen, Norway; [Oyen, Jannike; Apalset, Ellen Margrete; Vollset, Stein Emil; Tell, Grethe S.] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Gjesdal, Clara Gram; Nygard, Ottar Kjell; Ueland, Per Magne; Pedersen, Eva Ringdal] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Nygard, Ottar Kjell] Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway; [Lie, Stein Atle] Univ Bergen, Dept Clin Dent, Bergen, Norway; [Meyer, Haakon E.] Univ Oslo, Sect Prevent Med & Epidemiol, Oslo, Norway; [Meyer, Haakon E.] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway; [Ueland, Per Magne] Haukeland Hosp, Lab Clin Biochem, N-5021 Bergen, Norway; [Midttun, Oivind] Bevital AS, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Oslo; Norwegian Institute of Public Health (NIPH); University of Bergen; Haukeland University Hospital	Oyen, J (corresponding author), Haukeland Hosp, Dept Rheumatol, N-5021 Bergen, Norway.	jannike.oyen@igs.uib.no	Meyer, Haakon E./AAH-9333-2019; Øyen, Jannike/H-9857-2018; Ueland, Per M/C-7340-2013; Øyen, Jannike/G-4156-2017; Tell, Grethe/G-5639-2015	Øyen, Jannike/0000-0002-5590-5136; Øyen, Jannike/0000-0002-5590-5136; Tell, Grethe/0000-0003-1386-1638; Ueland, Per Magne/0000-0002-1903-0571; Meyer, Haakon E/0000-0002-3262-8260; Pedersen, Eva Ringdal/0000-0002-2545-1866	Western Norway Regional Health Authority; Research Council of Norway	Western Norway Regional Health Authority; Research Council of Norway(Research Council of Norway)	This work was supported by the Western Norway Regional Health Authority and The Hordaland Health Study was partially funded by the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron JA, 2001, ARCH INTERN MED, V161, P983, DOI 10.1001/archinte.161.7.983; BARON JA, 1990, AM J OBSTET GYNECOL, V162, P502, DOI 10.1016/0002-9378(90)90420-C; Benowitz NL, 1999, PRIMARY CARE, V26, P611, DOI 10.1016/S0095-4543(05)70120-2; Benson BW, 2005, NICOTINE TOB RES, V7, P719, DOI 10.1080/14622200500259119; Compston JE, 2011, AM J MED, V124, P1043, DOI 10.1016/j.amjmed.2011.06.013; Davies RB, 1987, BIOMETRIKA; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; EDELSTEIN SL, 1993, AM J EPIDEMIOL, V138, P160, DOI 10.1093/oxfordjournals.aje.a116842; Egger P, 1996, J EPIDEMIOL COMMUN H, V50, P47, DOI 10.1136/jech.50.1.47; Ensrud KE, 1997, AM J MED, V103, P274, DOI 10.1016/S0002-9343(97)00025-9; FELSON DT, 1993, J BONE MINER RES, V8, P567, DOI 10.1002/jbmr.5650080507; Forsen L, 1998, AM J PUBLIC HEALTH, V88, P1481, DOI 10.2105/AJPH.88.10.1481; FORSEN L, 1994, J BONE MINER RES, V9, P1671; Gjesdal CG, 2008, MATURITAS, V59, P191, DOI 10.1016/j.maturitas.2007.11.002; Gjesdal CG, 2007, J BONE MINER RES, V22, P747, DOI 10.1359/JBMR.070210; Gorber SC, 2009, NICOTINE TOB RES, V11, P12, DOI 10.1093/ntr/ntn010; Hannan MT, 2000, J BONE MINER RES, V15, P710, DOI 10.1359/jbmr.2000.15.4.710; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; HEMENWAY D, 1988, AM J PUBLIC HEALTH, V78, P1554, DOI 10.2105/AJPH.78.12.1554; Hermann AP, 2000, J BONE MINER RES, V15, P780, DOI 10.1359/jbmr.2000.15.4.780; Ho-Pham LT, 2014, J CLIN ENDOCR METAB, V99, P30, DOI 10.1210/jc.2013-3190; Hoidrup S, 2000, INT J EPIDEMIOL, V29, P253, DOI 10.1093/ije/29.2.253; HOLLENBACH KA, 1993, AM J PUBLIC HEALTH, V83, P1265, DOI 10.2105/AJPH.83.9.1265; Hsu YH, 2006, AM J CLIN NUTR, V83, P146; JENSEN GF, 1986, EUR J CLIN INVEST, V16, P239, DOI 10.1111/j.1365-2362.1986.tb01335.x; Joakimsen RM, 1998, OSTEOPOROSIS INT, V8, P436, DOI 10.1007/s001980050088; Jutberger H, 2010, J BONE MINER RES, V25, P1010, DOI 10.1359/jbmr.091112; Kanis J, 1999, OSTEOPOROSIS INT, V9, P45, DOI 10.1007/s001980050115; Kanis JA, 2008, BONE, V42, P467, DOI 10.1016/j.bone.2007.11.001; Krall EA, 1999, J BONE MINER RES, V14, P215, DOI 10.1359/jbmr.1999.14.2.215; LANDINWILHELMSEN K, 1995, CALCIFIED TISSUE INT, V56, P104, DOI 10.1007/BF00296339; Lau EMC, 2000, CALCIFIED TISSUE INT, V66, P47, DOI 10.1007/s002230050009; Law MR, 1997, BMJ-BRIT MED J, V315, P841, DOI 10.1136/bmj.315.7112.841; MEYER HE, 1993, AM J EPIDEMIOL, V137, P1203, DOI 10.1093/oxfordjournals.aje.a116622; Midttun O, 2009, RAPID COMMUN MASS SP, V23, P1371, DOI 10.1002/rcm.4013; Myong JP, 2013, OSTEOPOROSIS INT, V24, P1339, DOI 10.1007/s00198-012-2107-6; NYGARD O, 1995, JAMA-J AM MED ASSOC, V274, P1526, DOI 10.1001/jama.274.19.1526; PEREZSTABLE EJ, 1995, PREV MED, V24, P171, DOI 10.1006/pmed.1995.1031; PERKINS KA, 1992, J APPL PHYSIOL, V72, P401, DOI 10.1152/jappl.1992.72.2.401; PERKINS KA, 1992, BRIT J ADDICT, V87, P193; Prieto-Alhambra D, 2012, J BONE MINER RES, V27, P294, DOI 10.1002/jbmr.1466; Reid IR, 2010, ARCH BIOCHEM BIOPHYS, V503, P20, DOI 10.1016/j.abb.2010.06.027; REID IR, 1992, J CLIN ENDOCR METAB, V75, P45, DOI 10.1210/jc.75.1.45; RIEBEL GD, 1995, SPINE, V20, P2198, DOI 10.1097/00007632-199510001-00004; Seeman E, 2002, LANCET, V359, P1841, DOI 10.1016/S0140-6736(02)08706-8; SOWERS MR, 1992, J BONE MINER RES, V7, P647; Tanko LB, 2004, MENOPAUSE, V11, P104, DOI 10.1097/01.GME.0000079740.18541.DB; Walker LM, 2001, BONE, V28, P603, DOI 10.1016/S8756-3282(01)00427-6; Ward KD, 2001, CALCIFIED TISSUE INT, V68, P259, DOI 10.1007/BF02390832; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; Yaturu S, 2009, J DIABETES, V1, P246, DOI 10.1111/j.1753-0407.2009.00049.x; Zhao LJ, 2007, J CLIN ENDOCR METAB, V92, P1640, DOI 10.1210/jc.2006-0572	52	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92882	10.1371/journal.pone.0092882	http://dx.doi.org/10.1371/journal.pone.0092882			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667849	Green Submitted, Green Published, gold			2022-12-27	WOS:000333675600097
J	van Schalkwijk, DB; de Graaf, AA; Tsivtsivadze, E; Parnell, LD; van der Werff-van der Vat, BJC; van Ommen, B; van der Greef, J; Ordovas, JM				van Schalkwijk, Daniel B.; de Graaf, Albert A.; Tsivtsivadze, Evgeni; Parnell, Laurence D.; van der Werff-van der Vat, Bianca J. C.; van Ommen, Ben; van der Greef, Jan; Ordovas, Jose M.			Lipoprotein Metabolism Indicators Improve Cardiovascular Risk Prediction	PLOS ONE			English	Article							QUANTIFICATION; CHOLESTEROL	Background: Cardiovascular disease risk increases when lipoprotein metabolism is dysfunctional. We have developed a computational model able to derive indicators of lipoprotein production, lipolysis, and uptake processes from a single lipoprotein profile measurement. This is the first study to investigate whether lipoprotein metabolism indicators can improve cardiovascular risk prediction and therapy management. Methods and Results: We calculated lipoprotein metabolism indicators for 1981 subjects (145 cases, 1836 controls) from the Framingham Heart Study offspring cohort in which NMR lipoprotein profiles were measured. We applied a statistical learning algorithm using a support vector machine to select conventional risk factors and lipoprotein metabolism indicators that contributed to predicting risk for general cardiovascular disease. Risk prediction was quantified by the change in the Area-Under-the-ROC-Curve (Delta AUC) and by risk reclassification (Net Reclassification Improvement (NRI) and Integrated Discrimination Improvement (IDI)). Two VLDL lipoprotein metabolism indicators (VLDLE and VLDLH) improved cardiovascular risk prediction. We added these indicators to a multivariate model with the best performing conventional risk markers. Our method significantly improved both CVD prediction and risk reclassification. Conclusions: Two calculated VLDL metabolism indicators significantly improved cardiovascular risk prediction. These indicators may help to reduce prescription of unnecessary cholesterol-lowering medication, reducing costs and possible side-effects. For clinical application, further validation is required.	[van Schalkwijk, Daniel B.; Tsivtsivadze, Evgeni; van Ommen, Ben; van der Greef, Jan] TNO, Dept Microbiol & Syst Biol, NL-3700 AJ Zeist, Netherlands; [van Schalkwijk, Daniel B.] Amsterdam Univ Coll, Amsterdam, Netherlands; [de Graaf, Albert A.; van der Werff-van der Vat, Bianca J. C.] TNO, Dept Risk Anal Prod Dev, NL-3700 AJ Zeist, Netherlands; [Parnell, Laurence D.; Ordovas, Jose M.] Tufts Univ, Nutr & Genom Lab, JM USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [van der Greef, Jan] Leiden Amsterdam Ctr Drug Res, Analyt Sci Div, Sinodutch Ctr Prevent & Personalized Med, Leiden, Netherlands	Netherlands Organization Applied Science Research; University of Amsterdam; Netherlands Organization Applied Science Research; Tufts University; United States Department of Agriculture (USDA); Leiden University; Leiden University - Excl LUMC	de Graaf, AA (corresponding author), TNO, Dept Risk Anal Prod Dev, NL-3700 AJ Zeist, Netherlands.	albert.degraaf@tno.nl	; Ordovas, Jose/B-8727-2013	de Graaf, Albert/0000-0002-1067-3570; Ordovas, Jose/0000-0002-7581-5680				ALAKORPELA M, 1994, J LIPID RES, V35, P2292; Caulfield MP, 2008, CLIN CHEM, V54, P1307, DOI 10.1373/clinchem.2007.100586; Caulfield MP, 2008, CLIN CHEM, V54, P2088, DOI 10.1373/clinchem.2008.115667; Cromwell WC, 2007, J CLIN LIPIDOL, V1, P583, DOI 10.1016/j.jacl.2007.10.001; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Guyon I., 2006, STUDIES FUZZINESS SO; Hastie T., 2009, UNSUPERVISED LEARNIN; KULKARNI KR, 1994, J LIPID RES, V35, P159; Lin HT, 2007, MACH LEARN, V68, P267, DOI 10.1007/s10994-007-5018-6; Obuchowski NA, 2005, AM J ROENTGENOL, V184, P364, DOI 10.2214/ajr.184.2.01840364; OTVOS JD, 1992, CLIN CHEM, V38, P1632; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Platt JC, 2000, ADV NEUR IN, P61; Rambaldi DC, 2009, ANAL CHIM ACTA, V654, P64, DOI 10.1016/j.aca.2009.06.016; Tsivtsivadze E, 2010, PREFERENCE LEARNING, P107, DOI 10.1007/978-3-642-14125-6_6; Usui S, 2002, J LIPID RES, V43, P805; van Bochove K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038072; van Schalkwijk D, 2011, JOURNAL OF CLINICAL, V1, P1; van Schalkwijk DB, 2010, BRIEF BIOINFORM, V11, P403, DOI 10.1093/bib/bbp071; van Schalkwijk DB, 2009, J LIPID RES, V50, P2398, DOI 10.1194/jlr.M800354-JLR200; WILSON PWF, 1987, AM J CARDIOL, V59, pG91, DOI 10.1016/0002-9149(87)90165-2	21	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92840	10.1371/journal.pone.0092840	http://dx.doi.org/10.1371/journal.pone.0092840			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667559	Green Published, gold			2022-12-27	WOS:000333675600088
J	Wang, W; He, M; Zhou, MW; Zhang, XL				Wang, Wei; He, Miao; Zhou, Minwen; Zhang, Xiulan			Ocular Pseudoexfoliation Syndrome and Vascular Disease: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							OPEN-ANGLE GLAUCOMA; EXFOLIATION SYNDROME; ASSOCIATION; PREVALENCE; CATARACT; ANEURYSM	Objective: Many studies have assessed the association between ocular pseudoexfoliation syndrome (PEX) and vascular disease and produced controversial results. We performed a meta-analysis of epidemiologic studies to evaluate this relationship. Methods: Eligible studies that reported the incidence of vascular disease among PEX and control groups were identified via computer searches and reviewing the reference lists of the key articles. The summary odds ratio (OR) and 95% confidence interval (CI) were pooled using a random-effects model. Meta-regression to assess heterogeneity by several covariates and a subgroup analysis on study design and population were performed. Publication bias was tested by Begg's funnel plot and Egger's regression test. Results: Sixteen eligible studies involving 8,533 PEX patients and 135,720 control patients were included in the meta-analysis. All studies were performed primarily in whites with a mean age between 54.7 and 77.1 years. The overall combined ORs for patients with PEX compared with the reference group were 1.72 (95% CI: 1.31 to 2.26) for any vascular disease, 1.61 (95% CI: 1.22 to 2.14) for coronary heart disease, 1.59 (95% CI: 1.12 to 2.23) for cerebrovascular disease, and 2.48 (95% CI: 1.30 to 4.72) for aortic aneurysm. There was evidence of statistical heterogeneity; however, subgroup and sensitivity analyses showed this result to be robust. No evidence of publication bias was observed. Conclusions: The overall current literature suggests that PEX was associated with increased risk of vascular disease. Because of the limitations of the included studies and meta-analysis, the findings need to be confirmed in future research via well-designed cohort studies.	[Wang, Wei; He, Miao; Zhou, Minwen; Zhang, Xiulan] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhang, XL (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.	zhangxl2@mail.sysu.edu.cn			National Natural Science Foundation of China [81371008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (81371008). No additional external funding was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrikopoulos GK, 2009, EYE, V23, P442, DOI 10.1038/sj.eye.6702992; Browne JG, 2011, INVEST OPHTHALMOL VI; Citirik M, 2007, EYE, V21, P11, DOI 10.1038/sj.eye.6702177; Demir N, 2011, EYE, V25, P1177, DOI 10.1038/eye.2011.145; Djordjevic-Jocic J, 2012, CURR EYE RES, V37, P617, DOI 10.3109/02713683.2012.665120; Djordjevic-Jocic J, 2012, VOJNOSANIT PREGL, V69, P231, DOI 10.2298/VSP1203231D; Elhawy E, 2012, HUM GENOMICS, V6, DOI 10.1186/1479-7364-6-22; Emiroglu MY, 2010, N AM J MED SCI, V2, P306, DOI [10.4297/najms.2010.2306, 10.4297/najms.2010.2487]; French DD, 2012, N AM J MED SCI, V4, P468, DOI 10.4103/1947-2714.101987; Gonen KA, 2013, EYE, V27, P735, DOI 10.1038/eye.2013.56; Katsi Vasiliki, 2013, N Am J Med Sci, V5, P454, DOI 10.4103/1947-2714.117294; Kocabeyoglu S, 2013, EUR J OPHTHALMOL, V0; Koliakos GG, 2004, BRIT J OPHTHALMOL, V88, P523, DOI 10.1136/bjo.2003.028290; Konstas AGP, 1998, ACTA OPHTHALMOL SCAN, V76, P208, DOI 10.1034/j.1600-0420.1998.760217.x; Mitchell P, 1997, AM J OPHTHALMOL, V124, P685, DOI 10.1016/S0002-9394(14)70908-0; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Praveen MR, 2011, EYE, V25, P174, DOI 10.1038/eye.2010.175; Ritch R, 2001, SURV OPHTHALMOL, V45, P265, DOI 10.1016/S0039-6257(00)00196-X; Ritland JS, 2004, ACTA OPHTHALMOL SCAN, V82, P401, DOI 10.1111/j.1395-3907.2004.00297.x; Sekeroglu MA, 2008, EUR J OPHTHALMOL, V18, P551, DOI 10.1177/112067210801800408; Speckauskas M, 2012, ACTA OPHTHALMOL, V90, pe470, DOI 10.1111/j.1755-3768.2012.02439.x; Susic N, 2007, ACTA CLIN CROAT, V46, P317; Tarkkanen A, 2008, ACTA OPHTHALMOL, V86, P598, DOI 10.1111/j.1600-0420.2007.01122.x; Tarkkanen A, 2008, ACTA OPHTHALMOL, V86, P832, DOI 10.1111/j.1755-3768.2008.01464.x; Ulus T, 2013, J CARDIOVASC MED, V14, P587, DOI 10.2459/JCM.0b013e328358fde0; Viso E, 2010, OPHTHAL EPIDEMIOL, V17, P118, DOI 10.3109/09286581003624970; Wells G.A., NEWCASTLE OTTAWA SCA; Yokusoglu M, 2012, ANATOL J CARDIOL, V12, P488, DOI 10.5152/akd.2012.156; You QS, 2013, OPHTHALMOLOGY, V120, P1551, DOI 10.1016/j.ophtha.2013.01.020; Yuksel N, 2006, OPHTHALMOLOGICA, V220, P125, DOI 10.1159/000090578; Zakrzewski PA, 2012, J GLAUCOMA, V21, P562, DOI 10.1097/IJG.0b013e31821e83fe; Zenkel M, 2010, AM J PATHOL, V176, P2868, DOI 10.2353/ajpath.2010.090914	32	58	59	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92767	10.1371/journal.pone.0092767	http://dx.doi.org/10.1371/journal.pone.0092767			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667689	gold, Green Published, Green Submitted			2022-12-27	WOS:000333675600071
J	Xu, JW; Wang, TX; You, L; Zheng, LF; Shu, H; Zhang, TP; Zhao, YP				Xu, Jian-Wei; Wang, Tian-Xiao; You, Lei; Zheng, Lian-Fang; Shu, Hong; Zhang, Tai-Ping; Zhao, Yu-Pei			Insulin-Like Growth Factor 1 Receptor (IGF-1R) as a Target of MiR-497 and Plasma IGF-1R Levels Associated with TNM Stage of Pancreatic Cancer	PLOS ONE			English	Article							DUCTAL ADENOCARCINOMA; TUMOR LINE; CELLS; EXPRESSION; BIOMARKERS; NEOPLASIA; APOPTOSIS; PROMOTES; PATHWAY	The expression levels and regulatory roles of miR-497 in pancreatic cancer are unclear. The clinical value of plasma insulin-like growth factor 1 receptor (IGF-1R) in pancreatic cancers has not been investigated. In the present study, we demonstrated that miR-497 was significantly downregulated in pancreatic cancer tissues. Upregulation of miR-497 in BxPC-3 and AsPC-1 pancreatic cancer cell lines inhibited proliferation, enhanced apoptosis, re-sensitized cells to gemcitabine and suppressed IGF-1R and p-AKT expression through direct downregulation of IGF-1R protein expression. Opposite effects were observed after downregulation of miR-497. Plasma IGF-1R levels in patients with pancreatic cancer increased significantly, compared with that in patients with chronic pancreatitis, other pancreatic tumors and pancreatic neuroendocrine tumors (P = 0.006, P = 0.018 and P = 0.004, respectively), and displayed potential values for distinguishing pancreatic lesions. However, the levels in pancreatic cancer patients were comparable to that in healthy volunteers (P = 0.095). The tumor locations and TNM stage were associated with plasma IGF-1R levels (P = 0.013 and P = 0.01, respectively). There was no significant difference of overall survival between high and low IGF-1R expression groups. In conclusion, we demonstrated that miR-497 attenuated the malignancy of pancreatic cancer cells and promoted sensitivity of cells to gemcitabine by directly downregulation of IGF-1R expression. Plasma IGF-1R displayed a potential value for distinguishing pancreatic lesions and could be a new biomarker for guiding TNM stage of pancreatic cancer.	[Xu, Jian-Wei; You, Lei; Shu, Hong; Zhang, Tai-Ping; Zhao, Yu-Pei] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China; [Xu, Jian-Wei; You, Lei; Zheng, Lian-Fang; Shu, Hong; Zhang, Tai-Ping; Zhao, Yu-Pei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Tian-Xiao] Peking Univ Canc Hosp, Beijing Canc Hosp & Inst, Dept Head & Neck Surg, Beijing, Peoples R China; [Zheng, Lian-Fang] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Nucl Med, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Zhang, TP (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China.	tpingzhang@yahoo.com; zhao8028@263.net			National Natural Science Foundation of China [81272484, 81141027]; Beijing Natural Science Foundation [7132179]; Beijing Municipal Natural Science Foundation [7100003]; Research Special Fund for Public Welfare Industry of Health [201202007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Research Special Fund for Public Welfare Industry of Health	This study was supported by grants from the National Natural Science Foundation of China (No. 81272484, 81141027), Beijing Natural Science Foundation (No. 7132179), Beijing Municipal Natural Science Foundation (7100003) and the Research Special Fund for Public Welfare Industry of Health (201202007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caramuta S, 2013, ENDOCR-RELAT CANCER, V20, P551, DOI 10.1530/ERC-13-0098; Chen D, 2012, INT J MOL SCI, V13, P1186, DOI 10.3390/ijms13011186; CHEN WH, 1982, IN VITRO CELL DEV B, V18, P24; Costello E, 2012, NAT REV GASTRO HEPAT, V9, P435, DOI 10.1038/nrgastro.2012.119; Faissner A, 2006, ADV EXP MED BIOL, V557, P25; Furuta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060155; Guo ST, 2013, ONCOGENE, V32, P1910, DOI 10.1038/onc.2012.214; Hakam A, 2003, DIGEST DIS SCI, V48, P1972, DOI 10.1023/A:1026122421369; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Kleeff J, 1999, PANCREAS, V18, P364, DOI 10.1097/00006676-199905000-00006; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Luo M., 2013, SURGERY, V12, P751, DOI DOI 10.1016/J.SURG.2012.12.004; Macgregor-Das AM, 2013, J SURG ONCOL, V107, P8, DOI 10.1002/jso.23213; O'Kusky J, 2012, FRONT NEUROENDOCRIN, V33, P230, DOI 10.1016/j.yfrne.2012.06.002; Ozkan EE, 2011, MOL CELL ENDOCRINOL, V344, P1, DOI 10.1016/j.mce.2011.07.002; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Sachdev D, 2007, MOL CANCER THER, V6, P1, DOI 10.1158/1535-7163.MCT-06-0080; Shen L, 2012, EXP THER MED, V3, P475, DOI 10.3892/etm.2011.428; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; TAN MH, 1986, CANCER INVEST, V4, P15, DOI 10.3109/07357908609039823; Tian XD, 2013, DIGEST DIS SCI, V58, P2705, DOI 10.1007/s10620-013-2673-2; Trajkovic-Arsic M, 2013, J MOL ENDOCRINOL, V50, pR67, DOI 10.1530/JME-12-0259; Valsecchi ME, 2012, CANCER-AM CANCER SOC, V118, P3484, DOI 10.1002/cncr.26661; Winter JM, 2013, J SURG ONCOL, V107, P15, DOI 10.1002/jso.23192; Zhang XH, 2013, ANTI-CANCER AGENT ME, V13, P1575, DOI 10.2174/1871520613666131125123059; Zhao WY, 2013, BIOCHEM BIOPH RES CO, V435, P466, DOI 10.1016/j.bbrc.2013.05.010; Zhu W, 2012, MED ONCOL, V29, P384, DOI 10.1007/s12032-010-9797-4	28	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92847	10.1371/journal.pone.0092847	http://dx.doi.org/10.1371/journal.pone.0092847			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667580	Green Submitted, gold, Green Published			2022-12-27	WOS:000333675600089
J	Baldassi, C; Zamparo, M; Feinauer, C; Procaccini, A; Zecchina, R; Weigt, M; Pagnani, A				Baldassi, Carlo; Zamparo, Marco; Feinauer, Christoph; Procaccini, Andrea; Zecchina, Riccardo; Weigt, Martin; Pagnani, Andrea			Fast and Accurate Multivariate Gaussian Modeling of Protein Families: Predicting Residue Contacts and Protein-Interaction Partners	PLOS ONE			English	Article							CORRELATED MUTATIONS; SEQUENCE; INFORMATION; SPECIFICITY; COVARIANCE; PATHWAYS	In the course of evolution, proteins show a remarkable conservation of their three-dimensional structure and their biological function, leading to strong evolutionary constraints on the sequence variability between homologous proteins. Our method aims at extracting such constraints from rapidly accumulating sequence data, and thereby at inferring protein structure and function from sequence information alone. Recently, global statistical inference methods (e. g. direct-coupling analysis, sparse inverse covariance estimation) have achieved a breakthrough towards this aim, and their predictions have been successfully implemented into tertiary and quaternary protein structure prediction methods. However, due to the discrete nature of the underlying variable (amino-acids), exact inference requires exponential time in the protein length, and efficient approximations are needed for practical applicability. Here we propose a very efficient multivariate Gaussian modeling approach as a variant of direct-coupling analysis: the discrete amino-acid variables are replaced by continuous Gaussian random variables. The resulting statistical inference problem is efficiently and exactly solvable. We show that the quality of inference is comparable or superior to the one achieved by mean-field approximations to inference with discrete variables, as done by direct-coupling analysis. This is true for (i) the prediction of residue-residue contacts in proteins, and (ii) the identification of protein-protein interaction partner in bacterial signal transduction. An implementation of our multivariate Gaussian approach is available at the website http://areeweb.polito.it/ricerca/cmp/code.	[Baldassi, Carlo; Zamparo, Marco; Feinauer, Christoph; Zecchina, Riccardo; Pagnani, Andrea] Politecn Torino, Dept Appl Sci & Technol, Turin, Italy; [Baldassi, Carlo; Zamparo, Marco; Feinauer, Christoph; Zecchina, Riccardo; Pagnani, Andrea] Politecn Torino, Ctr Computat Sci, Turin, Italy; [Baldassi, Carlo; Zamparo, Marco; Procaccini, Andrea; Zecchina, Riccardo; Pagnani, Andrea] Human Genet Fdn Torino, Turin, Italy; [Weigt, Martin] Univ Paris 06, Univ Sorbonne, UMR 7238, Paris, France; [Weigt, Martin] CNRS, UMR 7238, Paris, France	Polytechnic University of Turin; Polytechnic University of Turin; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Pagnani, A (corresponding author), Politecn Torino, Dept Appl Sci & Technol, Turin, Italy.	andrea.pagnani@polito.it	Weigt, Martin/L-8851-2016; Pagnani, Andrea/J-2363-2015; Baldassi, Carlo/I-2212-2017; Feinauer, Christoph/AAU-3423-2021	Weigt, Martin/0000-0002-0492-3684; Pagnani, Andrea/0000-0002-6509-0807; Baldassi, Carlo/0000-0002-5451-8388; ZECCHINA, Riccardo/0000-0002-1221-5207	European Union under REA [290038]; European Research Council [267915]	European Union under REA; European Research Council(European Research Council (ERC)European Commission)	Christoph Feinauer acknowledges funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/ under REA grant agreement No. 290038. Riccardo Zecchina and Carlo Baldassi acknowledge the European Research Council for grant No. 267915. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; Balakrishnan S, 2011, PROTEINS, V79, P1061, DOI 10.1002/prot.22934; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Burger L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100203; Burger L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000633; Cocco S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003176; Dago AE, 2012, P NATL ACAD SCI; de Juan D, 2013, NATURE REV GENETICS; Diensthuber RP, 2013, STRUCTURE, V21, P1127, DOI 10.1016/j.str.2013.04.024; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Ekeberg M, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012707; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Garbuzynskiy SO, 2004, PROTEIN SCI, V13, P2871, DOI 10.1110/ps.04881304; Gelman A., 2003, BAYESIAN DATA ANAL; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Hoch JA, 2001, J BACTERIOL, V183, P4941, DOI 10.1128/JB.183.17.4941-4949.2001; Hopf T, 2012, CELL; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jaynes ET, 1957, PHYS REV 2, V108; Jiang M, 2000, MOL MICROBIOL, V38, P535, DOI 10.1046/j.1365-2958.2000.02148.x; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kamisetty H, 2013, P NATL ACAD SCI USA, V110, P15674, DOI 10.1073/pnas.1314045110; Lapedes A, 2012, ARXIV12072484; Lapedes A.S., 1999, LECT NOTES MONOGR SE, V33, P236, DOI [10.1214/lnms/1215455556, DOI 10.1214/LNMS/1215455556]; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Mora T, 2010, P NATL ACAD SCI USA, V107, P5405, DOI 10.1073/pnas.1001705107; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Ohta N, 2003, J BACTERIOL, V185, P4424, DOI 10.1128/JB.185.15.4424-4431.2003; Procaccini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019729; Sadowski MI, 2011, COMPUT BIOL CHEM, V35, P323, DOI 10.1016/j.compbiolchem.2011.08.002; Schug A, 2009, P NATL ACAD SCI USA, V106, P22124, DOI 10.1073/pnas.0912100106; SHINDYALOV IN, 1994, PROTEIN ENG, V7, P349, DOI 10.1093/protein/7.3.349; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Sreekumar J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-444; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, P10340, DOI 10.1073/pnas.1207864109; Szurmant H, 2010, CURR OPIN MICROBIOL, V13, P190, DOI 10.1016/j.mib.2010.01.007; Taylor WR, 2012, PROTEIN SCI, V21, P299, DOI 10.1002/pro.2002; Wang C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001493; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106	45	99	100	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92721	10.1371/journal.pone.0092721	http://dx.doi.org/10.1371/journal.pone.0092721			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663061	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900102
J	Benova, L; Campbell, OMR; Ploubidis, GB				Benova, Lenka; Campbell, Oona M. R.; Ploubidis, George B.			Socio-Economic Gradients in Maternal and Child Health-Seeking Behaviours in Egypt: Systematic Literature Review and Evidence Synthesis	PLOS ONE			English	Review							CARE; SERVICES; COUNTRIES	Background: Health-seeking behaviour lies on the direct pathway between socio-economic position (SEP) and health outcomes. The objective of this systematic review is to identify and synthesise evidence of socio-economic gradients in health-seeking behaviours related to maternal and child health in Egypt. Methods: Four databases (Medline, Embase, Global Health and Web of Science) were searched in September 2013 for material published in English from 1992 to 2013 for a combination of terms describing health-seeking behaviours, indicators of socio-economic position and geographical limitation to Egypt. Findings of studies were described and synthesised in a narrative format as meta-analysis was not possible. Findings: Among the 786 references identified, 10 articles met the inclusion criteria. Six studies examined maternal and five studies child health-seeking behaviours (one study examined both). For maternal health, three dimensions of health-seeking behaviour (receipt of any care, type of care and intensity of care) were covered by studies of ante-natal and one dimension (type of care) by analyses of delivery care. For child health, two dimensions of preventive care (coverage of and intensity of immunisation) and three dimensions of curative care (receipt of any care, type and cost of care) were analysed. Conclusions: Based on two studies of time trends in nationally-representative surveys, socio-economic inequalities in seeking care for basic preventive and curative interventions in maternal and child health appear to have narrowed. Limited evidence of gradients in intensity of maternal preventive and provider selection in child curative care showed that inequalities may have widened. In studies of more geographically and socially homogeneous samples, fewer gradients were identified. Current body of evidence contains numerous limitations and gaps and is insufficient to draw a conclusive summary of such gradients. Improved understanding of SEP gradients is crucial in designing and prioritising interventions to equitably improve maternal and child health outcomes.	[Benova, Lenka; Ploubidis, George B.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Populat Hlth, London WC1, England; [Campbell, Oona M. R.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Benova, L (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Populat Hlth, London WC1, England.	lenka.benova@lshtm.ac.uk	Ploubidis, George B/G-9531-2011	Ploubidis, George B/0000-0002-8198-5790; Campbell, Oona/0000-0002-9311-0115	Economic and Social Research Council (ESRC) 1+3 Studentship grant award [ES/I903224/1]; Medical Research Council (MRC) Population Health Science fellowship [G0802442]; MRC [G0802442] Funding Source: UKRI; Economic and Social Research Council [1013735] Funding Source: researchfish; Medical Research Council [G0802442] Funding Source: researchfish	Economic and Social Research Council (ESRC) 1+3 Studentship grant award(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council (MRC) Population Health Science fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Economic and Social Research Council (ESRC) 1+3 Studentship grant award (ES/I903224/1); and Medical Research Council (MRC) Population Health Science fellowship (G0802442). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel Houssein NA, 1997, B HIGH I PUBLIC HLTH, V27, P269; Adda J, 2003, J ECONOMETRICS, V112, P57, DOI 10.1016/S0304-4076(02)00146-X; Andersen RM, 2008, MED CARE, V46, P647, DOI [10.1097/MLR.0b013e31817a835d, 10.1097/MLR.0b013e31817f4d48]; Barros AJD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001390; Chiang CF, 2012, NAGOYA J MED SCI, V74, P233; El Deeb B, 2005, SOCIAL DETERMINANTS; Fadel KAM, 2007, ASSIUT MED J, V31, P73; Fahmy SI, 1983, B HIGH I PUBLIC HLTH, V8, P95; Gipson R, 2005, MATERN CHILD HLTH J, V9, P71, DOI 10.1007/s10995-005-3348-1; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Khadr Z, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-38; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Marmot M., 1995, SOC HLTH, P172; Mechanic D, 2002, HEALTH AFFAIR, V21, P48, DOI 10.1377/hlthaff.21.2.48; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Palloni A, 2009, SOC SCI MED, V68, P1574, DOI 10.1016/j.socscimed.2009.02.009; Pokhrel S, 2004, HEALTH POLICY PLANN, V19, P218, DOI 10.1093/heapol/czh027; Rashad A, 2012, CATASTROPHIC HLTH EX; Reichler MR, 1998, INT J EPIDEMIOL, V27, P1083, DOI 10.1093/ije/27.6.1083; Rutstein S.O., 2004, DHS COMP REPORTS; Stephenson R, 2012, PUBLIC HEALTH REP, V127, P96; Stowasser T, 2011, HLTH WEALTHY WISE RE; Tipping G, 1995, HLTH CARE SEEKING BE; Wells G.A., NEWCASTLE OTTAWA SCA; Yassin Khaled, 2003, Health Care Women Int, V24, P452, DOI 10.1080/07399330390212216; Yip W, 2001, HEALTH ECON, V10, P207, DOI 10.1002/hec.589; Yount KM, 2004, POP STUD-J DEMOG, V58, P345, DOI 10.1080/0032472042000272384; Yount KM, 2003, POPUL RES POLICY REV, V22, P267, DOI 10.1023/A:1026090207663	29	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93032	10.1371/journal.pone.0093032	http://dx.doi.org/10.1371/journal.pone.0093032			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD7QO	24663341	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000333459900145
J	Berthold, HK; Rizzo, M; Spenrath, N; Montalto, G; Krone, W; Gouni-Berthold, I				Berthold, Heiner K.; Rizzo, Manfredi; Spenrath, Nadine; Montalto, Giuseppe; Krone, Wilhelm; Gouni-Berthold, Ioanna			Effects of Lipid-Lowering Drugs on High-Density Lipoprotein Subclasses in Healthy Men-A Randomized Trial	PLOS ONE			English	Article							EZETIMIBE AND/OR SIMVASTATIN; CORONARY-ARTERY-DISEASE; HDL PARTICLE-SIZE; PRIMARY HYPERCHOLESTEROLEMIA; CARDIOVASCULAR EVENTS; CHOLESTEROL LEVELS; HEART-DISEASE; COMBINATION; RISK; LDL	Context and Objective: Investigating the effects of lipid-lowering drugs on HDL subclasses has shown ambiguous results. This study assessed the effects of ezetimibe, simvastatin, and their combination on HDL subclass distribution. Design and Participants: A single-center randomized parallel 3-group open-label study was performed in 72 healthy men free of cardiovascular disease with a baseline LDL-cholesterol of 111 +/- 30 mg/dl (2.9 +/- 0.8 mmol/l) and a baseline HDL-cholesterol of 64 +/- 15 mg/dl (1.7 +/- 0.4 mmol/l). They were treated with ezetimibe (10 mg/day, n = 24), simvastatin (40 mg/day, n = 24) or their combination (n = 24) for 14 days. Blood was drawn before and after the treatment period. HDL subclasses were determined using polyacrylamide gel-tube electrophoresis. Multivariate regression models were used to determine the influence of treatment and covariates on changes in HDL subclass composition. Results: Baseline HDL subclasses consisted of 33 +/- 10% large, 48 +/- 6% intermediate and 19 +/- 8% small HDL. After adjusting for baseline HDL subclass distribution, body mass index, LDL-C and the ratio triglycerides/HDL-C, there was a significant increase in large HDL by about 3.9 percentage points (P < 0.05) and a decrease in intermediate HDL by about 3.5 percentage points (P < 0.01) in both simvastatin-containing treatment arms in comparison to ezetimibe. The parameters obtained after additional adjustment for the decrease in LDL-C indicated that about one third to one half of these effects could be explained by the extent of LDL-C-lowering. Conclusions: In healthy men, treatment with simvastatin leads to favorable effects on HDL subclass composition, which was not be observed with ezetimibe. Part of these differential effects may be due to the stronger LDL-C-lowering effects of simvastatin.	[Berthold, Heiner K.] Bielefeld Evangel Hosp EvKB, Dept Internal Med & Geriatr, Bielefeld, Germany; [Rizzo, Manfredi; Montalto, Giuseppe] Univ Palermo, BioMed Dept Internal Med & Med Specialties, Palermo, Italy; [Rizzo, Manfredi] Euromediterranean Inst Sci & Technol, Palermo, Italy; [Spenrath, Nadine; Krone, Wilhelm; Gouni-Berthold, Ioanna] Univ Cologne, Ctr Endocrinol Diabet & Prevent Med, D-50931 Cologne, Germany	Evangelical Hospital Bethel (EvKB) - House Gilead I; University of Palermo; University of Cologne	Berthold, HK (corresponding author), Bielefeld Evangel Hosp EvKB, Dept Internal Med & Geriatr, Bielefeld, Germany.	heiner.berthold@evkb.de	Berthold, Heiner/E-6017-2011	Berthold, Heiner/0000-0002-1457-2216; RIZZO, Manfredi/0000-0002-9549-8504; MONTALTO, Giuseppe/0000-0002-8731-8577	MSD Sharp & Dohme (Munich, Germany); Wilhelm-Doerenkamp Foundation (Cologne, Germany)	MSD Sharp & Dohme (Munich, Germany); Wilhelm-Doerenkamp Foundation (Cologne, Germany)	The parent trial was supported in part by an investigator-initiated grant from MSD Sharp & Dohme (Munich, Germany) and the Wilhelm-Doerenkamp Foundation (Cologne, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeloni E, 2013, EUR HEART J, V34, P3557, DOI 10.1093/eurheartj/eht163; Asztalos BF, 2004, ARTERIOSCL THROM VAS, V24, P2181, DOI 10.1161/01.ATV.0000146325.93749.a8; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Bays HE, 2001, CLIN THER, V23, P1209, DOI 10.1016/S0149-2918(01)80102-8; Berneis K, 2010, EUR HEART J, V31, P1633, DOI 10.1093/eurheartj/ehq181; Berthold HK, 2006, DRUG SAFETY, V29, P703, DOI 10.2165/00002018-200629080-00007; Blackburn P, 2012, ATHEROSCLEROSIS, V223, P359, DOI 10.1016/j.atherosclerosis.2012.05.016; CHEUNG MC, 1993, ATHEROSCLEROSIS, V102, P107, DOI 10.1016/0021-9150(93)90089-D; Degoma EM, 2008, J AM COLL CARDIOL, V51, P2199, DOI 10.1016/j.jacc.2008.03.016; DORMANS TPJ, 1991, CLIN CHEM, V37, P853; El Harchaoui K, 2009, ANN INTERN MED, V150, P84, DOI 10.7326/0003-4819-150-2-200901200-00006; Farnier M, 2008, J LIPID RES, V49, P2641, DOI 10.1194/jlr.P800034-JLR200; Frikke-Schmidt R, 2010, ATHEROSCLEROSIS, V208, P305, DOI 10.1016/j.atherosclerosis.2009.06.005; Gentile M, 2008, CLIN CHIM ACTA, V388, P179, DOI 10.1016/j.cca.2007.10.033; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Goliasch G, 2012, EUR J CLIN INVEST, V42, P631, DOI 10.1111/j.1365-2362.2011.02629.x; Gouni-Berthold I, 2008, CLIN ENDOCRINOL, V68, P536, DOI 10.1111/j.1365-2265.2007.03080.x; Gouni-Berthold I, 2008, ATHEROSCLEROSIS, V198, P198, DOI 10.1016/j.atherosclerosis.2007.09.034; Harangi M, 2009, CARDIOVASC DRUG THER, V23, P501, DOI 10.1007/s10557-009-6205-4; Harangi M, 2009, TRANSL RES, V153, P190, DOI 10.1016/j.trsl.2009.01.007; Johannsen TH, 2009, J CLIN ENDOCR METAB, V94, P1264, DOI 10.1210/jc.2008-1342; Kalogirou M, 2007, CURR MED RES OPIN, V23, P1169, DOI 10.1185/030079907X188062; Knapp HH, 2001, AM J MED, V110, P352, DOI 10.1016/S0002-9343(01)00638-6; Kostapanos MS, 2009, J CARDIOVASC PHARM T, V14, P5, DOI 10.1177/1074248408331031; KWITEROVICH PO, 2000, AM J CARDIOL S1, V86, P5; Mackey RH, 2012, J AM COLL CARDIOL, V60, P508, DOI 10.1016/j.jacc.2012.03.060; McKenney JM, 2001, AM J CARDIOL, V88, P270, DOI 10.1016/S0002-9149(01)01639-3; Mikhailidis DP, 2011, CURR VASC PHARMACOL, V9, P531; Mikhailidis DP, 2005, CURR MED RES OPIN, V21, P959, DOI 10.1185/030079905x48447; Mora S, 2013, CIRCULATION, V128, P1189, DOI 10.1161/CIRCULATIONAHA.113.002671; Mora S, 2011, ANN INTERN MED, V155, P742, DOI 10.7326/0003-4819-155-11-201112060-00006; Movva R, 2009, ANN BIOL CLIN-PARIS, V67, P7, DOI [10.1373/clinchem.2007.101923, 10.1684/abc.2008.0284]; Nakou ES, 2008, CURR MED RES OPIN, V24, P1919, DOI [10.1185/03007990802177150, 10.1185/03007990802177150 ]; NEUMAN MP, 1991, ATHEROSCLEROSIS, V91, pS11, DOI 10.1016/0021-9150(91)90202-E; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; Oravec S, 2011, NEUROENDOCRINOL LETT, V32, P502; Oravec S, 2011, NEUROENDOCRINOL LETT, V32, P496; Otvos JD, 2006, CIRCULATION, V113, P1556, DOI 10.1161/CIRCULATIONAHA.105.565135; Rizzo M, 2006, CARDIOVASC DRUG THER, V20, P205, DOI 10.1007/s10557-006-8283-x; Rosenson RS, 2011, CLIN CHEM, V57, P392, DOI 10.1373/clinchem.2010.155333; Rye KA, 2014, J LIPID RES, V55, P168, DOI 10.1194/jlr.R039297; Soedamah-Muthu SS, 2003, ATHEROSCLEROSIS, V167, P243, DOI 10.1016/S0021-9150(02)00428-8; Tomassini JE, 2009, DIABETES OBES METAB, V11, P855, DOI 10.1111/j.1463-1326.2009.01061.x; Toth PP, 2005, EXPERT OPIN PHARMACO, V6, P131, DOI 10.1517/14656566.6.1.131; van de Woestijne AP, 2013, J AM COLL CARDIOL, V62, P1834, DOI 10.1016/j.jacc.2013.04.101; Varady KA, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-119; Vergeer M, 2010, J LIPID RES, V51, P2058, DOI 10.1194/jlr.R001610; Vickers KC, 2014, J LIPID RES, V55, P4, DOI 10.1194/jlr.R035964; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2	49	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91565	10.1371/journal.pone.0091565	http://dx.doi.org/10.1371/journal.pone.0091565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662777	gold, Green Published			2022-12-27	WOS:000333459900024
J	Boiko, N; Kucher, V; Wang, B; Stockand, JD				Boiko, Nina; Kucher, Volodymyr; Wang, Bin; Stockand, James D.			Restrictive Expression of Acid-Sensing Ion Channel 5 (Asic5) in Unipolar Brush Cells of the Vestibulocerebellum	PLOS ONE			English	Article							CEREBELLAR PURKINJE NEURONS; RESURGENT SODIUM CURRENT; CENTRAL-NERVOUS-SYSTEM; FUNCTIONAL EXPRESSION; NA+ CHANNEL; RECEPTOR; CLONING; HYDRA; GENE; FORM	Acid-sensing ion channels (Asic) are ligand-gated ion channels in the Degenerin/Epithelial Na+ channel (Deg/ENaC) family. Asic proteins are richly expressed in mammalian neurons. Mammals express five Asic genes: Asic1-5. The gene product of Asic5 is an orphan member of the family about which little is known. To investigate Asic5 expression, we created an Asic5 reporter mouse. We find that Asic5 is chiefly expressed in the brain in the cerebellum, specifically in the ventral uvula and nodulus of the vestibulocerebellum. Here, Asic5 is restrictively expressed in a subset of interneurons in the granular layer. The locale, distinctive shape and immunohistochemical properties of these Asic5-expressing interneurons identify them as unipolar brush cells (UBC). Asic5 is richly expressed in a subset of UBCs that also express the metabotropic glutamate receptor 1 alpha (mGluR1 alpha) but not those that express calretinin. Results from single cell RT-PCR and electrophysiological examination of these cells are consistent with this identity. Such observations are consistent with Asic5 playing a key role in the physiology of UBCs and in the function of the vestibulocerebellum.	[Boiko, Nina; Kucher, Volodymyr; Wang, Bin; Stockand, James D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Stockand, JD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA.	stockand@uthscsa.edu		Stockand, James/0000-0002-3817-4319	American Heart Association [EIA 0640054N]; UTHSCSA; NIH [NCI P30 CA54174]; NIA [P30 AG013319, P01AG19316]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013319, P01AG019316] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); UTHSCSA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the American Heart Association grant EIA 0640054N to JDS. The Core Optical Imaging Facility at UTHSCSA is supported by UTHSCSA and the NIH (NCI P30 CA54174 to the San Antonio Cancer Institute; NIA P30 AG013319 to the Nathan Shock Center; and NIA P01AG19316). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi L, 2002, NEURON, V34, P337, DOI 10.1016/S0896-6273(02)00687-6; Chu XP, 2013, ADV EXP MED BIOL, V961, P419, DOI 10.1007/978-1-4614-4756-6_36; Diana MA, 2007, J NEUROSCI, V27, P3823, DOI 10.1523/JNEUROSCI.4719-06.2007; Dino MR, 2000, NEUROSCIENCE, V98, P625, DOI 10.1016/S0306-4522(00)00123-8; Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Durrnagel S, 2010, J BIOL CHEM, V285, P11958, DOI 10.1074/jbc.M109.059998; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Golubovic A, 2007, J BIOL CHEM, V282, P35098, DOI 10.1074/jbc.M706849200; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Grieco TM, 2002, J NEUROSCI, V22, P3100, DOI 10.1523/JNEUROSCI.22-08-03100.2002; Hogan B, 1994, MANIPULATING MOUSE E; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kim JA, 2012, CEREBELLUM, V11, P1012, DOI 10.1007/s12311-012-0380-8; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leng TD, 2013, ACTA PHARMACOL SIN, V34, P33, DOI 10.1038/aps.2012.81; Mugnaini E, 2011, BRAIN RES REV, V66, P220, DOI 10.1016/j.brainresrev.2010.10.001; Nunzi MG, 2002, J COMP NEUROL, V451, P189, DOI 10.1002/cne.10344; Nunzi MG, 2000, J COMP NEUROL, V422, P55, DOI 10.1002/(SICI)1096-9861(20000619)422:1<55::AID-CNE4>3.0.CO;2-9; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; REGAN LJ, 1991, J NEUROSCI, V11, P2259; ROSSI DJ, 1995, J NEUROPHYSIOL, V74, P24, DOI 10.1152/jn.1995.74.1.24; Ruigrok TJH, 2011, J NEUROSCI, V31, P712, DOI 10.1523/JNEUROSCI.1959-10.2011; Russo MJ, 2007, J PHYSIOL-LONDON, V581, P709, DOI 10.1113/jphysiol.2007.129106; Russo MJ, 2008, J NEUROPHYSIOL, V100, P3351, DOI 10.1152/jn.90533.2008; Sakai H, 1999, J PHYSIOL-LONDON, V519, P323, DOI 10.1111/j.1469-7793.1999.0323m.x; Schaefer L, 2000, FEBS LETT, V471, P205, DOI 10.1016/S0014-5793(00)01403-4; Sekerkova G, 2014, BRAIN STRUCT FUNCT, V219, P719, DOI 10.1007/s00429-013-0531-9; Sherwood TW, 2012, AM J PHYSIOL-CELL PH, V303, pC699, DOI 10.1152/ajpcell.00188.2012; Vergo S, 2011, BRAIN, V134, P571, DOI 10.1093/brain/awq337; Wiemuth D, 2013, CHANNELS, V7, P38, DOI 10.4161/chan.22406; Wiemuth D, 2012, FASEB J, V26, P4122, DOI 10.1096/fj.12-207043; Xiong ZG, 2008, CURR OPIN PHARMACOL, V8, P25, DOI 10.1016/j.coph.2007.09.001; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103	36	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91326	10.1371/journal.pone.0091326	http://dx.doi.org/10.1371/journal.pone.0091326			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663811	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900018
J	Bratu, VA; Erpenbeck, VJ; Fehrenbach, A; Rausch, T; Rittinghausen, S; Krug, N; Hohlfeld, JM; Fehrenbach, H				Bratu, Vlad A.; Erpenbeck, Veit J.; Fehrenbach, Antonia; Rausch, Tanja; Rittinghausen, Susanne; Krug, Norbert; Hohlfeld, Jens M.; Fehrenbach, Heinz			Cell Counting in Human Endobronchial Biopsies - Disagreement of 2D versus 3D Morphometry	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NECROSIS-FACTOR-ALPHA; AIRWAY INFLAMMATION; BRONCHIAL BIOPSIES; T-LYMPHOCYTES; NUMBER; STEREOLOGY; EFFICIENCY; ASTHMA; MACROPHAGES	Question: Inflammatory cell numbers are important endpoints in clinical studies relying on endobronchial biopsies. Assumption-based bidimensional (2D) counting methods are widely used, although theoretically design-based stereologic three-dimensional (3D) methods alone offer an unbiased quantitative tool. We assessed the method agreement between 2D and 3D counting designs in practice when applied to identical samples in parallel. Materials and Methods: Biopsies from segmental bronchi were collected from healthy non-smokers (n = 7) and smokers (n = 7), embedded and sectioned exhaustively. Systematic uniform random samples were immunohistochemically stained for macrophages (CD68) and T-lymphocytes (CD3), respectively. In identical fields of view, cell numbers per volume unit (N-V) were assessed using the physical disector (3D), and profiles per area unit (N-A) were counted (2D). For CD68(+) cells, profiles with and without nucleus were separately recorded. In order to enable a direct comparison of the two methods, the zero-dimensional CD68(+)/CD3(+)-ratio was calculated for each approach. Method agreement was tested by Bland-Altmann analysis. Results: In both groups, mean CD68(+)/CD3(+) ratios for N-V and N-A were significantly different (non-smokers: 0.39 and 0.68, p<0.05; smokers: 0.49 and 1.68, p<0.05). When counting only nucleated CD68(+) profiles, mean ratios obtained by 2D and 3D counting were similar, but the regression-based Bland-Altmann analysis indicated a bias of the 2D ratios proportional to their magnitude. This magnitude dependent deviation differed between the two groups. Conclusions: 2D counts of cell and nuclear profiles introduce a variable size-dependent bias throughout the measurement range. Because the deviation between the 3D and 2D data was different in the two groups, it precludes establishing a 'universal conversion formula'.	[Bratu, Vlad A.; Fehrenbach, Antonia; Rausch, Tanja; Fehrenbach, Heinz] Univ Marburg, Dept Pneumol, Univ Giessen & Marburg Lung Ctr, Marburg, Germany; [Erpenbeck, Veit J.; Rittinghausen, Susanne; Krug, Norbert; Hohlfeld, Jens M.] BREATH, Fraunhofer Inst Toxicol & Expt Med ITEM, Hannover, Germany; [Erpenbeck, Veit J.; Hohlfeld, Jens M.] Hannover Med Sch, Dept Resp Med, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany	Philipps University Marburg; Fraunhofer Gesellschaft; Hannover Medical School	Fehrenbach, H (corresponding author), Airway Res Ctr North, Leibniz Ctr Med & Biosci, Res Ctr Borstel, Borstel, Germany.	hfehrenbach@fz-borstel.de	Fehrenbach, Heinz/A-9161-2008	Fehrenbach, Heinz/0000-0003-1935-9411; Rittinghausen, Susanne/0000-0001-6468-6994; Hohlfeld, Jens/0000-0003-2646-6186	German Research Foundation [EXC306, SFB587, B8]	German Research Foundation(German Research Foundation (DFG))	The study was funded in part by public grants from the German Research Foundation to i) HF (Cluster of Excellence Inflammation at Interfaces, EXC306) and ii) to JMH (Collaborative Research Grant SFB587, B8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleva RM, 1998, CHEST, V113, P182, DOI 10.1378/chest.113.1.182; ALTMAN DG, 1993, STAT MED, V12, P917, DOI 10.1002/sim.4780121003; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; [Anonymous], 1987, Am Rev Respir Dis, V136, P1066; Barnes NC, 2000, RESP MED, V94, pS16, DOI 10.1016/S0954-6111(00)90128-8; BENTLEY AM, 1992, AM REV RESPIR DIS, V146, P500, DOI 10.1164/ajrccm/146.2.500; Bland JM, 2003, ULTRASOUND OBST GYN, V22, P85, DOI 10.1002/uog.122; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bousquet J, 2000, Respir Med, V94 Suppl F, pS1; BRADLEY BL, 1991, J ALLERGY CLIN IMMUN, V88, P661, DOI 10.1016/0091-6749(91)90160-P; Caroll ML, 2006, EUR RESPIR J, V28, P612, DOI 10.1183/09031936.06.00037006; CruzOrive LM, 1997, J MICROSC-OXFORD, V186, P93, DOI 10.1046/j.1365-2818.1997.1380695.x; Erpenbeck VJ, 2004, AM J RESP CRIT CARE, V169, P578, DOI 10.1164/rccm.200301-104OC; Faul JL, 1999, AM J RESP CRIT CARE, V160, P1457, DOI 10.1164/ajrccm.160.5.9812027; Fehrenbach H, 2003, EUR RESPIR J, V21, P421, DOI 10.1183/09031936.03.00083002; Fehrenbach H, 2006, P AM THORACIC SOC, V3, pA619; Gallagher EJ, 1996, ANN EMERG MED, V27, P236, DOI 10.1016/S0196-0644(96)80067-9; Gamble E, 2006, EUR RESPIR J, V27, P293, DOI 10.1183/09031936.06.00027705; Global Initiative for Chronic Obstructive Lung Disease, 2011, GUID WORKSH REP GLOB; GUNDERSEN HJG, 1981, J MICROSC-OXFORD, V121, P65, DOI 10.1111/j.1365-2818.1981.tb01199.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; GUNDERSEN HJG, 1978, MICROSC ACTA, V81, P107; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hale SL, 2011, TOXICOL PATHOL, V39, P52, DOI 10.1177/0192623310394213; HOLGATE ST, 1992, AM REV RESPIR DIS, V145, pS2, DOI 10.1164/ajrccm/145.2_Pt_2.S2; HOWARD CV, 1998, ROY MICRO S, V41, P1; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; HURD SZ, 1991, J ALLERGY CLIN IMMUN, V88, P808; Innes AL, 2006, CHEST, V130, P1102, DOI 10.1378/chest.130.4.1102; Jeffery P, 2003, AM J RESP CRIT CARE, V168, pS1, DOI 10.1164/rccm.200202-150WS; Jeffery Peter K, 2004, Proc Am Thorac Soc, V1, P176, DOI 10.1513/pats.200402-009MS; Jeffery PK, 1998, EUR RESPIR J, V11, P524; Jeffery PK, 2000, RESP MED, V94, pS9, DOI 10.1016/S0954-6111(00)90127-6; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; Jeffery PK, 1996, EUR RESPIR J, V9, P1583, DOI 10.1183/09031936.96.09081583; Kalisnik M., 2001, IMAGE ANAL STEREOL, V20, P15; Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092; Keller KK, 2013, J MICROSC-OXFORD, V251, P68, DOI 10.1111/jmi.12044; LAMANTIA KR, 1990, ANESTHESIOLOGY, V72, P781, DOI 10.1097/00000542-199005000-00001; Madsen KM, 1999, J AM SOC NEPHROL, V10, P1124; Miller PB, 1997, BIOL REPROD, V56, P909, DOI 10.1095/biolreprod56.4.909; Mouton P.R., 2001, PRINCIPLES PRACTICES; Ochs M, 2006, J MICROSC-OXFORD, V222, P188, DOI 10.1111/j.1365-2818.2006.01587.x; OShaughnessy TC, 1997, AM J RESP CRIT CARE, V155, P852, DOI 10.1164/ajrccm.155.3.9117016; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Poulter LW, 2000, RESP MED, V94, pS3, DOI 10.1016/S0954-6111(00)90126-4; Saper CB, 1996, J COMP NEUROL, V364, P5; SILVA JRLE, 1989, THORAX, V44, P668, DOI 10.1136/thx.44.8.668; Sont JK, 1997, EUR RESPIR J, V10, P2602, DOI 10.1183/09031936.97.10112602; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Sullivan P, 1998, EUR RESPIR J, V12, P811, DOI 10.1183/09031936.98.12040811; ten Hacken NHT, 1998, MODERN PATHOL, V11, P292; West MJ, 1996, J COMP NEUROL, V370, P11; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Woodruff PG, 2004, AM J RESP CRIT CARE, V169, P1001, DOI 10.1164/rccm.200311-1529OC; Woodruff PG, 2010, AM J RESP CRIT CARE, V181, P438, DOI 10.1164/rccm.200909-1415OC; Zar JH, 1999, BIOSTATISTICAL ANAL	59	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92510	10.1371/journal.pone.0092510	http://dx.doi.org/10.1371/journal.pone.0092510			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663339	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900067
J	Conter, LJ; Song, E; Shlomchik, MJ; Tomayko, MM				Conter, Laura J.; Song, Eunice; Shlomchik, Mark J.; Tomayko, Mary M.			CD73 Expression Is Dynamically Regulated in the Germinal Center and Bone Marrow Plasma Cells Are Diminished in Its Absence	PLOS ONE			English	Article							MEMORY B-CELLS; CD4 T-CELLS; MURINE MEMORY; ADENOSINE GENERATION; IMMUNE SUPPRESSION; PURINE METABOLISM; VASCULAR LEAKAGE; CUTTING EDGE; SELECTION; HYPOXIA	CD73 catalyzes the conversion of extracellular nucleosides to adenosine, modulating inflammatory and T cell responses. Elevated expression of CD73 marks subpopulations of murine memory B cells (MBC), but its role in memory development or function is unknown. Here, we demonstrate that CD73 is progressively upregulated on germinal center (GC) B cells following immunization, is expressed at even higher levels among T follicular helper cells, but is absent among plasma cells (PC) and plasmablasts (PB). We analyzed the T-dependent B cell response in CD73 knockout mice (CD73KO). During the early response, CD73KO and wild type (WT) mice formed GCs, MBCs and splenic PBs and PCs similarly, and MBCs functioned similarly in the early secondary response. Late in the primary response, however, bone marrow (BM) PCs were markedly decreased in CD73KO animals. Tracking this phenotype, we found that CD73 expression was required on BM-derived cells for optimal BM PC responses. However, deletion of CD73 from either B or T lymphocytes alone did not recapitulate the phenotype. This suggests that CD73 expression is sufficient on either cell type, consistent with its function as an ectoenzyme. Together, these findings suggest that CD73-dependent adenosine signaling is prominent in the mature GC and required for establishment of the long-lived PC compartment, thus identifying a novel role for CD73 in humoral immunity.	[Conter, Laura J.; Tomayko, Mary M.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Song, Eunice; Shlomchik, Mark J.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Shlomchik, Mark J.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Tomayko, MM (corresponding author), Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA.	mary.tomayko@yale.edu	Shlomchik, Mark J./AAN-6189-2020	Shlomchik, Mark J./0000-0002-2152-0959	National Institutes of Health [AI43603, K08AI78533]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI078533, R01AI043603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI43603 (MJS) and K08AI78533 (MMT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algars A, 2011, BLOOD, V117, P4387, DOI 10.1182/blood-2010-11-321646; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Anderson SM, 2006, IMMUNOL REV, V211, P280, DOI 10.1111/j.0105-2896.2006.00398.x; Anderson SM, 2009, J IMMUNOL, V183, P7314, DOI 10.4049/jimmunol.0902452; BASTIAN JF, 1984, J IMMUNOL, V132, P1767; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Castrop H, 2004, J CLIN INVEST, V114, P634, DOI 10.1172/JCI200421851; Clayton A, 2011, J IMMUNOL, V187, P676, DOI 10.4049/jimmunol.1003884; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cyster JG, 2003, IMMUNOL REV, V194, P48, DOI 10.1034/j.1600-065X.2003.00041.x; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Gomez MR, 2010, J IMMUNOL, V185, P7180, DOI 10.4049/jimmunol.1002319; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Hasko G, 2011, J IMMUNOL, V187, P4256, DOI 10.4049/jimmunol.1003379; Hershberg U, 2008, INT IMMUNOL, V20, P683, DOI 10.1093/intimm/dxn026; Huang S, 1997, BLOOD, V90, P1600, DOI 10.1182/blood.V90.4.1600.1600_1600_1610; Jin DC, 2010, CANCER RES, V70, P2245, DOI 10.1158/0008-5472.CAN-09-3109; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Kiss J, 2007, EUR J IMMUNOL, V37, P3334, DOI 10.1002/eji.200737793; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; Kumar V, 2009, EUR J PHARMACOL, V616, P7, DOI 10.1016/j.ejphar.2009.05.005; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; Mandapathil M, 2010, J BIOL CHEM, V285, P7176, DOI 10.1074/jbc.M109.047423; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; Pabst O, 2005, J IMMUNOL, V174, P7492, DOI 10.4049/jimmunol.174.12.7492; Regateiro FS, 2013, CLIN EXP IMMUNOL, V171, P1, DOI 10.1111/j.1365-2249.2012.04623.x; Regateiro FS, 2011, EUR J IMMUNOL, V41, P2955, DOI 10.1002/eji.201141512; Resta R, 1998, IMMUNOL REV, V161, P95, DOI 10.1111/j.1600-065X.1998.tb01574.x; Reutershan J, 2009, FASEB J, V23, P473, DOI 10.1096/fj.08-119701; Romio M, 2011, AM J PHYSIOL-CELL PH, V301, pC530, DOI 10.1152/ajpcell.00385.2010; Scholz JL, 2008, P NATL ACAD SCI USA, V105, P15517, DOI 10.1073/pnas.0807841105; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; SHLOMCHIK MJ, 1993, INT IMMUNOL, V5, P1329, DOI 10.1093/intimm/5.10.1329; Stagg J, 2011, CANCER RES, V71, P2892, DOI 10.1158/0008-5472.CAN-10-4246; Stagg J, 2010, P NATL ACAD SCI USA, V107, P1547, DOI 10.1073/pnas.0908801107; Stewart M, 2002, HISTOPATHOLOGY, V40, P253, DOI 10.1046/j.1365-2559.2002.01357.x; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Takedachi M, 2012, J CELL PHYSIOL, V227, P2622, DOI 10.1002/jcp.23001; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Tomayko MM, 2008, J IMMUNOL, V181, P27, DOI 10.4049/jimmunol.181.1.27; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Van TC, 2011, NAT IMMUNOL, V12, P151, DOI 10.1038/ni.1981; Volmer JB, 2006, J IMMUNOL, V176, P4449, DOI 10.4049/jimmunol.176.7.4449; Yamashita Y, 1998, EUR J IMMUNOL, V28, P2981, DOI 10.1002/(SICI)1521-4141(199810)28:10<2981::AID-IMMU2981>3.0.CO;2-D; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Yegutkin GG, 2010, J IMMUNOL, V184, P5112, DOI 10.4049/jimmunol.0902760; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	55	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92009	10.1371/journal.pone.0092009	http://dx.doi.org/10.1371/journal.pone.0092009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664100	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900038
J	Hu, R; Ling, W; Xu, W; Han, DM				Hu, Rong; Ling, Wei; Xu, Wen; Han, Demin			Fibroblast-Like Cells Differentiated from Adipose-Derived Mesenchymal Stem Cells for Vocal Fold Wound Healing	PLOS ONE			English	Article							TISSUE REGENERATION; HYALURONIC-ACID; LAMINA PROPRIA; STROMAL CELLS; MATRIX; EXPRESSION; INJECTION; DECORIN; VIVO	Tissue engineering has revealed the potential to regenerate injured vocal folds, and identification of the most suitable seed cells has remained a hot topic of research. The aim of this study was to implant fibroblast-like cells differentiated from adipose-derived mesenchymal stem cells (ADSCs) in a canine acute vocal fold wound model. We then sought to characterize changes in the extracellular matrix (ECM) proteins of vocal fold lamina propria. For this purpose, ADSCs were induced to differentiate into fibroblasts under the regulation of connective tissue growth factor in vitro. Cell surface proteins were identified by immunofluorescence staining. Thirty vocal folds of 17 canines were injured by localized resection and injected with fibroblast-like cells (differentiated ADSCs, dADSCs), ADSCs or vocal fold fibroblasts (VFFs). The morphology of vocal folds was observed, and the characteristics of ECM protein components (collagen, elastin, hyaluronic acid, decorin and fibronectin) were evaluated by immunofluorescence staining from 15 days to 6 months following implantation. The results showed that in vitro, the dADSCs showed morphology and cell surface protein expression similar to those of VFFs. After implantation in vivo, the surfaces of the recipient vocal folds became almost smooth in the dADSCs and ADSCs groups at 6 months but remained slightly concave and stiff in the VFFs group. The elastin fluorescence intensity increased significantly and was maintained at a high level in the dADSCs group. The collagen fluorescence intensity increased slightly in the dADSCs and ADSCs groups, whereas it demonstrated a more irregular arrangement in the VFFs group. The fluorescence intensity of hyaluronic acid, decorin and fibronectin was similar between the three implanted groups. These results indicated that dADSCs may confer an advantage for vocal fold wound healing. Furthermore, dADSCs have the ability to secrete ECM components in vivo, particularly elastin, which may be beneficial for vocal fold vibration recovery.	[Hu, Rong; Xu, Wen; Han, Demin] Capital Med Univ, Beijing Tongren Hosp, Dept Otorhinolaryngol Head Neck Surg, Beijing, Peoples R China; [Ling, Wei] Capital Med Univ, Dept Anat, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Xu, W (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Otorhinolaryngol Head Neck Surg, Beijing, Peoples R China.	xuwendoc@gmail.com; handm@trhos.com			National Natural Science Foundation of China [30973294]; Beijing Natural Science Foundation [7102031]; program for Beijing Health Foundation of High-level Technical Personnel [2009-3-33]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); program for Beijing Health Foundation of High-level Technical Personnel	This study was supported by the National Natural Science Foundation of China (30973294), Beijing Natural Science Foundation (7102031) and program for Beijing Health Foundation of High-level Technical Personnel (2009-3-33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae S, 2009, CELL TISSUE RES, V335, P565, DOI 10.1007/s00441-008-0729-y; Bourget JM, 2012, BIOMATERIALS, V33, P9205, DOI 10.1016/j.biomaterials.2012.09.015; Cedervall J, 2007, LARYNGOSCOPE, V117, P2075, DOI 10.1097/MLG.0b013e3181379c7c; Chhetri DK, 2011, LARYNGOSCOPE, V121, P785, DOI 10.1002/lary.21417; Chhetri DK, 2004, OTOLARYNG HEAD NECK, V131, P864, DOI 10.1016/j.otohns.2004.07.010; Gaston J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030965; Halfon S, 2011, STEM CELLS DEV, V20, P53, DOI 10.1089/scd.2010.0040; Hall-Glenn F, 2011, CELL MOL LIFE SCI, V68, P3209, DOI 10.1007/s00018-011-0782-7; Hertegard S, 2006, LARYNGOSCOPE, V116, P1248, DOI 10.1097/01.mlg.0000224548.68499.35; Hirano M, 1981, CLIN EXAMINATION VOI, P5; Hirano S, 2003, ANN OTO RHINOL LARYN, V112, P617, DOI 10.1177/000348940311200708; Johnson BQ, 2010, LARYNGOSCOPE, V120, P537, DOI 10.1002/lary.20782; Kanemaru S, 2005, ANN OTO RHINOL LARYN, V114, P907, DOI 10.1177/000348940511401203; Kanemaru SI, 2003, ANN OTO RHINOL LARYN, V112, P915, DOI 10.1177/000348940311201101; Kim YM, 2014, LARYNGOSCOPE, V124, pE64, DOI 10.1002/lary.24405; Krishna P, 2006, OTOLARYNG HEAD NECK, V135, P937, DOI 10.1016/j.otohns.2006.07.011; Krishna P, 2010, LARYNGOSCOPE, V120, P2247, DOI 10.1002/lary.21087; Kumai Y, 2010, LARYNGOSCOPE, V120, P330, DOI 10.1002/lary.20753; Lee BJ, 2006, CELLS TISSUES ORGANS, V184, P198, DOI 10.1159/000099627; Lee CH, 2010, J CLIN INVEST, V120, P3340, DOI 10.1172/JCI43230; Liang Q, 2012, LARYNGOSCOPE, V122, P1815, DOI 10.1002/lary.23330; Lim JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054256; Ohno T, 2008, EUR ARCH OTO-RHINO-L, V265, P669, DOI 10.1007/s00405-007-0522-7; Rodriguez-Menocal L, 2012, STEM CELL TRANSL MED, V1, P221, DOI 10.5966/sctm.2011-0029; Rousseau B, 2003, LARYNGOSCOPE, V113, P620, DOI 10.1097/00005537-200304000-00007; Sahiner N, 2008, J BIOMAT SCI-POLYM E, V19, P223, DOI 10.1163/156856208783432462; Svensson B, 2010, LARYNGOSCOPE, V120, P1370, DOI 10.1002/lary.20926; Tateya I, 2006, ANN OTO RHINOL LARYN, V115, P135, DOI 10.1177/000348940611500210; Tateya T, 2006, ANN OTO RHINOL LARYN, V115, P285, DOI 10.1177/000348940611500406; Thibeault SL, 2002, ANN OTO RHINOL LARYN, V111, P8, DOI 10.1177/000348940211100102; Thibeault SL, 2009, TISSUE ENG PT A, V15, P1481, DOI 10.1089/ten.tea.2008.0299; Tong ZX, 2011, TISSUE ENG PT A, V17, P2773, DOI [10.1089/ten.TEA.2011.0219, 10.1089/ten.tea.2011.0219]; Xu W, 2011, ANN OTO RHINOL LARYN, V120, P123, DOI 10.1177/000348941112000209; Zinchuk V, 2011, NAT PROTOC, V6, P1554, DOI 10.1038/nprot.2011.384; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	35	38	41	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92676	10.1371/journal.pone.0092676	http://dx.doi.org/10.1371/journal.pone.0092676			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664167	Green Submitted, gold, Green Published			2022-12-27	WOS:000333459900095
J	Mirshahi, S; Soria, C; Kouchakji, B; Kierzek, G; Borg, JY; Varin, R; Chidiac, J; Drouet, L; Mirshahi, M; Soria, J				Mirshahi, Shahsoltan; Soria, Claudine; Kouchakji, Basile; Kierzek, Gerald; Borg, Jeanne Yvonne; Varin, Remi; Chidiac, Jean; Drouet, Ludovic; Mirshahi, Massoud; Soria, Jeannette			New Combinational Assay Using Soluble Fibrin and D-Dimer Determinations: A Promising Strategy for Identifying Patients with Suspected Venous Thromboembolism	PLOS ONE			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; MONOCLONAL-ANTIBODY; ENZYME-IMMUNOASSAY; DIAGNOSTIC-AID; PLASMA; DISEASE; ANTITHROMBIN; EXCLUSION	Aim: To establish a new and reliable assay for quantification of the soluble fibrin (SF) in combination with that of D-dimer for early diagnosis of venous thromboembolism. Methods and Samples: The SF assay is based on D-dimer generated after incubation of plasma with tissue-type plasminogen activator (t-PA). SF and standard D-dimer assays, run in blind, were used to test 119 untreated outpatients with clinically suspected deep-vein thrombosis (DVT, 49 patients) or pulmonary embolism (PE, 70 patients) consulting at the emergency unit of the hospital. Thromboses were confirmed by current imaging methods such as ultrasonography, scintigraphy, computed tomographic pulmonary angiography (CTPA) and ventilation/perfusion scan. Results: SF assay was validated in 270 healthy volunteers [51.8% males; mean age years +/- SD: 41 +/- 13; age range 19 to 65]. Among these normal plasmas, SF levels were <= 200 ng/mL in 97.8% of them, and 200-250 ng/mL in the remainder [26-46 years old; 50% males]. ROC curves were used to determine the SF cut-off value for plasma SF positivity, which was found to be 300 ng/mL. In patients with suspected venous thromboembolism, SF sensitivities for DVT and PE (92% and 94%, respectively) were comparable to those of D-dimer (96% and 94%), whereas SF specificities (86% and 95%) were higher than those of D-dimer (50% and 54%). Positive-predictive values for SF (89% and 94%) were again higher than those of D-dimer (70% and 65%) in DVT and PE. The amount of circulating SF normalized rapidly after anticoagulant therapy. Conclusion: Results from this small group of patients suggest that the evaluation of plasma SF, in combination with that of D-dimer, represents a potentially useful tool for the early diagnosis of venous thromboembolism, provided that the patients have not been treated previously by anticoagulants.	[Mirshahi, Shahsoltan; Chidiac, Jean; Mirshahi, Massoud; Soria, Jeannette] Hop Hotel Dieu, Serv Oncohematol, Paris, France; [Mirshahi, Shahsoltan; Mirshahi, Massoud; Soria, Jeannette] Univ Paris 07, INSERM, UMR U965, Paris, France; [Soria, Claudine; Drouet, Ludovic] Hop Lariboisiere, Hematol Lab, F-75475 Paris, France; Fac Med & Pharm, Lab MERCI, Rouen, France; [Kouchakji, Basile] Hop Neuilly, Serv Pneumol, Neuilly, France; [Kierzek, Gerald] Hop Hotel Dieu, Serv Urgences, Paris, France; [Borg, Jeanne Yvonne; Varin, Remi] Hop Charles Nicolle, Rouen, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Rouen	Soria, J (corresponding author), Hop Hotel Dieu, Serv Oncohematol, Paris, France.	jeannette.soria@htd.aphp.fr	DROUET, ludovic/GYR-3249-2022					Arkel YS, 2002, BLOOD COAGUL FIBRIN, V13, P199, DOI 10.1097/00001721-200204000-00005; Arkel YS, 2001, THROMB HAEMOSTASIS, V86, P1127; BIANCONE L, 1994, ITAL J GASTROENTEROL, V26, P116; BOUNAMEAUX H, 1991, LANCET, V337, P196, DOI 10.1016/0140-6736(91)92158-X; BOUNAMEAUX H, 1992, THROMB HAEMOSTASIS, V67, P603; BOUNAMEAUX H, 1991, J MAL VASCUL, V16, P133; Bounameaux H, 1990, BLOOD COAGUL FIBRIN, V1, P1577; Brimble KS, 1997, THROMB RES, V88, P291, DOI 10.1016/S0049-3848(97)00256-9; Brummel KE, 1999, J BIOL CHEM, V274, P22862, DOI 10.1074/jbc.274.32.22862; CHANDLER WL, 1990, BLOOD, V76, P930; Crowther MA, 2001, THROMB HAEMOSTASIS, V85, P390; DEMPFLE CE, 1993, BLOOD COAGUL FIBRIN, V4, P79, DOI 10.1097/00001721-199304010-00013; Dempfle CE, 2004, THROMB HAEMOSTASIS, V91, P812, DOI 10.1160/TH03-09-0577; Dempfle CE, 2001, THROMB HAEMOSTASIS, V86, P1204; DEMPFLE CE, 1995, THROMB HAEMOSTASIS, V74, P673; Derhaschnig U, 2002, CLIN CHEM, V48, P1924; Dirix LY, 2002, BRIT J CANCER, V86, P389, DOI 10.1038/sj.bjc.6600069; Duet M, 1998, THROMB RES, V91, P1, DOI 10.1016/S0049-3848(98)00048-6; EISENBERG PR, 1990, CIRCULATION, V82, P841, DOI 10.1161/01.CIR.82.3.841; Flores J, 2003, ARCH PATHOL LAB MED, V127, P310; Ginsberg JS, 1996, THROMB HAEMOSTASIS, V75, P551; GINSBERG JS, 1995, THROMB HAEMOSTASIS, V74, P833; Goldhaber SZ, 1992, J AM COLL CARDIOL, V9, P246; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hetland O, 2002, BLOOD COAGUL FIBRIN, V13, P301, DOI 10.1097/00001721-200206000-00005; HOGG PJ, 1989, P NATL ACAD SCI USA, V86, P3619, DOI 10.1073/pnas.86.10.3619; Iversen LH, 1996, THROMB RES, V81, P569, DOI 10.1016/0049-3848(96)00031-X; Koga Shin, 2004, Rinsho Byori, V52, P355; LaCapra S, 2000, BLOOD COAGUL FIBRIN, V11, P371, DOI 10.1097/00001721-200006000-00009; Lehman CM, 2004, AM J CLIN PATHOL, V122, P178, DOI 10.1309/X4YN001GU51NGG9Y; Lippi G, 2007, HAEMATOLOGICA, V92, P53, DOI 10.3324/haematol.12237; Mac Gillavry MR, 2000, THROMB HAEMOSTASIS, V84, P474; MIRSHAHI SS, 1992, CANCER, V69, P2289, DOI 10.1002/1097-0142(19920501)69:9<2289::AID-CNCR2820690914>3.0.CO;2-A; MOSESSON MW, 1963, J LAB CLIN MED, V62, P663; Nakahara K, 2003, THROMB HAEMOSTASIS, V89, P832; NIEUWENHUIZEN W, 1992, THROMB HAEMOSTASIS, V68, P273; NIEUWENHUIZEN W, 1993, BLOOD COAGUL FIBRIN, V4, P93, DOI 10.1097/00001721-199304010-00015; Okajima K, 1996, AM J HEMATOL, V51, P186, DOI 10.1002/(SICI)1096-8652(199603)51:3<186::AID-AJH2>3.0.CO;2-T; Reber G, 1999, THROMB HAEMOSTASIS, V81, P221; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; ROTKER J, 1986, EUR J BIOCHEM, V155, P583, DOI 10.1111/j.1432-1033.1986.tb09528.x; Scarano L, 1999, BLOOD COAGUL FIBRIN, V10, P245, DOI 10.1097/00001721-199907000-00005; SORIA J, 1983, BRIT J HAEMATOL, V53, P575, DOI 10.1111/j.1365-2141.1983.tb07309.x; Wada H, 2003, CLIN APPL THROMB-HEM, V9, P233, DOI 10.1177/107602960300900308; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010	46	8	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92379	10.1371/journal.pone.0092379	http://dx.doi.org/10.1371/journal.pone.0092379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664182	Green Submitted, gold, Green Published			2022-12-27	WOS:000333459900058
J	Su, S; Panmanee, W; Wilson, JJ; Mahtani, HK; Li, Q; VanderWielen, BD; Makris, TM; Rogers, M; McDaniel, C; Lipscomb, JD; Irvin, RT; Schurr, MJ; Lancaster, JR; Kovall, RA; Hassett, DJ				Su, Shengchang; Panmanee, Warunya; Wilson, Jeffrey J.; Mahtani, Harry K.; Li, Qian; VanderWielen, Bradley D.; Makris, Thomas M.; Rogers, Melanie; McDaniel, Cameron; Lipscomb, John D.; Irvin, Randall T.; Schurr, Michael J.; Lancaster, Jack R., Jr.; Kovall, Rhett A.; Hassett, Daniel J.			Catalase (KatA) Plays a Role in Protection against Anaerobic Nitric Oxide in Pseudomonas aeruginosa	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; DINITROSYL-IRON COMPLEXES; CYSTIC-FIBROSIS PATIENTS; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATOR; SUPEROXIDE-DISMUTASE; BURKHOLDERIA-CEPACIA; TREATMENT STRATEGIES; NITRATE RESPIRATION	Pseudomonas aeruginosa (PA) is a common bacterial pathogen, responsible for a high incidence of nosocomial and respiratory infections. KatA is the major catalase of PA that detoxifies hydrogen peroxide (H2O2), a reactive oxygen intermediate generated during aerobic respiration. Paradoxically, PA displays elevated KatA activity under anaerobic growth conditions where the substrate of KatA, H2O2, is not produced. The aim of the present study is to elucidate the mechanism underlying this phenomenon and define the role of KatA in PA during anaerobiosis using genetic, biochemical and biophysical approaches. We demonstrated that anaerobic wild-type PAO1 cells yielded higher levels of katA transcription and expression than aerobic cells, whereas a nitrite reductase mutant Delta nirS produced similar to 50% the KatA activity of PAO1, suggesting that a basal NO level was required for the increased KatA activity. We also found that transcription of the katA gene was controlled, in part, by the master anaerobic regulator, ANR. A Delta katA mutant and a mucoid mucA22 Delta katA bacteria demonstrated increased sensitivity to acidified nitrite (an NO generator) in anaerobic planktonic and biofilm cultures. EPR spectra of anaerobic bacteria showed that levels of dinitrosyl iron complexes (DNIC), indicators of NO stress, were increased significantly in the DkatA mutant, and dramatically in a Delta norCB mutant compared to basal levels of DNIC in PAO1 and DnirS mutant. Expression of KatA dramatically reduced the DNIC levels in Delta norCB mutant. We further revealed direct NO-KatA interactions in vitro using EPR, optical spectroscopy and X-ray crystallography. KatA has a 5-coordinate high spin ferric heme that binds NO without prior reduction of the heme iron (K-d similar to 6 mu M). Collectively, we conclude that KatA is expressed to protect PA against NO generated during anaerobic respiration. We proposed that such protective effects of KatA may involve buffering of free NO when potentially toxic concentrations of NO are approached.	[Su, Shengchang; Panmanee, Warunya; Wilson, Jeffrey J.; VanderWielen, Bradley D.; McDaniel, Cameron; Kovall, Rhett A.; Hassett, Daniel J.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45221 USA; [Mahtani, Harry K.; Li, Qian; Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL USA; [Mahtani, Harry K.; Li, Qian; Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Dept Cell, Birmingham, AL USA; [Mahtani, Harry K.; Li, Qian; Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Dept Dev & Integrat Biol, Birmingham, AL USA; [Mahtani, Harry K.; Li, Qian; Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Dept Environm Hlth Sci, Birmingham, AL USA; [Makris, Thomas M.; Rogers, Melanie; Lipscomb, John D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA; [Irvin, Randall T.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Schurr, Michael J.] Univ Colorado, Dept Microbiol, Aurora, CO USA; [Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL USA	University System of Ohio; University of Cincinnati; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Minnesota System; University of Minnesota Twin Cities; University of Alberta; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Alabama System; University of Alabama Birmingham	Hassett, DJ (corresponding author), Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45221 USA.	Daniel.Hassett@UC.Edu	Makris, Thomas/W-9965-2019; Schurr, Michael/AAX-6596-2020; Schurr, Michael/I-2481-2013	Makris, Thomas/0000-0001-7927-620X; Schurr, Michael/0000-0003-2585-0477; Lipscomb, John/0000-0002-8158-5594	Department of Veterans Affairs; Cincinnati VA Hospital (Cincinnati, OH); National Institutes of Health [GM100943]; Daniel Tyler Health and Education Foundation (Fort Collins, CO); Cystic Fibrosis Research, Inc. (Mountain View, CA); Cure Finders, Inc. (Sevierville, TN); Aires Pharma (San Diego, CA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024689, R01GM100943] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); Cincinnati VA Hospital (Cincinnati, OH); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Daniel Tyler Health and Education Foundation (Fort Collins, CO); Cystic Fibrosis Research, Inc. (Mountain View, CA); Cure Finders, Inc. (Sevierville, TN); Aires Pharma (San Diego, CA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Merit Review from the Department of Veterans Affairs, Cincinnati VA Hospital (Cincinnati, OH) (D.J.H.) and a National Institutes of Health Grant (GM100943, J.D.L.). Additional support was received from and the Daniel Tyler Health and Education Foundation (Fort Collins, CO) and from Cystic Fibrosis Research, Inc. (Mountain View, CA), Cure Finders, Inc. (Sevierville, TN), and Aires Pharma (San Diego, CA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antus B, 2010, AM J RESP CRIT CARE, V182, P1492, DOI 10.1164/rccm.201003-0451OC; ARAI H, 1995, FEBS LETT, V371, P73, DOI 10.1016/0014-5793(95)00885-D; ARAI H, 1995, BBA-GENE STRUCT EXPR, V1261, P279, DOI 10.1016/0167-4781(95)00018-C; Arai H, 2005, J BACTERIOL, V187, P3960, DOI 10.1128/JB.187.12.3960-3968.2005; Arai H, 1999, FEMS MICROBIOL LETT, V170, P19, DOI 10.1111/j.1574-6968.1999.tb13350.x; Arai H, 1997, MOL MICROBIOL, V25, P1141, DOI 10.1046/j.1365-2958.1997.5431906.x; Bandara DMI, 2011, J INORG BIOCHEM, V105, P1786, DOI 10.1016/j.jinorgbio.2011.09.026; BROWN GC, 1995, EUR J BIOCHEM, V232, P188, DOI 10.1111/j.1432-1033.1995.tb20798.x; BROWN SM, 1995, J BACTERIOL, V177, P6536, DOI 10.1128/jb.177.22.6536-6544.1995; BUZY A, 1995, J PROTEIN CHEM, V14, P59, DOI 10.1007/BF01888363; Castiglione N, 2009, MICROBIOL-SGM, V155, P2838, DOI 10.1099/mic.0.028027-0; Crack JC, 2013, J BIOL CHEM, V288, P11492, DOI 10.1074/jbc.M112.439901; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; Downey DG, 2009, THORAX, V64, P81, DOI 10.1136/thx.2007.082388; Elkins JG, 1999, APPL ENVIRON MICROB, V65, P4594; FARINHA MA, 1990, J BACTERIOL, V172, P3496, DOI 10.1128/jb.172.6.3496-3499.1990; Favero MS, 1996, AM J INFECT CONTROL, V24, P380; Frederick JR, 2001, APPL ENVIRON MICROB, V67, P1375, DOI 10.1128/AEM.67.3.1375-1379.2001; GALIMAND M, 1991, J BACTERIOL, V173, P1598, DOI 10.1128/jb.173.5.1598-1606.1991; Gardner PR, 1997, J BIOL CHEM, V272, P25071, DOI 10.1074/jbc.272.40.25071; Garrett ES, 1999, J BACTERIOL, V181, P7401, DOI 10.1128/JB.181.23.7401-7404.1999; Giardina G, 2008, J MOL BIOL, V378, P1002, DOI 10.1016/j.jmb.2008.03.013; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; HANCOCK REW, 1983, INFECT IMMUN, V42, P170, DOI 10.1128/IAI.42.1.170-177.1983; Hasset DJ, 2000, J BACTERIOL, V182, P4557, DOI 10.1128/JB.182.16.4557-4563.2000; Hassett DJ, 2010, EXPERT OPIN THER TAR, V14, P117, DOI 10.1517/14728220903454988; Hassett DJ, 1999, MOL MICROBIOL, V34, P1082, DOI 10.1046/j.1365-2958.1999.01672.x; Hassett DJ, 2002, ADV DRUG DELIVER REV, V54, P1425, DOI 10.1016/S0169-409X(02)00152-7; HASSETT DJ, 1992, INFECT IMMUN, V60, P328, DOI 10.1128/IAI.60.2.328-336.1992; Hassett DJ, 1999, METHOD ENZYMOL, V310, P599; Hassett DJ, 2006, OXIDATIVE STRESS SYS, P544; Heo YJ, 2010, J BACTERIOL, V192, P381, DOI 10.1128/JB.00980-09; Hickok JR, 2011, FREE RADICAL BIO MED, V51, P1558, DOI 10.1016/j.freeradbiomed.2011.06.030; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Kim SH, 2009, J MICROBIOL BIOTECHN, V19, P1520, DOI 10.4014/jmb.0906.06028; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Korshunov S, 2010, MOL MICROBIOL, V75, P1389, DOI 10.1111/j.1365-2958.2010.07059.x; Landry AP, 2011, FREE RADICAL BIO MED, V50, P1582, DOI 10.1016/j.freeradbiomed.2011.03.005; Lee JS, 2005, INFECT IMMUN, V73, P4399, DOI 10.1128/IAI.73.7.4399-4403.2005; Lu TT, 2010, CHEM-EUR J, V16, P8088, DOI 10.1002/chem.201000524; Ma JF, 1999, J BACTERIOL, V181, P3730, DOI 10.1128/JB.181.12.3730-3742.1999; Major TA, 2010, ANTIMICROB AGENTS CH, V54, P4671, DOI 10.1128/AAC.00379-10; Maniatis T., 1982, MOL CLONING; MARTIN DW, 1993, P NATL ACAD SCI USA, V90, P8377, DOI 10.1073/pnas.90.18.8377; Martinez-Solano L, 2008, CLIN INFECT DIS, V47, P1526, DOI 10.1086/593186; Mayburd AL, 2002, BIOCHEMISTRY-US, V41, P11582, DOI 10.1021/bi020058l; Miller JH., 1992, SHORT COURSE BACTERI, P72; O'Toole GA, 2003, J BACTERIOL, V185, P2687, DOI 10.1128/JB.185.9.2687-2689.2003; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; OHMAN DE, 1981, INFECT IMMUN, V33, P142, DOI 10.1128/IAI.33.1.142-148.1981; Panmanee W, 2008, J BACTERIOL, V190, P3658, DOI 10.1128/JB.00022-08; Panmanee W, 2009, FEMS MICROBIOL LETT, V295, P238, DOI 10.1111/j.1574-6968.2009.01605.x; Pela R, 1998, Monaldi Arch Chest Dis, V53, P262; Petrova OE, 2012, P NATL ACAD SCI USA, V109, P16690, DOI 10.1073/pnas.1207832109; Platt MD, 2008, J BACTERIOL, V190, P2739, DOI 10.1128/JB.01683-07; Purwar N, 2011, BIOCHEMISTRY-US, V50, P4491, DOI 10.1021/bi200130r; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; Quint JK, 2007, J ALLERGY CLIN IMMUN, V119, P1065, DOI 10.1016/j.jaci.2006.12.640; Ren BB, 2008, MOL MICROBIOL, V70, P953, DOI 10.1111/j.1365-2958.2008.06464.x; Schobert M, 2010, INT J MED MICROBIOL, V300, P549, DOI 10.1016/j.ijmm.2010.08.007; Schreiber K, 2007, J BACTERIOL, V189, P4310, DOI 10.1128/JB.00240-07; SCHWEIZER HP, 1995, GENE, V158, P15, DOI 10.1016/0378-1119(95)00055-B; SCHWEIZER HP, 1993, BIOTECHNIQUES, V15, P831; SHIMIZU N, 1988, J BIOCHEM-TOKYO, V104, P136, DOI 10.1093/oxfordjournals.jbchem.a122409; Shin DH, 2008, J BACTERIOL, V190, P2663, DOI 10.1128/JB.01580-07; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Smith AW, 1999, J MED MICROBIOL, V48, P419, DOI 10.1099/00222615-48-5-419; Soum E, 2003, J BIOL INORG CHEM, V8, P226, DOI 10.1007/s00775-002-0412-9; Su SC, 2012, EXPERT OPIN THER TAR, V16, P859, DOI 10.1517/14728222.2012.708025; Toledo JC, 2008, J BIOL CHEM, V283, P28926, DOI 10.1074/jbc.M707862200; Trunk K, 2010, ENVIRON MICROBIOL, V12, P1719, DOI 10.1111/j.1462-2920.2010.02252.x; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Valderrey AD, 2010, DIAGN MICR INFEC DIS, V68, P20, DOI 10.1016/j.diagmicrobio.2010.04.008; Vanin AF, 2007, NITRIC OXIDE-BIOL CH, V16, P82, DOI 10.1016/j.niox.2006.07.005; Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003; Wei Q, 2012, NUCLEIC ACIDS RES, V40, P4320, DOI 10.1093/nar/gks017; Winterbourn CC, 2006, J BIOL CHEM, V281, P39860, DOI 10.1074/jbc.M605898200; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Ye SF, 2010, J AM CHEM SOC, V132, P3646, DOI 10.1021/ja9091616; Yoon SS, 2007, EMBO J, V26, P3662, DOI 10.1038/sj.emboj.7601787; Yoon SS, 2006, J CLIN INVEST, V116, P436, DOI 10.1172/JCI24684; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	88	32	33	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91813	10.1371/journal.pone.0091813	http://dx.doi.org/10.1371/journal.pone.0091813			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663218	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900030
J	Akbarzadeh, S; Arof, AK; Ramesh, S; Khanmirzaei, MH; Nor, RM				Akbarzadeh, S.; Arof, A. K.; Ramesh, S.; Khanmirzaei, M. H.; Nor, R. M.			Prediction of Conductivity by Adaptive Neuro-Fuzzy Model	PLOS ONE			English	Article							INFERENCE SYSTEM; SPECTROSCOPY; TRANSPORT; ANFIS	Electrochemical impedance spectroscopy (EIS) is a key method for the characterizing the ionic and electronic conductivity of materials. One of the requirements of this technique is a model to forecast conductivity in preliminary experiments. The aim of this paper is to examine the prediction of conductivity by neuro-fuzzy inference with basic experimental factors such as temperature, frequency, thickness of the film and weight percentage of salt. In order to provide the optimal sets of fuzzy logic rule bases, the grid partition fuzzy inference method was applied. The validation of the model was tested by four random data sets. To evaluate the validity of the model, eleven statistical features were examined. Statistical analysis of the results clearly shows that modeling with an adaptive neuro-fuzzy is powerful enough for the prediction of conductivity.	[Akbarzadeh, S.; Arof, A. K.; Khanmirzaei, M. H.] Univ Malaya, Ctr Ion, Dept Phys, Kuala Lumpur, Malaysia; [Ramesh, S.; Nor, R. M.] Univ Malaya, Fac Sci, Dept Phys, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Nor, RM (corresponding author), Univ Malaya, Fac Sci, Dept Phys, Kuala Lumpur, Malaysia.	rmdnor@um.edu.my	Ramesh, T.Subramaniam/C-2353-2009; Arof, Abdul Kariem BinHj M/A-3389-2009; NOR, ROSLAN MD/B-5221-2010; Khanmirzaei, Mohammad Hassan/F-7826-2011; Akbarzadeh, Saman/I-6287-2013	Ramesh, T.Subramaniam/0000-0002-5505-6429; NOR, ROSLAN MD/0000-0003-0649-2272; Khanmirzaei, Mohammad Hassan/0000-0003-3372-0867; Akbarzadeh, Saman/0000-0003-4293-1797	University of Malaya under IPPP [PV094-2012A]	University of Malaya under IPPP	This work was funded by the University of Malaya under IPPP Grant no. PV094-2012A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsoukov E, 2005, IMPEDANCE SPECTROSCOPY: THEORY, EXPERIMENT, AND APPLICATIONS, 2ND EDITION, pXII; Beitollah H, 2012, J MOL LIQ, V173, P137, DOI 10.1016/j.molliq.2012.06.026; Bonanos N, 2012, IMPEDANCE SPECTROSCO; Caydas U, 2009, EXPERT SYST APPL, V36, P6135, DOI 10.1016/j.eswa.2008.07.019; Chang BY, 2010, ANNU REV ANAL CHEM, V3, P207, DOI 10.1146/annurev.anchem.012809.102211; Cohen A, 2009, ORGAN RES METHODS, V12, P148, DOI 10.1177/1094428107300365; Costa SIR, 2013, RSC ADV, V3, P7030, DOI 10.1039/c3ra40216a; Dudek M, 2008, J EUR CERAM SOC, V28, P965, DOI 10.1016/j.jeurceramsoc.2007.09.004; Erdinc O, 2010, RENEW SUST ENERG REV, V14, P2874, DOI 10.1016/j.rser.2010.07.060; Erdinc O, 2009, J POWER SOURCES, V194, P369, DOI 10.1016/j.jpowsour.2009.04.072; Jancikova Z, 2013, METALURGIJA, V52, P379; Jang J-SR., 1997, IEEE T AUTOMAT CONTR, V42, P1482, DOI [10.1109/TAC.1997.633847, DOI 10.1109/TAC.1997.633847]; JANG JSR, 1993, IEEE T SYST MAN CYB, V23, P665, DOI 10.1109/21.256541; Khanmirzaei MH, 2013, INT J ELECTROCHEM SC, V8, P9977; Liu J, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.174122; Macdonald DD, 2006, ELECTROCHIM ACTA, V51, P1376, DOI 10.1016/j.electacta.2005.02.107; Mendel J. M., 2017, UNCERTAIN RULE BASED, V2nd, DOI 10.1007/978-3-319-51370-6; Mizuno Y, 2012, ELECTROCHIM ACTA, V63, P139, DOI 10.1016/j.electacta.2011.12.068; Montero J, 2007, FUZZY SET SYST, V158, P2429, DOI 10.1016/j.fss.2007.04.021; Nauck D., 1997, FDN NEUROFUZZY SYSTE, DOI DOI 10.1029/2009GL041009; Onat N, 2010, INT J PHOTOENERGY, V2010, DOI 10.1155/2010/245316; Pedrycz W, 2009, NEUROCOMPUTING, V73, P10, DOI 10.1016/j.neucom.2008.10.027; Peng HJ, 2012, J POWER SOURCES, V197, P310, DOI 10.1016/j.jpowsour.2011.09.046; Prashantha K, 2009, COMPOS SCI TECHNOL, V69, P1756, DOI 10.1016/j.compscitech.2008.10.005; Rabinovich S, 2013, INT VOCABULARY METRO, P269; Rao BS, 2012, CHALCOGENIDE LETT, V9, P517; Ravanbod H, 2005, NDT&E INT, V38, P643, DOI 10.1016/j.ndteint.2005.03.001; Ross T.J., 2009, FUZZY LOGIC ENG APPL; Schneider H, 2008, J EUR CERAM SOC, V28, P329, DOI 10.1016/j.jeurceramsoc.2007.03.017; Thirugnanasambandam M, 2010, RENEW SUST ENERG REV, V14, P312, DOI 10.1016/j.rser.2009.07.014; Tkacik G, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/03/P03011; Tonurist K, 2012, ELECTROCHEM COMMUN, V22, P77, DOI 10.1016/j.elecom.2012.05.029; Wieland D, 2002, COMPUT-AIDED CIV INF, V17, P104, DOI 10.1111/1467-8667.00259; Willmott C.J., 1981, PHYS GEOGR, V2, P184, DOI [10.1080/02723646.1981.10642213, DOI 10.1080/02723646.1981.10642213]; Yetilmezsoy K, 2011, COLLOID SURFACE A, V389, P50, DOI 10.1016/j.colsurfa.2011.08.051; Ying LC, 2008, ENERG CONVERS MANAGE, V49, P205, DOI 10.1016/j.enconman.2007.06.015; Yoon S, 2010, J POWER SOURCES, V195, P4391, DOI 10.1016/j.jpowsour.2010.01.086; Zandi M, 2011, IEEE T VEH TECHNOL, V60, P433, DOI 10.1109/TVT.2010.2091433	38	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92241	10.1371/journal.pone.0092241	http://dx.doi.org/10.1371/journal.pone.0092241			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658582	gold, Green Submitted, Green Published			2022-12-27	WOS:000333355300063
J	Liu, HJ; Xu, YF; Sun, YH; Dumenci, L				Liu, Hongjie; Xu, Yongfang; Sun, Yehuan; Dumenci, Levent			Measuring HIV Stigma at the Family Level: Psychometric Assessment of the Chinese Courtesy Stigma Scales (CCSSs)	PLOS ONE			English	Article							SERVICE PROVIDERS; AIDS; INFECTION; CAREGIVERS; DEPRESSION; DISEASE; ILLNESS; PEOPLE; AREA; CARE	Courtesy stigma is the stigmatization a person perceives or experiences due to their association with a stigmatized individual or group. Most HIV-related stigma scales have been developed for people living with HIV/AIDS (PLWHAs), but not for their HIV-uninfected family members. To date, few measurement scales have been designed to measure the degree of stigma among both PLWHAs and their HIV-uninfected family members at the family level. We developed a set of courtesy stigma scales and estimated their reliability and validity from 256 PLWHAs and 256 of their HIV-uninfected family members. Exploratory and confirmatory factor analyses were performed in two independent samples: a development sample (N = 216) and a validation sample (N = 296), respectively. Two factors ("public stigma'' and "self-perceived stigma'') had high internal consistency reliability (Cronbach's alpha coefficient between 0.83-0.90) and good construct validity (standardized factor loading range: 0.37-0.95) in both samples. These findings document that the newly developed brief instrument is a psychometrically sound measure of HIV-related stigma among both PLWHAs and their HIV-uninfected family members.	[Liu, Hongjie] Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA; [Xu, Yongfang] Nanning Ctr Dis Control & Prevent, Dept HIV AIDS Control, Nanning, Guangxi, Peoples R China; [Sun, Yehuan] Anhui Med Univ, Dept Epidemiol, Hefei, Anhui, Peoples R China; [Dumenci, Levent] Virginia Commonwealth Univ, Dept Social & Behav Hlth, Richmond, VA USA	University System of Maryland; University of Maryland College Park; Anhui Medical University; Virginia Commonwealth University	Liu, HJ (corresponding author), Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA.	hliu1210@umd.edu			Virginia Commonwealth University School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041041] Funding Source: NIH RePORTER	Virginia Commonwealth University School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a research grant from the Virginia Commonwealth University School of Medicine. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 2012, MPLUS USERS GUIDE; Badahdah A, 2009, AIDS CARE, V21, P754, DOI 10.1080/09540120802511927; Bogart LM, 2008, AIDS BEHAV, V12, P244, DOI 10.1007/s10461-007-9231-x; Boyes ME, 2013, CLIN PSYCHOL SCI, V1, P323, DOI 10.1177/2167702613478595; Boyes ME, 2013, AIDS CARE, V25, P215, DOI 10.1080/09540121.2012.699668; Cohen MS, 2012, CURR OPIN HIV AIDS, V7, P99, DOI 10.1097/COH.0b013e32834f5cf2; Corrigan PW, 2005, ON THE STIGMA OF MENTAL ILLNESS: PRACTICAL STRATEGIES FOR RESEARCH AND SOCIAL CHANGE, P11, DOI 10.1037/10887-001; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; Goffman E., 1968, STIGMA NOTES MANAGEM; Ha TH, 2012, AIDS CARE, V24, P39, DOI 10.1080/09540121.2011.592820; Herek GM, 1997, J APPL SOC PSYCHOL, V27, P1, DOI 10.1111/j.1559-1816.1997.tb00621.x; Herek GM, 1999, AM BEHAV SCI, V42, P1106, DOI 10.1177/00027649921954787; Kalichman SC, 2005, AIDS BEHAV, V9, P135, DOI 10.1007/s10461-005-3895-x; Kingori C, 2013, AIDS PATIENT CARE ST, V27, P481, DOI 10.1089/apc.2012.0403; KLEINMAN A, 1995, SOC SCI MED, V40, P1319, DOI 10.1016/0277-9536(94)00254-Q; Kohout F J, 1993, J Aging Health, V5, P179, DOI 10.1177/089826439300500202; Li Li, 2008, Fam Syst Health, V26, P431; Lin K-M, 1981, NORMAL ABNORMAL BEHA, P95; Lin XY, 2010, AIDS CARE, V22, P545, DOI 10.1080/09540120903253999; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Liu H, 2009, SEX TRANSM INFECT, V85, P65, DOI 10.1136/sti.2008.032714; Liu HJ, 2006, AIDS PATIENT CARE ST, V20, P133, DOI 10.1089/apc.2006.20.133; Liu HJ, 2002, SEX TRANSM DIS, V29, P335, DOI 10.1097/00007435-200206000-00005; Liu HJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056815, 10.1371/journal.pone.0055680]; Logie C, 2013, AIDS PATIENT CARE ST, V27, P114, DOI 10.1089/apc.2012.0296; Louw J, 2012, SCI WORLD J, DOI 10.1100/2012/817315; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Ministry of Health of the People's Republic of China, 2012, 2012 CHIN AIDS RESP; Molina Y, 2013, AIDS CARE, V25, P1559, DOI 10.1080/09540121.2013.793268; Mwinituo PP, 2006, WESTERN J NURS RES, V28, P369, DOI 10.1177/0193945906286602; Rutledge SE, 2011, AIDS PATIENT CARE ST, V25, P673, DOI 10.1089/apc.2011.0008; Sayles JN, 2008, AIDS BEHAV, V12, P748, DOI 10.1007/s10461-008-9375-3; Scambler G, 1998, LANCET, V352, P1054, DOI 10.1016/S0140-6736(98)08068-4; Schumacker RE, 2010, BEGINNERS GUIDE STRU; Sherr L, 2011, PSYCHOL HEALTH MED, V16, P612, DOI 10.1080/13548506.2011.579991; Singh D, 2011, AIDS CARE, V23, P839, DOI 10.1080/09540121.2010.542122; Stein JA, 2008, AIDS BEHAV, V12, P789, DOI 10.1007/s10461-007-9339-z; Wight RG, 2006, SOC SCI MED, V62, P444, DOI 10.1016/j.socscimed.2005.06.004; Wilson DP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001231; ZHANG JX, 1995, PSYCHOLOGIA, V38, P174; Zhu TF, 2005, CELL RES, V15, P852, DOI 10.1038/sj.cr.7290358	41	14	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92855	10.1371/journal.pone.0092855	http://dx.doi.org/10.1371/journal.pone.0092855			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6GL	24658364	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300135
J	Wojkowska-Mach, J; Rozanska, A; Borszewska-Kornacka, M; Domanska, J; Gadzinowski, J; Gulczynska, E; Helwich, E; Kordek, A; Pawlik, D; Szczapa, J; Heczko, PB				Wojkowska-Mach, Jadwiga; Rozanska, Anna; Borszewska-Kornacka, Maria; Domanska, Joanna; Gadzinowski, Janusz; Gulczynska, Ewa; Helwich, Ewa; Kordek, Agnieszka; Pawlik, Dorota; Szczapa, Jerzy; Heczko, Piotr B.			Necrotising Enterocolitis in Preterm Infants: Epidemiology and Antibiotic Consumption in the Polish Neonatology Network Neonatal Intensive Care Units in 2009	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; BIRTH-WEIGHT INFANTS; GASTRIC RESIDUALS; MANAGEMENT	The aim of this study was to describe the epidemiology of necrotising enterocolitis (NEC), antibiotic consumption and the usefulness of microbiological tests in very low birth weight (VLBW) Polish newborns. \ Methods: Prospective surveillance was performed in the year 2009 by local infection control teams. The study covered 910 infants hospitalized in six Polish neonatal intensive care units. Two kinds of indicators were used for the description of antibiotic usage: the duration of treatment (days of treatment, DOTs) and the defined daily dose (DDD). Results: NEC incidence was 8.7% and fatality rate was 19%. Chorioamnionitis, late gestational age and low birth weight were identified as risk factors for NEC. Catheterization, mechanical ventilation and other selected procedures were used considerably longer in newborns with NEC than in the remaining neonates. Total usage of antibiotics reached 2.9 DDDs or 1.437 days; the average use of drugs per case of NEC amounted to 0.47 DDD or 23.2 DOTs. The level of antibiotic usage was analysed with correlation to microbiological tests performed and it was non-significantly greater in the group of children with NEC in whom the tests were performed. Conclusions: A high risk of developing NEC is closely associated with VLBW and with inflammation of the amnion during labour. We observed no relationship between the consumption of antibiotics in neonates with NEC and positive results of microbiological testing indicating sepsis accompanying NEC or gut colonization with pathogens.	[Wojkowska-Mach, Jadwiga; Rozanska, Anna; Heczko, Piotr B.] Jagiellonian Univ, Coll Med, Chair Microbiol, Krakow, Poland; [Borszewska-Kornacka, Maria] Med Univ Warsaw, Clin Neonatol & Intens Neonatal Care, Warsaw, Poland; [Domanska, Joanna] Polish Acad Sci, Inst Theoret & Appl Informat, Gliwice, Poland; [Gadzinowski, Janusz; Szczapa, Jerzy] Poznan Univ Med Sci, Chair & Dept Neonatol, Poznan, Poland; [Gulczynska, Ewa] Polish Mothers Mem Hosp, Res Inst, Clin Neonatol, Lodz, Poland; [Helwich, Ewa] Inst Mother & Child Hlth, Clin Neonatol & Intens Neonatal Care, Warsaw, Poland; [Kordek, Agnieszka] Pomeranian Med Univ, Dept Neonatal Dis, Szczecin, Poland; [Pawlik, Dorota] Jagiellonian Univ, Coll Med, Clin Neonatol, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Medical University of Warsaw; Polish Academy of Sciences; Institute of Theoretical & Applied Informatics of the Polish Academy of Sciences; Poznan University of Medical Sciences; Polish Mother's Memorial Hospital - Research Institute; Pomeranian Medical University; Jagiellonian University; Collegium Medicum Jagiellonian University	Rozanska, A (corresponding author), Jagiellonian Univ, Coll Med, Chair Microbiol, Krakow, Poland.	rozanska@ifb.pl	Kordek, Agnieszka/I-3843-2014; Helwich, Ewa/V-3054-2019; Domańska, Joanna/J-8501-2013; Wojkowska-Mach, Jadwiga/U-1186-2018	Helwich, Ewa/0000-0002-3914-0516; Wojkowska-Mach, Jadwiga/0000-0003-0756-1639; Borszewska-Kornacka, Maria,Katarzyna/0000-0001-8021-4284; Gulczynska, Ewa/0000-0003-2713-5258; Domanska, Joanna/0000-0002-1935-8358; Gadzinowski, Janusz/0000-0001-8397-6989				Atlalye-Jape G, 2012, J MATERN-FETAL NEO M, V14, P1; Been JV, 2013, J PEDIATR-US, V162, P236, DOI 10.1016/j.jpeds.2012.07.012; BENNET R, 1986, PEDIATR INFECT DIS J, V5, P533, DOI 10.1097/00006454-198609000-00009; Bertino E, 2009, J PEDIATR GASTR NUTR, V48, P437, DOI 10.1097/MPG.0b013e31817b6dbe; Brooks HJ, 2013, MICROBES INFLAMMATOR, DOI [10.5772/55039, DOI 10.5772/55039.AVAILABLE]; Central Statistical Office, 2010, DEM YB POL, P260; Claud EC, 2001, FASEB J, V15, P1398, DOI 10.1096/fj.00-0833hyp; Coates EW, 2005, PEDIATRICS, V116, pE241, DOI 10.1542/peds.2004-2537; Cobb BA, 2004, PEDIATRICS, V113, P50, DOI 10.1542/peds.113.1.50; Cotten CM, 2009, PEDIATRICS, V123, P58, DOI 10.1542/peds.2007-3423; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; Gagliardi L, 2008, J PEDIATR GASTR NUTR, V47, P206, DOI 10.1097/MPG.0b013e318174e855; Ganapathy V, 2012, BREASTFEED MED, V7, P29, DOI 10.1089/bfm.2011.0002; Gastmeier P, 2004, J HOSP INFECT, V57, P126, DOI 10.1016/j.jhin.2003.12.038; Horbar JD, 2012, PEDIATRICS, V129, P1019, DOI 10.1542/peds.2011-3028; Horton KK, 2005, NEONATAL NETW, V24, P37, DOI 10.1891/0730-0832.24.1.37; Hoy CM, 2000, J CLIN MICROBIOL, V38, P4539, DOI 10.1128/JCM.38.12.4539-4547.2000; Kliegman R M, 1987, Curr Probl Pediatr, V17, P213; Luoto R, 2010, ACTA PAEDIATR, V99, P1135, DOI 10.1111/j.1651-2227.2010.01795.x; Morgan J, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001970.pub3; Moro M, 2009, AM J PERINAT, V26, P335, DOI 10.1055/s-0028-1110083; Neu J, 2005, ACTA PAEDIATR, V94, P100, DOI 10.1080/08035320510043637; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Patel B.K., 2012, ISRN GASTROENTEROL, V12, P562, DOI [DOI 10.5402/2012/562594, 10.5402/2012/562594]; Polycarpou E, 2013, JPEN-PARENTER ENTER, V37, P617, DOI 10.1177/0148607112471561; Salhab Walid A, 2004, J Perinatol, V24, P534, DOI 10.1038/sj.jp.7211165; Sankaran K, 2004, J PEDIATR GASTR NUTR, V39, P366, DOI 10.1097/00005176-200410000-00012; SCHEIFELE DW, 1987, INFECT IMMUN, V55, P2268, DOI 10.1128/IAI.55.9.2268-2273.1987; SCHEIFELE DW, 1988, J CLIN MICROBIOL, V26, P279, DOI 10.1128/JCM.26.2.279-282.1988; Schnabl KL, 2008, WORLD J GASTROENTERO, V14, P2142, DOI 10.3748/wjg.14.2142; Shah D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007448.pub2; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Tita ATN, 2010, CLIN PERINATOL, V37, P339, DOI 10.1016/j.clp.2010.02.003; Venkatesh MP, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007137.pub2	34	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92865	10.1371/journal.pone.0092865	http://dx.doi.org/10.1371/journal.pone.0092865			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658445	Green Published, gold			2022-12-27	WOS:000333355300137
J	Kim, MY; Finch, AM; Lumbers, ER; Boyce, AC; Gibson, KJ; Eiby, YA; Lingwood, BE				Kim, Min Young; Finch, Angela M.; Lumbers, Eugenie R.; Boyce, Amanda C.; Gibson, Karen J.; Eiby, Yvonne A.; Lingwood, Barbara E.			Expression of Adrenoceptor Subtypes in Preterm Piglet Heart Is Different to Term Heart	PLOS ONE			English	Article							BETA-ADRENERGIC-RECEPTORS; VENA-CAVA FLOW; ALPHA-1-ADRENERGIC RECEPTOR; BINDING-SITES; INFANTS; MECHANISMS; OVEREXPRESSION; HEMORRHAGE; INOTROPES; DOPAMINE	preterm delivery increases the risk of inadequate systemic blood flow and hypotension and many preterm infants fail to respond to conventional inotrope treatments. If the profile of cardiac adrenoceptor subtypes in the preterm neonate is different to that at term this may contribute to these clinical problems. This study measured mRNA expression of beta(1), beta(2), alpha(1A,) alpha(2A) and alpha(2B)-adrenoceptor subtypes by real time PCR in term (113d), preterm (91d) and preterm piglets (91d) exposed to maternal glucocorticoid treatment. Abundance of beta(1)-adrenoceptor binding sites in the left ventricle was measured using saturation binding assays. Relative abundance of beta(1)-adrenoceptor mRNA in untreated Preterm hearts was similar to 50% term abundance in both left and right ventricles (P<0.001). Trends in receptor binding site density measurements supported this observation (P=0.07). Glucocorticoid exposure increased beta(1)-adrenoceptor mRNA levels in the right ventricle of preterm hearts (P=0.008) but did not alter expression in the left ventricle (P>0.1). Relative abundance of alpha(1A) adrenoceptor rnRNA was the same in preterm and term piglet hearts (P= >0.1) but was reduced by maternal glucocorticoid treatment (P<0.01); alpha(2A)-adrenoceptor mRNA abundance was higher in untreated and glucocorticoid exposed preterm piglet hearts than in term piglets (P < 0.001). There was no difference between male and female piglets in mRNA abundance of any of he genes studied. In conclusion, there is reduced mRNA abundance of beta(1)-adrenoceptors in he preterm pig heart. If this lower expression of beta-adrenoceptars occurs in human preterm infants, it could explain their poor cardiovascular function and their frequent failure to respond to commonly used inotropes.	[Kim, Min Young; Lumbers, Eugenie R.; Eiby, Yvonne A.; Lingwood, Barbara E.] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Finch, Angela M.] Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia; [Lumbers, Eugenie R.; Boyce, Amanda C.; Gibson, Karen J.] Univ New S Wales, Sch Med Sci, Dept Physiol, Sydney, NSW, Australia; [Lumbers, Eugenie R.] Univ Newcastle, Sch Biomed Sci & Pharm, Newcastle, NSW 2300, Australia	University of Queensland; University of New South Wales Sydney; University of New South Wales Sydney; University of Newcastle	Lingwood, BE (corresponding author), Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia.	b.lingwood@uq.edu.au	Finch, Angela M/F-5962-2012; Lingwood, Barbara E/F-1398-2010; Eiby, Yvonne/F-2772-2010; Lumbers, Eugenie/AAS-4930-2020	Finch, Angela M/0000-0002-4598-6745; Eiby, Yvonne/0000-0003-0079-7796; 	National Health and Medical Research Council of Australia [5696351]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia [grant number 5696351 (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adigun AA, 2010, NEUROTOXICOL TERATOL, V32, P193, DOI 10.1016/j.ntt.2009.10.002; Akhter SA, 1997, J BIOL CHEM, V272, P21253, DOI 10.1074/jbc.272.34.21253; BAKER SP, 1980, BRIT J PHARMACOL, V68, P65, DOI 10.1111/j.1476-5381.1980.tb10699.x; BEINLICH CJ, 1995, J MOL CELL CARDIOL, V27, P273, DOI 10.1016/S0022-2828(08)80026-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carron J, 2005, DOMEST ANIM ENDOCRIN, V28, P257, DOI 10.1016/j.domaniend.2004.10.001; CHEN FCM, 1979, EUR J PHARMACOL, V58, P255, DOI 10.1016/0014-2999(79)90474-6; Cox DJ, 2012, ACTA PAEDIATR, V101, P17, DOI 10.1111/j.1651-2227.2011.02545.x; De Matteo R, 2010, REPROD SCI, V17, P724, DOI 10.1177/1933719110369182; Eiby YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068763; Eiby YA, 2012, AM J PHYSIOL-REG I, V303, pR769, DOI 10.1152/ajpregu.00010.2012; Elsmen E, 2004, ACTA PAEDIATR, V93, P529, DOI 10.1080/08035250410024998; FOWDEN AL, 1995, EXP PHYSIOL, V80, P457, DOI 10.1113/expphysiol.1995.sp003860; Gilsbach R, 2010, CARDIOVASC RES, V86, P432, DOI 10.1093/cvr/cvq014; Giraud GD, 2006, ENDOCRINOLOGY, V147, P3643, DOI 10.1210/en.2006-0061; Grupp IL, 1998, AM J PHYSIOL-HEART C, V275, pH1338, DOI 10.1152/ajpheart.1998.275.4.H1338; HATJIS C G, 1982, Journal of Developmental Physiology (Eynsham), V4, P327; Jensen BC, 2009, N-S ARCH PHARMACOL, V379, P409, DOI 10.1007/s00210-008-0368-6; Kawano F, 2009, J PHYSIOL SCI, V59, P383, DOI 10.1007/s12576-009-0046-6; Kim MY, 2014, PLOS ONE IN PRESS; Kluckow M, 2000, ARCH DIS CHILD-FETAL, V82, pF188, DOI 10.1136/fn.82.3.F188; Kluckow M, 2004, NEOREVIEWS, V5, pe98; Lin G, 2001, CIRC RES, V89, P343, DOI 10.1161/hh1601.095912; Lumbers ER, 2005, AM J PHYSIOL-REG I, V288, pR567, DOI 10.1152/ajpregu.00556.2004; McMullen JR, 2002, REGUL PEPTIDES, V105, P83, DOI 10.1016/S0167-0115(02)00002-2; Metz LD, 1996, J MOL CELL CARDIOL, V28, P1033, DOI 10.1006/jmcc.1996.0096; Mohl MC, 2011, CARDIOVASC RES, V91, P310, DOI 10.1093/cvr/cvr081; MOISE AA, 1995, PEDIATRICS, V95, P845; Myslivecek J, 2003, N-S ARCH PHARMACOL, V368, P366, DOI 10.1007/s00210-003-0825-1; NAKADA MT, 1987, MOL PHARMACOL, V31, P377; NOGUCHI A, 1981, DEV PHARMACOL THERAP, V3, P179, DOI 10.1159/000457439; Osborn D, 2002, J PEDIATR-US, V140, P183, DOI 10.1067/mpd.2002.120834; Osborn DA, 2003, PEDIATRICS, V112, P33, DOI 10.1542/peds.112.1.33; Osborn DA, 2007, PEDIATRICS, V120, P372, DOI 10.1542/peds.2006-3398; Porter AC, 2003, LIFE SCI, V72, P1455, DOI 10.1016/S0024-3205(02)02381-0; Pradidarcheep W, 2009, N-S ARCH PHARMACOL, V379, P397, DOI 10.1007/s00210-009-0393-0; ROCKSON SG, 1981, J CLIN INVEST, V67, P319, DOI 10.1172/JCI110038; SCHMID G, 1985, VIRCHOWS ARCH B, V48, P59, DOI 10.1007/BF02890115; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seri I, 2001, Semin Neonatol, V6, P85, DOI 10.1053/siny.2000.0034; SLOTKIN TA, 1986, TOXICOLOGY, V41, P95, DOI 10.1016/0300-483X(86)90107-1; SMOLICH JJ, 1995, REPROD FERT DEVELOP, V7, P451, DOI 10.1071/RD9950451; Stark MJ, 2009, AM J PHYSIOL-REG I, V297, pR510, DOI 10.1152/ajpregu.00175.2009; Stevenson DK, 2000, ARCH DIS CHILD-FETAL, V83, pF182, DOI 10.1136/fn.83.3.F182; van der Voort CR, 2000, J NEUROIMMUNOL, V108, P82, DOI 10.1016/S0165-5728(00)00253-8; WHITSETT JA, 1981, PEDIATR RES, V15, P1363, DOI 10.1203/00006450-198110000-00013; Woodcock EA, 2007, CLIN EXP PHARMACOL P, V34, P884, DOI 10.1111/j.1440-1681.2007.04707.x; Zhang J, 1999, ARCH DIS CHILD-FETAL, V81, pF99, DOI 10.1136/fn.81.2.F99	48	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92167	10.1371/journal.pone.0092167	http://dx.doi.org/10.1371/journal.pone.0092167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670668	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000033
J	Paulsson, JF; Ludvigsson, J; Carlsson, A; Casas, R; Forsander, G; Ivarsson, SA; Kockum, I; Lernmark, A; Marcus, C; Lindblad, B; Westermark, GT				Paulsson, Johan F.; Ludvigsson, Johnny; Carlsson, Annelie; Casas, Rosaura; Forsander, Gun; Ivarsson, Sten A.; Kockum, Ingrid; Lernmark, Ake; Marcus, Claude; Lindblad, Bengt; Westermark, Gunilla T.			High Plasma Levels of Islet Amyloid Polypeptide in Young with New-Onset of Type 1 Diabetes Mellitus	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; INSULIN-SECRETION; AUTOANTIBODIES; EXPRESSION; DEPOSITION; PANCREAS; PROTEIN; AMYLIN	Aims/Hypothesis: Islet amyloid polypeptide (IAPP) is a beta cell hormone secreted together with insulin upon glucose stimulation. IAPP participates in normal glucose regulation, but IAPP is also known for its ability to misfold and form islet amyloid. Amyloid fibrils form through smaller cell toxic intermediates and deposited amyloid disrupts normal islet architecture. Even though IAPP and amyloid formation are much discussed in type 2 diabetes, our aim was to study the significance of IAPP in type 1 diabetes. Results: Plasma IAPP levels in children and adolescents with newly diagnosed type 1 diabetes (n = 224) were analysed and concentrations exceeding 100 pmol/L (127.2 - 888.7 pmol/L) were found in 11% (25/224). The IAPP increase did not correlate with C-peptide levels. Conclusions/Interpretation: Plasma levels of IAPP and insulin deviate in a subpopulation of young with newly-diagnosed type 1 diabetes. The determined elevated levels of IAPP might increase the risk for IAPP misfolding and formation of cell toxic amyloid in beta cells. This finding add IAPP-aggregation to the list over putative pathological factors causing type 1 diabetes.	[Paulsson, Johan F.; Ludvigsson, Johnny; Casas, Rosaura] Linkoping Univ Hosp, Dept Clin & Expt Med, Div Pediat, S-58185 Linkoping, Sweden; [Paulsson, Johan F.; Ludvigsson, Johnny; Casas, Rosaura] Linkoping Univ Hosp, Diabet Res Ctr, S-58185 Linkoping, Sweden; [Carlsson, Annelie] Univ Lund Hosp, Dept Pediat, S-22185 Lund, Sweden; [Forsander, Gun; Lindblad, Bengt] Queen Silvia Childrens Hosp, Dept Pediat, Gothenburg, Sweden; [Ivarsson, Sten A.] Univ Hosp MAS, Dept Pediat, Malmo, Sweden; [Kockum, Ingrid] Karolinska Inst, Dept Mol Med, Stockholm, Sweden; [Lernmark, Ake] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Marcus, Claude] Karolinska Univ Hosp, Dept Pediat, Huddinge, Sweden; [Westermark, Gunilla T.] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden	Linkoping University; Linkoping University; Lund University; Skane University Hospital; Queen Silvia Children's Hospital; Lund University; Skane University Hospital; Karolinska Institutet; Lund University; Karolinska Institutet; Karolinska University Hospital; Uppsala University	Westermark, GT (corresponding author), Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden.	Gunilla.Westermark@mcb.uu.se	Ludvigsson, Johnny/AAI-2051-2020; Kockum, Ingrid/O-8781-2018; Marcus, Claude/ABE-1177-2020; Lernmark, Åke/F-8140-2015	Ludvigsson, Johnny/0000-0003-1695-5234; Kockum, Ingrid/0000-0002-0867-4726; Marcus, Claude/0000-0003-0890-2650; Lernmark, Åke/0000-0003-1735-0499; Paulsson, Johan F/0000-0001-6601-8383; Forsander, Gun A/0000-0002-0266-9651	Swedish Research Council [GTW-1767]; Swedish Diabetes Association; Swedish Child Diabetes Foundation; Family Ernfors Fund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; Swedish Child Diabetes Foundation; Family Ernfors Fund	The work was funded by Swedish Research Council GTW-1767, Swedish Diabetes Association, the Swedish Child Diabetes Foundation, and Family Ernfors Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly T, 2004, DIABETES CARE, V27, P1205, DOI 10.2337/diacare.27.5.1205; Anguiano M, 2002, BIOCHEMISTRY-US, V41, P11338, DOI 10.1021/bi020314u; Bjerner J, 2002, CLIN CHEM, V48, P613; BOTTAZZO GF, 1985, NEW ENGL J MED, V313, P353, DOI 10.1056/NEJM198508083130604; CLARK A, 1991, DIABETIC MED, V8, P668, DOI 10.1111/j.1464-5491.1991.tb01675.x; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Gebre-Medhin S, 1998, BIOCHEM BIOPH RES CO, V250, P271, DOI 10.1006/bbrc.1998.9308; GORUS FK, 1992, DIABETOLOGIA, V35, P1080, DOI 10.1007/BF02221685; In't Veld P, 2007, DIABETES, V56, P2400, DOI 10.2337/db07-0416; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; KAHN SE, 1993, DIABETOLOGIA, V36, P570, DOI 10.1007/BF02743276; KAHN SE, 1991, HORM METAB RES, V23, P577, DOI 10.1055/s-2007-1003759; Kricka LJ, 1999, CLIN CHEM, V45, P942; Lernmark A, 1999, CLIN CHEM, V45, P1331; Martin S, 2001, NEW ENGL J MED, V345, P1036, DOI 10.1056/NEJMoa010465; Martinez A, 2000, ENDOCRINOLOGY, V141, P406, DOI 10.1210/en.141.1.406; Mather KJ, 2002, DIABETES-METAB RES, V18, P118, DOI 10.1002/dmrr.263; Matveyenko AV, 2006, DIABETES, V55, P2106, DOI 10.2337/db05-1672; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; Mulder H, 1996, AM J PHYSIOL-ENDOC M, V271, pE1008, DOI 10.1152/ajpendo.1996.271.6.E1008; Paulsson JF, 2005, DIABETES, V54, P2117, DOI 10.2337/diabetes.54.7.2117; Paulsson JF, 2008, EXP DIABETES RES, DOI 10.1155/2008/865850; Pihoker C, 2005, DIABETES, V54, pS52, DOI 10.2337/diabetes.54.suppl_2.S52; Rivera JF, 2011, CELL DEATH DIFFER, V18, P415, DOI 10.1038/cdd.2010.111; STRIDSBERG M, 1993, DIABETOLOGIA, V36, P843, DOI 10.1007/BF00400360; TOSHIMORI H, 1991, VIRCHOWS ARCH A, V418, P411, DOI 10.1007/BF01605927; TUCK AB, 1992, DIABETIC MED, V9, P781; Westermark GT, 2008, NEW ENGL J MED, V359, P977, DOI 10.1056/NEJMc0802893; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; Westermark P, 1996, FEBS LETT, V379, P203, DOI 10.1016/0014-5793(95)01512-4; WESTERMARK P, 1986, BIOCHEM BIOPH RES CO, V140, P827, DOI 10.1016/0006-291X(86)90708-4; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x; Williams AJK, 1997, J AUTOIMMUN, V10, P473, DOI 10.1006/jaut.1997.0154; Yoon Ji-Won, 2005, Am J Ther, V12, P580, DOI 10.1097/01.mjt.0000178767.67857.63	34	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93053	10.1371/journal.pone.0093053	http://dx.doi.org/10.1371/journal.pone.0093053			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671002	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677000107
J	Carre, N; Solomon, G; Gertler, A; Binart, N				Carre, Nadege; Solomon, Gili; Gertler, Arieh; Binart, Nadine			Effects of High Affinity Leptin Antagonist on Prolactin Receptor Deficient Male Mouse	PLOS ONE			English	Article							HIGH-FAT-DIET; BODY-WEIGHT; MICE; INSULIN; EXPRESSION; LACTATION; HORMONE; OBESITY	Hyperprolactinemia occurs during gestation and lactation with marked hyperphagia associated with leptin resistance. Prolactin (PRL) induces the expression of orexigenic neuropeptide Y (NPY) in hypothalamic dorsomedial nucleus (DMH) leading to hyperphagia. Along this line prolactin receptor deficient (PRLR-/-) mice are resistant to obesity under high fat diet due to increased energy expenditure. As these mice have an altered food intake, our objective was to test whether leptin is responsible for these characteristics. PRLR-/- male mice and control littermates were injected subcutaneously every other day with 12 mg/kg pegylated superactive mouse leptin antagonist (PEG-SMLA) for 3 weeks. We tested the effect of PEG-SMLA on body weight, food intake and metabolic parameters. The antagonist led to a rapid increase in body weight (20%) but increased adipose mass in PEG-SMLA treated mice was less pronounced in PRLR-/- than in WT mice. Food intake of PEG-SMLA-injected animals increased during the first week period of the experiment but then declined to a similar level of the control animals during the second week. Interestingly, PRLR-/- mice were found to have the same bone volume than those of control mice although PEG-SMLA increased bone mass by 7% in both strains. In addition, PEG-SMLA led to insulin resistance and glucose intolerance as well as an altered lipid profile in treated mice. Altogether, these results suggest that PRLR-/- mice respond to leptin antagonist similarly to the control mice, indicating no interaction between the actions of the two hormones.	[Carre, Nadege; Binart, Nadine] INSERM, U693, F-94275 Le Kremlin Bicetre, France; [Carre, Nadege; Binart, Nadine] Univ Paris 11, Fac Med Paris Sud, UMR S693, Le Kremlin Bicetre, France; [Solomon, Gili; Gertler, Arieh] Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, IL-76100 Rehovot, Israel; [Binart, Nadine] Hop Bicetre, AP HP, Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Hebrew University of Jerusalem; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Binart, N (corresponding author), INSERM, U693, F-94275 Le Kremlin Bicetre, France.	nadine.binart@inserm.fr	Binart, Nadine/F-2949-2013	Binart, Nadine/0000-0002-5606-3866	Agence Nationale de la Recherche [09-BLAN-0246]; Institut National de la Sante et de la Recherche Medicale, Universite Paris-Sud	Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale, Universite Paris-Sud	This work was supported by grants from Agence Nationale de la Recherche (09-BLAN-0246), Institut National de la Sante et de la Recherche Medicale, Universite Paris-Sud. N.B. was awarded an Institut National de la Sante et de la Recherche Medicale-Assistance Publique-Hopitaux de Paris Interface contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrikopoulos S, 2005, J ENDOCRINOL, V187, P45, DOI 10.1677/joe.1.06333; Auffret J, 2012, FASEB J, V26, P3728, DOI 10.1096/fj.12-204958; Ben-Jonathan N, 2006, TRENDS ENDOCRIN MET, V17, P110, DOI 10.1016/j.tem.2006.02.005; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; Chapnik N, 2013, J ENDOCRINOL, V217, P283, DOI 10.1530/JOE-13-0033; Chen PL, 2004, ENDOCRINOLOGY, V145, P823, DOI 10.1210/en.2003-1255; Elinav E, 2009, ENDOCRINOLOGY, V150, P3083, DOI 10.1210/en.2008-1706; Freemark M, 2001, ENDOCRINOLOGY, V142, P532, DOI 10.1210/en.142.2.532; Goffin V, 2002, ANNU REV PHYSIOL, V64, P47, DOI 10.1146/annurev.physiol.64.081501.131049; Greenman Y, 1998, CLIN ENDOCRINOL, V48, P547, DOI 10.1046/j.1365-2265.1998.00403.x; GUSTAFSON AB, 1980, J CLIN ENDOCR METAB, V51, P242, DOI 10.1210/jcem-51-2-242; Ling C, 2000, ENDOCRINOLOGY, V141, P3564, DOI 10.1210/en.141.10.3564; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Naliato ECO, 2007, CLIN ENDOCRINOL, V67, P845, DOI 10.1111/j.1365-2265.2007.02973.x; Nilsson L, 2011, MOL GENET METAB, V102, P78, DOI 10.1016/j.ymgme.2010.08.017; Sauve D, 2000, BRAIN RES, V868, P306, DOI 10.1016/S0006-8993(00)02344-1; Shpilman M, 2011, J BIOL CHEM, V286, P4429, DOI 10.1074/jbc.M110.196402; Solomon G, 2013, AM J PHYSIOL-ENDOC M, DOI [10.1152/ajpendo.00155.2013, DOI 10.1152/AJPEND0.00155.2013]; Syberg S, 2012, J OSTEOPOROS, V2012, DOI 10.1155/2012/637986; Viengchareun S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001535	20	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e91422	10.1371/journal.pone.0091422	http://dx.doi.org/10.1371/journal.pone.0091422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667351	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600007
J	Fu, R; Li, J; Zhong, H; Yu, DH; Zeng, XP; Deng, MX; Sun, YQ; Wen, WP; Li, HB				Fu, Ran; Li, Jian; Zhong, Hua; Yu, Dehong; Zeng, Xianping; Deng, Mengxia; Sun, Yueqi; Wen, Weiping; Li, Huabin			Broncho-Vaxom Attenuates Allergic Airway Inflammation by Restoring GSK3 beta-Related T Regulatory Cell Insufficiency	PLOS ONE			English	Article							DENDRITIC CELLS; ASTHMA; RHINITIS; INHIBITION; MATURATION; DISEASES; MUCOSAL; UPDATE; IMPACT; LYSATE	Background: Oral administration of bacterial extracts (eg, Broncho-Vaxom (BV)) has been proposed to attenuate asthma through modulating Treg cells. However, the underlying mechanism has not been fully characterized. This study sought to assess the effects of oral administration of BV on GSK-3 beta expression and Treg cells in ovalbumin (OVA)-induced asthmatic mice models. Method: Asthmatic mice models were established with OVA challenge and treated with oral administration of BV. Next, infiltration of inflammatory cells including eosinophil and neutrophils, mucous metaplasia, levels of Th1/Th2/Treg-typed cytokines and expression of GSK3 beta and Foxp3 were examined in asthmatic mice models by histological analysis, Bio-Plex and western blot, respectively. Moreover, the frequencies of Treg cells were evaluated in cultured splenocytes by flow cytometry in the presence of BV or GSK3 beta siRNA interference. Results: We found significant decrease of infiltrated inflammatory cells in bronchoalveolar lavage fluid (BALF) in asthmatic mice models after oral administration of BV. Oral administration of BV was shown to significantly suppress mucus metaplasia, Th2-typed cytokine levels and GSK3 beta expression while increasing Foxp3 production in asthmatic mice models. Moreover, BV significantly enhanced GSK3 beta-related expansion of Treg cells in cultured spleen cells in vitro. Conclusion: Our findings provide evidence that oral administration of BV is capable of attenuating airway inflammation in asthmatic mice models, which may be associated with GSK3 beta-related expansion of Treg cells.	[Fu, Ran; Li, Jian; Zhong, Hua; Zeng, Xianping; Deng, Mengxia; Sun, Yueqi; Wen, Weiping; Li, Huabin] Sun Yat Sen Univ, Affiliated Hosp 1, Otorhinolarygol Hosp, Allergy & Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Dehong; Li, Huabin] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China	Sun Yat Sen University; Shanghai Jiao Tong University	Wen, WP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Otorhinolarygol Hosp, Allergy & Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China.	wenwp@mail.sysu.edu.cn; allergyli@163.com	温, 家琦/GYV-3177-2022; Sun, Yueqi/N-4528-2018	Sun, Yueqi/0000-0002-2382-0429; Zhong, Hua/0000-0002-9120-2323	National Nature and Science Grant of China [81271055, 81371071]; Program from Administration of Hygiene [201202005, 2014BAI07B04]; Program for New Century Excellent Talents in University [NCET-10-0851]	National Nature and Science Grant of China; Program from Administration of Hygiene; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This study was supported by the National Nature and Science Grant of China (No. 81271055, 81371071) and Program from Administration of Hygiene (No. 201202005, 2014BAI07B04) and Program for New Century Excellent Talents in University (No. NCET-10-0851). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens B, 2011, INT ARCH ALLERGY IMM, V156, P196, DOI 10.1159/000322352; Bacchetta R, 2007, J ALLERGY CLIN IMMUN, V120, P227, DOI 10.1016/j.jaci.2007.06.023; Banche G, 2007, INT J IMMUNOPATH PH, V20, P129, DOI 10.1177/039463200702000115; Bao Z, 2007, AM J RESP CRIT CARE, V176, P431, DOI 10.1164/rccm.200609-1292OC; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Brooks C, 2013, CURR OPIN ALLERGY CL, V13, P70, DOI 10.1097/ACI.0b013e32835ad0d2; Chu KH, 2012, AM J RESP CELL MOL, V46, P651, DOI 10.1165/rcmb.2011-0246OC; Gagliardo R, 2003, AM J RESP CRIT CARE, V168, P1190, DOI 10.1164/rccm.200205-479OC; Graham JA, 2010, J BIOL CHEM, V285, P32852, DOI 10.1074/jbc.M110.150904; Greiner AN, 2011, LANCET, V378, P2112, DOI 10.1016/S0140-6736(11)60130-X; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Morandi B, 2011, IMMUNOL LETT, V138, P86, DOI 10.1016/j.imlet.2011.03.006; Navarro S, 2011, MUCOSAL IMMUNOL, V4, P53, DOI 10.1038/mi.2010.51; Parola C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082867; Pritchard DI, 2012, CLIN EXP ALLERGY, V42, P505, DOI 10.1111/j.1365-2222.2011.03911.x; Robinson DS, 2009, CLIN EXP ALLERGY, V39, P1314, DOI 10.1111/j.1365-2222.2009.03301.x; Rosenwasser LJ, 2011, IMMUNOL ALLERGY CLIN, V31, P433, DOI 10.1016/j.iac.2011.05.009; Russell SL, 2012, CURR OPIN GASTROEN, V28, P563, DOI 10.1097/MOG.0b013e3283573017; Schaad UB, 2010, WORLD J PEDIATR, V6, P5, DOI 10.1007/s12519-010-0001-x; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P1842, DOI 10.1111/j.1365-2222.2009.03326.x; Strickland DH, 2011, MUCOSAL IMMUNOL, V4, P43, DOI 10.1038/mi.2010.43; Sun YQ, 2012, STEM CELLS, V30, P2692, DOI 10.1002/stem.1241; Vighi G, 2008, CLIN EXP IMMUNOL, V153, P3, DOI 10.1111/j.1365-2249.2008.03713.x; Zelle-Rieser C, 2001, IMMUNOL LETT, V76, P63, DOI 10.1016/S0165-2478(00)00326-6	24	24	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92912	10.1371/journal.pone.0092912	http://dx.doi.org/10.1371/journal.pone.0092912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667347	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600103
J	Garcia-Armisen, T; Inceoglu, O; Ouattara, NK; Anzil, A; Verbanck, MA; Brion, N; Servais, P				Garcia-Armisen, Tamara; Inceoglu, Ozgul; Ouattara, Nouho Koffi; Anzil, Adriana; Verbanck, Michel A.; Brion, Natacha; Servais, Pierre			Seasonal Variations and Resilience of Bacterial Communities in a Sewage Polluted Urban River	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; SP-NOV.; WATER; LAKE; DIVERSITY; BACTERIOPLANKTON; TEMPERATURE; SYNCHRONY; ABUNDANCE; SEDIMENTS	The Zenne River in Brussels (Belgium) and effluents of the two wastewater treatment plants (WWTPs) of Brussels were chosen to assess the impact of disturbance on bacterial community composition (BCC) of an urban river. Organic matters, nutrients load and oxygen concentration fluctuated highly along the river and over time because of WWTPs discharge. Tag pyrosequencing of bacterial 16S rRNA genes revealed the significant effect of seasonality on the richness, the bacterial diversity (Shannon index) and BCC. The major grouping: -winter/fall samples versus spring/summer samples-could be associated with fluctuations of in situ bacterial activities (dissolved and particulate organic carbon biodegradation associated with oxygen consumption and N transformation). BCC of the samples collected upstream from the WWTPs discharge were significantly different from BCC of downstream samples and WWTPs effluents, while no significant difference was found between BCC of WWTPs effluents and the downstream samples as revealed by ANOSIM. Analysis per season showed that allochthonous bacteria brought by WWTPs effluents triggered the changes in community composition, eventually followed by rapid post-disturbance return to the original composition as observed in April (resilience), whereas community composition remained altered after the perturbation by WWTPs effluents in the other seasons.	[Garcia-Armisen, Tamara; Inceoglu, Ozgul; Ouattara, Nouho Koffi; Anzil, Adriana; Servais, Pierre] Univ Libre Bruxelles, Brussels, Belgium; [Verbanck, Michel A.] Univ Libre Bruxelles, Dept Water Pollut Control, Brussels, Belgium; [Brion, Natacha] Vrije Univ Brussels, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Servais, P (corresponding author), Univ Libre Bruxelles, Campus Plaine, Brussels, Belgium.	pservais@ulb.ac.be	Brion, Natacha/H-3565-2017; OUATTARA, KOFFI NOUHO/AAF-3109-2019	Brion, Natacha/0000-0002-3021-1445; 	Belgian Federal Science Policy Office (BELSPO); FNRS (Fonds National de la Recherche Scientifique, Belgium) grant	Belgian Federal Science Policy Office (BELSPO)(Belgian Federal Science Policy Office); FNRS (Fonds National de la Recherche Scientifique, Belgium) grant(Fonds de la Recherche Scientifique - FNRS)	This study was mainly performed in the scope of the GESZ research project (Towards the Good Ecological Status of River Zenne: Reevaluating Brussels wastewater management) from the "Impulse Environment 2008" program of the Brussels Institute for Research and Innovation (Innoviris). A part of the work was also performed in the scope of the project "Tracing and Integrated Modelling of Natural and Anthropogenic effects on Hydrosystems" (TIMOTHY), an Interuniversity Attraction Pole (IAP6.13) funded by the Belgian Federal Science Policy Office (BELSPO). O Ynceolu benefits from a FNRS (Fonds National de la Recherche Scientifique, Belgium) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WR, 2010, INT J MICROBIOL, V2011; Ademoroti CMA, 1996, ENV CHEM TOXICOLOGY, P70; Allison G, 2004, ECOL MONOGR, V74, P117, DOI 10.1890/02-0681; Araya R, 2003, J HEALTH SCI, V49, P379, DOI 10.1248/jhs.49.379; Barra Caracciolo A, 2011, CHEM ECOL, V27, P43, DOI 10.1080/02757540.2010.534082; Belanche L, 2000, ARTIF INTELL ENG, V14, P307, DOI 10.1016/S0954-1810(00)00012-1; Berga M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036959; Brion N, 2012, BRIDGE TROUBLED WATE, P241; Callaway TR, 2009, POULTRY SCI, V88, P298, DOI 10.3382/ps.2008-00222; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Crump BC, 1999, APPL ENVIRON MICROB, V65, P3192; Crump BC, 2005, LIMNOL OCEANOGR, V50, P1718, DOI 10.4319/lo.2005.50.6.1718; David R, 2010, LABDSV ORDINATION MU; Drury B, 2013, APPL ENVIRON MICROB, V79, P1897, DOI 10.1128/AEM.03527-12; Echeveste P, 2010, CHEMOSPHERE, V81, P161, DOI 10.1016/j.chemosphere.2010.06.072; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; EIKELBOOM DH, 1975, WATER RES, V9, P365, DOI 10.1016/0043-1354(75)90182-7; EVISON LM, 1988, WATER SCI TECHNOL, V20, P309, DOI 10.2166/wst.1988.0300; Finneran KT, 2003, INT J SYST EVOL MICR, V53, P669, DOI 10.1099/ijs.0.02298-0; Gamier J, 1992, ARCH HYDROBIOL ERGEB, V37, P83; GARNIER J, 1992, CAN J MICROBIOL, V38, P56, DOI 10.1139/m92-009; Ghiglione JF, 2012, ENVIRON MICROBIOL, V14, P617, DOI 10.1111/j.1462-2920.2011.02601.x; Gilbert JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015545; Gorley C.K., 2006, GETTING STARTED PRIM; Hu M, 2012, BIORESOURCE TECHNOL, V117, P72, DOI 10.1016/j.biortech.2012.04.061; Huerta B, 2013, SCI TOTAL ENVIRON, V456, P161, DOI 10.1016/j.scitotenv.2013.03.071; Ibekwe AM, 2012, FEMS MICROBIOL ECOL, V79, P155, DOI 10.1111/j.1574-6941.2011.01205.x; JAFFE R, 1991, ENVIRON POLLUT, V69, P237, DOI 10.1016/0269-7491(91)90147-O; Kent AD, 2007, ISME J, V1, P38, DOI 10.1038/ismej.2007.6; Kenzaka T, 2001, J HEALTH SCI, V47, P353, DOI 10.1248/jhs.47.353; KIRCHMAN DL, 1994, MICROBIAL ECOL, V28, P255, DOI 10.1007/BF00166816; Kostanjsek R, 2005, ENVIRON SCI POLLUT R, V12, P361, DOI 10.1065/espr2005.07.271; Kotay SM, 2011, WATER RES, V45, P694, DOI 10.1016/j.watres.2010.08.038; Lamy D, 2009, AQUAT MICROB ECOL, V58, P95, DOI 10.3354/ame01359; Li D, 2008, FEMS MICROBIOL ECOL, V65, P494, DOI 10.1111/j.1574-6941.2008.00540.x; Lliros M, 2008, FEMS MICROBIOL ECOL, V66, P331, DOI 10.1111/j.1574-6941.2008.00583.x; Methe BA, 1998, LIMNOL OCEANOGR, V43, P368, DOI 10.4319/lo.1998.43.2.0368; Moreno Y, 2003, APPL ENVIRON MICROB, V69, P1181, DOI 10.1128/AEM.69.2.1181-1186.2003; Murray AE, 1998, APPL ENVIRON MICROB, V64, P2585; Murray KS, 2001, J GREAT LAKES RES, V27, P220, DOI 10.1016/S0380-1330(01)70635-1; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Nielsen PH, 2010, WATER RES, V44, P5070, DOI 10.1016/j.watres.2010.07.036; Okpokwasili GC, 1996, ENVIRON TOXIC WATER, V11, P77; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Ouattara NK, 2011, ENVIRON MONIT ASSESS, V183, P243, DOI 10.1007/s10661-011-1918-9; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; R Development Core Team, 2011, R LANG ENV STAT COMP; Servais P, 2007, SCI TOTAL ENVIRON, V375, P152, DOI 10.1016/j.scitotenv.2006.12.010; Shade A., 2010, MICROB ECOL, V59, P546, DOI [10.1007/s00248-009-9589-6, DOI 10.1007/s00248-009-9589-6]; Shanks OC, 2013, APPL ENVIRON MICROB, V79, P2906, DOI 10.1128/AEM.03448-12; Smith DM, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-41; Spring S, 2005, INT J SYST EVOL MICR, V55, P621, DOI 10.1099/ijs.0.63356-0; Starliper CE, 2011, J ADV RES, V2, P97, DOI 10.1016/j.jare.2010.04.001; United Nations (UN), 2009, REV WORLD URB PROSP; Van der Gucht K, 2001, ENVIRON MICROBIOL, V3, P680, DOI 10.1046/j.1462-2920.2001.00242.x; Wakelin SA, 2008, APPL ENVIRON MICROB, V74, P2659, DOI 10.1128/AEM.02348-07; WEITHMAN AS, 1984, T AM FISH SOC, V113, P109, DOI 10.1577/1548-8659(1984)113<109:EODDOT>2.0.CO;2; Winter C, 2007, APPL ENVIRON MICROB, V73, P421, DOI 10.1128/AEM.01849-06; Yannarell AC, 2003, MICROB ECOL, V46, P391, DOI 10.1007/s00248-003-1008-9; Zhang ML, 2012, AQUAT SCI, V74, P113, DOI 10.1007/s00027-011-0201-z; Zhu J, 2013, MAR POLLUT B	65	39	43	4	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92579	10.1371/journal.pone.0092579	http://dx.doi.org/10.1371/journal.pone.0092579			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667680	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600050
J	Ibanez, J; de la Aleja, JG; Gallego, JA; Romero, JP; Saiz-Diaz, RA; Benito-Leon, J; Rocon, E				Ibanez, Jaime; Gonzalez de la Aleja, Jesus; Gallego, Juan A.; Romero, Juan P.; Saiz-Diaz, Rosana A.; Benito-Leon, Julian; Rocon, Eduardo			Effects of Alprazolam on Cortical Activity and Tremors in Patients with Essential Tremor	PLOS ONE			English	Article							SENSORIMOTOR-CORTEX; MOTOR CORTEX; EEG; NETWORK; UPDATE; PHARMACODYNAMICS; SYNCHRONIZATION; IDENTIFICATION; OSCILLATIONS; POTENTIALS	Background: Essential tremor (ET) is characterised by postural and action tremors with a frequency of 4-12 Hz. Previous studies suggest that the tremor activity originates in the cerebello-thalamocortical pathways. Alprazolam is a short-acting benzodiazepine that attenuates tremors in ET. The mechanisms that mediate the therapeutic action of alprazolam are unknown; however, in healthy subjects, benzodiazepines increase cortical beta activity. In this study, we investigated the effect of alprazolam both on beta and tremor-related cortical activity and on alterations in tremor presentation in ET patients. Therefore, we characterised the dynamics of tremor and cortical activity in ET patients after alprazolam intake. Methods: We recorded hand tremors and contralateral cortical activity in four recordings before and after a single dose of alprazolam. We then computed the changes in tremors, cortico-muscular coherence, and cortical activity at the tremor frequency and in the beta band. Results: Alprazolam significantly attenuated tremors (EMG: 76.2 +/- 22.68%), decreased cortical activity in the tremor frequency range and increased cortical beta activity in all patients (P<0.05). At the same time, the cortico-muscular coherence at the tremor frequency became non-significant (P<0.05). We also found a significant correlation (r = 0.757, P<0.001) between the reduction in tremor severity and the increased ratio of cortical activity in the beta band to the activity observed in the tremor frequency range. Conclusions: This study provides the first quantitative analysis of tremor reduction following alprazolam intake. We observed that the tremor severity decreased in association with an increased ratio of beta to tremor-related cortical activity. We hypothesise that the increase in cortical beta activity may act as a blocking mechanism and may dampen the pathological oscillatory activity, which in turn attenuates the observed tremor.	[Ibanez, Jaime; Gallego, Juan A.; Rocon, Eduardo] Consejo Super Invest Cientif, Bioengn Grp, Arganda Del Rey, Spain; [Gonzalez de la Aleja, Jesus; Romero, Juan P.; Saiz-Diaz, Rosana A.; Benito-Leon, Julian] Univ Hosp 12 Octubre, Dept Neurol, Madrid, Spain; [Gonzalez de la Aleja, Jesus; Saiz-Diaz, Rosana A.; Benito-Leon, Julian] Univ Complutense, Fac Med, Dept Med, E-28040 Madrid, Spain; [Benito-Leon, Julian] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Romero, Juan P.] Univ Francisco Vitoria, Pozuelo De Alarcon, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Hospital Universitario 12 de Octubre; Complutense University of Madrid; CIBERNED; Universidad Francisco de Vitoria	Ibanez, J (corresponding author), Consejo Super Invest Cientif, Bioengn Grp, Arganda Del Rey, Spain.	jaime.ibanez@csic.es	Ibáñez, Jaime/G-2123-2015; Romero, Juan Pablo/Y-6765-2018; Benito-León, Julián/AAA-1331-2019; Rocon, Eduardo/F-4866-2011	Ibáñez, Jaime/0000-0001-8439-151X; Romero, Juan Pablo/0000-0002-3190-1296; Benito-León, Julián/0000-0002-1769-4809; Rocon, Eduardo/0000-0001-9618-2176; Gallego, Juan Alvaro/0000-0003-2146-0703; Gonzalez de la Aleja Tejera, Jesus/0000-0001-8197-1519; saiz diaz, rosa ana/0000-0002-0457-0516	CSIC [CSIC-201050I040]; EU Commission [EU-FP7-2011-287739]	CSIC; EU Commission(European CommissionEuropean Commission Joint Research Centre)	This work has been partially funded by CSIC, through the program for the incorporation of tenure researches CSIC-201050I040, "Development and clinical validation of a neuroprosthesis for tremor suppression", and by the EU Commission through the grant EU-FP7-2011-287739, "NeuroTREMOR". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babij R, 2013, BRAIN, V136, P3051, DOI 10.1093/brain/awt238; Baker MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049088; Baker MR, 2003, J PHYSIOL-LONDON, V546, P931, DOI 10.1113/jphysiol.2002.029553; Baker SN, 2007, CURR OPIN NEUROBIOL, V17, P649, DOI 10.1016/j.conb.2008.01.007; Bazzigaluppi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046360; Benito-Leon J, 2011, MINERVA MED, V102, P417; Benito-Leon J, 2006, NAT CLIN PRACT NEURO, V2, P666, DOI 10.1038/ncpneuro0347; Benito-Leon J, 2009, J NEUROL SCI, V287, P138, DOI 10.1016/j.jns.2009.08.037; Boecker H, 1996, ANN NEUROL, V39, P650, DOI 10.1002/ana.410390515; Brown P, 2000, PROG NEUROBIOL, V60, P97, DOI 10.1016/S0301-0082(99)00029-5; Chakarov V, 2009, J NEUROPHYSIOL, V102, P1115, DOI 10.1152/jn.91095.2008; CONNORS BW, 1988, J PHYSIOL-LONDON, V406, P443, DOI 10.1113/jphysiol.1988.sp017390; Conway BA, 1995, J PHYSIOL-LONDON, V489, P917, DOI 10.1113/jphysiol.1995.sp021104; de Lima ER, 2006, MED BIOL ENG COMPUT, V44, P569, DOI 10.1007/s11517-006-0065-x; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; Deuschl G, 2011, LANCET NEUROL, V10, P148, DOI 10.1016/S1474-4422(10)70322-7; Elble RJ, 2009, CURR NEUROL NEUROSCI, V9, P273, DOI 10.1007/s11910-009-0041-6; Farina D, 2013, J PHYSIOL-LONDON, V591, P2403, DOI 10.1113/jphysiol.2012.246082; Gallego JA, 2010, SENSORS-BASEL, V10, P2129, DOI 10.3390/s100302129; GROWDON JH, 1975, NEUROLOGY, V25, P259, DOI 10.1212/WNL.25.3.259; Gunal DI, 2000, NEUROL SCI, V21, P315, DOI 10.1007/s100720070069; Hall SD, 2010, HUM BRAIN MAPP, V31, P581, DOI 10.1002/hbm.20889; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; Halliday DM, 1998, NEUROSCI LETT, V241, P5, DOI 10.1016/S0304-3940(97)00964-6; Hellwig B, 2003, CLIN NEUROPHYSIOL, V114, P1462, DOI 10.1016/S1388-2457(03)00116-0; Hellwig B, 2001, LANCET, V357, P519, DOI 10.1016/S0140-6736(00)04044-7; HJORTH B, 1975, ELECTROEN CLIN NEURO, V39, P526, DOI 10.1016/0013-4694(75)90056-5; Hua SE, 1998, J NEUROL NEUROSUR PS, V64, P273, DOI 10.1136/jnnp.64.2.273; HUBER SJ, 1988, NEUROLOGY, V38, P241, DOI 10.1212/WNL.38.2.241; Ilan AB, 2001, ALCOHOL, V25, P137, DOI 10.1016/S0741-8329(01)00191-4; JENKINS IH, 1993, ANN NEUROL, V34, P82, DOI 10.1002/ana.410340115; Jensen O, 2005, NEUROIMAGE, V26, P347, DOI 10.1016/j.neuroimage.2005.02.008; Kaplan GB, 1998, J CLIN PHARMACOL, V38, P14, DOI 10.1002/j.1552-4604.1998.tb04370.x; Kilner JM, 2000, J NEUROSCI, V20, P8838; Lindhardt K, 2001, BRIT J CLIN PHARMACO, V52, P521, DOI 10.1046/j.0306-5251.2001.01486.x; Louis ED, 2013, MOVEMENT DISORD, V28, P779, DOI 10.1002/mds.25400; Minc D, 2010, NEUROSCI LETT, V469, P145, DOI 10.1016/j.neulet.2009.11.062; Muthuraman M, 2012, NEUROIMAGE, V60, P1331, DOI 10.1016/j.neuroimage.2012.01.088; Negro F, 2011, J PHYSIOL-LONDON, V589, P629, DOI 10.1113/jphysiol.2010.202473; Niedermeyer E., 2005, ELECTROEN CLIN NEURO; Pahapill PA, 1999, ANN NEUROL, V46, P249, DOI 10.1002/1531-8249(199908)46:2<249::AID-ANA15>3.0.CO;2-C; Paris-Robidas S, 2012, BRAIN, V135, P105, DOI 10.1093/brain/awr301; Park YG, 2010, P NATL ACAD SCI USA, V107, P10731, DOI 10.1073/pnas.1002995107; Petersen TH, 2012, J PHYSIOL-LONDON, V590, P2443, DOI 10.1113/jphysiol.2012.227397; Raethjen J, 2007, J NEUROPHYSIOL, V97, P3219, DOI 10.1152/jn.00477.2006; Raethjen J, 2012, CLIN NEUROPHYSIOL, V123, P61, DOI 10.1016/j.clinph.2011.09.024; Rangaswamy M, 2002, BIOL PSYCHIAT, V52, P831, DOI 10.1016/S0006-3223(02)01362-8; ROSENBERG JR, 1989, PROG BIOPHYS MOL BIO, V53, P1, DOI 10.1016/0079-6107(89)90004-7; Schnitzler A, 2009, MOVEMENT DISORD, V24, P1629, DOI 10.1002/mds.22633; Sommerlade L, 2011, J NEUROSCI METH, V196, P182, DOI 10.1016/j.jneumeth.2010.12.019; Timmermann L, 2003, BRAIN, V126, P199, DOI 10.1093/brain/awg022; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Wilms H, 1999, MOVEMENT DISORD, V14, P557, DOI 10.1002/1531-8257(199907)14:4<557::AID-MDS1004>3.0.CO;2-G; Zesiewicz TA, 2011, NEUROLOGY, V77, P1752, DOI 10.1212/WNL.0b013e318236f0fd	54	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93159	10.1371/journal.pone.0093159	http://dx.doi.org/10.1371/journal.pone.0093159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667763	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000333675600150
J	Liu, J; Wei, W; Kuang, H; Tsien, JZ; Zhao, F				Liu, Jun; Wei, Wei; Kuang, Hui; Tsien, Joe Z.; Zhao, Fang			Heart Rate and Heart Rate Variability Assessment Identifies Individual Differences in Fear Response Magnitudes to Earthquake, Free Fall, and Air Puff in Mice	PLOS ONE			English	Article							ACOUSTIC STARTLE STIMULUS; CARDIOVASCULAR-RESPONSES; CONDITIONED FEAR; POTENTIATED STARTLE; STRESS-RESPONSE; MEMORY; BEHAVIOR; EMOTION; NEUROBIOLOGY; HABITUATION	Fear behaviors and fear memories in rodents have been traditionally assessed by the amount of freezing upon the presentation of conditioned cues or unconditioned stimuli. However, many experiences, such as encountering earthquakes or accidental fall from tree branches, may produce long-lasting fear memories but are behaviorally difficult to measure using freezing parameters. Here, we have examined changes in heartbeat interval dynamics as physiological readout for assessing fearful reactions as mice were subjected to sudden air puff, free-fall drop inside a small elevator, and a laboratory-version earthquake. We showed that these fearful events rapidly increased heart rate (HR) with simultaneous reduction of heart rate variability (HRV). Cardiac changes can be further analyzed in details by measuring three distinct phases: namely, the rapid rising phase in HR, the maximum plateau phase during which HRV is greatly decreased, and the recovery phase during which HR gradually recovers to baseline values. We showed that durations of the maximum plateau phase and HR recovery speed were quite sensitive to habituation over repeated trials. Moreover, we have developed the fear resistance index based on specific cardiac response features. We demonstrated that the fear resistance index remained largely consistent across distinct fearful events in a given animal, thereby enabling us to compare and rank individual mouse's fear responsiveness among the group. Therefore, the fear resistance index described here can represent a useful parameter for measuring personality traits or individual differences in stress-susceptibility in both wild-type mice and post-traumatic stress disorder (PTSD) models.	[Liu, Jun; Wei, Wei] E China Normal Univ, Key Lab Brain Funct Genom, Minist Educ, Inst Brain Funct Genom, Shanghai 200062, Peoples R China; [Kuang, Hui; Tsien, Joe Z.; Zhao, Fang] Xi Shuang Ban Na Prefecture, Banna Biomed Res Inst, Xishuangbanna, Yunnan, Peoples R China; [Liu, Jun; Wei, Wei; Kuang, Hui; Tsien, Joe Z.; Zhao, Fang] Georgia Regents Univ, Brain & Behav Discovery Inst, Med Coll Georgia, Augusta, GA USA; [Liu, Jun; Wei, Wei; Kuang, Hui; Tsien, Joe Z.; Zhao, Fang] Georgia Regents Univ, Dept Neurol, Med Coll Georgia, Augusta, GA USA	East China Normal University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Tsien, JZ (corresponding author), Xi Shuang Ban Na Prefecture, Banna Biomed Res Inst, Xishuangbanna, Yunnan, Peoples R China.	jtsien@gru.edu; zhaofang.magic@gmail.com			National Institutes of Health [NS079774, AG034663-01, MH060236]; Shanghai Commission of Science and Technology [10140900500]; Yunnan Province Department of Science and Technology [2012BA009]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee); Yunnan Province Department of Science and Technology	This work was supported by grants from National Institutes of Health (NS079774, AG034663-01, and MH060236), Shanghai Commission of Science and Technology (Grant # 10140900500), and Yunnan Province Department of Science and Technology (Grant # 2012BA009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Villaca Y, 2006, BEHAV BRAIN RES, V167, P175, DOI 10.1016/j.bbr.2005.09.003; Adolphs R, 2000, LEARN MEMORY, V7, P180, DOI 10.1101/lm.7.3.180; Appelhans BM, 2006, REV GEN PSYCHOL, V10, P229, DOI 10.1037/1089-2680.10.3.229; Baudrie V, 2001, CLIN EXP PHARMACOL P, V28, P1096, DOI 10.1046/j.1440-1681.2001.03593.x; Baudrie V, 1997, J AUTON PHARMACOL, V17, P303, DOI 10.1046/j.1365-2680.1997.00465.x; BERGER TW, 1978, P NATL ACAD SCI USA, V75, P1572, DOI 10.1073/pnas.75.3.1572; BLANCHARD DC, 1972, J COMP PHYSIOL PSYCH, V81, P281, DOI 10.1037/h0033521; Bradley M. M., 1999, STARTLE MODIFICATION, P157, DOI [10.1017/CBO9780511665523.010, DOI 10.1017/CBO9780511665523.010]; BRADLEY MM, 1992, J EXP PSYCHOL LEARN, V18, P379, DOI 10.1037/0278-7393.18.2.379; BROWN JS, 1951, J EXP PSYCHOL, V41, P317, DOI 10.1037/h0060166; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; CASTO R, 1989, AM J PHYSIOL, V256, pR1121, DOI 10.1152/ajpregu.1989.256.5.R1121; CHI CC, 1965, PSYCHOPHARMACOLOGIA, V7, P115, DOI 10.1007/BF00403634; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; DAVIS M, 1982, J NEUROSCI, V2, P791; Davis M., 1984, P287; DAVIS M, 1993, BEHAV BRAIN RES, V58, P175, DOI 10.1016/0166-4328(93)90102-V; Eder DN, 2009, INT J PSYCHOPHYSIOL, V71, P149, DOI 10.1016/j.ijpsycho.2008.09.001; Ellis BJ, 2006, DEV REV, V26, P175, DOI 10.1016/j.dr.2006.02.004; Fang FSC, 1997, ENTROPY OPTIMIZATION; FANSELOW MS, 1984, TRENDS NEUROSCI, V7, P460; Francis DD, 2003, NAT NEUROSCI, V6, P445, DOI 10.1038/nn1038; Gaburro S, 2011, INT J NEUROPSYCHOPH, V14, P1341, DOI 10.1017/S1461145711000058; Holmes A, 2005, NEUROSCI BIOBEHAV R, V29, P1335, DOI 10.1016/j.neubiorev.2005.04.012; Islam S, 2006, EUR J OPER RES, V173, P387, DOI 10.1016/j.ejor.2005.01.050; Jakovcevski M, 2008, GENES BRAIN BEHAV, V7, P235, DOI 10.1111/j.1601-183X.2007.00345.x; Kim JJ, 2006, NEUROSCI BIOBEHAV R, V30, P188, DOI 10.1016/j.neubiorev.2005.06.005; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Landis C, 1939, STARTLE PATTERN FARR; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Lathe R, 2004, GENES BRAIN BEHAV, V3, P317, DOI 10.1111/j.1601-183X.2004.00083.x; LEDOUX JE, 1994, SCI AM, V270, P50, DOI 10.1038/scientificamerican0694-50; Lin LN, 2005, P NATL ACAD SCI USA, V102, P6125, DOI 10.1073/pnas.0408233102; Liu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063590; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McCauley Mark D, 2010, J Vis Exp, DOI 10.3791/1739; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; Osan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016507; Palmer AA, 1999, NEUROSCIENCE, V89, P965, DOI 10.1016/S0306-4522(98)00333-9; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; RETTIG R, 1986, PHYSIOL BEHAV, V36, P1123, DOI 10.1016/0031-9384(86)90489-0; Ruiz-Padial E, 2003, PSYCHOPHYSIOLOGY, V40, P306, DOI 10.1111/1469-8986.00032; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Stiedl O, 2004, AUTON NEUROSCI-BASIC, V115, P15, DOI 10.1016/j.autneu.2004.07.006; Stiedl O, 1997, BEHAV NEUROSCI, V111, P703, DOI 10.1037/0735-7044.111.4.703; Stiedl O, 1999, BEHAV BRAIN RES, V104, P1, DOI 10.1016/S0166-4328(99)00047-9; Stiedl O, 2009, NEUROSCI BIOBEHAV R, V33, P181, DOI 10.1016/j.neubiorev.2008.08.015; Taylor BK, 1996, PHYSIOL BEHAV, V60, P919; Tovote P, 2005, BEHAV NEUROSCI, V119, P55, DOI 10.1037/0735-7044.119.1.55; Tsien JZ, 2013, NEUROBIOL LEARN MEM, V105, P200, DOI 10.1016/j.nlm.2013.06.019; Vogel EH, 2005, PHYSIOL BEHAV, V86, P516, DOI 10.1016/j.physbeh.2005.08.042; Wahlsten D, 2003, J NEUROBIOL, V54, P283, DOI 10.1002/neu.10173; Wang DV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017047; Weible AP, 2003, J NEUROPHYSIOL, V90, P599, DOI 10.1152/jn.01097.2002; Xie K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064907; YOUNG BJ, 1994, BEHAV NEUROSCI, V108, P1065, DOI 10.1037/0735-7044.108.6.1065; Zhang WN, 2004, BEHAV BRAIN RES, V154, P199, DOI 10.1016/j.bbr.2004.02.016	60	22	23	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93270	10.1371/journal.pone.0093270	http://dx.doi.org/10.1371/journal.pone.0093270			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667366	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600160
J	Marolt, D; Rode, M; Kregar-Velikonja, N; Jeras, M; Knezevic, M				Marolt, Darja; Rode, Matjaz; Kregar-Velikonja, Nevenka; Jeras, Matjaz; Knezevic, Miomir			Primary Human Alveolar Bone Cells Isolated from Tissue Samples Acquired at Periodontal Surgeries Exhibit Sustained Proliferation and Retain Osteogenic Phenotype during In Vitro Expansion	PLOS ONE			English	Article							MARROW STROMAL CELLS; MESENCHYMAL STEM-CELLS; OSTEOBLAST-LIKE CELLS; ENGINEERED BONE; SINUS AUGMENTATION; QUANTITATIVE-ANALYSIS; PERIOSTEAL CELLS; GENE-EXPRESSION; DIFFERENTIATION; REGENERATION	Objectives: Bone tissue regeneration requires a source of viable, proliferative cells with osteogenic differentiation capacity. Periodontal surgeries represent an opportunity to procure small amounts of autologous tissues for primary cell isolation. Our objective was to assess the potential of human alveolar bone as a source of autologous osteogenic cells for tissue engineering and biomaterials and drug testing studies. Materials and Methods: Alveolar bone tissue was obtained from 37 patients undergoing routine periodontal surgery. Tissue harvesting and cell isolation procedures were optimized to isolate viable cells. Primary cells were subcultured and characterized with respect to their growth characteristics, gene expression of osteogenic markers, alkaline phosphatase activity and matrix mineralization, under osteogenic stimulation. Results: Alveolar bone cells were successfully isolated from 28 of the 30 samples harvested with bone forceps, and from 2 of the 5 samples obtained by bone drilling. The yield of cells in primary cultures was variable between the individual samples, but was not related to the site of tissue harvesting and the patient age. In 80% of samples (n = 5), the primary cells proliferated steadily for eight subsequent passages, reaching cumulative numbers over 10(10) cells. Analyses confirmed stable gene expression of alkaline phosphatase, osteopontin and osteocalcin in early and late cell passages. In osteogenic medium, the cells from late passages increased alkaline phosphatase activity and accumulated mineralized matrix, indicating a mature osteoblastic phenotype. Conclusions: Primary alveolar bone cells exhibited robust proliferation and retained osteogenic phenotype during in vitro expansion, suggesting that they can be used as an autologous cell source for bone regenerative therapies and various in vitro studies.	[Marolt, Darja; Jeras, Matjaz; Knezevic, Miomir] Blood Transfus Ctr Slovenia, Ljubljana, Slovenia; [Marolt, Darja; Kregar-Velikonja, Nevenka; Knezevic, Miomir] Educell Doo, Trzin, Slovenia; [Rode, Matjaz] Ctr Community Hlth, Ljubljana, Slovenia; [Kregar-Velikonja, Nevenka] Fac Hlth Sci, Novo Mesto, Slovenia; [Jeras, Matjaz] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia; [Jeras, Matjaz] Celica Doo Biomed Ctr, Ljubljana, Slovenia	University of Ljubljana	Marolt, D (corresponding author), Blood Transfus Ctr Slovenia, Ljubljana, Slovenia.	darjamarolt@gmail.com	Velikonja, Nevenka Kregar/AAR-1166-2020	Velikonja, Nevenka Kregar/0000-0002-0479-3779; Marolt Presen, Darja/0000-0003-3638-4619	Republic of Slovenia Ministry of Education, Science and Sport [L4-6325-0311-04/4.06, 3311-01-831/476, P3-0371]; Slovene Human Resources Development and Scholarship Fund [11013-73/2012]	Republic of Slovenia Ministry of Education, Science and Sport; Slovene Human Resources Development and Scholarship Fund	This work was supported by Republic of Slovenia Ministry of Education, Science and Sport (grants L4-6325-0311-04/4.06, 3311-01-831/476, P3-0371) and Slovene Human Resources Development and Scholarship Fund (grant 11013-73/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akintoye SO, 2006, BONE, V38, P758, DOI 10.1016/j.bone.2005.10.027; Alves H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042908; Barlic A, 2008, J ORTHOP RES, V26, P847, DOI 10.1002/jor.20559; Beaumont C, 2008, J PERIODONTOL, V79, P541, DOI [10.1902/jop.2008.070255, 10.1902/jop.2008.070255 ]; Benisch P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045142; Bruder SP, 1999, CLIN ORTHOP RELAT R, pS68; Clausen C, 2006, CLIN ORAL IMPLAN RES, V17, P533, DOI 10.1111/j.1600-0501.2006.01254.X; Declercq H, 2004, BIOMATERIALS, V25, P757, DOI 10.1016/S0142-9612(03)00580-5; Dolan EB, 2012, J R SOC INTERFACE, V9, P3503, DOI 10.1098/rsif.2012.0520; Fekete N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043255; FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x; Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029; Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210; Hutmacher DW, 2003, TISSUE ENG, V9, pS45, DOI 10.1089/10763270360696978; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Janssen NG, 2013, CLIN ORAL INVESTIG; Jaquiery C, 2005, ANN SURG, V242, P859, DOI 10.1097/01.sla.0000189572.02554.2c; Jonsson KB, 1999, ACTA ORTHOP SCAND, V70, P365, DOI 10.3109/17453679908997826; Khan SN, 2005, J AM ACAD ORTHOP SUR, V13, P77, DOI 10.5435/00124635-200501000-00010; Kregar Velikonja N, 2012, BONE REGENERATION; Landesberg R, 2011, ANN NY ACAD SCI, V1218, P62, DOI 10.1111/j.1749-6632.2010.05835.x; Mailhot JM, 1998, CLIN ORAL IMPLAN RES, V9, P43, DOI 10.1034/j.1600-0501.1998.090106.x; Majors AK, 1997, J ORTHOPAED RES, V15, P546, DOI 10.1002/jor.1100150410; Malicev E, 2008, BIOTECHNOL BIOENG, V100, P773, DOI 10.1002/bit.21815; Mangano Carlo, 2009, Clin Implant Dent Relat Res, V11 Suppl 1, pe92, DOI 10.1111/j.1708-8208.2009.00227.x; Marolt D, 2012, J ORAL MAXIL SURG, V70, P1081, DOI 10.1016/j.joms.2011.05.002; Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456; Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366; McMahon RE, 2013, J BIOMED MATER RES B, V101B, P387, DOI 10.1002/jbm.b.32823; Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029; Muschler GF, 1997, J BONE JOINT SURG AM, V79A, P1699, DOI 10.2106/00004623-199711000-00012; Piek E, 2010, BONE, V46, P613, DOI 10.1016/j.bone.2009.10.024; Pradel W, 2006, ORAL SURG ORAL MED O, V101, P285, DOI 10.1016/j.tripleo.2005.06.001; Pradel W, 2008, J PHYSIOL PHARMACOL, V59, P47; Pradel W, 2012, ANN ANAT, V194, P545, DOI 10.1016/j.aanat.2012.06.002; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Schimming R, 2004, J ORAL MAXIL SURG, V62, P724, DOI 10.1016/j.joms.2004.01.009; Schmelzeisen R, 2003, J CRANIO MAXILL SURG, V31, P34, DOI 10.1016/S1010-5182(02)00163-4; Shui CX, 2001, J BONE MINER RES, V16, P731, DOI 10.1359/jbmr.2001.16.4.731; Siggelkow H, 1999, J CELL BIOCHEM, V75, P22, DOI 10.1002/(SICI)1097-4644(19991001)75:1<22::AID-JCB3>3.0.CO;2-6; Sodek J, 2000, PERIODONTOL 2000, V24, P99, DOI 10.1034/j.1600-0757.2000.2240106.x; Springer IN, 2006, TISSUE ENG, V12, P2649, DOI 10.1089/ten.2006.12.2649; Stefanik D, 2008, ORAL DIS, V14, P465, DOI 10.1111/j.1601-0825.2007.01402.x; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Suga H, 2007, CYTOTHERAPY, V9, P738, DOI 10.1080/14653240701679873; Voegele TJ, 2000, ANTICANCER RES, V20, P3575; Xiao Y, 2004, CELL TRANSPLANT, V13, P15, DOI 10.3727/000000004772664851; Xiao Y, 2003, TISSUE ENG, V9, P1167, DOI 10.1089/10763270360728071; Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	50	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92969	10.1371/journal.pone.0092969	http://dx.doi.org/10.1371/journal.pone.0092969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667745	gold, Green Published, Green Submitted			2022-12-27	WOS:000333675600112
J	Nakagawa, Y; Nishikimi, T; Kuwahara, K; Yasuno, S; Kinoshita, H; Kuwabara, Y; Nakao, K; Minami, T; Yamada, C; Ueshima, K; Ikeda, Y; Okamoto, H; Horii, K; Nagata, K; Kangawa, K; Minamino, N; Nakao, K				Nakagawa, Yasuaki; Nishikimi, Toshio; Kuwahara, Koichiro; Yasuno, Shinji; Kinoshita, Hideyuki; Kuwabara, Yoshihiro; Nakao, Kazuhiro; Minami, Takeya; Yamada, Chinatsu; Ueshima, Kenji; Ikeda, Yoshihiro; Okamoto, Hiroyuki; Horii, Kazukiyo; Nagata, Kiyoshi; Kangawa, Kenji; Minamino, Naoto; Nakao, Kazuwa			The Effects of Super-Flux (High Performance) Dialyzer on Plasma Glycosylated Pro-B-Type Natriuretic Peptide (proBNP) and Glycosylated N-Terminal proBNP in End-Stage Renal Disease Patients on Dialysis	PLOS ONE			English	Article							HEART-FAILURE; MORTALITY; ATRIAL; MARKER; FORMS; BNP	Background: Plasma BNP levels are predictive of prognosis in hemodialysis patients. However, recent studies showed that the current BNP immunoassay cross-reacts with glycosylated proBNP, and the NT-proBNP assay underestimates glycosylated NT-proBNP. In addition, the recently developed high performance dialyzer removes medium-sized molecular solutes such as beta 2-microgloburin. We therefore investigated the effects of high performance dialysis on measured levels of glycosylated proBNP, glycosylated NT-proBNP and other BNP-related peptides in end-stage renal disease (ESRD) patients on hemodialysis. Method: The relationships between clinical parameters and BNP-related molecule were also investigated. We used our newly developed immunoassay to measure plasma total BNP and proBNP in 105 normal subjects and 36 ESRD patients before and after hemodialysis. Plasma NT-proBNP was measured using Elecsys II after treatment with or without deglycosylating enzymes. We also measured plasma ANP and cGMP using radioimmunoassays. Results: All the measured BNP-related peptides were significantly higher in ESRD patients than healthy subjects. Total BNP (-38.9%), proBNP (-29.7%), glycoNT-proBNP (-45.5%), nonglycoNT-proBNP (-53.4%), ANP (-50.4%) and cGMP (-72.1%) were all significantly reduced after hemodialysis, and the magnitude of the reduction appeared molecular weight-dependent. Both the proBNP/total BNP and glycoNT-proBNP/nonglycoNT-proBNP ratios were increased after hemodialysis. The former correlated positively with hemodialysis vintage and negatively with systolic blood pressure, while the latter correlated positively with parathyroid hormone levels. Conclusion: These results suggest that hemodialysis using super-flux dialyzer removes BNP-related peptides in a nearly molecular weight-dependent manner. The ProBNP/total BNP and glycoNT-proBNP/nonglycoNT-proBNP ratios appear to be influenced by hemodialysis-related parameters in ESRD patients on hemodialysis.	[Nakagawa, Yasuaki; Nishikimi, Toshio; Kuwahara, Koichiro; Kinoshita, Hideyuki; Kuwabara, Yoshihiro; Nakao, Kazuhiro; Minami, Takeya; Yamada, Chinatsu; Nakao, Kazuwa] Kyoto Univ Grad Sch Med, Dept Med & Clin Sci, Kyoto, Japan; [Yasuno, Shinji; Ueshima, Kenji] Kyoto Univ Hosp, Dept EBM Res, Inst Adv Clin & Translat Sci, Kyoto 606, Japan; [Ikeda, Yoshihiro] Med Corp, Ikeda Clin, Kyoto, Japan; [Okamoto, Hiroyuki; Horii, Kazukiyo; Nagata, Kiyoshi] Shionogi & Co Ltd, Div Diagnost, Oska, Japan; [Kangawa, Kenji] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biochem, Suita, Osaka, Japan; [Minamino, Naoto] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Mol Pharmacol, Suita, Osaka, Japan	Kyoto University; Kyoto University; Shionogi & Company Limited; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan	Nishikimi, T (corresponding author), Kyoto Univ Grad Sch Med, Dept Med & Clin Sci, Kyoto, Japan.	nishikim@kuhp.kyoto-u.ac.jp	Kuwahara, Koichiro/AFK-1723-2022	Kuwahara, Koichiro/0000-0003-2670-7170; Kuwabara, Yoshihiro/0000-0003-4161-2970	Ministry of Education, Culture, Sports, Science and Technology of Japan [20590837, 23591041]; Japan Science and Technology Agency [AS 232Z01302F]; Suzuken Memorial Foundation; Grants-in-Aid for Scientific Research [24591095] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Suzuken Memorial Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Scientific Research Grants-in-Aid 20590837 and 23591041 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T. Nishikimi); a grant (AS 232Z01302F) from the Japan Science and Technology Agency (to T. Nishikimi); and a grant from the Suzuken Memorial Foundation (to T. Nishikimi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cataliotti A, 2001, MAYO CLIN PROC, V76, P1111, DOI 10.4065/76.11.1111; Cowie MR, 1997, LANCET, V350, P1349, DOI 10.1016/S0140-6736(97)06031-5; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; DAVIS M, 1994, LANCET, V343, P440, DOI 10.1016/S0140-6736(94)92690-5; Hammerer-Lercher A, 2008, CLIN CHEM, V54, P858, DOI 10.1373/clinchem.2007.090266; Hunt PJ, 1997, CLIN ENDOCRINOL, V47, P287, DOI 10.1046/j.1365-2265.1997.2361058.x; Jackson S, 1985, NURSES AIDS SERIES; Januzzi JL, 2005, AM J CARDIOL, V95, P948, DOI 10.1016/j.amjcard.2004.12.032; Jourdain P, 2003, EUR J HEART FAIL, V5, P155, DOI 10.1016/S1388-9842(02)00247-7; Liang FQ, 2007, J AM COLL CARDIOL, V49, P1071, DOI 10.1016/j.jacc.2006.10.063; Luckenbill KN, 2008, CLIN CHEM, V54, P619, DOI 10.1373/clinchem.2007.097998; Madsen LH, 2007, KIDNEY INT, V71, P548, DOI 10.1038/sj.ki.5002087; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Mallamaci F, 2001, KIDNEY INT, V59, P1559, DOI 10.1046/j.1523-1755.2001.0590041559.x; Niizuma S, 2009, CLIN CHEM, V55, P1347, DOI 10.1373/clinchem.2008.121236; Niizuma S, 2009, NEPHROL DIAL TRANSPL, V24, P597, DOI 10.1093/ndt/gfn491; Nishikimi T, 1996, HYPERTENSION, V28, P22, DOI 10.1161/01.HYP.28.1.22; Nishikimi T, 2006, CARDIOVASC RES, V69, P318, DOI 10.1016/j.cardiores.2005.10.001; Nishikimi T, 2010, HEART, V96, P432, DOI 10.1136/hrt.2009.178392; Nishikimi T, 2001, AM J KIDNEY DIS, V37, P1201; Nishikimi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053233; Nishikimi T, 2012, HEART, V98, P152, DOI 10.1136/heartjnl-2011-300102; Nishikimi T, 2011, J CARDIOL, V57, P131, DOI 10.1016/j.jjcc.2011.01.002; Satyan S, 2007, AM J KIDNEY DIS, V50, P1009, DOI 10.1053/j.ajkd.2007.08.017; Schellenberger U, 2006, ARCH BIOCHEM BIOPHYS, V451, P160, DOI 10.1016/j.abb.2006.03.028; Schluter KD, 1998, CARDIOVASC RES, V37, P34, DOI 10.1016/S0008-6363(97)00194-6; Seferian KR, 2008, CLIN CHEM, V54, P866, DOI 10.1373/clinchem.2007.100040; Sheen V, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.10.041; Sivalingam M, 2011, HEMODIAL INT, V15, P359, DOI 10.1111/j.1542-4758.2011.00557.x; Troughton RW, 2004, J AM COLL CARDIOL, V43, P416, DOI 10.1016/j.jacc.2003.08.046; Wang AYM, 2007, J AM SOC NEPHROL, V18, P321, DOI 10.1681/ASN.2005121299; Weber M, 2006, HEART, V92, P671, DOI 10.1136/hrt.2005.065607; Yamamoto K, 1996, HYPERTENSION, V28, P988, DOI 10.1161/01.HYP.28.6.988; YASUE H, 1994, CIRCULATION, V90, P195, DOI 10.1161/01.CIR.90.1.195	34	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92314	10.1371/journal.pone.0092314	http://dx.doi.org/10.1371/journal.pone.0092314			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667631	Green Published, gold			2022-12-27	WOS:000333675600032
J	Resende, PC; Motta, FC; Oliveira, MDA; Gregianini, TS; Fernandes, SB; Cury, ALF; Rosa, MDD; Souza, TML; Siqueira, MM				Resende, Paola Cristina; Motta, Fernando C.; Oliveira, Maria de Lourdes A.; Gregianini, Tatiana S.; Fernandes, Sandra B.; Cury, Ana Luisa F.; Rosa, Maria do Carmo D.; Souza, Thiago Moreno L.; Siqueira, Marilda M.			Polymorphisms at Residue 222 of the Hemagglutinin of Pandemic Influenza A(H1N1)pdm09: Association of Quasi-Species to Morbidity and Mortality in Different Risk Categories	PLOS ONE			English	Article							SUBSTITUTION; D222G; VIRUS; H1N1	The D222G substitution in the hemagglutinin (HA) gene of the pandemic influenza A(H1N1)pdm09 virus has been identified as a potential virulence marker, because this change allows for virus invasion deeper into the respiratory tract. In this study, we analyzed D, G and N polymorphisms at residue 222 by pyrosequencing (PSQ). We initially analyzed 401 samples from Brazilian patients. These were categorized with respect to clinical conditions due to influenza infection (mild, serious or fatal) and sub-stratified by risky factors. The frequency of mixed population of virus, with more than one polymorphism at residue 222, was significantly higher in serious (10.6%) and fatal (46.7%) influenza cases, whereas those who showed mild influenza infections were all infected by D222 wild-type. Mixtures of quasi-species showed a significant association of mortality, especially for those with risk factors, in special pregnant women. These results not only reinforce the association between D222G substitution and influenza A(H1N1)pdm09-associated morbidity and mortality, but also add the perspective that a worse clinical prognosis is most likely correlated with mixtures of quasi-species at this HA residue. Therefore, quasi-species may have a critical and underestimated role in influenza-related clinical outcomes.	[Resende, Paola Cristina; Motta, Fernando C.; Oliveira, Maria de Lourdes A.; Souza, Thiago Moreno L.; Siqueira, Marilda M.] Fiocruz MS, Inst Oswaldo Cruz, Lab Virus Resp & Sarampo, BR-21045900 Rio De Janeiro, Brazil; [Gregianini, Tatiana S.] Fundacao Estadual Prod & Pesquisa Saude Secao, Lab Cent Saude Publ Estado Rio Grande do Sul, Porto Alegre, RS, Brazil; [Fernandes, Sandra B.] Lab Cent Saude Publ Estado Santa Catarina, Florianopolis, SC, Brazil; [Cury, Ana Luisa F.] Inst Octavio Magalhaes, Lab Cent Saude Publ Estado Minas Gerais, Belo Horizonte, MG, Brazil; [Cury, Ana Luisa F.] Fundacao Ezequiel Dias, Belo Horizonte, MG, Brazil; [Rosa, Maria do Carmo D.] Lab Cent Saude Publ Estado Parana, Curitiba, Parana, Brazil	Fundacao Oswaldo Cruz	Resende, PC (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Virus Resp & Sarampo, BR-21045900 Rio De Janeiro, Brazil.	paola@ioc.fiocruz.br	DE LOURDES A OLIVEIRA, MARIA/H-2474-2018; Resende, Paola Cristina/P-5002-2015; de Lourdes Aguiar Oliveira, Maria/AAI-8473-2021; Souza, Thiago Moreno L./G-2900-2012; Motta, Fernando/AAJ-2647-2021	Resende, Paola Cristina/0000-0002-2884-3662; de Lourdes Aguiar Oliveira, Maria/0000-0002-2472-5263; Souza, Thiago Moreno L./0000-0003-2212-3899; 	Brazilian Ministry of Health and Ministry of Technology and Science; CNPq; FAPERJ	Brazilian Ministry of Health and Ministry of Technology and Science; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Brazilian Ministry of Health and Ministry of Technology and Science, CNPq and FAPERJ provided funding to conduct this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, Wkly Epidemiol Rec, V85, P21; Baldanti F, 2011, CLIN MICROBIOL INFEC, V17, P1166, DOI 10.1111/j.1469-0691.2010.03403.x; Belser JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025091; Chan KH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013757; Chen HL, 2010, J INFECT DIS, V201, P1517, DOI 10.1086/652661; Cheng VCC, 2012, CLIN MICROBIOL REV, V25, P223, DOI 10.1128/CMR.05012-11; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; Houng HSH, 2012, J CLIN VIROL, V53, P12, DOI 10.1016/j.jcv.2011.09.004; Kilander A, 2010, EUROSURVEILLANCE, V15, P1, DOI DOI 10.1128/JVI.01136-10; Kuroda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010256; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Ledesma J, 2011, J CLIN VIROL, V51, P75, DOI 10.1016/j.jcv.2011.01.020; Levine M, 2011, J CLIN MICROBIOL, V49, P1307, DOI 10.1128/JCM.02424-10; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Mak GC, 2010, EUROSURVEILLANCE, V15, P15; MILLER RR, 2010, EURO SURVEILL, V15; Mosby LG, 2011, AM J OBSTET GYNECOL, V205, P10, DOI 10.1016/j.ajog.2010.12.033; Orczyk-Pawilowicz M, 2013, GLYCOCONJUGATE J, V30, P599, DOI 10.1007/s10719-012-9460-8; Puzelli S, 2010, EMERG INFECT DIS, V16, P863, DOI [10.3201/eid1605.091858, 10.3201/eid1605.091815]; Rykkvin R, 2013, EUROSURVEILLANCE, V18, P18; Sdve Saude, 2010, INFL PAND H1N1 2009, P21; Selleri M., 2012, CLIN MICROBIOL INFEC; Souza TML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014158; Vazquez-Perez JA, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-41; Wang B., 2011, J CLIN VIROL; Wedde M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057059; WHO Global Influenza Surveillance Network, 2011, MAN LAB DIAGN VIR SU; World Health Organization, 2010, PAND H1N1 2009 UPD 1; Yasugi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030946	29	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92789	10.1371/journal.pone.0092789	http://dx.doi.org/10.1371/journal.pone.0092789			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667815	Green Submitted, Green Published, gold			2022-12-27	WOS:000333675600074
J	Tsukiyama, T; Kato-Itoh, M; Nakauchi, H; Ohinata, Y				Tsukiyama, Tomoyuki; Kato-Itoh, Megumi; Nakauchi, Hiromitsu; Ohinata, Yasuhide			A Comprehensive System for Generation and Evaluation of Induced Pluripotent Stem Cells Using piggyBac Transposition	PLOS ONE			English	Article							MAMMALIAN-CELLS; SOMATIC-CELLS; MOUSE SPERM; EXPRESSION; FIBROBLASTS; INJECTION; STATE; MICE	The most stringent criterion for evaluating pluripotency is generation of chimeric animals with germline transmission ability. Because the quality of induced pluripotent stem cell (iPSC) lines is heterogeneous, an easy and accurate system to evaluate these abilities would be useful. In this study, we describe a simple but comprehensive system for generating and evaluating iPSCs by single transfection of multiple piggyBac (PB) plasmid vectors encoding Tet-inducible polycistronic reprogramming factors, a pluripotent-cell-specific reporter, a constitutively active reporter, and a sperm-specific reporter. Using this system, we reprogrammed 129 and NOD mouse embryonic fibroblasts into iPSCs, and then evaluated the molecular and functional properties of the resultant iPSCs by quantitative RT-PCR analysis and chimera formation assays. The iPSCs contributed extensively to chimeras, as indicated by the constitutively active TagRFP reporter, and also differentiated into sperm, as indicated by the late-spermatogenesis-specific Acr (acrosin)-EGFP reporter. Next, we established secondary MEFs from E13.5 chimeric embryos and efficiently generated secondary iPSCs by simple addition of doxycycline. Finally, we applied this system to establishment and evaluation of rat iPSCs and production of rat sperm in mouse-rat interspecific chimeras. By monitoring the fluorescence of Acr-EGFP reporter, we could easily detect seminiferous tubules containing rat iPSC-derived spermatids and sperm. And, we succeeded to obtain viable offspring by intracytoplasmic sperm injection (ICSI) using these haploid male germ cells. We propose that this system will enable robust strategies for induction and evaluation of iPSCs, not only in rodents but also in other mammals. Such strategies will be especially valuable in non-rodent species, in which verification of germline transmission by mating is inefficient and time-consuming.	[Tsukiyama, Tomoyuki; Kato-Itoh, Megumi; Ohinata, Yasuhide] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama, Japan; [Tsukiyama, Tomoyuki; Ohinata, Yasuhide] RIKEN Ctr Dev Biol CDB, Lab Pluripotent Stem Cell Studies, Kobe, Hyogo, Japan; [Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Ctr Stem Cell Biol & Regenerat Med,Minato Ku, Tokyo, Japan; [Kato-Itoh, Megumi; Nakauchi, Hiromitsu] JST, ERATO, Nakauchi Stem Cell & Organ Regenerat Project, Chiyoda Ku, Tokyo, Japan; [Ohinata, Yasuhide] Univ Yamanashi, Fac Life & Environm Sci, Dept Biotechnol, Life Sci Expt Facil, Kofu, Yamanashi, Japan	Japan Science & Technology Agency (JST); RIKEN; University of Tokyo; Japan Science & Technology Agency (JST); University of Yamanashi	Ohinata, Y (corresponding author), Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama, Japan.	yasuhideohinata@gmail.com	TSUKIYAMA, Tomoyuki/AAI-3082-2020	TSUKIYAMA, Tomoyuki/0000-0002-2657-7719	PRESTO of the Japan Science and Technology Agency; Research Fellowship Program of the Japan Society for the Promotion of Science	PRESTO of the Japan Science and Technology Agency; Research Fellowship Program of the Japan Society for the Promotion of Science	This study was supported by grants from PRESTO of the Japan Science and Technology Agency (to Y.O.) and the Research Fellowship Program of the Japan Society for the Promotion of Science (to Y.O. and T. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Hasuwa H, 2010, EXP ANIM TOKYO, V59, P105, DOI 10.1538/expanim.59.105; Hirabayashi M, 2002, TRANSGENIC RES, V11, P221, DOI 10.1023/A:1015210604906; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Isotani A, 2011, GENES CELLS, V16, P397, DOI 10.1111/j.1365-2443.2011.01495.x; KASHIWABARA S, 1990, BIOCHEM BIOPH RES CO, V173, P240, DOI 10.1016/S0006-291X(05)81047-2; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Loew R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-81; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohinata Y, 2009, CELL, V137, P571, DOI 10.1016/j.cell.2009.03.014; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsukiyama T, 2011, GENES CELLS, V16, P815, DOI 10.1111/j.1365-2443.2011.01528.x; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Zhou X, 2006, GENE THER, V13, P1382, DOI 10.1038/sj.gt.3302780	30	19	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92973	10.1371/journal.pone.0092973	http://dx.doi.org/10.1371/journal.pone.0092973			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667806	Green Submitted, gold, Green Published			2022-12-27	WOS:000333675600114
J	Zhang, ZQ; Zoltewicz, JS; Mondello, S; Newsom, KJ; Yang, ZH; Yang, BX; Kobeissy, F; Guingab, J; Glushakova, O; Robicsek, S; Heaton, S; Buki, A; Hannay, J; Gold, MS; Rubenstein, R; Lu, XCM; Dave, JR; Schmid, K; Tortella, F; Robertson, CS; Wang, KKW				Zhang, Zhiqun; Zoltewicz, J. Susie; Mondello, Stefania; Newsom, Kimberly J.; Yang, Zhihui; Yang, Boxuan; Kobeissy, Firas; Guingab, Joy; Glushakova, Olena; Robicsek, Steven; Heaton, Shelley; Buki, Andras; Hannay, Julia; Gold, Mark S.; Rubenstein, Richard; Lu, Xi-chun May; Dave, Jitendra R.; Schmid, Kara; Tortella, Frank; Robertson, Claudia S.; Wang, Kevin K. W.			Human Traumatic Brain Injury Induces Autoantibody Response against Glial Fibrillary Acidic Protein and Its Breakdown Products	PLOS ONE			English	Article							SPINAL-CORD-INJURY; ALPHA-II-SPECTRIN; CENTRAL-NERVOUS-SYSTEM; GLASGOW OUTCOME SCALE; MULTIPLE-SCLEROSIS; ANTIMYELIN ANTIBODIES; ALZHEIMERS-DISEASE; ANTIPITUITARY ANTIBODIES; CEREBROSPINAL-FLUID; HEAD-INJURY	The role of systemic autoimmunity in human traumatic brain injury (TBI) and other forms of brain injuries is recognized but not well understood. In this study, a systematic investigation was performed to identify serum autoantibody responses to brain-specific proteins after TBI in humans. TBI autoantibodies showed predominant immunoreactivity against a cluster of bands from 38-50 kDa on human brain immunoblots, which were identified as GFAP and GFAP breakdown products. GFAP autoantibody levels increased by 7 days after injury, and were of the IgG subtype predominantly. Results from in vitro tests and rat TBI experiments also indicated that calpain was responsible for removing the amino and carboxyl termini of GFAP to yield a 38 kDa fragment. Additionally, TBI autoantibody staining co-localized with GFAP in injured rat brain and in primary rat astrocytes. These results suggest that GFAP breakdown products persist within degenerating astrocytes in the brain. Anti-GFAP autoantibody also can enter living astroglia cells in culture and its presence appears to compromise glial cell health. TBI patients showed an average 3.77 fold increase in anti-GFAP autoantibody levels from early (0-1 days) to late (7-10 days) times post injury. Changes in autoantibody levels were negatively correlated with outcome as measured by GOS-E score at 6 months, suggesting that TBI patients with greater anti-GFAP immune-responses had worse outcomes. Due to the long lasting nature of IgG, a test to detect anti-GFAP autoantibodies is likely to prolong the temporal window for assessment of brain damage in human patients.	[Zoltewicz, J. Susie; Newsom, Kimberly J.; Yang, Boxuan; Guingab, Joy; Glushakova, Olena] Univ Florida, Dept Psychiat, Ctr Neuroprote & Biomarker Res, Gainesville, FL 32611 USA; [Zhang, Zhiqun; Yang, Zhihui; Kobeissy, Firas; Wang, Kevin K. W.] Banyan Biomarkers Inc, Alachua, FL 32615 USA; [Mondello, Stefania; Gold, Mark S.] Univ Messina, Messina, Italy; [Robicsek, Steven] Univ Florida, Dept Anesthesiol, Gainesville, FL USA; [Heaton, Shelley] Univ Florida, Gainesville, FL USA; [Buki, Andras] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Buki, Andras] Hungarian Acad Sci, Clin Neurosci Image Ctr, Pecs, Hungary; [Hannay, Julia] Univ Houston, Dept Psychol, Houston, TX USA; [Rubenstein, Richard] Suny Downstate Med Ctr, Lab Neurodegenerat Dis & CNS Biomarkers, Dept Neurol, Brooklyn, NY 11203 USA; [Rubenstein, Richard] Suny Downstate Med Ctr, Lab Neurodegenerat Dis & CNS Biomarkers, Dept Physiol Pharmacol, Brooklyn, NY 11203 USA; [Lu, Xi-chun May; Dave, Jitendra R.; Schmid, Kara; Tortella, Frank] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA; [Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA	State University System of Florida; University of Florida; Banyan Biomarkers Inc.; University of Messina; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Pecs; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of Houston System; University of Houston; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Baylor College of Medicine	Zhang, ZQ (corresponding author), Banyan Biomarkers Inc, Alachua, FL 32615 USA.	zizizhang2012@gmail.com; susiezolt@gmail.com; kwang@ufl.edu	Glushakova, Olena/AAY-1130-2021; Kobeissy, Firas/E-7042-2017; Mondello, Stefania/A-1813-2012; Yang, Boxuan/HHM-3368-2022	Glushakova, Olena/0000-0002-2109-3651; Kobeissy, Firas/0000-0002-5008-6944; Mondello, Stefania/0000-0002-8587-3614; Yang, Boxuan/0000-0002-7262-0271; Hannay, H. Julia/0000-0001-7023-912X; Wang, Kevin/0000-0002-9343-6473; Heaton, Shelley/0000-0001-5860-522X	NIH [R01 NS049175-01, R01-NS052831-01, R01 NS051431-01]; Department of Defense [DAMD17-03-1-0772, DAMD17-03-1-0066]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052831, R01NS051431, R01NS049175] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by the NIH (R01 NS049175-01, R01-NS052831-01 and R01 NS051431-01), and in part by the Department of Defense (DAMD17-03-1-0772 and DAMD17-03-1-0066). The funders provide financial support and infrastructure support to this work.	Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; Ankeny DP, 2010, TRENDS IMMUNOL, V31, P332, DOI 10.1016/j.it.2010.06.006; Berger T, 2003, NEW ENGL J MED, V349, P139, DOI 10.1056/NEJMoa022328; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Colasanti T. T., 2010, AUTOIMMUN REV, V9, P5; Cox AL, 2006, J NEUROIMMUNOL, V174, P180, DOI 10.1016/j.jneuroim.2006.01.007; D'Andrea MR, 2005, MED HYPOTHESES, V64, P458, DOI 10.1016/j.mehy.2004.08.024; Dambinova SA, 1997, J NEUROL SCI, V152, P93, DOI 10.1016/S0022-510X(97)00150-0; Dambinova SA, 2003, CLIN CHEM, V49, P1752, DOI 10.1373/49.10.1752; Darrah E, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00428; Deng SX, 2000, INT IMMUNOL, V12, P415, DOI 10.1093/intimm/12.4.415; Fujita K, 1998, NEUROCHEM RES, V23, P169, DOI 10.1023/A:1022476724381; Gomez-Tourino I, 2010, DIABETIC MED, V27, P247, DOI 10.1111/j.1464-5491.2009.02911.x; Gorny M, 1990, Neurol Neurochir Pol, V24, P17; Goryunova A V, 2007, Neurosci Behav Physiol, V37, P761, DOI 10.1007/s11055-007-0079-3; Guingab-Cagmat JD, 2012, ELECTROPHORESIS, V33, P3786, DOI 10.1002/elps.201200326; Hauben E, 2000, LANCET, V355, P286, DOI 10.1016/S0140-6736(99)05140-5; Hedegaard CJ, 2009, IMMUNOLOGY, V128, pe451, DOI 10.1111/j.1365-2567.2008.02999.x; Kamchatnov PR, 2009, ZH NEVROL PSIKHIATR, V109, P69; Kuhle J, 2007, NEW ENGL J MED, V356, P371, DOI 10.1056/NEJMoa063602; Lang B, 2003, CURR OPIN NEUROL, V16, P351, DOI 10.1097/00019052-200306000-00016; Levin EC, 2010, BRAIN RES, V1345, P221, DOI 10.1016/j.brainres.2010.05.038; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Liu MC, 2011, ASN NEURO, V3, P25, DOI 10.1042/AN20100012; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Martinez JA, 2010, APOPTOSIS, V15, P1480, DOI 10.1007/s10495-010-0526-4; MECOCCI P, 1995, J NEUROIMMUNOL, V57, P165, DOI 10.1016/0165-5728(94)00180-V; MECOCCI P, 1992, BRAIN BEHAV IMMUN, V6, P286, DOI 10.1016/0889-1591(92)90049-T; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Mondello S., 2011, TRANSLATIONAL STROKE, V3, P1, DOI DOI 10.3389/FNEUR.2012.00147/ABSTRACT; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI [10.1586/erm.10.104, 10.1586/ERM.10.104]; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Moneim I A, 1999, J Egypt Public Health Assoc, V74, P121; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Pelayo R, 2007, NEW ENGL J MED, V356, P426, DOI 10.1056/NEJMc062467; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Poletaev AB, 2000, AUTOIMMUNITY, V32, P33, DOI 10.3109/08916930008995985; Ponomarenko NA, 2006, IMMUNOL LETT, V103, P45, DOI 10.1016/j.imlet.2005.10.006; Popovich PG, 1996, J NEUROSCI RES, V45, P349, DOI 10.1002/(SICI)1097-4547(19960815)45:4<349::AID-JNR4>3.0.CO;2-9; Schwartz M, 2002, PROG BRAIN RES, V137, P401; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Singh VK, 1997, PEDIATR NEUROL, V17, P88, DOI 10.1016/S0887-8994(97)00045-3; Sorokina EG, 2010, ZH NEVROL PSIKHIATR, V110, P30; TANAKA J, 1989, ACTA NEUROL SCAND, V80, P554, DOI 10.1111/j.1600-0404.1989.tb03926.x; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2010, EUR J ENDOCRINOL, V162, P861, DOI 10.1530/EJE-09-1024; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tomkins O, 2011, NEUROLOGY, P1; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wei P, 2013, TUMOR BIOL, V34, P2283, DOI 10.1007/s13277-013-0770-7; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z; Zoltewicz JS, 2013, J NEUROTRAUM, V30, P1161, DOI 10.1089/neu.2012.2762; Zoltewicz JS, 2012, BIOMARK INSIGHTS, V7, P71, DOI 10.4137/BMI.S9873	67	111	122	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92698	10.1371/journal.pone.0092698	http://dx.doi.org/10.1371/journal.pone.0092698			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667434	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600065
J	Kadri, NK; Guldbrandtsen, B; Sorensen, P; Sahana, G				Kadri, Naveen K.; Guldbrandtsen, Bernt; Sorensen, Peter; Sahana, Goutam			Comparison of Genome-Wide Association Methods in Analyses of Admixed Populations with Complex Familial Relationships	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; STRATIFICATION; VARIANTS; TRAITS; MODEL; INFERENCE; LOCI	Population structure is known to cause false-positive detection in association studies. We compared the power, precision, and type-I error rates of various association models in analyses of a simulated dataset with structure at the population (admixture from two populations; P) and family (K) levels. We also compared type-I error rates among models in analyses of publicly available human and dog datasets. The models corrected for none, one, or both structure levels. Correction for K was performed with linear mixed models incorporating familial relationships estimated from pedigrees or genetic markers. Linear models that ignored K were also tested. Correction for P was performed using principal component or structured association analysis. In analyses of simulated and real data, linear mixed models that corrected for K were able to control for type-I error, regardless of whether they also corrected for P. In contrast, correction for P alone in linear models was insufficient. The power and precision of linear mixed models with and without correction for P were similar. Furthermore, power, precision, and type-I error rate were comparable in linear mixed models incorporating pedigree and genomic relationships. In summary, in association studies using samples with both P and K, ancestries estimated using principal components or structured assignment were not sufficient to correct type-I errors. In such cases type-I errors may be controlled by use of linear mixed models with relationships derived from either pedigree or from genetic markers.	[Kadri, Naveen K.; Guldbrandtsen, Bernt; Sorensen, Peter; Sahana, Goutam] Aarhus Univ, Dept Mol Biol & Genet, Ctr Quantitat Genet & Genom, Aarhus, Denmark	Aarhus University	Kadri, NK (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Ctr Quantitat Genet & Genom, Aarhus, Denmark.	NaveenK.Kadri@agrsci.dk	Sahana, Goutam/AAI-7579-2021; Sahana, Goutam/K-7613-2014	Sahana, Goutam/0000-0001-7608-7577; Sahana, Goutam/0000-0001-7608-7577; Kadri, Naveen/0000-0002-2799-3896	Green Development and Demonstration Programme of the Danish Ministry of Food, Agriculture and Fisheries [3405-10-0137]; Milk Levy Fund; Viking Genetics; Nordic Cattle Genetic Evaluation	Green Development and Demonstration Programme of the Danish Ministry of Food, Agriculture and Fisheries; Milk Levy Fund; Viking Genetics; Nordic Cattle Genetic Evaluation	This work was supported by a grant (No. 3405-10-0137) funded jointly by the Green Development and Demonstration Programme of the Danish Ministry of Food, Agriculture and Fisheries, The Milk Levy Fund, Viking Genetics, and Nordic Cattle Genetic Evaluation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Falush D, 2003, GENETICS, V164, P1567; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Lai CQ, 2007, ARTERIOSCL THROM VAS, V27, P1417, DOI 10.1161/ATVBAHA.107.140103; LI CC, 1969, ANN HUM GENET, V33, P23, DOI 10.1111/j.1469-1809.1969.tb01625.x; MacLeod IM, 2010, J ANIM BREED GENET, V127, P133, DOI 10.1111/j.1439-0388.2009.00831.x; Madsen P., 2010, DMU PACKAGE ANAL MUL; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Pritchard JK, 2000, GENETICS, V155, P945; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Sargolzaei M, 2009, BIOINFORMATICS, V25, P680, DOI 10.1093/bioinformatics/btp045; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zaitlen N, 2010, AM J HUM GENET, V86, P23, DOI 10.1016/j.ajhg.2009.11.016; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhang ZW, 2009, AM J VET RES, V70, P483, DOI 10.2460/ajvr.70.4.483	21	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e88926	10.1371/journal.pone.0088926	http://dx.doi.org/10.1371/journal.pone.0088926			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662750	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900002
J	Llaneza, L; Garcia, EJ; Lopez-Bao, JV				Llaneza, Luis; Garcia, Emilio J.; Vicente Lopez-Bao, Jose			Intensity of Territorial Marking Predicts Wolf Reproduction: Implications for Wolf Monitoring	PLOS ONE			English	Article							SCENT-MARKING; IBERIAN WOLF; WOLVES; POPULATION; CONSERVATION; ABUNDANCE; PATTERNS; FOREST; FECES; BEAR	Background: The implementation of intensive and complex approaches to monitor large carnivores is resource demanding, restricted to endangered species, small populations, or small distribution ranges. Wolf monitoring over large spatial scales is difficult, but the management of such contentious species requires regular estimations of abundance to guide decision-makers. The integration of wolf marking behaviour with simple sign counts may offer a cost-effective alternative to monitor the status of wolf populations over large spatial scales. Methodology/Principal Findings: We used a multi-sampling approach, based on the collection of visual and scent wolf marks (faeces and ground scratching) and the assessment of wolf reproduction using howling and observation points, to test whether the intensity of marking behaviour around the pup-rearing period (summer-autumn) could reflect wolf reproduction. Between 1994 and 2007 we collected 1,964 wolf marks in a total of 1,877 km surveyed and we searched for the pups' presence (1,497 howling and 307 observations points) in 42 sampling sites with a regular presence of wolves (120 sampling sites/year). The number of wolf marks was ca. 3 times higher in sites with a confirmed presence of pups (20.3 vs. 7.2 marks). We found a significant relationship between the number of wolf marks (mean and maximum relative abundance index) and the probability of wolf reproduction. Conclusions/Significance: This research establishes a real-time relationship between the intensity of wolf marking behaviour and wolf reproduction. We suggest a conservative cutting point of 0.60 for the probability of wolf reproduction to monitor wolves on a regional scale combined with the use of the mean relative abundance index of wolf marks in a given area. We show how the integration of wolf behaviour with simple sampling procedures permit rapid, real-time, and cost-effective assessments of the breeding status of wolf packs with substantial implications to monitor wolves at large spatial scales.	[Llaneza, Luis; Garcia, Emilio J.] Asesores Recursos Nat SL, A RE NA, Lugo, Spain; [Vicente Lopez-Bao, Jose] Univ Oviedo, Res Unit Biodivers UO CSIC PA, Mieres, Spain; [Vicente Lopez-Bao, Jose] Swedish Univ Agr Sci SLU, Grimso Wildlife Res Stn, Riddarhyttan, Sweden	Consejo Superior de Investigaciones Cientificas (CSIC); University of Oviedo; Swedish University of Agricultural Sciences	Lopez-Bao, JV (corresponding author), Univ Oviedo, Res Unit Biodivers UO CSIC PA, Mieres, Spain.	jv.lopezbao@gmail.com	VICENTE, LIERN/B-6112-2008; Llaneza, Luis/R-3597-2018	VICENTE, LIERN/0000-0001-5883-9640; Lopez-Bao, Jose Vicente/0000-0001-9213-998X; Llaneza, Luis/0000-0001-9529-5128	Regional Government of Asturias; Spanish Environmental Ministry; Regional Government of Galicia	Regional Government of Asturias(Principality of Asturias); Spanish Environmental Ministry(Spanish Government); Regional Government of Galicia	Regional wolf surveys were funded by the Regional Government of Asturias, the Spanish Environmental Ministry and the Regional Government of Galicia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvares F, 2005, FRONTIERS WOLF RECOV; [Anonymous], 2006, SAS MIXED MODELS; Ausband DE, 2010, J WILDLIFE MANAGE, V74, P1043, DOI 10.2193/2009-303; Barja I, 2008, REPROD DOMEST ANIM, V43, P701, DOI 10.1111/j.1439-0531.2007.00974.x; Barja I, 2005, FOLIA ZOOL, V54, P21; Blanco J.C., 2002, ECOLOGIA CENSOS PERC; Boitani L, 2012, TECH ECOL CONSERVAT, P1, DOI 10.1093/acprof:oso/9780199558520.001.0001; Caniglia R, 2012, CONSERV GENET, V13, P53, DOI 10.1007/s10592-011-0266-1; Blanco JC, 2012, HYSTRIX, V23, P35; CRETE M, 1987, CAN FIELD NAT, V101, P147; FULLER TK, 1988, J WILDLIFE MANAGE, V52, P60, DOI 10.2307/3801059; Galaverni M, 2012, EUR J WILDLIFE RES, V58, P47, DOI 10.1007/s10344-011-0539-5; Garcia D, 2005, FOREST ECOL MANAG, V208, P29, DOI 10.1016/j.foreco.2004.10.071; Garcia E, 2012, 3 IB WOLF C, P44; Godinho R, 2011, 10 JORN ESP CONS EST, P64; GORMAN ML, 1990, REV SUISSE ZOOL, V97, P3, DOI 10.5962/bhl.part.79722; Gude JA, 2012, J WILDLIFE MANAGE, V76, P108, DOI 10.1002/jwmg.201; HARRINGTON FH, 1982, J WILDLIFE MANAGE, V46, P686, DOI 10.2307/3808560; Holling C.S., 1978, ADAPTIVE ENV ASSESSM; Jhala Y, 2011, J APPL ECOL, V48, P14, DOI 10.1111/j.1365-2664.2010.01901.x; Johansson Maria, 2012, Human Dimensions of Wildlife, V17, P58, DOI 10.1080/10871209.2012.619001; Kaczensky P, 2013, STATUS MANAGEMENT DI; Karanth KU, 2011, J APPL ECOL, V48, P1048, DOI 10.1111/j.1365-2664.2011.02002.x; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; KLEIMAN DEVRA, 1966, SYMP ZOOL SOC LONDON, V18, P167; Kunkel K, 2005, ASSESSMENT CURRENT M; LEADERWILLIAMS N, 1988, NATURE, V336, P533, DOI 10.1038/336533a0; Liberg O, 2012, HYSTRIX, V23, P29, DOI 10.4404/hystrix-23.1-4670; Linnell, 1998, NINA OPPDRAGSMELDING, V549, P1; Linnell JDC, 2012, HYSTRIX, V23, P80, DOI 10.4404/hystrix-23.1-4676; Llaneza L., 2005, Wildlife Biology in Practice, V1, P108; Llaneza L, 2012, DIVERS DISTRIB, V18, P459, DOI 10.1111/j.1472-4642.2011.00869.x; Long RA, 2008, NONINVASIVE SURVEY M; Lopez-Bao JV, 2013, CONSERV LETT, V6, P448, DOI 10.1111/conl.12014; Marucco F, 2012, HYSTRIX, V23, P1, DOI 10.4404/hystrix-23.1-6364; Marucco F, 2009, J APPL ECOL, V46, P1003, DOI 10.1111/j.1365-2664.2009.01696.x; Mech D., 2003, WOLVES BEHAV ECOLOGY; Mech LD, 2012, BIOL CONSERV, V150, P143, DOI 10.1016/j.biocon.2012.03.003; MECH LD, 1995, CONSERV BIOL, V9, P270, DOI 10.1046/j.1523-1739.1995.9020270.x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; OConnell AF, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P1, DOI 10.1007/978-4-431-99495-4; Palomares F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052923; Palomares F, 2011, CONSERV BIOL, V25, P4, DOI 10.1111/j.1523-1739.2010.01607.x; PETERS RP, 1975, AM SCI, V63, P628; Ralls K, 2010, J WILDLIFE MANAGE, V74, P1457, DOI 10.2193/2009-401; ROTHMAN RJ, 1979, ANIM BEHAV, V27, P750, DOI 10.1016/0003-3472(79)90010-1; Royle JA, 2009, J APPL ECOL, V46, P118, DOI 10.1111/j.1365-2664.2008.01578.x; Sands J, 2004, ANIM BEHAV, V67, P387, DOI 10.1016/j.anbehav.2003.03.019; Scandura M, 2011, EUR J WILDLIFE RES, V57, P949, DOI 10.1007/s10344-011-0509-y; Soulliere C., 2012, WILDLIFE SOC TECHNIC; Thirgood S, 2005, CONSERV BIOL SER, V9, P13; Treves A, 2009, J APPL ECOL, V46, P1350, DOI 10.1111/j.1365-2664.2009.01729.x; VILA C, 1994, CAN J ZOOL, V72, P374, DOI 10.1139/z94-053; Zub K, 2003, BEHAVIOUR, V140, P635, DOI 10.1163/156853903322149478	54	27	28	5	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93015	10.1371/journal.pone.0093015	http://dx.doi.org/10.1371/journal.pone.0093015			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663068	Green Submitted, Green Published, gold			2022-12-27	WOS:000333459900142
J	Yen, HC; Li, SL; Hsu, WC; Tang, P				Yen, Hsiu-Chuan; Li, Shiue-Li; Hsu, Wei-Chien; Tang, Petrus			Interference of Co-Amplified Nuclear Mitochondrial DNA Sequences on the Determination of Human mtDNA Heteroplasmy by Using the SURVEYOR Nuclease and the WAVE HS System	PLOS ONE			English	Article							RAPID IDENTIFICATION; MUTATIONS; GENOME; PSEUDOGENES; INSIGHTS; DISEASE; CANCER; PCR	High-sensitivity and high-throughput mutation detection techniques are useful for screening the homoplasmy or heteroplasmy status of mitochondrial DNA (mtDNA), but might be susceptible to interference from nuclear mitochondrial DNA sequences (NUMTs) co-amplified during polymerase chain reaction (PCR). In this study, we first evaluated the platform of SURVEYOR Nuclease digestion of heteroduplexed DNA followed by the detection of cleaved DNA by using the WAVE HS System (SN/WAVE-HS) for detecting human mtDNA variants and found that its performance was slightly better than that of denaturing high-performance liquid chromatography (DHPLC). The potential interference from co-amplified NUMTs on screening mtDNA heteroplasmy when using these 2 highly sensitive techniques was further examined by using 2 published primer sets containing a total of 65 primer pairs, which were originally designed to be used with one of the 2 techniques. We confirmed that 24 primer pairs could amplify NUMTs by conducting bioinformatic analysis and PCR with the DNA from 143B-rho(0) cells. Using mtDNA extracted from the mitochondria of human 143B cells and a cybrid line with the nuclear background of 143B-rho(0) cells, we demonstrated that NUMTs could affect the patterns of chromatograms for cell DNA during SN-WAVE/HS analysis of mtDNA, leading to incorrect judgment of mtDNA homoplasmy or heteroplasmy status. However, we observed such interference only in 2 of 24 primer pairs selected, and did not observe such effects during DHPLC analysis. These results indicate that NUMTs can affect the screening of low-level mtDNA variants, but it might not be predicted by bioinformatic analysis or the amplification of DNA from 143B-rho(0) cells. Therefore, using purified mtDNA from cultured cells with proven purity to evaluate the effects of NUMTs from a primer pair on mtDNA detection by using PCR-based high-sensitivity methods prior to the use of a primer pair in real studies would be a more practical strategy.	[Yen, Hsiu-Chuan; Li, Shiue-Li; Hsu, Wei-Chien] Chang Gung Univ, Coll Med, Dept & Grad Inst Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Tang, Petrus] Chang Gung Univ, Coll Med, Dept Publ Hlth & Parasitol, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University	Yen, HC (corresponding author), Chang Gung Univ, Coll Med, Dept & Grad Inst Med Biotechnol & Lab Sci, Tao Yuan, Taiwan.	yen@mail.cgu.edu.tw		Tang, Petrus/0000-0002-2779-0116; Yen, Hsiu-Chuan/0000-0002-9951-2000	Chang Gung Memorial Hospital, Taiwan [CMRPD180412, CMRPD1B0341]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This research was supported by grants CMRPD180412 and CMRPD1B0341 to Hsiu-Chuan Yen from Chang Gung Memorial Hospital, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Ballana E, 2008, HUM MUTAT, V29, P248, DOI 10.1002/humu.20639; Bannwarth S, 2008, MITOCHONDRION, V8, P136, DOI 10.1016/j.mito.2007.10.008; Bannwarth S, 2006, NAT PROTOC, V1, P2037, DOI 10.1038/nprot.2006.318; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Biggin A, 2005, MOL GENET METAB, V84, P61, DOI 10.1016/j.ymgme.2004.09.011; Calvignac S, 2011, MITOCHONDRION, V11, P246, DOI 10.1016/j.mito.2010.10.004; Chen SW, 2013, MITOCHONDRION, V13, P143, DOI 10.1016/j.mito.2013.01.007; Janne PA, 2006, CLIN CANCER RES, V12, P751, DOI 10.1158/1078-0432.CCR-05-2047; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kulawiec M, 2010, ENVIRON MOL MUTAGEN, V51, P427, DOI 10.1002/em.20582; Meierhofer D, 2005, MITOCHONDRION, V5, P282, DOI 10.1016/j.mito.2005.06.001; Mishmar D, 2004, HUM MUTAT, V23, P125, DOI 10.1002/humu.10304; Oleykowski CA, 1998, NUCLEIC ACIDS RES, V26, P4597, DOI 10.1093/nar/26.20.4597; Parr RL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-185; Ramos A, 2011, MITOCHONDRION, V11, P946, DOI 10.1016/j.mito.2011.08.009; Ramos A, 2009, ELECTROPHORESIS, V30, P1587, DOI 10.1002/elps.200800601; Ricchetti M, 2004, PLOS BIOL, V2, P1313, DOI 10.1371/journal.pbio.0020273; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; Tourmen Y, 2002, GENOMICS, V80, P71, DOI 10.1006/geno.2002.6798; TROUNCE I, 1994, P NATL ACAD SCI USA, V91, P8334, DOI 10.1073/pnas.91.18.8334; Vamvakas Spiridon, 1993, V2, P453; Venegas V, 2012, METHODS MOL BIOL, V837, P313, DOI 10.1007/978-1-61779-504-6_21; Wallace DC, 1997, P NATL ACAD SCI USA, V94, P14900, DOI 10.1073/pnas.94.26.14900; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190; Woischnik M, 2002, GENOME RES, V12, P885, DOI 10.1101/gr.227202; Yao YG, 2008, J MED GENET, V45, P769, DOI 10.1136/jmg.2008.059782; Yen HC, 2010, ANN NY ACAD SCI, V1201, P13, DOI 10.1111/j.1749-6632.2010.05626.x	30	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92817	10.1371/journal.pone.0092817	http://dx.doi.org/10.1371/journal.pone.0092817			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664244	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900118
J	Jennelle, CS; Henaux, V; Wasserberg, G; Thiagarajan, B; Rolley, RE; Samuel, MD				Jennelle, Christopher S.; Henaux, Viviane; Wasserberg, Gideon; Thiagarajan, Bala; Rolley, Robert E.; Samuel, Michael D.			Transmission of Chronic Wasting Disease in Wisconsin White-Tailed Deer: Implications for Disease Spread and Management	PLOS ONE			English	Article							MULE DEER; PRION DISEASE; SPATIAL EPIDEMIOLOGY; POPULATION-DYNAMICS; WILDLIFE EPIDEMIC; MODELS; PATTERNS; PREVALENCE; INFECTION; DEERYARDS	Few studies have evaluated the rate of infection or mode of transmission for wildlife diseases, and the implications of alternative management strategies. We used hunter harvest data from 2002 to 2013 to investigate chronic wasting disease (CWD) infection rate and transmission modes, and address how alternative management approaches affect disease dynamics in a Wisconsin white-tailed deer population. Uncertainty regarding demographic impacts of CWD on cervid populations, human and domestic animal health concerns, and potential economic consequences underscore the need for strategies to control CWD distribution and prevalence. Using maximum-likelihood methods to evaluate alternative multistate deterministic models of CWD transmission, harvest data strongly supports a frequency-dependent transmission structure with sex-specific infection rates that are two times higher in males than females. As transmissible spongiform encephalopathies are an important and difficult-to-study class of diseases with major economic and ecological implications, our work supports the hypothesis of frequency-dependent transmission in wild deer at a broad spatial scale and indicates that effective harvest management can be implemented to control CWD prevalence. Specifically, we show that harvest focused on the greater-affected sex (males) can result in stable population dynamics and control of CWD within the next 50 years, given the constraints of the model. We also provide a quantitative estimate of geographic disease spread in southern Wisconsin, validating qualitative assessments that CWD spreads relatively slowly. Given increased discovery and distribution of CWD throughout North America, insights from our study are valuable to management agencies and to the general public concerned about the impacts of CWD on white-tailed deer populations.	[Jennelle, Christopher S.; Henaux, Viviane; Thiagarajan, Bala] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53715 USA; [Wasserberg, Gideon] Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA; [Rolley, Robert E.] Wisconsin Dept Nat Resources, Madison, WI USA; [Samuel, Michael D.] Univ Wisconsin, US Geol Survey, Wisconsin Cooperat Wildlife Res Unit, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Greensboro; United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Madison	Jennelle, CS (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53715 USA.	chris.jennelle@dnr.iowa.gov		Jennelle, Christopher/0000-0003-4133-814X	Wisconsin Department of Natural Resources; U.S. Geological Survey; University of Wisconsin Department of Forest and Wildlife Ecology	Wisconsin Department of Natural Resources; U.S. Geological Survey(United States Geological Survey); University of Wisconsin Department of Forest and Wildlife Ecology	Funding was provided by the Wisconsin Department of Natural Resources and U.S. Geological Survey. The University of Wisconsin Department of Forest and Wildlife Ecology provided assistance with publication costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almberg ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019896; ANDERSON R M, 1991; Barlow ND, 1996, J APPL ECOL, V33, P303, DOI 10.2307/2404752; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Blanchong JA, 2008, BIOL LETTERS, V4, P130, DOI 10.1098/rsbl.2007.0523; Bolker B, 2008, ECOLOGICAL MODELS DA; BROWN P, 1991, LANCET, V337, P269, DOI 10.1016/0140-6736(91)90873-N; Burnham K. P., 1998, MODEL SELECTION INFE; Caswell, 2000, MATRIX POPULATION MO; Conner MM, 2004, ECOL APPL, V14, P1870, DOI 10.1890/03-5309; Cross ML, 2007, VET J, V174, P472, DOI 10.1016/j.tvjl.2006.10.005; Cross Paul C., 2009, P9, DOI 10.1007/978-4-431-77134-0_2; Dunkley L., 2003, COMPREHENSIVE REV EC; Ewald PW, 2011, ECOL RES, V26, P1017, DOI 10.1007/s11284-011-0874-8; Farnsworth ML, 2005, ECOL APPL, V15, P119, DOI 10.1890/04-0194; Fenichel EP, 2007, AM J AGR ECON, V89, P904, DOI 10.1111/j.1467-8276.2007.01025.x; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; GETZ WM, 1983, AM NAT, V121, P892, DOI 10.1086/284112; Grear DA, 2006, J WILDLIFE MANAGE, V70, P546, DOI 10.2193/0022-541X(2006)70[546:DPAHVO]2.0.CO;2; Grear DA, 2010, J APPL ECOL, V47, P532, DOI 10.1111/j.1365-2664.2010.01813.x; Gross JE, 2001, J WILDLIFE MANAGE, V65, P205, DOI 10.2307/3802899; Habib TJ, 2011, ECOL MODEL, V222, P2722, DOI 10.1016/j.ecolmodel.2011.05.007; HALLS L, 1984, WHITE TAILED DEER EC; Heisey DM, 2010, ECOL MONOGR, V80, P221, DOI 10.1890/09-0052.1; Hilborn Ray, 1997, V28; Holsman R. H., 2006, Human Dimensions of Wildlife, V11, P177, DOI 10.1080/10871200600669916; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Joly DO, 2006, J WILDLIFE DIS, V42, P578, DOI 10.7589/0090-3558-42.3.578; Joly DO, 2003, EMERG INFECT DIS, V9, P599, DOI 10.3201/eid0905.020721; Keane DP, 2008, J VET DIAGN INVEST, V20, P698, DOI 10.1177/104063870802000534; Keane DP, 2008, J VET DIAGN INVEST, V20, P58, DOI 10.1177/104063870802000110; Kjaer LJ, 2008, J WILDLIFE MANAGE, V72, P1819, DOI 10.2193/2007-489; Klepac P, 2011, THEOR ECOL-NETH, V4, P301, DOI 10.1007/s12080-010-0079-8; Lang KR, 2012, J WILDLIFE MANAGE, V76, P832, DOI 10.1002/jwmg.292; Long ES, 2005, J MAMMAL, V86, P623, DOI 10.1644/1545-1542(2005)86[623:FCIDDO]2.0.CO;2; Magle SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056568; Manache G, 2004, J WATER RES PL-ASCE, V130, P232, DOI 10.1061/(ASCE)0733-9496(2004)130:3(232); McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Miller MW, 2006, ECOL APPL, V16, P2208, DOI 10.1890/1051-0761(2006)016[2208:DOPDTI]2.0.CO;2; Miller MW, 2005, J WILDLIFE DIS, V41, P275, DOI 10.7589/0090-3558-41.2.275; Miller MW, 2000, J WILDLIFE DIS, V36, P676, DOI 10.7589/0090-3558-36.4.676; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Oli MK, 2006, ECOL MODEL, V198, P183, DOI 10.1016/j.ecolmodel.2006.04.007; Osnas EE, 2009, ECOL APPL, V19, P1311, DOI 10.1890/08-0578.1; Oyer AM, 2007, J WILDLIFE MANAGE, V71, P1635, DOI 10.2193/2006-381; Palmer MV, 2004, J WILDLIFE DIS, V40, P87, DOI 10.7589/0090-3558-40.1.87; Potapov A, 2013, ECOL MODEL, V250, P244, DOI 10.1016/j.ecolmodel.2012.11.012; Potapov A, 2012, P ROY SOC B-BIOL SCI, V279, P3139, DOI 10.1098/rspb.2012.0520; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Roberts MG, 1996, J ANIM ECOL, V65, P451, DOI 10.2307/5780; Robinson SJ, 2013, LANDSCAPE ECOL, V28, P1923, DOI 10.1007/s10980-013-9919-4; Robinson SJ, 2012, MOL ECOL, V21, P4190, DOI 10.1111/j.1365-294X.2012.05681.x; Robinson SJ, 2012, ECOL APPL, V22, P1050, DOI 10.1890/11-0907.1; Roseberry JL, 1991, WILDLIFE MONOGR, V117, P3; Rudolf VHW, 2005, AM NAT, V166, P112, DOI 10.1086/430674; Schauber EM, 2003, WILDLIFE SOC B, V31, P610; Silbernagel ER, 2011, J WILDLIFE MANAGE, V75, P1453, DOI 10.1002/jwmg.172; Storm DJ, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00141.1; Van Deelen TR, 1998, J WILDLIFE MANAGE, V62, P205, DOI 10.2307/3802280; Van Deelen TR, 1999, NAT AREA J, V19, P263; Walter WD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1203; Wasserberg G, 2009, J APPL ECOL, V46, P457, DOI 10.1111/j.1365-2664.2008.01576.x; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; Williams ES, 2002, J WILDLIFE MANAGE, V66, P551, DOI 10.2307/3803123; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89; Wisconsin Department of Natural Resources, 2010, WISC CHRON WAST DIS; Wobeser G.A, 2007, DIS WILD ANIMALS, V2nd; Wolfe LL, 2004, WILDLIFE SOC B, V32, P500, DOI 10.2193/0091-7648(2004)32[500:FOTFMC]2.0.CO;2	69	42	42	4	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91043	10.1371/journal.pone.0091043	http://dx.doi.org/10.1371/journal.pone.0091043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658535	Green Submitted, Green Published, gold			2022-12-27	WOS:000333355300023
J	Monsel, A; Lecart, S; Roquilly, A; Broquet, A; Jacqueline, C; Mirault, T; Troude, T; Fontaine-Aupart, MP; Asehnoune, K				Monsel, Antoine; Lecart, Sandrine; Roquilly, Antoine; Broquet, Alexis; Jacqueline, Cedric; Mirault, Tristan; Troude, Thibaut; Fontaine-Aupart, Marie-Pierre; Asehnoune, Karim			Analysis of Autofluorescence in Polymorphonuclear Neutrophils: A New Tool for Early Infection Diagnosis	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; BRONCHOALVEOLAR LAVAGE FLUID; ANTIBIOTIC-TREATMENT; CELLS; FLUORESCENCE; ACTIVATION; IDENTIFICATION; RECOGNITION; BACTEREMIA; EXPRESSION	Diagnosing bacterial infection (BI) remains a challenge for the attending physician. An ex vivo infection model based on human fixed polymorphonuclear neutrophils (PMNs) gives an autofluorescence signal that differs significantly between stimulated and unstimulated cells. We took advantage of this property for use in an in vivo pneumonia mouse model and in patients hospitalized with bacterial pneumonia. A 2-fold decrease was observed in autofluorescence intensity for cytospined PMNs from broncho-alveolar lavage (BAL) in the pneumonia mouse model and a 2.7-fold decrease was observed in patients with pneumonia when compared with control mice or patients without pneumonia, respectively. This optical method provided an autofluorescence mean intensity cut-off, allowing for easy diagnosis of BI. Originally set up on a confocal microscope, the assay was also effective using a standard epifluorescence microscope. Assessing the autofluorescence of PMNs provides a fast, simple, cheap and reliable method optimizing the efficiency and the time needed for early diagnosis of severe infections. Rationalized therapeutic decisions supported by the results from this method can improve the outcome of patients suspected of having an infection.	[Monsel, Antoine] La Pitie Salpetriere Hosp, AP HP, Dept Anesthesiol & Crit Care, Multidisciplinary Intens Care Unit, Paris, France; [Monsel, Antoine] Univ Paris 06, Paris, France; [Lecart, Sandrine; Fontaine-Aupart, Marie-Pierre] Univ Paris 11, CPBM CLUPS, Orsay, France; [Roquilly, Antoine; Broquet, Alexis; Jacqueline, Cedric; Asehnoune, Karim] Fac Nantes, Fac Med, Lab UPRES EA 3826, Nantes, France; [Roquilly, Antoine; Asehnoune, Karim] CHU Nantes, Serv Anesthesie Reanimat Chirurg, F-44035 Nantes 01, France; [Mirault, Tristan] Paris Descartes Univ, European Hosp Georges Pompidou, AP HP, PRES Paris Sorbonne Cite,Vasc Med Unit, Paris, France; [Troude, Thibaut; Fontaine-Aupart, Marie-Pierre] Univ Paris 11, CNRS, ISMO, F-91405 Orsay, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Monsel, A (corresponding author), La Pitie Salpetriere Hosp, AP HP, Dept Anesthesiol & Crit Care, Multidisciplinary Intens Care Unit, Paris, France.	monsela@anesthesia.ucsf.edu	Jacqueline, Cédric/G-5650-2010; Roquilly, Antoine/P-9826-2017; Mirault, Tristan/AAB-3997-2020	Jacqueline, Cédric/0000-0001-9606-5930; Mirault, Tristan/0000-0001-8690-1093; Broquet, Alexis/0000-0002-6635-9601; Monsel, Antoine/0000-0002-9647-7043	Fondation pour la Recherche Medicale (France); University of Orsay	Fondation pour la Recherche Medicale (France)(Fondation pour la Recherche Medicale); University of Orsay	This work was supported by the following institutions and grants: the Master Research grant from the Fondation pour la Recherche Medicale (France), and the University of Orsay funded the Argon UV laser. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaouchiche B, 1999, BRIT J ANAESTH, V83, P845, DOI 10.1093/bja/83.6.845; Andrade SS, 2008, SHOCK, V30, P41, DOI 10.1097/SHK.0b013e3181819f6c; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; BABIOR BM, 1984, J CLIN INVEST, V73, P599, DOI 10.1172/JCI111249; BABIOR BM, 1984, BLOOD, V64, P959; Bouadma L, 2010, LANCET, V375, P463, DOI 10.1016/S0140-6736(09)61879-1; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; CRADDOCK PR, 1979, SEMIN HEMATOL, V16, P140; Craig A, 2009, INFECT IMMUN, V77, P568, DOI 10.1128/IAI.00832-08; Erden V, 2003, INTENS CARE MED, V29, P1856, DOI 10.1007/s00134-003-1964-z; Evans ND, 2005, J PHOTOCH PHOTOBIO B, V80, P122, DOI 10.1016/j.jphotobiol.2005.04.001; Fabregas N, 1999, THORAX, V54, P867, DOI 10.1136/thx.54.10.867; FUERST DE, 1965, NATURE, V205, P1333, DOI 10.1038/2051333a0; HAFEMAN DG, 1982, SCIENCE, V215, P673, DOI 10.1126/science.6800035; Hall KK, 2006, CLIN MICROBIOL REV, V19, P788, DOI 10.1128/CMR.00062-05; Heintzelman DL, 2000, PHOTOCHEM PHOTOBIOL, V71, P327, DOI 10.1562/0031-8655(2000)071<0327:COTAOP>2.0.CO;2; Iregui M, 2002, CHEST, V122, P262, DOI 10.1378/chest.122.1.262; Kang CI, 2003, CLIN INFECT DIS, V37, P745, DOI 10.1086/377200; Kim YS, 2009, ANN CLIN LAB SCI, V39, P114; Klompas M, 2007, JAMA-J AM MED ASSOC, V297, P1583, DOI 10.1001/jama.297.14.1583; LIANG B, 1992, J CELL PHYSIOL, V152, P145, DOI 10.1002/jcp.1041520119; Liang J, 2007, SPECTROCHIM ACTA A, V67, P355, DOI 10.1016/j.saa.2006.07.035; Liu G, 2009, J IMMUNOL, V182, P5063, DOI 10.4049/jimmunol.0803526; Lodise Thomas P., 2003, Clinical Infectious Diseases, V36, P1418, DOI 10.1086/375057; Mayevsky A, 2007, AM J PHYSIOL-CELL PH, V292, pC615, DOI 10.1152/ajpcell.00249.2006; Ng PC, 2007, PEDIATR RES, V61, P93, DOI 10.1203/01.pdr.0000250207.95723.96; Nupponen I, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e12; Nuutila J, 2007, J IMMUNOL METHODS, V328, P189, DOI 10.1016/j.jim.2007.09.002; PAPAZIAN L, 1995, AM J RESP CRIT CARE, V152, P1982, DOI 10.1164/ajrccm.152.6.8520766; PINSKY MR, 1993, CHEST, V103, P565, DOI 10.1378/chest.103.2.565; PUGIN J, 1991, AM REV RESPIR DIS, V143, P1121, DOI 10.1164/ajrccm/143.5_Pt_1.1121; Rintala EM, 2001, SCAND J CLIN LAB INV, V61, P523; Roquilly A, 2013, EUR RESPIR J; Roquilly A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013228; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Sherwin C, 2008, AM J PERINAT, V25, P629, DOI 10.1055/s-0028-1090585; Singh N, 2000, AM J RESP CRIT CARE, V162, P505, DOI 10.1164/ajrccm.162.2.9909095; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; van Rijt LS, 2004, J IMMUNOL METHODS, V288, P111, DOI 10.1016/j.jim.2004.03.004; VERGHESE A, 1988, EXP LUNG RES, V14, P797, DOI 10.3109/01902148809087845; WATT SM, 1980, J HISTOCHEM CYTOCHEM, V28, P934, DOI 10.1177/28.9.7410816; Wu LP, 2007, AM J PHYSIOL-RENAL, V292, pF261, DOI 10.1152/ajprenal.00263.2006	44	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92564	10.1371/journal.pone.0092564	http://dx.doi.org/10.1371/journal.pone.0092564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658436	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300099
J	Souto, GR; Queiroz, CM; de Abreu, MHNG; Costa, FO; Mesquita, RA				Souto, Giovanna Ribeiro; Queiroz-Junior, Celso Martins; Nogueira Guimaraes de Abreu, Mauro Henrique; Costa, Fernando Oliveira; Mesquita, Ricardo Alves			Pro-inflammatory, Th1, Th2, Th17 Cytokines and Dendritic Cells: A Cross-sectional Study in Chronic Periodontitis	PLOS ONE			English	Article							CD34(+) HEMATOPOIETIC PROGENITORS; CORD BLOOD DIFFERENTIATE; T-CELLS; GINGIVAL TISSUES; LANGERHANS CELLS; INTERLEUKIN-6; PATHWAYS; DISEASE; ANTIGEN; LYMPHOCYTES	There are a limited number of studies correlating the different stages of dendritic cells (DC) maturation with cytokines in individuals presented chronic periodontitis (CP). The aim of the study was to evaluate the correlation among the expression of IL-2, IL-10, IL-4, IL-6, IFN-gamma, TNF-alpha, and IL-17A with the presence of DC and mild-moderate or advanced CP. Gingival samples were obtained from 24 individuals with CP and six samples of normal mucosa (NM) overlapping third molar for controls of the levels of cytokines. Periodontal examination was performed. Immunohistochemical staining was carried out, revealing CD1a+ immature, Fator XIIIa+ immature, and CD83+ mature DCs. The inflammatory infiltrate was counted, and the cytokines were measured by flow cytometry. Densities of DCs and inflammatory infiltrate, cytokines, subtypes of CP, and clinical periodontal parameters were correlated and compared. IL-6 expression was correlated positively with the increased numbers of CD1a+ immature DCs. Levels of IL-2, TNF-alpha, IFN-gamma, IL-10, and IL-17A were increased when compared with NM. The percentage of sites with clinical attachment level (CAL)>3 were positively correlated with densities of inflammatory infiltrate and negatively correlated with densities of immature DCs. IL-6 can contribute to the increase of the immature DCs in the CP. Higher levels of IL-2, TNF-alpha, IFN-gamma, IL-10, and IL-17A cytokines were observed in CP. Higher densities of inflammatory infiltrate as well as lower densities of immature DCs can result in a more severe degree of human CP.	[Souto, Giovanna Ribeiro; Queiroz-Junior, Celso Martins; Costa, Fernando Oliveira; Mesquita, Ricardo Alves] Univ Fed Minas Gerais, Sch Dent, Dept Oral Surg & Pathol, Belo Horizonte, MG, Brazil; [Nogueira Guimaraes de Abreu, Mauro Henrique] Univ Fed Minas Gerais, Sch Dent, Dept Social & Prevent Dent, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Souto, GR (corresponding author), Univ Fed Minas Gerais, Sch Dent, Dept Oral Surg & Pathol, Belo Horizonte, MG, Brazil.	grsouto@hotmail.com	Abreu, Mauro Henrique/G-6502-2012; Queiroz-Junior, Celso/L-5438-2013; Mesquita, Ricardo Alves/H-3256-2014; Souto, Giovanna R/B-1702-2019	Abreu, Mauro Henrique/0000-0001-8794-5725; Queiroz-Junior, Celso/0000-0002-7884-7709; Mesquita, Ricardo Alves/0000-0003-3207-4007; Souto, Giovanna R/0000-0003-3617-8794; COSTA, FERNANDO/0000-0002-7687-1238	CNPq	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors wish to thank the National Council for Scientific and Technological Development (CNPq) (309209/2010-2; 472045/2011-3). RA Mesquita, MH de Abreu and FO Costa are researchers funded by CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Allam JP, 2011, J CLIN PERIODONTOL, V38, P879, DOI 10.1111/j.1600-051X.2011.01752.x; Anjana R, 2012, ORAL DIS, V18, P778, DOI 10.1111/j.1601-0825.2012.01945.x; Armitage GC, 2004, PERIODONTOL 2000, V34, P9, DOI 10.1046/j.0906-6713.2002.003421.x; Baker PJ, 1999, INFECT IMMUN, V67, P2804, DOI 10.1128/IAI.67.6.2804-2809.1999; Behfarnia Parichehr, 2010, Dent Res J (Isfahan), V7, P45; Bratke K, 2008, AM J RESP CELL MOL, V38, P655, DOI 10.1165/rcmb.2007-0400OC; BRIDGES RB, 1977, INFECT IMMUN, V16, P240, DOI 10.1128/IAI.16.1.240-248.1977; Cardoso CR, 2009, ORAL MICROBIOL IMMUN, V24, P1, DOI 10.1111/j.1399-302X.2008.00463.x; Caux C, 1997, BLOOD, V90, P1458, DOI 10.1182/blood.V90.4.1458.1458_1458_1470; Caux C, 1996, J EXP MED, V184, P695, DOI 10.1084/jem.184.2.695; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Cohen J., 1988, STAT POWER ANAL BEHA, P140; Cury Patricia Ramos, 2008, Braz. oral res., V22, P258, DOI 10.1590/S1806-83242008000300012; Cutler CW, 2004, PERIODONTOL 2000, V35, P135, DOI 10.1111/j.0906-6713.2004.003560.x; Dereka XE, 2004, J PERIODONTAL RES, V39, P447, DOI 10.1111/j.1600-0765.2004.00764.x; Frick JS, 2010, INT J MED MICROBIOL, V300, P19, DOI 10.1016/j.ijmm.2009.08.010; Garlet GP, 2008, MICROBES INFECT, V10, P489, DOI 10.1016/j.micinf.2008.01.010; Gemmell E, 2007, PERIODONTOL 2000, V43, P14, DOI 10.1111/j.1600-0757.2006.00173.x; Goutoudi P, 2012, INT J DENT, V2012, DOI 10.1155/2012/362905; Graves D, 2008, J PERIODONTOL, V79, P1585, DOI 10.1902/jop.2008.080183; GUILLOT JL, 1995, J PERIODONTOL, V66, P667, DOI 10.1902/jop.1995.66.8.667; Hegde S, 2004, FASEB J, V18, P1439, DOI 10.1096/fj.03-0969fje; Huang CB, 2011, INFLAMM RES, V60, P119, DOI 10.1007/s00011-010-0242-0; ISHIMI Y, 1990, J IMMUNOL, V145, P3297; Jankovic D, 2001, TRENDS IMMUNOL, V22, P450, DOI 10.1016/S1471-4906(01)01975-5; JILKA RL, 1992, SCIENCE, V257, P88, DOI 10.1126/science.1621100; Jotwani R, 2001, J IMMUNOL, V167, P4693, DOI 10.4049/jimmunol.167.8.4693; Jotwani R, 2010, ANN NY ACAD SCI, V1192, P278, DOI 10.1111/j.1749-6632.2009.05247.x; Kawashima N, 1999, ARCH ORAL BIOL, V44, P55, DOI 10.1016/S0003-9969(98)00094-6; Lannes N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060893; Lappin DF, 2001, CLIN EXP IMMUNOL, V123, P294, DOI 10.1046/j.1365-2249.2001.01448.x; Laurence A, 2007, NAT IMMUNOL, V8, P903, DOI 10.1038/ni0907-903; Lechmann M, 2002, TRENDS IMMUNOL, V23, P273, DOI 10.1016/S1471-4906(02)02214-7; Liu YCG, 2010, PERIODONTOL 2000, V52, P163, DOI 10.1111/j.1600-0757.2009.00321.x; Lopez NJ, 2005, J PERIODONTOL, V76, P2144, DOI 10.1902/jop.2005.76.11-S.2144; Lunz JG, 2007, HEPATOLOGY, V46, P1946, DOI 10.1002/hep.21906; Moutsopoulos NM, 2012, J AUTOIMMUN, V39, P294, DOI 10.1016/j.jaut.2012.03.003; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; NEWCOMB GM, 1982, J CLIN PERIODONTOL, V9, P297, DOI 10.1111/j.1600-051X.1982.tb02096.x; Rezavandi K, 2002, J ORAL PATHOL MED, V31, P59, DOI 10.1046/j.0904-2512.2001.joptest.doc.x; Sallusto F, 2009, EUR J IMMUNOL, V39, P2076, DOI 10.1002/eji.200939722; Schmidt SV, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00274; Seguier S, 2000, ARCH ORAL BIOL, V45, P441, DOI 10.1016/S0003-9969(00)00018-2; Smyth LJC, 2008, CLIN EXP IMMUNOL, V154, P56, DOI 10.1111/j.1365-2249.2008.03729.x; Sousa CRE, 2001, IMMUNITY, V14, P495; Souto GR, 2011, J PERIODONTOL, V82, P619, DOI 10.1902/jop.2010.100488; Tew JG, 2012, J DENT RES, V91, P8, DOI 10.1177/0022034511407338; Thunell DH, 2010, J PERIODONTAL RES, V45, P148, DOI 10.1111/j.1600-0765.2009.01204.x; Tonetti MS, 2005, J CLIN PERIODONTOL, V32, P210, DOI 10.1111/j.1600-051X.2005.00822.x; Trombone AP, 2010, GENES IMMUN, V11, P479, DOI 10.1038/gene.2010.13; Tymkiw KD, 2011, J CLIN PERIODONTOL, V38, P219, DOI 10.1111/j.1600-051X.2010.01684.x; Vassallo R, 2008, MOL IMMUNOL, V45, P3321, DOI 10.1016/j.molimm.2008.04.014; Wykes M, 1998, J IMMUNOL, V161, P1313; Yu JJ, 2008, INFECT IMMUN, V76, P4206, DOI 10.1128/IAI.01209-07; Zhao L, 2011, J CLIN PERIODONTOL, V38, P509, DOI 10.1111/j.1600-051X.2011.01712.x	55	35	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e91636	10.1371/journal.pone.0091636	http://dx.doi.org/10.1371/journal.pone.0091636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670840	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000022
J	Blango, MG; Ott, EM; Erman, A; Veranic, P; Mulvey, MA				Blango, Matthew G.; Ott, Elizabeth M.; Erman, Andreja; Veranic, Peter; Mulvey, Matthew A.			Forced Resurgence and Targeting of Intracellular Uropathogenic Escherichia coli Reservoirs	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; UROTHELIAL CELLS; HOST DEFENSES; BACTERIAL COMMUNITIES; EPITHELIAL-CELLS; BLADDER; PERSISTENCE; CHITOSAN; DIFFERENTIATION; PERMEABILITY	Intracellular quiescent reservoirs of uropathogenic Escherichia coli (UPEC), which can seed the bladder mucosa during the acute phase of a urinary tract infection (UTI), are protected from antibiotic treatments and are extremely difficult to eliminate. These reservoirs are a potential source for recurrent UTIs that affect millions annually. Here, using murine infection models and the bladder cell exfoliant chitosan, we demonstrate that intracellular UPEC populations shift within the stratified layers of the urothelium during the course of a UTI. Following invasion of the terminally differentiated superficial layer of epithelial cells that line the bladder lumen, UPEC can multiply and disseminate, eventually establishing reservoirs within underlying immature host cells. If given access, UPEC can invade the superficial and immature bladder cells equally well. As infected immature host cells differentiate and migrate towards the apical surface of the bladder, UPEC can reinitiate growth and discharge into the bladder lumen. By inducing the exfoliation of the superficial layers of the urothelium, chitosan stimulates rapid regenerative processes and the reactivation and efflux of quiescent intracellular UPEC reservoirs. When combined with antibiotics, chitosan treatment significantly reduces bacterial loads within the bladder and may therefore be of therapeutic value to individuals with chronic, recurrent UTIs.	[Blango, Matthew G.; Ott, Elizabeth M.; Mulvey, Matthew A.] Univ Utah, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84112 USA; [Erman, Andreja; Veranic, Peter] Univ Ljubljana, Inst Cell Biol, Fac Med, Ljubljana, Slovenia	Utah System of Higher Education; University of Utah; University of Ljubljana	Mulvey, MA (corresponding author), Univ Utah, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84112 USA.	mulvey@path.utah.edu	Blango, Matthew/AAY-2384-2020; Veranic, Peter/I-6276-2015	Blango, Matthew/0000-0001-8015-9019; Veranic, Peter/0000-0003-1999-9988; Mulvey, Matthew/0000-0002-6016-7510	NIH [AI095647, AI090369, AI088086, T32AI055434]; Slovenian Ministry of Higher Education, Science and Technology [P3-0108]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088086, R01AI095647, T32AI055434, R21AI090369] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Slovenian Ministry of Higher Education, Science and Technology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research in the Mulvey lab was funded by NIH grants AI095647, AI090369, and AI088086. M. G. B. was supported by NIH microbial pathogenesis training grant T32AI055434. AE and PV were supported by Slovenian Ministry of Higher Education, Science and Technology (grant no. P3-0108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber AE, 2013, CLIN INFECT DIS, V57, P719, DOI 10.1093/cid/cit284; Blango MG, 2010, ANTIMICROB AGENTS CH, V54, P1855, DOI 10.1128/AAC.00014-10; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Dhakal BK, 2009, J BIOL CHEM, V284, P446, DOI 10.1074/jbc.M805010200; ELSINGHORST EA, 1994, METHOD ENZYMOL, V236, P405; Erman A, 2013, HISTOCHEM CELL BIOL; Eto DS, 2007, PLOS PATHOG, V3, P949, DOI 10.1371/journal.ppat.0030100; Eto DS, 2006, CELL MICROBIOL, V8, P704, DOI 10.1111/j.1462-5822.2006.00691.x; Gotoh H, 2010, Biofouling, V26, P603, DOI 10.1080/08927014.2010.501895; Horvath DJ, 2011, MICROBES INFECT, V13, P426, DOI 10.1016/j.micinf.2010.12.004; HULTGREN SJ, 1986, INFECT IMMUN, V54, P613, DOI 10.1128/IAI.54.3.613-620.1986; Hvidberg H, 2000, ANTIMICROB AGENTS CH, V44, P156, DOI 10.1128/AAC.44.1.156-163.2000; Jabbal-Gill I, 2012, EXPERT OPIN DRUG DEL, V9, P1051, DOI 10.1517/17425247.2012.697455; Justice SS, 2006, INFECT IMMUN, V74, P4793, DOI 10.1128/IAI.00355-06; Justice SS, 2004, P NATL ACAD SCI USA, V101, P1333, DOI 10.1073/pnas.0308125100; Kerec M, 2005, EUR J PHARM SCI, V25, P113, DOI 10.1016/j.ejps.2005.02.003; Kerrn MB, 2005, J ANTIMICROB CHEMOTH, V55, P383, DOI 10.1093/jac/dki002; Khasriya R, 2013, J CLIN MICROBIOL, V51, P2054, DOI 10.1128/JCM.03314-12; Kreft ME, 2010, PROTOPLASMA, V246, P3, DOI 10.1007/s00709-010-0112-1; Kulesus RR, 2008, INFECT IMMUN, V76, P3019, DOI 10.1128/IAI.00022-08; Lavelle J, 2002, AM J PHYSIOL-RENAL, V283, pF242, DOI 10.1152/ajprenal.00307.2001; Liu H, 2004, INT J FOOD MICROBIOL, V95, P147, DOI 10.1016/j.ijfoodmicro.2004.01.022; Lorian V., 2005, ANTIBIOTICS LAB MED; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; Mysorekar IU, 2002, J BIOL CHEM, V277, P7412, DOI 10.1074/jbc.M110560200; PARSONS CL, 1988, INFECT IMMUN, V56, P1341, DOI 10.1128/IAI.56.5.1341-1343.1988; Patel MP, 2010, J PHARM PHARM SCI, V13, P536, DOI 10.18433/J3JC7C; Robino L, 2013, PATHOG DIS, V68, P78, DOI 10.1111/2049-632X.12047; Romih R, 1999, HISTOCHEM CELL BIOL, V112, P375, DOI 10.1007/s004180050419; Rosen DA, 2007, PLOS MED, V4, P1949, DOI 10.1371/journal.pmed.0040329; Schilling JD, 2002, INFECT IMMUN, V70, P7042, DOI 10.1128/IAI.70.12.7042-7049.2002; Soto SM, 2006, CLIN MICROBIOL INFEC, V12, P1034, DOI 10.1111/j.1469-0691.2006.01543.x; Ulett GC, 2013, CURR OPIN MICROBIOL, V16, P100, DOI 10.1016/j.mib.2013.01.005; Veranic P, 2009, HISTOCHEM CELL BIOL, V131, P129, DOI 10.1007/s00418-008-0492-x; Zhou G, 2001, J CELL SCI, V114, P4095	39	42	42	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93327	10.1371/journal.pone.0093327	http://dx.doi.org/10.1371/journal.pone.0093327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667805	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600171
J	Fioretti, JM; Bello, G; Rocha, MS; Victoria, M; Leite, JPG; Miagostovich, MP				Fioretti, Julia Monassa; Bello, Gonzalo; Rocha, Monica Simoes; Victoria, Matias; Gagliardi Leite, Jose Paulo; Miagostovich, Marize Pereira			Temporal Dynamics of Norovirus GII.4 Variants in Brazil between 2004 and 2012	PLOS ONE			English	Article							NORWALK-LIKE VIRUSES; RIO-DE-JANEIRO; ACUTE GASTROENTERITIS; MOLECULAR EPIDEMIOLOGY; MAXIMUM-LIKELIHOOD; EPOCHAL EVOLUTION; UNITED-STATES; GENOGROUP-I; OUTBREAKS; IDENTIFICATION	Noroviruses (NoVs) are the major cause of acute gastroenteritis outbreaks, and, despite a wide genetic diversity, genotype II.4 is the most prevalent strain worldwide. Mutations and homologous recombination have been proposed as mechanisms driving the epochal evolution of the GII.4, with the emergence of new variants in 1-3-year intervals causing global epidemics. There are no data reporting the dynamics of GII.4 variants along a specific period in Brazil. Therefore, to improve the understanding of the comportment of these variants in the country, the aim of this study was to evaluate the circulation of NoV GII.4 variants during a 9-year period in 3 out of 5 Brazilian regions. A total of 147 samples were sequenced, and a phylogenetic analysis of subdomain P2 demonstrated the circulation of six GII.4 variants, Asia_2003, Hunter_2004, Den Haag_2006b, Yerseke_2006a, New Orleans_2009, and Sydney_2012, during this period. The most prevalent variant was Den Haag_2006b, circulating in different Brazilian regions from 2006 to 2011. A Bayesian coalescent analysis was used to calculate the mean evolutionary rate of subdomain P2 as 7.3x10(-3) (5.85x10(-3) -8.82x10(-3)) subst./site/year. These analyses also demonstrated that clade Den Haag_2006b experienced a rapid expansion in 2005 and another in 2008 after a period of decay. The evaluation of the temporal dynamics of NoV GII.4 in Brazil revealed a similar pattern, with few exceptions, to the worldwide observation. These data highlight the importance of surveillance for monitoring the emergence of new strains of NoV GII.4 and its impact on cases of acute gastroenteritis.	[Fioretti, Julia Monassa; Rocha, Monica Simoes; Gagliardi Leite, Jose Paulo; Miagostovich, Marize Pereira] Inst Oswaldo Cruz Fiocruz, Lab Virol Comparada & Ambiental, Rio De Janeiro, Brazil; [Bello, Gonzalo] Inst Oswaldo Cruz Fiocruz, Lab AIDS & Imunol Mol, Rio De Janeiro, Brazil; [Victoria, Matias] Univ La Republ, Lab Virol Mol Reg Norte, Ciudad De Salto, Uruguay	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidad de la Republica, Uruguay	Fioretti, JM (corresponding author), Inst Oswaldo Cruz Fiocruz, Lab Virol Comparada & Ambiental, Rio De Janeiro, Brazil.	juliafior@ioc.fiocruz.br	Bello, Gonzalo/E-6842-2013; Bentancor, Gonzalo Jose Bello/N-7377-2019; Victoria, Matias/ABE-1729-2020; LEITE, JOSE PAULO GAGLIARDI/AAY-1230-2020	Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; 	Excellence Program of Research (PROEP-CNPq/IOC); General Coordination of Laboratories/Secretary of Health Surveillance, Ministry of Health	Excellence Program of Research (PROEP-CNPq/IOC); General Coordination of Laboratories/Secretary of Health Surveillance, Ministry of Health	This work was funded by Excellence Program of Research (PROEP-CNPq/IOC) and General Coordination of Laboratories/Secretary of Health Surveillance, Ministry of Health. MP Miagostovich, JPG Leite and G Bello are CNPq fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Aragao GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056608; Belliot G, 2010, J CLIN MICROBIOL, V48, P994, DOI 10.1128/JCM.01888-09; Bennett S, 2013, EUROSURVEILLANCE, V18, P20349, DOI DOI 10.1017/S0950268813000435; Beuret C, 2002, APPL ENVIRON MICROB, V68, P1925, DOI 10.1128/AEM.68.4.1925-1931.2002; Fernandez MDB, 2012, SCI TOTAL ENVIRON, V437, P262, DOI 10.1016/j.scitotenv.2012.08.033; Bok K, 2009, J VIROL, V83, P11890, DOI 10.1128/JVI.00864-09; Boon D, 2011, J VIROL, V85, P8656, DOI 10.1128/JVI.00472-11; Borges AMT, 2006, MEM I OSWALDO CRUZ, V101, P721, DOI 10.1590/S0074-02762006000700003; Bull RA, 2006, J CLIN MICROBIOL, V44, P327, DOI 10.1128/JCM.44.2.327-333.2006; Bull RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000831; Campos GS, 2008, ARCH VIROL, V153, P1125, DOI 10.1007/s00705-008-0078-x; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P41; Chen R, 2006, P NATL ACAD SCI USA, V103, P8048, DOI 10.1073/pnas.0600421103; de Rougemont A, 2011, J VIROL, V85, P4057, DOI 10.1128/JVI.02077-10; Debbink K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002921; DINGLE KE, 1995, J GEN VIROL, V76, P2349, DOI 10.1099/0022-1317-76-9-2349; Donaldson EF, 2008, IMMUNOL REV, V225, P190, DOI 10.1111/j.1600-065X.2008.00680.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Eden JS, 2010, J CLIN VIROL, V49, P265, DOI 10.1016/j.jcv.2010.09.001; Fankhauser RL, 1998, J INFECT DIS, V178, P1571, DOI 10.1086/314525; Ferreira MSR, 2010, J MED VIROL, V82, P1442, DOI 10.1002/jmv.21831; Fioretti JM, 2011, MEM I OSWALDO CRUZ, V106, P942, DOI 10.1590/S0074-02762011000800008; Galeano ME, 2013, J CLIN VIROL, V58, P378, DOI 10.1016/j.jcv.2013.07.008; Gallimore CI, 2007, ARCH VIROL, V152, P1295, DOI 10.1007/s00705-007-0954-9; Gallimore CI, 2004, BRAZ J MED BIOL RES, V37, P321, DOI 10.1590/S0100-879X2004000300005; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Barreira DMPG, 2010, J CLIN VIROL, V47, P60, DOI 10.1016/j.jcv.2009.11.012; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall AJ, 2013, EMERG INFECT DIS, V19, P1305, DOI 10.3201/eid1908.130482; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Larsson MM, 2006, J INFECT DIS, V194, P1422, DOI 10.1086/508430; Leshem E, 2013, EMERG INFECT DIS, V19, P1231, DOI 10.3201/eid1908.130458; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lindesmith LC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002705; Lopman B, 2004, LANCET, V363, P682, DOI 10.1016/S0140-6736(04)15641-9; Meijer A, 2012, EUROSURVEILLANCE, V17, P2; Morillo SG, 2011, REV INST MED TROP SP, V53, P119, DOI 10.1590/S0036-46652011000200011; Motomura K, 2008, J VIROL, V82, P11247, DOI 10.1128/JVI.00897-08; Motomura K, 2010, J VIROL, V84, P8085, DOI 10.1128/JVI.02125-09; Noel JS, 1999, J INFECT DIS, V179, P1334, DOI 10.1086/314783; Okada M, 2006, ARCH VIROL, V151, P1635, DOI 10.1007/s00705-006-0739-6; Parker TD, 2005, J VIROL, V79, P7402, DOI 10.1128/JVI.79.12.7402-7409.2005; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Rambaut A, 2009, FIGTREE V1 3 1 TREE; Ribeiro LR, 2008, MEM I OSWALDO CRUZ, V103, P201, DOI 10.1590/S0074-02762008000200013; Ferreira MSR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033754; Seto Y, 2005, MICROBIOL IMMUNOL, V49, P275, DOI 10.1111/j.1348-0421.2005.tb03718.x; Siebenga J, 2008, EUROSURVEILLANCE, P13; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Siebenga JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000884; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Silva LD, 2013, MEM I O CRUZ, V11; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tran TNH, 2013, J CLIN VIROL, V56, P185, DOI 10.1016/j.jcv.2012.11.011; Tu ETV, 2008, CLIN INFECT DIS, V46, P413, DOI 10.1086/525259; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Vicentini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069348; Vinje J, 2004, J VIROL METHODS, V116, P109, DOI 10.1016/j.jviromet.2003.11.001; Widdowson MA, 2004, J INFECT DIS, V190, P27, DOI 10.1086/420888; Wright PJ, 1998, J MED VIROL, V55, P312, DOI 10.1002/(SICI)1096-9071(199808)55:4&lt;312::AID-JMV10&gt;3.0.CO;2-G; Yen C, 2011, CLIN INFECT DIS, V53, P568, DOI 10.1093/cid/cir478; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	71	31	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92988	10.1371/journal.pone.0092988	http://dx.doi.org/10.1371/journal.pone.0092988			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667283	gold, Green Published, Green Submitted			2022-12-27	WOS:000333675600120
J	Gaykalova, DA; Mambo, E; Choudhary, A; Houghton, J; Buddavarapu, K; Sanford, T; Darden, W; Adai, A; Hadd, A; Latham, G; Danilova, LV; Bishop, J; Li, RJ; Westra, WH; Hennessey, P; Koch, WM; Ochs, MF; Califano, JA; Sun, W				Gaykalova, Daria A.; Mambo, Elizabeth; Choudhary, Ashish; Houghton, Jeffery; Buddavarapu, Kalyan; Sanford, Tiffany; Darden, Will; Adai, Alex; Hadd, Andrew; Latham, Gary; Danilova, Ludmila V.; Bishop, Justin; Li, Ryan J.; Westra, William H.; Hennessey, Patrick; Koch, Wayne M.; Ochs, Michael F.; Califano, Joseph A.; Sun, Wenyue			Novel Insight into Mutational Landscape of Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							SOMATIC MUTATIONS; ONCOGENIC MUTATIONS; GROWTH-INHIBITION; TYROSINE KINASE; CANCER; RECEPTOR; GENE; TARGET; ACTIVATION; LEUKEMIA	Development of head and neck squamous cell carcinoma (HNSCC) is characterized by accumulation of mutations in several oncogenes and tumor suppressor genes. We have formerly described the mutation pattern of HNSCC and described NOTCH signaling pathway alterations. Given the complexity of the HNSCC, here we extend the previous study to understand the overall HNSCC mutation context and to discover additional genetic alterations. We performed high depth targeted exon sequencing of 51 highly actionable cancer-related genes with a high frequency of mutation across many cancer types, including head and neck. DNA from primary tumor tissues and matched normal tissues was analyzed for 37 HNSCC patients. We identified 26 non-synonymous or stop-gained mutations targeting 11 of 51 selected genes. These genes were mutated in 17 out of 37 (46%) studied HNSCC patients. Smokers harbored 3.2-fold more mutations than non-smokers. Importantly, TP53 was mutated in 30%, NOTCH1 in 8% and FGFR3 in 5% of HNSCC. HPV negative patients harbored 4-fold more TP53 mutations than HPV positive patients. These data confirm prior reports of the HNSCC mutational profile. Additionally, we detected mutations in two new genes, CEBPA and FES, which have not been previously reported in HNSCC. These data extend the spectrum of HNSCC mutations and define novel mutation targets in HNSCC carcinogenesis, especially for smokers and HNSCC without HPV infection.	[Gaykalova, Daria A.; Li, Ryan J.; Westra, William H.; Hennessey, Patrick; Koch, Wayne M.; Califano, Joseph A.; Sun, Wenyue] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Mambo, Elizabeth; Choudhary, Ashish; Houghton, Jeffery; Buddavarapu, Kalyan; Sanford, Tiffany; Darden, Will; Adai, Alex; Hadd, Andrew; Latham, Gary] Asuragen Inc, Austin, TX USA; [Bishop, Justin; Westra, William H.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Danilova, Ludmila V.; Ochs, Michael F.] Johns Hopkins Med Inst, Dept Oncol & Hlth Sci Informat, Baltimore, MD 21205 USA; [Califano, Joseph A.] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Asuragen; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Greater Baltimore Medical Center	Califano, JA (corresponding author), Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	jcalifa@jhmi.edu; wenyue.sun@nih.gov		Sun, Wenyue/0000-0003-1673-0895	National Institute of Dental and Craniofacial Research (NIDCR); NIH [RC1DE020324, RC2DE020789]; NCI [P50 DE 019032]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P50DE019032, R01DE013152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020789, RC1DE020324] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work was supported by National Institute of Dental and Craniofacial Research (NIDCR) and NIH Challenge Grant RC1DE020324 and RC2DE020789, and NCI P50 DE 019032 Head and Neck Cancer SPORE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Asthagiri AR, 2009, LANCET, V373, P1974, DOI 10.1016/S0140-6736(09)60259-2; Astier AL, 2003, BLOOD, V101, P1118, DOI 10.1182/blood-2002-05-1519; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Califano J, 1996, CANCER RES, V56, P2488; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen YX, 2006, P NATL ACAD SCI USA, V103, P1018, DOI 10.1073/pnas.0510347103; Chocarro-Calvo A, 2013, MOL CELL, V49, P474, DOI 10.1016/j.molcel.2012.11.022; Chung CH, 2006, J CLIN ONCOL, V24, P4170, DOI 10.1200/JCO.2006.07.2587; COOPER GM, 1982, SCIENCE, V217, P801, DOI 10.1126/science.6285471; Della Rocca GJ, 1999, J BIOL CHEM, V274, P13978, DOI 10.1074/jbc.274.20.13978; Demokan S, 2012, HEAD NECK-J SCI SPEC, V34, P1470, DOI 10.1002/hed.21949; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Elisei R, 2008, J CLIN ENDOCR METAB, V93, P682, DOI 10.1210/jc.2007-1714; Elnaggar MM, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-23; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fry TJ, 2002, BLOOD, V99, P3892, DOI 10.1182/blood.V99.11.3892; Fumagalli D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-101; Gaykalova D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040389; Ha PK, 2006, LANCET ONCOL, V7, P77, DOI 10.1016/S1470-2045(05)70540-4; Hadd AG, 2013, J MOL DIAGN, V15, P234, DOI 10.1016/j.jmoldx.2012.11.006; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Harari PM, 2007, J CLIN ONCOL, V25, P4057, DOI 10.1200/JCO.2007.11.8984; Hardisson D, 2003, EUR ARCH OTO-RHINO-L, V260, P502, DOI 10.1007/s00405-003-0581-3; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hill Stephen J., 2001, Current Opinion in Pharmacology, V1, P526, DOI 10.1016/S1471-4892(01)00091-1; Hornberg JJ, 2005, ONCOGENE, V24, P5533, DOI 10.1038/sj.onc.1208817; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Jagani Z, 2010, NAT MED, V16, P1429, DOI 10.1038/nm.2251; Jain P, 2013, CURR TREAT OPTION ON, V14, P127, DOI 10.1007/s11864-013-0234-8; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kawamura J, 2005, ONCOL REP, V14, P47; Kent D, 2008, CLIN CANCER RES, V14, P1926, DOI 10.1158/1078-0432.CCR-07-5134; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kikkawa N, 2010, BRIT J CANCER, V103, P877, DOI 10.1038/sj.bjc.6605811; Lechner M, 2013, GENOME MED, V5, DOI 10.1186/gm453; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Lui VWY, 2013, CANCER DISCOV, V3, P761, DOI 10.1158/2159-8290.CD-13-0103; Luzzatto L, 2002, NATURE, V417, P703, DOI 10.1038/417703a; MacFarlane M, 2004, EMBO REP, V5, P674, DOI 10.1038/sj.embor.7400191; Maestro R, 1996, CANCER RES, V56, P1146; MCCORMICK F, 1995, MOL REPROD DEV, V42, P500, DOI 10.1002/mrd.1080420419; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moliterno AR, 1998, NEW ENGL J MED, V338, P572, DOI 10.1056/NEJM199802263380903; Murugan AK, 2008, INT J ONCOL, V32, P101; Nichols AC, 2012, ARCH OTOLARYNGOL, V138, P732, DOI 10.1001/archoto.2012.1558; Nordstrom-O'Brien M, 2010, HUM MUTAT, V31, P521, DOI 10.1002/humu.21219; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; Okami K, 1998, CANCER RES, V58, P509; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Ono T, 2011, LEUKEMIA RES, V35, P598, DOI 10.1016/j.leukres.2010.12.006; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pickering CR, 2013, CANCER DISCOV, V3, P770, DOI 10.1158/2159-8290.CD-12-0537; Poeta ML, 2009, CLIN CANCER RES, V15, P7658, DOI 10.1158/1078-0432.CCR-09-1433; Psyrri A, 2011, ANTI-CANCER DRUG, V22, P586, DOI 10.1097/CAD.0b013e328344ec44; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Qiu W, 2006, ONCOGENE, V25, P2937, DOI 10.1038/sj.onc.1209325; Rand V, 2005, P NATL ACAD SCI USA, V102, P14344, DOI 10.1073/pnas.0507200102; ROSNET O, 1991, GENOMICS, V9, P380, DOI 10.1016/0888-7543(91)90270-O; Ruckert F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012243; Schindler CW, 2002, J CLIN INVEST, V109, P1133, DOI 10.1172/JCI200215644; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Scully C, 2000, ORAL ONCOL, V36, P404, DOI 10.1016/S1368-8375(00)00023-3; Seiwert TY, 2009, CANCER RES, V69, P3021, DOI 10.1158/0008-5472.CAN-08-2881; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Shao CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048582; Shioda T, 1998, P NATL ACAD SCI USA, V95, P9785, DOI 10.1073/pnas.95.17.9785; Smith IM, 2007, INT J CANCER, V121, P1724, DOI 10.1002/ijc.22889; Solt LA, 2008, IMMUNOL RES, V42, P3, DOI 10.1007/s12026-008-8025-1; STEHELIN D, 1977, VIROLOGY, V76, P675, DOI 10.1016/0042-6822(77)90250-1; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Sun WY, 2014, CANCER RES, V74, P1091, DOI 10.1158/0008-5472.CAN-13-1259; Sun WY, 2009, CLIN CANCER RES, V15, P476, DOI 10.1158/1078-0432.CCR-08-0930; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; Weber A, 2003, ONCOGENE, V22, P4757, DOI 10.1038/sj.onc.1206705; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zhang Y, 2005, INT J CANCER, V117, P166, DOI 10.1002/ijc.21145	89	62	63	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93102	10.1371/journal.pone.0093102	http://dx.doi.org/10.1371/journal.pone.0093102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667986	gold, Green Published, Green Submitted			2022-12-27	WOS:000333675600139
J	Heritage, B; Pollock, C; Roberts, L				Heritage, Brody; Pollock, Clare; Roberts, Lynne			Validation of the Organizational Culture Assessment Instrument	PLOS ONE			English	Article							JOB-SATISFACTION; VALUES; ATTITUDES	Organizational culture is a commonly studied area in industrial/organizational psychology due to its important role in workplace behaviour, cognitions, and outcomes. Jung et al.'s [1] review of the psychometric properties of organizational culture measurement instruments noted many instruments have limited validation data despite frequent use in both theoretical and applied situations. The Organizational Culture Assessment Instrument (OCAI) has had conflicting data regarding its psychometric properties, particularly regarding its factor structure. Our study examined the factor structure and criterion validity of the OCAI using robust analysis methods on data gathered from 328 (females = 226, males = 102) Australian employees. Confirmatory factor analysis supported a four factor structure of the OCAI for both ideal and current organizational culture perspectives. Current organizational culture data demonstrated expected reciprocally-opposed relationships between three of the four OCAI factors and the outcome variable of job satisfaction but ideal culture data did not, thus indicating possible weak criterion validity when the OCAI is used to assess ideal culture. Based on the mixed evidence regarding the measure's properties, further examination of the factor structure and broad validity of the measure is encouraged.	[Heritage, Brody; Roberts, Lynne] Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA 6845, Australia; [Pollock, Clare] Curtin Univ, Off Deputy Vice Chancellor Acad, Perth, WA 6845, Australia	Curtin University; Curtin University	Heritage, B (corresponding author), Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA 6845, Australia.	b.heritage@curtin.edu.au	Heritage, Brody/AAZ-3501-2021; Heritage, Brody/AAY-5111-2021; Roberts, Lynne/B-6647-2013	Heritage, Brody/0000-0002-6437-7232; Heritage, Brody/0000-0002-6437-7232; Roberts, Lynne/0000-0003-0085-9213				[Anonymous], 2004, EUR J WORK ORGAN PSY, DOI [DOI 10.1080/13594320344000246, 10.1080/13594320344000246]; Balthazard P.A., 2006, J MANAGE PSYCHOL, V21, P709, DOI [10.1108/02683940610713253, DOI 10.1108/02683940610713253]; Bellou V, 2010, CAREER DEV INT, V15, P4, DOI 10.1108/13620431011020862; Berson Y, 2008, J ORGAN BEHAV, V29, P615, DOI 10.1002/job.499; Byrne B. M., 2006, STRUCTURAL EQUATION, V2nd; Cameron K.S, 2006, DIAGNOSING CHANGING; Cameron K.S., 2011, DIAGNOSING CHANGING, V3rd ed.; Cammann C., 2002, TAKING MEASURE WORK, P71138; Choi YS, 2010, J SPORT MANAGE, V24, P169, DOI 10.1123/jsm.24.2.169; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Giberson TR, 2009, J BUS PSYCHOL, V24, P123, DOI 10.1007/s10869-009-9109-1; Goritz AS, 2006, INT J INTERNET SCI, V1, P58; Gregory BT, 2009, J BUS RES, V62, P673, DOI 10.1016/j.jbusres.2008.05.021; Hartnell CA, 2011, J APPL PSYCHOL, V96, P677, DOI 10.1037/a0021987; Heck RH, 2010, QUANT METH SER, P1; Helfrich CD, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-13; Hofstede G, 1998, ORGAN STUD, V19, P477, DOI 10.1177/017084069801900305; HOFSTEDE G, 1990, ADMIN SCI QUART, V35, P286, DOI 10.2307/2393392; Howell D, 2002, STAT METHODS PSYCHOL; Jung T, 2009, PUBLIC ADMIN REV, V69, P1087, DOI 10.1111/j.1540-6210.2009.02066.x; Kalliath TJ, 1999, EDUC PSYCHOL MEAS, V59, P143, DOI 10.1177/0013164499591010; Kim BP, 2009, INT J HOSP MANAG, V28, P612, DOI 10.1016/j.ijhm.2009.04.001; Kline RB, 2005, PRINCIPLES PRACTICE; Lee Huey Yiing, 2009, Leadership & Organization Development Journal, V30, P53, DOI 10.1108/01437730910927106; Lewis D., 1996, LEADERSHIP ORG DEV J, V17, P12, DOI [10.1108/01437739610105995, DOI 10.1108/01437739610105995]; Lim Bernard., 1995, LEADERSHIP ORG DEV J, V16, P16, DOI DOI 10.1108/01437739510088491; Lovas L, 2007, STUD PSYCHOL, V49, P215; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Martin J., 1988, MANAGING AMBIGUITY C; MEYER JP, 1993, J APPL PSYCHOL, V78, P538, DOI 10.1037/0021-9010.78.4.538; Mora T., 2009, J SOCIO-ECON, V38, P581, DOI [DOI 10.1016/J.SOCEC.2009.02.003, 10.1016/j.socec.2009.02.003]; Nelson RE, 2003, ORGAN STUD, V24, P1115, DOI 10.1177/01708406030247006; Ogbonna E, 2003, J MANAGE STUD, V40, P1151, DOI 10.1111/1467-6486.00375; OREILLY CA, 1991, ACAD MANAGE J, V34, P487, DOI 10.2307/256404; Quinn RE, 1991, RES ORG CHANGE DEV, P155; Schein E., 2000, HDB ORG CLIMATE CULT; SCHEIN EH, 1990, AM PSYCHOL, V45, P109, DOI 10.1037/0003-066X.45.2.109; Schneider B, 1998, J APPL PSYCHOL, V83, P462, DOI 10.1037/0021-9010.83.3.462; Smith M. E., 2003, LEADERSH ORG DEV J, V24, P249, DOI DOI 10.1108/01437730310485752; Stevens J. P, 1992, APPL MULTIVARIATE ST; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Taormina Robert J., 2008, Leadership & Organization Development Journal, V29, P85, DOI 10.1108/01437730810845315; THORNDIKE RM, 1976, MULTIVAR BEHAV RES, V11, P249, DOI 10.1207/s15327906mbr1102_10; Tzeng HM, 2002, INT J NURS STUD, V39, P79, DOI 10.1016/S0020-7489(00)00121-8; WALLACH EJ, 1983, TRAIN DEV J, V37, P29; Warr P., 1979, J OCCUP ORGAN PSYCH, V58, P229; Zammuto R.F., 1991, RES ORG CHANGE DEV	47	40	42	5	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92879	10.1371/journal.pone.0092879	http://dx.doi.org/10.1371/journal.pone.0092879			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SD	24667839	Green Published, gold			2022-12-27	WOS:000333675600096
J	Marrale, M; Albanese, NN; Cali, F; Romano, V				Marrale, Maurizio; Albanese, Nadia Ninfa; Cali, Francesco; Romano, Valentino			Assessing the Impact of Copy Number Variants on miRNA Genes in Autism by Monte Carlo Simulation	PLOS ONE			English	Article							LYMPHOBLASTOID CELL-LINES; DE-NOVO MUTATIONS; SPECTRUM DISORDERS; EXPRESSION; MICRORNAS; REVEALS; GENETICS; ETIOLOGY	Autism Spectrum Disorders (ASDs) are childhood neurodevelopmental disorders with complex genetic origins. Previous studies have investigated the role of de novo Copy Number Variants (CNVs) and microRNAs as important but distinct etiological factors in ASD. We developed a novel computational procedure to assess the potential pathogenic role of microRNA genes overlapping de novo CNVs in ASD patients. Here we show that for chromosomes # 1, 2 and 22 the actual number of miRNA loci affected by de novo CNVs in patients was found significantly higher than that estimated by Monte Carlo simulation of random CNV events. Out of 24 miRNA genes over-represented in CNVs from these three chromosomes only hsa-mir-4436b-1 and hsa-mir-4436b-2 have not been detected in CNVs from non-autistic subjects as reported in the Database of Genomic Variants. Altogether the results reported in this study represent a first step towards a full understanding of how a dysregulated expression of the 24 miRNAs genes affect neurodevelopment in autism. We also propose that the procedure used in this study can be effectively applied to CNVs/miRNA genes association data in other genomic disorders beyond autism.	[Marrale, Maurizio; Albanese, Nadia Ninfa; Romano, Valentino] Univ Palermo, Dipartimento Fis & Chim, Palermo, Italy; [Cali, Francesco; Romano, Valentino] Assoc Oasi Maria SS IRCCS, UOC Genet Med Lab Genet Mol, Troina, Italy	University of Palermo; IRCCS Oasi Maria SS	Romano, V (corresponding author), Univ Palermo, Dipartimento Fis & Chim, Palermo, Italy.	valentino.romano@unipa.it	Calì, Francesco/D-9178-2017; Albanese, Nadia/AAN-3634-2020; MARRALE, MAURIZIO/I-9926-2014; Scavuzzo, Cataldo/D-5048-2017	Calì, Francesco/0000-0001-8667-8223; MARRALE, MAURIZIO/0000-0002-0091-3243; Romano, Valentino/0000-0003-3238-5702; Scavuzzo, Cataldo/0000-0002-3905-4191	University of Palermo; Italian Ministry of Health	University of Palermo; Italian Ministry of Health(Ministry of Health, Italy)	The authors acknowledge funding from University of Palermo and from the Italian Ministry of Health: "Ricerca corrente 2013" entitled: "Ritardo mentale, epilessia e autismo: studio genetico, clinico e neurofisiologico". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Abu-Elneel K, 2008, NEUROGENETICS, V9, P153, DOI 10.1007/s10048-008-0133-5; [Anonymous], 2012, MIRPATH VERSION 20; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Baron CA, 2006, J AUTISM DEV DISORD, V36, P973, DOI 10.1007/s10803-006-0134-x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; Bressler JP, 2012, PEDIATR NEUROL, V47, P337, DOI 10.1016/j.pediatrneurol.2012.06.017; Burstyn I, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-2; Buxbaum JD, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-68; Chan A.W.S., 2012, FRONT GENET, V82, P1; Correia CT, 2010, PHARMACOGENOMICS J, V10, P418, DOI 10.1038/tpj.2009.63; Coutinho AM, 2007, HUM GENET, V121, P243, DOI 10.1007/s00439-006-0301-3; Cusco I, 2009, HUM MOL GENET, V18, P1795, DOI 10.1093/hmg/ddp092; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Gardener H, 2009, BRIT J PSYCHIAT, V195, P7, DOI 10.1192/bjp.bp.108.051672; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gregg JP, 2008, GENOMICS, V91, P22, DOI 10.1016/j.ygeno.2007.09.003; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Griswold AJ, 2012, HUM MOL GENET, V21, P3513, DOI 10.1093/hmg/dds164; Hu VW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005775; James SJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.8; Kalos M. H., 2008, MONTE CARLO METHODS; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; LaSalle JM, 2011, EPIGENETICS-US, V6, P862, DOI 10.4161/epi.6.7.16353; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Liftover, 2002, TOOL UCSC GENOME BRO; Marcinkowska M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-183; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Miller M, 2013, AUTISM RES; Miyake K, 2012, ADV EXP MED BIOL, V724, P91, DOI 10.1007/978-1-4614-0653-2_7; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; Pike N, SPREADSHEET CALCULAT; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Purcell AE, 2001, J AUTISM DEV DISORD, V31, P545, DOI 10.1023/A:1013290826504; Qiao Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-544; Ronemus M, 2014, NAT REV GENET, V15, P133, DOI 10.1038/nrg3585; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sarachana T, 2010, GENOME MED, V2, DOI 10.1186/gm144; Schaaf CP, 2011, NEURON, V70, P806, DOI 10.1016/j.neuron.2011.05.025; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Seno MMG, 2011, BRAIN RES, V1380, P85, DOI 10.1016/j.brainres.2010.09.046; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Talebizadeh Z, 2008, AUTISM RES, V1, P240, DOI 10.1002/aur.33; Vaishnavi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056781; van den Berg A, 2008, BBA-GENE REGUL MECH, V1779, P668, DOI 10.1016/j.bbagrm.2008.07.005; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Xu B, 2010, BRAIN RES, V1338, P78, DOI 10.1016/j.brainres.2010.03.109; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	55	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e90947	10.1371/journal.pone.0090947	http://dx.doi.org/10.1371/journal.pone.0090947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667286	Green Published, gold			2022-12-27	WOS:000333675600004
J	Quandt, D; Rothe, K; Scholz, R; Baerwald, CW; Wagner, U				Quandt, Dagmar; Rothe, Kathrin; Scholz, Roger; Baerwald, Christoph W.; Wagner, Ulf			Peripheral CD4CD8 Double Positive T Cells with a Distinct Helper Cytokine Profile Are Increased in Rheumatoid Arthritis	PLOS ONE			English	Article							CITRULLINATED PEPTIDE ANTIBODIES; ANTI-CD4 MONOCLONAL-ANTIBODY; LYMPHOCYTES; EXPRESSION; ATHEROSCLEROSIS; IMMUNITY; DISEASE	Peripheral CD4CD8 double positive (DP) T cells have been reported to play a role in several autoimmune diseases, virus infections and cancer. In rheumatoid arthritis (RA), both CD4 and CD8 single positive (SP) T cells are known to be involved in the pathogenesis, but the role of peripheral CD4CD8 DP T cells has not been investigated in detail. Anti cyclic citrullinated antibodies (ACPA) positive and ACPA negative RA patients, patients with systemic lupus erythematodes (SLE) and age matched healthy donors (HD) were enrolled in the analysis. The frequencies and phenotype of DP T cells in PBMC were investigated. In addition, DP T cells were quantified in biopsies from rheumatoid synovium. After in vitro restimulation, the cytokine production of DP T cells was investigated in cultures of PBMC. CMV specific cytokine secretion as well as proliferation was analyzed following antigen specific restimulation after an appropriate culture duration. DP T cells were found more frequently in RA patients than in healthy controls or patients with SLE. These DP T cells express ab TCRs, are of a memory phenotype and share features of both CD4 as well as CD8 SP T cells. Importantly, DP T cells were found to also be present in the rheumatoid synovium. Further characterization of DP T cells from RA patients revealed increased production of IL-21 and IL-4, implying a possible role as T helper cells. In addition, DP T cells in RA seem to contribute to the inflammatory process, because they produce significantly more IFN gamma than counterparts from HD and are increased in CMV+ RA patients. Given their capacity to produce a variety of cytokines (IL4, IL21 and IFN gamma), their association with ACPA positive RA and their presence in the synovium, we suggest an important role of double positive T cells in the pathogenesis of rheumatoid arthritis.	[Wagner, Ulf] Univ Leipzig, Gastroenterol Clin, Div Rheumatol, D-04109 Leipzig, Saxony, Germany; Univ Leipzig, Clin Rheumatol, Div Rheumatol, D-04109 Leipzig, Saxony, Germany	Leipzig University; Leipzig University	Wagner, U (corresponding author), Univ Leipzig, Gastroenterol Clin, Div Rheumatol, D-04109 Leipzig, Saxony, Germany.	ulf.wagner@medizin.uni-leipzig.de	Baerwald, Christoph/T-7107-2019; Rothe, Kathrin/AAQ-2842-2020; Baerwald, Christoph/AAD-9013-2020; Wagner, Ulf/F-4351-2016	Baerwald, Christoph/0000-0002-1406-3024; Quandt, Dagmar/0000-0001-6666-6874	German Research Foundation [WA 2765/3-1]; German Research Foundation (DFG); Leipzig University	German Research Foundation(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University	This study was supported by the German Research Foundation (WA 2765/3-1). The author(s) acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho BA, 2012, J CLIN IMMUNOL, V32, P709, DOI 10.1007/s10875-012-9674-3; Claude L, 2005, J CLIN IMMUNOL, V25, P418, DOI 10.1007/s10875-005-5257-x; Daridon C, 2009, CURR OPIN RHEUMATOL, V21, P205, DOI 10.1097/BOR.0b013e32832a0760; Desfrancois J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008437; Dorner T, 2009, NAT REV RHEUMATOL, V5, P433, DOI 10.1038/nrrheum.2009.141; DURIE FH, 1994, IMMUNOL TODAY, V15, P406, DOI 10.1016/0167-5699(94)90269-0; Frahm MA, 2012, J IMMUNOL, V188, P4289, DOI 10.4049/jimmunol.1103701; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Gerli R, 2008, ANN RHEUM DIS, V67, P724, DOI 10.1136/ard.2007.073718; Gerli R, 2009, ARTHRITIS RHEUM, V60, P631, DOI 10.1002/art.24297; Ghia P, 2007, BRIT J HAEMATOL, V139, P780, DOI 10.1111/j.1365-2141.2007.06867.x; Holling TM, 2002, J IMMUNOL, V168, P763, DOI 10.4049/jimmunol.168.2.763; HORNEFF G, 1991, ARTHRITIS RHEUM, V34, P129, DOI 10.1002/art.1780340202; Humby F, 2009, PLOS MED, V6, P59, DOI 10.1371/journal.pmed.0060001; Kelly-Rogers J, 2006, HUM IMMUNOL, V67, P863, DOI 10.1016/j.humimm.2006.08.292; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; Maxwell LJ, 2010, J RHEUMATOL, V37, P234, DOI 10.3899/jrheum.091066; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Nascimbeni M, 2004, BLOOD, V104, P478, DOI 10.1182/blood-2003-12-4395; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; PALIARD X, 1988, NATURE, V335, P642, DOI 10.1038/335642a0; Parel Y, 2004, AUTOIMMUN REV, V3, P215, DOI 10.1016/j.autrev.2003.09.001; Parel Y, 2007, ARTHRITIS RHEUM-US, V56, P3459, DOI 10.1002/art.22927; Pierer M, 2012, ARTHRITIS RHEUM-US, V64, P1740, DOI 10.1002/art.34346; Raza K, 2005, ARTHRITIS RES THER, V7, pR784, DOI 10.1186/ar1733; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Scheerens H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3502; Schmidt D, 1996, MOL MED, V2, P608, DOI 10.1007/BF03401644; Suni MA, 2001, EUR J IMMUNOL, V31, P2512, DOI 10.1002/1521-4141(200108)31:8<2512::AID-IMMU2512>3.0.CO;2-M; Wagner U, 2003, EUR J IMMUNOL, V33, P79, DOI 10.1002/immu.200390010; Zloza A, 2006, J LEUKOCYTE BIOL, V79, P4, DOI 10.1189/jlb.0805455	35	55	55	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93293	10.1371/journal.pone.0093293	http://dx.doi.org/10.1371/journal.pone.0093293			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667579	gold, Green Published, Green Submitted			2022-12-27	WOS:000333675600166
J	Mishra, R; Karande, AA				Mishra, Ritu; Karande, Anjali A.			Endoplasmic Reticulum Stress-Mediated Activation of p38 MAPK, Caspase-2 and Caspase-8 Leads to Abrin-Induced Apoptosis	PLOS ONE			English	Article							RIBOSOME-INACTIVATING PROTEINS; RICIN-A-CHAIN; ER; KINASE; INDUCTION; PATHWAY; DEATH; CELLS; PURIFICATION; INVOLVEMENT	Abrin from Abrus precatorius plant is a potent protein synthesis inhibitor and induces apoptosis in cells. However, the relationship between inhibition of protein synthesis and apoptosis is not well understood. Inhibition of protein synthesis by abrin can lead to accumulation of unfolded protein in the endoplasmic reticulum causing ER stress. The observation of phosphorylation of eukaryotic initiation factor 2 alpha and upregulation of CHOP (CAAT/enhancer binding protein (C/EBP) homologous protein), important players involved in ER stress signaling by abrin, suggested activation of ER stress in the cells. ER stress is also known to induce apoptosis via stress kinases such as p38 MAPK and JNK. Activation of both the pathways was observed upon abrin treatment and found to be upstream of the activation of caspases. Moreover, abrin-induced apoptosis was found to be dependent on p38 MAPK but not JNK. We also observed that abrin induced the activation of caspase-2 and caspase-8 and triggered Bid cleavage leading to mitochondrial membrane potential loss and thus connecting the signaling events from ER stress to mitochondrial death machinery.	[Mishra, Ritu; Karande, Anjali A.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Karande, AA (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	anjali@biochem.iisc.ernet.in			Council of Scientific and Industrial Research (CSIR); Department of Biotechnology (DBT), Government of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	Support was provided by the Council of Scientific and Industrial Research (CSIR) and the Department of Biotechnology (DBT), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai K, 2004, J NEUROCHEM, V89, P232, DOI 10.1111/j.1471-4159.2004.02317.x; Bolognesi A, 1996, INT J CANCER, V68, P349, DOI 10.1002/(SICI)1097-0215(19961104)68:3<349::AID-IJC13>3.0.CO;2-3; Brigotti M, 2002, FASEB J, V16, DOI 10.1096/fj.01-0521com; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Cheung HH, 2006, EXP CELL RES, V312, P2347, DOI 10.1016/j.yexcr.2006.03.027; ENDO Y, 1987, J BIOL CHEM, V262, P8128; FRAKER PJ, 1995, METHOD CELL BIOL, V46, P57; Gadadhar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058304; GODAL A, 1987, CANCER RES, V47, P6243; Gupta S, 2010, INT J CELL BIOL, V2010; Hartley MR, 2004, BBA-PROTEINS PROTEOM, V1701, P1, DOI 10.1016/j.bbapap.2004.06.004; He Q, 2002, ONCOGENE, V21, P2623, DOI 10.1038/sj.onc.1205345; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; HEGDE R, 1991, ANAL BIOCHEM, V194, P101, DOI 10.1016/0003-2697(91)90156-N; Homma K, 2009, EXPERT OPIN THER TAR, V13, P653, DOI 10.1517/14728220902980249; Horrix C, 2011, CELL MOL LIFE SCI, V68, P1269, DOI 10.1007/s00018-010-0524-2; Jetzt AE, 2009, INT J BIOCHEM CELL B, V41, P2503, DOI 10.1016/j.biocel.2009.08.007; Jimbo A, 2003, EXP CELL RES, V283, P156, DOI 10.1016/S0014-4827(02)00033-2; Kim DS, 2010, BIOL PHARM BULL, V33, P545, DOI 10.1248/bpb.33.545; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021533; Lee SY, 2008, CELL MICROBIOL, V10, P770, DOI 10.1111/j.1462-5822.2007.01083.x; Liu N, 2006, VIROLOGY, V348, P398, DOI 10.1016/j.virol.2006.01.002; Momoi T, 2004, J CHEM NEUROANAT, V28, P101, DOI 10.1016/j.jchemneu.2004.05.008; Narayanan S, 2005, FEBS LETT, V579, P1324, DOI 10.1016/j.febslet.2005.01.038; Nielsen K, 2001, ANNU REV PLANT PHYS, V52, P785, DOI 10.1146/annurev.arplant.52.1.785; Park HS, 2011, BIOCHEM PHARMACOL, V82, P1110, DOI 10.1016/j.bcp.2011.07.085; Penna F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045327; Peumans WJ, 2001, FASEB J, V15, P1493, DOI 10.1096/fj.00-0751rev; Roncuzzi L, 1996, FEBS LETT, V392, P16, DOI 10.1016/0014-5793(96)00776-4; Roxas-Duncan VI, 2012, BEANS BEADS RICIN AB; Saxena N, 2013, TOXICOLOGICAL SCI; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Seth R, 2005, J BIOL CHEM, V280, P31230, DOI 10.1074/jbc.M503305200; Sharma S, 1999, MOL CELL BIOCHEM, V200, P133, DOI 10.1023/A:1007043218769; Smith WE, 2003, INFECT IMMUN, V71, P1497, DOI 10.1128/IAI.71.3.1497-1504.2003; Surendranath K, 2008, CLIN VACCINE IMMUNOL, V15, P737, DOI 10.1128/CVI.00254-07; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Talukder KA, 2012, MICROB PATHOGENESIS, V52, P311, DOI 10.1016/j.micpath.2012.02.007; Tyagi A, 2006, CARCINOGENESIS, V27, P2269, DOI 10.1093/carcin/bgl098; Upton JP, 2008, MOL CELL BIOL, V28, P3943, DOI 10.1128/MCB.00013-08; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; WAWRZYNCZAK EJ, 1990, CANCER RES, V50, P7519; WEI CH, 1974, J BIOL CHEM, V249, P3061; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zhu GY, 2011, EUR J PHARMACOL, V668, P88, DOI 10.1016/j.ejphar.2011.06.008	46	42	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92586	10.1371/journal.pone.0092586	http://dx.doi.org/10.1371/journal.pone.0092586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664279	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000333459900080
J	Park, YM; Lee, BH; Um, TH; Kim, S				Park, Young-Min; Lee, Bun-Hee; Um, Tae Hyun; Kim, Sollip			Serum BDNF Levels in Relation to Illness Severity, Suicide Attempts, and Central Serotonin Activity in Patients with Major Depressive Disorder: A Pilot Study	PLOS ONE			English	Article							AUDITORY-EVOKED-POTENTIALS; LOUDNESS DEPENDENCE; INTENSITY DEPENDENCE; NEUROTROPHIC FACTOR; ERP COMPONENTS; NORADRENERGIC ANTIDEPRESSANTS; TREATMENT RESPONSE; CLINICAL-RESPONSE; BIPOLAR DISORDER; N1/P2 COMPONENT	The aim of this study was to test the hypothesis that serum levels of brain-derived neurotrophic factor (BDNF) are correlated with the loudness dependence of auditory evoked potentials (LDAEP). The question of whether there is a difference in BDNF levels between depressive patients according to their illness severity, history of suicide attempts, and central serotonin activity was also addressed. A sample of 51 patients who met the criteria for major depressive disorder following diagnosis using axis I of the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders - text revision comprised the study subjects. The patients were stratified into two subgroups based on their illness severity, history of suicide attempts, and their LDAEP values. The LDAEP was evaluated by measuring the auditory event-related potentials, and serum BDNF was measured using blood sampling before beginning medication with serotonergic agents. There was no difference in serum BDNF levels between the two patient subgroups. The subgroup with moderate-to-severe depression (n = 16) was reanalyzed after stratifying it into two subgroups according to LDAEP and BDNF values (dichotomized at the medians into low and high). The high-LDAEP subgroup had higher serum BDNF levels and total Barratt Impulsiveness Scale score than the low-LDAEP subgroup (p = 0.03 and 0.036, respectively). Serum BDNF levels were positively correlated with LDAEP and total Beck Hopelessness Scale (BHS) score (r = 0.56, p = 0.025, and r = 0.59, p = 0.016, respectively). The high-BDNF subgroup had a higher LDAEP and total BHS score than the low-BDNF subgroup (p = 0.046 and p = 0.011, respectively). This is the first study to demonstrate a relationship between the BDNF level and LDAEP in Asian depressive patients. Intriguingly, the high-BDNF subgroup (divided according to illness severity) exhibited a more severe psychopathology on some psychometric rating scales, a finding that conflicts with previous results.	[Park, Young-Min] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Psychiat, Goyang, South Korea; [Lee, Bun-Hee] Eulji Univ, Gangnam Eulji Hosp, Dept Psychiat, Seoul, South Korea; [Um, Tae Hyun; Kim, Sollip] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Lab Med, Goyang, South Korea	Inje University; Eulji University; Inje University	Park, YM (corresponding author), Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Psychiat, Goyang, South Korea.	medipark@hanmail.net	Kim, Sollip/AAB-5748-2022; Kim, Sollip/E-8546-2011	Kim, Sollip/0000-0003-0474-5897; Kim, Sollip/0000-0003-0474-5897	National Research Foundation of Korea (NRF); Ministry of Education and Science Technology (MEST) [2011-0010562]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education and Science Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by a grant from the National Research Foundation of Korea (NRF), funded by the Ministry of Education and Science Technology (MEST) (no. 2011-0010562). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Blais M, 2010, CURR CLIN PSYCHIAT, P1, DOI 10.1007/978-1-59745-387-5_1; Brocke B, 2000, NEUROPSYCHOBIOLOGY, V41, P24, DOI 10.1159/000026629; Chung Y, 1997, KOREAN J CLIN PSYCHO, V16, P117; Dias BG, 2003, NEUROPHARMACOLOGY, V45, P553, DOI 10.1016/S0028-3908(03)00198-9; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Eisch AJ, 2003, BIOL PSYCHIAT, V54, P994, DOI 10.1016/j.biopsych.2003.08.003; Fitzgerald PB, 2009, J AFFECT DISORDERS, V117, P212, DOI 10.1016/j.jad.2009.01.009; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Fujimura H, 2002, THROMB HAEMOSTASIS, V87, P728; Gallinat J, 2000, PSYCHOPHARMACOLOGY, V148, P404, DOI 10.1007/s002130050070; Groves JO, 2007, MOL PSYCHIATR, V12, P1079, DOI 10.1038/sj.mp.4002075; Gudlowski Y, 2009, SCHIZOPHR RES, V109, P141, DOI 10.1016/j.schres.2009.02.008; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HEGERL U, 1993, BIOL PSYCHIAT, V33, P173, DOI 10.1016/0006-3223(93)90137-3; Hegerl U, 2001, J AFFECT DISORDERS, V62, P93, DOI 10.1016/S0165-0327(00)00353-0; Hensch T, 2007, J AFFECT DISORDERS, V101, P13, DOI 10.1016/j.jad.2006.11.018; Jaworska N, 2013, PROG NEURO-PSYCHOPH, V44, P100, DOI 10.1016/j.pnpbp.2013.01.012; Juckel G, 2003, SCHIZOPHR RES, V64, P115, DOI 10.1016/S0920-9964(03)00016-1; Juckel G, 2008, PSYCHIAT RES, V158, P79, DOI 10.1016/j.psychres.2007.08.013; Juckel G, 2007, J CLIN PSYCHIAT, V68, P1206, DOI 10.4088/JCP.v68n0806; Juckel G, 2010, J PSYCHIATR RES, V44, P541, DOI 10.1016/j.jpsychires.2009.11.006; Kim DH, 2013, J AFFECT DISORDERS, V148, P72, DOI 10.1016/j.jad.2012.11.051; Kim YK, 2007, PROG NEURO-PSYCHOPH, V31, P78, DOI 10.1016/j.pnpbp.2006.06.024; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Lang UE, 2005, NEUROPSYCHOPHARMACOL, V30, P1148, DOI 10.1038/sj.npp.1300666; Lee BH, 2007, J AFFECT DISORDERS, V101, P239, DOI 10.1016/j.jad.2006.11.005; Lee BH, 2010, PSYCHIAT INVEST, V7, P231, DOI 10.4306/pi.2010.7.4.231; Lee BH, 2009, PROG NEURO-PSYCHOPH, V33, P849, DOI 10.1016/j.pnpbp.2009.04.002; Lee KS, 2012, PSYCHIAT INVEST, V9, P298, DOI 10.4306/pi.2012.9.3.298; Linka T, 2005, PHARMACOPSYCHIATRY, V38, P139, DOI 10.1055/s-2005-864126; Linka T, 2004, NEUROSCI LETT, V367, P375, DOI 10.1016/j.neulet.2004.06.038; Linka T, 2007, J AFFECT DISORDERS, V103, P139, DOI 10.1016/j.jad.2007.01.018; Linka T, 2009, NEUROSCI LETT, V463, P26, DOI 10.1016/j.neulet.2009.07.038; MAIER W, 1988, J AFFECT DISORDERS, V14, P61, DOI 10.1016/0165-0327(88)90072-9; Mamounas LA, 2000, J NEUROSCI, V20, P771, DOI 10.1523/JNEUROSCI.20-02-00771.2000; Mamounas LA, 1995, J NEUROSCI, V15, P7929; Mann JJ, 1998, NAT MED, V4, P25, DOI 10.1038/nm0198-025; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Miro X, 2002, NEUROPHARMACOLOGY, V43, P1148, DOI 10.1016/S0028-3908(02)00220-4; Mulert C, 2002, CLIN NEUROPHYSIOL, V113, P1566, DOI 10.1016/S1388-2457(02)00252-3; Mulert C, 2007, J AFFECT DISORDERS, V98, P215, DOI 10.1016/j.jad.2006.07.021; O'Neill BV, 2008, HUM PSYCHOPHARM CLIN, V23, P355, DOI 10.1002/hup.940; Papakostas GI, 2013, MOL PSYCHIATR, V18, P332, DOI 10.1038/mp.2011.166; Park G.B., 1991, KOREAN J CLIN PSYCHO, V10, P298; Park YM, 2013, PSYCHIAT INVEST, V10, P233, DOI 10.4306/pi.2013.10.3.233; Park YM, 2013, PSYCHIAT INVEST, V10, P143, DOI 10.4306/pi.2013.10.2.143; Park YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060340; Park YM, 2012, PSYCHIAT INVEST, V9, P80, DOI 10.4306/pi.2012.9.1.80; Park YM, 2011, PSYCHOPHARMACOLOGY, V213, P625, DOI 10.1007/s00213-010-2061-y; Park YM, 2010, PROG NEURO-PSYCHOPH, V34, P313, DOI 10.1016/j.pnpbp.2009.12.004; 이중서, 2005, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V44, P456; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; PliegoRivero FB, 1997, BIOCHEM PHARMACOL, V54, P207, DOI 10.1016/S0006-2952(97)00073-7; Radka SF, 1996, BRAIN RES, V709, P122, DOI 10.1016/0006-8993(95)01321-0; Rothman SM, 2013, NEUROSCIENCE, V239, P228, DOI 10.1016/j.neuroscience.2012.10.014; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Shin MS, 1990, KOREAN J CLIN PSYCHO, V9, P1; Strobel A, 2003, AM J MED GENET B, V118B, P41, DOI 10.1002/ajmg.b.10019; Zarate C, 2013, ANN NY ACAD SCI, V1292, P21, DOI 10.1111/nyas.12223; Zarate CA, 2013, BIOL PSYCHIAT, V73, P1142, DOI 10.1016/j.biopsych.2012.11.031	64	24	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91061	10.1371/journal.pone.0091061	http://dx.doi.org/10.1371/journal.pone.0091061			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663244	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900012
J	Rudrabhatla, P; Utreras, E; Jaffe, H; Kulkarni, AB				Rudrabhatla, Parvathi; Utreras, Elias; Jaffe, Howard; Kulkarni, Ashok B.			Regulation of Sox6 by Cyclin Dependent Kinase 5 in Brain	PLOS ONE			English	Article							APOPTOTIC CELL-DEATH; PROTEIN-KINASE; OLIGODENDROCYTE DIFFERENTIATION; NERVOUS-SYSTEM; CDK5; MOUSE; GENE; EXPRESSION; SURVIVAL; P35	Cyclin dependent kinase 5 (Cdk5) is a proline-directed Ser/Thr kinase involved in various biological functions during normal brain development and neurodegeneration. In brain, Cdk5 activity is specific to post-mitotic neurons, due to neuronal specific expression of its activator p35. The biological functions of Cdk5 have been ascribed to its cytoplasmic substrates, however not much is known in nucleus. Here, we show that nuclear transcription factor Sox6 is a direct nuclear target of Cdk5. Sox6 is expressed in Tuj1 positive neurons, suggesting that Sox6 is expressed in differentiating neurons. The expression of Sox6 is high in mitotic nuclei during embryonic day 12 (E12) and gradually decreases during development into adult. On the other hand, Cdk5 expression gradually increases during its development. We show that Sox6 is expressed in mitotic nuclei in embryonic day 12 (E12) and in migrating neurons of E16. Sox6 is phosphorylated in vivo. Sox6 was detected by phospho-Ser/Thr and phospho-Ser/Thr-Pro and MPM-2 (Mitotic protein # 2) antibodies in brain. Furthermore, calf intestinal alkaline phosphatase (CIAP) digestion resulted in faster migration of Sox6 band. The GST-Sox6 was phosphorylated by Cdk5/p35. The mass spectrometry analysis revealed that Sox6 is phosphorylated at T 119 PER motif. We show that Sox6 steady state levels are regulated by Cdk5. Cdk5 knockout mice die in utero and Sox6 protein expression is remarkably high in Cdk52/2 brain, however, there is no change in mRNA expression, suggesting a post-translational regulation of Sox6 by Cdk5. Transfection of primary cortical neurons with WT Cdk5 reduced Sox6 levels, while dominant negative (DN) Cdk5 and p35 increased Sox6 levels. Thus, our results indicate that Cdk5 regulates Sox6 steady state protein level that has an important role in brain development and function.	[Rudrabhatla, Parvathi] NINDS, Neurochem Lab, NIH, Bethesda, MD 20892 USA; [Rudrabhatla, Parvathi] NINDS, Neurobiol Lab, NIH, Bethesda, MD 20892 USA; [Jaffe, Howard] NINDS, Prot Peptide Sequencing Facil, NIH, Bethesda, MD 20892 USA; [Utreras, Elias; Kulkarni, Ashok B.] Natl Inst Dent & Craniofacial Res, Funct Genom Sect, Lab Cell & Dev Biol, NIH, Bethesda, MD USA; [Utreras, Elias] Univ Chile, Biol Dept, Fac Sci, Santiago, Chile	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Universidad de Chile	Rudrabhatla, P (corresponding author), NINDS, Neurochem Lab, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	parvathir@ninds.nih.gov	Utreras, Elias/I-1038-2013	Utreras, Elias/0000-0002-1004-0466; Rudrabhatla, Parvathi/0000-0002-7537-3130	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000664] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ahuja HS, 1997, DEV GENET, V21, P258, DOI 10.1002/(SICI)1520-6408(1997)21:4<258::AID-DVG3>3.0.CO;2-6; Alvarez A, 1999, FEBS LETT, V459, P421, DOI 10.1016/S0014-5793(99)01279-X; Azim E, 2009, NAT NEUROSCI, V12, P1238, DOI 10.1038/nn.2387; Batista-Brito R, 2009, NEURON, V63, P466, DOI 10.1016/j.neuron.2009.08.005; CONNOR F, 1995, NUCLEIC ACIDS RES, V23, P3365, DOI 10.1093/nar/23.17.3365; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Dumitriu B, 2006, BLOOD, V108, P1198, DOI 10.1182/blood-2006-02-004184; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Grant P, 2001, EUR J BIOCHEM, V268, P1534, DOI 10.1046/j.1432-1033.2001.02025.x; Hagiwara N, 2000, P NATL ACAD SCI USA, V97, P4180, DOI 10.1073/pnas.97.8.4180; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; Hirasawa M, 2004, P NATL ACAD SCI USA, V101, P6249, DOI 10.1073/pnas.0307322101; Ino H, 1996, BRAIN RES, V732, P179, DOI 10.1016/0006-8993(96)00523-9; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Ko J, 2001, J NEUROSCI, V21, P6758; Lai T, 2008, NEURON, V57, P232, DOI 10.1016/j.neuron.2007.12.023; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Liu YZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006827; Maccioni RB, 2001, EUR J BIOCHEM, V268, P1518, DOI 10.1046/j.1432-1327.2001.02024.x; Ohshima T, 2001, P NATL ACAD SCI USA, V98, P2764, DOI 10.1073/pnas.051628498; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Rudrabhatla P, 2010, FASEB J, V24, P4396, DOI 10.1096/fj.10-157859; Rudrabhatla P, 2009, J NEUROSCI, V29, P14869, DOI 10.1523/JNEUROSCI.4469-09.2009; Rudrabhatla P, 2008, J BIOL CHEM, V283, P26737, DOI 10.1074/jbc.M801633200; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stone K. L., 1993, PRACTICAL GUIDE PROT, P43; TAKAMATSU N, 1995, MOL CELL BIOL, V15, P3759; Tanaka T, 2001, J NEUROSCI, V21, P550, DOI 10.1523/JNEUROSCI.21-02-00550.2001; TSAI LH, 1993, DEVELOPMENT, V119, P1029; Ueda R, 2004, ONCOGENE, V23, P1420, DOI 10.1038/sj.onc.1207252; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Wu J, 2007, J PROTEOME RES, V6, P4684, DOI 10.1021/pr070481m; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Zhang J, 2008, P NATL ACAD SCI USA, V105, P8772, DOI 10.1073/pnas.0711355105; Zhang Q, 1997, DEV BIOL, V183, P222, DOI 10.1006/dbio.1996.8494; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018	41	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e89310	10.1371/journal.pone.0089310	http://dx.doi.org/10.1371/journal.pone.0089310			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662752	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900003
J	Kim, KM; Choi, YJ; Hwang, JH; Kim, AR; Cho, HJ; Hwang, ES; Park, JY; Lee, SH; Hong, JH				Kim, Kyung Min; Choi, Yoon Jung; Hwang, Jun-Ha; Kim, A. Rum; Cho, Hang Jun; Hwang, Eun Sook; Park, Joong Yull; Lee, Sang-Hoon; Hong, Jeong-Ho			Shear Stress Induced by an Interstitial Level of Slow Flow Increases the Osteogenic Differentiation of Mesenchymal Stem Cells through TAZ Activation	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; TRANSCRIPTIONAL COACTIVATOR; BONE; YAP; MECHANOTRANSDUCTION; ADIPOGENESIS; TRANSITION; INTERACTS; ENHANCER; CULTURE	Shear stress activates cellular signaling involved in cellular proliferation, differentiation, and migration. However, the mechanisms of mesenchymal stem cell (MSC) differentiation under interstitial flow are not fully understood. Here, we show the increased osteogenic differentiation of MSCs under exposure to constant, extremely low shear stress created by osmotic pressure-induced flow in a microfluidic chip. The interstitial level of shear stress in the proposed microfluidic system stimulated nuclear localization of TAZ (transcriptional coactivator with PDZ-binding motif), a transcriptional modulator of MSCs, activated TAZ target genes such as CTGF and Cyr61, and induced osteogenic differentiation. TAZ-depleted cells showed defects in shear stress-induced osteogenic differentiation. In shear stress induced cellular signaling, Rho signaling pathway was important forthe nuclear localization of TAZ. Taken together, these results suggest that TAZ is an important mediator of interstitial flow-driven shear stress signaling in osteoblast differentiation of MSCs.	[Kim, Kyung Min; Hwang, Jun-Ha; Kim, A. Rum; Cho, Hang Jun; Hong, Jeong-Ho] Korea Univ, Div Life Sci, Seoul, South Korea; [Choi, Yoon Jung; Lee, Sang-Hoon] Korea Univ, Dept Biomed Engn, Seoul, South Korea; [Hwang, Eun Sook] Ewha Womans Univ, Coll Pharm, Seoul, South Korea; [Hwang, Eun Sook] Ewha Womans Univ, Global Top5 Res Program, Seoul, South Korea; [Park, Joong Yull] Chung Ang Univ, Coll Engn, Sch Mech Engn, Seoul 156756, South Korea	Korea University; Korea University; Ewha Womans University; Ewha Womans University; Chung Ang University	Lee, SH (corresponding author), Korea Univ, Dept Biomed Engn, Seoul, South Korea.	dbiomed@korea.ac.kr; jh_hong@korea.ac.kr	Park, Joong Yull/L-4969-2018		Industrial Core Technology Development Program; Ministry of Knowledge Economy [10041913]; Korea Healthcare Technology R&D project, Ministry for Health & Welfare, Republic of Korea [A120349, A120476]; NRF; Ministry of Education, Science and Technology, Republic of Korea [2012R1A1A1015181]	Industrial Core Technology Development Program; Ministry of Knowledge Economy(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Korea Healthcare Technology R&D project, Ministry for Health & Welfare, Republic of Korea; NRF; Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Industrial Core Technology Development Program funded by the Ministry of Knowledge Economy (No. 10041913) and a grant from the Korea Healthcare Technology R&D project, Ministry for Health & Welfare (A120349 & A120476), Republic of Korea. J. Y. P. is supported by the Basic Science Research Program through the NRF funded by the Ministry of Education, Science and Technology, Republic of Korea (2012R1A1A1015181). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Case N, 2010, J ORTHOP RES, V28, P1531, DOI 10.1002/jor.21156; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; David V, 2007, ENDOCRINOLOGY, V148, P2553, DOI 10.1210/en.2006-1704; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Estes BT, 2004, CURR TOP DEV BIOL, V60, P91; Halder A, 2000, CLIN BIOMECH, V15, P456, DOI 10.1016/S0268-0033(99)00095-9; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; HILLSLEY MV, 1994, BIOTECHNOL BIOENG, V43, P573, DOI 10.1002/bit.260430706; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Huang Y, 2010, ARCH MED RES, V41, P497, DOI 10.1016/j.arcmed.2010.10.002; Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005; Jeong H, 2010, FASEB J, V24, P3310, DOI 10.1096/fj.09-151324; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Mammoto A, 2012, J CELL SCI, V125, P3061, DOI 10.1242/jcs.093005; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Murakami M, 2006, BIOCHEM BIOPH RES CO, V339, P533, DOI 10.1016/j.bbrc.2005.10.214; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Park JY, 2007, LAB CHIP, V7, P1673, DOI 10.1039/b710777c; Park JY, 2009, STEM CELLS, V27, P2646, DOI 10.1002/stem.202; Park KS, 2004, J BIOL CHEM, V279, P17384, DOI 10.1074/jbc.M312569200; Rutkowski JM, 2007, TRENDS CELL BIOL, V17, P44, DOI 10.1016/j.tcb.2006.11.007; Sen B, 2008, ENDOCRINOLOGY, V149, P6065, DOI 10.1210/en.2008-0687; Sen B, 2011, J BIOMECH, V44, P593, DOI 10.1016/j.jbiomech.2010.11.022; Shieh AC, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015012; Swartz MA, 2007, ANNU REV BIOMED ENG, V9, P229, DOI 10.1146/annurev.bioeng.9.060906.151850; Tada S, 2000, AM J PHYSIOL-HEART C, V278, pH1589, DOI 10.1152/ajpheart.2000.278.5.H1589; Thompson WR, 2012, GENE, V503, P179, DOI 10.1016/j.gene.2012.04.076; van der Pol L, 1998, TRENDS BIOTECHNOL, V16, P323, DOI 10.1016/S0167-7799(98)01209-8; Vanapalli SA, 2009, BIOMICROFLUIDICS, V3, DOI 10.1063/1.3067820; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; WANG DM, 1995, J BIOMECH ENG-T ASME, V117, P358, DOI 10.1115/1.2794192; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; YEDGAR S, 1986, LIPIDS, V21, P629, DOI 10.1007/BF02537211; Yourek G, 2010, REGEN MED, V5, P713, DOI 10.2217/RME.10.60; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200	41	119	122	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92427	10.1371/journal.pone.0092427	http://dx.doi.org/10.1371/journal.pone.0092427			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658423	gold, Green Published, Green Submitted			2022-12-27	WOS:000333355300081
J	Li, J; Han, YP; Xing, YP; Li, S; Kong, LH; Zhang, YX; Zhang, LL; Liu, N; Wang, Q; Wang, SX; Lu, S; Huang, ZH				Li, Jun; Han, Yaping; Xing, Yiping; Li, Shuang; Kong, Lianhua; Zhang, Yongxiang; Zhang, Lili; Liu, Ning; Wang, Qian; Wang, Shixia; Lu, Shan; Huang, Zuhu			Concurrent Measurement of Dynamic Changes in Viral Load, Serum Enzymes, T Cell Subsets, and Cytokines in Patients with Severe Fever with Thrombocytopenia Syndrome	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; BUNYAVIRUS; CHINA; STORM	Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infection caused by a novel Bunyavirus. Analysis on the dynamic changes of clinical, laboratory, and immunological abnormalities associated with SFTS in a concurrent study is lacking. Thirty-three SFTS patients were admitted to Jiangsu People's Hospital, Nanjing, China, and diagnosis was made based on the clinical symptoms and positive viral RNA detected by RT-PCR. Four patients deceased and twenty-nine survived. Blood samples were collected every other day between Day 5 and Day 15 from the onset of fever. Samples from healthy volunteers were used as normal controls. Peak viral RNA load, serum enzymes, IL-6, and IL-10 were significantly higher in deceased patients compared to survivors. Viral load, serum enzymes, and cytokines declined in survivors within 2 weeks from onset of fever. CD69+ T cells were elevated early after infection while HLA-DR+ and CTLA4+ T cells were elevated during the recovery phase of those who survived. High level SFTSV viral load was concurrently observed with reduced PLT, elevated serum enzymes, elevated pro-inflammatory and anti-inflammatory cytokines, and activation of CD69+ T cells. The degree and pattern of changes in these parameters may indicate the clinical outcome in SFTSV-infected patients.	[Li, Jun; Han, Yaping; Xing, Yiping; Li, Shuang; Kong, Lianhua; Zhang, Yongxiang; Zhang, Lili; Liu, Ning; Wang, Qian; Huang, Zuhu] Nanjing Med Univ, Affiliated Hosp 1, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China; [Li, Jun; Wang, Shixia; Lu, Shan] Nanjing Med Univ, Affiliated Hosp 1, China US Vaccine Res Ctr, Nanjing, Jiangsu, Peoples R China; [Wang, Shixia; Lu, Shan] Univ Massachusetts, Sch Med, Dept Med, Lab Nucle Acid Vaccines, Worcester, MA USA	Nanjing Medical University; Nanjing Medical University; University of Massachusetts System; University of Massachusetts Worcester	Li, J (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China.	dr-lijun@vip.sina.com; shan.lu@umassmed.edu			Ministry of Science and Technology; Ministry of Health (China Mega-Project for Infectious Diseases Grants) [2013ZX10004905, 2013ZX10002005-002-005]; Jiangsu Province Science and Technology Support Project [BE2012770]; Jiangsu Innovation of Medical Team and Leading Talents [LJ201121]; Priority Academic Program Development of Jiangsu Higher Education Institutions [JX10231801]; National Institutes of Health National Institute of Allergy and Infectious Disease Grant [U01-AI078073]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI078073] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health (China Mega-Project for Infectious Diseases Grants); Jiangsu Province Science and Technology Support Project; Jiangsu Innovation of Medical Team and Leading Talents; Priority Academic Program Development of Jiangsu Higher Education Institutions; National Institutes of Health National Institute of Allergy and Infectious Disease Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by from the Ministry of Science and Technology and the Ministry of Health (China Mega-Project for Infectious Diseases Grants: 2013ZX10004905 and 2013ZX10002005-002-005), Jiangsu Province Science and Technology Support Project (BE2012770), Jiangsu Innovation of Medical Team and Leading Talents (LJ201121), the Priority Academic Program Development of Jiangsu Higher Education Institutions (JX10231801), and National Institutes of Health National Institute of Allergy and Infectious Disease Grant (U01-AI078073 to S.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao CJ, 2011, CLIN INFECT DIS, V53, P1208, DOI 10.1093/cid/cir732; CDC, 2009, INT GUID CLIN ID CAR; Deng BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080802; Deng BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041365; Haque A, 2007, EMERG INFECT DIS, V13, P1512, DOI 10.3201/eid1310.061262; Huang KJ, 2005, J MED VIROL, V75, P185, DOI 10.1002/jmv.20255; Li DX, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.1; Li SB, 2011, BIOSCI TRENDS, V5, P273, DOI 10.5582/bst.2011.v5.6.273; Liu Y, 2012, VECTOR-BORNE ZOONOT, V12, P156, DOI 10.1089/vbz.2011.0758; Ministry of Health People's Republic of China, 2010, NAT GUID PREV CONTR; Sun L, 2013, CLIN EXP MED; Sun YL, 2012, J INFECT DIS, V206, P1085, DOI 10.1093/infdis/jis452; Sun YL, 2012, J CLIN VIROL, V53, P48, DOI 10.1016/j.jcv.2011.09.031; Weng Y, 2013, BRAZ J INFECT DIS; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang XS, 2013, SCI CHINA LIFE SCI, V56, P697, DOI 10.1007/s11427-013-4518-9; Zhang YZ, 2012, CLIN INFECT DIS, V54, P527, DOI 10.1093/cid/cir804; Zhang Yong-Zhen, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P209	19	28	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91679	10.1371/journal.pone.0091679	http://dx.doi.org/10.1371/journal.pone.0091679			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658451	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300039
J	Bonnegarde-Bernard, A; Jee, J; Fial, MJ; Steiner, H; DiBartola, S; Davis, IC; Cormet-Boyaka, E; Tome, D; Boyaka, PN				Bonnegarde-Bernard, Astrid; Jee, Junbae; Fial, Michael J.; Steiner, Haley; DiBartola, Stephanie; Davis, Ian C.; Cormet-Boyaka, Estelle; Tome, Daniel; Boyaka, Prosper N.			Routes of Allergic Sensitization and Myeloid Cell IKK beta Differentially Regulate Antibody Responses and Allergic Airway Inflammation in Male and Female Mice	PLOS ONE			English	Article							NF-KAPPA-B; SEX-DIFFERENCES; IMMUNE-RESPONSES; MURINE MODEL; MOUSE MODEL; T-CELLS; GENDER; ASTHMA; DISEASE; LUNG	Gender influences the incidence and/or the severity of several diseases and evidence suggests a higher rate of allergy and asthma among women. Most experimental models of allergy use mice sensitized via the parenteral route despite the fact that the mucosal tissues of the gastrointestinal and respiratory tracts are major sites of allergic sensitization and/or allergic responses. We analyzed allergen-specific Ab responses in mice sensitized either by gavage or intraperitoneal injection of ovalbumin together with cholera toxin as adjuvant, as well as allergic inflammation and lung functions following subsequent nasal challenge with the allergen. Female mice sensitized intraperitoneally exhibited higher levels of serum IgE than their male counterparts. After nasal allergen challenge, these female mice expressed higher Th2 responses and associated inflammation in the lung than males. On the other hand, male and female mice sensitized orally developed the same levels of allergen-specific Ab responses and similar levels of lung inflammation after allergen challenge. Interestingly, the difference in allergen-specific Ab responses between male and female mice sensitized by the intraperitoneal route was abolished in IKK beta(Delta Mye) mice, which lack IKK beta in myeloid cells. In summary, the oral or systemic route of allergic sensitization and IKK beta signaling in myeloid cells regulate how the gender influences allergen-specific responses and lung allergic inflammation.	[Bonnegarde-Bernard, Astrid; Jee, Junbae; Fial, Michael J.; Steiner, Haley; DiBartola, Stephanie; Davis, Ian C.; Cormet-Boyaka, Estelle; Boyaka, Prosper N.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Bonnegarde-Bernard, Astrid; Tome, Daniel] AgroParisTech, Human Nutr Lab, Paris, France; [Boyaka, Prosper N.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA	Ohio State University; AgroParisTech; Ohio State University	Boyaka, PN (corresponding author), Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA.	boyaka.1@osu.edu	Cormet-Boyaka, Estelle/H-5624-2011	Boyaka, Prosper/0000-0001-6857-9088	National Institutes of Health [R01 AI043197]; OSU Food Innovation Center; Fondation Lelous, France; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OSU Food Innovation Center; Fondation Lelous, France; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Studies were supported by grants from the National Institutes of Health (R01 AI043197) and the OSU Food Innovation Center (to PNB). ABB was the recipient of a fellowship from Fondation Lelous, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2004, J APPL PHYSIOL, V97, P286, DOI 10.1152/japplphysiol.00821.2003; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Beery Theresa A, 2003, Crit Care Nurs Clin North Am, V15, P55, DOI 10.1016/S0899-5885(02)00028-X; Bonnegarde-Bernard A, 2013, MUCOSAL IMMUNOL; Card JW, 2006, J IMMUNOL, V177, P621, DOI 10.4049/jimmunol.177.1.621; Carey MA, 2007, AM J PHYSIOL-LUNG C, V293, pL272, DOI 10.1152/ajplung.00174.2007; Corteling Randolph, 2004, BMC Pharmacology, V4, P4, DOI 10.1186/1471-2210-4-4; Fagan JK, 2001, ANN ALLERG ASTHMA IM, V86, P177, DOI 10.1016/S1081-1206(10)62688-9; Fischer R, 2005, AM J PATHOL, V167, P1621, DOI 10.1016/S0002-9440(10)61246-1; Ganeshan K, 2009, J ALLERGY CLIN IMMUN, V123, P231, DOI 10.1016/j.jaci.2008.10.011; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Gueders MM, 2009, INFLAMM RES, V58, P845, DOI 10.1007/s00011-009-0054-2; Hansen JS, 2011, SCAND J IMMUNOL, V73, P554, DOI 10.1111/j.1365-3083.2011.02529.x; Huvenne W, 2010, CLIN EXP ALLERGY, V40, P1079, DOI 10.1111/j.1365-2222.2010.03464.x; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; MARINARO M, 1995, J IMMUNOL, V155, P4621; MASSARO GD, 1995, P NATL ACAD SCI USA, V92, P1105, DOI 10.1073/pnas.92.4.1105; Melgert BN, 2005, CLIN EXP ALLERGY, V35, P1496, DOI 10.1111/j.1365-2222.2005.02362.x; Mine Y, 2007, BBA-PROTEINS PROTEOM, V1774, P200, DOI 10.1016/j.bbapap.2006.12.003; O'Connor MF, 2007, AM J PHYSIOL-REG I, V293, pR145, DOI 10.1152/ajpregu.00752.2006; Oyoshi MK, 2011, J CLIN INVEST, V121, P2210, DOI 10.1172/JCI43586; Reinhard C, 2002, MAMM GENOME, V13, P429, DOI 10.1007/s00335-002-3005-6; Repa A, 2004, CLIN EXP IMMUNOL, V137, P12, DOI 10.1111/j.1365-2249.2004.02519.x; Rhodes L, 2005, J ASTHMA, V42, P777, DOI 10.1080/02770900500308387; Seymour Brian W P, 2002, Dev Immunol, V9, P47, DOI 10.1080/1044667021000003989; Takeda M, 2013, RESPIROLOGY, V18, P797, DOI 10.1111/resp.12078; Tedeschi SK, 2013, CLIN IMMUNOL; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vancza EM, 2009, TOXICOL SCI, V107, P535, DOI 10.1093/toxsci/kfn253; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; WillsKarp M, 1997, AM J RESP CRIT CARE, V156, pS89, DOI 10.1164/ajrccm.156.4.12-tac-3; Zosky GR, 2009, AM J PHYSIOL-LUNG C, V297, pL373, DOI 10.1152/ajplung.00053.2009	32	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92307	10.1371/journal.pone.0092307	http://dx.doi.org/10.1371/journal.pone.0092307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667561	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600031
J	Fu, D; Tan, P; Kuznetsov, A; Molkov, YI				Fu, Daniel; Tan, Patrick; Kuznetsov, Alexey; Molkov, Yaroslav I.			Chaos and Robustness in a Single Family of Genetic Oscillatory Networks	PLOS ONE			English	Article							TEMPERATURE INDEPENDENCE; TOGGLE SWITCH; TIME; MECHANISM; DYNAMICS; CLOCK; DELAY; MODEL	Genetic oscillatory networks can be mathematically modeled with delay differential equations (DDEs). Interpreting genetic networks with DDEs gives a more intuitive understanding from a biological standpoint. However, it presents a problem mathematically, for DDEs are by construction infinitely-dimensional and thus cannot be analyzed using methods common for systems of ordinary differential equations (ODEs). In our study, we address this problem by developing a method for reducing infinitely-dimensional DDEs to two-and three-dimensional systems of ODEs. We find that the three-dimensional reductions provide qualitative improvements over the two-dimensional reductions. We find that the reducibility of a DDE corresponds to its robustness. For non-robust DDEs that exhibit high-dimensional dynamics, we calculate analytic dimension lines to predict the dependence of the DDEs' correlation dimension on parameters. From these lines, we deduce that the correlation dimension of non-robust DDEs grows linearly with the delay. On the other hand, for robust DDEs, we find that the period of oscillation grows linearly with delay. We find that DDEs with exclusively negative feedback are robust, whereas DDEs with feedback that changes its sign are not robust. We find that non-saturable degradation damps oscillations and narrows the range of parameter values for which oscillations exist. Finally, we deduce that natural genetic oscillators with highly-regular periods likely have solely negative feedback.	[Fu, Daniel] Pk Tudor Sch, Dept Math, Indianapolis, IN 46240 USA; [Tan, Patrick] Carmel High Sch, Dept Math, Carmel, IN USA; [Kuznetsov, Alexey; Molkov, Yaroslav I.] Indiana Univ Purdue Univ, Dept Math Sci, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Fu, D (corresponding author), Pk Tudor Sch, Dept Math, Indianapolis, IN 46240 USA.	danielyfu@hotmail.com	Kuznetsov, Alexey/L-1128-2017; Molkov, Yaroslav/C-6336-2012	Molkov, Yaroslav/0000-0002-0862-1974; Fu, Daniel/0000-0002-2500-2577	Indiana University Research Support Funds	Indiana University Research Support Funds	AK acknowledges financial support from the Indiana University Research Support Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz A., 1972, HDB MATH FUNCTIONS F; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; HASTINGS JW, 1957, P NATL ACAD SCI USA, V43, P804, DOI 10.1073/pnas.43.9.804; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hasty J, 2001, CHAOS, V11, P207, DOI 10.1063/1.1345702; Hegger R, 1999, CHAOS, V9, P413, DOI 10.1063/1.166424; Kaern M, 2001, FARADAY DISCUSS, V120, P295, DOI 10.1039/b103244p; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; MACKEY MC, 1977, SCIENCE, V197, P287, DOI 10.1126/science.267326; Martin A, 2001, J MATH BIOL, V43, P247, DOI 10.1007/s002850100095; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Nurse P, 2000, CELL, V100, P71, DOI 10.1016/S0092-8674(00)81684-0; PITTENDRIGH CS, 1954, P NATL ACAD SCI USA, V40, P1018, DOI 10.1073/pnas.40.10.1018; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Purcell O, 2010, J R SOC INTERFACE, V7, P1503, DOI 10.1098/rsif.2010.0183; Raghothama A, 2002, NONLINEAR DYNAM, V27, P341, DOI 10.1023/A:1015207726565; Smolen P, 2002, BIOPHYS J, V83, P2349, DOI 10.1016/S0006-3495(02)75249-1; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; THEILER J, 1990, J OPT SOC AM A, V7, P1055, DOI 10.1364/JOSAA.7.001055; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Tsaneva-Atanasova K, 2006, BIOPHYS J, V90, P3434, DOI 10.1529/biophysj.105.078360; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6	30	4	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e90666	10.1371/journal.pone.0090666	http://dx.doi.org/10.1371/journal.pone.0090666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667178	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600002
J	Joldybayeva, B; Prorok, P; Grin, IR; Zharkov, DO; Ishenko, AA; Tudek, B; Bissenbaev, AK; Saparbaev, M				Joldybayeva, Botagoz; Prorok, Paulina; Grin, Inga R.; Zharkov, Dmitry O.; Ishenko, Alexander A.; Tudek, Barbara; Bissenbaev, Amangeldy K.; Saparbaev, Murat			Cloning and Characterization of a Wheat Homologue of Apurinic/Apyrimidinic Endonuclease Ape1L	PLOS ONE			English	Article							ACTIVE DNA DEMETHYLATION; BASE EXCISION-REPAIR; STRUCTURAL CHEMISTRY; METAL SITES; DAMAGE; NUCLEOTIDE; PATHWAY; PURIFICATION; RECOGNITION; GLYCOSYLASE	Background: Apurinic/apyrimidinic (AP) endonucleases are key DNA repair enzymes involved in the base excision repair (BER) pathway. In BER, an AP endonuclease cleaves DNA at AP sites and 39-blocking moieties generated by DNA glycosylases and/or oxidative damage. A Triticum aestivum cDNA encoding for a putative homologue of ExoIII family AP endonucleases which includes E. coli Xth, human APE1 and Arabidopsis thaliana AtApe1L has been isolated and its protein product purified and characterized. Methodology/Principal Findings: We report that the putative wheat AP endonuclease, referred here as TaApe1L, contains AP endonuclease, 3'-repair phosphodiesterase, 3'-phosphatase and 3'-> 5' exonuclease activities. Surprisingly, in contrast to bacterial and human AP endonucleases, addition of Mg2+ and Ca2+ (5-10 mM) to the reaction mixture inhibited TaApe1L whereas the presence of Mn2+, Co2+ and Fe2+ cations (0.1-1.0 mM) strongly stimulated all its DNA repair activities. Optimization of the reaction conditions revealed that the wheat enzyme requires low divalent cation concentration (0.1 mM), mildly acidic pH (6-7), low ionic strength (20 mM KCl) and has a temperature optimum at around 20 degrees C. The steady-state kinetic parameters of enzymatic reactions indicate that TaApe1L removes 39-blocking sugar-phosphate and 3'-phosphate groups with good efficiency (k(cat)/K-M = 630 and 485 mu M-1.min(-1), respectively) but possesses a very weak AP endonuclease activity as compared to the human homologue, APE1. Conclusions/Significance: Taken together, these data establish the DNA substrate specificity of the wheat AP endonuclease and suggest its possible role in the repair of DNA damage generated by endogenous and environmental factors.	[Joldybayeva, Botagoz; Bissenbaev, Amangeldy K.] al Farabi Kazakh Natl Univ, Fac Biol, Dept Mol Biol & Genet, Alma Ata, Kazakhstan; [Prorok, Paulina; Grin, Inga R.; Ishenko, Alexander A.; Saparbaev, Murat] Univ Paris 11, Inst Gustave Roussy, CNRS UMR8200, Grp Reparat ADN, Villejuif, France; [Prorok, Paulina; Tudek, Barbara] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Grin, Inga R.; Zharkov, Dmitry O.] SB RAS Inst Chem Biol & Fundamental Med, Novosibirsk, Russia; [Grin, Inga R.; Zharkov, Dmitry O.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Tudek, Barbara] Univ Warsaw, Inst Genet & Biotechnol, Warsaw, Poland	Al-Farabi Kazakh National University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University; University of Warsaw	Bissenbaev, AK (corresponding author), al Farabi Kazakh Natl Univ, Fac Biol, Dept Mol Biol & Genet, Alma Ata, Kazakhstan.	Amangeldy.Bisenbaev@kaznu.kz; smurat@igr.fr	Ishchenko, Alexander/D-4133-2013; Grin, Inga/I-8188-2014; Saparbaev, Murat/AAC-5478-2020; Saparbaev, Murat K/N-3225-2015; Zharkov, Dmitry/K-2158-2012; Grin, Inga/U-8737-2019; Bissenbaev, Amangeldy/B-1767-2015	Ishchenko, Alexander/0000-0002-0488-8858; Grin, Inga/0000-0002-5685-1248; Saparbaev, Murat/0000-0002-4630-1074; Saparbaev, Murat K/0000-0002-4630-1074; Zharkov, Dmitry/0000-0001-5013-0194; Grin, Inga/0000-0002-5685-1248; Joldybayeva, Botagoz/0000-0003-1682-4947; Prorok, Paulina/0000-0002-1427-1528; Bissenbaev, Amangeldy/0000-0001-7837-8685	Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan [0145/GF, 0738GF]; Agence Nationale pour la Recherche [ANR-09-GENO-000]; Electricite de France Contract Radioprotection [RB 2013-23]; Centre National de la Recherche Scientifique [PICS N5479-Russie]; CNRS-INCA-MSHE Franco-Pologne [3037987]; Fondation de France [2012 00029161]; Polish-French collaborative grants [346/N-INCA/2008/0, 303 819540]; Russian Academy of Sciences [MKB 6.12]; Russian Foundation for Basic Research [12-04-33231-mol_a_ved]; International PhD Projects Programme of Foundation for Polish Science: "Studies of nucleic acids and proteins - from basic to applied research''; European Union - Regional Development Fund	Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Electricite de France Contract Radioprotection; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); CNRS-INCA-MSHE Franco-Pologne; Fondation de France(Fondation de France); Polish-French collaborative grants; Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); International PhD Projects Programme of Foundation for Polish Science: "Studies of nucleic acids and proteins - from basic to applied research''; European Union - Regional Development Fund	This work was supported by grants from Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan [grants No 0145/GF and No 0738GF] to A. K. B. and from Agence Nationale pour la Recherche [ANR Blanc 2010 Projet ANR-09-GENO-000 to M. S.] (http://www.agence-nationale-recherche.fr), Electricite de France (http://www.edf.fr) Contract Radioprotection [RB 2013-23 to M. S.]; Centre National de la Recherche Scientifique (http://www.cnrs.fr) [PICS N5479-Russie, and CNRS-INCA-MSHE Franco-Pologne #3037987 to M. S.] and by Fondation de France (http://www.fondationdefrance.org) [#2012 00029161 to A. A. I.] and by Polish-French collaborative grants No346/N-INCA/2008/0 and No303 819540 [to B. T.] and by Russian Academy of Sciences [MKB 6.12 to D.O.Z.]; Russian Foundation for Basic Research [12-04-33231-mol_a_ved to I. R. G.]; P. P. was supported by the fellowship from International PhD Projects Programme of Foundation for Polish Science: "Studies of nucleic acids and proteins - from basic to applied research''. The project is co-financed by European Union - Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreini C, 2013, NUCLEIC ACIDS RES, V41, pD312, DOI 10.1093/nar/gks1063; BABIYCHUK E, 1994, P NATL ACAD SCI USA, V91, P3299, DOI 10.1073/pnas.91.8.3299; Beernink PT, 2001, J MOL BIOL, V307, P1023, DOI 10.1006/jmbi.2001.4529; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bissenbaev AK, 2011, PLANT PHYSIOL BIOCH, V49, P1155, DOI 10.1016/j.plaphy.2011.07.017; BLAISDELL P, 1983, J BIOL CHEM, V258, P1603; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Cadet J, 2003, MUTAT RES-FUND MOL M, V531, P5, DOI 10.1016/j.mrfmmm.2003.09.001; Cordoba-Canero D, 2011, PLANT J, V68, P693, DOI 10.1111/j.1365-313X.2011.04720.x; Cordoba-Canero D, 2009, PLANT J, V60, P716, DOI 10.1111/j.1365-313X.2009.03994.x; Couve S, 2009, J BIOL CHEM, V284, P11963, DOI 10.1074/jbc.M900746200; CUNNINGHAM RP, 1986, J BACTERIOL, V168, P1120, DOI 10.1128/jb.168.3.1120-1127.1986; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DEMPLE B, 1986, P NATL ACAD SCI USA, V83, P7731, DOI 10.1073/pnas.83.20.7731; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Gelin A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012241; Georgiadis MM, 2008, MUTAT RES-FUND MOL M, V643, P54, DOI 10.1016/j.mrfmmm.2008.04.008; Gorman MA, 1997, EMBO J, V16, P6548, DOI 10.1093/emboj/16.21.6548; Gros L, 2004, NUCLEIC ACIDS RES, V32, P73, DOI 10.1093/nar/gkh165; He XJ, 2011, CELL RES, V21, P442, DOI 10.1038/cr.2011.23; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Hsin K, 2008, J APPL CRYSTALLOGR, V41, P963, DOI 10.1107/S002188980802476X; Martinez-Macias MI, 2012, MOL CELL, V45, P357, DOI 10.1016/j.molcel.2011.11.034; Ischenko AA, 2002, NATURE, V415, P183, DOI 10.1038/415183a; Ishchenko AA, 2005, MOL CELL BIOL, V25, P6380, DOI 10.1128/MCB.25.15.6380-6390.2005; Ishchenko AA, 2003, NUCLEIC ACIDS RES, V31, P6344, DOI 10.1093/nar/gkg812; KANE CM, 1981, J BIOL CHEM, V256, P3405; Kavli B, 2007, DNA REPAIR, V6, P505, DOI 10.1016/j.dnarep.2006.10.014; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Manvilla BA, 2013, ACTA CRYSTALLOGR D, V69, P2555, DOI 10.1107/S0907444913027042; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Murphy TM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004297; ROBSON CN, 1991, NUCLEIC ACIDS RES, V19, P1087, DOI 10.1093/nar/19.5.1087; Rogers S G, 1980, Methods Enzymol, V65, P201; Schmiedel R, 2009, DNA REPAIR, V8, P219, DOI 10.1016/j.dnarep.2008.10.009; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tsutakawa SE, 2013, J BIOL CHEM, V288, P8445, DOI 10.1074/jbc.M112.422774; Vanyushin BF, 2011, BBA-GENE REGUL MECH, V1809, P360, DOI 10.1016/j.bbagrm.2011.04.006; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Wyatt MD, 1999, BIOESSAYS, V21, P668, DOI 10.1002/(SICI)1521-1878(199908)21:8<668::AID-BIES6>3.3.CO;2-4; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	45	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92963	10.1371/journal.pone.0092963	http://dx.doi.org/10.1371/journal.pone.0092963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667595	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600109
J	Klompmaker, AA; Artal, P; van Bakel, BWM; Fraaije, RHB; Jagt, JWM				Klompmaker, Adiel A.; Artal, Pedro; van Bakel, Barry W. M.; Fraaije, Rene H. B.; Jagt, John W. M.			Parasites in the Fossil Record: A Cretaceous Fauna with Isopod-Infested Decapod Crustaceans, Infestation Patterns through Time, and a New Ichnotaxon	PLOS ONE			English	Article							CRABS CRUSTACEA; SQUAT LOBSTERS; BRACHYURA GLAESSNEROPSOIDEA; ANOMURA GALATHEOIDEA; TRACE FOSSILS; REVISION; BOPYRIDAE; GALATHEIDAE; DIVERSITY; ERNSTBRUNN	Parasites are common in modern ecosystems and are also known from the fossil record. One of the best preserved and easily recognisable examples of parasitism in the fossil record concerns isopod-induced swellings in the branchial chamber of marine decapod crustaceans. However, very limited quantitative data on the variability of infestation percentages at the species, genus, and family levels are available. Here we provide this type of data for a mid-Cretaceous (upper Lower Cretaceous, upper Albian) reef setting at Koskobilo, northern Spain, on the basis of 874 specimens of anomurans and brachyurans. Thirty-seven specimens (4.2%), arranged in ten species, are infested. Anomurans are more heavily infested than brachyurans, variability can be high within genera, and a relationship may exist between the number of specimens and infestation percentage per taxon, possibly suggesting host-specificity. We have also investigated quantitative patterns of infestation through geological time based on 88 infested species (25 anomurans, 55 brachyurans, seven lobsters, and one shrimp), to show that the highest number of infested species can be found in the Late Jurassic, also when corrected for the unequal duration of epochs. The same Late Jurassic peak is observed for the percentage of infested decapod species per epoch. This acme is caused entirely by infested anomurans and brachyurans. Biases (taphonomic and otherwise) and causes of variability with regard to the Koskobilo assemblage and infestation patterns through time are discussed. Finally, a new ichnogenus and -species, Kanthyloma crusta, are erected to accommodate such swellings or embedment structures (bioclaustrations).	[Klompmaker, Adiel A.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Klompmaker, Adiel A.] Kent State Univ, Dept Geol, Kent, OH 44242 USA; [Artal, Pedro] Museo Geol Seminario Barcelona, Barcelona, Spain; [van Bakel, Barry W. M.; Fraaije, Rene H. B.] Oertijdmuseum Groene Poort, Boxtel, Netherlands; [van Bakel, Barry W. M.] Naturalis Biodivers Ctr, Leiden, Netherlands; [Jagt, John W. M.] Nat Hist Museum Maastricht, Maastricht, Netherlands	State University System of Florida; University of Florida; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Naturalis Biodiversity Center	Klompmaker, AA (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.	adielklompmaker@gmail.com	Artal, Pablo/AGV-7547-2022; Artal, Pablo/AAG-4485-2020	Artal, Pablo/0000-0003-1284-6591; Artal, Pablo/0000-0003-1284-6591	Molengraaff Fonds; Amoco Alumni Scholarship; Graduate Student Senate (Kent State University) research grant; Sigma Gamma Epsilon (Gamma Zeta Chapter) research grant; NSF [EF-0531670]; Jon L. and Beverly A. Thompson Endowment Fund (Florida Museum of Natural History, University of Florida)	Molengraaff Fonds; Amoco Alumni Scholarship; Graduate Student Senate (Kent State University) research grant; Sigma Gamma Epsilon (Gamma Zeta Chapter) research grant; NSF(National Science Foundation (NSF)); Jon L. and Beverly A. Thompson Endowment Fund (Florida Museum of Natural History, University of Florida)	Fieldwork at Koskobilo was in part supported by the Molengraaff Fonds, an Amoco Alumni Scholarship, a Graduate Student Senate (Kent State University) research grant, and a Sigma Gamma Epsilon (Gamma Zeta Chapter) research grant to AAK, as well as an NSF grant (EF-0531670) to Feldmann and Schweitzer. This work was further supported by the Jon L. and Beverly A. Thompson Endowment Fund (Florida Museum of Natural History, University of Florida) to AAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhamid Marouf A. M., 1999, Revue de Paleobiologie, V18, P69; ABELE LG, 1976, MAR BIOL, V38, P263, DOI 10.1007/BF00388939; ALCOCK A, 1895, J ASIATIC SOC BENGAL, V64, P157, DOI DOI 10.5962/BHL.TITLE.16033; [Anonymous], 1972, ACTA GEOL POL; [Anonymous], GEOLOGICA HUNGARICA; Artal P, 2012, REV MEX CIENC GEOL, V29, P398; Baba K, 2008, ZOOTAXA, P1; BACHMAYER F., 1950, ANN NATURHIST STAATSMUS WIEN, V57, P133; Bachmayer F., 1955, Sitzungsberichte der Oesterreichischen Akademie der Wissenschaften Abt I, V164, P255; BACHMAYER F., 1955, PALAEONTOL ZEITSCHR, V29, P5; Bachmayer F., 1948, Sitzungsberichte der Oesterreichischen Akademie der Wissenschaften Wien Abt I, V157, P263; Bachmayer F, 1945, JB GEOLOGISCHEN BUND, V1945, P35; Bauer R.T., 1989, Crustacean Issues, V6, P49; BAUER R T, 1981, Journal of Crustacean Biology, V1, P153, DOI 10.2307/1548154; Baumiller Tomasz K., 2002, Paleontological Society Papers, V8, P195; Bell T., 1858, MONOGRAPH PALAEONTOG, V10, P1; Bell T., 1863, PALAEONTOGRAPHICAL S, P1, DOI DOI 10.5962/BHL.TITLE.11701; Bertling Markus, 2007, P81, DOI 10.1016/B978-044452949-7/50131-5; Bertling M, 2006, LETHAIA, V39, P265, DOI 10.1080/00241160600787890; Beschin C., 2007, MUSEO ARCHEOLOGIA SC, V2007, P9; Beurlen K., 1929, Zentralblatt fuer Mineralogie Geologie und Palaeontologie Stuttgart, V1929B, P125; BISHOP G A, 1974, Crustaceana (Leiden), V26, P212, DOI 10.1163/156854074X00578; BISHOP GA, 1983, CRUSTACEANA, V44, P23, DOI 10.1163/156854083X00028; Bittner, 1883, DENKSCHRIFTEN KAISER, V46, P299; Bittner A., 1875, DENKSCHRIFTEN KAISER, V34, P63; BLASCHKE F., 1911, ANN KAISERLICH KONIG, V25, P143; BOADA L V, 1981, Geobios (Villeurbanne), V14, P247; Bohaty J, 2012, J PALEONTOL, V86, P282, DOI 10.1666/11-007.1; Boucot A. J., 2011, FOSSIL BEHAV COMPEND; Boyko CB, 2013, SYST BIODIVERS, V11, P495, DOI 10.1080/14772000.2013.865679; Boyko CB, 2012, ZOOTAXA, P1; Boyko CB, 2011, BIOLOGY OF SQUAT LOBSTERS, P271; Boyko Christopher B., 2009, Crustacean Issues, V18, P197; Bradford-Grieve JM, 2002, HYDROBIOLOGIA, V485, P223, DOI 10.1023/A:1021373412738; Breton G, 2010, MUSEUM NATL HIST NAT, V2, P332; BRETT CE, 1985, J PALEONTOL, V59, P625; BROMLEY R. G, 1970, TRACE FOSSILS, P49; Bromley RG, 2004, GEOL SOC SPEC PUBL, V228, P455, DOI 10.1144/GSL.SP.2004.228.01.20; Bromley RG, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P361, DOI 10.1007/978-3-540-77598-0_18; BURSEY CR, 1978, B MAR SCI, V28, P566; CECCON L., 2013, LAVORI SOC VEN SCI N, V38, P83; Collins J.S.H., 1992, Gronlands Geologiske Undersogelse Bulletin, P1; Collins Joe S. H., 1995, Acta Palaeontologica Polonica, V40, P165; Combes C., 2004, PARASITISM ECOLOGY E; Console-Gonella C, 2014, LETHAIA, V47, P107, DOI 10.1111/let.12043; Dana JD, 1852, CRUSTACEA 1, V13, P1; Dana JD, 1851, P ACAD NAT SCI PHILA, V5, P247; De Angeli A., 2003, MEM SOC ITAL SCI NAT, V30, P1, DOI [10.1163/18759866-0720203006, DOI 10.1163/18759866-0720203006]; De Haan F, 1833, CRUSTACEA, p[i, i, ix, 1]; Eudes-Deslongchamps J.A., 1835, MEMOIRE SOC LINNEENN, V5, P37; Fabricius J.C., 1793, ENTOMOLOGIA SYSTEMAT, V3, P1; Feldmann R.M., 1993, PALEONTOLOGICAL SOC, V28, p[i, 1]; Feldmann RM, 1998, J PALEONTOL, V72, P493, DOI 10.1017/S0022336000024264; Feldmann Rodney M., 2009, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V111A, P183; Forster R., 1969, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V9, P45; Fraaije HB, 2013, NETH J GEOSCI, V92, P109, DOI 10.1017/S0016774600000032; Fraaije R. H. B., 2009, B SOC GEOL MEX, V61, P13, DOI DOI 10.18268/BSGM2009V61N1A2; Fraaije RHB, 2012, NEUES JAHRB GEOL P-A, V263, P85, DOI 10.1127/0077-7749/2012/0213; Frantescu Ovidiu D., 2014, Bulletin of the Mizunami Fossil Museum, V40, P13; Gatt M, 2010, PALAEONTOLOGY, V53, P1315, DOI 10.1111/j.1475-4983.2010.01008.x; Gibbes L.R, 1850, P AM ASS ADV SCI, V3, P165; GLAESSNER M F, 1980, Transactions of the Royal Society of South Australia, V104, P171; Glaessner MF, 1960, NZ GEOLOGICAL SURVEY, V31, P3; Gonzalez MT, 2004, J CRUSTACEAN BIOL, V24, P618, DOI 10.1651/C-2482; Hartnoll R.G., 1985, Crustacean Issues, V3, P101; Hartnoll R.G., 1982, P111; Hernaez P, 2010, J MAR BIOL ASSOC UK, V90, P691, DOI 10.1017/S0025315409991093; Hess H, 2010, J PALEONTOL, V84, P1031, DOI 10.1666/10-036.1; Hosie AM, 2008, ZOOTAXA, P1; Houssa V., 1963, Sbornik Geol Ust Csl, V28, P101; Howell BF, 1962, TREATISE INVERTEBR W, pF144; Hyzny Matus, 2011, Bulletin of the Mizunami Fossil Museum, V37, P37; Jacquinot H, 1842, VOYAGE POLE SUD OCEA; Jagt JWM, 2009, NATUURHISTORISCH MAA, V98, P108; Jakobsen SL, 1997, B GEOL SOC DENMARK, V44, P89; Jones A., 2013, THESIS KENT STATE U; Karasawa H., 2008, B MIZUNAMI FOSSIL MU, V34, P23; Kiessling W, 2009, ANNU REV ECOL EVOL S, V40, P173, DOI 10.1146/annurev.ecolsys.110308.120251; Kiessling Wolfgang, 2002, P625; Klompmaker AA, 2013, GEOLOGICAL SOC AM AB, V45, P460; Klompmaker AA, 2012, THESIS KENT STATE U, DOI 10.1666/0022-3360(2006)080[0083:P0SHDC]2.0.CO;2; Klompmaker AA, 2013, GEOLOGY, V41, P1179, DOI 10.1130/G34768.1; Klompmaker AA, 2013, CRETACEOUS RES, V41, P150, DOI 10.1016/j.cretres.2012.12.003; Klompmaker AA, 2013, PALAEOGEOGR PALAEOCL, V374, P256, DOI 10.1016/j.palaeo.2013.01.024; Klompmaker AA, 2012, J CRUSTACEAN BIOL, V32, P780, DOI 10.1163/193724012X635340; Klompmaker AA, 2012, CRETACEOUS RES, V36, P125, DOI 10.1016/j.cretres.2012.03.003; Klompmaker AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031893; Klompmaker AA, 2011, PALAEONTOLOGY, V54, P1199, DOI 10.1111/j.1475-4983.2011.01072.x; Klompmaker AA, 2011, NEUES JAHRB GEOL P-A, V260, P191, DOI 10.1127/0077-7749/2011/0170; Klompmaker AA, 2011, J PALEONTOL, V85, P226, DOI 10.1666/10-028.1; Knaust D., 2012, DEV SEDIMENTOL, P79; Kobayashi Nobuaki, 2008, Bulletin of the Mizunami Fossil Museum, V34, P111; Konig C., 1825, ICONES FOSSILIUM SEC, P1; Labandeira Conrad C., 2002, Paleontological Society Papers, V8, P211; Lorenthey E. u., 1929, Geologica Hungarica Ser Palaeont, V3, P1; M'Coy F., 1854, ANN MAG NAT HIST, V44, P116, DOI DOI 10.1080/037454809494314; Mantell GA, 1844, MEDALS CREATION 1 2, V1-2, P1; MARKHAM JC, 1986, CRUSTACEAN BIOGEOGRA, P143, DOI DOI 10.1201/9781315140674-7; MCDERMOTT JJ, 1991, OPHELIA, V33, P71, DOI 10.1080/00785326.1991.10429731; McKinney F, 2009, ICHNOS, V16, P193, DOI 10.1080/10420940802686160; Mercier J., 1936, B SOCIETE GEOLOGIQUE, V6, P149; Milne Edwards A., 1865, B SOC SCI HIST NATUR, V19, P341; Milne-Edwards A, 1886, GEOLOGIE DEP SARTHE; Miyashita Y., 1941, Japanese Journal of Zoology, V9, P251; Moericke W., 1889, PALAEONTOGRAPHICA S, V3, P43; Morris S.F., 1991, Bulletin of the British Museum (Natural History) Geology, V47, P1; MORRIS SC, 1981, PARASITOLOGY, V82, P489, DOI 10.1017/S0031182000067020; Muller P., 1991, Contributions to Tertiary and Quaternary Geology, V28, P47; O'Brien J., 1985, Crustacean Issues, V3, P191; Ortmann AE, 1892, ZOOLOGISCHE JB CHER, V6, P532, DOI 10.5962/bhl.part.26456; PALMER TJ, 1988, PALAEONTOLOGY, V31, P939; Patrulius D., 1959, Revue de Geologie et de Geographie Bucarest, V3, P249; Petric M, 2010, J MAR BIOL ASSOC UK, V90, P1395, DOI 10.1017/S0025315409991615; Pickerill Ron K., 1994, P3; Porter C. E, 1903, REV CHIL HIST NAT, V7, P274; Poulin R., 2004, PARASITE BIODIVERSIT; Radwanska U, 2005, ACTA GEOL POL, V55, P109; Radwanska U, 2010, ACTA GEOL POL, V60, P549; Rathbun M.J., 1917, P US NATL MUSEUM, V52, P385, DOI DOI 10.5479/SI.00963801.52-2182.385; Rathbun M. J., 1935, GEOLOGICAL SOC AM, V2, P1; Rathbun M. J., 1926, US GEOLOGICAL SURVEY, P184; RATHBUN MARY J., 1928, PROC U S NATION MUS, V73, P1; RAYNER G. W., 1935, DISCOVERY REPTS [GOV DEPEND FALKLAND IS], V10, P209; Remes M., 1923, Bul Intern Acad Prag, V23, P36; Remes M., 1895, B INT ACAD SCI BOHEM, V2, P200; Reuss, 1858, SITZUNGSBERICHTE MN, V31, P5; ROBERTS H.B., 1962, CRETACEOUS FOSSILS N, V61, P163; Robins Cristina M., 2013, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V115, P167; Robins Cristina M., 2012, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V114A, P289; Roccatagliata D, 1999, J CRUSTACEAN BIOL, V19, P720, DOI 10.2307/1549296; Roemer, 1887, NEUES JB MINERALOGIE, V1, P173; Roemer F. A., 1841, VERSTEINERUNGEN NORD; Roman J., 1952, Bulletin de la Societe Geologique de France Ser 6, V2, P3; Ruiz de Gaona M., 1943, B REAL SOC ESPANOLA, V40, P425; Schotte M., 2008, WORLD LIST MARINE FR; Schweitzer C. E., 2009, ANN NATURHISTORISC A, V110, P55; Schweitzer Carrie E., 2007, Senckenbergiana Lethaea, V87, P119; Schweitzer CE, 2010, NEUES JAHRB GEOL P-A, V258, P243, DOI 10.1127/0077-7749/2010/0096; Schweitzer CE, 2010, NEUES JAHRB GEOL P-A, V258, P51, DOI 10.1127/0077-7749/2010/0084; Schweitzer Carrie E., 2010, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V112A, P169; Schweitzer CE, 2010, NEUES JAHRB GEOL P-A, V256, P363, DOI 10.1127/0077-7749/2010/0059; Schweitzer Carrie E., 2001, Bulletin of the Mizunami Fossil Museum, V28, P173; Schweitzer CE, 2009, NEUES JAHRB GEOL P-A, V253, P357, DOI 10.1127/0077-7749/2009/0253-0357; Schweitzer CE, 2009, NEUES JAHRB GEOL P-A, V252, P1, DOI 10.1127/0077-7749/2009/0252-0001; Schweitzer CE, 2008, NEUES JAHRB GEOL P-A, V250, P273, DOI 10.1127/0077-7749/2008/0250-0273; Schweitzer Carrie E., 2009, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V111A, P207; Schweitzer CE, 2009, ANN CARNEGIE MUS, V77, P403, DOI 10.2992/0097-4463-77.4.403; Segerberg K.O., 1900, GEOLOGISKA F RENINGE, V22, P347; Selden PA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1049; Sepkoski JJ, 2000, CONTRIB ZOOL, V69, P213, DOI 10.1163/18759866-06904001; SHIELDS JD, 1985, J INVERTEBR PATHOL, V45, P122, DOI 10.1016/0022-2011(85)90060-6; Soergel W, 1913, NEUES HB MINERALOGIE, V36, P586; Stimpson W, 1860, ANN LYCEUM NATURAL H, V7, P177, DOI [10.1111/j.1749-6632.1862.tb00153.x, DOI 10.1111/J.1749-6632.1862.TB00153.X]; Tapanila L, 2005, LETHAIA, V38, P89, DOI 10.1080/00241160510013123; Tapanila Leif, 2007, P345, DOI 10.1016/B978-044452949-7/50145-5; Tapanila L, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P3, DOI 10.1007/978-3-540-77598-0_1; Todd Jonathan A., 2005, Bulletin of the Mizunami Fossil Museum, V32, P53; Van Bakel BWM, 2012, ZOOTAXA, P1; Van Straelen V., 1940, Bull Mus Hist nat Belg, V16, P1; Van Straelen V., 1944, B MUSEE ROYAL HIST N, V20, P1; VANWYK PM, 1982, PARASITOLOGY, V85, P459, DOI 10.1017/S0031182000056249; Voigt E., 1967, Palaeontologische Zeitschrift, V41, P86; Voigt E., 1959, PALAEONTOL Z, V33, P211, DOI DOI 10.1007/BF02987935; von Graff L, 1885, PALAEONTOGRAPHICA, V31, P183; von Meyer H., 1851, NEUES JB MINERALOGIE, V1851, P677; von Meyer H., 1857, NEUES JB MINERALOGIE, V1857, P556; von Meyer H., 1860, PALAEONTOGRAPHICA, V7, P183; von Meyer H., 1840, NEUE GATTUNGEN FOSSI; von Meyer H., 1842, BEITRAGE PETREFAKTEN, V5, P70; Ward M., 1942, Mauritius Institute Bulletin, V2, P49; Waugh DA, 2009, J CRUSTACEAN BIOL, V29, P141, DOI 10.1651/08-3105.1; Wehner G., 1988, THESIS LUDWIG MAXIMI; WELCH JR, 1976, J PALEONTOL, V50, P218; Wienberg Rasmussen H., 2008, B MIZUNAMI FOSSIL MU, V34, P31; Williams JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035350; Wolff Matthias, 1995, Revista de Biologia Marina, V30, P57; WRIGHT C. W., 1950, PROC GEOL ASSOC, V61, P13; WRIGHT C W, 1972, Palaeontographical Society Monographs (London), V126, P1; ZELDIS JR, 1985, MAR ECOL PROG SER, V22, P77, DOI 10.3354/meps022077	179	49	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92551	10.1371/journal.pone.0092551	http://dx.doi.org/10.1371/journal.pone.0092551			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667587	Green Submitted, Green Published, gold			2022-12-27	WOS:000333675600049
J	Ruyssinck, J; Van, AHT; Geurts, P; Dhaene, T; Demeester, P; Saeys, Y				Ruyssinck, Joeri; Van Anh Huynh-Thu; Geurts, Pierre; Dhaene, Tom; Demeester, Piet; Saeys, Yvan			NIMEFI: Gene Regulatory Network Inference using Multiple Ensemble Feature Importance Algorithms	PLOS ONE			English	Article							SELECTION	One of the long-standing open challenges in computational systems biology is the topology inference of gene regulatory networks from high-throughput omics data. Recently, two community-wide efforts, DREAM4 and DREAM5, have been established to benchmark network inference techniques using gene expression measurements. In these challenges the overall top performer was the GENIE3 algorithm. This method decomposes the network inference task into separate regression problems for each gene in the network in which the expression values of a particular target gene are predicted using all other genes as possible predictors. Next, using tree-based ensemble methods, an importance measure for each predictor gene is calculated with respect to the target gene and a high feature importance is considered as putative evidence of a regulatory link existing between both genes. The contribution of this work is twofold. First, we generalize the regression decomposition strategy of GENIE3 to other feature importance methods. We compare the performance of support vector regression, the elastic net, random forest regression, symbolic regression and their ensemble variants in this setting to the original GENIE3 algorithm. To create the ensemble variants, we propose a subsampling approach which allows us to cast any feature selection algorithm that produces a feature ranking into an ensemble feature importance algorithm. We demonstrate that the ensemble setting is key to the network inference task, as only ensemble variants achieve top performance. As second contribution, we explore the effect of using rankwise averaged predictions of multiple ensemble algorithms as opposed to only one. We name this approach NIMEFI (Network Inference using Multiple Ensemble Feature Importance algorithms) and show that this approach outperforms all individual methods in general, although on a specific network a single method can perform better. An implementation of NIMEFI has been made publicly available.	[Ruyssinck, Joeri; Dhaene, Tom; Demeester, Piet] Ghent Univ iMinds, Dept Informat Technol, Ghent, Belgium; [Van Anh Huynh-Thu; Geurts, Pierre] Univ Liege, Dept Elect Engn & Comp Sci, Liege, Belgium; [Van Anh Huynh-Thu; Geurts, Pierre] Univ Liege, GIGA R, Liege, Belgium; [Van Anh Huynh-Thu] Univ Edinburgh, Sch Informat, Edinburgh, Midlothian, Scotland; [Saeys, Yvan] Univ Ghent VIB, Immunoregulat Lab, Inflammat Res Ctr, Ghent, Belgium; [Saeys, Yvan] Univ Ghent, Dept Resp Med, B-9000 Ghent, Belgium	Ghent University; IMEC; University of Liege; University of Liege; University of Edinburgh; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Ruyssinck, J (corresponding author), Ghent Univ iMinds, Dept Informat Technol, Ghent, Belgium.	joeri.ruyssinck@intec.ugent.be	Dhaene, Tom/A-4541-2009; Saeys, Yvan/C-1311-2009	Dhaene, Tom/0000-0003-2899-4636; Saeys, Yvan/0000-0002-0415-1506	Interuniversity Attraction Poles Programme [IAP P6/25 BIOMAGNET]; Belgian State, Science Policy Office; French Community of Belgium (ARC REFRACT, ULg); European Commission [FP7-PEOPLE-2011, CardiomiR-285991]; Ghent University Multidisciplinary Research Partnership Bioinformatics: from nucleotides to networks; Ghent University; Hercules Foundation; Flemish Government department EWI	Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); Belgian State, Science Policy Office(Belgian Federal Science Policy Office); French Community of Belgium (ARC REFRACT, ULg); European Commission(European CommissionEuropean Commission Joint Research Centre); Ghent University Multidisciplinary Research Partnership Bioinformatics: from nucleotides to networks(Ghent University); Ghent University(Ghent University); Hercules Foundation; Flemish Government department EWI	This work was partially supported by the Interuniversity Attraction Poles Programme (IAP P6/25 BIOMAGNET), initiated by the Belgian State, Science Policy Office, by the French Community of Belgium (ARC REFRACT, ULg), and by a grant from the European Commission (FP7-PEOPLE-2011; CardiomiR-285991; Dr. Heymans). This work is supported by Ghent University Multidisciplinary Research Partnership Bioinformatics: from nucleotides to networks. This work was carried out using the Stevin Supercomputer Infrastructure at Ghent University, funded by Ghent University, the Hercules Foundation and the Flemish Government department EWI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2009, BIOINFORMATICS, V25, pI313, DOI 10.1093/bioinformatics/btp191; Altay G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-132; Bach FR., 2008, P 25 INT C MACHINE L, V33, P40, DOI [10.1145/1390156.1390161, DOI 10.1145/1390156.1390161]; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Butte A J, 2000, Pac Symp Biocomput, P418; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; de Matos Simoes Ricardo, 2012, PLoS One, V7, pe33624, DOI 10.1371/journal.pone.0033624; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Ding C, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P523, DOI 10.1109/CSB.2003.1227396; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hache H, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/617281; Haury AC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-145; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Kuffner R, 2012, BIOINFORMATICS, V28, P1376, DOI 10.1093/bioinformatics/bts143; Madhamshettiwar PB, 2012, GENOME MED, V4, DOI 10.1186/gm340; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Meyer PE, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/79879; Michoel T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-49; Narendra V, 2011, GENOMICS, V97, P7, DOI 10.1016/j.ygeno.2010.10.003; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Saeys Y, 2008, LECT NOTES ARTIF INT, V5212, P313, DOI 10.1007/978-3-540-87481-2_21; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Schaffter T, 2011, BIOINFORMATICS, V27, P2263, DOI 10.1093/bioinformatics/btr373; Smits GF, 2005, GENET PROGR SER, V8, P283, DOI 10.1007/0-387-23254-0_17; Soranzo N, 2007, BIOINFORMATICS, V23, P1640, DOI 10.1093/bioinformatics/btm163; Van den Bulcke T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-43; Vladislavleva K, 2010, GECCO 10, P941, DOI DOI 10.1145/1830483.1830651; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	36	38	38	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92709	10.1371/journal.pone.0092709	http://dx.doi.org/10.1371/journal.pone.0092709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667482	Green Published, gold			2022-12-27	WOS:000333675600066
J	Bayala, B; Bassole, IHN; Gnoula, C; Nebie, R; Yonli, A; Morel, L; Figueredo, G; Nikiema, JB; Lobaccaro, JMA; Simpore, J				Bayala, Bagora; Bassole, Imael Henri Nestor; Gnoula, Charlemagne; Nebie, Roger; Yonli, Albert; Morel, Laurent; Figueredo, Gilles; Nikiema, Jean-Baptiste; Lobaccaro, Jean-Marc A.; Simpore, Jacques			Chemical Composition, Antioxidant, Anti-Inflammatory and Anti-Proliferative Activities of Essential Oils of Plants from Burkina Faso	PLOS ONE			English	Article							OCIMUM-BASILICUM L.; HUMAN PROSTATIC-CARCINOMA; AGERATUM-CONYZOIDES L.; IN-VITRO; ANTIMICROBIAL ACTIVITY; LARVICIDAL ACTIVITY; BIOLOGICAL-ACTIVITY; LIPPIA-MULTIFLORA; MEDICINAL-PLANTS; OXIDATIVE STRESS	This research highlights the chemical composition, antioxidant, anti-inflammatory and anti-proliferative activities of essential oils from leaves of Ocimum basilicum, Ocimum americanum, Hyptis spicigera, Lippia multiflora, Ageratum conyzoides, Eucalyptus camaldulensis and Zingiber officinale. Essential oils were analyzed by gas chromatography-mass spectrometry and gas chromatography-flame ionization detector. Major constituents were alpha-terpineol (59.78%) and beta-caryophyllene (10.54%) for Ocimum basilicum; 1, 8-cineol (31.22%), camphor (12.730%), alpha-pinene (6.87%) and trans alpha-bergamotene (5.32%) for Ocimum americanum; beta-caryophyllene (21%), alpha-pinene (20.11%), sabinene (10.26%), beta-pinene (9.22%) and alpha-phellandrene (7.03%) for Hyptis spicigera; p-cymene (25.27%), beta-caryophyllene (12.70%), thymol (11.88), gamma-terpinene (9.17%) and thymyle acetate (7.64%) for Lippia multiflora; precocene (82.10%) for Ageratum conyzoides; eucalyptol (59.55%), a-pinene (9.17%) and limonene (8.76%) for Eucalyptus camaldulensis; arcurcumene (16.67%), camphene (12.70%), zingiberene (8.40%), beta-bisabolene (7.83%) and beta-sesquiphellandrene (5.34%) for Zingiber officinale. Antioxidant activities were examined using 1,1-diphenyl-2-picryl-hydrazyl (DPPH) and 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid (ABTS) methods. O. basilicum and L. multiflora exhibited the highest antioxidant activity in DPPH and ABTS tests, respectively. Anti-inflammatory properties were evaluated by measuring the inhibition of lipoxygenase activity and essential oil of Z. officinale was the most active. Anti-proliferative effect was assayed by the measurement of MTT on LNCaP and PC-3 prostate cancer cell lines, and SF-763 and SF-767 glioblastoma cell lines. Essential oils from A. conyzoides and L. multiflora were the most active on LNCaP and PC-3 cell lines, respectively. The SF-767 glioblastoma cell line was the most sensitive to O. basilicum and L. multiflora EOs while essential oil of A. conyzoides showed the highest activity on SF-763 cells. Altogether these results justify the use of these plants in traditional medicine in Burkina Faso and open a new field of investigation in the characterization of the molecules involved in anti-proliferative processes.	[Bayala, Bagora; Gnoula, Charlemagne; Yonli, Albert; Nikiema, Jean-Baptiste; Simpore, Jacques] Univ Ouagadougou, Ctr Med St Camille, Lab Biol & Genet LABIOGENE, Ctr Rech Biomol Pietro Annigoni CERBA, Ouagadougou, Burkina Faso; [Bayala, Bagora; Morel, Laurent; Lobaccaro, Jean-Marc A.] Univ Clermont Ferrand 2, Univ Blaise Pascal, Clermont Ferrand, France; [Bayala, Bagora; Morel, Laurent; Lobaccaro, Jean-Marc A.] CNRS, Unite Mixte Rech UMR 6293, GReD, Aubiere, France; [Bayala, Bagora; Morel, Laurent; Lobaccaro, Jean-Marc A.] INSERM, UMR 1103, GReD, Aubiere, France; [Bayala, Bagora; Morel, Laurent; Lobaccaro, Jean-Marc A.] Ctr Rech Nutr Humaine Auvergne, Clermont Ferrand, France; [Bassole, Imael Henri Nestor] Univ Ouagadougou, Lab Biochim Alimentaire Enzymol Biotechnol Ind &, Unite Format & Rech Sci Vie & Terre UFR SVT, Ouagadougou, Burkina Faso; [Gnoula, Charlemagne] Univ Ouagadougou, Lab Pharmacol Toxicol & Chim Therapeut, Unite Format & Rech Sci Sante UFR SDS, Ouagadougou, Burkina Faso; [Nebie, Roger] Inst Rech Sci Appl & Tech, Dept Subst Nat, Ouagadougou, Burkina Faso; [Figueredo, Gilles] Biopole Clermont Limagne, LEXVA Analyt, St Beauzire, France; [Nikiema, Jean-Baptiste; Simpore, Jacques] Ctr Med St Camille Ouagadougou, Ouagadougou, Burkina Faso	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm)	Lobaccaro, JMA (corresponding author), Univ Clermont Ferrand 2, Univ Blaise Pascal, Clermont Ferrand, France.	j-marc.lobaccaro@univ-bpclermont.fr; jacques.simpore@yahoo.fr	SIMPORE, Jacques/ABA-4873-2020; NEBIE, Roger/AAR-6586-2020; Lobaccaro, Jean-Marc/Q-3926-2019; Bassolé, Imaël Henri Nestor/Z-1151-2019; LOBACCARO, Jean-Marc/L-6151-2015	SIMPORE, Jacques/0000-0002-0415-9161; Lobaccaro, Jean-Marc/0000-0001-9890-2392; Bassolé, Imaël Henri Nestor/0000-0003-3538-0018; 	Conference Episcopale Italienne (CEI); Union Economique Monetaire Ouest Africaine (UEMOA); Fondation BNP-Paris; Region Auvergne; Fond Europeen de Developpement Regional (FEDER); Association de Recherche sur les Tumeurs Prostatiques (ARTP); Fondation ARC; Ligue contre le Cancer	Conference Episcopale Italienne (CEI); Union Economique Monetaire Ouest Africaine (UEMOA); Fondation BNP-Paris; Region Auvergne(Region Auvergne-Rhone-Alpes); Fond Europeen de Developpement Regional (FEDER)(European Commission); Association de Recherche sur les Tumeurs Prostatiques (ARTP); Fondation ARC; Ligue contre le Cancer(Ligue nationale contre le cancer)	This study was supported by Conference Episcopale Italienne (CEI), Union Economique Monetaire Ouest Africaine (UEMOA) and Campus France for BB, CG, IHNB, AY, J-BN, JS; Fondation BNP-Paris, Region Auvergne, Fond Europeen de Developpement Regional (FEDER), Association de Recherche sur les Tumeurs Prostatiques (ARTP), Fondation ARC, Ligue contre le Cancer for JMAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkader MSA, 2011, NAT PROD RES, V25, P909, DOI 10.1080/14786419.2010.531724; Abena AA, 2003, FITOTERAPIA, V74, P231, DOI 10.1016/S0367-326X(03)00029-7; Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; Alinkina E S, 2012, Prikl Biokhim Mikrobiol, V48, P564; Alzogaray RA, 2011, J ECON ENTOMOL, V104, P595, DOI 10.1603/EC10045; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Bassole IHN, 2011, PHYTOMEDICINE, V18, P1070, DOI 10.1016/j.phymed.2011.05.009; Bassole IHN, 2010, MOLECULES, V15, P7825, DOI 10.3390/molecules15117825; Bicas JL, 2011, FOOD CHEM TOXICOL, V49, P1610, DOI 10.1016/j.fct.2011.04.012; Bouda H, 2001, EFFECT ESSENTIAL OIL; Cavalcanti ESB, 2004, MEM I OSWALDO CRUZ, V99, P541, DOI 10.1590/S0074-02762004000500015; Cengiz S, 2011, MAR BIOTECHNOL, V13, P321, DOI 10.1007/s10126-010-9303-1; Cheng SS, 2009, BIORESOURCE TECHNOL, V100, P452, DOI 10.1016/j.biortech.2008.02.038; Cimanga K, 2002, J ETHNOPHARMACOL, V79, P213, DOI 10.1016/S0378-8741(01)00384-1; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dar MY, 2011, FOOD CHEM, V129, P1606, DOI 10.1016/j.foodchem.2011.06.016; de Melo NI, 2011, MOLECULES, V16, P762, DOI 10.3390/molecules16010762; del Castillo MD, 2002, J AGR FOOD CHEM, V50, P3698, DOI 10.1021/jf011702q; Djibo AK, 2004, CR CHIM, V7, P1033, DOI 10.1016/j.crci.2003.12.029; Edris AE, 2007, PHYTOTHER RES, V21, P308, DOI 10.1002/ptr.2072; Fragoso-Serrano M, 1999, J NAT PROD, V62, P45, DOI 10.1021/np980222z; Francisco JD, 2001, J AGR FOOD CHEM, V49, P2339, DOI 10.1021/jf0013611; Garcia DG, 2010, MOL CELL BIOCHEM, V345, P29, DOI 10.1007/s11010-010-0556-9; Yamamoto-Ribeiro MMG, 2013, FOOD CHEM, V141, P3147, DOI 10.1016/j.foodchem.2013.05.144; Ghasemi V, 2011, EXP APPL ACAROL, V55, P147, DOI 10.1007/s10493-011-9457-1; Gould MN, 1997, ENVIRON HEALTH PERSP, V105, P977, DOI 10.2307/3433313; Govindarajan M, 2013, EXP PARASITOL, V134, P7, DOI 10.1016/j.exppara.2013.01.018; Graham JG, 2000, J ETHNOPHARMACOL, V73, P347, DOI 10.1016/S0378-8741(00)00341-X; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Gupta S, 2001, CANCER-AM CANCER SOC, V91, P737, DOI 10.1002/1097-0142(20010215)91:4<737::AID-CNCR1059>3.0.CO;2-F; Herzi N, 2013, J FOOD SCI, V78, pC667, DOI 10.1111/1750-3841.12113; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Ilboudo Z, 2010, J STORED PROD RES, V46, P124, DOI 10.1016/j.jspr.2009.12.002; Jackson AL, 2001, MUTAT RES-FUND MOL M, V477, P7, DOI 10.1016/S0027-5107(01)00091-4; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kalaivani K, 2012, PARASITOL RES, V110, P1261, DOI 10.1007/s00436-011-2623-x; Kathirvel P, 2012, NAT PROD RES, V26, P1112, DOI 10.1080/14786419.2010.545357; Klaunig JE, 1998, ENVIRON HEALTH PERSP, V106, P289, DOI 10.2307/3433929; Liu RH, 2004, J NUTR, V134, p3479S, DOI 10.1093/jn/134.12.3479S; Lompo O M, 2009, J AFRICAIN CANC, V1, P207, DOI DOI 10.1007/S12558-009-0052-X; Lopez-Reyes JG, 2013, J FOOD PROTECT, V76, P631, DOI 10.4315/0362-028X.JFP-12-342; LYCKANDER IM, 1992, ACTA PHARM NORDICA, V4, P159; Mantovani A, 2005, NATURE, V435, P752, DOI 10.1038/435752a; Martinez-Velazquez M, 2011, PARASITOL RES, V108, P481, DOI 10.1007/s00436-010-2069-6; McNeil M, 2011, NAT PROD COMMUN, V6, P1775; Miguel MG, 2010, FLAVOUR FRAG J, V25, P291, DOI 10.1002/ffj.1961; Misharina T A, 2009, Prikl Biokhim Mikrobiol, V45, P710; Moura ACA, 2005, PHYTOMEDICINE, V12, P138, DOI 10.1016/j.phymed.2003.12.003; Murata S, 2013, ONCOL REP, V30, P2647, DOI 10.3892/or.2013.2763; Nacoulma O. G., 1996, THESIS, P328; Newell DR, 2005, EUR J CANCER, V41, P676, DOI 10.1016/j.ejca.2004.12.024; de Melo GAN, 2011, J NAT MED-TOKYO, V65, P241, DOI 10.1007/s11418-010-0479-5; Nogueira JHC, 2010, INT J FOOD MICROBIOL, V137, P55, DOI 10.1016/j.ijfoodmicro.2009.10.017; Pidgeon GP, 2002, CANCER RES, V62, P2721; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; RICEEVANS C, 1993, PROG LIPID RES, V32, P71, DOI 10.1016/0163-7827(93)90006-I; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Sanchez-Suarez JF, 2013, IRAN J PARASITOL, V8, P129; Sawadogo WR, 2012, NAT PROD RES, V26, P575, DOI 10.1080/14786419.2010.534737; Senatore F, 1998, FLAVOUR FRAG J, V13, P1, DOI 10.1002/(SICI)1099-1026(199801/02)13:1&lt;1::AID-FFJ672&gt;3.0.CO;2-4; Sims JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055509; Soares DG, 2003, J AGR FOOD CHEM, V51, P1077, DOI 10.1021/jf020864z; Stein S., 2002, NIST MASS SPECTRAL S; Storz P, 2005, FRONT BIOSCI-LANDMRK, V10, P1881, DOI 10.2741/1667; Takayama C, 2011, J ETHNOPHARMACOL, V135, P147, DOI 10.1016/j.jep.2011.03.002; Thaweboon S, 2009, SE ASIAN J TROP MED, V40, P1025; TRUSH MA, 1991, FREE RADICAL BIO MED, V10, P201, DOI 10.1016/0891-5849(91)90077-G; Wang SY, 2000, J AGR FOOD CHEM, V48, P5677, DOI 10.1021/jf000766i; Yu LL, 2002, J AGR FOOD CHEM, V50, P1619, DOI 10.1021/jf010964p; Zheljazkov VD, 2008, J AGR FOOD CHEM, V56, P241, DOI 10.1021/jf072447y; Zu YG, 2010, MOLECULES, V15, P3200, DOI 10.3390/molecules15053200	71	104	113	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92122	10.1371/journal.pone.0092122	http://dx.doi.org/10.1371/journal.pone.0092122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662935	gold, Green Submitted, Green Published			2022-12-27	WOS:000333459900041
J	Cox, EJ; Marsh, SA				Cox, Emily J.; Marsh, Susan A.			A Systematic Review of Fetal Genes as Biomarkers of Cardiac Hypertrophy in Rodent Models of Diabetes	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; MYOSIN HEAVY-CHAIN; TRANSCRIPTION FACTORS; CARDIOMYOCYTE HYPERTROPHY; CONTRACTILE DYSFUNCTION; DIASTOLIC DYSFUNCTION; SUBSTRATE METABOLISM; VENTRICULAR MYOCYTES; INSULIN-RESISTANCE; PRESSURE-OVERLOAD	Pathological cardiac hypertrophy activates a suite of genes called the fetal gene program (FGP). Pathological hypertrophy occurs in diabetic cardiomyopathy (DCM); therefore, the FGP is widely used as a biomarker of DCM in animal studies. However, it is unknown whether the FGP is a consistent marker of hypertrophy in rodent models of diabetes. Therefore, we analyzed this relationship in 94 systematically selected studies. Results showed that diabetes induced with cytotoxic glucose analogs such as streptozotocin was associated with decreased cardiac weight, but genetic or diet-induced models of diabetes were significantly more likely to show cardiac hypertrophy (P < 0.05). Animal strain, sex, age, and duration of diabetes did not moderate this effect. There were no correlations between the heart weight: body weight index and mRNA or protein levels of the fetal genes alpha-myosin heavy chain (alpha-MHC) or beta-MHC, sarco/endoplasmic reticulum Ca2+-ATPase, atrial natriuretic peptide (ANP), or brain natriuretic peptide. The only correlates of non-indexed heart weight were the protein levels of alpha-MHC (Spearman's rho = 1, P<0.05) and ANP (rho = -0.73, P<0.05). These results indicate that most commonly measured genes in the FGP are confounded by diabetogenic methods, and are not associated with cardiac hypertrophy in rodent models of diabetes.	[Cox, Emily J.] Washington State Univ, Coll Pharm, Grad Program Pharmaceut Sci, Spokane, WA USA; [Marsh, Susan A.] Washington State Univ, Coll Pharm, Dept Expt & Syst Pharmacol, Spokane, WA 99202 USA	Washington State University; Washington State University	Marsh, SA (corresponding author), Washington State Univ, Coll Pharm, Dept Expt & Syst Pharmacol, Spokane, WA 99202 USA.	susan.marsh@wsu.edu	Marsh, Sue/J-3711-2014	Marsh, Sue/0000-0002-7530-0417	National Institutes of Health [HL-104549]; Diabetes Action Research and Education Foundation; National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL104549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Action Research and Education Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (HL-104549) and the Diabetes Action Research and Education Foundation to SAM. EJC is supported by a National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2002, AM J PHYSIOL-HEART C, V282, pH138, DOI 10.1152/ajpheart.2002.282.1.H138; Amodio V, 2012, DEV DYNAM, V241, P190, DOI 10.1002/dvdy.22763; Aragno M, 2006, ENDOCRINOLOGY, V147, P5967, DOI 10.1210/en.2006-0728; Azakie A, 2006, J THORAC CARDIOV SUR, V132, P1262, DOI 10.1016/j.jtcvs.2006.08.005; Bartels ED, 2010, ENDOCRINOLOGY, V151, P5218, DOI 10.1210/en.2010-0355; Basu R, 2009, AM J PHYSIOL-HEART C, V297, pH2096, DOI 10.1152/ajpheart.00452.2009; Bell DSH, 2003, DIABETES CARE, V26, P2949, DOI 10.2337/diacare.26.10.2949; Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7; Branco AF, 2011, CARDIOVASC TOXICOL, V11, P191, DOI 10.1007/s12012-011-9111-5; Bupha-Intr T, 2011, AM J PHYSIOL-HEART C, V300, pH1661, DOI 10.1152/ajpheart.00411.2010; Castoldi G, 2010, CLIN SCI, V118, P211, DOI 10.1042/CS20090234; Chess DJ, 2008, CARDIOVASC RES, V79, P269, DOI 10.1093/cvr/cvn074; Christoffersen C, 2006, EUR J CLIN INVEST, V36, P69, DOI 10.1111/j.1365-2362.2006.01596.x; Coles JG, 2005, J THORAC CARDIOV SUR, V129, P1128, DOI 10.1016/j.jtcvs.2004.11.055; Costa MV, 2012, EUR J NUTR, V51, P89, DOI 10.1007/s00394-011-0196-1; Cox EJ, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-101; Depre C, 1998, NAT MED, V4, P1269, DOI 10.1038/3253; Dietz JR, 2005, CARDIOVASC RES, V68, P8, DOI 10.1016/j.cardiores.2005.06.008; Dirkx E, 2013, BIOCH BIOPHYSICA ACT; Driesen RB, 2009, J CELL MOL MED, V13, P896, DOI 10.1111/j.1582-4934.2008.00523.x; Ericsson M, 2010, J APPL PHYSIOL, V109, P1749, DOI 10.1152/japplphysiol.00282.2010; Essop MF, 2011, CARDIOVASC J AFR, V22, P175, DOI 10.5830/CVJA-2010-058; Feng BA, 2010, DIABETES-METAB RES, V26, P40, DOI 10.1002/dmrr.1054; Franco V, 2004, HYPERTENSION, V44, P746, DOI 10.1161/01.HYP.0000144801.09557.4c; GALDERISI M, 1991, AM J CARDIOL, V68, P85, DOI 10.1016/0002-9149(91)90716-X; Gao XR, 2011, CIRC J, V75, P2683, DOI 10.1253/circj.CJ-11-0238; Golfman L, 1999, MOL CELL BIOCHEM, V200, P15, DOI 10.1023/A:1006950218597; Gronholm T, 2005, EUR J PHARMACOL, V519, P267, DOI 10.1016/j.ejphar.2005.07.015; Guglielmino K, 2012, AM J PHYSIOL-HEART C, V303, pH853, DOI 10.1152/ajpheart.00154.2012; GUSTAFSON TA, 1987, J BIOL CHEM, V262, P13316; Gutkowska J, 2009, J PHYSIOL-LONDON, V587, P4725, DOI 10.1113/jphysiol.2009.176461; Hasegawa K, 1997, CIRCULATION, V96, P3943; Horio T, 2000, HYPERTENSION, V35, P19, DOI 10.1161/01.HYP.35.1.19; Horsthuis T, 2008, CIRC RES, V102, P849, DOI 10.1161/CIRCRESAHA.107.170571; Houweling AC, 2005, CARDIOVASC RES, V67, P583, DOI 10.1016/j.cardiores.2005.06.013; Howarth FC, 2005, MOL CELL BIOCHEM, V269, P103, DOI 10.1007/s11010-005-3088-y; Hsu BG, 2012, TRANSPL P, V44, P646, DOI 10.1016/j.transproceed.2011.11.008; Hui Hai-peng, 2006, Zhonghua Xinxueguanbing Zazhi, V34, P357; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kaminski KA, 2009, PHARMACOL REP, V61, P496, DOI 10.1016/S1734-1140(09)70092-1; Khan AM, 2011, J CLIN ENDOCR METAB, V96, P3242, DOI 10.1210/jc.2011-1182; Kiper C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070512; Kolwicz SC, 2011, CARDIOVASC RES, V90, P194, DOI 10.1093/cvr/cvr071; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; Konrad RJ, 2001, BIOCHEM J, V356, P31, DOI 10.1042/0264-6021:3560031; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; Ku PM, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-57; Kuwahara K, 2013, CIRCULATION J OFFICI; Kuwahara K, 2012, J PHARMACOL SCI, V119, P198, DOI 10.1254/jphs.12R04CP; Lafontan M, 2005, ARTERIOSCL THROM VAS, V25, P2032, DOI 10.1161/01.ATV.0000183728.14712.d8; Lahaye SL, 2012, APPL PHYSIOL NUTR ME, V37, P53, DOI [10.1139/h11-127, 10.1139/H11-127]; LaRocca TJ, 2012, AM J PHYSIOL-HEART C, V303, pH353, DOI 10.1152/ajpheart.01198.2011; Lee JH, 2010, J PHARM PHARMACOL, V62, P1, DOI [10.1211/jpp.62.01.0001, 10.1211/jpp/62.01.0001]; Lien CL, 1999, DEVELOPMENT, V126, P75; Ligeti L, 2006, INT J MOL MED, V17, P1035; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; Maalouf RM, 2012, AM J PHYSIOL-CELL PH, V302, pC597, DOI 10.1152/ajpcell.00331.2011; Maitra M, 2009, DEV BIOL, V326, P368, DOI 10.1016/j.ydbio.2008.11.004; Marsh SA, 2011, AMINO ACIDS, V40, P819, DOI 10.1007/s00726-010-0699-8; MATSUBARA H, 1990, CIRC RES, V67, P803, DOI 10.1161/01.RES.67.4.803; MIFUNE H, 1992, CELL TISSUE RES, V267, P267, DOI 10.1007/BF00302964; Miklos Z, 2012, ACTA PHYSIOL, V205, P381, DOI 10.1111/j.1748-1716.2012.02420.x; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P4947, DOI 10.1128/MCB.14.7.4947; Morin S, 2005, J BIOL CHEM, V280, P32272, DOI 10.1074/jbc.M507640200; Moskowitz IP, 2011, P NATL ACAD SCI USA, V108, P4006, DOI 10.1073/pnas.1019025108; Nielsen LB, 2002, J BIOL CHEM, V277, P27014, DOI 10.1074/jbc.M203458200; Nishikimi T, 2006, CARDIOVASC RES, V69, P318, DOI 10.1016/j.cardiores.2005.10.001; Opitz CA, 2005, J MUSCLE RES CELL M, V26, P333, DOI 10.1007/s10974-005-9040-7; Ou HC, 2010, J AGR FOOD CHEM, V58, P10347, DOI [10.1021/jf101606s, 10.1021/Jf101606s]; Pandya K, 2006, P NATL ACAD SCI USA, V103, P16864, DOI 10.1073/pnas.0607700103; Periasamy M, 2008, CARDIOVASC RES, V77, P265, DOI 10.1093/cvr/cvm056; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Rees DA, 2005, DIABETIC MED, V22, P359, DOI 10.1111/j.1464-5491.2005.01499.x; Reiser PJ, 2001, AM J PHYSIOL-HEART C, V280, pH1814, DOI 10.1152/ajpheart.2001.280.4.H1814; Ren RQ, 2012, ENDOCRINOLOGY, V153, P5346, DOI 10.1210/en.2012-1563; Ritchie RH, 2012, DIABETOLOGIA, V55, P3369, DOI 10.1007/s00125-012-2720-0; Rivera-Feliciano J, 2006, DEVELOPMENT, V133, P3607, DOI 10.1242/dev.02519; Rosenblatt-Velin N, 2004, FASEB J, V18, P872, DOI 10.1096/fj.03-1095fje; Rosenkranz AC, 2003, DIABETES, V52, P2389, DOI 10.2337/diabetes.52.9.2389; Ruzicska E, 2004, J HYPERTENS, V22, P1191, DOI 10.1097/00004872-200406000-00021; Sakata S, 2006, MOL THER, V13, P987, DOI 10.1016/j.ymthe.2006.01.002; Shah A, 2010, PEPTIDES, V31, P1779, DOI 10.1016/j.peptides.2010.06.013; Sheikh AQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036840; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Stanley WC, 1997, CARDIOVASC RES, V34, P25, DOI 10.1016/S0008-6363(97)00047-3; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Thattaliyath BD, 2002, J MOL CELL CARDIOL, V34, P1335, DOI 10.1006/jmcc.2002.2085; Thijssen VLJL, 2001, CARDIOVASC RES, V52, P14, DOI 10.1016/S0008-6363(01)00367-4; Van Linthout S, 2008, BASIC RES CARDIOL, V103, P319, DOI 10.1007/s00395-008-0715-2; Wang DJ, 2003, HYPERTENSION, V42, P88, DOI 10.1161/01.HYP.0000074905.22908.A6; Wang ZY, 1998, DIABETES, V47, P50, DOI 10.2337/diabetes.47.1.50; Wold LE, 2004, BIOCHEM BIOPH RES CO, V318, P1066, DOI 10.1016/j.bbrc.2004.04.138; Wu SQ, 1998, DIABETOLOGIA, V41, P660, DOI 10.1007/s001250050965; Ye G, 2005, CARDIOVASC TOXICOL, V5, P285, DOI 10.1385/CT:5:3:285; Yeih DF, 2009, AM J PHYSIOL-HEART C, V297, pH1411, DOI 10.1152/ajpheart.01269.2008; YIN FCP, 1982, AM J PHYSIOL, V243, pH941, DOI 10.1152/ajpheart.1982.243.6.H941; Yue P, 2007, AM J PHYSIOL-HEART C, V292, pH2106, DOI 10.1152/ajpheart.00856.2006; Zhang YH, 2008, PROG BIOPHYS MOL BIO, V98, P1, DOI 10.1016/j.pbiomolbio.2008.05.005; Zhong Y, 2001, AM J PHYSIOL-HEART C, V281, pH1137, DOI 10.1152/ajpheart.2001.281.3.H1137; Zhou H, 2011, ACTA PHARMACOL SIN, V32, P999, DOI 10.1038/aps.2011.54	103	49	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92903	10.1371/journal.pone.0092903	http://dx.doi.org/10.1371/journal.pone.0092903			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663494	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900129
J	Feve, M; Saliou, JM; Zeniou, M; Lennon, S; Carapito, C; Dong, JH; Van Dorsselaer, A; Junier, MP; Chneiweiss, H; Cianferani, S; Haiech, J; Kilhoffer, MC				Feve, Marie; Saliou, Jean-Michel; Zeniou, Maria; Lennon, Sarah; Carapito, Christine; Dong, Jihu; Van Dorsselaer, Alain; Junier, Marie-Pierre; Chneiweiss, Herve; Cianferani, Sarah; Haiech, Jacques; Kilhoffer, Marie-Claude			Comparative Expression Study of the Endo-G Protein Coupled Receptor (GPCR) Repertoire in Human Glioblastoma Cancer Stem-like Cells, U87-MG Cells and Non Malignant Cells of Neural Origin Unveils New Potential Therapeutic Targets	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; COMMERCIALLY AVAILABLE ANTIBODIES; HUMAN PANCREATIC-CANCER; GROWTH-FACTOR RECEPTOR; HUMAN GLIOMA-CELLS; GABA(B) RECEPTORS; TUMOR-GROWTH; PROGENITOR CELLS; DRUG DISCOVERY; BREAST-CANCER	Glioblastomas (GBMs) are highly aggressive, invasive brain tumors with bad prognosis and unmet medical need. These tumors are heterogeneous being constituted by a variety of cells in different states of differentiation. Among these, cells endowed with stem properties, tumor initiating/propagating properties and particularly resistant to chemo-and radiotherapies are designed as the real culprits for tumor maintenance and relapse after treatment. These cells, termed cancer stem-like cells, have been designed as prominent targets for new and more efficient cancer therapies. G-protein coupled receptors (GPCRs), a family of membrane receptors, play a prominent role in cell signaling, cell communication and crosstalk with the microenvironment. Their role in cancer has been highlighted but remains largely unexplored. Here, we report a descriptive study of the differential expression of the endo-GPCR repertoire in human glioblastoma cancer stem-like cells (GSCs), U-87 MG cells, human astrocytes and fetal neural stem cells (f-NSCs). The endo-GPCR transcriptome has been studied using Taqman Low Density Arrays. Of the 356 GPCRs investigated, 138 were retained for comparative studies between the different cell types. At the transcriptomic level, eight GPCRs were specifically expressed/overexpressed in GSCs. Seventeen GPCRs appeared specifically expressed in cells with stem properties (GSCs and f-NSCs). Results of GPCR expression at the protein level using mass spectrometry and proteomic analysis are also presented. The comparative GPCR expression study presented here gives clues for new pathways specifically used by GSCs and unveils novel potential therapeutic targets.	[Feve, Marie; Zeniou, Maria; Dong, Jihu; Haiech, Jacques; Kilhoffer, Marie-Claude] Univ Strasbourg, Fac Pharm, Lab Excellence Medalis, Lab Innovat Therapeut,UMR7200,CNRS, Illkirch Graffenstaden, France; [Saliou, Jean-Michel; Lennon, Sarah; Carapito, Christine; Van Dorsselaer, Alain; Cianferani, Sarah] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, CNRS, Lab Spectrometrie Masse BioOrgan,UMR7178, Strasbourg, France; [Junier, Marie-Pierre; Chneiweiss, Herve] Univ Paris 06, CNRS, Inserm U1130, UMR8246,Inst Biol Paris Seine, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Kilhoffer, MC (corresponding author), Univ Strasbourg, Fac Pharm, Lab Excellence Medalis, Lab Innovat Therapeut,UMR7200,CNRS, Illkirch Graffenstaden, France.	mckilhoffer@unistra.fr	haiech, jacques J/F-2890-2010; herve, chneiweiss/Q-6818-2019	herve, chneiweiss/0000-0001-7675-5061; haiech, jacques/0000-0003-2908-8053; Lennon, Sarah/0000-0001-5095-0141; Cianferani, Sarah/0000-0003-4013-4129; Carapito, Christine/0000-0002-0079-319X	La Ligue contre le Cancer, La Fondation pour la Recherche Medicale; Agence Nationale pour la Recherche (ANR); Proteomic French Infrastructure [ANR-10-INSB-08-03]; Region Alsace; Universite de Strasbourg; CNRS; French Ministere de l'enseignement superieur et de la recherche; Fondation ARC [SFI20121205939]; LABEX [ANR-10-LABX-0034]; French government; French Ministere de l'enseignement superieur	La Ligue contre le Cancer, La Fondation pour la Recherche Medicale; Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Proteomic French Infrastructure; Region Alsace(Region Grand-Est); Universite de Strasbourg; CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministere de l'enseignement superieur et de la recherche; Fondation ARC; LABEX; French government; French Ministere de l'enseignement superieur	This work was supported by La Ligue contre le Cancer, La Fondation pour la Recherche Medicale, the Agence Nationale pour la Recherche (ANR), the Proteomic French Infrastructure (ANR-10-INSB-08-03), the Region Alsace, Universite de Strasbourg, CNRS, the French Ministere de l'enseignement superieur et de la recherche, the Fondation ARC (SFI20121205939, HC/MPJ) and has been preformed within the LABEX ANR-10-LABX-0034_Medalis and received a financial support from French government managed by "Agence National de la Recherche'' under "Programme d'investissement d'avenir''. Marie Feve is indebted to French Ministere de l'enseignement superieur et de la recherche for doctoral fellowship and Sarah Lennon to the Fondation ARC pour la Recherche sur le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado T, 2007, J BIOL CHEM, V282, P6854, DOI 10.1074/jbc.M608900200; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alison MR, 2012, CANCER TREAT REV, V38, P589, DOI 10.1016/j.ctrv.2012.03.003; Arora P, 2008, ONCOGENE, V27, P4434, DOI 10.1038/onc.2008.84; Audigier Y, 2013, PROG MOL BIOL TRANSL, V115, P143, DOI 10.1016/B978-0-12-394587-7.00004-X; Aust G, 1997, CANCER RES, V57, P1798; Axelson M, 2013, CLIN CANCER RES, V19, P2289, DOI 10.1158/1078-0432.CCR-12-1956; Bai Y, 2009, NEUROREPORT, V20, P918, DOI 10.1097/WNR.0b013e32832c92d7; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Beermann S, 2012, N-S ARCH PHARMACOL, V385, P125, DOI 10.1007/s00210-011-0700-4; Bhola NE, 2008, FRONT BIOSCI-LANDMRK, V13, P1857, DOI 10.2741/2805; Billinton A, 2000, MOL BRAIN RES, V77, P111, DOI 10.1016/S0169-328X(00)00047-4; Birchmeier W, 2011, NATURE, V476, P287, DOI 10.1038/476287a; Bodei S, 2009, N-S ARCH PHARMACOL, V379, P413, DOI 10.1007/s00210-008-0384-6; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Boucard AA, 2012, J BIOL CHEM, V287, P9399, DOI 10.1074/jbc.M111.318659; Boutin C, 2012, CURR TOP DEV BIOL, V101, P161, DOI 10.1016/B978-0-12-394592-1.00010-7; Boyer SB, 2009, J NEUROSCI, V29, P15796, DOI 10.1523/JNEUROSCI.4103-09.2009; Brauner-Osborne H, 2000, GENOMICS, V65, P121, DOI 10.1006/geno.2000.6164; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Carracedo A, 2006, CANCER CELL, V9, P301, DOI 10.1016/j.ccr.2006.03.005; Chang WH, 2007, J BIOL CHEM, V282, P25030, DOI 10.1074/jbc.M700924200; Chen J, 2012, NATURE; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Chidambaram A, 2012, J NEUROSURG, V116, P843, DOI 10.3171/2011.11.JNS111455; Cool BH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010351; Cork SM, 2011, J MOL MED, V89, P743, DOI 10.1007/s00109-011-0759-x; Cork SM, 2012, ONCOGENE; Cricco G, 2006, ANTICANCER RES, V26, P4443; Cudaback E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008702; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Delcourt N, 2007, TRENDS PHARMACOL SCI, V28, P602, DOI 10.1016/j.tips.2007.09.007; DelValle J, 1997, AM J PHYSIOL-GASTR L, V273, pG987, DOI 10.1152/ajpgi.1997.273.5.G987; Deva S, 2012, COCHRANE DB SYST REV, V8; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Doyle SE, 2006, DEV DYNAM, V235, P3213, DOI 10.1002/dvdy.20973; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Driessens G, 2012, NATURE; Dutzmann S, 2010, CELL ADHES MIGR, V4, P515, DOI 10.4161/cam.4.4.12660; Ehtesham M, 2009, CANCER LETT, V274, P305, DOI 10.1016/j.canlet.2008.09.034; Elste AP, 2010, J MOL HISTOL, V41, P89, DOI 10.1007/s10735-010-9274-6; Eng L, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-18; Fareh M, 2012, CELL DEATH DIFFER, V19, P232, DOI 10.1038/cdd.2011.89; Feigin ME, 2013, FEBS J; Fernando RN, 2011, P NATL ACAD SCI USA, V108, P5837, DOI 10.1073/pnas.1014993108; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Fukui M, 2008, J CELL PHYSIOL, V216, P507, DOI 10.1002/jcp.21422; Galan-Moya EM, 2011, EMBO REP, V12, P470, DOI 10.1038/embor.2011.39; Gao Y, 2006, CANCER RES, V66, P11623, DOI 10.1158/0008-5472.CAN-06-2629; Gao Yun, 2009, Ai Zheng, V28, P104; Garcia-Lopez MT, 2010, CURR MED CHEM, V17, P109, DOI 10.2174/092986710790112639; Garland SL, 2013, J BIOMOL SCREEN; Garritano S, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.15; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Gessler F, 2010, NEUROSCIENCE, V165, P1312, DOI 10.1016/j.neuroscience.2009.11.049; Hamdani N, 2009, N-S ARCH PHARMACOL, V379, P403, DOI 10.1007/s00210-009-0392-1; Hannan S, 2011, J BIOL CHEM; Harada Y, 2007, BIOCHEM BIOPH RES CO, V358, P968, DOI 10.1016/j.bbrc.2007.04.208; Held-Feindt J, 2006, J NEUROCHEM, V98, P886, DOI 10.1111/j.1471-4159.2006.03911.x; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Herr DR, 2012, INT REV CEL MOL BIO, V297, P45, DOI 10.1016/B978-0-12-394308-8.00002-9; Hill SJ, 1997, PHARMACOL REV, V49, P253; Holdhoff M, 2011, ONCOLOGIST, V16, P351, DOI 10.1634/theoncologist.2010-0335; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Huang HY, 2005, CLIN CANCER RES, V11, P4357, DOI 10.1158/1078-0432.CCR-04-2107; Huang X, 2013, LEUK RES; Ichtchenko K, 1999, J BIOL CHEM, V274, P5491, DOI 10.1074/jbc.274.9.5491; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Jensen BC, 2009, N-S ARCH PHARMACOL, V379, P409, DOI 10.1007/s00210-008-0368-6; Jiang XN, 2012, J HISTOCHEM CYTOCHEM, V60, P269, DOI 10.1369/0022155412438105; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kaafarani I, 2009, FASEB J, V23, P3424, DOI 10.1096/fj.08-127852; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kang X, 2006, CANCER GENE THER, V13, P385, DOI 10.1038/sj.cgt.7700898; Kato S, 2006, NEPHRON EXP NEPHROL, V104, pE63, DOI 10.1159/000093999; Katoh M, 2005, ONCOL REP, V14, P1583; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaur B, 2003, AM J PATHOL, V162, P19, DOI 10.1016/S0002-9440(10)63794-7; Kee HJ, 2004, FEBS LETT, V569, P307, DOI 10.1016/j.febslet.2004.06.011; Kenessey I, 2012, PATHOL ONCOL RES; Kriegstein AR, 2005, NAT NEUROSCI, V8, P1132, DOI 10.1038/nn0905-1132; Kubecova M, 2011, EUR J PHARM SCI, V42, P439, DOI 10.1016/j.ejps.2011.02.004; Lappano R., 2013, J STEROID BIOCH MOL, DOI S0960-0760(13)00054-X; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Lee C, 2012, CAN J NEUROL SCI, V39, P145, DOI 10.1017/S0317167100013159; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li MZ, 2011, GLIA, V59, P108, DOI 10.1002/glia.21080; Lisy K, 2013, CLIN J ONCOL NURS, V17, P211, DOI 10.1188/13.CJON.211-212; Liu DR, 2010, INT J ONCOL, V36, P1401, DOI 10.3892/ijo_00000625; De Jesus ML, 2010, NEUROCHEM INT, V56, P829, DOI 10.1016/j.neuint.2010.03.007; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Luo R, 2011, P NATL ACAD SCI USA, V108, P12925, DOI 10.1073/pnas.1104821108; Mackrill John J, 2004, Methods Mol Biol, V259, P47; Magnus N, 2010, BLOOD, V116, P815, DOI 10.1182/blood-2009-10-250639; Malik Babar, 2012, Front Biosci (Elite Ed), V4, P2142; Marshall AD, 2011, CANCER RES, V71, P7471, DOI 10.1158/0008-5472.CAN-11-0924; Martinez A, 2002, J NATL CANCER I, V94, P1226; Matsushita H, 1999, FEBS LETT, V443, P348, DOI 10.1016/S0014-5793(99)00005-8; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Medina VA, 2010, BRIT J PHARMACOL, V161, P755, DOI 10.1111/j.1476-5381.2010.00961.x; Metellus P, 2011, EUR J CANCER, V47, P1727, DOI 10.1016/j.ejca.2011.02.021; Miguet L, 2009, J PROTEOME RES, V8, P3346, DOI 10.1021/pr801102c; Mizuta K, 2008, AM J RESP CELL MOL, V39, P296, DOI 10.1165/rcmb.2007-0414OC; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Nduom EKE, 2012, CANCER J, V18, P100, DOI 10.1097/PPO.0b013e3182452e0d; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; O'Sullivan ML, 2012, NEURON, V73, P903, DOI 10.1016/j.neuron.2012.01.018; Oehler MK, 2001, ONCOGENE, V20, P2937, DOI 10.1038/sj.onc.1204422; Oka M, 2006, BIOCHEM BIOPH RES CO, V341, P874, DOI 10.1016/j.bbrc.2006.01.039; Okajima D, 2010, J RECEPT SIG TRANSD, V30, P143, DOI 10.3109/10799891003671139; Oyama K, 2011, SEX DEV, V5, P205, DOI 10.1159/000329476; Patru C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-66; Persano L, 2013, BIOCHEM PHARMACOL, V85, P612, DOI 10.1016/j.bcp.2012.10.001; Pradidarcheep W, 2009, N-S ARCH PHARMACOL, V379, P397, DOI 10.1007/s00210-009-0393-0; Proto MC, 2012, J CELL PHYSIOL, V227, P250, DOI 10.1002/jcp.22727; Pyne NJ, 2012, BIOCHEM SOC T, V40, P94, DOI 10.1042/BST20110602; Rao S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033005; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Robbins MJ, 2000, GENOMICS, V67, P8, DOI 10.1006/geno.2000.6226; Roberts SS, 2009, PATHOL ONCOL RES, V15, P645, DOI 10.1007/s12253-009-9165-x; Safaee M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062765; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Schatton T, 2008, PIGM CELL MELANOMA R, V21, P39, DOI 10.1111/j.1755-148X.2007.00427.x; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Schechter CB, 1999, J NATL CANCER I, V91, P2050, DOI 10.1093/jnci/91.23.2050; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schley M, 2009, BRAIN RES BULL, V79, P333, DOI 10.1016/j.brainresbull.2009.01.011; Schulte A, 2011, GLIA, V59, P590, DOI 10.1002/glia.21127; Sharkis SJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003920; Shashidhar S, 2005, ONCOGENE, V24, P1673, DOI 10.1038/sj.onc.1208395; Silva JP, 2011, P NATL ACAD SCI USA, V108, P12113, DOI 10.1073/pnas.1019434108; Silva JP, 2010, ADV EXP MED BIOL, V706, P59; Singh SK, 2003, CANCER RES, V63, P5821; Smith SB, 2012, ARTHRITIS RHEUM-US, V64, P584, DOI 10.1002/art.33338; Snippert HJ, 2011, EMBO REP, V12, P113, DOI 10.1038/embor.2010.216; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Tamura S, 2009, HISTOL HISTOPATHOL, V24, P1009, DOI 10.14670/HH-24.1009; TATSUTA M, 1992, ONCOLOGY, V49, P241; Terasaki M, 2011, BRAIN TUMOR PATHOL, V28, P89, DOI 10.1007/s10014-010-0013-1; Terskikh AV, 2001, P NATL ACAD SCI USA, V98, P7934, DOI 10.1073/pnas.131200898; Thirant C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016375; Tissir F, 2006, EUR J NEUROSCI, V23, P597, DOI 10.1111/j.1460-9568.2006.04596.x; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Valente V, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-17; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varlet P, 2004, NEUROSURGERY, V55, P1377, DOI 10.1227/01.NEU.0000143033.36582.40; Verde Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026668; Villemure JF, 2005, BIOCHEM J, V388, P47, DOI 10.1042/BJ20041435; Wada H, 2006, DEVELOPMENT, V133, P4749, DOI 10.1242/dev.02665; Wang T, 2008, LIFE SCI, V82, P536, DOI 10.1016/j.lfs.2007.12.014; Wang ZL, 2010, FEBS LETT, V584, P4057, DOI 10.1016/j.febslet.2010.08.028; Ward Y, 2013, ONCOGENE, V32, P2726, DOI 10.1038/onc.2012.301; Ward Y, 2011, CANCER RES, V71, P7301, DOI 10.1158/0008-5472.CAN-11-2381; Webb DR, 2013, BIOCHEM PHARMACOL, V85, P147, DOI 10.1016/j.bcp.2012.08.021; White GRM, 1998, ONCOGENE, V17, P3513, DOI 10.1038/sj.onc.1202487; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Wootten D, 2013, NAT REV DRUG DISCOV, V12, P630, DOI 10.1038/nrd4052; Wu XY, 2012, J NEUROCHEM, V120, P842, DOI 10.1111/j.1471-4159.2011.07625.x; Xu L, 2006, P NATL ACAD SCI USA, V103, P9023, DOI 10.1073/pnas.0602681103; Xu L, 2010, CLIN EXP METASTAS, V27, P241, DOI 10.1007/s10585-010-9322-3; Yang G, 2012, BR J CANC; Yang LQ, 2011, CANCER RES, V71, P5558, DOI 10.1158/0008-5472.CAN-10-4543; Yin AA, 2013, CRIT REV ONCOL HEMAT, V87, P265, DOI 10.1016/j.critrevonc.2013.01.007; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zheng YS, 2013, MOL IMMUNOL, V54, P74, DOI 10.1016/j.molimm.2012.10.035; Zhou ZZ, 2010, BIOCHEM BIOPH RES CO, V398, P237, DOI 10.1016/j.bbrc.2010.06.066; Zhuang MQ, 2012, GENE, V495, P194, DOI 10.1016/j.gene.2011.12.037; Zigler M, 2011, CANCER RES, V71, P6561, DOI 10.1158/0008-5472.CAN-11-1432	180	24	24	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91519	10.1371/journal.pone.0091519	http://dx.doi.org/10.1371/journal.pone.0091519			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662753	Green Published, gold			2022-12-27	WOS:000333459900022
J	Thai, A; Papapanou, PN; Jacobs, DR; Desvarieux, M; Demmer, RT				Thai, Ashley; Papapanou, Panos N.; Jacobs, David R., Jr.; Desvarieux, Moise; Demmer, Ryan T.			Periodontal Infection and Cardiorespiratory Fitness in Younger Adults: Results from Continuous National Health and Nutrition Examination Survey 1999-2004	PLOS ONE			English	Article							EXAMINATION SURVEY NHANES; VASCULAR-DISEASE EPIDEMIOLOGY; CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; PHYSICAL-FITNESS; EXERCISE CAPACITY; QUALITY-ASSURANCE; ORAL INFECTIONS; TOOTH LOSS; RISK	Objective: Previous studies report associations between periodontal infection and cardiorespiratory fitness but no study has examined the association among younger adults. Our objective was to study the association between clinical measures of periodontal infection and cardiorespiratory fitness levels among a population-based sample of younger adults. Methods: The Continuous National Health and Nutrition Examination Survey 1999-2004 enrolled 2,863 participants (46% women) who received a partial-mouth periodontal examination and completed a submaximal treadmill test for the assessment of estimated VO2 max(eVO(2) max). Participants were mean +/- SD age 33 +/- 9 years (range = 20-49 years), 30% Hispanic, 48% White, 19% Black, and 3% other. Mean eVO(2) max (mL/kg/minute) as well as eVO(2) max <= 32 mL/kg/minute (20th percentile) were regressed across quartiles of mean probing depth and mean attachment loss in multivariable linear and logistic regression models. Results: After multivariable adjustment, mean eVO(2) max levels +/- SE across quartiles of attachment loss were 39.72 +/- 0.37, 39.64 +/- 0.34, 39.59 +/- 0.36, and 39.85 +/- 0.39 (P = 0.99). Mean eVO(2) max +/- SE across quartiles of probing depth were 39.57 +/- 0.32, 39.78 +/- 0.38, 39.19 +/- 0.25, and 40.37 +/- 0.53 (P = 0.28). Similarly, multivariable adjusted mean eVO(2) max values were similar between healthy participants vs. those with moderate/severe periodontitis: 39.70 +/- 0.21 vs. 39.70 +/- 0.90 (P = 1.00). The odds ratio (OR) for low eVO(2) max comparing highest vs. lowest quartile of attachment loss = 0.89[95% CI 0.64-1.24]. The OR for comparing highest vs. lowest probing depth quartile = 0.77[95% CI 0.51-1.15]. Conclusion: Clinical measures of periodontal infection were not related to cardiorespiratory fitness in a sample of generally healthy younger adults.	[Thai, Ashley; Desvarieux, Moise; Demmer, Ryan T.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Papapanou, Panos N.] Columbia Univ, Div Periodont, Coll Dent Med, Sect Oral & Diagnost Sci, New York, NY USA; [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Jacobs, David R., Jr.] Univ Oslo, Dept Nutr, Oslo, Norway; [Desvarieux, Moise] Ctr Rech Epidemiol & Biostat, INSERM, U1153, Equipe Methodes Evaluat Therapeut Malad Chron, Paris, France	Columbia University; Columbia University; University of Minnesota System; University of Minnesota Twin Cities; University of Oslo; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Demmer, RT (corresponding author), Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA.	rtd2106@columbia.edu	Desvarieux, Moise/C-4991-2019	Jacobs, David/0000-0002-7232-0543; Papapanou, Panos N./0000-0002-6538-3618; Demmer, Ryan/0000-0003-3429-0379	NIH grants [R00 DE-018739, R21 DE-022422]; Diabetes and Endocrinology Research Center, College of Physicians and Surgeons, Columbia University [DK-63608]; Chair in Chronic Disease, Ecole des Hautes Etudes en Sante Publique, France;  [R01 DE-13094]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013094, R21DE022422, R00DE018739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063608] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes and Endocrinology Research Center, College of Physicians and Surgeons, Columbia University; Chair in Chronic Disease, Ecole des Hautes Etudes en Sante Publique, France; ; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by NIH grants R00 DE-018739 and R21 DE-022422 to Dr. Demmer. Additional funding support was provided by a Pilot & Feasibility Award to Dr. Demmer from the Diabetes and Endocrinology Research Center, College of Physicians and Surgeons, Columbia University (DK-63608); a Chair in Chronic Disease, Ecole des Hautes Etudes en Sante Publique, France (Dr. Desvarieux); Dr. Desvarieux is also supported by R01 DE-13094. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Sports Medicine, 2009, ACSMS GUID EX TEST P, P8; Beck JD, 2001, ARTERIOSCL THROM VAS, V21, P1816, DOI 10.1161/hq1101.097803; Bieler GS, 2010, AM J EPIDEMIOL, V171, P618, DOI 10.1093/aje/kwp440; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Centers for Disease Control, 2004, NHANES CARD FITN PRO; Centers for Disease Control and Prevention, 2010, DEF OV OB; Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466; Demmer RT, 2008, COMMUNITY DENT ORAL, V36, P493, DOI 10.1111/j.1600-0528.2008.00435.x; Demmer RT, 2008, DIABETES CARE, V31, P1373, DOI 10.2337/dc08-0026; Demmer RT, 2006, J AM DENT ASSOC, V137, p14S, DOI 10.14219/jada.archive.2006.0402; Demmer RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077441; Demmer RT, 2012, DIABETES CARE, V35, P2235, DOI 10.2337/dc12-0072; Demmer RT, 2010, DIABETES CARE, V33, P1037, DOI 10.2337/dc09-1778; Demmer RT, 2010, PERIODONTOL 2000, V53, P28, DOI 10.1111/j.1600-0757.2009.00326.x; Demmer RT, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-2; Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15; Desvarieux M, 2004, STROKE, V35, P2029, DOI 10.1161/01.STR.0000136767.71518.36; Dowsett SA, 2002, J PERIODONTOL, V73, P975, DOI 10.1902/jop.2002.73.9.975; Duncan Glen E, 2006, Curr Diab Rep, V6, P29, DOI 10.1007/s11892-006-0048-1; Dye BA, 2007, COMMUNITY DENT ORAL, V35, P140, DOI 10.1111/j.1600-0528.2007.00310.x; Dye BA, 2008, J PUBLIC HEALTH DENT, V68, P218, DOI 10.1111/j.1752-7325.2007.00076.x; Eberhard J, 2013, J CLIN PERIODONTOL; Gulati M, 2003, CIRCULATION, V108, P1554, DOI 10.1161/01.CIR.0000091080.57509.E9; Hoyert DL, 2012, NATL VITAL STAT REPO, V21, P29; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Janket SJ, 2003, ORAL SURG ORAL MED O, V95, P559, DOI 10.1067/moe.2003.107; Joshipura KJ, 2003, STROKE, V34, P47, DOI 10.1161/01.STR.0000052974.79428.0C; Kaur G, 2009, J CLIN PERIODONTOL, V36, P765, DOI 10.1111/j.1600-051X.2009.01445.x; Kebschull M, 2010, J DENT RES, V89, P879, DOI 10.1177/0022034510375281; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Koromantzos PA, 2011, J CLIN PERIODONTOL, V38, P142, DOI 10.1111/j.1600-051X.2010.01652.x; Lu B, 2008, ATHEROSCLEROSIS, V200, P199, DOI 10.1016/j.atherosclerosis.2007.12.037; Mullooly Cathy, 2002, Curr Diab Rep, V2, P441, DOI 10.1007/s11892-002-0109-z; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Owens JD, 2003, J PERIODONTOL, V74, P1206, DOI 10.1902/jop.2003.74.8.1206; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Sfyroeras GS, 2012, J VASC SURG, V55, P1178, DOI 10.1016/j.jvs.2011.10.008; Shimazaki Y, 2010, J PERIODONTOL, V81, P1124, DOI 10.1902/jop.2010.100017; Slade GD, 2000, J DENT RES, V79, P49, DOI 10.1177/00220345000790010701; Smith AC, 2012, INT J STROKE, V7, P499, DOI 10.1111/j.1747-4949.2012.00791.x; Sullivan PW, 2007, OBESITY, V15, P3150, DOI 10.1038/oby.2007.375; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Wakai K, 1999, J CLIN PERIODONTOL, V26, P664, DOI 10.1034/j.1600-051X.1999.261006.x; Wang CY, 2010, AM J EPIDEMIOL, V171, P426, DOI 10.1093/aje/kwp412; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547; Wu TJ, 2000, ARCH INTERN MED, V160, P2749, DOI 10.1001/archinte.160.18.2749	49	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92441	10.1371/journal.pone.0092441	http://dx.doi.org/10.1371/journal.pone.0092441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663097	gold, Green Published, Green Submitted			2022-12-27	WOS:000333459900064
J	Tighiouart, M; Liu, Y; Rogatko, A				Tighiouart, Mourad; Liu, Yuan; Rogatko, Andre			Escalation with Overdose Control Using Time to Toxicity for Cancer Phase I Clinical Trials	PLOS ONE			English	Article							CONTINUAL REASSESSMENT METHOD; DOSE-ESCALATION; DESIGNS	Escalation with overdose control (EWOC) is a Bayesian adaptive phase I clinical trial design that produces consistent sequences of doses while controlling the probability that patients are overdosed. However, this design does not take explicitly into account the time it takes for a patient to exhibit dose limiting toxicity (DLT) since the occurrence of DLT is ascertained within a predetermined window of time. Models to estimate the Maximum Tolerated Dose (MTD) that use the exact time when the DLT occurs are expected to be more precise than those where the variable of interest is categorized as presence or absence of DLT, given that information is lost in the process of categorization of the variable. We develop a class of parametric models for time to toxicity data in order to estimate the MTD efficiently, and present extensive simulations showing that the method has good design operating characteristics relative to the original EWOC and a version of time to event EWOC (TITE-EWOC) which allocates weights to account for the time it takes for a patient to exhibit DLT. The methodology is exemplified by a cancer phase I clinical trial we designed in order to estimate the MTD of Veliparib (ABT-888) in combination with fixed doses of gemcitabine and intensity modulated radiation therapy in patients with locally advanced, un-resectable pancreatic cancer.	[Tighiouart, Mourad; Rogatko, Andre] Samuel Oschin Comprehens Canc Inst, Biostat & Bioinformat Res Ctr, Los Angeles, CA 90048 USA; [Liu, Yuan] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Cedars Sinai Medical Center; Emory University	Tighiouart, M (corresponding author), Samuel Oschin Comprehens Canc Inst, Biostat & Bioinformat Res Ctr, Los Angeles, CA 90048 USA.	mourad.tighiouart@cshs.org			National Center for Research Resources [UL1RR033176]; National Center for Advancing Translational Sciences [UL1TR000124, 5P01CA098912-05, P01DK046763, 2R01CA108646-07A1]; NATIONAL CANCER INSTITUTE [P01CA098912, R01CA108646] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK046763] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the National Center for Research Resources, Grant UL1RR033176, and is now at the National Center for Advancing Translational Sciences, Grant UL1TR000124 (M. T and A. R), Grant 5P01CA098912-05 (A. R.), P01DK046763 (A. R.), and 2R01CA108646-07A1 (A. R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babb J, 1998, STAT MED, V17, P1103, DOI 10.1002/(SICI)1097-0258(19980530)17:10<1103::AID-SIM793>3.0.CO;2-9; Braun TM, 2007, CLIN TRIALS, V4, P113, DOI 10.1177/1740774507076934; Cheung YK, 2005, BIOMETRIKA, V92, P863, DOI 10.1093/biomet/92.4.863; Cheung YK, 2000, BIOMETRICS, V56, P1177, DOI 10.1111/j.0006-341X.2000.01177.x; COX DR, 1972, J R STAT SOC B, V34, P187; Faries D, 1994, J Biopharm Stat, V4, P147, DOI 10.1080/10543409408835079; Fedorov V. V., 2011, BEST INTENTION DESIG; GOODMAN SN, 1995, STAT MED, V14, P1149, DOI 10.1002/sim.4780141102; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Klein JP, 2003, SURVIVAL ANAL; Le Tourneau C, 2009, JNCI-J NATL CANCER I, V101, P708, DOI 10.1093/jnci/djp079; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mauguen A, 2011, STAT MED, V30, P1584, DOI 10.1002/sim.4128; Maur M, 2007, HEMATOL ONCOL, V25, P53, DOI 10.1002/hon.808; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MOLLER S, 1995, STAT MED, V14, P911, DOI 10.1002/sim.4780140909; OQUIGLEY J, 1990, BIOMETRICS, V46, P33, DOI 10.2307/2531628; Oron AP, 2013, CLIN TRIALS, V10, P63, DOI 10.1177/1740774512469311; Piantadosi S, 1998, CANCER CHEMOTH PHARM, V41, P429, DOI 10.1007/s002800050763; Polley MYC, 2011, STAT MED, V30, P2130, DOI 10.1002/sim.4255; Rogatko A., 2012, USER GUIDE WEB BASED; Rosenberger WF, 2002, STAT MED, V21, P2757, DOI 10.1002/sim.1229; Storer BE, 2001, STAT MED, V20, P2399, DOI 10.1002/sim.903.abs; Tighiouart M, 2005, STAT MED, V24, P2183, DOI 10.1002/sim.2106; Tighiouart M, 2012, J PROBABILITY STAT, V2012, P18; TIGHIOUART M, 2012, J PROBABILITY STAT, V2012, P16, DOI DOI 10.1155/2012/692725; Tighiouart M, 2012, J PROBAB STAT, V2012, DOI 10.1155/2012/567819; Tighiouart M, 2010, STAT SCI, V25, P217, DOI 10.1214/10-STS333; Ting N., 2006, DOSE FINDING DRUG DE; Zacks S, 1998, STAT PROBABIL LETT, V38, P215, DOI 10.1016/S0167-7152(98)00016-9	30	18	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93070	10.1371/journal.pone.0093070	http://dx.doi.org/10.1371/journal.pone.0093070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663812	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900149
J	Yu, Z; Yang, J; Liu, LM				Yu, Zheng; Yang, Jun; Liu, Lemian			Denitrifier Community in the Oxygen Minimum Zone of a Subtropical Deep Reservoir	PLOS ONE			English	Article							NITRATE-REDUCING COMMUNITY; NITROUS-OXIDE REDUCTASE; NOSZ GENES; NITRIC-OXIDE; PCR PRIMERS; BACTERIA; NIRK; NARG; ABUNDANCE; QUANTIFICATION	Denitrification is an important pathway for nitrogen removal from aquatic systems and this could benefit water quality. However, little is known about the denitrifier community composition and key steps of denitrification in the freshwater environments, and whether different bacteria have a role in multiple processes of denitrification reduction. In this study, quantitative PCR, quantitative RT-PCR, clone library and 454 pyrosequencing were used together to investigate the bacterial and denitrifier community in a subtropical deep reservoir during the strongly stratified period. Our results indicated that the narG gene recorded the highest abundance among the denitrifying genes (2.76x10(9) copies L-1 for DNA and 4.19x10(8) copies L-1 for RNA), and the lowest value was nosZ gene (7.56x10(5) copies L-1 for DNA and undetected for RNA). The RNA: DNA ratios indicated that narG gene was the most active denitrifying gene in the oxygen minimum zone of Dongzhen Reservoir. Further, alpha-, beta- and gamma- Proteobacteria were the overwhelmingly dominant classes of denitrifier communities. Each functional gene had its own dominant groups which were different at the genus level: the narG gene was dominated by Albidiferax, while nirS gene was dominated by Dechloromonas. The main OTU of nirK gene was Rhodopseudomonas palustris, but for norB and nosZ genes, they were Bacillus and Bradyrhizobium, respectively. These results contribute to the understanding of linkages between denitrifier community, function and how they work together to complete the denitrification process. Studies on denitrifier community and activity may be useful in managing stratified reservoirs for the ecosystem services and aiding in constructing nitrogen budgets.	[Yu, Zheng; Yang, Jun; Liu, Lemian] Chinese Acad Sci, Inst Urban Environm, Aquat EcoHlth Grp, Key Lab Urban Environm & Hlth, Xiamen, Peoples R China; [Yu, Zheng] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Urban Environment, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, J (corresponding author), Chinese Acad Sci, Inst Urban Environm, Aquat EcoHlth Grp, Key Lab Urban Environm & Hlth, Xiamen, Peoples R China.	jyang@iue.ac.cn	Yang, Jun/E-6680-2011; CAS, KLUEH/T-5743-2019; YANG, Jun/J-2819-2014	Yang, Jun/0000-0002-7920-2777; YANG, Jun/0000-0002-5069-507X; Liu, Lemian/0000-0002-8977-6969	National High-Tech Research and Development Program of China [2012AA062607]; International Science and Technology Cooperation Program of China [2011DFB91710]; Natural Science Foundation for Distinguished Young Scholars of Fujian Province [2012J06009]; National Natural Science Foundation of China [31172114, 31370471]	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); International Science and Technology Cooperation Program of China; Natural Science Foundation for Distinguished Young Scholars of Fujian Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National High-Tech Research and Development Program of China (2012AA062607), the International Science and Technology Cooperation Program of China (2011DFB91710), the Natural Science Foundation for Distinguished Young Scholars of Fujian Province (2012J06009), the National Natural Science Foundation of China (31172114, 31370471). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RB, 2000, NATURE, V403, P758, DOI 10.1038/35001562; Angeloni NL, 2006, FEMS MICROBIOL LETT, V263, P86, DOI 10.1111/j.1574-6968.2006.00409.x; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Beaulieu JJ, 2011, P NATL ACAD SCI USA, V108, P214, DOI 10.1073/pnas.1011464108; Braker G, 1998, APPL ENVIRON MICROB, V64, P3769; Braker G, 2003, APPL ENVIRON MICROB, V69, P3476, DOI 10.1128/AEM.69.6.3476-3483.2003; Burgin AJ, 2007, FRONT ECOL ENVIRON, V5, P89, DOI 10.1890/1540-9295(2007)5[89:HWOTRO]2.0.CO;2; Burgin AJ, 2012, AQUAT MICROB ECOL, V66, P283, DOI 10.3354/ame01574; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; Casciotti KL, 2005, FEMS MICROBIOL ECOL, V52, P197, DOI 10.1016/j.femsec.2004.11.002; Cheneby D, 2003, MICROBIAL ECOL, V46, P113, DOI 10.1007/s00248-002-2042-8; Chon K, 2011, ECOL ENG, V37, P64, DOI 10.1016/j.ecoleng.2009.04.005; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Deiglmayr K, 2006, ENVIRON MICROBIOL, V8, P1600, DOI 10.1111/j.1462-2920.2006.01051.x; Finneran KT, 2003, INT J SYST EVOL MICR, V53, P669, DOI 10.1099/ijs.0.02298-0; Gruber N., 2004, OCEAN CARBON CYCLE C, P97, DOI DOI 10.1007/978-1-4020-2087-2_4; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Henry S, 2004, J MICROBIOL METH, V59, P327, DOI 10.1016/j.mimet.2004.07.002; Henry S, 2006, APPL ENVIRON MICROB, V72, P5181, DOI 10.1128/AEM.00231-06; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Kandeler E, 2006, APPL ENVIRON MICROB, V72, P5957, DOI 10.1128/AEM.00439-06; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lopez-Gutierrez JC, 2004, J MICROBIOL METH, V57, P399, DOI 10.1016/j.mimet.2004.02.009; Mounier E, 2004, ENVIRON MICROBIOL, V6, P301, DOI 10.1111/j.1462-2920.2004.00571.x; Naqvi SWA, 2008, BIOGEOSCIENCES, V5, P1033, DOI 10.5194/bg-5-1033-2008; Philippot L, 2002, APPL ENVIRON MICROB, V68, P6121, DOI 10.1128/AEM.68.12.6121-6128.2002; Philippot L, 2002, BBA-GENE STRUCT EXPR, V1577, P355, DOI 10.1016/S0167-4781(02)00420-7; Philippot L, 2007, ADV AGRON, V96, P249, DOI 10.1016/S0065-2113(07)96003-4; Pina-Ochoa E, 2010, P NATL ACAD SCI USA, V107, P1148, DOI 10.1073/pnas.0908440107; Saunders DL, 2001, HYDROBIOLOGIA, V443, P205, DOI 10.1023/A:1017506914063; Scala DJ, 1998, FEMS MICROBIOL LETT, V162, P61, DOI 10.1111/j.1574-6968.1998.tb12979.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seitzinger S, 2006, ECOL APPL, V16, P2064, DOI 10.1890/1051-0761(2006)016[2064:DALAWA]2.0.CO;2; Sim K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032543; Smith CJ, 2007, APPL ENVIRON MICROB, V73, P3612, DOI 10.1128/AEM.02894-06; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Throback IN, 2004, FEMS MICROBIOL ECOL, V49, P401, DOI 10.1016/j.femsec.2004.04.011; Vidali M, 2001, PURE APPL CHEM, V73, P1163, DOI 10.1351/pac200173071163; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Wallenstein MD, 2006, ECOL APPL, V16, P2143, DOI 10.1890/1051-0761(2006)016[2143:ECODCA]2.0.CO;2; Ward BB, 2009, NATURE, V461, P78, DOI 10.1038/nature08276; Yang J, 2012, ENVIRON SCI POLLUT R, V19, P1432, DOI 10.1007/s11356-011-0683-1; Yoshida M, 2010, MICROBES ENVIRON, V25, P45, DOI 10.1264/jsme2.ME09160; Yoshida M, 2009, SOIL BIOL BIOCHEM, V41, P2044, DOI 10.1016/j.soilbio.2009.07.012; Zehr JP, 2011, ANNU REV MAR SCI, V3, P197, DOI 10.1146/annurev-marine-120709-142819; ZUMFT WG, 1993, ARCH MICROBIOL, V160, P253, DOI 10.1007/BF00292074; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	47	23	24	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92055	10.1371/journal.pone.0092055	http://dx.doi.org/10.1371/journal.pone.0092055			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664112	gold, Green Submitted, Green Published			2022-12-27	WOS:000333459900039
J	Vieira, VMNDD; Mateus, MD				de Carvalho da Silva Vieira, Vasco Manuel Nobre; Mateus, Marcos Duarte			Regulation of the Demographic Structure in Isomorphic Biphasic Life Cycles at the Spatial Fine Scale	PLOS ONE			English	Article							GELIDIUM-SESQUIPEDALE RHODOPHYTA; CHONDRUS-CRISPUS RHODOPHYTA; POPULATION-DYNAMICS; WAVE EXPOSURE; TEMPORAL VARIATION; HISTORY STAGES; DIPLOID RATIO; NOVA-SCOTIA; RED ALGA; GIGARTINALES	Isomorphic biphasic algal life cycles often occur in the environment at ploidy abundance ratios (Haploid:Diploid) different from 1. Its spatial variability occurs within populations related to intertidal height and hydrodynamic stress, possibly reflecting the niche partitioning driven by their diverging adaptation to the environment argued necessary for their prevalence (evolutionary stability). Demographic models based in matrix algebra were developed to investigate which vital rates may efficiently generate an H:D variability at a fine spatial resolution. It was also taken into account time variation and type of life strategy. Ploidy dissimilarities in fecundity rates set an H:D spatial structure miss-fitting the ploidy fitness ratio. The same happened with ploidy dissimilarities in ramet growth whenever reproductive output dominated the population demography. Only through ploidy dissimilarities in looping rates (stasis, breakage and clonal growth) did the life cycle respond to a spatially heterogeneous environment efficiently creating a niche partition. Marginal locations were more sensitive than central locations. Related results have been obtained experimentally and numerically for widely different life cycles from the plant and animal kingdoms. Spore dispersal smoothed the effects of ploidy dissimilarities in fertility and enhanced the effects of ploidy dissimilarities looping rates. Ploidy dissimilarities in spore dispersal could also create the necessary niche partition, both over the space and time dimensions, even in spatial homogeneous environments and without the need for conditional differentiation of the ramets. Fine scale spatial variability may be the key for the prevalence of isomorphic biphasic life cycles, which has been neglected so far.	[de Carvalho da Silva Vieira, Vasco Manuel Nobre; Mateus, Marcos Duarte] Univ Tecn Lisboa, Inst Super Tecn, MARETEC, P-1096 Lisbon, Portugal	Universidade de Lisboa; Instituto Superior Tecnico	Vieira, VMNDD (corresponding author), Univ Tecn Lisboa, Inst Super Tecn, MARETEC, P-1096 Lisbon, Portugal.	vasco.vieira@ist.utl.pt	Mateus, Marcos Duarte/C-3083-2012	Mateus, Marcos Duarte/0000-0003-4916-6821; Vieira, Vasco/0000-0001-9858-6254	Portuguese Science Foundation (FCT) [SFRH/BD/19339/2004/MS47]; Portuguese Science Foundation (FCT) program Ciencia	Portuguese Science Foundation (FCT)(Portuguese Foundation for Science and Technology); Portuguese Science Foundation (FCT) program Ciencia	V.V. was supported by a Ph D grant from the Portuguese Science Foundation (FCT), SFRH/BD/19339/2004/MS47. M.M. was supported by the Portuguese Science Foundation (FCT) program Ciencia2008. www.fct.pt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbuti R, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-49; Carmona R, 2006, J PHYCOL, V42, P259, DOI 10.1111/j.1529-8817.2006.00190.x; Caswell, 2000, MATRIX POPULATION MO; Vieira VMNCS, 2012, J PHYCOL, V48, P1012, DOI 10.1111/j.1529-8817.2012.01192.x; Vieira VMNDD, 2010, J PHYCOL, V46, P1128, DOI 10.1111/j.1529-8817.2010.00924.x; DESTOMBE C, 1989, J EVOLUTION BIOL, V2, P317, DOI 10.1046/j.1420-9101.1989.2050317.x; DeWreede R.E., 1999, PHYCOL RES, V47, P153; Dyck LJ, 2006, PHYCOL RES, V54, P21, DOI 10.1111/j.1440-1835.2006.00405.x; Ehrlen J, 1999, MODELLING MEASURING; Engel C, 2001, J ECOL, V89, P436, DOI 10.1046/j.1365-2745.2001.00567.x; Fierst J, 2005, J PHYCOL, V41, P238, DOI 10.1111/j.1529-8817.2005.04024.x; Franco M, 1996, PHILOS T R SOC B, V351, P1341, DOI 10.1098/rstb.1996.0117; Garza-Sanchez F, 2000, BOT MAR, V43, P205, DOI 10.1515/BOT.2000.022; Gonzalez J, 1996, AQUACULTURE, V143, P91, DOI 10.1016/0044-8486(95)01203-6; Hughes JS, 1999, AM NAT, V154, P306, DOI 10.1086/303241; Lindgren A, 1998, J APPL PHYCOL, V10, P273, DOI 10.1023/A:1008065810904; Mudge B, 2003, J MAR BIOL ASSOC UK, V83, P701, DOI 10.1017/S0025315403007665h; Oostermeijer JGB, 1996, J ECOL, V84, P153, DOI 10.2307/2261351; Otaiza RD, 2001, J APPL PHYCOL, V13, P161, DOI 10.1023/A:1011135308283; Pacheco-Ruiz I, 2011, BOT MAR, V54, P127, DOI 10.1515/BOT.2011.019; Pandey M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-48; Prathep A, 2009, AQUAT BOT, V90, P179, DOI 10.1016/j.aquabot.2008.09.003; Rojas-Sandoval J, 2013, POPUL ECOL, V55, P479, DOI 10.1007/s10144-013-0378-1; Roleda MY, 2008, PHYCOLOGIA, V47, P361, DOI 10.2216/PH07-84.1; Santos R, 1996, HYDROBIOLOGIA, V327, P223, DOI 10.1007/BF00047811; Santos R, 1998, J APPL PHYCOL, V10, P261, DOI 10.1023/A:1008083926349; SCROSATI R, 1994, BOT MAR, V37, P293, DOI 10.1515/botm.1994.37.4.293; Scrosati R, 2004, HYDROBIOLOGIA, V520, P199, DOI 10.1023/B:HYDR.0000027839.48584.6c; Scrosati R, 2004, HYDROBIOLOGIA, V519, P215, DOI 10.1023/B:HYDR.0000026600.88646.31; Serviere-Zaragoza Elisa, 2002, Pacific Science, V56, P285, DOI 10.1353/psc.2002.0029; Thornber C, 2006, ECOLOGY, V87, P2255, DOI 10.1890/0012-9658(2006)87[2255:TTMSHO]2.0.CO;2; Thornber CS, 2004, ECOLOGY, V85, P1661, DOI 10.1890/02-4101; Thornber CS, 2003, MAR ECOL PROG SER, V258, P65, DOI 10.3354/meps258065; Verges A, 2008, ECOLOGY, V89, P1334, DOI 10.1890/07-0248.1; Vieira VMNCS, 2012, J BIOL DYNAM, V6, P1067, DOI 10.1080/17513758.2012.721901	35	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92602	10.1371/journal.pone.0092602	http://dx.doi.org/10.1371/journal.pone.0092602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658603	Green Submitted, gold, Green Published			2022-12-27	WOS:000333355300103
J	Brans, K; Verduyn, P				Brans, Karen; Verduyn, Philippe			Intensity and Duration of Negative Emotions: Comparing the Role of Appraisals and Regulation Strategies	PLOS ONE			English	Article							SELF; EXPERIENCES; MODEL; DETERMINANTS; RUMINATION; PROFILES	Intensity and duration are two central characteristics of an emotional response. Appraisals and regulation strategies are among the most important determinants of these emotion features. However, as intensity and duration are only moderately correlated, appraisals and regulation strategies may be differently related to these characteristics. A systematic empirical study comparing predictors of emotion intensity and duration is missing. The goal of the present study is to fill this gap. Participants were asked to recall recently experienced episodes of anger, fear, disgust, guilt, sadness, and shame. Subsequently, the were asked to answer a number of question regarding (a) the intensity and duration of these emotions, (b) their appraisal of the emotion elicting event, and (c) their use of a wide range of regulation strategies. Emotion intensity was found to be mainly predicted by appraisals whereas emotion duration was equally well predicted by appraisals and regulation strategies.	[Brans, Karen; Verduyn, Philippe] Katholieke Univ Leuven, Fac Psychol & Educ Sci, Brussels, Belgium	KU Leuven	Brans, K (corresponding author), Katholieke Univ Leuven, Fac Psychol & Educ Sci, Brussels, Belgium.	karen.brans@ppw.kuleuven.be		Verduyn, Philippe/0000-0001-8266-2216	Research Fund of the KU Leuven, Philippe Verduyn [GOA/10/02]; Research Foundation Flanders (MO)	Research Fund of the KU Leuven, Philippe Verduyn; Research Foundation Flanders (MO)	The present research was supported by Grant GOA/10/02 from the Research Fund of the KU Leuven, Philippe Verduyn is supported by the Research Foundation Flanders (MO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustine AA, 2009, COGNITION EMOTION, V23, P1181, DOI 10.1080/02699930802396556; Beedie CJ, 2005, COGNITION EMOTION, V19, P847, DOI 10.1080/02699930541000057; Brans K, 2013, EMOTION, V13, P926, DOI 10.1037/a0032400; Butler EA, 2003, EMOTION, V3, P48, DOI 10.1037/1528-3542.3.1.48; Campos B, 2013, COGNITION EMOTION, V27, P37, DOI 10.1080/02699931.2012.683852; Davidson RJ, 1998, COGNITION EMOTION, V12, P307, DOI 10.1080/026999398379628; Fischer A.H., 2001, APPRAISAL PROCESSES, P221; FREDRICKSON BL, 1993, J PERS SOC PSYCHOL, V65, P45, DOI 10.1037/0022-3514.65.1.45; Frijda N. H., 2007, LAWS EMOTION; Frijda N. H., 1986, EMOTIONS STUDIES EMO; Gross J.J., 2007, HDB EMOTION REGULATI, P3; Koole S, 2009, COGNITION EMOTION, V23, P4, DOI 10.1080/02699930802619031; Kreibig SD, 2012, BIOL PSYCHOL, V91, P365, DOI 10.1016/j.biopsycho.2012.08.007; Kross E, 2011, CURR DIR PSYCHOL SCI, V20, P187, DOI 10.1177/0963721411408883; Lazarus R.S., 1984, EMOTION ADAPTATION; Moberly NJ, 2008, J ABNORM PSYCHOL, V117, P314, DOI 10.1037/0021-843X.117.2.314; NOLENHOEKSEMA S, 1991, J ABNORM PSYCHOL, V100, P569, DOI 10.1037/0021-843X.100.4.569; Pe ML, 2013, COGNITION EMOTION, V27, P492, DOI 10.1080/02699931.2012.719489; Rime B, 2009, EMOT REV, V1, P60, DOI 10.1177/1754073908097189; Robinson MD, 2002, J PERS SOC PSYCHOL, V83, P198, DOI 10.1037//0022-3514.83.1.198; Rozin P., 2009, OXFORD COMPANION EMO, P121; Saucier G, 1996, 5 FACTOR MODEL PERSO, P21; Scherer K.R., 2001, APPRAISAL PROCESSES, DOI DOI 10.1016/S0166-4115(08)62387-0; Scherer K.R., 1984, APPROACHES EMOTION, P293; Scherer K. R., 1999, HDB COGNITION EMOTIO, P637, DOI [10.1002/0470013494.ch30, DOI 10.1002/0470013494.CH30]; Scherer KR, 1997, COGNITION EMOTION, V11, P113, DOI 10.1080/026999397379962; SCHERER KR, 1994, J PERS SOC PSYCHOL, V66, P310, DOI 10.1037/0022-3514.66.2.310; SHOTT S, 1979, AM J SOCIOL, V84, P1317, DOI 10.1086/226936; SMITH CA, 1993, COGNITION EMOTION, V7, P233, DOI 10.1080/02699939308409189; SONNEMANS J, 1994, COGNITION EMOTION, V8, P329, DOI 10.1080/02699939408408945; SONNEMANS J, 1995, COGNITION EMOTION, V9, P483, DOI 10.1080/02699939508408977; Tracy JL, 2004, PSYCHOL INQ, V15, P103, DOI 10.1207/s15327965pli1502_01; Trapnell PD, 1999, J PERS SOC PSYCHOL, V76, P284, DOI 10.1037/0022-3514.76.2.284; Tugade M., 2007, J HAPPINESS STUD, V8, P311, DOI [DOI 10.1007/S10902-006-9015-4, 10.1007/s10902-006-9015-4]; Van Dillen LF, 2007, EMOTION, V7, P715, DOI 10.1037/1528-3542.7.4.715; Van Mechelen I, 2013, CHANGING EMOTIONS, P174; Verduyn P, 2013, EUR J PERSONALITY, V27, P481, DOI 10.1002/per.1897; Verduyn P, 2012, EMOTION, V12, P1248, DOI 10.1037/a0028289; Verduyn P, 2012, COGNITION EMOTION, V26, P1486, DOI 10.1080/02699931.2012.662152; Verduyn P, 2011, EMOTION, V11, P20, DOI 10.1037/a0021239; Verduyn P, 2009, COGNITION EMOTION, V23, P1427, DOI 10.1080/02699930902949031; Verduyn P, 2009, EMOTION, V9, P83, DOI 10.1037/a0014610; Webb TL, 2012, PSYCHOL BULL, V138, P775, DOI 10.1037/a0027600	43	32	32	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92410	10.1371/journal.pone.0092410	http://dx.doi.org/10.1371/journal.pone.0092410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SR	24670979	gold, Green Published, Green Submitted			2022-12-27	WOS:000333677000044
J	Hyde, ER; Andrade, F; Vaksman, Z; Parthasarathy, K; Jiang, H; Parthasarathy, DK; Torregrossa, AC; Tribble, G; Kaplan, HB; Petrosino, JF; Bryan, NS				Hyde, Embriette R.; Andrade, Fernando; Vaksman, Zalman; Parthasarathy, Kavitha; Jiang, Hong; Parthasarathy, Deepa K.; Torregrossa, Ashley C.; Tribble, Gena; Kaplan, Heidi B.; Petrosino, Joseph F.; Bryan, Nathan S.			Metagenomic Analysis of Nitrate-Reducing Bacteria in the Oral Cavity: Implications for Nitric Oxide Homeostasis	PLOS ONE			English	Article							INCIDENT CARDIOVASCULAR EVENTS; FLOW-MEDIATED DILATION; DIETARY NITRATE; BLOOD-PRESSURE; ENDOTHELIAL FUNCTION; INORGANIC NITRATE; DYSFUNCTION; GENERATION; PHYSIOLOGY; DISEASE	The microbiota of the human lower intestinal tract helps maintain healthy host physiology, for example through nutrient acquisition and bile acid recycling, but specific positive contributions of the oral microbiota to host health are not well established. Nitric oxide (NO) homeostasis is crucial to mammalian physiology. The recently described entero-salivary nitrate-nitrite-nitric oxide pathway has been shown to provide bioactive NO from dietary nitrate sources. Interestingly, this pathway is dependent upon oral nitrate-reducing bacteria, since humans lack this enzyme activity. This pathway appears to represent a newly recognized symbiosis between oral nitrate-reducing bacteria and their human hosts in which the bacteria provide nitrite and nitric oxide from nitrate reduction. Here we measure the nitrate-reducing capacity of tongue-scraping samples from six healthy human volunteers, and analyze metagenomes of the bacterial communities to identify bacteria contributing to nitrate reduction. We identified 14 candidate species, seven of which were not previously believed to contribute to nitrate reduction. We cultivated isolates of four candidate species in single-and mixed-species biofilms, revealing that they have substantial nitrate-and nitrite-reduction capabilities. Colonization by specific oral bacteria may thus contribute to host NO homeostasis by providing nitrite and nitric oxide. Conversely, the lack of specific nitrate-reducing communities may disrupt the nitrate-nitrite-nitric oxide pathway and lead to a state of NO insufficiency. These findings may also provide mechanistic evidence for the oral systemic link. Our results provide a possible new therapeutic target and paradigm for NO restoration in humans by specific oral bacteria.	[Hyde, Embriette R.] Baylor Coll Med, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA; [Hyde, Embriette R.; Petrosino, Joseph F.] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA; [Andrade, Fernando; Vaksman, Zalman; Kaplan, Heidi B.] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Parthasarathy, Kavitha; Tribble, Gena] Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Periodont, Houston, TX 77030 USA; [Petrosino, Joseph F.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Jiang, Hong; Parthasarathy, Deepa K.; Torregrossa, Ashley C.; Bryan, Nathan S.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn, Inst Mol Med, Texas Therapeut Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Petrosino, JF (corresponding author), Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA.	jpetrosi@bcm.edu; Nathan.Bryan@uth.tmc.edu	Tribble, Gena/A-8755-2011; Petrosino, Joseph F./AAF-1621-2019	Tribble, Gena/0000-0002-6468-2851	Alkek Foundation; National Institute of Dental and Cranial Research of the NIH [R01 DE021394]; National Human Genome Research Institute [U54 HG004973]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008231] Funding Source: NIH RePORTER	Alkek Foundation; National Institute of Dental and Cranial Research of the NIH; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research reported here was supported in part by grants from The Alkek Foundation to JFP and the National Institute of Dental and Cranial Research of the NIH under award number R01 DE021394 to HBK. The authors would like to thank the Human Genome Sequencing Center at BCM, where DNA sequence data generation for this manuscript took place, especially Ginger Metcalf and Richard Gibbs and The National Human Genome Research Institute grant (U54 HG004973) to Richard Gibbs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Bryan NS, 2008, FREE RADICAL BIO MED, V45, P468, DOI 10.1016/j.freeradbiomed.2008.04.040; Bryan NS, 2007, P NATL ACAD SCI USA, V104, P19144, DOI 10.1073/pnas.0706579104; Bryan NS, 2007, FREE RADICAL BIO MED, V43, P645, DOI 10.1016/j.freeradbiomed.2007.04.026; Bugiardini R, 2004, CIRCULATION, V109, P2518, DOI 10.1161/01.CIR.0000128208.22378.E3; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carlstrom M, 2011, CARDIOVASC RES, V89, P574, DOI 10.1093/cvr/cvq366; Carlstrom M, 2010, P NATL ACAD SCI USA, V107, P17716, DOI 10.1073/pnas.1008872107; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Doel JJ, 2005, EUR J ORAL SCI, V113, P14, DOI 10.1111/j.1600-0722.2004.00184.x; DUNCAN C, 1995, NAT MED, V1, P546, DOI 10.1038/nm0695-546; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Hendgen-Cotta UB, 2012, CIRCULATION, V126, P1983, DOI 10.1161/CIRCULATIONAHA.112.112912; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Joshipura K, 2000, COMPEND CONTIN ED S, V12-23; Kapil V, 2013, FREE RADICAL BIO MED, V55, P93, DOI 10.1016/j.freeradbiomed.2012.11.013; Kleinbongard P, 2006, FREE RADICAL BIO MED, V40, P295, DOI 10.1016/j.freeradbiomed.2005.08.025; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; Lundberg JO, 2004, FREE RADICAL BIO MED, V37, P395, DOI 10.1016/j.freeradbiomed.2004.04.027; Lundberg JO, 2004, NAT REV MICROBIOL, V2, P593, DOI 10.1038/nrmicro929; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; MONCADA S, 1991, PHARMACOL REV, V43, P109; Petersson J, 2009, FREE RADICAL BIO MED, V46, P1068, DOI 10.1016/j.freeradbiomed.2009.01.011; Alonso VR, 2013, BRIT J NUTR, V109, pS21, DOI 10.1017/S0007114512005235; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; STACKEBRANDT E, 1991, APPL ENVIRON MICROB, V57, P1468, DOI 10.1128/AEM.57.5.1468-1477.1991; Webb A, 2004, P NATL ACAD SCI USA, V101, P13683, DOI 10.1073/pnas.0402927101; Webb AJ, 2008, HYPERTENSION, V51, P784, DOI 10.1161/HYPERTENSIONAHA.107.103523; Yeboah J, 2007, CIRCULATION, V115, P2390, DOI 10.1161/CIRCULATIONAHA.106.678276; Yeboah J, 2009, CIRCULATION, V120, P502, DOI 10.1161/CIRCULATIONAHA.109.864801	32	125	131	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e88645	10.1371/journal.pone.0088645	http://dx.doi.org/10.1371/journal.pone.0088645			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670812	Green Published, gold			2022-12-27	WOS:000333677000002
J	Abramowski, P; Otto, B; Martin, R				Abramowski, Pierre; Otto, Benjamin; Martin, Roland			The Orally Available, Synthetic Ether Lipid Edelfosine Inhibits T Cell Proliferation and Induces a Type I Interferon Response	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; GENE-EXPRESSION; HOMEOSTATIC PROLIFERATION; ET-18-OCH3 EDELFOSINE; SELECTIVE INDUCTION; CANCER-CELLS; APOPTOSIS; BETA; RISK; INVOLVEMENT	The drug edelfosine is a synthetic analog of 2-lysophosphatidylcholine. Edelfosine is incorporated by highly proliferating cells, e. g. activated immune cells. It acts on cellular membranes by selectively aggregating the cell death receptor Fas in membrane rafts and interference with phosphatidylcholine (PC) synthesis with subsequent induction of apoptosis. Edelfosine has been proposed for the treatment of autoimmune diseases like multiple sclerosis (MS). Earlier studies on the animal model of MS, experimental autoimmune encephalomyelitis (EAE), have generated first evidence for the efficacy of edelfosine treatment. However, it is unknown if the previously described mechanisms for edelfosine action, which are derived from in vitro studies, are solely responsible for the amelioration of EAE or if edelfosine may exert additional effects, which may be beneficial in the context of autoimmunity. Since it was the purpose of our studies to assess the potential usefulness of edelfosine for the treatment of MS, we examined its mechanism/s of action on immune functions in human T cells. Low doses of edelfosine led to a decrease in homeostatic proliferation, and further studies of the mechanism/s of action by genome-wide transcriptional profiling showed that edelfosine reduces the expression of MHC class II molecules, of molecules involved in MHC class II-associated processing and presentation, and finally upregulated a series of type I interferon-associated genes. The inhibition of homeostatic proliferation, as well as the effects on MHC class II expression and -presentation, and the induction of type I interferon-associated genes are novel and interesting in the context of developing edelfosine for clinical use in MS and possibly also other T cell-mediated autoimmune diseases.	[Abramowski, Pierre; Martin, Roland] Univ Med Ctr Hamburg Eppendorf, ZMNH, Inst Neuroimmunol & Clin Multiple Sclerosis Res I, Hamburg, Germany; [Abramowski, Pierre] Univ Med Ctr Hamburg Eppendorf, Clin Stem Cell Transplantat, Res Dept Cell & Gene Therapy, Hamburg, Germany; [Otto, Benjamin] Univ Med Ctr Hamburg Eppendorf, Ctr Internal Med, Dept Internal Med 1, Hamburg, Germany; [Otto, Benjamin] Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, Ctr Diagnost, Hamburg, Germany; [Martin, Roland] Univ Zurich Hosp, Dept Neurol, Neuroimmunol & MS Res, CH-8091 Zurich, Switzerland	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Zurich; University Zurich Hospital	Martin, R (corresponding author), Univ Med Ctr Hamburg Eppendorf, ZMNH, Inst Neuroimmunol & Clin Multiple Sclerosis Res I, Hamburg, Germany.	roland.martin@usz.ch		Abramowski, Pierre/0000-0002-7121-6912	Gemeinnuetzige Hertie Stiftung	Gemeinnuetzige Hertie Stiftung	This work and the inims were supported by the Gemeinnuetzige Hertie Stiftung (http://www.ghst.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREESEN R, 1980, IMMUNOBIOLOGY, V156, P498, DOI 10.1016/S0171-2985(80)80083-0; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; BOGGS KP, 1995, J BIOL CHEM, V270, P7757, DOI 10.1074/jbc.270.13.7757; BOGGS KP, 1995, J BIOL CHEM, V270, P11612, DOI 10.1074/jbc.270.19.11612; BRINKMANN V, 1993, J EXP MED, V178, P1655, DOI 10.1084/jem.178.5.1655; Cabaner C, 1999, BRIT J PHARMACOL, V127, P813, DOI 10.1038/sj.bjp.0702606; Chawla-Sarkar M, 2001, CLIN CANCER RES, V7, P1821; Cousens LP, 1999, J EXP MED, V189, P1315, DOI 10.1084/jem.189.8.1315; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; FUJIWARA K, 1994, CANCER CHEMOTH PHARM, V34, P472, DOI 10.1007/s002800050175; Gajate C, 2004, J EXP MED, V200, P353, DOI 10.1084/jem.20040213; Gajate C, 1998, MOL PHARMACOL, V53, P602, DOI 10.1124/mol.53.4.602; Gajate C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005044; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Haines JL, 1998, HUM MOL GENET, V7, P1229, DOI 10.1093/hmg/7.8.1229; Hilpert J, 2008, J NEUROIMMUNOL, V199, P115, DOI 10.1016/j.jneuroim.2008.04.036; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JERSILD C, 1973, LANCET, V2, P1221; Jones JL, 2013, P NATL ACAD SCI USA, V110, P20200, DOI 10.1073/pnas.1313654110; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kiss Z, 1997, FEBS LETT, V412, P313, DOI 10.1016/S0014-5793(97)00817-X; KLEINFRANKE A, 1992, J AUTOIMMUN, V5, P83, DOI 10.1016/S0896-8411(05)80053-8; Kny G, 1969, LYSOLECITHIN ANALOGA; Kondo T, 2001, NAT IMMUNOL, V2, P932, DOI 10.1038/ni711; Laplaud DA, 2004, BRAIN, V127, P981, DOI 10.1093/brain/awh119; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; Lunemann JD, 2008, J EXP MED, V205, P1763, DOI 10.1084/jem.20072397; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; MCRAE BL, 1995, J EXP MED, V182, P75, DOI 10.1084/jem.182.1.75; Micali OC, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-52; Mohme M, 2013, BRAIN, V136, P1783, DOI 10.1093/brain/awt108; Mollinedo F, 1997, CANCER RES, V57, P1320; Mollinedo F, 2004, CURR MED CHEM, V11, P3163, DOI 10.2174/0929867043363703; MOLLINEDO F, 1993, BIOCHEM BIOPH RES CO, V192, P603, DOI 10.1006/bbrc.1993.1458; MUNDER PG, 1990, CHEM IMMUNOL, V49, P206; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Muraro PA, 2004, J NEUROIMMUNOL, V150, P123, DOI 10.1016/j.jneuroim.2004.01.002; Revy P, 2001, NAT IMMUNOL, V2, P925, DOI 10.1038/ni713; Riise T, 2003, NEUROLOGY, V61, P1122, DOI 10.1212/01.WNL.0000081305.66687.D2; ROOS G, 1986, LEUKEMIA RES, V10, P195, DOI 10.1016/0145-2126(86)90042-1; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sellebjerg F, 2008, MULT SCLER J, V14, P615, DOI 10.1177/1352458507085976; Selleri C, 1997, BLOOD, V89, P957, DOI 10.1182/blood.V89.3.957; Serrano-Fernandez P, 2010, AUTOIMMUNITY, V43, P172, DOI 10.3109/08916930903219040; Singh MK, 2007, J NEUROL SCI, V258, P52, DOI 10.1016/j.jns.2007.02.034; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Sturzebecher S, 2003, BRAIN, V126, P1419, DOI 10.1093/brain/awg147; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; van Baarsen LGM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001927; van der Luit AH, 2002, J BIOL CHEM, V277, P39541, DOI 10.1074/jbc.M203176200; van der Luit AH, 2007, MOL CANCER THER, V6, P2337, DOI 10.1158/1535-7163.MCT-07-0202; Wang L, 2001, P NATL ACAD SCI USA, V98, P13884, DOI 10.1073/pnas.241358198; Zerp SF, 2008, ANTI-CANCER DRUG, V19, P65, DOI 10.1097/CAD.0b013e3282f16d36	57	12	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e91970	10.1371/journal.pone.0091970	http://dx.doi.org/10.1371/journal.pone.0091970			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667731	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000333675600015
J	Charrier, O; Dupont, P; Pornon, A; Escaravage, N				Charrier, Olivia; Dupont, Pierre; Pornon, Andre; Escaravage, Nathalie			Microsatellite Marker Analysis Reveals the Complex Phylogeographic History of Rhododendron ferrugineum (Ericaceae) in the Pyrenees	PLOS ONE			English	Article							GENETIC DIVERSITY; GLACIAL REFUGIA; L.; DIFFERENTIATION; POPULATIONS; SOFTWARE; GENOTYPE; NORTHERN; SURVIVAL; PLANTS	Genetic variation within plant species is determined by a number of factors such as reproductive mode, breeding system, life history traits and climatic events. In alpine regions, plants experience heterogenic abiotic conditions that influence the population's genetic structure. The aim of this study was to investigate the genetic structure and phylogeographic history of the subalpine shrub Rhododendron ferrugineum across the Pyrenees and the links between the populations in the Pyrenees, the Alps and Jura Mountains. We used 27 microsatellite markers to genotype 645 samples from 29 Pyrenean populations, three from the Alps and one from the Jura Mountains. These data were used to estimate population genetics statistics such as allelic richness, observed heterozygosity, expected heterozygosity, fixation index, inbreeding coefficient and number of migrants. Genetic diversity was found to be higher in the Alps than in the Pyrenees suggesting colonization waves from the Alps to the Pyrenees. Two separate genetic lineages were found in both the Alps and Pyrenees, with a substructure of five genetic clusters in the Pyrenees where a loss of genetic diversity was noted. The strong differentiation among clusters is maintained by low gene flow across populations. Moreover, some populations showed higher genetic diversity than others and presented rare alleles that may indicate the presence of alpine refugia. Two lineages of R. ferrugineum have colonized the Pyrenees from the Alps. Then, during glaciation events R. ferrugineum survived in the Pyrenees in different refugia such as lowland refugia at the eastern part of the chain and nunataks at high elevations leading to a clustered genetic pattern.	[Charrier, Olivia; Dupont, Pierre; Pornon, Andre; Escaravage, Nathalie] Univ Toulouse 3, Lab Evolut & Divers Biol EDB, F-31062 Toulouse, France; [Charrier, Olivia; Dupont, Pierre; Pornon, Andre; Escaravage, Nathalie] CNRS, EDB, UMR 5174, F-31062 Toulouse, France	Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA)	Charrier, O (corresponding author), Univ Toulouse 3, Lab Evolut & Divers Biol EDB, F-31062 Toulouse, France.	olcharrier@gmail.com	Dupont, Pierre/AAD-5659-2021	Dupont, Pierre/0000-0002-7438-7995; Dupont, Pierre-Yves/0000-0002-7384-5181	UniversitA(C) Paul Sabatier Toulouse - CNRS	UniversitA(C) Paul Sabatier Toulouse - CNRS	Funding provided by UniversitA (c) Paul Sabatier Toulouse - CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEgisdottir HH, 2009, ANN BOT-LONDON, V104, P1313, DOI 10.1093/aob/mcp242; AITKEN SN, 1994, EVOLUTION, V48, P1009, DOI [10.2307/2410362, 10.1111/j.1558-5646.1994.tb05289.x]; Alberto F, 2010, MOL ECOL, V19, P2626, DOI 10.1111/j.1365-294X.2010.04631.x; [Anonymous], 2003, ALPINE PLANT LIFE, DOI DOI 10.1007/978-3-642-18970-8; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; BARTON NH, 1986, HEREDITY, V56, P409, DOI 10.1038/hdy.1986.63; Belkhir K, 2004, GENETIX 4 0 LAB GENO; Beniston M, 1997, CLIMATIC CHANGE, V36, P281, DOI 10.1023/A:1005310214361; BRAUN-BLANQUET J., 1948, COLLECT BOT, V2, P1; Bruni I, 2012, PLANT BIOSYST, V146, P24, DOI 10.1080/11263504.2011.557093; Burga C., 1998, VEGETATION KLIMA SCH; Byars SG, 2009, ANN BOT-LONDON, V103, P885, DOI 10.1093/aob/mcp018; Charrier O, 2013, CONSERV GENET RESOUR, V5, P473, DOI 10.1007/s12686-012-9831-2; Delmas CEL, 2013, PLANT BIOL IN PRESS, DOI 10.111/plb.12039; Delmas CEL, 2011, AM J BOT, V98, pE120, DOI 10.3732/ajb.1000533; DEMESURE B, 1995, MOL ECOL, V4, P129, DOI 10.1111/j.1365-294X.1995.tb00201.x; Dzialuk A, 2009, PLANT SYST EVOL, V277, P197, DOI 10.1007/s00606-008-0123-y; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Escaravage N, 1997, CAN J BOT, V75, P736, DOI 10.1139/b97-084; Escaravage N, 1998, MOL ECOL, V7, P975, DOI 10.1046/j.1365-294x.1998.00415.x; Escaravage N, 2004, PLANT BIOL, V6; Escaravage N, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr029; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Frankel O.H., 1995, CONSERVATION PLANT B; Freeman S, 2007, EVOLUTIONARY ANAL, V4; Goetsch L, 2005, SYST BOT, V30, P616, DOI 10.1600/0363644054782170; Hadado TT, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-121; Hahn T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041608; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hensen I, 2010, PLANT BIOLOGY, V12, P526, DOI 10.1111/j.1438-8677.2009.00227.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Holderegger R, 2002, MOL ECOL, V11, P1409, DOI 10.1046/j.1365-294X.2002.01548.x; Holleley CE, 2009, BIOTECHNIQUES, V46, P511, DOI 10.2144/000113156; Iserbyt S, 2008, ANN SOC ENTOMOL FR, V44, P211, DOI 10.1080/00379271.2008.10697558; JALUT G, 1992, QUATERNARY SCI REV, V11, P449, DOI 10.1016/0277-3791(92)90027-6; Jeannel R, 1946, REV FRANCAISE ENTOMO, V14, P53; Koelling VA, 2012, HEREDITY, V106, P310; Kropf M, 2006, NEW PHYTOL, V172, P169, DOI 10.1111/j.1469-8137.2006.01795.x; Lauga B, 2009, ACTA BOT GALLICA, V156, P317, DOI 10.1080/12538078.2009.10516162; Ledig FT, 2000, J HERED, V91, P307, DOI 10.1093/jhered/91.4.307; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; MANTEL N, 1967, CANCER RES, V27, P209; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Ohsawa T, 2008, GLOBAL ECOL BIOGEOGR, V17, P152, DOI 10.1111/j.1466-8238.2007.00357.x; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pornon A, 2000, MOL ECOL, V9, P1099, DOI 10.1046/j.1365-294x.2000.00976.x; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Segarra-Moragues JG, 2007, J BIOGEOGR, V34, P1893, DOI 10.1111/j.1365-2699.2007.01740.x; Serrat D, 1993, 1386E2 US GEOL SURV; Stehlik I, 2002, BIOL J LINN SOC, V77, P87, DOI 10.1046/j.1095-8312.2002.00094.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wolf PG, 2004, J HERED, V95, P301, DOI 10.1093/jhered/esh053	61	33	34	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92976	10.1371/journal.pone.0092976	http://dx.doi.org/10.1371/journal.pone.0092976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667824	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600116
J	Huang, HB; Li, Y; Ariani, F; Chen, XL; Lin, JD				Huang, Huibin; Li, Ying; Ariani, Felinda; Chen, Xiaoli; Lin, Jiandong			Timing of Tracheostomy in Critically III Patients: A Meta-Analysis	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; PROLONGED ENDOTRACHEAL INTUBATION; MECHANICAL VENTILATION; ICU PATIENTS; ILL PATIENTS; TRACHEOTOMY; PNEUMONIA; IMPACT	Objective: To compare important outcomes between early tracheostomy (ET) and late tracheostomy (LT) or prolonged intubation (PI) for critically ill patients receiving long-term ventilation during their treatment. Method: We performed computerized searches for relevant articles on PubMed, EMBASE, and the Cochrane register of controlled trials (up to July 2013). We contacted international experts and manufacturers. We included in the study randomized controlled trials (RCTs) that compared ET (performed within 10 days after initiation of laryngeal intubation) and LT (after 10 days of laryngeal intubation) or PI in critically ill adult patients admitted to intensive care units (ICUs). Two investigators evaluated the articles; divergent opinions were resolved by consensus. Results: A meta-analysis was evaluated from nine randomized clinical trials with 2,072 participants. Compared to LT/PI, ET did not significantly reduce short-term mortality [relative risks (RR) = 0.91; 95% confidence intervals (CIs) = 0.81-1.03; p = 0.14] or long-term mortality (RR = 0.90; 95% CI = 0.76-1.08; p = 0.27). Additionally, ET was not associated with a markedly reduced length of ICU stay [weighted mean difference (WMD) = -4.41 days; 95% CI = -13.44-4.63 days; p = 0.34], ventilator-associated pneumonia (VAP) (RR = 0.88; 95% CI = 0.71-1.10; p = 0.27) or duration of mechanical ventilation (MV) (WMD = 2 -2.91 days; 95% CI = -7.21-1.40 days; p = 0.19). Conclusion: Among the patients requiring prolonged MV, ET showed no significant difference in clinical outcomes compared to that of the LT/PI group. But more rigorously designed and adequately powered RCTs are required to confirm it in future.	[Huang, Huibin; Li, Ying; Chen, Xiaoli; Lin, Jiandong] Fujian Med Univ, Affiliated Hosp 1, Dept Crit Care Med, Fuzhou, Peoples R China; [Ariani, Felinda] Fudan Univ, Shanghai Med Sch, Huadong Hosp, Dept Pulm Med, Shanghai 200433, Peoples R China	Fujian Medical University; Fudan University	Lin, JD (corresponding author), Fujian Med Univ, Affiliated Hosp 1, Dept Crit Care Med, Fuzhou, Peoples R China.	linjd01680067@sina.com						Al-Ansari MA, 2006, CRIT CARE, V10, DOI 10.1186/cc3900X; Barquist ES, 2006, J TRAUMA, V60, P91, DOI 10.1097/01.ta.0000196743.37261.3f; Blot F, 2005, CHEST, V127, P1347, DOI 10.1378/chest.127.4.1347; Blot F, 2008, INTENS CARE MED, V34, P1779, DOI 10.1007/s00134-008-1195-4; Bosel J, 2013, STROKE, V44, P21, DOI 10.1161/STROKEAHA.112.669895; Bouderka MA, 2004, J TRAUMA, V57, P251, DOI 10.1097/01.TA.0000087646.68382.9A; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; DUNHAM CM, 1984, J TRAUMA, V24, P120, DOI 10.1097/00005373-198402000-00005; Esteban A, 2000, AM J RESP CRIT CARE, V161, P1450, DOI 10.1164/ajrccm.161.5.9902018; Fischler L, 2000, INTENS CARE MED, V26, P1428, DOI 10.1007/s001340000634; Silva BNG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007271.pub2; Griffiths J, 2005, BMJ-BRIT MED J, V330, P1243, DOI 10.1136/bmj.38467.485671.E0; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Keenan SP, 2002, JAMA-J AM MED ASSOC, V287, P3238, DOI 10.1001/jama.287.24.3238; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Kluge S, 2008, ANESTH ANALG, V107, P1639, DOI 10.1213/ane.0b013e318188b818; Koch T, 2012, LANGENBECK ARCH SURG, V397, P1001, DOI 10.1007/s00423-011-0873-9; MacIntyre NR, 2001, CHEST, V120, p375S, DOI 10.1378/chest.120.6_suppl.375S; Mallick A, 2010, EUR J ANAESTH, V27, P676, DOI 10.1097/EJA.0b013e32833b1ba0; Nieszkowska A, 2005, CRIT CARE MED, V33, P2527, DOI 10.1097/01.CCM.0000186898.58709.AA; PLUMMER AL, 1989, CHEST, V96, P178, DOI 10.1378/chest.96.1.178; RODRIGUEZ JL, 1990, SURGERY, V108, P655; Rumbak MJ, 2004, CRIT CARE MED, V32, P1689, DOI 10.1097/01.CCM.0000134835.05161.B6; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Saffle JR, 2002, J BURN CARE REHABIL, V23, P431, DOI 10.1097/00004630-200211000-00009; Terra RM, 2007, CLINICS, V62, P427, DOI 10.1590/S1807-59322007000400009; Terragni PP, 2010, JAMA-J AM MED ASSOC, V303, P1483, DOI 10.1001/jama.2010.447; Trouillet JL, 2011, ANN INTERN MED, V154, P373, DOI 10.7326/0003-4819-154-6-201103150-00002; Wang F, 2011, CHEST, V140, P1456, DOI 10.1378/chest.11-2024; Young D, 2013, JAMA-J AM MED ASSOC, V309, P2121, DOI 10.1001/jama.2013.5154; Zheng Y, 2012, CHINESE MED J-PEKING, V125, P1925, DOI 10.3760/cma.j.issn.0366-6999.2012.11.016	32	51	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92981	10.1371/journal.pone.0092981	http://dx.doi.org/10.1371/journal.pone.0092981			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667875	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600118
J	Kennard, JTT; Guevremont, D; Mason-Parker, SE; Abraham, WC; Williams, JM				Kennard, Jeremy T. T.; Guevremont, Diane; Mason-Parker, Sara E.; Abraham, Wickliffe C.; Williams, Joanna M.			Redistribution of Ionotropic Glutamate Receptors Detected by Laser Microdissection of the Rat Dentate Gyrus 48 h following LTP Induction In Vivo	PLOS ONE			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL SYNAPTIC PLASTICITY; NR2B-CONTAINING NMDA RECEPTORS; GLUR2-LACKING AMPA RECEPTORS; PERFORANT PATH; CAPTURE MICRODISSECTION; PROTEIN-SYNTHESIS; DIFFERENTIAL ROLES; MOLECULAR ANALYSIS; LATE-PHASE	The persistence and input specificity of long-term potentiation (LTP) make it attractive as a mechanism of information storage. In its initial phase, both in vivo and in vitro studies have shown that LTP is associated with increased membrane localization of AMPA receptor subunits, but the molecular basis of LTP maintenance over the long-term is still unclear. We have previously shown that expression of AMPA and NMDA receptor subunits is elevated in whole homogenates prepared from dentate gyrus 48 h after LTP induction in vivo. In the present study, we utilized laser microdissection (LMD) techniques to determine whether AMPA and NMDA receptor upregulation occurs specifically in the stimulated regions of the dentate gyrus dendritic arbor. Receptor proteins GluN1, GluA1 and GluA2, as well as postsynaptic density protein of 95 kDa and tubulin were detected by Western blot analysis in microdissected samples. Gradients of expression were observed for GluN1 and GluA2, decreasing from the inner to the outer zones of the molecular layer, and were independent of LTP. When induced at medial perforant path synapses, LTP was associated with an apparent specific redistribution of GluA1 and GluN1 to the middle molecular layer that contains these synapses. These data indicate that glutamate receptor proteins are delivered specifically to dendritic regions possessing LTP-expressing synapses, and that these changes are preserved for at least 48 h.	[Kennard, Jeremy T. T.; Guevremont, Diane; Mason-Parker, Sara E.; Abraham, Wickliffe C.; Williams, Joanna M.] Univ Otago, Brain Hlth Res Ctr, Dunedin, New Zealand; [Kennard, Jeremy T. T.; Guevremont, Diane; Williams, Joanna M.] Otago Sch Med Sci, Dept Anat, Dunedin, New Zealand; [Kennard, Jeremy T. T.; Mason-Parker, Sara E.; Abraham, Wickliffe C.] Univ Otago, Dept Psychol, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	Williams, JM (corresponding author), Univ Otago, Brain Hlth Res Ctr, Dunedin, New Zealand.	joanna.williams@anatomy.otago.ac.nz			New Zealand Health Research Council [99/275]; Department of Anatomy, Postgraduate Support	New Zealand Health Research Council(Health Research Council of New Zealand); Department of Anatomy, Postgraduate Support	Funder: New Zealand Health Research Council; Grant Number: 99/275; Department of Anatomy, Postgraduate Support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 2006, NEUROBIOL LEARN MEM, V86, P82, DOI 10.1016/j.nlm.2005.12.007; Abraham WC, 2002, J NEUROSCI, V22, P9626; ABRAHAM WC, 1995, MOL BRAIN RES, V30, P367, DOI 10.1016/0169-328X(95)00026-O; Abraham WC, 2001, P NATL ACAD SCI USA, V98, P10924, DOI 10.1073/pnas.181342098; ABRAHAM WC, 1988, BRAIN RES, V462, P40, DOI 10.1016/0006-8993(88)90582-3; ABRAHAM WC, 1983, NATURE, V305, P717, DOI 10.1038/305717a0; Abraham WC, 1994, P NATL ACAD SCI USA, V91, P10053; Abraham WC, 2008, NEUROBIOL LEARN MEM, V89, P260, DOI 10.1016/j.nlm.2007.10.001; Barco A, 2008, NEUROSCI BIOBEHAV R, V32, P831, DOI 10.1016/j.neubiorev.2008.01.002; Bartlett TE, 2007, NEUROPHARMACOLOGY, V52, P60, DOI 10.1016/j.neuropharm.2006.07.013; BAUDE A, 1995, NEUROSCIENCE, V69, P1031, DOI 10.1016/0306-4522(95)00350-R; Bear MF, 1996, PROG BRAIN RES, V108, P205, DOI 10.1016/S0079-6123(08)62541-8; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bohm M, 1997, AM J PATHOL, V151, P63; Bonner RF, 1997, SCIENCE, V278, P1481, DOI 10.1126/science.278.5342.1481; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Catania MV, 1998, EUR J NEUROSCI, V10, P3479, DOI 10.1046/j.1460-9568.1998.00356.x; COLINO A, 1993, J NEUROPHYSIOL, V69, P1150, DOI 10.1152/jn.1993.69.4.1150; Davies KD, 2008, J BIOL CHEM, V283, P33138, DOI 10.1074/jbc.M803431200; Doyere V, 1997, J NEUROPHYSIOL, V77, P571, DOI 10.1152/jn.1997.77.2.571; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Fox CJ, 2006, HIPPOCAMPUS, V16, P907, DOI 10.1002/hipo.20230; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Guire ES, 2008, J NEUROSCI, V28, P6000, DOI 10.1523/JNEUROSCI.0384-08.2008; HANSE E, 1992, EUR J NEUROSCI, V4, P1191, DOI 10.1111/j.1460-9568.1992.tb00144.x; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Kennard JTT, 2009, NEUROPHARMACOLOGY, V56, P66, DOI 10.1016/j.neuropharm.2008.07.044; KNEISLER TB, 1995, HIPPOCAMPUS, V5, P151, DOI 10.1002/hipo.450050302; Kosuge Y, 2008, NEUROCHEM INT, V52, P1204, DOI 10.1016/j.neuint.2007.12.010; KRUG M, 1984, BRAIN RES BULL, V13, P39, DOI 10.1016/0361-9230(84)90005-4; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; Lee SH, 2001, NEUROPHARMACOLOGY, V41, P680, DOI 10.1016/S0028-3908(01)00124-1; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mallon AP, 2005, EXP BRAIN RES, V162, P374, DOI 10.1007/s00221-004-2193-6; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; Matsuo N, 2008, SCIENCE, V319, P1104, DOI 10.1126/science.1149967; Mezey S, 2004, EUR J NEUROSCI, V19, P2310, DOI 10.1111/j.0953-816X.2004.03334.x; Mockett BG, 2007, J NEUROSCI, V27, P2918, DOI 10.1523/JNEUROSCI.0838-06.2007; Moga DE, 2006, HIPPOCAMPUS, V16, P990, DOI 10.1002/hipo.20227; Murray GI, 2007, ACTA HISTOCHEM, V109, P171, DOI 10.1016/j.acthis.2007.02.001; OTANI S, 1989, NEUROSCIENCE, V28, P519, DOI 10.1016/0306-4522(89)90001-8; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; RACINE RJ, 1983, BRAIN RES, V260, P217, DOI 10.1016/0006-8993(83)90676-5; Redondo RL, 2010, J NEUROSCI, V30, P4981, DOI 10.1523/JNEUROSCI.3140-09.2010; Reymann KG, 2007, NEUROPHARMACOLOGY, V52, P24, DOI 10.1016/j.neuropharm.2006.07.026; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Simone NL, 1998, TRENDS GENET, V14, P272, DOI 10.1016/S0168-9525(98)01489-9; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; von Eggeling F, 2007, PROTEOMICS, V7, P2729, DOI 10.1002/pmic.200700079; Weitlauf C, 2005, J NEUROSCI, V25, P8386, DOI 10.1523/JNEUROSCI.2388-05.2005; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Williams JM, 1998, MOL BRAIN RES, V60, P21, DOI 10.1016/S0169-328X(98)00154-5; Williams JM, 2003, NEUROSCIENCE, V118, P1003, DOI 10.1016/S0306-4522(03)00028-9; Williams JM, 2007, J NEUROSCI, V27, P14171, DOI 10.1523/JNEUROSCI.2348-07.2007; Witter MP, 2007, PROG BRAIN RES, V163, P43, DOI 10.1016/S0079-6123(07)63003-9; Yang YL, 2008, P NATL ACAD SCI USA, V105, P11388, DOI 10.1073/pnas.0802978105; Yang YL, 2010, P NATL ACAD SCI USA, V107, P11999, DOI 10.1073/pnas.0913004107	66	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92972	10.1371/journal.pone.0092972	http://dx.doi.org/10.1371/journal.pone.0092972			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667777	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600113
J	Kiwanuka, J; Mulogo, E; Haberer, JE				Kiwanuka, Julius; Mulogo, Edgar; Haberer, Jessica E.			Caregiver Perceptions and Motivation for Disclosing or Concealing the Diagnosis of HIV Infection to Children Receiving HIV Care in Mbarara, Uganda: A Qualitative Study	PLOS ONE			English	Article							SOUTH-AFRICA; ADOLESCENTS; INTERVENTION; MORTALITY; HIV/AIDS; HEALTH	Background: Disclosure of the diagnosis of HIV to HIV-infected children is challenging for caregivers. Despite current recommendations, data suggest that levels of disclosure of HIV status to HIV-infected children receiving care in resource-limited settings are very low. Few studies describe the disclosure process for children in these settings, particularly the motivators, antecedent goals, and immediate outcomes of disclosure to HIV-infected children. This study examined caregivers' perception of the disclosure concept prior to disclosure, their motivation towards or away from disclosure, and their short-and long-term intentions for disclosure to their HIV-infected children. Methods: In-depth interviews were conducted with primary caregivers of 40 HIV-infected children (ages 5-15 years) who were receiving HIV care but did not know their HIV status. Results: Caregivers of HIV-infected children mainly perceived disclosure as a single event rather than a process of gradual delivery of information about the child's illness. They viewed disclosure as potentially beneficial both to children and themselves, as well as an opportunity to explain the parents' role in the transmission of HIV to the children. Caregivers desired to personally conduct the disclosure; however, most reported being over-whelmed with fear of negative outcomes and revealed a lack of self-efficacy towards managing the disclosure process. Consequently, most cope by deception to avoid or delay disclosure until they perceive their own readiness to disclose. Conclusions: Interventions for HIV disclosure should consider that caregivers may desire to be directly responsible for disclosure to children under their care. They, however, need to be empowered with practical skills to recognize opportunities to initiate the disclosure process early, as well as supported to manage it in a phased, developmentally appropriate manner. The potential role for peer counselors in the disclosure process deserves further study.	[Kiwanuka, Julius] Mbarara Univ Sci & Technol, Dept Paediat & Child Hlth, Mbarara, Uganda; [Mulogo, Edgar] Mbarara Univ Sci & Technol, Dept Community Hlth, Mbarara, Uganda; [Haberer, Jessica E.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Haberer, Jessica E.] Harvard Univ, Sch Med, Boston, MA USA	Mbarara University of Science & Technology; Mbarara University of Science & Technology; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kiwanuka, J (corresponding author), Mbarara Univ Sci & Technol, Dept Paediat & Child Hlth, Mbarara, Uganda.	jpkiwanuka@gmail.com	Haberer, Jessica/AAH-7976-2019	Haberer, Jessica/0000-0001-5845-3190	Canada-Africa Prevention Trials (CAPT) Network; US National Institutes of Health [K23MH087228]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH087228] Funding Source: NIH RePORTER	Canada-Africa Prevention Trials (CAPT) Network; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was funded by a mentorship grant from the Canada-Africa Prevention Trials (CAPT) Network (captnetwork.org). Dr. Haberer was supported by the US National Institutes of Health (K23MH087228). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwiine B, 2012, THESIS MBARARA U SCI; Biadgilign S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017572; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; Butler AM, 2009, PEDIATRICS, V123, P935, DOI 10.1542/peds.2008-1290; Chaudoir SR, 2011, SOC SCI MED, V72, P1618, DOI 10.1016/j.socscimed.2011.03.028; DEMATTEO D, 2002, PSYCHOL HEALTH MED, V7, P339, DOI DOI 10.1080/13548500220139395; Flanagan-Klygis E, 2001, J CLIN ETHIC, V12, P150; FunckBrentano I, 1997, ARCH PEDIAT ADOL MED, V151, P978, DOI 10.1001/archpedi.1997.02170470012002; Gerson A C, 2001, J Pediatr Health Care, V15, P161, DOI 10.1067/mph.2001.114835; Heeren GA, 2012, VULNERABLE CHILD YOU, V7, P47, DOI 10.1080/17450128.2012.656733; Hejoaka F, 2009, SOC SCI MED, V69, P869, DOI 10.1016/j.socscimed.2009.05.041; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Judd A, 2007, CLIN INFECT DIS, V45, P918, DOI 10.1086/521167; Kallem S, 2011, AIDS BEHAV, V15, P1121, DOI 10.1007/s10461-010-9741-9; Kouyoumdjian FG, 2005, J TROP PEDIATRICS, V51, P285, DOI 10.1093/tropej/fmi014; Kyaddondo D, 2013, SAHARA J-J SOC ASP H, V10, pS37, DOI 10.1080/02664763.2012.755323; Ledlie SW, 1999, NURS RES, V48, P141, DOI 10.1097/00006199-199905000-00004; Lee CL, 1999, AIDS PATIENT CARE ST, V13, P41, DOI 10.1089/apc.1999.13.41; LESTER P, 2002, CLIN CHILD PSYCHOL P, V7, P85, DOI DOI 10.1177/1359104502007001007; Madiba S, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/402403; Marston M, 2005, JAIDS-J ACQ IMM DEF, V38, P219, DOI 10.1097/00126334-200502010-00015; Medley A, 2013, AIDS BEHAV, V17, P224, DOI 10.1007/s10461-012-0344-5; Melvin D, 1999, J HIV THERAPY, V4, P77; Menon A, 2007, JAIDS-J ACQ IMM DEF, V46, P349, DOI 10.1097/QAI.0b013e3181565df0; Ministry of Health Uganda, 2012, UG AIDS IND SURV; Ministry of Health (Uganda), 2005, UG NAT POL GUID HIV; Nor B, 2012, MATERN CHILD NUTR, V8, P448, DOI 10.1111/j.1740-8709.2011.00332.x; Oberdorfer P, 2006, J PAEDIATR CHILD H, V42, P283, DOI 10.1111/j.1440-1754.2006.00855.x; Petersen I, 2010, AIDS CARE, V22, P970, DOI 10.1080/09540121003623693; Pinzon-Iregui MC, 2013, J TROP PEDIATRICS, V59, P84, DOI 10.1093/tropej/fms052; Riekert KA, 1999, CHILD HEALTH CARE, V28, P201, DOI 10.1207/s15326888chc2803_1; Ryan G.W., 2003, FIELD METHOD, V15, P85, DOI DOI 10.1177/1525822X02239569; Strauss A., 1998, BASICS QUALITATIVE R; Vaz LME, 2011, J DEV BEHAV PEDIATR, V32, P307, DOI 10.1097/DBP.0b013e31820f7a47; Vaz LME, 2010, AIDS PATIENT CARE ST, V24, P247, DOI 10.1089/apc.2009.0217; Vreeman RC, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18466; Waugh S, 2003, AIDS CARE, V15, P169, DOI 10.1080/0954012031000068317; WHO, 2013, GLOB UPD HIV TREATM; Wiener L, 2007, J DEV BEHAV PEDIATR, V28, P155, DOI 10.1097/01.DBP.0000267570.87564.cd; Wiener LS, 1996, PEDIATR AIDS HIV INF, V7, P310; Wilfert C, 1999, PEDIATRICS, V103, P164; World Health Organization, 2011, GUID HIV DISCL COUNS; World Health Organization, 2010, ANT THER HIV INF INF	43	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93276	10.1371/journal.pone.0093276	http://dx.doi.org/10.1371/journal.pone.0093276			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SD	24667407	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600161
J	Scharinger, C; Rabl, U; Kasess, CH; Meyer, BM; Hofmaier, T; Diers, K; Bartova, L; Pail, G; Huf, W; Uzelac, Z; Hartinger, B; Kalcher, K; Perkmann, T; Haslacher, H; Meyer-Lindenberg, A; Kasper, S; Freissmuth, M; Windischberger, C; Willeit, M; Lanzenberger, R; Esterbauer, H; Brocke, B; Moser, E; Sitte, HH; Pezawas, L				Scharinger, Christian; Rabl, Ulrich; Kasess, Christian H.; Meyer, Bernhard M.; Hofmaier, Tina; Diers, Kersten; Bartova, Lucie; Pail, Gerald; Huf, Wolfgang; Uzelac, Zeljko; Hartinger, Beate; Kalcher, Klaudius; Perkmann, Thomas; Haslacher, Helmuth; Meyer-Lindenberg, Andreas; Kasper, Siegfried; Freissmuth, Michael; Windischberger, Christian; Willeit, Matthaeus; Lanzenberger, Rupert; Esterbauer, Harald; Brocke, Burkhard; Moser, Ewald; Sitte, Harald H.; Pezawas, Lukas			Platelet Serotonin Transporter Function Predicts Default-Mode Network Activity	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; SCALE BRAIN NETWORKS; ANTIDEPRESSANT TREATMENT; TRYPTOPHAN DEPLETION; AMYGDALA REACTIVITY; GENETIC-VARIATION; ACUTE CITALOPRAM; BLOOD-PLATELETS; STATE; FMRI	Background: The serotonin transporter (5-HTT) is abundantly expressed in humans by the serotonin transporter gene SLC6A4 and removes serotonin (5-HT) from extracellular space. A blood-brain relationship between platelet and synaptosomal 5-HT reuptake has been suggested, but it is unknown today, if platelet 5-HT uptake can predict neural activation of human brain networks that are known to be under serotonergic influence. Methods: A functional magnetic resonance study was performed in 48 healthy subjects and maximal 5-HT uptake velocity (V-max) was assessed in blood platelets. We used a mixed-effects multilevel analysis technique (MEMA) to test for linear relationships between whole-brain, blood-oxygen-level dependent (BOLD) activity and platelet V-max. Results: The present study demonstrates that increases in platelet V-max significantly predict default-mode network (DMN) suppression in healthy subjects independent of genetic variation within SLC6A4. Furthermore, functional connectivity analyses indicate that platelet V-max is related to global DMN activation and not intrinsic DMN connectivity. Conclusion: This study provides evidence that platelet V-max predicts global DMN activation changes in healthy subjects. Given previous reports on platelet-synaptosomal V-max coupling, results further suggest an important role of neuronal 5-HT reuptake in DMN regulation.	[Scharinger, Christian; Rabl, Ulrich; Kasess, Christian H.; Meyer, Bernhard M.; Bartova, Lucie; Pail, Gerald; Huf, Wolfgang; Hartinger, Beate; Kalcher, Klaudius; Kasper, Siegfried; Willeit, Matthaeus; Lanzenberger, Rupert; Pezawas, Lukas] Med Univ Vienna, Dept Psychiat & Psychotherapy, Vienna, Austria; [Hofmaier, Tina; Perkmann, Thomas; Haslacher, Helmuth; Esterbauer, Harald] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Kasess, Christian H.; Huf, Wolfgang; Kalcher, Klaudius; Windischberger, Christian; Moser, Ewald] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Hofmaier, Tina; Uzelac, Zeljko; Freissmuth, Michael; Sitte, Harald H.] Med Univ Vienna, Ctr Biomol Med & Pharmacol, Vienna, Austria; [Diers, Kersten; Brocke, Burkhard] Tech Univ Dresden, Dept Psychol, Dresden, Germany; [Huf, Wolfgang; Kalcher, Klaudius] Vienna Univ Technol, Dept Stat & Probabil Theory, A-1040 Vienna, Austria; [Meyer-Lindenberg, Andreas] Heidelberg Univ, Cent Inst Mental Hlth, Mannheim, Germany	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Technische Universitat Dresden; Technische Universitat Wien; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Pezawas, L (corresponding author), Med Univ Vienna, Dept Psychiat & Psychotherapy, Vienna, Austria.	lukas.pezawas@meduniwien.ac.at	Haslacher, Helmuth/D-4233-2013; Moser, Ewald/B-3666-2013; Bartova, Lucie/ABC-1857-2021; Lanzenberger, Rupert/I-5438-2019; Pezawas, Lukas/A-2367-2011; Perkmann, Thomas/F-3074-2012; Sitte, Harald/O-7025-2019; Meyer-Lindenberg, Andreas/H-1076-2011	Haslacher, Helmuth/0000-0003-4605-2503; Moser, Ewald/0000-0001-8278-9583; Bartova, Lucie/0000-0002-1769-8025; Lanzenberger, Rupert/0000-0003-4641-9539; Pezawas, Lukas/0000-0002-1329-6352; Sitte, Harald/0000-0002-1339-7444; Kasper, Siegfried/0000-0001-8278-191X; Meyer-Lindenberg, Andreas/0000-0001-5619-1123; Kasess, Christian/0000-0002-5644-7229; Meyer, Bernhard M./0000-0002-9772-0471; Rabl, Ulrich/0000-0001-5285-7223; Kalcher, Klaudius/0000-0003-4558-7987; Freissmuth, Michael/0000-0001-9398-1765; Windischberger, Christian/0000-0002-9944-0190; Willeit, Matthaeus/0000-0001-8418-6188; Perkmann, Thomas/0000-0002-7976-0285; Esterbauer, Harald/0000-0001-7343-7455	Austrian Science Fund (FWF) [SFB-35, F3514-B11, F3510-B11, F3506-B11]; Institute for Study of Affective Neuroscience (ISAN); Austrian National Bank [OeNB P11903, OeNB P13214]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Institute for Study of Affective Neuroscience (ISAN); Austrian National Bank	This work was supported by the Special Research Project SFB-35 (Project No. F3514-B11, F3510-B11 and F3506-B11 to LP, MF and HHS, respectively) of the Austrian Science Fund (FWF) and the Institute for Study of Affective Neuroscience (ISAN) as well as by grants of the Austrian National Bank (OeNB P11903 to L. Pezawas and OeNB P13214 to R. Lanzenberger). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abney M, 2001, AM J HUM GENET, V68, P1302, DOI 10.1086/320112; Alasaari JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045813; Anderson GM, 2004, PEDIATR RES, V56, P418, DOI 10.1203/01.PDR.0000136278.23672.A0; Anderson GM, 2002, MOL PSYCHIATR, V7, P831, DOI 10.1038/sj.mp.4001099; Anderson IM, 2011, EUR NEUROPSYCHOPHARM, V21, P140, DOI 10.1016/j.euroneuro.2010.06.008; Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; APA, 1980, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890423349, DOI 10.1176/APPI.BOOKS.9780890423349]; Audhya T, 2012, BBA-GEN SUBJECTS, V1820, P1496, DOI 10.1016/j.bbagen.2012.05.012; Bauer M, 2013, WORLD J BIOL PSYCHIA, V14, P334, DOI 10.3109/15622975.2013.804195; Baune BT, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.18; Bigos KL, 2008, NEUROPSYCHOPHARMACOL, V33, P3221, DOI 10.1038/npp.2008.52; Boubela RN, 2012, MAGN RESON MATER PHY, V25, P313, DOI 10.1007/s10334-011-0290-7; Braun U, 2012, NEUROIMAGE, V59, P1404, DOI 10.1016/j.neuroimage.2011.08.044; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Bruchas MR, 2011, NEURON, V71, P498, DOI 10.1016/j.neuron.2011.06.011; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Carhart-Harris RL, 2012, P NATL ACAD SCI USA, V109, P2138, DOI 10.1073/pnas.1119598109; Carneiro AMD, 2008, J CLIN INVEST, V118, P1544, DOI 10.1172/JCI33374; Chen G, 2012, NEUROIMAGE, V60, P747, DOI 10.1016/j.neuroimage.2011.12.060; Cohen J.E., 1988, STAT POWER ANAL BEHA; Collins CM, 2012, J PSYCHOPHARMACOL; Cools R, 2008, TRENDS COGN SCI, V12, P31, DOI 10.1016/j.tics.2007.10.011; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dang LC, 2012, J NEUROSCI, V32, P9582, DOI 10.1523/JNEUROSCI.0909-12.2012; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Efron B, 1993, INTRO BOOTSTRAP, DOI [DOI 10.1007/978-1-4899-4541-9, 10.1007/978-1-4899-4541-9]; El-Kasaby A, 2010, J BIOL CHEM, V285, P39201, DOI 10.1074/jbc.M110.118000; ELLIS PM, 1994, BIOL PSYCHIAT, V36, P292, DOI 10.1016/0006-3223(94)90626-2; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fisher PM, 2009, CEREB CORTEX, V19, P2499, DOI 10.1093/cercor/bhp022; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friesen E., 1978, FACIAL ACTION CODING, V3, P5; Frokjaer VG, 2009, NEUROIMAGE, V46, P360, DOI 10.1016/j.neuroimage.2009.02.008; Fu CHY, 2004, ARCH GEN PSYCHIAT, V61, P877, DOI 10.1001/archpsyc.61.9.877; Graham J, 2013, J AFFECT DISORDERS, V151, P423, DOI 10.1016/j.jad.2013.07.002; Greenberg BD, 1999, AM J MED GENET, V88, P83, DOI 10.1002/(SICI)1096-8628(19990205)88:1<83::AID-AJMG15>3.3.CO;2-S; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hahn A, 2012, P NATL ACAD SCI USA, V109, P2619, DOI 10.1073/pnas.1117104109; Hamilton JP, 2011, BIOL PSYCHIAT, V70, P327, DOI 10.1016/j.biopsych.2011.02.003; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hardwick RM, 2013, NEUROIMAGE, V67, P283, DOI 10.1016/j.neuroimage.2012.11.020; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hayashi-Takagi A, 2013, BIOL PSYCHIAT; Hoflich A, 2012, REV NEUROSCIENCE, V23, P227, DOI 10.1515/revneuro-2012-0038; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Hyman SE, 2008, NATURE, V455, P890, DOI 10.1038/nature07454; JERNEJ B, 1990, PSYCHIAT RES, V32, P167, DOI 10.1016/0165-1781(90)90083-H; Jo HJ, 2010, NEUROIMAGE, V52, P571, DOI 10.1016/j.neuroimage.2010.04.246; Johnson VE, 2013, P NATL ACAD SCI USA, V110, P19313, DOI 10.1073/pnas.1313476110; Kinnally EL, 2010, GENES BRAIN BEHAV, V9, P45, DOI 10.1111/j.1601-183X.2009.00533.x; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Klomp A, 2012, JOVE-J VIS EXP, DOI 10.3791/3956; Kraus C, 2014, NEUROIMAGE, V84, P236, DOI 10.1016/j.neuroimage.2013.08.036; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Kunisato Y, 2011, NEUROSCI RES, V69, P129, DOI 10.1016/j.neures.2010.11.005; Kupfer DJ, 2012, LANCET, V379, P1045, DOI 10.1016/S0140-6736(11)60602-8; Lang PJ, 1997, TECHNICAL REPORT; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McKie S, 2005, PSYCHOPHARMACOLOGY, V180, P680, DOI 10.1007/s00213-005-2270-y; MELTZER HY, 1981, ARCH GEN PSYCHIAT, V38, P1322; MELTZER HY, 1988, PSYCHIAT RES, V24, P263, DOI 10.1016/0165-1781(88)90108-4; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Mercado CP, 2010, MOL INTERV, V10, P231, DOI 10.1124/mi.10.4.6; Minzenberg MJ, 2011, PSYCHOPHARMACOLOGY, V215, P23, DOI 10.1007/s00213-010-2111-5; Murphy DL, 2008, NEUROPHARMACOLOGY, V55, P932, DOI 10.1016/j.neuropharm.2008.08.034; Neumeister A, 2004, ARCH GEN PSYCHIAT, V61, P765, DOI 10.1001/archpsyc.61.8.765; Nobile M, 1999, J AM ACAD CHILD PSY, V38, P1396, DOI 10.1097/00004583-199911000-00014; Olsson CA, 2010, BIOL PSYCHOL, V83, P159, DOI 10.1016/j.biopsycho.2009.12.003; Passamonti L, 2012, BIOL PSYCHIAT, V71, P36, DOI 10.1016/j.biopsych.2011.07.033; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Posner J, 2013, JAMA PSYCHIAT, V70, P373, DOI 10.1001/jamapsychiatry.2013.455; Preece MA, 2009, NEUROSCIENCE, V159, P751, DOI 10.1016/j.neuroscience.2008.12.032; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rausch J, 2005, PSYCHOPHARMACOLOGY, V180, P391, DOI 10.1007/s00213-005-2178-6; Rhodes RA, 2007, J NEUROSCI, V27, P9233, DOI 10.1523/JNEUROSCI.1175-07.2007; Savli M, 2013, NEUROIMAGE; Savli M, 2012, NEUROIMAGE, V63, P447, DOI 10.1016/j.neuroimage.2012.07.001; Scharinger C, 2011, WORLD J BIOL PSYCHIA, V12, P474, DOI 10.3109/15622975.2011.596220; Scholze P, 2001, NEUROSCI LETT, V309, P173, DOI 10.1016/S0304-3940(01)02058-4; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Singh YS, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.2; Singh YS, 2010, ACS CHEM NEUROSCI, V1, P49, DOI 10.1021/cn900012y; Steiger H, 2006, NEUROPSYCHOPHARMACOL, V31, P1785, DOI 10.1038/sj.npp.1301011; Uebelback R, 2006, NEUROSCI LETT, V406, P153, DOI 10.1016/j.neulet.2006.06.004; van de Ven V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068355; van Ijzendoorn MH, 2010, BIOL PSYCHIAT, V68, P405, DOI 10.1016/j.biopsych.2010.05.008; van Wingen GA, 2014, NEUROIMAGE, V88, P47, DOI 10.1016/j.neuroimage.2013.11.022; Varnas K, 2004, HUM BRAIN MAPP, V22, P246, DOI 10.1002/hbm.20035; Vul E, 2012, NEUROIMAGE, V62, P945, DOI 10.1016/j.neuroimage.2012.01.027; Wendland JR, 2006, MOL PSYCHIATR, V11, P224, DOI 10.1038/sj.mp.4001789; Willeit M, 2008, NEUROPSYCHOPHARMACOL, V33, P1503, DOI 10.1038/sj.npp.1301560; Windischberger C, 2010, NEUROIMAGE, V49, P1161, DOI 10.1016/j.neuroimage.2009.10.013; Yubero-Lahoz S, 2013, CURR MED CHEM, V20, P1382, DOI 10.2174/0929867311320110003; Yubero-Lahoz S, 2012, EUR J PHARMACOL, V674, P337, DOI 10.1016/j.ejphar.2011.10.033; Ziegelstein RC, 2009, INTERN MED J, V39, P38, DOI 10.1111/j.1445-5994.2008.01794.x	99	19	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92543	10.1371/journal.pone.0092543	http://dx.doi.org/10.1371/journal.pone.0092543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667541	gold, Green Submitted, Green Published			2022-12-27	WOS:000333675600048
J	Croy, I; D' Angelo, S; Olausson, H				Croy, Ilona; D' Angelo, Silvia; Olausson, Hakan			Reduced Pleasant Touch Appraisal in the Presence of a Disgusting Odor	PLOS ONE			English	Article							PERCEPTION; IDENTIFICATION; AFFERENTS; OLFACTION; RESPONSES; SCALE; FEEL; CUES	Objectives: Odors are powerful emotional stimuli influencing mood, attention and behavior. Here we examined if odors change the perception of pleasant touch. In line with the warning function of the olfactory system, we proposed that especially unpleasant odors will reduce touch pleasantness, presumably through a disgust-related mechanism. Methods: Forty-five healthy participants (mean age 23.3 +/- 3years SD, 24 females) were presented to slow (3 cm/s) and fast (30 cm/s) brush stroking delivered by a robot to the forearm. Touch pleasantness under the influence of an unpleasant odor (Civette, smelling like feces) and an intensity matched pleasant odor (Rose) was compared to an odorless control condition. In a pilot study with 30 participants (mean age 25.9 +/-6 years, 21 females), the odors were matched according to their intensity, and we studied the influence of disgust sensitivity on the perception of 4 different odor qualities. Results: The unpleasant odor decreased touch pleasantness for both stroking velocities compared to the odorless control (p<0.005) whereas the rose odor did not change touch pleasantness significantly. Disgust sensitivity was correlated with the modulation of touch pleasantness. The pilot study revealed a significant correlation between disgust sensitivity and the perception of the unpleasant odor qualities (r = -0.56; p = 0.007), but not with any of the other odors. Conclusion: Unpleasant odors are powerful in modulating touch pleasantness, and disgust might be a moderating variable.	[Croy, Ilona; D' Angelo, Silvia; Olausson, Hakan] Univ Gothenburg, Dept Clin Neurophysiol, Sahlgrenska Univ Hosp, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg	Croy, I (corresponding author), Univ Gothenburg, Dept Clin Neurophysiol, Sahlgrenska Univ Hosp, Gothenburg, Sweden.	ilona.croy@neuro.gu.se		Croy, Ilona/0000-0002-0361-5559	Swedish Research Council; German Research Foundation (DFG) [CR 479/1-1]	Swedish Research Council(Swedish Research CouncilEuropean Commission); German Research Foundation (DFG)(German Research Foundation (DFG))	The work was supported by the Swedish Research Council. IC is funded by a scholarship from the German Research Foundation (DFG; CR 479/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlaouiIsmaili O, 1997, CHEM SENSES, V22, P237, DOI 10.1093/chemse/22.3.237; Ardiel EL, 2010, PAED CHILD HEALT-CAN, V15, P153, DOI 10.1093/pch/15.3.153; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bensafi M, 2002, NEUROPHYSIOL CLIN, V32, P326, DOI 10.1016/S0987-7053(02)00339-8; Bjorklund F, 2004, SCAND J PSYCHOL, V45, P279, DOI 10.1111/j.1467-9450.2004.00406.x; Borg C, 2013, SOC COGN AFFECT NEUR, V8, P351, DOI 10.1093/scan/nss006; Churchill A, 2009, FOOD QUAL PREFER, V20, P320, DOI 10.1016/j.foodqual.2009.02.002; Croy I, 2013, INT J PSYCHOPHYSIOL, V88, P104, DOI 10.1016/j.ijpsycho.2013.02.005; Croy I, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00510; Croy I, 2011, EMOTION, V11, P1331, DOI 10.1037/a0024437; Croy I, 2010, EUR ARCH OTO-RHINO-L, V267, P67, DOI 10.1007/s00405-009-1054-0; de Groot JHB, 2012, PSYCHOL SCI, V23, P1417, DOI 10.1177/0956797612445317; DEETHARDT JF, 1983, J NONVERBAL BEHAV, V8, P143; Dematte ML, 2007, CHEM SENSES, V32, P603, DOI 10.1093/chemse/bjm030; Dematte ML, 2007, ACTA PSYCHOL, V124, P332, DOI 10.1016/j.actpsy.2006.04.001; Dematte ML, 2006, CHEM SENSES, V31, P291, DOI 10.1093/chemse/bjj031; Eck J, 2013, NEUROIMAGE, V75, P123, DOI 10.1016/j.neuroimage.2013.02.075; Ellingsen DM, 2014, PSYCHONEUROENDOCRINO, V39, P11, DOI 10.1016/j.psyneuen.2013.09.017; Ferdenzi C, 2011, EMOTION, V11, P1168, DOI 10.1037/a0022853; Guest S, 2002, EXP BRAIN RES, V146, P161, DOI 10.1007/s00221-002-1164-z; HAIDT J, 1994, PERS INDIV DIFFER, V16, P701, DOI 10.1016/0191-8869(94)90212-7; Herz RS, 2009, INT J NEUROSCI, V119, P263, DOI 10.1080/00207450802333953; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Kettenmann B, 2005, CHEM SENSES, V30, pI234, DOI 10.1093/chemse/bjh200; Loken LS, 2009, NAT NEUROSCI, V12, P547, DOI 10.1038/nn.2312; Michael GA, 2003, NEUROSCI LETT, V352, P221, DOI 10.1016/j.neulet.2003.08.068; Oaten M, 2009, PSYCHOL BULL, V135, P303, DOI 10.1037/a0014823; Olausson H, 2010, NEUROSCI BIOBEHAV R, V34, P185, DOI 10.1016/j.neubiorev.2008.09.011; Olausson HW, 2008, NEUROSCI LETT, V436, P128, DOI 10.1016/j.neulet.2008.03.015; Oum RE, 2011, COGNITION EMOTION, V25, P717, DOI 10.1080/02699931.2010.496997; Parma V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030645; ROZIN P, 1987, PSYCHOL REV, V94, P23, DOI 10.1037/0033-295X.94.1.23; Seo HS, 2011, CHEM SENSES, V36, P301, DOI 10.1093/chemse/bjq129; Seo HS, 2011, CHEM SENSES, V36, P177, DOI 10.1093/chemse/bjq112; Sepulcre J, 2012, J NEUROSCI, V32, P10649, DOI 10.1523/JNEUROSCI.0759-12.2012; Seubert J, 2013, NEUROIMAGE, V66, P333, DOI 10.1016/j.neuroimage.2012.10.030; Seubert J, 2010, NEUROIMAGE, V53, P746, DOI 10.1016/j.neuroimage.2010.07.012; Small DM, 2005, NEURON, V47, P593, DOI 10.1016/j.neuron.2005.07.022; Stevenson RJ, 2010, CHEM SENSES, V35, P3, DOI 10.1093/chemse/bjp083; Triscoli C, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00208; Tubaldi F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001795; Villemure C, 2003, PAIN, V106, P101, DOI 10.1016/S0304-3959(03)00297-5; Vrontou S, 2013, NATURE, V493, P669, DOI 10.1038/nature11810	43	49	49	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92975	10.1371/journal.pone.0092975	http://dx.doi.org/10.1371/journal.pone.0092975			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD7QO	24664177	Green Submitted, Green Published, gold			2022-12-27	WOS:000333459900136
J	Masuyama, H; Hiramatsu, Y				Masuyama, Hisashi; Hiramatsu, Yuji			Additive Effects of Maternal High Fat Diet during Lactation on Mouse Offspring	PLOS ONE			English	Article							INSULIN-RESISTANCE; METABOLIC SYNDROME; SATURATED FAT; OBESITY; LEPTIN; ADIPONECTIN; PREGNANCY; NUTRITION; EXPOSURE; GLUCOSE	Recent reports indicated that nutrition in early infancy might influence later child health outcomes such as obesity and metabolic syndrome. Therefore, we examined the effects of maternal high fat diet (HFD) during lactation on the onset of a metabolic syndrome in their offspring. All offspring were cross-fostered by dams on the same or opposite diet to yield 4 groups: offspring from HFD-fed dams suckled by HFD-fed dams (OHH) and by control diet (CD)-fed dams (OHC) and CD-fed dams suckled by HFD-fed dams (OCH) and by CD-fed dams (OCC) mice. We examined several metabolic syndrome-related factors including body weight, blood pressure, glucose tolerance and adipocytokines. Mean body weights of OHH and OCH mice were significantly higher than those of OHC and OCC mice, respectively, with elevated systolic blood pressure. Moreover, OHH and OCH mice revealed significantly worse glucose tolerance compared with the OHC and OCC mice, respectively. Triglyceride and leptin levels were significantly increased and adiponectin levels were significantly reduced by the maternal HFD during lactation, with similar changes in leptin and adiponectin mRNA expression but without histone modifications in adipose tissues. In addition, maternal obesity induced by HFD during lactation increased and prolonged the leptin surge in the offspring and the gender differences of leptin surge were observed. Our data suggested that maternal HFD during lactation might have an additive effect on the onset of the metabolic syndrome in the offspring, irrespective of the nutritional status in utero through the modified leptin surge.	[Masuyama, Hisashi; Hiramatsu, Yuji] Okayama Univ, Dept Obstet & Gynecol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan	Okayama University	Masuyama, H (corresponding author), Okayama Univ, Dept Obstet & Gynecol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	masuyama@cc.okayama-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22591856, 25462558]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by research grants (numbers 22591856 and 25462558) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Buckley AJ, 2005, METABOLISM, V54, P500, DOI 10.1016/j.metabol.2004.11.003; Cai F, 2007, J ENDOCRINOL, V192, P605, DOI 10.1677/JOE-06-0080; Carlyle M, 2002, HYPERTENSION, V39, P496, DOI 10.1161/hy0202.104398; Carter LG, 2012, AM J PHYSIOL-ENDOC M, V303, pE1061, DOI 10.1152/ajpendo.00213.2012; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Cerf ME, 2006, BRIT J NUTR, V95, P391, DOI 10.1079/BJN20051632; Cerf ME, 2005, AM J PHYSIOL-REG I, V288, pR1122, DOI 10.1152/ajpregu.00335.2004; Choi SW, 2010, ADV NUTR, V1, P8, DOI 10.3945/an.110.1004; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; DelPrado M, 1997, J NUTR, V127, P458, DOI 10.1093/jn/127.3.458; Fasshauer M, 2003, DIABETOLOGIA, V46, P1594, DOI 10.1007/s00125-003-1228-z; Gao J, 2009, J BIOL CHEM, V284, P25984, DOI 10.1074/jbc.M109.016808; Gil-Campos M, 2004, CLIN NUTR, V23, P963, DOI 10.1016/j.clnu.2004.04.010; Gniuli D, 2008, J LIPID RES, V49, P1936, DOI 10.1194/jlr.M800033-JLR200; Granado M, 2012, OBESITY FACTS, V5, P138, DOI 10.1159/000336967; Gregersen S, 2005, METABOLISM, V54, P1316, DOI 10.1016/j.metabol.2005.04.020; Grummer-Strawn LM, 2004, PEDIATRICS, V113, P81; Harder T, 2005, AM J EPIDEMIOL, V162, P397, DOI 10.1093/aje/kwi222; HOSKER JP, 1985, DIABETOLOGIA, V28, P401, DOI 10.1007/BF00280882; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Jansson N, 2008, AM J CLIN NUTR, V87, P1743, DOI 10.1093/ajcn/87.6.1743; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; Koukkou E, 1998, CIRCULATION, V98, P2899, DOI 10.1161/01.CIR.98.25.2899; Lihn AS, 2005, OBES REV, V6, P13, DOI 10.1111/j.1467-789X.2005.00159.x; Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638; Masuyama H, 2012, ENDOCRINOLOGY, V153, P2823, DOI 10.1210/en.2011-2161; Morgan K, 2004, J BIOL CHEM, V279, P31139, DOI 10.1074/jbc.M400458200; Myers MG, 2004, RECENT PROG HORM RES, V59, P287, DOI 10.1210/rp.59.1.287; Neary NM, 2004, CLIN ENDOCRINOL, V60, P153, DOI 10.1046/j.1365-2265.2003.01839.x; Oben JA, 2010, J HEPATOL, V52, P913, DOI 10.1016/j.jhep.2009.12.042; Ohashi K, 2006, HYPERTENSION, V47, P1108, DOI 10.1161/01.HYP.0000222368.43759.a1; Owen CG, 2005, PEDIATRICS, V115, P1367, DOI 10.1542/peds.2004-1176; Palou M, 2011, BRIT J NUTR, V106, P769, DOI 10.1017/S0007114511000973; Qiu J, 2006, NATURE, V441, P143, DOI 10.1038/441143a; Rosenbloom A, 2000, DIABETES CARE, V23, P381; Sakurai N, 2009, J NUTR SCI VITAMINOL, V55, P131, DOI 10.3177/jnsv.55.131; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V291, pE792, DOI 10.1152/ajpendo.00078.2006; Stefan N, 2002, HORM METAB RES, V34, P469, DOI 10.1055/s-2002-34785; Sun B, 2012, DIABETES, V61, P2833, DOI 10.2337/db11-0957; Tan KCB, 2004, J CLIN ENDOCR METAB, V89, P765, DOI 10.1210/jc.2003-031012; Trout KK, 2011, CURR DIABETES REP, V11, P7, DOI 10.1007/s11892-010-0159-6; van Schothorst EM, 2009, FASEB J, V23, P1092, DOI 10.1096/fj.08-117119; Wiedmeier JE, 2011, NUTR REV, V69, P76, DOI 10.1111/j.1753-4887.2010.00370.x; Wynne K, 2005, J ENDOCRINOL, V184, P291, DOI 10.1677/joe.1.05866; Yokomori N, 2002, DIABETOLOGIA, V45, P140, DOI 10.1007/s125-002-8255-4	49	49	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92805	10.1371/journal.pone.0092805	http://dx.doi.org/10.1371/journal.pone.0092805			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664181	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900116
J	Miller-Gallacher, JL; Nehme, R; Warne, T; Edwards, PC; Schertler, GFX; Leslie, AGW; Tate, CG				Miller-Gallacher, Jennifer L.; Nehme, Rony; Warne, Tony; Edwards, Patricia C.; Schertler, Gebhard F. X.; Leslie, Andrew G. W.; Tate, Christopher G.			The 2.1 angstrom Resolution Structure of Cyanopindolol-Bound beta(1)-Adrenoceptor Identifies an Intramembrane Na+ Ion that Stabilises the Ligand-Free Receptor	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; CRYSTALLIZING MEMBRANE-PROTEINS; CONSERVED ASPARTATE RESIDUE; BETA-ADRENERGIC-RECEPTORS; ADENOSINE A(2A) RECEPTOR; NEUROTENSIN RECEPTOR; TRANSMEMBRANE DOMAIN; AGONIST BINDING; MUTATION; SODIUM	The beta(1)-adrenoceptor (beta(1)AR) is a G protein-coupled receptor (GPCR) that is activated by the endogenous agonists adrenaline and noradrenaline. We have determined the structure of an ultra-thermostable beta(1)AR mutant bound to the weak partial agonist cyanopindolol to 2.1 angstrom resolution. High-quality crystals (100 mm plates) were grown in lipidic cubic phase without the assistance of a T4 lysozyme or BRIL fusion in cytoplasmic loop 3, which is commonly employed for GPCR crystallisation. An intramembrane Na+ ion was identified co-ordinated to Asp87(2.50), Ser128(3.39) and 3 water molecules, which is part of a more extensive network of water molecules in a cavity formed between transmembrane helices 1, 2, 3, 6 and 7. Remarkably, this water network and Na+ ion is highly conserved between beta(1)AR and the adenosine A(2A) receptor (rmsd of 0.3 angstrom), despite an overall rmsd of 2.4 angstrom for all C alpha atoms and only 23% amino acid identity in the transmembrane regions. The affinity of agonist binding and nanobody Nb80 binding to beta(1)AR is unaffected by Na+ ions, but the stability of the receptor is decreased by 7.5 degrees C in the absence of Na+. Mutation of amino acid side chains that are involved in the co-ordination of either Na+ or water molecules in the network decreases the stability of beta(1)AR by 5-10 degrees C. The data suggest that the intramembrane Na+ and associated water network stabilise the ligand-free state of beta(1)AR, but still permits the receptor to form the activated state which involves the collapse of the Na+ binding pocket on agonist binding.	[Miller-Gallacher, Jennifer L.; Nehme, Rony; Warne, Tony; Edwards, Patricia C.; Schertler, Gebhard F. X.; Leslie, Andrew G. W.; Tate, Christopher G.] MRC, Mol Biol Lab, Struct Studies Div, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Tate, CG (corresponding author), MRC, Mol Biol Lab, Struct Studies Div, Hills Rd, Cambridge CB2 2QH, England.	cgt@mrc-lmb.cam.ac.uk	Schertler, Gebhard/M-9512-2014	Miller-Gallacher, Jennifer/0000-0003-0539-0223; Tate, Christopher/0000-0002-2008-9183; Schertler, Gebhard F.X./0000-0002-5846-6810; Warne, Tony/0000-0001-9646-6080	Commonwealth Scholarship; Medical Research Council [MRC U105197215]; Wellcome Trust; BBSRC [BB/G003653/1]; Heptares Therapeutics; Biotechnology and Biological Sciences Research Council [BB/G003653/1] Funding Source: researchfish; Medical Research Council [MC_U105197215, MC_U105184325] Funding Source: researchfish; MRC [MC_U105197215, MC_U105184325] Funding Source: UKRI	Commonwealth Scholarship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Heptares Therapeutics; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	JLMG was the recipient of a Commonwealth Scholarship. Research in CGT's laboratory on G protein-coupled receptors is funded by the Medical Research Council (MRC U105197215), the Wellcome Trust, the BBSRC (BB/G003653/1) and by grants from Heptares Therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2006, J PHARMACOL SCI, V102, P167, DOI 10.1254/jphs.FP0060640; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Barbhaiya H, 1996, MOL PHARMACOL, V50, P1635; BIHOREAU C, 1993, P NATL ACAD SCI USA, V90, P5133, DOI 10.1073/pnas.90.11.5133; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caffrey M, 2012, BIOCHEMISTRY-US, V51, P6266, DOI 10.1021/bi300010w; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Caffrey M, 2009, ANNU REV BIOPHYS, V38, P29, DOI 10.1146/annurev.biophys.050708.133655; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CHUNG FZ, 1988, J BIOL CHEM, V263, P4052; Congreve M, 2012, J MED CHEM, V55, P1898, DOI 10.1021/jm201376w; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dore AS, 2011, STRUCTURE, V19, P1283, DOI 10.1016/j.str.2011.06.014; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FRASER CM, 1989, MOL PHARMACOL, V36, P840; Gaisford W, 2011, NATURE METHODS, V8, pi; Gao ZG, 2000, BIOCHEM PHARMACOL, V60, P669, DOI 10.1016/S0006-2952(00)00360-9; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; KONG HY, 1993, J BIOL CHEM, V268, P23055; KONG HY, 1993, MOL PHARMACOL, V44, P380; Lebon G, 2012, CURR OPIN STRUC BIOL, V22, P482, DOI 10.1016/j.sbi.2012.03.007; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lebon G, 2011, J MOL BIOL, V409, P298, DOI 10.1016/j.jmb.2011.03.075; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Magnani F, 2008, P NATL ACAD SCI USA, V105, P10744, DOI 10.1073/pnas.0804396105; Mason JS, 2012, TRENDS PHARMACOL SCI, V33, P249, DOI 10.1016/j.tips.2012.02.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller JL, 2011, J MOL BIOL, V413, P628, DOI 10.1016/j.jmb.2011.08.057; MINUTH M, 1986, N-S ARCH PHARMACOL, V333, P124, DOI 10.1007/BF00506514; Moukhametzianov R, 2011, P NATL ACAD SCI USA, V108, P8228, DOI 10.1073/pnas.1100185108; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEVE KA, 1991, MOL PHARMACOL, V39, P733; Parent JL, 1996, BIOCHEM BIOPH RES CO, V219, P968, DOI 10.1006/bbrc.1996.0341; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; Proulx CD, 2008, MOL PHARMACOL, V74, P552, DOI 10.1124/mol.108.045054; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shibata Y, 2013, BBA-BIOMEMBRANES, V1828, P1293, DOI 10.1016/j.bbamem.2013.01.008; Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068; STRADER CD, 1988, J BIOL CHEM, V263, P10267; SURPRENANT A, 1992, SCIENCE, V257, P977, DOI 10.1126/science.1354394; Tao Q, 1998, J PHARMACOL EXP THER, V285, P651; Tate CG, 2009, CURR OPIN STRUC BIOL, V19, P386, DOI 10.1016/j.sbi.2009.07.004; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Warne T, 2003, BBA-BIOMEMBRANES, V1610, P133, DOI 10.1016/S0005-2736(02)00716-2; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2013, BIOCHEM SOC T, V41, P159, DOI 10.1042/BST20120228; Warne T, 2012, STRUCTURE, V20, P841, DOI 10.1016/j.str.2012.03.014; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Warne T, 2009, PROTEIN EXPRES PURIF, V65, P204, DOI 10.1016/j.pep.2009.01.014; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Wilson MH, 2001, MOL PHARMACOL, V59, P929, DOI 10.1124/mol.59.4.929; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Zeidel ML, 2010, ENDOCR PRACT, V16, P882, DOI 10.4158/EP10154.RA; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701	66	130	132	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92727	10.1371/journal.pone.0092727	http://dx.doi.org/10.1371/journal.pone.0092727			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663151	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900104
J	Wolff, J; McCrone, P; Auber, G; Fiedler, P; Patel, A; Wetterauer, U				Wolff, Jan; McCrone, Paul; Auber, Gerd; Fiedler, Petra; Patel, Anita; Wetterauer, Ulrich			Where, When and What? A Time Study of Surgeons' Work in Urology	PLOS ONE			English	Article							BINOMIAL CONFIDENCE-INTERVALS; PHYSICIANS	Introduction: Staff time is a relevant resource in the delivery of health care interventions. Its measurement is a prerequisite for unit costing but usually complex. The aim of this study was to analyse the distribution of surgeons' work time among types and places of activities. A second aim was to use these data to calculate costs per unit of output. Methods: A self-reporting work sampling study was carried out at a department of Urology. All of twelve surgeons involved in clinical care participated in a two-week analysis of their work time. Results: A total of 2,485 data-points were collected, representing about 1,242 hours of work time. Surgeons spent the greater part of their work time in direct patient care, but substantial shares were required for documentation and organisation. Assistants were mainly required at the wards and consultants at the operating theatre and the outpatient unit. Staff costs of surgeons were 32 (sic) and 29 (sic) per patient day at the wards, respectively, 1.30 (sic) per minute at the operating theatre and 32 (sic) per visit at the outpatient unit. Conclusion: Results provided a basis for costing of health care interventions at the study site. However, future research should focus on the establishment of standardised terminology in order to increase transferability of results.	[Wolff, Jan; Auber, Gerd] Univ Med Ctr Freiburg, Dept Management & Controlling, Freiburg, Germany; [McCrone, Paul; Patel, Anita] Kings Coll London, Inst Psychiat Hlth Serv & Populat Res, Ctr Econ Mental & Phys Hlth, London, England; [Fiedler, Petra; Wetterauer, Ulrich] Univ Med Ctr Freiburg, Dept Urol, Freiburg, Germany	University of Freiburg; University of London; King's College London; University of Freiburg	Wolff, J (corresponding author), Univ Med Ctr Freiburg, Dept Management & Controlling, Freiburg, Germany.	jan.wolff@kcl.ac.uk	Patel, Anita/F-9832-2010	McCrone, Paul/0000-0001-7001-4502; Patel, Anita/0000-0003-0769-1732; Wolff, Jan/0000-0003-2750-0606				Agresti A, 2001, BIOMETRICS, V57, P963, DOI 10.1111/j.0006-341X.2001.00963.x; Amalberti R, 2005, ANN INTERN MED, V142, P756, DOI 10.7326/0003-4819-142-9-200505030-00012; Barnes R., 1957, WORK SAMPLING; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; CASELLA G, 1986, CAN J STAT, V14, P113, DOI 10.2307/3314658; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Fehrle M, 2013, GESUNDH QUAL, V18, P23, DOI 10.1055/s-0032-1325601; Mache S, 2009, Z GASTROENTEROL, V47, P814, DOI 10.1055/s-0028-1109175; Mache S, 2010, LANGENBECK ARCH SURG, V395, P81, DOI 10.1007/s00423-009-0541-5; Morse A, 2012, HLTH CARE UK COMP NH; Taylor FrederickWinslow., 1911, PRINCIPLES SCI MANAG; Tippett L., 1935, J TEXT I, V26, pT51, DOI [DOI 10.1080/19447023508661637, 10.1080/19447023508661637]; Tipping MD, 2010, J HOSP MED, V5, P353, DOI 10.1002/jhm.647; Weigl M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-110; WIRTH P, 1977, MED CARE, V15, P953, DOI 10.1097/00005650-197711000-00009	16	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92979	10.1371/journal.pone.0092979	http://dx.doi.org/10.1371/journal.pone.0092979			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664214	Green Published, gold			2022-12-27	WOS:000333459900137
J	Zahoor, Z; Lockyer, AE; Davies, AJ; Kirk, RS; Emery, AM; Rollinson, D; Jones, CS; Noble, LR; Walker, AJ				Zahoor, Zahida; Lockyer, Anne E.; Davies, Angela J.; Kirk, Ruth S.; Emery, Aidan M.; Rollinson, David; Jones, Catherine S.; Noble, Leslie R.; Walker, Anthony J.			Differences in the Gene Expression Profiles of Haemocytes from Schistosome-Susceptible and -Resistant Biomphalaria glabrata Exposed to Schistosoma mansoni Excretory-Secretory Products	PLOS ONE			English	Article							LYMNAEA-STAGNALIS HEMOCYTES; DEFENSE CELLS; HEAT-SHOCK-PROTEIN-70 FAMILY; IN-VITRO; PROTEINS; IDENTIFICATION; KINASE; PHAGOCYTOSIS; ACTIVATION; PARASITE	During its life cycle, the helminth parasite Schistosoma mansoni uses the freshwater snail Biomphalaria glabrata as an intermediate host to reproduce asexually generating cercariae for infection of the human definitive host. Following invasion of the snail, the parasite develops from a miracidium to a mother sporocyst and releases excretory-secretory products (ESPs) that likely influence the outcome of host infection. To better understand molecular interactions between these ESPs and the host snail defence system, we determined gene expression profiles of haemocytes from S. mansoni-resistant or -susceptible strains of B. glabrata exposed in vitro to S. mansoni ESPs (20 mg/ ml) for 1 h, using a 5K B. glabrata cDNA microarray. Ninety-eight genes were found differentially expressed between haemocytes from the two snail strains, 57 resistant specific and 41 susceptible specific, 60 of which had no known homologue in GenBank. Known differentially expressed resistant-snail genes included the nuclear factor kappa B subunit Relish, elongation factor 1 alpha, 40S ribosomal protein S9, and matrilin; known susceptible-snail specific genes included cathepsins D and L, and theromacin. Comparative analysis with other gene expression studies revealed 38 of the 98 identified genes to be uniquely differentially expressed in haemocytes in the presence of ESPs, thus identifying for the first time schistosome ESPs as important molecules that influence global snail host-defence cell gene expression profiles. Such immunomodulation may benefit the schistosome, enabling its survival and successful development in the snail host.	[Zahoor, Zahida; Davies, Angela J.; Kirk, Ruth S.; Walker, Anthony J.] Univ Kingston, Sch Life Sci, Mol Parasitol Lab, Kingston Upon Thames KT1 2EE, Surrey, England; [Zahoor, Zahida; Lockyer, Anne E.; Emery, Aidan M.; Rollinson, David] Nat Hist Museum, Wolfson Wellcome Biomed Lab, London SW7 5BD, England; [Lockyer, Anne E.; Jones, Catherine S.; Noble, Leslie R.] Univ Aberdeen, Sch Biol Sci, Inst Biol & Environm Sci, Aberdeen, Scotland	Kingston University; Natural History Museum London; University of Aberdeen	Walker, AJ (corresponding author), Univ Kingston, Sch Life Sci, Mol Parasitol Lab, Kingston Upon Thames KT1 2EE, Surrey, England.	t.walker@kingston.ac.uk	Kirk, Ruth/B-6246-2009; Rollinson, David/C-7406-2009; Lockyer, Anne/AAO-4327-2021	Lockyer, Anne/0000-0002-3498-2423; Noble, leslie/0000-0003-3076-0759; Emery, Aidan/0000-0001-9028-8586; ZAHOOR, ZAHIDA/0000-0002-7487-7097	Kingston University; Wellcome Trust [9068589/Z/02/Z]	Kingston University; Wellcome Trust(Wellcome TrustEuropean Commission)	A Kingston University studentship award funded ZZ. AEL, CSJ, LRN and DR acknowledge support with funding from the Wellcome Trust 9068589/Z/02/Z; www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayne CJ, 2009, MOL BIOCHEM PARASIT, V165, P8, DOI 10.1016/j.molbiopara.2009.01.005; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Boros J, 2009, GENOME RES, V19, P1963, DOI 10.1101/gr.093047.109; CHERNIN E, 1963, J PARASITOL, V49, P353, DOI 10.2307/3275797; CLEVELAND WS, 1981, AM STAT, V35, P54, DOI 10.2307/2683591; CONNORS VA, 1991, J INVERTEBR PATHOL, V58, P387, DOI 10.1016/0022-2011(91)90185-S; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Genard B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064534; Guillou F, 2007, MOL BIOCHEM PARASIT, V155, P45, DOI 10.1016/j.molbiopara.2007.05.009; Hahn UK, 2000, DEV COMP IMMUNOL, V24, P531, DOI 10.1016/S0145-305X(00)00017-3; Hahn UK, 2001, J PARASITOL, V87, P778, DOI 10.1645/0022-3395(2001)087[0778:IONOIK]2.0.CO;2; Hanington PC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001591; Hanington PC, 2010, INT J PARASITOL, V40, P819, DOI 10.1016/j.ijpara.2009.12.005; Huang XD, 2012, FISH SHELLFISH IMMUN, V33, P659, DOI 10.1016/j.fsi.2012.06.029; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Ittiprasert W, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002677; Ittiprasert W, 2010, MOL BIOCHEM PARASIT, V169, P27, DOI 10.1016/j.molbiopara.2009.09.009; Jiang YG, 2006, DEV COMP IMMUNOL, V30, P855, DOI 10.1016/j.dci.2005.12.004; Jiang YS, 2007, DEV COMP IMMUNOL, V31, P121, DOI 10.1016/j.dci.2006.05.014; Jung S, 2012, J BIOL CHEM, V287, P14246, DOI 10.1074/jbc.M111.336495; Karlin S, 1998, J MOL EVOL, V47, P565, DOI 10.1007/PL00006413; Lacchini AH, 2006, J EXP BIOL, V209, P4829, DOI 10.1242/jeb.02561; LIE KJ, 1977, J INVERTEBR PATHOL, V29, P118, DOI 10.1016/0022-2011(77)90183-5; Lockyer AE, 2004, EXP PARASITOL, V107, P97, DOI 10.1016/j.exppara.2004.04.004; Lockyer AE, 2007, DEV COMP IMMUNOL, V31, P763, DOI 10.1016/j.dci.2006.11.004; Lockyer AE, 2007, MOL BIOCHEM PARASIT, V151, P18, DOI 10.1016/j.molbiopara.2006.09.009; Lockyer AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051102; Lockyer AE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-634; LODES MJ, 1989, J PARASITOL, V75, P853, DOI 10.2307/3282863; LODES MJ, 1990, J INVERTEBR PATHOL, V56, P75, DOI 10.1016/0022-2011(90)90147-X; Ludtmann MHR, 2009, INT J PARASITOL, V39, P1223, DOI 10.1016/j.ijpara.2009.04.002; Mitta G, 2005, DEV COMP IMMUNOL, V29, P393, DOI 10.1016/j.dci.2004.10.002; Mitta G, 2012, DEV COMP IMMUNOL, V37, P1, DOI 10.1016/j.dci.2011.09.002; Mone Y, 2011, INT J PARASITOL, V41, P721, DOI 10.1016/j.ijpara.2011.01.007; PARAENSE W. L., 1963, REV INST MED TROP SAO PAULO, V5, P15; Petalidis L, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng142; Plows LD, 2006, J INVERTEBR PATHOL, V91, P74, DOI 10.1016/j.jip.2005.10.011; Plows LD, 2004, BBA-MOL CELL RES, V1692, P25, DOI 10.1016/j.bbamer.2004.03.002; Plows LD, 2006, BBA-MOL CELL RES, V1763, P779, DOI 10.1016/j.bbamcr.2006.04.008; Roger E, 2008, MOL BIOCHEM PARASIT, V157, P217, DOI 10.1016/j.molbiopara.2007.11.015; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Walker AJ, 2006, TRENDS PARASITOL, V22, P154, DOI 10.1016/j.pt.2006.02.003; Walker AJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-203; Wu XJ, 2009, MOL BIOCHEM PARASIT, V164, P32, DOI 10.1016/j.molbiopara.2008.11.005; Zahoor Z, 2008, DEV COMP IMMUNOL, V32, P1561, DOI 10.1016/j.dci.2008.05.014; Zahoor Z, 2010, CELL STRESS CHAPERON, V15, P639, DOI 10.1007/s12192-010-0176-z; Zahoor Z, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-18; Zhang SM, 2011, MOL IMMUNOL, V48, P1868, DOI 10.1016/j.molimm.2011.05.017; Zhou Z, 2013, FISH SHELLFISH IMMUN, V34, P1209, DOI 10.1016/j.fsi.2013.01.009	50	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93215	10.1371/journal.pone.0093215	http://dx.doi.org/10.1371/journal.pone.0093215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663063	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000333459900162
J	Zhang, L; Borror, CM; Sandrin, TR				Zhang, Lin; Borror, Connie M.; Sandrin, Todd R.			A Designed Experiments Approach to Optimization of Automated Data Acquisition during Characterization of Bacteria with MALDI-TOF Mass Spectrometry	PLOS ONE			English	Article							DESORPTION-IONIZATION-TIME; RESISTANT STAPHYLOCOCCUS-AUREUS; SAMPLE PREPARATION METHODS; RAPID IDENTIFICATION; SPECTRUM QUALITY; STRAIN LEVEL; MS; REPRODUCIBILITY; DIFFERENTIATION; DISCRIMINATION	MALDI-TOF MS has been shown capable of rapidly and accurately characterizing bacteria. Highly reproducible spectra are required to ensure reliable characterization. Prior work has shown that spectra acquired manually can have higher reproducibility than those acquired automatically. For this reason, the objective of this study was to optimize automated data acquisition to yield spectra with reproducibility comparable to those acquired manually. Fractional factorial design was used to design experiments for robust optimization of settings, in which values of five parameters (peak selection mass range, signal to noise ratio (S:N), base peak intensity, minimum resolution and number of shots summed) commonly used to facilitate automated data acquisition were varied. Pseudomonas aeruginosa was used as a model bacterium in the designed experiments, and spectra were acquired using an intact cell sample preparation method. Optimum automated data acquisition settings (i.e., those settings yielding the highest reproducibility of replicate mass spectra) were obtained based on statistical analysis of spectra of P. aeruginosa. Finally, spectrum quality and reproducibility obtained from non-optimized and optimized automated data acquisition settings were compared for P. aeruginosa, as well as for two other bacteria, Klebsiella pneumoniae and Serratia marcescens. Results indicated that reproducibility increased from 90% to 97% (p-value congruent to 0.002) for P. aeruginosa when more shots were summed and, interestingly, decreased from 95% to 92% (p-value congruent to 0.013) with increased threshold minimum resolution. With regard to spectrum quality, highly reproducible spectra were more likely to have high spectrum quality as measured by several quality metrics, except for base peak resolution. Interaction plots suggest that, in cases of low threshold minimum resolution, high reproducibility can be achieved with fewer shots. Optimization yielded more reproducible spectra than non-optimized settings for all three bacteria.	[Zhang, Lin; Borror, Connie M.; Sandrin, Todd R.] Arizona State Univ, Sch Math & Nat Sci, Phoenix, AZ 85004 USA	Arizona State University; Arizona State University-Downtown Phoenix	Sandrin, TR (corresponding author), Arizona State Univ, Sch Math & Nat Sci, Phoenix, AZ 85004 USA.	Todd.Sandrin@asu.edu		Sandrin, Todd/0000-0001-5079-2999	New College of Interdisciplinary Arts & Sciences at Arizona State University	New College of Interdisciplinary Arts & Sciences at Arizona State University	This work was supported by the New College of Interdisciplinary Arts & Sciences at Arizona State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo PW, 1996, TRAC-TREND ANAL CHEM, V15, P26, DOI 10.1016/0165-9936(96)88034-4; Avila A, 2005, CHEMOMETR INTELL LAB, V77, P247, DOI 10.1016/j.chemolab.2004.10.010; Barbuddhe SB, 2008, APPL ENVIRON MICROB, V74, P5402, DOI 10.1128/AEM.02689-07; Benagli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048441; Dieckmann R, 2005, APPL MICROBIOL BIOT, V67, P539, DOI 10.1007/s00253-004-1812-2; Eddabra R, 2012, MICROBIOL RES, V167, P226, DOI 10.1016/j.micres.2011.09.002; Edwards-Jones V, 2000, J MED MICROBIOL, V49, P295, DOI 10.1099/0022-1317-49-3-295; Evason DJ, 2001, J AM SOC MASS SPECTR, V12, P49, DOI 10.1016/S1044-0305(00)00192-6; Feldsine PT, 2003, J AOAC INT, V86, P275; Ford BA, 2013, J CLIN MICROBIOL, V51, P1412, DOI 10.1128/JCM.01803-12; Giebel R, 2010, ADV APPL MICROBIOL, V71, P149, DOI 10.1016/S0065-2164(10)71006-6; Giebel RA, 2008, WATER RES, V42, P931, DOI 10.1016/j.watres.2007.09.005; Goldstein JE, 2013, LETT APPL MICROBIOL, V57, P144, DOI 10.1111/lam.12092; Goyer M, 2012, J CLIN MICROBIOL, V50, P3066, DOI 10.1128/JCM.06381-11; Haag AM, 1998, J MASS SPECTROM, V33, P750, DOI 10.1002/(SICI)1096-9888(199808)33:8<750::AID-JMS680>3.0.CO;2-1; Hsieh SY, 2008, MOL CELL PROTEOMICS, V7, P448, DOI 10.1074/mcp.M700339-MCP200; Ichiki Y, 2008, J PESTIC SCI, V33, P122, DOI 10.1584/jpestics.G07-22; Jackson KA, 2005, J MICROBIOL METH, V62, P273, DOI 10.1016/j.mimet.2005.04.015; Johnson RA., 2007, APPL MULTIVARIATE ST; Kern CC, 2013, J MICROBIOL METH, V93, P185, DOI 10.1016/j.mimet.2013.03.012; Khot PD, 2012, J CLIN MICROBIOL, V50, P3845, DOI 10.1128/JCM.00626-12; Kincl M, 2005, INT J PHARMACEUT, V291, P39, DOI 10.1016/j.ijpharm.2004.07.041; Koubek J, 2012, INT BIODETER BIODEGR, V69, P82, DOI 10.1016/j.ibiod.2011.12.007; Liu HH, 2007, APPL ENVIRON MICROB, V73, P1899, DOI 10.1128/AEM.02391-06; Mellmann A, 2009, J CLIN MICROBIOL, V47, P3732, DOI 10.1128/JCM.00921-09; Montgomery D.C., 2013, DESIGN ANAL EXPT; Ruelle V, 2004, RAPID COMMUN MASS SP, V18, P2013, DOI 10.1002/rcm.1584; Rupf S, 2005, ORAL MICROBIOL IMMUN, V20, P267, DOI 10.1111/j.1399-302X.2005.00223.x; Salaun S, 2010, TALANTA, V80, P1758, DOI 10.1016/j.talanta.2009.10.020; Sandrin TR, 2013, MASS SPECTROM REV, V32, P188, DOI 10.1002/mas.21359; Sauer S, 2010, NAT REV MICROBIOL, V8, P74, DOI 10.1038/nrmicro2243; Schumaker S, 2012, RAPID COMMUN MASS SP, V26, P243, DOI 10.1002/rcm.5309; Sedo O, 2011, SYST APPL MICROBIOL, V34, P30, DOI 10.1016/j.syapm.2010.11.008; Stafsnes MH, 2013, ANTON LEEUW INT J G, V103, P603, DOI 10.1007/s10482-012-9844-6; STATHAM PJ, 1977, ANAL CHEM, V49, P2149, DOI 10.1021/ac50022a014; Stephan R, 2011, J MICROBIOL METH, V87, P150, DOI 10.1016/j.mimet.2011.08.016; Stets MI, 2013, J BIOTECHNOL, V165, P167, DOI 10.1016/j.jbiotec.2013.04.001; Stojanovic BJ, 2013, CHROMATOGRAPHIA, V76, P227, DOI 10.1007/s10337-012-2350-1; Tani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040784; Thevenon F, 2012, ECOTOX ENVIRON SAFE, V78, P50, DOI 10.1016/j.ecoenv.2011.11.005; Toh-Boyo GM, 2012, ANAL CHEM, V84, P9971, DOI 10.1021/ac302375e; Uhlik O, 2011, APPL ENVIRON MICROB, V77, P6858, DOI 10.1128/AEM.05465-11; Vargha M, 2006, J MICROBIOL METH, V66, P399, DOI 10.1016/j.mimet.2006.01.006; Walker J, 2002, J MICROBIOL METH, V48, P117, DOI 10.1016/S0167-7012(01)00316-5; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047152; Wolters M, 2011, INT J MED MICROBIOL, V301, P64, DOI 10.1016/j.ijmm.2010.06.002; Zhang X, 2007, CHEMOMETR INTELL LAB, V89, P45, DOI 10.1016/j.chemolab.2007.05.006; Ziegler D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037189	48	15	15	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92720	10.1371/journal.pone.0092720	http://dx.doi.org/10.1371/journal.pone.0092720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662978	gold, Green Published, Green Submitted			2022-12-27	WOS:000333459900101
J	Tachibana, RO; Oosugi, N; Okanoya, K				Tachibana, Ryosuke O.; Oosugi, Naoya; Okanoya, Kazuo			Semi-Automatic Classification of Birdsong Elements Using a Linear Support Vector Machine	PLOS ONE			English	Article							CONTINUOUS RECORDINGS; RECOGNITION; SEQUENCE	Birdsong provides a unique model for understanding the behavioral and neural bases underlying complex sequential behaviors. However, birdsong analyses require laborious effort to make the data quantitatively analyzable. The previous attempts had succeeded to provide some reduction of human efforts involved in birdsong segment classification. The present study was aimed to further reduce human efforts while increasing classification performance. In the current proposal, a linear-kernel support vector machine was employed to minimize the amount of human-generated label samples for reliable element classification in birdsong, and to enable the classifier to handle highly-dimensional acoustic features while avoiding the over-fitting problem. Bengalese finch's songs in which distinct elements (i.e., syllables) were aligned in a complex sequential pattern were used as a representative test case in the neuroscientific research field. Three evaluations were performed to test (1) algorithm validity and accuracy with exploring appropriate classifier settings, (2) capability to provide accuracy with reducing amount of instruction dataset, and (3) capability in classifying large dataset with minimized manual labeling. The results from the evaluation (1) showed that the algorithm is 99.5% reliable in song syllables classification. This accuracy was indeed maintained in evaluation (2), even when the instruction data classified by human were reduced to one-minute excerpt (corresponding to 300-400 syllables) for classifying two-minute excerpt. The reliability remained comparable, 98.7% accuracy, when a large target dataset of whole day recordings (similar to 30,000 syllables) was used. Use of a linear-kernel support vector machine showed sufficient accuracies with minimized manually generated instruction data in bird song element classification. The methodology proposed would help reducing laborious processes in birdsong analysis without sacrificing reliability, and therefore can help accelerating behavior and studies using songbirds.	[Tachibana, Ryosuke O.; Oosugi, Naoya; Okanoya, Kazuo] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan; [Okanoya, Kazuo] RIKEN, Okanoya Emot Informat Project, ERATO, Japan Sci & Technol Agcy, Wako, Saitama, Japan	University of Tokyo; Japan Science & Technology Agency (JST); RIKEN	Okanoya, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan.	cokanoya@mail.ecc.u-tokyo.ac.jp	Tachibana, Ryosuke/Q-2510-2019	Tachibana, Ryosuke/0000-0002-4766-4504	MEXT, JAPAN [23118003]	MEXT, JAPAN(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Adolescent Mind & Self-Regulation, Grant-in-Aid for Scientific Research on Innovative Areas, MEXT, JAPAN (Grant Number: 23118003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SE, 1996, J ACOUST SOC AM, V100, P1209, DOI 10.1121/1.415968; Chen ZX, 2006, J ACOUST SOC AM, V120, P2974, DOI 10.1121/1.2345831; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dufour O, 2013, P 1 WORKSH MACH LEAR, P89; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Hamaguchi K, 2012, J NEUROSCI, V32, P11671, DOI 10.1523/JNEUROSCI.1666-12.2012; Kogan JA, 1998, J ACOUST SOC AM, V103, P2185, DOI 10.1121/1.421364; Mencia EL, 2013, P NEUR INF PROC SCAL, P184; Okanoya K, 2004, ANN NY ACAD SCI, V1016, P724, DOI 10.1196/annals.1298.026; Peeters G., 2004, LARGE SET AUDIO FEAT; Peeters G, 2011, J ACOUST SOC AM, V130, P2902, DOI 10.1121/1.3642604; Rajan R, 2013, CURR BIOL, V23, P87, DOI 10.1016/j.cub.2012.11.040; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Tchernichovski O, 2004, ANN NY ACAD SCI, V1016, P348, DOI 10.1196/annals.1298.031	15	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92584	10.1371/journal.pone.0092584	http://dx.doi.org/10.1371/journal.pone.0092584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658578	gold, Green Published, Green Submitted			2022-12-27	WOS:000333355300102
J	Wurpel, DJ; Totsika, M; Allsopp, LP; Hartley-Tassell, LE; Day, CJ; Peters, KM; Sarkar, S; Ulett, GC; Yang, J; Tiralongo, J; Strugnell, RA; Jennings, MP; Schembri, MA				Wurpel, Daniel J.; Totsika, Makrina; Allsopp, Luke P.; Hartley-Tassell, Lauren E.; Day, Christopher J.; Peters, Kate M.; Sarkar, Sohinee; Ulett, Glen C.; Yang, Ji; Tiralongo, Joe; Strugnell, Richard A.; Jennings, Michael P.; Schembri, Mark A.			F9 Fimbriae of Uropathogenic Escherichia coli Are Expressed at Low Temperature and Recognise Gal beta 1-3GlcNAc-Containing Glycans	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; H-NS; MOLECULAR CHARACTERIZATION; AUTOTRANSPORTER PROTEINS; BIOFILM FORMATION; CLONING VEHICLES; S-FIMBRIAE; E.-COLI; IDENTIFICATION; COMMENSAL	Uropathogenic Escherichia coli (UPEC) is the leading causative agent of urinary tract infections (UTI) in the developed world. Among the major virulence factors of UPEC, surface expressed adhesins mediate attachment and tissue tropism. UPEC strains typically possess a range of adhesins, with type 1 fimbriae and P fimbriae of the chaperone-usher class the best characterised. We previously identified and characterised F9 as a new chaperone-usher fimbrial type that mediates biofilm formation. However, the regulation and specific role of F9 fimbriae remained to be determined in the context of wild-type clinical UPEC strains. In this study we have assessed the distribution and genetic context of the f9 operon among diverse E. coli lineages and pathotypes and demonstrated that f9 genes are significantly more conserved in a UPEC strain collection in comparison to the well-defined E. coli reference (ECOR) collection. In the prototypic UPEC strain CFT073, the global regulator protein H-NS was identified as a transcriptional repressor of f9 gene expression at 37 degrees C through its ability to bind directly to the f9 promoter region. F9 fimbriae expression was demonstrated at 20 degrees C, representing the first evidence of functional F9 fimbriae expression by wild-type E. coli. Finally, glycan array analysis demonstrated that F9 fimbriae recognise and bind to terminal Gal beta 1-3GlcNAc structures.	[Wurpel, Daniel J.; Totsika, Makrina; Allsopp, Luke P.; Peters, Kate M.; Sarkar, Sohinee; Schembri, Mark A.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Hartley-Tassell, Lauren E.; Day, Christopher J.; Tiralongo, Joe; Jennings, Michael P.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia; [Ulett, Glen C.] Griffith Univ, Ctr Med & Oral Hlth, Sch Med Sci, Southport, Qld 4215, Australia; [Yang, Ji; Strugnell, Richard A.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	University of Queensland; Griffith University; Griffith University; University of Melbourne	Totsika, M (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.	m.totsika@uq.edu.au; m.schembri@uq.edu.au	Schembri, Mark A/C-7262-2009; Totsika, Makrina/A-8993-2011; Allsopp, Luke/AAG-2488-2020; Jennings, Michael P/G-4822-2013	Schembri, Mark A/0000-0003-4863-9260; Totsika, Makrina/0000-0003-2468-0293; Allsopp, Luke/0000-0002-0313-9265; Jennings, Michael P/0000-0002-1027-4684; Sarkar, Sohinee/0000-0001-9364-1920; Day, Christopher/0000-0001-7953-4408; Tiralongo, Joe/0000-0002-3529-6310; Strugnell, Richard/0000-0003-0614-5641; Ulett, Glen/0000-0002-9638-8091	Australian National Health and Medical Research Council [631654, APP1012076]; Australian Research Council (ARC) [FT100100662, FT110101048]; ARC [DE130101169]; NHMRC Program [565526]; Smart Futures Fund Research Partnerships Program Grant	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); ARC(Australian Research Council); NHMRC Program(National Health and Medical Research Council (NHMRC) of Australia); Smart Futures Fund Research Partnerships Program Grant	This work was supported by grants from the Australian National Health and Medical Research Council (631654 and APP1012076). MAS and GCU are supported by Australian Research Council (ARC) Future Fellowships (FT100100662 and FT110101048). MT is supported by an ARC Discovery Early Career Researcher Award (DE130101169). MPJ is supported by a NHMRC Program Grant 565526 and a Smart Futures Fund Research Partnerships Program Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsopp LP, 2012, INFECT IMMUN, V80, P321, DOI 10.1128/IAI.05322-11; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez RA, 2006, METHOD ENZYMOL, V415, P292, DOI 10.1016/S0076-6879(06)15018-1; Amit R, 2003, BIOPHYS J, V84, P2467, DOI 10.1016/S0006-3495(03)75051-6; [Anonymous], 2005, Nat Methods, V2, P629; Archer CT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-9; Avasthi TS, 2011, J BACTERIOL, V193, P4272, DOI 10.1128/JB.05413-11; Beloin C, 2003, MOL MICROBIOL, V47, P825, DOI 10.1046/j.1365-2958.2003.03347.x; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Chaudhuri RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008801; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Crossman LC, 2010, J BACTERIOL, V192, P5822, DOI 10.1128/JB.00710-10; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Day CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004927; Dorman CJ, 2007, NAT REV MICROBIOL, V5, P157, DOI 10.1038/nrmicro1598; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Dziva F, 2004, MICROBIOL-SGM, V150, P3631, DOI 10.1099/mic.0.27448-0; Easton DM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00120; Eppinger M, 2011, P NATL ACAD SCI USA, V108, P20142, DOI 10.1073/pnas.1107176108; Ferenci T, 2009, J BACTERIOL, V191, P4025, DOI 10.1128/JB.00118-09; Foxman B, 2002, AM J MED, V113, p5S; Fricke WF, 2008, J BACTERIOL, V190, P6779, DOI 10.1128/JB.00661-08; Garnett JA, 2012, P NATL ACAD SCI USA, V109, P3950, DOI 10.1073/pnas.1106733109; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Grote A, 2009, NUCLEIC ACIDS RES, V37, pD61, DOI 10.1093/nar/gkn837; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hochhut B, 2006, MOL MICROBIOL, V61, P584, DOI 10.1111/j.1365-2958.2006.05255.x; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; KALLENIUS G, 1981, LANCET, V2, P1369; Khan AS, 2000, INFECT IMMUN, V68, P3541, DOI 10.1128/IAI.68.6.3541-3547.2000; Kjaergaard K, 2000, ENVIRON MICROBIOL, V2, P695, DOI 10.1046/j.1462-2920.2000.00152.x; Klemm P, 2000, INT J MED MICROBIOL, V290, P27; Korea CG, 2010, ENVIRON MICROBIOL, V12, P1957, DOI 10.1111/j.1462-2920.2010.02202.x; KORHONEN TK, 1986, INFECT IMMUN, V54, P322, DOI 10.1128/IAI.54.2.322-327.1986; Krause DO, 2011, J BACTERIOL, V193, P583, DOI 10.1128/JB.01290-10; Kulasekara BR, 2009, INFECT IMMUN, V77, P3713, DOI 10.1128/IAI.00198-09; Kyle JL, 2012, J BACTERIOL, V194, P1885, DOI 10.1128/JB.00120-12; LEFFLER H, 1981, INFECT IMMUN, V34, P920, DOI 10.1128/IAI.34.3.920-929.1981; Lehti TA, 2013, MOL MICROBIOL, V87, P1200, DOI 10.1111/mmi.12161; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Low AS, 2006, INFECT IMMUN, V74, P2233, DOI 10.1128/IAI.74.4.2233-2244.2006; Lu ST, 2011, J BACTERIOL, V193, P7005, DOI 10.1128/JB.06284-11; MARRE R, 1990, INFECT IMMUN, V58, P3434, DOI 10.1128/IAI.58.10.3434-3437.1990; Miquel S, 2010, J BACTERIOL, V192, P1832, DOI 10.1128/JB.01679-09; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Moriel DG, 2010, P NATL ACAD SCI USA, V107, P9072, DOI 10.1073/pnas.0915077107; Muller CM, 2006, J BACTERIOL, V188, P5428, DOI 10.1128/JB.01956-05; MURPHY TF, 1989, MICROB PATHOGENESIS, V6, P159, DOI 10.1016/0882-4010(89)90066-1; Nash JHE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-667; NILSSON P, 1991, MOL MICROBIOL, V5, P1791, DOI 10.1111/j.1365-2958.1991.tb01928.x; Nuccio SP, 2007, MICROBIOL MOL BIOL R, V71, P551, DOI 10.1128/MMBR.00014-07; Oelschlaeger Tobias A, 2002, Curr Opin Urol, V12, P33, DOI 10.1097/00042307-200201000-00007; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0; Ono S, 2005, BIOCHEM J, V391, P203, DOI 10.1042/BJ20050453; Oshima K, 2008, DNA RES, V15, P375, DOI 10.1093/dnares/dsn026; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Pouttu R, 2001, J BACTERIOL, V183, P4727, DOI 10.1128/JB.183.16.4727-4736.2001; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rendon MA, 2007, P NATL ACAD SCI USA, V104, P10637, DOI 10.1073/pnas.0704104104; Schembri MA, 2001, INFECT IMMUN, V69, P1322, DOI 10.1128/IAI.69.3.1322-1328.2001; STAHL B, 1994, ANAL BIOCHEM, V223, P218, DOI 10.1006/abio.1994.1577; STAMM WE, 1991, AM J MED, V91, pS65, DOI 10.1016/0002-9343(91)90345-X; STROMBERG N, 1990, EMBO J, V9, P2001, DOI 10.1002/j.1460-2075.1990.tb08328.x; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Teneberg S, 2002, J BIOL CHEM, V277, P19709, DOI 10.1074/jbc.M201113200; Toh H, 2010, J BACTERIOL, V192, P1165, DOI 10.1128/JB.01543-09; Totsika M, 2012, APPL ENVIRON MICROB, V78, P2179, DOI 10.1128/AEM.06680-11; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Ulett GC, 2007, MICROBIOL-SGM, V153, P2321, DOI 10.1099/mic.0.2006/004648-0; van Diemen PA, 2005, INFECT IMMUN, V73, P1735, DOI 10.1128/IAI.73.3.1735-1743.2005; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wu XR, 1996, P NATL ACAD SCI USA, V93, P9630, DOI 10.1073/pnas.93.18.9630; Wurpel DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052835; Xiong YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036144; Zdziarski J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001078; Zhou ZM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008700	88	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93177	10.1371/journal.pone.0093177	http://dx.doi.org/10.1371/journal.pone.0093177			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671091	Green Published, gold			2022-12-27	WOS:000333677000124
J	Cai, H; Xie, ZY; Liu, GH; Sun, XM; Peng, GT; Lin, BQ; Liao, QF				Cai, Hao; Xie, Zhiyong; Liu, Guanghui; Sun, Xiuman; Peng, Guangtian; Lin, Baoqin; Liao, Qiongfeng			Isolation, Identification and Activities of Natural Antioxidants from Callicarpa kwangtungensis Chun	PLOS ONE			English	Article							PHENOLIC CONTENTS; PEPTIDES; CAPACITY; TRANSITION; ACTEOSIDE; RADICALS; TANNINS; BARLEY; FRUITS; L.	Reactive oxygen species leads to some diseases associated with oxidative stress. Callicarpa kwangtungensis Chun (CK) is a common remedy in traditional Chinese medicine and possesses diverse biological activities involving antioxidant properties; its main compounds phenylethanoid glycosides (PG) and flavonoids are always reported as antioxidants. In order to develop CK as a safe and activated antioxidant, our investigation was performed to validate antioxidant properties and assess which types of compounds (similar polarity or similar structure), even which compounds, played the role of antioxidants. The extracted compounds of CK were analyzed qualitatively and quantitatively by HPLC-DAD-ESI-Trap MS and UV for their contents and antioxidant activities. The correlations between antioxidant activities and known contents were respectively counted and a semi-quantitative experiment was designed to screen antioxidant compounds of CK with HPLC-UV. The n-butanol fraction (BF) showed the highest total phenolic and flavonoid contents (TPC, TFC), and three PG (forsythiaside B, poliumoside and acteoside) contents. BF showed the significantly best (P<0.05) activities in most assays. There were significant correlations (P<0.05) between DPPH center dot, ABTS(+)center dot, center dot O-2(-) scavenging, Cu2+-chelating, anti-lipidperoxidation activities and TPC. BF also has significant antioxidant activities on CCl4-induced acute liver injury Mice and TBHP-reduced HepG2 cells. Nine PG (forsythiaside B, poliumoside, acteoside, alyssonoside, brandioside and their derivatives) and one flavone (rhamnazin) were screened out as antioxidants. BF in CK contained abundant polyphenolic, which reflected some definite antioxidant properties. The antioxidant compounds consisted at the least of nine PG and one flavone.	[Cai, Hao; Liu, Guanghui; Sun, Xiuman; Peng, Guangtian; Lin, Baoqin; Liao, Qiongfeng] Guangzhou Univ Chinese Med, Sch Chinese Mat Med, Guangzhou, Guangdong, Peoples R China; [Cai, Hao; Xie, Zhiyong] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Sun Yat Sen University	Xie, ZY (corresponding author), Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China.	xiezy2074@yahoo.com; liaoqf2075@yahoo.com		Xie, Zhi/0000-0002-5589-4836	National Natural Science Foundation of China [81173564, 81274028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant Nos. 81173564 and 81274028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarowicz R, 2004, FOOD CHEM, V84, P551, DOI 10.1016/S0308-8146(03)00278-4; Bourgou S, 2008, CR BIOL, V331, P48, DOI 10.1016/j.crvi.2007.11.001; Cai H, 2013, CHIN J EXP TRADIT ME, V19, P63; Celep E, 2012, FOOD CHEM TOXICOL, V50, P3329, DOI 10.1016/j.fct.2012.06.010; Chao J, 2013, INT J MOL SCI, V14, P2928, DOI 10.3390/ijms14022928; Chen DJ, 2012, FOOD CHEM, V134, P2126, DOI 10.1016/j.foodchem.2012.04.011; Chung KT, 1998, CRIT REV FOOD SCI, V38, P421, DOI 10.1080/10408699891274273; Eder K, 2002, J NUTR, V132, P3400, DOI 10.1093/jn/132.11.3400; Hagerman AE, 1998, J AGR FOOD CHEM, V46, P1887, DOI 10.1021/jf970975b; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; HALLIWELL B, 1990, FREE RADICAL RES COM, V9, P1, DOI 10.3109/10715769009148569; Huang MH, 2011, J ETHNOPHARMACOL, V133, P743, DOI 10.1016/j.jep.2010.11.005; Huang X, 1998, CHINESE TRADITIONAL, V29, P246; Iturbe-Ormaetxe I, 1998, PLANT PHYSIOL, V116, P173, DOI 10.1104/pp.116.1.173; Jiang H, 1999, CHINESE TRADITIONAL, V22, P139; Koo KA, 2006, LIFE SCI, V79, P709, DOI 10.1016/j.lfs.2006.02.019; Kumar NSS, 2012, AMINO ACIDS, V42, P1641, DOI 10.1007/s00726-011-0858-6; Lee KY, 2006, BIOL PHARM BULL, V29, P71, DOI 10.1248/bpb.29.71; Lee YR, 2007, FOOD SCI BIOTECHNOLO, V16; Li XC, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-140; Li XC, 2012, MOLECULES, V17, P13457, DOI 10.3390/molecules171113457; Li XC, 2009, MOLECULES, V14, P5349, DOI 10.3390/molecules14125349; [林朝展 LIN Chao-zhan], 2009, [热带亚热带植物学报, Journal of Tropical and Subtropical Botany], V17, P401; Liu LX, 2009, FOOD CHEM, V112, P35, DOI 10.1016/j.foodchem.2008.05.038; Morkunaite-Haimi S, 2003, BIOCHEM PHARMACOL, V65, P43, DOI 10.1016/S0006-2952(02)01450-8; Nie W., 2011, MODERN CHINESE MED, V13, P37; Ning D, 2012, GUIHAIA, V32, P845; Ozsoy N, 2009, FOOD CHEM, V116, P867, DOI 10.1016/j.foodchem.2009.03.036; Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698; Prochazkova D, 2011, FITOTERAPIA, V82, P513, DOI 10.1016/j.fitote.2011.01.018; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2; Saiga A, 2003, J AGR FOOD CHEM, V51, P3661, DOI 10.1021/jf021156g; Sharma P, 2012, FOOD CHEM, V131, P1406, DOI 10.1016/j.foodchem.2011.10.009; Singh A, 2012, INT RES J PHARM, V3, P452; Tu YH, 2013, J ETHNOPHARMACOL, V146, P465, DOI 10.1016/j.jep.2012.12.051; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wiriyaphan C, 2012, FOOD CHEM, V132, P104, DOI 10.1016/j.foodchem.2011.10.040; Xie ZJ, 2008, FOOD CHEM, V111, P370, DOI 10.1016/j.foodchem.2008.03.078; Yamasaki T, 2007, J NAT MED, V61, P318, DOI 10.1007/s11418-007-0135-x; Yan H., 2006, CHINA PHARM, V15, P3; Yesilada E, 2000, J ETHNOPHARMACOL, V73, P471, DOI 10.1016/S0378-8741(00)00327-5; Zhao HF, 2008, FOOD CHEM, V107, P296, DOI 10.1016/j.foodchem.2007.08.018; Zheng Q, 2012, STUDIES MED MAT QUAL, P1; Zhu XW, 2004, BRAIN RES, V1000, P32, DOI 10.1016/j.brainres.2004.01.012; Zou YP, 2011, J AGR FOOD CHEM, V59, P2268, DOI 10.1021/jf104640k	46	42	49	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93000	10.1371/journal.pone.0093000	http://dx.doi.org/10.1371/journal.pone.0093000			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667350	Green Submitted, Green Published, gold			2022-12-27	WOS:000333675600122
J	Glaeser, SP; Berghoff, BA; Stratmann, V; Grossart, HP; Glaeser, J				Glaeser, Stefanie P.; Berghoff, Bork A.; Stratmann, Verena; Grossart, Hans-Peter; Glaeser, Jens			Contrasting Effects of Singlet Oxygen and Hydrogen Peroxide on Bacterial Community Composition in a Humic Lake	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; PHOTOCHEMICAL FORMATION; GENUS POLYNUCLEOBACTER; ULTRAVIOLET-RADIATION; SEASONAL DYNAMICS; SURFACE WATERS; UV-RADIATION; DIVERSITY; SEQUENCE; CARBON	Light excitation of humic matter generates reactive oxygen species (ROS) in surface waters of aquatic ecosystems. Abundant ROS generated in humic matter rich lakes include singlet oxygen (O-1(2)) and hydrogen peroxide (H2O2). Because these ROS differ in half-life time and toxicity, we compared their effects on microbial activity (C-14-Leucine incorporation) and bacterial community composition (BCC) in surface waters of humic Lake Grosse Fuchskuhle (North-eastern Germany). For this purpose, experiments with water samples collected from the lake were conducted in July 2006, September 2008 and August 2009. Artificially increased O-1(2) and H2O2 concentrations inhibited microbial activity in water samples to a similar extent, but the effect of the respective ROS on BCC varied strongly. BCC analysis by 16S rRNA gene clone libraries and RT-PCR DGGE revealed ROS specific changes in relative abundance and activity of major bacterial groups and composition of dominating phylotypes. These changes were consistent in the three experiments performed in different years. The relative abundance of Polynucleobacter necessarius, Limnohabitans-related phylotypes (Betaproteobacteria), and Novosphingobium acidiphilum (Alphaproteobacteria) increased or was not affected by photo-sensitized O-1(2) exposure, but decreased after H2O2 exposure. The opposite pattern was found for Actinobacteria of the freshwater AcI-B cluster which were highly sensitive to O-1(2) but not to H2O2 exposure. Furthermore, group-specific RT-PCR DGGE analysis revealed that particle-attached P. necessarius and Limnohabitans-related phylotypes exhibit higher resistance to O-1(2) exposure compared to free-living populations. These results imply that O-1(2) acts as a factor in niche separation of closely affiliated Polynucleobacter and Limnohabitans-related phylotypes. Consequently, oxidative stress caused by photochemical ROS generation should be regarded as an environmental variable determining abundance, activity, and phylotype composition of environmentally relevant bacterial groups, in particular in illuminated and humic matter rich waters.	[Glaeser, Stefanie P.; Berghoff, Bork A.; Stratmann, Verena; Glaeser, Jens] Univ Giessen, Inst Microbiol & Mol Biol, D-35390 Giessen, Germany; [Glaeser, Stefanie P.] Univ Giessen, Inst Appl Microbiol, D-35390 Giessen, Germany; [Berghoff, Bork A.] Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden; [Grossart, Hans-Peter] Leibniz Inst Freshwater Ecol & Inland Fisheries, Stechlin, Germany; [Grossart, Hans-Peter] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Uppsala University; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Potsdam	Grossart, HP (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Stechlin, Germany.	hgrossart@igb-berlin.de; jens.glaeser@mikro.bio.uni-giessen.de	Glaeser, Stefanie/ABI-5518-2020		German Science Foundation (DFG) [JG-620/2-1, GR-1540/17-1, PA- 1655/1-1]	German Science Foundation (DFG)(German Research Foundation (DFG))	This work was supported by funds of the German Science Foundation (DFG) given to JG (JG-620/2-1) and to HPG (GR-1540/17-1 and PA- 1655/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2006, APPL ENVIRON MICROB, V72, P3489, DOI 10.1128/AEM.72.5.3489-3497.2006; Allgaier M, 2006, AQUAT MICROB ECOL, V45, P115, DOI 10.3354/ame045115; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anesio AM, 2005, APPL ENVIRON MICROB, V71, P6267, DOI 10.1128/AEM.71.10.6267-6275.2005; BAXTER RM, 1983, NATURE, V306, P575, DOI 10.1038/306575a0; Bertilsson S, 2000, LIMNOL OCEANOGR, V45, P753, DOI 10.4319/lo.2000.45.4.0753; BROSIUS J, 1978, P NATL ACAD SCI USA, V75, P4801, DOI 10.1073/pnas.75.10.4801; Buck U, 2008, AQUAT MICROB ECOL, V51, P97, DOI 10.3354/ame01188; Buck U, 2009, ENVIRON MICROBIOL, V11, P1854, DOI 10.1111/j.1462-2920.2009.01910.x; Burkert U, 2003, APPL ENVIRON MICROB, V69, P6550, DOI 10.1128/AEM.69.11.6550-6559.2003; Carlos L, 2011, PHOTOCH PHOTOBIO SCI, V10, P1080, DOI 10.1039/c1pp00003a; Cooper W.J., 1989, ADV CHEM SER, P333; COOPER WJ, 1989, ENVIRON SCI TECHNOL, V23, P1425, DOI 10.1021/es00069a017; Cory RM, 2010, ENVIRON SCI TECHNOL, V44, P3683, DOI 10.1021/es902989y; Dalrymple RM, 2010, ENVIRON SCI TECHNOL, V44, P5824, DOI 10.1021/es101005u; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; Dufour YS, 2008, J MOL BIOL, V383, P713, DOI 10.1016/j.jmb.2008.08.017; Eichler S, 2004, MOL MICROBIAL ECOLOG, P103; Garcia SL, 2013, ISME J, V7, P137, DOI 10.1038/ismej.2012.86; Glaeser J, 2011, ADV MICROB PHYSIOL, V58, P141, DOI 10.1016/B978-0-12-381043-4.00004-0; Glaeser SP, 2010, ENVIRON MICROBIOL, V12, P3124, DOI 10.1111/j.1462-2920.2010.02285.x; Glaeser SP, 2009, INT J SYST EVOL MICR, V59, P323, DOI 10.1099/ijs.0.65852-0; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; Goldstone JV, 2002, ENVIRON SCI TECHNOL, V36, P364, DOI 10.1021/es0109646; Grandbois M, 2008, ENVIRON SCI TECHNOL, V42, P9184, DOI 10.1021/es8017094; Grossart HP, 2008, ENVIRON MICROBIOL, V10, P635, DOI 10.1111/j.1462-2920.2007.01487.x; Grossart HP, 2010, ENV MICROBIOL REP, V2, P706, DOI 10.1111/j.1758-2229.2010.00179.x; Grossart HP, 1997, LIMNOL OCEANOGR, V42, P1651, DOI 10.4319/lo.1997.42.8.1651; HAAG WR, 1986, ENVIRON SCI TECHNOL, V20, P341, DOI 10.1021/es00146a005; Hahn MW, 2009, INT J SYST EVOL MICR, V59, P2002, DOI 10.1099/ijs.0.005801-0; Hakkinen PJ, 2004, CAN J FISH AQUAT SCI, V61, P1520, DOI 10.1139/F04-098; Hutalle-Schmelzer KML, 2010, FEMS MICROBIOL ECOL, V72, P58, DOI 10.1111/j.1574-6941.2009.00831.x; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jones SE, 2009, ENVIRON MICROBIOL, V11, P2463, DOI 10.1111/j.1462-2920.2009.01977.x; Joux F, 2009, PHOTOCHEM PHOTOBIOL, V85, P783, DOI 10.1111/j.1751-1097.2008.00474.x; Judd KE, 2007, AQUAT SCI, V69, P96, DOI 10.1007/s00027-006-0908-4; KEIL RG, 1994, MAR CHEM, V45, P187, DOI 10.1016/0304-4203(94)90002-7; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Latch DE, 2006, SCIENCE, V311, P1743, DOI 10.1126/science.1121636; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Lourenco RF, 2009, MOL MICROBIOL, V72, P1159, DOI 10.1111/j.1365-2958.2009.06714.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Minella M, 2011, CHEMOSPHERE, V83, P1480, DOI 10.1016/j.chemosphere.2011.02.093; Moran MA, 1997, LIMNOL OCEANOGR, V42, P1307, DOI 10.4319/lo.1997.42.6.1307; Morris JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016805; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Ogilby PR, 2010, CHEM SOC REV, V39, P3181, DOI 10.1039/b926014p; Perez MT, 2007, ENVIRON MICROBIOL, V9, P2200, DOI 10.1111/j.1462-2920.2007.01334.x; Petasne RG, 1997, MAR CHEM, V56, P215, DOI 10.1016/S0304-4203(96)00072-2; Piccini C, 2009, PHOTOCH PHOTOBIO SCI, V8, P1321, DOI 10.1039/b905040j; POMEROY LR, 1974, BIOSCIENCE, V24, P499, DOI 10.2307/1296885; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ryter SW, 1998, FREE RADICAL BIO MED, V24, P1520, DOI 10.1016/S0891-5849(97)00461-9; Salka I, 2011, ENVIRON MICROBIOL, V13, P2865, DOI 10.1111/j.1462-2920.2011.02562.x; Scully NM, 1996, LIMNOL OCEANOGR, V41, P540, DOI 10.4319/lo.1996.41.3.0540; Simek K, 2010, APPL ENVIRON MICROB, V76, P1406, DOI 10.1128/AEM.02517-09; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tranvik L, 1998, AQUAT MICROB ECOL, V14, P301, DOI 10.3354/ame014301; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watanabe K, 2009, FEMS MICROBIOL ECOL, V67, P57, DOI 10.1111/j.1574-6941.2008.00606.x; ZEPP RG, 1977, NATURE, V267, P421, DOI 10.1038/267421a0; Ziegelhoffer EC, 2009, NAT REV MICROBIOL, V7, P856, DOI 10.1038/nrmicro2237	63	17	17	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92518	10.1371/journal.pone.0092518	http://dx.doi.org/10.1371/journal.pone.0092518			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667441	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600046
J	Barkallah, M; Gharbi, Y; Ben Hassena, A; Ben Slima, A; Mallek, Z; Gautier, M; Greub, G; Gdoura, R; Fendri, I				Barkallah, Mohamed; Gharbi, Yaakoub; Ben Hassena, Amal; Ben Slima, Ahlem; Mallek, Zouhir; Gautier, Michel; Greub, Gilbert; Gdoura, Radhouane; Fendri, Imen			Survey of Infectious Etiologies of Bovine Abortion during Mid- to Late Gestation in Dairy Herds	PLOS ONE			English	Article							REAL-TIME PCR; LINKED-IMMUNOSORBENT-ASSAY; COXIELLA-BURNETII; WADDLIA-CHONDROPHILA; CATTLE; PARACHLAMYDIA; PREVALENCE; IDENTIFICATION; BRUCELLOSIS; SAMPLES	Bovine abortion of unknown infectious etiology still remains a major economic problem. Thus, we investigated whether Brucella spp., Listeria monocytogenes, Salmonella spp., Campylobacter spp. and Coxiella burnetii are associated with abortion and/or stillbirth in Tunisian dairy cattle. Using a pan-Chlamydiales PCR, we also investigated the role of Chlamydiaceae, Waddlia chondrophila, Parachlamydia acanthamoebae and other members of the Chlamydiales order in this setting. Veterinary samples taken from mid to late-term abortions from twenty dairy herds were tested. From a total of 150 abortion cases collected, infectious agents were detected by PCR in 73 (48.66%) cases, 13 (8.66%) of which represented co-infections with two infectious agents. Detected pathogens include Brucella spp (31.3%), Chlamydiaceae (4.66%), Waddlia chondrophila (8%), Parachlamydia acanthamoebae (5.33%), Listeria monocytogenes (4.66%) and Salmonella spp. (3.33%). In contrast, Campylobacter spp. and Coxiella burnetii DNA were not detected among the investigated veterinary samples. This demonstrates that different bacterial agents may cause bovine abortion in Tunisia. This is the first report suggesting the role of Parachlamydia acanthamoebae in bovine abortion in Africa. Further studies with a larger number of samples are necessary to confirm whether this emerging pathogen is directly linked to abortion in cattle.	[Barkallah, Mohamed; Gharbi, Yaakoub; Ben Hassena, Amal; Ben Slima, Ahlem; Gdoura, Radhouane; Fendri, Imen] Univ Sfax Tunisia, Fac Sci Sfax, Unite Rech Toxicol Microbiol Environm & Sante UR1, Sfax, Tunisia; [Mallek, Zouhir] Ctr Vet Rech, Sfax, Tunisia; [Gautier, Michel; Fendri, Imen] Agrocampus Ouest, Microbiol Lab, Dept Agroalimentaire, Rennes, France; [Greub, Gilbert] Univ Hosp Ctr, Inst Microbiol, Lausanne, Switzerland; [Greub, Gilbert] Univ Lausanne, Lausanne, Switzerland	Universite de Sfax; Faculty of Sciences Sfax; Institut Agro; Agrocampus Ouest; University of Lausanne	Fendri, I (corresponding author), Univ Sfax Tunisia, Fac Sci Sfax, Unite Rech Toxicol Microbiol Environm & Sante UR1, Sfax, Tunisia.	imen.fendri@yahoo.fr	Greub, Gilbert GG/K-5804-2017; ben hassena, amal/GNP-4643-2022; Gdoura, Radhouane/I-6865-2018; Gdoura, Radhouane/AAD-6486-2022	Greub, Gilbert GG/0000-0001-9529-3317; ben hassena, amal/0000-0001-7046-487X; Gdoura, Radhouane/0000-0003-1140-3780; FENDRI, Imen/0000-0002-4071-5444	Ministere de l'enseignement superieur et de la recherche scientifique; ISESCO Organization	Ministere de l'enseignement superieur et de la recherche scientifique; ISESCO Organization	This work received financial support from "Ministere de l'enseignement superieur et de la recherche scientifique'' and the ISESCO Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla A, 2012, TROP ANIM HEALTH PRO, V44, P1151, DOI 10.1007/s11250-011-0051-7; Aggad H., 2006, Eastern Mediterranean Health Journal, V12, P119; Al-Majali AM, 2009, J VET SCI, V10, P61, DOI 10.4142/jvs.2009.10.1.61; Alter T, 2011, BUNDESGESUNDHEITSBLA, V54, P728, DOI 10.1007/s00103-011-1289-y; Alton GG, 1975, WHO MONOGR SER, V5, P1; Anderson ML, 2007, THERIOGENOLOGY, V68, P474, DOI 10.1016/j.theriogenology.2007.04.001; Barkallah M, 2013, VET MICROBIOL, V164, P101, DOI 10.1016/j.vetmic.2013.01.036; Baud D, 2008, CURR OPIN INFECT DIS, V21, P70, DOI 10.1097/QCO.0b013e3282f3e6a5; Baud D, 2011, CLIN INFECT DIS, V52, P1469, DOI 10.1093/cid/cir205; Berri M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-130; Blumer S, 2011, VET MICROBIOL, V152, P385, DOI 10.1016/j.vetmic.2011.05.024; Borel N, 2006, VET PATHOL, V43, P702, DOI 10.1354/vp.43-5-702; Borel N, 2007, EMERG INFECT DIS, V13, P1904, DOI 10.3201/eid1312.070655; Boukary AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083175; Carrique-Mas JJ, 2010, VET REC, V167, P560, DOI 10.1136/vr.c4943; Casson N, 2008, J CLIN MICROBIOL, V46, P1491, DOI 10.1128/JCM.02302-07; *CDCP, 2007, MMWR-MORBID MORTAL W, V57, P1097; Centers for Disease Control and Prevention (CDC), 2006, MMWR-MORBID MORTAL W, P432; Dean AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071501; Fishbein DB, 1999, AM J TROP MED, V247, P35; Givens MD, 2006, THERIOGENOLOGY, V66, P648, DOI 10.1016/j.theriogenology.2006.04.021; Guatteo R, 2012, VET MICROBIOL, V155, P430, DOI 10.1016/j.vetmic.2011.09.026; Gutierrez J, 2011, VET MICROBIOL, V147, P119, DOI 10.1016/j.vetmic.2010.06.015; Hinic V, 2008, J MICROBIOL METH, V75, P375, DOI 10.1016/j.mimet.2008.07.002; HOLLIMAN A, 1994, VET REC, V134, P500, DOI 10.1136/vr.134.19.500; Iraola G, 2012, J VET SCI, V13, P371, DOI 10.4142/jvs.2012.13.4.371; Kirkbride C. A., 1990, Laboratory diagnosis of livestock abortion., P17; Lienard J, 2011, J CLIN MICROBIOL, V49, P2637, DOI 10.1128/JCM.00114-11; Livingstone M, 2006, VET J, V172, P3, DOI 10.1016/j.tvjl.2005.05.001; Makita K, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-60; Mayfield J. E., 1990, Animal brucellosis., P97; Mshelia GD, 2010, VET ITAL, V46, P337; Mshelia GD, 2012, TROP ANIM HEALTH PRO, V44, P1487, DOI 10.1007/s11250-012-0092-6; Natale A, 2012, COMP IMMUNOL MICROB, V35, P375, DOI 10.1016/j.cimid.2012.03.002; Ning P, 2012, J DAIRY SCI, V95, P4863, DOI 10.3168/jds.2012-5600; Njiro SM, 2011, J S AFR VET ASSOC, V82, P213; Okwumabua O, 2005, FEMS MICROBIOL LETT, V249, P275, DOI 10.1016/j.femsle.2005.06.018; ON SLW, 1991, J CLIN MICROBIOL, V29, P1785, DOI 10.1128/JCM.29.9.1785-1788.1991; Ortega-Mora L.M., 2007, RUMINANTS GUIDELINES; Pantchev A, 2010, COMP IMMUNOL MICROB, V33, P473, DOI 10.1016/j.cimid.2009.08.002; PETER O, 1987, J CLIN MICROBIOL, V25, P1063; Petit T, 2008, VET MICROBIOL, V127, P325, DOI 10.1016/j.vetmic.2007.08.022; Poudel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044961; Radostits O.M., 2007, VET MED TXB DIS CATT, VTenth Edition, P3; RANKIN JD, 1966, VET REC, V78, P706, DOI 10.1136/vr.78.21.706; Rekiki A, 2005, REV MED VET-TOULOUSE, V156, P395; Rekiki A, 2004, CHLAMYDIOSE ABORTIVE, P233; RICHARDSON A, 1975, VET REC, V96, P329, DOI 10.1136/vr.96.15.329; RINGS DM, 1985, VET CLIN N AM-FOOD A, V1, P529; Rodolakis A, 2007, J DAIRY SCI, V90, P5352, DOI 10.3168/jds.2006-815; ROMERO C, 1995, J CLIN MICROBIOL, V33, P3198, DOI 10.1128/JCM.33.12.3198-3200.1995; Storz J., 1988, Microbiology of Chlamydia., P167; Storz J, 1993, RICKETTSIAL CHLAMYDI, P27; THOMAS R, 1990, BRIT VET J, V146, P364, DOI 10.1016/S0007-1935(11)80031-X; Tramuta C, 2011, J VET DIAGN INVEST, V23, P657, DOI 10.1177/1040638711407880; Wheelhouse N, 2012, VET J, V193, P586, DOI 10.1016/j.tvjl.2012.01.008; Yang N, 2012, ACTA VET HUNG, V60, P83, DOI 10.1556/AVet.2012.007	57	51	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91549	10.1371/journal.pone.0091549	http://dx.doi.org/10.1371/journal.pone.0091549			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662769	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900023
J	Kinnebrew, MA; Lee, YJ; Jenq, RR; Lipuma, L; Littmann, ER; Gobourne, A; No, D; van den Brink, M; Pamer, EG; Taur, Y				Kinnebrew, Melissa A.; Lee, Yeon Joo; Jenq, Robert R.; Lipuma, Lauren; Littmann, Eric R.; Gobourne, Asia; No, Daniel; van den Brink, Marcel; Pamer, Eric G.; Taur, Ying			Early Clostridium difficile Infection during Allogeneic Hematopoietic Stem Cell Transplantation	PLOS ONE			English	Article							VANCOMYCIN-RESISTANT ENTEROCOCCI; VERSUS-HOST-DISEASE; REAL-TIME PCR; DIARRHEA; RISK; COLONIZATION; EPIDEMIOLOGY; MICROBIOTA; FIDAXOMICIN; DOMINATION	Clostridium difficile infection (CDI) is frequently diagnosed in recipients of allogeneic hematopoietic stem cell transplantation (allo-HSCT). We characterized early-transplant CDI and its associations, and analyzed serially-collected feces to determine intestinal carriage of toxigenic C. difficile. Fecal specimens were collected longitudinally from 94 patients during allo-HSCT hospitalization, from the start of pre-transplant conditioning until up to 35 days after stem cell infusion. Presence of C. difficile 16S rRNA and tcdB genes was determined. Clinical variables and specimen data were analyzed for association with development of CDI. Historical data from an additional 1144 allo-HSCT patients was also used. Fecal specimens from 37 patients (39%) were found to harbor C. difficile. Early-transplant CDI was diagnosed in 16 of 94 (17%) patients undergoing allo-HSCT; cases were generally mild and resembled non-CDI diarrhea associated with transplant conditioning. CDI was associated with preceding colonization with tcdB-positive C. difficile and conditioning regimen intensity. We found no associations between early-transplant CDI and graft-versus-host disease or CDI later in transplant. CDI occurs with high frequency during the early phase of allo-HSCT, where recipients are pre-colonized with toxigenic C. difficile. During this time, CDI incidence peaks during pre-transplant conditioning, and is correlated to intensity of the treatment. In this unique setting, high rates of CDI may be explained by prior colonization and chemotherapy; however, cases were generally mild and resembled non-infectious diarrhea due to conditioning, raising concerns of misdiagnosis. Further study of this unique population with more discriminating CDI diagnostic tests are warranted.	[Lee, Yeon Joo; Littmann, Eric R.; Pamer, Eric G.; Taur, Ying] Mem Sloan Kettering Canc Ctr, Infect Dis Serv, New York, NY 10021 USA; [Jenq, Robert R.; van den Brink, Marcel] Mem Sloan Kettering Canc Ctr, Adult Bone Marrow Transplant Serv, New York, NY 10021 USA; [Lipuma, Lauren; Gobourne, Asia; No, Daniel; van den Brink, Marcel; Pamer, Eric G.; Taur, Ying] Mem Sloan Kettering Canc Ctr, Lucille Castori Ctr Microbes Inflammat & Canc, New York, NY 10021 USA; [Kinnebrew, Melissa A.; van den Brink, Marcel; Pamer, Eric G.] Sloan Kettering Inst, Program Immunol, New York, NY USA; [Kinnebrew, Melissa A.; Jenq, Robert R.; van den Brink, Marcel; Pamer, Eric G.; Taur, Ying] Weill Cornell Med Coll, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Taur, Y (corresponding author), Mem Sloan Kettering Canc Ctr, Infect Dis Serv, New York, NY 10021 USA.	taury@mskcc.org	van den Brink, Marcel R. M./HGB-9434-2022	Lee, Yeon Joo/0000-0002-2997-0217; Taur, Ying/0000-0002-6601-8284	National Institutes of Health [1K23 AI095398-01, 1RO1 AI42135, T32GM07739]; Lucille Castori Center for Microbes, Inflamation, and Cancer; Tow Foundation; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA023766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI095398, R01AI042135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lucille Castori Center for Microbes, Inflamation, and Cancer; Tow Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health [grant numbers 1K23 AI095398-01 to Y.T., 1RO1 AI42135 to E.G.P., and T32GM07739 to M.A.K.], the Lucille Castori Center for Microbes, Inflamation, and Cancer, and the Tow Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso CD, 2012, CLIN INFECT DIS, V54, P1053, DOI 10.1093/cid/cir1035; Avery R, 2000, BONE MARROW TRANSPL, V25, P67, DOI 10.1038/sj.bmt.1702086; Bacigalupo A, 2009, BIOL BLOOD MARROW TR, V15, P1628, DOI 10.1016/j.bbmt.2009.07.004; Chakrabarti S, 2000, BONE MARROW TRANSPL, V26, P871, DOI 10.1038/sj.bmt.1702627; Chopra T, 2011, CLIN TRANSPLANT, V25, pE82, DOI 10.1111/j.1399-0012.2010.01331.x; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Donskey CJ, 1999, J INFECT DIS, V180, P384, DOI 10.1086/314874; Donskey CJ, 2000, NEW ENGL J MED, V343, P1925, DOI 10.1056/NEJM200012283432604; Dubberke ER, 2010, CLIN TRANSPLANT, V24, P192, DOI 10.1111/j.1399-0012.2009.01035.x; Heinze G, 2001, BIOMETRICS, V57, P114, DOI 10.1111/j.0006-341X.2001.00114.x; Jakubowski AA, 2011, BIOL BLOOD MARROW TR, V17, P1335, DOI 10.1016/j.bbmt.2011.01.005; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; Kaltsas A, 2012, J CLIN MICROBIOL, V50, P1303, DOI 10.1128/JCM.05711-11; Knetsch CW, 2011, J CLIN MICROBIOL, V49, P227, DOI 10.1128/JCM.01743-10; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Leung S, 2010, INFECT CONT HOSP EP, V31, P313, DOI 10.1086/651066; Manichanh C, 2010, GENOME RES, V20, P1411, DOI 10.1101/gr.107987.110; McFarland LV, 2002, AM J GASTROENTEROL, V97, P1769, DOI 10.1111/j.1572-0241.2002.05839.x; Mullane KM, 2011, CLIN INFECT DIS, V53, P440, DOI 10.1093/cid/cir404; Naaber P, 2011, J CLIN MICROBIOL, V49, P3656, DOI 10.1128/JCM.05115-11; Nerandzic MM, 2012, CLIN INFECT DIS, V55, pS121, DOI 10.1093/cid/cis440; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Pultz NJ, 2005, J INFECT DIS, V191, P949, DOI 10.1086/428090; Rowlings PA, 1997, BRIT J HAEMATOL, V97, P855, DOI 10.1046/j.1365-2141.1997.1112925.x; Ryder AB, 2010, J CLIN MICROBIOL, V48, P4129, DOI 10.1128/JCM.01104-10; SAMORE MH, 1994, CLIN INFECT DIS, V18, P181, DOI 10.1093/clinids/18.2.181; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; van den Berg RJ, 2007, J MED MICROBIOL, V56, P36, DOI 10.1099/jmm.0.46680-0; van den Berg RJ, 2006, CLIN MICROBIOL INFEC, V12, P184, DOI 10.1111/j.1469-0691.2005.01301.x; Walker AS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001172; Wilcox MH, 2012, CLIN MICROBIOL INFEC, V18, P13, DOI 10.1111/1469-0691.12057; Willems L, 2012, BIOL BLOOD MARROW TR, V18, P1295, DOI 10.1016/j.bbmt.2012.02.010	35	49	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e90158	10.1371/journal.pone.0090158	http://dx.doi.org/10.1371/journal.pone.0090158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662889	Green Submitted, Green Published, gold			2022-12-27	WOS:000333459900006
J	Li, YQ; Zhou, CM; Shao, XF; Liu, XY; Guo, J; Zhang, Y; Wang, HL; Wang, XH; Li, B; Deng, KP; Liu, Q; Holthofer, H; Zou, HQ				Li, Yongqiang; Zhou, Chaomin; Shao, Xiaofei; Liu, Xinyu; Guo, Jia; Zhang, Ying; Wang, Honglei; Wang, Xiaohong; Li, Bin; Deng, Kangping; Liu, Qin; Holthoefer, Harry; Zou, Hequn			Hypertriglyceridemic Waist Phenotype and Chronic Kidney Disease in a Chinese Population Aged 40 Years and Older	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; BODY-MASS INDEX; METABOLIC SYNDROME; ABDOMINAL OBESITY; INSULIN-RESISTANCE; RISK; ASSOCIATION; SENSITIVITY; PREVALENCE; MEN	Objective: To examine the relationship between the HW phenotype and risk for CKD in a community population aged 40 years and older. Methods: A cross-sectional study was conducted in Zhuhai from June to October 2012. The participants were divided into three groups: Group 1, Waist circumference >90 cm in men or >85 cm in women and triglycerides >= 2 mmol/l; Group 3, Waist circumference <= 90 cm in men or <= 85 cm in women and triglycerides <2 mmol/l; Group 2, The remaining participants. The prevalence of the three subgroups and CKD were determined. The association between HW phenotype and CKD was then analyzed using SPSS (version 13.0). Results: After adjusting for age and sex, Group 1 was associated with CKD (OR 3.08, 95% CI 2.01, 4.73, P<0.001), when compared with Group 3. Further adjustment for factors which were potential confounders and unlikely to be in the causal pathway between the HW phenotype and CKD, Group 1 was still significantly associated with CKD. The OR for CKD was 2.65 (95% CI 1.65, 4.26, P<0.001). When adjusted for diabetes and hypertension, the association of Group 1 and CKD was still significant (OR 2.09, 95% CI 1.26, 3.45, P = 0.004). Group 2 was associated with CKD (OR 1.81, 95% CI 1.29, 2.53, P = 0.001), when compared with Group 3. Further adjustment for factors which were potential confounders, Group 2 was still significantly associated with CKD. The OR for CKD was 1.75 (95% CI 1.22, 2.51, P = 0.002). When adjusted for diabetes and hypertension, the association between Group 2 and CKD still existed. The OR for CKD was 1.48 (95% CI 1.01, 2.16, P = 0.046). Conclusion: Our results showed that HW phenotype was associated with CKD in the population aged 40 years and older.	[Li, Yongqiang; Zhou, Chaomin; Shao, Xiaofei; Liu, Xinyu; Guo, Jia; Zhang, Ying; Wang, Honglei; Wang, Xiaohong; Li, Bin; Deng, Kangping; Liu, Qin; Zou, Hequn] Southern Med Univ, Affiliated Hosp 3, Dept Nephrol, Guangzhou, Guangdong, Peoples R China; [Holthoefer, Harry] Dublin City Univ, Natl Ctr Sensor Res BioAnalyt Sci, Dublin 9, Ireland	Southern Medical University - China; Dublin City University	Zou, HQ (corresponding author), Southern Med Univ, Affiliated Hosp 3, Dept Nephrol, Guangzhou, Guangdong, Peoples R China.	hequnzou@hotmail.com	Zou, He/GXH-0280-2022; wang, xiao/HGB-7081-2022	wang, xiao/0000-0002-4088-3341	EU FP7 Program, UroSense; Guangdong Provincial Science and Technique Program [2011B031800386]	EU FP7 Program, UroSense; Guangdong Provincial Science and Technique Program	This study was supported by the following Science Foundation: 1. EU FP7 Program, UroSense, 2011; 2. Guangdong Provincial Science and Technique Program (No. 2011B031800386), 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenault BJ, 2010, CAN MED ASSOC J, V182, P1427, DOI 10.1503/cmaj.091276; Ayodele OE, 2010, ADV CHRONIC KIDNEY D, V17, P215, DOI 10.1053/j.ackd.2010.02.001; Blackburn P, 2012, METABOLISM, V61, P56, DOI 10.1016/j.metabol.2011.05.017; Buchholz AC, 2005, SPINAL CORD, V43, P513, DOI 10.1038/sj.sc.3101744; Carlsson AC, 2014, OBESITY, V22, P526, DOI 10.1002/oby.20434; Curhan GC, 2010, CLIN J AM SOC NEPHRO, V5, P557, DOI 10.2215/CJN.01650210; Despres JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228; Esmaillzadeh A, 2006, AM J CLIN NUTR, V83, P36; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gomez-Huelgas R, 2011, INT J OBESITY, V35, P292, DOI 10.1038/ijo.2010.127; Hallan S, 2006, AM J KIDNEY DIS, V47, P396, DOI 10.1053/j.ajkd.2005.11.027; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Irwin M, 2000, AM POETRY REV, V29, P23; Kahn HS, 2003, AM J CLIN NUTR, V78, P928, DOI 10.1093/ajcn/78.5.928; Kwakernaak AJ, 2013, J AM SOC NEPHROL, V24, P987, DOI 10.1681/ASN.2012050460; LaMonte MJ, 2003, ATHEROSCLEROSIS, V171, P123, DOI 10.1016/j.atherosclerosis.2003.07.008; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Lemieux I, 2002, CAN J CARDIOL, V18, P725; Lemieux I, 2000, CIRCULATION, V102, P179, DOI 10.1161/01.CIR.102.2.179; Li YQ, 2013, INT J ENV RES PUB HE, V10, P3987, DOI 10.3390/ijerph10093987; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; MATSUBARA K, 1989, METABOLISM, V38, P698, DOI 10.1016/0026-0495(89)90110-8; Rosolova H, 2008, MED SCI MONITOR, V14, pCR411; Ross R, 2002, J CLIN ENDOCR METAB, V87, P5044, DOI 10.1210/jc.2002-020570; Ross R, 2002, AM J PHYSIOL-ENDOC M, V282, pE657, DOI 10.1152/ajpendo.00469.2001; Sam S, 2009, DIABETES CARE, V32, P1916, DOI 10.2337/dc09-0412; St-Pierre J, 2002, AM J CARDIOL, V90, P15, DOI 10.1016/S0002-9149(02)02378-0; Wahba IM, 2007, CLIN J AM SOC NEPHRO, V2, P550, DOI 10.2215/CJN.04071206; Wang HY, 2005, KIDNEY INT, V67, pS63, DOI 10.1111/j.1523-1755.2005.09416.x; Weinberg JM, 2006, KIDNEY INT, V70, P1560, DOI 10.1038/sj.ki.5001834; Yao Q, 2008, PERITON DIALYSIS INT, V28, pS42; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhe XW, 2012, NEPHRON CLIN PRACT, V122, P146, DOI 10.1159/000351042	33	13	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92322	10.1371/journal.pone.0092322	http://dx.doi.org/10.1371/journal.pone.0092322			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663403	Green Submitted, gold, Green Published			2022-12-27	WOS:000333459900050
J	Nzonza, A; Lecollinet, S; Chat, S; Lowenski, S; Merour, E; Biacchesi, S; Bremont, M				Nzonza, Angella; Lecollinet, Sylvie; Chat, Sophie; Lowenski, Steeve; Merour, Emilie; Biacchesi, Stephane; Bremont, Michel			A Recombinant Novirhabdovirus Presenting at the Surface the E Glycoprotein from West Nile Virus (WNV) Is Immunogenic and Provides Partial Protection against Lethal WNV Challenge in BALB/c Mice	PLOS ONE			English	Article							ENVELOPE PROTEIN VACCINE; DOMAIN-III; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; ENCEPHALITIS; IMMUNIZATION; ANTIBODY; INFECTION; VECTOR; DENGUE	West Nile Virus (WNV) is a zoonotic mosquito-transmitted flavivirus that can infect and cause disease in mammals including humans. Our study aimed at developing a WNV vectored vaccine based on a fish Novirhabdovirus, the Viral Hemorrhagic Septicemia virus (VHSV). VHSV replicates at temperatures lower than 20 degrees C and is naturally inactivated at higher temperatures. A reverse genetics system has recently been developed in our laboratory for VHSV allowing the addition of genes in the viral genome and the recovery of the respective recombinant viruses (rVHSV). In this study, we have generated rVHSV vectors bearing the complete WNV envelope gene (E-WNV) (rVHSV-E-WNV) or fragments encoding E subdomains (either domain III alone or domain III fused to domain II) (rVHSV-DIIIWNV and rVHSV-DII-DIIIWNV, respectively) in the VHSV genome between the N and P cistrons. With the objective to enhance the targeting of the E-WNV protein or E-WNV-derived domains to the surface of VHSV virions, Novirhadovirus G-derived signal peptide and transmembrane domain (SPG and TMG) were fused to E-WNV at its amino and carboxy termini, respectively. By Western-blot analysis, electron microscopy observations or inoculation experiments in mice, we demonstrated that both the E-WNV and the DIIIWNV could be expressed at the viral surface of rVHSV upon addition of SPG. Every constructs expressing E-WNV fused to SPG protected 40 to 50% of BALB/cJ mice against WNV lethal challenge and specifically rVHSV-SPGEWNV induced a neutralizing antibody response that correlated with protection. Surprisingly, rVHSV expressing E-WNV-derived domain III or II and III were unable to protect mice against WNV challenge, although these domains were highly incorporated in the virion and expressed at the viral surface. In this study we demonstrated that a heterologous glycoprotein and non membrane-anchored protein, can be efficiently expressed at the surface of rVHSV making this approach attractive to develop new vaccines against various pathogens.	[Nzonza, Angella; Merour, Emilie; Biacchesi, Stephane; Bremont, Michel] CRJ, INRA, Unite Virol & Immunol Mol UR0892, Jouy En Josas, France; [Lecollinet, Sylvie; Lowenski, Steeve] UPEC ENVA, ANSES, INRA, UMR Virol 1161, Maisons Alfort, France; [Chat, Sophie] CRJ, INRA, Unite Genom & Physiol Lactat UR1196, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); INRAE; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Bremont, M (corresponding author), CRJ, INRA, Unite Virol & Immunol Mol UR0892, Jouy En Josas, France.	michel.bremont@jouy.inra.fr	Lecollinet, Sylvie/M-1728-2019; Biacchesi, Stephane/A-6924-2010; Lecollinet, Sylvie/AAV-5276-2021	Biacchesi, Stephane/0000-0002-7020-2391; Chat, Sophie/0000-0003-0671-5229; Lecollinet, Sylvie/0000-0001-8535-2133	Region Ile de France through a DIM Malinf project; Animal Health Division of INRA	Region Ile de France through a DIM Malinf project(Region Ile-de-France); Animal Health Division of INRA	The PhD fellowship to AN has been supported by the Region Ile de France through a DIM Malinf project. This work has been in part supported by the Animal Health Division of INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Padilla J, 2011, VACCINE, V29, P1830, DOI 10.1016/j.vaccine.2010.12.081; An HY, 2013, VIRUS RES, V171, P168, DOI 10.1016/j.virusres.2012.11.007; Bellier B, 2009, VACCINE, V27, P5772, DOI 10.1016/j.vaccine.2009.07.059; Biacchesi S, 2002, J VIROL, V76, P2881, DOI 10.1128/JVI.76.6.2881-2889.2002; Biacchesi S, 2000, J VIROL, V74, P11247, DOI 10.1128/JVI.74.23.11247-11253.2000; Biacchesi S, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-12; Biacchesi S, 2010, J VIROL, V84, P10038, DOI 10.1128/JVI.00343-10; Bonafe N, 2009, VACCINE, V27, P213, DOI 10.1016/j.vaccine.2008.10.046; Chu JHJ, 2007, J IMMUNOL, V178, P2699, DOI 10.4049/jimmunol.178.5.2699; Chu JJH, 2005, J GEN VIROL, V86, P405, DOI 10.1099/vir.0.80411-0; Chua AJS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-129; Coutant F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003973; De Filette M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-16; Despres P, 2005, J INFECT DIS, V191, P207, DOI 10.1086/426824; Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x; Diamond MS, 2009, FRONT BIOSCI-LANDMRK, V14, P3024, DOI 10.2741/3432; Escribano-Romero E, 2013, VACCINE, V31, P4523, DOI 10.1016/j.vaccine.2013.07.071; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10; Harmache A, 2006, J VIROL, V80, P3655, DOI 10.1128/JVI.80.7.3655-3659.2006; Iglesias MC, 2006, J GENE MED, V8, P265, DOI 10.1002/jgm.837; Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06; Kramer LD, 2007, LANCET NEUROL, V6, P171, DOI 10.1016/S1474-4422(07)70030-3; Ledizet M, 2005, VACCINE, V23, P3915, DOI 10.1016/j.vaccine.2005.03.006; Lieberman MM, 2009, CLIN VACCINE IMMUNOL, V16, P1332, DOI 10.1128/CVI.00119-09; Lucas M, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-9; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; Martina BE, 2008, VACCINE, V26, P153, DOI 10.1016/j.vaccine.2007.10.055; Martina BEE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018995; MATHEWS JH, 1984, J IMMUNOL, V132, P1533; McLean Robert G., 2007, P17, DOI 10.1002/9780470344668.ch2; Minke JM, 2011, VACCINE, V29, P4608, DOI 10.1016/j.vaccine.2011.04.058; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07; Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002; Purdy DE, 2005, VIROLOGY, V333, P239, DOI 10.1016/j.virol.2004.12.036; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Roehrig JT, 2001, ANN NY ACAD SCI, V951, P286; Schneeweiss A, 2011, VACCINE, V29, P6352, DOI 10.1016/j.vaccine.2011.04.116; Spohn G, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-146; Tan LCM, 2010, PROTEIN EXPRES PURIF, V74, P129, DOI 10.1016/j.pep.2010.06.015; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11; Wang T, 2001, J IMMUNOL, V167, P5273, DOI 10.4049/jimmunol.167.9.5273; Watts DM, 2007, VACCINE, V25, P2913, DOI 10.1016/j.vaccine.2006.08.008; Wertz GW, 2002, J VIROL, V76, P7642, DOI 10.1128/JVI.76.15.7642-7650.2002; Zlatkovic J, 2011, J VIROL, V85, P1994, DOI 10.1128/JVI.01886-10	49	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91766	10.1371/journal.pone.0091766	http://dx.doi.org/10.1371/journal.pone.0091766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663075	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900028
J	Song, LH; Lu, YF; He, J; Yu, YH; Zuo, TT; Li, YW; Zhu, H; Duan, Q				Song, Lihua; Lu, Yongfeng; He, Jun; Yu, Yonghui; Zuo, Tingting; Li, Yanwei; Zhu, Hong; Duan, Qing			Multi-Organ Lesions in Suckling Mice Infected with SARS-Associated Mammalian Reovirus Linked with Apoptosis Induced by Viral Proteins mu 1 and sigma 1	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; CENTRAL-NERVOUS-SYSTEM; OBLITERANS ORGANIZING PNEUMONIA; ATTACHMENT PROTEIN; DIFFERENTIAL ROLE; TISSUE-INJURY; T-CELLS; CORONAVIRUS; MENINGITIS; DISEASE	We reported the isolation and characterization of a novel mammalian reassortant reovirus BYD1 that may have played an accomplice role with SARS-coronavirus during the 2003 SARS pandemic. The pathogenic mechanism of this novel reovirus is unknown. Reovirus pathogenicity has been associated with virus-induced apoptosis in cultured cells and in vivo. The reovirus outer capsid protein mu 1 is recognized as the primary determinant of reovirus-induced apoptosis. Here, we investigated the apoptosis induced by BYD1, its outer capsid protein mu 1, and its cell-attachment protein sigma 1 to understand the pathogenesis of BYD1. We also investigated BYD1 caused systemic complications in suckling mice. Under electron microscopy, BYD1-infected cells showed characteristics typical of apoptosis. Notably, ectopically expressed mu 1 and sigma 1 induced similar pathological apoptosis, independent of BYD1 infection, in host cells in which they were expressed, which suggests that mu 1 and sigma 1 are both apoptotic virulence factors. Consistent with previous reports of reovirus pathogenicity, suckling mice intracranially inoculated with BYD1 developed central nerve damage, myocarditis, and pneumonia. Collectively, our data suggest that BYD1 mu 1- and sigma 1-induced apoptosis is involved in the multi-organ lesions in a suckling mouse BYD1 infection model.	[Song, Lihua; Lu, Yongfeng; He, Jun; Yu, Yonghui; Zuo, Tingting; Li, Yanwei; Zhu, Hong; Duan, Qing] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Song, LH (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	songlihua@gmail.com; hongz62@gmail.com; duanq@nic.bmi.ac.cn	li, yan/GTI-4638-2022		National Natural Science Foundation of China [81071360]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81071360) to LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avasarala S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057285; Beckham JD, 2007, J VIROL, V81, P6984, DOI 10.1128/JVI.00467-07; Chua KB, 2007, P NATL ACAD SCI USA, V104, P11424, DOI 10.1073/pnas.0701372104; Clarke P, 2005, VIRAL IMMUNOL, V18, P89, DOI 10.1089/vim.2005.18.89; Coffey CM, 2006, J VIROL, V80, P8422, DOI 10.1128/JVI.02601-05; Connolly JL, 2001, J VIROL, V75, P4029, DOI 10.1128/JVI.75.9.4029-4039.2001; Danthi P, 2006, J VIROL, V80, P1261, DOI 10.1128/JVI.80.3.1261-1270.2006; Danthi P, 2008, J VIROL, V82, P161, DOI 10.1128/JVI.01739-07; Danthi P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000248; DeBiasi RL, 2004, J VIROL, V78, P11040, DOI 10.1128/JVI.78.20.11040-11050.2004; ESTES MK, 2001, FIELDS VIROLOGY, V2, P1747; He C, 2005, DNA CELL BIOL, V24, P491, DOI 10.1089/dna.2005.24.491; Hermann L, 2004, PEDIATR INFECT DIS J, V23, P373, DOI 10.1097/00006454-200404000-00026; HINSHAW VS, 1994, J VIROL, V68, P3667, DOI 10.1128/JVI.68.6.3667-3673.1994; Johansson PJH, 1996, SCAND J INFECT DIS, V28, P117, DOI 10.3109/00365549609049060; Law PTW, 2005, J GEN VIROL, V86, P1921, DOI 10.1099/vir.0.80813-0; LEE PWK, 1981, VIROLOGY, V108, P156, DOI 10.1016/0042-6822(81)90535-3; Liang LC, 2005, DNA CELL BIOL, V24, P485, DOI 10.1089/dna.2005.24.485; London L, 2002, EXP MOL PATHOL, V72, P24, DOI 10.1006/exmp.2001.2414; Lopez AD, 2009, J IMMUNOL, V183, P8244, DOI 10.4049/jimmunol.0901958; Majeski EI, 2003, AM J RESP CELL MOL, V28, P208, DOI 10.1165/rcmb.4891; Mandell GL, 2010, MANDELL DOUGLAS BENN; Markotic A, 2003, J GEN VIROL, V84, P2197, DOI 10.1099/vir.0.19090-0; MEYAARD L, 1992, SCIENCE, V257, P217, DOI 10.1126/science.1352911; Nibert ML., 2001, FIELDS VIROLOGY, P1679; O'Donnell SM, 2005, J CLIN INVEST, V115, P2341, DOI 10.1172/JCI22428; Oberhaus SM, 1997, J VIROL, V71, P2100, DOI 10.1128/JVI.71.3.2100-2106.1997; RAZVI ES, 1995, ADV VIRUS RES, V45, P1, DOI 10.1016/S0065-3527(08)60057-3; Richardson-Burns SM, 2004, J VIROL, V78, P5466, DOI 10.1128/JVI.78.10.5466-5475.2004; Rodgers SE, 1997, J VIROL, V71, P2540, DOI 10.1128/JVI.71.3.2540-2546.1997; SABIN AB, 1959, SCIENCE, V130, P1387, DOI 10.1126/science.130.3386.1387; Song LH, 2008, VIRUS GENES, V37, P392, DOI 10.1007/s11262-008-0283-4; [苏裕心 Su Yuxin], 2005, [军事医学科学院院刊, Bulletin of the Academy of Military Medical Sciences], V29, P418; TYLER KL, 1995, J VIROL, V69, P6972, DOI 10.1128/JVI.69.11.6972-6979.1995; Tyler KL, 2004, J INFECT DIS, V189, P1664, DOI 10.1086/383129; TYLER KL, 2001, FIELDS VIROLOGY, P1725; WEINER HL, 1980, J IMMUNOL, V124, P2143; Wisniewski ML, 2011, J VIROL, V85, P296, DOI 10.1128/JVI.01982-10; Xu J, 2005, CLIN INFECT DIS, V41, P1089, DOI 10.1086/444461; Yan HM, 2004, J MED VIROL, V73, P323, DOI 10.1002/jmv.20094; [左庭婷 Zuo Tingting], 2003, [军事医学科学院院刊, Bulletin of the Academy of Military Medical Sciences], V27, P241; 端青, 2003, [科学通报, Chinese science bulletin], V48, P1369; [No title captured]	43	1	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92678	10.1371/journal.pone.0092678	http://dx.doi.org/10.1371/journal.pone.0092678			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664247	gold, Green Submitted, Green Published			2022-12-27	WOS:000333459900097
J	White, WM; Garrett, AT; Craici, IM; Wagner, SJ; Fitz-Gibbon, PD; Butters, KA; Brost, BC; Rose, CH; Grande, JP; Garovic, VD				White, Wendy M.; Garrett, Angelica T.; Craici, Iasmina M.; Wagner, Steven J.; Fitz-Gibbon, Patrick D.; Butters, Kim A.; Brost, Brian C.; Rose, Carl H.; Grande, Joseph P.; Garovic, Vesna D.			Persistent Urinary Podocyte Loss following Preeclampsia May Reflect Subclinical Renal Injury	PLOS ONE			English	Article							ANGIOGENIC FACTORS; DISEASE-ACTIVITY; RISK-FACTOR; PREGNANCY; EXCRETION; NEPHRIN; MICROALBUMINURIA; HYPERTENSION; PROTEINURIA; MARKER	Objective: Studies have shown that podocyturia, i.e., urinary loss of viable podocytes (glomerular epithelial cells), is associated with proteinuria in preeclampsia. We postulated that urinary podocyte loss may persist after preeclamptic pregnancies, thus resulting in renal injury. This may lead to future chronic renal injury. In addition, we compared the postpartum levels of the angiogenic factors, which previously have been associated with preeclampsia, between normotensive versus preeclamptic pregnancies. Study Design: The diagnosis of preeclampsia was confirmed using standard clinical criteria. Random blood and urine samples were obtained within 24 hours prior to delivery and 5 to 8 weeks postpartum. Urine sediments were cultured for 24 hours to select for viable cells and staining for podocin was used to identify podocytes. Serum samples were analyzed for the levels of angiogenic markers using ELISA (enzyme-linked immunosorbent assay) methodology. Results: At delivery, preeclamptic patients (n = 10) had significantly higher proteinuria (p = 0.006) and podocyturia (p<0.001) than normotensive pregnant patients (n = 18). Postpartum proteinuria was similar between these two groups (p = 0.37), while podocyturia was present in 3 of 10 women with preeclampsia and in none of the normotensive controls (p = 0.037). Angiogenic marker levels, including placental growth factor, soluble vascular endothelial growth factor receptor fms-like tyrosine kinase receptor-1 and endoglin, were not significantly different between women with preeclampsia and women with a normotensive pregnancy, either at delivery or postpartum. Conclusion: Persistent urinary podocyte loss after preeclamptic pregnancies may constitute a marker of ongoing, subclinical renal injury.	[White, Wendy M.; Garrett, Angelica T.; Brost, Brian C.; Rose, Carl H.] Mayo Clin, Dept Obstet & Gynecol, Rochester, MN USA; [Craici, Iasmina M.; Wagner, Steven J.; Butters, Kim A.; Garovic, Vesna D.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA; [Fitz-Gibbon, Patrick D.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Grande, Joseph P.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Garovic, VD (corresponding author), Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA.	garovic.vesna@mayo.edu	Grande, Joseph P./AAG-2128-2020	Grande, Joseph P./0000-0001-5674-1682; Garovic, Vesna/0000-0001-6891-0578; Brost, Brian/0000-0002-4903-4186	Fulk Career Development Fund for Research in Nephrology, Glomerular Diseases and Clinical Trials; Eunice Kennedy Shriver National Institute of Child Health & Human Development [K08 HD051714]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD051714] Funding Source: NIH RePORTER	Fulk Career Development Fund for Research in Nephrology, Glomerular Diseases and Clinical Trials; Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The project described was supported by: (1) Fulk Career Development Fund for Research in Nephrology, Glomerular Diseases and Clinical Trials (Wendy M. White) and (2) Award Number K08 HD051714 (Vesna D. Garovic) from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development or the National Institutes of Health. The writing of the manuscript and the decision to submit it for publication were solely the authors' responsibilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach J, 2008, NEPHROL DIAL TRANSPL, V23, P3138, DOI 10.1093/ndt/gfn235; Aita K, 2009, NEPHRON CLIN PRACT, V112, pC65, DOI 10.1159/000213083; Bar J, 1999, NEPHROL DIAL TRANSPL, V14, P1129, DOI 10.1093/ndt/14.5.1129; Chen GX, 2013, REPROD SCI, V20, P579, DOI 10.1177/1933719112459227; Craici IM, 2013, HYPERTENSION; Garovic VD, 2007, NAT CLIN PRACT NEPHR, V3, P613, DOI 10.1038/ncpneph0623; Garovic VD, 2013, NEPHROL DIAL TRANSPL, V28, P1555, DOI 10.1093/ndt/gfs074; Garovic VD, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.02.007; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Hara M, 2001, NEPHRON, V89, P342, DOI 10.1159/000046097; HEATON JM, 1985, J PATHOL, V147, P121, DOI 10.1002/path.1711470207; Jim B, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/984630; Jones SL, 1998, HEMATOPATHOL MOL HEM, V11, P147; Kattah AG, 2013, J CLIN HYPERTENS, V15, P617, DOI 10.1111/jch.12116; Kelder TP, 2012, HYPERTENSION, V60, P1538, DOI 10.1161/HYPERTENSIONAHA.112.201681; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Nakamura T, 2000, NEPHROL DIAL TRANSPL, V15, P1379, DOI 10.1093/ndt/15.9.1379; Nakamura T, 2000, AM J MED SCI, V320, P112, DOI 10.1097/00000441-200008000-00009; Petermann AT, 2003, KIDNEY INT, V64, P1222, DOI 10.1046/j.1523-1755.2003.00217.x; Roest M, 2001, CIRCULATION, V103, P3057, DOI 10.1161/hc2501.091353; Sato Y, 2009, J AM SOC NEPHROL, V20, P1041, DOI 10.1681/ASN.2007121328; Son GH, 2013, EUR J OBSTET GYN R B, V166, P139, DOI 10.1016/j.ejogrb.2012.10.011; Verhave JC, 2004, KIDNEY INT, V66, pS18, DOI 10.1111/j.1523-1755.2004.09205.x; Vikse BE, 2008, NEW ENGL J MED, V359, P800, DOI 10.1056/NEJMoa0706790; Vogelmann SU, 2003, AM J PHYSIOL-RENAL, V285, pF40, DOI 10.1152/ajprenal.00404.2002; Wang IK, 2013, CAN MED ASSOC J, V185, P207, DOI 10.1503/cmaj.120230; Wang YP, 2012, AM J PHYSIOL-RENAL, V302, pF1084, DOI 10.1152/ajprenal.00597.2011; Yu DH, 2005, J AM SOC NEPHROL, V16, P1733, DOI 10.1681/ASN.2005020159; Zhao S, 2011, REPROD SCI, V18, P772, DOI 10.1177/1933719111398145	31	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92693	10.1371/journal.pone.0092693	http://dx.doi.org/10.1371/journal.pone.0092693			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664365	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900099
J	Yang, SY; Kim, NH; Cho, YS; Lee, H; Kwon, HJ				Yang, Seung Ya; Kim, Nam Hee; Cho, Yoon Sun; Lee, Hukeun; Kwon, Ho Jeong			Convallatoxin, a Dual Inducer of Autophagy and Apoptosis, Inhibits Angiogenesis In Vitro and In Vivo	PLOS ONE			English	Article							CANCER; CYTOTOXICITY; GLYCOSIDES; DEATH; CELLS	Autophagy and apoptosis are important processes that control cellular homeostasis and have been highlighted as promising targets for novel cancer therapies. Here, we identified convallatoxin (CNT), isolated from Antiaris toxicaria, as a dual inducer of autophagy and apoptosis. CNT exerts cytotoxic effects on a number of cancer and normal cell lines and induces apoptosis by increasing caspase-3 and poly ADP ribose polymerase (PARP) cleavage. Moreover, dose-and time-dependent autophagic activity was detected in CNT-treated cells, and mammalian target of rapamycin (mTOR)/p70S6K signal pathway inhibition was observed. Notably, CNT inhibits human umbilical vein endothelial cell (HUVEC) growth and exerts anti-angiogenic activity in vitro and in vivo. Collectively, these results demonstrate that the naturally occurring compound, CNT, is a novel anti-angiogenic compound via dual inducing of autophagy and apoptosis.	[Yang, Seung Ya; Kim, Nam Hee; Cho, Yoon Sun; Lee, Hukeun; Kwon, Ho Jeong] Yonsei Univ, Coll Life Sci & Biotechnol, Translat Res Ctr Prot Funct Control, Dept Biotechnol, Seoul 120749, South Korea	Yonsei University	Kwon, HJ (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Translat Res Ctr Prot Funct Control, Dept Biotechnol, Seoul 120749, South Korea.	kwonhj@yonsei.ac.kr	권, 호정/AAS-3642-2021		National Research Foundation of Korea (NRF); Korean government (MSIP) [2009-0092964, 2009-0083522, 2011-0006165, 2012M3A9D1054520]; Center for Food and Drug Materials of Agriculture Science & Technology Development [PJ0079772012]; Rural Development Administration; National RD Program; Ministry of Health Welfare [0620360-1]; Brain Korea 21 Plus Project	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MSIP); Center for Food and Drug Materials of Agriculture Science & Technology Development; Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); National RD Program; Ministry of Health Welfare; Brain Korea 21 Plus Project	This study was partly supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP; 2009-0092964, 2009-0083522, 2011-0006165, 2012M3A9D1054520), the Center for Food and Drug Materials of Agriculture Science & Technology Development (PJ0079772012), the Rural Development Administration, the National R&D Program, the Ministry of Health & Welfare (0620360-1), and the Brain Korea 21 Plus Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINI A, 1987, CANCER RES, V47, P3239; BATTEGAY EJ, 1995, J MOL MED, V73, P333; Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Dong WH, 2011, PLANTA MED, V77, P1730, DOI 10.1055/s-0030-1271045; Felth J, 2009, J NAT PROD, V72, P1969, DOI 10.1021/np900210m; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Kim KH, 2011, BIOCHEM BIOPH RES CO, V404, P541, DOI 10.1016/j.bbrc.2010.12.022; Kim NH, 2010, BIOCHEM BIOPH RES CO, V399, P20, DOI 10.1016/j.bbrc.2010.07.025; Klausmeyer P, 2009, J NAT PROD, V72, P805, DOI 10.1021/np8006342; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lian J, 2011, CELL DEATH DIFFER, V18, P60, DOI 10.1038/cdd.2010.74; Newman RA, 2008, MOL INTERV, V8, P36, DOI 10.1124/mi.8.1.8; Nguyen TMB, 2007, BLOOD, V109, P4793, DOI 10.1182/blood-2006-11-059352; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Prassas I, 2011, MOL CANCER THER, V10, P2083, DOI 10.1158/1535-7163.MCT-11-0421; Shim JS, 2003, CHEM BIOL, V10, P695, DOI 10.1016/S1074-5521(03)00169-8; Wang TM, 2007, J NAT PROD, V70, P1429, DOI 10.1021/np070150o; WEHRLI W, 1962, HELV CHIM ACTA, V45, P1183, DOI 10.1002/hlca.19620450416; Yokoyama T, 2008, AUTOPHAGY, V4, P629, DOI 10.4161/auto.5941	24	31	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91094	10.1371/journal.pone.0091094	http://dx.doi.org/10.1371/journal.pone.0091094			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663328	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900013
J	Hsieh, LC; Chen, JW; Wang, LY; Tsang, YM; Shueng, PW; Liao, LJ; Lo, WC; Lin, YC; Tseng, CF; Kuo, YS; Jhuang, JY; Tien, HJ; Juan, HF; Hsieh, CH				Hsieh, Li-Chun; Chen, John W.; Wang, Li-Ying; Tsang, Yuk-Ming; Shueng, Pei-Wei; Liao, Li-Jen; Lo, Wu-Chia; Lin, Yu-Chin; Tseng, Chien-Fu; Kuo, Ying-Shiung; Jhuang, Jie-Yang; Tien, Hui-Ju; Juan, Hsueh-Fen; Hsieh, Chen-Hsi			Predicting the Severity and Prognosis of Trismus after Intensity-Modulated Radiation Therapy for Oral Cancer Patients by Magnetic Resonance Imaging	PLOS ONE			English	Article							NASOPHARYNGEAL CARCINOMA; POSTOPERATIVE TREATMENT; NECK RADIOTHERAPY; CAVITY CANCER; HEAD; EXPERIENCE; SEQUELAE; TERMS	To develop magnetic resonance imaging (MRI) indicators to predict trismus outcome for post-operative oral cavity cancer patients who received adjuvant intensity-modulated radiation therapy (IMRT), 22 patients with oral cancer treated with IMRT were studied over a two-year period. Signal abnormality scores (SA scores) were computed from Likert-type ratings of the abnormalities of nine masticator structures and compared with the Mann-Whitney U-test and Kruskal-Wallis one-way ANOVA test between groups. Seventeen patients (77.3%) experienced different degrees of trismus during the two-year follow-up period. The SA score correlated with the trismus grade (r = 0.52, p < 0.005). Patients having progressive trismus had higher mean doses of radiation to multiple structures, including the masticator and lateral pterygoid muscles, and the parotid gland (p < 0.05). In addition, this group also had higher SA-masticator muscle dose product at 6 months and SA scores at 12 months (p < 0.05). At the optimum cut-off points of 0.38 for the propensity score, the sensitivity was 100% and the specificity was 93% for predicting the prognosis of the trismus patients. The SA score, as determined using MRI, can reflect the radiation injury and correlate to trismus severity. Together with the radiation dose, it could serve as a useful biomarker to predict the outcome and guide the management of trismus following radiation therapy.	[Hsieh, Li-Chun; Tsang, Yuk-Ming] Far Eastern Mem Hosp, Dept Radiol, Div Med Imaging, Taipei, Taiwan; [Shueng, Pei-Wei; Tien, Hui-Ju; Hsieh, Chen-Hsi] Far Eastern Mem Hosp, Dept Radiol, Div Radiat Oncol, Taipei, Taiwan; [Liao, Li-Jen; Lo, Wu-Chia] Far Eastern Mem Hosp, Dept Otolaryngol, Taipei, Taiwan; [Lin, Yu-Chin] Far Eastern Mem Hosp, Dept Internal Med, Div Med Oncol & Hematol, Taipei, Taiwan; [Tseng, Chien-Fu; Kuo, Ying-Shiung] Far Eastern Mem Hosp, Dept Dent & Oral Surg, Taipei, Taiwan; [Jhuang, Jie-Yang] Far Eastern Mem Hosp, Dept Anat Pathol, Taipei, Taiwan; [Hsieh, Chen-Hsi] Natl Yang Ming Univ, Sch Med, Dept Med, Taipei 112, Taiwan; [Hsieh, Chen-Hsi] Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei 112, Taiwan; [Wang, Li-Ying] Natl Taiwan Univ, Coll Med, Sch & Grad Inst Phys Therapy, Taipei 10764, Taiwan; [Shueng, Pei-Wei] Natl Def Med Ctr, Dept Radiat Oncol, Taipei, Taiwan; [Chen, John W.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Syst Biol, Cambridge, MA 02138 USA; [Chen, John W.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiol, Cambridge, MA 02138 USA; [Hsieh, Li-Chun] Natl Taiwan Univ, Ctr Syst Biol, Inst Mol & Cellular Biol, Dept Life Sci, Taipei 10764, Taiwan; [Juan, Hsueh-Fen] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Hsieh, Li-Chun; Juan, Hsueh-Fen] Taipei Med Univ Hosp, Med Imaging Ctr, Taipei, Taiwan	Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan University; National Defense Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; National Taiwan University; National Taiwan University; Taipei Medical University; Taipei Medical University Hospital	Hsieh, CH (corresponding author), Far Eastern Mem Hosp, Dept Radiol, Div Radiat Oncol, Taipei, Taiwan.	chenciab@gmail.com		WANG, LI-YING/0000-0003-3075-6872; JUAN, HSUEH-FEN/0000-0003-4876-3309	Far Eastern Memorial Hospital [FEMH-2012-C-055, FEMH 101-2314-B-418-010-MY3]	Far Eastern Memorial Hospital	This work was supported by the Far Eastern Memorial Hospital grants (FEMH-2012-C-055; FEMH 101-2314-B-418-010-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXEL L, 1987, RADIOLOGY, V162, P874, DOI 10.1148/radiology.162.3.3809508; Bensadoun RJ, 2010, SUPPORT CARE CANCER, V18, P1033, DOI 10.1007/s00520-010-0847-4; Bhatia KSS, 2009, EUR RADIOL, V19, P2586, DOI 10.1007/s00330-009-1445-z; Chen WC, 2009, ORAL ONCOL, V45, P505, DOI 10.1016/j.oraloncology.2008.07.002; Chen YY, 2011, CANCER-AM CANCER SOC, V117, P2910, DOI 10.1002/cncr.25773; Chua DTT, 2001, AM J CLIN ONCOL-CANC, V24, P366, DOI 10.1097/00000421-200108000-00010; Dijkstra PU, 2004, ORAL ONCOL, V40, P879, DOI 10.1016/j.oraloncology.2004.04.003; Goldstein M, 1999, ORAL SURG ORAL MED O, V88, P365, DOI 10.1016/S1079-2104(99)70044-2; Gomez DR, 2009, INT J RADIAT ONCOL, V73, P1096, DOI 10.1016/j.ijrobp.2008.05.024; HENDEE WR, 1989, JAMA-J AM MED ASSOC, V262, P2420; Hsieh CH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-37; Hsiung CY, 2008, BRIT J RADIOL, V81, P809, DOI 10.1259/bjr/17942449; Israel HA, 2003, J ORAL MAXIL SURG, V61, P662, DOI 10.1053/joms.2003.50133; JANSMA J, 1992, INT J RADIAT ONCOL, V24, P359, DOI 10.1016/0360-3016(92)90692-B; Johnson J, 2010, MED SCI MONITOR, V16, pCR278; Keeling AN, 2011, J CARDIOVASC MED, V12, P460, DOI 10.2459/JCM.0b013e3283483916; Kent ML, 2008, SUPPORT CARE CANCER, V16, P305, DOI 10.1007/s00520-007-0345-5; Liu Yuan, 2007, Ai Zheng, V26, P64; QIN DX, 1988, CANCER, V61, P1117, DOI 10.1002/1097-0142(19880315)61:6<1117::AID-CNCR2820610611>3.0.CO;2-J; Steelman R, 1986, Mo Dent J, V66, P21; Teguh DN, 2008, HEAD NECK-J SCI SPEC, V30, P622, DOI 10.1002/hed.20760; van der Molen L, 2011, DYSPHAGIA, V26, P155, DOI 10.1007/s00455-010-9288-y; Vissink A, 2003, CRIT REV ORAL BIOL M, V14, P199, DOI 10.1177/154411130301400305; Wang CJ, 2005, LARYNGOSCOPE, V115, P1458, DOI 10.1097/01.mlg.0000171019.80351.46; Yao M, 2007, INT J RADIAT ONCOL, V67, P1332, DOI 10.1016/j.ijrobp.2006.11.030	25	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92561	10.1371/journal.pone.0092561	http://dx.doi.org/10.1371/journal.pone.0092561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658376	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300098
J	Morris, EJ; Nader, GPF; Ramalingam, N; Bartolini, F; Gundersen, GG				Morris, Edward J.; Nader, Guilherme P. F.; Ramalingam, Nagendran; Bartolini, Francesca; Gundersen, Gregg G.			Kif4 Interacts with EB1 and Stabilizes Microtubules Downstream of Rho-mDia in Migrating Fibroblasts	PLOS ONE			English	Article							DETYROSINATED GLU MICROTUBULES; PLUS-END; INTERMEDIATE-FILAMENTS; CELL-MIGRATION; ALPHA-TUBULIN; SELECTIVE STABILIZATION; STABLE MICROTUBULES; KINESIN SUPERFAMILY; MTOC REORIENTATION; MIDZONE FORMATION	Selectively stabilized microtubules (MTs) form in the lamella of fibroblasts and contribute to cell migration. A Rho-mDia-EB1 pathway regulates the formation of stable MTs, yet how selective stabilization of MTs is achieved is unknown. Kinesin activity has been implicated in selective MT stabilization and a number of kinesins regulate MT dynamics both in vitro and in cells. Here, we show that the mammalian homolog of Xenopus XKLP1, Kif4, is both necessary and sufficient for the induction of selective MT stabilization in fibroblasts. Kif4 localized to the ends of stable MTs and participated in the Rho-mDia-EB1 MT stabilization pathway since Kif4 depletion blocked mDia- and EB1-induced selective MT stabilization and EB1 was necessary for Kif4 induction of stable MTs. Kif4 and EB1 interacted in cell extracts, and binding studies revealed that the tail domain of Kif4 interacted directly with the N-terminal domain of EB1. Consistent with its role in regulating formation of stable MTs in interphase cells, Kif4 knockdown inhibited migration of cells into wounded monolayers. These data identify Kif4 as a novel factor in the Rho-mDia-EB1 MT stabilization pathway and cell migration.	[Morris, Edward J.; Nader, Guilherme P. F.; Ramalingam, Nagendran; Bartolini, Francesca; Gundersen, Gregg G.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA	Columbia University	Gundersen, GG (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA.	ggg1@columbia.edu		Morris, Edward/0000-0002-7960-2842	National Institutes of Health [GM062939]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062939] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM062939 to GGG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Andres-Delgado L, 2012, J CELL BIOL, V198, P1025, DOI 10.1083/jcb.201202137; Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149; Bartolini F, 2009, BIOCH BIOPHYS ACTA; Bartolini F, 2008, J CELL BIOL, V181, P523, DOI 10.1083/jcb.200709029; Bartolini F, 2012, MOL BIOL CELL, V23, P4032, DOI 10.1091/mbc.E12-05-0338; Bastos RN, 2013, J CELL BIOL, V202, P605, DOI 10.1083/jcb.201301094; Bieling P, 2010, CELL, V142, P420, DOI 10.1016/j.cell.2010.06.033; Bisbal M, 2009, J BIOL CHEM, V284, P9489, DOI 10.1074/jbc.M808586200; Bringmann H, 2004, SCIENCE, V303, P1519, DOI 10.1126/science.1094838; Browning H, 2005, J BIOL CHEM, V280, P12299, DOI 10.1074/jbc.M413620200; Butler B, 2009, CURR BIOL, V19, P1886, DOI 10.1016/j.cub.2009.10.029; Chao WT, 2009, FEBS LETT, V583, P1337, DOI 10.1016/j.febslet.2009.03.037; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Du YQ, 2010, CURR BIOL, V20, P374, DOI 10.1016/j.cub.2009.12.049; Dunn S, 2008, J CELL SCI, V121, P1085, DOI 10.1242/jcs.026492; Ems-McClung SC, 2010, SEMIN CELL DEV BIOL, V21, P276, DOI 10.1016/j.semcdb.2010.01.016; Eng CH, 2006, MOL BIOL CELL, V17, P5004, DOI 10.1091/mbc.E05-10-0914; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Gardner MK, 2008, TRENDS CELL BIOL, V18, P307, DOI 10.1016/j.tcb.2008.05.003; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Goulimari P, 2005, J BIOL CHEM, V280, P42242, DOI 10.1074/jbc.M508690200; GUNDERSEN GG, 1987, J CELL BIOL, V105, P251, DOI 10.1083/jcb.105.1.251; GUNDERSEN GG, 1994, J CELL SCI, V107, P645; Gundersen GG, 2004, CURR OPIN CELL BIOL, V16, P106, DOI 10.1016/j.ceb.2003.11.010; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; GUNDERSEN GG, 1984, CELL, V38, P779, DOI 10.1016/0092-8674(84)90273-3; GURLAND G, 1995, J CELL BIOL, V131, P1275, DOI 10.1083/jcb.131.5.1275; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hu CK, 2011, CURR BIOL, V21, P815, DOI 10.1016/j.cub.2011.04.019; Infante AS, 2000, J CELL SCI, V113, P3907; Jaulin F, 2010, J CELL BIOL, V190, P443, DOI 10.1083/jcb.201006044; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; KHAWAJA S, 1988, J CELL BIOL, V106, P141, DOI 10.1083/jcb.106.1.141; Kim WK, 1998, J VIROL, V72, P6898, DOI 10.1128/JVI.72.8.6898-6901.1998; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; KOONCE MP, 1984, J CELL BIOL, V98, P1999, DOI 10.1083/jcb.98.6.1999; Kreitzer G, 1999, MOL BIOL CELL, V10, P1105, DOI 10.1091/mbc.10.4.1105; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Lewkowicz E, 2008, J CELL BIOL, V183, P1287, DOI 10.1083/jcb.200807023; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Liao GJ, 1998, J BIOL CHEM, V273, P9797, DOI 10.1074/jbc.273.16.9797; Lin SX, 2002, MOL BIOL CELL, V13, P96, DOI 10.1091/mbc.01-05-0224; Luxton GWG, 2011, CURR OPIN CELL BIOL, V23, P579, DOI 10.1016/j.ceb.2011.08.001; Luxton GWG, 2010, SCIENCE, V329, P956, DOI 10.1126/science.1189072; Martinez NW, 2008, J VIROL, V82, P9937, DOI 10.1128/JVI.00819-08; Mazumdar M, 2004, J CELL BIOL, V166, P613, DOI 10.1083/jcb.200401142; Miller PM, 2009, NAT CELL BIOL, V11, P1069, DOI 10.1038/ncb1920; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Naghavi MH, 2007, EMBO J, V26, P41, DOI 10.1038/sj.emboj.7601475; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Oliver Constance, 2010, Methods Mol Biol, V588, piv; Palazzo A, 2003, NATURE, V421, P230, DOI 10.1038/421230a; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Palazzo RE, 2001, CENTROSOMES SPINDLE; Peretti D, 2000, J CELL BIOL, V149, P141, DOI 10.1083/jcb.149.1.141; Peris L, 2009, J CELL BIOL, V185, P1159, DOI 10.1083/jcb.200902142; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Schmoranzer J, 2003, J CELL SCI, V116, P4513, DOI 10.1242/jcs.00748; Schmoranzer J, 2009, CURR BIOL, V19, P1065, DOI 10.1016/j.cub.2009.05.065; SEKINE Y, 1994, J CELL BIOL, V127, P187, DOI 10.1083/jcb.127.1.187; Stumpff J, 2011, MOL CELL, V43, P764, DOI 10.1016/j.molcel.2011.07.022; Su XL, 2012, TRENDS CELL BIOL, V22, P567, DOI 10.1016/j.tcb.2012.08.003; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; Thurston SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048041; Wakida NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015462; Weaver LN, 2011, CURR BIOL, V21, P1500, DOI 10.1016/j.cub.2011.08.005; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; WEBSTER DR, 1990, J CELL BIOL, V111, P113, DOI 10.1083/jcb.111.1.113; Wen YD, 2004, KENYON REV, V26, P1; Wordeman L, 2005, CURR OPIN CELL BIOL, V17, P82, DOI 10.1016/j.ceb.2004.12.003; Xu JS, 2005, P NATL ACAD SCI USA, V102, P6884, DOI 10.1073/pnas.0502106102; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102	83	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91568	10.1371/journal.pone.0091568	http://dx.doi.org/10.1371/journal.pone.0091568			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658398	gold, Green Published, Green Submitted			2022-12-27	WOS:000333355300038
J	Qi, Z; Tretter, F; Voit, EO				Qi, Zhen; Tretter, Felix; Voit, Eberhard O.			A Heuristic Model of Alcohol Dependence	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS MICRODIALYSATE; EXTRACELLULAR DOPAMINE; IN-VIVO; ETHANOL; WITHDRAWAL; SEROTONIN; GLUTAMATE; RELEASE; NEUROTRANSMISSION; INCREASES	Background: Substance dependence poses a critical health problem. Sadly, its neurobiological mechanisms are still unclear, and this lack of real understanding is reflected in insufficient treatment options. It has been hypothesized that alcohol effects are due to an imbalance between neuroexcitatory and neuroinhibitory amino acids. However, glutamate and GABA interact with other neurotransmitters, which form a complicated network whose functioning evades intuition and should be investigated systemically with methods of biomedical systems analysis. Methods and Results: We present a heuristic model of neurotransmitters that combines a neurochemical interaction matrix at the biochemical level with a mobile describing the balances between pairs of neurotransmitters at the physiological and behavioral level. We investigate the effects of alcohol on the integrated neurotransmitter systems at both levels. The model simulation results are consistent with clinical and experimental observations. The model demonstrates that the drug diazepam for symptoms of alcohol withdrawal effectively reduces the imbalances between neurotransmitters. Moreover, the acetylcholine signal is suggested as a novel target for treatment of symptoms associated with alcohol withdrawal. Conclusions: Efficient means of integrating clinical symptoms across multiple levels are still scarce and difficult to establish. We present a heuristic model of systemic neurotransmitter functionality that permits the assessment of genetic, biochemical, and pharmacological perturbations. The model can serve as a tool to represent clinical and biological observations and explore various scenarios associated with alcohol dependence and its treatments. It also is very well suited for educational purposes.	[Qi, Zhen; Voit, Eberhard O.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Qi, Zhen; Voit, Eberhard O.] Emory Univ, Sch Med, Atlanta, GA USA; [Qi, Zhen; Voit, Eberhard O.] Georgia Inst Technol, Integrat BioSyst Inst, Atlanta, GA 30332 USA; [Qi, Zhen] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA USA; [Tretter, Felix] Isar Amper Klinikum Gemeinnutzige GmbH, Klinikum Munchen Ost, Munich, Germany	University System of Georgia; Georgia Institute of Technology; Emory University; University System of Georgia; Georgia Institute of Technology; Emory University	Voit, EO (corresponding author), Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.	eberhard.voit@bme.gatech.edu		Tretter, Felix/0000-0002-1076-1220	National Institutes of Health [P01-ES016731]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a grant from the National Institutes of Health (P01-ES016731, Gary W. Miller, PI) and an endowment from the Georgia Research Alliance (to EOV, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barik Jacques, 2009, Handb Exp Pharmacol, P173, DOI 10.1007/978-3-540-69248-5_7; Bender W, 2006, PHARMACOPSYCHIATRY, V39, pS4, DOI 10.1055/s-2006-931482; Bunin MA, 1998, J NEUROSCI, V18, P4854; CARBONI S, 1993, NEUROSCI LETT, V152, P133, DOI 10.1016/0304-3940(93)90501-B; Carlson RW, 2012, CRIT CARE CLIN, V28, P549, DOI 10.1016/j.ccc.2012.07.004; CHURCH WH, 1987, EUR J PHARMACOL, V139, P345, DOI 10.1016/0014-2999(87)90592-9; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; Dahchour A, 1996, BRAIN RES, V735, P9; Dahchour A, 1998, PSYCHIAT RES-NEUROIM, V82, P107, DOI 10.1016/S0925-4927(98)00016-X; De Witte P, 2004, ADDICT BEHAV, V29, P1325, DOI 10.1016/j.addbeh.2004.06.020; Devaud LL, 1997, J NEUROCHEM, V69, P126; ELGUEBALY N, 1981, INT J ADDICT, V16, P1207, DOI 10.3109/10826088109039174; Ferguson JA, 1996, J GEN INTERN MED, V11, P410, DOI 10.1007/BF02600188; Fritze J, 1989, BIOL PSYCHIAT; GLUE P, 1990, BRIT J PSYCHIAT, V157, P491, DOI 10.1192/bjp.157.4.491; GOLDSTEIN DB, 1973, J PHARMACOL EXP THER, V186, P1; Goldstein DS, 2003, J PHARMACOL EXP THER, V305, P800, DOI 10.1124/jpet.103.049270; Greene SL, 2008, EMERG MED AUSTRALAS, V20, P391, DOI 10.1111/j.1742-6723.2008.01114.x; GUINDON GE, 2003, 6 HNP WORLD BANK; Hutchinson PJ, 2002, J NEUROL NEUROSUR PS, V72, P99, DOI 10.1136/jnnp.72.1.99; KANTHAN R, 1995, STROKE, V26, P870, DOI 10.1161/01.STR.26.5.870; Kuczenski R, 1997, J NEUROCHEM, V68, P2032; LEIBOWITZ JO, 1967, BRIT J ADDICT, V62, P83; LIEBER CS, 1991, ALCOHOL CLIN EXP RES, V15, P573, DOI 10.1111/j.1530-0277.1991.tb00563.x; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Nirogi R, 2010, BIOMED CHROMATOGR, V24, P39, DOI 10.1002/bmc.1347; Noble D, 2011, PHARMACOPSYCHIATRY, V44, pS9, DOI 10.1055/s-0031-1271703; NUTT D, 1988, ALCOHOL CLIN EXP RES, V12, P14, DOI 10.1111/j.1530-0277.1988.tb00125.x; POMERLEAU OF, 1989, PSYCHONEUROENDOCRINO, V14, P407, DOI 10.1016/0306-4530(89)90040-1; Popa D, 2010, EUR J PHARMACOL, V628, P83, DOI 10.1016/j.ejphar.2009.11.037; Qi Z, 2013, PHARMACOPSYCHIATRY, V46, pS53, DOI 10.1055/s-0033-1337920; Qi Z, 2012, SYSTEMS BIOL PARKINS; Qi Z, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-26; Qi Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002444; ROSSETTI ZL, 1995, EUR J PHARMACOL, V283, P177, DOI 10.1016/0014-2999(95)00344-K; SANO H, 1992, ALCOHOL CLIN EXP RES, V16, P1047, DOI 10.1111/j.1530-0277.1992.tb00697.x; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Smith TD, 2000, SYNAPSE, V38, P460, DOI 10.1002/1098-2396(20001215)38:4<460::AID-SYN11>3.0.CO;2-D; Steinberg LL, 1998, SPINAL CORD, V36, P18, DOI 10.1038/sj.sc.3100516; Torres N., 2005, PATHWAY ANAL OPTIMIZ; Tretter F, 2004, EINFURHUNG PSYCHIOPH; Tsai GC, 1998, ANNU REV MED, V49, P173; Uutela P, 2005, RAPID COMMUN MASS SP, V19, P2950, DOI 10.1002/rcm.2160; Valenzuela CF, 1997, ALCOHOL HEALTH RES W, V21, P144; Victor M, 1953, RES PUBL ASSOC RES N, V32, P526; Voit EO, 2012, PHARMACOPSYCHIATRY, V45, pS22, DOI 10.1055/s-0032-1304653; Voit E. O., 2013, ISRN BIOMATH, V2013, P53, DOI [10.1155/2013/897658, DOI 10.1155/2013/897658]; Voit E. O., 2000, COMPUTATIONAL ANAL B; Voit EO, 2014, BBA-PROTEINS PROTEOM, V1844, P258, DOI 10.1016/j.bbapap.2013.03.023; Weiss F, 1996, J NEUROSCI, V16, P3474; Zhang XZ, 2007, RAPID COMMUN MASS SP, V21, P3621, DOI 10.1002/rcm.3251	53	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92221	10.1371/journal.pone.0092221	http://dx.doi.org/10.1371/journal.pone.0092221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658530	Green Submitted, Green Published, gold			2022-12-27	WOS:000333355300061
J	Zhao, C; Wu, NN; Deng, F; Zhang, HM; Wang, N; Zhang, WW; Chen, X; Wen, S; Zhang, JH; Yin, LJ; Liao, Z; Zhang, ZL; Zhang, Q; Yan, ZJ; Liu, W; Wu, D; Ye, JX; Deng, YL; Zhou, GL; Luu, HH; Haydon, RC; Si, W; He, TC				Zhao, Chen; Wu, Ningning; Deng, Fang; Zhang, Hongmei; Wang, Ning; Zhang, Wenwen; Chen, Xian; Wen, Sheng; Zhang, Junhui; Yin, Liangjun; Liao, Zhan; Zhang, Zhonglin; Zhang, Qian; Yan, Zhengjian; Liu, Wei; Wu, Di; Ye, Jixing; Deng, Youlin; Zhou, Guolin; Luu, Hue H.; Haydon, Rex C.; Si, Weike; He, Tong-Chuan			Adenovirus-Mediated Gene Transfer in Mesenchymal Stem Cells Can Be Significantly Enhanced by the Cationic Polymer Polybrene	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; BMP-9-INDUCED OSTEOGENIC DIFFERENTIATION; HEPATIC PROGENITOR CELLS; OSTEOBLAST DIFFERENTIATION; RECOMBINANT ADENOVIRUSES; TUMOR-GROWTH; IN-VITRO; DNA; TRANSDUCTION; EFFICIENCY	Mesenchymal stem cells (MSCs) are multipotent progenitors, which can undergo self-renewal and give rise to multi-lineages. A great deal of attentions have been paid to their potential use in regenerative medicine as potential therapeutic genes can be introduced into MSCs. Genetic manipulations in MSCs requires effective gene deliveries. Recombinant adenoviruses are widely used gene transfer vectors. We have found that although MSCs can be infected in vitro by adenoviruses, high virus titers are needed to achieve high efficiency. Here, we investigate if the commonly-used cationic polymer Polybrene can potentiate adenovirus-mediated transgene delivery into MSCs, such as C2C12 cells and iMEFs. Using the AdRFP adenovirus, we find that AdRFP transduction efficiency is significantly increased by Polybrene in a dose-dependent fashion peaking at 8 mu g/ml in C2C12 and iMEFs cells. Quantitative luciferase assay reveals that Polybrene significantly enhances AdFLuc-mediated luciferase activity in C2C12 and iMEFs at as low as 4 mu g/ml and 2 mu g/ml, respectively. FACS analysis indicates that Polybrene (at 4 mu g/ml) increases the percentage of RFP-positive cells by approximately 430 folds in AdRFP-transduced iMEFs, suggesting Polybrene may increase adenovirus infection efficiency. Furthermore, Polybrene can enhance AdBMP9-induced osteogenic differentiation of MSCs as early osteogenic marker alkaline phosphatase activity can be increased more than 73 folds by Polybrene (4 mg/ml) in AdBMP9-transduced iMEFs. No cytotoxicity was observed in C2C12 and iMEFs at Polybrene up to 40 mu g/ml, which is about 10-fold higher than the effective concentration required to enhance adenovirus transduction in MSCs. Taken together, our results demonstrate that Polybrene should be routinely used as a safe, effective and inexpensive augmenting agent for adenovirus-mediated gene transfer in MSCs, as well as other types of mammalian cells.	[Zhao, Chen; Deng, Fang; Wang, Ning; Si, Weike] Third Mil Med Univ, Affiliated Southwest Hosp, Dept Clin Hematol Cell Biol & Oncol, Chongqing, Peoples R China; [Zhao, Chen; Wu, Ningning; Deng, Fang; Zhang, Hongmei; Wang, Ning; Zhang, Wenwen; Chen, Xian; Wen, Sheng; Zhang, Junhui; Yin, Liangjun; Liao, Zhan; Zhang, Zhonglin; Zhang, Qian; Yan, Zhengjian; Liu, Wei; Wu, Di; Ye, Jixing; Deng, Youlin; Zhou, Guolin; Luu, Hue H.; Haydon, Rex C.; Si, Weike; He, Tong-Chuan] Univ Chicago, Med Ctr, Dept Orthopaed Surg, Mol Oncol Lab, Chicago, IL 60637 USA; [Wu, Ningning; Wen, Sheng; Zhang, Qian; Liu, Wei; He, Tong-Chuan] Chongqing Med Univ, Childrens Hosp, Stem Cell Biol & Therapy Lab, Key Lab Pediat,Minist Educ, Chongqing, Peoples R China; [Zhang, Hongmei; Chen, Xian; Zhang, Junhui; Yin, Liangjun; Yan, Zhengjian; Deng, Youlin] Chongqing Med Univ, Key Lab Diagnost Med, Minist Educ, Chongqing, Peoples R China; [Zhang, Hongmei; Chen, Xian; Zhang, Junhui; Yin, Liangjun; Yan, Zhengjian; Deng, Youlin] Chongqing Med Univ, Affiliated Hosp, Chongqing, Peoples R China; [Zhang, Wenwen] Bingzhou Med Univ, Affiliated Hosp, Dept Lab Med, Yantai, Peoples R China; [Liao, Zhan] Cent S Univ, Affiliated Xiang Ya Hosp, Dept Orthopaed Surg, Changsha, Peoples R China; [Zhang, Zhonglin] Wuhan Univ, Affiliated Zhongnan Hosp, Dept Surg, Wuhan 430072, Peoples R China; [Ye, Jixing] Chongqing Univ, Sch Bioengn, Chongqing 630044, Peoples R China	Army Medical University; University of Chicago; University of Chicago Medical Center; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Central South University; Wuhan University; Chongqing University	Si, W (corresponding author), Third Mil Med Univ, Affiliated Southwest Hosp, Dept Clin Hematol Cell Biol & Oncol, Chongqing, Peoples R China.	weikesi2004@hotmail.com; tche@uchicago.edu		Yin, Liang-jun/0000-0002-9244-4965; Deng, Fang/0000-0002-7927-5394	National Institutes of Health; 973 Program of the Ministry of Science and Technology (MOST) of China [2011CB707906]; Natural Science Foundation of China [81370624]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 973 Program of the Ministry of Science and Technology (MOST) of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The reported work was supported in part by research grants from the National Institutes of Health (RCH, TCH and HHL), the 973 Program of the Ministry of Science and Technology (MOST) of China (#2011CB707906 to TCH), and the Natural Science Foundation of China (Grant# 81370624 to WS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcasoy SM, 1997, GENE THER, V4, P32, DOI 10.1038/sj.gt.3300349; Aubin Remy A., 1994, Molecular Biotechnology, V1, P29, DOI 10.1007/BF02821509; AUBIN RJ, 1988, SOMAT CELL MOLEC GEN, V14, P155, DOI 10.1007/BF01534401; Benihoud K, 1999, CURR OPIN BIOTECH, V10, P440, DOI 10.1016/S0958-1669(99)00007-5; Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254; Breyer Benjamin, 2001, Current Gene Therapy, V1, P149, DOI 10.2174/1566523013348689; CHANEY WG, 1986, SOMAT CELL MOLEC GEN, V12, P237, DOI 10.1007/BF01570782; Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; COELEN RJ, 1983, ARCH VIROL, V75, P307, DOI 10.1007/BF01314897; Crystal RG, 1999, CANCER CHEMOTH PHARM, V43, pS90, DOI 10.1007/s002800051105; Davis HE, 2002, BIOPHYS CHEM, V97, P159, DOI 10.1016/S0301-4622(02)00057-1; Davis HE, 2004, BIOPHYS J, V86, P1234, DOI 10.1016/S0006-3495(04)74197-1; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Doebis C, 2002, TRANSPL IMMUNOL, V9, P323, DOI 10.1016/S0966-3274(02)00034-5; Gao YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082436; Gerard RD, 1997, CARDIOVASC RES, V35, P451, DOI 10.1016/S0008-6363(97)00134-X; He BC, 2011, MOL PHARMACOL, V79, P211, DOI 10.1124/mol.110.068668; He BC, 2011, INT J ONCOL, V38, P437, DOI 10.3892/ijo.2010.858; He BC, 2010, CLIN CANCER RES, V16, P2235, DOI 10.1158/1078-0432.CCR-09-2499; He T.-C., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P363; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; He TC, 2004, ADENOVIRAL VECTORS C; Hu N, 2013, J CELL SCI, V126, P532, DOI 10.1242/jcs.114231; Huang EY, 2012, J BONE MINER RES, V27, P1566, DOI 10.1002/jbmr.1622; Huang EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032428; Huang JY, 2009, LIVER INT, V29, P1569, DOI 10.1111/j.1478-3231.2009.02111.x; Jacobsen F, 2006, J GENE MED, V8, P138, DOI 10.1002/jgm.843; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Kim JH, 2013, THER ADV MUSCULOSKEL, V5, P13, DOI 10.1177/1759720X12466608; Lamplot JD, 2013, AM J STEM CELLS, V2, P1; Landazuri N, 2007, BIOTECHNOL PROGR, V23, P480, DOI 10.1021/bp060336y; Liu H, 2003, CURR TOP MICROBIOL, V272, P131; Luo J, 2005, CURR GENE THER, V5, P167, DOI 10.2174/1566523053544218; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Luther G, 2011, CURR GENE THER, V11, P229; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; MORGAN TL, 1986, IN VITRO CELL DEV B, V22, P317, DOI 10.1007/BF02623404; Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200; Peng Y, 2003, J CELL BIOCHEM, V90, P1149, DOI 10.1002/jcb.10744; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rastegar Farbod, 2010, World J Stem Cells, V2, P67, DOI 10.4252/wjsc.v2.i4.67; Sambrook J., 2006, CSH PROTOC; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Shenaq DS, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/519028; Shui W, 2013, J BIOMED MAT RES A; Shui W, 2014, J BIOMED MAT RES A; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; TOYOSHIMA K, 1969, VIROLOGY, V38, P414, DOI 10.1016/0042-6822(69)90154-8; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Wagner Eric R, 2011, Curr Mol Pharmacol, V4, P14; Zhang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073086; Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009; Zhang WW, 2013, INT J MED SCI, V10, P1888, DOI 10.7150/ijms.6019	57	77	82	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92908	10.1371/journal.pone.0092908	http://dx.doi.org/10.1371/journal.pone.0092908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658746	Green Submitted, Green Published, gold			2022-12-27	WOS:000333355300144
J	Schorr, GS; Falcone, EA; Moretti, DJ; Andrews, RD				Schorr, Gregory S.; Falcone, Erin A.; Moretti, David J.; Andrews, Russel D.			First Long-Term Behavioral Records from Cuvier's Beaked Whales (Ziphius cavirostris) Reveal Record-Breaking Dives	PLOS ONE			English	Article							MESOPLODON-DENSIROSTRIS; DIVING BEHAVIOR; STRANDINGS	Cuvier's beaked whales (Ziphius cavirostris) are known as extreme divers, though behavioral data from this difficult-to-study species have been limited. They are also the species most often stranded in association with Mid-Frequency Active (MFA) sonar use, a relationship that remains poorly understood. We used satellite-linked tags to record the diving behavior and locations of eight Ziphius off the Southern California coast for periods up to three months. The effort resulted in 3732 hr of dive data with associated regional movements - the first dataset of its kind for any beaked whale - and included dives to 2992 m depth and lasting 137.5 min, both new mammalian dive records. Deep dives had a group mean depth of 1401 m (s.d. = 137.8, n = 1142) and duration of 67.4 min (s.d. = 6.9). The group mean time between deep dives was 102.3 min (s.d. = 30.8, n = 783). While the previously described stereotypic pattern of deep and shallow dives was apparent, there was considerable inter-and intra-individual variability in most parameters. There was significant diel behavioral variation, including increased time near the surface and decreased shallow diving at night. However, maximum depth and the proportion of time spent on deep dives (presumed foraging), varied little from day to night. Surprisingly, tagged whales were present within an MFA sonar training range for 38% of days locations were received, and though comprehensive records of sonar use during tag deployments were not available, we discuss the effects frequent acoustic disturbance may have had on the observed behaviors. These data better characterize the true behavioral range of this species, and suggest caution should be exercised when drawing conclusions about behavior using short-term datasets.	[Schorr, Gregory S.; Falcone, Erin A.] Cascadia Res Collect, Olympia, WA 98501 USA; [Moretti, David J.] Naval Undersea Warfare Ctr, Newport, RI USA; [Andrews, Russel D.] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA; [Andrews, Russel D.] Alaska SeaLife Ctr, Seward, AK USA	United States Department of Defense; United States Navy; US Navy Naval Sea Systems Command; University of Alaska System; University of Alaska Fairbanks	Schorr, GS (corresponding author), Cascadia Res Collect, Olympia, WA 98501 USA.	gschorr@cascadiaresearch.org		Andrews, Russel/0000-0002-4545-137X	United States Navy (N45) via the Naval Postgraduate School [N00244-10-1-0050]; Wildlife Computers; Office of Naval Research [N000140811203]; Alaska SeaLife Center; National Oceanic and Atmospheric Administration/Northwest Fisheries Science Center; United States Navy (N45) via the Living Marine Resources program	United States Navy (N45) via the Naval Postgraduate School; Wildlife Computers; Office of Naval Research(Office of Naval Research); Alaska SeaLife Center; National Oceanic and Atmospheric Administration/Northwest Fisheries Science Center; United States Navy (N45) via the Living Marine Resources program	Field work was funded by a grant to Cascadia Research Collective from the United States Navy (N45) via the Naval Postgraduate School (Grant Number N00244-10-1-0050) (http://www.nps.edu/). Development of the Mk10-A LIMPET tag was funded by Wildlife Computers and the Office of Naval Research (Grant Number N000140811203) with additional support from the Alaska SeaLife Center and National Oceanic and Atmospheric Administration/Northwest Fisheries Science Center. Marine Mammal Monitoring on Navy Ranges (M3R) is funded by the United States Navy (N45) via the Living Marine Resources program (http://www.lmr.navy.mil/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RD, 2008, POLAR BIOL, V31, P1461, DOI 10.1007/s00300-008-0487-z; [Anonymous], 2009, TAKING IMPORTING MAR; [Anonymous], 2008, SO CALIFORNIA RANGE; Baird RW, 2008, MAR MAMMAL SCI, V24, P630, DOI 10.1111/j.1748-7692.2008.00211.x; Baird RW, 2006, CAN J ZOOL, V84, P1120, DOI 10.1139/Z06-095; Brandt MJ, 2011, MAR ECOL PROG SER, V421, P205, DOI 10.3354/meps08888; Carretta J, 2012, US PACIFIC MARINE MA; Costa DP, 2010, INTEGR COMP BIOL, V50, P1018, DOI 10.1093/icb/icq054; Cox TM, 2006, J CETACEAN RES MANAG, P177; D'Amico Angela, 2009, Aquatic Mammals, V35, P452, DOI 10.1578/AM.35.4.2009.452; DeRuiter SL, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0223; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Falcone EA, 2009, MAR BIOL, V156, P2631, DOI 10.1007/s00227-009-1289-8; Filadelfo Ronald, 2009, Aquatic Mammals, V35, P445, DOI 10.1578/AM.35.4.2009.445; HINDELL MA, 1992, CAN J ZOOL, V70, P370, DOI 10.1139/z92-055; Hooker SK, 2009, RESP PHYSIOL NEUROBI, V167, P235, DOI 10.1016/j.resp.2009.04.023; Jepson PD, 2003, NATURE, V425, P575, DOI 10.1038/425575a; McGlatchie S, 2013, REGIONAL FISHERIES O; Moretti D., 2006, J ACOUSTICAL SOC AM, V119, P3374, DOI [10.1121/1.4786579, DOI 10.1121/1.4786579]; Morton AB, 2002, ICES J MAR SCI, V59, P71, DOI 10.1006/jmsc.2001.1136; Schorr Gregory S., 2010, Endangered Species Research, V10, P203, DOI 10.3354/esr00229; Soto NA, 2006, MAR MAMMAL SCI, V22, P690, DOI 10.1111/j.1748-7692.2006.00044.x; Tyack PL, 2006, J EXP BIOL, V209, P4238, DOI 10.1242/jeb.02505; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; Wildlife Computers, 2012, WILDL COMP MK10 TAG; Wildlife Computers, 2013, WILDL COMP DAT AN PR; Zimmer WMX, 2007, MAR MAMMAL SCI, V23, P888, DOI 10.1111/j.1748-7692.2007.00152.x	27	191	195	1	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92633	10.1371/journal.pone.0092633	http://dx.doi.org/10.1371/journal.pone.0092633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670984	gold, Green Published			2022-12-27	WOS:000333677000060
J	Yang, FY; Ko, CE; Huang, SY; Chung, IF; Chen, GS				Yang, Feng-Yi; Ko, Chia-En; Huang, Sheng-Yao; Chung, I-Fang; Chen, Gin-Shin			Pharmacokinetic Changes Induced by Focused Ultrasound in Glioma-Bearing Rats as Measured by Dynamic Contrast-Enhanced MRI	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; GLIOBLASTOMA-MULTIFORME; LIPOSOMAL DOXORUBICIN; MOLECULAR DELIVERY; PERMEABILITY; DISRUPTION; MODEL; TRACER; IMAGES; AGENTS	Focused ultrasound (FUS) combined with microbubbles has been shown to be a noninvasive and targeted drug delivery technique for brain tumor treatment. The purpose of this study was to measure the kinetics of Gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA) in glioma-bearing rats in the presence of FUS-induced blood-brain barrier disruption (BBB-D) by magnetic resonance imaging (MRI). A total of ten glioma-bearing rats (9-12 weeks, 290-340 g) were used in this study. Using dynamic contrast-enhanced (DCE)-MRI, the spatial permeability of FUS-induced BBB-D was evaluated and the kinetic parameters were calculated by a general kinetic model (GKM). The results demonstrate that the mean K-trans of the sonicated tumor (0.128 +/- 0.019 at 20 min and 0.103 +/- 0.023 at 24 h after sonication, respectively) was significantly higher than (2.46-fold at 20 min and 1.78-fold at 24 h) that of the contralateral (non-sonicated) tumor (0.052 +/- 0.019 at 20 min and 0.058 +/- 0.012 at 24 h after sonication, respectively). In addition, the transfer constant K-trans in the sonicated tumor correlated strongly with tissue EB extravasation (R = 0.95), which suggests that DCE-MRI may reflect drug accumulation in the brain. Histological observations showed no macroscopic damage except for a few small erythrocyte extravasations. The current study demonstrates that DCE-MRI can monitor the dynamics of the FUS-induced BBB-D process and constitutes a useful tool for quantifying BBB permeability in tumors.	[Yang, Feng-Yi; Ko, Chia-En] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Yang, Feng-Yi] Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei 112, Taiwan; [Huang, Sheng-Yao; Chung, I-Fang] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Chen, Gin-Shin] Natl Hlth Res Inst, Div Med Engn Res, Zhunan, Miaoli County, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan	Yang, FY (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan.	fyyang@ym.edu.tw	Chen, Gin-Shin/E-3988-2010	Chen, Gin-Shin/0000-0003-3368-7470; Huang, Sheng-Yao/0000-0002-3241-430X				Bilgen M, 2001, MAGN RESON MED, V46, P1099, DOI 10.1002/mrm.1305; Black Keith L, 2004, Cancer Control, V11, P165; Choi JJ, 2007, PHYS MED BIOL, V52, P5509, DOI 10.1088/0031-9155/52/18/004; GOLDSTEIN EJ, 1984, PHYSIOL CHEM PHYS, V16, P97; Hsieh CH, 2005, J NUCL MED, V46, P1858; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Hynynen K, 2008, ADV DRUG DELIVER REV, V60, P1209, DOI 10.1016/j.addr.2008.03.010; Kroll RA, 1998, NEUROSURGERY, V42, P1083, DOI 10.1097/00006123-199805000-00082; Liu YY, 2006, J CONTROL RELEASE, V114, P89, DOI 10.1016/j.jconrel.2006.05.018; Marty B, 2012, J CEREBR BLOOD F MET, V32, P1948, DOI 10.1038/jcbfm.2012.100; Neuwelt EA, 1999, NEUROSURGERY, V44, P604, DOI 10.1097/00006123-199903000-00095; Park J, 2012, J CONTROL RELEASE, V162, P134, DOI 10.1016/j.jconrel.2012.06.012; Peruzzo D, 2011, COMPUT METH PROG BIO, V104, pE148, DOI 10.1016/j.cmpb.2011.02.012; Simpson NE, 1999, MAGN RESON MED, V42, P42, DOI 10.1002/(SICI)1522-2594(199907)42:1<42::AID-MRM8>3.0.CO;2-Z; Su MY, 1996, MAGNET RESON MED, V36, P868, DOI 10.1002/mrm.1910360609; Su MY, 1998, MAGN RESON MED, V39, P259, DOI 10.1002/mrm.1910390213; Tartis MS, 2008, J CONTROL RELEASE, V131, P160, DOI 10.1016/j.jconrel.2008.07.030; Thomas DL, 2006, MAGN RESON MED, V55, P943, DOI 10.1002/mrm.20823; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Vlachos F, 2010, PHYS MED BIOL, V55, P5451, DOI 10.1088/0031-9155/55/18/012; Vlachos F, 2011, MAGN RESON MED, V66, P821, DOI 10.1002/mrm.22848; Yang FY, 2013, ULTRASOUND MED BIOL, V39, P620, DOI 10.1016/j.ultrasmedbio.2012.11.027; Yang FY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045468; Yang FY, 2012, J CONTROL RELEASE, V160, P652, DOI 10.1016/j.jconrel.2012.02.023; Yang FY, 2012, INT J NANOMED, V7, P965, DOI 10.2147/IJN.S29229; Yang FY, 2012, INT J NANOMED, V7, P723, DOI 10.2147/IJN.S28503; Yang FY, 2011, IEEE T ULTRASON FERR, V58, P964, DOI 10.1109/TUFFC.2011.1897; Yang FY, 2011, J NUCL MED, V52, P478, DOI 10.2967/jnumed.110.083071; Yang FY, 2011, J CONTROL RELEASE, V150, P111, DOI 10.1016/j.jconrel.2010.10.038; Yang FY, 2010, J MAGN RESON IMAGING, V32, P593, DOI 10.1002/jmri.22297	31	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92910	10.1371/journal.pone.0092910	http://dx.doi.org/10.1371/journal.pone.0092910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670992	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000091
J	Cardador, L; De Caceres, M; Bota, G; Giralt, D; Casas, F; Arroyo, B; Mougeot, F; Cantero-Martinez, C; Moncunill, J; Butler, SJ; Brotons, L				Cardador, Laura; De Caceres, Miquel; Bota, Gerard; Giralt, David; Casas, Fabian; Arroyo, Beatriz; Mougeot, Francois; Cantero-Martinez, Carlos; Moncunill, Judit; Butler, Simon J.; Brotons, Lluis			A Resource-Based Modelling Framework to Assess Habitat Suitability for Steppe Birds in Semiarid Mediterranean Agricultural Systems	PLOS ONE			English	Article							CURLEW BURHINUS-OEDICNEMUS; PARTRIDGE ALECTORIS-RUFA; BUSTARDS TETRAX-TETRAX; FARMLAND BIRDS; SET-ASIDE; SPECIES DISTRIBUTION; VEGETATION STRUCTURE; RANGING BEHAVIOR; LESSER KESTREL; SELECTION	European agriculture is undergoing widespread changes that are likely to have profound impacts on farmland biodiversity. The development of tools that allow an assessment of the potential biodiversity effects of different land-use alternatives before changes occur is fundamental to guiding management decisions. In this study, we develop a resource-based model framework to estimate habitat suitability for target species, according to simple information on species' key resource requirements (diet, foraging habitat and nesting site), and examine whether it can be used to link land-use and local species' distribution. We take as a study case four steppe bird species in a lowland area of the north-eastern Iberian Peninsula. We also compare the performance of our resource-based approach to that obtained through habitat-based models relating species' occurrence and land-cover variables. Further, we use our resource-based approach to predict the effects that change in farming systems can have on farmland bird habitat suitability and compare these predictions with those obtained using the habitat-based models. Habitat suitability estimates generated by our resource-based models performed similarly (and better for one study species) than habitat based-models when predicting current species distribution. Moderate prediction success was achieved for three out of four species considered by resource-based models and for two of four by habitat-based models. Although, there is potential for improving the performance of resource-based models, they provide a structure for using available knowledge of the functional links between agricultural practices, provision of key resources and the response of organisms to predict potential effects of changing land-uses in a variety of context or the impacts of changes such as altered management practices that are not easily incorporated into habitat-based models.	[Cardador, Laura; De Caceres, Miquel; Bota, Gerard; Giralt, David; Brotons, Lluis] Forest Sci Ctr Catalonia CTFC, Solsona, Catalonia, Spain; [Casas, Fabian; Mougeot, Francois] CSIC, EEZA, La Canada De San Urbano, Almeria, Spain; [Arroyo, Beatriz] CSIC UCLM JCCM, Inst Invest Recursos Cineget IREC, Ciudad Real, Spain; [Cantero-Martinez, Carlos; Moncunill, Judit] Univ Lleida UDL, Dept Prod Vegetal & Ciencia Forestal, Lleida, Spain; [Butler, Simon J.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [De Caceres, Miquel; Brotons, Lluis] CREAF, Bellaterra, Catalonia, Spain	Centre Tecnologic Forestal de Catalunya (CTFC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Universitat de Lleida; University of East Anglia; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF)	Cardador, L (corresponding author), Forest Sci Ctr Catalonia CTFC, Solsona, Catalonia, Spain.	laura.cardador@ctfc.cat	Cantero-Martinez, Carlos/D-3231-2013; De Caceres, Miquel/I-1279-2016; Casas, Fabian/Y-3021-2018; Giralt, David/ABG-6410-2020; Mougeot, Francois/B-1894-2009; Arroyo, Beatriz/A-3504-2013; Cardador, Laura/K-4412-2014; Mougeot, Francois/Y-9569-2019; Casas, Fabian/AAE-9846-2020; Brotons, Lluís/D-1570-2009; Butler, Simon/H-1703-2011	Cantero-Martinez, Carlos/0000-0002-6984-2025; De Caceres, Miquel/0000-0001-7132-2080; Casas, Fabian/0000-0003-3662-6585; Giralt, David/0000-0001-9712-1957; Mougeot, Francois/0000-0002-5819-6275; Arroyo, Beatriz/0000-0002-4657-6609; Cardador, Laura/0000-0003-2548-8578; Mougeot, Francois/0000-0002-5819-6275; Casas, Fabian/0000-0003-3662-6585; Brotons, Lluís/0000-0002-4826-4457; Bota Cabau, Gerard/0000-0001-9020-7272; Butler, Simon/0000-0002-5111-5639	Project "Steppeahead"; Fundacion General del Consejo Superior de Investigaciones Cientificas from Spain (FGCSIC); Banco Santander; JAE-Doc contract; CSIC; European Social Fund (ESF); FGCSIC; Infraestructures.cat (Generalitat de Catalunya); Aigues del Segarra-Garrigues SA; BBSRC [BB/F011911/1] Funding Source: UKRI; NERC [NE/I020350/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F011911/1] Funding Source: researchfish; Natural Environment Research Council [NE/I020350/1] Funding Source: researchfish	Project "Steppeahead"; Fundacion General del Consejo Superior de Investigaciones Cientificas from Spain (FGCSIC); Banco Santander; JAE-Doc contract; CSIC; European Social Fund (ESF)(European Social Fund (ESF)); FGCSIC; Infraestructures.cat (Generalitat de Catalunya); Aigues del Segarra-Garrigues SA; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by the Project "Steppeahead" funded by Fundacion General del Consejo Superior de Investigaciones Cientificas from Spain (FGCSIC) and Banco Santander. F. C. was supported by a JAE-Doc contract financed by CSIC and the European Social Fund (ESF). L. C. was supported by a postdoctoral contract funded by FGCSIC and Banco Santander. FARMDINDIS project, funded by Infraestructures.cat (Generalitat de Catalunya) and Aigues del Segarra-Garrigues SA, provided data on field censuses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAT JA, 1986, BIRD STUDY, V33, P71, DOI 10.1080/00063658609476898; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Benton TG, 2002, J APPL ECOL, V39, P673, DOI 10.1046/j.1365-2664.2002.00745.x; Bouma J, 1998, AGR ECOSYST ENVIRON, V67, P103, DOI 10.1016/S0167-8809(97)00109-6; Brotons L, 2004, BIODIVERS CONSERV, V13, P1039, DOI 10.1023/B:BIOC.0000014468.71368.35; Brotons L, 2007, DIVERS DISTRIB, V13, P276, DOI 10.1111/j.1472-4642.2007.00339.x; Buckley LB, 2010, ECOL LETT, V13, P1041, DOI 10.1111/j.1461-0248.2010.01479.x; Buenestado FJ, 2008, AGR ECOSYST ENVIRON, V126, P158, DOI 10.1016/j.agee.2008.01.020; Burfield IJ., 2005, ECOLOGY CONSERVATION, P119, DOI DOI 10.1111/OIK.01758; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Butler SJ, 2007, SCIENCE, V315, P381, DOI 10.1126/science.1136607; Butler SJ, 2010, AGR ECOSYST ENVIRON, V137, P348, DOI 10.1016/j.agee.2010.03.005; Butler SJ, 2013, AGR ECOSYST ENVIRON, V164, P200, DOI 10.1016/j.agee.2012.11.001; Cantero C., 2012, SISTEMAS AGRICOLAS P; Cardador L, 2011, ANIM CONSERV, V14, P382, DOI 10.1111/j.1469-1795.2011.00449.x; Casas F, 2010, ENVIRON CONSERV, V37, P177, DOI 10.1017/S0376892910000299; Catry I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058320; Catry I, 2012, J APPL ECOL, V49, P99, DOI 10.1111/j.1365-2664.2011.02071.x; Cramp S., 1994, BIRDS W PALEARCTIC; Dettki H, 2003, AMBIO, V32, P549, DOI 10.1639/0044-7447(2003)032[0549:MHSFMI]2.0.CO;2; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Estrada A, 2012, BIOL CONSERV, V152, P37, DOI 10.1016/j.biocon.2012.03.031; Estrada J., 2004, ATLES DELS OCELLS NI; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Fortuna Miguel Angel, 2002, Ardeola, V49, P59; Gillings S, 2010, IBIS, V152, P713, DOI 10.1111/j.1474-919X.2010.01058.x; Graf RF, 2006, ECOGRAPHY, V29, P319, DOI 10.1111/j.2006.0906-7590.04328.x; Green RE, 2000, J ZOOL, V250, P161, DOI 10.1111/j.1469-7998.2000.tb01067.x; GREEN RE, 1984, IBIS, V126, P332, DOI 10.1111/j.1474-919X.1984.tb00254.x; Henle K, 2008, AGR ECOSYST ENVIRON, V124, P60, DOI 10.1016/j.agee.2007.09.005; Herkert JR, 2009, CONSERV BIOL, V23, P1036, DOI 10.1111/j.1523-1739.2009.01234.x; Holland JM, 2006, ANN APPL BIOL, V148, P49, DOI 10.1111/j.1744-7348.2006.00039.x; Homem de Brito P, 1996, CONSERVATION STEPPE; Jiguet F, 2000, BEHAV PROCESS, V51, P63, DOI 10.1016/S0376-6357(00)00119-4; Jiguet F, 2002, BIRD STUDY, V49, P105, DOI 10.1080/00063650209461253; Joseph LN, 2006, CONSERV BIOL, V20, P1679, DOI 10.1111/j.1523-1739.2006.00529.x; Kleijn D, 2005, CONSERV BIOL, V19, P963, DOI 10.1111/j.1523-1739.2005.00603.x; Koks BJ, 2007, IBIS, V149, P575, DOI 10.1111/j.1474-919X.2007.00683.x; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Martinez C., 2011, ENCICLOPEDIA VIRTUAL; Mcmahon BJ, 2010, BIRD STUDY, V57, P289, DOI 10.1080/00063651003749680; Morales MB, 2008, ACTA OECOL, V34, P345, DOI 10.1016/j.actao.2008.06.009; Morales M. B., 2009, ADAPTACION EVOLUCION; Moreira F, 1999, BIRD STUDY, V46, P309, DOI 10.1080/00063659909461144; Morgado R, 2010, ACTA OECOL, V36, P63, DOI 10.1016/j.actao.2009.10.002; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; Ponjoan A, 2012, BEHAV PROCESS, V91, P35, DOI 10.1016/j.beproc.2012.05.005; RANDS MRW, 1988, ORNIS SCAND, V19, P35, DOI 10.2307/3676525; Ribeiro PF, 2014, AGR ECOSYST ENVIRON, V183, P138, DOI 10.1016/j.agee.2013.11.002; RICCI J C, 1990, Gibier Faune Sauvage, V7, P231; Robertson MP, 2003, ECOL MODEL, V164, P153, DOI 10.1016/S0304-3800(03)00028-0; Rueda Ma Jesus, 1993, Ecologia (Madrid), V7, P429; RUEDA MJ, 1993, B MENS ONC, V184, P2; Sanza MA, 2012, J ORNITHOL, V153, P525, DOI 10.1007/s10336-011-0773-3; Sarda-Palomera F, 2012, IBIS, V154, P703, DOI 10.1111/j.1474-919X.2012.01254.x; Silva JP, 2007, BIOL CONSERV, V139, P186, DOI 10.1016/j.biocon.2007.06.013; Suarez F, 2009, ALONDRAS ESPANA PENI; Sutherland WJ, 2012, PHILOS T R SOC B, V367, P322, DOI 10.1098/rstb.2011.0181; Swets K. A., 1988, SCIENCE, V240, P1285; Tella JL, 1998, CONSERV BIOL, V12, P593, DOI 10.1046/j.1523-1739.1998.96288.x; Van Dyck H, 2012, EVOL APPL, V5, P144, DOI 10.1111/j.1752-4571.2011.00230.x; Vargas J.M., 1996, TROFEO, V317, P23; Vizeu Pinheiro M.F., 1977, Boletin Estac cent Ecol, V6, P105; Wade ASI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064552; Whittingham MJ, 2006, J APPL ECOL, V43, P640, DOI 10.1111/j.1365-2664.2006.01186.x; Wilson JD, 2005, IBIS, V147, P453, DOI 10.1111/j.1474-919x.2005.00440.x; Wilson MW, 2012, IBIS, V154, P578, DOI 10.1111/j.1474-919X.2012.01236.x; Wright HL, 2012, CONSERV LETT, V5, P11, DOI 10.1111/j.1755-263X.2011.00208.x	70	22	22	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92790	10.1371/journal.pone.0092790	http://dx.doi.org/10.1371/journal.pone.0092790			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667825	Green Published, Green Accepted, gold			2022-12-27	WOS:000333675600075
J	Ghashut, RA; Talwar, D; Kinsella, J; Duncan, A; McMillan, DC				Ghashut, Rawia A.; Talwar, Dinesh; Kinsella, John; Duncan, Andrew; McMillan, Donald C.			The Effect of the Systemic Inflammatory Response on Plasma Vitamin 25 (OH) D Concentrations Adjusted for Albumin	PLOS ONE			English	Article							ELECTIVE KNEE ARTHROPLASTY; FLAVIN ADENINE-DINUCLEOTIDE; CRITICAL ILLNESS; RED-CELLS; DEFINITIONS; PYRIDOXAL; MORTALITY; SEPSIS	Background: Plasma 25-hydroxyvitamin D (25(OH) D) deficiencies are associated with several diseases. The magnitude of systemic inflammatory response, as evidenced by C-reactive protein (CRP), is a major factor associated with lower 25(OH) D. Other aspects of the systemic inflammatory response may be important in determining plasma 25 (OH) D concentrations. Aim: To examine the relationship between plasma 25(OH) D, CRP and albumin concentrations in two patient cohorts. Methods: 5327 patients referred for nutritional assessment and 117 patients with critical illness were examined. Plasma 25 (OH) D concentrations were measured using standard methods. Intra and between assay imprecision was <10%. Result: In the large cohort, plasma 25 (OH) D was significantly associated with CRP (r(s) = -0.113, p < 0.001) and albumin (r(s) = 0.192, p<0.001). 3711 patients had CRP concentrations <= 10 mg/L; with decreasing albumin concentrations >= 35, 25-34 and <25 g/l, median concentrations of 25 (OH) D were significantly lower from 35 to 28 to 14 nmol/l (p<0.001). This decrease was significant when albumin concentrations were reduced between 25-34 g/L (p<0.001) and when albumin < 25 g/L (p<0.001). 1271 patients had CRP concentrations between 11-80 mg/L; with decreasing albumin concentrations >= 35, 25-34 and <25 g/l, median concentrations of 25 (OH) D were significantly lower from 31 to 24 to 19 nmol/l (p<0.001). This decrease was significant when albumin concentration were 25-34 g/L (p<0.001) and when albumin <25 g/L (p<0.001). 345 patients had CRP concentrations >80 mg/L; with decreasing albumin concentrations >= 35, 25-34 and <25 g/l, median concentrations of 25 (OH) D were not significantly altered varying from 19 to 23 to 23 nmol/l. Similar relationships were also obtained in the cohort of patients with critical illness. Conclusion: Plasma concentrations of 25(OH) D were independently associated with both CRP and albumin and consistent with the systemic inflammatory response as a major confounding factor in determining vitamin D status.	[Ghashut, Rawia A.; Kinsella, John] Univ Glasgow, Glasgow Royal Infirm, Coll Med Vet & Life Sci, Acad Unit Anaesthesia, Glasgow G31 2ER, Lanark, Scotland; [Ghashut, Rawia A.; McMillan, Donald C.] Univ Glasgow, Glasgow Royal Infirm, Coll Med Vet & Life Sci, Acad Surg Unit, Glasgow G31 2ER, Lanark, Scotland; [Talwar, Dinesh; Duncan, Andrew] Glasgow Royal Infirm, Dept Biochem, Scottish Trace Element & Micronutrient Reference, Glasgow G4 0SF, Lanark, Scotland	University of Glasgow; University of Glasgow; University of Glasgow	Ghashut, RA (corresponding author), Univ Glasgow, Glasgow Royal Infirm, Coll Med Vet & Life Sci, Acad Unit Anaesthesia, Glasgow G31 2ER, Lanark, Scotland.	r.ghashut.1@research.gla.ac.uk		McMillan, Donald/0000-0003-4260-5334	Libyan government	Libyan government	This work was supported by the Libyan government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Danik Jacqueline S, 2012, Curr Treat Options Cardiovasc Med, V14, P414, DOI 10.1007/s11936-012-0183-8; Duncan A, 2012, AM J CLIN NUTR, V95, P64, DOI 10.3945/ajcn.111.023812; Galloway P, 2000, ANN CLIN BIOCHEM, V37, P289; Ghashut AR, 2013, J CLIN NUTR, V8, pe193; Goldwasser P, 1997, J CLIN EPIDEMIOL, V50, P693, DOI 10.1016/S0895-4356(97)00015-2; Gray A, 2005, CLIN NUTR, V24, P746, DOI 10.1016/j.clnu.2005.02.008; Gray A, 2004, CLIN NUTR, V23, P1080, DOI 10.1016/j.clnu.2004.01.013; Hewison M, 2010, ENDOCRIN METAB CLIN, V39, P365, DOI 10.1016/j.ecl.2010.02.010; HUDSON S, 2007, SURGERY, V25, P117; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Marsik C, 2008, CLIN CHEM, V54, P343, DOI 10.1373/clinchem.2007.091959; Oakes EJC, 2008, CLIN NUTR, V27, P115, DOI 10.1016/j.clnu.2007.10.003; Reid D, 2011, AM J CLIN NUTR, V93, P1006, DOI 10.3945/ajcn.110.008490; Stafanowicz F, 2013, J CRITICAL CARE, P1; Vasilaki AT, 2008, AM J CLIN NUTR, V88, P140, DOI 10.1093/ajcn/88.1.140; Vasilaki AT, 2010, CLIN CHIM ACTA, V411, P1750, DOI 10.1016/j.cca.2010.07.024; Vasilaki AT, 2009, CLIN CHIM ACTA, V409, P41, DOI 10.1016/j.cca.2009.08.008; Waldron JL, 2013, J CLIN PATHOL, V66, P620, DOI 10.1136/jclinpath-2012-201301; Zgaga L, 2011, J NUTR, V141, P1535, DOI 10.3945/jn.111.140012	21	42	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92614	10.1371/journal.pone.0092614	http://dx.doi.org/10.1371/journal.pone.0092614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667823	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000333675600054
J	Ryskin, RA; Brown-Schmidt, S				Ryskin, Rachel A.; Brown-Schmidt, Sarah			Do Adults Show a Curse of Knowledge in False-Belief Reasoning? A Robust Estimate of the True Effect Size	PLOS ONE			English	Article							MECHANICAL TURK; HINDSIGHT BIAS; MIND USE; PERSPECTIVE; CHILDREN; TESTS; SELF	Seven experiments use large sample sizes to robustly estimate the effect size of a previous finding that adults are more likely to commit egocentric errors in a false-belief task when the egocentric response is plausible in light of their prior knowledge. We estimate the true effect size to be less than half of that reported in the original findings. Even though we found effects in the same direction as the original, they were substantively smaller; the original study would have had less than 33% power to detect an effect of this magnitude. The influence of plausibility on the curse of knowledge in adults appears to be small enough that its impact on real-life perspective-taking may need to be reevaluated.	[Ryskin, Rachel A.; Brown-Schmidt, Sarah] Univ Illinois, Dept Psychol, Champaign, IL 61820 USA; [Brown-Schmidt, Sarah] Beckman Inst Adv Sci & Technol, Champaign, IL USA	University of Illinois System; University of Illinois Urbana-Champaign	Ryskin, RA (corresponding author), Univ Illinois, Dept Psychol, Champaign, IL 61820 USA.	ryskin2@illinois.edu		Ryskin, Rachel/0000-0002-9516-4467	National Science Foundation [10-19161]	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation under Grant No. 10-19161 to S. Brown-Schmidt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apperly IA, 2008, COGNITION, V106, P1093, DOI 10.1016/j.cognition.2007.05.005; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Bernstein DM, 2004, PSYCHOL SCI, V15, P264, DOI 10.1111/j.0963-7214.2004.00663.x; Birch SAJ, 2003, PSYCHOL SCI, V14, P283, DOI 10.1111/1467-9280.03436; Birch SAJ, 2007, PSYCHOL SCI, V18, P382, DOI 10.1111/j.1467-9280.2007.01909.x; Brown-Schmidt S, 2009, PSYCHON B REV, V16, P893, DOI 10.3758/PBR.16.5.893; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; CAMERER C, 1989, J POLIT ECON, V97, P1232, DOI 10.1086/261651; Converse BA, 2008, EMOTION, V8, P725, DOI 10.1037/a0013283; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Gardner WL, 1999, PSYCHOL SCI, V10, P321, DOI 10.1111/1467-9280.00162; Germine L, 2012, PSYCHON B REV, V19, P847, DOI 10.3758/s13423-012-0296-9; Hanna JE, 2003, J MEM LANG, V49, P43, DOI 10.1016/S0749-596X(03)00022-6; Keysar B, 2003, COGNITION, V89, P25, DOI 10.1016/S0010-0277(03)00064-7; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Pohl RF, 1998, EUR J COGN PSYCHOL, V10, P191, DOI 10.1080/713752272; Simonsohn U, 2013, EVALUATING REPLICATI, DOI DOI 10.2139/SSRN.2259879; TRAFIMOW D, 1991, J PERS SOC PSYCHOL, V60, P649, DOI 10.1037/0022-3514.60.5.649; WASSERMAN D, 1991, PERS SOC PSYCHOL B, V17, P30, DOI 10.1177/0146167291171005; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5	20	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92406	10.1371/journal.pone.0092406	http://dx.doi.org/10.1371/journal.pone.0092406			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SD	24667826	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600039
J	Sarsero, JP; Holloway, TP; Li, LL; Finkelstein, DI; Ioannou, PA				Sarsero, Joseph P.; Holloway, Timothy P.; Li, Lingli; Finkelstein, David I.; Ioannou, Panos A.			Rescue of the Friedreich Ataxia Knockout Mutation in Transgenic Mice Containing an FXN-EGFP Genomic Reporter	PLOS ONE			English	Article							REPEAT EXPANSION; TRIPLET-REPEAT; FRATAXIN GENE; SACCHAROMYCES-CEREVISIAE; EPIGENETIC CHANGES; IRON ACCUMULATION; YEAST FRATAXIN; MOUSE MODELS; DNA; TRANSCRIPTION	Friedreich ataxia (FRDA) is an autosomal recessive disorder characterized by neurodegeneration and cardiomyopathy. The presence of a GAA trinucleotide repeat expansion in the first intron of the FXN gene results in the inhibition of gene expression and an insufficiency of the mitochondrial protein frataxin. We previously generated BAC-based transgenic mice containing an FXN-EGFP genomic reporter construct in which the EGFP gene is fused in-frame immediately following the final codon of exon 5a of the human FXN gene. These transgenic mice were mated with mice heterozygous for a knockout mutation of the murine Fxn gene, to generate mice homozygous for the Fxn knockout mutation and hemizygous or homozygous for the human transgene. Rescue of the embryonic lethality that is associated with homozygosity for the Fxn knockout mutation was observed. Rescue mice displayed normal behavioral and histological parameters with normal viability, fertility and life span and without any signs of aberrant phenotype. Immunoblotting demonstrated the production of full-length frataxin-EGFP fusion protein that appears to act as a bifunctional hybrid protein. This study shows frataxin replacement may be a viable therapeutic option. Further, these mice should provide a useful resource for the study of human FXN gene expression, frataxin function, the evaluation of pharmacologic inducers of FXN expression in a whole-animal model and provide a useful source of cells for stem cell transplantation studies.	[Sarsero, Joseph P.; Holloway, Timothy P.; Li, Lingli; Ioannou, Panos A.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Sarsero, Joseph P.; Ioannou, Panos A.] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Finkelstein, David I.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Sarsero, JP (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	joe@sarsero.com	Finkelstein, David/B-9617-2009	Finkelstein, David/0000-0002-8167-4917	Muscular Dystrophy Association (USA) [3657, 3725]; Friedreich's Ataxia Research Alliance (USA); Brockhoff Foundation (Australia); Seek A Miracle (USA); Victorian Government's Operational Infrastructure Support Program	Muscular Dystrophy Association (USA)(Muscular Dystrophy Association); Friedreich's Ataxia Research Alliance (USA); Brockhoff Foundation (Australia); Seek A Miracle (USA); Victorian Government's Operational Infrastructure Support Program	This work was supported by the Muscular Dystrophy Association (USA) (grants 3657, 3725), the Friedreich's Ataxia Research Alliance (USA), the Brockhoff Foundation (Australia), Seek A Miracle (USA) and the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; Al-Mahdawi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074956; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Buck NE, 2012, BIOCHEM BIOPH RES CO, V427, P30, DOI 10.1016/j.bbrc.2012.08.134; Castaldo I, 2008, J MED GENET, V45, P808, DOI 10.1136/jmg.2008.058594; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Cossee M, 2000, HUM MOL GENET, V9, P1219, DOI 10.1093/hmg/9.8.1219; Delatycki MB, 1999, ANN NEUROL, V45, P673, DOI 10.1002/1531-8249(199905)45:5<673::AID-ANA20>3.3.CO;2-H; Evans-Galea MV, 2012, ANN NEUROL, V71, P487, DOI 10.1002/ana.22671; Foury F, 2007, EMBO REP, V8, P194, DOI 10.1038/sj.embor.7400881; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Grabczyk E, 2007, NUCLEIC ACIDS RES, V35, P5351, DOI 10.1093/nar/gkm589; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Hogan B, 1994, MANIPULATING MOUSE E; Koeppen AH, 2007, ACTA NEUROPATHOL, V114, P163, DOI 10.1007/s00401-007-0220-y; Koeppen AH, 2009, ACTA NEUROPATHOL, V118, P763, DOI 10.1007/s00401-009-0589-x; Li LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055940; Narayanan K, 1999, GENE THER, V6, P442, DOI 10.1038/sj.gt.3300901; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Pandolfo M, 2006, METH MOLEC MED, V126, P197; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Puspasari N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022001; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; Sakamoto N, 2001, J BIOL CHEM, V276, P27171, DOI 10.1074/jbc.M101879200; Sarsero JP, 2005, MAMM GENOME, V16, P228, DOI 10.1007/s00335-004-3021-9; Sarsero JP, 2004, MAMM GENOME, V15, P370, DOI 10.1007/s00335-004-3019-3; Sarsero JP, 2003, J GENE MED, V5, P72, DOI 10.1002/jgm.320; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Turner BJ, 2003, J NEUROSCI RES, V74, P605, DOI 10.1002/jnr.10796; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Xu CP, 2009, CHEM BIOL, V16, P980, DOI 10.1016/j.chembiol.2009.07.010; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i	35	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93307	10.1371/journal.pone.0093307	http://dx.doi.org/10.1371/journal.pone.0093307			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667739	Green Published, gold			2022-12-27	WOS:000333675600169
J	Tsoli, M; Schweiger, M; Vanniasinghe, AS; Painter, A; Zechner, R; Clarke, S; Robertson, G				Tsoli, Maria; Schweiger, Martina; Vanniasinghe, Anne S.; Painter, Arran; Zechner, Rudolf; Clarke, Stephen; Robertson, Graham			Depletion of White Adipose Tissue in Cancer Cachexia Syndrome Is Associated with Inflammatory Signaling and Disrupted Circadian Regulation	PLOS ONE			English	Article							LIPID-METABOLISM; PALLIATIVE CARE; WEIGHT-LOSS; FOOD-INTAKE; IN-VITRO; FAT; LIPOLYSIS; MUSCLE; INTERLEUKIN-6; CLOCK	Involuntary weight loss in patients with cancer is the hallmark of cancer cachexia. The etiology of cachexia is multifactorial involving loss of skeletal muscle and adipose tissue associated with high systemic levels of acute phase proteins and inflammatory cytokines. While muscle wasting overtly impacts on cancer patient quality of life, loss of lipid depots represents a sustained energy imbalance. In this study fat depletion was examined in Colon-26 model of cancer cachexia, which is a widely used rodent model of this syndrome. We investigated diurnal expression of circadian rhythm regulators as well as key mediators of energy metabolism and cytokine signaling. Mice bearing the C26 tumour exhibited reduced adipose mass, elevated adipose tissue lipolysis and a 5-fold increase in plasma levels of free fatty acids. These changes were associated with activated IL-6 signaling in WAT through a 3-fold increase in phosphorylated STAT3 and high SOCS3 gene expression levels. In addition perturbations in circadian regulation of lipid metabolism were also observed. Lipid catabolism did not appear to be influenced by the classical PKA pathway activating the lipase HSL. ATGL protein levels were elevated 2-fold in cachectic mice while 4-fold increase phosphorylated ACC and a 2-fold decrease in phosphorylated 4EBP1 was observed indicating that lipid metabolism is modulated by the ATGL & AMPK/mTOR pathways. This study provides evidence for activation of cytokine signaling and concomitant alterations in circadian rhythm and regulators of lipid metabolism in WAT of cachectic animals.	[Tsoli, Maria; Vanniasinghe, Anne S.] Childrens Canc Inst Med Res, Randwick, NSW, Australia; [Schweiger, Martina; Zechner, Rudolf] Graz Univ, Inst Mol Biosci, Graz, Austria; [Tsoli, Maria; Vanniasinghe, Anne S.; Painter, Arran; Robertson, Graham] Concord Repatriat Gen Hosp, Anzac Res Inst, Canc Pharmacol Unit, Concord West, NSW, Australia; [Clarke, Stephen] Univ Sydney, Royal N Shore Hosp, Northern Clin Sch, St Leonards, NSW 2065, Australia; [Robertson, Graham] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia	Children's Cancer Institute; Children's Medical Research Institute - Australia; University of Graz; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; Royal North Shore Hospital; University of Sydney; Garvan Institute of Medical Research; St Vincents Hospital Sydney	Robertson, G (corresponding author), Concord Repatriat Gen Hosp, Anzac Res Inst, Canc Pharmacol Unit, Concord West, NSW, Australia.	g.robertson@garvan.org.au	Tsoli, Maria/P-3941-2018; Research Institute, ANZAC/CAE-9030-2022	Tsoli, Maria/0000-0003-1155-0510; Zechner, Rudolf/0000-0001-5483-1182; Clarke, Stephen/0000-0001-5817-1222; Schweiger, Martina/0000-0002-3419-1007	Cancer Institute NSW translational program grant for colorectal cancer; Austrian Science Fund (FWF) [Z 136, F 3002] Funding Source: researchfish	Cancer Institute NSW translational program grant for colorectal cancer; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by a Cancer Institute NSW translational program grant for colorectal cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Argiles JM, 2004, CURR DRUG TARGETS, V5, P265, DOI 10.2174/1389450043490505; Arner P, 2011, SCIENCE, V333, P163, DOI 10.1126/science.1209418; Barnea M, 2010, OBESITY, V18, P230, DOI 10.1038/oby.2009.276; Batista ML, 2012, J ENDOCRINOL, V215, P363, DOI 10.1530/JOE-12-0307; Bertile F, 2011, J NUTR BIOCHEM, V22, P372, DOI 10.1016/j.jnutbio.2010.03.005; Bing C, 2006, BRIT J CANCER, V95, P1028, DOI 10.1038/sj.bjc.6603360; Blum D, 2011, CRIT REV ONCOL HEMAT, V80, P114, DOI 10.1016/j.critrevonc.2010.10.004; Bonetto A, 2012, AM J PHYSIOL-ENDOC M, V303, pE410, DOI 10.1152/ajpendo.00039.2012; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Bruera E, 1997, BRIT MED J, V315, P1219, DOI 10.1136/bmj.315.7117.1219; Cao DX, 2010, CANCER SCI, V101, P1639, DOI 10.1111/j.1349-7006.2010.01582.x; Carson JA, 2010, EXERC SPORT SCI REV, V38, P168, DOI 10.1097/JES.0b013e3181f44f11; Dahlman I, 2010, BRIT J CANCER, V102, P1541, DOI 10.1038/sj.bjc.6605665; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Fearon KCH, 2011, NEW ENGL J MED, V365, P565, DOI 10.1056/NEJMcibr1106880; Fouladiun M, 2005, CANCER-AM CANCER SOC, V103, P2189, DOI 10.1002/cncr.21013; Franck N, 2011, J CLIN ENDOCR METAB, V96, pE413, DOI 10.1210/jc.2009-2534; Froy O, 2011, CLIN SCI, V120, P65, DOI 10.1042/CS20100327; Gomez-Abellan P, 2008, INT J OBESITY, V32, P121, DOI 10.1038/sj.ijo.0803689; Haugen F., 2011, Archives of Physiology and Biochemistry, V117, P78, DOI 10.3109/13813455.2011.560609; Johnston JD, 2009, OBES REV, V10, P52, DOI 10.1111/j.1467-789X.2009.00665.x; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Karatsoreos IN, 2011, P NATL ACAD SCI USA, V108, P1657, DOI 10.1073/pnas.1018375108; Kelly M, 2004, BIOCHEM BIOPH RES CO, V320, P449, DOI 10.1016/j.bbrc.2004.05.188; Lee SJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-2; Loboda A, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-7; Murphy KT, 2012, DIS MODEL MECH, V5, P533, DOI 10.1242/dmm.008839; Palesty JA, 2003, DIGEST DIS, V21, P198, DOI 10.1159/000073337; Petersen EW, 2005, AM J PHYSIOL-ENDOC M, V288, pE155, DOI 10.1152/ajpendo.00257.2004; Richards CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041883; Ryden M, 2008, CANCER-AM CANCER SOC, V113, P1695, DOI 10.1002/cncr.23802; Ryden M, 2007, CLIN NUTR, V26, P1, DOI 10.1016/j.clnu.2006.09.009; Sahar S, 2012, TRENDS ENDOCRIN MET, V23, P1, DOI 10.1016/j.tem.2011.10.005; Soliman GA, 2010, LIPIDS, V45, P1089, DOI 10.1007/s11745-010-3488-y; Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23; STRASSMANN G, 1993, J CLIN INVEST, V92, P2152, DOI 10.1172/JCI116816; STRASSMANN G, 1992, J CLIN INVEST, V89, P1681, DOI 10.1172/JCI115767; Tsoli M, 2012, CANCER RES, V72, P4372, DOI 10.1158/0008-5472.CAN-11-3536; Van Cauter E, 2008, SLEEP MED, V9, pS23, DOI 10.1016/S1389-9457(08)70013-3; Wallenius K, 2002, BIOCHEM BIOPH RES CO, V293, P560, DOI 10.1016/S0006-291X(02)00230-9; Xue BZ, 2006, J PHYSIOL-LONDON, V574, P73, DOI 10.1113/jphysiol.2006.113217; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	48	57	59	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92966	10.1371/journal.pone.0092966	http://dx.doi.org/10.1371/journal.pone.0092966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667661	Green Submitted, Green Published, gold			2022-12-27	WOS:000333675600110
J	Wonkam, A; Bitoungui, VJN; Vorster, AA; Ramesar, R; Cooper, RS; Tayo, B; Lettre, G; Ngogang, J				Wonkam, Ambroise; Bitoungui, Valentina J. Ngo; Vorster, Anna A.; Ramesar, Raj; Cooper, Richard S.; Tayo, Bamidele; Lettre, Guillaume; Ngogang, Jeanne			Association of Variants at BCL11A and HBS1L-MYB with Hemoglobin F and Hospitalization Rates among Sickle Cell Patients in Cameroon	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ACUTE CHEST SYNDROME; FETAL-HEMOGLOBIN; GENETIC-VARIATION; BETA-THALASSEMIA; ANEMIA PATIENTS; RISK-FACTORS; DISEASE; POPULATION; HAPLOTYPES	Background: Genetic variation at loci influencing adult levels of HbF have been shown to modify the clinical course of sickle cell disease (SCD). Data on this important aspect of SCD have not yet been reported from West Africa. We investigated the relationship between HbF levels and the relevant genetic loci in 610 patients with SCD (98% HbSS homozygotes) from Cameroon, and compared the results to a well-characterized African-American cohort. Methods and Findings: Socio-demographic and clinical features were collected and medical records reviewed. Only patients >5 years old, who had not received a blood transfusion or treatment with hydroxyurea were included. Hemoglobin electrophoresis and a full blood count were conducted upon arrival at the hospital. RFLP-PCR was used to describe the HBB gene haplotypes. SNaPshot PCR, Capillary electrophoresis and cycle sequencing were used for the genotyping of 10 selected SNPs. Genetic analysis was performed with PLINK software and statistical models in the statistical package R. Allele frequencies of relevant variants at BCL11A were similar to those detected in African Americans; although the relationships with Hb F were significant (p < .001), they explained substantially less of the variance in HbF than was observed among African Americans (similar to 2% vs 10%). SNPs in HBS1L-MYB region (HMIP) likewise had a significant impact on HbF, however, we did not find an association between HbF and the variations in HBB cluster and OR51B5/6 locus on chromosome 11p, due in part to the virtual absence of the Senegal and Indian Arab haplotypes. We also found evidence that selected SNPs in HBS1L-MYB region (HMIP) and BCL11A affect both other hematological indices and rates of hospitalization. Conclusions: This study has confirmed the associations of SNPs in BCL11A and HBS1L-MYB and fetal haemoglobin in Cameroonian SCA patients; hematological indices and hospitalization rates were also associated with specific allelic variants.	[Wonkam, Ambroise; Vorster, Anna A.; Ramesar, Raj] Univ Cape Town, Div Human Genet, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Bitoungui, Valentina J. Ngo; Ngogang, Jeanne] Univ Yaounde I, Fac Med & Biomed Sci, Dept Microbiol Parasitol & Haematol, Yaounde, Cameroon; [Ramesar, Raj] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, UCT MRC Human Genet Res Unit,Div Human Genet, ZA-7925 Cape Town, South Africa; [Cooper, Richard S.; Tayo, Bamidele] Loyola Univ Chicago, Stritch Sch Med, Dept Publ Hlth Sci, Maywood, IL USA; [Lettre, Guillaume] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Lettre, Guillaume] Univ Montreal, Montreal, PQ, Canada	University of Cape Town; University of Yaounde I; University of Cape Town; Loyola University Chicago; Universite de Montreal; Universite de Montreal	Wonkam, A (corresponding author), Univ Cape Town, Div Human Genet, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa.	ambroise.wonkam@uct.ac.za	Wonkam, Ambroise/AFU-6901-2022; Ramesar, Raj S/I-6941-2015	Ramesar, Raj S/0000-0001-5688-1634	National Health Laboratory Services (NHLS), South Africa; University of Cape Town (UCT) Research Committee; Carnegie Research Development Grant, South Africa; Third World Academy of Sciences (TWAS)	National Health Laboratory Services (NHLS), South Africa; University of Cape Town (UCT) Research Committee; Carnegie Research Development Grant, South Africa; Third World Academy of Sciences (TWAS)	The molecular experiments of the study were funded by the National Health Laboratory Services (NHLS), South Africa; the University of Cape Town (UCT) Research Committee and Carnegie Research Development Grant, South Africa. The students' bursaries were supported by the Third World Academy of Sciences (TWAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae HT, 2012, BLOOD, V120, P1961, DOI 10.1182/blood-2012-06-432849; Bartolucci P, 2012, CURR OPIN HEMATOL, V19, P149, DOI 10.1097/MOH.0b013e328351c35f; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Bean CJ, 2013, BRIT J HAEMATOL, V163, P268, DOI 10.1111/bjh.12507; Creary LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004218; Elderdery AY, 2012, INT J LAB HEMATOL, V34, P262, DOI 10.1111/j.1751-553X.2011.01388.x; Farrell JJ, 2011, BLOOD, V117, P4935, DOI 10.1182/blood-2010-11-317081; Galarneau G, 2013, BLOOD, V122, P434, DOI 10.1182/blood-2013-01-478776; Garner C, 2000, BLOOD, V95, P342; Grosse SD, 2011, AM J PREV MED, V41, pS398, DOI 10.1016/j.amepre.2011.09.013; Hanchard N, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-52; LABIE D, 1985, P NATL ACAD SCI USA, V82, P2111, DOI 10.1073/pnas.82.7.2111; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Makani J, 2011, BLOOD, V117, P1390, DOI 10.1182/blood-2010-08-302703; Menzel S, 2007, BLOOD, V110, P3624, DOI 10.1182/blood-2007-05-093419; Njamnshi AK, 2006, J NEUROL SCI, V250, P79, DOI 10.1016/j.jns.2006.07.003; Ondei LS, 2007, GENET MOL RES, V6, P453; Pati N, 2004, J BIOCHEM BIOPH METH, V60, P1, DOI 10.1016/j.jbbm.2003.11.005; Piel FB, 2013, LANCET, V381, P142, DOI 10.1016/S0140-6736(12)61229-X; Platt OS, 2008, NEW ENGL J MED, V358, P1362, DOI 10.1056/NEJMct0708272; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ruffieux N, 2013, CHILD NEUROPSYCHOL, V19, P143, DOI 10.1080/09297049.2011.640932; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Solovieff N, 2010, BLOOD, V115, P1815, DOI 10.1182/blood-2009-08-239517; STEINBERG MH, 1984, BLOOD, V63, P1353; Steinberg MH, 1998, AM J HEMATOL, V59, P121, DOI 10.1002/(SICI)1096-8652(199810)59:2<121::AID-AJH4>3.0.CO;2-#; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104; Thein SL, 2009, BRIT J HAEMATOL, V145, P455, DOI 10.1111/j.1365-2141.2009.07650.x; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Weatherall DJ, 2001, B WORLD HEALTH ORGAN, V79, P704; Wonkam A, 2013, J GENETIC COUNSELING; World Bank, 2010, 48373CM WORLD BANK, P1; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053	35	67	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92506	10.1371/journal.pone.0092506	http://dx.doi.org/10.1371/journal.pone.0092506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667352	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600044
J	Xie, YY; Li, J; Fan, GB; Qi, SH; Li, B				Xie, Yuying; Li, Jun; Fan, Guibo; Qi, Sihua; Li, Bing			Reperfusion Promotes Mitochondrial Biogenesis following Focal Cerebral Ischemia in Rats	PLOS ONE			English	Article							NEURONAL CELL-DEATH; BRAIN-INJURY; GENE-EXPRESSION; PERMEABILITY TRANSITION; OXIDATIVE STRESS; DNA CONTENT; NUCLEAR; PROTEIN; TRANSCRIPTION; COACTIVATORS	Background and Purpose: Reperfusion after transient cerebral ischemia causes severe damage to mitochondria; however, little is known regarding the continuous change in mitochondrial biogenesis during reperfusion. Mitochondrial biogenesis causes an increase in the individual mitochondrial mass of neurons and maintains their aerobic set-point in the face of declining function. The aim of this study was to examine mitochondrial biogenesis in the cortex during reperfusion following focal cerebral ischemia. Methods: Male Wistar rats were subjected to transient focal cerebral ischemia. The relative amount of cortical mitochondrial DNA was analyzed using quantitative real-time PCR at 0 h, 24 h, 72 h, and 7 d after reperfusion. Three critical transcriptional regulators of mitochondrial biogenesis were measured by semi-quantitative reverse-transcription PCR. The protein expression of cytochrome C oxidase subunits I and IV was detected by Western blotting. Results: Evidence of increased mitochondrial biogenesis was observed after reperfusion. The cortical mitochondrial DNA content increased after 24 h, peaked after 72 h, and maintained a high level for 7 d. The cortical expression of three critical genes for the transcriptional regulation of mitochondrial biogenesis, namely, peroxisome proliferator-activated receptor coactivator-1 alpha, nuclear respiratory factor-1, and mitochondrial transcription factor A, also increased at 24 h and 72 h. The expression of peroxisome proliferator-activated receptor coactivator-1a returned to the baseline level at 7 d, but two other factors maintained higher levels compared with the controls. Moreover, the expression of cytochrome C oxidase subunits I and IV was increased in the cortex. Conclusions: These results indicate that reperfusion increased mitochondrial biogenesis following focal cerebral ischemia, and this tendency was exacerbated as the reperfusion time was extended. Reperfusion-induced mitochondrial biogenesis was mediated through up-regulation of critical transcriptional regulators of mitochondrial biogenesis.	[Xie, Yuying; Li, Jun; Fan, Guibo; Qi, Sihua] Harbin Med Univ, Affiliated Hosp 4, Dept Anesthesiol, Harbin, Peoples R China; [Li, Bing] Harbin Med Univ, Affiliated Hosp 2, Dept Nephrol, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Qi, SH (corresponding author), Harbin Med Univ, Affiliated Hosp 4, Dept Anesthesiol, Harbin, Peoples R China.	sihuaqi_2013@163.com; bingliqi_2013@126.com			Natural Science Foundation of China [81271456]; Nature Science Foundation of Heilongjiang Province [ZD201017]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This project was supported by grants from the Natural Science Foundation of China (No. 81271456) and the Nature Science Foundation of Heilongjiang Province (ZD201017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819; Anderson MF, 1999, J NEUROCHEM, V73, P1189, DOI 10.1046/j.1471-4159.1999.0731189.x; Aronowski J, 1997, J CEREBR BLOOD F MET, V17, P1048, DOI 10.1097/00004647-199710000-00006; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Canevari L, 1997, J CEREBR BLOOD F MET, V17, P1166, DOI 10.1097/00004647-199711000-00005; Cannino G, 2007, MITOCHONDRION, V7, P359, DOI 10.1016/j.mito.2007.07.001; Chan PH, 2004, NEUROCHEM RES, V29, P1943, DOI 10.1007/s11064-004-6869-x; Chen H, 2001, STROKE, V32, P2382, DOI 10.1161/hs1001.097099; Chen SD, 2011, INT J MOL SCI, V12, P7199, DOI 10.3390/ijms12107199; Chen SD, 2010, J NEUROSCI RES, V88, P3144, DOI 10.1002/jnr.22469; Diaz F, 2008, CELL CALCIUM, V44, P24, DOI 10.1016/j.ceca.2007.12.004; Edwards JL, 2010, DIABETOLOGIA, V53, P160, DOI 10.1007/s00125-009-1553-y; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Escriva H, 1999, BIOCHIMIE, V81, P965, DOI 10.1016/S0300-9084(99)00223-0; Ferrer I, 2009, J BIOENERG BIOMEMBR, V41, P425, DOI 10.1007/s10863-009-9243-5; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Garcia-Roves PM, 2006, AM J PHYSIOL-ENDOC M, V290, pE1172, DOI 10.1152/ajpendo.00633.2005; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Hota KB, 2012, HIPPOCAMPUS, V22, P723, DOI 10.1002/hipo.20934; JALC P, 1995, MOL CHEM NEUROPATHOL, V25, P143, DOI 10.1007/BF02960909; Jones AWE, 2012, MITOCHONDRION, V12, P86, DOI 10.1016/j.mito.2011.09.009; Kao TK, 2006, NEUROCHEM INT, V48, P166, DOI 10.1016/j.neuint.2005.10.008; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kleiner S, 2009, J BIOL CHEM, V284, P18624, DOI 10.1074/jbc.M109.008797; Kumari S, 2012, TRANSL STROKE RES, V3, P296, DOI 10.1007/s12975-012-0158-9; Kutik S, 2009, BBA-GEN SUBJECTS, V1790, P409, DOI 10.1016/j.bbagen.2009.04.004; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Lee HM, 2008, FREE RADICAL BIO MED, V44, P807, DOI 10.1016/j.freeradbiomed.2007.11.005; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046498; Lin Tsu-Kung, 2009, Chang Gung Med J, V32, P589; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Mandemakers W, 2007, J CELL SCI, V120, P1707, DOI 10.1242/jcs.03443; Manoli I, 2007, TRENDS ENDOCRIN MET, V18, P190, DOI 10.1016/j.tem.2007.04.004; Matsumori Y, 2005, J CEREBR BLOOD F MET, V25, P899, DOI 10.1038/sj.jcbfm.9600080; Mattingly KA, 2008, MOL ENDOCRINOL, V22, P609, DOI 10.1210/me.2007-0029; Nagata T, 2006, THESCIENTIFICWORLDJO, V6, P1583, DOI 10.1100/tsw.2006.265; Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101; Onyango IG, 2010, BBA-MOL BASIS DIS, V1802, P228, DOI 10.1016/j.bbadis.2009.07.014; PARIKH VS, 1987, SCIENCE, V235, P576, DOI 10.1126/science.3027892; Peinado MA, 1997, ANAT REC, V247, P420; Poyton RO, 1996, ANNU REV BIOCHEM, V65, P563, DOI 10.1146/annurev.bi.65.070196.003023; Pundik S, 2012, NEUROLOGY, V79, pS44, DOI 10.1212/WNL.0b013e3182695a14; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Shimamura N, 2006, J NEUROSCI METH, V156, P161, DOI 10.1016/j.jneumeth.2006.02.017; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Valerio A, 2011, J NEUROCHEM, V116, P1148, DOI 10.1111/j.1471-4159.2011.07171.x; Villa RF, 2006, J NEURAL TRANSM, V113, P1659, DOI 10.1007/s00702-006-0569-4; VILLA RF, 1981, BIOCHEM PHARMACOL, V30, P2399, DOI 10.1016/0006-2952(81)90333-6; Villa RF, 2013, NEUROCHEM INT, V63, P765, DOI 10.1016/j.neuint.2013.10.004; Wang XL, 2009, J NEUROCHEM, V109, P153, DOI 10.1111/j.1471-4159.2009.05867.x; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yaffe MP, 1999, NAT CELL BIOL, V1, pE149, DOI 10.1038/14101; Yin W, 2006, NEUROBIOL DIS, V21, P358, DOI 10.1016/j.nbd.2005.07.015; Yin W, 2008, STROKE, V39, P3057, DOI 10.1161/STROKEAHA.108.520114; Zaidan E, 1997, BRAIN RES, V772, P23, DOI 10.1016/S0006-8993(97)00833-0; Zhang Q, 2012, NEUROSCIENCE, V205, P10, DOI 10.1016/j.neuroscience.2011.12.053	60	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92443	10.1371/journal.pone.0092443	http://dx.doi.org/10.1371/journal.pone.0092443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667167	gold, Green Published, Green Submitted			2022-12-27	WOS:000333675600040
J	Chiang, KC; Tsui, KH; Chung, LC; Yeh, CN; Chen, WT; Chang, PL; Juang, HH				Chiang, Kun-Chun; Tsui, Ke-Hung; Chung, Li-Chuan; Yeh, Chun-Nan; Chen, Wen-Tsung; Chang, Phei-Lang; Juang, Horng-Heng			Celastrol Blocks Interleukin-6 Gene Expression via Downregulation of NF-kappa B in Prostate Carcinoma Cells	PLOS ONE			English	Article							CANCER-SPECIFIC SURVIVAL; ANDROGEN-RECEPTOR; UP-REGULATION; GOD VINE; GROWTH; INHIBITION; PATHWAYS; THERAPY; KINASE; IL-6	Interleukin-6 (IL-6), a multifunctional cytokine, contributes to proliferation or differentiation of prostate carcinoma cells in a highly cell type-specific manner. Celastrol (3-hydroxy-24-nor-2oxo-1(10), 3,5,7-friedelatetrane-29-oic acid), also named as tripterine, is extracted from root of Chinese traditional herb Tripterygiumwilfordii Hook f with potent anti-inflammatory and anti-cancer activities. In this study, we evaluated the molecular mechanisms of celastrol on cell proliferation and IL-6 gene expression in prostate carcinoma cells. 3 H-thymidine incorporation and flow cytometric analysis indicated that celastrol treatments arrested the cell cycle at the G0/ G1 phase, thus attenuating cell proliferation in prostate carcinoma PC-3 cells; moreover, celastrol induced cell apoptosis at higher dosage. Knockdown of IL-6 attenuated the anti-proliferative effect of celastrol on PC-3 cells. Results from ELISA and 5'-deletion transient gene expression assays indicated that celastrol treatment decreased IL-6 secretion and gene expression, and this effect is dependent on the NF-kappa B response element within IL-6 promoter area since mutation of the NF-kappa B response element from AAATGTCCCATTTTCCC to AAATGTTACATTTTCCC by site-directed mutagenesis abolished the inhibition of celastrol on the IL-6 promoter activity. Celastrol also attenuated the activation of PMA and TNF alpha on the gene expression and secretion of IL-6 in PC-3 cells. Immunoblot assays revealed that celastrol treatment downregulated the expressions of IKK alpha, p50 and p65, supporting the 5'-deletion transient gene expression assay result that celastrol blocked IL-6 expression through the NF-kappa B pathway in PC-3 cells. For the first time, our results concluded that celastrol attenuates PC-3 cell proliferation via downregulation of IL-6 gene expression through the NF-kappa B-dependent pathway.	[Chiang, Kun-Chun] Chang Gung Mem Hosp, Dept Gen Surg, Keelung, Taiwan; [Tsui, Ke-Hung] Chang Gung Mem Hosp, Dept Urol, Tao Yuan, Taiwan; [Chung, Li-Chuan; Juang, Horng-Heng] Chang Gung Univ, Sch Med, Dept Anat, Tao Yuan, Taiwan; [Yeh, Chun-Nan] Chang Gung Mem Hosp, Dept Gen Surg, Tao Yuan, Taiwan; [Chen, Wen-Tsung] Natl Kaohsiung Univ Hosp & Tourism, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; National Kaohsiung University of Hospitality & Tourism	Juang, HH (corresponding author), Chang Gung Univ, Sch Med, Dept Anat, Tao Yuan, Taiwan.	hhj143@mail.cgu.edu.tw	Juang, Horng-Heng/AAG-7683-2020; Tsui, Ke hung/O-3551-2016; Juang, Horng-Heng/G-2313-2012	Tsui, Ke hung/0000-0001-9814-0914; Juang, Horng-Heng/0000-0002-8524-8253	Chang Gung Memorial Hospital [CMRP-D190543, CMRP-D190613, CMRP-G3B1891, D1D0201, CMRP-G3D0311]; National Science Council [101-2314-B-182A-099-MY3, 102-2320-B-182-003 -MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council(Ministry of Science and Technology, Taiwan)	This Research was supported by Chang Gung Memorial Hospital (CMRP-D190543, -D190613, -G3B1891, D1D0201, and -G3D0311) and Taiwan National Science Council (101-2314-B-182A-099-MY3 and 102-2320-B-182-003 -MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara T, 2010, EUR J CANCER, V46, P1223, DOI 10.1016/j.ejca.2010.02.026; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bellone S, 2005, GYNECOL ONCOL, V98, P92, DOI 10.1016/j.ygyno.2005.03.016; Cardillo MR, 2006, ANTICANCER RES, V26, P3409; Chung LC, 2012, AM J PHYSIOL-CELL PH, V302, pC676, DOI 10.1152/ajpcell.00180.2011; Collett NP, 2010, SEMIN ONCOL, V37, P258, DOI 10.1053/j.seminoncol.2010.06.014; Conze D, 2001, CANCER RES, V61, P8851; Cozen W, 2004, BLOOD, V103, P3216, DOI 10.1182/blood-2003-08-2860; D'Amico AV, 2002, J CLIN ONCOL, V20, P4567, DOI 10.1200/JCO.2002.03.061; Dai Y, 2009, INT J RADIAT ONCOL, V74, P1217, DOI 10.1016/j.ijrobp.2009.03.057; Edwards J, 2005, BJU INT, V95, P1327, DOI 10.1111/j.1464-410X.2005.05527.x; George DJ, 2005, CLIN CANCER RES, V11, P1815, DOI 10.1158/1078-0432.CCR-04-1560; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Han M, 2001, UROL CLIN N AM, V28, P555, DOI 10.1016/S0094-0143(05)70163-4; He D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-343; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Jee SH, 2004, J INVEST DERMATOL, V123, P1169, DOI 10.1111/j.0022-202X.2004.23497.x; Jia L, 2004, CANCER RES, V64, P2619, DOI 10.1158/0008-5472.CAN-03-3486; Juang HH, 2013, PROSTATE, V73, P1495, DOI 10.1002/pros.22697; Kannaiyan R, 2011, CANCER LETT, V303, P9, DOI 10.1016/j.canlet.2010.10.025; Keller ET, 1996, J BIOL CHEM, V271, P26267, DOI 10.1074/jbc.271.42.26267; Lee JH, 2006, BIOCHEM PHARMACOL, V72, P1311, DOI 10.1016/j.bcp.2006.08.014; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Pang XF, 2010, CANCER RES, V70, P1951, DOI 10.1158/0008-5472.CAN-09-3201; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Salminen A, 2010, BIOCHEM BIOPH RES CO, V394, P439, DOI 10.1016/j.bbrc.2010.03.050; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Steiner H, 2006, PROSTATE, V66, P1744, DOI 10.1002/pros.20492; Sung B, 2010, J BIOL CHEM, V285, P11498, DOI 10.1074/jbc.M109.090209; Tsui KH, 2008, ACTA PHARMACOL SIN, V29, P1334, DOI 10.1111/j.1745-7254.2008.00887.x; Tsui KH, 2008, ANTICANCER RES, V28, P1969; Tsui KH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/791212; Tsui KH, 2012, J MOL ENDOCRINOL, V49, P153, DOI 10.1530/JME-11-0149; Xiao WH, 2004, PROSTATE, V61, P354, DOI 10.1002/pros.20113; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Zhu H, 2010, CANCER LETT, V297, P155, DOI 10.1016/j.canlet.2010.04.030	38	36	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e93151	10.1371/journal.pone.0093151	http://dx.doi.org/10.1371/journal.pone.0093151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664372	gold, Green Published, Green Submitted			2022-12-27	WOS:000333459900159
J	Hedge, LH; Johnston, EL				Hedge, Luke H.; Johnston, Emma L.			Colonisation of the Non-Indigenous Pacific Oyster Crassostrea gigas Determined by Predation, Size and Initial Settlement Densities	PLOS ONE			English	Article							SYDNEY ROCK OYSTERS; PROPAGULE PRESSURE; HABITAT COMPLEXITY; BIOTIC RESISTANCE; NONNATIVE OYSTERS; BALLAST WATER; INVASION; COMMUNITIES; DISTURBANCE; DIVERSITY	Survival of incipient non-indigenous populations is dramatically altered by early predation on new colonisers. These effects can be influenced by morphological traits, such as coloniser size and density. The Australian non-native Pacific Oyster Crassostrea gigas is generally more fecund and faster growing compared to the native Saccostrea glomerata found in the same habitat. It is therefore important to quantify how the two species differ in survival across coloniser density and predation gradients. This information could become pertinent to the management of wild and aquaculture populations of the non-native C. gigas. Using a field-based factorial experiment we model the survival of incipient populations of both the native S. glomerata and the non-indigenous C. gigas as a function of coloniser density, predator reduction and individual size. Unexpectedly, survival of the non-indigenous C. gigas increased compared to S. glomerata when individuals were larger. The proportional survival of newly colonised oyster populations also increased with larger initial populations, regardless of species identity. Further, predator reduction resulted in increased survival of both oyster species, irrespective of coloniser size or initial density. Here we quantitatively demonstrate the effects of recruit density and size on enhancing the survivability of incipient oyster populations.	[Hedge, Luke H.] Univ New S Wales, Sydney Inst Marine Sci, Sydney, NSW, Australia; Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia	Sydney Institute of Marine Science; University of New South Wales Sydney; University of New South Wales Sydney	Hedge, LH (corresponding author), Univ New S Wales, Sydney Inst Marine Sci, Sydney, NSW, Australia.	l.hedge@unsw.edu.au	Johnston, Emma L/B-7210-2009; Johnston, Emma/AAC-2878-2022	Johnston, Emma L/0000-0002-2117-366X; Johnston, Emma/0000-0002-2117-366X	Australian Research Foundation Discovery Grant	Australian Research Foundation Discovery Grant	This work partially funded from an Australian Research Foundation Discovery Grant. No additional external funding was received for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 1999, MAR ECOL PROG SER, V187, P203, DOI 10.3354/meps187203; Bishop MJ, 2010, MAR FRESHWATER RES, V61, P714, DOI 10.1071/MF09177; Bishop MJ, 2006, ECOL APPL, V16, P718, DOI 10.1890/1051-0761(2006)016[0718:WRMNPI]2.0.CO;2; BUTMAN CA, 1994, LIMNOL OCEANOGR, V39, P1755, DOI 10.4319/lo.1994.39.7.1755; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Clark GF, 2005, MAR ECOL PROG SER, V298, P9, DOI 10.3354/meps298009; Clark GF, 2009, OIKOS, V118, P1679, DOI 10.1111/j.1600-0706.2009.17564.x; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Costello C, 2007, ECOL APPL, V17, P655, DOI 10.1890/06-0190; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; CRAWLEY MJ, 2006, R BOOK; Drake JM, 2006, BIOL INVASIONS, V8, P365, DOI 10.1007/s10530-004-8122-6; Drake JM, 2005, BIOL LETTERS, V1, P480, DOI 10.1098/rsbl.2005.0375; Drake JM, 2007, CAN J FISH AQUAT SCI, V64, P530, DOI 10.1139/F07-029; Drake LM, 2004, P ROYAL SOC, V271, P575; Dutertre M, 2010, MAR ENVIRON RES, V69, P1, DOI 10.1016/j.marenvres.2009.07.002; Eschtruth AK, 2009, ECOL MONOGR, V79, P265, DOI 10.1890/08-0221.1; Grabowski JH, 2004, MAR ECOL PROG SER, V277, P291, DOI 10.3354/meps277291; Grabowski JH, 2004, ECOLOGY, V85, P995, DOI 10.1890/03-0067; Grabowski JH, 2008, ECOLOGY, V89, P3413, DOI 10.1890/07-1057.1; Green TJ, 2008, AQUACULTURE, V280, P35, DOI 10.1016/j.aquaculture.2008.04.004; Hedge LH, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-000375.1; Holling C. S., 1959, Canadian Entomologist, V91, P385; Hughes AR, 2006, OECOLOGIA, V149, P256, DOI 10.1007/s00442-006-0439-7; Jonsson PR, 2005, LIMNOL OCEANOGR, V50, P1989, DOI 10.4319/lo.2005.50.6.1989; Krassoi FR, 2008, J ANIM ECOL, V77, P5, DOI 10.1111/j.1365-2656.2007.01316.x; Lambrinos JG, 2006, OECOLOGIA, V147, P327, DOI 10.1007/s00442-005-0259-1; Leung B, 2004, ECOLOGY, V85, P1651, DOI 10.1890/02-0571; Liu W, 2009, AQUACULTURE, V299, P99; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; Lopez MS, 2010, MAR ECOL PROG SER, V403, P101, DOI 10.3354/meps08409; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Range P, 2008, J EXP MAR BIOL ECOL, V365, P23, DOI 10.1016/j.jembe.2008.07.031; Rico-Villa B, 2009, AQUACULTURE, V287, P395, DOI 10.1016/j.aquaculture.2008.10.054; ROBERTS CM, 1987, MAR ECOL PROG SER, V41, P1, DOI 10.3354/meps041001; Ruesink JL, 2007, MAR ECOL PROG SER, V331, P1, DOI 10.3354/meps331001; Ruesink JL, 2005, ANNU REV ECOL EVOL S, V36, P643, DOI 10.1146/annurev.ecolsys.36.102003.152638; Ruiz GM, 2000, ANNU REV ECOL SYST, V31, P481, DOI 10.1146/annurev.ecolsys.31.1.481; Schmidt A, 2008, HELGOLAND MAR RES, V62, P367, DOI 10.1007/s10152-008-0125-8; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Smith IR, 2000, AQUACULTURE, V185, P197, DOI 10.1016/S0044-8486(99)00350-6; Taylor JJ, 1998, J SHELLFISH RES, V17, P281; Troost K, 2010, J SEA RES, V64, P145, DOI 10.1016/j.seares.2010.02.004; Von Holle B, 2005, ECOLOGY, V86, P3212, DOI 10.1890/05-0427; Wilkie EM, 2012, MAR FRESHWATER RES, V63, P1201, DOI 10.1071/MF12078; Wilkie EM, 2012, J EXP MAR BIOL ECOL, V420, P16, DOI 10.1016/j.jembe.2012.03.018; Zuur Alain F., 2009, P1	48	12	12	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e90621	10.1371/journal.pone.0090621	http://dx.doi.org/10.1371/journal.pone.0090621			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663029	gold, Green Published, Green Submitted			2022-12-27	WOS:000333459900009
J	Remy, S; Govarts, E; Bruckers, L; Paulussen, M; Wens, B; Den Hond, E; Nelen, V; Baeyens, W; van Larebeke, N; Loots, I; Sioen, I; Schoeters, G				Remy, Sylvie; Govarts, Eva; Bruckers, Liesbeth; Paulussen, Melissa; Wens, Britt; Den Hond, Elly; Nelen, Vera; Baeyens, Willy; van Larebeke, Nicolas; Loots, Ilse; Sioen, Isabelle; Schoeters, Greet			Expression of the sFLT1 Gene in Cord Blood Cells Is Associated to Maternal Arsenic Exposure and Decreased Birth Weight	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-1; DNA METHYLATION; REACTIVE OXYGEN; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; HYPERTENSION; CHINESE; VASCULOGENESIS; ANGIOGENESIS; METABOLITES	There is increasing epidemiologic evidence that arsenic exposure in utero is associated with adverse pregnancy outcomes and may contribute to long-term health effects. These effects may occur at low environmental exposures but the underlying molecular mechanism is not clear. We collected cord blood samples of 183 newborns to identify associations between arsenic levels and birth anthropometric parameters in an area with very low arsenic exposure. Our core research aim was to screen for transcriptional marks that mechanistically explain these associations. Multiple regression analyses showed that birth weight decreased with 47 g (95% CI: 16-78 g) for an interquartile range increase of 0.99 mg/L arsenic. The model was adjusted for child's sex, maternal smoking during pregnancy, gestational age, and parity. Higher arsenic concentrations and reduced birth weight were positively associated with changes in expression of the sFLT1 (soluble fms-like tyrosine kinase-1) gene in cord blood cells in girls. The protein product of sFLT1 is a scavenger of vascular endothelial growth factor (VEGF) in the extracellular environment and plays a key role in the inhibition of placental angiogenesis. In terms of fetal development, inhibition of placental angiogenesis leads to impaired nutrition and hence to growth retardation. Various genes related to DNA methylation and oxidative stress showed also changed expression in relation to arsenic exposure but were not related to birth outcome parameters. In conclusion, this study suggests that increased expression of sFLT1 is an intermediate marker that points to placental angiogenesis as a pathway linking prenatal arsenic exposure to reduced birth weight.	[Remy, Sylvie; Govarts, Eva; Paulussen, Melissa; Wens, Britt; Den Hond, Elly; Schoeters, Greet] Flemish Inst Technol Res VITO, Mol, Belgium; [Bruckers, Liesbeth] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Diepenbeek, Belgium; [Remy, Sylvie; Wens, Britt; Schoeters, Greet] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium; [Nelen, Vera] Prov Inst Hyg, Dept Hlth, Antwerp, Belgium; [Baeyens, Willy; van Larebeke, Nicolas] Vrije Univ Brussel, Dept Analyt Environm & Geochem AEGC, Brussels, Belgium; [van Larebeke, Nicolas] Univ Ghent, Dept Radiotherapy & Expt Canc Res, B-9000 Ghent, Belgium; [Loots, Ilse] Univ Antwerp, Dept Sociol, Fac Polit & Social Sci, B-2020 Antwerp, Belgium; [Sioen, Isabelle] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Sioen, Isabelle] FWO Res Fdn, Brussels, Belgium; [Schoeters, Greet] Univ Southern Denmark, Dept Environm Med, Odense, Denmark	VITO; Hasselt University; University of Antwerp; Vrije Universiteit Brussel; Ghent University; University of Antwerp; Ghent University; University of Southern Denmark	Remy, S (corresponding author), Flemish Inst Technol Res VITO, Mol, Belgium.	sylvie.remy@vito.be		Schoeters, Greta/0000-0002-6556-4814; Baeyens, Willy/0000-0002-5281-903X; van Larebeke, Nik/0000-0002-3183-3369; Remy, Sylvie/0000-0003-0322-9620	Ministry of the Flemish Community; European Community [OBELIX 227391]; Research Foundation - Flanders [1.2.683.11.N.00]	Ministry of the Flemish Community; European Community(European Commission); Research Foundation - Flanders(FWO)	The studies of the Flemish Center of Expertise on Environment and Health were commissioned, financed and steered by the Ministry of the Flemish Community (Department of Economics, Science and Innovation; Flemish Agency for Care and Health; and Department of Environment, Nature and Energy). The research received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement OBELIX 227391. Isabelle Sioen is financially supported by the Research Foundation - Flanders (Grant no: 1.2.683.11.N.00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, CIRC RES, V95, P884, DOI 10.1161/01.RES.0000147365.86159.f5; Alam MGM, 2002, INT J ENVIRON HEAL R, V12, P236, DOI 10.1080/0960312021000000998; Alexander BT, 2003, HYPERTENSION, V41, P457, DOI 10.1161/01.HYP.0000053448.95913.3D; Arroyo JA, 2008, SEMIN PERINATOL, V32, P172, DOI 10.1053/j.semperi.2008.02.006; Barchowsky A, 1999, FREE RADICAL BIO MED, V27, P1405, DOI 10.1016/S0891-5849(99)00186-0; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bodwell JE, 2006, CHEM RES TOXICOL, V19, P1619, DOI 10.1021/tx060122q; Bos I, 2012, NEUROSCIENCE, V223, P131, DOI 10.1016/j.neuroscience.2012.07.057; Burton GJ, 2002, J CLIN ENDOCR METAB, V87, P2954, DOI 10.1210/jc.87.6.2954; Cheng TF, 2012, J APPL TOXICOL, V32, P643, DOI 10.1002/jat.2717; Concha G, 1998, TOXICOL SCI, V44, P185, DOI 10.1006/toxs.1998.2486; Fangstrom B, 2008, ENVIRON HEALTH PERSP, V116, P963, DOI 10.1289/ehp.11094; Fei DL, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-58; Fry RC, 2007, PLOS GENET, V3, P2180, DOI 10.1371/journal.pgen.0030207; Furuya M, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/123717; Gosse JA, 2014, J APPL TOXICOL, V34, P498, DOI 10.1002/jat.2898; Guan H, 2012, BIOL TRACE ELEM RES, V149, P10, DOI 10.1007/s12011-012-9396-7; He WJ, 2007, TOXICOL SCI, V99, P244, DOI 10.1093/toxsci/kfm162; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hsueh YM, 1998, ATHEROSCLEROSIS, V141, P249, DOI 10.1016/S0021-9150(98)00178-6; Illsley NP, 2000, PLACENTA, V21, P14, DOI 10.1053/plac.1999.0448; Intarasunanont P, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-31; Jauniaux E, 2003, AM J PATHOL, V162, P115, DOI 10.1016/S0002-9440(10)63803-5; Jebbink J, 2011, HYPERTENSION, V58, P70, DOI 10.1161/HYPERTENSIONAHA.110.164079; Kile ML, 2012, ENVIRON HEALTH PERSP, V120, P1061, DOI 10.1289/ehp.1104173; Leonce J, 2006, PLACENTA, V27, pS103, DOI 10.1016/j.placenta.2006.02.006; Liu J, 2001, TOXICOL SCI, V61, P314, DOI 10.1093/toxsci/61.2.314; Liu J, 2007, TOXICOL APPL PHARM, V220, P284, DOI 10.1016/j.taap.2007.01.018; Lu FX, 2007, AM J OBSTET GYNECOL, V197, pS141, DOI 10.1016/j.ajog.2007.10.558; Makris A, 2007, KIDNEY INT, V71, P977, DOI 10.1038/sj.ki.5002175; McDermott S, 2012, SPAT SPATIO-TEMPORAL, V3, P265, DOI 10.1016/j.sste.2012.05.001; Muralimanoharan S, 2013, PLACENTA, V34, P1183, DOI 10.1016/j.placenta.2013.09.015; Neter J., 1996, APPL LINEAR REGRESSI; Ojeda NB, 2007, AM J PHYSIOL-REG I, V292, pR758, DOI 10.1152/ajpregu.00311.2006; Pi JB, 2002, ENVIRON HEALTH PERSP, V110, P331, DOI 10.1289/ehp.02110331; Pi JB, 2000, FREE RADICAL BIO MED, V28, P1137, DOI 10.1016/S0891-5849(00)00209-4; Pilsner JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037147; Rajakumar A, 2005, PLACENTA, V26, P563, DOI 10.1016/j.placenta.2004.09.001; Schoeters G, 2012, INT J HYG ENVIR HEAL, V215, P102, DOI 10.1016/j.ijheh.2011.11.006; Schroijen C, 2008, CHEMOSPHERE, V71, P1317, DOI 10.1016/j.chemosphere.2007.11.053; States JC, 2009, TOXICOL SCI, V107, P312, DOI 10.1093/toxsci/kfn236; Tchounwou PB, 2003, TOXICOL PATHOL, V31, P575, DOI 10.1080/01926230390242007; Tsai SH, 2001, TOXICOL LETT, V123, P11, DOI 10.1016/S0378-4274(01)00373-3; Tseng CH, 2007, J ENVIRON BIOL, V28, P349; Vahter M, 2002, TOXICOLOGY, V181, P211, DOI 10.1016/S0300-483X(02)00285-8; Vahter ME, 2007, J NUTR, V137, P2798, DOI 10.1093/jn/137.12.2798; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang CH, 2002, CIRCULATION, V105, P1804, DOI 10.1161/01.CIR.0000015862.64816.B2; Wang TS, 1996, J CELL PHYSIOL, V169, P256, DOI 10.1002/(SICI)1097-4652(199611)169:2<256::AID-JCP5>3.0.CO;2-N; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wilson D, 2012, J ENVIRON HEALTH, V75, P14; Xie YX, 2007, TOXICOLOGY, V236, P7, DOI 10.1016/j.tox.2007.03.021; Xu Lei, 2011, Nihon Koshu Eisei Zasshi, V58, P89; Zhong CXY, 2001, TOXICOL LETT, V122, P223, DOI 10.1016/S0378-4274(01)00365-4	55	24	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92677	10.1371/journal.pone.0092677	http://dx.doi.org/10.1371/journal.pone.0092677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664213	Green Published, gold			2022-12-27	WOS:000333459900096
J	Clark, CJ; Everson-Rose, SA; Alonso, A; Spencer, RA; Brady, SS; Resnick, MD; Borowsky, IW; Connett, JE; Krueger, RF; Suglia, SF				Clark, Cari Jo; Everson-Rose, Susan A.; Alonso, Alvaro; Spencer, Rachael A.; Brady, Sonya S.; Resnick, Michael D.; Borowsky, Iris W.; Connett, John E.; Krueger, Robert F.; Suglia, Shakira F.			Effect of Partner Violence in Adolescence and Young Adulthood on Blood Pressure and Incident Hypertension	PLOS ONE			English	Article							PHYSICAL HEALTH CONSEQUENCES; SEX-DIFFERENCES; HELP-SEEKING; INTIMATE; WOMEN; AMERICAN; STRESS; REACTIVITY; DISEASE; FORMS	Intimate partner violence has adverse health consequences, but little is known about its association with hypertension. This study investigates sex differences in the relationship between intimate partner violence and blood pressure outcomes. Data included 9,699 participants from waves 3 (2001-02) and 4 (2008-09) of the National Longitudinal Study of Adolescent Health (51% female). Systolic (SBP) and diastolic (DBP) blood pressure and incident hypertension (SBP >= 140 mmHg, DBP >= 90 mmHg, or taking antihypertensive medication) were ascertained at wave 4. Intimate partner violence was measured at wave 3 with 8 items from the revised Conflict Tactics Scales. Separate victimization and perpetration scores were calculated. Sex-specific indicators of severe victimization and perpetration were created using the 66th percentile among those exposed as a cut point. Sex-specific, linear and logistic regression models were developed adjusting for age, race, financial stress, and education. Thirty-three percent of men and 47% of women reported any intimate partner violence exposure; participants were categorized as having: no exposure, moderate victimization and / or perpetration only, severe victimization, severe perpetration, and severe victimization and perpetration. Men experiencing severe perpetration and victimization had a 2.66 mmHg (95% CI: 0.05, 5.28) higher SBP and a 59% increased odds (OR: 1.59, 95% CI: 1.07, 2.37) of incident hypertension compared to men not exposed to intimate partner violence. No other category of violence was associated with blood pressure outcomes in men. Intimate partner violence was not associated with blood pressure outcomes in women. Intimate partner violence may have long-term consequences for men's hemodynamic health. Screening men for victimization and perpetration may assist clinicians to identify individuals at increased risk of hypertension.	[Clark, Cari Jo; Everson-Rose, Susan A.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Clark, Cari Jo; Alonso, Alvaro; Brady, Sonya S.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Clark, Cari Jo; Everson-Rose, Susan A.] Univ Minnesota, Program Hlth Dispar Res, Minneapolis, MN USA; [Spencer, Rachael A.] Independent Researcher, Atlanta, GA USA; [Resnick, Michael D.; Borowsky, Iris W.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Connett, John E.] Univ Minnesota, Biostat Design & Anal Ctr, Div Biostat, Minneapolis, MN USA; [Krueger, Robert F.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Suglia, Shakira F.] Columbia Univ, Dept Epidemiol, New York, NY USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Columbia University	Clark, CJ (corresponding author), Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.	cjclark@umn.edu	Clark, Cari Jo/P-1856-2018; Alonso, Alvaro/A-4917-2010; Everson-Rose, Susan A/L-7582-2017	Clark, Cari Jo/0000-0002-9959-5221; Alonso, Alvaro/0000-0002-2225-8323; Everson-Rose, Susan/0000-0002-9839-2537; Brady, Sonya/0000-0001-8660-9308; Borowsky, Iris/0000-0001-6451-7779	National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) [8UL1TR000114-02]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [R03HD068045-02, P01-HD31921]; Centers for Disease Control and Prevention [5U48DP001939]; National Institute on Minority Health and Health Disparities [1P60MD003422]; Program in Health Disparities Research; Applied Clinical Research Program at the University of Minnesota; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD068045, P01HD031921] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114, KL2TR000113] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP001939] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P60MD003422] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences of the National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Program in Health Disparities Research; Applied Clinical Research Program at the University of Minnesota; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH), Award Number 8UL1TR000114-02 (Drs. Clark and Connett). Dr. Clark was additionally funded in part by grant number R03HD068045-02 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Dr. Resnick was supported in part by Cooperative Agreement Number 5U48DP001939 from the Centers for Disease Control and Prevention. Dr. Everson-Rose was supported in part by grant 1P60MD003422 from the National Institute on Minority Health and Health Disparities. Additional support was provided by the Program in Health Disparities Research and the Applied Clinical Research Program (Drs. Clark and Dr. Everson-Rose) at the University of Minnesota. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Centers for Disease Control and Prevention. The National Longitudinal Study of Adolescent Health was funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackard Diann M, 2003, J Gend Specif Med, V6, P39; Archer J, 2000, PSYCHOL BULL, V126, P651, DOI [10.1037/0033-2909.126.5.651, 10.1037//0033-2909.126.5.651]; Barnett RC, 2005, ANN BEHAV MED, V30, P36, DOI 10.1207/s15324796abm3001_5; Black M.C., 2011, NATL INTIMATE PARTNE; Bonomi AE, 2009, ARCH INTERN MED, V169, P1692, DOI 10.1001/archinternmed.2009.292; Breiding MJ, 2008, ANN EPIDEMIOL, V18, P538, DOI 10.1016/j.annepidem.2008.02.005; Campbell J, 2002, ARCH INTERN MED, V162, P1157, DOI 10.1001/archinte.162.10.1157; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Catalano S, 2011, INTIMATE PARTNER VIO; Chantala K., 2010, STRATEGIES PERFORM D, P19; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Chyu L, 2011, BIODEMOGR SOC BIOL, V57, P184, DOI 10.1080/19485565.2011.614572; Coker AL, 2000, AM J PREV MED, V19, P316, DOI 10.1016/S0749-3797(00)00239-7; Coker AL, 2000, ARCH FAM MED, V9, P451, DOI 10.1001/archfami.9.5.451; Din-Dzietham R, 2007, CIRCULATION, V116, P1488, DOI 10.1161/CIRCULATIONAHA.106.683243; Entzel P., 2009, ADD HLTH WAVE 4 DOCU, DOI 10.17615/C6HM11; Flicker SM, 2011, VIOLENCE AGAINST WOM, V17, P1067, DOI 10.1177/1077801211414846; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Halpern CT, 2009, J ADOLESCENT HEALTH, V45, P508, DOI 10.1016/j.jadohealth.2009.03.011; Hamby S, 2009, PSYCHOL TRAUMA-US, V1, P24, DOI 10.1037/a0015066; Harris K.M., 2008, NATL LONGITUDINAL ST; Kajantie E, 2006, PSYCHONEUROENDOCRINO, V31, P151, DOI 10.1016/j.psyneuen.2005.07.002; Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Lown EA, 2001, PSYCHOSOM MED, V63, P352, DOI 10.1097/00006842-200105000-00004; Mason SM, 2012, ANN EPIDEMIOL, V22, P562, DOI 10.1016/j.annepidem.2012.05.003; Nealey-Moore JB, 2007, J BEHAV MED, V30, P505, DOI 10.1007/s10865-007-9124-5; Ordaz S, 2012, PSYCHONEUROENDOCRINO, V37, P1135, DOI 10.1016/j.psyneuen.2012.01.002; Paulozzi Leonard, 2012, Morbidity and Mortality Weekly Report, V61, P10; Ruiz-Perez I, 2007, EUR J PUBLIC HEALTH, V17, P437, DOI 10.1093/eurpub/ckl280; Straus M A, 1999, Clin Child Fam Psychol Rev, V2, P55, DOI 10.1023/A:1021891529770; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Suglia SF, 2008, J TRAUMA STRESS, V21, P479, DOI 10.1002/jts.20362; Suglia SF, 2010, PSYCHOL TRAUMA-US, V2, P326, DOI 10.1037/a0018953; Tabor J, 2010, ADD HLTH WAVE 4 DOCU; Tjaden P., 2000, 183781 NCJ US DEP JU; Tjaden P.G., 2000, FULL REPORT PREVALEN; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Vives-Cases C, 2011, J PUBLIC HEALTH-UK, V33, P15, DOI 10.1093/pubmed/fdq101; Whitaker DJ, 2007, AM J PUBLIC HEALTH, V97, P941, DOI 10.2105/AJPH.2005.079020; Williams SL, 2005, SEX ROLES, V52, P771, DOI 10.1007/s11199-005-4198-4; Wright RJ, 2010, J EPIDEMIOL COMMUN H, V64, P630, DOI 10.1136/jech.2009.090795	44	17	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92204	10.1371/journal.pone.0092204	http://dx.doi.org/10.1371/journal.pone.0092204			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6GL	24658452	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300060
J	Gjersoe, NL; Newman, GE; Chituc, V; Hood, B				Gjersoe, Nathalia L.; Newman, George E.; Chituc, Vladimir; Hood, Bruce			Individualism and the Extended-Self: Cross-Cultural Differences in the Valuation of Authentic Objects	PLOS ONE			English	Article							UNITED-STATES; CHILDREN; JUDGMENTS; CONTAGION; CAUSATION; THINKING; BELIEFS	The current studies examine how valuation of authentic items varies as a function of culture. We find that U.S. respondents value authentic items associated with individual persons (a sweater or an artwork) more than Indian respondents, but that both cultures value authentic objects not associated with persons (a dinosaur bone or a moon rock) equally. These differences cannot be attributed to more general cultural differences in the value assigned to authenticity. Rather, the results support the hypothesis that individualistic cultures place a greater value on objects associated with unique persons and in so doing, offer the first evidence for how valuation of certain authentic items may vary cross-culturally.	[Gjersoe, Nathalia L.] Open Univ, Fac Educ, Milton Keynes MK7 6AA, Bucks, England; [Newman, George E.] Yale Univ, Sch Management, New Haven, CT USA; [Chituc, Vladimir] Yale Univ, Sch Psychol, New Haven, CT USA; [Hood, Bruce] Univ Bristol, Bristol Cognit Dev Ctr, Bristol, Gols, England	Open University - UK; Yale University; Yale University; University of Bristol	Gjersoe, NL (corresponding author), Open Univ, Fac Educ, Milton Keynes MK7 6AA, Bucks, England.	Nathalia.Gjersoe@open.ac.uk		hood, bruce/0000-0001-7258-981X	Immortality Project	Immortality Project	Funding for publication has been provided by a research grant from the Immortality Project, administered by UC Riverside, to the first and last authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argo JJ, 2008, J MARKETING RES, V45, P690, DOI 10.1509/jmkr.45.6.690; Argo JJ, 2006, J MARKETING, V70, P81, DOI 10.1509/jmkg.70.2.81; Armstrong D., 1980, TIME CAUSE, P67, DOI DOI 10.1007/978-94-017-3528-5_5; BELK RW, 1988, J CONSUM RES, V15, P139, DOI 10.1086/209154; Bloom P, 2010, PLEASURE WORKS NEW S; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Dittmar H., 1992, SOCIAL PSYCHOL MAT P; Frazer JG, 1895, GOLDEN BOUGH STUDY M; Frazier BN, 2009, J COGN CULT, V9, P1, DOI 10.1163/156853709X414601; Frazier BN, 2009, COGNITIVE DEV, V24, P284, DOI 10.1016/j.cogdev.2009.06.003; Gelman SA, 2012, CHILD DEV, V83, P1732, DOI 10.1111/j.1467-8624.2012.01806.x; Hejmadi A, 2004, DEV PSYCHOL, V40, P467, DOI 10.1037/0012-1649.40.4.467; Hofstede G., 1980, CULTURES CONSEQUENCE; Hood B, 2012, COGNITION, V125, P466, DOI 10.1016/j.cognition.2012.07.005; Hood BM, 2008, COGNITION, V106, P455, DOI 10.1016/j.cognition.2007.01.012; Hood Bruce M., 2009, SUPERSENSE WHY WE BE; James W, 1890, PRINCIPLES PSYCHOL, V1; Kitayama S., 1995, JPN J EXP SOC PSYCHO, V35, P133, DOI 10.2130/jjesp.35.133; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Marriott M., 1976, T MEANING DIRECTIONS; Meyer M, 2013, COGNITIVE SCI, V37, P668, DOI 10.1111/cogs.12023; NEMEROFF C, 1994, ETHOS, V22, P158, DOI 10.1525/eth.1994.22.2.02a00020; Newman GE, 2012, J EXP PSYCHOL GEN, V141, P558, DOI 10.1037/a0026035; Newman GE, 2011, J CONSUM RES, V38, P215, DOI 10.1086/658999; NOZICK R, 1981, PHILOS EXPLANATIONS; O'Guinn T., 1991, HIGHWAYS BUYWAYS NAT, P102; Pronin E, 2006, J PERS SOC PSYCHOL, V91, P218, DOI 10.1037/0022-3514.91.2.218; Rosengren K. S., 2000, IMAGINING IMPOSSIBLE; Rozin Paul., 2002, HEURISTICS BIASES PS, P201, DOI DOI 10.1017/CBO9780511808098.013; SAMPSON EE, 1988, AM PSYCHOL, V43, P15, DOI 10.1037/0003-066X.43.1.15; Shoemaker S., 1979, MIDWEST STUD PHILOS, V4, P321, DOI DOI 10.1111/J.1475-4975.1979.TB00384.X; Sinha J.B.P., 1987, GROWTH PROGR CROSS C, P123; Sinha JBP, 2002, INT J PSYCHOL, V37, P309, DOI 10.1080/00207590244000124; Subbotsky E, 2004, BRIT J DEV PSYCHOL, V22, P123, DOI 10.1348/026151004772901140; Triandis H. C., 1998, M INT ASS CROSS CULT; Triandis H. C., 1995, INDIVIDUALISM COLLEC, DOI 10.4324/9780429499845; Triandis H.C., 1997, NEW PERSPECTIVES INT, P13; Triandis HC, 2000, INT J PSYCHOL, V35, P145, DOI 10.1080/002075900399448; Verma J, 1999, LATEST CONTRIBUTIONS, P228; World Resources Institute website, 2005, WHAT CAN YOU BUY DOL	40	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e90787	10.1371/journal.pone.0090787	http://dx.doi.org/10.1371/journal.pone.0090787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6GL	24658437	Green Published, gold, Green Accepted			2022-12-27	WOS:000333355300021
J	AbdElgawad, H; Peshev, D; Zinta, G; Van den Ende, W; Janssens, IA; Asard, H				AbdElgawad, Hamada; Peshev, Darin; Zinta, Gaurav; Van den Ende, Wim; Janssens, Ivan A.; Asard, Han			Climate Extreme Effects on the Chemical Composition of Temperate Grassland Species under Ambient and Elevated CO2: A Comparison of Fructan and Non-Fructan Accumulators	PLOS ONE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; ULTRAVIOLET-B RADIATION; LOLIUM-PERENNE L.; SUCROSE SYNTHASE; LITTER DECOMPOSITION; LOTUS-CORNICULATUS; SHORTGRASS STEPPE; CONDENSED TANNIN; WATER-STRESS; ROOT-GROWTH	Elevated CO2 concentrations and extreme climate events, are two increasing components of the ongoing global climatic change factors, may alter plant chemical composition and thereby their economic and ecological characteristics, e.g. nutritional quality and decomposition rates. To investigate the impact of climate extremes on tissue quality, four temperate grassland species: the fructan accumulating grasses Lolium perenne, Poa pratensis, and the nitrogen (N) fixing legumes Medicago lupulina and Lotus corniculatus were subjected to water deficit at elevated temperature (+3 degrees C), under ambient CO2 (392 ppm) and elevated CO2 (620 ppm). As a general observation, the effects of the climate extreme were larger and more ubiquitous in combination with elevated CO2. The imposed climate extreme increased non-structural carbohydrate and phenolics in all species, whereas it increased lignin in legumes and decreased tannins in grasses. However, there was no significant effect of climate extreme on structural carbohydrates, proteins, lipids and mineral contents and stoichiometric ratios. In combination with elevated CO2, climate extreme elicited larger increases in fructan and sucrose content in the grasses without affecting the total carbohydrate content, while it significantly increased total carbohydrates in legumes. The accumulation of carbohydrates in legumes was accompanied by higher activity of sucrose phosphate synthase, sucrose synthase and ADP-Glc pyrophosphorylase. In the legumes, elevated CO2 in combination with climate extreme reduced protein, phosphorus (P) and magnesium (Mg) contents and the total element: N ratio and it increased phenol, lignin, tannin, carbon (C), nitrogen (N) contents and C:N, C:P and N: P ratios. On the other hand, the tissue composition of the fructan accumulating grasses was not affected at this level, in line with recent views that fructans contribute to cellular homeostasis under stress. It is speculated that quality losses will be less prominent in grasses (fructan accumulators) than legumes under climate extreme and its combination with elevated CO2 conditions.	[AbdElgawad, Hamada; Zinta, Gaurav; Asard, Han] Univ Antwerp, Dept Biol, Lab Mol Plant Physiol & Biotechnol, B-2020 Antwerp, Belgium; [Peshev, Darin; Van den Ende, Wim] Katholieke Univ Leuven, Plant Mol Biol Lab, Leuven, Belgium; [Zinta, Gaurav; Janssens, Ivan A.] Univ Antwerp, Dept Biol, Res Grp Plant & Vegetat Ecol, Antwerp, Belgium	University of Antwerp; KU Leuven; University of Antwerp	Asard, H (corresponding author), Univ Antwerp, Dept Biol, Lab Mol Plant Physiol & Biotechnol, B-2020 Antwerp, Belgium.	han.asard@ua.ac.be	Van Den Ende, Wim/I-6899-2013; Campos, Gustavo R C Ribeiro/O-3981-2017; Zinta, Gaurav/A-1530-2015; Janssens, Ivan A/P-1331-2014; AbdElgawad, Hamada/N-2488-2017	Van Den Ende, Wim/0000-0003-1137-3614; Zinta, Gaurav/0000-0002-5503-8618; Janssens, Ivan A/0000-0002-5705-1787; AbdElgawad, Hamada/0000-0001-9764-9006	University of Antwerp [GOA-BOF-UA-2007]	University of Antwerp	This research was funded by the University of Antwerp concerted research project "Changes in the stress sensitivity of plants and ecosystems under climate change conditions'' (GOA-BOF-UA-2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2002, GLOBAL CHANGE BIOL, V8, P695, DOI 10.1046/j.1365-2486.2002.00498.x; ANURAGA M, 1993, AUST J AGR RES, V44, P1667, DOI 10.1071/AR9931667; Barbehenn RV, 2004, GLOBAL CHANGE BIOL, V10, P1565, DOI 10.1111/j.1365-2486.2004.00833.x; Baroja-Fernandez E, 2009, PLANT CELL PHYSIOL, V50, P1651, DOI 10.1093/pcp/pcp108; Billings SA, 2003, GLOBAL CHANGE BIOL, V9, P729, DOI 10.1046/j.1365-2486.2003.00608.x; Bolouri Moghaddam MR, 2013, J EXP BOT, V64, P1439, DOI 10.1093/jxb/ert046; Carlier L, 2009, NOT BOT HORTI AGROBO, V37, P25; Carter EB, 1999, J SCI FOOD AGR, V79, P1431, DOI 10.1002/(SICI)1097-0010(199908)79:11&lt;1431::AID-JSFA384&gt;3.0.CO;2-4; CHERNEY J. H., 2007, FORAGE QUALITY PERSP; Ciais P, 2011, GLOBAL CHANGE BIOL, V17, P320, DOI 10.1111/j.1365-2486.2010.02341.x; DaMatta FM, 2010, FOOD RES INT, V43, P1814, DOI 10.1016/j.foodres.2009.11.001; De Boeck HJ, 2006, PLANT SOIL, V288, P249, DOI 10.1007/s11104-006-9112-5; De Boeck HJ, 2011, NEW PHYTOL, V189, P806, DOI 10.1111/j.1469-8137.2010.03515.x; De Souza AP, 2008, PLANT CELL ENVIRON, V31, P1116, DOI 10.1111/j.1365-3040.2008.01822.x; Delzenne NM, 2001, AM J CLIN NUTR, V73, p456S, DOI 10.1093/ajcn/73.2.456s; Devacht S, 2011, PHOTOSYNTHETICA, V49, P161, DOI 10.1007/s11099-011-0015-1; Ehleringer JR, 2002, INTEGR COMP BIOL, V42, P424, DOI 10.1093/icb/42.3.424; Erice G, 2006, PHYSIOL PLANTARUM, V126, P458, DOI 10.1111/j.1399-3054.2006.00599.x; Farfan-Vignolo ER, 2012, PLANT PHYSIOL BIOCH, V59, P55, DOI 10.1016/j.plaphy.2012.06.014; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Fisher DS, 1999, J ANIM SCI, V77, P762; FOG K, 1988, BIOL REV, V63, P433, DOI 10.1111/j.1469-185X.1988.tb00725.x; GALTIER N, 1995, J EXP BOT, V46, P1335, DOI 10.1093/jxb/46.special_issue.1335; Geigenberger P, 1997, PLANTA, V201, P502, DOI 10.1007/s004250050095; Goverde M, 2002, BASIC APPL ECOL, V3, P221, DOI 10.1078/1439-1791-00095; Griggs D. J., 2002, WEATHER, V57, P267; HAGERMAN AE, 1978, J AGR FOOD CHEM, V26, P809, DOI 10.1021/jf60218a027; Hay R K M, 2006, PHYSL CROP YIELD, V2; Jackson KG, 1999, BRIT J NUTR, V82, P23, DOI 10.1017/S0007114599001087; King JY, 2004, ECOSYSTEMS, V7, P147, DOI 10.1007/s10021-003-0201-5; Kinmonth-Schultz H, 2011, FUNCT PLANT BIOL, V38, P797, DOI 10.1071/FP11060; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; Kraus TEC, 2003, PLANT SOIL, V256, P41, DOI 10.1023/A:1026206511084; Larsen KS, 2011, GLOBAL CHANGE BIOL, V17, P1884, DOI 10.1111/j.1365-2486.2010.02351.x; Larson SR, 2007, MOL BREEDING, V20, P331, DOI 10.1007/s11032-007-9095-9; Le Martret B, 2011, PLANT BIOTECHNOL J, V9, P661, DOI 10.1111/j.1467-7652.2011.00611.x; Lee TD, 2003, PLANT SOIL, V255, P475, DOI 10.1023/A:1026072130269; Li ZM, 2012, J EXP BOT, V63, P1155, DOI 10.1093/jxb/err329; Liao JX, 2002, FUNCT PLANT BIOL, V29, P891, DOI 10.1071/PP01168; Lin CC, 2001, J PLANT PHYSIOL, V158, P667, DOI 10.1078/0176-1617-00245; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luomala EM, 2005, PLANT CELL ENVIRON, V28, P733, DOI 10.1111/j.1365-3040.2005.01319.x; MANSELL RL, 1974, PHYTOCHEMISTRY, V13, P2427, DOI 10.1016/S0031-9422(00)86917-4; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Milchunas DG, 2005, AGR ECOSYST ENVIRON, V111, P166, DOI 10.1016/j.agee.2005.06.014; Miller LA, 2001, GRASS FORAGE SCI, V56, P383, DOI 10.1046/j.1365-2494.2001.00288.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Moore BD, 1997, PLANT PHYSIOL, V115, P241, DOI 10.1104/pp.115.1.241; MORELL M, 1985, PLANT PHYSIOL, V78, P149, DOI 10.1104/pp.78.1.149; Mueller-Harvey I, 2006, J SCI FOOD AGR, V86, P2010, DOI 10.1002/jsfa.2577; Munoz FJ, 2005, PLANT CELL PHYSIOL, V46, P1366, DOI 10.1093/pcp/pci148; Muntifering RB, 2006, FUNCT ECOL, V20, P269, DOI 10.1111/j.1365-2435.2006.01093.x; Naudts K, 2013, PLANT SOIL, V369, P497, DOI 10.1007/s11104-013-1595-2; NEUHAUS HE, 1990, PLANTA, V181, P583, DOI 10.1007/BF00193014; Novotny AM, 2007, OECOLOGIA, V151, P687, DOI 10.1007/s00442-006-0599-5; Oh MM, 2009, J PLANT PHYSIOL, V166, P180, DOI 10.1016/j.jplph.2008.04.015; Oliveira VF, 2013, PLANT BIOLOGY, V15, P471, DOI 10.1111/j.1438-8677.2012.00654.x; Perkins MC, 2004, ARCH INSECT BIOCHEM, V55, P153, DOI 10.1002/arch.10133; Peshev D, 2013, J EXP BOT, V64, P1025, DOI 10.1093/jxb/ers377; PILONSMITS EAH, 1995, PLANT PHYSIOL, V107, P125, DOI 10.1104/pp.107.1.125; Poorter H, 1997, PLANT CELL ENVIRON, V20, P472, DOI 10.1046/j.1365-3040.1997.d01-84.x; Powell MC, 2003, ENVIRON POLLUT, V122, P313, DOI 10.1016/S0269-7491(02)00331-7; Prasad PVV, 2004, PLANT SCI, V166, P1565, DOI 10.1016/j.plantsci.2004.02.009; PREISS J, 2009, FOOD SCI TECH-INT SE, P83; Ramel F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-450; Read JJ, 1997, ANN BOT-LONDON, V79, P197, DOI 10.1006/anbo.1996.0331; Reddy KR, 2004, PHOTOCHEM PHOTOBIOL, V79, P416, DOI 10.1562/2003-11-19-RA.1; Refregier G, 2004, PLANT PHYSIOL, V135, P959, DOI 10.1104/pp.104.038711; Ritsema T, 2003, CURR OPIN PLANT BIOL, V6, P223, DOI 10.1016/S1369-5266(03)00034-7; Rogers A, 2006, PLANT CELL ENVIRON, V29, P1651, DOI 10.1111/j.1365-3040.2006.01549.x; Roitsch T, 2003, J EXP BOT, V54, P513, DOI 10.1093/jxb/erg050; Roumet C, 1999, NEW PHYTOL, V143, P73, DOI 10.1046/j.1469-8137.1999.00437.x; Runion GB, 1999, TREE PHYSIOL, V19, P329; Sanz-Saez A, 2012, J PLANT PHYSIOL, V169, P782, DOI 10.1016/j.jplph.2012.01.010; Schade JD, 2003, ECOL LETT, V6, P96, DOI 10.1046/j.1461-0248.2003.00409.x; Scholz-Ahrens KE, 2001, AM J CLIN NUTR, V73, p459S, DOI 10.1093/ajcn/73.2.459s; Sharma PK, 1998, PLANT SCI, V132, P21, DOI 10.1016/S0168-9452(97)00266-5; Storeheier PV, 2002, LICHENOLOGIST, V34, P247, DOI 10.1006/lich.2002.0394; Sun L, 2014, MOL PLANT PATHOL, V15, P161, DOI 10.1111/mpp.12078; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Taub DR, 2008, GLOBAL CHANGE BIOL, V14, P565, DOI 10.1111/j.1365-2486.2007.01511.x; Teng NJ, 2006, NEW PHYTOL, V172, P92, DOI 10.1111/j.1469-8137.2006.01818.x; THOMAS H, 1991, NEW PHYTOL, V118, P35, DOI 10.1111/j.1469-8137.1991.tb00563.x; Torbert HA, 2004, FIELD CROP RES, V88, P57, DOI 10.1016/j.fcr.2003.11.011; Turunen M, 2009, POLAR BIOL, V32, P813, DOI 10.1007/s00300-009-0609-2; Van den Ende W, 2013, ENV EXP BOT IN PRESS; Van den Ende W, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00247; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; Vandoorne B, 2012, J EXP BOT, V63, P4359, DOI 10.1093/jxb/ers095; Vergauwen R, 2000, J EXP BOT, V51, P1261, DOI 10.1093/jexbot/51.348.1261; Verspreet J, 2012, J AGR FOOD CHEM, V60, P2102, DOI 10.1021/jf204774n; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; Warren JM, 2003, TREE PHYSIOL, V23, P527, DOI 10.1093/treephys/23.8.527; Xu ZZ, 2006, PLANTA, V224, P1080, DOI 10.1007/s00425-006-0281-5; Zhang DQ, 2008, J PLANT ECOL, V1, P85, DOI 10.1093/jpe/rtn002; Zhang Q, 2006, J APPL PHYCOL, V18, P445, DOI 10.1007/s10811-006-9048-4	96	62	64	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92044	10.1371/journal.pone.0092044	http://dx.doi.org/10.1371/journal.pone.0092044			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670435	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677000030
J	Dejmal, M; Lisa, L; Nyvltova, MF; Bajer, A; Petr, L; Kocar, P; Kocarova, R; Nejman, L; Rybnicek, M; Suvova, Z; Culp, R; Vavrcik, H				Dejmal, Miroslav; Lisa, Lenka; Nyvltova, Miriam Fisakova; Bajer, Ales; Petr, Libor; Kocar, Petr; Kocarova, Romana; Nejman, Ladislav; Rybnicek, Michal; Suvova, Zdenka; Culp, Randy; Vavrcik, Hanus			Medieval Horse Stable; The Results of Multi Proxy Interdisciplinary Research	PLOS ONE			English	Article							CARBON ISOTOPES; SEDIMENTS; TURNOVER; HOUSES; HAIR; DIET	A multi proxy approach was applied in the reconstruction of the architecture of Medieval horse stable architecture, the maintenance practices associated with that structure as well as horse alimentation at the beginning of 13th century in Central Europe. Finally, an interpretation of the local vegetation structure along Morava River, Czech Republic is presented. The investigated stable experienced two construction phases. The infill was well preserved and its composition reflects maintenance practices. The uppermost part of the infill was composed of fresh stabling, which accumulated within a few months at the end of summer. Horses from different backgrounds were kept in the stable and this is reflected in the results of isotope analyses. Horses were fed meadow grasses as well as woody vegetation, millet, oat, and less commonly hemp, wheat and rye. Three possible explanations of stable usage are suggested. The stable was probably used on a temporary basis for horses of workers employed at the castle, courier horses and horses used in battle.	[Dejmal, Miroslav] Archaia Brno Ops, Brno, Czech Republic; [Lisa, Lenka; Petr, Libor] AS CR, Inst Geol, Vvi, Prague, Czech Republic; [Nyvltova, Miriam Fisakova] AS CR, Inst Archaeol, Vvi, Brno, Czech Republic; [Bajer, Ales; Rybnicek, Michal; Vavrcik, Hanus] Mendel Univ Brno, Fac Forestry & Wood Technol, Brno, Czech Republic; [Petr, Libor; Kocar, Petr; Kocarova, Romana; Suvova, Zdenka] Univ Western Bohemia, Dept Archaeol, Plzen, Czech Republic; [Nejman, Ladislav] Univ Georgia, Ctr Appl Isotope Studies, Athens, GA 30602 USA; [Culp, Randy] Univ Queensland, Sch Social Sci, St Lucia, Qld, Australia	Czech Academy of Sciences; Institute of Geology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Archaeology of the Czech Academy of Sciences - Brno; Mendel University in Brno; University of West Bohemia Pilsen; University System of Georgia; University of Georgia; University of Queensland	Lisa, L (corresponding author), AS CR, Inst Geol, Vvi, Prague, Czech Republic.	lisa@gli.cas.cz	Petr, Libor/N-2066-2014; Vavrčík, Hanuš/B-4751-2014; Petr, Libor/AAA-9154-2019; Lisa, Lenka/I-8777-2014; Kocar, Petr/H-9731-2014; Bajer, Ales/B-8877-2014; Dejmal, Miroslav/AAH-9061-2021; Nývltová Fišáková, Miriam/H-6862-2014; Rybníček, Michal/B-5714-2014	Vavrčík, Hanuš/0000-0001-9386-9554; Petr, Libor/0000-0002-8187-3035; Bajer, Ales/0000-0001-6809-3723; Dejmal, Miroslav/0000-0003-1474-1996; Rybníček, Michal/0000-0003-1299-8923; Nyvltova Fisakova, Miriam/0000-0001-8467-4712; Lisa, Lenka/0000-0003-0823-5448	Czech Grant Agency [P405/11/1729]; grant agency of CR	Czech Grant Agency(Grant Agency of the Czech Republic); grant agency of CR	The research was supported by the Czech Grant Agency project no. P405/11/1729 (Veseli nad Moravou - Medieval Castle in alluvial plain). The grant agency of CR supported financially the analyses, manuscript preparation and publication.	[Anonymous], 1995, ARCHAEOLOGICAL SEDIM; Ayliffe LK, 2004, OECOLOGIA, V139, P11, DOI 10.1007/s00442-003-1479-x; Beranova Magdalena, 2010, DEJINY ZEMEDELSTVI C; Beug H.J, 2004, LEITFADEN POLLENBEST; Bocherens Herve, 2003, Deinsea, V9, P57; Bocherens Herve, 1994, Historical Biology, V7, P187; BROCHIER JE, 1992, J ANTHROPOL ARCHAEOL, V11, P47, DOI 10.1016/0278-4165(92)90010-9; Bullock P., 1983, SOIL MICROMORPHOLOGY; Bullock P., 1985, HDB SOIL THIN SECTIO; Cappers R.T.J., 2009, DIGITAL ATLAS EC PLA; Cappers R. T. J, 2006, DIGITAL SEED ATLAS N; Cerny V, 1932, SBORNIK PRACI VENOVA, P105; Chytry M., 2009, VEGETACE CESKE REPUB; Clark John, 2004, MEDIEVAL HORSE ITS E; Cook E.R., 2013, METHODS DENDROCHRONO; Courty M.A., 1989, SOILS MICROMORPHOLOG; Courty MA, 2001, EARTH SCIENCES AND ARCHAEOLOGY, P205; Curwin E.C., 1953, PLOUGH PASTURE EARLY; Dejmal M, 2012, ARCHAEOLOGIA HIST, V37, P209; Dejmal M., 2011, ARCHAEOLOGIA HIST, V36, P125; Dusek J, 1995, KUN SLUZBACH CLOVEKA; Eis Gerhard, 1939, SCHRIFTEN DTSCH WISS, V9; Ewald J, 1975, BERICHTE GRABUNGEN 1, V2; Friedrich W, 2006, CHATEAU PEUPLEMENT, V22, P163; Goldberg P, 2006, PRACTICAL THEORETICA; Graus F., 1957, DEJINY VENKOVSKEHO L, VII; Graus F, 1953, DEJINY VENKOVSKEHO L; Hajkova P, 2011, PRESLIA, V83, P185; Hejcman M., 2014, HOLOCENE IN PRESS; Hejny S., 1990, KVETENA CESKE REPUBL; Hodder I, 2004, AM ANTIQUITY, V69, P17, DOI 10.2307/4128346; Jacomet S., 1999, ARCHAOBOTANIK AUFGAB; Jarosova M, 2010, GEOL VYZK MOR SLEZ B, V2010, P39; Karkanas P, 2009, ANTIQUITY, V83, P955, DOI 10.1017/S0003598X00099270; Kolar T, 2012, DENDROCHRON IN PRESS, DOI [10.1016/j.dendro.2012.02.002, DOI 10.1016/J.DENDR0.2012.02.002]; Krasa J, 1990, CESKE ILUMINOVANE RU; Kuhtreiber T., 2010, BESTIAL MIRRORS USIN, P66; Kuns L, 2006, OSEDLY ROLNIK ROLNIC; LANGDON J, 1982, AGR HIST REV, V30, P31; Lisa D., 2011, INTERDISCIPLINARIA A, V2, P15; Lisa V., 2008, ARCHAEOLOGICAL SOIL, V30, P67; Macphail RI, 2004, J ARCHAEOL SCI, V31, P175, DOI 10.1016/j.jas.2003.07.005; Madella M, 2005, ANN BOT-LONDON, V96, P253, DOI 10.1093/aob/mci172; Madella M, 1998, J ARCHAEOL SCI, V25, P801, DOI 10.1006/jasc.1997.0226; Matthews W, 1997, WORLD ARCHAEOL, V29, P281, DOI 10.1080/00438243.1997.9980378; Matthews W., 1996, SURFACE CATALHOYUK, P301; Matthews W., 2005, CATALHOYUK PERSPECTI, V40, P125; Matthews W., 1994, WHITHER ENV ARCHAEOL, V38, P171; Matthews W., 1995, ARCHAEOLOGICAL SEDIM, P41; Milek K, 2012, MEDIEV ARCHAEOL, V56, P85, DOI 10.1179/0076609712Z.0000000004; Milek KB, 2012, J ANTHROPOL ARCHAEOL, V31, P119, DOI 10.1016/j.jaa.2011.11.001; Moore P.D., 1991, BLACKWELL SCI PUBLI; Muldner G, 2005, J ARCHAEOL SCI, V32, P39, DOI 10.1016/j.jas.2004.05.007; Nalepka Dorota, 2003, Acta Palaeobotanica, V43, P125; NELSON BK, 1986, GEOCHIM COSMOCHIM AC, V50, P1941, DOI 10.1016/0016-7037(86)90250-4; Niederle L, 1918, MORAVSKE SLOVENSKO S, VI; Novak J, 2012, J ARCHAEOL SCI, V39, P808, DOI 10.1016/j.jas.2011.06.026; Pearsall DM., 2015, PALEOETHNOBOTANY HDB; Piperno DR, 2006, PHYTOLITHS COMPERHAT; radnicek L, 2009, DREVINY CESKE REPUBL; Reille M., 1995, POLLEN SPORES EUROPE; Reille M., 1998, POLLEN SPORES EUROPE; Rodiere M, 1996, CR ACAD SCI II A, V323, P179; Rybnicek M., 2006, Journal of Forest Science (Prague), V52, P141; Schweingruber F. H., 1978, MIKROSKOPISCHE HOLZA; Stepanek L, 1978, USTAJENI ZVIRAT ROLN, V18, P195; Stoops G, 2010, INTERPRETATION OF MICROMORPHOLOGICAL FEATURES OF SOILS AND REGOLITHS, P1; Stoops G., 2003, GUIDELINES ANAL DESC; Vareka J., 2007, LIDOVA ARCHITEKTURA; Wagenfuhr R, 2000, HOLZATLAS ATLAS WOOD; West AG, 2004, FUNCT ECOL, V18, P616, DOI 10.1111/j.0269-8463.2004.00862.x; Zazzo A, 2007, CAN J ZOOL, V85, P1239, DOI 10.1139/Z07-110; Zbranek H, 2013, ZAMECKA JIZDARNA LED	74	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e89273	10.1371/journal.pone.0089273	http://dx.doi.org/10.1371/journal.pone.0089273			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AE0SR	24670874	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000003
J	Lehner, K; Santarelli, F; Vasold, R; Penning, R; Sidoroff, A; Konig, B; Landthaler, M; Baumler, W				Lehner, Karin; Santarelli, Francesco; Vasold, Rudolf; Penning, Randolph; Sidoroff, Alexis; Koenig, Burkhard; Landthaler, Michael; Baeumler, Wolfgang			Black Tattoos Entail Substantial Uptake of Genotoxicpolycyclic Aromatic Hydrocarbons (PAH) in Human Skin and Regional Lymph Nodes	PLOS ONE			English	Article							DIESEL EXHAUST PARTICLES; GENE-EXPRESSION; DNA-ADDUCTS; CANCER; ACTIVATION; CELLS; INKS; CARCINOGENS; METABOLISM; EXPOSURE	Hundreds of millions of people worldwide have tattoos, which predominantly contain black inks consisting of soot products like Carbon Black or polycyclic aromatic hydrocarbons (PAH). We recently found up to 200 mu g/g of PAH in commercial black inks. After skin tattooing, a substantial part of the ink and PAH should be transported to other anatomical sites like the regional lymph nodes. To allow a first estimation of health risk, we aimed to extract and quantify the amount of PAH in black tattooed skin and the regional lymph nodes of pre-existing tattoos. Firstly, we established an extraction method by using HPLC - DAD technology that enables the quantification of PAH concentrations in human tissue. After that, 16 specimens of human tattooed skin and corresponding regional lymph nodes were included in the study. All skin specimen and lymph nodes appeared deep black. The specimens were digested and tested for 20 different PAH at the same time. PAH were found in twelve of the 16 tattooed skin specimens and in eleven regional lymph nodes. The PAH concentration ranged from 0.1-0.6 mu g/cm(2) in the tattooed skin and 0.1-11.8 mu g/g in the lymph nodes. Two major conclusions can be drawn from the present results. Firstly, PAH in black inks stay partially in skin or can be found in the regional lymph nodes. Secondly, the major part of tattooed PAH had disappeared from skin or might be found in other organs than skin and lymph nodes. Thus, beside inhalation and ingestion, tattooing has proven to be an additional, direct and effective route of PAH uptake into the human body.	[Lehner, Karin; Santarelli, Francesco; Landthaler, Michael; Baeumler, Wolfgang] Univ Regensburg, Dept Dermatol, D-93053 Regensburg, Germany; [Vasold, Rudolf; Koenig, Burkhard] Univ Regensburg, Dept Organ Chem, D-93053 Regensburg, Germany; [Penning, Randolph] Univ Munich, Dept Forens Med, Munich, Germany; [Sidoroff, Alexis] Univ Innsbruck, Dept Dermatol & Venereol, A-6020 Innsbruck, Austria	University of Regensburg; University of Regensburg; University of Munich; University of Innsbruck	Baumler, W (corresponding author), Univ Regensburg, Dept Dermatol, D-93053 Regensburg, Germany.	baeumler.wolfgang@klinik.uni-regensburg.de	Koenig, Burkhard/A-1362-2009; Koenig, Burkhard/GRX-2026-2022; Koenig, Burkhard/O-8172-2019	Koenig, Burkhard/0000-0002-6131-4850; Koenig, Burkhard/0000-0002-6131-4850; Koenig, Burkhard/0000-0002-6131-4850	Deutsche Forschungsgemeinschaft (DFG) [BA 1741/3-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (DFG, grant BA 1741/3-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akintobi AM, 2007, TOXICOL APPL PHARM, V220, P9, DOI 10.1016/j.taap.2006.12.002; Benford D, 2010, FOOD CHEM TOXICOL, V48, pS42, DOI 10.1016/j.fct.2009.09.039; BICKERS DR, 1978, J CLIN INVEST, V62, P1061, DOI 10.1172/JCI109211; BIZUB D, 1986, P NATL ACAD SCI USA, V83, P6048, DOI 10.1073/pnas.83.16.6048; Bosetti C, 2007, ANN ONCOL, V18, P431, DOI 10.1093/annonc/mdl172; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; Burchiel SW, 2001, CLIN IMMUNOL, V98, P2, DOI 10.1006/clim.2000.4934; Buters JTM, 1999, P NATL ACAD SCI USA, V96, P1977, DOI 10.1073/pnas.96.5.1977; Davila DR, 1996, TOXICOL APPL PHARM, V139, P333, DOI 10.1006/taap.1996.0173; EC-SCF, 2002, POL AR HYDR OCC FOOD; Engel E, 2010, EXP DERMATOL, V19, P54, DOI 10.1111/j.1600-0625.2009.00925.x; GELBOIN HV, 1980, PHYSIOL REV, V60, P1107, DOI 10.1152/physrev.1980.60.4.1107; Gerde P, 2001, CARCINOGENESIS, V22, P741, DOI 10.1093/carcin/22.5.741; Haftka JJH, 2009, SAR QSAR ENVIRON RES, V20, P221, DOI 10.1080/10629360902949336; [IARC] International Agency for Research on Cancer, 2005, IARC MONOGRAPHS EVAL; IARC (International Agency for Research on Cancer), 2006, IARC MON, V92; Jira W, 2008, FOOD ADDIT CONTAM A, V25, P704, DOI 10.1080/02652030701697769; Kaur RR, 2009, J COSMET DERMATOL-US, V8, P295, DOI 10.1111/j.1473-2165.2009.00469.x; Klugl I, 2010, DERMATOLOGY, V221, P43, DOI 10.1159/000292627; Kluger N, 2012, LANCET ONCOL, V13, pE161, DOI 10.1016/S1470-2045(11)70340-0; KOREEDA M, 1978, SCIENCE, V199, P778, DOI 10.1126/science.622566; Laumann AE, 2006, J AM ACAD DERMATOL, V55, P413, DOI 10.1016/j.jaad.2006.03.026; Lehner K, 2011, J EUR ACAD DERMATOL; Lehner K, 2011, CONTACT DERMATITIS, V65, P231, DOI 10.1111/j.1600-0536.2011.01947.x; Lewtas J, 2007, MUTAT RES-REV MUTAT, V636, P95, DOI 10.1016/j.mrrev.2007.08.003; Matikainen T, 2001, NAT GENET, V28, P355, DOI 10.1038/ng575; Melendez-Colon VJ, 1999, CARCINOGENESIS, V20, P1885, DOI 10.1093/carcin/20.10.1885; Moraitis AG, 2013, ENDOCR PRACT, V19, pE50, DOI 10.4158/EP12092.CR; Nel AE, 1998, J ALLERGY CLIN IMMUN, V102, P539, DOI 10.1016/S0091-6749(98)70269-6; NEWMAN MJ, 1988, J CLIN INVEST, V82, P145, DOI 10.1172/JCI113563; Penning TM, 1999, CHEM RES TOXICOL, V12, P1, DOI 10.1021/tx980143n; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Pratt MM, 2011, INT J ENV RES PUB HE, V8, P2675, DOI 10.3390/ijerph8072675; Regensburger J, 2010, EXP DERMATOL, V19, pE275, DOI 10.1111/j.1600-0625.2010.01068.x; Ren AG, 2011, P NATL ACAD SCI USA, V108, P12770, DOI 10.1073/pnas.1105209108; Schlager A, 2008, BREAST J, V14, P299, DOI 10.1111/j.1524-4741.2008.00578.x; Shimada T, 2004, CANCER SCI, V95, P1, DOI 10.1111/j.1349-7006.2004.tb03162.x; Solhaug A, 2004, CARCINOGENESIS, V25, P809, DOI 10.1093/carcin/bgh069; Tsien A, 1997, TOXICOL APPL PHARM, V142, P256, DOI 10.1006/taap.1996.8063; van Grevenynghe J, 2003, J IMMUNOL, V170, P2374, DOI 10.4049/jimmunol.170.5.2374; Varga E, 2011, J CUTAN PATHOL	41	24	24	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92787	10.1371/journal.pone.0092787	http://dx.doi.org/10.1371/journal.pone.0092787			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670978	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000075
J	Sun, H; Zhang, SX; Zhang, AH; Yan, GL; Wu, XH; Han, Y; Wang, XJ				Sun, Hui; Zhang, Shuxiang; Zhang, Aihua; Yan, Guangli; Wu, Xiuhong; Han, Ying; Wang, Xijun			Metabolomic Analysis of Diet-Induced Type 2 Diabetes Using UPLC/MS Integrated with Pattern Recognition Approach	PLOS ONE			English	Article							RAT MODEL; SERUM	Metabolomics represents an emerging discipline concerned with comprehensive assessment of small molecule endogenous metabolites in biological systems and provides a powerful approach insight into the mechanisms of diseases. Type 2 diabetes (T2D), called the burden of the 21st century, is growing with an epidemic rate. However, its precise molecular mechanism has not been comprehensively explored. In this study, we applied urinary metabolomics based on the UPLC/MS integrated with pattern recognition approaches to discover differentiating metabolites, to characterize and explore metabolic pathway disruption in an experimental model for high-fat-diet induced T2D. Six differentiating urinary metabolites were found in the negative mode, and two (2-(4-hydroxy-3-methoxy-phenyl) acetaldehyde sulfate, 2-phenylethanol glucuronide) of which were identified involving the key metabolic pathways linked to pentose and glucuronate interconversions, starch, sucrose metabolism and tyrosine metabolism. Our study provides new insight into pathophysiologic mechanisms and may enhance the understanding of T2D pathogenesis.	[Sun, Hui; Zhang, Shuxiang; Zhang, Aihua; Yan, Guangli; Wu, Xiuhong; Han, Ying; Wang, Xijun] Heilongjiang Univ Chinese Med, Dept Pharmaceut Anal, Key Lab Metabol & Chinmed, Natl TCM Key Lab Serum Pharmacochem, Harbin, Peoples R China	Heilongjiang University of Chinese Medicine	Wang, XJ (corresponding author), Heilongjiang Univ Chinese Med, Dept Pharmaceut Anal, Key Lab Metabol & Chinmed, Natl TCM Key Lab Serum Pharmacochem, Harbin, Peoples R China.	xijunwangls@126.com	Wang, Xijun/C-4477-2014	Wang, Xijun/0000-0002-0949-3492	Key Program of Natural Science Foundation of State [90709019]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2011BAI03B03, 2011BAI03B06, 2011BAI03B08]; Key Science and Technology Program of Heilongjiang Province, China [GC06C501, GA08C303, GA06C30101]; Foundation of Heilongjiang University of Chinese Medicine [201209]; National Key Subject of Drug Innovation [2009ZX09502-005]	Key Program of Natural Science Foundation of State(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Key Science and Technology Program of Heilongjiang Province, China; Foundation of Heilongjiang University of Chinese Medicine; National Key Subject of Drug Innovation	This work was supported by grants from the Key Program of Natural Science Foundation of State (Grant No. 90709019), National Key Technology Research and Development Program of the Ministry of Science and Technology of China (Grant No. 2011BAI03B03, 2011BAI03B06, 2011BAI03B08), Key Science and Technology Program of Heilongjiang Province, China (Grant No. GC06C501, GA08C303, GA06C30101), Foundation of Heilongjiang University of Chinese Medicine (Grant No. 201209), and National Key Subject of Drug Innovation (Grant No. 2009ZX09502-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai J, 2005, WORLD J GASTROENTERO, V11, P3675, DOI 10.3748/wjg.v11.i24.3675; Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Gjesing AP, 2012, EUR J CLIN INVEST, V42, P579, DOI 10.1111/j.1365-2362.2012.02678.x; Gregory JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063544; Jung Y, 2011, ANALYST, V136, P4222, DOI 10.1039/c1an15403f; Mihalik SJ, 2012, DIABETES CARE, V35, P605, DOI [10.2337/DC11-1577, 10.2337/dc11-1577]; Miura D, 2012, J PROTEOMICS, V75, P5052, DOI 10.1016/j.jprot.2012.02.011; Ng DPK, 2012, DIABETOLOGIA, V55, P499, DOI 10.1007/s00125-011-2339-6; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Rosengren AH, 2010, SCIENCE, V327, P217, DOI 10.1126/science.1176827; Skappak C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065035; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Thwe AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065349; Ugarte M, 2012, GENOME MED, V4, DOI 10.1186/gm334; van Vliet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064545; Wang XJ, 2013, HEPATOLOGY, V57, P2072, DOI 10.1002/hep.26130; Wang XJ, 2012, ANALYST, V137, P4703, DOI 10.1039/c2an35891c; Wang XJ, 2012, MOL CELL PROTEOMICS, V11, P370, DOI 10.1074/mcp.M111.016006; Wang XJ, 2012, J PROTEOME RES, V11, P1284, DOI 10.1021/pr200963e; Wang XJ, 2012, J PROTEOMICS, V75, P1411, DOI 10.1016/j.jprot.2011.11.011; Zhang AH, 2014, J PHYSIOL BIOCHEM, V70, P117, DOI 10.1007/s13105-013-0286-z; Zhang AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064381; Zhang AH, 2012, ANAL BIOANAL CHEM, V404, P1239, DOI 10.1007/s00216-012-6117-1; Zhang AH, 2012, ANALYST, V137, P293, DOI 10.1039/c1an15605e; Zhang SX, 2010, J PHARMACEUT BIOMED, V53, P1011, DOI 10.1016/j.jpba.2010.06.033; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065880	28	22	23	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93384	10.1371/journal.pone.0093384	http://dx.doi.org/10.1371/journal.pone.0093384			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671089	Green Submitted, gold, Green Published			2022-12-27	WOS:000333677000139
J	Flaven-Pouchon, J; Garcia, T; Abed-Vieillard, D; Farine, JP; Ferveur, JF; Everaerts, C				Flaven-Pouchon, Justin; Garcia, Thibault; Abed-Vieillard, Dehbia; Farine, Jean-Pierre; Ferveur, Jean-Francois; Everaerts, Claude			Transient and Permanent Experience with Fatty Acids Changes Drosophila melanogaster Preference and Fitness	PLOS ONE			English	Article							ENVIRONMENT INTERACTIONS; OVIPOSITION BEHAVIOR; FEEDING EXPERIENCE; SITE SELECTION; PREGNANT RATS; HOST; CHOICE; METHYLATION; ADAPTATION; EXPOSURE	Food and host-preference relies on genetic adaptation and sensory experience. In vertebrates, experience with food-related cues during early development can change adult preference. This is also true in holometabolous insects, which undergo a drastic nervous system remodelling during their complete metamorphosis, but remains uncertain in Drosophila melanogaster. We have conditioned D. melanogaster with oleic (C18:1) and stearic (C18:0) acids, two common dietary fatty acids, respectively preferred by larvae and adult. Wild-type individuals exposed either during a transient period of development-from embryo to adult-or more permanently-during one to ten generation cycles-were affected by such conditioning. In particular, the oviposition preference of females exposed to each fatty acid during larval development was affected without cross-effect indicating the specificity of each substance. Permanent exposure to each fatty acid also drastically changed oviposition preference as well as major fitness traits (development duration, sex-ratio, fecundity, adult lethality). This suggests that D. melanogaster ability to adapt to new food sources is determined by its genetic and sensory plasticity both of which may explain the success of this generalist-diet species.	[Flaven-Pouchon, Justin; Garcia, Thibault; Abed-Vieillard, Dehbia; Farine, Jean-Pierre; Ferveur, Jean-Francois; Everaerts, Claude] Univ Bourgogne, UMR INRA 1324, UMR CNRS 6265, Ctr Sci Gout & Alimentat, Dijon, France	INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Ferveur, JF (corresponding author), Univ Bourgogne, UMR INRA 1324, UMR CNRS 6265, Ctr Sci Gout & Alimentat, Dijon, France.	Jean-Francois.ferveur@u-bourgogne.fr; claude.everaerts@u-bourgogne.fr			Centre National de la Recherche Scientifique (INSB); Burgundy Regional Council (PARI); French Ministry of Research and Higher Education	Centre National de la Recherche Scientifique (INSB)(Centre National de la Recherche Scientifique (CNRS)); Burgundy Regional Council (PARI)(Region Bourgogne-Franche-Comte); French Ministry of Research and Higher Education	This work was funded in part by the Centre National de la Recherche Scientifique (INSB), the Burgundy Regional Council (PARI), and the French Ministry of Research and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addinsoft, 2012, XLSTAT 2012 DAT AN S; Akhtar Y, 2003, J CHEM ECOL, V29, P1853, DOI 10.1023/A:1024802328458; ALLOWAY TM, 1972, ANNU REV ENTOMOL, V17, P43, DOI 10.1146/annurev.en.17.010172.000355; Anderson P, 2013, ANIM BEHAV, V85, P1169, DOI 10.1016/j.anbehav.2013.03.002; Ashburner M., 1989, DROSOPHILA LAB HDB; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Barron AB, 2000, ENTOMOL EXP APPL, V94, P159, DOI 10.1023/A:1003998715018; Barron AB, 1999, ANIM BEHAV, V58, P621, DOI 10.1006/anbe.1999.1169; Barron AB, 2001, J INSECT BEHAV, V14, P725, DOI 10.1023/A:1013033332535; Barrozo RB, 2004, CHEM SENSES, V29, P833, DOI 10.1093/chemse/bjh249; Blackiston DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001736; Bosch OJ, 2000, CHEM SENSES, V25, P323, DOI 10.1093/oxfordjournals.chemse.a014042; Burdge GC, 2007, BRIT J NUTR, V97, P435, DOI 10.1017/S0007114507352392; Burns JG, 2012, P NATL ACAD SCI USA, V109, P17239, DOI 10.1073/pnas.1121265109; Cattin MF, 2004, NATURE, V427, P835, DOI 10.1038/nature02327; Colomb J, 2007, ANIM BEHAV, V73, P587, DOI 10.1016/j.anbehav.2006.04.016; Davis JM, 2008, Q REV BIOL, V83, P363, DOI 10.1086/592851; Fougeron AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026899; Fricke C, 2007, EVOLUTION, V61, P440, DOI 10.1111/j.1558-5646.2007.00038.x; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; Grishkevich V, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.19; Gutierrez-Ibanez C, 2007, NATURWISSENSCHAFTEN, V94, P595, DOI 10.1007/s00114-007-0233-3; HERSHBERGER WA, 1967, ANIM BEHAV, V15, P259, DOI 10.1016/0003-3472(67)90008-5; HIRSCH HVB, 1995, ANIM BEHAV, V50, P1211, DOI 10.1016/0003-3472(95)80038-7; HOFFMANN AA, 1988, J INSECT PHYSIOL, V34, P197, DOI 10.1016/0022-1910(88)90050-9; Hussein N, 2009, LIPIDS, V44, P685, DOI 10.1007/s11745-009-3318-2; Ingleby FC, 2013, J EVOLUTION BIOL, V26, P94, DOI 10.1111/jeb.12030; JAENIKE J, 1988, Journal of Insect Behavior, V1, P3, DOI 10.1007/BF01052500; JAENIKE J, 1983, OECOLOGIA, V58, P320, DOI 10.1007/BF00385230; JAENIKE J, 1982, AM NAT, V119, P784, DOI 10.1086/283955; KAROWE DN, 1989, OECOLOGIA, V78, P106, DOI 10.1007/BF00377204; Kent CF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000609; King-Jones K, 2005, CELL, V121, P773, DOI 10.1016/j.cell.2005.03.030; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Kruidhof HM, 2013, OIKOS, V122, P1094, DOI 10.1111/j.1600-0706.2012.00142.x; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; MANNING A, 1967, NATURE, V216, P338, DOI 10.1038/216338a0; Martel V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025658; Milo R, 2007, P NATL ACAD SCI USA, V104, P16998, DOI 10.1073/pnas.0707673104; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Montmayeur J-P, 2010, FAT DECTECTION TASTE; Mullens BA, 2009, PEST MANAG SCI, V65, P1360, DOI 10.1002/ps.1823; Peralta Quesada PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053229; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; PHILLIPS WM, 1977, ENTOMOL EXP APPL, V21, P71, DOI 10.1007/BF00300343; PROKOPY RJ, 1982, SCIENCE, V218, P76, DOI 10.1126/science.218.4567.76; Radziute S, 2013, ENTOMOL EXP APPL, V146, P286, DOI 10.1111/eea.12028; Reaume CJ, 2006, CURR BIOL, V16, pR623, DOI 10.1016/j.cub.2006.07.042; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Schaal B, 2004, CLIN PERINATOL, V31, P261, DOI 10.1016/j.clp.2004.04.003; Shikano I, 2009, ANIM BEHAV, V77, P247, DOI 10.1016/j.anbehav.2008.08.033; SKINNER WA, 1970, EXPERIENTIA, V26, P728, DOI 10.1007/BF02232510; Smallegange RC, 2009, J CHEM ECOL, V35, P933, DOI 10.1007/s10886-009-9668-7; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Svetec N, 2005, CURR BIOL, V15, pR790, DOI 10.1016/j.cub.2005.09.034; Thorpe WH, 1939, PROC R SOC SER B-BIO, V127, P424, DOI 10.1098/rspb.1939.0032; Tremmel M, 2013, BEHAV ECOL, V24, P386, DOI 10.1093/beheco/ars175; VET LEM, 1983, NETH J ZOOL, V33, P225, DOI 10.1163/002829683X00101; Yach D, 2006, NAT MED, V12, P367, DOI 10.1038/nm0306-367a; Yang CH, 2008, SCIENCE, V319, P1679, DOI 10.1126/science.1151842	62	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92352	10.1371/journal.pone.0092352	http://dx.doi.org/10.1371/journal.pone.0092352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667657	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600033
J	Negro, F; Yavuz, US; Farina, D				Negro, Francesco; Yavuz, Utku S.; Farina, Dario			Limitations of the Spike-Triggered Averaging for Estimating Motor Unit Twitch Force: A Theoretical Analysis	PLOS ONE			English	Article							ORDERLY RECRUITMENT; DORSAL INTEROSSEUS; DISCHARGE RATE; MUSCLE; SYNCHRONIZATION; STIMULATION; CONTRACTION; MICROSTIMULATION; THRESHOLD; MASSETER	Contractile properties of human motor units provide information on the force capacity and fatigability of muscles. The spike-triggered averaging technique (STA) is a conventional method used to estimate the twitch waveform of single motor units in vivo by averaging the joint force signal. Several limitations of this technique have been previously discussed in an empirical way, using simulated and experimental data. In this study, we provide a theoretical analysis of this technique in the frequency domain and describe its intrinsic limitations. By analyzing the analytical expression of STA, first we show that a certain degree of correlation between the motor unit activities prevents an accurate estimation of the twitch force, even from relatively long recordings. Second, we show that the quality of the twitch estimates by STA is highly related to the relative variability of the inter-spike intervals of motor unit action potentials. Interestingly, if this variability is extremely high, correct estimates could be obtained even for high discharge rates. However, for physiological inter-spike interval variability and discharge rate, the technique performs with relatively low estimation accuracy and high estimation variance. Finally, we show that the selection of the triggers that are most distant from the previous and next, which is often suggested, is not an effective way for improving STA estimates and in some cases can even be detrimental. These results show the intrinsic limitations of the STA technique and provide a theoretical framework for the design of new methods for the measurement of motor unit force twitch.	[Negro, Francesco; Yavuz, Utku S.; Farina, Dario] Univ Gottingen, Dept Neurorehabil Engn, Bernstein Focus Neurotechnol Gottingen, Bernstein Ctr Computat Neurosci, D-37073 Gottingen, Germany; [Yavuz, Utku S.] Univ Gottingen, Dept Orthob, Bernstein Focus Neurotechnol Gottingen, Bernstein Ctr Computat Neurosci, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen	Negro, F (corresponding author), Univ Gottingen, Dept Neurorehabil Engn, Bernstein Focus Neurotechnol Gottingen, Bernstein Ctr Computat Neurosci, D-37073 Gottingen, Germany.	negro.francesco@bccn.uni-goettingen.de	Negro, Francesco/K-1345-2013; Negro, Francesco/H-4471-2019; Farina, Dario/AAB-2648-2019	Negro, Francesco/0000-0002-9094-8932; Negro, Francesco/0000-0002-9094-8932; Yavuz, Utku Sukru/0000-0002-6968-8064	European Research Council Advanced Grant DEMOVE [267888]	European Research Council Advanced Grant DEMOVE	The authors acknowledge financial support by the European Research Council Advanced Grant DEMOVE (contract #267888) (DF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen S, 1983, BIOMEDICAL ENG IEEE, P742; BURKE RE, 1967, J PHYSIOL-LONDON, V193, P141, DOI 10.1113/jphysiol.1967.sp008348; CALANCIE B, 1986, MUSCLE NERVE, V9, P78, DOI 10.1002/mus.880090113; Carpentier A, 2001, J PHYSIOL-LONDON, V534, P903, DOI 10.1111/j.1469-7793.2001.00903.x; Celichowski J, 2008, J BIOMECH, V41, P3448, DOI 10.1016/j.jbiomech.2008.09.013; Cescon C, 2004, MED BIOL ENG COMPUT, V42, P496, DOI 10.1007/BF02350990; COGGSHALL JC, 1973, KYBERNETIK, V13, P30, DOI 10.1007/BF00289108; Cox DR., 1977, THEORY STOCHASTIC PR; DATTA AK, 1990, J PHYSIOL-LONDON, V422, P397, DOI 10.1113/jphysiol.1990.sp017991; Dideriksen JL, 2012, J NEUROPHYSIOL, V107, P3357, DOI 10.1152/jn.00938.2011; Drzymala-Celichowska H, 2010, J ELECTROMYOGR KINES, V20, P599, DOI 10.1016/j.jelekin.2010.01.006; FUGLEVAND AJ, 1993, J NEUROPHYSIOL, V70, P2470, DOI 10.1152/jn.1993.70.6.2470; GOLDBERG LJ, 1977, J NEUROPHYSIOL, V40, P879, DOI 10.1152/jn.1977.40.4.879; Gossen ER, 2003, J PHYSIOL-LONDON, V552, P657, DOI 10.1113/jphysiol.2003.048132; Gossen ER, 2003, J NEUROSCI METH, V126, P155, DOI 10.1016/S0165-0270(03)00077-3; Heckman C, 2012, COMPREHENSIVE PHYSL; Heckman C, 2004, HAND CLIN N, V4, P119; Katznelson Y., 2004, INTRO HARMONIC ANAL, Vthird, DOI DOI 10.1017/CBO9781139165372; Keen DA, 2004, J NEUROPHYSIOL, V91, P2515, DOI 10.1152/jn.01178.2003; Keen DA, 2012, J NEUROPHYSIOL, V108, P3264, DOI 10.1152/jn.01154.2011; KOSSEV A, 1994, ELECTROEN CLIN NEURO, V93, P100, DOI 10.1016/0168-5597(94)90072-8; Kutch JJ, 2007, J COMPUT NEUROSCI, V22, P347, DOI 10.1007/s10827-007-0023-0; Kutch JJ, 2010, J NEUROPHYSIOL, V103, P3535, DOI 10.1152/jn.00956.2009; LIM KY, 1995, MUSCLE NERVE, V18, P165, DOI 10.1002/mus.880180204; MILNERBR.HS, 1973, J PHYSIOL-LONDON, V230, P359, DOI 10.1113/jphysiol.1973.sp010192; Moritz CT, 2005, J NEUROPHYSIOL, V93, P2449, DOI 10.1152/jn.01122.2004; Negro F, 2010, 40 ANN M SOC NEUR NE; Negro F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044894; NORDSTROM MA, 1989, MUSCLE NERVE, V12, P556, DOI 10.1002/mus.880120706; NORDSTROM MA, 1992, J PHYSIOL-LONDON, V453, P547, DOI 10.1113/jphysiol.1992.sp019244; Raikova R, 2010, J BIOMECH, V43, P1546, DOI 10.1016/j.jbiomech.2010.01.034; Roatta S, 2008, J PHYSIOL-LONDON, V586, P5561, DOI 10.1113/jphysiol.2008.160770; STEIN RB, 1972, BRAIN RES, V40, P187, DOI 10.1016/0006-8993(72)90126-6; STEPHENS JA, 1977, BRAIN RES, V125, P91, DOI 10.1016/0006-8993(77)90361-4; Suresh N, 2012, IEEE ENG MED BIO, P3604, DOI 10.1109/EMBC.2012.6346746; Taylor AM, 2002, J NEUROPHYSIOL, V88, P265, DOI 10.1152/jn.2002.88.1.265; THOMAS CK, 1990, J NEUROPHYSIOL, V64, P1347, DOI 10.1152/jn.1990.64.4.1347; William R, 1978, EXPT NEUROLOGY, V61, P31; YEMM R, 1977, J PHYSIOL-LONDON, V265, P163, DOI 10.1113/jphysiol.1977.sp011710	39	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92390	10.1371/journal.pone.0092390	http://dx.doi.org/10.1371/journal.pone.0092390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667744	Green Submitted, Green Published, gold			2022-12-27	WOS:000333675600035
J	Palanisamy, AP; Cheng, G; Sutter, AG; Liu, J; Lewin, DN; Chao, J; Chavin, K				Palanisamy, Arun P.; Cheng, Gang; Sutter, Alton G.; Liu, John; Lewin, David N.; Chao, Julie; Chavin, Kenneth			Adenovirus-Mediated eNOS Expression Augments Liver Injury after Ischemia/Reperfusion in Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ISCHEMIA-REPERFUSION INJURY; CYTOCHROME-C; INDUCED APOPTOSIS; MITOCHONDRIAL RESPIRATION; TYROSINE NITRATION; GENE-TRANSFER; CELL-LINE; PIG-LIVER; RAT-LIVER	Hepatic ischemia/reperfusion (l/R) injury continues to be a critical problem. The role of nitric oxide in liver I/R injury is still controversial. This study examines the effect of endothelial nitric oxide synthase (eNOS) over-expression on hepatic function following I/R. Adenovirus expressing human eNOS (Ad-eNOS) was administered by tail vein injection into C57BL/6 mice. Control mice received either adenovirus expressing LacZ or vehicle only. Sixty minutes of total hepatic ischemia was performed 3 days after adenovirus treatment, and mice were sacrificed after 6 or 24 hrs of reperfusion to assess hepatic injury. eNOS over expression caused increased liver injury as evidenced by elevated AST and ALT levels and decreased hepatic ATP content. While necrosis was not pervasive in any group, TUNEL demonstrated significantly increased apoptosis in Ad-eNOS infected livers. Western blotting demonstrated increased levels of protein nitration and upregulation of the proapoptotic proteins bax and p53. Our data suggest that over-expression of eNOS is detrimental in the setting of hepatic I/R.	[Palanisamy, Arun P.; Cheng, Gang; Sutter, Alton G.; Liu, John; Chavin, Kenneth] Med Univ S Carolina, Dept Surg, Div Transplant Surg, Charleston, SC 29425 USA; [Lewin, David N.; Chao, Julie] Med Univ S Carolina, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Chavin, K (corresponding author), Med Univ S Carolina, Dept Surg, Div Transplant Surg, Charleston, SC 29425 USA.	chavinkd@musc.edu	Sutter, Alton/GWV-3369-2022; Palanisamy, Arun/I-7712-2019; Palanisamy, Arun/L-2019-2014	Palanisamy, Arun/0000-0002-7793-0682; Palanisamy, Arun/0000-0002-7793-0682				Alexander B, 1998, NUTRITION, V14, P376, DOI 10.1016/S0899-9007(97)00492-9; Alexander HS, 1998, J VIROL METHODS, V74, P9, DOI 10.1016/S0166-0934(98)00062-7; Bal-Price A, 2000, J NEUROCHEM, V75, P1455, DOI 10.1046/j.1471-4159.2000.0751455.x; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3; Cassina A, 1996, ARCH BIOCHEM BIOPHYS, V328, P309, DOI 10.1006/abbi.1996.0178; Chatterjee PK, 2002, KIDNEY INT, V61, P862, DOI 10.1046/j.1523-1755.2002.00234.x; Cheng G, 2002, DEV DYNAM, V223, P119, DOI 10.1002/dvdy.1244; Cheng G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075980; Clemens MG, 1999, HEPATOLOGY, V30, P1, DOI 10.1002/hep.510300148; Cottart CH, 1999, HEPATOLOGY, V29, P809, DOI 10.1002/hep.510290317; DENICOLA A, 1995, FREE RADICAL BIO MED, V19, P11, DOI 10.1016/0891-5849(94)00239-G; Dhar DK, 1998, HEPATOLOGY, V28, P782, DOI 10.1002/hep.510280327; Elibol B, 2001, NEUROSCIENCE, V105, P79, DOI 10.1016/S0306-4522(01)00159-2; Evans ZP, 2012, AM J PHYSIOL-GASTR L, V302, pG336, DOI 10.1152/ajpgi.00049.2011; Farmer D. G., 2000, TRANSPLANT REV, V14, P106, DOI DOI 10.1053/TR.2000.4651; Farzaneh-Far R, 2001, LIVER, V21, P161, DOI 10.1034/j.1600-0676.2001.021003161.x; Gogvadze V, 2001, J BIOL CHEM, V276, P19066, DOI 10.1074/jbc.M100614200; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gujral JS, 2001, HEPATOLOGY, V33, P397, DOI 10.1053/jhep.2001.22002; Hines IN, 2002, MOL CELL BIOCHEM, V234, P229, DOI 10.1023/A:1015952926016; Hortelano S, 1997, FEBS LETT, V410, P373, DOI 10.1016/S0014-5793(97)00623-6; Hortelano S, 1999, FASEB J, V13, P2311, DOI 10.1096/fasebj.13.15.2311; Ilan Y, 1999, SEMIN LIVER DIS, V19, P49, DOI 10.1055/s-2007-1007097; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; JAESCHKE H, 1992, LIFE SCI, V50, P1797, DOI 10.1016/0024-3205(92)90064-V; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kawachi S, 2000, BIOCHEM BIOPH RES CO, V276, P851, DOI 10.1006/bbrc.2000.3559; Kobayashi H, 1995, J SURG RES, V59, P772, DOI 10.1006/jsre.1995.1238; LANCASTER JR, 1990, P NATL ACAD SCI USA, V87, P1223, DOI 10.1073/pnas.87.3.1223; Lin KT, 1998, AM J PHYSIOL-CELL PH, V274, pC855, DOI 10.1152/ajpcell.1998.274.4.C855; Ling H, 1999, AM J PHYSIOL-RENAL, V277, pF383; Lizasoain I, 1996, BIOCHEM J, V314, P877, DOI 10.1042/bj3140877; MA TT, 1995, GASTROENTEROLOGY, V108, P463, DOI 10.1016/0016-5085(95)90075-6; Meguro M, 2003, TRANSPLANTATION, V75, P703, DOI 10.1097/01.TP.0000053400.42842.5C; Meguro M, 2002, TRANSPLANTATION, V73, P1439, DOI 10.1097/00007890-200205150-00013; Messmer UK, 1996, BIOCHEM J, V319, P299, DOI 10.1042/bj3190299; MESSMER UK, 1994, FEBS LETT, V355, P23; Nutt LK, 2002, J BIOL CHEM, V277, P9219, DOI 10.1074/jbc.M106817200; Palanisamy AP, 2013, METAB SYNDR RELAT DI; Peralta C, 1997, HEPATOLOGY, V25, P934, DOI 10.1002/hep.510250424; Pryor WA, 1995, AM J PHYSL, V268; Ricciardi R, 2001, TRANSPLANTATION, V71, P193, DOI 10.1097/00007890-200101270-00004; SCHWEIZER M, 1994, BIOCHEM BIOPH RES CO, V204, P169, DOI 10.1006/bbrc.1994.2441; Serracino-Inglott F, 2001, AM J SURG, V181, P160, DOI 10.1016/S0002-9610(00)00573-0; SHAW P, 1992, P NATL ACAD SCI USA, V89, P4495, DOI 10.1073/pnas.89.10.4495; Shimamura T, 1999, J AM COLL SURGEONS, V188, P43, DOI 10.1016/S1072-7515(98)00259-2; Smith RS, 2002, ARTERIOSCL THROM VAS, V22, P1279, DOI 10.1161/01.ATV.0000026613.18742.67; Stadler J, 1991, AM J PHYSL, V260; Stuehr DJ, 1999, BIOCH BIOPHYSICA ACT, V5; Sullivan DE, 1997, HUM GENE THER, V8, P1195, DOI 10.1089/hum.1997.8.10-1195; TAKEHARA Y, 1995, ARCH BIOCHEM BIOPHYS, V323, P27, DOI 10.1006/abbi.1995.0005; Tzeng E, 1998, SURGERY, V124, P278, DOI 10.1067/msy.1998.90569; Wang PH, 1996, J BIOL CHEM, V271, P29223, DOI 10.1074/jbc.271.46.29223; Wang Y, 1998, SHOCK, V10, P20, DOI 10.1097/00024382-199807000-00004; Wu B, 2002, FREE RADICAL BIO MED, V33, P649, DOI 10.1016/S0891-5849(02)00917-6; Zhou S, 2013, J SURG RES	58	10	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93304	10.1371/journal.pone.0093304	http://dx.doi.org/10.1371/journal.pone.0093304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667691	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600168
J	Yang, WJ; Liu, PD; Wei, DT; Li, WF; Hitchman, G; Li, XP; Qiu, J; Zhang, QL				Yang, Wenjing; Liu, Peiduo; Wei, Dongtao; Li, Wenfu; Hitchman, Glenn; Li, Xueping; Qiu, Jiang; Zhang, Qinglin			Females and Males Rely on Different Cortical Regions in Raven's Matrices Reasoning Capacity: Evidence from a Voxel-Based Morphometry Study	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; ADVANCED PROGRESSIVE MATRICES; SEX-DIFFERENCES; GENERAL INTELLIGENCE; MENTAL ROTATION; FUNCTIONAL MRI; MEMORY; LANGUAGE; FLUID; PERFORMANCE	Raven's Matrices test (RMT) is a non-verbal test designed to assess individuals' ability to reason and solve new problems without relying extensively on declarative knowledge derived from schooling or previous experience. Despite a large number of behavioral studies that demonstrated gender differences in Raven's Matrices reasoning ability, no neural evidence supported this difference. In this study, voxel-based morphometry (VBM) was used in an attempt to uncover the gender-specific neural basis of Raven's Matrices reasoning ability as measured by the combined Raven's Matrices test (CRT) in 370 healthy young adults. The behavioral results showed no difference between males and females. However, the VBM results showed that the relationship between reasoning ability and regional gray matter volume (rGMV) differed between sexes. The association between CRT scores and rGMV in the dorsolateral prefrontal cortex (associated with visuospatial ability) was significantly greater in males than in females, whereas the reverse was true for the inferior frontal cortex (relating to verbal reasoning ability) and the medial frontal cortex (engaged in information binding) where the association was greater in females. These findings suggest that males and females use differently structured brains in different ways to achieve similar levels of overall Raven's Matrices reasoning ability.	[Yang, Wenjing; Liu, Peiduo; Wei, Dongtao; Li, Wenfu; Hitchman, Glenn; Qiu, Jiang; Zhang, Qinglin] Minist Educ, Key Lab Cognit & Personal SWU, Chongqing, Peoples R China; [Yang, Wenjing; Liu, Peiduo; Wei, Dongtao; Li, Wenfu; Hitchman, Glenn; Qiu, Jiang; Zhang, Qinglin] Southwest Univ, Fac Psychol, Chongqing, Peoples R China; [Li, Xueping] China West Normal Univ, Inst Educ, Nanchong, Peoples R China	Southwest University - China; China West Normal University	Qiu, J (corresponding author), Minist Educ, Key Lab Cognit & Personal SWU, Chongqing, Peoples R China.	qiuj318@swu.edu.cn; zhangql@swu.edu.cn	Hitchman, Glenn/F-6974-2014	Hitchman, Glenn/0000-0003-3268-5246	National Natural Science Foundation of China [31170983]; Fundamental Research Funds for the Central Universities [SWU1309433]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the National Natural Science Foundation of China (31170983) and the Fundamental Research Funds for the Central Universities (SWU1309433). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad FJ, 2004, PERS INDIV DIFFER, V36, P1459, DOI 10.1016/S0191-8869(03)00241-1; Abdel-Khalek AM, 2006, PERS INDIV DIFFER, V40, P175, DOI 10.1016/j.paid.2005.06.020; ALDERTON DL, 1990, EDUC PSYCHOL MEAS, V50, P887, DOI 10.1177/0013164490504019; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Astur RS, 1998, BEHAV BRAIN RES, V93, P185, DOI 10.1016/S0166-4328(98)00019-9; BERMAN KF, 1988, ARCH GEN PSYCHIAT, V45, P616; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; BRAINE MDS, 1978, PSYCHOL REV, V85, P1, DOI 10.1037//0033-295X.85.1.1; Brown MRG, 2004, J NEUROPHYSIOL, V91, P873, DOI 10.1152/jn.00382.2003; Butler T, 2006, NEUROIMAGE, V32, P445, DOI 10.1016/j.neuroimage.2006.03.030; CARPENTER PA, 1990, PSYCHOL REV, V97, P404, DOI 10.1037/0033-295X.97.3.404; CATTELL RB, 1963, J EDUC PSYCHOL, V54, P1, DOI 10.1037/h0046743; Christoff K, 2001, NEUROIMAGE, V14, P1136, DOI 10.1006/nimg.2001.0922; Clements AM, 2006, BRAIN LANG, V98, P150, DOI 10.1016/j.bandl.2006.04.007; Colom R, 2002, PERS INDIV DIFFER, V32, P445, DOI 10.1016/S0191-8869(01)00040-X; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Curtis CE, 2006, J NEUROPHYSIOL, V95, P3923, DOI 10.1152/jn.01120.2005; D'Esposito M, 2000, NEUROIMAGE, V11, P400, DOI 10.1006/nimg.2000.0571; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Desco M, 2011, NEUROIMAGE, V57, P281, DOI 10.1016/j.neuroimage.2011.03.063; DeShon RP, 1995, INTELLIGENCE, V21, P135, DOI 10.1016/0160-2896(95)90023-3; Diwadkar VA, 2000, NEUROIMAGE, V12, P85, DOI 10.1006/nimg.2000.0586; Funahashi S, 2013, PROG NEUROBIOL, V103, P131, DOI 10.1016/j.pneurobio.2012.04.002; Gauthier CT, 2009, CORTEX, V45, P164, DOI 10.1016/j.cortex.2007.09.006; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; Haier RJ, 2005, NEUROIMAGE, V25, P320, DOI 10.1016/j.neuroimage.2004.11.019; HAIER RJ, 1988, INTELLIGENCE, V12, P199, DOI 10.1016/0160-2896(88)90016-5; Haier RJ, 2003, INTELLIGENCE, V31, P429, DOI 10.1016/S0160-2896(03)00025-4; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; HYDE JS, 1975, MULTIVAR BEHAV RES, V10, P289, DOI 10.1207/s15327906mbr1003_3; Irwing P, 2005, BRIT J PSYCHOL, V96, P505, DOI 10.1348/000712605X53542; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Just MA, 2001, J EXP PSYCHOL GEN, V130, P493, DOI 10.1037/0096-3445.130.3.493; Kaiser A, 2007, INT J PSYCHOPHYSIOL, V63, P192, DOI 10.1016/j.ijpsycho.2006.03.008; Kalbfleisch ML, 2007, COGN NEURODYNAMICS, V1, P71, DOI 10.1007/s11571-006-9007-4; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Khaleefa O, 2008, MANKIND QUART, V49, P58; KIMURA D, 1992, SCI AM, V267, P119; Kroger JK, 2002, CEREB CORTEX, V12, P477, DOI 10.1093/cercor/12.5.477; Lee KH, 2006, NEUROIMAGE, V29, P578, DOI 10.1016/j.neuroimage.2005.07.036; Lewin C, 2001, NEUROPSYCHOLOGY, V15, P165, DOI 10.1037//0894-4105.15.2.165; Li D., 1988, PSYCHOL SCI, V4, P27, DOI DOI 10.16719/J.CNKI.1671-6981.1988.04.007; LIM TK, 1994, INTELLIGENCE, V19, P179, DOI 10.1016/0160-2896(94)90012-4; Lynn R, 1998, J BIOSOC SCI, V30, P529, DOI 10.1017/S002193209800529X; Lynn R, 2004, INTELLIGENCE, V32, P411, DOI 10.1016/j.intell.2004.06.007; Lynn R, 2004, PERS INDIV DIFFER, V36, P779, DOI 10.1016/S0191-8869(03)00132-6; Mackintosh NJ, 2005, INTELLIGENCE, V33, P663, DOI 10.1016/j.intell.2005.03.004; Markowska AL, 1999, J NEUROSCI, V19, P8122; McGrew K.S., 1998, INTELLIGENCE TEST DE; Meyer GF, 2011, J COGNITIVE NEUROSCI, V23, P2291, DOI 10.1162/jocn.2010.21593; Mitchell JP, 2004, J NEUROSCI, V24, P4912, DOI 10.1523/JNEUROSCI.0481-04.2004; Newton JH, 2010, PSYCHOL SCHOOLS, V47, P621, DOI 10.1002/pits.20495; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Postle BR, 2000, J COGNITIVE NEUROSCI, V12, P2, DOI 10.1162/089892900564028; Postma A, 2004, BRAIN COGNITION, V54, P24, DOI 10.1016/S0278-2626(03)00238-0; Prabhakaran V, 1997, COGNITIVE PSYCHOL, V33, P43, DOI 10.1006/cogp.1997.0659; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Qin SZ, 2007, NEUROIMAGE, V38, P212, DOI 10.1016/j.neuroimage.2007.07.020; Raven J, 2000, COGNITIVE PSYCHOL, V41, P1, DOI 10.1006/cogp.1999.0735; Raven J.C., 1938, PROGR MATRICES PERCE; RISBERG J, 1986, NEUROPSYCHOLOGIA, V24, P135, DOI 10.1016/0028-3932(86)90047-3; Rodriguez-Moreno D, 2009, NEUROPSYCHOLOGIA, V47, P949, DOI 10.1016/j.neuropsychologia.2008.08.030; Rubia K, 2010, NEUROIMAGE, V51, P817, DOI 10.1016/j.neuroimage.2010.02.058; Rushton JP, 2010, INTELLIGENCE, V38, P213, DOI 10.1016/j.intell.2009.12.002; Rushton JP, 2000, INTELLIGENCE, V28, P251, DOI 10.1016/S0160-2896(00)00035-0; Stuss DT, 1998, J INT NEUROPSYCH SOC, V4, P265, DOI 10.1017/S1355617798002653; Takeuchi H, 2014, BRAIN STRUCT FUNCT, V219, P71, DOI 10.1007/s00429-012-0485-3; van der Ven AHGS, 2000, PERS INDIV DIFFER, V29, P45, DOI 10.1016/S0191-8869(99)00177-4; Wagner AD, 1999, NEURON, V22, P19, DOI 10.1016/S0896-6273(00)80674-1; Wallentin M, 2009, BRAIN LANG, V108, P175, DOI 10.1016/j.bandl.2008.07.001; WANG D, 1989, REPORTS PSYCHOL SCI, V5, P23; [王栋 WANG Dong], 2007, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V15, P559; Yamasue H, 2008, CEREB CORTEX, V18, P2331, DOI 10.1093/cercor/bhm254	73	11	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93104	10.1371/journal.pone.0093104	http://dx.doi.org/10.1371/journal.pone.0093104			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667298	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600140
J	Henriksen, DP; Nielsen, SL; Laursen, CB; Hallas, J; Pedersen, C; Lassen, AT				Henriksen, Daniel Pilsgaard; Nielsen, Stig Lonberg; Laursen, Christian Borbjerg; Hallas, Jesper; Pedersen, Court; Lassen, Annmarie Touborg			How Well Do Discharge Diagnoses Identify Hospitalised Patients with Community-Acquired Infections? - A Validation Study	PLOS ONE			English	Article							SERIOUS BACTERIAL-INFECTIONS; ADMINISTRATIVE DATA; UNITED-STATES; SEVERE SEPSIS; CRITERIA; CODES; EPIDEMIOLOGY; SURVEILLANCE; MORTALITY; AGREEMENT	Background: Credible measures of disease incidence, trends and mortality can be obtained through surveillance using manual chart review, but this is both time-consuming and expensive. ICD-10 discharge diagnoses are used as surrogate markers of infection, but knowledge on the validity of infections in general is sparse. The aim of the study was to determine how well ICD-10 discharge diagnoses identify patients with community-acquired infections in a medical emergency department (ED), overall and related to sites of infection and patient characteristics. Methods: We manually reviewed 5977 patients admitted to a medical ED in a one-year period (September 2010-August 2011), to establish if they were hospitalised with community-acquired infection. Using the manual review as gold standard, we calculated the sensitivity, specificity, predictive values, and likelihood ratios of discharge diagnoses indicating infection. Results: Two thousand five hundred eleven patients were identified with community-acquired infection according to chart review (42.0%, 95% confidence interval [95% CI]: 40.8-43.3%) compared to 2550 patients identified by ICD-10 diagnoses (42.8%, 95% CI: 41.6-44.1%). Sensitivity of the ICD-10 diagnoses was 79.9% (95% CI: 78.1-81.3%), specificity 83.9% (95% CI: 82.6-85.1%), positive likelihood ratio 4.95 (95% CI: 4.58-5.36) and negative likelihood ratio 0.24 (95% CI: 0.22-0.26). The two most common sites of infection, the lower respiratory tract and urinary tract, had positive likelihood ratios of 8.3 (95% CI: 7.5-9.2) and 11.3 (95% CI: 10.2-12.9) respectively. We identified significant variation in diagnostic validity related to age, comorbidity and disease severity. Conclusion: ICD-10 discharge diagnoses identify specific sites of infection with a high degree of validity, but only a moderate degree when identifying infections in general.	[Henriksen, Daniel Pilsgaard; Lassen, Annmarie Touborg] Odense Univ Hosp, Dept Emergency Med, DK-5000 Odense, Denmark; [Nielsen, Stig Lonberg; Pedersen, Court] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark; [Laursen, Christian Borbjerg] Odense Univ Hosp, Dept Resp Med, DK-5000 Odense, Denmark; [Hallas, Jesper] Univ Southern Denmark, Dept Clin Pharmacol, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Henriksen, DP (corresponding author), Odense Univ Hosp, Dept Emergency Med, DK-5000 Odense, Denmark.	dphenriksen@health.sdu.dk	Nielsen, Stig Lønberg/B-8421-2014; Lassen, Annmarie/AAA-5816-2019	Nielsen, Stig Lønberg/0000-0002-7780-7131; Lassen, Annmarie/0000-0003-4942-6152; Laursen, Christian Borbjerg/0000-0001-6382-9906; Henriksen, Daniel Pilsgaard/0000-0003-1303-6195	Faculty of Health Sciences, Odense University Hospital; Research Foundation of Odense University Hospital, University of Southern Denmark; private philanthropic fund TrygFonden	Faculty of Health Sciences, Odense University Hospital; Research Foundation of Odense University Hospital, University of Southern Denmark; private philanthropic fund TrygFonden	The study was funded as a part of the corresponding authors PhD study: A stipend for PhD students from the Faculty of Health Sciences, Odense University Hospital, as well as a stipend from the Research Foundation of Odense University Hospital, University of Southern Denmark and an unrestricted grant from the private philanthropic fund TrygFonden given to the University of Southern Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Barber C, 2013, ARTHRIT CARE RES, V65, P1343, DOI 10.1002/acr.21959; Chalfine A, 2006, INFECT CONT HOSP EP, V27, P794, DOI 10.1086/506393; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Curtis JR, 2007, ARTHRITIS RHEUM-US, V56, P1125, DOI 10.1002/art.22504; Esteban A, 2007, CRIT CARE MED, V35, P1284, DOI 10.1097/01.CCM.0000260960.94300.DE; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Gedeborg R, 2007, J CLIN EPIDEMIOL, V60, P155, DOI 10.1016/j.jclinepi.2006.05.013; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Guevara RE, 1999, AM J EPIDEMIOL, V149, P282, DOI 10.1093/oxfordjournals.aje.a009804; Hallas J, 2001, PHARMACOEPIDEM DR S, V10, P619, DOI 10.1002/pds.638; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Klouwenberg PMCK, 2013, CRIT CARE MED, V41, P2373, DOI 10.1097/CCM.0b013e3182923712; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Micallef L, 2012, 12 ANN G HOPP CEL WO; Patkar NM, 2009, J CLIN EPIDEMIOL, V62, P321, DOI 10.1016/j.jclinepi.2008.06.006; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Schmidt Morten, 2010, Clin Epidemiol, V2, P195, DOI 10.2147/CLEP.S12171; Schneeweiss S, 2007, J CLIN EPIDEMIOL, V60, P397, DOI 10.1016/j.jclinepi.2006.07.011; Shapiro N, 2006, ANN EMERG MED, V48, P583, DOI 10.1016/j.annemergmed.2006.07.007; Sogaard Mette, 2011, Clin Epidemiol, V3, P85, DOI 10.2147/CLEP.S16931; van De Garde EMW, 2007, J CLIN EPIDEMIOL, V60, P834, DOI 10.1016/j.jclinepi.2006.10.018; van Tuijn CFJ, 2010, INT J EMERG MED, V3, P293, DOI 10.1007/s12245-010-0220-x; Wang HE, 2007, CRIT CARE MED, V35, P1928, DOI 10.1097/01.CCM.0000277043.85378.C1; Wilhelms SB, 2010, CRIT CARE MED, V38, P1442, DOI 10.1097/CCM.0b013e3181de4406	27	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92891	10.1371/journal.pone.0092891	http://dx.doi.org/10.1371/journal.pone.0092891			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663388	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900127
J	Morissette, MC; Lamontagne, M; Berube, JC; Gaschler, G; Williams, A; Yauk, C; Couture, C; Laviolette, M; Hogg, JC; Timens, W; Halappanavar, S; Stampfli, MR; Bosse, Y				Morissette, Mathieu C.; Lamontagne, Maxime; Berube, Jean-Christophe; Gaschler, Gordon; Williams, Andrew; Yauk, Carole; Couture, Christian; Laviolette, Michel; Hogg, James C.; Timens, Wim; Halappanavar, Sabina; Stampfli, Martin R.; Bosse, Yohan			Impact of Cigarette Smoke on the Human and Mouse Lungs: A Gene-Expression Comparison Study	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; ACTIVATING-FACTOR ACETYLHYDROLASE; ATHEROSCLEROSIS; COMPONENT; ATP6V0D2; FUSION; ALPHA	Cigarette smoke is well known for its adverse effects on human health, especially on the lungs. Basic research is essential to identify the mechanisms involved in the development of cigarette smoke-related diseases, but translation of new findings from pre-clinical models to the clinic remains difficult. In the present study, we aimed at comparing the gene expression signature between the lungs of human smokers and mice exposed to cigarette smoke to identify the similarities and differences. Using human and mouse whole-genome gene expression arrays, changes in gene expression, signaling pathways and biological functions were assessed. We found that genes significantly modulated by cigarette smoke in humans were enriched for genes modulated by cigarette smoke in mice, suggesting a similar response of both species. Sixteen smoking-induced genes were in common between humans and mice including six newly reported to be modulated by cigarette smoke. In addition, we identified a new conserved pulmonary response to cigarette smoke in the induction of phospholipid metabolism/degradation pathways. Finally, the majority of biological functions modulated by cigarette smoke in humans were also affected in mice. Altogether, the present study provides information on similarities and differences in lung gene expression response to cigarette smoke that exist between human and mouse. Our results foster the idea that animal models should be used to study the involvement of pathways rather than single genes in human diseases.	[Morissette, Mathieu C.; Gaschler, Gordon; Stampfli, Martin R.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Lamontagne, Maxime; Berube, Jean-Christophe; Couture, Christian; Laviolette, Michel; Bosse, Yohan] Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Hogg, James C.] Univ British Columbia, St Pauls Hosp, Ctr Heart & Lung Hlth, Vancouver, BC V5Z 1M9, Canada; [Hogg, James C.] Univ British Columbia, Dept Med, Div Resp, Vancouver, BC, Canada; [Timens, Wim] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Williams, Andrew; Yauk, Carole; Halappanavar, Sabina] Hlth Canada, Environm & Radiat Hlth Sci Directorate, Ottawa, ON K1A 0L2, Canada; [Stampfli, Martin R.] McMaster Univ, Firestone Inst Resp Hlth St Josephs Healthcare, Dept Med, Hamilton, ON, Canada; [Bosse, Yohan] Univ Laval, Dept Mol Med, Quebec City, PQ, Canada	McMaster University; Laval University; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of British Columbia; University of Groningen; Health Canada; McMaster University; Laval University	Morissette, MC (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	morissm@mcmaster.ca	Timens, Wim/K-5570-2013	Timens, Wim/0000-0002-4146-6363; Williams, Andrew/0000-0002-7637-7686; Stampfli, Martin/0000-0003-4918-5889; Berube, Jean-Christophe/0000-0002-7634-5270; Lamontagne, Maxime/0000-0001-6674-4983; Yauk, Carole/0000-0003-4919-876X; Yauk, Carole/0000-0002-6725-3454	Canadian Institutes of Health Research [MOP-123369, MPO-64390]; "Chaire de pneumologie de la Fondation JD Begin de l'Universite Laval''; "Fondation de l'Institut universitaire de cardiologie et de pneumologie de Quebec''; Respiratory Health Network of the FRQS; Cancer Research Society; Read for the Cure	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); "Chaire de pneumologie de la Fondation JD Begin de l'Universite Laval''; "Fondation de l'Institut universitaire de cardiologie et de pneumologie de Quebec''; Respiratory Health Network of the FRQS; Cancer Research Society; Read for the Cure	This study was partly supported by the Canadian Institutes of Health Research (MOP-123369 and MPO-64390), "Chaire de pneumologie de la Fondation JD Begin de l'Universite Laval'', the "Fondation de l'Institut universitaire de cardiologie et de pneumologie de Quebec'', the Respiratory Health Network of the FRQS, and the Cancer Research Society and Read for the Cure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez JAG, 2004, CURR DRUG METAB, V5, P211, DOI 10.2174/1389200043335621; Arai H, 2002, J BIOCHEM, V131, P635, DOI 10.1093/oxfordjournals.jbchem.a003145; Bakker ABH, 1999, P NATL ACAD SCI USA, V96, P9792, DOI 10.1073/pnas.96.17.9792; Bauer CMT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013251; Bosse Y, 2012, CANCER RES, V72, P3753, DOI 10.1158/0008-5472.CAN-12-1160; Botelho FM, 2010, AM J RESP CELL MOL, V42, P394, DOI 10.1165/rcmb.2008-0301OC; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; Churg A, 2003, AM J RESP CRIT CARE, V167, P1083, DOI 10.1164/rccm.200212-1396OC; Churg A, 2011, AM J RESP CELL MOL B; de Jager SCA, 2011, J EXP MED, V208, P217, DOI 10.1084/jem.20100370; de Souza AR, 2011, J BIOL CHEM, V286, P43214, DOI 10.1074/jbc.M111.258764; Esser C, 2009, TRENDS IMMUNOL, V30, P447, DOI 10.1016/j.it.2009.06.005; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2, DOI 10.1002/jlb.65.1.2; Fry AM, 2012, J CELL SCI, V125, P4423, DOI 10.1242/jcs.111195; Gaschler GJ, 2010, EUR RESP J; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hayman AR, 2008, AUTOIMMUNITY, V41, P218, DOI 10.1080/08916930701694667; Hochholzer W, 2010, AM HEART J, V160, P583, DOI 10.1016/j.ahj.2010.06.010; IMAIZUMI T-A, 1990, Heart and Vessels, V5, P81, DOI 10.1007/BF02058322; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Khaled YS, 2012, CANCER BIOMARK, V11, P183, DOI 10.3233/CBM-2012-00287; Kim T, 2010, BIOCHEM BIOPH RES CO, V403, P73, DOI 10.1016/j.bbrc.2010.10.117; Kim T, 2009, BIOCHEM BIOPH RES CO, V390, P585, DOI 10.1016/j.bbrc.2009.10.010; Korashy HM, 2006, DRUG METAB REV, V38, P411, DOI 10.1080/03602530600632063; Lagente V, 2009, EXPERT OPIN THER TAR, V13, P287, DOI [10.1517/14728220902751632, 10.1517/14728220902751632 ]; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Rahman I, 2002, AM J RESP CRIT CARE, V166, P490, DOI 10.1164/rccm.2110101; Schmidt-Ott KM, 2007, J AM SOC NEPHROL, V18, P407, DOI 10.1681/ASN.2006080882; Shan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003041; Sharif O, 2008, IMMUNOBIOLOGY, V213, P701, DOI 10.1016/j.imbio.2008.07.008; Singh U, 2004, CLIN SCI, V106, P421, DOI 10.1042/CS20030375; Strelau J, 2000, ADV RES NEURODEGENER, V8, P273; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suter A, 2001, DEVELOPMENT, V128, P4899; Thatcher TH, 2007, AM J PATHOL, V170, P855, DOI 10.2353/ajpath.2007.060391; Thimmulappa RK, 2012, BIOCHEM BIOPH RES CO, V426, P253, DOI 10.1016/j.bbrc.2012.08.076; Toth PP, 2010, EXPERT REV CARDIOVAS, V8, P425, DOI 10.1586/ERC.10.18; Tsai VWW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055174; Wu HP, 2009, J BONE MINER RES, V24, P871, DOI [10.1359/JBMR.081239, 10.1359/jbmr.081239]; Wu Q, 2012, INNATE IMMUN-LONDON, V18, P617, DOI 10.1177/1753425911429837; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yamada K, 2005, FRONT BIOSCI-LANDMRK, V10, P3151, DOI 10.2741/1772; Zhang HQ, 2009, TOXICOL IND HEALTH, V25, P269, DOI 10.1177/0748233709102209	46	31	31	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92498	10.1371/journal.pone.0092498	http://dx.doi.org/10.1371/journal.pone.0092498			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663285	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900066
J	Wang, JJ; Cao, ZD; Zeng, DD; Wang, QY; Wang, XL; Qian, HK				Wang, Jiaojiao; Cao, Zhidong; Zeng, Daniel Dajun; Wang, Quanyi; Wang, Xiaoli; Qian, Haikun			Epidemiological Analysis, Detection, and Comparison of Space-Time Patterns of Beijing Hand-Foot-Mouth Disease (2008-2012)	PLOS ONE			English	Article							COXSACKIEVIRUS A6; ENTEROVIRUS 71; OUTBREAK; CLUSTER; CHINA; ONYCHOMADESIS; CHILDREN; CANCER	Background: Hand, foot, and mouth disease (HFMD) mostly affects the health of infants and preschool children. Many studies of HFMD in different regions have been published. However, the epidemiological characteristics and space-time patterns of individual-level HFMD cases in a major city such as Beijing are unknown. The objective of this study was to investigate epidemiological features and identify high relative risk space-time HFMD clusters at a fine spatial scale. Methods: Detailed information on age, occupation, pathogen and gender was used to analyze the epidemiological features of HFMD epidemics. Data on individual-level HFMD cases were examined using Local Indicators of Spatial Association (LISA) analysis to identify the spatial autocorrelation of HFMD incidence. Spatial filtering combined with scan statistics methods were used to detect HFMD clusters. Results: A total of 157,707 HFMD cases (60.25% were male, 39.75% were female) reported in Beijing from 2008 to 2012 included 1465 severe cases and 33 fatal cases. The annual average incidence rate was 164.3 per 100,000 (ranged from 104.2 in 2008 to 231.5 in 2010). Male incidence was higher than female incidence for the 0 to 14-year age group, and 93.88% were nursery children or lived at home. Areas at a higher relative risk were mainly located in the urban-rural transition zones (the percentage of the population at risk ranged from 33.89% in 2011 to 39.58% in 2012) showing High-High positive spatial association for HFMD incidence. The most likely space-time cluster was located in the mid-east part of the Fangshan district, southwest of Beijing. Conclusions: The spatial-time patterns of Beijing HFMD (2008-2012) showed relatively steady. The population at risk were mainly distributed in the urban-rural transition zones. Epidemiological features of Beijing HFMD were generally consistent with the previous research. The findings generated computational insights useful for disease surveillance, risk assessment and early warning.	[Wang, Jiaojiao; Cao, Zhidong; Zeng, Daniel Dajun] Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, Beijing, Peoples R China; [Cao, Zhidong] Chinese Acad Sci, Cloud Comp Ctr, Dongguan, Peoples R China; [Wang, Quanyi; Wang, Xiaoli; Qian, Haikun] Beijing Ctr Dis Prevent & Control, Inst Infect Dis & Endem Dis Control, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Automation, CAS; Chinese Academy of Sciences	Cao, ZD (corresponding author), Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, Beijing, Peoples R China.	zhidong.cao@ia.ac.cn			National Natural Science Foundation of China [90924302, 91224008, 91024030, 91324007]; Important National Science & Technology Specific Projects [2012ZX10004801, 2013ZX10004218]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Important National Science & Technology Specific Projects	This study was funded by National Natural Science Foundation of China (Nos. 90924302, 91224008, 91024030, 91324007) and Important National Science & Technology Specific Projects (Nos. 2012ZX10004801, 2013ZX10004218). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L., 1996, SPATIAL ANAL PERSPEC, P111, DOI [10.1201/9780203739051-8, DOI 10.1201/9780203739051-8]; Anselin L., 2006, RATE TRANSFORMATIONS; Bauch CT, 2013, SCIENCE, V342, P47, DOI 10.1126/science.1244492; Bracho MA, 2011, EMERG INFECT DIS, V17, P2223, DOI 10.3201/eid1712.110395; Cai Q, 2007, MAPPING DIS RISK USI; Cao ZD, 2010, CHINESE SCI BULL, V55, P1142, DOI 10.1007/s11434-010-0144-0; Chua Kaw Bing, 2011, Virologica Sinica, V26, P221, DOI 10.1007/s12250-011-3195-8; Deng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056943; Toan DTT, 2013, GLOBAL HEALTH ACTION, V6, P7, DOI 10.3402/gha.v6i0.18632; Fujimoto T, 2012, EMERG INFECT DIS, V18, P337, DOI 10.3201/eid1802.111147; Gopalkrishna V, 2012, J MED MICROBIOL, V61, P420, DOI 10.1099/jmm.0.036400-0; Hjalmars U, 1996, STAT MED, V15, P707, DOI 10.1002/(SICI)1097-0258(19960415)15:7/9<707::AID-SIM242>3.3.CO;2-W; Ibrahim S. M. A., 2013, Journal of Vaccines and Vaccination, V4, P191; Impoinvil DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022192; JiaoJiao Wang, 2011, Intelligence and Security Informatics. Proceedings Pacific Asia Workshop, PAISI 2011, P94, DOI 10.1007/978-3-642-22039-5_10; Kamdem C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031843; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377; Kulldorff M, 1999, STAT IND TECHNOL, P303; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M, 2011, SATSCAN USER GUIDE V; Liao YL, 2011, STOCH ENV RES RISK A, V25, P99, DOI 10.1007/s00477-010-0439-3; Liu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025287; Liu YD, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.25079, 10.4161/psb.23864, 10.1371/journal.pone.0065361]; Ma E, 2010, JPN J INFECT DIS, V63, P422; NAUS JI, 1965, J AM STAT ASSOC, V60, P532, DOI 10.2307/2282688; Ni HX, 2012, J CLIN VIROL, V54, P342, DOI 10.1016/j.jcv.2012.04.021; Ozdenerol Esra, 2005, Int J Health Geogr, V4, P19, DOI 10.1186/1476-072X-4-19; Park SK, 2010, J KOREAN MED SCI, V25, P677, DOI 10.3346/jkms.2010.25.5.677; ROBINSON C R, 1958, Can Med Assoc J, V79, P615; Rushton G, 1996, STAT MED, V15, P717, DOI 10.1002/(SICI)1097-0258(19960415)15:7/9<717::AID-SIM243>3.0.CO;2-0; Talbot TO, 2000, STAT MED, V19, P2399, DOI 10.1002/1097-0258(20000915/30)19:17/18<2399::AID-SIM577>3.3.CO;2-I; Wei SH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-346; Wu D, 2011, ARCH VIROL, V156, P945, DOI 10.1007/s00705-011-0929-8; Xu W, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-8; Yang F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-508; Zhu FC, 2013, LANCET, V381, P2024, DOI 10.1016/S0140-6736(13)61049-1	42	85	94	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92745	10.1371/journal.pone.0092745	http://dx.doi.org/10.1371/journal.pone.0092745			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663329	gold, Green Published, Green Submitted			2022-12-27	WOS:000333459900106
J	Han, Q; Wang, RN; Sun, CK; Jin, X; Liu, DJ; Zhao, X; Wang, LL; Ji, N; Li, J; Zhou, Y; Ye, L; Liang, XH; Jiang, L; Liao, G; Dan, HX; Zeng, X; Chen, QM				Han, Qi; Wang, Ruinan; Sun, Chongkui; Jin, Xin; Liu, Dongjuan; Zhao, Xin; Wang, Lili; Ji, Ning; Li, Jing; Zhou, Yu; Ye, Ling; Liang, Xinhua; Jiang, Lu; Liao, Ga; Dan, Hongxia; Zeng, Xin; Chen, Qianming			Human Beta-Defensin-1 Suppresses Tumor Migration and Invasion and Is an Independent Predictor for Survival of Oral Squamous Cell Carcinoma Patients	PLOS ONE			English	Article							BETA-DEFENSIN 1; ANTIMICROBIAL PEPTIDE; EPITHELIAL-CELLS; MESSENGER-RNA; EXPRESSION; CANCER; METASTASIS; INDUCTION; PATTERN; GLANDS	Background: Human beta-defensin-1 (hBD-1) has recently been considered as a candidate tumor suppressor in renal and prostate cancer. The aim of this study was to investigate the role of hBD-1 in the progression of oral squamous cell carcinoma (OSCC) and its potential as diagnostic/prognostic biomarker and therapeutic target for OSCC. Methods: HBD-1 expression in tissues at different stages of oral carcinogenesis, as well as OSCC cell lines was examined. HBD-1 was overexpressed in HSC-3, UM1, SCC-9 and SCC-25 cells and subjected to cell growth, apoptosis, migration and invasion assays. Tissue microarray constructed with tissues from 175 patients was used to examine clinicopathological significance of hBD-1 expression in OSCC. Results: HBD-1 expression decreased from oral precancerous lesions to OSCC and was lower in OSCC with lymph node metastasis than those without metastasis. In vitro, the expression of hBD-1 was related to the invasive potential of OSCC cell lines. Induction of exogenous expression of hBD-1 inhibited migration and invasion of OSCC cells, probably by regulation of RhoA, RhoC and MMP-2; but had no significant effect on proliferation or apoptosis. In a cohort of patients with primary OSCC, cases with no expression of hBD-1 had more chance to be involved in lymph node metastasis. Eventually, the positive expression of hBD-1 was associated with longer survival of patients with OSCC, and multivariate analysis and ROC curve analysis confirmed hBD-1 positivity to be an independent prognostic factor of OSCC, especially OSCC at early stage. Conclusions: Overall, these data indicated that hBD-1 suppressed tumor migration and invasion of OSCC and was likely to be a prognostic biomarker and a potential target for treatment of OSCC.	[Han, Qi; Wang, Ruinan; Sun, Chongkui; Jin, Xin; Liu, Dongjuan; Zhao, Xin; Wang, Lili; Ji, Ning; Li, Jing; Zhou, Yu; Ye, Ling; Liang, Xinhua; Jiang, Lu; Liao, Ga; Dan, Hongxia; Zeng, Xin; Chen, Qianming] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China	Sichuan University	Dan, HX (corresponding author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China.	hxdan@foxmail.com; zengxin22@163.com	Sun, Chongkui/Q-1534-2019	Sun, Chongkui/0000-0003-0362-4129; Dan, Hongxia/0000-0002-9765-0012	National Natural Science Foundation of China [81321002, 30772424, 81200791, 81102060, 81072218]; Doctoral Program of the Ministry of Education of China [20110181110055, 20120181120011]; ISTCPC [2012DFA31370]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program of the Ministry of Education of China(Ministry of Education, China); ISTCPC	This work was supported by grants from the National Natural Science Foundation of China (No. 81321002, 30772424, 81200791, 81102060, 81072218), the Doctoral Program of the Ministry of Education of China (No. 20110181110055, 20120181120011) and the ISTCPC (2012DFA31370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko Y, 1999, CANCER LETT, V143, P37, DOI 10.1016/S0304-3835(99)00171-8; Ai JY, 2012, INT J ORAL SCI, V4, P85, DOI 10.1038/ijos.2012.26; Ali RS, 2001, J INVEST DERMATOL, V117, P106; Bissell J, 2004, J ORAL PATHOL MED, V33, P278, DOI 10.1111/j.0904-2512.2004.00143.x; Bose SK, 2009, MOL IMMUNOL, V46, P1140, DOI 10.1016/j.molimm.2008.11.004; Bullard RS, 2008, MOL IMMUNOL, V45, P839, DOI 10.1016/j.molimm.2006.11.026; Dale BA, 2001, J PERIODONTAL RES, V36, P285, DOI 10.1034/j.1600-0765.2001.360503.x; Donald CD, 2003, LAB INVEST, V83, P501, DOI 10.1097/01.LAB.0000063929.61760.F6; Duits LA, 2002, IMMUNOLOGY, V106, P517, DOI 10.1046/j.1365-2567.2002.01430.x; Gambichler T, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-163; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Hu L, 2004, ONCOGENE, V23, P298, DOI 10.1038/sj.onc.1206483; Iiizumi M, 2008, CANCER RES, V68, P7613, DOI 10.1158/0008-5472.CAN-07-6700; Islam M, 2009, MOL CANCER RES, V7, P1771, DOI 10.1158/1541-7786.MCR-08-0512; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Joly S, 2005, MOL IMMUNOL, V42, P1073, DOI 10.1016/j.molimm.2004.11.001; Joly S, 2009, ORAL MICROBIOL IMMUN, V24, P353, DOI 10.1111/j.1399-302X.2009.00512.x; Krisanaprakornkit S, 1998, INFECT IMMUN, V66, P4222; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033860; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; Mendes O, 2007, CLIN EXP METASTAS, V24, P341, DOI 10.1007/s10585-007-9071-0; Messadi DV, 2013, INT J ORAL SCI, V5, P59, DOI 10.1038/ijos.2013.24; Nakayama Shuko, 1998, Invasion and Metastasis, V18, P219, DOI 10.1159/000024515; Nishimura M, 2004, J DERMATOL SCI, V36, P87, DOI 10.1016/j.jdermsci.2004.07.001; Nishitani Junko, 2002, Cellular and Molecular Biology Online Papers, V48, pOL331; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Sahasrabudhe KS, 2000, J DENT RES, V79, P1669, DOI 10.1177/00220345000790090601; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Sobin LH, 2010, CANCER-AM CANCER SOC, V116, P5336, DOI 10.1002/cncr.25537; Sorensen OE, 2005, J IMMUNOL, V174, P4870, DOI 10.4049/jimmunol.174.8.4870; Struckhoff AP, 2011, FRONT BIOSCI-LANDMRK, V16, P1915, DOI 10.2741/3830; Sun CQ, 2006, CANCER RES, V66, P8542, DOI 10.1158/0008-5472.CAN-06-0294; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Wang Z, 2008, MOL CELL PROTEOMICS, V7, P1639, DOI 10.1074/mcp.M700520-MCP200; Wang Z, 2009, EUR J CANCER, V45, P490, DOI 10.1016/j.ejca.2008.11.012; Wenghoefer M, 2008, INT J ORAL MAX SURG, V37, P660, DOI 10.1016/j.ijom.2008.02.003; Winter J, 2011, CANCER INVEST, V29, P196, DOI 10.3109/07357907.2010.543210; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Zhao CQ, 1996, FEBS LETT, V396, P319, DOI 10.1016/0014-5793(96)01123-4; Zhou Y, 2012, ORAL ONCOL, V48, P110, DOI 10.1016/j.oraloncology.2011.09.007	40	30	33	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91867	10.1371/journal.pone.0091867	http://dx.doi.org/10.1371/journal.pone.0091867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658581	gold, Green Submitted, Green Published			2022-12-27	WOS:000333355300042
J	Lanzerstorfer, P; Borgmann, D; Schutz, G; Winkler, SM; Hoglinger, O; Weghuber, J				Lanzerstorfer, Peter; Borgmann, Daniela; Schuetz, Gerhard; Winkler, Stephan M.; Hoeglinger, Otmar; Weghuber, Julian			Quantification and Kinetic Analysis of Grb2-EGFR Interaction on Micro-Patterned Surfaces for the Characterization of EGFR-Modulating Substances	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; TYROSINE KINASE INHIBITORS; ERBB RECEPTORS; LUNG-CANCER; GROWTH; GRB2; INTERNALIZATION; DOMAIN; PHOSPHORYLATION; ACTIVATION	The identification of the epidermal growth factor receptor (EGFR) as an oncogene has led to the development of several anticancer therapeutics directed against this receptor tyrosine kinase. However, drug resistance and low efficacy remain a severe challenge, and have led to a demand for novel systems for an efficient identification and characterization of new substances. Here we report on a technique which combines micro-patterned surfaces and total internal reflection fluorescence (TIRF) microscopy (m-patterning assay) for the quantitative analysis of EGFR activity. It does not simply measure the phosphorylation of the receptor, but instead quantifies the interaction of the key signal transmitting protein Grb2 (growth factor receptor-bound protein 2) with the EGFR in a live cell context. It was possible to demonstrate an EGF dependent recruitment of Grb2 to the EGFR, which was significantly inhibited in the presence of clinically tested EGFR inhibitors, including small tyrosine kinase inhibitors and monoclonal antibodies targeting the EGF binding site. Importantly, in addition to its potential use as a screening tool, our experimental setup offers the possibility to provide insight into the molecular mechanisms of bait-prey interaction. Recruitment of the EGFR together with Grb2 to clathrin coated pits (CCPs) was found to be a key feature in our assay. Application of bleaching experiments enabled calculation of the Grb2 exchange rate, which significantly changed upon stimulation or the presence of EGFR activity inhibiting drugs.	[Lanzerstorfer, Peter; Hoeglinger, Otmar; Weghuber, Julian] Univ Appl Sci Upper Austria, Wels, Austria; [Borgmann, Daniela; Winkler, Stephan M.] Univ Appl Sci Upper Austria, Hagenberg, Austria; [Schuetz, Gerhard] Vienna Univ Technol, Inst Appl Phys, A-1040 Vienna, Austria	Technische Universitat Wien	Weghuber, J (corresponding author), Univ Appl Sci Upper Austria, Wels, Austria.	julian.weghuber@fh-wels.at	Schuetz, Gerhard/B-1243-2008	Schuetz, Gerhard/0000-0003-1542-1089; Weghuber, Julian/0000-0001-6312-4666; Lanzerstorfer, Peter/0000-0003-4512-7964	Regionale Wettbewerbsfahigkeit; European fund for regional development	Regionale Wettbewerbsfahigkeit; European fund for regional development(European Commission)	This work was funded by the program "Regionale Wettbewerbsfahigkeit OO2007-2013" with financial means of the European fund for regional development as well as the country of Upper Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RA, 2012, CARDIOVASC RES, V94, P125, DOI 10.1093/cvr/cvs017; Antczak C, 2012, ASSAY DRUG DEV TECHN, V10, P24, DOI 10.1089/adt.2011.423; Arteaga CL, 2002, ONCOLOGIST, V7, P31; BATZER AG, 1994, MOL CELL BIOL, V14, P5192, DOI 10.1128/MCB.14.8.5192; Borgmann DM, 2012, P 24 EUR MOD SIM S; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Chen MM, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4807605; Ciaccio MF, 2010, NAT METHODS, V7, P148, DOI [10.1038/nmeth.1418, 10.1038/NMETH.1418]; Ferraro DA, 2013, P NATL ACAD SCI USA, V110, P1815, DOI 10.1073/pnas.1220763110; Fortian A, 2013, J CELL SCI; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Giocanti N, 2004, BRIT J CANCER, V91, P2026, DOI 10.1038/sj.bjc.6602242; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Grecco HE, 2010, NAT METHODS, V7, P467, DOI [10.1038/NMETH.1458, 10.1038/nmeth.1458]; Grewal T, 2009, CELL SIGNAL, V21, P847, DOI 10.1016/j.cellsig.2009.01.031; Heukers R, 2013, J CELL SCI; Hubbard SR, 2007, CURR OPIN CELL BIOL, V19, P117, DOI 10.1016/j.ceb.2007.02.010; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Kuan CT, 2001, ENDOCR-RELAT CANCER, V8, P83, DOI 10.1677/erc.0.0080083; Lanzerstorfer P, 2013, PROTEIN PUR IN PRESS; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Morimatsu M, 2007, P NATL ACAD SCI USA, V104, P18013, DOI 10.1073/pnas.0701330104; Narayanan R, 2012, INT J ONCOL, V40, P13, DOI 10.3892/ijo.2011.1211; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Oh D, 2012, P NATL ACAD SCI USA, V109, P14024, DOI 10.1073/pnas.1203397109; Olive DM, 2004, EXPERT REV PROTEOMIC, V1, P327, DOI 10.1586/14789450.1.3.327; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Pennucci J, 2010, J BIOMOL SCREEN, V15, P644, DOI 10.1177/1087057110370893; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Schwarzenbacher M, 2008, NAT METHODS, V5, P1053, DOI 10.1038/nmeth.1268; Sequist LV, 2008, ANNU REV MED, V59, P429, DOI 10.1146/annurev.med.59.090506.202405; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Sorkina T, 2002, J BIOL CHEM, V277, P27433, DOI 10.1074/jbc.M201595200; Sunzenauer S, 2013, CYTOM PART A, V83, P847, DOI 10.1002/cyto.a.22225; Thomas SM, 2004, CANCER TREAT REV, V30, P255, DOI 10.1016/j.ctrv.2003.10.003; Walker F, 2009, HUM PATHOL, V40, P1517, DOI 10.1016/j.humpath.2009.05.010; Weghuber J, 2010, J VIS EXP; Weghuber J, 2010, ANAL BIOANAL CHEM, V397, P3339, DOI 10.1007/s00216-010-3854-x; Weghuber J, 2010, METHOD ENZYMOL, V472, P133, DOI 10.1016/S0076-6879(10)72012-7; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Yamazaki T, 2002, J CELL SCI, V115, P1791; Zhang HT, 2007, J CLIN INVEST, V117, P2051, DOI 10.1172/JCI32278	47	38	38	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92151	10.1371/journal.pone.0092151	http://dx.doi.org/10.1371/journal.pone.0092151			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658383	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300058
J	Montagud-Romero, S; Daza-Losada, M; Vidal-Infer, A; Maldonado, C; Aguilar, MA; Minarro, J; Rodriguez-Arias, M				Montagud-Romero, Sandra; Daza-Losada, Manuel; Vidal-Infer, Antonio; Maldonado, Concepcion; Aguilar, Maria A.; Minarro, Jose; Rodriguez-Arias, Marta			The Novelty-Seeking Phenotype Modulates the Long-Lasting Effects of Intermittent Ethanol Administration during Adolescence	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; ELEVATED PLUS-MAZE; TRIAL OBJECT RECOGNITION; SENSATION-SEEKING; INDIVIDUAL-DIFFERENCES; SOCIAL-BEHAVIOR; ANIMAL-MODELS; RISK-TAKING; ADULT RATS; DRUG-ADDICTION	The aim of the present study was to investigate if a novelty-seeking phenotype mediates the long-lasting consequences of intermittent EtOH intoxication during adolescence. The hole board test was employed to classify adolescent mice as High-or Low-Novelty Seekers. Subsequently, animals were administered ethanol (1.25 or 2.5 g/kg) on two consecutive days at 48-h intervals over a 14-day period. Anxiety levels - measured using the elevated plus maze-spontaneous motor activity and social interaction test were studied 3 weeks later. A different set of mice underwent the same procedure, but received only the 2.5 g/kg dose of ethanol. Three weeks later, in order to induce CPP, the same animals were administered 1 or 6 mg/kg of cocaine or 1 or 2.5 mg/kg MDMA. The results revealed a decrease in aggressive behaviors and an anxiolytic profile in HNS mice and longer latency to explore the novel object by LNS mice. Ethanol exposure enhanced the reinforcing effects of cocaine and MDMA in both groups when CPP was induced with a sub-threshold dose of the drugs. The extinguished cocaine-induced CPP (1 and 6 mg/kg) was reinstated after a priming dose in HNS animals only. Our results confirm that intermittent EtOH administration during adolescence induces long-lasting effects that are manifested in adult life, and that there is an association between these effects and the novelty-seeking phenotype.	[Montagud-Romero, Sandra; Daza-Losada, Manuel; Vidal-Infer, Antonio; Maldonado, Concepcion; Aguilar, Maria A.; Minarro, Jose; Rodriguez-Arias, Marta] Univ Valencia, Fac Psicol, Dept Psicobiol, Unidad Invest Psicobiol Drogodependencias, Valencia, Spain	University of Valencia	Rodriguez-Arias, M (corresponding author), Univ Valencia, Fac Psicol, Dept Psicobiol, Unidad Invest Psicobiol Drogodependencias, Valencia, Spain.	marta.rodriguez@uv.es	Aguilar, Maria A/D-3416-2011; Vidal-Infer, Antonio/AAR-6567-2021; Minarro, Jose/B-4414-2011; Romero, Sandra Montagud/AAF-9408-2021; Montagud-Romero, Sandra/E-6537-2017; Rodriguez-Arias, Marta/B-5163-2011; Vidal-Infer, Antonio/D-2314-2015	Aguilar, Maria A/0000-0002-1935-6619; Minarro, Jose/0000-0002-5731-7821; Romero, Sandra Montagud/0000-0002-3380-7252; Montagud-Romero, Sandra/0000-0002-3380-7252; Vidal-Infer, Antonio/0000-0002-7860-8652	Ministerio de Economia y Competitividad, Direccion General de Investigacion [PSI2011-24762]; Generalidad Valenciana, Consejeria de Educacion [PROMETEO/2009/072]; Instituto de Salud 'Carlos III' (FIS), Redes Telematicas de Investigacion Cooperativa en Salud (RETICS), Red de Trastornos Adictivos (RTA), fondos FEDER [RD06/001/0016, RD12/0028/005]	Ministerio de Economia y Competitividad, Direccion General de Investigacion; Generalidad Valenciana, Consejeria de Educacion; Instituto de Salud 'Carlos III' (FIS), Redes Telematicas de Investigacion Cooperativa en Salud (RETICS), Red de Trastornos Adictivos (RTA), fondos FEDER	This work was supported by the following grants: Ministerio de Economia y Competitividad, Direccion General de Investigacion (PSI2011-24762); Generalidad Valenciana, Consejeria de Educacion (PROMETEO/2009/072); and Instituto de Salud 'Carlos III' (FIS), Redes Telematicas de Investigacion Cooperativa en Salud (RETICS), Red de Trastornos Adictivos (RTA), fondos FEDER (RD06/001/0016, RD12/0028/005). The funding organisms had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar MA, 2009, BRAIN RES REV, V59, P253, DOI 10.1016/j.brainresrev.2008.08.002; Alfonso-Loeches S, 2011, CRIT REV CL LAB SCI, V48, P19, DOI 10.3109/10408363.2011.580567; Bahi A, 2013, PHARMACOL BIOCHEM BE, V105, P83, DOI 10.1016/j.pbb.2013.01.023; Ballaz SJ, 2007, NEUROSCIENCE, V149, P192, DOI 10.1016/j.neuroscience.2007.07.043; Ballaz SJ, 2007, BEHAV NEUROSCI, V121, P1113, DOI 10.1037/0735-7044.121.5.1113; Bardo MT, 1996, BEHAV BRAIN RES, V77, P23, DOI 10.1016/0166-4328(95)00203-0; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Bird J, 2013, ADDICT BIOL, V18, P654, DOI 10.1111/j.1369-1600.2012.00477.x; BLANCHARD RJ, 1987, PHARMACOL BIOCHEM BE, V27, P641, DOI 10.1016/0091-3057(87)90187-0; BRAIN PF, 1981, BEHAV PROCESS, V6, P319, DOI 10.1016/0376-6357(81)90049-8; Brain PF, 1989, NEUROMETHODS, V13, P687; Brown SA, 2008, PEDIATRICS, V121, pS290, DOI 10.1542/peds.2007-2243D; Busse GD, 2005, PHARMACOL BIOCHEM BE, V81, P459, DOI 10.1016/j.pbb.2005.04.003; Calabrese EJ, 2008, CRIT REV TOXICOL, V38, P489, DOI 10.1080/10408440802014238; Conrad KL, 2011, ALCOHOL, V45, P585, DOI 10.1016/j.alcohol.2010.11.002; Daza-Losada M, 2007, NEUROPSYCHOPHARMACOL, V32, P1750, DOI 10.1038/sj.npp.1301309; Daza-Losada M, 2009, ADDICT BIOL, V14, P447, DOI 10.1111/j.1369-1600.2009.00173.x; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Doremus TL, 2003, PHARMACOL BIOCHEM BE, V75, P411, DOI 10.1016/S0091-3057(03)00134-5; EDADES, 2010, DEL GOB PLAN NAC DRO; EMCDDA, 2011, ANN REP 2011 STAT DR; EMCDDA-European Monitoring Centre for Drugs and Drug Addiction, 2009, POL US PATT RESP SEL; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; ESTUDES, 2010, INF ENC EST US DROG; EVERILL B, 1987, PHYSIOL BEHAV, V39, P45, DOI 10.1016/0031-9384(87)90342-8; Fillmore MT, 2009, DRUG ALCOHOL DEPEN, V100, P91, DOI 10.1016/j.drugalcdep.2008.09.007; Forbes A, 2013, ALCOHOL, V47, P95, DOI 10.1016/j.alcohol.2012.12.007; Frick KM, 2003, BEHAV NEUROSCI, V117, P1283, DOI 10.1037/0735-7044.117.6.1283; Fukushiro DF, 2012, PHARMACOL BIOCHEM BE, V101, P132, DOI 10.1016/j.pbb.2011.12.013; Grimm JW, 1997, PHYSIOL BEHAV, V61, P755, DOI 10.1016/S0031-9384(96)00532-X; Guerri C, 2002, NEUROTOX RES, V4, P327, DOI 10.1080/1029842021000010884; Harper C, 2005, CURR OPIN PHARMACOL, V5, P73, DOI 10.1016/j.coph.2004.06.011; Hefner K, 2007, BEHAV BRAIN RES, V176, P210, DOI 10.1016/j.bbr.2006.10.001; HILAKIVI LA, 1989, ALCOHOL CLIN EXP RES, V13, P622, DOI 10.1111/j.1530-0277.1989.tb00393.x; Hutchison MA, 2012, PHARMACOL BIOCHEM BE, V101, P458, DOI 10.1016/j.pbb.2012.02.007; Kankaanpaa A, 1998, PHARMACOL BIOCHEM BE, V59, P1003, DOI 10.1016/S0091-3057(97)00527-3; Kelley AE, 2004, ANN NY ACAD SCI, V1021, P27, DOI 10.1196/annals.1308.003; Kelly TH, 2006, PSYCHOPHARMACOLOGY, V189, P17, DOI 10.1007/s00213-006-0487-z; Kerman IA, 2011, BRAIN RES, V1419, P34, DOI 10.1016/j.brainres.2011.08.038; Kliethermes CL, 2007, GENES BRAIN BEHAV, V6, P608, DOI 10.1111/j.1601-183X.2006.00289.x; KRSIAK M, 1973, PSYCHOPHARMACOLOGIA, V32, P201, DOI 10.1007/BF00428691; Kushner MG, 2000, CLIN PSYCHOL REV, V20, P149, DOI 10.1016/S0272-7358(99)00027-6; Laviola G, 1999, NEUROSCI BIOBEHAV R, V23, P993, DOI 10.1016/S0149-7634(99)00032-9; Laviola G, 2003, NEUROSCI BIOBEHAV R, V27, P19, DOI 10.1016/S0149-7634(03)00006-X; Le Pen G, 1998, NEUROREPORT, V9, P2887, DOI 10.1097/00001756-199808240-00038; MacPherson L, 2010, ALCOHOL CLIN EXP RES, V34, P1400, DOI 10.1111/j.1530-0277.2010.01223.x; Maldonado C, 2006, BEHAV PHARMACOL, V17, P119, DOI 10.1097/01.fbp.0000190685.84984.ec; Mantsch JR, 2001, PSYCHOPHARMACOLOGY, V157, P31, DOI 10.1007/s002130100744; Manzanedo C, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-19; Marinelli M, 2000, J NEUROSCI, V20, P8876; Marquez C, 2005, PSYCHONEUROENDOCRINO, V30, P179, DOI 10.1016/j.psyneuen.2004.05.012; Martin CA, 2002, J AM ACAD CHILD PSY, V41, P1495, DOI 10.1097/00004583-200212000-00022; Martin CA, 2004, PSYCHOL REP, V94, P1075; McClain JA, 2013, ADDICT BIOL IN PRESS; Milivojevic D, 2012, AM J ADDICTION, V21, P462, DOI 10.1111/j.1521-0391.2012.00251.x; MUGFORD RA, 1970, NATURE, V226, P967, DOI 10.1038/226967a0; National Institute on Alcohol Abuse and Alcoholism, 2004, NIAAA NEWSLETTER; Pascual M, 2007, EUR J NEUROSCI, V25, P541, DOI 10.1111/j.1460-9568.2006.05298.x; PELLOW S, 1986, PHARMACOL BIOCHEM BE, V24, P525, DOI 10.1016/0091-3057(86)90552-6; Piazza PV, 2000, J NEUROSCI, V20, P4226; Do Couto BR, 2012, ADDICT BIOL, V17, P588, DOI 10.1111/j.1369-1600.2011.00382.x; Rodgers RJ, 1997, PHARMACOL BIOCHEM BE, V57, P127, DOI 10.1016/S0091-3057(96)00134-7; Rodriguez-Arias M, 1998, EUR NEUROPSYCHOPHARM, V8, P95, DOI 10.1016/S0924-977X(97)00051-5; Rodriguez-Arias M, 2011, PSYCHOPHARMACOLOGY, V218, P429, DOI 10.1007/s00213-011-2329-x; Rodriguez-Arias M, 2010, PROG NEURO-PSYCHOPH, V34, P166, DOI 10.1016/j.pnpbp.2009.10.019; Schramm-Sapyta NL, 2008, ALCOHOL CLIN EXP RES, V32, P754, DOI 10.1111/j.1530-0277.2008.00631.x; Schramm-Sapyta NL, 2009, PSYCHOPHARMACOLOGY, V206, P1, DOI 10.1007/s00213-009-1585-5; Schramm-Sapyta NL, 2004, PSYCHOPHARMACOLOGY, V173, P41, DOI 10.1007/s00213-003-1696-3; SMOOTHY R, 1986, PHYSIOL BEHAV, V37, P689, DOI 10.1016/0031-9384(86)90173-3; Spear HJ, 2004, PUBLIC HEALTH NURS, V21, P144, DOI 10.1111/j.0737-1209.2004.021208.x; Spear Linda Patia, 2005, Recent Dev Alcohol, V17, P143, DOI 10.1007/0-306-48626-1_7; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Spear LP, 2004, ANN NY ACAD SCI, V1021, P23, DOI 10.1196/annals.1308.002; Spear LP, 2002, ALCOHOL RES HEALTH, V26, P287; Stansfield KH, 2007, PHARMACOL BIOCHEM BE, V86, P637, DOI 10.1016/j.pbb.2007.02.008; Stoops WW, 2007, ADDICT BEHAV, V32, P1177, DOI 10.1016/j.addbeh.2006.08.006; Tur JA, 2003, ALCOHOL ALCOHOLISM, V38, P243, DOI 10.1093/alcalc/agg061; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Varlinskaya EI, 2002, ALCOHOL CLIN EXP RES, V26, P1502, DOI 10.1097/01.ALC.0000034033.95701.E3; Vidal-Infer A, 2012, PHARMACOL BIOCHEM BE, V102, P124, DOI 10.1016/j.pbb.2012.03.031; White AM, 2006, ALCOHOL CLIN EXP RES, V30, P1006, DOI 10.1111/j.1530-0277.2006.00122.x; YANAI J, 1977, PSYCHOPHARMACOLOGY, V52, P31, DOI 10.1007/BF00426596	82	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92576	10.1371/journal.pone.0092576	http://dx.doi.org/10.1371/journal.pone.0092576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658541	Green Submitted, Green Published, gold			2022-12-27	WOS:000333355300101
J	Nagarajan, R; Gromiha, MM				Nagarajan, R.; Gromiha, M. Michael			Prediction of RNA Binding Residues: An Extensive Analysis Based on Structure and Function to Select the Best Predictor	PLOS ONE			English	Article							PROTEIN; SITES; DNA; INFORMATION; SEQUENCE; REPLICATION; DATABASE; SERVER; SVM	Protein-RNA complexes play key roles in several cellular processes by the interactions of amino acids with RNA. To understand the recognition mechanism, it is important to identify the specific amino acids involved in RNA binding. Various computational methods have been developed for predicting RNA binding residues from protein sequence. However, their performances mainly depend on the training dataset, feature selection for developing a model and learning capacity of the model. Hence, it is important to reveal the correspondence between the performance of methods and properties of RNA-binding proteins (RBPs). In this work, we have collected all available RNA binding residues prediction methods and revealed their performances on unbiased, stringent and diverse datasets for RBPs with less than 25% sequence identity based on structural class, fold, superfamily, family, protein function, RNA type, RNA strand and RNA conformation. The best methods for each type of RBPs and the type of RBPs, which require further refinement in prediction, have been brought out. We also analyzed the performance of these methods for the disordered regions, structures which are not included in the training dataset and recently solved structures. The reliability of prediction is better than randomly choosing any method or combination of methods. This approach would be a valuable resource for biologists to choose the best method based on the type of RBPs for designing their experiments and the tool is freely accessible online at www.iitm.ac.in/bioinfo/RNA-protein/.	[Nagarajan, R.; Gromiha, M. Michael] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Gromiha, MM (corresponding author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	gromiha@iitm.ac.in	Gromiha, Michael/H-8493-2019; Raju, Nagarajan/H-9157-2013	Raju, Nagarajan/0000-0003-3851-5520; Michael, Gromiha/0000-0002-1776-4096	Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	Funding came from the Department of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2008, BIOL CHEM, V389, P243, DOI 10.1515/BC.2008.022; Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; Anderson JSJ, 2000, NUCLEIC ACIDS RES, V28, P1604, DOI 10.1093/nar/28.7.1604; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bahadur RP, 2008, NUCLEIC ACIDS RES, V36, P2705, DOI 10.1093/nar/gkn102; Beaudoin ME, 2008, NUCLEIC ACIDS RES, V36, P6835, DOI 10.1093/nar/gkn792; Berman HM, 2012, STRUCTURE, V20, P391, DOI 10.1016/j.str.2012.01.010; BERMAN HM, 1992, BIOPHYS J, V63, P751, DOI 10.1016/S0006-3495(92)81649-1; Carson MB, 2010, NUCLEIC ACIDS RES, V38, pW431, DOI 10.1093/nar/gkq361; Cheng CW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S6; Ellis JJ, 2007, PROTEINS, V66, P903, DOI 10.1002/prot.21211; Gromiha MM, 2013, ADV PROTEIN CHEM STR, V91, P65, DOI 10.1016/B978-0-12-411637-5.00003-2; Gromiha MM, 2010, LECT NOTES COMPUT SC, V6215, P626, DOI 10.1007/978-3-642-14922-1_78; Hertel KJ, 2005, TRENDS BIOCHEM SCI, V30, P115, DOI 10.1016/j.tibs.2005.01.002; Jeong Euna, 2004, Genome Inform, V15, P105; Jones S, 2001, NUCLEIC ACIDS RES, V29, P943, DOI 10.1093/nar/29.4.943; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; Ma X, 2011, PROTEINS, V79, P1230, DOI 10.1002/prot.22958; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nagarajan R, 2013, NUCLEIC ACIDS RES, V41, P7606, DOI 10.1093/nar/gkt544; Newcomb LL, 2009, J VIROL, V83, P29, DOI 10.1128/JVI.02293-07; Noller HF, 2005, SCIENCE, V309, P1508, DOI 10.1126/science.1111771; Puton T, 2012, J STRUCT BIOL, V179, P261, DOI 10.1016/j.jsb.2011.10.001; Saunus JM, 2008, CANCER RES, V68, P9469, DOI 10.1158/0008-5472.CAN-08-1159; Terribilini M, 2007, NUCLEIC ACIDS RES, V35, pW578, DOI 10.1093/nar/gkm294; Tjong H, 2007, NUCLEIC ACIDS RES, V35, P1465, DOI 10.1093/nar/gkm008; Walia RR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-89; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Wang LJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S3; Wang Y, 2008, AMINO ACIDS, V35, P295, DOI 10.1007/s00726-007-0634-9; Wang Y, 2013, MOL BIOSYST, V9, P133, DOI 10.1039/c2mb25292a; Yu Z, 2005, P NATL ACAD SCI USA, V102, P4027, DOI 10.1073/pnas.0408889102	32	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91140	10.1371/journal.pone.0091140	http://dx.doi.org/10.1371/journal.pone.0091140			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658593	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300025
J	Peng, TM; Qian, ZH; Liu, AH; Li, YX; Jiang, CH; Wu, ZX				Peng, Tangming; Qian, Zenghui; Liu, Aihua; Li, Youxiang; Jiang, Chuhan; Wu, Zhongxue			Progressive Occlusion of Enterprise Stent-Assisted Coiling of Ruptured Wide-Necked Intracranial Aneurysms and Related Factors on Angiographic Follow-Up: A Single-Center Experience with 468 Patients	PLOS ONE			English	Article							ENDOVASCULAR TREATMENT; EMBOLIZATION; NEUROFORM	This study was designed to assess the effect of the Enterprise stent on progressive occlusion of wide-necked aneurysms and to evaluate the association between dubious factors and progressive occlusion, which is a consecutive, retrospective, single-center study. Data from 468 patients with 495 wide-necked aneurysms, who had undergone Enterprise stent-assisted coiling (SAC) were reviewed, and the clinical outcomes and the angiographic results were analyzed. A 14-month clinical follow-up was achieved in 421 of the 468 patients (90.0%), showing modified Rankin Scale (mRS) 0-1 in 364 (86.4%), mRS 2 in 17 (4.1%), mRS 3 in 17 (4.1%), mRS 4-5 in 9 (2.1%), and mRS 6 in 14 (3.3%) patients. Overall, the morbidity and mortality were 10.2% and 3.3%, respectively. Initial angiographic results showed Raymond scale (RS) 1 in 273 (55.2%), RS2 in 194 (39.2%), and RS3 in 28 (5.6%) patients. Eight-month angiographic follow-up was available in 394 of 495 patients (79.6%), and RS1 was seen in 315 (79.9%), RS2 in 65 (16.5%) and RS3 in 14 (3.6%) cases. At the end of the follow-up, 115 of the 165 (69.7%) patients with initial RS2 and RS3 showed progressive occlusion. Statistical analysis showed no significant difference between progressive occlusion and age (p = 0.654), sex (p = 0.016), aneurysm diameter (p = 0.010), neck size (p = 0.124), dome-to neck ratio (DNR) (p = 0.018) and location (p = 0.001) at the time of follow-up. SAC using Enterprise stent is not only feasible for wide-necked aneurysms, but can achieve a high rate of progressive occlusion with good clinical outcomes at medium-term follow-up. Patient age and aneurysm neck size showed no associated with progressive occlusion at follow-up, while sex, aneurysm diameter, DNR and location were significantly associated with progressive occlusion.	[Peng, Tangming; Qian, Zenghui; Liu, Aihua; Li, Youxiang; Jiang, Chuhan; Wu, Zhongxue] Capital Med Univ, Beijing Tiantan Hosp, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, Beijing, Peoples R China	Beijing Neurosurgical Institute; Capital Medical University	Liu, AH (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, Beijing, Peoples R China.	liuaihua_ttyy@126.com			National Natural Science Foundation of China [30901557]; High Level Health Technique Talent Training Plan of Beijing Health System [2011-3-036]; Nova Plan of Beijing Municipal Science and Technology [2007A043]; Disciplines Backbone of Beijing Tiantan Hospital [DLB2011-09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High Level Health Technique Talent Training Plan of Beijing Health System; Nova Plan of Beijing Municipal Science and Technology; Disciplines Backbone of Beijing Tiantan Hospital	This article was supported by the National Natural Science Foundation of China (No. 30901557), The High Level Health Technique Talent Training Plan of Beijing Health System (No. 2011-3-036), and the Nova Plan of Beijing Municipal Science and Technology (2007A043), Disciplines Backbone of Beijing Tiantan Hospital (No. DLB2011-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fargen KM, 2012, NEUROSURGERY, V71, P239, DOI 10.1227/NEU.0b013e3182571953; Gentric JC, 2013, AM J NEURORADIOL, V34, P1203, DOI 10.3174/ajnr.A3379; Golshani Kiarash, 2012, Surg Neurol Int, V3, P84, DOI 10.4103/2152-7806.99174; Gu DQ, 2013, J CLIN NEUROSCI, V20, P238, DOI 10.1016/j.jocn.2012.01.053; Heller RS, 2011, AM J NEURORADIOL, V32, P1714, DOI 10.3174/ajnr.A2584; Huang QH, 2013, J CLIN NEUROSCI, V20, P261, DOI 10.1016/j.jocn.2012.02.027; Jeon P, 2012, AM J NEURORADIOL, V33, P965, DOI 10.3174/ajnr.A2857; Jia J, 2012, INTERV NEURORADIOL, V18, P426, DOI 10.1177/159101991201800408; Kadkhodayan Y, 2013, AM J ROENTGENOL, V200, P872, DOI 10.2214/AJR.12.8954; Kim DJ, 2010, ACTA NEUROCHIR, V152, P423, DOI 10.1007/s00701-009-0522-z; Lazzaro Marc A, 2011, Front Neurol, V2, P52, DOI 10.3389/fneur.2011.00052; Lee JI, 2012, J KOREAN NEUROSURG S, V51, P370, DOI 10.3340/jkns.2012.51.6.370; Lodi YM, 2012, J NEUROINTERV SURG, V4, P281, DOI 10.1136/neurintsurg-2011-010035; Lopes D, 2005, NEUROSURGERY, V56, P416, DOI 10.1227/01.NEU.0000145867.25167.CF; Lubicz B, 2008, NEUROSURGERY, V62, P1063, DOI 10.1227/01.neu.0000325868.06764.de; Lv XL, 2012, EUR J RADIOL, V81, P1179, DOI 10.1016/j.ejrad.2011.03.052; Maldonado IL, 2011, AM J NEURORADIOL, V32, P131, DOI 10.3174/ajnr.A2245; Shima H, 2009, J CLIN NEUROSCI, V16, P560, DOI 10.1016/j.jocn.2008.05.031; Spiotta AM, 2013, J NEUROINTERV SURG, V5, P582, DOI 10.1136/neurintsurg-2012-010552; Tahtinen OI, 2009, RADIOLOGY, V253, P199, DOI 10.1148/radiol.2531081923; Wanke I, 2008, NEURORADIOLOGY, V50, P991, DOI 10.1007/s00234-008-0460-0; Weber W, 2007, NEURORADIOLOGY, V49, P555, DOI 10.1007/s00234-007-0232-2; Xu XA, 2011, CHINESE MED J-PEKING, V124, P611, DOI 10.3760/cma.j.issn.0366-6999.2011.04.023	23	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92407	10.1371/journal.pone.0092407	http://dx.doi.org/10.1371/journal.pone.0092407			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658387	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300080
J	Sward, K; Albinsson, S; Rippe, C				Sward, Karl; Albinsson, Sebastian; Rippe, Catarina			Arterial Dysfunction but Maintained Systemic Blood Pressure in Cavin-1-Deficient Mice	PLOS ONE			English	Article							MESENTERIC SMALL ARTERIES; CAVEOLIN-1-DEFICIENT MICE; CAVEOLAE; KNOCKOUT; CAVIN; RAT; ABNORMALITIES; CONTRACTILITY; HYPERTENSION; ENDOTHELIUM	Caveolae are omega-shaped plasma membrane micro-domains that are abundant in cells of the vascular system. Formation of caveolae depends on caveolin-1 and cavin-1 and lack of either protein leads to loss of caveolae. Mice with caveolin-1 deficiency have dysfunctional blood vessels, but whether absence of cavin-1 similarly leads to vascular dysfunction is not known. Here we addressed this hypothesis using small mesenteric arteries from cavin-1-deficient mice. Cavin-1-reporter staining was intense in mesenteric arteries, brain arterioles and elsewhere in the vascular system, with positive staining of both endothelial and smooth muscle cells. Arterial expression of cavin-1, -2 and -3 was reduced in knockout (KO) arteries as was expression of caveolin-1, -2 and -3. Caveolae were absent in the endothelial and smooth muscle layers of small mesenteric arteries as determined by electron microscopy. Arginase, a negative regulator of nitric oxide production, was elevated in cavin-1 deficient arteries as was contraction in response to the alpha(1)-adrenergic agonist cirazoline. Detailed assessment of vascular dimensions revealed increased media thickness and reduced distensibility, arguing that enhanced contraction was due to increased muscle mass. Contrasting with increased alpha(1)-adrenergic contraction, myogenic tone was essentially absent and this appeared to be due in part to increased nitric oxide production. Vasomotion was less frequent in the knock-out vessels. In keeping with the opposing influences on arterial resistance of increased agonist-induced contractility and reduced myogenic tone, arterial blood pressure was unchanged in vivo. We conclude that deficiency of cavin-1 affects the function of small arteries, but that opposing influences on arterial resistance balance each other such that systemic blood pressure in unstressed mice is well maintained.	[Sward, Karl; Albinsson, Sebastian; Rippe, Catarina] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University	Rippe, C (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	catarina.rippe@med.lu.se	Albinsson, Sebastian/B-4105-2010; Rippe, Catarina/B-4110-2010	Albinsson, Sebastian/0000-0001-6936-3967; Rippe, Catarina/0000-0001-8621-9836; Sward, Karl/0000-0002-7255-5510	Crafoord Foundation; Ake Wiberg Foundation; Magnus Bergvall Foundation; Olle Engqvist Byggmastare the Swedish Research Council [K2009-65X-4955-01-3, K2011-67P-20608-02-4, 524-2009-7774]; Faculty of Medicine at Lund University	Crafoord Foundation; Ake Wiberg Foundation; Magnus Bergvall Foundation; Olle Engqvist Byggmastare the Swedish Research Council(Swedish Research Council); Faculty of Medicine at Lund University	The authors' work is supported by Grants from the Crafoord Foundation, the Ake Wiberg Foundation, the Magnus Bergvall Foundation, Olle Engqvist Byggmastare the Swedish Research Council (K2009-65X-4955-01-3, K2011-67P-20608-02-4, 524-2009-7774), and the Faculty of Medicine at Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalkjaer C, 2011, ACTA PHYSIOL, V202, P253, DOI 10.1111/j.1748-1716.2011.02320.x; Adebiyi A, 2007, AM J PHYSIOL-HEART C, V292, pH1584, DOI 10.1152/ajpheart.00584.2006; Albinsson S, 2007, AM J PHYSIOL-REG I, V293, pR1222, DOI 10.1152/ajpregu.00092.2007; Asterholm IW, 2012, CELL METAB, V15, P171, DOI 10.1016/j.cmet.2012.01.004; Aung CS, 2011, EUR J CELL BIOL, V90, P136, DOI 10.1016/j.ejcb.2010.06.004; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; BUUS NH, 1994, BRIT J PHARMACOL, V112, P579, DOI 10.1111/j.1476-5381.1994.tb13114.x; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Desjardins F, 2008, CARDIOVASC RES, V79, P527, DOI 10.1093/cvr/cvn080; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Govender P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062045; GUSTAFSSON H, 1993, ACTA PHYSIOL SCAND, V148, P153, DOI 10.1111/j.1748-1716.1993.tb09545.x; Haddock RE, 2006, AM J PHYSIOL-HEART C, V291, pH2047, DOI 10.1152/ajpheart.00484.2006; Hansen CG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2808; Hassan GS, 2006, AM J PHYSIOL-HEART C, V290, pH2393, DOI 10.1152/ajpheart.01161.2005; Hausman N, 2012, J CELL MOL MED, V16, P1720, DOI 10.1111/j.1582-4934.2011.01457.x; Heagerty AM, 2010, J CELL MOL MED, V14, P1037, DOI 10.1111/j.1582-4934.2010.01080.x; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hill MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043041; Jansa P, 1998, EMBO J, V17, P2855, DOI 10.1093/emboj/17.10.2855; Jhun BS, 2012, CIRC RES, V110, P59, DOI 10.1161/CIRCRESAHA.111.254672; Karbalaei MS, 2012, EUR J PHARMACOL, V689, P179, DOI 10.1016/j.ejphar.2012.05.023; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Li SW, 1998, FEBS LETT, V434, P127, DOI 10.1016/S0014-5793(98)00945-4; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Magyar J, 2012, CHANNELS, V6, P166, DOI 10.4161/chan.20192; Neidhold S, 2007, BRIT J PHARMACOL, V150, P261, DOI 10.1038/sj.bjp.0706980; Rahman A, 2009, ACTA PHYSIOL, V195, P231, DOI 10.1111/j.1748-1716.2008.01907.x; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Razani B, 2001, J BIOL CHEM, V276, P38121; Saliez J, 2008, CIRCULATION, V117, P1065, DOI 10.1161/CIRCULATIONAHA.107.731679; Schubert R, 2008, CARDIOVASC RES, V77, P8, DOI 10.1016/j.cardiores.2007.07.018; Shakirova Y, 2006, AM J PHYSIOL-CELL PH, V291, pC1326, DOI 10.1152/ajpcell.00046.2006; Sward K, 2003, CURR HYPERTENS REP, V5, P66, DOI 10.1007/s11906-003-0013-1; Sward K, 2002, CIRC RES, V90, P792, DOI 10.1161/01.RES.0000015214.40360.84; Sward K, 2013, PHYSL REPORTS, V1; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799	37	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92428	10.1371/journal.pone.0092428	http://dx.doi.org/10.1371/journal.pone.0092428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658465	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300082
J	Zhang, YH; Ge, L; Liu, L; Huo, XX; Xiong, HR; Liu, YY; Liu, DY; Luo, F; Li, JL; Ling, JX; Chen, W; Liu, J; Hou, W; Zhang, Y; Fan, H; Yang, ZQ				Zhang, Yi-Hui; Ge, Liang; Liu, Li; Huo, Xi-Xiang; Xiong, Hai-Rong; Liu, Yuan-Yuan; Liu, Dong-Ying; Luo, Fan; Li, Jin-Lin; Ling, Jia-Xin; Chen, Wen; Liu, Jing; Hou, Wei; Zhang, Yun; Fan, Hong; Yang, Zhan-Qiu			The Epidemic Characteristics and Changing Trend of Hemorrhagic Fever with Renal Syndrome in Hubei Province, China	PLOS ONE			English	Article							HANTAVIRUS PULMONARY SYNDROME; GENETIC-CHARACTERIZATION; RODENT HOSTS; VIRUS; VARIABILITY; INFECTION; DISEASE; REGION; GIS	Background: Hemorrhagic fever with renal syndrome (HFRS) is caused by different hantaviruses within the Bunyaviridae family. HFRS is a fulminant, infectious disease that occurs worldwide and is endemic in all 31 provinces of China. Since the first HFRS case in Hubei Province was reported in 1957, the disease has spread across the province and Hubei has become one of the seriously affected areas in China with the greatest number of reported HFRS cases in the 1980's. However, the epidemic characteristics of HFRS in Hubei are still not entirely clear and long-term, systematic investigations of this epidemic area have been very limited. Methods: The spatiotemporal distribution of HFRS was investigated using data spanning the years 1980 to 2009. The annual HFRS incidence, fatality rate and seasonal incidence between 1980 and 2009 were calculated and plotted. GIS-based spatial analyses were conducted to detect the spatial distribution and seasonal pattern of HFRS. A spatial statistical analysis, using Kulldorff's spatial scan statistic, was performed to identify clustering of HFRS. Results: A total of 104,467 HFRS cases were reported in Hubei Province between 1980 and 2009. Incidence of and mortality due to HFRS declined after the outbreak in 1980s and HFRS cases have been sporadic in recent years. The locations and scale of disease clusters have changed during the three decades. The seasonal epidemic pattern of HFRS was characterized by the shift from the unimodal type (autumn/winter peak) to the bimodal type. Conclusions: Socioeconomic development has great influence on the transmission of hantaviruses to humans and new epidemic characteristics have emerged in Hubei Province. It is necessary to reinforce preventative measures against HFRS according to the newly-presented seasonal variation and to intensify these efforts especially in the urban areas of Hubei Province.	[Zhang, Yi-Hui; Xiong, Hai-Rong; Liu, Yuan-Yuan; Liu, Dong-Ying; Luo, Fan; Li, Jin-Lin; Ling, Jia-Xin; Chen, Wen; Liu, Jing; Hou, Wei; Yang, Zhan-Qiu] Wuhan Univ, Sch Med, Inst Med Virol, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Ge, Liang] Tianjin Inst Surveying & Mapping, Tianjin, Peoples R China; [Liu, Li; Huo, Xi-Xiang] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Hubei, Peoples R China; [Zhang, Yun] Inst Mil Med Sci, Nanjing, Jiangsu, Peoples R China; [Fan, Hong] Wuhan Univ, State Key Lab Informat Engn Survey Mapping & Remo, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Wuhan University	Yang, ZQ (corresponding author), Wuhan Univ, Sch Med, Inst Med Virol, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	zqyang@whu.edu.cn	xiong, hai/GVT-7305-2022; hou, wei/GWM-4800-2022	Li, Jinlin/0000-0002-8998-9278; Ge, Liang/0000-0002-3365-353X	National High Technology Research and Development 863 Program of China [2007AA02Z465]; National Natural Science Foundation of China (NSFC) [81371865, 30770096, 81000734]; Specialized Research Fund for the Doctoral Program of Higher Education of China [2009141120013]; Natural Science Foundation of Hubei Province [2011CDB467]	National High Technology Research and Development 863 Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work was supported by the National High Technology Research and Development 863 Program of China (No. 2007AA02Z465), grants from the National Natural Science Foundation of China (NSFC project No. 81371865, 30770096, 81000734), Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 2009141120013), and Natural Science Foundation of Hubei Province (2011CDB467). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An XR, 2008, POLICY, P15; ARMSTRONG LR, 1995, J INFECT DIS, V172, P1166, DOI 10.1093/infdis/172.4.1166; Bi P, 1998, AM J EPIDEMIOL, V148, P276, DOI 10.1093/oxfordjournals.aje.a009636; Bi P, 2002, INT J EPIDEMIOL, V31, P189, DOI 10.1093/ije/31.1.189; Bi ZQ, 2008, J INFECT DEV COUNTR, V2, P3; CHEN HX, 1993, CHINESE MED J-PEKING, V106, P857; CHEN HX, 1986, J INFECT DIS, V154, P394, DOI 10.1093/infdis/154.3.394; Chen HX, 2001, HEMORRHAGIC FEVER RE; Chen HX, 1994, ZHONGHUA LIU XING BI, V8, P197; Dai XW, 1995, XIN CHAO LUN CONG, P13; Engelthaler DM, 1999, EMERG INFECT DIS, V5, P87, DOI 10.3201/eid0501.990110; Fang LQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000789; Fang LQ, 2009, EMERG INFECT DIS, V15, P2043, DOI 10.3201/eid1512.081078; Fang LQ, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-77; Hjalmars U, 1996, STAT MED, V15, P707, DOI 10.1002/(SICI)1097-0258(19960415)15:7/9<707::AID-SIM242>3.3.CO;2-W; Jiang JF, 2007, VIRUS RES, V130, P292, DOI 10.1016/j.virusres.2007.05.021; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; KIM YS, 1995, NEPHRON, V71, P419, DOI 10.1159/000188762; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M, 2006, SATSCAN V6 1 SOFTWAR; [李波 Li Bo], 2005, [中国生态农业学报, Chinese journal of eco-agriculture], V13, P152; Li Q, 2005, ACTA VIROL, V49, P51; Liu J, 2012, VIRUS RES, V163, P439, DOI 10.1016/j.virusres.2011.11.006; Liu XD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-331; Plyusnin A, 2001, CURR TOP MICROBIOL, V256, P47; Reusken C, 2013, CURR OPIN VIROL, V3, P92, DOI 10.1016/j.coviro.2013.01.002; Tang F, 2003, CHIN J VECTOR BIO CO, V14, P315; Tang Li-hua, 2007, Chinese Journal of Virology, V23, P320; Vaheri A, 2013, NAT REV MICROBIOL, V11, P539, DOI 10.1038/nrmicro3066; Vaheri A, 2013, REV MED VIROL, V23, P35, DOI 10.1002/rmv.1722; Wu W, 2009, EPIDEMIOL INFECT, V137, P1766, DOI 10.1017/S0950268809002659; Wu YW, 2007, INT J ENVIRON HEAL R, V17, P25, DOI 10.1080/09603120601124280; XIAO SY, 1993, J GEN VIROL, V74, P1657, DOI 10.1099/0022-1317-74-8-1657; Xiong HR, 2011, EUR J CLIN MICROBIOL, V30, P645, DOI 10.1007/s10096-010-1134-5; Xu JJ, 1994, JIN RI HU BEI, P22; Yan L, 2007, EMERG INFECT DIS, V13, P1301, DOI 10.3201/eid1309.061481; Yang MX, 2008, POLICY, P31; Zeier M, 2005, VIRUS GENES, V30, P157, DOI 10.1007/s11262-004-5625-2; Zhang M.W., 2003, ZHONG GUO NONG YE KE, V36, P223; Zhang Yong-Zhen, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P466; Zhang YZ, 2010, EMERG INFECT DIS, V16, P1195, DOI 10.3201/eid1608.090470; Zhang YZ, 2009, EMERG INFECT DIS, V15, P885, DOI 10.3201/eid1506.081126; Zou Y, 2008, J MED VIROL, V80, P680, DOI 10.1002/jmv.21119; Zuo SQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000945	44	14	23	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92700	10.1371/journal.pone.0092700	http://dx.doi.org/10.1371/journal.pone.0092700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658382	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300119
J	Bhardwaj, AR; Joshi, G; Pandey, R; Kukreja, B; Goel, S; Jagannath, A; Kumar, A; Katiyar-Agarwal, S; Agarwal, M				Bhardwaj, Ankur R.; Joshi, Gopal; Pandey, Ritu; Kukreja, Bharti; Goel, Shailendra; Jagannath, Arun; Kumar, Amar; Katiyar-Agarwal, Surekha; Agarwal, Manu			A Genome-Wide Perspective of miRNAome in Response to High Temperature, Salinity and Drought Stresses in Brassica juncea (Czern) L.	PLOS ONE			English	Article							SMALL RNAS; SUPEROXIDE-DISMUTASE; TARGET GENES; COMPUTATIONAL IDENTIFICATION; COPPER CHAPERONE; INNATE IMMUNITY; MICRORNAS; ARABIDOPSIS; NAPUS; EXPRESSION	Micro RNAs (miRNAs) are involved in diverse biological processes including adaptive response towards abiotic stresses. To unravel small RNAs and more specifically miRNAs that can potentially regulate determinants of abiotic stress tolerance, next generation sequencing of B. juncea seedlings subjected to high temperature, high salt and drought conditions was carried out. With the help of UEA sRNA workbench software package, 51 conserved miRNAs belonging to 30 miRNA families were identified. As there was limited genomic information available for B. juncea, we generated and assembled its genome sequence at a low coverage. Using the generated sequence and other publically available Brassica genomic/transcriptomic resources as mapping reference, 126 novel (not reported in any plant species) were discovered for the first time in B. juncea. Further analysis also revealed existence of 32 and 37 star sequences for conserved and novel miRNAs, respectively. The expression of selected conserved and novel miRNAs under conditions of different abiotic stresses was revalidated through universal TaqMan based real time PCR. Putative targets of identified conserved and novel miRNAs were predicted in B. rapa to gain insights into functional roles manifested by B. juncea miRNAs. Furthermore, SPL2-like, ARF17-like and a NAC domain containing protein were experimentally validated as targets of miR156, miR160 and miR164 respectively. Investigation of gene ontologies linked with targets of known and novel miRNAs forecasted their involvement in various biological functions.	[Bhardwaj, Ankur R.; Joshi, Gopal; Kukreja, Bharti; Goel, Shailendra; Jagannath, Arun; Kumar, Amar; Agarwal, Manu] Univ Delhi, Dept Bot, Delhi 110007, India; [Pandey, Ritu; Katiyar-Agarwal, Surekha] Univ Delhi, Dept Plant Mol Biol, Delhi 110007, India	University of Delhi; University of Delhi	Katiyar-Agarwal, S (corresponding author), Univ Delhi, Dept Plant Mol Biol, South Campus, Delhi 110007, India.	katiyars@south.du.ac.in; agarwalm71@gmail.com		Joshi, Gopal/0000-0002-6238-9926; Goel, Shailendra/0000-0002-8731-8892; AGARWAL, MANU/0000-0003-4241-5055	Department of Biotechnology (DBT), Delhi, India [BT/PR628/AGR/36/674/20111]; University of Delhi, Delhi, India; DBT, India; Council of Scientific and Industrial research (CSIR), India; DBT-funded High-Throughput Sequencing Facility at University of Delhi South Campus, University of Delhi, New Delhi, India	Department of Biotechnology (DBT), Delhi, India(Department of Biotechnology (DBT) India); University of Delhi, Delhi, India(University of Delhi); DBT, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); DBT-funded High-Throughput Sequencing Facility at University of Delhi South Campus, University of Delhi, New Delhi, India	The work was financially supported by grant from the Department of Biotechnology (DBT), Delhi, India (grant No. BT/PR628/AGR/36/674/20111. The support from University of Delhi, Delhi, India is also duly acknowledged. ARB, GJ and BK arc supported by DBT, India. RP is thankful for research fellowship from Council of Scientific and Industrial research (CSIR), India and DBT, India. Deep sequencing was carried out by DBT-funded High-Throughput Sequencing Facility at University of Delhi South Campus, University of Delhi, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2010, INDIAN J AGR SCI, V80, P1043; Aung K, 2006, PLANT PHYSIOL, V141, P1000, DOI 10.1104/pp.106.078063; Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; Beauclair L, 2010, PLANT J, V62, P454, DOI 10.1111/j.1365-313X.2010.04162.x; Benhassaine-Kesri G, 2002, PHYSIOL PLANTARUM, V115, P221, DOI 10.1034/j.1399-3054.2002.1150207.x; Bhuiyan NH, 2007, J EXP BOT, V58, P4203, DOI 10.1093/jxb/erm278; Chen XM, 2012, CURR OPIN GENET DEV, V22, P361, DOI 10.1016/j.gde.2012.04.004; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chu CC, 2005, PLANT PHYSIOL, V139, P425, DOI 10.1104/pp.105.065284; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dalal M, 2009, J BIOTECHNOL, V139, P137, DOI 10.1016/j.jbiotec.2008.09.014; Dhandapani V, 2011, MOL CELLS, V32, P21, DOI 10.1007/s10059-011-2313-7; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Ghuge SA, 2011, ARCH AGRON SOIL SCI, V57, P127, DOI 10.1080/03650340903296793; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Han YJ, 2012, PLANT CELL REP, V31, P1677, DOI 10.1007/s00299-012-1280-6; Herr AJ, 2005, FEBS LETT, V579, P5879, DOI 10.1016/j.febslet.2005.08.040; Huang SQ, 2010, PLANT BIOTECHNOL J, V8, P887, DOI 10.1111/j.1467-7652.2010.00517.x; Jamil M, 2007, Pak J Biol Sci, V10, P910, DOI 10.3923/pjbs.2007.910.914; Jia XY, 2009, J PLANT PHYSIOL, V166, P2046, DOI 10.1016/j.jplph.2009.06.011; Jia XY, 2009, PLANT MOL BIOL, V71, P51, DOI 10.1007/s11103-009-9508-8; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kawashima CG, 2009, PLANT J, V57, P313, DOI 10.1111/j.1365-313X.2008.03690.x; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim B, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-218; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; Korbes AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050663; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Lee KH, 2006, CELL, V126, P1109, DOI 10.1016/j.cell.2006.07.034; Li T, 2011, NUCLEIC ACIDS RES, V39, P2821, DOI 10.1093/nar/gkq1047; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Li Y, 2010, PLANT PHYSIOL, V152, P2222, DOI 10.1104/pp.109.151803; Liang G, 2010, PLANT J, V62, P1046, DOI 10.1111/j.1365-313X.2010.04216.x; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Manavella PA, 2013, PLANT PHYSIOL, V161, P805, DOI 10.1104/pp.112.207068; Miyoshi K, 2010, MOL GENET GENOMICS, V284, P95, DOI 10.1007/s00438-010-0556-1; Moldovan D, 2010, J EXP BOT, V61, P165, DOI 10.1093/jxb/erp296; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Palmieri MC, 2010, PLANT PHYSIOL, V152, P1514, DOI 10.1104/pp.109.152579; Pant BD, 2009, PLANT PHYSIOL, V150, P1541, DOI 10.1104/pp.109.139139; Phillips JR, 2007, FEBS LETT, V581, P3592, DOI 10.1016/j.febslet.2007.04.007; Poethig RS, 2009, CURR OPIN GENET DEV, V19, P374, DOI 10.1016/j.gde.2009.06.001; Pradhan AK, 2003, THEOR APPL GENET, V106, P607, DOI 10.1007/s00122-002-1083-1; Purty Ram Singh, 2008, Physiology and Molecular Biology of Plants, V14, P39, DOI 10.1007/s12298-008-0004-4; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rogers K, 2013, PLANT CELL, V25, P2383, DOI 10.1105/tpc.113.113159; Rogers SO., 1994, PLANT MOL BIOL, V1, P183, DOI 10.1007/978-94-011-0511-8_12; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047810; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Song JB, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-210; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Srivastava S, 2013, J EXP BOT, V64, P303, DOI 10.1093/jxb/ers333; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Vidal EA, 2010, P NATL ACAD SCI USA, V107, P4477, DOI 10.1073/pnas.0909571107; Wang FD, 2012, MOL GENET GENOMICS, V287, P555, DOI 10.1007/s00438-012-0699-3; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang JY, 2012, GENE, V505, P300, DOI 10.1016/j.gene.2012.06.002; Wang PT, 2011, CHINESE SCI BULL, V56, P3538, DOI 10.1007/s11434-011-4802-7; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xie FL, 2007, FEBS LETT, V581, P1464, DOI 10.1016/j.febslet.2007.02.074; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Xu MY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-421; Yadava SK, 2012, THEOR APPL GENET, V125, P1553, DOI 10.1007/s00122-012-1934-3; Yamasaki H, 2007, J BIOL CHEM, V282, P16369, DOI 10.1074/jbc.M700138200; Yang JH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-9; Young LW, 2004, J EXP BOT, V55, P485, DOI 10.1093/jxb/erh038; Youssefi A., 2011, American-Eurasian Journal of Agricultural & Environmental Sciences, V11, P406; Yu X, 2012, J EXP BOT, V63, P1025, DOI 10.1093/jxb/err337; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang JZ, 2012, MOL BIOTECHNOL, V51, P44, DOI 10.1007/s12033-011-9439-x; Zhang WX, 2011, PLANT MOL BIOL, V75, P93, DOI 10.1007/s11103-010-9710-8; Zhang XM, 2011, MOL CELL, V42, P356, DOI 10.1016/j.molcel.2011.04.010; Zhao YT, 2012, PLANT PHYSIOL, V158, P813, DOI 10.1104/pp.111.187666; Zhou ZS, 2012, J EXP BOT, V63, P4597, DOI 10.1093/jxb/ers136; Zhou ZS, 2012, PLANT CELL ENVIRON, V35, P86, DOI 10.1111/j.1365-3040.2011.02418.x; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295	93	39	46	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92456	10.1371/journal.pone.0092456	http://dx.doi.org/10.1371/journal.pone.0092456			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671003	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000046
J	Brault, G; Shareck, F; Hurtubise, Y; Lepine, F; Doucet, N				Brault, Guillaume; Shareck, Francois; Hurtubise, Yves; Lepine, Francois; Doucet, Nicolas			Short-Chain Flavor Ester Synthesis in Organic Media by an E-coli Whole-Cell Biocatalyst Expressing a Newly Characterized Heterologous Lipase	PLOS ONE			English	Article							BIODIESEL PRODUCTION; IMMOBILIZED LIPASE; ENZYMATIC PRODUCTION; SOLVENT-FREE; ESTERIFICATION; SUBSTRATE; DISPLAY; ENZYMES; SURFACE; SYSTEM	Short-chain aliphatic esters are small volatile molecules that produce fruity and pleasant aromas and flavors. Most of these esters are artificially produced or extracted from natural sources at high cost. It is, however, possible to 'naturally' produce these molecules using biocatalysts such as lipases and esterases. A gene coding for a newly uncovered lipase was isolated from a previous metagenomic study and cloned into E. coli BL21 (DE3) for overexpression using the pET16b plasmid. Using this recombinant strain as a whole-cell biocatalyst, short chain esters were efficiently synthesized by transesterification and esterification reactions in organic media. The recombinant lipase (LipIAF5-2) showed good affinity toward glyceryl trioctanoate and the highest conversion yields were obtained for the transesterification of glyceryl triacetate with methanol. Using a simple cetyl-trimethylammonium bromide pretreatment increased the synthetic activity by a six-fold factor and the whole-cell biocatalyst showed the highest activity at 40 degrees C with a relatively high water content of 10% (w/w). The whole-cell biocatalyst showed excellent tolerance to alcohol and short-chain fatty acid denaturation. Substrate affinity was equally effective with all primary alcohols tested as acyl acceptors, with a slight preference for methanol. The best transesterification conversion of 50 mmol glyceryl triacetate into isoamyl acetate (banana fragrance) provided near 100% yield after 24 hours using 10% biocatalyst loading (w/w) in a fluidized bed reactor, allowing recycling of the biocatalyst up to five times. These results show promising potential for an industrial approach aimed at the biosynthesis of short-chain esters, namely for natural flavor and fragrance production in micro-aqueous media.	[Brault, Guillaume; Shareck, Francois; Lepine, Francois; Doucet, Nicolas] Univ Quebec, INRS Inst Armand Frappier, Laval, PQ, Canada; [Hurtubise, Yves] Innu Sci Canada Inc, Trois Rivieres, PQ, Canada; [Doucet, Nicolas] PROTEO, Quebec City, PQ, Canada; [Doucet, Nicolas] GRASP, Quebec City, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS)	Doucet, N (corresponding author), Univ Quebec, INRS Inst Armand Frappier, Laval, PQ, Canada.	nicolas.doucet@iaf.inrs.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) Collaborative Research and Development grant; NSERC Discovery grant [RGPIN 402623-2011]; Innu-Science Canada; BMP Innovation scholarship from NSERC; Fonds de Recherche du Quebec - Nature et Technologies; "Fonds de Recherche Quebec - Sante'' Research Scholar Junior 1 Career Award	Natural Sciences and Engineering Research Council of Canada (NSERC) Collaborative Research and Development grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Innu-Science Canada; BMP Innovation scholarship from NSERC; Fonds de Recherche du Quebec - Nature et Technologies; "Fonds de Recherche Quebec - Sante'' Research Scholar Junior 1 Career Award	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Collaborative Research and Development grant (awarded to FS) and NSERC Discovery grant RGPIN 402623-2011 (awarded to ND), as well as private funding from Innu-Science Canada. GB was the recipient of a BMP Innovation scholarship from NSERC and the Fonds de Recherche du Quebec - Nature et Technologies. ND is also supported by a "Fonds de Recherche Quebec - Sante'' Research Scholar Junior 1 Career Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas H, 2003, ENZYME MICROB TECH, V32, P589, DOI 10.1016/S0141-0229(03)00022-X; Balcao VM, 1996, ENZYME MICROB TECH, V18, P392, DOI 10.1016/0141-0229(95)00125-5; Ban K, 2002, J MOL CATAL B-ENZYM, V17, P157, DOI 10.1016/S1381-1177(02)00023-1; Ban K, 2001, BIOCHEM ENG J, V8, P39, DOI 10.1016/S1369-703X(00)00133-9; Becker S, 2005, FEBS LETT, V579, P1177, DOI 10.1016/j.febslet.2004.12.087; Berger RG, 2009, BIOTECHNOL LETT, V31, P1651, DOI 10.1007/s10529-009-0083-5; Brault G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032041; Canovas M, 2005, ENZYME MICROB TECH, V37, P300, DOI 10.1016/j.enzmictec.2004.07.023; Chen JP, 2010, APPL BIOCHEM BIOTECH, V161, P181, DOI 10.1007/s12010-009-8776-8; Cote A, 2008, ENZYME MICROB TECH, V42, P381, DOI 10.1016/j.enzmictec.2008.01.009; Cote A, 2010, J IND MICROBIOL BIOT, V37, P883, DOI 10.1007/s10295-010-0735-4; Dubal S.A., 2008, ADV BIOTECHNOL, V3, P20; Fjerbaek L, 2009, BIOTECHNOL BIOENG, V102, P1298, DOI 10.1002/bit.22256; Fontanille P, 2003, APPL MICROBIOL BIOT, V60, P534, DOI 10.1007/s00253-002-1164-8; Fukuda H, 2008, TRENDS BIOTECHNOL, V26, P668, DOI 10.1016/j.tibtech.2008.08.001; Gao B, 2009, J BIOTECHNOL, V139, P169, DOI 10.1016/j.jbiotec.2008.10.004; Glogauer A, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-54; Hama S, 2008, APPL MICROBIOL BIOT, V81, P637, DOI 10.1007/s00253-008-1689-6; Hasan F, 2006, ENZYME MICROB TECH, V39, P235, DOI 10.1016/j.enzmictec.2005.10.016; Hills G, 2003, EUR J LIPID SCI TECH, V105, P601, DOI 10.1002/ejlt.200300853; Ishige T, 2005, CURR OPIN CHEM BIOL, V9, P174, DOI 10.1016/j.cbpa.2005.02.001; Jaeger KE, 1998, TRENDS BIOTECHNOL, V16, P396, DOI 10.1016/S0167-7799(98)01195-0; Jin Z, 2012, J BIOTECHNOL, V159, P108, DOI 10.1016/j.jbiotec.2012.02.013; Kennedy J, 2011, J APPL MICROBIOL, V111, P787, DOI 10.1111/j.1365-2672.2011.05106.x; Klibanov AM, 2001, NATURE, V409, P241, DOI 10.1038/35051719; Krings U, 1998, APPL MICROBIOL BIOT, V49, P1, DOI 10.1007/s002530051129; Krings U, 2008, BIOTECHNOL LETT, V30, P1347, DOI 10.1007/s10529-008-9690-9; Krishna SH, 2001, J BIOTECHNOL, V87, P193, DOI 10.1016/S0168-1656(00)00432-6; Lee SH, 2004, APPL ENVIRON MICROB, V70, P5074, DOI 10.1128/AEM.70.9.5074-5080.2004; Li AT, 2012, BIORESOURCE TECHNOL, V114, P725, DOI 10.1016/j.biortech.2012.03.034; Li W, 2008, BIOCHEM ENG J, V41, P111, DOI 10.1016/j.bej.2008.04.003; Longo MA, 2006, FOOD TECHNOL BIOTECH, V44, P335; Lorenz P, 2005, NAT REV MICROBIOL, V3, P510, DOI 10.1038/nrmicro1161; Mahapatra P, 2009, J MOL CATAL B-ENZYM, V60, P57, DOI 10.1016/j.molcatb.2009.03.010; Matsumoto M, 2001, J CHEM TECHNOL BIOT, V76, P1070, DOI 10.1002/jctb.491; Matsumoto T, 2001, APPL MICROBIOL BIOT, V57, P515; Meilleur C, 2009, J IND MICROBIOL BIOT, V36, P853, DOI 10.1007/s10295-009-0562-7; Pagot Y, 1997, LETT APPL MICROBIOL, V25, P113, DOI 10.1046/j.1472-765X.1997.00182.x; Paiva AL, 2000, ENZYME MICROB TECH, V27, P187, DOI 10.1016/S0141-0229(00)00206-4; Palomo JM, 2003, BIOMACROMOLECULES, V4, P1, DOI 10.1021/bm025729+; Ranganathan SV, 2008, BIORESOURCE TECHNOL, V99, P3975, DOI 10.1016/j.biortech.2007.04.060; Romero MD, 2007, J BIOTECHNOL, V127, P269, DOI 10.1016/j.jbiotec.2006.07.009; Saponjic S, 2010, ELECTRON J BIOTECHN, V13, DOI 10.2225/vol13-issue6-fulltext-8; Schrader J, 2004, BIOTECHNOL LETT, V26, P463, DOI 10.1023/B:BILE.0000019576.80594.0e; Schreier P., 1997, BIOTECHNOLOGY AROMA, P51; Serra S, 2005, TRENDS BIOTECHNOL, V23, P193, DOI 10.1016/j.tibtech.2005.02.003; Sharma D, 2011, BIO-TECHNOL, V10, P23, DOI [10.3923/biotech.2011.23.40, DOI 10.3923/BI0TECH.2011.23.40, DOI 10.3923/BIOTECH.2011.23.40]; Vandamme EJ, 2002, J CHEM TECHNOL BIOT, V77, P1323, DOI 10.1002/jctb.722; Xu Y, 2012, J BIOTECHNOL, V162, P407, DOI 10.1016/j.jbiotec.2012.05.017; Yan JY, 2012, BIORESOURCE TECHNOL, V123, P332, DOI 10.1016/j.biortech.2012.07.103; YANG B, 1994, ENZYME MICROB TECH, V16, P577, DOI 10.1016/0141-0229(94)90122-8; Zheng GW, 2010, J BIOTECHNOL, V150, P108, DOI 10.1016/j.jbiotec.2010.07.007	52	38	42	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e91872	10.1371/journal.pone.0091872	http://dx.doi.org/10.1371/journal.pone.0091872			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670408	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000028
J	Hartanto, D; Kampmann, IL; Morina, N; Emmelkamp, PGM; Neerincx, MA; Brinkman, WP				Hartanto, Dwi; Kampmann, Isabel L.; Morina, Nexhmedin; Emmelkamp, Paul G. M.; Neerincx, Mark A.; Brinkman, Willem-Paul			Controlling Social Stress in Virtual Reality Environments	PLOS ONE			English	Article							PUBLIC SPEAKING; EXPOSURE THERAPY; ANXIETY; RESPONSES; PHOBIA; FEAR; VALIDATION; DISORDERS; DIALOGUE	Virtual reality exposure therapy has been proposed as a viable alternative in the treatment of anxiety disorders, including social anxiety disorder. Therapists could benefit from extensive control of anxiety eliciting stimuli during virtual exposure. Two stimuli controls are studied in this study: the social dialogue situation, and the dialogue feedback responses (negative or positive) between a human and a virtual character. In the first study, 16 participants were exposed in three virtual reality scenarios: a neutral virtual world, blind date scenario, and job interview scenario. Results showed a significant difference between the three virtual scenarios in the level of self-reported anxiety and heart rate. In the second study, 24 participants were exposed to a job interview scenario in a virtual environment where the ratio between negative and positive dialogue feedback responses of a virtual character was systematically varied on-the-fly. Results yielded that within a dialogue the more positive dialogue feedback resulted in less self-reported anxiety, lower heart rate, and longer answers, while more negative dialogue feedback of the virtual character resulted in the opposite. The correlations between on the one hand the dialogue stressor ratio and on the other hand the means of SUD score, heart rate and audio length in the eight dialogue conditions showed a strong relationship: r(6) = 0.91, p = 0.002; r(6) = 0.76, p = 0.028 and r(6) = -0.94, p = 0.001 respectively. Furthermore, more anticipatory anxiety reported before exposure was found to coincide with more self-reported anxiety, and shorter answers during the virtual exposure. These results demonstrate that social dialogues in a virtual environment can be effectively manipulated for therapeutic purposes.	[Hartanto, Dwi; Neerincx, Mark A.; Brinkman, Willem-Paul] Delft Univ Technol, Dept Intelligent Syst, Delft, Netherlands; [Kampmann, Isabel L.; Morina, Nexhmedin; Emmelkamp, Paul G. M.] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands; [Emmelkamp, Paul G. M.] King Abdulaziz Univ, Dept Psychol, Jeddah 21413, Saudi Arabia; [Neerincx, Mark A.] TNO Human Factors, Soesterberg, Netherlands	Delft University of Technology; University of Amsterdam; King Abdulaziz University; Netherlands Organization Applied Science Research	Hartanto, D (corresponding author), Delft Univ Technol, Dept Intelligent Syst, Delft, Netherlands.	d.hartanto@tudelft.nl	Morina, Nexhmedin/AAK-7071-2021; Morina, Nexhmedin/D-4976-2012; Brinkman, Willem-Paul/H-8159-2013; Neerincx, Mark/J-9086-2012; , paulemmelkamp/G-3274-2011	Morina, Nexhmedin/0000-0002-2331-9140; Brinkman, Willem-Paul/0000-0001-8485-7092; , paulemmelkamp/0000-0001-6066-5512	Netherlands Organization for Scientific Research (NWO) [655.010.207]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research is supported by the Netherlands Organization for Scientific Research (NWO), grant number 655.010.207. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler R. B, 2000, UNDERSTANDING HUMAN, V7th; Anderson P, 2003, COGN BEHAV PRACT, V10, P240, DOI 10.1016/S1077-7229(03)80036-6; Anderson PL, 2013, J CONSULT CLIN PSYCH, V81, P751, DOI 10.1037/a0033559; Beidel DC, 1989, J ANXIETY DIORD, V3, P149, DOI DOI 10.1016/0887-6185(89)90009-1; Brinkman WP, 2011, STUD HEALTH TECHNOL, V167, P86, DOI 10.3233/978-1-60750-766-6-86; Brinkman WP, 2010, INTERACT COMPUT, V22, P299, DOI 10.1016/j.intcom.2010.03.005; Brinkman WP, 2012, CHI 12 EXTENDED ABST, P1099; Brinkman WP, 2008, VIRTUAL REALITY EXPO, P85; Broekens Joost, 2012, Intelligent Virtual Agents. Proceedings 12th International Conference, IVA 2012, P218, DOI 10.1007/978-3-642-33197-8_23; Broekens J, 2013, INT J HUM-COMPUT ST, V71, P641, DOI 10.1016/j.ijhcs.2013.02.003; Brown EJ, 1997, PSYCHOL ASSESSMENT, V9, P21, DOI 10.1037/1040-3590.9.1.21; Busscher B, 2010, P ECCE2010 WORKSH CO, P978; Cooley C.H, 1902, HUMAN NATURE SOCIAL, P179; Emmelkamp PMG, 2013, BERGIN GARFIELDS HDB, P343; Garau M, 2005, PRESENCE-TELEOP VIRT, V14, P104, DOI 10.1162/1054746053890242; Garcia-Palacios A, 2007, CYBERPSYCHOL BEHAV, V10, P722, DOI 10.1089/cpb.2007.9962; Garcia-Palacios A, 2001, CYBERPSYCHOL BEHAV, V4, P341, DOI 10.1089/109493101300210231; GIBB JR, 1961, J COMMUN, V11, P141, DOI 10.1111/j.1460-2466.1961.tb00344.x; Graesser AC, 2004, BEHAV RES METH INS C, V36, P180, DOI 10.3758/BF03195563; Gregg L, 2007, SOC PSYCH PSYCH EPID, V42, P343, DOI 10.1007/s00127-007-0173-4; Grillon H., 2006, P 6 INT C DIS VIRT R, P105; Harris SR, 2002, CYBERPSYCHOL BEHAV, V5, P543, DOI 10.1089/109493102321018187; Hartanto D, 2012, STUD HEALTH TECHNOL, V181, P192, DOI 10.3233/978-1-61499-121-2-192; Heimberg R.G., 2002, COGNITIVE BEHAV GROU; Herbelin B, 2005, THESIS ECOLE POLYTEC; Hofmann S.G., 2008, COGNITIVE BEHAV THER, DOI [10.4324/9780203927526, DOI 10.4324/9780203927526]; Irtel H., 2008, PXLAB SELF ASSESSMEN; James LK, 2003, CYBERPSYCHOL BEHAV, V6, P237, DOI 10.1089/109493103322011515; Kang N, IEEE T AFFE IN PRESS; Kelly O, 2007, CYBERPSYCHOL BEHAV, V10, P655, DOI 10.1089/cpb.2007.9973; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim Yanghee, 2005, P FONETIK, P9; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Klinger E, 2005, CYBERPSYCHOL BEHAV, V8, P76, DOI 10.1089/cpb.2005.8.76; Klinger E, 2004, ST HEAL T, V99, P91; Krijn M, 2004, BEHAV RES THER, V42, P229, DOI 10.1016/S0005-7967(03)00139-6; Ku J, 2006, CYBERPSYCHOL BEHAV, V9, P531, DOI 10.1089/cpb.2006.9.531; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; Lee TY, 2007, 7TH IEEE INTERNATIONAL CONFERENCE ON ADVANCED LEARNING TECHNOLOGIES, PROCEEDINGS, P300, DOI 10.1109/ICALT.2007.87; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; Mitrovic A, 2012, COMPUTERS ED; Pan XN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032931; Parsons TD, 2008, J BEHAV THER EXP PSY, V39, P250, DOI 10.1016/j.jbtep.2007.07.007; Pertaub DP, 2002, PRESENCE-TELEOP VIRT, V11, P68, DOI 10.1162/105474602317343668; Pertaub DP, 2001, STUD HEALTH TECHNOL, V81, P372; Powers MB, 2008, J ANXIETY DISORD, V22, P561, DOI 10.1016/j.janxdis.2007.04.006; Qu C, COMPUTERS H IN PRESS; Reeves B., 1997, MEDIA EQUATION PEOPL, V34, p34, DOI 10.5860/CHOICE.34-3702; Rushforth M, 2009, LECT NOTES ARTIF INT, V5773, P541, DOI 10.1007/978-3-642-04380-2_82; Schilbach L, 2006, NEUROPSYCHOLOGIA, V44, P718, DOI 10.1016/j.neuropsychologia.2005.07.017; Schubert T, 2001, PRESENCE-VIRTUAL AUG, V10, P266, DOI 10.1162/105474601300343603; Slater M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000039; Slater M, 2006, PRESENCE-VIRTUAL AUG, V15, P553, DOI 10.1162/pres.15.5.553; Slater M, 2006, CYBERPSYCHOL BEHAV, V9, P627, DOI 10.1089/cpb.2006.9.627; Somerville LH, 2006, NAT NEUROSCI, V9, P1007, DOI 10.1038/nn1728; ter Heijden N, 2011, J CYBERTHERAPY REHAB, V4, P41; Wallergard M, 2011, PRESENCE-VIRTUAL AUG, V20, P325, DOI 10.1162/PRES_a_00052; Wolpe J, 1958, PSYCHOTHEAPY RECIPRO	58	52	55	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92804	10.1371/journal.pone.0092804	http://dx.doi.org/10.1371/journal.pone.0092804			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SR	24671006	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000077
J	Asante-Poku, A; Nyaho, MS; Borrell, S; Comas, I; Gagneux, S; Yeboah-Manu, D				Asante-Poku, Adwoa; Nyaho, Michael Selasi; Borrell, Sonia; Comas, Inaki; Gagneux, Sebastien; Yeboah-Manu, Dorothy			Evaluation of Customised Lineage-Specific Sets of MIRU-VNTR Loci for Genotyping Mycobacterium tuberculosis Complex Isolates in Ghana	PLOS ONE			English	Article							INTERSPERSED REPETITIVE UNITS; FRAGMENT-LENGTH-POLYMORPHISM; MOLECULAR EPIDEMIOLOGY; BEIJING FAMILY; GENETIC DIVERSITY; TANDEM REPEATS; IS6110; IDENTIFICATION; TRANSMISSION; PULMONARY	Background: Different combinations of variable number of tandem repeat (VNTR) loci have been proposed for genotyping Mycobacterium tuberculosis complex (MTBC). Existing VNTR schemes show different discriminatory capacity among the six human MTBC lineages. Here, we evaluated the discriminatory power of a "customized MIRU12" loci format proposed previously by Comas et al. based on the standard 24 loci defined by Supply et al. for VNTR-typing of MTBC in Ghana. Method: One hundred and fifty-eight MTBC isolates classified into Lineage 4 and Lineage 5 were used to compare a customized lineage-specific panel of 12 MIRU-VNTR loci ("customized MIRU-12") to the standard MIRU-15 genotyping scheme. The resolution power of each typing method was determined based on the Hunter-Gaston-Discriminatory Index (HGDI). A minimal set of customized MIRU-VNTR loci for typing Lineages 4 (Euro-American) and 5 (M. africanum West African 1) strains from Ghana was defined based on the cumulative HGDI. Results and Conclusion: Among the 106 Lineage 4 strains, the customized MIRU-12 identified a total of 104 distinct genotypes consisting of 2 clusters of 2 isolates each (clustering rate 1.8%), and 102 unique strains while standard MIRU-15 yielded a total of 105 different genotypes, including 1 cluster of 2 isolates (clustering rate: 0.9%) and 104 singletons. Among, 52 Lineage 5 isolates, customized MIRU-12 genotyping defined 51 patterns with 1 cluster of 2 isolates (clustering rate: 0.9%) and 50 unique strains whereas MIRU-15 classified all 52 strains as unique. Cumulative HGDI values for customized MIRU-12 for Lineages 4 and 5 were 0.98 respectively whilst that of standard MIRU-15 was 0.99. A union of loci from the customised MIRU-12 and standard MIRU-15 revealed a set of customized eight highly discriminatory loci: 4052, 2163B, 40, 4165, 2165, 10,16 and 26 with a cumulative HGDI of 0.99 for genotyping Lineage 4 and 5 strains from Ghana.	[Asante-Poku, Adwoa; Nyaho, Michael Selasi; Yeboah-Manu, Dorothy] Univ Ghana, Noguchi Mem Inst Med Res, Dept Bacteriol, Legon, Ghana; [Asante-Poku, Adwoa; Borrell, Sonia; Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Asante-Poku, Adwoa; Borrell, Sonia; Gagneux, Sebastien] Univ Basel, Basel, Switzerland; [Nyaho, Michael Selasi] Univ Ghana, Dept Biochem, Legon, Ghana; [Comas, Inaki] Ctr Publ Hlth Res, Genom & Hlth Unit, Valencia, Spain; [Comas, Inaki] CIBER Ctr Invest Biomed Red Epidemiol & Publ Hlth, Madrid, Spain	University of Ghana; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Ghana; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Yeboah-Manu, D (corresponding author), Univ Ghana, Noguchi Mem Inst Med Res, Dept Bacteriol, Legon, Ghana.	dyeboah-manu@noguchi.ug.edu.gh	Comas, Iñaki/AAA-1155-2019; Comas, Iñaki/F-1185-2011; Asante-Poku, Adwoa/AAF-5216-2020; Gagneux, Sebastien/ABE-7909-2020; Yeboah-Manu, Dorothy/A-1933-2016	Comas, Iñaki/0000-0001-5504-9408; Comas, Iñaki/0000-0001-5504-9408; Asante-Poku, Adwoa/0000-0001-8929-193X; Gagneux, Sebastien/0000-0001-7783-9048; Yeboah-Manu, Dorothy/0000-0002-1663-6287	UNICEF/UNDP/World Bank/WHO; Leverhulme-Royal Society Africa; NTP Ghana	UNICEF/UNDP/World Bank/WHO(World Health Organization); Leverhulme-Royal Society Africa; NTP Ghana	This study was supported financially by the UNICEF/UNDP/World Bank/WHO special program for research and training in Tropical Diseases for DY-M and the Leverhulme-Royal Society Africa (DY-M and SG) and NTP Ghana. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-110; Addo Kk, 2007, Ghana Med J, V41, P52; Allix C, 2006, J CLIN MICROBIOL, V44, P1951, DOI 10.1128/JCM.01775-05; [Anonymous], 2011, GHANA HEALTH SERVICE; [Anonymous], 2007, GUIDELINES FOR THE C; Assam Assam, 2013, BMC INFECTIOUS DISEA, V13, P431; Assam-Assam JP, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-94; Barlow REL, 2001, J MED MICROBIOL, V50, P902, DOI 10.1099/0022-1317-50-10-902; Blackwood KS, 2004, J CLIN MICROBIOL, V42, P5001, DOI 10.1128/JCM.42.11.5001-5006.2004; Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Coscolla M, 2013, EMERG INFECT DIS, V19, P969, DOI 10.3201/eid1906.121012; Cowan LS, 2005, J CLIN MICROBIOL, V43, P688, DOI 10.1128/JCM.43.2.688-695.2005; Cowan LS, 2002, J CLIN MICROBIOL, V40, P1592, DOI 10.1128/JCM.40.5.1592-1602.2002; Dong H., 2012, PLOS ONE, V7; Firdessa R, 2013, EMERG INFECT DIS, V19, P460, DOI 10.3201/eid1903.120256; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; Goyal M, 1999, J INFECTION, V38, P171, DOI 10.1016/S0163-4453(99)90246-3; Homolka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039855; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kan B, 2008, INT J TUBERC LUNG D, V12, P199; Kato-Maeda M, 2000, WESTERN J MED, V172, P256, DOI 10.1136/ewjm.172.4.256; Kim SJ, 2001, INT J TUBERC LUNG D, V5, P824; Kremer K, 2005, J CLIN MICROBIOL, V43, P314, DOI 10.1128/JCM.43.1.314-320.2005; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Mokrousov I, 2004, J CLIN MICROBIOL, V42, P2438, DOI 10.1128/JCM.42.6.2438-2444.2004; Murase Y, 2008, J MED MICROBIOL, V57, P873, DOI 10.1099/jmm.0.47564-0; Niobe-Eyangoh SN, 2003, J CLIN MICROBIOL, V41, P2547, DOI 10.1128/JCM.41.6.2547-2553.2003; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Savine E, 2002, J CLIN MICROBIOL, V40, P4561, DOI 10.1128/JCM.40.12.4561-4566.2002; Scott AN, 2005, J CLIN MICROBIOL, V43, P89, DOI 10.1128/JCM.43.1.89-94.2005; Shamputa IC, 2010, J CLIN MICROBIOL, V48, P387, DOI 10.1128/JCM.02167-09; Stucki D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041253; Sun YJ, 2004, J CLIN MICROBIOL, V42, P1986, DOI 10.1128/JCM.42.5.1986-1993.2004; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Wampande EM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-484; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yeboah-Manu D, 2001, J CLIN MICROBIOL, V39, P4166, DOI 10.1128/JCM.39.11.4166-4168.2001; Yeboah-Manu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021906; Yesilkaya H, 2006, J CLIN MICROBIOL, V44, P3826, DOI 10.1128/JCM.00225-06; Yong-Jiang S, 2004, J CLIN MICROBIOL, V42, P1986; Zhou A, 2011, INT J TUBERC LUNG D, V15, P517, DOI 10.5588/ijtld.10.0495	48	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92675	10.1371/journal.pone.0092675	http://dx.doi.org/10.1371/journal.pone.0092675			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667333	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000333675600063
J	Dhanwani, R; Khan, M; Lomash, V; Rao, PVL; Ly, H; Parida, M				Dhanwani, Rekha; Khan, Mohsin; Lomash, Vinay; Rao, Putcha Venkata Lakshmana; Ly, Hinh; Parida, Manmohan			Characterization of Chikungunya Virus Induced Host Response in a Mouse Model of Viral Myositis	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; PYRUVATE-KINASE; SYNOVIAL-FLUID; ARTHRITIS; CELLS; INFECTION; DISEASE; STRESS; INFLAMMATION; EXPRESSION	While a number of studies have documented the persistent presence of chikungunya virus (CHIKV) in muscle tissue with primary fibroblast as the preferable cell target, little is known regarding the alterations that take place in muscle tissue in response to CHIKV infection. Hence, in the present study a permissive mouse model of CHIKV infection was established and characterized in order to understand the pathophysiology of the disease. The two dimensional electrophoresis of muscle proteome performed for differential analysis indicated a drastic reprogramming of the proteins from various classes like stress, inflammation, cytoskeletal, energy and lipid metabolism. The roles of the affected proteins were explained in relation to virus induced myopathy which was further supported by the histopathological and behavioural experiments proving the lack of hind limb coordination and other loco-motor abnormalities in the infected mice. Also, the level of various pro-inflammatory mediators like IL-6, MCP-1, Rantes and TNF-alpha was significantly elevated in muscles of infected mice. Altogether this comprehensive study of characterizing CHIKV induced mouse myopathy provides many potential targets for further evaluation and biomarker study.	[Dhanwani, Rekha; Khan, Mohsin; Parida, Manmohan] DRDE, Dept Virol, Gwalior, India; [Lomash, Vinay] DRDE, Dept Pharmacol & Toxicol, Gwalior, India; [Rao, Putcha Venkata Lakshmana] Bharathiar Univ Campus, DRDO BU Ctr Life Sci, Coimbatore, Tamil Nadu, India; [Ly, Hinh] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN USA	Defence Research & Development Organisation (DRDO); Defence Research & Development Establishment (DRDE); Defence Research & Development Organisation (DRDO); Defence Research & Development Establishment (DRDE); Bharathiar University; Defence Research & Development Organisation (DRDO); DRDO BU Center Life Sciences; University of Minnesota System; University of Minnesota Twin Cities	Parida, M (corresponding author), DRDE, Dept Virol, Gwalior, India.	paridamm@rediffmail.com	Khan, Mohsin/O-2827-2013	Khan, Mohsin/0000-0002-4142-2213; LOMASH, VINAY/0000-0001-9556-0366	Defence Research and Development Organisation (DRDO), Govt. of India	Defence Research and Development Organisation (DRDO), Govt. of India(Defence Research & Development Organisation (DRDO))	The study was funded by Defence Research and Development Organisation (DRDO), Govt. of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abere B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034800; AlShamma MRR, 1997, THORAX, V52, P1056, DOI 10.1136/thx.52.12.1056; Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0; Baatartsogt O., 2009, Biotechnology, V8, P13; Butt RH, 2005, J PROTEOME RES, V4, P982, DOI 10.1021/pr050054d; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Dash PK, 2007, VECTOR-BORNE ZOONOT, V7, P519, DOI 10.1089/vbz.2007.7272; Dhanwani R, 2012, VIRUS RES, V163, P563, DOI 10.1016/j.virusres.2011.12.009; Dhanwani R, 2011, PROTEOMICS, V11, P1936, DOI 10.1002/pmic.201000500; Dong WJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2588; Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864; Escobedo J, 2004, FREE RADICAL BIO MED, V37, P1455, DOI 10.1016/j.freeradbiomed.2004.07.024; Fernandez-Arenas E, 2007, MOL CELL PROTEOMICS, V6, P460, DOI 10.1074/mcp.M600210-MCP200; FRANKE WW, 1979, EXP CELL RES, V123, P25, DOI 10.1016/0014-4827(79)90418-X; FRASER JRE, 1981, AUST NZ J MED, V11, P168, DOI 10.1111/j.1445-5994.1981.tb04226.x; Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09; Geiben-Lynn R, 2003, J BIOL CHEM, V278, P1569, DOI 10.1074/jbc.M209964200; Harley D, 2001, CLIN MICROBIOL REV, V14, P909, DOI 10.1128/CMR.14.4.909-932.2001; HAZELTON RA, 1985, AUST NZ J MED, V15, P336, DOI 10.1111/j.1445-5994.1985.tb04048.x; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; HIRUMA M, 1990, JPN J VET SCI, V52, P767; Ho PP, 2010, J IMMUNOL, V184, P379, DOI 10.4049/jimmunol.0901639; Jain M, 2008, TROP DOCT, V38, P70, DOI 10.1258/td.2007.070019; Koh TJ, 2004, AM J PHYSIOL-CELL PH, V286, pC713, DOI 10.1152/ajpcell.00341.2003; Liu YF, 2001, FRONT BIOSCI-LANDMRK, V6, pD12, DOI 10.2741/Liu; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARINKOVIC S, 1989, J IMMUNOL, V142, P808; Miller I, 1999, ELECTROPHORESIS, V20, P836, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<836::AID-ELPS836>3.0.CO;2-6; Moisan E, 2006, J LEUKOCYTE BIOL, V79, P489, DOI 10.1189/jlb.0405190; Morrison TE, 2006, J VIROL, V80, P737, DOI 10.1128/JVI.80.2.737-749.2006; Morrison TE, 2011, AM J PATHOL, V178, P32, DOI 10.1016/j.ajpath.2010.11.018; Naito H, 2000, J APPL PHYSIOL, V88, P359, DOI 10.1152/jappl.2000.88.1.359; Nakaya HI, 2012, ARTHRITIS RHEUM-US, V64, P3553, DOI 10.1002/art.34631; NIEDERMEIER W, 1965, ARTHRITIS RHEUM-US, V8, P355, DOI 10.1002/art.1780080303; Oliviero F, 2009, CLIN EXP RHEUMATOL, V27, P79; Oremek GM, 2003, ANTICANCER RES, V23, P1131; Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527; Patil DR, 2012, MICROBES INFECT, V14, P457, DOI 10.1016/j.micinf.2011.12.008; Queyriaux B, 2008, LANCET INFECT DIS, V8, P2, DOI 10.1016/S1473-3099(07)70294-3; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; RITTLING SR, 1987, MOL CELL BIOL, V7, P3908, DOI 10.1128/MCB.7.11.3908; Robin S, 2008, J CHILD NEUROL, V23, P1028, DOI 10.1177/0883073808314151; Rulli NE, 2011, J INFECT DIS, V204, P1026, DOI 10.1093/infdis/jir470; Sam I-C, 2006, Med J Malaysia, V61, P264; Santhosh SR, 2008, VIRUS RES, V135, P36, DOI 10.1016/j.virusres.2008.02.004; Santhosh SR, 2007, J CLIN VIROL, V39, P188, DOI 10.1016/j.jcv.2007.04.015; Seematter G, 2004, CURR OPIN CLIN NUTR, V7, P169, DOI 10.1097/00075197-200403000-00011; Selsby JT, 2005, AM J PHYSIOL-REG I, V289, pR134, DOI 10.1152/ajpregu.00497.2004; Sharma JN, 1976, INFLAMM RES, V6, P147; Shrivastav M, 2002, CLIN RHEUMATOL, V21, P505, DOI 10.1007/s100670200124; SKALLI O, 1991, CELL MOTIL CYTOSKEL, V19, P67, DOI 10.1002/cm.970190202; Soden M, 2000, ARTHRITIS RHEUM, V43, P365, DOI 10.1002/1529-0131(200002)43:2<365::AID-ANR16>3.0.CO;2-E; TESH RB, 1982, ANNU REV MED, V33, P31, DOI 10.1146/annurev.me.33.020182.000335; Trgovcich J, 1996, VIROLOGY, V224, P73, DOI 10.1006/viro.1996.0508; Villoing S, 2000, J VIROL, V74, P173, DOI 10.1128/JVI.74.1.173-183.2000; WELCH WJ, 1992, PHYSIOL REV, V72, P1063, DOI 10.1152/physrev.1992.72.4.1063; Wu XY, 2008, FEBS LETT, V582, P2155, DOI 10.1016/j.febslet.2008.05.033; Zhang P, 1997, J BIOL CHEM, V272, P30615, DOI 10.1074/jbc.272.49.30615; Ziegler SA, 2008, AM J TROP MED HYG, V79, P133, DOI 10.4269/ajtmh.2008.79.133	60	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92813	10.1371/journal.pone.0092813	http://dx.doi.org/10.1371/journal.pone.0092813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667237	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600080
J	Lyall, R; Ingle, RA; Illing, N				Lyall, Rafe; Ingle, Robert A.; Illing, Nicola			The Window of Desiccation Tolerance Shown by Early-Stage Germinating Seedlings Remains Open in the Resurrection Plant, Xerophyta viscosa	PLOS ONE			English	Article							GENTIAN AXILLARY BUDS; SEED DORMANCY; INDUCTION; MATURATION; PRECULTURE; MECHANISMS; EVOLUTION; SURVIVAL; SUCROSE	Resurrection plants are renowned for their vegetative desiccation tolerance (DT). While DT in vegetative tissues is rare in angiosperms, it is ubiquitous in mature orthodox seeds. During germination, seedlings gradually lose DT until they pass a point of no return, after which they can no longer survive dehydration. Here we investigate whether seedlings of the resurrection plant Xerophyta viscosa ever lose the capacity to establish DT. Seedlings from different stages of germination were dehydrated for 48 hours and assessed for their ability to recover upon rehydration. While a transient decline in the ability of X. viscosa seedlings to survive dehydration was observed, at no point during germination was the ability to re-establish DT completely lost in all seedlings. Pre-treatment of seedlings with PEG or sucrose reduced this transient decline, and improved the survival rate at all stages of germination. Additionally, we observed that the trait of poikilochlorophylly (or loss of chlorophyll) observed in adult X. viscosa leaves can be induced throughout seedling development. These results suggest that the window of DT seen in germinating orthodox seeds remains open in X. viscosa seedlings and that vegetative DT in Xerophyta species may have evolved from the ability to retain this program through to adulthood.	[Lyall, Rafe; Ingle, Robert A.; Illing, Nicola] Univ Cape Town, Dept Mol & Cell Biol, ZA-7700 Rondebosch, South Africa	University of Cape Town	Illing, N (corresponding author), Univ Cape Town, Dept Mol & Cell Biol, ZA-7700 Rondebosch, South Africa.	Nicola.Illing@uct.ac.za	Ingle, Robert A/C-5599-2008	Ingle, Robert A/0000-0002-8362-3777; Lyall, Rafe/0000-0003-3353-4212	National Research Foundation of South Africa; University of Cape Town	National Research Foundation of South Africa(National Research Foundation - South Africa); University of Cape Town	This research was supported by incentive funding from the National Research Foundation of South Africa (http://www.nrf.ac.za/index.php), and the University of Cape Town. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud S, 2002, PLANT PHYSIOL BIOCH, V40, P151, DOI 10.1016/S0981-9428(01)01350-X; Berjak P, 2006, SEED SCI RES, V16, P1, DOI 10.1079/SSR2005236; Bewley J. D., 1992, Water and life: comparative analysis of water relationships at the organismic, cellular and molecular level., P141; Bewley J. D., 2013, SEEDS, DOI [10.1017/S0960258513000287, DOI 10.1007/978-1-4614-4693-4_1]; BEWLEY JD, 1979, ANNU REV PLANT PHYS, V30, P195, DOI 10.1146/annurev.pp.30.060179.001211; BRUGGINK T, 1995, SEED SCI RES, V5, P1, DOI 10.1017/S096025850000252X; Buitink J, 2003, SEED SCI RES, V13, P273, DOI 10.1079/SSR2003145; Buitink J, 2008, CR BIOL, V331, P788, DOI 10.1016/j.crvi.2008.08.002; Buitink J, 2006, PLANT J, V47, P735, DOI 10.1111/j.1365-313X.2006.02822.x; Cuming AC, 1999, SEED PROTEINS, P753; Emery D.E., 1988, ICSID REV, V29, P451; EVENARI M., 1971, NEGEV CHALLENGE DESE; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; FRIEDMAN J, 1981, OECOLOGIA, V51, P400, DOI 10.1007/BF00540912; Gaff DF, 2013, FUNCT PLANT BIOL, V40, P315, DOI 10.1071/FP12321; Gibson SI, 2005, CURR OPIN PLANT BIOL, V8, P93, DOI 10.1016/j.pbi.2004.11.003; Gray A, 1887, ELEMENTS BOT BEGINNE; Gutterman Yitzchak, 2000, Plant Species Biology, V15, P113, DOI 10.1046/j.1442-1984.2000.00032.x; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Huang ZY, 2004, PLANT SOIL, V259, P231, DOI 10.1023/B:PLSO.0000020971.66784.fc; Illing N, 2005, INTEGR COMP BIOL, V45, P771, DOI 10.1093/icb/45.5.771; Ingle RA, 2007, PLANT CELL ENVIRON, V30, P435, DOI 10.1111/j.1365-3040.2006.01631.x; Kermode Allison R., 2002, P149, DOI 10.1079/9780851995342.0149; KERMODE AR, 1990, CRIT REV PLANT SCI, V9, P155, DOI 10.1080/07352689009382286; LEPRINCE O, 1990, PLANT CELL ENVIRON, V13, P539, DOI 10.1111/j.1365-3040.1990.tb01070.x; Lopez-Molina L, 2002, PLANT J, V32, P317, DOI 10.1046/j.1365-313X.2002.01430.x; Maia J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029123; MEURS C, 1992, PLANT PHYSIOL, V98, P1484, DOI 10.1104/pp.98.4.1484; MICHEL BE, 1983, PLANT PHYSIOL, V72, P66, DOI 10.1104/pp.72.1.66; Mundree S.G., 2000, PLANT TOLERANCE ABIO, P201; Negbi M, 1962, P MADRID S UNESCO, P249; Oliver M. J., 1996, Horticultural Reviews, V18, P171, DOI 10.1002/9780470650608.ch3; Oliver MJ, 2000, PLANT ECOL, V151, P85, DOI 10.1023/A:1026550808557; SARANGA Y, 1990, Hortscience, V25, P1088; Sarkar A, 2009, PLANT STEM CELLS; SENARATNA T, 1989, PLANT SCI, V65, P253, DOI 10.1016/0168-9452(89)90072-1; Suzuki M, 2005, PLANT CELL TISS ORG, V83, P115, DOI 10.1007/s11240-005-4854-y; Suzuki M, 1998, PLANT SCI, V135, P69, DOI 10.1016/S0168-9452(98)00054-5; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Vertucci C. W., 1995, SEED DEV GERMINATION, P237, DOI 10.1201/9780203740071-10; Vicente-Carbajosa J, 2005, INT J DEV BIOL, V49, P645, DOI 10.1387/ijdb.052046jc; Vieira CV, 2010, PLANT GROWTH REGUL, V62, P257, DOI 10.1007/s10725-010-9496-3	42	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93093	10.1371/journal.pone.0093093	http://dx.doi.org/10.1371/journal.pone.0093093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667896	gold, Green Published, Green Submitted			2022-12-27	WOS:000333675600137
J	Burrell, JR; Hornberger, M; Vucic, S; Kiernan, MC; Hodges, JR				Burrell, James R.; Hornberger, Michael; Vucic, Steve; Kiernan, Matthew C.; Hodges, John R.			Apraxia and Motor Dysfunction in Corticobasal Syndrome	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; AMYOTROPHIC-LATERAL-SCLEROSIS; ADDENBROOKES COGNITIVE EXAMINATION; PROGRESSIVE SUPRANUCLEAR PALSY; THRESHOLD TRACKING TECHNIQUES; FRONTOTEMPORAL DEMENTIA; LIMB APRAXIA; ALZHEIMERS-DISEASE; CORTICAL HYPEREXCITABILITY; DEGENERATION SYNDROME	Background: Corticobasal syndrome (CBS) is characterized by multifaceted motor system dysfunction and cognitive disturbance; distinctive clinical features include limb apraxia and visuospatial dysfunction. Transcranial magnetic stimulation (TMS) has been used to study motor system dysfunction in CBS, but the relationship of TMS parameters to clinical features has not been studied. The present study explored several hypotheses; firstly, that limb apraxia may be partly due to visuospatial impairment in CBS. Secondly, that motor system dysfunction can be demonstrated in CBS, using threshold-tracking TMS, and is linked to limb apraxia. Finally, that atrophy of the primary motor cortex, studied using voxel-based morphometry analysis (VBM), is associated with motor system dysfunction and limb apraxia in CBS. Methods: Imitation of meaningful and meaningless hand gestures was graded to assess limb apraxia, while cognitive performance was assessed using the Addenbrooke's Cognitive Examination - Revised (ACE-R), with particular emphasis placed on the visuospatial subtask. Patients underwent TMS, to assess cortical function, and VBM. Results: In total, 17 patients with CBS (7 male, 10 female; mean age 64.4+/- 6.6 years) were studied and compared to 17 matched control subjects. Of the CBS patients, 23.5% had a relatively inexcitable motor cortex, with evidence of cortical dysfunction in the remaining 76.5% patients. Reduced resting motor threshold, and visuospatial performance, correlated with limb apraxia. Patients with a resting motor threshold <50% performed significantly worse on the visuospatial sub-task of the ACE-R than other CBS patients. Cortical function correlated with atrophy of the primary and pre-motor cortices, and the thalamus, while apraxia correlated with atrophy of the pre-motor and parietal cortices. Conclusions: Cortical dysfunction appears to underlie the core clinical features of CBS, and is associated with atrophy of the primary motor and pre-motor cortices, as well as the thalamus, while apraxia correlates with pre-motor and parietal atrophy.	[Burrell, James R.; Hornberger, Michael; Vucic, Steve; Kiernan, Matthew C.; Hodges, John R.] Neurosci Res Australia, Sydney, NSW, Australia; [Burrell, James R.; Kiernan, Matthew C.] Prince Wales Clin Sch Hosp, Sydney, NSW, Australia; [Burrell, James R.; Hornberger, Michael; Kiernan, Matthew C.; Hodges, John R.] Univ New S Wales, Sydney, NSW, Australia; [Vucic, Steve] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	Neuroscience Research Australia; University of New South Wales Sydney; University of Sydney	Hodges, JR (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	j.hodges@neura.edu.au	Hornberger, Michael/C-9610-2011; Kiernan, Matthew C/E-4460-2011	Hornberger, Michael/0000-0002-2214-3788; Kiernan, Matthew/0000-0001-9054-026X; Vucic, Steve/0000-0002-8323-873X; Burrell, James/0000-0001-9638-2768	National Health and Medical Research Council of Australia; Motor Neuron Disease Research Institute of Australia; Australian Research Council Discovery Grant; Australian Research Council Federation Fellowship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Motor Neuron Disease Research Institute of Australia; Australian Research Council Discovery Grant(Australian Research Council); Australian Research Council Federation Fellowship(Australian Research Council)	JRB gratefully acknowledges funding support from the National Health and Medical Research Council of Australia and the Motor Neuron Disease Research Institute of Australia. MH is supported by an Australian Research Council Discovery Grant. SV and MCK acknowledge funding support from the National Health and Medical Research Council of Australia. JRH is supported by an Australian Research Council Federation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberici A, 2008, ACTA NEUROL SCAND, V118, P275, DOI 10.1111/j.1600-0404.2008.01017.x; Almeida QJ, 2002, BRAIN COGNITION, V48, P253, DOI 10.1006/breg.2001.1356; Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R, 2007, TR07JA2 FMRIB; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Boeve BF, 1999, NEUROLOGY, V53, P795, DOI 10.1212/WNL.53.4.795; Boeve BF, 2003, ANN NEUROL, V54, pS15, DOI 10.1002/ana.10570; Borroni B, 2008, ARCH NEUROL-CHICAGO, V65, P796, DOI 10.1001/archneur.65.6.796; Burrell JR, 2012, NEUROLOGY, V78, P1816, DOI 10.1212/WNL.0b013e318258f75c; Burrell JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061025; Burrell JR, 2011, BRAIN, V134, P2582, DOI 10.1093/brain/awr195; Burrell JR, 2011, AMYOTROPH LATERAL SC, V12, P283, DOI 10.3109/17482968.2011.551940; Buxbaum LJ, 2007, CORTEX, V43, P411, DOI 10.1016/S0010-9452(08)70466-0; CANTELLO R, 1992, NEUROLOGY, V42, P1951; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chen R, 2008, CLIN NEUROPHYSIOL, V119, P504, DOI 10.1016/j.clinph.2007.10.014; CLAUS D, 1990, MUSCLE NERVE, V13, P1125, DOI 10.1002/mus.880131207; DERENZI E, 1988, BRAIN, V111, P1173, DOI 10.1093/brain/111.5.1173; Di Lazzaro V, 2004, J NEUROL NEUROSUR PS, V75, P555, DOI 10.1136/jnnp.2003.018127; Fisher RJ, 2002, EXP BRAIN RES, V143, P240, DOI 10.1007/s00221-001-0988-2; Frasson E, 2003, CLIN NEUROPHYSIOL, V114, P272, DOI 10.1016/S1388-2457(02)00340-1; Fukui T, 1996, NEUROLOGY, V47, P467, DOI 10.1212/WNL.47.2.467; GOLDENBERG G, 1986, J NEUROL NEUROSUR PS, V49, P1266, DOI 10.1136/jnnp.49.11.1266; Goldenberg G, 2013, BRAIN, V136, P2592, DOI 10.1093/brain/awt181; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gottlieb J, 2010, CURR OPIN NEUROBIOL, V20, P731, DOI 10.1016/j.conb.2010.09.015; Graham NL, 2003, NEUROLOGY, V61, P493, DOI 10.1212/01.WNL.0000081230.09863.ED; Graham NL, 2003, MOVEMENT DISORD, V18, P1224, DOI 10.1002/mds.10536; Gross RG, 2008, CURR NEUROL NEUROSCI, V8, P490, DOI 10.1007/s11910-008-0078-y; Haaland KY, 2000, BRAIN, V123, P2306, DOI 10.1093/brain/123.11.2306; Heath M, 2001, BRAIN COGNITION, V46, P165, DOI 10.1016/S0278-2626(01)80057-9; Hodges JR, 2007, COGNITIVE ASSESSMENT; Holl AK, 2011, NEURODEGENER DIS, V8, P208, DOI 10.1159/000322230; Hornberger M, 2011, BRAIN, V134, P2502, DOI 10.1093/brain/awr173; Huey ED, 2009, ARCH NEUROL-CHICAGO, V66, P1274, DOI 10.1001/archneurol.2009.218; Josephs KA, 2010, MOVEMENT DISORD, V25, P1246, DOI 10.1002/mds.23062; Kertesz A, 2000, NEUROLOGY, V55, P1368, DOI 10.1212/WNL.55.9.1368; Kertesz A, 2010, J NEUROL SCI, V289, P138, DOI 10.1016/j.jns.2009.08.036; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kuhn AA, 2004, CLIN NEUROPHYSIOL, V115, P1786, DOI 10.1016/j.clinph.2004.03.020; Lang AE, 1994, NEURODEGENER DIS, P877; Lee SE, 2011, ANN NEUROL, V70, P327, DOI 10.1002/ana.22424; Leiguarda R, 2001, NEUROIMAGE, V14, pS137, DOI 10.1006/nimg.2001.0833; LEIGUARDA R, 1994, J NEUROL NEUROSUR PS, V57, P455, DOI 10.1136/jnnp.57.4.455; Ling HL, 2010, BRAIN, V133, P2045, DOI 10.1093/brain/awq123; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Mathew R, 2012, J NEUROL NEUROSUR PS, V83, P405, DOI 10.1136/jnnp-2011-300875; Mathew R, 2011, DEMENT GERIATR COGN, V31, P254, DOI 10.1159/000327169; Mathuranath PS, 2000, NEUROLOGY, V55, P1613, DOI 10.1212/01.wnl.0000434309.85312.19; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Morgan G. A., 2011, IBM SPSS INTERMEDIAT; OKUDA B, 1994, J NEUROL NEUROSUR PS, V57, P1548, DOI 10.1136/jnnp.57.12.1548; Okuma Y, 2000, ACTA NEUROL SCAND, V102, P244, DOI 10.1034/j.1600-0404.2000.102004244.x; Pal PK, 2008, J CLIN NEUROPHYSIOL, V25, P304, DOI 10.1097/WNP.0b013e318182d304; Pazzaglia M, 2008, J NEUROSCI, V28, P3030, DOI 10.1523/JNEUROSCI.5748-07.2008; Pengas G, 2010, NEUROBIOL AGING, V31, P25, DOI 10.1016/j.neurobiolaging.2008.03.014; Pramstaller PP, 1996, BRAIN, V119, P319, DOI 10.1093/brain/119.1.319; RINNE JO, 1994, BRAIN, V117, P1183, DOI 10.1093/brain/117.5.1183; ROBINSON LR, 1988, MUSCLE NERVE, V11, P174, DOI 10.1002/mus.880110214; Rohrer JD, 2010, J NEUROL, V257, P569, DOI 10.1007/s00415-009-5371-4; ROTHI LJG, 1991, COGN NEUROPSYCHOL, V8, P443, DOI 10.1080/02643299108253382; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Shelley BP, 2009, MOVEMENT DISORD, V24, P1593, DOI 10.1002/mds.22558; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Soliveri P, 2005, NEUROLOGY, V64, P448, DOI 10.1212/01.WNL.0000150732.92567.BA; Stamenova V, 2011, CORTEX, V47, P460, DOI 10.1016/j.cortex.2010.04.010; Tsuchiya K, 1997, ACTA NEUROPATHOL, V94, P416, DOI 10.1007/s004010050728; Valls-Sole J, 2001, BRAIN, V124, P1131, DOI 10.1093/brain/124.6.1131; Vucic S, 2006, MUSCLE NERVE, V33, P477, DOI 10.1002/mus.20481; Vucic S, 2008, BRAIN, V131, P1540, DOI 10.1093/brain/awn071; Vucic S, 2008, CLIN NEUROPHYSIOL, V119, P1088, DOI 10.1016/j.clinph.2008.01.011; Vucic S, 2006, BRAIN, V129, P2436, DOI 10.1093/brain/awl172; WATSON RT, 1986, ARCH NEUROL-CHICAGO, V43, P787, DOI 10.1001/archneur.1986.00520080035016; Whitwell JL, 2010, NEUROLOGY, V75, P1879, DOI 10.1212/WNL.0b013e3181feb2e8; Zadikoff C, 2005, BRAIN, V128, P1480, DOI 10.1093/brain/awh560; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Ziemann U, 2004, CLIN NEUROPHYSIOL, V115, P1717, DOI 10.1016/j.clinph.2004.03.006; Ziemann U., 2004, HAND CLIN N, V4, P317; Zwinkels A, 2004, CLIN REHABIL, V18, P819, DOI 10.1191/0269215504cr816oa	80	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92944	10.1371/journal.pone.0092944	http://dx.doi.org/10.1371/journal.pone.0092944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664085	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900133
J	Choi, H; Kim, YK; Oh, SW; Im, HJ; Hwang, DW; Kang, H; Lee, B; Lee, YS; Jeong, JM; Kim, EE; Chung, JK; Lee, DS				Choi, Hongyoon; Kim, Yu Kyeong; Oh, So Won; Im, Hyung-Jun; Hwang, Do Won; Kang, Hyejin; Lee, Boeun; Lee, Yun-Sang; Jeong, Jae Min; Kim, E. Edmund; Chung, June-Key; Lee, Dong Soo			In Vivo Imaging of mGluR5 Changes during Epileptogenesis Using [C-11]ABP688 PET in Pilocarpine-Induced Epilepsy Rat Model	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; INDUCED STATUS-EPILEPTICUS; UP-REGULATION; EXPRESSION; C-11-ABP688; DEPRESSION; REDUCTION; SUBTYPE-5; BINDING; ROLES	Introduction: Metabotropic glutamate receptor 5 (mGluR5) that regulates glutamatergic neurotransmission contributes to pathophysiology of epilepsy. In this study, we monitored the changes of mGluR5 in vivo using [C-11]ABP688 PET during the epileptogenesis in a pilocarpine-induced epilepsy rat model. Methods: In vivo mGluR5 images were acquired using [C-11]ABP688 microPET/CT in pilocarpine-induced chronic epilepsy rat models and controls. We also acquired microPET/CT at acute, subacute as well as chronic periods after status epilepticus. Non-displaceable binding potential (BPND) of [C-11]ABP688 was calculated using simplified reference tissue model in a voxel-based manner. mGluR5 BPND of the rat brains of epilepsy models and controls were compared. Results: Status epilepticus developed after pilocarpine administration and was followed by recurrent spontaneous seizures for more than 3 weeks. In chronic epilepsy rat model, BPND in hippocampus and amygdala was reduced on a voxel-based analysis. Temporal changes of mGluR5 BPND was also found. In acute period after status epilepticus, mGluR5 BPND was reduced in the whole brain. BPND of caudate-putamen was restored in subacute period, while BPND of the rest of the brain was still lower. In chronic period, global BPND was normalized except in hippocampus and amygdala. Conclusions: In vivo imaging of mGluR5 using [C-11]ABP688 microPET/CT could successfully reveal the regional changes of mGluR5 binding potential of the rat brain in a pilocarpine-induced epilepsy model. The temporal and spatial changes in mGluR5 availability suggest [C-11]ABP688 PET imaging in epilepsy provide abnormal glutamatergic network during epileptogenesis.	[Choi, Hongyoon; Kim, Yu Kyeong; Oh, So Won; Im, Hyung-Jun; Hwang, Do Won; Kang, Hyejin; Lee, Boeun; Lee, Yun-Sang; Jeong, Jae Min; Kim, E. Edmund; Chung, June-Key; Lee, Dong Soo] Seoul Natl Univ, Coll Med, Dept Nucl Med, Seoul, South Korea; [Kim, Yu Kyeong; Oh, So Won] Seoul Natl Univ, Boramae Med Ctr, Dept Nucl Med, Seoul, South Korea; [Hwang, Do Won] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Choi, Hongyoon; Im, Hyung-Jun; Lee, Boeun; Kim, E. Edmund; Lee, Dong Soo] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, YK (corresponding author), Seoul Natl Univ, Coll Med, Dept Nucl Med, Seoul, South Korea.	yk3181@snu.ac.kr; dsl@plaza.snu.ac.kr	Im, Hyung-jun/AAY-1309-2020; Im, Hyung-Jun/D-7588-2017; Hong, Juyeon/G-2059-2010; Lee, Boeun/AAG-4646-2022; Lee, Boeun/ADT-1205-2022; Jeong, Jae Min/E-2102-2012	Lee, Boeun/0000-0002-7525-7164; Lee, Boeun/0000-0002-7525-7164; Jeong, Jae Min/0000-0003-2611-6020; Choi, Hongyoon/0000-0002-8895-2449	Nano-Biotechnology Project (Regenomics) [20100002086]; WCU [R31-2008-000-10103-0]; future-based technology development program [20100028755]; Basic Science Research Program through the National Research Foundation of Korea (NRF) [2012R1A1A2008799, 2011-0030815, 2008-0060169]; Ministry of Education, Science and Technology (MEST); Korea Research Council of Fundamental Science & Technology (KRCF), Korea [kiom-2010-2]	Nano-Biotechnology Project (Regenomics); WCU; future-based technology development program; Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Research Council of Fundamental Science & Technology (KRCF), Korea	This work was supported by the Nano-Biotechnology Project (Regenomics, 20100002086), WCU project (R31-2008-000-10103-0), the future-based technology development program (20100028755), Basic Science Research Program (2012R1A1A2008799, No. 2011-0030815, and No. 2008-0060169) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) and a grant (kiom-2010-2) from the Inter-Institutional Collaboration Research Program provided by the Korea Research Council of Fundamental Science & Technology (KRCF), Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkus F, 2013, P NATL ACAD SCI USA, V110, P737, DOI 10.1073/pnas.1210984110; Ametamey SM, 2007, J NUCL MED, V48, P247; Ametamey SM, 2006, J NUCL MED, V47, P698; Aronica E, 2003, EPILEPSIA, V44, P785, DOI 10.1046/j.1528-1157.2003.54802.x; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Bianchi R., 2012, JASPERS BASIC MECH E; Blumcke I, 2000, J NEUROPATH EXP NEUR, V59, P1; Cavarsan CF, 2012, EPILEPSY RES, V101, P253, DOI 10.1016/j.eplepsyres.2012.04.011; Costa MS, 2004, NEUROSCI LETT, V356, P41, DOI 10.1016/j.neulet.2003.11.019; Deschwanden A, 2011, AM J PSYCHIAT, V168, P727, DOI 10.1176/appi.ajp.2011.09111607; Doherty J, 2002, CNS NEUROL DISORD-DR, V1, P251, DOI 10.2174/1568007023339355; Elmenhorst D, 2010, J CEREBR BLOOD F MET, V30, P1538, DOI 10.1038/jcbfm.2010.65; Enz R, 2012, CURR DRUG TARGETS, V13, P145, DOI 10.2174/138945012798868452; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Kirschstein T, 2007, J NEUROSCI, V27, P7696, DOI 10.1523/JNEUROSCI.4572-06.2007; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Lee H, 2009, KOREAN J PATHOL, V43, P43, DOI 10.4132/KoreanJPathol.2009.43.1.43; Lojkova-Janeckova D, 2009, EPILEPSIA, V50, P2123, DOI 10.1111/j.1528-1167.2009.02091.x; Merlin Lisa R, 2008, Epilepsy Curr, V8, P43, DOI 10.1111/j.1535-7511.2008.00232.x; Merlin LR, 2002, J NEUROPHYSIOL, V87, P621, DOI 10.1152/jn.00579.2001; Miyake N, 2011, BIOL PSYCHIAT, V69, P822, DOI 10.1016/j.biopsych.2010.12.023; Nairismagi J, 2006, EPILEPSIA, V47, P479, DOI 10.1111/j.1528-1167.2006.00455.x; Niessen HG, 2005, EPILEPSIA, V46, P1021, DOI 10.1111/j.1528-1167.2005.60704.x; Notenboom RGE, 2006, BRAIN, V129, P96, DOI 10.1093/brain/awh673; RACINE R, 1972, ELECTROEN CLIN NEURO, V32, P295, DOI 10.1016/0013-4694(72)90178-2; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Sakagami Y, 2005, EUR J NEUROSCI, V21, P3229, DOI 10.1111/j.1460-9568.2005.04165.x; Schiffer WK, 2006, J NEUROSCI METH, V155, P272, DOI 10.1016/j.jneumeth.2006.01.027; Tang FR, 2007, NEUROPHARMACOLOGY, V53, P821, DOI 10.1016/j.neuropharm.2007.08.012; Ure J, 2006, J NEUROL SCI, V247, P1, DOI 10.1016/j.jns.2006.03.018; Wang JQ, 2007, SYNAPSE, V61, P951, DOI 10.1002/syn.20445; Watabe AM, 2002, J NEUROPHYSIOL, V87, P1395, DOI 10.1152/jn.00723.2001	32	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92765	10.1371/journal.pone.0092765	http://dx.doi.org/10.1371/journal.pone.0092765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663806	Green Submitted, Green Published, gold			2022-12-27	WOS:000333459900111
J	Lennon, FE; Mirzapoiazova, T; Mambetsariev, B; Poroyko, VA; Salgia, R; Moss, J; Singleton, PA				Lennon, Frances E.; Mirzapoiazova, Tamara; Mambetsariev, Bolot; Poroyko, Valeriy A.; Salgia, Ravi; Moss, Jonathan; Singleton, Patrick A.			The Mu Opioid Receptor Promotes Opioid and Growth Factor-Induced Proliferation, Migration and Epithelial Mesenchymal Transition (EMT) in Human Lung Cancer	PLOS ONE			English	Article							FACTOR-I RECEPTOR; ANESTHETIC TECHNIQUE; SUBSTANCE-P; GRB2-ASSOCIATED BINDER-1; BREAST-CANCER; RECURRENCE; SURGERY; ACTIVATION; EGFR; SURVIVAL	Recent epidemiologic studies implying differences in cancer recurrence based on anesthetic regimens raise the possibility that the mu opioid receptor (MOR) can influence cancer progression. Based on our previous observations that overexpression of MOR in human non-small cell lung cancer (NSCLC) cells increased tumor growth and metastasis, this study examined whether MOR regulates growth factor receptor signaling and epithelial mesenchymal transition (EMT) in human NSCLC cells. We utilized specific siRNA, shRNA, chemical inhibitors and overexpression vectors in human H358 NSCLC cells that were either untreated or treated with various concentrations of DAMGO, morphine, fentanyl, EGF or IGF. Cell function assays, immunoblot and immunoprecipitation assays were then performed. Our results indicate MOR regulates opioid and growth factor-induced EGF receptor signaling (Src, Gab-1, PI3K, Akt and STAT3 activation) which is crucial for consequent human NSCLC cell proliferation and migration. In addition, human NSCLC cells treated with opioids, growth factors or MOR overexpression exhibited an increase in snail, slug and vimentin and decrease ZO-1 and claudin-1 protein levels, results consistent with an EMT phenotype. Further, these effects were reversed with silencing (shRNA) or chemical inhibition of MOR, Src, Gab-1, PI3K, Akt and STAT3 (p < 0.05). Our data suggest a possible direct effect of MOR on opioid and growth factor-signaling and consequent proliferation, migration and EMT transition during lung cancer progression. Such an effect provides a plausible explanation for the epidemiologic findings.	[Lennon, Frances E.; Mirzapoiazova, Tamara; Mambetsariev, Bolot; Singleton, Patrick A.] Univ Chicago, Pritzker Sch Med, Dept Med, Sect Pulm & Crit Care, Chicago, IL 60637 USA; [Poroyko, Valeriy A.] Univ Chicago, Pritzker Sch Med, Dept Surg, Chicago, IL 60637 USA; [Salgia, Ravi] Univ Chicago, Pritzker Sch Med, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Moss, Jonathan; Singleton, Patrick A.] Univ Chicago, Pritzker Sch Med, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Singleton, PA (corresponding author), Univ Chicago, Pritzker Sch Med, Dept Med, Sect Pulm & Crit Care, Chicago, IL 60637 USA.	psinglet@medicine.bsd.uchicago.edu			National Institutes of Health [CTSA UL1 TR000430]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Support was provided from institutional and/or departmental sources and National Institutes of Health grant CTSA UL1 TR000430. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afsharimani B, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00046; Afsharimani B, 2011, CANCER METAST REV, V30, P225, DOI 10.1007/s10555-011-9285-0; Aicher SA, 2000, J NEUROSCI, V20, P4345; Akca H, 2006, LUNG CANCER, V54, P25, DOI 10.1016/j.lungcan.2006.06.007; Beland MD, 2010, RADIOLOGY, V254, P301, DOI 10.1148/radiol.2541090174; Belcheva MM, 2001, J BIOL CHEM, V276, P33847, DOI 10.1074/jbc.M101535200; Belcheva MM, 2003, MOL PHARMACOL, V64, P1391, DOI 10.1124/mol.64.6.1391; Bigliardi-Qi M, 2007, J INVEST DERMATOL, V127, P1479, DOI 10.1038/sj.jid.5700661; Biki B, 2008, ANESTHESIOLOGY, V109, P180, DOI 10.1097/ALN.0b013e31817f5b73; Bovill JG, 2010, ANESTH ANALG, V110, P1524, DOI 10.1213/ANE.0b013e3181d8d183; Cannito S, 2009, ANTIOXID REDOX SIGNA; Carlson Josh J, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P409, DOI 10.1586/erp.09.49; Chan PC, 2003, J BIOL CHEM, V278, P44075, DOI 10.1074/jbc.M305745200; Charpidou A, 2008, IN VIVO, V22, P529; Choi EJ, 2010, MOL CANCER RES, V8, P1027, DOI 10.1158/1541-7786.MCR-09-0507; Chow G, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/485468; Christopherson R, 2008, ANESTH ANALG, V107, P325, DOI 10.1213/ane.0b013e3181770f55; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; De Greve J, 2008, B CANCER, V95, P358, DOI 10.1684/bdc.2008.0591; Debruyne D, 2010, ANTICANCER RES, V30, P9; Denlinger CE, 2010, J THORAC CARDIOV SUR, V140, P505, DOI 10.1016/j.jtcvs.2010.02.061; Devarajan E, 2009, CURR MOL MED, V9, P626, DOI 10.2174/156652409788488720; Exadaktylos AK, 2006, ANESTHESIOLOGY, V105, P660, DOI 10.1097/00000542-200610000-00008; Frank JW, 2014, PAIN MED; Fujioka N, 2011, ANESTH ANALG, V113, P1353, DOI 10.1213/ANE.0b013e318232b35a; Ganjoo KN, 2007, BIOL-TARGETS THER, V1, P335; Garcia-Recio S, 2013, CANCER RES, V73, P6424, DOI 10.1158/0008-5472.CAN-12-4573; Giubellino A, 2008, EXPERT OPIN THER TAR, V12, P1021, DOI 10.1517/14728222.12.8.1021 ; Gridelli C, 2010, EXPERT OPIN INV DRUG, V19, P631, DOI 10.1517/13543781003767434; Gridelli C, 2010, LUNG CANCER, V67, P86, DOI 10.1016/j.lungcan.2009.03.021; Gualberto A, 2009, CLIN LUNG CANCER, V10, P273, DOI 10.3816/CLC.2009.n.038; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Hart JR, 2011, P NATL ACAD SCI USA, V108, P13247, DOI 10.1073/pnas.1110486108; Holz C, 2011, RADIOTHER ONCOL, V101, P158, DOI 10.1016/j.radonc.2011.05.042; Illing S, 2013, BRIT J PHARM; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kiyatkin A, 2006, J BIOL CHEM, V281, P19925, DOI 10.1074/jbc.M600482200; Lee K, 2012, INT REV CEL MOL BIO, V294, P171, DOI 10.1016/B978-0-12-394305-7.00004-5; Lee MW, 2011, CANC SCI; Lennon FE, 2012, ANESTHESIOLOGY, V116, P857, DOI 10.1097/ALN.0b013e31824babe2; Lennon FE, 2012, ANESTHESIOLOGY, V116, P940, DOI 10.1097/ALN.0b013e31824b9512; Lim CP, 2006, MOL BIOSYST, V2, P536, DOI 10.1039/b606246f; Maione P, 2010, EXPERT OPIN PHARMACO, V11, P2997, DOI 10.1517/14656566.2010.511615; Mathew B, 2011, ANESTH ANALG, V112, P558, DOI 10.1213/ANE.0b013e31820568af; Mercadante S, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-013-0395-y; Myles PS, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1491; Ng R, 2008, LUNG CANCER, V61, P262, DOI 10.1016/j.lungcan.2008.02.002; Nishida K, 2003, CANCER SCI, V94, P1029, DOI 10.1111/j.1349-7006.2003.tb01396.x; Pene F, 2002, ONCOGENE, V21, P6587, DOI 10.1038/sj.onc.1205923; Perez S, 2007, J NEUROCHEM, V103, P2153, DOI 10.1111/j.1471-4159.2007.04944.x; Pfeiffer M, 2003, J BIOL CHEM, V278, P51630, DOI 10.1074/jbc.M307095200; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Schaeper U, 2000, J CELL BIOL, V149, P1419, DOI 10.1083/jcb.149.7.1419; Singleton PA, 2008, MOL CANCER THER, V7, P1669, DOI 10.1158/1535-7163.MCT-07-2217; Singleton PA, 2010, FUTURE ONCOL, V6, P1237, DOI 10.2217/FON.10.99; Singleton Patrick A, 2010, J Angiogenes Res, V2, P5, DOI 10.1186/2040-2384-2-5; Snyder GL, 2010, BRIT J ANAESTH, V105, P106, DOI 10.1093/bja/aeq164; Spiro SG, 2010, RESPIROLOGY, V15, P44, DOI 10.1111/j.1440-1843.2009.01674.x; Stinchcombe TE, 2011, J THORAC ONCOL, V6, P1443, DOI 10.1097/JTO.0b013e3182246413; Subramanian J, 2010, J THORAC ONCOL, V5, P1116, DOI 10.1097/JTO.0b013e3181e76159; Tavare AN, 2011, INT J CANC; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tiseo M, 2011, LUNG CANCER, V71, P241, DOI 10.1016/j.lungcan.2010.11.014; Uramoto H, 2010, ANTICANCER RES, V30, P2513; Vogt PK, 2011, CANCER DISCOV, V1, P481, DOI 10.1158/2159-8290.CD-11-0218; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wan Q, 2006, J NEUROSCI RES, V84, P1588, DOI 10.1002/jnr.21053; Xu J, 2009, J NEUROCHEM, V108, P962, DOI 10.1111/j.1471-4159.2008.05833.x; Yeager MP, 2010, REGION ANESTH PAIN M, V35, P483, DOI 10.1097/AAP.0b013e3181fa11a9; Yin M, 2009, AM J TRANSL RES, V1, P101; Yin ZJ, 2010, J SURG RES; Yu YJ, 2009, J NEUROSCI, V29, P222, DOI 10.1523/JNEUROSCI.4315-08.2009	74	129	133	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91577	10.1371/journal.pone.0091577	http://dx.doi.org/10.1371/journal.pone.0091577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662916	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900025
J	Menet, MC; Marchal, J; Dal-Pan, A; Taghi, M; Nivet-Antoine, V; Dargere, D; Laprevote, O; Beaudeux, JL; Aujard, F; Epelbaum, J; Cottart, CH				Menet, Marie-Claude; Marchal, Julia; Dal-Pan, Alexandre; Taghi, Meryam; Nivet-Antoine, Valerie; Dargere, Delphine; Laprevote, Olivier; Beaudeux, Jean-Louis; Aujard, Fabienne; Epelbaum, Jacques; Cottart, Charles-Henry			Resveratrol Metabolism in a Non-Human Primate, the Grey Mouse Lemur (Microcebus murinus), Using Ultra-High-Performance Liquid Chromatography-Quadrupole Time of Flight	PLOS ONE			English	Article							CANCER CHEMOPREVENTIVE AGENT; TRANS-RESVERATROL; CALORIE RESTRICTION; DIETARY RESVERATROL; HEALTHY-VOLUNTEERS; HUMAN PLASMA; RED WINE; HUMANS; BIOAVAILABILITY; TOXICITY	The grey mouse lemur (Microcebus murinus) is a non-human primate used to study the ageing process. Resveratrol is a polyphenol that may increase lifespan by delaying age-associated pathologies. However, no information about resveratrol absorption and metabolism is available for this primate. Resveratrol and its metabolites were qualitatively and quantitatively analyzed in male mouse-lemur plasma (after 200 mg.kg(-1) of oral resveratrol) by ultra-high performance liquid chromatography (UHPLC), coupled to a quadrupole-time-of-flight (Q-TOF) mass spectrometer used in full-scan mode. Data analyses showed, in MSE mode, an ion common to resveratrol and all its metabolites: m/z 227.072, and an ion common to dihydro-resveratrol metabolites: m/z 229.08. A semi-targeted study enabled us to identify six hydrophilic resveratrol metabolites (one diglucurono-conjugated, two monoglucurono-conjugated, one monosulfo-conjugated and two both sulfo-and glucurono-conjugated derivatives) and three hydrophilic metabolites of dihydro-resveratrol (one monoglucurono- conjugated, one monosulfo-conjugated, and one both sulfo-and glucurono-conjugated derivatives). The presence of such metabolites has been already detected in the mouse, rat, pig, and humans. Free resveratrol was measurable for several hours in mouse-lemur plasma, and its two main metabolites were trans-resveratrol-3-O-glucuronide and trans-resveratrol-3-sulfate. Free dihydro-resveratrol was not measurable whatever the time of plasma collection, while its hydrophilic metabolites were present at 24 h after intake. These data will help us interpret the effect of resveratrol in mouse lemurs and provide further information on the inter-species characteristics of resveratrol metabolism.	[Menet, Marie-Claude; Taghi, Meryam; Dargere, Delphine; Laprevote, Olivier] Univ Paris 05, Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, EA 4463, Paris, France; [Marchal, Julia; Dal-Pan, Alexandre; Aujard, Fabienne] Museum Natl Hist Nat, CNRS, UMR 7179, Brunoy, France; [Nivet-Antoine, Valerie; Beaudeux, Jean-Louis; Cottart, Charles-Henry] Univ Paris 05, Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, EA 4466, Paris, France; [Nivet-Antoine, Valerie] Hop Europeen Georges Pompidou, AP HP, Serv Biochim, Paris, France; [Laprevote, Olivier] GH Lariboisiere St Louis Fernand Widal, AP HP, Serv Toxicol Biol, Paris, France; [Beaudeux, Jean-Louis; Cottart, Charles-Henry] AP HP, GH Necker Enfants Malad, Serv Biochim A, Paris, France; [Epelbaum, Jacques] Univ Paris 05, Fac Med, INSERM, Ctr Psychiat & Neurosci,UMR 894, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Menet, MC (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, EA 4463, Paris, France.	marie-claude.menet@parisdescartes.fr	Menet, Marie Claude/N-4723-2017; Epelbaum, Jacques/B-2263-2013; Menet, Marie-Claude/ABB-3019-2020; Dargere, Delphine/G-5004-2013; Nivet-Antoine, Valerie/R-1981-2017; Taghi, Meryam/ABE-4982-2020	Menet, Marie Claude/0000-0002-3180-9588; Nivet-Antoine, Valerie/0000-0003-2490-0428; Taghi, Meryam/0000-0001-7543-0409; Cottart, Charles-Henry/0000-0003-3776-957X	Paris Descartes University	Paris Descartes University	This study was supported by a "BQR'' grant from the Paris Descartes University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal B, 2011, ANN NY ACAD SCI, V1215, P138, DOI 10.1111/j.1749-6632.2010.05850.x; Amiot MJ, 2013, BIOCHIMIE, V95, P1233, DOI 10.1016/j.biochi.2013.01.008; Andres-Lacueva C, 2012, J AGR FOOD CHEM, V60, P4833, DOI 10.1021/jf3001108; Azorin-Ortuno M, 2011, MOL NUTR FOOD RES, V55, P1154, DOI 10.1002/mnfr.201100140; Azorin-Ortuno M, 2010, J AGR FOOD CHEM, V58, P11165, DOI 10.1021/jf102799m; Barbara JE, 2012, DRUG METAB DISPOS, V40, P1966, DOI 10.1124/dmd.112.047027; Beaudeux JL, 2010, CURR OPIN CLIN NUTR, V13, P729, DOI 10.1097/MCO.0b013e32833ef291; Bode LM, 2013, AM J CLIN NUTR, V97, P295, DOI 10.3945/ajcn.112.049379; Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022; Boocock DJ, 2007, J CHROMATOGR B, V848, P182, DOI 10.1016/j.jchromb.2006.10.017; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Burkon A, 2008, MOL NUTR FOOD RES, V52, P549, DOI 10.1002/mnfr.200700290; Camont L, 2009, ANAL CHIM ACTA, V634, P121, DOI 10.1016/j.aca.2008.12.003; Chow HHS, 2010, CANCER PREV RES, V3, P1168, DOI 10.1158/1940-6207.CAPR-09-0155; Cottart CH, 2014, MOL NUTR FOOD RES, V58, P7, DOI 10.1002/mnfr.201200589; Cottart CH, 2010, MOL NUTR FOOD RES, V54, P7, DOI 10.1002/mnfr.200900437; Crowell JA, 2004, TOXICOL SCI, V82, P614, DOI 10.1093/toxsci/kfh263; Dal-Pan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016581; Dal-Pan Alexandre, 2010, BMC Physiology, V10, P11, DOI 10.1186/1472-6793-10-11; Dal-Pan A, 2011, AGE, V33, P15, DOI 10.1007/s11357-010-9156-6; Delmas D, 2011, ANN NY ACAD SCI, V1215, P48, DOI 10.1111/j.1749-6632.2010.05871.x; Juan ME, 2010, J AGR FOOD CHEM, V58, P7472, DOI 10.1021/jf100836j; Juan ME, 2010, J PHARMACEUT BIOMED, V51, P391, DOI 10.1016/j.jpba.2009.03.026; Frombaum M, 2012, BIOCHIMIE, V94, P269, DOI 10.1016/j.biochi.2011.11.001; Howells LM, 2011, CANCER PREV RES, V4, P1419, DOI 10.1158/1940-6207.CAPR-11-0148; Hu Y, 2011, FREE RADICAL BIO MED, V51, P250, DOI 10.1016/j.freeradbiomed.2011.04.034; Johnson WD, 2011, FOOD CHEM TOXICOL, V49, P3319, DOI 10.1016/j.fct.2011.08.023; Jung CM, 2009, FEMS MICROBIOL LETT, V297, P266, DOI 10.1111/j.1574-6968.2009.01691.x; Kapetanovic IM, 2011, CANCER CHEMOTH PHARM, V68, P593, DOI 10.1007/s00280-010-1525-4; Languille S, 2012, AGEING RES REV, V11, P150, DOI 10.1016/j.arr.2011.07.001; Li F, 2012, CURR PHARM DESIGN, V18, P27, DOI 10.2174/138161212798919075; Maier-Salamon A, 2011, DRUG METAB PHARMACOK, V26, P364, DOI 10.2133/dmpk.DMPK-11-RG-006; Marchal J, 2013, EXP GERONTOL, V48, P992, DOI 10.1016/j.exger.2013.07.002; Marchal J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034289; Marier JF, 2002, J PHARMACOL EXP THER, V302, P369, DOI 10.1124/jpet.102.033340; Menet MC, 2013, ANAL CHIM ACTA, V761, P128, DOI 10.1016/j.aca.2012.11.048; Muzzio M, 2012, J PHARMACEUT BIOMED, V59, P201, DOI 10.1016/j.jpba.2011.10.023; Patel KR, 2010, CANCER RES, V70, P7392, DOI 10.1158/0008-5472.CAN-10-2027; Petrovski G, 2011, ANN NY ACAD SCI, V1215, P22, DOI 10.1111/j.1749-6632.2010.05843.x; Pifferi F, 2012, CHRONOBIOL INT, V29, P261, DOI 10.3109/07420528.2011.654019; Planas JM, 2012, ARCH BIOCHEM BIOPHYS, V527, P67, DOI 10.1016/j.abb.2012.06.004; Richard T, 2011, ANN NY ACAD SCI, V1215, P103, DOI 10.1111/j.1749-6632.2010.05865.x; Rotches-Ribalta M, 2012, PHARMACOL RES, V66, P375, DOI 10.1016/j.phrs.2012.08.001; Shu XH, 2010, BIOCHEM PHARMACOL, V79, P1516, DOI 10.1016/j.bcp.2010.01.022; Shukla Y, 2011, ANN NY ACAD SCI, V1215, P1, DOI 10.1111/j.1749-6632.2010.05870.x; Stark T, 2011, ANAL CHEM, V83, P3398, DOI 10.1021/ac103305s; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Urpi-Sarda M, 2007, CLIN CHEM, V53, P292, DOI 10.1373/clinchem.2006.071936; Vitaglione P, 2005, MOL NUTR FOOD RES, V49, P495, DOI 10.1002/mnfr.200500002; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Wang DG, 2005, J CHROMATOGR B, V829, P97, DOI 10.1016/j.jchromb.2005.09.040; Wenzel E, 2005, MOL NUTR FOOD RES, V49, P482, DOI 10.1002/mnfr.200500003; Williams LD, 2009, FOOD CHEM TOXICOL, V47, P2170, DOI 10.1016/j.fct.2009.06.002; Yoshino J, 2012, CELL METAB, V16, P658, DOI 10.1016/j.cmet.2012.09.015; Zamora-Ros R, 2006, CLIN CHEM, V52, P1373, DOI 10.1373/clinchem.2005.065870; Zhu WZ, 2012, NUTR CANCER, V64, P393, DOI 10.1080/01635581.2012.654926	56	11	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e91932	10.1371/journal.pone.0091932	http://dx.doi.org/10.1371/journal.pone.0091932			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663435	gold, Green Submitted, Green Published			2022-12-27	WOS:000333459900033
J	Pires, FV; da Cunha, MDRD; Abraao, LM; Martins, PYF; Camargo, CH; Fortaleza, CMCB				Pires, Fabiana Venegas; Ribeiro de Souza da Cunha, Maria de Lourdes; Abraao, Ligia Maria; Martins, Patricia Y. F.; Camargo, Carlos Henrique; Castelo Branco Fortaleza, Carlos Magno			Nasal Carriage of Staphylococcus aureus in Botucatu, Brazil: A Population-Based Survey	PLOS ONE			English	Article							METHICILLIN-RESISTANT STRAINS; UNITED-STATES; SKIN INFECTIONS; CA-MRSA; COLONIZATION; PREVALENCE; EPIDEMIOLOGY; CHILDREN; EMERGENCE; IDENTIFICATION	Recent increases in the incidence and severity of staphylococcal infections renewed interest in studies that assess the burden of asymptomatic carriage of Staphylococcus aureus in the community setting. We conducted a population-based survey in the city of Botucatu, Brazil (122,000 inhabitants), in order to identify the prevalence of nasal carriage of Staphylococcus aureus (including methicillin-resistant strains). Nasal swabs were obtained from 686 persons over one year of age. Resistance to methicillin was assessed through phenotypic methods, identification of the mecA gene and typing of the Staphylococcal Chromosome Cassette mec (SCCmec). Methicillin-resistant S. aureus (MRSA) isolates were characterized using Pulsed-Field Gel Electrophoresis (PFGE), Multilocus Sequence Typing (MLST) and spa typing. Polymerase chain reaction was applied to identify genes coding for Panton-Valentine Leukocidin (PVL) in isolates. The prevalence of overall S. aureus carriage was 32.7% (95% CI, 29.2%-36.2%). Carriers were significantly younger (mean age, 28.1 versus 36.3 for non-carriers; OR for age, 0.98; 95% CI, 0.97-0.99) and likely to report recent skin infection (OR, 1.85; 95% CI, 1.03-3.34). Carriage of methicillin-resistant S. aureus (MRSA) was found in 0.9% of study subjects (95% CI, 0.4%-1.8%). All MRSA isolates harbored SCCmec type IV, and belonged to spa types t002 or t021, but none among them harbored genes coding for PLV. In MLST, most isolates belonged to clones ST5 or ST1776. However, we found one subject who carried a novel clone, ST2594. Two out of six MRSA carriers had household contacts colonized with isolates similar to theirs. Our study pointed to dissemination of community-associated MRSA among the Brazilian population.	[Pires, Fabiana Venegas; Abraao, Ligia Maria; Castelo Branco Fortaleza, Carlos Magno] Univ Estadual Paulista, Fac Med Botucatu, Dept Doencas Tropicais, Botucatu, SP, Brazil; [Ribeiro de Souza da Cunha, Maria de Lourdes; Martins, Patricia Y. F.; Camargo, Carlos Henrique] Univ Estadual Paulista, Inst Biociencias Botucatu, Dept Microbiol & Imunol, Botucatu, SP, Brazil	Universidade Estadual Paulista; Instituto de Botanica - Sao Paulo; Universidade Estadual Paulista	Fortaleza, CMCB (corresponding author), Univ Estadual Paulista, Fac Med Botucatu, Dept Doencas Tropicais, Botucatu, SP, Brazil.	cmfortaleza@uol.com.br	de Lourdes Ribeiro de Souza da Cunha, Maria/A-6287-2008; Fortaleza, Carlos Magno C. B./C-3807-2013; Camargo, Carlos/E-6448-2010; ABRAÃO, LIGIA/CAA-6140-2022	de Lourdes Ribeiro de Souza da Cunha, Maria/0000-0001-9079-2723; Fortaleza, Carlos Magno C. B./0000-0003-4120-1258; Camargo, Carlos/0000-0001-6834-0085; 	"Fundacao de Amparo a Pesquisa do Estado de Sao Paulo'' (FAPESP) [2011/06988-2]	"Fundacao de Amparo a Pesquisa do Estado de Sao Paulo'' (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo'' (FAPESP, grant #2011/06988-2, www.fapesp.br). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2010, J CLIN MICROBIOL, V48, P531, DOI 10.1128/JCM.02290-08; Bassetti M, 2009, INT J ANTIMICROB AG, V34, pS15, DOI 10.1016/S0924-8579(09)70544-8; Breurec S, 2011, CLIN MICROBIOL INFEC, V17, P633, DOI 10.1111/j.1469-0691.2010.03320.x; Breurec S, 2011, CLIN MICROBIOL INFEC, V17, P160, DOI 10.1111/j.1469-0691.2010.03219.x; Camargo CH, 2013, DIAGN MICR INFEC DIS, V76, P372, DOI 10.1016/j.diagmicrobio.2013.03.013; Carmo MS, 2011, BRAZ J MED BIOL RES, V44, P1013, DOI 10.1590/S0100-879X2011007500114; Casey JA, 2013, EPIDEMIOL INFECT, V141, P1166, DOI 10.1017/S0950268812001872; Cesar CLG, 2005, SAUDE CONDICAO VIDA; Chen CJ, 2011, J CLIN MICROBIOL, V49, P131, DOI 10.1128/JCM.01774-10; Chuang YY, 2013, LANCET INFECT DIS, V13, P698, DOI 10.1016/S1473-3099(13)70136-1; Clinical and Laboratory Standards Institute, 2009, M02A10 CLSI; Demos M, 2012, BRIT J DERMATOL, V167, P725, DOI 10.1111/j.1365-2133.2012.11151.x; Durupt F, 2007, BRIT J DERMATOL, V157, P1161, DOI 10.1111/j.1365-2133.2007.08197.x; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Ertam I, 2007, J EUR ACAD DERMATOL, V21, P777, DOI 10.1111/j.1468-3083.2006.02083.x; Fritz SA, 2012, ARCH PEDIAT ADOL MED, V166, P551, DOI 10.1001/archpediatrics.2011.900; Fritz SA, 2012, CLIN INFECT DIS, V54, P743, DOI 10.1093/cid/cir919; Fritz SA, 2009, J INFECTION, V59, P394, DOI 10.1016/j.jinf.2009.09.001; Gardella N, 2011, INFECT GENET EVOL, V11, P1066, DOI 10.1016/j.meegid.2011.03.019; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Goud R, 2011, REV SOC BRAS MED TRO, V44, P309, DOI 10.1590/S0037-86822011005000035; Graham PL, 2006, ANN INTERN MED, V144, P318, DOI 10.7326/0003-4819-144-5-200603070-00006; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Hamdan-Partida A, 2010, J CLIN MICROBIOL, V48, P1701, DOI 10.1128/JCM.01929-09; Hayward A, 2008, EMERG INFECT DIS, V14, P720, DOI 10.3201/eid1405.070153; Johnson AP, 2011, J ANTIMICROB CHEMOTH, V66, pIV43, DOI 10.1093/jac/dkr076; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kock R, 2010, EUROSURVEILLANCE, V15, P12, DOI 10.2807/ese.15.41.19688-en; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Lear A, 2011, J AM BOARD FAM MED, V24, P429, DOI 10.3122/jabfm.2011.04.100286; Lee CJ, 2011, CLIN INFECT DIS, V52, P775, DOI 10.1093/cid/cir026; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Malik S, 2009, EPIDEMIOL INFECT, V137, P1237, DOI 10.1017/S0950268809002222; Martineau F, 1998, J CLIN MICROBIOL, V36, P618, DOI 10.1128/JCM.36.3.618-623.1998; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Melles DC, 2008, J CLIN MICROBIOL, V46, P235, DOI 10.1128/JCM.00887-07; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Miller LG, 2008, CLIN INFECT DIS, V46, P752, DOI 10.1086/526773; Miller M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006708; Mithoe D, 2012, EUR J CLIN MICROBIOL, V31, P349, DOI 10.1007/s10096-011-1316-9; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Munckhof WJ, 2009, CLIN MICROBIOL INFEC, V15, P149, DOI 10.1111/j.1469-0691.2008.02652.x; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240, DOI 10.1128/JCM.29.10.2240-2244.1991; Ngoa UA, 2012, ACTA TROP, V124, P42, DOI 10.1016/j.actatropica.2012.06.005; O'Brien FG, 2009, J ANTIMICROB CHEMOTH, V64, P684, DOI 10.1093/jac/dkp285; Olsen K, 2013, EPIDEMIOL INFECT, V141, P143, DOI 10.1017/S0950268812000465; Onanuga A, 2011, AFR HEALTH SCI, V11, P176; Pacheco RL, 2011, CLINICS, V66, P2071, DOI 10.1590/S1807-59322011001200012; Petry V, 2014, INT J DERMATOL, V53, P731, DOI 10.1111/ijd.12020; Qu F, 2010, J CLIN MICROBIOL, V48, P64, DOI 10.1128/JCM.01572-09; Rahimian J, 2007, INFECT CONT HOSP EP, V28, P1415, DOI 10.1086/523273; Reinert C, 2008, BRAZ J INFECT DIS, V12, P213, DOI 10.1590/S1413-86702008000300010; Ribeiro A, 2007, DIAGN MICR INFEC DIS, V59, P339, DOI 10.1016/j.diagmicrobio.2007.05.007; Rim JY, 2007, INFECT CONT HOSP EP, V28, P1044, DOI 10.1086/519934; Rossney AS, 2007, J CLIN MICROBIOL, V45, P2554, DOI 10.1128/JCM.00245-07; Safdar N, 2008, AM J MED, V121, P310, DOI 10.1016/j.amjmed.2007.07.034; Saxena S, 2010, EMERG INFECT DIS, V16, P530, DOI 10.3201/eid1603.090809; Scerri J, 2013, J EPIDEMIOL GLOB HEA, V3, P165, DOI 10.1016/j.jegh.2013.05.003; Schaumburg F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001150; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Silva-Carvalho MC, 2009, DIAGN MICR INFEC DIS, V65, P300, DOI 10.1016/j.diagmicrobio.2009.07.023; Smith CH, 2012, CAN FAM PHYSICIAN, V58, P1350; Talpur R, 2008, BRIT J DERMATOL, V159, P105, DOI 10.1111/j.1365-2133.2008.08612.x; Tavares DA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-110; Weems J. John, 2002, Curr Infect Dis Rep, V4, P420, DOI 10.1007/s11908-002-0009-z; WILLIAMS RE, 1963, BACTERIOL REV, V27, P56, DOI 10.1128/MMBR.27.1.56-71.1963; Winn W. C., 2005, KONEMANS COLOR ATLAS, V1; Wu DJ, 2010, DIAGN MICR INFEC DIS, V67, P1, DOI 10.1016/j.diagmicrobio.2009.12.006	71	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92537	10.1371/journal.pone.0092537	http://dx.doi.org/10.1371/journal.pone.0092537			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24663818	Green Published, gold, Green Submitted			2022-12-27	WOS:000333459900072
J	Song, YL; Yu, JJ; Huang, B				Song, Yali; Yu, Jingjin; Huang, Bingru			Elevated CO2-Mitigation of High Temperature Stress Associated with Maintenance of Positive Carbon Balance and Carbohydrate Accumulation in Kentucky Bluegrass	PLOS ONE			English	Article							GLOBAL CLIMATE-CHANGE; AIR CO2 ENRICHMENT; ACUTE HEAT-STRESS; PHYSIOLOGICAL-RESPONSES; ATMOSPHERIC CO2; PHOTOSYNTHETIC ACCLIMATION; METABOLIC-RESPONSES; GROWTH TEMPERATURE; DARK RESPIRATION; PERENNIAL GRASS	Elevated CO2 concentration may promote plant growth while high temperature is inhibitory for C-3 plant species. The interactive effects of elevated CO2 and high temperatures on C-3 perennial grass growth and carbon metabolism are not well documented. Kentucky bluegrass (Poa pratensis) plants were exposed to two CO2 levels (400 and 800 mu mol mol(-1)) and five temperatures (15/12, 20/17, 25/22, 30/27, 35/32 degrees C, day/night) in growth chambers. Increasing temperatures to 25 degrees C and above inhibited leaf photosynthetic rate (Pn) and shoot and root growth, but increased leaf respiration rate (R), leading to a negative carbon balance and a decline in soluble sugar content under ambient CO2. Elevated CO2 did not cause shift of optimal temperatures in Kentucky bluegrass, but promoted Pn, shoot and root growth under all levels of temperature (15, 20, 25, 30, and 35 degrees C) and mitigated the adverse effects of severe high temperatures (30 and 35 degrees C). Elevated CO2-mitigation of adverse effects of high temperatures on Kentucky bluegrass growth could be associated with the maintenance of a positive carbon balance and the accumulation of soluble sugars and total nonstructural carbohydrates through stimulation of Pn and suppression of R and respiratory organic acid metabolism.	[Song, Yali] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China; [Yu, Jingjin] Nanjing Agr Univ, Coll Agro Grassland Sci, Nanjing, Jiangsu, Peoples R China; [Song, Yali; Huang, Bingru] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08901 USA	Beijing Forestry University; Nanjing Agricultural University; Rutgers State University New Brunswick	Huang, B (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08901 USA.	huang@aesop.rutgers.edu			Chinese Scholarship Council; Center for Turfgrass Science at Rutgers University; Chinese Natural Science Foundation [720700003]	Chinese Scholarship Council(China Scholarship Council); Center for Turfgrass Science at Rutgers University; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC))	Chinese Scholarship Council for providing stipend to Y. Song to conduct the research project at Rutgers University and Center for Turfgrass Science at Rutgers University for funding support of research expenses, as well as Chinese Natural Science Foundation (No. 720700003) for funding support of metabolite analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert KR, 2011, J EXP BOT, V62, P4253, DOI 10.1093/jxb/err133; Albert KR, 2011, J PLANT PHYSIOL, V168, P1550, DOI 10.1016/j.jplph.2011.02.011; BAKER JT, 1992, PLANT CELL ENVIRON, V15, P231, DOI 10.1111/j.1365-3040.1992.tb01477.x; Beard J. B., 1972, TURFGRASS SCI CULTUR; Bencze S, 2005, CEREAL RES COMMUN, V33, P385, DOI 10.1556/CRC.33.2005.1.95; Bernacchi CJ, 2005, PLANTA, V220, P434, DOI 10.1007/s00425-004-1320-8; BOWES G, 1991, PLANT CELL ENVIRON, V14, P795, DOI 10.1111/j.1365-3040.1991.tb01443.x; Campbell C, 2007, NEW PHYTOL, V176, P375, DOI 10.1111/j.1469-8137.2007.02183.x; Cannell MGR, 1998, ANN BOT-LONDON, V82, P883, DOI 10.1006/anbo.1998.0777; Casella E, 1997, J EXP BOT, V48, P1309, DOI 10.1093/jxb/48.6.1309; Centritto M, 2011, TREE PHYSIOL, V31, P275, DOI 10.1093/treephys/tpq112; Cowling SA, 1998, PLANT CELL ENVIRON, V21, P427, DOI 10.1046/j.1365-3040.1998.00290.x; Cui LJ, 2006, BOT STUD, V47, P61; DIPAOLA J.M., 1992, AGRON MONOGR, V32, P231, DOI DOI 10.2134/AGRONMONOGR32.C7; Drake BG, 1999, PLANT CELL ENVIRON, V22, P649, DOI 10.1046/j.1365-3040.1999.00438.x; Drake BG, 1997, ANNU REV PLANT PHYS, V48, P609, DOI 10.1146/annurev.arplant.48.1.609; Du HM, 2011, PHYSIOL PLANTARUM, V141, P251, DOI 10.1111/j.1399-3054.2010.01432.x; Erice G, 2006, PLANT SCI, V170, P1059, DOI 10.1016/j.plantsci.2005.12.018; Fares S, 2011, ATMOS ENVIRON, V45, P155, DOI 10.1016/j.atmosenv.2010.09.036; Faria T, 1996, J EXP BOT, V47, P1755, DOI 10.1093/jxb/47.11.1755; FARRAR JF, 1991, PLANT CELL ENVIRON, V14, P819, DOI 10.1111/j.1365-3040.1991.tb01445.x; Foss AR, 2013, ENVIRON ENTOMOL, V42, P503, DOI 10.1603/EN12074; Fry J., 2004, APPL TURFGRASS SCI P; Fukayama H, 2009, PLANT SCI, V177, P203, DOI 10.1016/j.plantsci.2009.05.014; Ge ZM, 2011, PHOTOSYNTHETICA, V49, P172, DOI 10.1007/s11099-011-0029-8; Ge ZM, 2012, PHOTOSYNTHETICA, V50, P141, DOI 10.1007/s11099-012-0014-x; Ge ZM, 2012, BIOMASS BIOENERG, V46, P251, DOI 10.1016/j.biombioe.2012.08.019; Gifford RM, 1995, GLOBAL CHANGE BIOL, V1, P385, DOI 10.1111/j.1365-2486.1995.tb00037.x; GonzalezMeler MA, 1996, PLANT PHYSIOL, V112, P1349, DOI 10.1104/pp.112.3.1349; Grunzweig JM, 2003, FUNCT ECOL, V17, P766, DOI 10.1111/j.1365-2435.2003.00797.x; Hamilton EW, 2008, J INTEGR PLANT BIOL, V50, P1375, DOI 10.1111/j.1744-7909.2008.00747.x; Hoagland D.R., 1950, CALIF AES C, V347, P1, DOI DOI 10.1016/S0140-6736(00)73482-9; Hu WH, 2010, BIOL PLANTARUM, V54, P761, DOI 10.1007/s10535-010-0137-5; Huang BR, 2003, CROP SCI, V43, P258, DOI 10.2135/cropsci2003.0258; Huang BR, 2000, PLANT SOIL, V227, P17, DOI 10.1023/A:1026512212113; Hunt HW, 1996, GLOB CHANGE BIOL, V2, P35, DOI 10.1111/j.1365-2486.1996.tb00047.x; IDSO KE, 1994, AGR FOREST METEOROL, V69, P153, DOI 10.1016/0168-1923(94)90025-6; Kirkham MB, 2011, ELEVATED CARBON DIOX; Leakey ADB, 2006, PLANT PHYSIOL, V140, P779, DOI 10.1104/pp.105.073957; Leakey ADB, 2009, P NATL ACAD SCI USA, V106, P3597, DOI 10.1073/pnas.0810955106; Lee TD, 2011, GLOBAL CHANGE BIOL, V17, P2893, DOI 10.1111/j.1365-2486.2011.02435.x; Liu XZ, 2008, J PLANT PHYSIOL, V165, P1947, DOI 10.1016/j.jplph.2008.05.001; Liu XZ, 2001, HORTSCIENCE, V36, P1131, DOI 10.21273/HORTSCI.36.6.1131; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Luo Y, 2006, ANNU REV PLANT BIOL, V55, P591, DOI [10.1890/04-1724, DOI 10.1890/04-1724]; Lyons EM, 2007, ENVIRON EXP BOT, V59, P307, DOI 10.1016/j.envexpbot.2006.04.002; Majeau N, 1996, PLANT PHYSIOL, V112, P569, DOI 10.1104/pp.112.2.569; Moore BD, 1998, PLANT CELL ENVIRON, V21, P905, DOI 10.1046/j.1365-3040.1998.00324.x; Morison JIL, 1999, PLANT CELL ENVIRON, V22, P659, DOI 10.1046/j.1365-3040.1999.00443.x; Morison JIL, 1998, J EXP BOT, V49, P443, DOI 10.1093/jexbot/49.suppl_1.443; Nobel PS, 1996, J ARID ENVIRON, V34, P187, DOI 10.1006/jare.1996.0100; Ow LF, 2008, NEW PHYTOL, V178, P123, DOI 10.1111/j.1469-8137.2007.02357.x; PEET MM, 1986, PLANT PHYSIOL, V80, P63, DOI 10.1104/pp.80.1.63; Pote J, 2006, J AM SOC HORTIC SCI, V131, P608, DOI 10.21273/JASHS.131.5.608; Prasad PVV, 2009, FUNCT PLANT BIOL, V36, P761, DOI 10.1071/FP09043; Qaderi MM, 2006, PHYSIOL PLANTARUM, V128, P710, DOI 10.1111/j.1399-3054.2006.00804.x; Qiu Y, 2007, ANAL CHIM ACTA, V583, P277, DOI 10.1016/j.aca.2006.10.025; Rachmilevitch S, 2006, NEW PHYTOL, V170, P479, DOI 10.1111/j.1469-8137.2006.01684.x; Reddy AR, 2010, CURR SCI INDIA, V99, P46; Rodriguez-Calcerrada J, 2010, TREE PHYSIOL, V30, P214, DOI 10.1093/treephys/tpp104; RUSSELL JB, 1986, BRIT J NUTR, V56, P153, DOI 10.1079/BJN19860095; Salvucci ME, 2004, PHYSIOL PLANTARUM, V120, P179, DOI 10.1111/j.0031-9317.2004.0173.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tan KY, 2013, CHINESE SCI BULL, V58, P1795, DOI 10.1007/s11434-012-5605-1; TING SV, 1956, J AGR FOOD CHEM, V4, P263, DOI 10.1021/jf60061a009; Turgeon A. J., 2011, TURFGRASS MANAGEMENT; Wang D, 2008, AM J BOT, V95, P165, DOI 10.3732/ajb.95.2.165; Wang XZ, 2002, PLANT ECOL, V161, P251, DOI 10.1023/A:1020305006949; Winter K, 1997, PLANTA, V201, P389, DOI 10.1007/s004250050081; Woodward FI, 2002, CURR OPIN PLANT BIOL, V5, P207, DOI 10.1016/S1369-5266(02)00253-4; Xu QZ, 2000, CROP SCI, V40, P1363, DOI 10.2135/cropsci2000.4051363x; Yu JJ, 2012, J AM SOC HORTIC SCI, V137, P221, DOI 10.21273/JASHS.137.4.221; Yu JJ, 2012, CROP SCI, V52, P1848, DOI 10.2135/cropsci2012.01.0030	73	76	76	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e89725	10.1371/journal.pone.0089725	http://dx.doi.org/10.1371/journal.pone.0089725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662768	gold, Green Published, Green Submitted			2022-12-27	WOS:000333459900004
J	Zhu, WB; Cromie, MM; Cai, QS; Lv, TF; Singh, K; Gao, WM				Zhu, Wenbin; Cromie, Meghan M.; Cai, Qingsong; Lv, Tangfeng; Singh, Kamaleshwar; Gao, Weimin			Curcumin and Vitamin E Protect against Adverse Effects of Benzo[a]pyrene in Lung Epithelial Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; DNA-ADDUCTS; FLUOROMETRIC ASSAY; CARCINOMA-CELLS; BETA-CAROTENE; BREAST-CANCER; IN-VIVO; EXPRESSION; P53; DAMAGE	Benzo[a] pyrene (BaP), a well-known environmental carcinogen, promotes oxidative stress and DNA damage. Curcumin and vitamin E (VE) have potent antioxidative activity that protects cells from oxidative stress and cellular damage. The objectives of the present study were to investigate the adverse effects of BaP on normal human lung epithelial cells (BEAS-2B), the potential protective effects of curcumin and VE against BaP-induced cellular damage, and the molecular mechanisms of action. MTT assay, flow cytometry, fluorescence microplate assay, HPLC, qRT-PCR, and western blot were performed to analyze cytotoxicity, cell cycle, reactive oxygen species (ROS), BaP diol-epoxidation (BPDE)-DNA adducts, gene expression, and protein expression, respectively. Curcumin or VE prevented cells from BaP-induced cell cycle arrest and growth inhibition, significantly suppressed BaP-induced ROS levels, and decreased BPDE-DNA adducts. While CYP1A1 and 1B1 were induced by BaP, these inductions were not significantly reduced by curcumin or VE. Moreover, the level of activated p53 and PARP-1 were significantly induced by BaP, whereas this induction was markedly reduced after curcumin and VE cotreatment. Survivin was significantly down-regulated by BaP, and curcumin significantly restored survivin expression in BaP-exposed cells. The ratio of Bax/Bcl-2 was also significantly increased in cells exposed to BaP and this increase was reversed by VE co-treatment. Taken together, BaP-induced cytotoxicity occurs through DNA damage, cell cycle arrest, ROS production, modulation of metabolizing enzymes, and the expression/activation of p53, PARP-1, survivin, and Bax/Bcl-2. Curcumin and VE could reverse some of these BaP-mediated alterations and therefore be effective natural compounds against the adverse effects of BaP in lung cells.	[Zhu, Wenbin; Cromie, Meghan M.; Cai, Qingsong; Lv, Tangfeng; Singh, Kamaleshwar; Gao, Weimin] Texas Tech Univ, Dept Environm Toxicol, Inst Environm & Human Hlth, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Gao, WM (corresponding author), Texas Tech Univ, Dept Environm Toxicol, Inst Environm & Human Hlth, Lubbock, TX 79409 USA.	weimin.gao@ttu.edu	Singh, Kamaleshwar Prasad/AAE-9166-2020					Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; ALEXANDROV K, 1992, CANCER RES, V52, P6248; American Cancer Society, 2013, CANCER FACTS FIGURES; Anand P, 2008, CANCER LETT, V267, P133, DOI 10.1016/j.canlet.2008.03.025; Basu A, 1998, MOL HUM REPROD, V4, P1099, DOI 10.1093/molehr/4.12.1099; Bouchard WJ, 2003, EXP HEMATOL, V31, P446, DOI 10.1016/S0301-472X(03)00083-3; Castell JV, 2005, EXP TOXICOL PATHOL, V57, P189, DOI 10.1016/j.etp.2005.05.008; Chan MMY, 1998, BIOCHEM PHARMACOL, V55, P1955, DOI 10.1016/S0006-2952(98)00114-2; Chen LX, 2010, TOXICOL SCI, V116, P206, DOI 10.1093/toxsci/kfq123; Chen YH, 2013, TOXICOLOGY, V304, P167, DOI 10.1016/j.tox.2013.01.003; CHENG KC, 1992, J BIOL CHEM, V267, P166; Chhunchha B, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.121; Ciolino HP, 1998, BIOCHEM PHARMACOL, V56, P197, DOI 10.1016/S0006-2952(98)00143-9; Deng B, 2013, OXIDATIVE MEDICINE A, V2013, P11; Garner RC, 1998, MUTAT RES-FUND MOL M, V402, P67; GELBOIN HV, 1980, PHYSIOL REV, V60, P1107, DOI 10.1152/physrev.1980.60.4.1107; Graziewicz M, 1996, CARCINOGENESIS, V17, P2501, DOI 10.1093/carcin/17.11.2501; HECHT SS, 1993, J CELL BIOCHEM, P27; Heinonen OP, 1998, J NATL CANCER I, V90, P440, DOI 10.1093/jnci/90.6.440; Jeffy BD, 2000, NEOPLASIA, V2, P460, DOI 10.1038/sj.neo.7900104; Jin Q, 2008, CARCINOGENESIS, V29, P1614, DOI 10.1093/carcin/bgm234; KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849; Khan N, 2008, ANTIOXID REDOX SIGN, V10, P475, DOI 10.1089/ars.2007.1740; Kim JH, 2004, TOXICOL APPL PHARM, V199, P210, DOI 10.1016/j.taap.2003.11.015; Krishnan R, 2004, J AGR FOOD CHEM, V52, P4261, DOI 10.1021/jf049979o; Li CY, 2012, ASIAN PAC J CANCER P, V13, P3757, DOI 10.7314/APJCP.2012.13.8.3757; Lin MT, 2001, J BIOL CHEM, V276, P48997, DOI 10.1074/jbc.M107829200; Lobo V, 2010, Pharmacogn Rev, V4, P118, DOI 10.4103/0973-7847.70902; Luch A, 1999, CARCINOGENESIS, V20, P859, DOI 10.1093/carcin/20.5.859; Mandal MNA, 2009, FREE RADICAL BIO MED, V46, P672, DOI 10.1016/j.freeradbiomed.2008.12.006; Mattson MP, 2008, AGEING RES REV, V7, P43, DOI 10.1016/j.arr.2007.08.004; Mattson MP, 2006, TRENDS NEUROSCI, V29, P632, DOI 10.1016/j.tins.2006.09.001; Mcclean MD, 2004, ANN OCCUP HYG, V48, P565, DOI 10.1093/annhyg/meh044; Melchini A, 2011, CELL BIOL TOXICOL, V27, P371, DOI 10.1007/s10565-011-9194-6; Messarah M, 2013, TOXICOL IND HEALTH, V29, P77, DOI 10.1177/0748233712446726; Numakawa Y, 2006, J NEUROCHEM, V97, P1191, DOI 10.1111/j.1471-4159.2006.03827.x; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pan MH, 2008, CHEM SOC REV, V37, P2558, DOI 10.1039/b801558a; Penning TM, 1996, CHEM RES TOXICOL, V9, P84, DOI 10.1021/tx950055s; Perocco P, 2000, MUTAT RES-GEN TOX EN, V465, P151, DOI 10.1016/S1383-5718(99)00223-5; Poirier MC, 2004, NAT REV CANCER, V4, P630, DOI 10.1038/nrc1410; REDDY ACP, 1994, ANN NUTR METAB, V38, P349, DOI 10.1159/000177833; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rietjens IMCM, 2002, ENVIRON TOXICOL PHAR, V11, P321, DOI 10.1016/S1382-6689(02)00003-0; Ripple MO, 1997, JNCI-J NATL CANCER I, V89, P40, DOI 10.1093/jnci/89.1.40; ROJAS M, 1994, CARCINOGENESIS, V15, P557, DOI 10.1093/carcin/15.3.557; Sehgal A, 2012, HUM EXP TOXICOL, V31, P473, DOI 10.1177/0960327111421943; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Sinha D, 2012, CURR DRUG TARGETS, V13, P1799, DOI 10.2174/138945012804545632; Sithanandam G, 2005, AM J RESP CELL MOL, V33, P490, DOI 10.1165/rcmb.2005-0049OC; Tao GH, 2009, MOL BIOL REP, V36, P2413, DOI 10.1007/s11033-009-9472-z; Traber MG, 2007, FREE RADICAL BIO MED, V43, P4, DOI 10.1016/j.freeradbiomed.2007.03.024; Vakharia DD, 2001, DRUG METAB DISPOS, V29, P999; Zhang L, 2011, J BIOL CHEM, V286, P25644, DOI 10.1074/jbc.M111.240739; Zheng Z, 2011, J KOREAN MED SCI, V26, P222, DOI 10.3346/jkms.2011.26.2.222	57	54	57	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92992	10.1371/journal.pone.0092992	http://dx.doi.org/10.1371/journal.pone.0092992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24664296	gold, Green Submitted, Green Published			2022-12-27	WOS:000333459900139
J	Moriyama, T; Tanaka, K; Iwasaki, C; Oshima, Y; Ochi, A; Kataoka, H; Itabashi, M; Takei, T; Uchida, K; Nitta, K				Moriyama, Takahito; Tanaka, Kayu; Iwasaki, Chihiro; Oshima, Yasuko; Ochi, Ayami; Kataoka, Hiroshi; Itabashi, Mitsuyo; Takei, Takashi; Uchida, Keiko; Nitta, Kosaku			Prognosis in IgA Nephropathy: 30-Year Analysis of 1,012 Patients at a Single Center in Japan	PLOS ONE			English	Article							IMMUNOGLOBULIN-A NEPHROPATHY; IMPAIRED RENAL-FUNCTION; RANDOMIZED CONTROLLED-TRIAL; STEROID PULSE THERAPY; SERUM URIC-ACID; OXFORD CLASSIFICATION; COMBINATION THERAPY; RISK-FACTORS; FOLLOW-UP; COHORT	Background: Little is known about the long-term prognosis of patients with IgA nephropathy (IgAN). Methods: This retrospective cohort analysis evaluated clinical and histological findings at the time of renal biopsy, initial treatment, patient outcomes over 30 years, and risk factors associated with progression in 1,012 patients diagnosed with IgAN at our center since 1974. Results: Of the 1,012 patients, 40.5% were male. Mean patient age was 33612 years and mean blood pressure was 122 +/- 17/75 +/- 13 mmHg. Mean serum creatinine concentration was 0.89 +/- 0.42 mg/dL, and mean estimated glomerular filtration rate (eGFR) was 78.5 +/- 26.2 ml/min/1.73 m(2). Mean proteinuria was 1.19 +/- 1.61 g/day, and mean urinary red blood cells were 36.6 +/- 35.3/high-powered field. Histologically, mesangial hypercellularity was present in 47.6% of patients, endothelial hypercellularity in 44.3%, segmental sclerosis in 74.6%, and tubular atrophy/interstitial fibrosis in 28.8% by Oxford classification. Initial treatment consisted of corticosteroids in 26.9% of patients, renin-angiotensin-aldosterone system inhibitor in 28.9%, and tonsillectomy plus steroids in 11.7%. The 10-, 20-, and 30-year renal survival rates were 84.3, 66.6, and 50.3%, respectively. Tonsillectomy plus steroids dramatically improved renal outcome. Cox multivariate regression analysis showed that higher proteinuria, lower eGFR, and higher uric acid at the time of renal biopsy were independent risk factors for the development of end stage renal disease (ESRD). Conclusions: IgAN is not a benign disease, with about 50% of patients progressing to ESRD within 30 years despite treatment.	[Moriyama, Takahito; Tanaka, Kayu; Iwasaki, Chihiro; Oshima, Yasuko; Ochi, Ayami; Kataoka, Hiroshi; Itabashi, Mitsuyo; Takei, Takashi; Uchida, Keiko; Nitta, Kosaku] Tokyo Womens Med Univ, Kidney Ctr, Dept Med, Tokyo, Japan	Tokyo Women's Medical University	Moriyama, T (corresponding author), Tokyo Womens Med Univ, Kidney Ctr, Dept Med, Tokyo, Japan.	takamori@kc.twmu.ac.jp	Kataoka, Hiroshi/AAL-8850-2021; Kataoka, Hiroshi/AAD-1531-2019	Kataoka, Hiroshi/0000-0001-9543-7608; Moriyama, Takahito/0000-0002-9459-4924				ALAMARTINE E, 1991, AM J KIDNEY DIS, V18, P12, DOI 10.1016/S0272-6386(12)80284-8; Alamartine E, 2011, CLIN J AM SOC NEPHRO, V6, P2384, DOI 10.2215/CJN.01170211; Berger J, 1968, J Urol Nephrol (Paris), V74, P694; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Cheng GY, 2013, CLIN NEPHROL, V80, P40, DOI 10.5414/CN107813; Hotta O, 2001, AM J KIDNEY DIS, V38, P736, DOI 10.1053/ajkd.2001.27690; Kamei D, 2013, CLIN EXP NE IN PRESS; Katafuchi R, 2011, CLIN J AM SOC NEPHRO, V6, P2806, DOI 10.2215/CJN.02890311; Kobayashi Y, 1996, NEPHRON, V72, P237, DOI 10.1159/000188848; Komatsu H, 2009, AM J NEPHROL, V30, P19, DOI 10.1159/000197116; Koyama A, 1997, AM J KIDNEY DIS, V29, P526, DOI 10.1016/S0272-6386(97)90333-4; Le WB, 2012, NEPHROL DIAL TRANSPL, V27, P1479, DOI 10.1093/ndt/gfr527; Lee H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051225; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsuzaki K, 2013, CLIN EXP NE IN PRESS; Miura N, 2009, CLIN EXP NEPHROL, V13, P460, DOI 10.1007/s10157-009-0179-1; Moriyama T, 2013, REN FAIL IN PRESS; Moriyama Takahito, 2004, Clin Exp Nephrol, V8, P237; Moriyama T, 2013, INTERNAL MED, V52, P193, DOI 10.2169/internalmedicine.52.8323; Moriyama T, 2012, INT UROL NEPHROL, V44, P1177, DOI 10.1007/s11255-011-0109-5; Moriyama T, 2012, CLIN EXP NEPHROL, V16, P231, DOI 10.1007/s10157-011-0545-7; Moriyama T, 2011, CLIN EXP NEPHROL, V15, P700, DOI 10.1007/s10157-011-0455-8; Moriyama T, 2011, AM J NEPHROL, V34, P233, DOI 10.1159/000330189; Moriyama T, 2010, NEPHRON CLIN PRACT, V115, pC227, DOI 10.1159/000313040; Myllymaki J, 2005, NEPHROL DIAL TRANSPL, V20, P89, DOI 10.1093/ndt/gfh584; Ochi A, 2013, INT UROL NEPHROL, V45, P469, DOI 10.1007/s11255-012-0251-8; Ohno I, 2001, NEPHRON, V87, P333, DOI 10.1159/000045939; Pozzi C, 2004, J AM SOC NEPHROL, V15, P157, DOI 10.1097/01.ASN.0000103869.08096.4F; Pozzi C, 1999, LANCET, V353, P883, DOI 10.1016/S0140-6736(98)03563-6; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Shi YJ, 2012, KIDNEY BLOOD PRESS R, V35, P153, DOI 10.1159/000331453; Yau T, 2011, AM J NEPHROL, V34, P435, DOI 10.1159/000332223	32	126	141	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91756	10.1371/journal.pone.0091756	http://dx.doi.org/10.1371/journal.pone.0091756			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658533	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300040
J	Bonnet, X; Brischoux, F; Bonnet, C; Plichon, P; Fauvel, T				Bonnet, Xavier; Brischoux, Francois; Bonnet, Christophe; Plichon, Patrice; Fauvel, Thomas			Coastal Nurseries and Their Importance for Conservation of Sea Kraits	PLOS ONE			English	Article							CORAL-REEFS; SNAKES; POPULATIONS; DECLINE; SERPENTES; MORTALITY; ECOLOGY; HABITAT; ELAPIDAE; SURVIVAL	Destruction and pollution of coral reefs threaten these marine biodiversity hot stops which shelter more than two thirds of sea snake species. Notably, in many coral reef ecosystems of the Western Pacific Ocean, large populations of sea kraits (amphibious sea snakes) have drastically declined during the past three decades. Protecting remaining healthy populations is thus essential. In New Caledonia, coral reefs shelter numerous sea krait colonies spread throughout an immense lagoon (24,000 km(2)). Sea kraits feed on coral fish but lay their eggs on land. However, ecological information on reproduction and juveniles is extremely fragmentary, precluding protection of key habitats for reproduction. Our 10 years mark recapture study on Yellow sea kraits (L. saintgironsi >8,700 individuals marked) revealed that most neonates aggregate in highly localized coastal sites, where they feed and grow during several months before dispersal. Hundreds of females emigrate seasonally from remote populations (>50 km away) to lay their eggs in these coastal nurseries, and then return home. Protecting these nurseries is a priority to maintain recruitment rate, and to retain sea krait populations in the future.	[Bonnet, Xavier; Brischoux, Francois; Fauvel, Thomas] CNRS, Ctr Etud Biol Chize, Unite Mixte Rech 7372, Villiers En Bois, France; [Bonnet, Xavier; Brischoux, Francois; Fauvel, Thomas] Univ La Rochelle, Villiers En Bois, France; [Bonnet, Christophe] Ctr Hosp Terr Gaston Bourret, Noumea, New Caledonia; [Plichon, Patrice] Direct Environm, Noumea, Province Sud, New Caledonia; [Fauvel, Thomas] Univ Paris 06, Paris, France	Centre National de la Recherche Scientifique (CNRS); La Rochelle Universite; UDICE-French Research Universities; Sorbonne Universite	Bonnet, X (corresponding author), CNRS, Ctr Etud Biol Chize, Unite Mixte Rech 7372, Villiers En Bois, France.	bonnet@cebc.cnrs.fr		Bonnet, Xavier/0000-0001-6150-8199	Province Sud [C.283-11]	Province Sud	The Province Sud (convention C.283-11) provided a financial support to this study that covered part of the field equipment (< 20%) and boat transportation expenses (80%). This study did not receive any other specific funding (e.g. no funding for salary, general functioning, logistic), and thus this study essentially relied on the participation of unpaid volunteers (e.g. Christophe Bonnet) and on the personal involvement of researchers (CNRS employees, XB, TF, FB) and marine rangers (Province Sud employees, PP). The funders played a limited role in study design and data collection. Indeed, the Province Sud issued permits (see ethical statements) to perform surveys in several Natural Reserves (e.g. Signal Island). Yet, the main study site of this study is not a Natural Reserve and thus, no specific permit was required to perform surveys (note that sea kraits are not protected in New Caledonia). Thus funders had no role in most of the study design and data collection; and they played no role at all in analysis, decision to publish, or preparation of the manuscript.	Ackerman R.A., 1991, P193, DOI 10.1017/CBO9780511585739.013; Bacolod P.T., 1983, Philippine Scientist, V20, P39; BACOLOD P T, 1984, Philippine Scientist, V21, P155; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; Bonnet X, 2005, BIOL J LINN SOC, V85, P433, DOI 10.1111/j.1095-8312.2005.00505.x; Bonnet X, 1999, BIOL CONSERV, V89, P39, DOI 10.1016/S0006-3207(98)00140-2; BONNET X, 2012, INTEGR COMP BIOL, V52, P1; Bonnet X, 2014, SCI TOTAL ENVIRON, V470, P876, DOI 10.1016/j.scitotenv.2013.10.027; Bonnet X, 2010, CORAL REEFS, V29, P379, DOI 10.1007/s00338-010-0588-3; Bonnet X, 2009, ENVIRON CONSERV, V36, P62, DOI 10.1017/S0376892909005451; Breininger DR, 2012, ANIM CONSERV, V15, P361, DOI 10.1111/j.1469-1795.2012.00524.x; Brischoux F., 2009, ZOOLOGIA NEOCALEDONI, V7, P37; Brischoux F, 2007, MAR ECOL PROG SER, V350, P145, DOI 10.3354/meps07133; Brischoux F, 2011, AUSTRAL ECOL, V36, P46, DOI 10.1111/j.1442-9993.2010.02115.x; Brischoux F, 2009, OIKOS, V118, P145, DOI 10.1111/j.1600-0706.2008.17011.x; Brischoux F, 2009, BIODIVERS CONSERV, V18, P2473, DOI 10.1007/s10531-009-9602-x; Brooks SE, 2010, BIOL CONSERV, V143, P2127, DOI 10.1016/j.biocon.2010.05.023; Cogger HG, 2006, REC AUST MUS, V58, P245, DOI 10.3853/j.0067-1975.58.2006.1452; Delmas V, 2008, PHYSIOL BIOCHEM ZOOL, V81, P345, DOI 10.1086/529459; Elfes CT, 2013, HERPETOL CONSERV BIO, V8, P37; Fauvel T, 2012, AMPHIBIA-REPTILIA, V33, P365, DOI 10.1163/15685381-00002839; Fitzgerald LA, 2000, WILDLIFE SOC B, V28, P235; Goiran C, 2013, CORAL REEFS, V32, P281, DOI 10.1007/s00338-012-0977-x; GRAVES BM, 1995, HERPETOLOGICAL MONOGRAPHS, NO 9, 1995, P102; Guinea M. L., 2007, DEWHA FINAL REP SURV, P1; Heatwole H, 1997, WILDLIFE SOC B, V25, P766; HEATWOLE H, 1999, AUSTR NATURAL HIST S; HERRE AWCT, 1949, COPEIA, P282; Hibbitts TJ, 2009, SOUTHWEST NAT, V54, P461, DOI 10.1894/GC-195.1; Ineich I, 2007, MAR BIOL, V151, P793, DOI 10.1007/s00227-006-0527-6; Lane A, 2011, MOL PHYLOGENET EVOL, V59, P567, DOI 10.1016/j.ympev.2011.03.005; Lowenborg K, 2012, BIODIVERS CONSERV, V21, P2477, DOI 10.1007/s10531-012-0308-0; Luiselli L, 2012, BIOTROPICA, V44, P569, DOI 10.1111/j.1744-7429.2011.00842.x; Lukoschek V, 2013, BIOL CONSERV, V166, P191, DOI 10.1016/j.biocon.2013.07.004; Milton DA, 2001, BIOL CONSERV, V101, P281, DOI 10.1016/S0006-3207(00)00232-9; Natusch DJD, 2012, BIODIVERS CONSERV, V21, P2899, DOI 10.1007/s10531-012-0345-8; Packard G.C., 1988, Biology of Reptilia, V16, P523; Pike DA, 2008, BIOL LETTERS, V4, P704, DOI 10.1098/rsbl.2008.0359; Pike DA, 2008, ECOLOGY, V89, P607, DOI 10.1890/06-2162.1; Rasmussen AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027373; Reading CJ, 2010, BIOL LETTERS, V6, P777, DOI 10.1098/rsbl.2010.0373; SAINT GIRONS H., 1964, TERRE VIE, V111, P185; Santos X, 2009, ACTA HERPETOL, V4, P161; Sasaki K, 2012, J HERPETOL, V46, P689, DOI 10.1670/11-023; Shetty S, 2002, CONSERV BIOL, V16, P1422, DOI 10.1046/j.1523-1739.2002.00515.x; Shine R, 2003, J ZOOL, V259, P261, DOI 10.1017/S0952836902003242; Shine R, 1997, ECOLOGY, V78, P2559; Shine Richard, 2009, P172; TU MC, 1990, J HERPETOL, V24, P119, DOI 10.2307/1564218; Wilkinson C, 2006, CONSERV BIOL SER, P3; Winne CT, 2007, COPEIA, P507, DOI 10.1643/0045-8511(2007)2007[507:EDOAPP]2.0.CO;2; *WRI, 2011, REEFS RISK REVISITED; 2012, SCIENCE, V335, P150	53	11	12	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e90246	10.1371/journal.pone.0090246	http://dx.doi.org/10.1371/journal.pone.0090246			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670985	Green Published, gold			2022-12-27	WOS:000333677000007
J	Keenan, K; Grundy, E; Kenward, MG; Leon, DA				Keenan, Katherine; Grundy, Emily; Kenward, Michael G.; Leon, David A.			Women's Risk of Repeat Abortions Is Strongly Associated with Alcohol Consumption: A Longitudinal Analysis of a Russian National Panel Study, 1994-2009	PLOS ONE			English	Article							ST-PETERSBURG; UNINTENDED PREGNANCY; SUBSTANCE USE; CONDOM USE; DRUG-USE; OUTCOMES; HEALTH; TRENDS; DRINKING; PATTERNS	Abortion rates in Russia, particularly repeat abortions, are among the highest in the world, and abortion complications make a substantial contribution to the country's high maternal mortality rate. Russia also has a very high rate of hazardous alcohol use. However, the association between alcohol use and abortion in Russia remains unexplored. We investigated the longitudinal predictors of first and repeat abortion, focussing on women's alcohol use as a risk factor. Follow-up data from 2,623 women of reproductive age (16-44 years) was extracted from 14 waves of the Russian Longitudinal Monitoring Survey (RLMS), a nationally representative panel study covering the period 1994-2009. We used discrete time hazard models to estimate the probability of having a first and repeat abortion by social, demographic and health characteristics at the preceding study wave. Having a first abortion was associated with demographic factors such as age and parity, whereas repeat abortions were associated with low education and alcohol use. After adjustment for demographic and socioeconomic factors, the risk of having a repeat abortion increased significantly as women's drinking frequency increased (P<0.001), and binge drinking women were significantly more likely to have a repeat abortion than non-drinkers (OR 2.28, 95% CI 1.62-3.20). This association was not accounted for by contraceptive use or a higher risk of pregnancy. Therefore the determinants of first and repeat abortion in Russia between 1994-2009 were different. Women who had repeat abortions were distinguished by their heavier and more frequent alcohol use. The mechanism for the association is not well understood but could be explained by unmeasured personality factors, such as risk taking, or social non-conformity increasing the risk of unplanned pregnancy. Heavy or frequent drinkers constitute a particularly high risk group for repeat abortion, who could be targeted in prevention efforts.	[Keenan, Katherine; Kenward, Michael G.; Leon, David A.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Grundy, Emily] Univ London London Sch Econ & Polit Sci, Dept Social Policy, London WC2A 2AE, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School Economics & Political Science	Keenan, K (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England.	Katherine.keenan@lshtm.ac.uk	Leon, David A/G-2195-2010; Grundy, Emily/AAC-3260-2019	Leon, David A/0000-0001-9747-1762; Grundy, Emily/0000-0002-9633-1116; Keenan, Katherine/0000-0002-9670-1607	United Kingdom Economic and Social Research Council PhD Studentship	United Kingdom Economic and Social Research Council PhD Studentship	KK was funded by a United Kingdom Economic and Social Research Council PhD Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala N, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-28; Abdala N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-676; Alexandrova YN, 1999, CANCER LETT, V145, P43, DOI 10.1016/S0304-3835(99)00218-9; Asamoah BO, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-10; Bobak M, 2004, J EPIDEMIOL COMMUN H, V58, P238, DOI 10.1136/jech.2003.011825; Carpenter J. R., 2013, MULTIPLE IMPUTATION; Centers for Disease Control and Prevention ORC Macro, 2003, REPR MAT CHILD HLTH; Charles VE, 2008, CONTRACEPTION, V78, P436, DOI 10.1016/j.contraception.2008.07.005; David PH, 2007, HEALTH POLICY PLANN, V22, P83, DOI 10.1093/heapol/czm003; Denisov BP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049986; Dianov MA, 2011, ZDRAVOOKHRANENIYE RO; England & Wales Department of Health, 2012, AB STAT ENGL WAL 201; Fahrmeir L, 1998, ENCY BIOSTATISTICS, V2; Gerber TP, 2008, STUD FAMILY PLANN, V39, P1, DOI 10.1111/j.1728-4465.2008.00147.x; Hagenaars A. J., 1996, POVERTY STAT LATE 19; Higher School of Economics, 1992, DEM; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Horga M, 2006, PREVENTING UNSAFE AB, P209; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Klemetti R, 2012, HUM REPROD, V27, P3315, DOI 10.1093/humrep/des294; Leon DA, 2009, ADDICTION, V104, P1630, DOI 10.1111/j.1360-0443.2009.02655.x; Martino SC, 2006, PERSPECT SEX REPRO H, V38, P66, DOI 10.1363/3806606; MENSCH B, 1992, DEMOGRAPHY, V29, P409, DOI 10.2307/2061826; Naimi TS, 2003, PEDIATRICS, V111, P1136; Oliveras E, 2005, J BIOSOC SCI, V37, P585, DOI 10.1017/S0021932004006960; Perlman F, 2009, PERSPECT SEX REPRO H, V41, P40, DOI [10.1363/4104009, 10.1111/j.1931-2393.2009.4114009.x]; Philipov D, 2004, EUR J POPUL, V20, P95, DOI 10.1023/B:EUJP.0000034499.24658.7a; Pietila I, 2008, SOCIOL HEALTH ILL, V30, P1070, DOI 10.1111/j.1467-9566.2008.01106.x; Prager SW, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.007; Reardon DC, 2004, AM J DRUG ALCOHOL AB, V30, P369, DOI 10.1081/ADA-120037383; Regushevskaya E, 2009, EUR J CONTRACEP REPR, V14, P176, DOI 10.1080/13625180902916038; Sedgh G, 2012, LANCET, V379, P625, DOI 10.1016/S0140-6736(11)61786-8; Shuper PA, 2010, ALCOHOL ALCOHOLISM, V45, P159, DOI 10.1093/alcalc/agp091; UNICEF, 2012, TRANSMONEE 2012 DAT; WHO, 2011, GLOB STAT REP ALC 20	35	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e90356	10.1371/journal.pone.0090356	http://dx.doi.org/10.1371/journal.pone.0090356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SR	24671000	Green Accepted, gold, Green Published			2022-12-27	WOS:000333677000008
J	Kovacs, S; Hawes, SE; Maley, SN; Mosites, E; Wong, L; Stergachis, A				Kovacs, Stephanie; Hawes, Stephen E.; Maley, Stephen N.; Mosites, Emily; Wong, Ling; Stergachis, Andy			Technologies for Detecting Falsified and Substandard Drugs in Low and Middle-Income Countries	PLOS ONE			English	Article							COUNTERFEIT DRUGS; QUALITY; IDENTIFICATION; SPECTROMETRY; SPECTROSCOPY; ARTESUNATE; PRODUCTS; TABLETS	Falsified and substandard drugs are a global health problem, particularly in low-and middle-income countries (LMIC) that have weak pharmacovigilance and drug regulatory systems. Poor quality medicines have important health consequences, including the potential for treatment failure, development of antimicrobial resistance, and serious adverse drug reactions, increasing healthcare costs and undermining the public's confidence in healthcare systems. This article presents a review of the methods employed for the analysis of pharmaceutical formulations. Technologies for detecting substandard and falsified drugs were identified primarily through literature reviews. Key-informant interviews with experts augmented our methods when warranted. In order to aid comparisons, technologies were assigned a suitability score for use in LMIC ranging from 0-8. Scores measured the need for electricity, need for sample preparation, need for reagents, portability, level of training required, and speed of analysis. Technologies with higher scores were deemed the most feasible in LMICs. We categorized technologies that cost $10,000 USD or less as low cost, $10,000-100,000 USD as medium cost and those greater than $100,000 USD as high cost technologies (all prices are 2013 USD). This search strategy yielded information on 42 unique technologies. Five technologies were deemed both low cost and had feasibility scores between 6-8, and an additional four technologies had medium cost and high feasibility. Twelve technologies were deemed portable and therefore could be used in the field. Many technologies can aid in the detection of substandard and falsified drugs that vary from the simplest of checklists for packaging to the most complex mass spectrometry analyses. Although there is no single technology that can serve all the requirements of detecting falsified and substandard drugs, there is an opportunity to bifurcate the technologies into specific niches to address specific sections within the workflow process of detecting products.	[Kovacs, Stephanie; Hawes, Stephen E.; Maley, Stephen N.; Mosites, Emily; Stergachis, Andy] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Wong, Ling] Bill & Melinda Gates Fdn, Seattle, WA USA; [Stergachis, Andy] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Stergachis, Andy] Univ Washington, Global Med Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Bill & Melinda Gates Foundation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kovacs, S (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	kovacs2@uw.edu		Mosites, Emily/0000-0002-2968-9564	Strategic Analysis and Research Training Program (START); Bill and Melinda Gates Foundation	Strategic Analysis and Research Training Program (START); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was funded by the Strategic Analysis and Research Training Program (START) funded by the Bill and Melinda Gates Foundation. The funders role was limited to the design of the original project. The funders had no role in decision to publish or preparation of the manuscript.	Almuzaini T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002923; [Anonymous], QUALITY ANTIMALARIAL; [Anonymous], 2013, COUNT PROBL FALS SUB; Bate R, 2012, RES REP TROP MED, V3, P57, DOI 10.2147/RRTM.S33108; Bate R, 2009, AFR J PHARM PHARMACO, V3, P165; Davison Mark, 2011, PHARM ANTICOUNTERFEI; Deconinck E, 2013, J CHROMATOGR SCI, V51, P791, DOI 10.1093/chromsci/bmt006; Felton LA, 2011, DRUG DEV IND PHARM, V37, P88, DOI 10.3109/03639045.2010.492397; Fernandes RD, 2012, J PHARMACEUT BIOMED, V66, P85, DOI 10.1016/j.jpba.2012.03.004; Fernandez FM, 2011, ANALYST, V136, P3073, DOI 10.1039/c0an00627k; Food and Drug Administration, 1995, GUID IND IMM REL SOL; GPHF, GPHF MIN PROT COUNT; Green MD, 2001, TROP MED INT HEALTH, V6, P980, DOI 10.1046/j.1365-3156.2001.00793.x; Green MD, 2007, J PHARMACEUT BIOMED, V43, P105, DOI 10.1016/j.jpba.2006.06.047; Harris GA, 2012, ANALYST, V137, P3039, DOI 10.1039/c2an35431d; Harris GA, 2011, ANAL CHEM, V83, P1908, DOI 10.1021/ac102246h; Holzgrabe U, 2011, J PHARMACEUT BIOMED, V55, P679, DOI 10.1016/j.jpba.2010.12.017; Hostetler DM, 2012, ANAL METHODS-UK, V4, P3392, DOI 10.1039/c2ay25443c; Hu CQ, 2006, J PHARMACEUT BIOMED, V40, P68, DOI 10.1016/j.jpba.2005.06.026; KAINE LA, 1994, J CHROMATOGR A, V674, P255, DOI 10.1016/0021-9673(94)85231-6; Kaur H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003403; KENYON AS, 1995, J AOAC INT, V78, P41; Lal R, 2010, AAPS J, V12, P716, DOI 10.1208/s12248-010-9232-y; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Marini RD, 2010, J PHARMACEUT BIOMED, V53, P1278, DOI 10.1016/j.jpba.2010.07.026; Martino R, 2010, ANAL BIOANAL CHEM, V398, P77, DOI 10.1007/s00216-010-3748-y; Maurin JK, 2007, J PHARMACEUT BIOMED, V43, P1514, DOI 10.1016/j.jpba.2006.10.033; Nayyar GML, 2012, LANCET INFECT DIS, V12, P488, DOI 10.1016/S1473-3099(12)70064-6; Newton PN, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001139; Poole C, 2021, GAS CHROMATOGRAPHY; Roll Back Malaria, 2012, GLOB MAL ACT PLAN; Santamaria-Fernandez R, 2009, SCI JUSTICE, V49, P102, DOI 10.1016/j.scijus.2008.12.003; Sherma J, 2007, ACTA CHROMATOGR, V19, P5; Stanton C, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000431; Stein MJ, 2012, ANAL CHEM, V84, P1572, DOI 10.1021/ac2028134; Storme-Paris I, 2010, ANAL CHIM ACTA, V658, P163, DOI 10.1016/j.aca.2009.11.005; Twohig M, 2010, DRUG TEST ANAL, V2, P45, DOI 10.1002/dta.115; USP, 2013, PQM PROM QUAL MED DE; Weaver AA, 2013, ANAL CHEM, V85, P6453, DOI 10.1021/ac400989p; WHO, 2011, SURV QUAL SEL ANT ME; Wilkinson N, 2012, BRIEFCASE ENCOUNTER; World Health Organization, TOOL VIS INSP; World Health Organization, 2012, SPUR FALS LAB FALS C	43	82	84	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e90601	10.1371/journal.pone.0090601	http://dx.doi.org/10.1371/journal.pone.0090601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671033	Green Published, Green Submitted, gold			2022-12-27	WOS:000333677000009
J	Brown, ST; Tate, JP; Kyriakides, TC; Kirkwood, KA; Holodniy, M; Goulet, JL; Angus, BJ; Cameron, DW; Justice, AC				Brown, Sheldon T.; Tate, Janet P.; Kyriakides, Tassos C.; Kirkwood, Katherine A.; Holodniy, Mark; Goulet, Joseph L.; Angus, Brian J.; Cameron, D. William; Justice, Amy C.		OPTIMA Team	The VACS Index Accurately Predicts Mortality and Treatment Response among Multi-Drug Resistant HIV Infected Patients Participating in the Options in Management with Antiretrovirals (OPTIMA) Study	PLOS ONE			English	Article							VETERANS AGING COHORT; NON-AIDS EVENTS; NONFATAL AIDS; RISK; THERAPY; PROGRESSION; EFFICACY; DISEASE; TRIALS; SAFETY	Objectives: The VACS Index is highly predictive of all-cause mortality among HIV infected individuals within the first few years of combination antiretroviral therapy (cART). However, its accuracy among highly treatment experienced individuals and its responsiveness to treatment interventions have yet to be evaluated. We compared the accuracy and responsiveness of the VACS Index with a Restricted Index of age and traditional HIV biomarkers among patients enrolled in the OPTIMA study. Methods: Using data from 324/339 (96%) patients in OPTIMA, we evaluated associations between indices and mortality using Kaplan-Meier estimates, proportional hazards models, Harrel's C-statistic and net reclassification improvement (NRI). We also determined the association between study interventions and risk scores over time, and change in score and mortality. Results: Both the Restricted Index (c = 0.70) and VACS Index (c = 0.74) predicted mortality from baseline, but discrimination was improved with the VACS Index (NRI = 23%). Change in score from baseline to 48 weeks was more strongly associated with survival for the VACS Index than the Restricted Index with respective hazard ratios of 0.26 (95% CI 0.14-0.49) and 0.39(95% CI 0.22-0.70) among the 25% most improved scores, and 2.08 (95% CI 1.27-3.38) and 1.51 (95% CI 0.90-2.53) for the 25% least improved scores. Conclusions: The VACS Index predicts all-cause mortality more accurately among multi-drug resistant, treatment experienced individuals and is more responsive to changes in risk associated with treatment intervention than an index restricted to age and HIV biomarkers. The VACS Index holds promise as an intermediate outcome for intervention research.	[Brown, Sheldon T.] James J Peters VA Med Ctr, Bronx, NY 10468 USA; [Brown, Sheldon T.] Icahn Sch Med Mt Sinai, Dept Med, New York, NY USA; [Tate, Janet P.; Goulet, Joseph L.; Justice, Amy C.] VA Connecticut Healthcare Syst, Gen Internal Med Sect, West Haven, CT USA; [Tate, Janet P.; Goulet, Joseph L.; Justice, Amy C.] Yale Univ, Sch Med, New Haven, CT USA; [Tate, Janet P.; Goulet, Joseph L.; Justice, Amy C.] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Kyriakides, Tassos C.; Kirkwood, Katherine A.] VA Connecticut Healthcare Syst, VA Cooperat Studies Program, Coordinating Ctr, West Haven, CT USA; [Holodniy, Mark] VA Palo Alto Healthcare Syst, Palo Alto, CA USA; [Holodniy, Mark] Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA; [Angus, Brian J.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Cameron, D. William] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON, Canada	US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; University of Oxford; University of Ottawa; Ottawa Hospital Research Institute	Brown, ST (corresponding author), James J Peters VA Med Ctr, Bronx, NY 10468 USA.	sheldon.brown@va.gov	Cameron, Bill/E-9180-2010; Angus, Brian/L-9246-2019; Kyriakides, Tassos/E-4980-2013	Cameron, Bill/0000-0002-0090-3539; Angus, Brian/0000-0003-3598-7784; Kyriakides, Tassos/0000-0001-8913-108X; Holodniy, Mark/0000-0002-6655-7982; Kozal, Michael/0000-0002-3100-8254; , Michael/0000-0002-7719-7396; Goulet, Joseph Lucien/0000-0002-0842-804X	Office of Research and Development (Cooperative Studies Program), US Department of Veterans Affairs; US National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism [U01-13566]; Canadian Institutes for Health Research; United Kingdom Medical Research Council; Ontario HIV Treatment Network/Ministry of Health, Canada; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U24AA022001, U01AA020790] Funding Source: NIH RePORTER	Office of Research and Development (Cooperative Studies Program), US Department of Veterans Affairs(US Department of Veterans Affairs); US National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ontario HIV Treatment Network/Ministry of Health, Canada; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Office of Research and Development (Cooperative Studies Program), US Department of Veterans Affairs; US National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism [U01-13566]; Canadian Institutes for Health Research; and United Kingdom Medical Research Council. DWC is a Career Scientist supported by the Ontario HIV Treatment Network/Ministry of Health, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achhra AC, 2010, AIDS, V24, P1877, DOI 10.1097/QAD.0b013e32833b1b26; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; Eichler K, 2007, AM HEART J, V153, P722, DOI 10.1016/j.ahj.2007.02.027; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014764, 10.1371/journal.pone.0025792]; Justice AC, 2010, HIV MED, V11, P143, DOI 10.1111/j.1468-1293.2009.00757.x; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Justice AC, 2013, JAIDS-J ACQ IMM DEF, V62, P149, DOI 10.1097/QAI.0b013e31827df36c; Justice AC, 2012, CLIN INFECT DIS, V55, P751, DOI 10.1093/cid/cis539; Justice AC, 2012, CLIN INFECT DIS, V54, P984, DOI 10.1093/cid/cir989; Katlama C, 2009, AIDS, V23, P2289, DOI 10.1097/QAD.0b013e3283316a5e; Kyriakides TC, 2003, CONTROL CLIN TRIALS, V24, P481, DOI 10.1016/S0197-2456(03)00029-1; May M, 2004, STAT MED, V23, P2375, DOI 10.1002/sim.1825; Medapalli RK, 2012, JAIDS-J ACQ IMM DEF, V60, P393, DOI 10.1097/QAI.0b013e31825b70d9; Mills EJ, 2008, HIV MED, V9, P849, DOI 10.1111/j.1468-1293.2008.00643.x; Mocroft A, 2007, AIDS, V21, P1867, DOI 10.1097/QAD.0b013e328270b877; Neuhaus J, 2010, AIDS, V24, P697, DOI 10.1097/QAD.0b013e3283365356; Reekie J, 2011, AIDS, V25, P2259, DOI 10.1097/QAD.0b013e32834cdb4b; Steigbigel RT, 2010, CLIN INFECT DIS, V50, P605, DOI 10.1086/650002; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Sullivan LE, 2006, CLIN INFECT DIS, V43, pS184, DOI 10.1086/508182; Tate JP, 2013, AIDS, V27, P563, DOI 10.1097/QAD.0b013e32835b8c7f	25	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92606	10.1371/journal.pone.0092606	http://dx.doi.org/10.1371/journal.pone.0092606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667813	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600053
J	Ioacara, S; Guja, C; Ionescu-Tirgoviste, C; Fica, S; Roden, M				Ioacara, Sorin; Guja, Cristian; Ionescu-Tirgoviste, Constantin; Fica, Simona; Roden, Michael			Cancer Specific Mortality in Insulin-Treated Type 2 Diabetes Patients	PLOS ONE			English	Article							RISK; GLARGINE; ANALOGS; MALIGNANCIES; COHORT	Aims: To test the hypothesis that cumulative exposure to insulin and long-acting insulin analogs might be associated with cancer mortality in diabetes patients. Methods: All consecutive diabetes patients aged over 40 years, residing in a major urban area were screened at their first diabetes outpatient visit between 01/01/2001-12/31/2008 (n = 79869). Exclusion criteria were insulin treatment at screening, no insulin treatment until 12/31/2008, less than 6 months of glucose-lowering treatment alone before insulin initiation, insulin prescription before glargine became available, age <40/>= 80 years at first insulin prescription, and <6 months of insulin exposure. A total 4990 subjects were followed-up for death based on death certificate, until 12/31/2011. Adjusted time-dependent competing risk regression analysis, with daily updates of treatment modalities was performed. Results are expressed for every 10,000 IU of cumulative dose or one year of cumulative time exposure to insulin. Results: Mean baseline age was 62 +/- 9 years, and follow-up 4.7 +/- 1.9 years. Glargine cumulative dose was associated with lower cancer mortality risk (subhazard ratio, SHR: 0.94 (95%CI 0.89-0.99, p = 0.033)). Cumulative exposure limited to that attained one year prior to death revealed lower SHRs for cumulative time (0.94 (95%CI 0.89-0.99, p = 0.018)) and cumulative dose of glargine (0.92 (95%CI 0.86-0.98, p = 0.014)). Glargine cumulative time and cumulative dose were significant predictors for lower pancreatic and breast cancer mortality, but not for deaths from lung, colorectal, female genital, liver, and urinary tract cancer. No increased hazards were found for any other subtypes of insulins. Conclusions: The cumulative dose exposure to insulin glargine was associated with a lower risk of cancer mortality in general, and of breast and pancreatic cancer in particular. This effect remained even after additional "fixed" cohort or propensity score analyses.	[Ioacara, Sorin; Fica, Simona] Elias Hosp, Bucharest, Romania; [Ioacara, Sorin; Guja, Cristian; Ionescu-Tirgoviste, Constantin; Fica, Simona] Carol Davila Univ Med & Pharm, Bucharest, Romania; [Guja, Cristian; Ionescu-Tirgoviste, Constantin] N Paulescu Natl Inst Diabet Nutr & Metab Dis, Bucharest, Romania; [Roden, Michael] Univ Dusseldorf, Dept Endocrinol & Diabetol, Dusseldorf, Germany; [Roden, Michael] German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany	Carol Davila University of Medicine & Pharmacy; Heinrich Heine University Dusseldorf; Deutsches Diabetes-Zentrum (DDZ)	Ioacara, S (corresponding author), Elias Hosp, Bucharest, Romania.	drsorin@yahoo.com	Guja, Cristian/K-2334-2019; Roden, Michael/AAD-3843-2019; Ioacara, Sorin/AAO-9210-2021	Ioacara, Sorin/0000-0001-5663-3593				Blin P, 2012, DIABETOLOGIA, V55, P644, DOI 10.1007/s00125-011-2429-5; Carstensen B, 2012, DIABETOLOGIA, V55, P948, DOI 10.1007/s00125-011-2381-4; Colhoun HM, 2012, DIABETOLOGIA, V55, P2929, DOI 10.1007/s00125-012-2668-0; Colhoun HM, 2009, DIABETOLOGIA, V52, P1755, DOI 10.1007/s00125-009-1453-1; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; Home PD, 2009, DIABETOLOGIA, V52, P2499, DOI 10.1007/s00125-009-1530-5; Ioacara S, 2011, DIABETES RES CLIN PR, V92, P400, DOI 10.1016/j.diabres.2011.03.022; Johnson JA, 2011, DIABETOLOGIA, V54, P2263, DOI 10.1007/s00125-011-2242-1; Jonasson JM, 2009, DIABETOLOGIA, V52, P1745, DOI 10.1007/s00125-009-1444-2; Mannucci E, 2010, DIABETES CARE, V33, P1997, DOI 10.2337/dc10-0476; Morden NE, 2011, DIABETES CARE, V34, P1965, DOI 10.2337/dc11-0699; Renehan AG, 2012, DIABETOLOGIA, V55, P7, DOI 10.1007/s00125-011-2352-9; Rosenstock J, 2009, DIABETOLOGIA, V52, P1971, DOI 10.1007/s00125-009-1452-2; Ruiter R, 2012, DIABETOLOGIA, V55, P51, DOI 10.1007/s00125-011-2312-4; Stefansdottir G, 2011, DIABETOLOGIA, V54, P1608, DOI 10.1007/s00125-011-2104-x; Suissa S, 2011, DIABETOLOGIA, V54, P2254, DOI 10.1007/s00125-011-2190-9; van Staa TP, 2012, DIABETOLOGIA, V55, P654, DOI 10.1007/s00125-011-2390-3; WHO Collaborating Centre for Drug statistics Methodology, 2012, ATC DDD IND	22	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93132	10.1371/journal.pone.0093132	http://dx.doi.org/10.1371/journal.pone.0093132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667573	gold, Green Published, Green Submitted			2022-12-27	WOS:000333675600146
J	Koyama, N; Nishida, Y; Ishii, T; Yoshida, T; Furukawa, Y; Narahara, H				Koyama, Naoko; Nishida, Yoshihiro; Ishii, Terukazu; Yoshida, Toshie; Furukawa, Yuichi; Narahara, Hisashi			Telmisartan Induces Growth Inhibition, DNA Double-Strand Breaks and Apoptosis in Human Endometrial Cancer Cells	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; PROSTATE-CANCER; ESTROGEN-RECEPTOR; CROSS-TALK; X-RAY; PROLIFERATION; CARCINOMA; BLOCKER; DAMAGE; LIGAND	Telmisartan, an angiotensin II receptor type 1 blocker, is often used as an antihypertension drug, and it has also been characterized as a peroxisome proliferator-activated receptor-gamma (PPAR gamma) ligand. The purpose of this study was to elucidate the antitumor effects of telmisartan on endometrial cancer cells. We treated three endometrial cancer cell lines with various concentrations of telmisartan, and we investigated the effects of the telmisartan on the cell proliferation, apoptosis, and their related measurements in vitro. We also administered telmisartan to nude mice with experimental tumors to determine its in vivo effects and toxicity. All three endometrial cancer cell lines were sensitive to the growth-inhibitory effect of telmisartan. The induction of apoptosis was confirmed in concert with the altered expression of genes and proteins related to the apoptosis. We also observed that DNA double-strand breaks (DSBs) were induced in HHUA (human endometrial cancer) cells by telmisartan treatment. In addition, experiments in nude mice showed that telmisartan significantly inhibited human endometrial tumor growth, without toxic side effects. Our results suggest that telmisartan might be a new therapeutic option for the treatment of endometrial cancers.	[Koyama, Naoko; Nishida, Yoshihiro; Ishii, Terukazu; Yoshida, Toshie; Furukawa, Yuichi; Narahara, Hisashi] Oita Univ, Fac Med, Dept Obstet & Gynecol, Oita 87011, Japan	Oita University	Nishida, Y (corresponding author), Oita Univ, Fac Med, Dept Obstet & Gynecol, Oita 87011, Japan.	ynishida@oita-u.ac.jp			Oita University	Oita University(Oita University)	This study was supported by a Research Fund at the Discretion of the President, Oita University (HN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson SC, 2004, HYPERTENSION, V43, P993, DOI 10.1161/01.HYP.0000123072.34629.57; Benson SC, 2008, J HYPERTENS, V26, P973, DOI 10.1097/HJH.0b013e3282f56ba5; Berstein LM, 2004, J CANCER RES CLIN, V130, P687, DOI 10.1007/s00432-004-0587-2; Boisvert M, 2008, VIROLOGY, V380, P1, DOI 10.1016/j.virol.2008.07.023; Chen L, 2013, UPTODATE; Chen Y, 2001, CANCER RES, V61, P6437; de Feraudy S, 2010, P NATL ACAD SCI USA, V107, P6870, DOI 10.1073/pnas.1002175107; Doyle MC, 2013, BIOCHEM BIOPH RES CO, V431, P472, DOI 10.1016/j.bbrc.2013.01.036; Evans T, 2011, BRIT J CANCER, V104, P1505, DOI 10.1038/bjc.2011.68; Funao K, 2008, ONCOL REP, V20, P295, DOI 10.3892/or_00000006; Funao K, 2009, MOL MED REP, V2, P193, DOI 10.3892/mmr_00000083; Ghous Z, 2008, ANTICANCER RES, V28, P3757; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Hardwick JM, 2012, TRENDS CELL BIOL, V22, P318, DOI 10.1016/j.tcb.2012.03.005; Hu FB, 2003, J WOMEN HEALTH GEN-B, V12, P163, DOI 10.1089/154099903321576565; Ishiguro H, 2007, PROSTATE, V67, P924, DOI 10.1002/pros.20571; Isobe A, 2008, HUM REPROD, V23, P440, DOI 10.1093/humrep/dem247; KELLER H, 1995, MOL ENDOCRINOL, V9, P794, DOI 10.1210/me.9.7.794; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kociecka B, 2010, EUR J PHARMACOL, V628, P51, DOI 10.1016/j.ejphar.2009.11.043; Koike M, 2013, J VET MED SCI, V75, P415, DOI 10.1292/jvms.12-0333; Matsuyama M, 2010, EXP THER MED, V1, P301, DOI 10.3892/etm_00000046; Nishida M, 1996, Hum Cell, V9, P109; Nishida M, 1985, Nihon Sanka Fujinka Gakkai Zasshi, V37, P1103; Nishida Masato, 2002, Hum Cell, V15, P104, DOI 10.1111/j.1749-0774.2002.tb00105.x; Nusuetrong P, 2012, J TOXICOL SCI, V37, P803, DOI 10.2131/jts.37.803; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Obel Jennifer C, 2006, Clin Adv Hematol Oncol, V4, P459; Ota K, 2006, CLIN CANCER RES, V12, P4200, DOI 10.1158/1078-0432.CCR-05-1833; Plesca D, 2008, METHOD ENZYMOL, V446, P107, DOI 10.1016/S0076-6879(08)01606-6; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Rimon G, 1997, J NEUROSCI RES, V48, P563, DOI 10.1002/(SICI)1097-4547(19970615)48:6<563::AID-JNR9>3.0.CO;2-8; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Uemura H, 2003, MOL CANCER THER, V2, P1139; Vale CL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003915.pub4; Wang L, 2012, CHINESE MED J-PEKING, V125, P2200, DOI 10.3760/cma.j.issn.0366-6999.2012.12.021; Wang TT, 2006, CRIT REV ONCOL HEMAT, V58, P1, DOI 10.1016/j.critrevonc.2005.08.011; Wang X, 2002, MOL CELL ENDOCRINOL, V194, P123, DOI 10.1016/S0303-7207(02)00154-5; Xin B, 2007, CANCER, V110, P791, DOI 10.1002/cncr.22854; Yamamoto K, 2009, HYPERTENSION, V54, P1353, DOI 10.1161/HYPERTENSIONAHA.109.138750; Yang YC, 2007, INT J GYNECOL CANCER, V17, P418, DOI 10.1111/j.1525-1438.2006.00866.x; You H, 2013, J HUAZHONG U SCI-MED, V33, P43, DOI 10.1007/s11596-013-1069-z	44	39	42	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93050	10.1371/journal.pone.0093050	http://dx.doi.org/10.1371/journal.pone.0093050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667764	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600132
J	Lin, GG; Andrejeva, G; Te Fong, ACW; Hill, DK; Orton, MR; Parkes, HG; Koh, DM; Robinson, SP; Leach, MO; Eykyn, TR; Chung, YL				Lin, Gigin; Andrejeva, Gabriela; Te Fong, Anne-Christine Wong; Hill, Deborah K.; Orton, Matthew R.; Parkes, Harry G.; Koh, Dow-Mu; Robinson, Simon P.; Leach, Martin O.; Eykyn, Thomas R.; Chung, Yuen-Li			Reduced Warburg Effect in Cancer Cells Undergoing Autophagy: Steady-State H-1-MRS and Real-Time Hyperpolarized C-13-MRS Studies	PLOS ONE			English	Article							TUMOR RESPONSE; BREAST; PYRUVATE; LACTATE; INHIBITOR; INDUCTION; PROSTATE; RECOVERY; SURVIVAL; BRAIN	Autophagy is a highly regulated, energy dependent cellular process where proteins, organelles and cytoplasm are sequestered in autophagosomes and digested to sustain cellular homeostasis. We hypothesized that during autophagy induced in cancer cells by i) starvation through serum and amino acid deprivation or ii) treatment with PI-103, a class I PI3K/mTOR inhibitor, glycolytic metabolism would be affected, reducing flux to lactate, and that this effect may be reversible. We probed metabolism during autophagy in colorectal HT29 and HCT116 Bax knock-out cells using hyperpolarized C-13-magnetic resonance spectroscopy (MRS) and steady-state H-1-MRS. 24 hr PI103-treatment or starvation caused significant reduction in the apparent forward rate constant (k(PL)) for pyruvate to lactate exchange compared with controls in HT29 (100 mu M PI-103: 82%, p = 0.05) and HCT116 Bax-ko cells (10 mu M PI-103: 53%, p = 0.05; 20 mu M PI-103: 42%, p<0.0001; starvation: 52%, p<0.001), associated with reduced lactate excretion and intracellular lactate in all cases, and unchanged lactate dehydrogenase (LDH) activity and increased NAD+/NADH ratio following PI103 treatment or decreased LDH activity and unchanged NAD+/NADH ratio following starvation. After 48 hr recovery from PI103 treatment, k(PL) remained below control levels in HT29 cells (74%, p = 0.02), and increased above treated values, but remained below 24 hr vehicle-treated control levels in HCT116 Bax-ko cells (65%, p = 0.004) both were accompanied by sustained reduction in lactate excretion, recovery of NAD+/NADH ratio and intracellular lactate. Following recovery from starvation, k(PL) was significantly higher than 24 hr vehicle-treated controls (140%, p = 0.05), associated with increased LDH activity and total cellular NAD(H). Changes in k(PL) and cellular and excreted lactate provided measureable indicators of the major metabolic processes accompanying starvation-and drug-induced autophagy. The changes are reversible, returning towards and exceeding control values on cellular recovery, which potentially identifies resistance. k(PL) (hyperpolarized C-13-MRS) and lactate (H-1-MRS) provide useful biomarkers for the autophagic process, enabling non-invasive monitoring of the Warburg effect.	[Lin, Gigin; Andrejeva, Gabriela; Te Fong, Anne-Christine Wong; Hill, Deborah K.; Orton, Matthew R.; Parkes, Harry G.; Koh, Dow-Mu; Robinson, Simon P.; Leach, Martin O.; Eykyn, Thomas R.; Chung, Yuen-Li] Canc Res UK, Sutton, Surrey, England; [Lin, Gigin; Andrejeva, Gabriela; Te Fong, Anne-Christine Wong; Hill, Deborah K.; Orton, Matthew R.; Parkes, Harry G.; Koh, Dow-Mu; Robinson, Simon P.; Leach, Martin O.; Eykyn, Thomas R.; Chung, Yuen-Li] Inst Canc Res, Div Radiotherapy & Imaging, EPSRC Canc Imaging Ctr, Sutton, Surrey, England; [Lin, Gigin; Andrejeva, Gabriela; Te Fong, Anne-Christine Wong; Hill, Deborah K.; Orton, Matthew R.; Parkes, Harry G.; Koh, Dow-Mu; Robinson, Simon P.; Leach, Martin O.; Eykyn, Thomas R.; Chung, Yuen-Li] Royal Marsden Hosp, Sutton, Surrey, England; [Lin, Gigin] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Linkou, Dept Med Imaging & Intervent, Taoyuan, Taiwan; [Eykyn, Thomas R.] St Thomas Hosp, Rayne Inst, Kings Coll London, Div Imaging Sci & Biomed Engn, London SE1 7EH, England	Cancer Research UK; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Chang Gung Memorial Hospital; Chang Gung University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Leach, MO (corresponding author), Canc Res UK, Sutton, Surrey, England.	Martin.Leach@icr.ac.uk; ylichung@icr.ac.uk	Eykyn, Thomas/J-3284-2016; Lin, Gigin/A-2676-2017; Chung, Yuen-Li/K-2269-2019; leach, martin o/C-2248-2008; Parkes, Harold G/I-7412-2012	Eykyn, Thomas/0000-0003-1768-3808; Lin, Gigin/0000-0001-7246-1058; Chung, Yuen-Li/0000-0003-0807-1658; leach, martin o/0000-0002-0756-5368; Hill, Deborah/0000-0002-6441-5489; Robinson, Simon/0000-0003-4101-7274; Andrejeva, Gabriela/0000-0002-3508-7682; Koh, Dow-Mu/0000-0001-7654-8011; Parkes, Harold/0000-0003-4981-864X	Cancer Research UK; EPSRC Cancer Imaging Centre; MRC; Department of Health (England) [C1060/A10334]; NHS; Chang Gung Medical Foundation (Taiwan) [CMRPG370443, CMRPG3B1922]; EPSRC [EP/H046526/1] Funding Source: UKRI; Cancer Research UK [16464] Funding Source: researchfish; Engineering and Physical Sciences Research Council [GR/S23612/01, EP/H046526/1] Funding Source: researchfish; Medical Research Council [1100738] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10162] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); EPSRC Cancer Imaging Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health (England); NHS; Chang Gung Medical Foundation (Taiwan); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors acknowledge the support received from the Cancer Research UK and EPSRC Cancer Imaging Centre in association with the MRC and Department of Health (England) grant C1060/A10334, also NHS funding to the NIHR Biomedical Research Centre, MRC-funded studentship, also Chang Gung Medical Foundation (Taiwan) grants CMRPG370443 and CMRPG3B1922. MOL is an NIHR Senior Investigator. The authors also thank Alice Warley at the King's College London Centre for Ultrastructural Imaging (CUI) for assistance with electron microscopy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; BOARD M, 1990, BIOCHEM J, V265, P503, DOI 10.1042/bj2650503; Bohndiek SE, 2010, MOL CANCER THER, V9, P3278, DOI 10.1158/1535-7163.MCT-10-0706; Christensen CE, 2013, J BIOL CHEM, DOI [10.1074/jbc.M113.498626, DOI 10.1074/JBC.M113.498626.32.SANTIDRIAN]; Crowley LC, 2011, AM J HEMATOL, V86, P38, DOI 10.1002/ajh.21914; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; Day SE, 2011, MAGN RESON MED, V65, P557, DOI 10.1002/mrm.22698; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Golman K, 2006, CANCER RES, V66, P10855, DOI 10.1158/0008-5472.CAN-06-2564; Han J, 2008, J BIOL CHEM, V283, P19665, DOI 10.1074/jbc.M710169200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris T, 2009, P NATL ACAD SCI USA, V106, P18131, DOI 10.1073/pnas.0909049106; Hill DK, 2013, NMR BIOMED, V26, P1321, DOI 10.1002/nbm.2957; Hill DK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071996, 10.1371/journal.pone.0074627]; HOURI JJ, 1995, BIOCHEM J, V309, P521, DOI 10.1042/bj3090521; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Kwock L, 2006, LANCET ONCOL, V7, P859, DOI 10.1016/S1470-2045(06)70905-6; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lodi A, 2013, NMR BIOMED, V26, P299, DOI 10.1002/nbm.2848; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Nishida K, 2009, CELL DEATH DIFFER, V16, P31, DOI 10.1038/cdd.2008.163; O'Donovan TR, 2011, AUTOPHAGY, V7, P509, DOI 10.4161/auto.7.5.15066; Park I, 2011, J MAGN RESON IMAGING, V33, P1284, DOI 10.1002/jmri.22563; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Raynaud FI, 2007, CANCER RES, V67, P5840, DOI 10.1158/0008-5472.CAN-06-4615; Rosenfeldt MT, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001306; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Sitter B, 2002, NMR BIOMED, V15, P327, DOI 10.1002/nbm.775; Tyagi RK, 1996, MAGN RESON MED, V35, P194, DOI 10.1002/mrm.1910350210; Ward CS, 2010, CANCER RES, V70, P1296, DOI 10.1158/0008-5472.CAN-09-2251; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Witney TH, 2011, J BIOL CHEM, V286, P24572, DOI 10.1074/jbc.M111.237727; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	36	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92645	10.1371/journal.pone.0092645	http://dx.doi.org/10.1371/journal.pone.0092645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667972	Green Submitted, Green Published, gold			2022-12-27	WOS:000333675600059
J	Morignat, E; Perrin, JB; Gay, E; Vinard, JL; Calavas, D; Henaux, V				Morignat, Eric; Perrin, Jean-Baptiste; Gay, Emilie; Vinard, Jean-Luc; Calavas, Didier; Henaux, Viviane			Assessment of the Impact of the 2003 and 2006 Heat Waves on Cattle Mortality in France	PLOS ONE			English	Article							EXCESS MORTALITY; TEMPERATURES; EXTREMES	Objectives: While several studies have highlighted and quantified human mortality during the major heat waves that struck Western Europe in 2003 and 2006, the impact on farm animals has been overlooked. The aim of this study was to assess the effect of these two events on cattle mortality in France, one of the most severely impacted countries. Methods: Poisson regressions were used to model the national baseline for cattle mortality between 2004 and 2005 and predict the weekly number of expected deaths in 2003 and 2006 for the whole cattle population and by subpopulation based on age and type of production. Observed and estimated values were compared to identify and quantify excess mortality. The same approach was used at a departmental scale (a French department being an administrative and territorial division) to assess the spatio-temporal evolution of the mortality pattern. Results: Overall, the models estimated relative excess mortality of 24% [95% confidence interval: 22-25%] for the two-week heat wave of 2003, and 12% [11-14%] for the three-week heat wave of 2006. In 2003, most cattle subpopulations were impacted during the heat wave and some in the following weeks too. In 2006, cattle subpopulations were impacted for a limited time only, with no excess mortality at the beginning or after the heat wave. No marked differences in cattle mortality were found among the different subpopulations by age and type of production. The implications of these results for risk prevention are discussed.	[Morignat, Eric; Gay, Emilie; Vinard, Jean-Luc; Calavas, Didier; Henaux, Viviane] Agence Natl Securite Sanit Alimentat Environm & T, Unite Epidemiol Lab Lyon, Lyon, France; [Perrin, Jean-Baptiste] Bur Sante Anim, Direct Gen Alimentat DGAI, Paris, France		Morignat, E (corresponding author), Agence Natl Securite Sanit Alimentat Environm & T, Unite Epidemiol Lab Lyon, Lyon, France.	eric.morignat@anses.fr						Bessemoulin P., 2004, METEOROLOGIE, V46, P25; Crescio MI, 2010, PREV VET MED, V97, P191, DOI 10.1016/j.prevetmed.2010.09.004; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Farrington CP, 1996, J ROY STAT SOC A STA, V159, P547, DOI 10.2307/2983331; Fouillet A, 2008, INT J EPIDEMIOL, V37, P309, DOI 10.1093/ije/dym253; Fouillet A, 2006, INT ARCH OCC ENV HEA, V80, P16, DOI 10.1007/s00420-006-0089-4; Fouillet A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-114; Frich P, 2002, CLIMATE RES, V19, P193, DOI 10.3354/cr019193; Hahn GL, 1999, J ANIM SCI, V77, P10; Hajat S, 2006, EPIDEMIOLOGY, V17, P632, DOI 10.1097/01.ede.0000239688.70829.63; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Nardone A, 2010, LIVEST SCI, V130, P57, DOI 10.1016/j.livsci.2010.02.011; Perrin JB, 2011, INRA PROD ANIM, V24, P235; Perrin JB, 2010, EPIDEMICS-NETH, V2, P207, DOI 10.1016/j.epidem.2010.10.002; Poumadere M, 2005, RISK ANAL, V25, P1483, DOI 10.1111/j.1539-6924.2005.00694.x; R Core Team, 2012, R LANG ENV STAT COMP; Rey G, 2007, INT ARCH OCC ENV HEA, V80, P615, DOI 10.1007/s00420-007-0173-4; Sahai H, 1996, STAT EPIDEMIOLOGY ME; Schneider M, 2007, BEH, P22; Silanikove N, 2000, LIVEST PROD SCI, V67, P1, DOI 10.1016/S0301-6226(00)00162-7; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; Ung A., 2013, BEH, V11, P99; Wilson EB, 1931, P NATL ACAD SCI USA, V17, P684, DOI 10.1073/pnas.17.12.684	23	33	33	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93176	10.1371/journal.pone.0093176	http://dx.doi.org/10.1371/journal.pone.0093176			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667835	Green Submitted, gold, Green Published			2022-12-27	WOS:000333675600153
J	Pereira, S; Malard, V; Ravanat, JL; Davin, AH; Armengaud, J; Foray, N; Adam-Guillermin, C				Pereira, Sandrine; Malard, Veronique; Ravanat, Jean-Luc; Davin, Anne-Helene; Armengaud, Jean; Foray, Nicolas; Adam-Guillermin, Christelle			Low Doses of Gamma-Irradiation Induce an Early Bystander Effect in Zebrafish Cells Which Is Sufficient to Radioprotect Cells	PLOS ONE			English	Article							MEDIATED INTERCELLULAR COMMUNICATION; C3H 10T(1)/(2) CELLS; DOUBLE-STRAND BREAKS; ADAPTIVE RESPONSE; GLIOMA-CELLS; HUMAN FIBROBLASTS; ALPHA-PARTICLES; RADIOADAPTIVE RESPONSE; MAMMALIAN-CELLS; NITRIC-OXIDE	The term "bystander effect'' is used to describe an effect in which cells that have not been exposed to radiation are affected by irradiated cells though various intracellular signaling mechanisms. In this study we analyzed the kinetics and mechanisms of bystander effect and radioadaptation in embryonic zebrafish cells (ZF4) exposed to chronic low dose of gamma rays. ZF4 cells were irradiated for 4 hours with total doses of gamma irradiation ranging from 0.01-0.1 Gy. In two experimental conditions, the transfer of irradiated cells or culture medium from irradiated cells results in the occurrence of DNA double strand breaks in non-irradiated cells (assessed by the number of gamma-H2AX foci) that are repaired at 24 hours post-irradiation whatever the dose. At low total irradiation doses the bystander effect observed does not affect DNA repair mechanisms in targeted and bystander cells. An increase in global methylation of ZF4 cells was observed in irradiated cells and bystander cells compared to control cells. We observed that pre-irradiated cells which are then irradiated for a second time with the same doses contained significantly less gamma-H2AX foci than in 24 h gamma-irradiated control cells. We also showed that bystander cells that have been in contact with the pre-irradiated cells and then irradiated alone present less gamma-H2AX foci compared to the control cells. This radioadaptation effect is significantly more pronounced at the highest doses. To determine the factors involved in the early events of the bystander effect, we performed an extensive comparative proteomic study of the ZF4 secretomes upon irradiation. In the experimental conditions assayed here, we showed that the early events of bystander effect are probably not due to the secretion of specific proteins neither the oxidation of these secreted proteins. These results suggest that early bystander effect may be due probably to a combination of multiple factors.	[Pereira, Sandrine; Adam-Guillermin, Christelle] Inst Radioprotect & Surete Nucl, PRP Environm SERIS, Lab Ecotoxicol Radionucleides, Cadarache, St Paul Lez Dur, France; [Pereira, Sandrine; Foray, Nicolas] CRCL UMR INSERM 1052 CNRS 5286, Equipe Radiobiol, Lyon, France; [Malard, Veronique; Davin, Anne-Helene; Armengaud, Jean] CEA, DSV, IBEB, Lab Biochim Syst Perturb, Bagnols Sur Ceze, France; [Ravanat, Jean-Luc] CEA Grenoble, INAC Scib UMR CEA UJF E3, Lab Les Acides Nucl, F-38054 Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Pereira, S (corresponding author), Inst Radioprotect & Surete Nucl, PRP Environm SERIS, Lab Ecotoxicol Radionucleides, Cadarache, St Paul Lez Dur, France.	sandrine.pereira@ymail.com	malard, veronique/AAF-6253-2020; Ravanat, Jean-Luc/E-3452-2018; Foray, Nicolas/Q-2363-2019; malard, veronique/AAY-1670-2021; Foray, Nicolas/I-4755-2018	Ravanat, Jean-Luc/0000-0002-7123-6358; Foray, Nicolas/0000-0002-1282-1303; malard, veronique/0000-0002-0020-0518; Foray, Nicolas/0000-0002-1282-1303; ARMENGAUD, Jean/0000-0003-1589-445X; Adam-Guillermin, christelle/0000-0002-8833-0762	European Union programme STAR (Strategy for Allied Radioecology) [Fission-2010-3.5.1-269672]; Institute for Radioprotection and Nuclear Safety (IRSN); National Institute for Medical Research (INSERM)	European Union programme STAR (Strategy for Allied Radioecology); Institute for Radioprotection and Nuclear Safety (IRSN); National Institute for Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This research was supported by the European Union programme STAR (Strategy for Allied Radioecology) (Fission-2010-3.5.1-269672). S. Pereira is a postdoctoral fellow funded by the Institute for Radioprotection and Nuclear Safety (IRSN) and the National Institute for Medical Research (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armengaud J, 2012, EXPERT REV PROTEOMIC, V9, P561, DOI [10.1586/epr.12.52, 10.1586/EPR.12.52]; Azzam EI, 2003, ONCOGENE, V22, P7050, DOI 10.1038/sj.onc.1206961; Azzam EI, 1998, RADIAT RES, V150, P497, DOI 10.2307/3579865; Azzam EI, 2001, P NATL ACAD SCI USA, V98, P473, DOI 10.1073/pnas.011417098; Azzam EI, 2000, CANCER RES, V60, P2623; Barcellos-Hoff MH, 2001, RADIAT RES, V156, P618, DOI 10.1667/0033-7587(2001)156[0618:ESTTMA]2.0.CO;2; Belyakov OV, 2002, RADIAT PROT DOSIM, V99, P249, DOI 10.1093/oxfordjournals.rpd.a006775; Burdak-Rothkamm S, 2007, ONCOGENE, V26, P993, DOI 10.1038/sj.onc.1209863; Burdak-Rothkamm S, 2009, EUR J PHARMACOL, V625, P151, DOI 10.1016/j.ejphar.2009.09.068; Choi VWY, 2013, ENVIRON SCI TECHNOL, V47, P6368, DOI 10.1021/es401171h; Choi VWY, 2012, ENVIRON SCI TECHNOL, V46, P226, DOI 10.1021/es2016928; Choi VWY, 2010, ENVIRON SCI TECHNOL, V44, P8829, DOI 10.1021/es101535f; Clair G, 2010, MOL CELL PROTEOMICS, V9, P1486, DOI 10.1074/mcp.M000027-MCP201; Dickey JS, 2009, CARCINOGENESIS, V30, P1686, DOI 10.1093/carcin/bgp192; Dupierris V, 2009, BIOINFORMATICS, V25, P1980, DOI 10.1093/bioinformatics/btp301; Foray N, 2003, EMBO J, V22, P2860, DOI 10.1093/emboj/cdg274; Gerashchenko BI, 2003, CYTOM PART A, V56A, P71, DOI 10.1002/cyto.a.10092; Gilbin R, 2008, J ENVIRON RADIOACTIV, V99, P134, DOI 10.1016/j.jenvrad.2007.07.004; Herok R, 2010, INT J RADIAT ONCOL, V77, P244, DOI 10.1016/j.ijrobp.2009.11.033; Hu BR, 2006, CARCINOGENESIS, V27, P245, DOI 10.1093/carcin/bgi224; Ilnytskyy Y, 2011, MUTAT RES-FUND MOL M, V714, P113, DOI 10.1016/j.mrfmmm.2011.06.014; Jarvis RB, 2003, MUTAT RES-GEN TOX EN, V541, P63, DOI 10.1016/S1383-5718(03)00182-7; Kashino G, 2004, MUTAT RES-FUND MOL M, V556, P209, DOI 10.1016/j.mrfmmm.2004.08.009; Kovalchuk O, 2003, MUTAT RES-FUND MOL M, V529, P13, DOI 10.1016/S0027-5107(03)00103-9; Liu CS, 2012, AQUAT TOXICOL, V118, P108, DOI 10.1016/j.aquatox.2012.04.001; Lyng FM, 2002, RADIAT RES, V157, P365, DOI 10.1667/0033-7587(2002)157[0365:IOAICE]2.0.CO;2; Maguire P, 2005, RADIAT RES, V163, P384, DOI 10.1667/RR3325; Malard V, 2012, J PROTEOMICS, V75, P1043, DOI 10.1016/j.jprot.2011.10.025; Mitchell SA, 2004, INT J RADIAT BIOL, V80, P465, DOI 10.1080/09553000410001725116; Mothersill C, 1997, INT J RADIAT BIOL, V72, P597, DOI 10.1080/095530097143095; Mothersill C, 2006, RADIAT RES, V165, P26, DOI 10.1667/RR3488.1; Mothersill C, 2004, RADIAT RES, V161, P256, DOI 10.1667/RR3136; Mothersill C, 2004, NAT REV CANCER, V4, P158, DOI 10.1038/nrc1277; Mothersill C, 2009, INT J RADIAT BIOL, V85, P909, DOI 10.3109/09553000903105452; Ojima Mitsuaki, 2001, Physiological Chemistry and Physics and Medical NMR, V33, P41; Ojima M, 2011, RADIAT PROT DOSIM, V146, P276, DOI 10.1093/rpd/ncr169; OLIVIERI G, 1984, SCIENCE, V223, P594, DOI 10.1126/science.6695170; Pereira S, 2011, ENVIRON TOXICOL CHEM, V30, P2831, DOI 10.1002/etc.695; Postiglione I, 2010, MED ONCOL, V27, P495, DOI 10.1007/s12032-009-9241-9; Prise KM, 2005, LANCET ONCOL, V6, P520, DOI 10.1016/S1470-2045(05)70246-1; Raiche J, 2004, BIOCHEM BIOPH RES CO, V325, P39, DOI 10.1016/j.bbrc.2004.10.002; Ravanat JL, 2002, CARCINOGENESIS, V23, P1911, DOI 10.1093/carcin/23.11.1911; Ryan LA, 2008, J ENVIRON RADIOACTIV, V99, P739, DOI 10.1016/j.jenvrad.2007.10.001; Sawant SG, 2001, RADIAT RES, V156, P177, DOI 10.1667/0033-7587(2001)156[0177:ARATBE]2.0.CO;2; Shao C, 2008, ONCOGENE, V27, P434, DOI 10.1038/sj.onc.1210653; Shao C, 2005, INT J CANCER, V116, P45, DOI 10.1002/ijc.21003; Shao C, 2003, CANCER RES, V63, P8437; Shao CL, 2004, P NATL ACAD SCI USA, V101, P13495, DOI 10.1073/pnas.0404930101; Shao CL, 2003, RADIAT RES, V160, P318, DOI 10.1667/RR3044; Smith RW, 2007, PROTEOMICS, V7, P4171, DOI 10.1002/pmic.200700573; Smith RW, 2013, INT J RADIAT BIOL, V89, P225, DOI 10.3109/09553002.2013.754558; Smith RW, 2011, BBA-PROTEINS PROTEOM, V1814, P290, DOI 10.1016/j.bbapap.2010.11.002; Sokolov MV, 2005, ONCOGENE, V24, P7257, DOI 10.1038/sj.onc.1208886; Tawa R, 1998, J RADIAT RES, V39, P271, DOI 10.1269/jrr.39.271; Yang HY, 2005, ONCOGENE, V24, P2096, DOI 10.1038/sj.onc.1208439; Yasuda T, 2006, J RADIAT RES, V47, P295, DOI 10.1269/jrr.0617; Zhou HN, 2000, P NATL ACAD SCI USA, V97, P2099, DOI 10.1073/pnas.030420797	57	43	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92974	10.1371/journal.pone.0092974	http://dx.doi.org/10.1371/journal.pone.0092974			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667817	Green Published, gold			2022-12-27	WOS:000333675600115
J	Zheng, WJ; Hou, YJ; Yao, W				Zheng, Weijiang; Hou, Yanjun; Yao, Wen			Lactulose Increases Equol Production and Improves Liver Antioxidant Status in Barrows Treated with Daidzein	PLOS ONE			English	Article							IN-VITRO FERMENTATION; DIVERSITY ANALYSIS; IDENTIFICATION; QUANTITATION; ISOFLAVONES; POPULATIONS; METABOLISM; BACTERIA; CULTURE; LIGNANS	Equol, one of the intestinal microflora metabolites of daidzein, has gained much attention for having greater bioactivity than its precursor (daidzein and daidzin) and seeming to be promoted by hydrogen gas. The effects of lactulose on the equol-producing capacity and liver antioxidant status of barrows treated with daidzein were investigated in this study. Male castrated piglets (barrows) of Landrace x Duroc, aged 40 days, were randomly divided into the following three groups: control group (C, n = 12, fed an isoflavones-free basic diet), daidzein group (D, n = 12, fed an isoflavones-free basic diet with 50 mg/kg of daidzein supplementation) and daidzein+lactulose group (D+L, n = 12, fed an isoflavones-free basic diet with 1% of lactulose and 50 mg/kg of daidzein supplementation). After 20 days, the profile of short-chain fatty acids in the colon digesta showed that lactulose significantly increased the fermented capacity in the gastrointestinal tract of the barrows. First-void urinary equol concentrations were significantly higher in the D+L group than in the D group (3.13 +/- 0.93 compared to 2.11 +/- 0.82 mu g/ml, respectively). Furthermore, fecal equol levels were also significantly higher in the D+L group than in the D group (12.00 +/- 2.68 compared to 10.00 +/- 2.26 mu g/g, respectively). The population of bacteroidetes and the percentage of bacteroidetes to bacteria in feces were higher in the D+L group than in the D group. The DGGE profiles results indicate that lactulose might shift the pathways of hydrogen utilization, and changing the profiles of SRB in feces. Moreover, the D+L group had weak enhancement of T-SOD and CuZn-SOD activities in the livers of barrows treated with daidzein.	[Zheng, Weijiang; Hou, Yanjun; Yao, Wen] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Yao, Wen] Minist Agr, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Ministry of Agriculture & Rural Affairs	Yao, W (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	yaowen67jp@njau.edu.cn		Zheng, Weijiang/0000-0002-1725-2488	Ph.D. Programs Foundation of Ministry of Education of China [B0201100681]; Scientific Research Foundation for Returned Overseas Chinese Scholars [G0201100315]; Special Fund for Agro-scientific Research in the Public Interest [201003011]	Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Scientific Research Foundation for Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Special Fund for Agro-scientific Research in the Public Interest	This study was funded by Ph.D. Programs Foundation of Ministry of Education of China (B0201100681), Scientific Research Foundation for Returned Overseas Chinese Scholars (G0201100315) and the Special Fund for Agro-scientific Research in the Public Interest (201003011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blay M, 2010, J PHARMACEUT BIOMED, V51, P382, DOI 10.1016/j.jpba.2009.03.028; Bolca S, 2007, J NUTR, V137, P2242, DOI 10.1093/jn/137.10.2242; Bolca S, 2010, ANAEROBE, V16, P247, DOI 10.1016/j.anaerobe.2010.03.002; Bowey E, 2003, FOOD CHEM TOXICOL, V41, P631, DOI 10.1016/S0278-6915(02)00324-1; Cheng YF, 2009, LETT APPL MICROBIOL, V48, P585, DOI 10.1111/j.1472-765X.2009.02583.x; Choi EJ, 2009, J FOOD SCI, V74, pH65, DOI 10.1111/j.1750-3841.2008.01039.x; Decroos K, 2005, ARCH MICROBIOL, V183, P45, DOI 10.1007/s00203-004-0747-4; Denman SE, 2007, FEMS MICROBIOL ECOL, V62, P313, DOI 10.1111/j.1574-6941.2007.00394.x; Deplancke B, 2000, APPL ENVIRON MICROB, V66, P2166, DOI 10.1128/AEM.66.5.2166-2174.2000; FLORENT C, 1985, J CLIN INVEST, V75, P608, DOI 10.1172/JCI111738; GIBSON GR, 1990, GUT, V31, P679, DOI 10.1136/gut.31.6.679; HANE BG, 1993, ELECTROPHORESIS, V14, P967, DOI 10.1002/elps.11501401154; Jin JS, 2010, INT J SYST EVOL MICR, V60, P1721, DOI 10.1099/ijs.0.016774-0; Konstantinov SR, 2003, FEMS MICROBIOL ECOL, V43, P225, DOI 10.1111/j.1574-6941.2003.tb01062.x; Lane D.J., 1991, NUCL ACID TECHNIQUES, DOI [10.1099/ijs.0.060731-0, DOI 10.1099/ijs.0.060731-0]; Layton A, 2006, APPL ENVIRON MICROB, V72, P4214, DOI 10.1128/AEM.01036-05; Mao SY, 2007, ANIM FEED SCI TECH, V136, P154, DOI 10.1016/j.anifeedsci.2006.09.012; Maubach J, 2003, J CHROMATOGR B, V784, P137, DOI 10.1016/S1570-0232(02)00789-4; Minamida K, 2008, INT J SYST EVOL MICR, V58, P1238, DOI 10.1099/ijs.0.64894-0; Minamida K, 2006, J BIOSCI BIOENG, V102, P247, DOI 10.1263/jbb.102.247; NRC, 1998, NUTR REQ SWIN, DOI [10.17226/6016, DOI 10.17226/6016]; Nubel U, 1996, J BACTERIOL, V178, P5636; Possemiers S, 2007, FEMS MICROBIOL ECOL, V61, P372, DOI 10.1111/j.1574-6941.2007.00330.x; Rimbach G, 2003, XENOBIOTICA, V33, P913, DOI 10.1080/0049825031000150444; SANGUINETTI CJ, 1994, BIOTECHNIQUES, V17, P914; Setchell KDR, 2002, J NUTR, V132, P3577, DOI 10.1093/jn/132.12.3577; SETCHELL KDR, 1984, AM J CLIN NUTR, V40, P569, DOI 10.1093/ajcn/40.3.569; Setchell KDR, 2010, J NUTR, V140, p1355S, DOI 10.3945/jn.109.119776; Setchell KDR, 2010, J NUTR, V140, p1363S, DOI 10.3945/jn.109.119784; Shannon-Weaver, 1963, MATH THEOR COMM; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Tousen Y, 2012, J NUTR SCI, V1, DOI 10.1017/jns.2012.14; Tousen Y, 2011, METABOLISM, V60, P1425, DOI 10.1016/j.metabol.2011.02.009; Ueno T., 2002, ANN NUTR METAB, V45, P114; Wang XL, 2007, ARCH MICROBIOL, V187, P155, DOI 10.1007/s00203-006-0183-8; Wei XJ, 2011, ANIMAL, V5, P320, DOI 10.1017/S1751731110001771; XU X, 1994, J NUTR, V124, P825, DOI 10.1093/jn/124.6.825; Yu ZT, 2008, FEMS MICROBIOL LETT, V282, P73, DOI 10.1111/j.1574-6968.2008.01108.x; Zhang Xun, 2012, Weishengwu Xuebao, V52, P866; Zheng WJ, 2014, ANAEROBE, V25, P47, DOI 10.1016/j.anaerobe.2013.11.011; Zhu WY, 2003, ANAEROBE, V9, P175, DOI 10.1016/S1075-9964(03)00083-0	41	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93163	10.1371/journal.pone.0093163	http://dx.doi.org/10.1371/journal.pone.0093163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667812	Green Published, gold, Green Submitted			2022-12-27	WOS:000333675600152
J	Hart, LA; Bowker, MB; Tarboton, W; Downs, CT				Hart, Lorinda A.; Bowker, Meyrick B.; Tarboton, Warwick; Downs, Colleen T.			Species Composition, Distribution and Habitat Types of Odonata in the iSimangaliso Wetland Park, KwaZulu-Natal, South Africa and the Associated Conservation Implications	PLOS ONE			English	Article							FRESH-WATER BIODIVERSITY; DRAGONFLIES ODONATA; RED LIST; ASSEMBLAGES; INDICATORS; HOTSPOTS; TAXA	Maputaland-Pondoland-Albany, South Africa has been identified as a biodiversity hotspot and centre for endemism. Odonata make good indicators of freshwater ecosystem health. Consequently we compiled a list of Odonata species recorded to date in the iSimangaliso Wetland Park. We then detailed important species in terms of endemism, conservation status, and potential as indicator species. Finally, we compared Odonata assemblages of different sites sampled within the park to illustrate habitat importance. Species identified during two formal surveys and incidental observations made during the study period were combined with an existing database to compile an accurate and up to date species list for the iSimangaliso Wetland Park. Data from this study were then analyzed to determine which water bodies had the most similar species composition. The Dragonfly Biotic Index (DBI) value of each study area was also determined. We recorded 68 odonate species in the iSimangaliso Wetland Park, adding 13 species to the Ezemvelo KwaZulu-Natal Wildlife database for the area. This brings the total number of Odonata species for the iSimangaliso Wetland Park to 86. Eight species are red-listed, 12 are restricted in South Africa to the coastal plains of northern KwaZulu-Natal, and the remainder occurs widely across the southern African savanna. Analyses indicate that species odonate assemblages were most similar in water bodies with comparable habitats. iSimangaliso Wetland Park is identified as an important area for Odonata diversity and endemism, a trend also reflected by the DBI values. Shifts in the existing species assemblages would indicate changes within the ecosystem and thus this species account provides necessary baseline data for the area. Species Conservation efforts should thus target water bodies of varying habitat types to protect greater species diversity.	[Hart, Lorinda A.; Bowker, Meyrick B.; Tarboton, Warwick; Downs, Colleen T.] Univ KwaZulu Natal, Sch Life Sci, Pietermaritzburg, South Africa	University of Kwazulu Natal	Downs, CT (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Pietermaritzburg, South Africa.	Downs@ukzn.ac.za	Downs, Colleen T./A-7770-2010; Hart, Lorinda A/A-8391-2019	Downs, Colleen T./0000-0001-8334-1510; Hart, Lorinda/0000-0002-3942-0374				BALINSKY B. I., 1961, JOUR ENT SOC SOUTHERN AFRICA, V24, P72; Balinsky B. I., 1965, Koedoe Pretoria, Vno. 8, P95; BALINSKY B. I., 1967, J ENTOMOL SOC S AFR, V29, P3; Bried JT, 2005, SOUTHEAST NAT, V4, P731, DOI 10.1656/1528-7092(2005)004[0731:DOAOAL]2.0.CO;2; Bruton MN, 1980, STUDIES ECOLOGY MAPU, pxvii; CLARK TE, 1994, AFR ENTOMOL, V2, P61; Clausnitzer V, 2012, FRONT ECOL ENVIRON, V10, P129, DOI 10.1890/110247; Clausnitzer V, 2009, BIOL CONSERV, V142, P1864, DOI 10.1016/j.biocon.2009.03.028; Dolny A, 2011, TROP ZOOL, V24, P63; Dolny A, 2012, BIOL CONSERV, V145, P109, DOI 10.1016/j.biocon.2011.10.020; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Grant PBC, 2011, BIOL CONSERV, V144, P772, DOI 10.1016/j.biocon.2010.11.008; Harabis F, 2012, J INSECT CONSERV, V16, P121, DOI 10.1007/s10841-011-9400-0; Humphries MS, 2013, CHEMOSPHERE, V93, P1494, DOI 10.1016/j.chemosphere.2013.07.047; Kalkman VJ, 2008, HYDROBIOLOGIA, V363, P595; Kati V, 2004, CONSERV BIOL, V18, P667, DOI 10.1111/j.1523-1739.2004.00465.x; Kinvig RG, 2000, ODONATOLOGICA, V29, P195; Magoba RN, 2010, J INSECT CONSERV, V14, P627, DOI 10.1007/s10841-010-9291-5; Maud R.R., 1980, STUDIES ECOLOGY MAPU, P1; Mucina L, 2006, VEGETATION S AFRICA, P584; Oertli B, 2002, BIOL CONSERV, V104, P59, DOI 10.1016/S0006-3207(01)00154-9; PICKER M., 2002, FIELD GUIDE INSECTS; PINHEY E, 1985, J ENTOMOL SOC S AFR, V48, P1; PINHEY E, 1984, J ENTOMOL SOC S AFR, V47, P147; Samways MJ, 2006, ODONATOLOGICA, V35, P341; Samways MJ, 2007, BIODIVERS CONSERV, V16, P2575, DOI 10.1007/s10531-006-9023-z; Samways Michael J., 2010, BioRisk, V5, P73; Samways Michael J., 2008, P97; Samways MJ, 2004, S AFR J SCI, V100, P78; Simaika JP, 2013, BIOL CONSERV, V157, P245, DOI 10.1016/j.biocon.2012.08.039; Simaika JP, 2012, ORG DIVERS EVOL, V12, P251, DOI 10.1007/s13127-012-0104-4; Simaika JP, 2011, ECOL INDIC, V11, P370, DOI 10.1016/j.ecolind.2010.06.005; Simaika JP, 2009, BIODIVERS CONSERV, V18, P1171, DOI 10.1007/s10531-008-9484-3; Simaika John P., 2008, P109; Simaika JP, 2009, BIOL CONSERV, V142, P638, DOI 10.1016/j.biocon.2008.11.012; Simaika JP, 2008, THESIS STELLENDOSCH; Smith J, 2007, BIODIVERS CONSERV, V16, P2695, DOI 10.1007/s10531-006-9081-2; Steenkamp Y., 2004, HOTSPOTS REVISITED E; Stewart DAB, 1998, CONSERV BIOL, V12, P683, DOI 10.1046/j.1523-1739.1998.96465.x; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Suhling F, 2006, BIODIVERS CONSERV, V15, P311, DOI 10.1007/s10531-005-2007-6; Taylor R. H., 1995, ST LUCIA WETLAND PAR; WISSINGER S A, 1988, Journal of the North American Benthological Society, V7, P13, DOI 10.2307/1467827	43	14	17	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2014	9	3							e92588	10.1371/journal.pone.0092588	http://dx.doi.org/10.1371/journal.pone.0092588			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7QO	24662948	Green Published, Green Submitted, gold			2022-12-27	WOS:000333459900081
J	Graciotti, M; Alam, M; Solyakov, L; Schmid, R; Burley, G; Bottrill, AR; Doerig, C; Cullis, P; Tobin, AB				Graciotti, Michele; Alam, Mahmood; Solyakov, Lev; Schmid, Ralf; Burley, Glenn; Bottrill, Andrew R.; Doerig, Christian; Cullis, Paul; Tobin, Andrew B.			Malaria Protein Kinase CK2 (PfCK2) Shows Novel Mechanisms of Regulation	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; TYROSINE KINASE; FUNCTIONAL-ANALYSIS; TRYPANOSOMA-BRUCEI; GLOBAL ANALYSIS; PARASITE; PHOSPHORYLATION; KINOME; INHIBITOR; INSIGHTS	Casein kinase 2 (protein kinase CK2) is a conserved eukaryotic serine/theronine kinase with multiple substrates and roles in the regulation of cellular processes such as cellular stress, cell proliferation and apoptosis. Here we report a detailed analysis of the Plasmodium falciparum CK2, PfCK2, demonstrating that this kinase, like the mammalian orthologue, is a dual specificity kinase able to phosphorylate at both serine and tyrosine. However, unlike the human orthologue that is auto-phosphorylated on tyrosine within the activation loop, PfCK2 shows no activation loop auto-phosphorylation but rather is auto-phosphorylated at threonine 63 within subdomain I. Phosphorylation at this site in PfCK2 is shown here to regulate the intrinsic kinase activity of PfCK2. Furthermore, we generate an homology model of PfCK2 in complex with the known selective protein kinase CK2 inhibitor, quinalizarin, and in so doing identify key co-ordinating residues in the ATP binding pocket that could aid in designing selective inhibitors to PfCK2.	[Graciotti, Michele] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Alam, Mahmood; Solyakov, Lev; Tobin, Andrew B.] Univ Leicester, Med Res Council Toxicol Unit, Leicester, Leics, England; [Schmid, Ralf] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Burley, Glenn] Univ Strathclyde, Dept Pure & Appl Chem, Glasgow, Lanark, Scotland; [Bottrill, Andrew R.] Univ Leicester, Prot Nucle Acid Chem Lab, Leicester, Leics, England; [Doerig, Christian] Monash Univ, Sch Biomed Sci, Dept Microbiol, Clayton, Vic, Australia; [Cullis, Paul] Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England	University of Leicester; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Leicester; University of Leicester; University of Strathclyde; University of Leicester; Monash University; University of Leicester	Tobin, AB (corresponding author), Univ Leicester, Med Res Council Toxicol Unit, Leicester, Leics, England.	tba@le.ac.uk	Doerig, Christian/Q-9900-2019; Burley, Glenn/AAV-8541-2021; Bottrill, Andrew/ABD-1459-2021; Alam, Mahmood/GQQ-9664-2022; Schmid, Ralf/E-6722-2011; Schmid, Ralf/ABE-1065-2020; Bottrill, Andrew/C-6367-2013; Cullis, Paul/B-1151-2016	Bottrill, Andrew/0000-0002-5182-3643; Schmid, Ralf/0000-0002-0203-4023; Schmid, Ralf/0000-0002-0203-4023; Bottrill, Andrew/0000-0002-5182-3643; Doerig, Christian/0000-0002-3188-094X; Burley, Glenn/0000-0002-4896-113X; Cullis, Paul/0000-0003-3583-0162; Alam, Mahmood M/0000-0003-2148-4887	MRC; University of Leicester; MRC [G1100712, MC_UP_A600_1110] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1653478] Funding Source: researchfish; Medical Research Council [MC_UP_A600_1110, G1100712] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Leicester; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Sources of funding: MRC and University of Leicester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KA, 2005, ANTI-CANCER DRUG, V16, P1037, DOI 10.1097/00001813-200511000-00001; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cozza G, 2009, BIOCHEM J, V421, P387, DOI 10.1042/BJ20090069; Dastidar EG, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-5; Doerig C, 2010, BBA-PROTEINS PROTEOM, V1804, P604, DOI 10.1016/j.bbapap.2009.10.009; Donella-Deana A, 2001, BIOCHEM J, V357, P563, DOI 10.1042/0264-6021:3570563; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gazarini ML, 2003, BRAZ J MED BIOL RES, V36, P1465, DOI 10.1590/S0100-879X2003001100003; Holland Z, 2009, EUKARYOT CELL, V8, P388, DOI 10.1128/EC.00334-08; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; Lasonder E, 2012, J PROTEOME RES, V11, P5323, DOI 10.1021/pr300557m; Lasonder E, 2012, MICROBES INFECT, V14, P811, DOI 10.1016/j.micinf.2012.04.008; Leroy D, 2008, TRENDS PHARMACOL SCI, V29, P241, DOI 10.1016/j.tips.2008.02.005; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Lochhead PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.254pe4; Low HY, 2012, CELL MOL LIFE SCI, V69, P1523, DOI 10.1007/s00018-011-0888-y; Lucet IS, 2012, FUTURE MED CHEM, V4, P2295, DOI [10.4155/FMC.12.183, 10.4155/fmc.12.183]; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Manning G, 2008, P NATL ACAD SCI USA, V105, P9674, DOI 10.1073/pnas.0801314105; Manning G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r66; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Mishra Neerad C., 1999, Indian Journal of Experimental Biology, V37, P418; Nett IRE, 2009, MOL CELL PROTEOMICS, V8, P1527, DOI 10.1074/mcp.M800556-MCP200; Niefind K, 2001, EMBO J, V20, P5320, DOI 10.1093/emboj/20.19.5320; Pagano MA, 2004, J MED CHEM, V47, P6239, DOI 10.1021/jm049854a; Pantaleo A, 2010, PROTEOMICS, V10, P3469, DOI 10.1002/pmic.201000269; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; PARSONS M, 1993, P NATL ACAD SCI USA, V90, P2656, DOI 10.1073/pnas.90.7.2656; Pease BN, 2013, J PROTEOME RES, V12, P4028, DOI 10.1021/pr400394g; Peixoto L, 2010, CELL HOST MICROBE, V8, P208, DOI 10.1016/j.chom.2010.07.004; Pierre F, 2011, MOL CELL BIOCHEM, V356, P37, DOI 10.1007/s11010-011-0956-5; Sarno S, 2003, BIOCHEM J, V374, P639, DOI 10.1042/BJ20030674; Shiu SH, 2004, MOL BIOL EVOL, V21, P828, DOI 10.1093/molbev/msh077; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Talevich E, 2012, PHILOS T R SOC B, V367, P2607, DOI 10.1098/rstb.2012.0014; Tewari R, 2010, CELL HOST MICROBE, V8, P377, DOI 10.1016/j.chom.2010.09.006; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	44	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e85391	10.1371/journal.pone.0085391	http://dx.doi.org/10.1371/journal.pone.0085391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658579	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300001
J	Zhang, P; Guan, P; Bai, XL; Song, ZP				Zhang, Pen; Guan, Ping; Bai, Xiao-Lu; Song, Zhi-Ping			New Aspects of HERG K+ Channel Function Depending upon Cardiac Spatial Heterogeneity	PLOS ONE			English	Article							RECTIFIER POTASSIUM CURRENTS; I-KR; OUTWARD CURRENT; TRANSIENT; REPOLARIZATION; IMPAIRMENT; DEPENDENCE; ARRHYTHMIA; MYOCYTES; CELLS	HERG K+ channel, the genetic counterpart of rapid delayed rectifier K+ current in cardiac cells, is responsible for many cases of inherited and drug-induced long QT syndromes. HERG has unusual biophysical properties distinct from those of other K+ channels. While the conventional pulse protocols in patch-clamp studies have helped us elucidate these properties, their limitations in assessing HERG function have also been progressively noticed. We employed AP-clamp techniques using physiological action potential waveforms recorded from various regions of canine heart to study HERG function in HEK293 cells and identified several novel aspects of HERG function. We showed that under AP-clamp IHERG increased gradually with membrane repolarization, peaked at potentials around 20-30 mV more negative than revealed by pulse protocols and at action potential duration (APD) to 60%-70% full repolarization, and fell rapidly at the terminal phase of repolarization. We found that the rising phase of IHERG was conferred by removal of inactivation and the decaying phase resulted from a fall in driving force, which were all determined by the rate of membrane repolarization. We identified regional heterogeneity and transmural gradient of IHERG when quantified with the area covered by IHERG trace. In addition, we observed regional and transmural differences of IHERG in response to dofetilide blockade. Finally, we characterized the influence of HERG function by selective inhibition of other ion currents. Based on our results, we conclude that the distinct biophysical properties of HERG reported by AP-clamp confer its unique function in cardiac repolarization thereby in antiarrhythmia and arrhythmogenesis.	[Zhang, Pen; Guan, Ping; Bai, Xiao-Lu; Song, Zhi-Ping] Minhang Cent Hosp, Dept Cardiol, Shanghai, Peoples R China		Song, ZP (corresponding author), Minhang Cent Hosp, Dept Cardiol, Shanghai, Peoples R China.	zpsong.dcmch@sina.com						Anson BD, 2004, AM J PHYSIOL-HEART C, V286, pH2434, DOI 10.1152/ajpheart.00891.2003; Antzelevitch C, 2001, BASIC RES CARDIOL, V96, P517, DOI 10.1007/s003950170002; Berecki G, 2005, BIOPHYS J, V88, P566, DOI 10.1529/biophysj.104.047290; BOYDEN PA, 1995, CARDIOVASC RES, V29, P312, DOI 10.1016/S0008-6363(96)88586-5; Carmeliet E, 1999, PHYSIOL REV, V79, P917, DOI 10.1152/physrev.1999.79.3.917; Corr PB, 1995, CARDIAC ELECTROPHYSI, P182; Di Diego JM, 2003, CIRCULATION, V108, P1027, DOI 10.1161/01.CIR.0000085066.05180.40; Gintant GA, 2000, AM J PHYSIOL-HEART C, V278, pH806, DOI 10.1152/ajpheart.2000.278.3.H806; Goldhaber, 1998, J Cardiovasc Pharmacol Ther, V3, P37, DOI 10.1177/107424849800300105; Hancox JC, 1998, PFLUG ARCH EUR J PHY, V436, P843, DOI 10.1007/s004240050713; Hua F, 2004, AM J PHYSIOL-HEART C, V286, pH2342, DOI 10.1152/ajpheart.00793.2003; Hua F, 2004, CIRC RES, V94, P810, DOI 10.1161/01.RES.0000121102.24277.89; LITOVSKY SH, 1989, J AM COLL CARDIOL, V14, P1053, DOI 10.1016/0735-1097(89)90490-7; LIU DW, 1995, CIRC RES, V76, P351, DOI 10.1161/01.RES.76.3.351; Lu Y, 2003, J PHYSIOL-LONDON, V551, P253, DOI 10.1113/jphysiol.2003.046045; Marban E, 2002, NATURE, V415, P213, DOI 10.1038/415213a; Priebe L, 1998, CIRC RES, V82, P1206, DOI 10.1161/01.RES.82.11.1206; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; SICOURI S, 1991, CIRC RES, V68, P1729, DOI 10.1161/01.RES.68.6.1729; Taglialatela M, 1998, BIOCHEM PHARMACOL, V55, P1741, DOI 10.1016/S0006-2952(98)00002-1; Tsuji Y, 2000, CARDIOVASC RES, V48, P300, DOI 10.1016/S0008-6363(00)00180-2; Wang HZ, 2000, CIRCULATION, V102, P1165, DOI 10.1161/01.CIR.102.10.1165; Wang JX, 2004, J BIOL CHEM, V279, P13289, DOI 10.1074/jbc.C400025200; Wang JX, 2001, CIRCULATION, V104, P2645, DOI 10.1161/hc4701.100513; WANG ZG, 1993, CIRC RES, V73, P1061, DOI 10.1161/01.RES.73.6.1061; WANG ZG, 1993, CIRC RES, V73, P276, DOI 10.1161/01.RES.73.2.276; Yue LX, 1999, CIRC RES, V84, P776; Yue LX, 2000, CARDIOVASC RES, V46, P151, DOI 10.1016/S0008-6363(99)00430-7; Zhang YQ, 2003, J BIOL CHEM, V278, P10417, DOI 10.1074/jbc.M211044200; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	31	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e72181	10.1371/journal.pone.0072181	http://dx.doi.org/10.1371/journal.pone.0072181			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475014	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300001
J	Jeon, SJ; Oh, M; Yeo, WS; Galvao, KN; Jeong, KC				Jeon, Soo Jin; Oh, Manhwan; Yeo, Won-Sik; Galvao, Klibs N.; Jeong, Kwang Cheol			Underlying Mechanism of Antimicrobial Activity of Chitosan Microparticles and Implications for the Treatment of Infectious Diseases	PLOS ONE			English	Article							ESCHERICHIA-COLI; OUTER-MEMBRANE; ANTIBACTERIAL ACTIVITY; CELL-MEMBRANE; DAIRY-COWS; NANOPARTICLES; PROTEIN; PATHOGENS; TRANSPORT; CEFTIOFUR	The emergence of antibiotic resistant microorganisms is a great public health concern and has triggered an urgent need to develop alternative antibiotics. Chitosan microparticles (CM), derived from chitosan, have been shown to reduce E. coli O157:H7 shedding in a cattle model, indicating potential use as an alternative antimicrobial agent. However, the underlying mechanism of CM on reducing the shedding of this pathogen remains unclear. To understand the mode of action, we studied molecular mechanisms of antimicrobial activity of CM using in vitro and in vivo methods. We report that CM are an effective bactericidal agent with capability to disrupt cell membranes. Binding assays and genetic studies with an ompA mutant strain demonstrated that outer membrane protein OmpA of E. coli O157:H7 is critical for CM binding, and this binding activity is coupled with a bactericidal effect of CM. This activity was also demonstrated in an animal model using cows with uterine diseases. CM treatment effectively reduced shedding of intrauterine pathogenic E. coli (IUPEC) in the uterus compared to antibiotic treatment. Since Shiga-toxins encoded in the genome of bacteriophage is often overexpressed during antibiotic treatment, antibiotic therapy is generally not recommended because of high risk of hemolytic uremic syndrome. However, CM treatment did not induce bacteriophage or Shiga-toxins in E. coli O157:H7; suggesting that CM can be a potential candidate to treat infections caused by this pathogen. This work establishes an underlying mechanism whereby CM exert antimicrobial activity in vitro and in vivo, providing significant insight for the treatment of diseases caused by a broad spectrum of pathogens including antibiotic resistant microorganisms.	[Jeon, Soo Jin; Oh, Manhwan; Yeo, Won-Sik; Jeong, Kwang Cheol] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA; [Jeon, Soo Jin; Oh, Manhwan; Yeo, Won-Sik; Jeong, Kwang Cheol] Univ Florida, Inst Food & Agr Sci, Dept Anim Sci, Gainesville, FL 32611 USA; [Galvao, Klibs N.] Univ Florida, Coll Vet Med, Dept Large Anim Clin Sci, Gainesville, FL 32610 USA; [Galvao, Klibs N.] Univ Florida, DH Barron Reprod & Perinatal Biol Res Program, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Jeong, KC (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.	kcjeong@ufl.edu		Lee, Inhee/0000-0001-5723-9678; Jeon, Soo Jin/0000-0001-7473-3184	USDA-AFRI Grants program (Nanotechnology for Agricultural and Food Systems) [2014-67021-21597]; Milk Check-Off grants [F003431]; USDA-NIFA-CRIS program [FLA-VME-005176]	USDA-AFRI Grants program (Nanotechnology for Agricultural and Food Systems); Milk Check-Off grants; USDA-NIFA-CRIS program	This work was supported by USDA-AFRI Grants program (Nanotechnology for Agricultural and Food Systems, 2014-67021-21597) to KCJ. This work was also supported in part by Milk Check-Off grants (F003431) and USDA-NIFA-CRIS program (FLA-VME-005176) to KNG and KCJ. The funders had not role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung YC, 2003, BIORESOURCE TECHNOL, V88, P179, DOI 10.1016/S0960-8524(03)00002-6; DARMADJI P, 1994, MEAT SCI, V38, P243, DOI 10.1016/0309-1740(94)90114-7; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davydova VN, 2008, BIOPHYS CHEM, V136, P1, DOI 10.1016/j.bpc.2008.03.006; Dundas S, 2001, CLIN INFECT DIS, V33, P923, DOI 10.1086/322598; Galvao KN, 2009, J DAIRY SCI, V92, P1532, DOI 10.3168/jds.2008-1615; Grif K, 1998, EUR J CLIN MICROBIOL, V17, P761, DOI 10.1007/s100960050181; Helander IM, 2001, INT J FOOD MICROBIOL, V71, P235, DOI 10.1016/S0168-1605(01)00609-2; Jeong KC, 2011, APPL ENVIRON MICROB, V77, P2611, DOI 10.1128/AEM.02587-10; Karmali MA, 2004, MOL BIOTECHNOL, V26, P117, DOI 10.1385/MB:26:2:117; KILLMANN H, 1993, EMBO J, V12, P3007, DOI 10.1002/j.1460-2075.1993.tb05969.x; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; KLEBBA PE, 1994, EMBO J, V13, P4670, DOI 10.1002/j.1460-2075.1994.tb06790.x; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Koebnik R, 1999, J BACTERIOL, V181, P3688, DOI 10.1128/JB.181.12.3688-3694.1999; Kong M, 2010, INT J FOOD MICROBIOL, V144, P51, DOI 10.1016/j.ijfoodmicro.2010.09.012; Liu H, 2004, INT J FOOD MICROBIOL, V95, P147, DOI 10.1016/j.ijfoodmicro.2004.01.022; Lopez-Leon T, 2005, J COLLOID INTERF SCI, V283, P344, DOI 10.1016/j.jcis.2004.08.186; Mahae N., 2011, International Food Research Journal, V18, P1543; McDougall S, 2007, ANIM REPROD SCI, V99, P9, DOI 10.1016/j.anireprosci.2006.03.017; McLaughlin CL, 2012, J DAIRY SCI, V95, P4363, DOI 10.3168/jds.2011-5111; Ozenc E, 2010, J ANIM VET ADV, V9, P3000, DOI 10.3923/javaa.2010.3000.3004; PAPINEAU AM, 1991, FOOD BIOTECHNOL, V5, P45, DOI 10.1080/08905439109549790; Park D, 2013, APPL ENVIRON MICROB, V79, P1563, DOI 10.1128/AEM.03158-12; Pascal TA, 2010, J BIOL CHEM, V285, P37753, DOI 10.1074/jbc.M110.122804; Pautsch A, 2000, J MOL BIOL, V298, P273, DOI 10.1006/jmbi.2000.3671; Prasadarao NV, 2003, INFECT IMMUN, V71, P1680, DOI 10.1128/IAI.71.4.1680-1688.2003; Prasadarao NV, 2002, INFECT IMMUN, V70, P6513, DOI 10.1128/IAI.70.11.6513.2002; Qi LF, 2004, CARBOHYD RES, V339, P2693, DOI 10.1016/j.carres.2004.09.007; Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; ROWE PM, 1993, LANCET, V342, P110, DOI 10.1016/0140-6736(93)91308-9; Serna A, 2008, CURR OPIN GASTROEN, V24, P38, DOI 10.1097/MOG.0b013e3282f2dfb8; Shahidi F, 1999, TRENDS FOOD SCI TECH, V10, P37, DOI 10.1016/S0924-2244(99)00017-5; Sheldon IM, 2009, BIOL REPROD, V81, P1025, DOI 10.1095/biolreprod.109.077370; Sheldon IM, 2006, THERIOGENOLOGY, V65, P1516, DOI 10.1016/j.theriogenology.2005.08.021; Shu XZ, 2001, J MICROENCAPSUL, V18, P237; Stoll BJ, 2002, NEW ENGL J MED, V347, P240, DOI 10.1056/NEJMoa012657; SUDARSHAN NR, 1992, FOOD BIOTECHNOL, V6, P257, DOI 10.1080/08905439209549838; US Food and Drug Administration, 2012, SHRIMP DER CHIT GRAS; van der Lubben IM, 2001, BIOMATERIALS, V22, P687, DOI 10.1016/S0142-9612(00)00231-3; Xing K, 2009, INT J FOOD MICROBIOL, V132, P127, DOI 10.1016/j.ijfoodmicro.2009.04.013; Yoh M, 1997, EPIDEMIOL INFECT, V119, P101, DOI 10.1017/S0950268897007541	43	127	129	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92723	10.1371/journal.pone.0092723	http://dx.doi.org/10.1371/journal.pone.0092723			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	26778895	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300121
J	Huang, YL; Chen, HW; Han, BC; Liu, CW; Chuang, HC; Lin, LY; Chuang, KJ				Huang, Ya-Li; Chen, Hua-Wei; Han, Bor-Cheng; Liu, Chien-Wei; Chuang, Hsiao-Chi; Lin, Lian-Yu; Chuang, Kai-Jen			Personal Exposure to Household Particulate Matter, Household Activities and Heart Rate Variability among Housewives	PLOS ONE			English	Article							AIR-POLLUTION; ENVIRONMENTAL EXPOSURE; DISEASE; ASSOCIATION; INFLAMMATION; PARTICLES; WORKERS; SMOKE; PM2.5; RISK	Background: The association between indoor air pollution and heart rate variability (HRV) has been well-documented. Little is known about effects of household activities on indoor air quality and HRV alteration. To investigate changes in HRV associated with changes in personal exposure to household particulate matter (PM) and household activities. Methods: We performed 24-h continuous monitoring of electrocardiography and measured household PM exposure among 50 housewives. The outcome variables were log(10)-transformed standard deviation of normal-to-normal (NN) intervals (SDNN) and the square root of the mean of the sum of the squares of differences between adjacent NN intervals (r-MSSD). ,Household PM was measured as the mass concentration of PM with an aerodynamic diameter <2.5 mu m (PM2.5). We used mixed-effects models to examine the association between household PM2.5 exposure and log(10)-transformed HRV indices. Results: After controlling for potential confounders, an interquartile range change in household PM2.5 with 1- to 4-h mean was associated with 1.25-4.31% decreases in SDNN and 0.12-3.71% decreases in r-MSSD. Stir-frying, cleaning with detergent and burning incense may increase household PM2.5 concentrations and modify the effects of household PM2.5 on HRV indices among housewives. Conclusions: Indoor PM2.5 exposures were associated with decreased SDNN and r-MSSD among housewives, especially during stir-frying, cleaning with detergent and burning incense.	[Huang, Ya-Li; Chuang, Kai-Jen] Taipei Med Univ, Coll Med, Sch Med, Dept Publ Hlth, Taipei, Taiwan; [Huang, Ya-Li; Han, Bor-Cheng; Chuang, Kai-Jen] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Publ Hlth, Taipei, Taiwan; [Chen, Hua-Wei] St Marys Jr Coll Med Nursing & Management, Dept Cosmet Applicat & Management, Yilan, Taiwan; [Liu, Chien-Wei] St Marys Jr Coll Med Nursing & Management, Dept Informat Management, Yilan, Taiwan; [Chuang, Hsiao-Chi] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Chuang, Hsiao-Chi] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan; [Lin, Lian-Yu] Natl Taiwan Univ Hosp, Dept Internal Med, Div Cardiol, Taipei 100, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; National Taiwan University; National Taiwan University Hospital	Chuang, KJ (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Publ Hlth, Taipei, Taiwan.	kjc@tmu.edu.tw	Chuang, Hsiao-Chi/E-7912-2010	Chuang, Hsiao-Chi/0000-0003-4651-5192; Han, Bor-Cheng/0000-0002-8493-8199; LIN, LIAN-YU/0000-0001-7505-6429; Huang, Yan-Ping/0000-0002-3301-2847	National Science Council of Taiwan [NSC 101-2314-B-038-053-MY3, TMU101-AE1-B08]; Taipei Medical University	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University	This study was supported by grants (NSC 101-2314-B-038-053-MY3 and TMU101-AE1-B08) from the National Science Council of Taiwan and Taipei Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behera D, 2006, CANCER RES, V66, P4961; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Chan CC, 2004, ENVIRON HEALTH PERSP, V112, P1063, DOI 10.1289/ehp.6897; Chuang KJ, 2007, AM J RESP CRIT CARE, V176, P370, DOI 10.1164/rccm.200611-1627OC; Chuang KJ, 2007, J OCCUP ENVIRON MED, V49, P610, DOI 10.1097/JOM.0b013e318058205b; Chuang KJ, 2005, ENVIRON HEALTH PERSP, V113, P1693, DOI 10.1289/ehp.8145; Gold DR, 2000, CIRCULATION, V101, P1267, DOI 10.1161/01.CIR.101.11.1267; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; Lanki T, 2007, J EXPO SCI ENV EPID, V17, P124, DOI 10.1038/sj.jes.7500470; Lee GS, 2010, AUTON NEUROSCI-BASIC, V155, P94, DOI 10.1016/j.autneu.2009.12.008; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lin LY, 2012, SCI TOTAL ENVIRON, V414, P68, DOI 10.1016/j.scitotenv.2011.08.050; Lung SC, 1999, COMMUNITY AIR QUALIT; Magari SR, 2002, EPIDEMIOLOGY, V13, P305, DOI 10.1097/00001648-200205000-00011; Magari SR, 2001, CIRCULATION, V104, P986, DOI 10.1161/hc3401.095038; McCracken J, 2011, ENVIRON HEALTH PERSP, V119, P1562, DOI 10.1289/ehp.1002834; Pan CH, 2008, CANCER EPIDEM BIOMAR, V17, P3351, DOI 10.1158/1055-9965.EPI-08-0075; Polidori A, 2006, J EXPO SCI ENV EPID, V16, P321, DOI 10.1038/sj.jes.7500476; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Svendsen K, 2003, AM J IND MED, V43, P436, DOI 10.1002/ajim.10197; Syazwan AI, 2012, DRUG HEALTHC PATIENT, V4, P107, DOI 10.2147/DHPS.S33400; Tse LA, 2011, ENVIRON HEALTH PERSP, V119, P1641, DOI 10.1289/ehp.1002790; WHO-Europe, 2006, AIR QUAL GUID GLOB U	24	36	37	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89969	10.1371/journal.pone.0089969	http://dx.doi.org/10.1371/journal.pone.0089969			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24667838	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900050
J	Hu, YS; Young, AJ; Ehli, EA; Nowotny, D; Davies, PS; Droke, EA; Soundy, TJ; Davies, GE				Hu, Yueshan; Young, Alan J.; Ehli, Erik A.; Nowotny, Dustin; Davies, Paige S.; Droke, Elizabeth A.; Soundy, Timothy J.; Davies, Gareth E.			Metformin and Berberine Prevent Olanzapine-Induced Weight Gain in Rats	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MESSENGER-RNA EXPRESSION; FATTY LIVER-DISEASE; DOUBLE-BLIND; BODY-WEIGHT; INSULIN-RESISTANCE; METABOLIC SYNDROME; SCHIZOPHRENIA; CLOZAPINE; GLUCOSE	Olanzapine is a first line medication for the treatment of schizophrenia, but it is also one of the atypical antipsychotics carrying the highest risk of weight gain. Metformin was reported to produce significant attenuation of antipsychotic-induced weight gain in patients, while the study of preventing olanzapine-induced weight gain in an animal model is absent. Berberine, an herbal alkaloid, was shown in our previous studies to prevent fat accumulation in vitro and in vivo. Utilizing a well-replicated rat model of olanzapine-induced weight gain, here we demonstrated that two weeks of metformin or berberine treatment significantly prevented the olanzapine-induced weight gain and white fat accumulation. Neither metformin nor berberine treatment demonstrated a significant inhibition of olanzapine-increased food intake. But interestingly, a significant loss of brown adipose tissue caused by olanzapine treatment was prevented by the addition of metformin or berberine. Our gene expression analysis also demonstrated that the weight gain prevention efficacy of metformin or berberine treatment was associated with changes in the expression of multiple key genes controlling energy expenditure. This study not only demonstrates a significant preventive efficacy of metformin and berberine treatment on olanzapine-induced weight gain in rats, but also suggests a potential mechanism of action for preventing olanzapine-reduced energy expenditure.	[Hu, Yueshan; Ehli, Erik A.; Nowotny, Dustin; Davies, Paige S.; Davies, Gareth E.] Avera McKennan Hosp, Avera Inst Human Genet, Sioux Falls, SD 57117 USA; [Hu, Yueshan; Ehli, Erik A.; Nowotny, Dustin; Davies, Paige S.; Davies, Gareth E.] Univ Hlth Ctr, Sioux Falls, SD USA; [Hu, Yueshan; Ehli, Erik A.; Soundy, Timothy J.; Davies, Gareth E.] Univ S Dakota, Dept Psychiat, Sanford Sch Med, Sioux Falls, SD USA; [Young, Alan J.] S Dakota State Univ, Dept Vet & Biomed Sci, Coll Agr & Biol Sci, Brookings, SD 57007 USA; [Droke, Elizabeth A.] S Dakota State Univ, Dept Hlth & Nutr Sci, Coll Educ & Human Sci, Brookings, SD 57007 USA; [Davies, Gareth E.] S Dakota State Univ, Coll Pharm, Dept Pharm Practice, Brookings, SD 57007 USA	University of South Dakota; South Dakota State University; South Dakota State University; South Dakota State University	Hu, YS (corresponding author), Avera McKennan Hosp, Avera Inst Human Genet, Sioux Falls, SD 57117 USA.	Yueshan.Hu@avera.org		Xiang, Zou/0000-0003-3925-0296	Avera Research Institute	Avera Research Institute	Avera Research Institute sponsored this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaugh VL, 2006, OBESITY, V14, P36, DOI 10.1038/oby.2006.6; Blouin M, 2008, OBESITY, V16, P1780, DOI 10.1038/oby.2008.277; Boyda HN, 2014, PROG NEURO-PSYCHOPH, V48, P170, DOI 10.1016/j.pnpbp.2013.10.006; Boyda HN, 2012, J PSYCHIATR NEUROSCI, V37, P407, DOI 10.1503/jpn.110140; Case M, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-72; Chen CH, 2008, PROG NEURO-PSYCHOPH, V32, P925, DOI 10.1016/j.pnpbp.2007.11.013; Citrome L, 2011, CLIN DRUG INVEST, V31, P455, DOI 10.2165/11589060-000000000-00000; D'Agostino G, 2007, J PHARMACOL EXP THER, V322, P1137, DOI 10.1124/jpet.107.123265; De Hert MA, 2006, SCHIZOPHR RES, V83, P87, DOI 10.1016/j.schres.2005.12.855; Hert M, 2012, NAT REV ENDOCRINOL, V8, P114, DOI 10.1038/nrendo.2011.156; Dessalle K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050878; Faulkner G, 2006, CAN J PSYCHIAT, V51, P502, DOI 10.1177/070674370605100805; Fell MJ, 2007, PSYCHOPHARMACOLOGY, V194, P221, DOI 10.1007/s00213-007-0833-9; Feng S, 2012, NEUROENDOCRINOL LETT, V33, P493; Gilles M, 2010, CLIN NEUROPHARMACOL, V33, P248, DOI 10.1097/WNF.0b013e3181f0ec33; Goudie AJ, 2002, J PSYCHOPHARMACOL, V16, P291, DOI 10.1177/026988110201600402; Haupt DW, 2006, EUR NEUROPSYCHOPHARM, V16, pS149, DOI 10.1016/j.euroneuro.2006.06.003; Hu Y, 2012, PHARMACOGENOMICS J, V12, P372, DOI 10.1038/tpj.2011.24; Hu Y, 2009, PHYTOMEDICINE, V16, P864, DOI 10.1016/j.phymed.2009.03.002; Hu YS, 2012, PHYTOMEDICINE, V19, P861, DOI 10.1016/j.phymed.2012.05.009; Hu YS, 2010, PHYTOTHER RES, V24, P1831, DOI 10.1002/ptr.3204; Hu YS, 2010, FITOTERAPIA, V81, P358, DOI 10.1016/j.fitote.2009.10.010; Hu YS, 2010, FITOTERAPIA, V81, P259, DOI 10.1016/j.fitote.2009.09.012; Ikegami M, 2013, EUR J PHARM; Jarskog LF, 2007, ANNU REV MED, V58, P49, DOI 10.1146/annurev.med.58.060904.084114; Jassim G, 2012, PSYCHOPHARMACOLOGY, V219, P783, DOI 10.1007/s00213-011-2397-y; Kluge M, 2007, J CLIN PSYCHOPHARM, V27, P662, DOI 10.1097/jcp.0b013e31815a8872; Kreuzer P, 2012, NERVENARZT, V83, P630, DOI 10.1007/s00115-011-3310-y; Kudoh A, 2004, ANESTH ANALG, V98, P111, DOI 10.1213/01.ANE.0000093313.16711.5E; Kulkarni SK, 2010, PHYTOTHER RES, V24, P317, DOI 10.1002/ptr.2968; Lecomte V, 2010, MOL CELL BIOL, V30, P1182, DOI 10.1128/MCB.00690-09; Lee MS, 2011, J NUTR, V141, P1947, DOI 10.3945/jn.111.146050; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Liebig M, 2010, OBESITY, V18, P1952, DOI 10.1038/oby.2010.17; Lindenmayer JP, 2003, AM J PSYCHIAT, V160, P290, DOI 10.1176/appi.ajp.160.2.290; Maayan L, 2010, NEUROPSYCHOPHARMACOL, V35, P1520, DOI 10.1038/npp.2010.21; Makino T, 2009, BIOL PHARM BULL, V32, P1741, DOI 10.1248/bpb.32.1741; de Morentin PBM, 2012, DIABETES, V61, P807, DOI 10.2337/db11-1079; Miyamoto S, 2005, MOL PSYCHIATR, V10, P79, DOI 10.1038/sj.mp.4001556; Muench J, 2010, AM FAM PHYSICIAN, V81, P617; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Newcomer JW, 2006, CAN J PSYCHIAT, V51, P480, DOI 10.1177/070674370605100803; Newcomer JW, 2004, CLIN THER, V26, P1936, DOI 10.1016/j.clinthera.2004.12.003; Oh JE, 2012, EXP MOL MED, V44, P545, DOI 10.3858/emm.2012.44.9.062; Praharaj SK, 2011, BRIT J CLIN PHARMACO, V71, P377, DOI 10.1111/j.1365-2125.2010.03783.x; Russo GL, 2013, BIOCHEM PHARMACOL, V86, P339, DOI 10.1016/j.bcp.2013.05.023; Saddichha S, 2008, SCHIZOPHR RES, V101, P266, DOI 10.1016/j.schres.2008.01.004; Schreiner A, 2012, J CLIN PSYCHOPHARM, V32, P449, DOI 10.1097/JCP.0b013e31825cccad; Sejima E, 2011, CELL MOL NEUROBIOL, V31, P985, DOI 10.1007/s10571-011-9663-8; Shirzadi AA, 2006, HARVARD REV PSYCHIAT, V14, P152, DOI 10.1080/10673220600748486; Skrede S, 2012, INT J NEUROPSYCHOPH, V15, P163, DOI 10.1017/S1461145711001271; Smith G. C., 2011, Archives of Physiology and Biochemistry, V117, P241, DOI 10.3109/13813455.2011.576681; Stefanidis A, 2009, OBESITY, V17, P16, DOI 10.1038/oby.2008.468; Thakore JH, 2004, BRIT J PSYCHIAT, V184, pS76, DOI 10.1192/bjp.184.47.s76; Toalson Patrick, 2004, Prim Care Companion J Clin Psychiatry, V6, P152; Tschoner A, 2007, INT J CLIN PRACT, V61, P1356, DOI 10.1111/j.1742-1241.2007.01416.x; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Vuddanda PR, 2010, EXPERT OPIN INV DRUG, V19, P1297, DOI 10.1517/13543784.2010.517745; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wang YW, 2011, METABOLISM, V60, P298, DOI 10.1016/j.metabol.2010.02.005; Wu RR, 2008, AM J PSYCHIAT, V165, P352, DOI 10.1176/appi.ajp.2007.07010079; Xing LJ, 2011, EUR J PHARMACOL, V668, P467, DOI 10.1016/j.ejphar.2011.07.036; Yang QH, 2011, CHIN J INTEGR MED, V17, P205, DOI 10.1007/s11655-011-0668-4; Zhang M, 2012, MOL CELL ENDOCRINOL, V363, P122, DOI 10.1016/j.mce.2012.08.006; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040320, 10.1371/journal.pone.0042529]; Zhang YF, 2008, J CLIN ENDOCR METAB, V93, P2559, DOI 10.1210/jc.2007-2404	66	150	161	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93310	10.1371/journal.pone.0093310	http://dx.doi.org/10.1371/journal.pone.0093310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24676355	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600170
J	Wang, ST; Sun, XL; Hoshino, Y; Yu, Y; Jia, B; Sun, ZW; Sun, MZ; Duan, XB; Zhu, YM				Wang, Sun-ting; Sun, Xiao-li; Hoshino, Yoichiro; Yu, Yang; Jia, Bei; Sun, Zhong-wen; Sun, Ming-zhe; Duan, Xiang-bo; Zhu, Yan-ming			MicroRNA319 Positively Regulates Cold Tolerance by Targeting OsPCF6 and OsTCP21 in Rice (Oryza sativa L.)	PLOS ONE			English	Article							APOPLASTIC OXIDATIVE BURST; PLANT MICRORNAS; TRANSCRIPTION FACTORS; LOW-TEMPERATURE; GENE-REGULATION; SMALL RNAS; STRESS; ARABIDOPSIS; EXPRESSION; LANCEOLATE	The microRNA319 (miR319) family is conserved among diverse plant species. In rice (Oryza sativa L.), the miR319 gene family is comprised of two members, Osa-miR319a and Osa-miR319b. We found that overexpressing Osa-miR319b in rice resulted in wider leaf blades and delayed development. Here, we focused on the biological function and potential molecular mechanism of the Osa-miR319b gene in response to cold stress in rice. The expression of Osa-miR319b was down-regulated by cold stress, and the overexpression of Osa-miR319b led to an enhanced tolerance to cold stress, as evidenced by higher survival rates and proline content. Also, the expression of a handful of cold stress responsive genes, such as DREB1A/B/C, DREB2A, TPP1/2, was increased in Osa-miR319b transgenic lines. Furthermore, we demonstrated the nuclear localization of the transcription factors, OsPCF6 and OsTCP21, which may be Osa-miR319b-targeted genes. We also showed that OsPCF6 and OsTCP21 expression was largely induced by cold stress, and the degree of induction was obviously repressed in plants overexpressing Osa-miR319b. As expected, the down-regulation of OsPCF6 and OsTCP21 resulted in enhanced tolerance to cold stress, partially by modifying active oxygen scavenging. Taken together, our findings suggest that Osa-miR319b plays an important role in plant response to cold stress, maybe by targeting OsPCF6 and OsTCP21.	[Wang, Sun-ting; Sun, Xiao-li; Yu, Yang; Jia, Bei; Sun, Zhong-wen; Sun, Ming-zhe; Duan, Xiang-bo; Zhu, Yan-ming] Northeast Agr Univ, Key Lab Agr Biol Funct Genes, Harbin, Peoples R China; [Hoshino, Yoichiro] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Kita Ku, Sapporo, Hokkaido, Japan	Northeast Agricultural University - China; Hokkaido University	Zhu, YM (corresponding author), Northeast Agr Univ, Key Lab Agr Biol Funct Genes, Harbin, Peoples R China.	ymzhu2001@neau.edu.cn	han, xiao/HDN-9782-2022; Sun, Xiaoli/AAH-2265-2020; Hoshino, Yoichiro/A-5115-2012	Sun, Xiaoli/0000-0003-1134-3976; Hoshino, Yoichiro/0000-0003-3828-0696; Sun, Mingzhe/0000-0001-7557-623X	National Natural Science Foundation of China [31171578]; "863" project [2008AA10Z153]; Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program [2011TD005]; National basic scientific talent training fund projects [J1210069]; Graduate student innovation research project in Heilongjiang province [YJSCX2012-047HLJ]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "863" project(National High Technology Research and Development Program of China); Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program; National basic scientific talent training fund projects; Graduate student innovation research project in Heilongjiang province	This work was supported by the National Natural Science Foundation of China (31171578), the "863" project (2008AA10Z153), Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program (2011TD005), National basic scientific talent training fund projects (J1210069), Graduate student innovation research project in Heilongjiang province (YJSCX2012-047HLJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Andaya VC, 2003, THEOR APPL GENET, V106, P1084, DOI 10.1007/s00122-002-1126-7; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Armengaud P, 2004, PHYSIOL PLANTARUM, V120, P442, DOI 10.1111/j.0031-9317.2004.00251.x; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Ben-Gera H, 2012, PLANT SIGNAL BEHAV, V7, P1255, DOI 10.4161/psb.21550; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; Chinnusamy V, 2010, METHODS MOL BIOL, V639, P39, DOI 10.1007/978-1-60761-702-0_3; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; Efroni I, 2008, PLANT CELL, V20, P2293, DOI 10.1105/tpc.107.057521; Eldem V, 2013, TURK J AGRIC FOR, V37, P1, DOI 10.3906/tar-1206-50; Fattash I, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-13; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; GLASZMANN JC, 1990, EUPHYTICA, V45, P95; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Hsieh TH, 2002, PLANT PHYSIOL, V129, P1086, DOI 10.1104/pp.003442; Huang J, 2009, BIOCHEM BIOPH RES CO, V389, P556, DOI 10.1016/j.bbrc.2009.09.032; Jagadeeswaran G, 2009, PLANTA, V229, P1009, DOI 10.1007/s00425-009-0889-3; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Liu JP, 1997, PLANT PHYSIOL, V114, P591, DOI 10.1104/pp.114.2.591; Liu Q, 2009, FEBS LETT, V583, P723, DOI 10.1016/j.febslet.2009.01.020; Lou QJ, 2007, EUPHYTICA, V158, P87, DOI 10.1007/s10681-007-9431-5; Lv DK, 2010, GENE, V459, P39, DOI 10.1016/j.gene.2010.03.011; Ma QB, 2009, PLANT PHYSIOL, V150, P244, DOI 10.1104/pp.108.133454; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mao DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047275; Martin-Trillo M, 2010, TRENDS PLANT SCI, V15, P31, DOI 10.1016/j.tplants.2009.11.003; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Nag A, 2009, P NATL ACAD SCI USA, V106, P22534, DOI 10.1073/pnas.0908718106; Nonogaki H, 2010, PLANT CELL PHYSIOL, V51, P1840, DOI 10.1093/pcp/pcq154; Ori N, 2007, NAT GENET, V39, P787, DOI 10.1038/ng2036; Ozhuner E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059543; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Peyman S, 2010, RICE SCI, V1, P77; Phillips JR, 2007, FEBS LETT, V581, P3592, DOI 10.1016/j.febslet.2007.04.007; Saini A., 2012, MICRORNAS PLANT DEV, P219, DOI [10.1016/j.tplants.2012.01.010, DOI 10.1016/J.TPLANTS.2012.01.010]; Schommer C., 2012, SIGNAL COMMUN PLANTS, V15, P29, DOI [DOI 10.1007/978-3-642-27384-1_2, 10.1007/978-3-642-27384-1_2]; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Sharma R., 2010, J PLANT MOL BIOL BIO, V1, P24; Song SY, 2011, PLANTA, V234, P331, DOI 10.1007/s00425-011-1403-2; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Suzuki N, 2006, PHYSIOL PLANTARUM, V126, P45, DOI 10.1111/j.0031-9317.2005.00582.x; Talmor-Neiman M, 2006, PLANT J, V47, P25, DOI 10.1111/j.1365-313X.2006.02768.x; Thiebaut F, 2012, PLANT CELL ENVIRON, V35, P502, DOI 10.1111/j.1365-3040.2011.02430.x; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Ueno M, 2003, PLANT J, V36, P215, DOI 10.1046/j.1365-313X.2003.01875.x; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Warthmann N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001829; Xin Z, 2000, PLANT CELL ENVIRON, V23, P893, DOI 10.1046/j.1365-3040.2000.00611.x; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yanai O, 2011, PLANT J, V68, P571, DOI 10.1111/j.1365-313X.2011.04716.x; Yang CH, 2013, PLANT CELL ENVIRON, V36, P2207, DOI 10.1111/pce.12130; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zhao K, 2013, PLANT CELL PHYSIOL, V54, P1415, DOI 10.1093/pcp/pct087	61	208	242	8	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e91357	10.1371/journal.pone.0091357	http://dx.doi.org/10.1371/journal.pone.0091357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667308	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600005
J	Wang, S; Han, XH; Wang, JF; Yao, JR; Shi, YK				Wang, Shuai; Han, Xiaohong; Wang, Jianfei; Yao, Jiarui; Shi, Yuankai			Antitumor Effects of a Novel Chromosome Region Maintenance 1 (CRM1) Inhibitor on Non-Small Cell Lung Cancer Cells In Vitro and in Mouse Tumor Xenografts	PLOS ONE			English	Article							NUCLEAR EXPORT SIGNAL; SELECTIVE INHIBITORS; PROGNOSTIC-FACTOR; TRANSPORT; RECEPTOR; APOPTOSIS; EGFR	Background: Chromosome Region Maintenance 1 (CRM1) is a nuclear exporter and its inhibitor has anti-tumor activity in various cancers. This study assessed the therapeutic efficiency of the novel CRM1 inhibitor KPT-185 on non-small cell lung cancer (NSCLC). Methods: NSCLC cell lines were treated with KPT-185 to assess changes in cell viability, cell cycle, apoptosis, and protein expression. NOD-SCID mice carrying NSCLC cell xenografts were orally treated with KPT-276, a clinical analog of KPT-185, to examine the efficacy and side effects of KPT-276 in vivo. Results: KPT-185 significantly reduced the viability of six NSCLC cell lines in a time-and dose-dependent manner, including epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-resistant H1975 and H1650GR cell lines. In addition, KPT-185 induced these NSCLC cells to arrest at G1 phase of the cell cycle and caused apoptosis in a dose-dependent manner. KPT-185 treatment also reduced CRM1 protein levels in six NSCLC cell lines, and the reduction could be completely abolished by the proteasome inhibitor bortezomib. KPT-185 activated caspase 3, 8, and 9, but inhibited survivin expression in NSCLC cells. In a mouse H1975 cell xenograft model, tumor growth was significantly inhibited by oral KPT-276 administration, and there was no significant mouse body weight loss or other side effects. Conclusions: The current study demonstrated the anti-tumor effects of KPT-185 in NSCLC cells, including EGFR-TKI-resistant NSCLC cell lines. Further studies will assess anti-tumor activity of KPT-185 in a clinical trial for NSCLC patients.	[Shi, Yuankai] Chinese Acad Med Sci, Dept Med Oncol, Canc Inst Hosp, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China; Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Shi, YK (corresponding author), Chinese Acad Med Sci, Dept Med Oncol, Canc Inst Hosp, Beijing 100730, Peoples R China.	syuankai@cicams.ac.cn	han, xiao/HDN-9782-2022; Sun, Xiaoli/AAH-2265-2020; Hoshino, Yoichiro/A-5115-2012	Sun, Xiaoli/0000-0003-1134-3976; Hoshino, Yoichiro/0000-0003-3828-0696; Sun, Mingzhe/0000-0001-7557-623X				Azmi AS, 2013, GASTROENTEROLOGY, V144, P447, DOI 10.1053/j.gastro.2012.10.036; Bartholomeusz G, 2006, MOL CARCINOGEN, V45, P73, DOI 10.1002/mc.20156; Bonazzi S, 2010, J AM CHEM SOC, V132, P1432, DOI 10.1021/ja9097093; Cahir-McFarland ED, 2000, P NATL ACAD SCI USA, V97, P6055, DOI 10.1073/pnas.100119497; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Etchin J, 2013, LEUKEMIA, V27, P66, DOI 10.1038/leu.2012.219; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Keller Shannon A., 2000, Blood, V96, P2537; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Meissner T, 2004, FEBS LETT, V576, P27, DOI 10.1016/j.febslet.2004.08.056; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; Murakami N, 2002, BIOORG MED CHEM LETT, V12, P2807, DOI 10.1016/S0960-894X(02)00624-8; Mutka SC, 2009, CANCER RES, V69, P510, DOI 10.1158/0008-5472.CAN-08-0858; Newlands ES, 1996, BRIT J CANCER, V74, P648, DOI 10.1038/bjc.1996.415; Noske A, 2008, CANCER-AM CANCER SOC, V112, P1733, DOI 10.1002/cncr.23354; Noske A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-294; Phelps RM, 1996, J CELL BIOCHEM, P32; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Sakakibara K, 2011, BLOOD, V118, P3922, DOI 10.1182/blood-2011-01-333138; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Turner JG, 2012, BIOCHEM PHARMACOL, V83, P1021, DOI 10.1016/j.bcp.2011.12.016; Van Neck T, 2008, BIOORGAN MED CHEM, V16, P9487, DOI 10.1016/j.bmc.2008.09.051; Wach JY, 2010, BIOORG MED CHEM LETT, V20, P2843, DOI 10.1016/j.bmcl.2010.03.049; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Zhang KJ, 2013, EXP HEMATOL, V41, P67, DOI 10.1016/j.exphem.2012.09.002	31	208	242	8	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89848	10.1371/journal.pone.0089848	http://dx.doi.org/10.1371/journal.pone.0089848			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24667308	gold, Green Published, Green Submitted			2022-12-27	WOS:000332475500025
J	Wang, SL; Yang, H; Yu, LJ; Jin, JL; Qian, L; Zhao, H; Xu, Y; Zhu, XL				Wang, Sulei; Yang, Hui; Yu, Linjie; Jin, Jiali; Qian, Lai; Zhao, Hui; Xu, Yun; Zhu, Xiaolei			Oridonin Attenuates A beta(1-42)-Induced Neuroinflammation and Inhibits NF-kappa B Pathway	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; OXIDATIVE STRESS; IN-VITRO; PROINFLAMMATORY CYTOKINES; INFLAMMATION; ACTIVATION; HYPOTHESIS; PROTECTS; NEURONS	Neuroinflammation induced by beta-amyloid (A beta) plays a critical role in the pathogenesis of Alzheimer's disease (AD), and inhibiting A beta-induced neuroinflammation serves as a potential strategy for the treatment of AD. Oridonin (Ori), a compound of Rabdosia rubescens, has been shown to exert anti-inflammatory effects. In this study, we demonstrated that Ori inhibited glial activation and decreased the release of inflammatory cytokines in the hippocampus of A beta(1-42)-induced AD mice. In addition, Ori inhibited the NF-kappa B pathway and A beta(1-42)-induced apoptosis. Furthermore, Ori could attenuate memory deficits in A beta(1-42)-induced AD mice. In conclusion, our study demonstrated that Ori inhibited the neuroinflammation and attenuated memory deficits induced by A beta(1-42), suggesting that Ori might be a promising candidate for AD treatment.	[Wang, Sulei; Yang, Hui; Xu, Yun] Nanjing Univ Chinese Med, Nanjing Drum Tower Hosp, Clin Coll Tradit Chinese & Western Med, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Yu, Linjie; Jin, Jiali; Qian, Lai; Zhao, Hui; Xu, Yun; Zhu, Xiaolei] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Neurol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University of Chinese Medicine; Nanjing University	Xu, Y (corresponding author), Nanjing Univ Chinese Med, Nanjing Drum Tower Hosp, Clin Coll Tradit Chinese & Western Med, Dept Neurol, Nanjing, Jiangsu, Peoples R China.	xuyun20042001@aliyun.com; zhuquelee@126.com	han, xiao/HDN-9782-2022; Sun, Xiaoli/AAH-2265-2020; Hoshino, Yoichiro/A-5115-2012	Sun, Xiaoli/0000-0003-1134-3976; Hoshino, Yoichiro/0000-0003-3828-0696; Sun, Mingzhe/0000-0001-7557-623X	National Nature Science Foundation of China [81200839, 81230026, 81171085]; Natural Science Foundation [BL2012013]; Bureau of Health of the Jiangsu Province of China [LJ201101]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Bureau of Health of the Jiangsu Province of China	This study was supported by the National Nature Science Foundation of China (81200839, 81230026, and 81171085), the Natural Science Foundation (BL2012013) and the Bureau of Health (LJ201101) of the Jiangsu Province of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae S, 2014, INT J MOL MED, V33, P185, DOI 10.3892/ijmm.2013.1561; Batsch N., 2012, WORLD ALZHEIMER REPO; Boissiere F, 1997, NEUROREPORT, V8, P2849, DOI 10.1097/00001756-199709080-00009; Bu HQ, 2014, ONCOL REP, V31, P975, DOI 10.3892/or.2013.2888; Capiralla H, 2012, J NEUROCHEM, V120, P461, DOI 10.1111/j.1471-4159.2011.07594.x; Couturier J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-72; Fan H, 2013, J BIOMED RES, V27, P296, DOI 10.7555/JBR.27.20120100; Gubandru M, 2013, FOOD CHEM TOXICOL, V61, P209, DOI 10.1016/j.fct.2013.07.013; Han LJ, 2013, NEUROCHEM INT, V62, P913, DOI 10.1016/j.neuint.2013.03.003; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heneka MT, 2010, J NEURAL TRANSM, V117, P919, DOI 10.1007/s00702-010-0438-z; Huang Y, 2005, NEUROSCI LETT, V373, P115, DOI 10.1016/j.neulet.2004.09.074; Jaturapatporn D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006378.pub2; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kim HG, 2014, NEUROTOXICOLOGY, V40, P23, DOI 10.1016/j.neuro.2013.10.004; Ku CM, 2013, FOOD CHEM, V141, P1104, DOI 10.1016/j.foodchem.2013.04.044; Kurt MA, 1997, NEUROSCI LETT, V239, P41, DOI 10.1016/S0304-3940(97)00876-8; Lawrence T, 2010, INT J BIOCHEM CELL B, V42, P519, DOI 10.1016/j.biocel.2009.12.016; Leung CH, 2005, MOL PHARMACOL, V68, P286, DOI 10.1124/mol.105.012765; Llano DA, 2012, ALZ DIS ASSOC DIS, V26, P322, DOI 10.1097/WAD.0b013e31823b2728; Lyman M, 2014, NEUROSCI RES, V79, P1, DOI 10.1016/j.neures.2013.10.004; McGeer PL, 2013, ACTA NEUROPATHOL, V126, P479, DOI 10.1007/s00401-013-1177-7; Meng QH, 2013, PHARMAZIE, V68, P904, DOI 10.1691/ph.2013.3571; Overmyer M, 1999, DEMENT GERIATR COGN, V10, P252, DOI 10.1159/000017128; Paris D, 2007, NEUROSCI LETT, V415, P11, DOI 10.1016/j.neulet.2006.12.029; PRICE DL, 1995, CURR OPIN NEUROL, V8, P268, DOI 10.1097/00019052-199508000-00004; Rozemuller AJM, 2012, NEURODEGENER DIS, V10, P301, DOI 10.1159/000335380; Thangavel R, 2012, NEUROPATH APPL NEURO, V38, P572, DOI 10.1111/j.1365-2990.2011.01232.x; Valerio A, 2006, EUR J NEUROSCI, V23, P1711, DOI 10.1111/j.1460-9568.2006.04722.x; Wang C, 2011, NEUROSCI LETT, V491, P127, DOI 10.1016/j.neulet.2011.01.022; Wu J, 2011, BIOCHEM BIOPH RES CO, V408, P382, DOI 10.1016/j.bbrc.2011.04.013; Xu Y, 2009, INT IMMUNOPHARMACOL, V9, P360, DOI 10.1016/j.intimp.2009.01.002; Zhang J, 2013, BEHAV BRAIN RES, V244, P70, DOI 10.1016/j.bbr.2013.01.037; Zhang YY, 2013, CLIN INTERV AGING, V8, DOI 10.2147/CIA.S40405; Zhao H, 2013, CNS NEUROSCI THER, V19, P117, DOI 10.1111/cns.12043; Zhu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035823	37	208	242	8	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104745	10.1371/journal.pone.0104745	http://dx.doi.org/10.1371/journal.pone.0104745			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	24667308	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000058
J	Hu, Y; Zhu, Q; Tang, LL				Hu, Yu; Zhu, Qin; Tang, Lili			MiR-99a Antitumor Activity in Human Breast Cancer Cells through Targeting of mTOR Expression	PLOS ONE			English	Article							DOWN-REGULATION; HEPATOCELLULAR-CARCINOMA; LUNG-CANCER; S6 KINASE; MICRORNA; PATHWAY; GROWTH; AKT; TRANSLATION; APOPTOSIS	MicroRNAs (miRNAs) play an important role in human tumorigenesis as oncogenes or tumor suppressors. miR-99a has been reported as a tumor suppressor gene in various cancers in humans. However, only limited information about the function of miR-99a in human breast cancers is available. Here we investigated the expression of miR-99a in breast cancer tissue specimens and its antitumor activity in breast cancer cells. We initially identified that the expression of miR-99a was significantly reduced in four breast cancer cell lines. More importantly, we found downregulation of miR-99a in breast cancer specimens from ten different patients. We then analyzed the mechanism of miR-99a in inhibiting tumorigenesis. Cell-based assays that showed overexpression of miR-99a not only reduced breast cancer cell viability by inducing accumulation of cells at sub-G1 phase and cell apoptosis, but also inhibited tumorigenicity in vivo. As a critical miR-99a target, we have shown that the function of mammalian target of rapamycin (mTOR) was greatly inhibited by miR-99a-based Luciferase report assay; overexpression of miR-99a reduced the expression of mTOR and its downstream phosphorylated proteins (p-4E-BP1 and p-S6K1). Similar to restoring miR-99a expression, mTOR downregulation suppressed cell viability and increased cell apoptosis, whereas restoration of mTOR expression significantly reversed the inhibitory effects of miR-99a on the mTOR/p-4E-BP1/p-S6K1 signal pathway and the miR-99a antitumor activity. In clinical specimens and cell lines, mTOR was commonly overexpressed and its protein levels were statistically inversely correlated with miR-99a expression. Taken together, these results have demonstrated that miR-99a antitumor activity is achieved by targeting the mTOR/p-4E-BP1/p-S6K1 pathway in human breast cancer cells. This study suggests a potential therapeutic strategy to effectively control breast cancer development.	[Hu, Yu; Tang, Lili] Cent S Univ, Xiangya Hosp, Dept Breast Surg, Changsha, Hunan, Peoples R China; [Zhu, Qin] Cent S Univ, Xiangya Hosp, Dept Gen Surg, Changsha, Hunan, Peoples R China	Central South University; Central South University	Tang, LL (corresponding author), Cent S Univ, Xiangya Hosp, Dept Breast Surg, Changsha, Hunan, Peoples R China.	lilitangxy@126.com		Xiang, Zou/0000-0003-3925-0296				Bose S, 2006, MODERN PATHOL, V19, P238, DOI 10.1038/modpathol.3800525; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen ZJ, 2012, ORAL ONCOL, V48, P686, DOI 10.1016/j.oraloncology.2012.02.020; Cui L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-546; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Ekman S, 2012, J THORAC ONCOL, V7, P947, DOI 10.1097/JTO.0b013e31825581bd; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Grabinski N, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-85; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Heinonen H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-348; Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091; Jastrzebski K, 2007, GROWTH FACTORS, V25, P209, DOI 10.1080/08977190701779101; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Kajstura M, 2007, CYTOM PART A, V71A, P125, DOI 10.1002/cyto.a.20357; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kremer CL, 2006, PROSTATE, V66, P1203, DOI 10.1002/pros.20410; Li D, 2011, J BIOL CHEM, V286, P36677, DOI 10.1074/jbc.M111.270561; Li M, 2012, ONCOL LETT, V4, P1213, DOI 10.3892/ol.2012.930; Li XH, 2011, MOL CANCER RES, V9, P824, DOI 10.1158/1541-7786.MCR-10-0529; Lin HJ, 2005, BRIT J CANCER, V93, P1372, DOI 10.1038/sj.bjc.6602862; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Martelli AM, 2009, EXPERT OPIN INV DRUG, V18, P1333, DOI 10.1517/14728220903136775; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Mueller AC, 2013, ONCOGENE, V32, P1164, DOI 10.1038/onc.2012.131; Nagayama K, 2007, GENE CHROMOSOME CANC, V46, P1000, DOI 10.1002/gcc.20485; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Noh WC, 2004, CLIN CANCER RES, V10, P1013, DOI 10.1158/1078-0432.CCR-03-0043; Oberg AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020465; Oneyama C, 2011, ONCOGENE, V30, P3489, DOI 10.1038/onc.2011.63; Radimerski T, 2002, NAT CELL BIOL, V4, P251, DOI 10.1038/ncb763; Rojo F, 2007, CLIN CANCER RES, V13, P81, DOI 10.1158/1078-0432.CCR-06-1560; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Soni A, 2008, MOL CANCER THER, V7, P1782, DOI 10.1158/1535-7163.MCT-07-2357; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Sun J, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0411-9; TELFORD WG, 1992, CYTOMETRY, V13, P137, DOI 10.1002/cyto.990130205; Turcatel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031032; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang BY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047053; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Zhou J, 2010, MOL MED REP, V3, P387, DOI 10.3892/mmr_00000269	45	150	161	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92099	10.1371/journal.pone.0092099	http://dx.doi.org/10.1371/journal.pone.0092099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24676355	Green Submitted, gold, Green Published			2022-12-27	WOS:000333254100111
J	Liu, N; Lin, ZF; Guan, LL; Gaughan, G; Lin, GZ				Liu, Nan; Lin, Zhifang; Guan, Lanlan; Gaughan, Gerald; Lin, Guizhu			Antioxidant Enzymes Regulate Reactive Oxygen Species during Pod Elongation in Pisum sativum and Brassica chinensis	PLOS ONE			English	Article							HYDROXYL RADICALS; HYDROGEN-PEROXIDE; CELL-WALL; ROOT; SUPEROXIDE; GROWTH; LEAVES; H2O2	Previous research has focused on the involvement of reactive oxygen species (ROS) in cell wall loosening and cell extension in plant vegetative growth, but few studies have investigated ROS functions specifically in plant reproductive organs. In this study, ROS levels and antioxidant enzyme activities were assessed in Pisum sativum and Brassica chinensis pods at five developmental stages. In juvenile pods, the high levels of O-2(-) and OH indicates that they had functions in cell wall loosening and cell elongation. In later developmental stages, high levels of. OH were also related to increases in cell wall thickness in lignified tissues. Throughout pod development, most of the O-2(-) was detected on plasma membranes of parenchyma cells and outer epidermis cells of the mesocarp, while most of the H2O2 was detected on plasma membranes of most cells throughout the mesocarp. This suggests that these sites are presumably the locations of ROS generation. The antioxidant enzymes superoxide dismutase (SOD), peroxidase (POD), and catalase (CAT) apparently contributed to ROS accumulation in pod wall tissues. Furthermore, specifically SOD and POD were found to be associated with pod growth through the regulation of ROS generation and transformation. Throughout pod development, O-2(-) decreases were associated with increased SOD activity, while changes in H2O2 accumulation were associated with changes in CAT and POD activities. Additionally, high POD activity may contribute to the generation of. OH in the early development of pods. It is concluded that the ROS are produced in different sites of plasma membranes with the regulation of antioxidant enzymes, and that substantial ROS generation and accumulation are evident in cell elongation and cell wall loosening in pod wall cells.	[Liu, Nan; Lin, Zhifang; Guan, Lanlan; Lin, Guizhu] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Gaughan, Gerald] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lin, ZF (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	linzhif@scbg.ac.cn	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	China Scholarship Council [201204910138]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The current study was supported by China Scholarship Council (No. 201204910138, http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher RG, 1997, PHYSIOL PLANTARUM, V100, P224, DOI 10.1034/j.1399-3054.1997.1000203.x; BARRETO JC, 1994, LIFE SCI, V56, pPL89, DOI 10.1016/0024-3205(94)00925-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carol RJ, 2006, J EXP BOT, V57, P1829, DOI 10.1093/jxb/erj201; Derbyshire P, 2007, J EXP BOT, V58, P2079, DOI 10.1093/jxb/erm074; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fry SC, 2001, BIOCHEM J, V357, P729, DOI 10.1042/0264-6021:3570729; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; GILBERT DL, 1981, OXYGEN LIVING PROCES; Hernandez JA, 2001, PLANT PHYSIOL, V127, P817, DOI 10.1104/pp.010188; Ivakov A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00439; Ivanchenko MG, 2013, ANN BOT, DOI [10.1093/aob/mct181, DOI 10.1093/A0B/MCT181]; Johnansen DA, 1940, PLANT MICROTECHNIQUE; Kranner I, 2010, J PLANT PHYSIOL, V167, P805, DOI 10.1016/j.jplph.2010.01.019; Kukavica B, 2009, PLANT CELL PHYSIOL, V50, P304, DOI 10.1093/pcp/pcn199; Li SW, 2009, ENVIRON EXP BOT, V65, P63, DOI 10.1016/j.envexpbot.2008.06.004; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Liu N, 2013, J PLANT GROWTH REGUL, V32, P83, DOI 10.1007/s00344-012-9278-4; Liu N, 2010, ECOTOX ENVIRON SAFE, V73, P1238, DOI 10.1016/j.ecoenv.2010.06.017; Muller K, 2009, PLANT PHYSIOL, V150, P1855, DOI 10.1104/pp.109.139204; Perl RT., 2002, OXIDATIVE STRESS PLA, P1; Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1122, DOI 10.1111/j.1365-3040.2004.01217.x; Barcelo AR, 2009, SIGNAL COMMUN PLANTS, P73, DOI 10.1007/978-3-642-00390-5_5; Schopfer P, 2006, BIOFACTORS, V28, P73, DOI 10.1002/biof.5520280202; Schopfer P, 2002, PLANTA, V214, P821, DOI 10.1007/s00425-001-0699-8; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; Yang XF, 2001, ANALYST, V126, P928, DOI 10.1039/b100085n; ZENG S-X, 1991, Acta Phytophysiologica Sinica, V17, P177; [张玲玲 ZHANG LingLing], 2006, [生态学报, Acta Ecologica Sinica], V26, P1330, DOI 10.1016/S1872-2032(06)60025-5	32	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87588	10.1371/journal.pone.0087588	http://dx.doi.org/10.1371/journal.pone.0087588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24671213	Green Published, gold, Green Submitted			2022-12-27	WOS:000330631800048
J	Hobbelen, PHF; Paveley, ND; van den Bosch, F				Hobbelen, Peter H. F.; Paveley, Neil D.; van den Bosch, Frank			The Emergence of Resistance to Fungicides	PLOS ONE			English	Article							STRESS-INDUCED MUTAGENESIS; MYCOSPHAERELLA-GRAMINICOLA; PESTICIDE RESISTANCE; SPRAY HETEROGENEITY; SEPTORIA-TRITICI; SELECTION; MIXTURES; PATHOGEN; MODEL; POPULATIONS	Many studies exist about the selection phase of fungicide resistance evolution, where a resistant strain is present in a pathogen population and is differentially selected for by the application of fungicides. The emergence phase of the evolution of fungicide resistance - where the resistant strain is not present in the population and has to arise through mutation and subsequently invade the population - has not been studied to date. Here, we derive a model which describes the emergence of resistance in pathogen populations of crops. There are several important examples where a single mutation, affecting binding of a fungicide with the target protein, shifts the sensitivity phenotype of the resistant strain to such an extent that it cannot be controlled effectively('qualitative' or 'single-step' resistance). The model was parameterized for this scenario for Mycosphaerella graminicola on winter wheat and used to evaluate the effect of fungicide dose rate on the time to emergence of resistance for a range of mutation probabilities, fitness costs of resistance and sensitivity levels of the resistant strain. We also evaluated the usefulness of mixing two fungicides of differing modes of action for delaying the emergence of resistance. The results suggest that it is unlikely that a resistant strain will already have emerged when a fungicide with a new mode of action is introduced. Hence, 'anti-emergence' strategies should be identified and implemented. For all simulated scenarios, the median emergence time of a resistant strain was affected little by changing the dose rate applied, within the range of doses typically used on commercial crops. Mixing a single-site acting fungicide with a multi-site acting fungicide delayed the emergence of resistance to the single-site component. Combining the findings with previous work on the selection phase will enable us to develop more efficient anti-resistance strategies.	[Hobbelen, Peter H. F.; van den Bosch, Frank] Rothamsted Res, Harpenden, Herts, England; [Paveley, Neil D.] ADAS UK Ltd, Malton, N Yorkshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	van den Bosch, F (corresponding author), Rothamsted Res, Harpenden, Herts, England.	frank.vandenbosch@rothamsted.ac.uk	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Biological and Biotechnological Research Council of the United Kingdom; Department for Environment, Food and Rural Affairs of the United Kingdom [PS2712]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Biological and Biotechnological Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs of the United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives support from the Biological and Biotechnological Research Council of the United Kingdom. Part of this research was funded by the Department for Environment, Food and Rural Affairs of the United Kingdom (project number PS2712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch CPD, 1997, J APPL ECOL, V34, P1032, DOI 10.2307/2405292; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Carnegie SF, 2008, POTATO RES, V51, P113, DOI 10.1007/s11540-008-9094-1; DOSTER MA, 1990, PHYTOPATHOLOGY, V80, P1190, DOI 10.1094/Phyto-80-1190; Eyal Z, 1999, EUR J PLANT PATHOL, V105, P629, DOI 10.1023/A:1008716812259; Fraaije BA, 2005, PHYTOPATHOLOGY, V95, P933, DOI 10.1094/PHYTO-95-0933; Fraaije BA, 2012, MOL PLANT PATHOL, V13, P263, DOI 10.1111/j.1364-3703.2011.00746.x; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Genet JL, 2006, PEST MANAG SCI, V62, P188, DOI 10.1002/ps.1146; Grabski C., 1985, BRIT CROP PROT C MON, V31, P315; Grimmer M, 2011, RESISTANCE 2011, P94; Gubbins S, 1999, P ROY SOC B-BIOL SCI, V266, P2539, DOI 10.1098/rspb.1999.0957; Hall RJ, 2007, B MATH BIOL, V69, P525, DOI 10.1007/s11538-006-9139-z; Hall RJ, 2004, B MATH BIOL, V66, P825, DOI 10.1016/j.bulm.2003.11.006; HOARE FA, 1986, PLANT PATHOL, V35, P506, DOI 10.1111/j.1365-3059.1986.tb02048.x; Hobbelen PHF, 2013, PHYTOPATHOLOGY, V103, P690, DOI 10.1094/PHYTO-06-12-0142-R; Hobbelen PHF, 2011, PHYTOPATHOLOGY, V101, P1224, DOI 10.1094/PHYTO-10-10-0290; Hobbelen PHF, 2011, PLANT PATHOL, V60, P304, DOI 10.1111/j.1365-3059.2010.02380.x; Horsten JAHM, 1979, THESIS WAGENINGEN U; HUNTER T, 1987, ANN APPL BIOL, V110, P515, DOI 10.1111/j.1744-7348.1987.tb04169.x; Iwasa Y, 2004, J THEOR BIOL, V226, P205, DOI 10.1016/j.jtbi.2003.08.014; JOSEPOVITS G, 1989, CROP PROT, V8, P106, DOI 10.1016/0261-2194(89)90084-7; Kang JM, 2006, FASEB J, V20, P2476, DOI 10.1096/fj.06-6209com; LaMondia J. A., 2001, Journal of Environmental Horticulture, V19, P51; Mavroeidi VI, 2006, PLANT PATHOL, V55, P715, DOI 10.1111/j.1365-3059.2006.01441.x; McCartney C, 2007, CROP PROT, V26, P1272, DOI 10.1016/j.cropro.2006.10.027; Metcalfe RJ, 2000, PLANT PATHOL, V49, P546, DOI 10.1046/j.1365-3059.2000.00486.x; MILGROOM MG, 1990, PHYTOPATHOLOGY, V80, P410, DOI 10.1094/Phyto-80-410; Parnell S, 2006, PHYTOPATHOLOGY, V96, P549, DOI 10.1094/PHYTO-96-0549; Parnell S, 2005, PHYTOPATHOLOGY, V95, P632, DOI 10.1094/PHYTO-95-0632; Paveley ND, 2011, HGCA WHEAT DIS MANAG; Robert C, 2008, FUNCT PLANT BIOL, V35, P997, DOI 10.1071/FP08066; SANDERS PL, 1985, PLANT DIS, V69, P939; SANOAMUANG N, 1995, MYCOL RES, V99, P677, DOI 10.1016/S0953-7562(09)80527-3; Serra MC, 2007, THEOR POPUL BIOL, V72, P167, DOI 10.1016/j.tpb.2007.01.005; Serra MC, 2006, J APPL PROBAB, V43, P296, DOI 10.1239/jap/1143936262; Shaw MW, 2000, PHYTOPATHOLOGY, V90, P333, DOI 10.1094/PHYTO.2000.90.4.333; SHAW MW, 1993, CROP PROT, V12, P120, DOI 10.1016/0261-2194(93)90138-9; Tenaillon O, 2004, TRENDS MICROBIOL, V12, P264, DOI 10.1016/j.tim.2004.04.002; Thornley JHM., 1990, PLANT CROP MODELLING; Thygesen K, 2009, EUR J PLANT PATHOL, V123, P435, DOI 10.1007/s10658-008-9381-3; Turechek WW, 2004, PLANT HLTH PROG; VALI RJ, 1992, PLANT DIS, V76, P919, DOI 10.1094/PD-76-0919; van den Bosch F, 2011, PLANT PATHOL, V60, P597, DOI 10.1111/j.1365-3059.2011.02439.x; van den Bosch F, 2008, ANNU REV PHYTOPATHOL, V46, P123, DOI 10.1146/annurev.phyto.011108.135838; WAGGONER PE, 1987, PHYTOPATHOLOGY, V77, P393; Zhang CQ, 2008, ANN APPL BIOL, V153, P205, DOI 10.1111/j.1744-7348.2008.00248.x	48	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91910	10.1371/journal.pone.0091910	http://dx.doi.org/10.1371/journal.pone.0091910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24671213	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300044
J	da Silva, VCP; Bertin, A; Blin, A; Germain, JF; Bernardi, D; Rignol, G; Botton, M; Malausa, T				Pacheco da Silva, Vitor C.; Bertin, Aline; Blin, Aurelie; Germain, Jean-Francois; Bernardi, Daniel; Rignol, Guylene; Botton, Marcos; Malausa, Thibaut			Molecular and Morphological Identification of Mealybug Species (Hemiptera: Pseudococcidae) in Brazilian Vineyards	PLOS ONE			English	Article							FERRISIA FULLAWAY HEMIPTERA; SCALE INSECTS HEMIPTERA; EXPORT GRAPE PRODUCTION; MULTIPLEX PCR; PEST; PHYLOGENY; MARKERS	Mealybugs (Hemiptera: Pseudococcidae) are pests constraining the international trade of Brazilian table grapes. They damage grapes by transmitting viruses and toxins, causing defoliation, chlorosis, and vigor losses and favoring the development of sooty mold. Difficulties in mealybug identification remain an obstacle to the adequate management of these pests. In this study, our primary aim was to identify the principal mealybug species infesting the major table grape-producing regions in Brazil, by morphological and molecular characterization. Our secondary aim was to develop a rapid identification kit based on species-specific Polymerase Chain Reactions, to facilitate the routine identification of the most common pest species. We surveyed 40 sites infested with mealybugs and identified 17 species: Dysmicoccus brevipes (Cockerell), Dysmicoccus sylvarum Williams and Granara de Willink, Dysmicoccus texensis (Tinsley), Ferrisia cristinae Kaydan and Gullan, Ferrisia meridionalis Williams, Ferrisia terani Williams and Granara de Willink, Phenacoccus baccharidis Williams, Phenacoccus parvus Morrison, Phenacoccus solenopsis Tinsley, Planococcus citri (Risso), Pseudococcus viburni (Signoret), Pseudococcus cryptus Hempel, four taxa closely related each of to Pseudococcus viburni, Pseudococcus sociabilis Hambleton, Pseudococcus maritimus (Ehrhorn) and Pseudococcus meridionalis Prado, and one specimen from the genus Pseudococcus Westwood. The PCR method developed effectively identified five mealybug species of economic interest on grape in Brazil: D. brevipes, Pl. citri, Ps. viburni, Ph. solenopsis and Planococcus ficus (Signoret). Nevertheless, it is not possible to assure that this procedure is reliable for taxa that have not been sampled already and might be very closely related to the target species.	[Pacheco da Silva, Vitor C.; Botton, Marcos] Embrapa Uva & Vinho, Bento Goncalves, Brazil; [Bertin, Aline; Bernardi, Daniel] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil; [Blin, Aurelie; Rignol, Guylene; Malausa, Thibaut] INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, F-06903 Sophia Antipolis, France; [Germain, Jean-Francois] ANSES, Lab Sante Vegetaux, Unite Entomol & Plantes Invas, Montferrier Sur Lez, France	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	Malausa, T (corresponding author), INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, BP 167, F-06903 Sophia Antipolis, France.	tmalausa@sophia.inra.fr	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	European Union [265865, 269196, 324475]; French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS) [1001001]; Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	European Union(European Commission); French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS); Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Union Seventh Framework Programme FP7-KBBE #265865 "PURE'', FP7-IRSES #269196 "IPRABIO'' and FP7-IAPP #324475 "COLBICS'' and by the French grants Agropolis Fondation (http://www.agropolis-fondation.fr/) (RTRA - Montpellier, BIOFIS project number 1001001) and 'Bibliotheque du Vivant'. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Rabou S, 2012, B ENTOMOL RES, V102, P515, DOI 10.1017/S0007485312000041; Beltra A, 2012, B ENTOMOL RES, V102, P165, DOI 10.1017/S0007485311000514; Ben-Dov Y, 2012, SCALENET DATABASE SC; Bertin S, 2010, PHYTOPARASITICA, V38, P401, DOI 10.1007/s12600-010-0109-5; Beuning LL, 1999, J ECON ENTOMOL, V92, P463, DOI 10.1093/jee/92.2.463; Camargo UA, 2011, REV BRAS FRUTIC, V33, P144, DOI 10.1590/S0100-29452011000500017; Cavalieri V, 2008, ZOOTAXA, P65, DOI 10.11646/zootaxa.1816.1.6; Charles J. G., 2006, New Zealand Plant Protection, V59, P330; Charles JG, 2011, BIOCONTROL, V56, P155, DOI 10.1007/s10526-010-9322-x; Correa L. R. B., 2005, Laranja, V26, P265; Correa MCG, 2012, B ENTOMOL RES, V102, P524, DOI 10.1017/S0007485312000053; Correa M, 2011, ZOOTAXA, P46, DOI 10.11646/zootaxa.2926.1.2; Santa-Cecilia LVC, 2009, ACTA SCI-AGRON, V31, P13, DOI 10.4025/actasciagron.v31i1.6603; Culik Mark Paul, 2007, Biota Neotrop., V7, P61, DOI 10.1590/S1676-06032007000300006; Culik MP, 2005, ZOOTAXA, P1; Daane KM, 2008, CALIF AGR, V62, P167, DOI 10.3733/ca.v062n04p167; Daane Kent M., 2012, P271; Daane KM, 2011, ENVIRON ENTOMOL, V40, P1595, DOI 10.1603/EN11075; Granara De Willink María Cristina, 2007, Rev. Soc. Entomol. Argent., V66, P29; Demontis MA, 2007, J APPL ENTOMOL, V131, P59, DOI 10.1111/j.1439-0418.2006.01126.x; Foldi Imre, 2005, Nouvelle Revue d'Entomologie, V22, P305; GARAU R, 1995, VITIS, V34, P67; Gimpel William F. Jr, 1996, Contributions on Entomology International, V2, P1; Golino D. A., 2002, California Agriculture, V56, P196, DOI 10.3733/ca.v056n06p196; Gonzalez R. H., 2004, Revista Fruticola, V25, P41; Gullan PJ, 2010, SYST ENTOMOL, V35, P329, DOI 10.1111/j.1365-3113.2009.00513.x; Gullan PJ, 2003, ANN ENTOMOL SOC AM, V96, P723, DOI 10.1603/0013-8746(2003)096[0723:ANPSOT]2.0.CO;2; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kaydan MB, 2012, ZOOTAXA, P1; Kuniyuki Hugo, 2006, Summa phytopathol., V32, P151, DOI 10.1590/S0100-54052006000200009; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; Martelli G P, 2002, Arch Virol, V147, P2039, DOI 10.1007/s007050200048; Mello LMR, 2013, VITICULTURA BRASILEI; Miller DR, 2002, P ENTOMOL SOC WASH, V104, P825; Morandi Filho WJ, 2008, ARQ I BIOL-SAO PAULO, V76, P427; Morse GE, 2006, SYST ENTOMOL, V31, P338, DOI 10.1111/j.1365-3113.2005.00316.x; Park DS, 2011, B ENTOMOL RES, V101, P429, DOI 10.1017/S0007485310000714; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Saccaggi DL, 2008, B ENTOMOL RES, V98, P27, DOI 10.1017/S000748530700538X; SANTA-CECÍLIA LENIRA V.C., 2002, Neotrop. entomol., V31, P333, DOI 10.1590/S1519-566X2002000200024; Selwyn B, 2007, J AGRAR CHANGE, V7, P526, DOI 10.1111/j.1471-0366.2007.00155.x; Selwyn B, 2010, J AGRAR CHANGE, V10, P537, DOI 10.1111/j.1471-0366.2009.00245.x; Souza B., 2008, Coffee Science, V3, P104; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Villard P, 2013, MOL ECOL RESOUR, V13, P755, DOI 10.1111/1755-0998.12116; Walton V. M., 2004, South African Journal of Enology and Viticulture, V25, P54; Walton VM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.4701; Willians DJ, 1992, MEALYBUGS CENTRAL S; Yokogawa T, 2009, GENES GENET SYST, V84, P57, DOI 10.1266/ggs.84.57	50	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103267	10.1371/journal.pone.0103267	http://dx.doi.org/10.1371/journal.pone.0103267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	24671213	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992600050
J	Ramos, JE; Pecl, GT; Moltschaniwskyj, NA; Strugnell, JM; Leon, RI; Semmens, JM				Ramos, Jorge E.; Pecl, Gretta T.; Moltschaniwskyj, Natalie A.; Strugnell, Jan M.; Leon, Rafael I.; Semmens, Jayson M.			Body Size, Growth and Life Span: Implications for the Polewards Range Shift of Octopus tetricus in South-Eastern Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMON OCTOPUS; REPRODUCTIVE-CYCLE; UPWELLING SYSTEM; VULGARIS; SQUID; EVOLUTIONARY; ECOLOGY; AGE; TEMPERATURE	Understanding the response of any species to climate change can be challenging. However, in short-lived species the faster turnover of generations may facilitate the examination of responses associated with longer-term environmental change. Octopus tetricus, a commercially important species, has undergone a recent polewards range shift in the coastal waters of south-eastern Australia, thought to be associated with the southerly extension of the warm East Australian Current. At the cooler temperatures of a polewards distribution limit, growth of a species could be slower, potentially leading to a bigger body size and resulting in a slower population turnover, affecting population viability at the extreme of the distribution. Growth rates, body size, and life span of O. tetricus were examined at the leading edge of a polewards range shift in Tasmanian waters (40 degrees S and 147 degrees E) throughout 2011. Octopus tetricus had a relatively small body size and short lifespan of approximately 11 months that, despite cooler temperatures, would allow a high rate of population turnover and may facilitate the population increase necessary for successful establishment in the new extended area of the range. Temperature, food availability and gender appear to influence growth rate. Individuals that hatched during cooler and more productive conditions, but grew during warming conditions, exhibited faster growth rates and reached smaller body sizes than individuals that hatched into warmer waters but grew during cooling conditions. This study suggests that fast growth, small body size and associated rapid population turnover may facilitate the range shift of O. tetricus into Tasmanian waters.	[Ramos, Jorge E.; Pecl, Gretta T.; Leon, Rafael I.; Semmens, Jayson M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Moltschaniwskyj, Natalie A.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia; [Strugnell, Jan M.] La Trobe Univ, Dept Genet, La Trobe Inst Mol Sci, Bundoora, Vic, Australia	University of Tasmania; University of Newcastle; La Trobe University	Ramos, JE (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	jeramos@utas.edu.au	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Consejo Nacional de Ciencia y Tecnologia of Mexico [308672]; University of Tasmania; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Consejo Nacional de Ciencia y Tecnologia of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Tasmania; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J. Ramos was awarded the scholarship 308672 by Consejo Nacional de Ciencia y Tecnologia of Mexico, a Tasmania Graduate Research scholarship from the University of Tasmania and a Bookend Lynchpin Ocean Scholarship 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amundsen PA, 2012, BIOL INVASIONS, V14, P1501, DOI 10.1007/s10530-012-0175-3; Anderson RC, 2008, MAR ECOL PROG SER, V371, P199, DOI 10.3354/meps07649; Arenas M, 2012, MOL BIOL EVOL, V29, P207, DOI 10.1093/molbev/msr187; Arkhipkin AI, 2005, MAR FRESHWATER RES, V56, P371, DOI 10.1071/MF04274; Barratt IM, 2010, ICES J MAR SCI, V67, P1452, DOI 10.1093/icesjms/fsq047; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Calosi P, 2013, INTEGR COMP BIOL, V53, P660, DOI 10.1093/icb/ict041; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Canali E, 2011, MAR ECOL PROG SER, V441, P141, DOI 10.3354/meps09399; Carrasco JF, 2006, AQUAC RES, V37, P1601, DOI 10.1111/j.1365-2109.2006.01594.x; CHEN Y, 1992, CAN J FISH AQUAT SCI, V49, P1228, DOI 10.1139/f92-138; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1105, DOI 10.1098/rstb.1996.0096; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Dia M.A., 1988, THESIS U W BRITTANY THESIS U W BRITTANY; Domain F, 2000, J MAR BIOL ASSOC UK, V80, P699, DOI 10.1017/S0025315400002526; Doubleday Z, 2006, J EXP MAR BIOL ECOL, V338, P35, DOI 10.1016/j.jembe.2006.06.027; Edgar G, 2000, AUSTR MARINE LIFE PL; Engel Katharina, 2011, Communicative & Integrative Biology, V4, P247, DOI 10.4161/cib.4.3.14885; Forsythe J.W., 1987, P135; FORSYTHE JW, 1988, MAR BIOL, V98, P369, DOI 10.1007/BF00391113; Forsythe JW, 2004, MAR FRESHWATER RES, V55, P331, DOI 10.1071/MF03146; Fox J., 2019, R COMPANION APPL REG, V.; Fulton EA, 2011, ICES J MAR SCI, V68, P1329, DOI 10.1093/icesjms/fsr032; Guzik MT, 2005, MOL PHYLOGENET EVOL, V37, P235, DOI 10.1016/j.ympev.2005.05.009; Hanlon RT, 1996, CEPHALOPOD BEHAV; Harrington JJ, 2006, FISH RES, V77, P10, DOI 10.1016/j.fishres.2005.09.003; Hermosilla CA, 2010, ICES J MAR SCI, V67, P1458, DOI 10.1093/icesjms/fsq054; Herwig JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043679; Hill KL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032912; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Holt RD, 2003, EVOL ECOL RES, V5, P159; Hoving HJT, 2013, GLOBAL CHANGE BIOL, V19, P2089, DOI 10.1111/gcb.12198; Jackson GD, 2004, MAR FRESHWATER RES, V55, P357, DOI 10.1071/MF03152; Jackson GD, 2003, MAR BIOL, V142, P925, DOI 10.1007/s00227-002-1005-4; Jackson GD, 2001, MAR ECOL PROG SER, V218, P167, DOI 10.3354/meps218167; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Katsanevakis S, 2006, ICES J MAR SCI, V63, P151, DOI 10.1016/j.icesjms.2005.07.004; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leporati SC, 2008, MAR ECOL PROG SER, V367, P213, DOI 10.3354/meps07558; Leporati SC, 2008, MAR BIOL, V155, P375, DOI 10.1007/s00227-008-1033-9; Leporati SC, 2007, MAR BIOL, V151, P1375, DOI 10.1007/s00227-006-0575-y; Lourenco S, 2012, FISH RES, V127, P116, DOI 10.1016/j.fishres.2012.04.006; Mangold K., 1983, P335; Mangold K., 1987, P157; Mather JA, 2012, CURR ZOOL, V58, P597, DOI 10.1093/czoolo/58.4.597; McMahon RF, 2002, CAN J FISH AQUAT SCI, V59, P1235, DOI 10.1139/F02-105; Moreno A, 2012, J MAR BIOL ASSOC UK, V92, P1619, DOI 10.1017/S0025315411002141; Norman M.D., 2000, GUIDE SQUID CUTTLEFI; Okei N, 1999, STOCK ENHANCEMENT AND SEA RANCHING, P468; Oosthuizen A, 2003, J MAR BIOL ASSOC UK, V83, P535, DOI 10.1017/S0025315403007458h; Otero J, 2008, MAR ECOL PROG SER, V362, P181, DOI 10.3354/meps07437; Otero J, 2007, FISH RES, V85, P122, DOI 10.1016/j.fishres.2007.01.007; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pecl GT, 2008, REV FISH BIOL FISHER, V18, P373, DOI 10.1007/s11160-007-9077-3; Pecl GT, 2004, MAR FRESHWATER RES, V55, P387, DOI 10.1071/MF03153; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; R Core Team, 2021, R LANGUAGE ENV STAT; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030392; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosas C, 2008, AQUACULTURE, V275, P291, DOI 10.1016/j.aquaculture.2008.01.015; Sandery PA, 2007, ESTUAR COAST SHELF S, V74, P684, DOI 10.1016/j.ecss.2007.05.011; Scandol J, 2008, STATUS FISHERIES RES, P193; Schwarz R, 2010, FISH RES, V106, P177, DOI 10.1016/j.fishres.2010.06.008; Semmens J, 2011, J EXP BIOL, V214, P2799, DOI 10.1242/jeb.051631; Semmens JM, 2004, MAR FRESHWATER RES, V55, P367, DOI 10.1071/MF03155; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Spiess A, 2013, QPCR MODELLING ANAL; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Tasmania Wild Fisheries Management Branch Tasmania Department of Primary Industries and Water, 2009, SACL FISH MAN PLAN R; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Villanueva R, 1995, CAN J FISH AQUAT SCI, V52, P2639, DOI 10.1139/f95-853; VILLANUEVA R, 1992, J EXP MAR BIOL ECOL, V159, P157, DOI 10.1016/0022-0981(92)90034-8; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Wolf BM, 1997, J SHELLFISH RES, V16, P533	85	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103480	10.1371/journal.pone.0103480	http://dx.doi.org/10.1371/journal.pone.0103480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	24671213	Green Accepted, Green Published, gold			2022-12-27	WOS:000339812700029
J	Wu, KL; Zeng, SJ; Lin, DI; da Silva, JAT; Bu, ZY; Zhang, JX; Duan, J				Wu, Kunlin; Zeng, Songjun; Lin, Danni; da Silva, Jaime A. Teixeira; Bu, Zhaoyang; Zhang, Jianxia; Duan, Ju			In Vitro Propagation and Reintroduction of the Endangered Renanthera imschootiana Rolfe	PLOS ONE			English	Article							ASYMBIOTIC SEED-GERMINATION; CALCIUM HYPOCHLORITE; ESTABLISHMENT; REGENERATION; GROWTH; ORCHID	Renanthera imschootiana Rolfe is an endangered tropical epiphytic orchid that is threatened with extinction due to over-collection and the loss of suitable habitats. In vitro propagation is a useful way to mass produce plants for re-establishment in the wild and for commercial propagation. Seeds collected 150 days after pollination (DAP) were the optimum stage for in vitro culture. Seed germination reached 93.1% on quarter-strength MS (i.e., MS containing a quarter of macro-and micronutrients) medium containing 0.5 mg l(-1) a-naphthaleneacetic acid (NAA), 20% coconut water (CW), 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 1.0 g l(-1) activated charcoal (AC). Quarter-strength MS medium supplemented with 1.0 mg l(-1) BA, 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 20% CW was suitable for the sub-culture of protocorm-like bodies (PLBs) in which the PLB proliferation ratio was 2.88. Quarter-strength MS medium containing 1.0 mg l(-1) NAA, 1.0 g l(-1) peptone, 100 g l(-1) banana homogenate (BH), and 1.0 g l(-1) AC was suitable for plantlet formation and 95.67% of plantlets developed from PLBs within 60 days of culture. Hyponex N016 medium supplemented with 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 20 g l(-1) sucrose, 150 g l(-1) BH, and 1.0 g l(-1) AC was suitable for the in vitro growth of plantlets about 2-cm in height. Plantlets 3-cm in height or taller were transplanted to Chilean sphagnum moss, and 95% of plantlets survived after 60 days in a greenhouse. Three hundred transplanted of seedlings 360-days old were reintroduced into three natural habitats. Highest percentage survival (79.67%) was observed in Yuanjiang Nature Reserve two years after reintroduction, followed by Huolu Mountain forest park (71.33%). This protocol is an efficient means for the large-scale propagation and in vitro and in vivo germplasm conservation of R. imschootiana.	[Wu, Kunlin; Zeng, Songjun; Lin, Danni; Zhang, Jianxia] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Duan, Ju] Chinese Acad Sci, South China Bot Garden, Key Lab S China Agr Plant Mol Anal & Gene Improve, Guangzhou, Guangdong, Peoples R China; [da Silva, Jaime A. Teixeira] Kagawa Ken, Takamatsu, Kagawa, Japan; [Bu, Zhaoyang] Guangxi Acad Agr Sci, Flower Res Inst, Nanning 150931, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Guangxi Academy of Agricultural Sciences	Zeng, SJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	zengsongjun@scib.ac.cn; yangnv@126.com	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences [211026]; Guangzhou Key Technology Research and Development Program [Y233051001]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences; Guangzhou Key Technology Research and Development Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by a fund of the Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences (No. 211026), and the Guangzhou Key Technology Research and Development Program (Y233051001). Songjun Zeng received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeroyd J., 1995, HDB BOT GARDENS REIN; [Anonymous], 2014, WORLD CHECKLIST SELE; Arditti J., 1993, MICROPROPAGATION ORC; Arditti J, 1982, ORCHID BIOL REV PERS, P352; Chu Chin-Chang, 1994, Lindleyana, V9, P153; Chugh S, 2009, SCI HORTIC-AMSTERDAM, V122, P507, DOI 10.1016/j.scienta.2009.07.016; da Silva JAT, 2006, PLANT CELL TISS ORG, V84, P135, DOI 10.1007/s11240-005-9003-0; da Silva JAT, 2005, PROPAG ORNAM PLANTS, V5, P129; DASILVA JAT, 2012, ASIAN AUSTRALASIAN J, V6, P121; DeMarie E., 1991, HORTSCIENCE, V26, P272; Dix L., 1982, PLANT CELL TISSUE OR, V12, P39; Ernst R., 1975, American Orchid Society Bulletin, V44, P12; Ernst R., 1974, American Orchid Society Bulletin, V43, P35; Goh C. J., 1982, Orchid Review, V90, P295; GOH CJ, 1990, SCI HORTIC-AMSTERDAM, V44, P315, DOI 10.1016/0304-4238(90)90132-X; HARVAIS G, 1973, CAN J BOT, V51, P327, DOI 10.1139/b73-040; Hossain MM, 2013, CRIT REV PLANT SCI, V32, P69, DOI 10.1080/07352689.2012.715984; Kauth P.J., 2008, FLORICULTURE ORNAMEN, P375; Kishor R, 2009, EUPHYTICA, V165, P247, DOI 10.1007/s10681-008-9755-9; Knudson Lewis, 1946, AMER ORCHID SOC BULL, V15, P214; Lee YI, 2006, ANN BOT-LONDON, V98, P1311, DOI 10.1093/aob/mcl222; Lin DL, 2008, J FOOD DRUG ANAL, V16, P1; Lo SF, 2004, IN VITRO CELL DEV-PL, V40, P528, DOI 10.1079/IVP2004571; McNaughton S.J., 1989, P109; Miyoshi K, 1998, PHYSIOL PLANTARUM, V102, P481, DOI 10.1034/j.1399-3054.1998.1020401.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mweetwa AM, 2008, SCI HORTIC-AMSTERDAM, V117, P257, DOI 10.1016/j.scienta.2008.03.035; NAGASHIMA T, 1982, J JPN SOC HORTIC SCI, V51, P94, DOI 10.2503/jjshs.51.94; PIERIK RLM, 1988, SCI HORTIC-AMSTERDAM, V34, P139, DOI 10.1016/0304-4238(88)90084-2; Raghavan V., 1977, CRC HDB SERIES NUTR, P361; Ren H, 2012, ORYX, V46, P391, DOI 10.1017/S0030605311000615; Rout TM, 2009, ECOL APPL, V19, P515, DOI 10.1890/07-1989.1; SEENI S, 1992, PLANT CELL TISS ORG, V29, P167, DOI 10.1007/BF00034349; Seeni S, 2000, PLANT CELL TISS ORG, V61, P1, DOI 10.1023/A:1006444614657; Teixeira da Silva J., 2013, FLORIC ORNAM BIOTECH, V7, P1, DOI DOI 10.1016/0168-1656(90)90117-T; Thomale H., 1954, ORCHIDEEN, P62; Thomas TD, 2008, BIOTECHNOL ADV, V26, P618, DOI 10.1016/j.biotechadv.2008.08.003; Tsi Z. H., 1999, FLORA REIPUBLICAE PO, V19, P291; VACIN EF, 1949, BOT GAZ, V110, P605, DOI 10.1086/335561; van der Kinderen G., 1987, LINDLEYANA, V2, P84; VANWAES JM, 1986, PHYSIOL PLANTARUM, V66, P435, DOI 10.1111/j.1399-3054.1986.tb05947.x; Vyas S, 2009, SCI HORTIC-AMSTERDAM, V121, P32, DOI 10.1016/j.scienta.2009.01.012; Wu KL, 2012, SCI HORTIC-AMSTERDAM, V135, P194, DOI 10.1016/j.scienta.2011.11.028; Wu KunLin, 2010, Acta Horticulturae Sinica, V37, P685; Wu Z.Y., 2009, FLORA CHINA, V25; YAM T W, 1990, Lindleyana, V5, P256; Yong JWH, 2009, MOLECULES, V14, P5144, DOI 10.3390/molecules14125144; Zeng SJ, 2015, CRIT REV BIOTECHNOL, V35, P279; Zeng SJ, 2011, HORTSCIENCE, V46, P460, DOI 10.21273/HORTSCI.46.3.460; Zeng SJ, 2012, SCI HORTIC-AMSTERDAM, V138, P198, DOI 10.1016/j.scienta.2012.02.026	51	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110033	10.1371/journal.pone.0110033	http://dx.doi.org/10.1371/journal.pone.0110033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	24671213	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100017
